PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Oneyama, C; Ikeda, J; Okuzaki, D; Suzuki, K; Kanou, T; Shintani, Y; Morii, E; Okumura, M; Aozasa, K; Okada, M				Oneyama, C.; Ikeda, J.; Okuzaki, D.; Suzuki, K.; Kanou, T.; Shintani, Y.; Morii, E.; Okumura, M.; Aozasa, K.; Okada, M.			MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways	ONCOGENE			English	Article						c-Src; tumor; miRNA; mTOR; FGFR3	PROTEIN-TYROSINE KINASE; HUMAN LUNG-CANCER; FACTOR RECEPTORS; FAMILY KINASES; C-SRC; V-SRC; MTOR; EXPRESSION; PHOSPHORYLATION; TRANSFORMATION	The tyrosine kinase c-Src is upregulated in various human cancers, but the molecular mechanisms underlying c-Src-mediated tumor growth remain unclear. Here we examined the involvement of microRNAs in the c-Src-mediated tumor growth. Microarray profiling revealed that c-Src activation downregulates a limited set of microRNAs, including miR-99a, which targets oncogenic mammalian target of rapamycin (mTOR) and fibroblast growth factor receptor 3 (FGFR3). Re-expression of miR-99a suppressed tumor growth of c-Src-transformed cells, and this effect was restored by the overexpression of mTOR. The downregulation of miR-99a was also observed in epidermal growth factor-and Ras-transformed cells, and it was suppressed by inhibiting the mitogen-activated protein kinase (MAPK) pathway. Furthermore, miR-99a downregulation is associated with mTOR/FGFR3 upregulation in various human lung cancer cells/tissues. The tumorigenicity of these cells was suppressed by the introduction of miR-99a. These findings suggest that the miR-99a-mTOR/FGFR3 pathway is crucial for controlling tumor growth in a wide range of human cancers that harbor upregulation of the Src-related oncogenic pathways. Oncogene (2011) 30, 3489-3501; doi:10.1038/onc.2011.63; published online 7 March 2011	[Oneyama, C.; Suzuki, K.; Kanou, T.; Okada, M.] Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Ikeda, J.; Morii, E.; Aozasa, K.] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan; [Okuzaki, D.] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, Suita, Osaka 5650871, Japan; [Kanou, T.; Shintani, Y.; Okumura, M.] Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Osaka University	Oneyama, C (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	coneyama@biken.osaka-u.ac.jp	Okumura, Mitsutaka/L-5388-2013; Okuzaki, Daisuke/AAN-5641-2020	Okumura, Mitsutaka/0000-0001-7403-1318; Okuzaki, Daisuke/0000-0002-4552-783X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Osaka University; Grants-in-Aid for Scientific Research [22689009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Drs A Imamoto, T Akagi and M Yutsudo for generous gifts of reagents. This work was supported by a Grant-in-aid for Young Scientists from the Ministry of Education, Culture, Sports, Science and Technology of Japan and The Exciting Leading-Edge Research Project at Osaka University.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hakak Y, 1999, CURR BIOL, V9, P1039, DOI 10.1016/S0960-9822(99)80453-9; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Li X, 2009, ONCOGENE, V28, P4272, DOI 10.1038/onc.2009.278; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Nagayama K, 2007, GENE CHROMOSOME CANC, V46, P1000, DOI 10.1002/gcc.20485; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Noro R, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-277; Nozawa H, 2007, CANCER LETT, V251, P105, DOI 10.1016/j.canlet.2006.11.008; OKADA M, 1991, J BIOL CHEM, V266, P24249; Oneyama C, 2008, GENES CELLS, V13, P1, DOI 10.1111/j.1365-2443.2007.01145.x; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Penuel E, 1999, MOL BIOL CELL, V10, P1693, DOI 10.1091/mbc.10.6.1693; Petroulakis E, 2006, BRIT J CANCER, V94, P195, DOI 10.1038/sj.bjc.6602902; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Trudel S, 2004, BLOOD, V103, P3521, DOI 10.1182/blood-2003-10-3650; van Rhijn BWG, 2001, CANCER RES, V61, P1265; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vojtechova M, 2008, NEOPLASIA, V10, P99, DOI 10.1593/neo.07905; Wang FZ, 2008, J VIROL, V82, P9065, DOI 10.1128/JVI.00961-08; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu Jianmin, 2011, J CANCER RES CLIN, V137, P1379, DOI [10.1007/s00432-011-0999-8, DOI 10.1007/S00432-011-0999-8, DOI 10.1007/S00432-011-0976-2]; Yamada H, 2008, GENE CHROMOSOME CANC, V47, P810, DOI 10.1002/gcc.20582; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yokota J, 2004, CANCER SCI, V95, P197, DOI 10.1111/j.1349-7006.2004.tb02203.x	49	86	90	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2011	30	32					3489	3501		10.1038/onc.2011.63	http://dx.doi.org/10.1038/onc.2011.63			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	806CR	21383697				2022-12-25	WOS:000293782300002
J	Donati, G; Bertoni, S; Brighenti, E; Vici, M; Trere, D; Volarevic, S; Montanaro, L; Derenzini, M				Donati, G.; Bertoni, S.; Brighenti, E.; Vici, M.; Trere, D.; Volarevic, S.; Montanaro, L.; Derenzini, M.			The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells	ONCOGENE			English	Article						p53 expression; rRNA transcription; ribosomal proteins; nucleolus; mammalian cells	TRANSCRIPTION FACTOR UBF; POLYMERASE-I TRANSCRIPTION; DEPENDENT REGULATION; GENE-TRANSCRIPTION; BIOGENESIS; MDM2; ACTIVATION; INHIBITION; PATHWAY; CANCER	Data on the relationship between ribosome biogenesis and p53 function indicate that the tumour suppressor can be activated by either nucleolar disruption or ribosomal protein defects. However, there is increasing evidence that the induction of p53 does not always require these severe cellular changes, and data are still lacking on a possible role of ribosome biogenesis in the downregulation of p53. Here, we studied the effect of the up-and downregulation of the rRNA transcription rate on p53 induction in mammalian cells. We found that a downregulation of rRNA synthesis, induced by silencing the POLR1A gene coding for the RNA polymerase I catalytic subunit, stabilised p53 without altering the nucleolar integrity in human cancer cells. p53 stabilisation was due to the inactivation of the MDM2-mediated p53 degradation by the binding of ribosomal proteins no longer used for ribosome building. p53 stabilisation did not occur when rRNA synthesis downregulation was associated with a contemporary reduction of protein synthesis. Furthermore, we demonstrated that in three different experimental models characterised by an upregulation of rRNA synthesis, cancer cells treated with insulin or exposed to the insulin-like growth factor 1, rat liver stimulated by cortisol and regenerating rat liver after partial hepatectomy, the p53 protein level was reduced due to a lowered ribosomal protein availability for MDM2 binding. It is worth noting that the upregulation of rRNA synthesis was responsible for a decreased p53-mediated response to cytotoxic stresses. These findings demonstrated that the balance between rRNA and ribosomal protein synthesis controls the function of p53 in mammalian cells, that p53 can be induced without the occurrence of severe changes of the cellular components controlling ribosome biogenesis, and that conditions characterised by an upregulated rRNA synthesis are associated with a reduced p53 response. Oncogene (2011) 30, 3274-3288; doi:10.1038/onc.2011.48; published online 14 March 2011	[Derenzini, M.] Univ Bologna, Dipartimento Clin Sci Radiol & Isocitopatol, I-40138 Bologna, Italy; [Donati, G.; Bertoni, S.; Brighenti, E.; Vici, M.; Trere, D.; Montanaro, L.] Univ Bologna, Dipartimento Patol Sperimentale, I-40138 Bologna, Italy; [Brighenti, E.] Univ Bologna, Ctr Interdipartimentale Ric Canc G Prodi, I-40138 Bologna, Italy; [Volarevic, S.] Univ Rijeka, Sch Med, Dept Mol Med & Biotechnol, Rijeka, Croatia	University of Bologna; University of Bologna; University of Bologna; University of Rijeka	Derenzini, M (corresponding author), Univ Bologna, Dipartimento Clin Sci Radiol & Isocitopatol, Via Massarenti 9, I-40138 Bologna, Italy.	massimo.derenzini@unibo.it	Trere', Davide/AAC-4725-2021; Montanaro, Lorenzo/I-4236-2019; Volarevic, Sinisa/O-4349-2018	Trere', Davide/0000-0003-1127-1052; Montanaro, Lorenzo/0000-0001-9776-9518; Volarevic, Sinisa/0000-0003-4893-389X; Donati, Giulio/0000-0003-0875-9233	Roberto and Cornelia Pallotti's Legacy for Cancer Research; Vanini-Cavagnino Grant; Italian Ministry of Education, University and Research (MIUR)	Roberto and Cornelia Pallotti's Legacy for Cancer Research; Vanini-Cavagnino Grant; Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Roberto and Cornelia Pallotti's Legacy for Cancer Research, the Vanini-Cavagnino Grant and the Italian Ministry of Education, University and Research (MIUR: grants for orientated fundamental research). We thank Professor U Scheer for the generous gift of the anti-ribosomal protein S14 antibody. We are indebted with Dr Maurizio Brigotti for performing polysomal fraction analysis.	Abmayr S.M., 2006, CURR PROTOC MOL BIOL; Albrecht JH, 1997, HEPATOLOGY, V25, P557, DOI 10.1002/hep.510250311; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Barkic M, 2009, MOL CELL BIOL, V29, P2489, DOI 10.1128/MCB.01588-08; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Bilanges B, 2007, MOL CELL BIOL, V27, P5746, DOI 10.1128/MCB.02136-06; Boisvert FM, 2000, J CELL BIOL, V148, P283, DOI 10.1083/jcb.148.2.283; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Burns TF, 1999, J CELL PHYSIOL, V181, P231, DOI 10.1002/(SICI)1097-4652(199911)181:2<231::AID-JCP5>3.0.CO;2-L; Caldarola S, 2004, J BIOL CHEM, V279, P13522, DOI 10.1074/jbc.M310574200; Cannata D, 2010, MT SINAI J MED, V77, P197, DOI 10.1002/msj.20167; Chan PK, 1996, CANCER LETT, V100, P191, DOI 10.1016/0304-3835(95)04100-1; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; DERENZINI M, 1981, J ULTRA MOL STRUCT R, V75, P229, DOI 10.1016/S0022-5320(81)80138-4; DERENZINI M, 1978, J ULTRA MOL STRUCT R, V62, P213, DOI 10.1016/S0022-5320(78)80018-5; DONATI G, 2010, SELECTIVE INHI UNPUB; Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; GLIBETIC M, 1993, MOL CELL ENDOCRINOL, V94, P243, DOI 10.1016/0303-7207(93)90173-H; GLIBETIC M, 1995, J BIOL CHEM, V270, P4209, DOI 10.1074/jbc.270.9.4209; Gong X, 2007, CANCER RES, V67, P5380, DOI 10.1158/0008-5472.CAN-07-0323; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Hannan KM, 1998, AM J PHYSIOL-CELL PH, V275, pC130, DOI 10.1152/ajpcell.1998.275.1.C130; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Higgins GM, 1931, ARCH PATHOL, V12, P186; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Khutornenko AA, 2010, P NATL ACAD SCI USA, V107, P12828, DOI 10.1073/pnas.0910885107; Kruger T, 2007, J CELL BIOL, V177, P573, DOI 10.1083/jcb.200612048; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; MAHAJAN PB, 1994, INT J IMMUNOPHARMACO, V16, P711, DOI 10.1016/0192-0561(94)90091-4; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Montanaro L, 2007, CELL PROLIFERAT, V40, P532, DOI 10.1111/j.1365-2184.2007.00448.x; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; NADAL C, 1995, LIVER, V15, P63; OMAHONY DJ, 1992, J BIOL CHEM, V267, P35; Panic L, 2007, CELL CYCLE, V6, P20, DOI 10.4161/cc.6.1.3666; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Renehan Andrew G., 2008, Archives of Physiology and Biochemistry, V114, P71, DOI [10.1080/13813450801954303, 10.1080/13813450801954303 ]; Renehan AG, 2006, TRENDS ENDOCRIN MET, V17, P328, DOI 10.1016/j.tem.2006.08.006; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Sax JK, 2003, CELL DEATH DIFFER, V10, P413, DOI 10.1038/sj.cdd.4401227; SIRRI V, 1995, J HISTOCHEM CYTOCHEM, V43, P887, DOI 10.1177/43.9.7642962; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; THOMPSON NL, 1986, CANCER RES, V46, P3111; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wu A, 2005, J BIOL CHEM, V280, P2863, DOI 10.1074/jbc.M406138200; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	67	68	71	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2011	30	29					3274	3288		10.1038/onc.2011.48	http://dx.doi.org/10.1038/onc.2011.48			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	795VW	21399665				2022-12-25	WOS:000293006800006
J	Lee, M; Daniels, MJ; Garnett, MJ; Venkitaraman, AR				Lee, M.; Daniels, M. J.; Garnett, M. J.; Venkitaraman, A. R.			A mitotic function for the high-mobility group protein HMG20b regulated by its interaction with the BRC repeats of the BRCA2 tumor suppressor	ONCOGENE			English	Article						HMG20b; mitosis; BRCA2; BRC repeats; cytokinesis	CANCER SUSCEPTIBILITY; DNA-BINDING; BREAST; CYTOKINESIS; GENETICS; COMPLEX; DEFICIENT; ANILLIN; MYOSIN	The inactivation of BRCA2, a suppressor of breast, ovarian and other epithelial cancers, triggers instability in chromosome structure and number, which are thought to arise from defects in DNA recombination and mitotic cell division, respectively. Human BRCA2 controls DNA recombination via eight BRC repeats, evolutionarily conserved motifs of similar to 35 residues, that interact directly with the recombinase RAD51. How BRCA2 controls mitotic cell division is debated. Several studies by different groups report that BRCA2 deficiency affects cytokinesis. Moreover, its interaction with HMG20b, a protein of uncertain function containing a promiscuous DNA-binding domain and kinesin-like coiled coils, has been implicated in the G2-M transition. We show here that HMG20b depletion by RNA interference disturbs the completion of cell division, suggesting a novel function for HMG20b. In vitro, HMG20b binds directly to the BRC repeats of BRCA2, and exhibits the highest affinity for BRC5, a motif that binds poorly to RAD51. Conversely, the BRC4 repeat binds strongly to RAD51, but not to HMG20b. In vivo, BRC5 overexpression inhibits the BRCA2-HMG20b interaction, recapitulating defects in the completion of cell division provoked by HMG20b depletion. In contrast, BRC4 inhibits the BRCA2-RAD51 interaction and the assembly of RAD51 at sites of DNA damage, but not the completion of cell division. Our findings suggest that a novel function for HMG20b in cytokinesis is regulated by its interaction with the BRC repeats of BRCA2, and separate this unexpected function for the BRC repeats from their known activity in DNA recombination. We propose that divergent tumor-suppressive pathways regulating chromosome segregation as well as chromosome structure may be governed by the conserved BRC motifs in BRCA2. Oncogene (2011) 30, 3360-3369; doi:10.1038/onc.2011.55; published online 14 March 2011	[Venkitaraman, A. R.] Univ Cambridge, Dept Oncol, MRC, Canc Cell Unit,Hutchison MRC Res Ctr, Cambridge CB2 0XZ, Cambs, England	University of Cambridge	Venkitaraman, AR (corresponding author), Univ Cambridge, Dept Oncol, MRC, Canc Cell Unit,Hutchison MRC Res Ctr, Hills Rd, Cambridge CB2 0XZ, Cambs, England.	arv22@cam.ac.uk	Lee, MiYoung/G-3748-2014	Daniels, Matthew/0000-0002-9250-6214	Canadian Institute for Health Research; Medical Research Council; Medical Research Council [G9900064, MC_U105359877, G0600332, G0700651] Funding Source: researchfish; MRC [MC_U105359877, G0600332, G9900064, G0700651] Funding Source: UKRI	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	ML performed the experiments reported here and conceived them with ARV. MJD and MJG generated preliminary data, suggested experiments and assisted with data interpretation. We thank Dr Mark Petronczki (Clare Hall Labs, London) for sharing protocols and the siRNA sequences Q#6 and I#7 (Lekomtsev et al., 2010), and the members of our lab for helpful discussions. MJG was supported in part by a fellowship from the Canadian Institute for Health Research, and ARV was supported by a grant from the Medical Research Council, which also funded ML and MJD.	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Ayoub Nabieh, 2009, Curr Biol, V19, P1075, DOI 10.1016/j.cub.2009.05.057; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Chen CF, 1999, J BIOL CHEM, V274, P32931, DOI 10.1074/jbc.274.46.32931; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; Jonsdottir AB, 2009, CELL ONCOL, V31, P191, DOI 10.3233/CLO-2009-0465; King TA, 2007, ANN SURG ONCOL, V14, P2510, DOI 10.1245/s10434-007-9372-1; Lee M, 2004, ONCOGENE, V23, P865, DOI 10.1038/sj.onc.1207223; Lee YM, 2003, BIOCHEM J, V374, P497, DOI 10.1042/BJ20030452; Lekomtsev S, 2010, J CELL SCI, V123, P1395, DOI 10.1242/jcs.068015; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Meng X, 2007, ONCOGENE, V26, P6253, DOI 10.1038/sj.onc.1210460; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Rahman N, 1998, ANNU REV GENET, V32, P95, DOI 10.1146/annurev.genet.32.1.95; Rajendra E, 2010, NUCLEIC ACIDS RES, V38, P82, DOI 10.1093/nar/gkp873; Rowley M, 2011, GASTROENTEROLOGY, V140, P1303, DOI 10.1053/j.gastro.2010.12.039; Shivji MKK, 2006, NUCLEIC ACIDS RES, V34, P4000, DOI 10.1093/nar/gkl505; Shivji MKK, 2009, P NATL ACAD SCI USA, V106, P13254, DOI 10.1073/pnas.0906208106; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Sumoy L, 2000, CYTOGENET CELL GENET, V88, P62, DOI 10.1159/000015486; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Vinciguerra P, 2010, J CLIN INVEST, V120, P3834, DOI 10.1172/JCI43391; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Yu VPCC, 2000, GENE DEV, V14, P1400; Yuan SSF, 1999, CANCER RES, V59, P3547; Zhao WM, 2005, J BIOL CHEM, V280, P33516, DOI 10.1074/jbc.M504657200; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102	34	26	26	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2011	30	30					3360	3369		10.1038/onc.2011.55	http://dx.doi.org/10.1038/onc.2011.55			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	798NO	21399666	Green Published, hybrid			2022-12-25	WOS:000293215700006
J	Benanti, EL; Chivers, PT				Benanti, Erin L.; Chivers, Peter T.			Helicobacter pylori NikR Protein Exhibits Distinct Conformations When Bound to Different Promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICKEL-RESPONSIVE REGULATOR; N-TERMINAL ARM; DNA-BINDING; GNOTOBIOTIC PIGLETS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; OPERATOR COMPLEX; STRUCTURAL BASIS; BETA-SHEETS; REPRESSOR	Helicobacter pylori NikR (HpNikR) is a ribbon-helix-helix (RHH) DNA-binding protein that binds to several different promoter regions. The binding site sequences are not absolutely conserved. The ability of HpNikR to discriminate specific DNA sites resides partly in its nine-amino acid N-terminal arm. Previously, indirect evidence indicated that the arm exists in different conformations when HpNikR is bound to the nixA and ureA promoters. Here, we directly examined HpNikR conformation when it was bound to nixA and ureA DNA fragments by tethering (S)-1{[bis(carboxymethyl) amino] methyl}-2-{4-[(2-bromoacetyl) amino] phenylethyl}(carboxymethyl)amino]acetic acid, iron(III) to different positions in the N-terminal arm and RHH DNA binding domain. Different cleavage patterns at each promoter directly demonstrated that both the RHH domain and the arm adopt different conformations on the nixA and ureA promoters. Additionally, the two RHH domain dimers of the HpNikR tetramer are in distinct conformations at ureA. Site-directed mutagenesis identified an interchain salt bridge (Lys(48)-Glu(47')) in the RHH domain remote from the DNA binding interface that is required for high affinity binding to ureA but not nixA. Finally, DNA affinity measurements of wild-type HpNikR and a salt bridge mutant (K48A) to hybrid nixA-ureA promoters demonstrated that inverted repeat half-sites, spacers, and flanking DNA are all required for sequence-specific DNA binding by HpNikR. Notably, the spacer region made the largest contribution to DNA affinity. HpNikR exhibits a substantially expanded regulon compared with other NikR proteins. The results presented here provide a molecular basis for understanding regulatory network expansion by NikR as well as other prokaryotic regulatory proteins.	[Benanti, Erin L.; Chivers, Peter T.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Chivers, PT (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, Box 8231,660 S Euclid Ave, St Louis, MO 63108 USA.	chivers@wustl.edu		Chivers, Peter/0000-0002-8779-1452	National Science Foundation [MCB 0520877]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB 0520877.	Abraham LO, 2006, J INORG BIOCHEM, V100, P1005, DOI 10.1016/j.jinorgbio.2005.10.014; Akada JK, 2000, MOL MICROBIOL, V36, P1071, DOI 10.1046/j.1365-2958.2000.01918.x; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Bahlawane C, 2010, NUCLEIC ACIDS RES, V38, P3106, DOI 10.1093/nar/gkp1216; Benanti EL, 2007, J BIOL CHEM, V282, P20365, DOI 10.1074/jbc.M702982200; Benanti EL, 2010, J BACTERIOL, V192, P4327, DOI 10.1128/JB.00152-10; Benanti EL, 2009, J BACTERIOL, V191, P2405, DOI 10.1128/JB.01657-08; Berggrun A, 2000, J MOL BIOL, V301, P959, DOI 10.1006/jmbi.2000.4007; Berggrun A, 2001, P NATL ACAD SCI USA, V98, P2301, DOI 10.1073/pnas.041612198; Bradley MJ, 2008, J MOL BIOL, V378, P1155, DOI 10.1016/j.jmb.2008.03.010; Chivers PT, 1999, PROTEIN SCI, V8, P2494, DOI 10.1110/ps.8.11.2494; Chivers PT, 1996, EMBO J, V15, P2659, DOI 10.1002/j.1460-2075.1996.tb00626.x; Chivers PT, 2000, J BIOL CHEM, V275, P19735, DOI 10.1074/jbc.M002232200; Chivers PT, 2002, CHEM BIOL, V9, P1141, DOI 10.1016/S1074-5521(02)00241-7; Contreras M, 2003, MOL MICROBIOL, V49, P947, DOI 10.1046/j.1365-2958.2003.03621.x; Davis GS, 2006, INFECT IMMUN, V74, P6811, DOI 10.1128/IAI.01188-06; De Pina K, 1999, J BACTERIOL, V181, P670, DOI 10.1128/JB.181.2.670-674.1999; Delany I, 2005, J BACTERIOL, V187, P7703, DOI 10.1128/JB.187.22.7703-7715.2005; DELSOLAR G, 1992, MOL MICROBIOL, V6, P83; Dian C, 2006, J MOL BIOL, V361, P715, DOI 10.1016/j.jmb.2006.06.058; Dosanjh NS, 2006, CURR OPIN CHEM BIOL, V10, P123, DOI 10.1016/j.cbpa.2006.02.011; Dosanjh NS, 2007, BIOCHEMISTRY-US, V46, P2520, DOI 10.1021/bi062092w; Dosanjh NS, 2009, BIOCHEMISTRY-US, V48, P527, DOI 10.1021/bi801481j; EATON KA, 1994, INFECT IMMUN, V62, P3604, DOI 10.1128/IAI.62.9.3604-3607.1994; EATON KA, 1991, INFECT IMMUN, V59, P2470, DOI 10.1128/IAI.59.7.2470-2475.1991; Ernst FD, 2005, INFECT IMMUN, V73, P7252, DOI 10.1128/IAI.73.11.7252-7258.2005; Ernst FD, 2006, INFECT IMMUN, V74, P6821, DOI 10.1128/IAI.01196-06; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gomis-Ruth FX, 1998, EMBO J, V17, P7404, DOI 10.1093/emboj/17.24.7404; Hall KB, 1999, METHODS, V18, P78, DOI 10.1006/meth.1999.0759; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hopper S, 2000, INFECT IMMUN, V68, P896, DOI 10.1128/IAI.68.2.896-905.2000; KNIGHT KL, 1989, P NATL ACAD SCI USA, V86, P797, DOI 10.1073/pnas.86.3.797; KOUDELKA GB, 1987, NATURE, V326, P886, DOI 10.1038/326886a0; Li YJ, 2009, BIOCHEMISTRY-US, V48, P2486, DOI 10.1021/bi801742r; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; MARQUSEE S, 1990, PROTEIN FOLDING : DECIPHERING THE SECOND HALF OF THE GENETIC CODE, P85; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Mukherjee S, 2002, CELL, V110, P81, DOI 10.1016/S0092-8674(02)00815-2; Ni L, 2009, NUCLEIC ACIDS RES, V37, P6970, DOI 10.1093/nar/gkp756; OLD IG, 1991, PROG BIOPHYS MOL BIO, V56, P145, DOI 10.1016/0079-6107(91)90012-H; Olson JW, 2002, SCIENCE, V298, P1788, DOI 10.1126/science.1077123; PABO CO, 1982, NATURE, V298, P441, DOI 10.1038/298441a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAUMANN BE, 1994, NATURE, V367, P754, DOI 10.1038/367754a0; RAUMANN BE, 1994, CURR OPIN STRUC BIOL, V4, P36, DOI 10.1016/S0959-440X(94)90057-4; Schreiter ER, 2007, NAT REV MICROBIOL, V5, P710, DOI 10.1038/nrmicro1717; Schreiter ER, 2006, P NATL ACAD SCI USA, V103, P13676, DOI 10.1073/pnas.0606247103; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B; Sindhikara DJ, 2009, BIOCHEMISTRY-US, V48, P12024, DOI 10.1021/bi9013352; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; SUSSKIND MM, 1978, MICROBIOL REV, V42, P385, DOI 10.1128/MMBR.42.2.385-413.1978; Weihofen WA, 2006, NUCLEIC ACIDS RES, V34, P1450, DOI 10.1093/nar/gkl015; Zambelli B, 2008, J MOL BIOL, V383, P1129, DOI 10.1016/j.jmb.2008.08.066	56	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.196055	http://dx.doi.org/10.1074/jbc.M110.196055			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21393642	Green Published, hybrid			2022-12-25	WOS:000290022800012
J	Zhu, YX; Gumlaw, N; Karman, J; Zhao, HM; Zhang, JH; Jiang, JL; Maniatis, P; Edling, A; Chuang, WL; Siegel, C; Shayman, JA; Kaplan, J; Jiang, CW; Cheng, SH				Zhu, Yunxiang; Gumlaw, Nathan; Karman, Jozsef; Zhao, Hongmei; Zhang, Jinhua; Jiang, Ji-Lei; Maniatis, Pete; Edling, Andrea; Chuang, Wei-Lien; Siegel, Craig; Shayman, James A.; Kaplan, Johanne; Jiang, Canwen; Cheng, Seng H.			Lowering Glycosphingolipid Levels in CD4(+) T Cells Attenuates T Cell Receptor Signaling, Cytokine Production, and Differentiation to the Th-17 Lineage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; LCK TYROSINE KINASE; LIPID-RAFTS; MEMBRANE MICRODOMAINS; IMMUNOLOGICAL SYNAPSE; INSULIN SENSITIVITY; HUMAN-LYMPHOCYTES; ANTIGEN RECEPTOR; GLCNAC TERMINI; ACTIVATION	Lipid rafts reportedly have a role in coalescing key signaling molecules into the immunological synapse during T cell activation, thereby modulating T cell receptor (TCR) signaling activity. Recent findings suggest that a correlation may exist between increased levels of glycosphingolipids (GSLs) in the lipid rafts of T cells and a heightened response of those T cells toward activation. Here, we show that lowering the levels of GSLs in CD4(+) T cells using a potent inhibitor of glucosylceramide synthase (Genz-122346) led to a moderation of the T cell response toward activation. TCR proximal signaling events, such as phosphorylation of Lck, Zap70 and LAT, as well as early Ca2+ mobilization, were attenuated by treatment with Genz-122346. Concomitant with these events were significant reductions in IL-2 production and T cell proliferation. Similar findings were obtained with CD4(+) T cells isolated from transgenic mice genetically deficient in GM3 synthase activity. Interestingly, lowering the GSL levels in CD4(+) T cells by either pharmacological inhibition or disruption of the gene for GM3 synthase also specifically inhibited the differentiation of T cells to the Th-17 lineage but not to other Th subsets in vitro. Taken together with the recently reported effects of Raftlin deficiency on Th-17 differentiation, these results strongly suggest that altering the GSL composition of lipid rafts modulates TCR signaling activity and affects Th-17 differentiation.	[Zhu, Yunxiang; Gumlaw, Nathan; Karman, Jozsef; Zhao, Hongmei; Zhang, Jinhua; Jiang, Ji-Lei; Maniatis, Pete; Edling, Andrea; Chuang, Wei-Lien; Siegel, Craig; Kaplan, Johanne; Jiang, Canwen; Cheng, Seng H.] Genzyme Corp, Framingham, MA 01701 USA; [Shayman, James A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Sanofi-Aventis; Genzyme Corporation; University of Michigan System; University of Michigan	Zhu, YX (corresponding author), Genzyme Corp, 49 New York Ave, Framingham, MA 01701 USA.	yunxiang.zhu@genzyme.com	Cheng, Seng H/AAC-6564-2022		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS079633] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK055823] Funding Source: Medline; NINDS NIH HHS [R21 NS079633] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Blank N, 2005, BIOCHEM PHARMACOL, V71, P126, DOI 10.1016/j.bcp.2005.10.004; Deng GM, 2008, J IMMUNOL, V181, P4019, DOI 10.4049/jimmunol.181.6.4019; Dykstra M, 2001, J LEUKOCYTE BIOL, V70, P699; Garofalo T, 2002, J BIOL CHEM, V277, P11233, DOI 10.1074/jbc.M109601200; Harder T, 2004, TRAFFIC, V5, P265, DOI 10.1111/j.1600-0854.2003.00163.x; He X, 2002, EUR J IMMUNOL, V32, P2578, DOI 10.1002/1521-4141(200209)32:9<2578::AID-IMMU2578>3.0.CO;2-3; Horejsi V, 2004, IMMUNOL LETT, V92, P43, DOI 10.1016/j.imlet.2003.10.013; Horejsi V, 2003, IMMUNOL REV, V191, P148, DOI 10.1034/j.1600-065X.2003.00001.x; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jury EC, 2004, J CLIN INVEST, V113, P1176, DOI 10.1172/JCI200420345; Jury EC, 2006, J IMMUNOL, V177, P7416, DOI 10.4049/jimmunol.177.10.7416; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Kasahara K, 2000, GLYCOCONJUGATE J, V17, P153, DOI 10.1023/A:1026576804247; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Kosugi A, 2001, IMMUNOL LETT, V76, P133, DOI 10.1016/S0165-2478(01)00174-2; Krishnan S, 2004, J IMMUNOL, V172, P7821, DOI 10.4049/jimmunol.172.12.7821; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Ma XY, 2007, BIOCHEM BIOPH RES CO, V356, P67, DOI 10.1016/j.bbrc.2007.02.080; Miceli MC, 2001, SEMIN IMMUNOL, V13, P115, DOI 10.1006/smim.2000.0303; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Nakamura I, 1996, TOHOKU J EXP MED, V179, P291, DOI 10.1620/tjem.179.291; Pizzo P, 2002, EUR J IMMUNOL, V32, P3082, DOI 10.1002/1521-4141(200211)32:11<3082::AID-IMMU3082>3.0.CO;2-2; Rouquette-Jazdanian AK, 2006, CELL SIGNAL, V18, P105, DOI 10.1016/j.cellsig.2005.03.024; Rouquette-Jazdanian AK, 2007, CELL SIGNAL, V19, P1404, DOI 10.1016/j.cellsig.2007.01.015; Saeki K, 2009, J IMMUNOL, V182, P5929, DOI 10.4049/jimmunol.0802672; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sorice M, 2003, GLYCOCONJUGATE J, V20, P63, DOI 10.1023/B:GLYC.0000018018.29488.c6; Tavano R, 2004, J IMMUNOL, V173, P5392, DOI 10.4049/jimmunol.173.9.5392; Tuosto L, 2001, EUR J IMMUNOL, V31, P345, DOI 10.1002/1521-4141(200102)31:2<345::AID-IMMU345>3.3.CO;2-C; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yasuda K, 2000, J IMMUNOL, V165, P3226, DOI 10.4049/jimmunol.165.6.3226; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Yoon SJ, 2006, GLYCOCONJUGATE J, V23, P639, DOI 10.1007/s10719-006-9001-4; Zeyda M, 2006, PROG LIPID RES, V45, P187, DOI 10.1016/j.plipres.2006.01.002; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	39	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14787	14794		10.1074/jbc.M111.218610	http://dx.doi.org/10.1074/jbc.M111.218610			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21402703	Green Published, hybrid			2022-12-25	WOS:000289788300008
J	Zou, WQ; Xiao, XZ; Yuan, J; Puoti, G; Fujioka, HS; Wang, XL; Richardson, S; Zhou, XC; Zou, R; Li, SH; Zhu, XW; McGeer, PL; McGeehan, J; Kneale, G; Rincon-Limas, DE; Fernandez-Funez, P; Lee, HG; Smith, MA; Petersen, RB; Guo, JP				Zou, Wen-Quan; Xiao, Xiangzhu; Yuan, Jue; Puoti, Gianfranco; Fujioka, Hisashi; Wang, Xinglong; Richardson, Sandy; Zhou, Xiaochen; Zou, Roger; Li, Shihao; Zhu, Xiongwei; McGeer, Patrick L.; McGeehan, John; Kneale, Geoff; Rincon-Limas, Diego E.; Fernandez-Funez, Pedro; Lee, Hyoung-gon; Smith, Mark A.; Petersen, Robert B.; Guo, Jian-Ping			Amyloid-beta 42 Interacts Mainly with Insoluble Prion Protein in the Alzheimer Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; MONOCLONAL-ANTIBODY; COGNITIVE DEFICITS; NEURONAL ISOFORM; APLYSIA CPEB; MEMORY; DISEASE; GENE; FORM; PRPC	The prion protein (PrP) is best known for its association with prion diseases. However, a controversial new role for PrP in Alzheimer disease (AD) has recently emerged. In vitro studies and mouse models of AD suggest that PrP may be involved in AD pathogenesis through a highly specific interaction with amyloid-beta (A beta 42) oligomers. Immobilized recombinant human PrP (huPrP) also exhibited high affinity and specificity for A beta 42 oligomers. Here we report the novel finding that aggregated forms of huPrP and A beta 42 are co-purified from AD brain extracts. Moreover, an anti-PrP antibody and an agent that specifically binds to insoluble PrP (iPrP) co-precipitate insoluble A beta from human AD brain. Finally, using peptide membrane arrays of 99 13-mer peptides that span the entire sequence of mature huPrP, two distinct types of A beta binding sites on huPrP are identified in vitro. One specifically binds to A beta 42 and the other binds to both A beta 42 and A beta 40. Notably, A beta 42-specific binding sites are localized predominantly in the octapeptide repeat region, whereas sites that bind both A beta 40 and A beta 42 are mainly in the extreme N-terminal or C-terminal domains of PrP. Our study suggests that iPrP is the major PrP species that interacts with insoluble A beta 42 in vivo. Although this work indicated the interaction of A beta 42 with huPrP in the AD brain, the pathophysiological relevance of the iPrP/A beta 42 interaction remains to be established.	[Zou, Wen-Quan] Case Western Reserve Univ, Inst Pathol, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Zou, Wen-Quan; Xiao, Xiangzhu; Yuan, Jue] Case Western Reserve Univ, Sch Med, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH 44106 USA; [Fujioka, Hisashi] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Elect Microscopy Facil,Ctr Mitochondrial Dis, Cleveland, OH 44106 USA; [Petersen, Robert B.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [McGeer, Patrick L.; Guo, Jian-Ping] Univ British Columbia, Fac Med, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1Z3, Canada; [McGeehan, John; Kneale, Geoff] Univ Portsmouth, Inst Biomed & Biomol Sci, Biophys Labs, Portsmouth PO1 2DT, Hants, England; [Rincon-Limas, Diego E.; Fernandez-Funez, Pedro; Smith, Mark A.] Univ Florida, McKnight Brain Inst, Dept Neurol, Gainesville, FL 32610 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of British Columbia; University of Portsmouth; State University System of Florida; University of Florida	Zou, WQ (corresponding author), Case Western Reserve Univ, Inst Pathol, Sch Med, Dept Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.	wenquan.zou@case.edu	xiao, xiangzhu/B-9300-2014; Zhu, Xiongwei/A-9629-2009; Lee, Hyoung-gon/A-9637-2009; Petersen, Robert/B-5075-2011; Puoti, Gianfranco/AAB-8288-2019; Zou, Wenquan/GWQ-3489-2022; /C-1310-2010; Zou, Wenquan/ABF-2875-2020	xiao, xiangzhu/0000-0002-8013-9074; Zhu, Xiongwei/0000-0003-2092-6508; Petersen, Robert/0000-0002-3154-0072; puoti, gianfranco/0000-0002-6452-2321; McGeehan, John/0000-0002-6750-1462; Rincon-Limas, Diego/0000-0003-3099-0642; Wang, Xinglong/0000-0001-8657-0159	National Institutes of Health [R01NS062787]; Creutzfeldt-Jakob Disease Foundation; Alliance BioSecure; University Center on Aging and Health; McGregor Foundation; Case Western Reserve University; Pacific Alzheimer Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062787] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/E500595/1] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Creutzfeldt-Jakob Disease Foundation; Alliance BioSecure; University Center on Aging and Health; McGregor Foundation; Case Western Reserve University; Pacific Alzheimer Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS062787 (to W.-Q.Z.), grants from the Creutzfeldt-Jakob Disease Foundation (to W.-Q.Z.), Alliance BioSecure (to W.-Q.Z.), the University Center on Aging and Health with the support of the McGregor Foundation and the President's Discretionary Fund (Case Western Reserve University) (to W.-Q.Z.), and the Pacific Alzheimer Research Foundation (to J.-P.G. and P.L.M.).	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Benilova I, 2010, EMBO MOL MED, V2, P289, DOI 10.1002/emmm.201000088; Berr C, 2003, ACTA NEUROPATHOL, V106, P71, DOI 10.1007/s00401-003-0700-7; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1997, EXP NEUROL, V146, P104, DOI 10.1006/exnr.1997.6505; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Del Bo R, 2006, NEUROBIOL AGING, V27, DOI 10.1016/j.neurobiolaging.2005.05.025; Dudal S, 2004, NEUROBIOL AGING, V25, P861, DOI 10.1016/j.neurobiolaging.2003.08.008; Esiri MM, 2000, NEUROPATH APPL NEURO, V26, P273, DOI 10.1046/j.1365-2990.2000.00239.x; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P49; Giasson BI, 2003, NEUROMOL MED, V4, P49, DOI 10.1385/NMM:4:1-2:49; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Gunther EC, 2010, J MOL MED, V88, P331, DOI 10.1007/s00109-009-0568-7; Guo JP, 2006, P NATL ACAD SCI USA, V103, P1953, DOI 10.1073/pnas.0509386103; Guo JP, 2004, VIROLOGY, V324, P251, DOI 10.1016/j.virol.2004.04.017; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Kandel ER, 2009, J NEUROSCI, V29, P12748, DOI 10.1523/JNEUROSCI.3958-09.2009; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kovacs GG, 2002, NEUROSCI LETT, V329, P269, DOI 10.1016/S0304-3940(02)00668-7; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Ledford H, 2010, NATURE, V466, P1031, DOI 10.1038/4661031a; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Oliver AW, 2000, J MOL BIOL, V301, P575, DOI 10.1006/jmbi.2000.3991; Papassotiropoulos A, 2005, HUM MOL GENET, V14, P2241, DOI 10.1093/hmg/ddi228; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Schwarze-Eicker KA, 2005, NEUROBIOL AGING, V26, P1177, DOI 10.1016/j.neurobiolaging.2004.10.004; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Tompa P, 1998, NEUROSCIENCE, V86, P1037; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Yuan J, 2008, CELL MOL LIFE SCI, V65, P631, DOI 10.1007/s00018-007-7478-z; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang H, 1997, BIOCHEMISTRY-US, V36, P3543, DOI 10.1021/bi961965r; Zou WQ, 2007, CELL MOL LIFE SCI, V64, P3266, DOI 10.1007/s00018-007-7380-8; Zou WQ, 2010, J BIOL CHEM, V285, P13874, DOI 10.1074/jbc.M109.088831; Zou WQ, 2004, P NATL ACAD SCI USA, V101, P1380, DOI 10.1073/pnas.0307825100	49	67	67	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15095	15105		10.1074/jbc.M110.199356	http://dx.doi.org/10.1074/jbc.M110.199356			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21393248	Green Published, hybrid			2022-12-25	WOS:000289788300040
J	Crossman, DJ; Ruygrok, PR; Soeller, C; Cannell, MB				Crossman, David J.; Ruygrok, Peter R.; Soeller, Christian; Cannell, Mark B.			Changes in the Organization of Excitation-Contraction Coupling Structures in Failing Human Heart	PLOS ONE			English	Article							TRANSVERSE TUBULAR SYSTEM; HUMAN CARDIAC MYOCYTES; T-TUBULES; VENTRICULAR MYOCYTES; REDUCED SYNCHRONY; CA2+ RELEASE; RYANODINE RECEPTORS; HUMAN MYOCARDIUM; RAT MYOCYTES; FAILURE	Background: The cardiac myocyte t-tubular system ensures rapid, uniform cell activation and several experimental lines of evidence suggest changes in the t-tubular system and associated excitation-contraction coupling proteins may occur in heart failure. Methods and Results: The organization of t-tubules, L-type calcium channels (DHPRs), ryanodine receptors (RyRs) and contractile machinery were examined in fixed ventricular tissue samples from both normal and failing hearts (idiopathic (non-ischemic) dilated cardiomyopathy) using high resolution fluorescent imaging. Wheat germ agglutinin (WGA), Na-Ca exchanger, DHPR and caveolin-3 labels revealed a shift from a predominantly transverse orientation to oblique and axial directions in failing myocytes. In failure, dilation of peripheral t-tubules occurred and a change in the extent of protein glycosylation was evident. There was no change in the fractional area occupied by myofilaments (labeled with phalloidin) but there was a small reduction in the number of RyR clusters per unit area. The general relationship between DHPRs and RyR was not changed and RyR labeling overlapped with 51 +/- 3% of DHPR labeling in normal hearts. In longitudinal (but not transverse) sections there was an similar to 30% reduction in the degree of colocalization between DHPRs and RyRs as measured by Pearson's correlation coefficient in failing hearts. Conclusions: The results show that extensive remodelling of the t-tubular network and associated excitation-contraction coupling proteins occurs in failing human heart. These changes may contribute to abnormal calcium handling in heart failure. The general organization of the t-system and changes observed in failure samples have subtle differences to some animal models although the general direction of changes are generally similar.	[Crossman, David J.; Ruygrok, Peter R.; Soeller, Christian; Cannell, Mark B.] Univ Auckland, Dept Physiol, Fac Med & Hlth Sci, Auckland, New Zealand; [Ruygrok, Peter R.] Auckland City Hosp, Auckland, New Zealand	University of Auckland; Auckland City Hospital	Crossman, DJ (corresponding author), Univ Auckland, Dept Physiol, Fac Med & Hlth Sci, Auckland, New Zealand.	m.cannell@auckland.ac.nz	Soeller, Christian/G-5525-2011	Soeller, Christian/0000-0002-9302-2203; Crossman, David/0000-0003-3811-5455	Health Research Council of New Zealand [05/049]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by the Health Research Council of New Zealand (05/049) http://hrc.govt.nz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquila LA, 2004, J HEART LUNG TRANSPL, V23, P954, DOI 10.1016/j.healun.2004.05.018; Balijepalli RC, 2003, CARDIOVASC RES, V59, P67, DOI 10.1016/S0008-6363(03)00325-0; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; Cannell MB, 2006, J MUSCLE RES CELL M, V27, P297, DOI 10.1007/s10974-006-9089-y; Cannell MB, 1997, BIOPHYS J, V73, P112, DOI 10.1016/S0006-3495(97)78052-4; Cannell MB, 1998, TRENDS PHARMACOL SCI, V19, P16, DOI 10.1016/S0165-6147(97)01149-8; CANNELL MB, 1994, BIOPHYS J, V67, P1942, DOI 10.1016/S0006-3495(94)80677-0; CHENG H, 1994, PFLUG ARCH EUR J PHY, V428, P415, DOI 10.1007/BF00724526; Dibb KM, 2009, CIRC-HEART FAIL, V2, P482, DOI 10.1161/CIRCHEARTFAILURE.109.852228; FAWCETT DW, 1969, J CELL BIOL, V42, P1, DOI 10.1083/jcb.42.1.1; FORBES MS, 1988, ANAT RECORD, V222, P362, DOI 10.1002/ar.1092220409; FORSSMAN.WG, 1970, J CELL BIOL, V44, P1, DOI 10.1083/jcb.44.1.1; Franzini-Armstrong C, 2004, BIOL RES, V37, P507; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; He JQ, 2001, CARDIOVASC RES, V49, P298, DOI 10.1016/S0008-6363(00)00256-X; Heinzel FR, 2008, CIRC RES, V102, P338, DOI 10.1161/CIRCRESAHA.107.160085; Heling A, 2000, CIRC RES, V86, P846, DOI 10.1161/01.RES.86.8.846; Jayasinghe ID, 2009, BIOPHYS J, V97, P2664, DOI 10.1016/j.bpj.2009.08.036; Kaprielian RR, 2000, CIRCULATION, V101, P2586, DOI 10.1161/01.CIR.101.22.2586; Kostin S, 1998, CELL TISSUE RES, V294, P449, DOI 10.1007/s004410051196; Kostin S, 2000, Heart Fail Rev, V5, P271; Lindner M, 2002, CELL CALCIUM, V31, P175, DOI 10.1054/ceca.2002.0272; Louch WE, 2004, CARDIOVASC RES, V62, P63, DOI 10.1016/j.cardiores.2003.12.031; Louch WE, 2006, J PHYSIOL-LONDON, V574, P519, DOI 10.1113/jphysiol.2006.107227; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Meethal SV, 2007, CELL CALCIUM, V41, P123, DOI 10.1016/j.ceca.2006.05.006; Ohler A, 2009, CARDIOL RES PRACT, V2009, DOI 10.4061/2009/802373; PAGE E, 1979, CIRC RES, V45, P260, DOI 10.1161/01.RES.45.2.260; PETERS BP, 1979, BIOCHEMISTRY-US, V18, P5505, DOI 10.1021/bi00591a038; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Savio-Galimberti E, 2008, BIOPHYS J, V95, P2053, DOI 10.1529/biophysj.108.130617; Scriven DRL, 2002, ANN NY ACAD SCI, V976, P488; Soeller C, 1999, CIRC RES, V84, P266, DOI 10.1161/01.RES.84.3.266; Soeller C, 2007, P NATL ACAD SCI USA, V104, P14958, DOI 10.1073/pnas.0703016104; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Vatta M, 2002, LANCET, V359, P936, DOI 10.1016/S0140-6736(02)08026-1; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	38	114	114	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17901	10.1371/journal.pone.0017901	http://dx.doi.org/10.1371/journal.pone.0017901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408028	gold, Green Published			2022-12-25	WOS:000288170900054
J	Sendina-Nadal, I; Ofran, Y; Almendral, JA; Buldu, JM; Leyva, I; Li, DQ; Havlin, S; Boccaletti, S				Sendina-Nadal, Irene; Ofran, Yanay; Almendral, Juan A.; Buldu, Javier M.; Leyva, Inmaculada; Li, Daqing; Havlin, Shlomo; Boccaletti, Stefano			Unveiling Protein Functions through the Dynamics of the Interaction Network	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; PREDICTION; DISCOVERY; COMPLEXES	Protein interaction networks have become a tool to study biological processes, either for predicting molecular functions or for designing proper new drugs to regulate the main biological interactions. Furthermore, such networks are known to be organized in sub-networks of proteins contributing to the same cellular function. However, the protein function prediction is not accurate and each protein has traditionally been assigned to only one function by the network formalism. By considering the network of the physical interactions between proteins of the yeast together with a manual and single functional classification scheme, we introduce a method able to reveal important information on protein function, at both micro-and macro-scale. In particular, the inspection of the properties of oscillatory dynamics on top of the protein interaction network leads to the identification of misclassification problems in protein function assignments, as well as to unveil correct identification of protein functions. We also demonstrate that our approach can give a network representation of the meta-organization of biological processes by unraveling the interactions between different functional classes.	[Sendina-Nadal, Irene; Almendral, Juan A.; Buldu, Javier M.; Leyva, Inmaculada] Univ Rey Juan Carlos, Complex Syst Grp, Madrid, Spain; [Sendina-Nadal, Irene; Almendral, Juan A.; Buldu, Javier M.; Leyva, Inmaculada] Ctr Biomed Technol, Lab Biol Networks, Madrid, Spain; [Ofran, Yanay] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Li, Daqing; Havlin, Shlomo] Bar Ilan Univ, Dept Phys, Minerva Ctr, Ramat Gan, Israel; [Boccaletti, Stefano] CNR, Ist Sistemi Complessi, Sesto Fiorentino, Italy	Universidad Rey Juan Carlos; Bar Ilan University; Bar Ilan University; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Sendina-Nadal, I (corresponding author), Univ Rey Juan Carlos, Complex Syst Grp, Madrid, Spain.	irene.sendina@urjc.es	Buldu, Javier Martin/R-8167-2018; Almendral, Juan/ABC-8025-2021; Leyva, I./M-1820-2013; Sendiña-Nadal, Irene/M-3083-2013; Havlin, Shlomo/ABF-1527-2020; Buldu, Javier/N-5422-2014; Boccaletti, Stefano/U-7603-2019	Almendral, Juan/0000-0003-1100-7446; Leyva, I./0000-0001-9634-5385; Sendiña-Nadal, Irene/0000-0003-0432-235X; Buldu, Javier/0000-0002-9345-599X; Boccaletti, Stefano/0000-0002-5758-7012	EU [043309 GABA]; Spanish Ministry of ST [FIS2009-07072]; Community of Madrid [MODELICO-CM/S2009ESP-1691]	EU(European Commission); Spanish Ministry of ST; Community of Madrid(Comunidad de Madrid)	Work partly supported by EU contract 043309 GABA, the Spanish Ministry of S&T under Project n. FIS2009-07072, and the Community of Madrid under the R&D Program of activities MODELICO-CM/S2009ESP-1691. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almendral JA, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016115; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bu DB, 2003, NUCLEIC ACIDS RES, V31, P2443, DOI 10.1093/nar/gkg340; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hu PZ, 2007, NAT REV CANCER, V7, P23, DOI 10.1038/nrc2036; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Li D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168701; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Punta M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000160; Rost B, 2003, CELL MOL LIFE SCI, V60, P2637, DOI 10.1007/s00018-003-3114-8; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Yeang CH, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r62; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636	30	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17679	10.1371/journal.pone.0017679	http://dx.doi.org/10.1371/journal.pone.0017679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408013	gold, Green Accepted, Green Published			2022-12-25	WOS:000288170900040
J	Walther, T; Dietrich, N; Langhammer, M; Kucia, M; Hammon, H; Renne, U; Siems, WE; Metges, CC				Walther, Thomas; Dietrich, Nils; Langhammer, Martina; Kucia, Marzena; Hammon, Harald; Renne, Ulla; Siems, Wolf-Eberhard; Metges, Cornelia C.			High-Protein Diet in Lactation Leads to a Sudden Infant Death-Like Syndrome in Mice	PLOS ONE			English	Article							MATERNAL NUTRITION; LATE PREGNANCY; EXPRESSION; WEIGHT; STRAIN; GROWTH; BIRTH; RISK; LIFE	Background: It is well accepted that reduced foetal growth and development resulting from maternal malnutrition are associated with a number of chronic conditions in later life. On the other hand such generation-transcending effects of overnutrition and of high-protein consumption in pregnancy and lactation, a proven fact in all developed societies, are widely unknown. Thus, we intended to describe the generation-transcending effects of a high-protein diet, covering most relevant topics of human life like embryonic mortality, infant death, and physical health in later life. Methods: Female mice received control food (21% protein) or were fed a high protein diet (42% protein) during mating. After fertilisation, females stayed on their respective diet until weaning. At birth, pups were put to foster mothers who were fed with standard food or with HP diet. After weaning, control diet was fed to all mice. All offspring were monitored up to 360 days after birth. We determined glucose-tolerance and measured cardiovascular parameters using a tip-catheter. Finally, abdominal fat amount was measured. Results and Conclusions: We identified a worried impact of high-protein diet during pregnancy on dams' body weight gain, body weight of newborns, number of offspring, and also survival in later life. Even more important is the discovery that high-protein diet during lactation caused a more than eight-fold increase in offspring mortality. The observed higher newborn mortality during lactation is a hitherto non-described, unique link to the still incompletely understood human sudden infant death syndrome (SIDS). Thus, although offspring of lactating mothers on high-protein diet might have the advantage of lower abdominal fat within the second half of life, this benefit seems not to compensate the immense risk of an early sudden death during lactation. Our data may implicate that both pregnant women and lactating mothers should not follow classical high-protein diets.	[Walther, Thomas] Univ Giessen, Dept Expt Cardiol, Giessen, Germany; [Walther, Thomas] Univ Hull, Ctr Biomed Res, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Dietrich, Nils; Langhammer, Martina; Kucia, Marzena; Hammon, Harald; Renne, Ulla; Metges, Cornelia C.] Leibniz Inst Farm Anim Biol FBN, Res Unit Nutr Physiol, Dummerstorf, Germany; [Dietrich, Nils] Free Univ Berlin, D-1000 Berlin, Germany; [Siems, Wolf-Eberhard] Leibniz Inst Mol Pharmakol FMP, Berlin, Germany	Justus Liebig University Giessen; University of Hull; University of York - UK; Forschungsinstitut fur Nutztierbiologie (FBN); Free University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Walther, T (corresponding author), Univ Giessen, Dept Expt Cardiol, Giessen, Germany.	thomas.walther@hyms.ac.uk	Hammon, Harald/AAD-9990-2020		Commission of the European Community [5.4.3.1, Food-CT-2005-007036]; Deutsche Forschungsgemeinschaft (DFG) [WA1441/18, SI483/8]	Commission of the European Community(European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Commission of the European Community, within the FP 6 priority 5.4.3.1, Food quality and safety (EARNEST, Food-CT-2005-007036); and by the Deutsche Forschungsgemeinschaft (DFG): WA1441/18 and SI483/8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasyan K, 2007, EUR J CLIN NUTR, V61, P498, DOI 10.1038/sj.ejcn.1602552; Baker JL, 2008, EPIDEMIOLOGY, V19, P197, DOI 10.1097/EDE.0b013e31816339c6; Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; Dietl G, 2004, ARCH TIERZUCHT, V47, P595, DOI 10.5194/aab-47-595-2004; Gors S, 2009, J DAIRY SCI, V92, P632, DOI 10.3168/jds.2008-1563; Golding J, 1997, EARLY HUM DEV, V49, pS1, DOI 10.1016/S0378-3782(97)00050-9; Greco A M, 1983, Arch Sci Med (Torino), V140, P139; Ip Stanley, 2007, Evid Rep Technol Assess (Full Rep), P1; Lacroix M, 2004, AM J PHYSIOL-REG I, V287, pR934, DOI 10.1152/ajpregu.00100.2004; Martorell R, 2001, J NUTR, V131, p874S, DOI 10.1093/jn/131.3.874S; McCowen KC, 2005, CURR OPIN GASTROEN, V21, P207, DOI 10.1097/01.mog.0000153361.90653.cb; McVea K L, 2000, J Hum Lact, V16, P13, DOI 10.1177/089033440001600104; Mitchell EA, 2009, ACTA PAEDIATR, V98, P1712, DOI 10.1111/j.1651-2227.2009.01503.x; Mitchell M, 2009, BIOL REPROD, V80, P295, DOI 10.1095/biolreprod.108.069864; Ostfeld BM, 2010, PEDIATRICS, V125, P447, DOI 10.1542/peds.2009-0038; Prandota Joseph, 2004, Am J Ther, V11, P517, DOI 10.1097/01.mjt.0000140648.30948.bd; Raiten DJ, 2007, AM J CLIN NUTR, V85, p577S, DOI 10.1093/ajcn/85.2.577S; Reynolds RM, 2007, J CLIN ENDOCR METAB, V92, P2208, DOI 10.1210/jc.2007-0071; Sullivan FM, 2001, PAEDIATR PERINAT EP, V15, P144; Thone-Reineke C, 2006, AM J PHYSIOL-REG I, V291, pR1025, DOI 10.1152/ajpregu.00898.2005; Timtchenko D, 1999, INT J OBESITY, V23, P586, DOI 10.1038/sj.ijo.0800872; Wang Y, 2007, EUR J HEART FAIL, V9, P548, DOI 10.1016/j.ejheart.2007.02.006	23	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17443	10.1371/journal.pone.0017443	http://dx.doi.org/10.1371/journal.pone.0017443			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408058	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170900016
J	Wang, L; Wu, XP; Zhang, W; Zhu, DH; Wang, Y; Li, YP; Tian, Y; Li, RC; Li, Z; Zhu, XL; Li, JH; Cai, J; Liu, L; Miao, XP; Liu, Y; Li, H				Wang, Li; Wu, Xiao-Pan; Zhang, Wei; Zhu, Da-Hai; Wang, Ying; Li, Yan-Ping; Tian, Yao; Li, Rong-Cheng; Li, Zhuo; Zhu, Xinlin; Li, Jun-Hong; Cai, Jun; Liu, Li; Miao, Xiao-Ping; Liu, Ying; Li, Hui			Evaluation of Genetic Susceptibility Loci for Chronic Hepatitis B in Chinese: Two Independent Case-Control Studies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VITAMIN-D-RECEPTOR; VIRUS INFECTION; TNF-ALPHA; HEPATOCELLULAR-CARCINOMA; PROMOTER POLYMORPHISMS; OUTCOMES; POPULATION; ALLELE; CLEARANCE	Background: A recent genome-wide scan has identified two genetic variants in the HLA-DP region strongly associated with hepatitis B infection in Japanese. This study evaluates the effects of these risk variants in Chinese, where the HBV infection is the most popular in the world. Methods and Findings: We have assessed the relationship between these two single nucleotide polymorphisms (rs3077 and rs9277535) and chronic hepatitis B infection in two independent case-control studies. The first population in Chinese Han included 736 patients and 782 spontaneously recovered controls. The second set was established in Chinese Zhuang minority of 177 patients and 208 controls. Both A alleles of rs3077 and rs9277535 significantly deceased the risk to CHB in Chinese Han (OR = 0.540, 95% CI: 0.464-0.628, P = 4.068x10(-16) and OR = 0.696, 95% CI: 0.601-0.806, P = 1.062x10(-26), respectively). Conceivably, rs9277535 was found to be associated with decreased risk of the disease in Chinese Zhuang, with an OR of 0.606 (95% CI, 0.441-0.833, P = 0.002). Conclusion: Chronic hepatitis B susceptibility loci in HLA-DP region (rs3077 and rs9277535) identified by genome-wide scan in Japanese population were validated in Chinese population. These findings might provide clues to develop screening and surveillance strategies.	[Wang, Li; Li, Hui] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China; [Wu, Xiao-Pan; Tian, Yao; Liu, Ying] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhang, Wei] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Wang, Ying; Liu, Li; Miao, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China; [Wang, Ying; Liu, Li; Miao, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ Key Lab Environm & Hlth, Wuhan 430074, Hubei, Peoples R China; [Li, Yan-Ping; Li, Rong-Cheng] Guangxi Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China; [Li, Zhuo; Li, Jun-Hong] Capital Univ Med Sci, Affiliated Youan Hosp, Dept Infect Dis, Beijing, Peoples R China; [Cai, Jun] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Wang, Ying] Wuhan Ctr Dis Prevent & Control, Dept Virol, Wuhan, Hubei, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Capital Medical University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Wang, L (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China.	miaoxp@mail.hust.edu.cn; liuyingpumc@yahoo.com; lihui99360@vip.sohu.com	wang, YA XING/K-9671-2016; li, yan/GTI-4638-2022; miao, xiaoping/C-4336-2011	wang, YA XING/0000-0003-2749-7793; miao, xiaoping/0000-0002-6818-9722	National Key Project of Infectious disease [2009ZX10004-903, 2008ZX10002-001]; National Basic Research Program of China (973 program) [2007CB512806]; National High Technology Research and Development Program of China (863 Program) [2006AA02A4100]; Science Fund for Creative Research Groups [30721063]; Foundation of Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences [2009PY16]	National Key Project of Infectious disease; National Basic Research Program of China (973 program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Science Fund for Creative Research Groups(Science Fund for Creative Research Groups); Foundation of Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences	This work was supported by National Key Project of Infectious disease (Grant number: 2009ZX10004-903 and 2008ZX10002-001); National Basic Research Program of China (973 program, Grant number: 2007CB512806); National High Technology Research and Development Program of China (863 Program, Grant number: 2006AA02A4100); Science Fund for Creative Research Groups (Grant number: 30721063); Foundation of Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (Grant number: 2009PY16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cao TH, 2002, J GEN VIROL, V83, P3023, DOI 10.1099/0022-1317-83-12-3023; Cheong JY, 2006, J GASTROEN HEPATOL, V21, P1163, DOI 10.1111/j.1440-1746.2006.04304.x; Cho SW, 2008, J KOREAN MED SCI, V23, P838, DOI 10.3346/jkms.2008.23.5.838; Diaz G, 2003, INT IMMUNOL, V15, P565, DOI 10.1093/intimm/dxg057; Du T, 2006, J VIRAL HEPATITIS, V13, P618, DOI 10.1111/j.1365-2893.2006.00731.x; Gaston JSH, 1997, HUM IMMUNOL, V54, P40, DOI 10.1016/S0198-8859(97)00003-7; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Huang YW, 2010, GENES IMMUN, V11, P87, DOI 10.1038/gene.2009.65; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Koulentaki Meri, 2004, Eur J Intern Med, V15, P35, DOI 10.1016/j.ejim.2003.11.004; Kummee P, 2007, J VIRAL HEPATITIS, V14, P841, DOI 10.1111/j.1365-2893.2007.00880.x; Li HQ, 2006, BIOMED ENVIRON SCI, V19, P133; Li Jun-hong, 2006, Zhonghua Yi Xue Za Zhi, V86, P1952; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; LIN TM, 1989, ANTICANCER RES, V9, P737; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Lu Liang-ping, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P427; Nicholson I, 1997, HUM IMMUNOL, V55, P163, DOI 10.1016/S0198-8859(97)00091-8; Pungpapong S, 2007, MAYO CLIN PROC, V82, P967, DOI 10.4065/82.8.967; Ramezani A, 2008, J GASTROEN HEPATOL, V23, P1716, DOI 10.1111/j.1440-1746.2008.05482.x; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suneetha PV, 2006, J HEPATOL, V44, P856, DOI 10.1016/j.jhep.2006.01.028; Thursz M, 2001, ANTIVIR RES, V52, P113, DOI 10.1016/S0166-3542(01)00175-9; THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604; Urbani S, 2005, HEPATOLOGY, V41, P826, DOI 10.1002/hep.20614; Wang FS, 2003, WORLD J GASTROENTERO, V9, P641, DOI 10.3748/wjg.v9.i4.641; Wu Jiang, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P555; Xun Yun-hao, 2009, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V23, P430; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Yuen MF, 2008, GASTROENTEROLOGY, V135, P1192, DOI 10.1053/j.gastro.2008.07.008; Zheng MH, 2010, INT J INFECT DIS, V14, pE580, DOI 10.1016/j.ijid.2009.08.010	36	57	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17608	10.1371/journal.pone.0017608	http://dx.doi.org/10.1371/journal.pone.0017608			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408128	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170000046
J	Smeenk, L; van Heeringen, SJ; Koeppel, M; Gilbert, B; Janssen-Megens, E; Stunnenberg, HG; Lohrum, M				Smeenk, Leonie; van Heeringen, Simon J.; Koeppel, Max; Gilbert, Bianca; Janssen-Megens, Eva; Stunnenberg, Hendrik G.; Lohrum, Marion			Role of p53 Serine 46 in p53 Target Gene Regulation	PLOS ONE			English	Article							CELL-CYCLE ARREST; INTERACTING PROTEIN KINASE-2; DNA-DAMAGE; TUMOR-SUPPRESSOR; POSTTRANSLATIONAL MODIFICATION; APOPTOTIC RESPONSE; PHOSPHORYLATES P53; BINDING-SITES; STRESS; CHROMATIN	The tumor suppressor p53 plays a crucial role in cellular growth control inducing a plethora of different response pathways. The molecular mechanisms that discriminate between the distinct p53-responses have remained largely elusive. Here, we have analyzed the p53-regulated pathways induced by Actinomycin D and Etoposide treatment resulting in more growth arrested versus apoptotic cells respectively. We found that the genome-wide p53 DNA-binding patterns are almost identical upon both treatments notwithstanding transcriptional differences that we observed in global transcriptome analysis. To assess the role of post-translational modifications in target gene choice and activation we investigated the genome-wide level of phosphorylation of Serine 46 of p53 bound to DNA ( p53-pS46) and of Serine 15 (p53-pS15). Interestingly, the extent of S46 phosphorylation of p53 bound to DNA is considerably higher in cells directed towards apoptosis while the degree of phosphorylation at S15 remains highly similar. Moreover, our data suggest that following different chemotherapeutical treatments, the amount of chromatin-associated p53 phosphorylated at S46 but not at pS15 is higher on certain apoptosis related target genes. Our data provide evidence that cell fate decisions are not made primarily on the level of general p53 DNA-binding and that post-translationally modified p53 can have distinct DNA-binding characteristics.	[Smeenk, Leonie; van Heeringen, Simon J.; Koeppel, Max; Janssen-Megens, Eva; Stunnenberg, Hendrik G.; Lohrum, Marion] Radboud Univ Nijmegen, Fac Sci, Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands; [Gilbert, Bianca; Lohrum, Marion] Georg Speyer Haus, Frankfurt, Germany	Radboud University Nijmegen	Smeenk, L (corresponding author), Radboud Univ Nijmegen, Fac Sci, Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands.	Lohrum@em.uni-frankfurt.de	Stunnenberg, Hendrik G./D-6875-2012; van Heeringen, Simon/Q-8530-2017	Stunnenberg, Hendrik G./0000-0002-0066-1576; van Heeringen, Simon/0000-0002-0411-3219; Smeenk, Leonie/0000-0001-7025-8515	Dutch Cancer Foundation (KWF) [KUN 2003-2926, KUN 2005-3347]; Netherlands Organisation for Scientific Research (NWO) [Vidi 846.05.002]	Dutch Cancer Foundation (KWF)(KWF Kankerbestrijding); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Funding for this work was provided by Dutch Cancer Foundation (KWF) (KUN 2003-2926 to LS and MK, KUN 2005-3347 to LS) and by the Netherlands Organisation for Scientific Research (NWO) (Vidi 846.05.002 to SJH and ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Braastad CD, 2003, J BIOL CHEM, V278, P8261, DOI 10.1074/jbc.M204256200; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Coutts AS, 2005, BIOCHEM BIOPH RES CO, V331, P778, DOI 10.1016/j.bbrc.2005.03.150; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Denissov S, 2007, EMBO J, V26, P944, DOI 10.1038/sj.emboj.7601550; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Espinosa JM, 2008, ONCOGENE, V27, P4013, DOI 10.1038/onc.2008.37; Georges SA, 2009, CELL CYCLE, V8, P680; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Hussain SP, 1999, MUTAT RES-FUND MOL M, V428, P23, DOI 10.1016/S1383-5742(99)00028-9; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kodama M, 2010, MOL CELL BIOL, V30, P1620, DOI 10.1128/MCB.00810-09; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shaked H, 2008, CANCER RES, V68, P9671, DOI 10.1158/0008-5472.CAN-08-0865; Shmueli A, 2007, MOL CELL, V25, P794, DOI 10.1016/j.molcel.2007.03.006; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Smeenk L, 2010, INT J ONCOL, V37, P1061, DOI 10.3892/ijo_00000757; Sullivan A, 2007, BRIT J CANCER, V96, P196, DOI 10.1038/sj.bjc.6603525; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Vrba L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-486; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	51	120	122	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17574	10.1371/journal.pone.0017574	http://dx.doi.org/10.1371/journal.pone.0017574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394211	Green Submitted, gold, Green Published			2022-12-25	WOS:000288025500017
J	Schulz, EC; Bergfeld, AK; Ficner, R; Muhlenhoff, M				Schulz, Eike C.; Bergfeld, Anne K.; Ficner, Ralf; Muehlenhoff, Martina			Crystal Structure Analysis of the Polysialic Acid Specific O-Acetyltransferase NeuO	PLOS ONE			English	Article							ESCHERICHIA-COLI; SEROGROUP-C; POLYSACCHARIDE ANTIGENS; CAPSULAR POLYSACCHARIDE; FORM VARIATION; BETA-HELIX; GROUP-B; GENE; ACETYLATION; BACTEREMIA	The major virulence factor of the neuroinvasive pathogen Escherichia coli K1 is the K1 capsule composed of alpha 2,8-linked polysialic acid (polySia). K1 strains harboring the CUS-3 prophage modify their capsular polysaccharide by phase-variable O-acetlyation, a step that is associated with increased virulence. Here we present the crystal structure of the prophage-encoded polysialate O-acetyltransferase NeuO. The homotrimeric enzyme belongs to the left-handed beta-helix (L beta H) family of acyltransferases and is characterized by an unusual funnel-shaped outline. Comparison with other members of the L beta H family allowed the identification of active site residues and proposal of a catalytic mechanism and highlighted structural characteristics of polySia specific O-acetyltransferases. As a unique feature of NeuO, the enzymatic activity linearly increases with the length of the N-terminal poly-psi-domain which is composed of a variable number of tandem copies of an RLKTQDS heptad. Since the poly-psi-domain was not resolved in the crystal structure it is assumed to be unfolded in the apo-enyzme.	[Schulz, Eike C.; Ficner, Ralf] Univ Gottingen, Abt Mol Strukturbiol, Inst Mikrobiol & Genet, Gottingen, Germany; [Bergfeld, Anne K.; Muehlenhoff, Martina] Hannover Med Sch, Inst Zellulare Chem, D-30623 Hannover, Germany	University of Gottingen; Hannover Medical School	Schulz, EC (corresponding author), Univ Gottingen, Abt Mol Strukturbiol, Inst Mikrobiol & Genet, Gottingen, Germany.	rficner@gwdg.de; muehlenhoff.martina@mh-hannover.de			Deutsche Forschungsgemeinschaft [MU1774/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (grant number MU1774/2 to M.M.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beaman TW, 1998, BIOCHEMISTRY-US, V37, P6689, DOI 10.1021/bi980106v; Bergfeld AK, 2007, J BIOL CHEM, V282, P22217, DOI 10.1074/jbc.M703044200; Bergfeld AK, 2009, J BIOL CHEM, V284, P6, DOI 10.1074/jbc.M807518200; BHATTACHARJEE AK, 1976, CAN J BIOCHEM CELL B, V54, P1, DOI 10.1139/o76-001; BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926; Claus H, 2004, MOL MICROBIOL, V51, P227, DOI 10.1046/j.1365-2958.2003.03819.x; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Deszo EL, 2005, P NATL ACAD SCI USA, V102, P5564, DOI 10.1073/pnas.0407428102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FINNE J, 1987, J IMMUNOL, V138, P4402; FRASA H, 1993, J CLIN MICROBIOL, V31, P3174, DOI 10.1128/JCM.31.12.3174-3178.1993; HIGA HH, 1988, J BIOL CHEM, V263, P8872; Imai YN, 2007, J MED CHEM, V50, P1189, DOI 10.1021/jm061038a; Iwaoka M, 2002, J AM CHEM SOC, V124, P10613, DOI 10.1021/ja026472q; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Johnson CM, 2005, ARCH BIOCHEM BIOPHYS, V433, P85, DOI 10.1016/j.abb.2004.08.014; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; King MR, 2007, J BACTERIOL, V189, P6447, DOI 10.1128/JB.00657-07; Kisker C, 1996, EMBO J, V15, P2323, DOI 10.1002/j.1460-2075.1996.tb00588.x; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Lee HJ, 2009, J BIOL CHEM, V284, P24501, DOI 10.1074/jbc.M109.006049; LEWENDON A, 1995, J BIOL CHEM, V270, P26326, DOI 10.1074/jbc.270.44.26326; LEYING H, 1990, INFECT IMMUN, V58, P222, DOI 10.1128/IAI.58.1.222-227.1990; Lo Leggio L, 2003, BIOCHEMISTRY-US, V42, P5225, DOI 10.1021/bi0271446; Mordhorst IL, 2009, ENVIRON MICROBIOL, V11, P3154, DOI 10.1111/j.1462-2920.2009.02019.x; ORSKOV F, 1979, J EXP MED, V149, P669, DOI 10.1084/jem.149.3.669; Pal D, 2001, J BIOMOL STRUCT DYN, V19, P115, DOI 10.1080/07391102.2001.10506725; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; ROHR TE, 1980, J BIOL CHEM, V255, P2332; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Stein DM, 2006, VACCINE, V24, P221, DOI 10.1016/j.vaccine.2005.07.084; Stummeyer K, 2006, MOL MICROBIOL, V60, P1123, DOI 10.1111/j.1365-2958.2006.05173.x; Sugantino M, 2002, BIOCHEMISTRY-US, V41, P2209, DOI 10.1021/bi011991b; Taylor G, 1996, CURR OPIN STRUC BIOL, V6, P830, DOI 10.1016/S0959-440X(96)80014-5; VAARA M, 1992, FEMS MICROBIOL LETT, V97, P249, DOI 10.1016/0378-1097(92)90344-N; Wang XG, 2002, STRUCTURE, V10, P581, DOI 10.1016/S0969-2126(02)00741-4; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Xie Y, 2004, FEMS IMMUNOL MED MIC, V42, P271, DOI 10.1016/j.femsim.2004.09.001	45	9	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17403	10.1371/journal.pone.0017403	http://dx.doi.org/10.1371/journal.pone.0017403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390252	Green Published, gold			2022-12-25	WOS:000287932100015
J	Bailey, RI; Innocenti, P; Morrow, EH; Friberg, U; Qvarnstrom, A				Bailey, Richard I.; Innocenti, Paolo; Morrow, Edward H.; Friberg, Urban; Qvarnstrom, Anna			Female Drosophila melanogaster Gene Expression and Mate Choice: The X Chromosome Harbours Candidate Genes Underlying Sexual Isolation	PLOS ONE			English	Article							INCIPIENT SPECIATION; EVOLUTION; POPULATIONS; SELECTION; REINFORCEMENT; INCOMPATIBILITIES; BUTTERFLIES; ADAPTATION; RESPONSES; AFRICAN	Background: The evolution of female choice mechanisms favouring males of their own kind is considered a crucial step during the early stages of speciation. However, although the genomics of mate choice may influence both the likelihood and speed of speciation, the identity and location of genes underlying assortative mating remain largely unknown. Methods and Findings: We used mate choice experiments and gene expression analysis of female Drosophila melanogaster to examine three key components influencing speciation. We show that the 1,498 genes in Zimbabwean female D. melanogaster whose expression levels differ when mating with more (Zimbabwean) versus less (Cosmopolitan strain) preferred males include many with high expression in the central nervous system and ovaries, are disproportionately X-linked and form a number of clusters with low recombination distance. Significant involvement of the brain and ovaries is consistent with the action of a combination of pre- and postcopulatory female choice mechanisms, while sex linkage and clustering of genes lead to high potential evolutionary rate and sheltering against the homogenizing effects of gene exchange between populations. Conclusion: Taken together our results imply favourable genomic conditions for the evolution of reproductive isolation through mate choice in Zimbabwean D. melanogaster and suggest that mate choice may, in general, act as an even more important engine of speciation than previously realized.	[Bailey, Richard I.; Innocenti, Paolo; Morrow, Edward H.; Friberg, Urban; Qvarnstrom, Anna] Uppsala Univ, Dept Ecol & Genet, EBC, Uppsala, Sweden	Uppsala University	Bailey, RI (corresponding author), Uppsala Univ, Dept Ecol & Genet, EBC, Uppsala, Sweden.	anna.qvarnstrom@ebc.uu.se	Friberg, Urban/C-9412-2015; Morrow, Edward/C-2358-2011; Morrow, Edward H/Q-6730-2019; Friberg, Urban/H-4569-2011; Bailey, Richard/HHM-4964-2022	Friberg, Urban/0000-0001-6112-9586; Morrow, Edward/0000-0002-1853-7469; Morrow, Edward H/0000-0002-1853-7469; Bailey, Richard/0000-0001-9870-410X; Qvarnstrom, Anna/0000-0002-1178-4053; Innocenti, Paolo/0000-0003-2082-0586	Wenner-Gren foundation; European Young Investigator Award; Swedish Research Council	Wenner-Gren foundation; European Young Investigator Award; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was financed by the Wenner-Gren foundation (AQ), a European Young Investigator Award (AQ), and the Swedish Research Council (AQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipaz JA, 2001, P ROY SOC B-BIOL SCI, V268, P789, DOI 10.1098/rspb.2000.1420; Andolfatto P, 2001, MOL BIOL EVOL, V18, P279, DOI 10.1093/oxfordjournals.molbev.a003804; Bailey RI, 2004, J EVOLUTION BIOL, V17, P108, DOI 10.1046/j.1420-9101.2003.00648.x; BEGUN DJ, 1993, NATURE, V365, P548, DOI 10.1038/365548a0; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Chintapalli V., 2007, FLYATLAS DROSOPHILA; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Coyne JA, 2006, EVOLUTION, V60, P279; Cummings ME, 2008, P ROY SOC B-BIOL SCI, V275, P393, DOI 10.1098/rspb.2007.1454; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; Davies N, 1997, P ROY SOC B-BIOL SCI, V264, P845, DOI 10.1098/rspb.1997.0118; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GRULA JW, 1980, EVOLUTION, V34, P688, DOI 10.1111/j.1558-5646.1980.tb04007.x; Hall DW, 2006, EVOLUTION, V60, P908; Hollocher H, 1997, EVOLUTION, V51, P1175, DOI 10.1111/j.1558-5646.1997.tb03965.x; Hollocher H, 1997, GENETICS, V147, P1191; Innocenti P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000335; Kauer M, 2003, MOL BIOL EVOL, V20, P1329, DOI 10.1093/molbev/msg148; Keller A, 2007, CURR BIOL, V17, pR77, DOI 10.1016/j.cub.2006.12.031; Kirkpatrick M, 2004, EVOLUTION, V58, P683; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kulathinal RJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000550; Lawniczak MKN, 2004, GENOME, V47, P900, DOI 10.1139/G04-050; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Mack PD, 2006, P NATL ACAD SCI USA, V103, P10358, DOI 10.1073/pnas.0604046103; Michalak P, 2007, MOL ECOL, V16, P1179, DOI 10.1111/j.1365-294X.2007.03201.x; Orr HA, 2001, GENETICS, V157, P875; Osada N, 2006, MOL BIOL EVOL, V23, P1585, DOI 10.1093/molbev/msl023; Qvarnstrom A, 2009, HEREDITY, V102, P4, DOI 10.1038/hdy.2008.93; R Development Core Team, 2009, R FDN STAT COMP; Rice WR, 2005, P NATL ACAD SCI USA, V102, P6527, DOI 10.1073/pnas.0501889102; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Saether SA, 2007, SCIENCE, V318, P95, DOI 10.1126/science.1141506; Schlotterer C, 2002, MOL ECOL, V11, P947, DOI 10.1046/j.1365-294X.2002.01491.x; Servedio MR, 2001, EVOLUTION, V55, P1909, DOI 10.1111/j.0014-3820.2001.tb01309.x; Ting CT, 2001, P NATL ACAD SCI USA, V98, P6709, DOI 10.1073/pnas.121418898; Via S, 2008, MOL ECOL, V17, P4334, DOI 10.1111/j.1365-294X.2008.03921.x; Voolstra C, 2007, GENOME RES, V17, P42, DOI 10.1101/gr.5683806	38	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17358	10.1371/journal.pone.0017358	http://dx.doi.org/10.1371/journal.pone.0017358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386982	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000287931400061
J	Wang, QL; Liang, B; Shirwany, NA; Zou, MH				Wang, Qilong; Liang, Bin; Shirwany, Najeeb A.; Zou, Ming-Hui			2-Deoxy-D-Glucose Treatment of Endothelial Cells Induces Autophagy by Reactive Oxygen Species-Mediated Activation of the AMP-Activated Protein Kinase	PLOS ONE			English	Article							OXIDATIVE STRESS; GLUCOSE DEPRIVATION; CANCER-CELLS; MITOCHONDRIAL DYSFUNCTION; MAMMALIAN TARGET; SKELETAL-MUSCLE; IN-VIVO; APOPTOSIS; ROS; DISEASE	Autophagy is a cellular self-digestion process activated in response to stresses such as energy deprivation and oxidative stress. However, the mechanisms by which energy deprivation and oxidative stress trigger autophagy remain undefined. Here, we report that activation of AMP-activated protein kinase (AMPK) by mitochondria-derived reactive oxygen species (ROS) is required for autophagy in cultured endothelial cells. AMPK activity, ROS levels, and the markers of autophagy were monitored in confluent bovine aortic endothelial cells (BAEC) treated with the glycolysis blocker 2-deoxy-D-glucose (2-DG). Treatment of BAEC with 2-DG (5 mM) for 24 hours or with low concentrations of H2O2 (100 mu M) induced autophagy, including increased conversion of microtubule-associated protein light chain 3 (LC3)-I to LC3-II, accumulation of GFP-tagged LC3 positive intracellular vacuoles, and increased fusion of autophagosomes with lysosomes. 2-DG-treatment also induced AMPK phosphorylation, which was blocked by either co-administration of two potent anti-oxidants (Tempol and N-Acetyl-L-cysteine) or overexpression of superoxide dismutase 1 or catalase in BAEC. Further, 2-DG-induced autophagy in BAEC was blocked by overexpressing catalase or siRNA-mediated knockdown of AMPK. Finally, pretreatment of BAEC with 2-DG increased endothelial cell viability after exposure to hypoxic stress. Thus, AMPK is required for ROS-triggered autophagy in endothelial cells, which increases endothelial cell survival in response to cell stress.	[Wang, Qilong; Liang, Bin; Shirwany, Najeeb A.; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Dept Med,Sect Mol Med, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Wang, QL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Dept Med,Sect Mol Med, Oklahoma City, OK 73190 USA.	ming-hui-zou@ouhsc.edu	wang, qinghong/M-7969-2017; wang, qilong/O-1962-2013	wang, qilong/0000-0002-4375-991X	NIH [HL079584, HL080499, HL074399, HL089920, HL096032, HL105157]; American Diabetes Association; Paul H. Doris Eaton Travis Chair in Endocrinology from the University of Oklahoma Health Sciences Center; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110488, R01HL089920, R01HL096032, R01HL074399, R01HL105157, R01HL079584, R01HL080499] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Paul H. Doris Eaton Travis Chair in Endocrinology from the University of Oklahoma Health Sciences Center; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants (HL079584, HL080499, HL074399, HL089920, HL096032, and HL105157), a research award from the American Diabetes Association, and the funds from Paul H. Doris Eaton Travis Chair in Endocrinology from the University of Oklahoma Health Sciences Center. Dr. Zou is a recipient of the National Established Investigator Award of American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2008, HEPATOLOGY, V47, P677, DOI 10.1002/hep.21991; An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Cai Y, 2007, FREE RADICAL BIO MED, V42, P64, DOI 10.1016/j.freeradbiomed.2006.09.018; Caruso R, 2004, ANAL BIOCHEM, V330, P43, DOI 10.1016/j.ab.2004.03.063; Ceolotto G, 2007, ARTERIOSCL THROM VAS, V27, P2627, DOI 10.1161/ATVBAHA.107.155762; CHAMBERS MA, 2009, J PHYSL; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; Dixit M, 2008, CARDIOVASC RES, V77, P160, DOI 10.1093/cvr/cvm017; Dworakowski R, 2008, PHARMACOL REP, V60, P21; ESSICK EE, OXID MED CELL LONGEV, V3, P168; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Gurusamy N, 2009, ANTIOXID REDOX SIGN, V11, P1975, DOI [10.1089/ars.2009.2524, 10.1089/ARS.2009.2524]; Gusarova GA, 2009, MOL CELL BIOL, V29, P3455, DOI 10.1128/MCB.00054-09; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Hayashi S, 2009, ARTERIOSCL THROM VAS, V29, P1909, DOI 10.1161/ATVBAHA.109.188516; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hwang JT, 2008, GENES NUTR, V2, P323, DOI 10.1007/s12263-007-0069-7; Jiang WQ, 2008, MOL CARCINOGEN, V47, P616, DOI 10.1002/mc.20425; Kemp BE, 2007, STRUCTURE, V15, P1161, DOI 10.1016/j.str.2007.09.006; Kim WH, 2007, CELL SIGNAL, V19, P791, DOI 10.1016/j.cellsig.2006.10.004; Klimova TA, 2009, FASEB J, V23, P783, DOI 10.1096/fj.08-114256; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Kumar SH, 2009, J VIROL, V83, P8565, DOI 10.1128/JVI.00603-09; Kwon YN, 2009, DRUG METAB DISPOS, V37, P1187, DOI 10.1124/dmd.108.025908; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liu Y, 2003, J CELL MOL MED, V7, P49, DOI 10.1111/j.1582-4934.2003.tb00202.x; MARAMBIO P, BIOCH BIOPHYS ACTA; Marsh J, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-33; Martinet W, 2008, CURR ATHEROSCLER REP, V10, P216, DOI 10.1007/s11883-008-0034-y; Matsuda F, 2009, AUTOPHAGY, V5, P484, DOI 10.4161/auto.5.4.7760; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; MAZURE NM, 2009, CURR OPIN CELL BIOL; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163; Nystrom GJ, 2008, INT J CLIN EXP MED, V1, P50; Park HK, 2009, NEUROSCI LETT, V451, P16, DOI 10.1016/j.neulet.2008.12.019; Racanelli AC, 2009, CANCER RES, V69, P5467, DOI 10.1158/0008-5472.CAN-08-4979; Sandstrom ME, 2006, J PHYSIOL-LONDON, V575, P251, DOI 10.1113/jphysiol.2006.110601; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; SHIRWANY NA, ACTA PHARM SIN, V31, P1075; SOLS A, 1954, J BIOL CHEM, V206, P925; Tannous P, 2007, CIRCULATION, V116, P255; Xie ZL, 2008, DIABETES, V57, P3222, DOI 10.2337/db08-0610; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Yin L, 2009, INT J ONCOL, V34, P1691, DOI 10.3892/ijo_00000300; Yoo BH, 2009, AUTOPHAGY, V5, P1166, DOI 10.4161/auto.5.8.10167; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200; Zou MH, 2008, CLIN EXP PHARMACOL P, V35, P535, DOI 10.1111/j.1440-1681.2007.04851.x	60	148	155	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17234	10.1371/journal.pone.0017234	http://dx.doi.org/10.1371/journal.pone.0017234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386904	gold, Green Submitted, Green Published			2022-12-25	WOS:000287931400039
J	Li, G; Zhang, JJ; Tong, XM; Liu, WJ; Ye, X				Li, Gang; Zhang, Junjie; Tong, Xiaomei; Liu, Wenjun; Ye, Xin			Heat Shock Protein 70 Inhibits the Activity of Influenza A Virus Ribonucleoprotein and Blocks the Replication of Virus In Vitro and In Vivo	PLOS ONE			English	Article							CELL-CYCLE ARREST; RNA-POLYMERASE; PA SUBUNIT; VIRAL-RNA; PROSTAGLANDIN-A; NUCLEAR IMPORT; CAP-BINDING; PROTEIN; IDENTIFICATION; ENDONUCLEASE	Background: Heat shock protein 70 (Hsp70) was identified as a cellular interaction partner of the influenza virus ribonucleoprotein (RNP) complex. The biological significance of the interaction between Hsp70 and RNP has not been fully investigated. Principal Findings: Here we demonstrated that Hsp70 was involved in the regulation of influenza A viral transcription and replication. It was found that Hsp70 was associated with viral RNP by directly interacting with the PB1 and PB2 subunits, and the ATPase domain of Hsp70 was required for the association. Immunofluorescence analysis showed that Hsp70 was translocated from the cytoplasm into the nucleus in infected cells. Then we found that Hsp70 negatively regulated the expression of viral proteins in infected cells. Real-time PCR analysis revealed that the transcription and replication of all eight viral segments were significantly reduced in Hsp70 overexpressed cells and greatly increased as Hsp70 was knocked down by RNA interference. Luciferase assay showed that overexpression of Hsp70 could inhibit the viral RNP activity on both vRNA and cRNA promoters. Biochemical analysis demonstrated that Hsp70 interfered with the integrity of RNP. Furthermore, delivered Hsp70 could inhibit the replication of influenza A virus in mice. Significance: Our study indicated that Hsp70 interacted with PB1 and PB2 of RNP and could interfere with the integrity of RNP and block the virus replication in vitro and in vivo possibly through disrupting the binding of viral polymerase with viral RNA.	[Li, Gang; Zhang, Junjie; Tong, Xiaomei; Ye, Xin] Chinese Acad Sci, Ctr Mol Immunol, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [Liu, Wenjun] Chinese Acad Sci, Ctr Mol Virol, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [Li, Gang; Zhang, Junjie] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, G (corresponding author), Chinese Acad Sci, Ctr Mol Immunol, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China.	yex@im.ac.cn		Zhang, Junjie/0000-0003-3812-3850	Ministry of Science and Technology of China [2007DFC30240, 2004BA519A64, 2009ZX10004-101, 2008ZX10002-009, 2011CB504705]; Chinese Academy of Sciences [KSCX2-YW-N-054, KSCX2-YW-R-198]; Innovative Research Group of the National Natural Science Foundation of China (NSFC) [81021003]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Innovative Research Group of the National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from The Ministry of Science and Technology of China (2007DFC30240, 2004BA519A64, 2009ZX10004-101, 2008ZX10002-009, 2011CB504705) and Chinese Academy of Sciences Innovation projects (KSCX2-YW-N-054, KSCX2-YW-R-198). Xin Ye is a principal investigator of the Innovative Research Group of the National Natural Science Foundation of China (NSFC, Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICI C, 1991, J GEN VIROL, V72, P1877, DOI 10.1099/0022-1317-72-8-1877; AMICI C, 1992, P NATL ACAD SCI USA, V89, P6227, DOI 10.1073/pnas.89.14.6227; Broquet AH, 2007, J VIROL, V81, P1297, DOI 10.1128/JVI.01336-06; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Carrello A, 2004, CELL STRESS CHAPERON, V9, P167, DOI 10.1379/CSC-26R.1; Chan W, 2008, VIROLOGY, V380, P304, DOI 10.1016/j.virol.2008.07.027; Chromy LR, 2003, P NATL ACAD SCI USA, V100, P10477, DOI 10.1073/pnas.1832245100; Dalton RM, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-58; Deng T, 2006, J VIROL, V80, P11911, DOI 10.1128/JVI.01565-06; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; DIGARD P, 1989, VIROLOGY, V171, P162, DOI 10.1016/0042-6822(89)90523-0; Doeppner TR, 2009, J CEREBR BLOOD F MET, V29, P1187, DOI 10.1038/jcbfm.2009.44; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fislova T, 2010, J VIROL, V84, P8691, DOI 10.1128/JVI.00813-10; Ghanem A, 2007, J VIROL, V81, P7801, DOI 10.1128/JVI.00724-07; Glotzer JB, 2000, NATURE, V407, P207, DOI 10.1038/35025102; Gonzalez S, 1999, EMBO J, V18, P3767, DOI 10.1093/emboj/18.13.3767; Gonzalez S, 1999, J VIROL, V73, P631; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hirayama E, 2004, J VIROL, V78, P1263, DOI 10.1128/JVI.78.3.1263-1270.2004; Honda A, 2007, GENES CELLS, V12, P133, DOI 10.1111/j.1365-2443.2007.01047.x; Iordanskiy S, 2004, BLOOD, V104, P1867, DOI 10.1182/blood-2004-01-0081; Iordanskiy S, 2004, J VIROL, V78, P9697, DOI 10.1128/JVI.78.18.9697-9704.2004; Ivanovic T, 2007, J BIOL CHEM, V282, P12210, DOI 10.1074/jbc.M610258200; Jones JC, 2006, J VIROL, V80, P11960, DOI 10.1128/JVI.01678-06; Judd AK, 1997, ANTIMICROB AGENTS CH, V41, P687, DOI 10.1128/AAC.41.3.687; Kawaguchi A, 2005, J VIROL, V79, P732, DOI 10.1128/JVI.79.2.732-744.2005; KOESTLER TP, 1984, P NATL ACAD SCI-BIOL, V81, P4505, DOI 10.1073/pnas.81.14.4505; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Lee MTM, 2002, NUCLEIC ACIDS RES, V30, P429, DOI 10.1093/nar/30.2.429; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Maier HJ, 2008, VIROLOGY, V370, P194, DOI 10.1016/j.virol.2007.08.029; MARK GE, 1979, J VIROL, V29, P744, DOI 10.1128/JVI.29.2.744-752.1979; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Michels AA, 1999, J BIOL CHEM, V274, P36757, DOI 10.1074/jbc.274.51.36757; MILARSKI KL, 1986, P NATL ACAD SCI USA, V83, P9517, DOI 10.1073/pnas.83.24.9517; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; Nagata K, 2008, REV MED VIROL, V18, P247, DOI 10.1002/rmv.575; Nagel F, 2008, J NEUROSCI METH, V171, P226, DOI 10.1016/j.jneumeth.2008.03.008; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Odunuga OO, 2003, J BIOL CHEM, V278, P6896, DOI 10.1074/jbc.M206867200; Pica F, 2000, ANTIMICROB AGENTS CH, V44, P200, DOI 10.1128/AAC.44.1.200-204.2000; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Pogany J, 2008, P NATL ACAD SCI USA, V105, P19956, DOI 10.1073/pnas.0810851105; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; SANTORO MG, 1988, ARCH VIROL, V99, P89, DOI 10.1007/BF01311026; SANZEZQUERRO JJ, 1995, J VIROL, V69, P2420, DOI 10.1128/JVI.69.4.2420-2426.1995; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Stahl M, 2007, J VIROL, V81, P13354, DOI 10.1128/JVI.01196-07; Vidya Priyadarsini R, 2010, Eur J Pharmacol, V649, P84, DOI 10.1016/j.ejphar.2010.09.020; Wang RYL, 2009, J VIROL, V83, P3276, DOI 10.1128/JVI.02313-08; Watanabe K, 2006, FEBS LETT, V580, P5785, DOI 10.1016/j.febslet.2006.09.040; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	62	54	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16546	10.1371/journal.pone.0016546	http://dx.doi.org/10.1371/journal.pone.0016546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390211	Green Submitted, Green Published, gold			2022-12-25	WOS:000287761700010
J	Pai, VP; Horseman, ND				Pai, Vaibhav P.; Horseman, Nelson D.			Multiple Cellular Responses to Serotonin Contribute to Epithelial Homeostasis	PLOS ONE			English	Article							MAMMARY-GLAND INVOLUTION; STEM-CELLS; TIGHT JUNCTIONS; APOPTOSIS; TURNOVER; CANCER; MECHANISMS; LACTATION; PROSTATE; RELEASE	Epithelial homeostasis incorporates the paradoxical concept of internal change (epithelial turnover) enabling the maintenance of anatomical status quo. Epithelial cell differentiation and cell loss (cell shedding and apoptosis) form important components of epithelial turnover. Although the mechanisms of cell loss are being uncovered the crucial triggers that modulate epithelial turnover through regulation of cell loss remain undetermined. Serotonin is emerging as a common autocrine-paracine regulator in epithelia of multiple organs, including the breast. Here we address whether serotonin affects epithelial turnover. Specifically, serotonin's roles in regulating cell shedding, apoptosis and barrier function of the epithelium. Using in vivo studies in mouse and a robust model of differentiated human mammary duct epithelium (MCF10A), we show that serotonin induces mammary epithelial cell shedding and disrupts tight junctions in a reversible manner. However, upon sustained exposure, serotonin induces apoptosis in the replenishing cell population, causing irreversible changes to the epithelial membrane. The staggered nature of these events induced by serotonin slowly shifts the balance in the epithelium from reversible to irreversible. These finding have very important implications towards our ability to control epithelial regeneration and thus address pathologies of aberrant epithelial turnover, which range from degenerative disorders (e.g.; pancreatitis and thyrioditis) to proliferative disorders (e. g.; mastitis, ductal ectasia, cholangiopathies and epithelial cancers).	[Pai, Vaibhav P.; Horseman, Nelson D.] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati	Pai, VP (corresponding author), Tufts Univ, Dept Biol, Ctr Regenerat & Dev Biol, Medford, MA 02155 USA.	nelson.horseman@uc.edu			National Institutes of Health [DK52134]; Department of the Army [BC052576]; USDA Cooperative State Research, Education and Extension Service [2007-35206-17898]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of the Army; USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work reported here was supported by grants from the National Institutes of Health (DK52134) and Department of the Army (BC052576) (NDH). This project was supported by National Research Initiative Competitive Grant no: 2007-35206-17898 from the USDA Cooperative State Research, Education and Extension Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bement WM, 2002, CURR BIOL, V12, pR12, DOI 10.1016/S0960-9822(01)00639-X; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Bussard KM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2754; Conder R, 2009, CELL, V137, P1185, DOI 10.1016/j.cell.2009.06.006; Corfe BM, 2000, CELL DEATH DIFFER, V7, P234, DOI 10.1038/sj.cdd.4400634; GKONOS PJ, 1995, UROL RES, V23, P81, DOI 10.1007/BF00307937; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; HALL PA, 1994, J CELL SCI, V107, P3569; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hetts SW, 1998, JAMA-J AM MED ASSOC, V279, P300, DOI 10.1001/jama.279.4.300; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jones BA, 1997, AM J PHYSIOL-GASTR L, V273, pG1174, DOI 10.1152/ajpgi.1997.273.6.G1174; LEBLOND C. P., 1964, NAT CANCER INST MONOGR, V14, P119; Lopez JI, 2008, ONCOGENE, V27, P6981, DOI 10.1038/onc.2008.348; MADARA JL, 1990, J MEMBRANE BIOL, V116, P177, DOI 10.1007/BF01868675; MARSHALL AM, 2008, CELL TISSUE RES; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Marzioni M, 2005, GASTROENTEROLOGY, V128, P121, DOI 10.1053/j.gastro.2004.10.002; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Medh RD, 2000, CELL TISSUE RES, V301, P101, DOI 10.1007/s004419900159; Mohammad-Zadeh LF, 2008, J VET PHARMACOL THER, V31, P187, DOI 10.1111/j.1365-2885.2008.00944.x; Molyneux G, 2007, CELL MOL LIFE SCI, V64, P3248, DOI 10.1007/s00018-007-7391-5; Monks J, 2008, BIOL REPROD, V78, P586, DOI 10.1095/biolreprod.107.065045; Norgaard JV, 2008, J DAIRY SCI, V91, P2319, DOI 10.3168/jds.2007-0767; Pai VP, 2008, J BIOL CHEM, V283, P30901, DOI 10.1074/jbc.M802476200; Pai VP, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2448; Pan J, 2006, AM J PHYSIOL-LUNG C, V290, pL185, DOI 10.1152/ajplung.00167.2005; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Park M, 2008, BIOSCI BIOTECH BIOCH, V72, P2456, DOI 10.1271/bbb.80220; PELC SR, 1964, J CELL BIOL, V22, P21, DOI 10.1083/jcb.22.1.21; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Reinhardt TA, 2009, BIOCHEM BIOPH RES CO, V378, P99, DOI 10.1016/j.bbrc.2008.11.004; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Schulte-Hermann R, 1995, Prog Liver Dis, V13, P1; Smith GH, 2001, MICROSC RES TECHNIQ, V52, P190, DOI 10.1002/1097-0029(20010115)52:2<190::AID-JEMT1005>3.0.CO;2-O; Stein T, 2007, J MAMMARY GLAND BIOL, V12, P25, DOI 10.1007/s10911-007-9035-7; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; Sutherland KD, 2007, J MAMMARY GLAND BIOL, V12, P15, DOI 10.1007/s10911-007-9034-8; Suzuki A, 2001, J CLIN INVEST, V108, P749, DOI 10.1172/JCI200112312; Turner JT, 1996, J DENT RES, V75, P935, DOI 10.1177/00220345960750031101; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yu PL, 2001, AM J PHYSIOL-GASTR L, V280, pG1099, DOI 10.1152/ajpgi.2001.280.6.G1099; Yuan TC, 2007, ENDOCR-RELAT CANCER, V14, P531, DOI 10.1677/ERC-07-0061	44	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17028	10.1371/journal.pone.0017028	http://dx.doi.org/10.1371/journal.pone.0017028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390323	Green Published, gold, Green Submitted			2022-12-25	WOS:000287761700026
J	Geiger, TR; Song, JY; Rosado, A; Peeper, DS				Geiger, Thomas R.; Song, Ji-Ying; Rosado, Aranzazu; Peeper, Daniel S.			Functional Characterization of Human Cancer-Derived TRKB Mutations	PLOS ONE			English	Article							NEUROTROPHIC RECEPTOR TRKB; HER2-POSITIVE BREAST-CANCER; ETV6-NTRK3 GENE FUSION; TYROSINE KINASE; CELL-LINES; ADJUVANT CHEMOTHERAPY; ANOIKIS RESISTANCE; COLORECTAL CANCERS; SOMATIC MUTATIONS; LUNG-CANCER	Cancer originates from cells that have acquired mutations in genes critical for controlling cell proliferation, survival and differentiation. Often, tumors continue to depend on these so-called driver mutations, providing the rationale for targeted anticancer therapies. To date, large-scale sequencing analyses have revealed hundreds of mutations in human tumors. However, without their functional validation it remains unclear which mutations correspond to driver, or rather bystander, mutations and, therefore, whether the mutated gene represents a target for therapeutic intervention. In human colorectal tumors, the neurotrophic receptor TRKB has been found mutated on two different sites in its kinase domain (TRKB(T695I) and TRKB(D751N)). Another site, in the extracellular part of TRKB, is mutated in a human lung adenocarcinoma cell line (TRKB(L138F)). Lastly, our own analysis has identified one additional TRKB point mutation proximal to the kinase domain (TRKB(P507L)) in a human melanoma cell line. The functional consequences of all these point mutations, however, have so far remained elusive. Previously, we have shown that TRKB is a potent suppressor of anoikis and that TRKB-expressing cells form highly invasive and metastatic tumors in nude mice. To assess the functional consequences of these four TRKB mutations, we determined their potential to suppress anoikis and to form tumors in nude mice. Unexpectedly, both colon cancer-derived mutants, TRKB(T695I) and TRKB(D751N), displayed reduced activity compared to that of wild-type TRKB. Consistently, upon stimulation with the TRKB ligand BDNF, these mutants were impaired in activating TRKB and its downstream effectors AKT and ERK. The two mutants derived from human tumor cell lines (TRKB(L138F) and TRKB(P507L)) were functionally indistinguishable from wild-type TRKB in both in-vitro and in-vivo assays. In conclusion, we fail to detect any gain-of-function of four cancer-derived TRKB point mutations.	[Geiger, Thomas R.; Rosado, Aranzazu; Peeper, Daniel S.] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Song, Ji-Ying] Netherlands Canc Inst, Dept Expt Anim Pathol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Geiger, TR (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	d.peeper@nki.nl	Peeper, Daniel/AAA-2430-2020	Rosado Diez, Aranzazu/0000-0002-3362-2450	European Union	European Union(European Commission)	This work was supported by a European Union FP6 grant to T. R. G., A. R. and D. S. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; BLAY J, 1984, CELL BIOL INT REP, V8, P551, DOI 10.1016/0309-1651(84)90054-7; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BONGARZONE I, 1989, ONCOGENE, V4, P1457; BRINKLEY BR, 1980, CANCER RES, V40, P3118; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Coxon A, 2005, CANCER RES, V65, P7137, DOI 10.1158/0008-5472.CAN-05-1125; Daniels GM, 1998, METHOD ENZYMOL, V296, P307; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Desmet CJ, 2006, CELL MOL LIFE SCI, V63, P755, DOI 10.1007/s00018-005-5490-8; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Eide FF, 1996, J NEUROSCI, V16, P3123; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Geiger TR, 2005, CANCER RES, V65, P7033, DOI 10.1158/0008-5472.CAN-05-0709; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; Li ZK, 2009, CANCER RES, V69, P7851, DOI 10.1158/0008-5472.CAN-08-4002; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti A, 2008, HUM MUTAT, V29, P609, DOI 10.1002/humu.20707; Ninkina N, 1997, J BIOL CHEM, V272, P13019, DOI 10.1074/jbc.272.20.13019; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Ruggeri BA, 1999, CURR MED CHEM, V6, P845; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Weinstein IB, 1997, CLIN CANCER RES, V3, P2696; WINDISCH JM, 1995, BIOCHEMISTRY-US, V34, P11256, DOI 10.1021/bi00035a035	50	36	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16871	10.1371/journal.pone.0016871	http://dx.doi.org/10.1371/journal.pone.0016871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379385	Green Submitted, Green Published, gold			2022-12-25	WOS:000287482300023
J	Soto-De Leon, S; Camargo, M; Sanchez, R; Munoz, M; Perez-Prados, A; Purroy, A; Patarroyo, ME; Patarroyo, MA				Soto-De Leon, Sara; Camargo, Milena; Sanchez, Ricardo; Munoz, Marina; Perez-Prados, Antonio; Purroy, Antonio; Elkin Patarroyo, Manuel; Alfonso Patarroyo, Manuel			Distribution Patterns of Infection with Multiple Types of Human Papillomaviruses and Their Association with Risk Factors	PLOS ONE			English	Article							CERVICAL-CANCER; GENETIC SUSCEPTIBILITY; AFRICAN-AMERICAN; HPV INFECTION; PCR DETECTION; PRIMER SETS; WOMEN; EPIDEMIOLOGY; PREVALENCE; HLA-DQB1	Background: Infection with multiple types of human papillomavirus (HPV) is one of the main risk factors associated with the development of cervical lesions. In this study, cervical samples collected from 1,810 women with diverse sociocultural backgrounds, who attended to their cervical screening program in different geographical regions of Colombia, were examined for the presence of cervical lesions and HPV by Papanicolau testing and DNA PCR detection, respectively. Principal Findings: The negative binomial distribution model used in this study showed differences between the observed and expected values within some risk factor categories analyzed. Particularly in the case of single infection and coinfection with more than 4 HPV types, observed frequencies were smaller than expected, while the number of women infected with 2 to 4 viral types were higher than expected. Data analysis according to a negative binomial regression showed an increase in the risk of acquiring more HPV types in women who were of indigenous ethnicity (+37.8%), while this risk decreased in women who had given birth more than 4 times (-31.1%), or were of mestizo (-24.6%) or black (-40.9%) ethnicity. Conclusions: According to a theoretical probability distribution, the observed number of women having either a single infection or more than 4 viral types was smaller than expected, while for those infected with 2-4 HPV types it was larger than expected. Taking into account that this study showed a higher HPV coinfection rate in the indigenous ethnicity, the role of underlying factors should be assessed in detail in future studies.	[Soto-De Leon, Sara; Camargo, Milena; Sanchez, Ricardo; Munoz, Marina; Elkin Patarroyo, Manuel; Alfonso Patarroyo, Manuel] Fdn Inst Inmunol Colombia, Dept Mol Biol, Bogota, Colombia; [Soto-De Leon, Sara; Camargo, Milena; Munoz, Marina; Alfonso Patarroyo, Manuel] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia; [Sanchez, Ricardo; Elkin Patarroyo, Manuel] Univ Nacl Colombia, Sch Med, Bogota, Colombia; [Perez-Prados, Antonio; Purroy, Antonio] Univ Publ Navarra, Dept Math, Navarra, Spain	Universidad del Rosario; Universidad Nacional de Colombia; Universidad Publica de Navarra	Soto-De Leon, S (corresponding author), Fdn Inst Inmunol Colombia, Dept Mol Biol, Bogota, Colombia.	mapatarr.fidic@gmail.com	Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017; Patarroyo, Manuel A/I-8046-2016; De León, Sara Cecilia Soto/AAF-6301-2021; Leon, Sara Cecilia Soto-De/ABD-3186-2020; Sanchez, Ricardo/K-8254-2015	Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; Patarroyo, Manuel A/0000-0002-4751-2500; De León, Sara Cecilia Soto/0000-0003-4515-6749; Perez Prados, Antonio/0000-0002-6496-4242; Camargo, Milena/0000-0003-0246-0716; Sanchez, Ricardo/0000-0002-7540-4734	Asociacion Investigacion Solidaria SADAR; Caja Navarra (Navarra, Spain); Spanish Agency for International Development Cooperation (AECID) [08-CAP2-0609]	Asociacion Investigacion Solidaria SADAR; Caja Navarra (Navarra, Spain); Spanish Agency for International Development Cooperation (AECID)	This project was funded by Asociacion Investigacion Solidaria SADAR, Caja Navarra (Navarra, Spain) and the Spanish Agency for International Development Cooperation (AECID) (Project 08-CAP2-0609). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonte M, 2008, VACCINE, V26, pL16, DOI 10.1016/j.vaccine.2008.06.008; Au WW, 2004, TOXICOLOGY, V198, P117, DOI 10.1016/j.tox.2004.01.022; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008; CAMARGO M, 2010, ANN EPIDEMI IN PRESS; Castellsague X, 2002, VIRUS RES, V89, P191, DOI 10.1016/S0168-1702(02)00188-0; Cervantes Jorge, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P131, DOI 10.1590/S0036-46652003000300003; Chang DY, 1997, J MED MICROBIOL, V46, P54, DOI 10.1099/00222615-46-1-54; Chaturvedi AK, 2005, CANCER EPIDEM BIOMAR, V14, P2439, DOI 10.1158/1055-9965.EPI-05-0465; Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68; Dal Bello B, 2009, J MED VIROL, V81, P703, DOI 10.1002/jmv.21429; Dao DD, 2005, GYNECOL ONCOL, V96, P349, DOI 10.1016/j.ygyno.2004.10.002; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Depuydt CE, 2007, J CELL MOL MED, V11, P881, DOI 10.1111/j.1582-4934.2007.00073.x; Franco EL, 1999, J INFECT DIS, V180, P1415, DOI 10.1086/315086; Franco EL, 2003, CANCER J, V9, P348, DOI 10.1097/00130404-200309000-00004; Goncalves MAG, 2008, EUR J OBSTET GYN R B, V141, P70, DOI 10.1016/j.ejogrb.2008.06.010; Gauthier A, 2008, EUR J PUBLIC HEALTH, V18, P674, DOI 10.1093/eurpub/ckn064; GREGOIRE L, 1994, INT J CANCER, V57, P504, DOI 10.1002/ijc.2910570411; Haws ALF, 2004, J VIROL METHODS, V122, P87, DOI 10.1016/j.jviromet.2004.08.007; Herrero R, 2008, VACCINE, V26, P4795, DOI 10.1016/j.vaccine.2008.07.002; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Iftner Thomas, 2003, J Natl Cancer Inst Monogr, P80; Javanbakht M, 2010, SEX TRANSM DIS, V37, P68, DOI 10.1097/OLQ.0b013e3181bcd3e7; Karlsen F, 1996, J CLIN MICROBIOL, V34, P2095, DOI 10.1128/JCM.34.9.2095-2100.1996; Kenney JW, 1996, J ADV NURS, V23, P1221, DOI 10.1046/j.1365-2648.1996.11721.x; Kim H, 2009, OCCUP ENVIRON MED, V66, P733, DOI 10.1136/oem.2008.042887; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; Lee Yuan-Ming, 2001, Journal of Microbiology Immunology and Infection, V34, P87; Leon SCSD, 2009, CLIN MICROBIOL INFEC, V15, P100, DOI 10.1111/j.1469-0691.2008.02120.x; Madeleine MM, 2008, CANCER RES, V68, P3532, DOI 10.1158/0008-5472.CAN-07-6471; Mahmud SM, 2007, J INFECT DIS, V196, P82, DOI 10.1086/518612; McLaughlin-Drubin ME, 2003, VIROLOGY, V312, P1, DOI 10.1016/S0042-6822(03)00312-X; Mejlhede N, 2010, APMIS, V118, P346, DOI 10.1111/j.1600-0463.2010.02602.x; Mejlhede N, 2009, APMIS, V117, P108, DOI 10.1111/j.1600-0463.2008.00019.x; Molano M, 2002, BRIT J CANCER, V87, P324, DOI 10.1038/sj.bjc.6600442; Moscicki AB, 2005, J ADOLESCENT HEALTH, V37, pS3, DOI 10.1016/j.jadohealth.2005.09.011; Napoles-Springer A, 1996, J Med Syst, V20, P277, DOI 10.1007/BF02257041; Nelson JH, 2000, J CLIN MICROBIOL, V38, P688, DOI 10.1128/JCM.38.2.688-695.2000; Orjuela K, 2007, DIAGN MICR INFEC DIS, V59, P101, DOI 10.1016/j.diagmicrobio.2007.04.003; Parkin DM, 2008, VACCINE, V26, pM1, DOI 10.1016/j.vaccine.2008.05.010; PISTA A, 2010, CLIN MICROB IN PRESS; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; Ragin Camille C, 2009, Infect Agent Cancer, V4 Suppl 1, pS9, DOI 10.1186/1750-9378-4-S1-S9; Remmerbach TW, 2004, J CLIN VIROL, V30, P302, DOI 10.1016/j.jcv.2003.12.011; Rousseau MC, 2003, CANCER EPIDEM BIOMAR, V12, P1029; Rousseau MC, 2001, J INFECT DIS, V184, P1508, DOI 10.1086/324579; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Souza PSD, 2003, MUTAT RES-REV MUTAT, V544, P375, DOI 10.1016/j.mrrev.2003.06.013; Tabora N, 2009, CANCER CAUSE CONTROL, V20, P1663, DOI 10.1007/s10552-009-9414-z; Tate JE, 1996, MOL CELL PROBE, V10, P347, DOI 10.1006/mcpr.1996.0047; Tonon SA, 2004, INT J INFECT DIS, V8, P13, DOI 10.1016/j.ijid.2003.03.001; Tortolero-Luna G, 1998, Cad Saude Publica, V14 Suppl 3, P149, DOI 10.1590/S0102-311X1998000700015; Van Tine BA, 2004, J VIROL, V78, P11172, DOI 10.1128/JVI.78.20.11172-11186.2004; Villa LL, 1997, ADV CANCER RES, V71, P321, DOI 10.1016/S0065-230X(08)60102-5; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; WHO/ICO Information Centre on HPV and Cervical Cancer, 2007, Vaccine, V25 Suppl 3, pC1; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Winer RL, 2005, J INFECT DIS, V191, P731, DOI 10.1086/427557; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064	60	32	34	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e14705	10.1371/journal.pone.0014705	http://dx.doi.org/10.1371/journal.pone.0014705			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379574	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000287482300008
J	Vogne, C; Bisht, H; Arias, S; Fraile, S; Lal, R; van der Meer, JR				Vogne, Christelle; Bisht, Hansi; Arias, Sagrario; Fraile, Sofia; Lal, Rup; van der Meer, Jan Roelof			Characterisation of the Putative Effector Interaction Site of the Regulatory HbpR Protein from Pseudomonas azelaica by Site-Directed Mutagenesis	PLOS ONE			English	Article							SP STRAIN CF600; TRANSCRIPTIONAL REGULATORS; 2-HYDROXYBIPHENYL DEGRADATION; AROMATIC-COMPOUNDS; GENETIC-EVIDENCE; SWISS-MODEL; TOL PLASMID; NTRC FAMILY; B-LINKER; BINDING	Bacterial transcription activators of the XylR/DmpR subfamily exert their expression control via sigma(54)-dependent RNA polymerase upon stimulation by a chemical effector, typically an aromatic compound. Where the chemical effector interacts with the transcription regulator protein to achieve activation is still largely unknown. Here we focus on the HbpR protein from Pseudomonas azelaica, which is a member of the XylR/DmpR subfamily and responds to biaromatic effectors such as 2-hydroxybiphenyl. We use protein structure modeling to predict folding of the effector recognition domain of HbpR and molecular docking to identify the region where 2-hydroxybiphenyl may interact with HbpR. A large number of site-directed HbpR mutants of residues in-and outside the predicted interaction area was created and their potential to induce reporter gene expression in Escherichia coli from the cognate P(C) promoter upon activation with 2-hydroxybiphenyl was studied. Mutant proteins were purified to study their conformation. Critical residues for effector stimulation indeed grouped near the predicted area, some of which are conserved among XylR/DmpR subfamily members in spite of displaying different effector specificities. This suggests that they are important for the process of effector activation, but not necessarily for effector specificity recognition.	[Vogne, Christelle; Arias, Sagrario; van der Meer, Jan Roelof] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland; [Bisht, Hansi; Lal, Rup] Univ Delhi, Dept Zool, Delhi 110007, India; [Fraile, Sofia] CSIC, Natl Biotechnol Ctr, Madrid, Spain	University of Lausanne; University of Delhi; Consejo Superior de Investigaciones Cientificas (CSIC)	Vogne, C (corresponding author), Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland.	janroelof.vandermeer@unil.ch	van der Meer, Jan Roelof/G-6610-2012; Lal, Rup/AFP-1009-2022; Arias Rivas, Sagrario/G-8082-2012	van der Meer, Jan Roelof/0000-0003-1485-3082; 	Indo-Swiss Joint Research Program [LS04 TRAROMAT]; Spanish government	Indo-Swiss Joint Research Program; Spanish government(Spanish GovernmentEuropean Commission)	This work was supported by a grant under the Indo-Swiss Joint Research Program (http://indo-swiss.epfl.ch/, grant number: LS04 TRAROMAT). S. A. acknowledges support from the Spanish government for a travel grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenghi FLG, 2001, EMBO REP, V2, P409, DOI 10.1093/embo-reports/kve092; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beggah S, 2008, MICROB BIOTECHNOL, V1, P68, DOI 10.1111/j.1751-7915.2007.00008.x; DELGADO A, 1994, J BIOL CHEM, V269, P8059; Devos D, 2002, ENVIRON MICROBIOL, V4, P29, DOI 10.1046/j.1462-2920.2002.00265.x; FERNANDEZ S, 1995, MOL MICROBIOL, V16, P205, DOI 10.1111/j.1365-2958.1995.tb02293.x; Fraile S, 2001, J BACTERIOL, V183, P5571, DOI 10.1128/JB.183.19.5571-5579.2001; Galvao TC, 2007, MOL MICROBIOL, V65, P907, DOI 10.1111/j.1365-2958.2007.05832.x; Garmendia J, 2000, MOL MICROBIOL, V38, P401, DOI 10.1046/j.1365-2958.2000.02139.x; Garmendia J, 2000, MICROBIOL-SGM, V146, P2555, DOI 10.1099/00221287-146-10-2555; Garmendia J, 2001, MOL MICROBIOL, V42, P47, DOI 10.1046/j.1365-2958.2001.02633.x; Jaspers MCM, 2000, J BACTERIOL, V182, P405, DOI 10.1128/JB.182.2.405-417.2000; Jaspers MCM, 2001, MICROBIOL-SGM, V147, P2183, DOI 10.1099/00221287-147-8-2183; Jaspers MCM, 2001, J BACTERIOL, V183, P270, DOI 10.1128/JB.183-1.270-279.2001; Laurie AD, 1999, J BACTERIOL, V181, P531, DOI 10.1128/JB.181.2.531-540.1999; Leahy JG, 1997, APPL ENVIRON MICROB, V63, P3736, DOI 10.1128/AEM.63.9.3736-3739.1997; Neuwald AF, 1999, GENOME RES, V9, P27; Ng LC, 1996, J BIOL CHEM, V271, P17281, DOI 10.1074/jbc.271.29.17281; O'Neill E, 1998, MOL MICROBIOL, V28, P131, DOI 10.1046/j.1365-2958.1998.00780.x; O'Neill E, 2001, EMBO J, V20, P819, DOI 10.1093/emboj/20.4.819; PAVEL H, 1994, J BACTERIOL, V176, P7550, DOI 10.1128/JB.176.24.7550-7557.1994; PerezMartin J, 1996, CELL, V86, P331, DOI 10.1016/S0092-8674(00)80104-X; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; Salto R, 1998, J BACTERIOL, V180, P600, DOI 10.1128/JB.180.3.600-604.1998; Sambrook J, 2001, MOL CLONING LAB MANU; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shingler V, 1996, MOL MICROBIOL, V19, P409, DOI 10.1046/j.1365-2958.1996.388920.x; SHINGLER V, 1994, J BACTERIOL, V176, P1555, DOI 10.1128/jb.176.6.1555-1560.1994; Skarfstad E, 2000, J BACTERIOL, V182, P3008, DOI 10.1128/JB.182.11.3008-3016.2000; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; Tropel D, 2005, FEBS J, V272, P1756, DOI 10.1111/j.1742-4658.2005.04607.x; Tropel D, 2004, ENVIRON MICROBIOL, V6, P1186, DOI 10.1111/j.1462-2920.2004.00645.x; Tropel D, 2002, J BACTERIOL, V184, P2914, DOI 10.1128/JB.184.11.2914-2924.2002; Van Dien SJ, 2003, J THEOR BIOL, V224, P437, DOI 10.1016/S0022-5193(03)00191-7; ZAFRA O, 2010, ENVIRON MICROBIOL, DOI DOI 10.1111/J.1462-2920.2010.02401.X	36	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16539	10.1371/journal.pone.0016539	http://dx.doi.org/10.1371/journal.pone.0016539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379585	Green Published, Green Submitted, gold			2022-12-25	WOS:000287482300017
J	Guigon, CJ; Kim, DW; Willingham, MC; Cheng, SY				Guigon, C. J.; Kim, D. W.; Willingham, M. C.; Cheng, S-y			Mutation of thyroid hormone receptor-beta in mice predisposes to the development of mammary tumors	ONCOGENE			English	Article						thyroid hormone receptor; breast cancer; mammary tumors; Pten; mouse models	BREAST-CANCER RISK; C-ERBA-BETA; HEPATOCELLULAR-CARCINOMA; NUCLEAR RECEPTORS; TRANSGENIC MICE; LIGAND-BINDING; MOUSE MODEL; GENE; EXPRESSION; DISEASE	Correlative data suggest that thyroid hormone receptor-beta (TR beta) mutations could increase the risk of mammary tumor development, but unequivocal evidence is still lacking. To explore the role of TR beta mutants in vivo in breast tumor development and progression, we took advantage of a knock-in mouse model harboring a mutation in the Thrb gene encoding TR beta (Thrb(PV) mouse). Although in adult nulliparous females, a single ThrbPV allele did not contribute to mammary gland abnormalities, the presence of two ThrbPV alleles led to mammary hyperplasia in similar to 36% Thrb(PV/PV) mice. The ThrbPV mutation further markedly augmented the risk of mammary hyperplasia in a mouse model with high susceptibility to mammary tumors (Pten(+/-) mouse), as demonstrated by the occurrence of mammary hyperplasia in similar to 60% of Thrb(PV/+) Pten(+/-) and similar to 77% of Thrb(PV/PV) Pten(+/-) mice versus similar to 33% of Thrb(+/+) Pten(+/-) mice. The Thrb(PV) mutation increased the activity of signal transducer and activator of transcription (STAT5) to increase cell proliferation and the expression of the STAT5 target gene encoding beta-casein in the mammary gland. We next sought to understand the molecular mechanism underlying STAT5 overactivation by TR beta PV. Cell-based studies with a breast cancer cell line (T47D cells) showed that thyroid hormone (T3) repressed STAT5 signaling in TR beta-expressing cells through decreasing STAT5-mediated transcription activity and target gene expression, whereas sustained STAT5 signaling was observed in TR beta PV-expressing cells. Collectively, these findings show for the first time that a TR beta mutation promotes the development of mammary hyperplasia via aberrant activation of STAT5, thereby conferring a fertile genetic ground for tumorigenesis. Oncogene (2011) 30, 3381-3390; doi:10.1038/onc.2011.50; published online 14 March 2011	[Guigon, C. J.; Kim, D. W.; Cheng, S-y] NCI, Mol Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Willingham, M. C.] Wake Forest Univ, Dept Pathol, Winston Salem, NC 27109 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Wake Forest University	Cheng, SY (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, 37 Convent Dr,Room 5128, Bethesda, MD 20892 USA.	chengs@mail.nih.gov	guigon, celine/L-3518-2017	guigon, celine/0000-0002-4489-4304	Center for Cancer Research, National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011191] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr L Fozzatti for her help in mouse dissection, Dr C Lu for taking mouse body pictures, and Drs B Vonderhaar and E Ginsburg for providing T47D cells and helpful technical advice. This research was supported by the Intramural Research Program of Center for Cancer Research, National Cancer Institute, National Institutes of Health.	Agarwal Dwarka P, 2007, J Cancer Res Ther, V3, P172; Alberg Anthony J., 1997, Current Opinion in Oncology, V9, P505, DOI 10.1097/00001622-199711000-00003; ALI IU, 1989, J NATL CANCER I, V81, P1815, DOI 10.1093/jnci/81.23.1815; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; ALVARADOPISANI AR, 1986, ANTICANCER RES, V6, P1347; Banneau G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2626; Barash I, 2006, J CELL PHYSIOL, V209, P305, DOI 10.1002/jcp.20771; BARLOW C, 1994, EMBO J, V13, P4241, DOI 10.1002/j.1460-2075.1994.tb06744.x; Beatson G., 1896, LANCET, V2, P104, DOI DOI 10.1016/S0140-6736(01)72307-0; BRINTON LA, 1984, J CHRON DIS, V37, P877, DOI 10.1016/0021-9681(84)90062-6; BRONNEGARD M, 1994, J CLIN ENDOCR METAB, V79, P384, DOI 10.1210/jc.79.2.384; Conde I, 2006, ANN ONCOL, V17, P60, DOI 10.1093/annonc/mdj040; Conzen SD, 2008, MOL ENDOCRINOL, V22, P2215, DOI 10.1210/me.2007-0421; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; Ditsch N, 2010, ANTICANCER RES, V30, P1713; Eilon T, 2007, INT J CANCER, V121, P1892, DOI 10.1002/ijc.22954; Eng C, 2002, ANN NY ACAD SCI, V968, P213, DOI 10.1111/j.1749-6632.2002.tb04337.x; Fang F, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-11; FRANCESCHI S, 1990, EUR J CANCER, V26, P781, DOI 10.1016/0277-5379(90)90151-I; Furumoto H, 2005, MOL CELL BIOL, V25, P124, DOI 10.1128/MCB.25.1.124-135.2005; Giani C, 1996, J CLIN ENDOCR METAB, V81, P990, DOI 10.1210/jc.81.3.990; GOLDMAN MB, 1992, ONCOLOGY-BASEL, V49, P461; Guigon CJ, 2009, ONCOGENE, V28, P509, DOI 10.1038/onc.2008.407; Guigon CJ, 2008, MOL CELL BIOL, V28, P4598, DOI 10.1128/MCB.02192-07; HAYDEN TJ, 1977, J ENDOCRINOL, V75, pP38; HEDLEY AJ, 1981, LANCET, V1, P131; Iavnilovitch E, 2004, INT J CANCER, V112, P607, DOI 10.1002/ijc.20484; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; KALACHE A, 1982, BRIT J SURG, V69, P434, DOI 10.1002/bjs.1800690731; Kaneshige M, 2000, P NATL ACAD SCI USA, V97, P13209, DOI 10.1073/pnas.230285997; Kuijpens JLP, 2005, THYROID, V15, P1253, DOI 10.1089/thy.2005.15.1253; LEMAIRE M, 1986, EUR J CANCER CLIN ON, V22, P301, DOI 10.1016/0277-5379(86)90395-0; Li G, 2002, DEVELOPMENT, V129, P4159; Li Z, 2002, CANCER RES, V62, P1939; Lin KH, 1999, MOL CARCINOGEN, V26, P53, DOI 10.1002/(SICI)1098-2744(199909)26:1<53::AID-MC7>3.0.CO;2-Z; Lynch ED, 1997, AM J HUM GENET, V61, P1254, DOI 10.1086/301639; Manhes C, 2006, J ENDOCRINOL, V190, P271, DOI 10.1677/joe.1.06829; MEIER CA, 1992, MOL ENDOCRINOL, V6, P248, DOI 10.1210/me.6.2.248; MITTRA I, 1974, NATURE, V248, P525, DOI 10.1038/248525a0; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; PARRILLA R, 1991, J CLIN INVEST, V88, P2123, DOI 10.1172/JCI115542; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Puzianowska-Kuznicka M, 2002, J CLIN ENDOCR METAB, V87, P1120, DOI 10.1210/jc.87.3.1120; Rhei E, 1997, CANCER RES, V57, P3657; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; Saraiva PP, 2005, BRAZ J MED BIOL RES, V38, P761, DOI 10.1590/S0100-879X2005000500014; Silva JM, 2002, ONCOGENE, V21, P4307, DOI 10.1038/sj.onc.1205534; Simon MS, 2002, CANCER EPIDEM BIOMAR, V11, P1574; SMYTH PPA, 1993, J ENDOCRINOL INVEST, V16, P396, DOI 10.1007/BF03348865; Smyth PPA, 1997, ANN MED, V29, P189, DOI 10.3109/07853899708999335; Stambolic V, 2000, CANCER RES, V60, P3605; Strain JJ, 1997, NUTR CANCER, V27, P48, DOI 10.1080/01635589709514500; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; TAKATANI O, 1989, CANCER RES, V49, P3109; Thormeyer D, 1999, INT J MOL MED, V4, P351; Tosovic A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2587; Turken O, 2003, BREAST CANCER RES, V5, pR110, DOI 10.1186/bcr609; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; Vonderhaar BK, 1999, ENDOCR-RELAT CANCER, V6, P389, DOI 10.1677/erc.0.0060389; WALLIN G, 1992, THYROID, V2, P307, DOI 10.1089/thy.1992.2.307; Wennbo H, 1997, ENDOCRINOLOGY, V138, P4410, DOI 10.1210/en.138.10.4410; Wyszomierski SL, 1999, MOL ENDOCRINOL, V13, P330, DOI 10.1210/me.13.2.330; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zhang ZX, 1997, J BIOL CHEM, V272, P30607, DOI 10.1074/jbc.272.49.30607; ZUMOFF B, 1981, ANTICANCER RES, V1, P287	65	38	41	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2011	30	30					3381	3390		10.1038/onc.2011.50	http://dx.doi.org/10.1038/onc.2011.50			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	798NO	21399657	Green Accepted			2022-12-25	WOS:000293215700008
J	Nour, AM; Reichelt, M; Ku, CC; Ho, MY; Heineman, TC; Arvin, AM				Nour, Adel M.; Reichelt, Mike; Ku, Chia-Chi; Ho, Min-Yin; Heineman, Thomas C.; Arvin, Ann M.			Varicella-Zoster Virus Infection Triggers Formation of an Interleukin-1 beta (IL-1 beta)-processing Inflammasome Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR MESANGIAL CELLS; INNATE IMMUNE-RESPONSE; NALP3 INFLAMMASOME; AIM2 INFLAMMASOME; MONONUCLEAR-CELLS; CASPASE-1 ACTIVATION; MURINE MACROPHAGES; NLRP3 INFLAMMASOME; VIRAL REPLICATION; DENDRITIC CELLS	Innate cellular immunity is the immediate host response against pathogens, and activation of innate immunity also modulates the induction of adaptive immunity. The nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) are a family of intracellular receptors that recognize conserved patterns associated with intracellular pathogens, but information about their role in the host defense against DNA viruses is limited. Here we report that varicella-zoster virus (VZV), an alphaherpesvirus that is the causative agent of varicella and herpes zoster, induces formation of the NLRP3 inflammasome and the associated processing of the proinflammatory cytokine IL-1 beta by activated caspase-1 in infected cells. NLRP3 inflammasome formation was induced in VZV-infected human THP-1 cells, which are a transformed monocyte cell line, primary lung fibroblasts, and melanoma cells. Absent in melanoma gene-2 (AIM2) is an interferon-inducible protein that can form an alternative inflammasome complex with caspase-1 in virus-infected cells. Experiments in VZV-infected melanoma cells showed that NLRP3 protein recruits the adaptor protein ASC and caspase-1 to form an NLRP3 inflammasome complex independent of AIM2 protein and in the absence of free radical reactive oxygen species release. NLRP3 was also expressed extensively in infected skin xenografts in the severe combined immunodeficiency mouse model of VZV pathogenesis in vivo. We conclude that NLRP3 inflammasome formation is an innate cellular response to infection with this common pathogenic human herpesvirus.	[Nour, Adel M.; Reichelt, Mike; Arvin, Ann M.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Nour, Adel M.; Reichelt, Mike; Arvin, Ann M.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Heineman, Thomas C.] GlaxoSmithKline Biol, King Of Prussia, PA 19101 USA; [Ku, Chia-Chi; Ho, Min-Yin] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan	Stanford University; Stanford University; GlaxoSmithKline; National Taiwan University	Nour, AM (corresponding author), Stanford Univ, Dept Pediat, Sch Med, 300 Pasteur Dr, Stanford, CA 94305 USA.	adelmn@stanford.edu		KU, CHIA-CHI/0000-0002-5740-1505	NCI, National Institutes of Health [AI20459, AI053846, CA49605]; NATIONAL CANCER INSTITUTE [P01CA049605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020459, R01AI053846, R01AI020459] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI20459 and AI053846 and Grant CA49605 from the NCI.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; ARBEIT RD, 1982, INTERVIROLOGY, V18, P56, DOI 10.1159/000149304; Arlehamn CSL, 2010, J BIOL CHEM, V285, P10508, DOI 10.1074/jbc.M109.067298; ARVIN AM, 1986, J INFECT DIS, V154, P422, DOI 10.1093/infdis/154.3.422; Bannister B., 2006, INFECTION MICROBIOLO; BEUSCHER HU, 1990, J IMMUNOL, V144, P2179; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Bruder E, 2000, VIRCHOWS ARCH, V437, P440, DOI 10.1007/s004280000236; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Choubey D, 2000, FEBS LETT, V474, P38, DOI 10.1016/S0014-5793(00)01571-4; Cohen J. I., 2007, VIROLOGY, P2773; COHEN JI, 1993, P NATL ACAD SCI USA, V90, P7376, DOI 10.1073/pnas.90.15.7376; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; DeYoung KL, 1997, ONCOGENE, V15, P453, DOI 10.1038/sj.onc.1201206; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Fujioka N, 1999, J VIROL, V73, P2401, DOI 10.1128/JVI.73.3.2401-2409.1999; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hwang SM, 2009, CELL HOST MICROBE, V5, P166, DOI 10.1016/j.chom.2008.12.013; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Jaworska J, 2007, J VIROL, V81, P5737, DOI 10.1128/JVI.02443-06; Joly S, 2009, J IMMUNOL, V183, P3578, DOI 10.4049/jimmunol.0901323; Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07; KAKIZAKI Y, 1993, CLIN EXP IMMUNOL, V91, P521; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Ku CC, 2004, J EXP MED, V200, P917, DOI 10.1084/jem.20040634; Ku CC, 2011, IMMUNOL CELL BIOL, V89, P173, DOI 10.1038/icb.2010.83; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Lagos D, 2008, CELL HOST MICROBE, V4, P470, DOI 10.1016/j.chom.2008.09.012; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; LOVETT DH, 1988, AM J PATHOL, V133, P472; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2007, EUR J IMMUNOL, V37, P3003, DOI 10.1002/eji.200737871; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; Monack DM, 2000, J EXP MED, V192, P249, DOI 10.1084/jem.192.2.249; Mueller NH, 2008, NEUROL CLIN, V26, P675, DOI 10.1016/j.ncl.2008.03.011; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nour AM, 2009, INFECT IMMUN, V77, P1262, DOI 10.1128/IAI.01032-08; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Reichelt M, 2009, J VIROL, V83, P3904, DOI 10.1128/JVI.02137-08; ROY S, 1995, FEBS LETT, V376, P164, DOI 10.1016/0014-5793(95)01266-X; Sen N, 2010, J VIROL, V84, P9240, DOI 10.1128/JVI.01147-10; Shaikh S, 2002, AM FAM PHYSICIAN, V66, P1723; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Silveira TN, 2010, INFECT IMMUN, V78, P1403, DOI 10.1128/IAI.00905-09; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Squires RC, 2007, J BIOL CHEM, V282, P34260, DOI 10.1074/jbc.M705687200; TAKAHASH.M, 1974, LANCET, V2, P1288, DOI 10.1016/S0140-6736(74)90144-5; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Torigoe S, 2000, MICROBIOL IMMUNOL, V44, P1027, DOI 10.1111/j.1348-0421.2000.tb02599.x; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; WHITACRE CM, 1992, CELL IMMUNOL, V144, P287, DOI 10.1016/0008-8749(92)90245-K; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zhu SM, 2009, J ZHEJIANG UNIV-SC B, V10, P625, DOI 10.1631/jzus.B0920049	77	69	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17921	17933		10.1074/jbc.M110.210575	http://dx.doi.org/10.1074/jbc.M110.210575			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21385879	hybrid, Green Published			2022-12-25	WOS:000290585200055
J	Jaffe, EK; Shanmugam, D; Gardberg, A; Dieterich, S; Sankaran, B; Stewart, LJ; Myler, PJ; Roos, DS				Jaffe, Eileen K.; Shanmugam, Dhanasekaran; Gardberg, Anna; Dieterich, Shellie; Sankaran, Banumathi; Stewart, Lance J.; Myler, Peter J.; Roos, David S.			Crystal Structure of Toxoplasma gondii Porphobilinogen Synthase INSIGHTS ON OCTAMERIC STRUCTURE AND PORPHOBILINOGEN FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUATERNARY STRUCTURE ISOFORMS; X-RAY-STRUCTURE; CATALYZED REACTION; ESCHERICHIA-COLI; ACID; DEHYDRATASE; MORPHEEINS; CRYSTALLOGRAPHY; BIOSYNTHESIS; INHIBITOR	Porphobilinogen synthase (PBGS) is essential for heme biosynthesis, but the enzyme of the protozoan parasite Toxoplasma gondii (TgPBGS) differs from that of its human host in several important respects, including subcellular localization, metal ion dependence, and quaternary structural dynamics. We have solved the crystal structure of TgPBGS, which contains an octamer in the crystallographic asymmetric unit. Crystallized in the presence of substrate, each active site contains one molecule of the product porphobilinogen. Unlike prior structures containing a substrate-derived heterocycle directly bound to an active site zinc ion, the product-bound TgPBGS active site contains neither zinc nor magnesium, placing in question the common notion that all PBGS enzymes require an active site metal ion. Unlike human PBGS, the TgPBGS octamer contains magnesium ions at the intersections between pro-octamer dimers, which are presumed to function in allosteric regulation. TgPBGS includes N- and C-terminal regions that differ considerably from previously solved crystal structures. In particular, the C-terminal extension found in all apicomplexan PBGS enzymes forms an intersubunit beta-sheet, stabilizing a pro-octamer dimer and preventing formation of hexamers that can form in human PBGS. The TgPBGS structure suggests strategies for the development of parasite-selective PBGS inhibitors.	[Jaffe, Eileen K.] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA; [Shanmugam, Dhanasekaran; Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Gardberg, Anna; Dieterich, Shellie; Stewart, Lance J.] Emerald BioStruct Inc, Bainbridge Isl, WA 98110 USA; [Sankaran, Banumathi] Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA; [Myler, Peter J.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Myler, Peter J.] Univ Washington, Dept Global Hlth & Med Educ, Seattle, WA 98195 USA; [Stewart, Lance J.] Univ Washington, Dept Biomed Informat, Seattle, WA 98195 USA; [Gardberg, Anna; Dieterich, Shellie; Stewart, Lance J.; Myler, Peter J.] Seattle Struct Genom Ctr Infect Dis, Seattle, WA 98109 USA	Fox Chase Cancer Center; University of Pennsylvania; Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Jaffe, EK (corresponding author), Fox Chase Canc Ctr, Inst Canc Res, 333 Cottman Ave, Philadelphia, PA 19111 USA.	eileen.jaffe@fccc.edu	Myler, Peter John/AAR-9535-2021	Myler, Peter/0000-0002-0056-0513; Roos, David Siker/0000-0001-6725-4089	National Institutes of Health NIAID [HHSN272200700057C]; NIAID [R56AI077577]; NIEHS [R01ES003654]; National Institutes of Health; NIGMS; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI077577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003654] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health NIAID under Federal Contract HHSN272200700057C, NIAID Grant R56AI077577 (to E. K. J.), and NIEHS Grant R01ES003654 (to E. K. J.). The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, NIGMS, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract DE-AC02-05CH11231.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; BRANDEN C, 1999, INTRO PROTEIN STRUCT, P53; Breinig S, 2003, NAT STRUCT BIOL, V10, P757, DOI 10.1038/nsb963; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coates L, 2005, ACTA CRYSTALLOGR D, V61, P1594, DOI 10.1107/S0907444905030350; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erskine PT, 1997, NAT STRUCT BIOL, V4, P1025, DOI 10.1038/nsb1297-1025; Erskine PT, 2001, FEBS LETT, V503, P196, DOI 10.1016/S0014-5793(01)02721-1; Frankenberg N, 1999, J MOL BIOL, V289, P591, DOI 10.1006/jmbi.1999.2808; Frankenberg N, 1999, BIOCHEMISTRY-US, V38, P13976, DOI 10.1021/bi9906470; Heinemann IU, 2010, ANTIMICROB AGENTS CH, V54, P267, DOI 10.1128/AAC.00553-09; Holliday GL, 2007, NAT PROD REP, V24, P972, DOI 10.1039/b703107f; Jaffe EK, 2004, BIOORG CHEM, V32, P316, DOI 10.1016/j.bioorg.2004.05.010; Jaffe EK, 2003, CHEM BIOL, V10, P25, DOI 10.1016/S1074-5521(02)00296-X; JAFFE EK, 1995, BIOCHEMISTRY-US, V34, P244, DOI 10.1021/bi00001a029; JAFFE EK, 1986, J BIOL CHEM, V261, P9348; Jaffe EK, 2005, TRENDS BIOCHEM SCI, V30, P490, DOI 10.1016/j.tibs.2005.07.003; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kervinen J, 2001, BIOCHEMISTRY-US, V40, P8227, DOI 10.1021/bi010656k; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Kokona B, 2008, BIOCHEMISTRY-US, V47, P10649, DOI 10.1021/bi801128d; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawrence SH, 2008, CHEM BIOL, V15, P586, DOI 10.1016/j.chembiol.2008.04.012; Lawrence SH, 2008, BIOCHEM MOL BIOL EDU, V36, P274, DOI 10.1002/bmb.20211; Lawrence SH, 2009, J BIOL CHEM, V284, P35807, DOI 10.1074/jbc.M109.026294; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLSDAVIES NL, 2000, THESIS U SOUTHAMPTON; MITCHELL LW, 1993, ARCH BIOCHEM BIOPHYS, V300, P169, DOI 10.1006/abbi.1993.1024; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Sawada N, 2005, J BIOL INORG CHEM, V10, P199, DOI 10.1007/s00775-005-0629-5; Selwood T, 2008, BIOCHEMISTRY-US, V47, P3245, DOI 10.1021/bi702113z; Shanmugam D, 2010, J BIOL CHEM, V285, P22122, DOI 10.1074/jbc.M110.107243; SPANO AJ, 1991, BIOCHIM BIOPHYS ACTA, V1076, P29, DOI 10.1016/0167-4838(91)90216-M; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tang L, 2006, J BIOL CHEM, V281, P6682, DOI 10.1074/jbc.M511134200; Tang L, 2005, J BIOL CHEM, V280, P15786, DOI 10.1074/jbc.M500218200; Van Voorhis WC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000530	43	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15298	15307		10.1074/jbc.M111.226225	http://dx.doi.org/10.1074/jbc.M111.226225			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21383008	Green Published, hybrid			2022-12-25	WOS:000289788300061
J	Ling, SY; Lin, WC				Ling, Shiyun; Lin, Weei-Chin			EDD Inhibits ATM-mediated Phosphorylation of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; E3 UBIQUITIN LIGASE; TUMOR-SUPPRESSOR GENE; HYPERPLASTIC-DISCS; BINDING-PROTEIN; HISTONE H2AX; ACTIVATION; CANCER; CHECKPOINTS; TOPBP1	The EDD (E3 identified by differential display) gene, first identified as a progestin-induced gene in T-47D breast cancer cells, encodes an E3 ubiquitin ligase with a HECT domain. It was reported that EDD is involved in the G(2)/M progression through ubiquitination of phospho-katanin p60. Previous study has also shown that EDD can act as a transcription cofactor independently of its E3 ligase activity. In this study, we uncover a new role for EDD during cell cycle progression in an E3 ligase-independent manner. We demonstrate that EDD can physically interact with p53 and that this interaction blocks the phosphorylation of p53 by ataxia telangiectasia mutated (ATM). Silencing of EDD induces phosphorylation of p53 at Ser(15) and activates p53 target genes in fibroblasts and some transformed cells without activation of DNA damage response. The G(1)/S arrest induced by EDD depletion depends on p53. On the other hand, overexpression of EDD inhibits p53-Ser(15) phosphorylation and suppresses the induction of p53 target genes during DNA damage, and this effect does not require its E3 ligase activity. Thus, through binding to p53, EDD actively inhibits p53 phosphorylation by ATM and plays a role in ensuring smooth G(1)/S progression.	Baylor Coll Med, Dept Med, Hematol Oncol Sect, Houston, TX 77030 USA; [Lin, Weei-Chin] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Ling, Shiyun] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	Baylor College of Medicine; Baylor College of Medicine; University of Alabama System; University of Alabama Birmingham	Lin, WC (corresponding author), 1 Baylor Plaza,MS BCM187, Houston, TX 77030 USA.	weeichil@bcm.edu	Ling, Shiyun/P-2242-2014		National Institutes of Health [RO1CA100857, RO1CA138641, ARRA 3 P30CA125123-03S5]; Department of Defense [W81XWH-09-1-0338]; NATIONAL CANCER INSTITUTE [R01CA138641, P30CA125123, R01CA100857] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1CA100857, RO1CA138641 (to W.C.L.), and ARRA 3 P30CA125123-03S5 and the Department of Defense Breast Cancer Research Program (Grant W81XWH-09-1-0338) (to W.C.L.).	Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartkova J, 2005, CELL CYCLE, V4, P838, DOI 10.4161/cc.4.6.1742; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cheng WH, 2003, BIOCHEM J, V370, P927, DOI 10.1042/BJ20021870; Clancy JL, 2003, ONCOGENE, V22, P5070, DOI 10.1038/sj.onc.1206775; Dohoney KM, 2004, ONCOGENE, V23, P49, DOI 10.1038/sj.onc.1207005; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; Hu GQ, 2010, J BIOL CHEM, V285, P11800, DOI 10.1074/jbc.M109.079384; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lee JD, 2002, DEVELOPMENT, V129, P5697, DOI 10.1242/dev.00159; Li DWC, 2006, ONCOGENE, V25, P3006, DOI 10.1038/sj.onc.1209334; Lin WC, 2001, GENE DEV, V15, P1833; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Liu K, 2006, EMBO J, V25, P4795, DOI 10.1038/sj.emboj.7601355; Liu K, 2009, MOL CELL BIOL, V29, P2673, DOI 10.1128/MCB.01140-08; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; MacPhail SH, 2003, RADIAT RES, V159, P759, DOI 10.1667/RR3003; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McDonald WJ, 2010, J CELL BIOCHEM, V110, P1123, DOI 10.1002/jcb.22624; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; O'Brien PM, 2008, BRIT J CANCER, V98, P1085, DOI 10.1038/sj.bjc.6604281; Ohshima R, 2007, GENES CELLS, V12, P1339, DOI 10.1111/j.1365-2443.2007.01138.x; Okorokov AL, 2003, CELL CYCLE, V2, P233, DOI 10.4161/cc.2.3.394; Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502; RENZING J, 1995, ONCOGENE, V10, P1865; Sarkaria JN, 1998, CANCER RES, V58, P4375; Saunders DN, 2004, MOL CELL BIOL, V24, P7225, DOI 10.1128/MCB.24.16.7225-7234.2004; Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079	44	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14972	14982		10.1074/jbc.M110.182527	http://dx.doi.org/10.1074/jbc.M110.182527			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21383020	Green Published, hybrid			2022-12-25	WOS:000289788300027
J	Suissa, Y; Ziv, O; Dinur, T; Arama, E; Gerlitz, O				Suissa, Yaron; Ziv, Oren; Dinur, Tama; Arama, Eli; Gerlitz, Offer			The NAB-Brk Signal Bifurcates at JNK to Independently Induce Apoptosis and Compensatory Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA IMAGINAL DISCS; DEVELOPMENTAL CELL-DEATH; CASPASE DRONC; DEPENDENT APOPTOSIS; REAPER; HID; INHIBITION; REQUIRES; DIAP1; REGENERATION	Apoptosis operates to eliminate damaged or potentially dangerous cells. This loss is often compensated by extra proliferation of neighboring cells. Studies in Drosophila imaginal discs suggest that the signal for the additional growth emanates from the dying cells. In particular, it was suggested that the initiator caspase Dronc mediates compensatory proliferation (CP) through Dp53 in wing discs. However, the exact mechanism that governs this CP remained poorly understood. We have previously shown that elimination of misspecified cells due to reduced Dpp signaling is achieved by the interaction of the corepressor NAB with the transcriptional repressor Brk, which in turn induces Jun N-terminal kinase-dependent apoptosis. Here, we performed a systematic in vivo loss-and gain-of-function analysis to study NAB-induced death and CP. Our findings indicate that the NAB primary signal activates JNK, which in turn transmits two independent signals. One triggers apoptosis through the pro-apoptotic proteins Reaper and Hid, which in turn promote activation of caspases by the apoptosome components Ark and Dronc. The other signal induces CP in a manner that is independent of the death signal, Dronc, or Dp53. Once induced, the apoptotic pathway further activates a CP response. Our data suggest that JNK is the candidate factor that differentiates between apoptosis that involves CP and apoptosis that does not.	[Suissa, Yaron; Ziv, Oren; Dinur, Tama; Gerlitz, Offer] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel; [Arama, Eli] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Weizmann Institute of Science	Gerlitz, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel.	offerg@ekmd.huji.ac.il	Arama, Eli/GYJ-0491-2022	Gerlitz, Offer/0000-0002-1574-2088	Israel Science Foundation [869/04]; Israel Cancer Research Foundation; Abisch-Frenkel Foundation [0304624]	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Foundation; Abisch-Frenkel Foundation	This work was supported by Israel Science Foundation Grant 869/04, the Israel Cancer Research Foundation, and Abisch-Frenkel Foundation Grant 0304624.	Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Adrain C, 2006, TRENDS BIOCHEM SCI, V31, P243, DOI 10.1016/j.tibs.2006.03.004; Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Bergantinos C, 2010, DEVELOPMENT, V137, P1169, DOI 10.1242/dev.045559; Bosch M, 2005, DEV BIOL, V280, P73, DOI 10.1016/j.ydbio.2005.01.002; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Burke R, 1996, DEVELOPMENT, V122, P2261; Chew SK, 2004, DEV CELL, V7, P897, DOI 10.1016/j.devcel.2004.09.016; Daish TJ, 2004, DEV CELL, V7, P909, DOI 10.1016/j.devcel.2004.09.018; Ditzel M, 2008, MOL CELL, V32, P540, DOI 10.1016/j.molcel.2008.09.025; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Felix JT, 2007, DEVELOPMENT, V134, P1845, DOI 10.1242/dev.003830; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Igaki T, 2009, APOPTOSIS, V14, P1021, DOI 10.1007/s10495-009-0361-7; Kondo S, 2006, MOL CELL BIOL, V26, P7258, DOI 10.1128/MCB.00183-06; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Lisi S, 2000, GENETICS, V154, P669; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Mattila J, 2005, INT J DEV BIOL, V49, P391, DOI 10.1387/ijdb.052006jm; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Perez-Garijo A, 2009, DEVELOPMENT, V136, P1169, DOI 10.1242/dev.034017; Peters M, 2002, P NATL ACAD SCI USA, V99, P11305, DOI 10.1073/pnas.172382899; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Shapiro PJ, 2008, NAT CELL BIOL, V10, P1440, DOI 10.1038/ncb1803; Smith-Bolton RK, 2009, DEV CELL, V16, P797, DOI 10.1016/j.devcel.2009.04.015; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wells BS, 2006, CURR BIOL, V16, P1606, DOI 10.1016/j.cub.2006.07.046; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Xu DB, 2005, DEVELOPMENT, V132, P2125, DOI 10.1242/dev.01790; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Ziv O, 2009, DEVELOPMENT, V136, P1137, DOI 10.1242/dev.032383	40	15	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15556	15564		10.1074/jbc.M110.193235	http://dx.doi.org/10.1074/jbc.M110.193235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21385866	hybrid, Green Published			2022-12-25	WOS:000289788300083
J	Greenup, AG; Sasani, S; Oliver, SN; Walford, SA; Millar, AA; Trevaskis, B				Greenup, Aaron G.; Sasani, Sharyar; Oliver, Sandra N.; Walford, Sally A.; Millar, Anthony A.; Trevaskis, Ben			Transcriptome Analysis of the Vernalization Response in Barley (Hordeum vulgare) Seedlings	PLOS ONE			English	Article							LOW-TEMPERATURE TOLERANCE; TRITICUM-AESTIVUM L.; NEAR-ISOGENIC LINES; FREEZING TOLERANCE; COLD-ACCLIMATION; GENE-EXPRESSION; FROST TOLERANCE; LOCUS FR-A(M)2; CBF GENES; WHEAT	Temperate cereals, such as wheat (Triticum spp.) and barley (Hordeum vulgare), respond to prolonged cold by becoming more tolerant of freezing (cold acclimation) and by becoming competent to flower (vernalization). These responses occur concomitantly during winter, but vernalization continues to influence development during spring. Previous studies identified VERNALIZATION1 (VRN1) as a master regulator of the vernalization response in cereals. The extent to which other genes contribute to this process is unclear. In this study the Barley1 Affymetrix chip was used to assay gene expression in barley seedlings during short or prolonged cold treatment. Gene expression was also assayed in the leaves of plants after prolonged cold treatment, in order to identify genes that show lasting responses to prolonged cold, which might contribute to vernalization-induced flowering. Many genes showed altered expression in response to short or prolonged cold treatment, but these responses differed markedly. A limited number of genes showed lasting responses to prolonged cold treatment. These include genes known to be regulated by vernalization, such as VRN1 and ODDSOC2, and also contigs encoding a calcium binding protein, 23-KD jasmonate induced proteins, an RNase S-like protein, a PR17d secretory protein and a serine acetyltransferase. Some contigs that were up-regulated by short term cold also showed lasting changes in expression after prolonged cold treatment. These include COLD REGULATED 14B (COR14B) and the barley homologue of WHEAT COLD SPECIFIC 19 (WSC19), which were expressed at elevated levels after prolonged cold. Conversely, two C-REPEAT BINDING FACTOR (CBF) genes showed reduced expression after prolonged cold. Overall, these data show that a limited number of barley genes exhibit lasting changes in expression after prolonged cold treatment, highlighting the central role of VRN1 in the vernalization response in cereals.	[Greenup, Aaron G.; Oliver, Sandra N.; Walford, Sally A.; Trevaskis, Ben] CSIRO, Div Plant Ind, Canberra, ACT, Australia; [Greenup, Aaron G.; Millar, Anthony A.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Sasani, Sharyar] Seed & Plant Improvement Inst, Dept Cereals Res, Tehran, Iran	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University	Greenup, AG (corresponding author), CSIRO, Div Plant Ind, Canberra, ACT, Australia.	Ben.Trevaskis@csiro.au	Walford, Sally/B-5488-2011; sasani, shahryar/U-7757-2019; Millar, Anthony A/C-9323-2009; Trevaskis, Ben/B-5350-2011	sasani, shahryar/0000-0001-9077-3274; Trevaskis, Ben/0000-0001-7277-4994; Millar, Anthony/0000-0002-6668-1326	Commonwealth Scientific and Industrial Research Organization (CSIRO) Division of Plant Industry; CSIRO Office of the Chief Executive (OCE); Australian National University College of Science	Commonwealth Scientific and Industrial Research Organization (CSIRO) Division of Plant Industry(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); CSIRO Office of the Chief Executive (OCE); Australian National University College of Science	This research was supported by the Commonwealth Scientific and Industrial Research Organization (CSIRO) Division of Plant Industry and the CSIRO Office of the Chief Executive (OCE). Aaron Greenup was supported by a scholarship from the Australian National University College of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; CHOUARD P, 1960, ANNU REV PLANT PHYS, V11, P191, DOI 10.1146/annurev.pp.11.060160.001203; Close TJ, 2004, PLANT PHYSIOL, V134, P960, DOI 10.1104/pp.103.034462; Crosatti C, 1999, PLANT PHYSIOL, V119, P671, DOI 10.1104/pp.119.2.671; Danyluk J, 2003, PLANT PHYSIOL, V132, P1849, DOI 10.1104/pp.103.023523; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Dhillon T, 2010, PLANT PHYSIOL, V153, P1846, DOI 10.1104/pp.110.159079; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Doherty CJ, 2009, PLANT CELL, V21, P972, DOI 10.1105/tpc.108.063958; ENTZ MH, 1991, AGRON J, V83, P527, DOI 10.2134/agronj1991.00021962008300030002x; Fowler DB, 1996, THEOR APPL GENET, V93, P554, DOI 10.1007/BF00417947; Francia E, 2004, THEOR APPL GENET, V108, P670, DOI 10.1007/s00122-003-1468-9; Galiba G, 2009, PLANT SCI, V176, P12, DOI 10.1016/j.plantsci.2008.09.016; Garcion C, 2006, TRENDS PLANT SCI, V11, P320, DOI 10.1016/j.tplants.2006.05.009; Gassner G, 1918, Z BOT, V10, P27, DOI DOI 10.1007/BF00709593; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GOTT MB, 1955, ANN BOT, V21, P87; Gray GR, 1997, PLANT PHYSIOL, V114, P467, DOI 10.1104/pp.114.2.467; Greenup AG, 2010, PLANT PHYSIOL, V153, P1062, DOI 10.1104/pp.109.152488; HAYES PM, 1993, GENOME, V36, P66, DOI 10.1139/g93-009; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Hemming MN, 2009, MOL GENET GENOMICS, V282, P107, DOI 10.1007/s00438-009-0449-3; King RW, 2009, FUNCT PLANT BIOL, V36, P1027, DOI 10.1071/FP09170; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Knox AK, 2008, PLANT MOL BIOL, V67, P257, DOI 10.1007/s11103-008-9316-6; Knox AK, 2010, THEOR APPL GENET, V121, P21, DOI 10.1007/s00122-010-1288-7; Kobayashi F, 2005, J EXP BOT, V56, P887, DOI 10.1093/jxb/eri081; Koemel JE, 2004, THEOR APPL GENET, V109, P839, DOI 10.1007/s00122-004-1686-9; Kwon CS, 2009, PLANT J, V60, P112, DOI 10.1111/j.1365-313X.2009.03938.x; Limin AE, 2002, ANN BOT-LONDON, V89, P579, DOI 10.1093/aob/mcf102; Limin AE, 2006, PLANTA, V224, P360, DOI 10.1007/s00425-006-0219-y; Miller AK, 2006, MOL GENET GENOMICS, V275, P193, DOI 10.1007/s00438-005-0076-6; Monroy AF, 2007, PLANT MOL BIOL, V64, P409, DOI 10.1007/s11103-007-9161-z; Murai K, 2003, PLANT CELL PHYSIOL, V44, P1255, DOI 10.1093/pcp/pcg171; Nilan RA, 1971, P388; Oikawa A, 2009, BREEDING SCI, V59, P664, DOI 10.1270/jsbbs.59.664; Oliver SN, 2009, P NATL ACAD SCI USA, V106, P8386, DOI 10.1073/pnas.0903566106; Purvis ON, 1934, ANN BOT-LONDON, V48, P919, DOI 10.1093/oxfordjournals.aob.a090485; ROBERTS DWA, 1990, GENOME, V33, P247, DOI 10.1139/g90-039; SAEED AI, 2006, 9 TM4 MICROARRAY SOF, P134; Sasani S, 2009, J EXP BOT, V60, P2169, DOI 10.1093/jxb/erp098; Shitsukawa N, 2007, GENES GENET SYST, V82, P167, DOI 10.1266/ggs.82.167; Skinner J, 2006, THEOR APPL GENET, V112, P832, DOI 10.1007/s00122-005-0185-y; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stockinger EJ, 2007, PLANT J, V51, P308, DOI 10.1111/j.1365-313X.2007.0141.x; SUTKA J, 1989, EUPHYTICA, V42, P41, DOI 10.1007/BF00042613; Svensson JT, 2006, PLANT PHYSIOL, V141, P257, DOI 10.1104/pp.105.072645; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tommasini L, 2008, FUNCT INTEGR GENOMIC, V8, P387, DOI 10.1007/s10142-008-0081-z; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Trevaskis B, 2003, P NATL ACAD SCI USA, V100, P13099, DOI 10.1073/pnas.1635053100; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Trevaskis B, 2010, FUNCT PLANT BIOL, V37, P479, DOI 10.1071/FP10056; Vagujfalvi A, 2000, MOL GEN GENET, V263, P194, DOI 10.1007/s004380051160; von Zitzewitz J, 2005, PLANT MOL BIOL, V59, P449, DOI 10.1007/s11103-005-0351-2; Winfield MO, 2010, PLANT BIOTECHNOL J, V8, P749, DOI 10.1111/j.1467-7652.2010.00536.x; Winfield MO, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-55; WISE R. P., 2008, PLANT BIOINFORMATICS, P347; Wit E, 2004, STAT MICROARRAYS DES; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100	61	45	46	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17900	10.1371/journal.pone.0017900	http://dx.doi.org/10.1371/journal.pone.0017900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408015	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170900053
J	Miller, N; Saada, R; Fishman, S; Hurwitz, I; Susswein, AJ				Miller, Nimrod; Saada, Ravit; Fishman, Shlomi; Hurwitz, Itay; Susswein, Abraham J.			Neurons Controlling Aplysia Feeding Inhibit Themselves by Continuous NO Production	PLOS ONE			English	Article							IDENTIFIED HISTAMINERGIC NEURON; BUCCAL MOTOR PROGRAMS; NITRIC-OXIDE SYNTHASE; ORTHOGRADE COTRANSMITTER; PROTRACTION PHASE; BEHAVIORAL STATE; CYCLIC-GMP; IN-VITRO; C-PR; FOOD	Background: Neural activity can be affected by nitric oxide (NO) produced by spiking neurons. Can neural activity also be affected by NO produced in neurons in the absence of spiking? Methodology/Principal Findings: Applying an NO scavenger to quiescent Aplysia buccal ganglia initiated fictive feeding, indicating that NO production at rest inhibits feeding. The inhibition is in part via effects on neurons B31/B32, neurons initiating food consumption. Applying NO scavengers or nitric oxide synthase (NOS) blockers to B31/B32 neurons cultured in isolation caused inactive neurons to depolarize and fire, indicating that B31/B32 produce NO tonically without action potentials, and tonic NO production contributes to the B31/B32 resting potentials. Guanylyl cyclase blockers also caused depolarization and firing, indicating that the cGMP second messenger cascade, presumably activated by the tonic presence of NO, contributes to the B31/B32 resting potential. Blocking NO while voltage-clamping revealed an inward leak current, indicating that NO prevents this current from depolarizing the neuron. Blocking nitrergic transmission had no effect on a number of other cultured, isolated neurons. However, treatment with NO blockers did excite cerebral ganglion neuron C-PR, a command-like neuron initiating food-finding behavior, both in situ, and when the neuron was cultured in isolation, indicating that this neuron also inhibits itself by producing NO at rest. Conclusion/Significance: Self-inhibitory, tonic NO production is a novel mechanism for the modulation of neural activity. Localization of this mechanism to critical neurons in different ganglia controlling different aspects of a behavior provides a mechanism by which a humeral signal affecting background NO production, such as the NO precursor L-arginine, could control multiple aspects of the behavior.	[Miller, Nimrod] Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel; Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Miller, N (corresponding author), Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel.	avy@mail.biu.ac.il		Madar, Ravit/0000-0002-2025-8178; Susswein, Abraham J./0000-0001-6107-5901; Miller, Nimrod/0000-0002-2221-139X	Israel Science Foundation [420/06]	Israel Science Foundation(Israel Science Foundation)	The research was supported by grant 420/06 from the Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov I, 2007, J NEUROSCI, V27, P10993, DOI 10.1523/JNEUROSCI.2357-07.2007; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bon CLM, 2003, J NEUROSCI, V23, P1941; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; CHIEL HJ, 1986, J NEUROSCI, V6, P2427; Dembrow NC, 2004, J NEUROSCI, V24, P5230, DOI 10.1523/JNEUROSCI.5649-03.2004; Douglas SJ, 2005, TRENDS NEUROSCI, V28, P644, DOI 10.1016/j.tins.2005.09.006; Elliott CJH, 2002, J EXP BIOL, V205, P877; ELPHICK MR, 1995, J NEUROSCI, V15, P7653; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Fossier P, 1999, NEUROSCIENCE, V93, P597, DOI 10.1016/S0306-4522(99)00165-7; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Garthwaite G, 2006, J NEUROSCI, V26, P7730, DOI 10.1523/JNEUROSCI.1528-06.2006; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Hopper RA, 2006, J NEUROSCI, V26, P11513, DOI 10.1523/JNEUROSCI.2259-06.2006; Hurwitz I, 2003, J NEUROPHYSIOL, V89, P2120, DOI 10.1152/jn.00497.2002; Hurwitz I, 1996, J NEUROPHYSIOL, V75, P1309, DOI 10.1152/jn.1996.75.4.1309; HURWITZ I, 1994, J NEUROPHYSIOL, V71, P1514, DOI 10.1152/jn.1994.71.4.1514; Hurwitz I, 1996, J NEUROPHYSIOL, V75, P1327, DOI 10.1152/jn.1996.75.4.1327; Hurwitz I, 1997, J NEUROPHYSIOL, V78, P1305, DOI 10.1152/jn.1997.78.3.1305; Hurwitz I, 1999, J NEUROPHYSIOL, V81, P521, DOI 10.1152/jn.1999.81.2.521; Hurwitz I, 2008, J NEUROPHYSIOL, V99, P814, DOI 10.1152/jn.00972.2007; JACKLET JW, 1995, J NEUROPHYSIOL, V74, P891, DOI 10.1152/jn.1995.74.2.891; Jacklet JW, 2004, J NEUROPHYSIOL, V91, P656, DOI 10.1152/jn.00409.2003; Jacklet JW, 2001, AM ZOOL, V41, P282, DOI 10.1668/0003-1569(2001)041[0282:NOAAOC]2.0.CO;2; Katzoff A, 2002, J NEUROSCI, V22, P9581; Katzoff A, 2006, J NEUROPHYSIOL, V96, P1247, DOI 10.1152/jn.00056.2006; Katzoff A, 2010, LEARN MEMORY, V17, P839, DOI 10.1101/lm.1624610; Kaun KR, 2009, GENOME, V52, P1, DOI 10.1139/G08-090; Kobayashi S, 2000, NEUROSCI LETT, V285, P209, DOI 10.1016/S0304-3940(00)01079-X; Kobayashi S, 2000, NEUROSCI RES, V38, P27, DOI 10.1016/S0168-0102(00)00136-X; Kupferman I., 1968, Commns Behav Biol, V2A, P13; KUPFERMANN I, 1974, BEHAV BIOL, V10, P89, DOI 10.1016/S0091-6773(74)91694-0; KUPFERMANN I, 1991, BIOL BULL, V180, P262, DOI 10.2307/1542396; KUPFERMANN I, 1974, BEHAV BIOL, V10, P1, DOI 10.1016/S0091-6773(74)91644-7; Kyriakatos A, 2009, J NEUROSCI, V29, P13283, DOI 10.1523/JNEUROSCI.3069-09.2009; Lewin MR, 1999, NAT NEUROSCI, V2, P18, DOI 10.1038/4520; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; LU TZ, 2009, 2009 NEUR M PLANN; Lucas C, 2010, ARCH INSECT BIOCHEM, V74, P52, DOI 10.1002/arch.20363; Lucas C, 2009, P NATL ACAD SCI USA, V106, P6351, DOI 10.1073/pnas.0809463106; Mahadevan A, 2004, J NEUROSCI, V24, P2813, DOI 10.1523/JNEUROSCI.3779-03.2004; MCCAMAN RE, 1985, J NEUROPHYSIOL, V53, P1016, DOI 10.1152/jn.1985.53.4.1016; McLean DL, 2000, J EXP BIOL, V203, P705; McLean DL, 2002, J NEUROSCI, V22, P4175, DOI 10.1523/JNEUROSCI.22-10-04175.2002; MILLER N, 2011, J NEUROPHYS IN PRESS; Miller N, 2008, J EXP BIOL, V211, P2388, DOI 10.1242/jeb.015040; Morgan PT, 2002, J NEUROPHYSIOL, V87, P49, DOI 10.1152/jn.00438.2001; Moroz LL, 1996, J NEUROCHEM, V66, P873; Moroz LL, 2006, J COMP NEUROL, V495, P10, DOI 10.1002/cne.20842; MORTON DW, 1993, J COMP PHYSIOL A, V172, P17, DOI 10.1007/BF00214712; NAGAHAMA T, 1993, J NEUROPHYSIOL, V70, P1231, DOI 10.1152/jn.1993.70.3.1231; Nargeot R, 1999, J NEUROSCI, V19, P2261; RAYPORT SG, 1986, J NEUROSCI, V6, P759; ROSEN SC, 1991, J NEUROSCI, V11, P3630; Saada R, 2009, CURR BIOL, V19, P479, DOI 10.1016/j.cub.2009.01.060; Sasaki K, 2007, J NEUROPHYSIOL, V98, P3796, DOI 10.1152/jn.00965.2007; Schacher S, 1999, J NEUROSCI, V19, P6338; Scholz NL, 2001, J NEUROSCI, V21, P1610, DOI 10.1523/JNEUROSCI.21-05-01610.2001; SCHWARZ M, 1988, BEHAV NEUROSCI, V102, P124, DOI 10.1037/0735-7044.102.1.124; Staras K, 2003, CURR BIOL, V13, P116, DOI 10.1016/S0960-9822(02)01435-5; Straub VA, 2007, J NEUROPHYSIOL, V97, P1088, DOI 10.1152/jn.01048.2006; STUART DK, 1980, J NEUROPHYSIOL, V43, P499, DOI 10.1152/jn.1980.43.2.499; SUSSWEIN AJ, 1988, J NEUROSCI, V8, P2049; TEYKE T, 1990, SCIENCE, V247, P85, DOI 10.1126/science.2294596; WEISS KR, 1986, J NEUROSCI, V6, P2393; Ye XY, 2010, ACS CHEM NEUROSCI, V1, P182, DOI 10.1021/cn900016z	68	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17779	10.1371/journal.pone.0017779	http://dx.doi.org/10.1371/journal.pone.0017779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408021	gold, Green Submitted, Green Published			2022-12-25	WOS:000288170900046
J	Dao, KK; Pey, AL; Gjerde, AU; Teigen, K; Byeon, IJL; Doskeland, SO; Gronenborn, AM; Martinez, A				Dao, Khanh K.; Pey, Angel L.; Gjerde, Anja Underhaug; Teigen, Knut; Byeon, In-Ja L.; Doskeland, Stein O.; Gronenborn, Angela M.; Martinez, Aurora			The Regulatory Subunit of PKA-I Remains Partially Structured and Undergoes beta-Aggregation upon Thermal Denaturation	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; DIFFERENTIAL SCANNING CALORIMETRY; CIRCULAR-DICHROISM SPECTRA; AMYLOID FIBRIL; STRUCTURE REVEALS; ESCHERICHIA-COLI; BINDING-SITES; FORCE-FIELD; CAMP; STABILITY	Background: The regulatory subunit (R) of cAMP-dependent protein kinase (PKA) is a modular flexible protein that responds with large conformational changes to the binding of the effector cAMP. Considering its highly dynamic nature, the protein is rather stable. We studied the thermal denaturation of full-length RI alpha and a truncated RIa(92-381) that contains the tandem cyclic nucleotide binding (CNB) domains A and B. Methodology/Principal Findings: As revealed by circular dichroism (CD) and differential scanning calorimetry, both RIa proteins contain significant residual structure in the heat-denatured state. As evidenced by CD, the predominantly alpha-helical spectrum at 25 degrees C with double negative peaks at 209 and 222 nm changes to a spectrum with a single negative peak at 212-216 nm, characteristic of beta-structure. A similar alpha ->beta transition occurs at higher temperature in the presence of cAMP. Thioflavin T fluorescence and atomic force microscopy studies support the notion that the structural transition is associated with cross-beta-intermolecular aggregation and formation of non-fibrillar oligomers. Conclusions/Significance: Thermal denaturation of RIa leads to partial loss of native packing with exposure of aggregation-prone motifs, such as the B' helices in the phosphate-binding cassettes of both CNB domains. The topology of the beta-sandwiches in these domains favors inter-molecular beta-aggregation, which is suppressed in the ligand-bound states of RI alpha under physiological conditions. Moreover, our results reveal that the CNB domains persist as structural cores through heat-denaturation.	[Dao, Khanh K.; Gjerde, Anja Underhaug; Teigen, Knut; Doskeland, Stein O.; Martinez, Aurora] Univ Bergen, Dept Biomed, Bergen, Norway; [Pey, Angel L.] Univ Granada, Fac Ciencias, Dept Quim Fis, Granada, Spain; [Byeon, In-Ja L.; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA USA	University of Bergen; University of Granada; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dao, KK (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	aurora.martinez@biomed.uib.no	Teigen, Knut/K-3934-2012; Martinez, Aurora/M-3088-2019	Teigen, Knut/0000-0002-7031-9215; Martinez, Aurora/0000-0003-1643-6506; Pey, Angel Luis/0000-0001-7706-3243; Gronenborn, Angela M/0000-0001-9072-3525; Doskeland, Stein Ove/0000-0002-4009-4756	Research Council of Norway; Norwegian Cancer Society; Spanish Ministry of Sciences and Innovation (MICINN)	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Spanish Ministry of Sciences and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was financed in part with grants from The Research Council of Norway and the Norwegian Cancer Society (to AM and SOD). ALP is supported by a Ramon y Cajal research contract from the Spanish Ministry of Sciences and Innovation (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MS, 2002, BIOCHEMISTRY-US, V41, P3819, DOI 10.1021/bi0116700; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Aoki R, 2009, J AGR FOOD CHEM, V57, P4995, DOI 10.1021/jf900168y; Arutyunyan AM, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1378, DOI 10.1023/A:1013337930104; Azakami H, 2005, J AGR FOOD CHEM, V53, P1254, DOI 10.1021/jf049325f; Banky P, 2003, J MOL BIOL, V330, P1117, DOI 10.1016/S0022-2836(03)00552-7; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Byeon IJL, 2010, J BIOL CHEM, V285, P14062, DOI 10.1074/jbc.M110.106666; Canaves JM, 2000, BIOCHEMISTRY-US, V39, P15022, DOI 10.1021/bi001563q; CARNEY JA, 1995, DERMATOL CLIN, V13, P19, DOI 10.1016/S0733-8635(18)30102-5; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Day R, 2002, J MOL BIOL, V322, P189, DOI 10.1016/S0022-2836(02)00672-1; del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M; Deu E, 2007, BIOCHEMISTRY-US, V46, P5810, DOI 10.1021/bi602621t; DOSKELAND SO, 1984, J BIOL CHEM, V259, P2291; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Ferguson N, 2005, J MOL BIOL, V347, P855, DOI 10.1016/j.jmb.2004.12.061; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Greene EL, 2008, HUM MUTAT, V29, P633, DOI 10.1002/humu.20688; Hamada D, 2002, PROTEIN SCI, V11, P2417, DOI 10.1110/ps.0217702; HAYNIE DT, 1993, PROTEINS, V16, P115, DOI 10.1002/prot.340160202; Hilser VJ, 1996, PROTEINS, V26, P123, DOI 10.1002/(SICI)1097-0134(199610)26:2<123::AID-PROT2>3.0.CO;2-H; HOLM L, 1994, PROTEIN ENG, V7, P1449, DOI 10.1093/protein/7.12.1449; Horvath A, 2010, HUM MUTAT, V31, P369, DOI 10.1002/humu.21178; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamerzell TJ, 2008, J PHARM SCI-US, V97, P3494, DOI 10.1002/jps.21269; Kannan N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r264; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kopperud R, 2002, J BIOL CHEM, V277, P13443, DOI 10.1074/jbc.M109869200; Kornev AP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000056; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; LEON DA, 1991, BIOCHEMISTRY-US, V30, P3035, DOI 10.1021/bi00226a008; Leon DA, 2000, BIOCHEMISTRY-US, V39, P5662, DOI 10.1021/bi992819z; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Louis JM, 2005, J MOL BIOL, V348, P687, DOI 10.1016/j.jmb.2005.02.071; Luque I, 1998, PROTEINS, V30, P74, DOI 10.1002/(SICI)1097-0134(199801)30:1<74::AID-PROT7>3.3.CO;2-G; Manno M, 2006, BIOPHYS J, V90, P4585, DOI 10.1529/biophysj.105.077636; Mauro M, 2007, J MOL BIOL, V366, P258, DOI 10.1016/j.jmb.2006.11.008; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Natalello A, 2008, J MOL BIOL, V381, P1349, DOI 10.1016/j.jmb.2008.06.063; PoteetSmith CE, 1997, J BIOL CHEM, V272, P379; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; Shrivastava R, 2007, INT J BIOL MACROMOL, V41, P154, DOI 10.1016/j.ijbiomac.2007.01.010; Soldi G, 2008, J AM CHEM SOC, V130, P4295, DOI 10.1021/ja076628s; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Tang KES, 1998, J BIOMOL STRUCT DYN, V16, P397, DOI 10.1080/07391102.1998.10508256; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Thorolfsson M, 2002, BIOCHEMISTRY-US, V41, P7573, DOI 10.1021/bi0160720; Vetri V, 2007, BIOPHYS CHEM, V125, P184, DOI 10.1016/j.bpc.2006.07.012; Vigil D, 2006, PROTEIN SCI, V15, P113, DOI 10.1110/ps.051723606; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu J, 2004, STRUCTURE, V12, P1057, DOI 10.1016/j.str.2004.03.022; Zhou A, 2008, J MOL BIOL, V375, P36, DOI 10.1016/j.jmb.2007.10.055	68	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17602	10.1371/journal.pone.0017602	http://dx.doi.org/10.1371/journal.pone.0017602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394209	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000288025500018
J	Neeb, L; Hellen, P; Boehnke, C; Hoffmann, J; Schuh-Hofer, S; Dirnagl, U; Reuter, U				Neeb, Lars; Hellen, Peter; Boehnke, Carsten; Hoffmann, Jan; Schuh-Hofer, Sigrid; Dirnagl, Ulrich; Reuter, Uwe			IL-1 beta Stimulates COX-2 Dependent PGE(2) Synthesis and CGRP Release in Rat Trigeminal Ganglia Cells	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; NECROSIS-FACTOR-ALPHA; PRIMARY AFFERENT NEURONS; NITRIC-OXIDE SYNTHASE; MESSENGER-RNA LEVELS; DORSAL-ROOT GANGLIA; SUBSTANCE-P RELEASE; PROINFLAMMATORY CYTOKINES; PROSTAGLANDIN E-2; MIGRAINE PATIENTS	Objective: Pro-inflammatory cytokines like Interleukin-1 beta (IL-1 beta) have been implicated in the pathophysiology of migraine and inflammatory pain. The trigeminal ganglion and calcitonin gene-related peptide (CGRP) are crucial components in the pathophysiology of primary headaches. 5-HT1B/D receptor agonists, which reduce CGRP release, and cyclooxygenase (COX) inhibitors can abort trigeminally mediated pain. However, the cellular source of COX and the interplay between COX and CGRP within the trigeminal ganglion have not been clearly identified. Methods and Results: 1. We used primary cultured rat trigeminal ganglia cells to assess whether IL-1 beta can induce the expression of COX-2 and which cells express COX-2. Stimulation with IL-1 beta caused a dose and time dependent induction of COX-2 but not COX-1 mRNA. Immunohistochemistry revealed expression of COX-2 protein in neuronal and glial cells. 2. Functional significance was demonstrated by prostaglandin E2 (PGE(2)) release 4 hours after stimulation with IL-1 beta, which could be aborted by a selective COX-2 (parecoxib) and a non-selective COX-inhibitor (indomethacin). 3. Induction of CGRP release, indicating functional neuronal activation, was seen 1 hour after PGE(2) and 24 hours after IL-1 beta stimulation. Immunohistochemistry showed trigeminal neurons as the source of CGRP. IL-1 beta induced CGRP release was blocked by parecoxib and indomethacin, but the 5-HT1B/D receptor agonist sumatriptan had no effect. Conclusion: We identified a COX-2 dependent pathway of cytokine induced CGRP release in trigeminal ganglia neurons that is not affected by 5-HT1B/D receptor activation. Activation of neuronal and glial cells in the trigeminal ganglion by IL-beta leads to an elevated expression of COX-2 in these cells. Newly synthesized PGE(2) (by COX-2) in turn activates trigeminal neurons to release CGRP. These findings support a glia-neuron interaction in the trigeminal ganglion and demonstrate a sequential link between COX-2 and CGRP. The results could help to explain the mechanism of action of COX-2 inhibitors in migraine.	[Neeb, Lars; Hellen, Peter; Boehnke, Carsten; Hoffmann, Jan; Dirnagl, Ulrich; Reuter, Uwe] Charite, Dept Neurol & Expt Neurol, D-13353 Berlin, Germany; [Schuh-Hofer, Sigrid] Univ Klinikum Tubingen, Dept Neurol, Tubingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Neeb, L (corresponding author), Charite, Dept Neurol & Expt Neurol, D-13353 Berlin, Germany.	uwe.reuter@charite.de	Neeb, Lars/ABG-6683-2021; Hoffmann, Jan/AAP-8376-2020	Reuter, Uwe/0000-0002-8527-0725; Dirnagl, Ulrich/0000-0003-0755-6119	Bundesministerium fur Bildung und Forschung [BMBF 01EM 0515]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the Bundesministerium fur Bildung und Forschung (BMBF 01EM 0515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACCAGLINI PI, 1983, P NATL ACAD SCI-BIOL, V80, P594, DOI 10.1073/pnas.80.2.594; Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326; Binshtok AM, 2008, J NEUROSCI, V28, P14062, DOI 10.1523/JNEUROSCI.3795-08.2008; Bowen EJ, 2006, J NEUROCHEM, V96, P65, DOI 10.1111/j.1471-4159.2005.03524.x; Bruno PP, 2007, EUR REV MED PHARMACO, V11, P245; Capuano A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-43; Ceruti S, 2008, CELL CALCIUM, V43, P576, DOI 10.1016/j.ceca.2007.10.003; CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660, DOI 10.1111/j.1476-5381.1992.tb14503.x; Cunha JM, 2000, BRIT J PHARMACOL, V130, P1418, DOI 10.1038/sj.bjp.0703434; Damodaram S, 2009, HEADACHE, V49, P5, DOI 10.1111/j.1526-4610.2008.01262.x; Durham PL, 2006, HEADACHE, V46, P1291, DOI 10.1111/j.1526-4610.2006.00538.x; Durham PL, 1999, J NEUROSCI, V19, P3423; Durham PL, 2006, HEADACHE, V46, pS3, DOI 10.1111/j.1526-4610.2006.00483.x; Durham PL, 2004, HEADACHE, V44, P35, DOI 10.1111/j.1526-4610.2004.04007.x; Eberhardt M, 2009, NEUROPEPTIDES, V43, P483, DOI 10.1016/j.npep.2009.09.002; Ebersberger A, 1999, NEUROSCIENCE, V89, P901, DOI 10.1016/S0306-4522(98)00366-2; EDVINSSON L, 1989, J CEREBR BLOOD F MET, V9, P212, DOI 10.1038/jcbfm.1989.31; Eftekhari S, 2010, NEUROSCIENCE, V169, P683, DOI 10.1016/j.neuroscience.2010.05.016; Fanciullacci Marcello, 1995, Pain, V60, P119, DOI 10.1016/0304-3959(94)00097-X; Fehrenbacher JC, 2005, PAIN, V113, P113, DOI 10.1016/j.pain.2004.09.031; GOEBEL H, 2003, AKTUELLE NEUROLOG S1, P776; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Ho TW, 2008, LANCET, V372, P2115, DOI 10.1016/S0140-6736(08)61626-8; Hou LF, 2003, J NEUROSCI RES, V73, P188, DOI 10.1002/jnr.10651; Igwe OJ, 2001, NEUROSCIENCE, V105, P971, DOI 10.1016/S0306-4522(01)00253-6; Inoue A, 1999, J NEUROCHEM, V73, P2206; Ivanov AI, 2002, AM J PHYSIOL-REG I, V283, pR1104, DOI 10.1152/ajpregu.00347.2002; Jansen-Olesen I, 2005, BASIC CLIN PHARMACOL, V97, P355, DOI 10.1111/j.1742-7843.2005.pto_195.x; Jenkins DW, 2004, NEUROSCI LETT, V366, P241, DOI 10.1016/j.neulet.2004.05.067; Jenkins DW, 2001, BRIT J PHARMACOL, V134, P1296, DOI 10.1038/sj.bjp.0704357; Juhasz G, 2003, PAIN, V106, P461, DOI 10.1016/j.pain.2003.09.008; Kocer A, 2009, PAIN PRACT, V9, P375, DOI 10.1111/j.1533-2500.2009.00301.x; Kuris A, 2007, BRAIN RES, V1173, P6, DOI 10.1016/j.brainres.2007.07.073; Lassen LH, 2002, CEPHALALGIA, V22, P54, DOI 10.1046/j.1468-2982.2002.00310.x; Li J, 2008, BRAIN RES, V1196, P22, DOI 10.1016/j.brainres.2007.12.028; Matsushita K, 2000, J NEUROSCI, V20, P6879, DOI 10.1523/JNEUROSCI.20-18-06879.2000; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; Morioka N, 2002, NEUROPHARMACOLOGY, V43, P868, DOI 10.1016/S0028-3908(02)00143-0; OCONNOR TP, 1988, J NEUROSCI, V8, P2468; OKA T, 1995, BRAIN RES, V692, P123, DOI 10.1016/0006-8993(95)00691-I; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Perini F, 2005, HEADACHE, V45, P926, DOI 10.1111/j.1526-4610.2005.05135.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rasmussen M K, 2001, Curr Med Res Opin, V17 Suppl 1, ps26, DOI 10.1185/0300799039117012; Reuter U, 2001, BRAIN, V124, P2490, DOI 10.1093/brain/124.12.2490; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Sarchielli P, 2006, HEADACHE, V46, P200, DOI 10.1111/j.1526-4610.2006.00337.x; Silberstein S, 2004, NEUROLOGY, V62, P1552, DOI 10.1212/01.WNL.0000123260.61631.C4; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Sommer C, 2004, NEUROSCI LETT, V361, P184, DOI 10.1016/j.neulet.2003.12.007; Storer RJ, 2004, BRIT J PHARMACOL, V142, P1171, DOI 10.1038/sj.bjp.0705807; Takeda M, 2007, PAIN, V129, P155, DOI 10.1016/j.pain.2006.10.007; Thalakoti S, 2007, HEADACHE, V47, P1008, DOI 10.1111/j.1526-4610.2007.00854.x; UDDMAN R, 1985, NEUROSCI LETT, V62, P131, DOI 10.1016/0304-3940(85)90296-4; Waeber C, 2005, NEUROLOGY, V64, pS9, DOI 10.1212/WNL.64.10_suppl_2.S9; Zhang ZM, 2007, J NEUROSCI, V27, P2693, DOI 10.1523/JNEUROSCI.4542-06.2007; Zimmermann K, 2003, PAIN, V103, P313, DOI 10.1016/S0304-3959(02)00459-1	59	97	106	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17360	10.1371/journal.pone.0017360	http://dx.doi.org/10.1371/journal.pone.0017360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394197	Green Published, Green Submitted, gold			2022-12-25	WOS:000288025500011
J	Adekar, SP; Segan, AT; Chen, C; Bermudez, R; Elias, MD; Selling, BH; Kapadnis, BP; Simpson, LL; Simon, PM; Dessain, SK				Adekar, Sharad P.; Segan, Andrew T.; Chen, Cindy; Bermudez, Rodney; Elias, M. D.; Selling, Bernard H.; Kapadnis, B. P.; Simpson, Lance L.; Simon, Paul M.; Dessain, Scott K.			Enhanced Neutralization Potency of Botulinum Neurotoxin Antibodies Using a Red Blood Cell-Targeting Fusion Protein	PLOS ONE			English	Article							CLEARANCE; BINDING; TOXIN; RECEPTOR; SEROTYPE; IDENTIFICATION; STREPTAVIDIN; COMPLEMENT; MECHANISMS; VACCINE	Botulinum neurotoxin (BoNT) potently inhibits cholinergic signaling at the neuromuscular junction. The ideal countermeasures for BoNT exposure are monoclonal antibodies or BoNT antisera, which form BoNT-containing immune complexes that are rapidly cleared from the general circulation. Clearance of opsonized toxins may involve complement receptor-mediated immunoadherence to red blood cells (RBC) in primates or to platelets in rodents. Methods of enhancing immunoadherence of BoNT-specific antibodies may increase their potency in vivo. We designed a novel fusion protein (FP) to link biotinylated molecules to glycophorin A (GPA) on the RBC surface. The FP consists of an scFv specific for murine GPA fused to streptavidin. FP: mAb: BoNT complexes bound specifically to the RBC surface in vitro. In a mouse model of BoNT neutralization, the FP increased the potency of single and double antibody combinations in BoNT neutralization. A combination of two antibodies with the FP gave complete neutralization of 5,000 LD50 BoNT in mice. Neutralization in vivo was dependent on biotinylation of both antibodies and correlated with a reduction of plasma BoNT levels. In a post-exposure model of intoxication, FP: mAb complexes gave complete protection from a lethal BoNT/A1 dose when administered within 2 hours of toxin exposure. In a pre-exposure prophylaxis model, mice were fully protected for 72 hours following administration of the FP: mAb complex. These results demonstrate that RBC-targeted immunoadherence through the FP is a potent enhancer of BoNT neutralization by antibodies in vivo.	[Adekar, Sharad P.; Segan, Andrew T.; Chen, Cindy; Dessain, Scott K.] Lankenau Inst Med Res, Wynnewood, PA USA; [Adekar, Sharad P.; Bermudez, Rodney] Immunome Inc, Wynnewood, PA USA; [Elias, M. D.; Simpson, Lance L.] Thomas Jefferson Univ, Div Infect Dis & Environm Med, Philadelphia, PA 19107 USA; [Selling, Bernard H.] Impact Biol Inc, Wallingford, PA USA; [Kapadnis, B. P.] Univ Pune, Dept Microbiol, Pune, Maharashtra, India; [Adekar, Sharad P.; Simon, Paul M.] Augmenta Biol LLC, Wynnewood, PA USA	Lankenau Medical Center; Lankenau Institute for Medical Research; Jefferson University; Savitribai Phule Pune University	Adekar, SP (corresponding author), Lankenau Inst Med Res, Wynnewood, PA USA.	simonpm@augmentabio.com; scott.dessain@gmail.com		Chen, Cindy/0000-0001-8796-7983	National Institutes of Health, NIAID [R01 AI065967]; Augmenta, LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065967] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Augmenta, LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health, NIAID R01 AI065967 to S. K. D. and institutional support from the Lankenau Institute for Medical Research. Augmenta, LLC, provided support for PMS and contracted Impact Biologicals, Inc. for production of the FP. PMS, as a corresponding author, participated in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Adekar SP, 2008, J IMMUNOL METHODS, V333, P156, DOI 10.1016/j.jim.2008.01.015; Adekar SP, 2008, HYBRIDOMA, V27, P11, DOI 10.1089/hyb.2007.0536; Adekar SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003023; Al-Saleem FH, 2008, J PHARMACOL EXP THER, V326, P856, DOI 10.1124/jpet.108.136242; Alexander JJ, 2001, J BIOL CHEM, V276, P32129, DOI 10.1074/jbc.M101299200; Arnon SS, 2006, NEW ENGL J MED, V354, P462, DOI 10.1056/NEJMoa051926; *CA DEP HLTH, 2009, SUMM BAS APPR BOT IM; CHASIS JA, 1992, BLOOD, V80, P1869; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; DAVIES KA, 1990, J IMMUNOL, V144, P4613; DAVIES KA, 1992, J CLIN INVEST, V90, P2075, DOI 10.1172/JCI116090; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Eubanks LM, 2007, P NATL ACAD SCI USA, V104, P2602, DOI 10.1073/pnas.0611213104; Lindorfer MA, 2001, IMMUNOL REV, V183, P10, DOI 10.1034/j.1600-065x.2001.1830102.x; Mazuet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012416; NELSON RA, 1953, SCIENCE, V118, P733, DOI 10.1126/science.118.3077.733; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; PAHLER A, 1987, J BIOL CHEM, V262, P13933; Pier CL, 2008, INFECT IMMUN, V76, P437, DOI 10.1128/IAI.00843-07; Ravichandran E, 2007, INFECT IMMUN, V75, P3043, DOI 10.1128/IAI.01893-06; Ravichandran E, 2006, J PHARMACOL EXP THER, V318, P1343, DOI 10.1124/jpet.106.104661; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; SANO T, 1990, J BIOL CHEM, V265, P3369; Sepulveda J, 2010, INFECT IMMUN, V78, P756, DOI 10.1128/IAI.01084-09; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Spitzer D, 2004, MOL IMMUNOL, V40, P911, DOI 10.1016/j.molimm.2003.10.017; Takahashi T, 2009, VACCINE, V27, P2616, DOI 10.1016/j.vaccine.2009.02.051; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; Taylor RP, 1997, CANCER IMMUNOL IMMUN, V45, P152, DOI 10.1007/s002620050420	31	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17491	10.1371/journal.pone.0017491	http://dx.doi.org/10.1371/journal.pone.0017491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399689	Green Published, gold, Green Submitted			2022-12-25	WOS:000287933300027
J	Deng, M; Yu, CL; Liang, QA; He, RL; Yau, SST				Deng, Mo; Yu, Chenglong; Liang, Qian; He, Rong L.; Yau, Stephen S. -T.			A Novel Method of Characterizing Genetic Sequences: Genome Space with Biological Distance and Applications	PLOS ONE			English	Article							DNA-SEQUENCES; EVOLUTION; HUMANS; EMERGENCE; VIRUSES; H1	Background: Most existing methods for phylogenetic analysis involve developing an evolutionary model and then using some type of computational algorithm to perform multiple sequence alignment. There are two problems with this approach: (1) different evolutionary models can lead to different results, and (2) the computation time required for multiple alignments makes it impossible to analyse the phylogeny of a whole genome. This motivates us to create a new approach to characterize genetic sequences. Methodology: To each DNA sequence, we associate a natural vector based on the distributions of nucleotides. This produces a one-to-one correspondence between the DNA sequence and its natural vector. We define the distance between two DNA sequences to be the distance between their associated natural vectors. This creates a genome space with a biological distance which makes global comparison of genomes with same topology possible. We use our proposed method to analyze the genomes of the new influenza A (H1N1) virus, human rhinoviruses (HRV) and mammalian mitochondrial. The result shows that a triple-reassortant swine virus circulating in North America and the Eurasian swine virus belong to the lineage of the influenza A (H1N1) virus. For the HRV and mammalian mitochondrial genomes, the results coincide with biologists' analyses. Conclusions: Our approach provides a powerful new tool for analyzing and annotating genomes and their phylogenetic relationships. Whole or partial genomes can be handled more easily and more quickly than using multiple alignment methods. Once a genome space has been constructed, it can be stored in a database. There is no need to reconstruct the genome space for subsequent applications, whereas in multiple alignment methods, realignment is needed to add new sequences. Furthermore, one can make a global comparison of all genomes simultaneously, which no other existing method can achieve.	[Deng, Mo; Liang, Qian; Yau, Stephen S. -T.] Univ Illinois, Dept Math Stat & Comp Sci, Chicago, IL 60680 USA; [Yu, Chenglong] Chinese Univ Hong Kong, Inst Math Sci, Shatin, Hong Kong, Peoples R China; [He, Rong L.] Chicago State Univ, Dept Biol Sci, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Chinese University of Hong Kong; Chicago State University	Deng, M (corresponding author), Univ Illinois, Dept Math Stat & Comp Sci, Chicago, IL 60680 USA.	yau@uic.edu		Yu, Chenglong/0000-0002-0546-2779	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM098180] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1120824] Funding Source: National Science Foundation; NIGMS NIH HHS [SC3 GM098180] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe T, 2003, GENOME RES, V13, P693, DOI 10.1101/gr.634603; AMANO K, 2003, GENOME INFORM, V14, P575; Belshe RB, 2009, NEW ENGL J MED, V360, P2667, DOI 10.1056/NEJMe0903995; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; Carr K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009550; Chuzhanova NA, 1998, BIOINFORMATICS, V14, P139, DOI 10.1093/bioinformatics/14.2.139; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; EMRICH SJ, 2006, HDB COMPUTATIONAL MO; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Kamimura T., 2003, GENOME INFORM, V14, P350, DOI [10.11234/gi1990.14.350., DOI 10.11234/GI1990.14.350]; KARLIN S, 1994, P NATL ACAD SCI USA, V91, P12832, DOI 10.1073/pnas.91.26.12832; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kingsford C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006402; Kou Z, 2009, CHINESE SCI BULL, V54, P2159, DOI 10.1007/s11434-009-0412-z; Kullberg M, 2006, MOL BIOL EVOL, V23, P1493, DOI 10.1093/molbev/msl027; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu FGR, 2001, SCIENCE, V291, P1786, DOI 10.1126/science.1056346; Liu LB, 2006, MOL PHYLOGENET EVOL, V41, P64, DOI 10.1016/j.ympev.2006.05.019; Ma W, 2009, J MOL GENET MED, V3, P158; Murtagh F., 1985, COMPSTAT LECT, V4; Musto H, 1997, MEM I OSWALDO CRUZ, V92, P835, DOI 10.1590/S0074-02761997000600020; Nakashima H, 1998, DNA Res, V5, P251, DOI 10.1093/dnares/5.5.251; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Raina SZ, 2005, GENOME RES, V15, P665, DOI 10.1101/gr.3128605; SCHOLTISSEK C, 1990, Medical Principles and Practice, V2, P65; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Wang L., 1994, J COMPUT BIOL, V13, P1323; Waterman S. M, 1995, INTRO COMPUTATIONAL; Yau SST, 2003, NUCLEIC ACIDS RES, V31, P3078, DOI 10.1093/nar/gkg432; Yau SST, 2008, DNA CELL BIOL, V27, P241, DOI 10.1089/dna.2007.0676; Yu CL, 2010, DNA RES, V17, P155, DOI 10.1093/dnares/dsq008	35	86	86	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17293	10.1371/journal.pone.0017293	http://dx.doi.org/10.1371/journal.pone.0017293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399690	Green Published, Green Submitted, gold			2022-12-25	WOS:000287933300015
J	Kyba, CCM; Ruhtz, T; Fischer, J; Holker, F				Kyba, Christopher C. M.; Ruhtz, Thomas; Fischer, Juergen; Hoelker, Franz			Cloud Coverage Acts as an Amplifier for Ecological Light Pollution in Urban Ecosystems	PLOS ONE			English	Article							NIGHT-SKY BRIGHTNESS; BREAST-CANCER; AT-NIGHT; BEHAVIOR; ZOOPLANKTON; MOONLIGHT; FLAGSTAFF; ARIZONA; FISH	The diurnal cycle of light and dark is one of the strongest environmental factors for life on Earth. Many species in both terrestrial and aquatic ecosystems use the level of ambient light to regulate their metabolism, growth, and behavior. The sky glow caused by artificial lighting from urban areas disrupts this natural cycle, and has been shown to impact the behavior of organisms, even many kilometers away from the light sources. It could be hypothesized that factors that increase the luminance of the sky amplify the degree of this "ecological light pollution''. We show that cloud coverage dramatically amplifies the sky luminance, by a factor of 10.1 for one location inside of Berlin and by a factor of 2.8 at 32 km from the city center. We also show that inside of the city overcast nights are brighter than clear rural moonlit nights, by a factor of 4.1. These results have important implications for choronobiological and chronoecological studies in urban areas, where this amplification effect has previously not been considered.	[Kyba, Christopher C. M.; Ruhtz, Thomas; Fischer, Juergen] Free Univ Berlin, Inst Space Sci, D-1000 Berlin, Germany; [Kyba, Christopher C. M.; Hoelker, Franz] Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany	Free University of Berlin; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Kyba, CCM (corresponding author), Free Univ Berlin, Inst Space Sci, D-1000 Berlin, Germany.	christopher.kyba@wew.fu-berlin.de	Hölker, Franz/A-5683-2009; Kyba, Christopher CM/I-2014-2012; Ruhtz, Thomas/Z-5496-2019	Hölker, Franz/0000-0001-5932-266X; Kyba, Christopher CM/0000-0001-7014-1843; Ruhtz, Thomas/0000-0003-4646-3791	Federal Ministry of Education and Research, Germany [BMBF-033L038A]; MILIEU (FU Berlin)	Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); MILIEU (FU Berlin)	This work was supported by the project Verlust der Nacht (funded by the Federal Ministry of Education and Research, Germany, BMBF-033L038A) and by MILIEU (FU Berlin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aube M., 2007, P STARL 2007 C PALM; Bender DJ, 1996, AM MIDL NAT, V136, P413, DOI 10.2307/2426745; Bergen F, 1997, J ORNITHOL, V138, P451, DOI 10.1007/BF01651380; Boscarino BT, 2009, AQUAT BIOL, V5, P263, DOI 10.3354/ab00161; Bramm ME, 2009, FRESHWATER BIOL, V54, P1093, DOI 10.1111/j.1365-2427.2008.02156.x; BUCHANAN BW, 1993, ANIM BEHAV, V45, P893, DOI 10.1006/anbe.1993.1109; Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; Cinzano P., 2000, Memorie della Societa Astronomica Italiana, V71, P231; Cinzano P., 2005, 9 ISTIL; CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; Duriscoe DM, 2007, PUBL ASTRON SOC PAC, V119, P192, DOI 10.1086/512069; Eisenbeis Gerhard, 2001, Schriftenreihe fuer Landschaftspflege und Naturschutz, V67, P75; Elvidge CD, 2010, SENSORS-BASEL, V10, P3961, DOI 10.3390/s100403961; Evans Ogden LJ, 1996, FATAL LIGHT AWARE PR, V1, P3; Gannon MR, 1997, BIOTROPICA, V29, P525, DOI 10.1111/j.1744-7429.1997.tb00048.x; GARSTANG RH, 1989, PUBL ASTRON SOC PAC, V101, P306, DOI 10.1086/132436; GLIWICZ ZM, 1986, ECOLOGY, V67, P883, DOI 10.2307/1939811; Holker F, 2010, ECOL SOC, V15; Holker F, 2010, TRENDS ECOL EVOL, V25, P681, DOI 10.1016/j.tree.2010.09.007; Kantermann T, 2009, CHRONOBIOL INT, V26, P1069, DOI 10.1080/07420520903223984; Kloog I, 2008, CHRONOBIOL INT, V25, P65, DOI 10.1080/07420520801921572; Kocifaj M, 2010, MON NOT R ASTRON SOC, V403, P2105, DOI 10.1111/j.1365-2966.2010.16241.x; Kocifaj M, 2007, APPL OPTICS, V46, P3013, DOI 10.1364/AO.46.003013; Kokhanovsky A. A., 2005, LIGHT SCATTERING MED; Kokhanovsky AA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD001543; Kollath Z, 2010, J PHYS CONF SER, V218, DOI 10.1088/1742-6596/218/1/012001; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.1890/1540-9295(2004)002[0191:ELP]2.0.CO;2; Luginbuhl CB, 2009, PUBL ASTRON SOC PAC, V121, P185, DOI 10.1086/597625; Luginbuhl CB, 2009, PUBL ASTRON SOC PAC, V121, P204, DOI 10.1086/597626; Meeus JH., 1991, ASTRONOMICAL ALGORIT; Moore Marianne V., 2006, P365; Moore MV, 2000, VERH INT VER LIMNOL, V27, P779, DOI DOI 10.1080/03680770.1998.11901341; Moser JC, 2004, J ZOOL, V264, P69, DOI 10.1017/S0952836904005527; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Petty G. W., 2006, 1 COURSE ATMOSPHERIC, V2; Reiter R.J., 2011, J EXP INTEGR MED, V1, P13, DOI DOI 10.5455/JEIM.101210.IR.001; Rich C., 2006, ECOLOGICAL CONSEQUEN; Salmon M, 1995, J HERPETOL, V29, P568, DOI 10.2307/1564740; Smith M, 2009, NATURE, V457, P27, DOI 10.1038/457027a; SO CW, 2010, THESIS U HONG KONG; STEVENS RG, 1987, AM J EPIDEMIOL, V125, P556, DOI 10.1093/oxfordjournals.aje.a114569; Stevens RG, 2009, INT J EPIDEMIOL, V38, P963, DOI 10.1093/ije/dyp178; *UN, 2009, SKY QUAL MET LENS ET; Woods CP, 2008, WILSON J ORNITHOL, V120, P505, DOI 10.1676/06-067.1; Yela JL, 1997, ENVIRON ENTOMOL, V26, P1283, DOI 10.1093/ee/26.6.1283	45	182	183	4	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17307	10.1371/journal.pone.0017307	http://dx.doi.org/10.1371/journal.pone.0017307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399694	Green Published, gold, Green Submitted			2022-12-25	WOS:000287933300016
J	Wong, PG; Winter, SL; Zaika, E; Cao, TV; Oguz, U; Koomen, JM; Hamlin, JL; Alexandrow, MG				Wong, Philip G.; Winter, Sherry L.; Zaika, Elena; Cao, Thinh V.; Oguz, Umut; Koomen, John M.; Hamlin, Joyce L.; Alexandrow, Mark G.			Cdc45 Limits Replicon Usage from a Low Density of preRCs in Mammalian Cells	PLOS ONE			English	Article							ORIGIN RECOGNITION COMPLEX; XENOPUS EGG EXTRACTS; MINICHROMOSOME MAINTENANCE PROTEINS; EUKARYOTIC DNA-REPLICATION; DIHYDROFOLATE-REDUCTASE ORIGIN; MCM PROTEINS; S-PHASE; SACCHAROMYCES-CEREVISIAE; CHROMATIN ASSOCIATION; BUDDING YEAST	Little is known about mammalian preRC stoichiometry, the number of preRCs on chromosomes, and how this relates to replicon size and usage. We show here that, on average, each 100-kb of the mammalian genome contains a preRC composed of approximately one ORC hexamer, 4-5 MCM hexamers, and 2 Cdc6. Relative to these subunits, similar to 0.35 total molecules of the pre-Initiation Complex factor Cdc45 are present. Thus, based on ORC availability, somatic cells contain similar to 70,000 preRCs of this average total stoichiometry, although subunits may not be juxtaposed with each other. Except for ORC, the chromatin-bound complement of preRC subunits is even lower. Cdc45 is present at very low levels relative to the preRC subunits, but is highly stable, and the same limited number of stable Cdc45 molecules are present from the beginning of S-phase to its completion. Efforts to artificially increase Cdc45 levels through ectopic expression block cell growth. However, microinjection of excess purified Cdc45 into S-phase nuclei activates additional replication foci by threefold, indicating that Cdc45 functions to activate dormant preRCs and is rate-limiting for somatic replicon usage. Paradoxically, although Cdc45 colocalizes in vivo with some MCM sites and is rate-limiting for DNA replication to occur, neither Cdc45 nor MCMs colocalize with active replication sites. Embryonic metazoan chromatin consists of small replicons that are used efficiently via an excess of preRC subunits. In contrast, somatic mammalian cells contain a low density of preRCs, each containing only a few MCMs that compete for limiting amounts of Cdc45. This provides a molecular explanation why, relative to embryonic replicon dynamics, somatic replicons are, on average, larger and origin efficiency tends to be lower. The stable, continuous, and rate-limiting nature of Cdc45 suggests that Cdc45 contributes to the staggering of replicon usage throughout S-phase, and that replicon activation requires reutilization of existing Cdc45 during S-phase.	[Wong, Philip G.; Winter, Sherry L.; Cao, Thinh V.; Koomen, John M.; Alexandrow, Mark G.] H Lee Moffitt Canc Ctr & Res Inst, Program Mol Oncol, Tampa, FL 33612 USA; [Oguz, Umut; Koomen, John M.] H Lee Moffitt Canc Ctr & Res Inst, Prote Facil, Tampa, FL USA; [Zaika, Elena; Hamlin, Joyce L.] Univ Virginia, Charlottesville, VA USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University of Virginia	Wong, PG (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Program Mol Oncol, Tampa, FL 33612 USA.	Mark.Alexandrow@Moffitt.org	Koomen, John/D-1844-2013		Bankhead-Coley; Florida Department of Health [06BS-02-9614]; Analytic Microscopy Facility at Moffitt; NIH [GM26108]; Florida Department of Health; James and Esther King Foundation [06-NIR-01]; NCI [CA130865]; NATIONAL CANCER INSTITUTE [R01CA130865, P30CA076292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026108] Funding Source: NIH RePORTER	Bankhead-Coley; Florida Department of Health; Analytic Microscopy Facility at Moffitt; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; James and Esther King Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Proteomics Facility is supported by the National Functional Genomics Center (DAMD17-02-2-0051), the NCI (P30-CA076292), and the Moffitt Foundation. The triple quadrupole mass spectrometer was purchased with funds from Bankhead-Coley and the Florida Department of Health (06BS-02-9614). This work was supported in part by the Analytic Microscopy Facility at Moffitt. Additional funding was provided by the NIH (to J. L. Hamlin; GM26108), the Florida Department of Health and James and Esther King Foundation (to M. G. Alexandrow; 06-NIR-01), and the NCI (to M. G. Alexandrow; CA130865). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; Alexandrow MG, 2004, MOL CELL BIOL, V24, P1614, DOI 10.1128/MCB.24.4.1614-1627.2004; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; BLOW JJ, 1989, J CELL SCI, P183; Blow JJ, 2001, J CELL BIOL, V152, P15, DOI 10.1083/jcb.152.1.15; Blow JJ, 2001, EMBO J, V20, P3293, DOI 10.1093/emboj/20.13.3293; Blumenthal AB, 1974, COLD SPRING HARB SYM, V38, P205, DOI 10.1101/sqb.1974.038.01.024; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; BURKHART R, 1995, EUR J BIOCHEM, V228, P431; Cadoret JC, 2008, P NATL ACAD SCI USA, V105, P15837, DOI 10.1073/pnas.0805208105; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; DIJKWEL PA, 1994, NUCLEIC ACIDS RES, V22, P4989, DOI 10.1093/nar/22.23.4989; Dijkwel PA, 2000, EXP CELL RES, V256, P150, DOI 10.1006/excr.2000.4809; DIJKWEL PA, 1995, MOL CELL BIOL, V15, P3023; Dijkwel PA, 2002, MOL CELL BIOL, V22, P3053, DOI 10.1128/MCB.22.9.3053-3065.2002; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Harlow E., 1988, ANTIBODIES LAB MANUA; Harvey KJ, 2003, MOL CELL BIOL, V23, P6769, DOI 10.1128/MCB.23.19.6769-6779.2003; Hiraiwa A, 1997, INT J CANCER, V74, P180, DOI 10.1002/(SICI)1097-0215(19970422)74:2<180::AID-IJC7>3.3.CO;2-E; Hua XQH, 1998, J CELL BIOL, V140, P271, DOI 10.1083/jcb.140.2.271; HUBERMAN JA, 1966, P NATL ACAD SCI USA, V55, P599, DOI 10.1073/pnas.55.3.599; HUBERMAN JA, 1995, CELL, V82, P535, DOI 10.1016/0092-8674(95)90025-X; HYRIEN O, 1993, EMBO J, V12, P4511, DOI 10.1002/j.1460-2075.1993.tb06140.x; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ishimi Y, 1996, J BIOL CHEM, V271, P24115, DOI 10.1074/jbc.271.39.24115; Kalejta RF, 1996, MOL CELL BIOL, V16, P4915; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Krude T, 1996, J CELL SCI, V109, P309; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lee C, 2010, MOL CELL BIOL, V30, P423, DOI 10.1128/MCB.01240-09; Lei M, 1996, MOL CELL BIOL, V16, P5081; MADINE MA, 1995, CURR BIOL, V5, P1270, DOI 10.1016/S0960-9822(95)00253-3; MAHBUBANI HM, 1992, NUCLEIC ACIDS RES, V20, P1457, DOI 10.1093/nar/20.7.1457; Mahbubani HM, 1997, J CELL BIOL, V136, P125, DOI 10.1083/jcb.136.1.125; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mesner LD, 2006, MOL CELL, V21, P719, DOI 10.1016/j.molcel.2006.01.015; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Norio P, 2005, MOL CELL, V20, P575, DOI 10.1016/j.molcel.2005.10.029; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Patel PK, 2008, MOL BIOL CELL, V19, P5550, DOI 10.1091/mbc.E08-06-0645; Pollok S, 2007, FEBS J, V274, P3669, DOI 10.1111/j.1742-4658.2007.05900.x; Quintana DG, 1998, J BIOL CHEM, V273, P27137, DOI 10.1074/jbc.273.42.27137; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Ritzi M, 1998, J BIOL CHEM, V273, P24543, DOI 10.1074/jbc.273.38.24543; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; Santocanale C, 1996, EMBO J, V15, P6671, DOI 10.1002/j.1460-2075.1996.tb01057.x; Schulte D, 1996, EUR J BIOCHEM, V235, P144, DOI 10.1111/j.1432-1033.1996.00144.x; Sun W, 2000, J CELL SCI, V113, P683; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Todovov IT, 1998, LAB INVEST, V78, P73; Trivedi A, 1998, DNA CELL BIOL, V17, P885, DOI 10.1089/dna.1998.17.885; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; VAUGHN JP, 1990, CELL, V61, P1075, DOI 10.1016/0092-8674(90)90071-L; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Winter Sherry L., 2009, V523, P27, DOI 10.1007/978-1-59745-190-1_3; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Wu PYJ, 2009, CELL, V136, P852, DOI 10.1016/j.cell.2009.01.017; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; You ZY, 1999, MOL CELL BIOL, V19, P8003; ZIMM S, 1985, CANCER RES, V45, P4156	81	64	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17533	10.1371/journal.pone.0017533	http://dx.doi.org/10.1371/journal.pone.0017533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390258	Green Published, gold, Green Submitted			2022-12-25	WOS:000287932100022
J	Yu, FY; Chen, QA; Yu, XJ; Li, QQ; Ding, BX; Yang, LH; Chen, C; Qin, ZQ; Parsons, C; Zhang, XQ; Huang, JW; Luo, Y; Wang, LX; Pan, JY				Yu, Fangyou; Chen, Qiang; Yu, Xiaojun; Li, Qiaoqiao; Ding, Baixing; Yang, Lehe; Chen, Cong; Qin, Zhiqiang; Parsons, Chris; Zhang, Xueqing; Huang, Jinwei; Luo, Yun; Wang, Liangxing; Pan, Jingye			High Prevalence of Extended-Spectrum Beta Lactamases among Salmonella enterica Typhimurium Isolates from Pediatric Patients with Diarrhea in China	PLOS ONE			English	Article							GENOTYPE DISTRIBUTION; SEROVAR ENTERITIDIS; ESCHERICHIA-COLI; RESISTANCE; EMERGENCE; GENES; CTX-M-15; OUTBREAK	We investigated the extended-spectrum beta lactamases among 62 Salmonella enterica Typhimurium isolates recovered from children with diarrhea in a Chinese pediatric hospital. A large proportion of S. enterica Typhimurium isolates were resistant to multiple antimicrobial agents, including ampicillin (90.3%), tetracycline (80.6%), trimethoprim/sulfamethoxazole (74.2%), chloramphenicol (66.1%), cefotaxime (27.4%). Forty-nine (79.0%) of S. enterica Typhimurium isolates were positive for bla(TEM-1b) and resistant to ampicillin. Thirteen S. enterica Typhimurium isolates (21.0%) were positive for bla(CTX-M-1-group) and bla(CTX-M-9-group), and all isolates harboring bla(CTX-M) genes were positive for ISEcp1. Two main clones (PFGE type A and D) accounted for nearly 70% of S. enterica Typhimurium isolates, and 7 CTX-M-producing isolates belonged to PFGE type D. Collectively, our data reveal multi-drug resistance and a high prevalence of extended spectrum beta lactamases among S. enterica Typhimurium isolates from children in China. In addition, we report the first identification of bla(CTX-M-55) within Salmonella spp. Our data also suggest that clonal spread is responsible for the dissemination of S. enterica Typhimurium isolates.	[Yu, Fangyou; Zhang, Xueqing] Wenzhou Med Coll, Dept Lab Med, Affiliated Hosp 1, Wenzhou, Peoples R China; [Chen, Qiang; Yu, Xiaojun] Jiangxi Prov Children Hosp, Dept Lab Med, Nanchang, Peoples R China; [Li, Qiaoqiao; Yang, Lehe; Wang, Liangxing] Wenzhou Med Coll, Dept Resp Med, Affiliated Hosp 1, Wenzhou, Peoples R China; [Ding, Baixing; Chen, Cong; Pan, Jingye] Wenzhou Med Coll, Dept Intens Care Unit, Affiliated Hosp 1, Wenzhou, Peoples R China; [Qin, Zhiqiang; Parsons, Chris] Med Univ S Carolina, Dept Med, Div Infect Dis, Charleston, SC 29425 USA; [Huang, Jinwei] Lishui Ctr Hosp, Dept Lab Med, Lishui, Peoples R China; [Luo, Yun] Zhejiang Prov Ctr Dis Control & Prevent, Dept Microbiol, Hangzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Medical University of South Carolina; Zhejiang Provincial Center for Disease Control & Prevention	Yu, FY (corresponding author), Wenzhou Med Coll, Dept Lab Med, Affiliated Hosp 1, Wenzhou, Peoples R China.	wzyxywlx@163.com; 081101072@fudan.edu.cn	Chen, Qiang/AAC-3689-2019; chen, qiang/GWZ-7308-2022; Chen, Qiang/GRJ-2224-2022; chen, qiang/HGU-5418-2022	Chen, Qiang/0000-0001-8714-6819; 	Medical Science Fund of Jiangxi Province, China [20094009, 20091256]	Medical Science Fund of Jiangxi Province, China	This work was supported by Medical Science Fund of Jiangxi Province, China (20094009; 20091256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelGhani SMM, 2010, J INFECT DEV COUNTR, V4, P58, DOI 10.3855/jidc.386; Archambault M, 2006, MICROB DRUG RESIST, V12, P192, DOI 10.1089/mdr.2006.12.192; Batchelor M, 2005, ANTIMICROB AGENTS CH, V49, P1319, DOI 10.1128/AAC.49.4.1319-1322.2005; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Bouallegue-Godet O, 2005, J CLIN MICROBIOL, V43, P1037, DOI 10.1128/JCM.43.3.1037-1044.2005; Cheung TKM, 2005, J ANTIMICROB CHEMOTH, V56, P586, DOI 10.1093/jac/dki250; Chyou S C, 1988, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V29, P213; *CLSI, 2008, PERF STAND ANT SUSC; Cui SH, 2009, J ANTIMICROB CHEMOTH, V63, P87, DOI 10.1093/jac/dkn452; Gonzalez-Sanz R, 2009, J ANTIMICROB CHEMOTH, V64, P1181, DOI 10.1093/jac/dkp361; Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514; Hamidian M, 2009, JPN J INFECT DIS, V62, P368; Izumiya H, 2005, ANTIMICROB AGENTS CH, V49, P2568, DOI 10.1128/AAC.49.6.2568-2570.2005; Jiang XF, 2005, J CLIN MICROBIOL, V43, P826, DOI 10.1128/JCM.43.2.826-831.2005; Kiratisin P, 2007, DIAGN MICR INFEC DIS, V58, P349, DOI 10.1016/j.diagmicrobio.2007.02.005; Li WC, 2005, J CLIN MICROBIOL, V43, P3237, DOI 10.1128/JCM.43.7.3237-3243.2005; Liu WE, 2009, J ANTIMICROB CHEMOTH, V63, P895, DOI 10.1093/jac/dkp068; Rotimi VO, 2008, J MED MICROBIOL, V57, P881, DOI 10.1099/jmm.0.47509-0; Shi WF, 2009, CHINESE MED J-PEKING, V122, P1092, DOI 10.3760/cma.j.issn.0366-6999.2009.09.015; SUN Y, 2009, CLIN MICROBIOL INFEC; Touati A, 2008, PEDIATR INFECT DIS J, V27, P479, DOI 10.1097/INF.0b013e31816a35bd; Usha G, 2008, DIAGN MICR INFEC DIS, V62, P86, DOI 10.1016/j.diagmicrobio.2008.04.014; Verdet C, 2000, ANTIMICROB AGENTS CH, V44, P222, DOI 10.1128/AAC.44.1.222-225.2000; Wang MG, 2003, ANTIMICROB AGENTS CH, V47, P2242, DOI 10.1128/AAC.47.7.2242-2248.2003; Xia SL, 2009, J CLIN MICROBIOL, V47, P401, DOI 10.1128/JCM.01099-08; Yin J, 2009, J MED MICROBIOL, V58, P811, DOI 10.1099/jmm.0.006007-0; Yu YS, 2007, J INFECTION, V54, P53, DOI 10.1016/j.jinf.2006.01.014	27	26	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e16801	10.1371/journal.pone.0016801	http://dx.doi.org/10.1371/journal.pone.0016801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390297	Green Published, Green Submitted, gold			2022-12-25	WOS:000287932100004
J	McGowan, PO; Suderman, M; Sasaki, A; Huang, TCT; Hallett, M; Meaney, MJ; Szyf, M				McGowan, Patrick O.; Suderman, Matthew; Sasaki, Aya; Huang, Tony C. T.; Hallett, Michael; Meaney, Michael J.; Szyf, Moshe			Broad Epigenetic Signature of Maternal Care in the Brain of Adult Rats	PLOS ONE			English	Article							RECEPTOR SUBUNIT EXPRESSION; LONG-TERM POTENTIATION; DE-NOVO METHYLATION; PROTOCADHERIN-ALPHA; DNA METHYLATION; ENVIRONMENTAL ENRICHMENT; GLUCOCORTICOID-RECEPTOR; STRESS RESPONSES; MESSENGER-RNA; BREAST-CANCER	Background: Maternal care is associated with long-term effects on behavior and epigenetic programming of the NR3C1 (GLUCOCORTICOID RECEPTOR) gene in the hippocampus of both rats and humans. In the rat, these effects are reversed by cross-fostering, demonstrating that they are defined by epigenetic rather than genetic processes. However, epigenetic changes at a single gene promoter are unlikely to account for the range of outcomes and the persistent change in expression of hundreds of additional genes in adult rats in response to differences in maternal care. Methodology/Principal Findings: We examine here using high-density oligonucleotide array the state of DNA methylation, histone acetylation and gene expression in a 7 million base pair region of chromosome 18 containing the NR3C1 gene in the hippocampus of adult rats. Natural variations in maternal care are associated with coordinate epigenetic changes spanning over a hundred kilobase pairs. The adult offspring of high compared to low maternal care mothers show epigenetic changes in promoters, exons, and gene ends associated with higher transcriptional activity across many genes within the locus examined. Other genes in this region remain unchanged, indicating a clustered yet specific and patterned response. Interestingly, the chromosomal region containing the protocadherin-alpha, -beta, and -gamma (Pcdh) gene families implicated in synaptogenesis show the highest differential response to maternal care. Conclusions/Significance: The results suggest for the first time that the epigenetic response to maternal care is coordinated in clusters across broad genomic areas. The data indicate that the epigenetic response to maternal care involves not only single candidate gene promoters but includes transcriptional and intragenic sequences, as well as those residing distantly from transcription start sites. These epigenetic and transcriptional profiles constitute the first tiling microarray data set exploring the relationship between epigenetic modifications and RNA expression in both protein coding and non-coding regions across a chromosomal locus in the mammalian brain.	[McGowan, Patrick O.; Sasaki, Aya; Meaney, Michael J.] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [McGowan, Patrick O.; Suderman, Matthew; Sasaki, Aya; Meaney, Michael J.; Szyf, Moshe] McGill Univ, Sackler Program Epigenet & Dev Psychobiol, Montreal, PQ, Canada; [McGowan, Patrick O.; Sasaki, Aya] Univ Toronto, Ctr Neurobiol Stress, Toronto, ON, Canada; [Suderman, Matthew; Huang, Tony C. T.; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Suderman, Matthew; Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Meaney, Michael J.] Singapore Inst Clin Sci, Singapore, Singapore; [Meaney, Michael J.; Szyf, Moshe] Canadian Inst Adv Res, Experience Based Brain & Biol Dev Program, Toronto, ON, Canada	McGill University; University of Toronto; McGill University; McGill University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Canadian Institute for Advanced Research (CIFAR)	McGowan, PO (corresponding author), Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	patrick.mcgowan@utoronto.ca; moshe.szyf@mcgill.ca	Meaney, Michael/N-5931-2019	Suderman, Matthew/0000-0002-2715-9930; Hallett, Michael/0000-0001-6738-6786	Canadian Institutes of Mental Health (CIHR); Sackler Foundation	Canadian Institutes of Mental Health (CIHR)(Canadian Institutes of Health Research (CIHR)); Sackler Foundation	This study was supported by grants from the Canadian Institutes of Mental Health (CIHR) and the Sackler Foundation to MJM and MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bredy TW, 2004, EUR J NEUROSCI, V20, P1355, DOI 10.1111/j.1460-9568.2004.03599.x; Bredy TW, 2003, NEUROSCIENCE, V118, P571, DOI 10.1016/S0306-4522(02)00918-1; Bredy TW, 2003, EUR J NEUROSCI, V18, P2903, DOI 10.1111/j.1460-9568.2003.02965.x; Brown SE, 2008, CELL CYCLE, V7, P382, DOI 10.4161/cc.7.3.5283; Caldji C, 2003, NEUROPSYCHOPHARMACOL, V28, P1950, DOI 10.1038/sj.npp.1300237; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Coldwell J, 2006, J CHILD PSYCHOL PSYC, V47, P1116, DOI 10.1111/j.1469-7610.2006.01655.x; COOLEN MW, NAT CELL BIOL, V12, P235; Crane-Robinson C, 1999, METHOD ENZYMOL, V304, P533; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Flanagan JM, 2009, HUM MOL GENET, V18, P1332, DOI 10.1093/hmg/ddp033; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Junghans D, 2005, CURR OPIN CELL BIOL, V17, P446, DOI 10.1016/j.ceb.2005.08.008; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Katori S, 2009, J NEUROSCI, V29, P9137, DOI 10.1523/JNEUROSCI.5478-08.2009; Kawaguchi M, 2008, J BIOL CHEM, V283, P12064, DOI 10.1074/jbc.M709648200; Kendler KS, 2002, AM J PSYCHIAT, V159, P1133, DOI 10.1176/appi.ajp.159.7.1133; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; KOROSI A, DEV PSYCHOBIOL, V52, P661; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; McCormick JA, 2000, MOL ENDOCRINOL, V14, P506, DOI 10.1210/me.14.4.506; McEwen BS, 2003, MENT RETARD DEV D R, V9, P149, DOI 10.1002/mrdd.10074; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Menard JL, 2007, BEHAV BRAIN RES, V176, P302, DOI 10.1016/j.bbr.2006.10.014; Nemeroff CB, 2004, J CLIN PSYCHIAT, V65, P18; Nemeroff CB Charles B, 2004, Psychopharmacol Bull, V38, P14; Nishida H, 2006, CHROMOSOME RES, V14, P203, DOI 10.1007/s10577-006-1036-7; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Ovtscharoff W, 2006, BRAIN RES, V1116, P58, DOI 10.1016/j.brainres.2006.07.106; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Poeggel G, 2003, P NATL ACAD SCI USA, V100, P16137, DOI 10.1073/pnas.2434663100; R Development Core Team, 2007, R LANG ENV STAT COMP; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; RIDEOUT WM, 1994, MOL CELL BIOL, V14, P6143, DOI 10.1128/MCB.14.9.6143; Sadikovic B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002834; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Smith DT, 2009, GENET RES, V91, P237, DOI 10.1017/S0016672309000226; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tang AC, 2002, HIPPOCAMPUS, V12, P398, DOI 10.1002/hipo.10017; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Toki S, 2007, EUR J NEUROSCI, V25, P815, DOI 10.1111/j.1460-9568.2007.05288.x; WAKSHLAK A, 1990, PHYSIOL BEHAV, V48, P289, DOI 10.1016/0031-9384(90)90315-U; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; WILSON DA, 1986, BEHAV BRAIN RES, V21, P223, DOI 10.1016/0166-4328(86)90240-8; Wong DJ, 1999, MOL CELL BIOL, V19, P5642; Yagi T, 2008, DEV GROWTH DIFFER, V50, pS131, DOI 10.1111/j.1440-169X.2008.00991.x; Zou C, 2007, NEUROSCIENCE, V144, P579, DOI 10.1016/j.neuroscience.2006.10.011	57	283	286	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e14739	10.1371/journal.pone.0014739	http://dx.doi.org/10.1371/journal.pone.0014739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386994	Green Published, gold, Green Submitted			2022-12-25	WOS:000287931400004
J	Zhang, HF; Liu, KY; Zhang, X; Tang, W; Wang, JS; Guo, M; Zhao, QA; Zheng, XB; Wang, P; Zhang, ZG				Zhang, Haifeng; Liu, Kaiyue; Zhang, Xing; Tang, Wei; Wang, Jiansheng; Guo, Min; Zhao, Qian; Zheng, Xiaobo; Wang, Ping; Zhang, Zhengguang			Two Phosphodiesterase Genes, PDEL and PDEH, Regulate Development and Pathogenicity by Modulating Intracellular Cyclic AMP Levels in Magnaporthe oryzae	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; RICE BLAST FUNGUS; AFFINITY CAMP-PHOSPHODIESTERASE; SACCHAROMYCES-CEREVISIAE MUTANT; CELL-WALL INTEGRITY; OXIDATIVE STRESS; NUCLEOTIDE PHOSPHODIESTERASE; CATALYTIC SUBUNIT; HYDROPHOBIN GENE; APPRESSORIUM FORMATION	Cyclic AMP (cAMP) signaling plays an important role in regulating multiple cellular responses, such as growth, morphogenesis, and/or pathogenicity of eukaryotic organisms such as fungi. As a second messenger, cAMP is important in the activation of downstream effector molecules. The balance of intracellular cAMP levels depends on biosynthesis by adenylyl cyclases (ACs) and hydrolysis by cAMP phosphodiesterases (PDEases). The rice blast fungus Magnaporthe oryzae contains a high-affinity (PdeH/Pde2) and a low-affinity (PdeL/Pde1) PDEases, and a previous study showed that PdeH has a major role in asexual differentiation and pathogenicity. Here, we show that PdeL is required for asexual development and conidial morphology, and it also plays a minor role in regulating cAMP signaling. This is in contrast to PdeH whose mutation resulted in major defects in conidial morphology, cell wall integrity, and surface hydrophobicity, as well as a significant reduction in pathogenicity. Consistent with both PdeH and PdeL functioning in cAMP signaling, disruption of PDEH only partially rescued the mutant phenotype of Delta magB and Delta pka1. Further studies suggest that PdeH might function through a feedback mechanism to regulate the expression of pathogenicity factor Mpg1 during surface hydrophobicity and pathogenic development. Moreover, microarray data revealed new insights into the underlying cAMP regulatory mechanisms that may help to identify potential pathogenicity factors for the development of new disease management strategies.	[Zhang, Haifeng; Liu, Kaiyue; Zhang, Xing; Tang, Wei; Wang, Jiansheng; Guo, Min; Zhao, Qian; Zheng, Xiaobo; Zhang, Zhengguang] Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Peoples R China; [Zhang, Haifeng; Liu, Kaiyue; Zhang, Xing; Tang, Wei; Wang, Jiansheng; Guo, Min; Zhao, Qian; Zheng, Xiaobo; Zhang, Zhengguang] Minist Agr, Key Lab Monitoring & Management Crop Dis & Pest I, Nanjing, Peoples R China; [Wang, Ping] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA; [Wang, Ping] Louisiana State Univ, Hlth Sci Ctr, Res Inst Children, New Orleans, LA USA	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Zhang, ZG (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Peoples R China.	zhgzhang@njau.edu.cn	Zhang, Zhengguang/F-3917-2014		Special Fund for Agro-scientific Research in the Public Interest [200803008]; Natural Science Foundations of China [30771394, 30971890]; Ministry of Education of China [NCET-07-0442]; US NIH/NIAID [AI054958]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054958] Funding Source: NIH RePORTER	Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); US NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Special Fund for Agro-scientific Research in the Public Interest (200803008 to ZG Zhang), the Natural Science Foundations of China (30771394 and 30971890 to XB Zheng), and the New Century Excellent Scholar Project of the Ministry of Education of China (NCET-07-0442 to ZG Zhang). Research in Ping Wang lab was partially supported by a US grant (NIH/NIAID AI054958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Adachi K, 1998, PLANT CELL, V10, P1361, DOI 10.1105/tpc.10.8.1361; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; APOSTOL I, 1989, PLANT PHYSIOL, V90, P109, DOI 10.1104/pp.90.1.109; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bahn YS, 2003, MOL MICROBIOL, V50, P391, DOI 10.1046/j.1365-2958.2003.03692.x; Banno S, 2005, GENES GENET SYST, V80, P25, DOI 10.1266/ggs.80.25; BARNUN N, 1988, PHYTOCHEMISTRY, V27, P2505, DOI 10.1016/0031-9422(88)87018-3; BELLPEDERSEN D, 1992, GENE DEV, V6, P2382, DOI 10.1101/gad.6.12a.2382; Bencina M, 1997, MICROBIOL-SGM, V143, P1211, DOI 10.1099/00221287-143-4-1211; BRADLEY DJ, 1992, CELL, V70, P21, DOI 10.1016/0092-8674(92)90530-P; Brakhage AA, 2005, MED MYCOL, V43, pS75, DOI 10.1080/13693780400028967; Cabib E, 2001, J BIOL CHEM, V276, P19679, DOI 10.1074/jbc.R000031200; CHARBONNEAU H, 1986, P NATL ACAD SCI USA, V83, P9308, DOI 10.1073/pnas.83.24.9308; Chi MH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000401; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; D'Angelo MA, 2004, BIOCHEM J, V378, P63, DOI 10.1042/BJ20031147; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; Davey J, 1998, YEAST, V14, P1529, DOI 10.1002/(SICI)1097-0061(199812)14:16<1529::AID-YEA357>3.0.CO;2-0; DEVOTI J, 1991, EMBO J, V10, P3759, DOI 10.1002/j.1460-2075.1991.tb04945.x; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Dou XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016439; DUNLAP PV, 1993, J BACTERIOL, V175, P4615, DOI 10.1128/JB.175.15.4615-4624.1993; Durrenberger F, 1998, P NATL ACAD SCI USA, V95, P5684, DOI 10.1073/pnas.95.10.5684; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Fang EGC, 2000, MOL PLANT MICROBE IN, V13, P1214, DOI 10.1094/MPMI.2000.13.11.1214; Gold SE, 1997, PLANT CELL, V9, P1585, DOI 10.1105/tpc.9.9.1585; Grosse C, 2008, APPL ENVIRON MICROB, V74, P4923, DOI 10.1128/AEM.00470-08; Guo M, 2010, MOL PLANT MICROBE IN, V23, P1053, DOI 10.1094/MPMI-23-8-1053; Hicks JK, 2005, EUKARYOT CELL, V4, P1971, DOI 10.1128/EC.4.12.1971-1981.2005; Higuchi T, 2002, MOL CELL BIOL, V22, P1, DOI 10.1128/MCB.22.1.1-11.2002; Hoffman CS, 2005, BIOCHEM SOC T, V33, P257, DOI 10.1042/BST0330257; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; HOYER LL, 1994, MICROBIOL-UK, V140, P1533, DOI 10.1099/13500872-140-7-1533; Ivey FD, 2002, EUKARYOT CELL, V1, P634, DOI 10.1128/EC.1.4.634-642.2002; Jeon J, 2008, MOL PLANT MICROBE IN, V21, P525, DOI 10.1094/MPMI-21-5-0525; Jones DL, 2004, COMP FUNCT GENOM, V5, P419, DOI 10.1002/cfg.415; Jones DL, 2003, PHYSIOL GENOMICS, V16, P107, DOI 10.1152/physiolgenomics.00139.2003; Jung WH, 2005, YEAST, V22, P285, DOI 10.1002/yea.1199; Kays AM, 2004, GENETICS, V166, P1229, DOI 10.1534/genetics.166.3.1229; Kays AM, 2000, MOL CELL BIOL, V20, P7693, DOI 10.1128/MCB.20.20.7693-7705.2000; Kim S, 2005, MOL MICROBIOL, V57, P1224, DOI 10.1111/j.1365-2958.2005.04750.x; Kunz S, 2004, EUR J BIOCHEM, V271, P637, DOI 10.1111/j.1432-1033.2003.03967.x; LACOMBE ML, 1986, J BIOL CHEM, V261, P6811; Lafon A, 2006, FUNGAL GENET BIOL, V43, P490, DOI 10.1016/j.fgb.2006.02.001; Larraya LM, 2005, EUKARYOT CELL, V4, P2029, DOI 10.1128/EC.4.12.2029-2043.2005; Lauge R, 1997, MOL PLANT MICROBE IN, V10, P725, DOI 10.1094/MPMI.1997.10.6.725; LAUTER FR, 1992, GENE DEV, V6, P2373, DOI 10.1101/gad.6.12a.2373; Lee N, 2002, EUKARYOT CELL, V1, P954, DOI 10.1128/EC.1.6.954-966.2002; LEE YH, 1993, PLANT CELL, V5, P693, DOI 10.1105/tpc.5.6.693; Lemaire K, 2004, MOL CELL, V16, P293, DOI 10.1016/j.molcel.2004.10.004; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Liebmann B, 2004, INFECT IMMUN, V72, P5193, DOI 10.1128/IAI.72.9.5193-5203.2004; Liebmann B, 2003, MOL GENET GENOMICS, V269, P420, DOI 10.1007/s00438-003-0852-0; Lin CH, 2009, MOL PLANT MICROBE IN, V22, P942, DOI 10.1094/MPMI-22-8-0942; Liu H, 2007, EMBO J, V26, P690, DOI 10.1038/sj.emboj.7601536; Liu SH, 1997, MOL PLANT MICROBE IN, V10, P1075, DOI 10.1094/MPMI.1997.10.9.1075; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma PS, 1999, MOL BIOL CELL, V10, P91, DOI 10.1091/mbc.10.1.91; Mei CS, 2006, MOL PLANT MICROBE IN, V19, P1127, DOI 10.1094/MPMI-19-1127; Meima ME, 2003, J BIOL CHEM, V278, P14356, DOI 10.1074/jbc.M209648200; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; MITCHELL TK, 1995, PLANT CELL, V7, P1869, DOI 10.1105/tpc.7.11.1869; Moye-Rowley WS, 2003, EUKARYOT CELL, V2, P381, DOI 10.1128/EC.2.3.381-389.2003; NIKAWA J, 1987, GENE DEV, V1, P931, DOI 10.1101/gad.1.9.931; NIKAWA JI, 1987, MOL CELL BIOL, V7, P3629, DOI 10.1128/MCB.7.10.3629; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Oh Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r85; Pan XW, 1999, MOL CELL BIOL, V19, P4874; Park JI, 2005, BIOCHEM BIOPH RES CO, V327, P311, DOI 10.1016/j.bbrc.2004.12.019; PIETERSE CMJ, 1993, PHYSIOL MOL PLANT P, V43, P69, DOI 10.1006/pmpp.1993.1041; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Ramanujam R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000897; Rascon A, 2000, MOL BIOCHEM PARASIT, V106, P283, DOI 10.1016/S0166-6851(99)00224-8; Regenfelder E, 1997, EMBO J, V16, P1934, DOI 10.1093/emboj/16.8.1934; Schneper L, 2004, EUKARYOT CELL, V3, P108, DOI 10.1128/EC.3.1.108-120.2004; Song WW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013193; Spanu P, 1998, PHYSIOL MOL PLANT P, V52, P323, DOI 10.1006/pmpp.1998.0157; Staudohar M, 2002, MICROBIOL-SGM, V148, P2635, DOI 10.1099/00221287-148-8-2635; Stephenson SA, 2000, MOL PLANT MICROBE IN, V13, P929, DOI 10.1094/MPMI.2000.13.9.929; STRINGER MA, 1991, GENE DEV, V5, P1161, DOI 10.1101/gad.5.7.1161; STRINGER MA, 1995, MOL MICROBIOL, V16, P33, DOI 10.1111/j.1365-2958.1995.tb02389.x; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tanaka A, 2006, PLANT CELL, V18, P1052, DOI 10.1105/tpc.105.039263; Toone WM, 1999, CURR OPIN GENET DEV, V9, P55, DOI 10.1016/S0959-437X(99)80008-2; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; vanWetter MA, 1996, FEMS MICROBIOL LETT, V140, P265, DOI 10.1016/0378-1097(96)00192-9; Wilson D, 2007, MOL MICROBIOL, V65, P841, DOI 10.1111/j.1365-2958.2007.05788.x; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Xu JR, 1997, MOL PLANT MICROBE IN, V10, P187, DOI 10.1094/MPMI.1997.10.2.187; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; Yamamoto M, 1996, TRENDS BIOCHEM SCI, V21, P18, DOI 10.1016/0968-0004(96)80880-2; Yi M, 2009, PLANT CELL, V21, P681, DOI 10.1105/tpc.107.055988; Zhang HF, 2010, CURR GENET, V56, P517, DOI 10.1007/s00294-010-0319-x; Zhang HF, 2009, FEMS MICROBIOL LETT, V293, P160, DOI 10.1111/j.1574-6968.2009.01524.x; Zhou ZZ, 2009, MOL PLANT MICROBE IN, V22, P402, DOI 10.1094/MPMI-22-4-0402	99	77	86	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17241	10.1371/journal.pone.0017241	http://dx.doi.org/10.1371/journal.pone.0017241			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386978	gold, Green Published			2022-12-25	WOS:000287931400041
J	Jedelsky, PL; Dolezal, P; Rada, P; Pyrih, J; Smid, O; Hrdy, I; Sedinova, M; Marcincikova, M; Voleman, L; Perry, AJ; Beltran, NC; Lithgow, T; Tachezy, J				Jedelsky, Petr L.; Dolezal, Pavel; Rada, Petr; Pyrih, Jan; Smid, Ondrej; Hrdy, Ivan; Sedinova, Miroslava; Marcincikova, Michaela; Voleman, Lubomir; Perry, Andrew J.; Beltran, Neritza Campo; Lithgow, Trevor; Tachezy, Jan			The Minimal Proteome in the Reduced Mitochondrion of the Parasitic Protist Giardia intestinalis	PLOS ONE			English	Article							GENOME SEQUENCE; CRYPTOSPORIDIUM-PARVUM; TOM COMPLEX; MEMBRANE; IMPORT; TRANSPORTER; ORGANELLE; EVOLUTION; PROTEINS; REMNANT	The mitosomes of Giardia intestinalis are thought to be mitochondria highly-reduced in response to the oxygen-poor niche. We performed a quantitative proteomic assessment of Giardia mitosomes to increase understanding of the function and evolutionary origin of these enigmatic organelles. Mitosome-enriched fractions were obtained from cell homogenate using Optiprep gradient centrifugation. To distinguish mitosomal proteins from contamination, we used a quantitative shot-gun strategy based on isobaric tagging of peptides with iTRAQ and tandem mass spectrometry. Altogether, 638 proteins were identified in mitosome-enriched fractions. Of these, 139 proteins had iTRAQ ratio similar to that of the six known mitosomal markers. Proteins were selected for expression in Giardia to verify their cellular localizations and the mitosomal localization of 20 proteins was confirmed. These proteins include nine components of the FeS cluster assembly machinery, a novel diflavo-protein with NADPH reductase activity, a novel VAMP-associated protein, and a key component of the outer membrane protein translocase. None of the novel mitosomal proteins was predicted by previous genome analyses. The small proteome of the Giardia mitosome reflects the reduction in mitochondrial metabolism, which is limited to the FeS cluster assembly pathway, and a simplicity in the protein import pathway required for organelle biogenesis.	[Jedelsky, Petr L.; Dolezal, Pavel; Rada, Petr; Pyrih, Jan; Smid, Ondrej; Hrdy, Ivan; Sedinova, Miroslava; Marcincikova, Michaela; Voleman, Lubomir; Beltran, Neritza Campo; Tachezy, Jan] Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic; [Jedelsky, Petr L.] Charles Univ Prague, Lab Mass Spectrometry, Fac Sci, Prague, Czech Republic; [Perry, Andrew J.; Lithgow, Trevor] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia	Charles University Prague; Charles University Prague; Monash University	Jedelsky, PL (corresponding author), Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic.	tachezy@gmail.com	Šmíd, Ondřej/M-7545-2017; Lithgow, Trevor J/H-5925-2017; Perry, Andrew/E-5607-2010; Dolezal, Pavel/V-1907-2017; Tachezy, Jan/R-4945-2017; Jedelsky, Petr/C-5879-2009; Rada, Petr/M-5289-2017; Voleman, Luboš/M-8076-2017; Hrdý, Ivan/K-8931-2017	Šmíd, Ondřej/0000-0001-9260-6509; Lithgow, Trevor J/0000-0002-0102-7884; Perry, Andrew/0000-0001-9256-6068; Dolezal, Pavel/0000-0003-1285-9026; Tachezy, Jan/0000-0001-6976-8446; Jedelsky, Petr/0000-0003-3813-2343; Rada, Petr/0000-0001-6241-969X; Voleman, Luboš/0000-0003-0589-240X; Hrdý, Ivan/0000-0002-5595-9177; Pyrih, Jan/0000-0003-0715-2448	Czech Ministry of Education [MSM0021620858, LC07032]; Czech Science Foundation [204/05/H023, 204/06/0947]; Australian Research Council	Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Australian Research Council(Australian Research Council)	This work was supported by the Czech Ministry of Education (MSM0021620858, LC07032) and the Czech Science Foundation grants 204/05/H023 (P.J.) and 204/06/0947 (J.T.) and the Australian Research Council (T.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Alcock F, 2010, SCIENCE, V327, P649, DOI 10.1126/science.1182129; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Billington D, 1998, ANAL BIOCHEM, V258, P251, DOI 10.1006/abio.1998.2561; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Cavalier-Smith T, 2010, BIOL LETTERS, V6, P342, DOI 10.1098/rsbl.2009.0948; CAVALIERSMITH T, 1987, ANN NY ACAD SCI, V503, P17, DOI 10.1111/j.1749-6632.1987.tb40596.x; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chan KW, 2005, CURR BIOL, V15, P737, DOI 10.1016/j.cub.2005.02.068; Clements A, 2009, P NATL ACAD SCI USA, V106, P15791, DOI 10.1073/pnas.0908264106; Dagley MJ, 2009, MOL BIOL EVOL, V26, P1941, DOI 10.1093/molbev/msp117; Ding H, 2004, J BIOL CHEM, V279, P37499, DOI 10.1074/jbc.M404533200; Dolezal P, 2005, P NATL ACAD SCI USA, V102, P10924, DOI 10.1073/pnas.0500349102; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Dolezal P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000812; Dunkley TPJ, 2004, MOL CELL PROTEOMICS, V3, P1128, DOI 10.1074/mcp.T400009-MCP200; Elsner S, 2009, INT J MOL SCI, V10, P2041, DOI 10.3390/ijms10052041; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; Gabaldon T, 2004, BBA-BIOENERGETICS, V1659, P212, DOI 10.1016/j.bbabio.2004.07.011; Gabaldon T, 2007, PLOS COMPUT BIOL, V3, P2209, DOI 10.1371/journal.pcbi.0030219; Gatsos X, 2008, FEMS MICROBIOL REV, V32, P995, DOI 10.1111/j.1574-6976.2008.00130.x; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Goldberg AV, 2008, NATURE, V452, P624, DOI 10.1038/nature06606; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; HRDY I, 2008, MICROBIOL MONOGR, V9, P113, DOI DOI 10.1007/7171_2007_110; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kmita H, 2000, BBA-BIOMEMBRANES, V1509, P86, DOI 10.1016/S0005-2736(00)00284-4; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Krebs C, 2001, BIOCHEMISTRY-US, V40, P14069, DOI 10.1021/bi015656z; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Likic VA, 2010, METHODS MOL BIOL, V619, P271, DOI 10.1007/978-1-60327-412-8_16; Macasev D, 2004, MOL BIOL EVOL, V21, P1557, DOI 10.1093/molbev/msh166; Mi-ichi F, 2009, P NATL ACAD SCI USA, V106, P21731, DOI 10.1073/pnas.0907106106; Mokranjac D, 2006, EMBO J, V25, P4675, DOI 10.1038/sj.emboj.7601334; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Pelzer W, 2000, FEBS LETT, V476, P134, DOI 10.1016/S0014-5793(00)01711-7; Pusnik M, 2009, MOL BIOL EVOL, V26, P671, DOI 10.1093/molbev/msn288; Putignani L, 2004, PARASITOLOGY, V129, P1, DOI 10.1017/S003118200400527X; Rada P, 2009, EUKARYOT CELL, V8, P1584, DOI 10.1128/EC.00181-09; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Riordan CE, 1999, J EUKARYOT MICROBIOL, V46, p52S; Sanderson SJ, 2008, PROTEOMICS, V8, P1398, DOI 10.1002/pmic.200700804; Schneider A, 2008, TRENDS CELL BIOL, V18, P12, DOI 10.1016/j.tcb.2007.09.009; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Simpson AGB, 2006, MOL BIOL EVOL, V23, P615, DOI 10.1093/molbev/msj068; Smid O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000243; Song DS, 2009, J BIOL CHEM, V284, P35297, DOI 10.1074/jbc.M109.040014; Sun CH, 1998, MOL BIOCHEM PARASIT, V92, P123, DOI 10.1016/S0166-6851(97)00239-9; Tachezy J, 2001, MOL BIOL EVOL, V18, P1919, DOI 10.1093/oxfordjournals.molbev.a003732; TACHEZY J, 2008, MICROBIOL MONOGR, V9, P201, DOI DOI 10.1007/7171_2007_113; Tovar J, 1999, MOL MICROBIOL, V32, P1013, DOI 10.1046/j.1365-2958.1999.01414.x; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Tsaousis AD, 2008, NATURE, V453, P553, DOI 10.1038/nature06903; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; Vernis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004376; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Waller RF, 2009, EUKARYOT CELL, V8, P19, DOI 10.1128/EC.00313-08; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	73	89	89	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17285	10.1371/journal.pone.0017285	http://dx.doi.org/10.1371/journal.pone.0017285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390322	Green Published, gold, Green Submitted			2022-12-25	WOS:000287761700043
J	Li, YY; Tollefsbol, TO				Li, Yuanyuan; Tollefsbol, Trygve O.			p16(INK4a) Suppression by Glucose Restriction Contributes to Human Cellular Lifespan Extension through SIRT1-Mediated Epigenetic and Genetic Mechanisms	PLOS ONE			English	Article							CALORIC RESTRICTION; CYCLE PROGRESSION; RAPAMYCIN TOR; GROWTH; SIR2; METHYLATION; EXPRESSION; P53; SENESCENCE; NUTRITION	Although caloric restriction (CR) has been shown to increase lifespan in various animal models, the mechanisms underlying this phenomenon have not yet been revealed. We developed an in vitro system to mimic CR by reducing glucose concentration in cell growth medium which excludes metabolic factors and allows assessment of the effects of CR at the cellular and molecular level. We monitored cellular proliferation of normal WI-38, IMR-90 and MRC-5 human lung fibroblasts and found that glucose restriction (GR) can inhibit cellular senescence and significantly extend cellular lifespan compared with cells receiving normal glucose (NG) in the culture medium. Moreover, GR decreased expression of p16(INK4a) (p16), a well-known senescence-related gene, in all of the tested cell lines. Over-expressed p16 resulted in early replicative senescence in glucose-restricted cells suggesting a crucial role of p16 regulation in GR-induced cellular lifespan extension. The decreased expression of p16 was partly due to GR-induced chromatin remodeling through effects on histone acetylation and methylation of the p16 promoter. GR resulted in an increased expression of SIRT1, a NAD-dependent histone deacetylase, which has positive correlation with CR-induced longevity. The elevated SIRT1 was accompanied by enhanced activation of the Akt/p70S6K1 signaling pathway in response to GR. Furthermore, knockdown of SIRT1 abolished GR-induced p16 repression as well as Akt/p70S6K1 activation implying that SIRT1 may affect p16 repression through direct deacetylation effects and indirect regulation of Akt/p70S6K1 signaling. Collectively, these results provide new insights into interactions between epigenetic and genetic mechanisms on CR-induced longevity that may contribute to anti-aging approaches and also provide a general molecular model for studying CR in vitro in mammalian systems.	[Li, Yuanyuan; Tollefsbol, Trygve O.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Ctr Aging, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Li, YY (corresponding author), Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA.	trygve@uab.edu		Tollefsbol, Trygve/0000-0002-0284-1511	Glenn Foundation for Medical Research; National Cancer Institute [R01 CA 129415]; American Institute for Cancer Research (AICR); NATIONAL CANCER INSTITUTE [R01CA129415] Funding Source: NIH RePORTER	Glenn Foundation for Medical Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Institute for Cancer Research (AICR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Glenn Foundation for Medical Research, the National Cancer Institute (R01 CA 129415), Susan G. Komen for the Cure, and a Postdoctoral Award (PDA) sponsored by the American Institute for Cancer Research (AICR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaszadegan MR, 2005, J GASTROINTEST CANC, V36, P47, DOI 10.1385/IJGC:36:1:047; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Cooper TM, 2004, FASEB J, V18, P1591, DOI 10.1096/fj.03-1464fje; Dennis PB, 1999, CURR OPIN GENET DEV, V9, P49, DOI 10.1016/S0959-437X(99)80007-0; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Greenwood SK, 2004, ENVIRON MOL MUTAGEN, V43, P36, DOI 10.1002/em.10207; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710; Jarmalaite S, 2003, INT J CANCER, V106, P913, DOI 10.1002/ijc.11322; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Li YY, 2010, FASEB J, V24, P1442, DOI 10.1096/fj.09-149328; Li YY, 2010, EPIGENETICS OF AGING, P407, DOI 10.1007/978-1-4419-0639-7_22; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Liu L, 2003, MECH AGEING DEV, V124, P989, DOI 10.1016/j.mad.2003.08.001; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Martin B, 2010, P NATL ACAD SCI USA, V107, P6127, DOI 10.1073/pnas.0912955107; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; MCCAY CM, 1989, NUTRITION, V5, P155; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Romanelli A, 2002, J BIOL CHEM, V277, P40281, DOI 10.1074/jbc.M205168200; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Weindruch R., 1988, RETARDATION AGING DI	41	45	52	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17421	10.1371/journal.pone.0017421	http://dx.doi.org/10.1371/journal.pone.0017421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390332	Green Published, gold, Green Submitted			2022-12-25	WOS:000287761700054
J	Sancier, F; Dumont, A; Sirvent, A; de Plater, LP; Edmonds, T; David, G; Jan, M; de Montrion, C; Coge, F; Leonce, S; Burbridge, M; Bruno, A; Boutin, JA; Lockhart, B; Roche, S; Cruzalegui, F				Sancier, Florence; Dumont, Aurelie; Sirvent, Audrey; de Plater, Ludmilla Paquay; Edmonds, Thomas; David, Geraldine; Jan, Michel; de Montrion, Catherine; Coge, Francis; Leonce, Stephane; Burbridge, Michael; Bruno, Alain; Boutin, Jean A.; Lockhart, Brian; Roche, Serge; Cruzalegui, Francisco			Specific Oncogenic Activity of the Src-Family Tyrosine Kinase c-Yes in Colon Carcinoma Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CANCER-CELLS; DISTINCT POOLS; DNA-SYNTHESIS; BETA-CATENIN; METASTASIS; ACTIVATION; EXPRESSION; CADHERIN; PP2	c-Yes, a member of the Src tyrosine kinase family, is found highly activated in colon carcinoma but its importance relative to c-Src has remained unclear. Here we show that, in HT29 colon carcinoma cells, silencing of c-Yes, but not of c-Src, selectively leads to an increase of cell clustering associated with a localisation of beta-catenin at cell membranes and a reduction of expression of beta-catenin target genes. c-Yes silencing induced an increase in apoptosis, inhibition of growth in soft-agar and in mouse xenografts, inhibition of cell migration and loss of the capacity to generate liver metastases in mice. Reintroduction of c-Yes, but not c-Src, restores transforming properties of c-Yes depleted cells. Moreover, we found that c-Yes kinase activity is required for its role in beta-catenin localisation and growth in soft agar, whereas kinase activity is dispensable for its role in cell migration. We conclude that c-Yes regulates specific oncogenic signalling pathways important for colon cancer progression that is not shared with c-Src.	[Sancier, Florence; Dumont, Aurelie; de Plater, Ludmilla Paquay; Edmonds, Thomas; David, Geraldine; Jan, Michel; de Montrion, Catherine; Coge, Francis; Leonce, Stephane; Burbridge, Michael; Bruno, Alain; Boutin, Jean A.; Lockhart, Brian; Cruzalegui, Francisco] Inst Rech Servier, Croissy Sur Seine, France; [Sirvent, Audrey; Roche, Serge] UMR5237 Ctr Natl Rech Sci, Ctr Rech Biochim Macromol, Equipe Iabellisee LA LIGUE 2009, Montpellier, France	Servier; Institut de Recherches Internationales Servier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Sancier, F (corresponding author), Inst Rech Servier, Croissy Sur Seine, France.	serge.roche@crbm.cnrs.fr; francisco.cruzalegui@fr.netgrs.com	Boutin, Jean Albert/W-9103-2019	Boutin, Jean Albert/0000-0003-0068-7204; roche, serge/0000-0003-3413-3859	Servier laboratories; CNRS; University of Montpellier I and II; charity "la Ligue National Contre le Cancer"; INCa institute (Institut national du cancer)	Servier laboratories; CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Montpellier I and II; charity "la Ligue National Contre le Cancer"; INCa institute (Institut national du cancer)(Institut National du Cancer (INCA) France)	This work was supported by Servier laboratories (http://www.servier.fr), the CNRS (http://www.cnrs.fr), the University of Montpellier I and II and the charity "la Ligue National Contre le Cancer" (http://www.ligue-cancer.net). SR is a research fellow of the INSERM institute (http://www.inserm.fr) and AS was supported by the INCa institute (Institut national du cancer; http://www.e-cancer.fr). The Institut de Recherches Servier employed some authors of this study and so have played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Boureux A, 2005, J CELL SCI, V118, P3717, DOI 10.1242/jcs.02491; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Calcagno AM, 2005, MOL PHARMACEUT, V2, P170, DOI 10.1021/mp0499003; Chen YH, 2002, MOL BIOL CELL, V13, P1227, DOI 10.1091/mbc.01-08-0423; Clump DA, 2005, GROWTH FACTORS, V23, P263, DOI 10.1080/08977190500199360; Coluccia AML, 2006, CANCER RES, V66, P2279, DOI 10.1158/0008-5472.CAN-05-2057; Easwaran V, 2003, CANCER RES, V63, P3145; Han NM, 1996, CLIN CANCER RES, V2, P1397; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Kopetz S, 2007, CLIN CANCER RES, V13, P7232, DOI 10.1158/1078-0432.CCR-07-1902; Luton F, 1999, MOL CELL, V4, P627, DOI 10.1016/S1097-2765(00)80213-0; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Nam JS, 2002, CLIN CANCER RES, V8, P2430; Oneyama C, 2009, MOL CELL BIOL, V29, P6462, DOI 10.1128/MCB.00941-09; Owens DW, 2000, MOL BIOL CELL, V11, P51, DOI 10.1091/mbc.11.1.51; PENA SV, 1995, GASTROENTEROLOGY, V108, P117, DOI 10.1016/0016-5085(95)90015-2; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; ROCHE S, 1997, ONCOGENIC CYTOPLASMI, pP87; Sirvent A, 2007, ONCOGENE, V26, P7313, DOI 10.1038/sj.onc.1210543; SIRVENT A, ONCOGENE, V29, P1303; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Veracini L, 2005, BIOCHEM SOC T, V33, P1313, DOI 10.1042/BST0331313; Veracini L, 2006, J CELL SCI, V119, P2921, DOI 10.1242/jcs.03015; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130	27	34	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17237	10.1371/journal.pone.0017237	http://dx.doi.org/10.1371/journal.pone.0017237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390316	Green Published, gold, Green Submitted			2022-12-25	WOS:000287761700038
J	Lee, HY; Johnson, KD; Boyer, ME; Bresnick, EH				Lee, Hsiang-Ying; Johnson, Kirby D.; Boyer, Meghan E.; Bresnick, Emery H.			Relocalizing Genetic Loci into Specific Subnuclear Neighborhoods	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; CHROMATIN DOMAIN ACTIVATION; EMBRYONIC STEM-CELLS; BETA-GLOBIN LOCUS; ERYTHROID DEVELOPMENT; DEPENDENT REGULATION; FINGER PROTEIN; KRUPPEL FAMILY; CONTROL REGION; EXPRESSION	A poorly understood problem in genetics is how the three-dimensional organization of the nucleus contributes to establishment and maintenance of transcriptional networks. Genetic loci can reside in chromosome "territories" and undergo dynamic changes in subnuclear positioning. Such changes appear to be important for regulating transcription, although many questions remain regarding how loci reversibly transit in and out of their territories and the functional significance of subnuclear transitions. We addressed this issue using GATA-1, a master regulator of hematopoiesis implicated in human leukemogenesis, which often functions with the coregulator Friend of GATA-1 (FOG-1). In a genetic complementation assay in GATA-1-null cells, GATA-1 expels FOG-1-dependent target genes from the nuclear periphery during erythroid maturation, but the underlying mechanisms are unknown. We demonstrate that GATA-1 induces extrusion of the beta-globin locus away from its chromosome territory at the nuclear periphery, and extrusion precedes the maturation-associated transcriptional surge and morphological transition. FOG-1 and its interactor Mi-2 beta, a chromatin remodeling factor commonly linked to repression, were required for locus extrusion. Erythroid Kruppel-like factor, a pivotal regulator of erythropoiesis that often co-occupies chromatin with GATA-1, also promoted locus extrusion. Disruption of transcriptional maintenance did not restore the locus subnuclear position that preceded activation. These results lead to a model for how a master developmental regulator relocalizes a locus into a new subnuclear neighborhood that is permissive for high level transcription as an early step in establishing a cell type-specific genetic network. Alterations in the regulatory milieu can abrogate maintenance without reversion of locus residency back to its original neighborhood.	[Lee, Hsiang-Ying; Johnson, Kirby D.; Boyer, Meghan E.; Bresnick, Emery H.] Univ Wisconsin, Wisconsin Inst Med Res, Paul Carbone Canc Ctr, Dept Cell & Regenerat Biol,Sch Med & Publ Hlth, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Bresnick, EH (corresponding author), Univ Wisconsin, Wisconsin Inst Med Res, Paul Carbone Canc Ctr, Dept Cell & Regenerat Biol,Sch Med & Publ Hlth, Madison, WI 53705 USA.	ehbresni@wisc.edu		Lee, Hsiang-Ying/0000-0002-1503-5818	National Institutes of Health [DK50190, DK68634]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK050190, R01DK050190, R56DK068634, R37DK050107, R01DK068634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK50190 and DK68634 (to E. H. B.).; Recipient of a predoctoral fellowship from the American Heart Association.	Bresnick EH, 2006, PROG NUCLEIC ACID RE, V81, P435, DOI 10.1016/S0079-6603(06)81011-1; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; Dean A, 2006, TRENDS GENET, V22, P38, DOI 10.1016/j.tig.2005.11.001; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deniaud E, 2009, CURR OPIN GENET DEV, V19, P187, DOI 10.1016/j.gde.2009.01.005; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Gao ZG, 2010, EMBO J, V29, P457, DOI 10.1038/emboj.2009.368; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Im H, 2005, P NATL ACAD SCI USA, V102, P17065, DOI 10.1073/pnas.0506164102; Johnson KD, 2007, BLOOD, V109, P5230, DOI 10.1182/blood-2007-02-072983; Johnson KD, 2006, P NATL ACAD SCI USA, V103, P15939, DOI 10.1073/pnas.0604041103; Kim SI, 2007, ONCOGENE, V26, P6777, DOI 10.1038/sj.onc.1210761; Kim SI, 2007, MOL CELL BIOL, V27, P4551, DOI 10.1128/MCB.00235-07; Kim SI, 2009, P NATL ACAD SCI USA, V106, P2259, DOI 10.1073/pnas.0806420106; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Lee HY, 2009, MOL CELL, V36, P984, DOI 10.1016/j.molcel.2009.11.005; Letting DL, 2004, P NATL ACAD SCI USA, V101, P476, DOI 10.1073/pnas.0306315101; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; Miccio A, 2010, MOL CELL BIOL, V30, P3460, DOI 10.1128/MCB.00001-10; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; PERKINS AC, 1995, NATURE, V375, P318; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Pope NJ, 2010, NUCLEIC ACIDS RES, V38, P2190, DOI 10.1093/nar/gkp1159; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Shimizu R, 2008, NAT REV CANCER, V8, P279, DOI 10.1038/nrc2348; SIMON MC, 1992, NAT GENET, V1, P92, DOI 10.1038/ng0592-92; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Volpi EV, 2000, J CELL SCI, V113, P1565; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Zhao R, 2009, CURR OPIN GENET DEV, V19, P172, DOI 10.1016/j.gde.2009.02.007	50	31	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18834	18844		10.1074/jbc.M111.221481	http://dx.doi.org/10.1074/jbc.M111.221481			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21398517	hybrid, Green Published			2022-12-25	WOS:000290785700056
J	Lee, YC; Jogie-Brahim, S; Lee, DY; Han, JF; Harada, A; Murphy, LJ; Oh, Y				Lee, Yong-Chul; Jogie-Brahim, Sherryline; Lee, Dae-Yeol; Han, Jinfeng; Harada, Aki; Murphy, Liam J.; Oh, Youngman			Insulin-like Growth Factor-binding Protein-3 (IGFBP-3) Blocks the Effects of Asthma by Negatively Regulating NF-kappa B Signaling through IGFBP-3R-mediated Activation of Caspases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA; FACTOR-I; EPITHELIAL-CELLS; CLEAVAGE; BREAST; EXPRESSION; HYPERRESPONSIVENESS; DIFFERENTIATION; INFLAMMATION; INVOLVEMENT	Insulin-like growth factor-binding protein-3 (IGFBP-3) is a multifunctional protein known for modulating mitogenic and metabolic actions of IGFs as well as exerting a variety of biological actions not involving IGFs. Here, we show that IGFBP-3 blocks specific physiological consequences of asthma in an IGF-independent manner in vitro and in vivo. IGFBP-3 treatment effectively reduced all physiological manifestations of asthma examined in vivo (airway hyper-responsiveness, cellular and pathological changes in bronchoalveolar lavage fluid and lung tissue, and expression of numerous proinflammatory molecules). These unique IGFBP-3 effects were further confirmed in IGFBP-3-transgenic mice, thus strengthening the notion of IGFBP-3 actions within the respiratory system. Using human epithelial cells, we demonstrated the following: 1) IGFBP-3 blocks TNF-alpha-induced expression of proinflammatory molecules; 2) IGFBP-3 attenuates the TNF-alpha-induced migratory response of eosinophils; and 3) IGFBP-3 negatively regulates TNF-alpha-induced expression of the key NF-kappa B regulatory molecules I kappa B alpha and p65-NF-kappa B at the post-translational level. We identified that IGFBP-3 degrades I kappa Ba and p65-NF-kappa B proteins through IGFBP-3 receptor (IGFBP-3R)-mediated activation of caspases thereby inhibiting TNF-alpha-induced activation of NF-kappa B signaling cascades. This unique IGFBP-3/IGFBP-3R action was further confirmed by demonstrating complete inhibition of IGFBP-3 action in the presence of caspase inhibitors as well as IGFBP-3R siRNAs. Non-IGF-binding IGFBP-3 mutants further proved the IGF-independent action of IGFBP-3. Our findings indicate that IGFBP-3 inhibits airway inflammation and hyper-responsiveness via an IGF-independent mechanism that involves activation of IGFBP-3R signaling and cross-talk with NF-kappa B signaling. The IGFBP-3/IGFBP-3R system therefore plays a pivotal role in the pathogenesis of asthma and can serve as a newly identified potential therapeutic target for this debilitating disease.	[Lee, Yong-Chul] Chonbuk Natl Univ, Dept Internal Med, Sch Med, Jeonju 56182, South Korea; [Lee, Dae-Yeol] Chonbuk Natl Univ, Dept Pediat, Sch Med, Jeonju 56182, South Korea; [Murphy, Liam J.] Univ Manitoba, Dept Internal Med, Winnipeg, MB R2E 0W3, Canada; [Murphy, Liam J.] Univ Manitoba, Dept Physiol, Winnipeg, MB R2E 0W3, Canada; [Jogie-Brahim, Sherryline; Han, Jinfeng; Harada, Aki; Oh, Youngman] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pathol, Richmond, VA 23298 USA	Jeonbuk National University; Jeonbuk National University; University of Manitoba; University of Manitoba; Virginia Commonwealth University	Oh, Y (corresponding author), 1101 E Marshall St,POB 980662, Richmond, VA 23298 USA.	yoh@mcvh-vcu.edu			Korea Healthcare Technology RD Project [A084144]; United States Department of Defense [PC04097, PC061151]	Korea Healthcare Technology RD Project; United States Department of Defense(United States Department of Defense)	This work was supported by Korea Healthcare Technology R&D Project Grant A084144 (to Y.-C.L.) and United States Department of Defense Grants PC04097 and PC061151 (to Y.O.). Y.O. is a founder of BioCure Pharma LLC.	Allen JT, 1998, AM J RESP CELL MOL, V19, P250, DOI 10.1165/ajrcmb.19.2.3080; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Barkett M, 1997, J BIOL CHEM, V272, P29419, DOI 10.1074/jbc.272.47.29419; Barnes PJ, 2006, EUR RESPIR J, V27, P413, DOI 10.1183/09031936.06.00125404; BAXTER RC, 1991, ACTA PAEDIATR SCAND, P107; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Blackman MR, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2271; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Buckway CK, 2001, J CLIN ENDOCR METAB, V86, P4943, DOI 10.1210/jc.86.10.4943; CAMBREY AD, 1995, CLIN SCI, V89, P611, DOI 10.1042/cs0890611; Chan SSY, 2009, AM J PHYSIOL-ENDOC M, V296, pE654, DOI 10.1152/ajpendo.90846.2008; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Chen XY, 2006, GROWTH HORM IGF RES, V16, P41, DOI 10.1016/j.ghir.2005.09.003; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; De Benedetti F, 2001, ENDOCRINOLOGY, V142, P4818, DOI 10.1210/en.142.11.4818; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Deveci F, 2008, RESPIROLOGY, V13, P488, DOI 10.1111/j.1440-1843.2008.01278.x; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Eivindson M, 2007, GROWTH HORM IGF RES, V17, P33, DOI 10.1016/j.ghir.2006.10.003; Eum SY, 2003, AM J RESP CELL MOL, V28, P25, DOI 10.1165/rcmb.4532; Forgues M, 2001, J BIOL CHEM, V276, P22797, DOI 10.1074/jbc.M101259200; FRIGAS E, 1986, J ALLERGY CLIN IMMUN, V77, P527, DOI 10.1016/0091-6749(86)90341-6; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grimberg A, 2005, J CLIN ENDOCR METAB, V90, P3568, DOI 10.1210/jc.2004-1213; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Holgate ST, 2000, J ALLERGY CLIN IMMUN, V105, P193, DOI 10.1016/S0091-6749(00)90066-6; Hoshino M, 1998, CLIN EXP ALLERGY, V28, P568; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Ingermann AR, 2010, J BIOL CHEM, V285, P30233, DOI 10.1074/jbc.M110.122226; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KAY AB, 1991, J ALLERGY CLIN IMMUN, V87, P893, DOI 10.1016/0091-6749(91)90408-G; Kielczewski JL, 2009, CIRC RES, V105, P897, DOI 10.1161/CIRCRESAHA.109.199059; Kim HS, 2004, CANCER RES, V64, P2229, DOI 10.1158/0008-5472.CAN-03-1675; Kim KW, 2002, J CELL BIOCHEM, V85, P334, DOI 10.1002/jcb.10139; Kim KS, 2007, AGING CELL, V6, P535, DOI 10.1111/j.1474-9726.2007.00315.x; Koyama S, 1999, EUR RESPIR J, V14, P767, DOI 10.1034/j.1399-3003.1999.14d07.x; Krunkosky TM, 2000, AM J RESP CELL MOL, V22, P685, DOI 10.1165/ajrcmb.22.6.3925; Kwak YG, 2003, J CLIN INVEST, V111, P1083, DOI 10.1172/JCI200316440; Launay S, 2005, ONCOGENE, V24, P5137, DOI 10.1038/sj.onc.1208524; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lofqvist C, 2007, P NATL ACAD SCI USA, V104, P10589, DOI 10.1073/pnas.0702031104; Martin JL, 2006, ENDOCRINOLOGY, V147, P4400, DOI 10.1210/en.2006-0094; Netea MG, 2008, P NATL ACAD SCI USA, V105, P3515, DOI 10.1073/pnas.0712381105; OH YM, 1993, J BIOL CHEM, V268, P14964; Ozen M, 2004, PEDIATR INT, V46, P429, DOI 10.1111/j.1442-200x.2004.01925.x; Park GY, 2006, CURR DRUG TARGETS, V7, P661, DOI 10.2174/138945006777435317; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; ROSENFELD RG, 1986, J PEDIATR-US, V109, P428, DOI 10.1016/S0022-3476(86)80112-3; Rotwein P, 1991, Growth Factors, V5, P3, DOI 10.3109/08977199109000267; SHIMASAKI S, 1991, Progress in Growth Factor Research, V3, P243, DOI 10.1016/0955-2235(91)90003-M; Veraldi KL, 2009, AM J RESP CRIT CARE, V180, P611, DOI 10.1164/rccm.200810-1555OC; WERNER H, 2001, ADV CELL AGING GERON, V6, P1; Wong SC, 2008, GROWTH HORM IGF RES, V18, P369, DOI 10.1016/j.ghir.2008.01.006; Yamashita N, 2005, CELL IMMUNOL, V235, P85, DOI 10.1016/j.cellimm.2005.07.006	59	62	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17898	17909		10.1074/jbc.M111.231035	http://dx.doi.org/10.1074/jbc.M111.231035			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21383009	Green Published, hybrid			2022-12-25	WOS:000290585200053
J	Lee, S; Kang, C				Lee, Sooncheol; Kang, Changwon			Opposite Consequences of Two Transcription Pauses Caused by an Intrinsic Terminator Oligo(U) ANTITERMINATION VERSUS TERMINATION BY BACTERIOPHAGE T7 RNA POLYMERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; SEQUENCE-SPECIFIC TERMINATION; ESCHERICHIA-COLI; ELONGATION COMPLEX; DNA HYBRID; ANTITERMINATION; MECHANISM; T7-RNA-POLYMERASE; PREDICTION; HAIRPIN	The RNA oligo(U) sequence, along with an immediately preceding RNA hairpin structure, is an essential cis-acting element for bacterial class I intrinsic termination. This sequence not only causes a pause in transcription during the beginning of the termination process but also facilitates transcript release at the end of the process. In this study, the oligo(U) sequence of the bacteriophage T7 intrinsic terminator T phi, rather than the hairpin structure, induced pauses of phage T7 RNA polymerase not only at the termination site, triggering a termination process, but also 3 bp upstream, exerting an antitermination effect. The upstream pause presumably allowed RNA to form a thermodynamically more stable secondary structure rather than a terminator hairpin and to persist because the 5'-half of the terminator hairpin-forming sequence could be sequestered by a farther upstream sequence via sequence-specific hybridization, prohibiting formation of the terminator hairpin and termination. The putative antiterminator RNA structure lacked several base pairs essential for termination when probed using RNases A, T1, and V1. When the antiterminator was destabilized by incorporation of IMP into nascent RNA at G residue positions, antitermination was abolished. Furthermore, antitermination strength increased with more stable antiterminator secondary structures and longer pauses. Thus, the oligo(U)-mediated pause prior to the termination site can exert a cis-acting antitermination activity on intrinsic terminator T phi, and the termination efficiency depends primarily on the termination-interfering pause that precedes the termination-facilitating pause at the termination site.	[Lee, Sooncheol; Kang, Changwon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Kang, C (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Taejon 305701, South Korea.	ckang@kaist.ac.kr	Kang, Changwon/C-1938-2011	Kang, Changwon/0000-0002-0867-6385	National Research Foundation of Korea [2010-0014162]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Grant 2010-0014162 from the National Research Foundation of Korea.	Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; CARAFA YD, 1990, J MOL BIOL, V216, P835, DOI 10.1016/S0022-2836(99)80005-9; Ciampi MS, 2006, MICROBIOL-SGM, V152, P2515, DOI 10.1099/mic.0.28982-0; DUNN JJ, 1980, NUCLEIC ACIDS RES, V8, P2119, DOI 10.1093/nar/8.10.2119; Epshtein V, 2007, MOL CELL, V28, P991, DOI 10.1016/j.molcel.2007.10.011; FARNHAM PJ, 1982, CELL, V29, P945, DOI 10.1016/0092-8674(82)90457-3; Grundy FJ, 2002, P NATL ACAD SCI USA, V99, P11121, DOI 10.1073/pnas.162366799; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; HENKIN TM, 1994, MOL MICROBIOL, V13, P381, DOI 10.1111/j.1365-2958.1994.tb00432.x; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; LEE JT, 1991, MOL CELLS, V1, P203; Lee S, 2010, NUCLEIC ACIDS RES, V38, P6045, DOI 10.1093/nar/gkq450; LOWMAN HB, 1986, J BIOL CHEM, V261, P5396; Lyakhov DL, 1998, J MOL BIOL, V280, P201, DOI 10.1006/jmbi.1998.1854; MARTIN FH, 1980, NUCLEIC ACIDS RES, V8, P2295, DOI 10.1093/nar/8.10.2295; MCALLISTER WT, 1981, J MOL BIOL, V153, P527, DOI 10.1016/0022-2836(81)90406-X; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; REYNOLDS R, 1992, J MOL BIOL, V224, P31, DOI 10.1016/0022-2836(92)90574-4; SANTALUCIA J, 1992, SCIENCE, V256, P217, DOI 10.1126/science.1373521; Shen HH, 2001, J BIOL CHEM, V276, P4080, DOI 10.1074/jbc.M008616200; Sohn YH, 2005, P NATL ACAD SCI USA, V102, P75, DOI 10.1073/pnas.0406581101; Sohn YH, 2003, METHOD ENZYMOL, V371, P170; Song HS, 2001, GENES CELLS, V6, P291, DOI 10.1046/j.1365-2443.2001.00420.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; WILSON KS, 1994, J MOL BIOL, V244, P36, DOI 10.1006/jmbi.1994.1702; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	32	2	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.203521	http://dx.doi.org/10.1074/jbc.M110.203521			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21398520	hybrid, Green Published			2022-12-25	WOS:000290022800013
J	Francescone, RA; Scully, S; Faibish, M; Taylor, SL; Oh, D; Moral, L; Yan, W; Bentley, B; Shao, R				Francescone, Ralph A.; Scully, Steve; Faibish, Michael; Taylor, Sherry L.; Oh, Dennis; Moral, Luis; Yan, Wei; Bentley, Brooke; Shao, Rong			Role of YKL-40 in the Angiogenesis, Radioresistance, and Progression of Glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-GROWTH-FACTOR; HUMAN CARTILAGE GLYCOPROTEIN-39; ACTIVATED PROTEIN-KINASE; TUMOR ANGIOGENESIS; BREAST-CANCER; SERUM YKL-40; TYROSINE PHOSPHORYLATION; MALIGNANT GLIOMAS; GENE-EXPRESSION; SHORT SURVIVAL	Glioblastoma is one of the most fatal cancers, characterized by a strong vascularized phenotype. YKL-40, a secreted glycoprotein, is overexpressed in patients with glioblastomas and has potential as a novel tumor biomarker. The molecular mechanisms of YKL-40 in glioblastoma development, however, are poorly understood. Here, we aimed to elucidate the role YKL-40 plays in the regulation of VEGF expression, tumor angiogenesis, and radioresistance. YKL-40 up-regulated VEGF expression in glioblastoma cell line U87, and both YKL-40 and VEGF synergistically promote endothelial cell angiogenesis. Interestingly, long term inhibition of VEGF up-regulated YKL-40. YKL-40 induced coordination of membrane receptor syndecan-1 and integrin alpha v beta 5, and triggered a signaling cascade through FAK(397) to ERK-1 and ERK-2, leading to elevated VEGF and enhanced angiogenesis. In addition, gamma-irradiation of U87 cells increased YKL-40 expression that protects cell death through AKT activation and also enhances endothelial cell angiogenesis. Blockade of YKL-40 activity or expression decreased tumor growth, angiogenesis, and metastasis in xenografted animals. Immunohistochemical analysis of human glioblastomas revealed a correlation between YKL-40, VEGF, and patient survival. These findings have shed light on the mechanisms by which YKL-40 promotes tumor angiogenesis and malignancy, and thus provide a therapeutic target for tumor treatment.	[Scully, Steve; Bentley, Brooke; Shao, Rong] Univ Massachusetts Amherst, Pioneer Valley Life Sci Inst, Springfield, MA 01107 USA; [Francescone, Ralph A.; Scully, Steve; Faibish, Michael; Yan, Wei; Shao, Rong] Univ Massachusetts, Morrill Sci Ctr, Mol & Cellular Biol Program, Amherst, MA 01003 USA; [Shao, Rong] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Taylor, Sherry L.; Oh, Dennis] Tufts Univ, Baystate Med Ctr, Dept Neurosurg, Springfield, MA 01199 USA; [Moral, Luis] Tufts Univ, Baystate Med Ctr, Dept Pathol, Springfield, MA 01199 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Baystate Medical Center; Tufts University; Baystate Medical Center; Tufts University	Shao, R (corresponding author), Univ Massachusetts Amherst, Pioneer Valley Life Sci Inst, Springfield, MA 01107 USA.	rong.shao@bhs.org		Francescone, Ralph/0000-0002-3149-6825	National Institutes of Health from the NCI [R01 CA120659]; NATIONAL CANCER INSTITUTE [R01CA120659] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA120659 from the NCI (to R. S.).	Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bergmann OJ, 2005, CLIN CANCER RES, V11, P8644, DOI 10.1158/1078-0432.CCR-05-1317; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Cintin C, 1999, BRIT J CANCER, V79, P1494, DOI 10.1038/sj.bjc.6690238; Cintin C, 2002, CANCER-AM CANCER SOC, V95, P267, DOI 10.1002/cncr.10644; De Ceuninck F, 2001, BIOCHEM BIOPH RES CO, V285, P926, DOI 10.1006/bbrc.2001.5253; Dreyfuss JM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-71; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; FABISH M, 2011, MOL CANC TH IN PRESS; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; Hogdall EVS, 2003, ONCOL REP, V10, P1535; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Hormigo A, 2006, CLIN CANCER RES, V12, P5698, DOI 10.1158/1078-0432.CCR-06-0181; Ido K, 2008, NEUROPATHOLOGY, V28, P604, DOI 10.1111/j.1440-1789.2008.00926.x; Ilhan A, 2009, ANTICANCER RES, V29, P731; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Jensen BV, 2003, CLIN CANCER RES, V9, P4423; Johansen JS, 2000, J HEPATOL, V32, P911, DOI 10.1016/S0168-8278(00)80095-1; Johansen JS, 2003, BREAST CANCER RES TR, V80, P15, DOI 10.1023/A:1024431000710; JOHANSEN JS, 1992, J BONE MINER RES, V7, P501; Kirkpatrick RB, 1997, EXP CELL RES, V237, P46, DOI 10.1006/excr.1997.3764; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Lal A, 1999, CANCER RES, V59, P5403; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Li HF, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-43; Lorger M, 2009, P NATL ACAD SCI USA, V106, P10666, DOI 10.1073/pnas.0903035106; Malinda KM, 1999, EXP CELL RES, V250, P168, DOI 10.1006/excr.1999.4511; Millauer B, 1996, CANCER RES, V56, P1615; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Pelloski CE, 2006, CLIN CANCER RES, V12, P3935, DOI 10.1158/1078-0432.CCR-05-2202; Prewett M, 1999, CANCER RES, V59, P5209; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; Richert MM, 2005, BREAST CANCER RES, V7, pR819, DOI 10.1186/bcr1292; Saidi A, 2008, INT J CANCER, V122, P2187, DOI 10.1002/ijc.23313; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Sharif M, 2006, RHEUMATOLOGY, V45, P522, DOI 10.1093/rheumatology/kei216; Tanwar MK, 2002, CANCER RES, V62, P4364; Verhoeff JJC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-444; Volck B, 2001, OSTEOARTHR CARTILAGE, V9, P203, DOI 10.1053/joca.2000.0377; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wheeler-Jones C, 1997, FEBS LETT, V420, P28, DOI 10.1016/S0014-5793(97)01481-6; Wick W, 2010, J CLIN ONCOL, V28, pE188, DOI 10.1200/JCO.2009.26.9027; Yan W, 2008, MOL BIOL CELL, V19, P2278, DOI 10.1091/mbc.E07-10-1068; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zhang Z, 2010, CELL DEATH DIFFER, V17, P499, DOI 10.1038/cdd.2009.152; Zhao JH, 2004, CANCER LETT, V204, P87, DOI 10.1016/j.canlet.2003.09.018	56	172	184	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15332	15343		10.1074/jbc.M110.212514	http://dx.doi.org/10.1074/jbc.M110.212514			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21385870	Green Published, hybrid			2022-12-25	WOS:000289788300064
J	Guttenberg, G; Papatheodorou, P; Genisyuerek, S; Lu, W; Jank, T; Einsle, O; Aktories, K				Guttenberg, Gregor; Papatheodorou, Panagiotis; Genisyuerek, Selda; Lue, Wei; Jank, Thomas; Einsle, Oliver; Aktories, Klaus			Inositol Hexakisphosphate-dependent Processing of Clostridium sordellii Lethal Toxin and Clostridium novyi alpha-Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFICILE TOXIN; CONFORMATIONAL-CHANGES; CLEAVAGE; GLUCOSYLATION; PROTEINS; CELLS; RHO; TRANSLOCATION; RAS	Clostridium sordellii lethal toxin and Clostridium novyi alpha-toxin, which are virulence factors involved in the toxic shock and gas gangrene syndromes, are members of the family of clostridial glucosylating toxins. The toxins inactivate Rho/Ras proteins by glucosylation or attachment of GlcNAc (alpha-toxin). Here, we studied the activation of the autoproteolytic processing of the toxins by inositol hexakisphosphate (InsP(6)) and compared it with the processing of Clostridium difficile toxin B. In the presence of low concentrations of InsP(6) (< 1 mu M), toxin fragments consisting of the N-terminal glucosyltransferase (or GlcNActransferase) domains and the cysteine protease domains (CPDs) of C. sordellii lethal toxin, C. novyi alpha-toxin, and C. difficile toxin B were autocatalytically processed. The cleavage sites of lethal toxin (Leu-543) and alpha-toxin (Leu-548) and the catalytic cysteine residues (Cys-698 of lethal toxin and Cys-707 of alpha-toxin) were identified. Affinity of the CPDs for binding InsP(6) was determined by isothermal titration calorimetry. In contrast to full-length toxin B and alpha-toxin, autocatalytic cleavage and InsP(6) binding of full-length lethal toxin depended on low pH (pH 5) conditions. The data indicate that C. sordellii lethal toxin and C. novyi alpha-toxin are InsP(6)-dependently processed. However, full-length lethal toxin, but not its short toxin fragments consisting of the glucosyltransferase domain and the CPD, requires a pH-sensitive conformational change to allow binding of InsP(6) and subsequent processing of the toxin.	[Guttenberg, Gregor; Papatheodorou, Panagiotis; Genisyuerek, Selda; Jank, Thomas; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Lue, Wei; Einsle, Oliver] Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Albertstr 25,Otto Krayer Haus, D-79104 Freiburg, Germany.	klaus.aktories@pharmakol.uni-freiburg.de	Jank, Thomas/R-9627-2017; Aktories, Klaus/CAJ-5682-2022; Papatheodorou, Panagiotis/N-7509-2015	Aktories, Klaus/0000-0002-5397-0436; Einsle, Oliver/0000-0001-8722-2893; Papatheodorou, Panagiotis/0000-0003-3571-695X	Deutsche Forschungsgemeinschaft [AK6/16-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant AK6/16-3.	Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; BORIELLO SP, 2005, TOPLEY WILSONS MICRO, P1089; Cohen AL, 2007, OBSTET GYNECOL, V110, P1027, DOI 10.1097/01.AOG.0000287291.19230.ba; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Egerer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000942; Egerer M, 2009, J BIOL CHEM, V284, P3389, DOI 10.1074/jbc.M806002200; Genisyuerek S, 2011, MOL MICROBIOL, V79, P1643, DOI 10.1111/j.1365-2958.2011.07549.x; Greco A, 2006, NAT STRUCT MOL BIOL, V13, P460, DOI 10.1038/nsmb1084; Ho CS, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.023; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hofmann F, 1997, J BIOL CHEM, V272, P11074; IQBAL TH, 1994, GUT, V35, P1233, DOI 10.1136/gut.35.9.1233; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; JUST I, 1995, J CLIN INVEST, V95, P1026, DOI 10.1172/JCI117747; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kelly CP, 2008, NEW ENGL J MED, V359; Kreimeyer I, 2011, N-S ARCH PHARMACOL, V383, P253, DOI 10.1007/s00210-010-0574-x; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Popoff MR, 1996, J BIOL CHEM, V271, P10217, DOI 10.1074/jbc.271.17.10217; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Prochazkova K, 2009, J BIOL CHEM, V284, P26557, DOI 10.1074/jbc.M109.025510; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Pruitt RN, 2009, J BIOL CHEM, V284, P21934, DOI 10.1074/jbc.M109.018929; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Qa'Dan M, 2001, INFECT IMMUN, V69, P5487, DOI 10.1128/IAI.69.9.5487-5493.2001; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Selzer J, 1996, J BIOL CHEM, V271, P25173, DOI 10.1074/jbc.271.41.25173; Tsokos M, 2008, INT J LEGAL MED, V122, P35, DOI 10.1007/s00414-007-0163-9; VONEICHELSTREIBER C, 1992, J BACTERIOL, V174, P6707, DOI 10.1128/JB.174.20.6707-6710.1992; Voth DE, 2004, INFECT IMMUN, V72, P3366, DOI 10.1128/IAI.72.6.3366-3372.2004; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Ziegler MOP, 2008, J MOL BIOL, V377, P1346, DOI 10.1016/j.jmb.2007.12.065	38	21	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14779	14786		10.1074/jbc.M110.200691	http://dx.doi.org/10.1074/jbc.M110.200691			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21385871	hybrid, Green Published			2022-12-25	WOS:000289788300007
J	Pedemonte, N; Tomati, V; Sondo, E; Caci, E; Millo, E; Armirotti, A; Damonte, G; Zegarra-Moran, O; Galietta, LJV				Pedemonte, Nicoletta; Tomati, Valeria; Sondo, Elvira; Caci, Emanuela; Millo, Enrico; Armirotti, Andrea; Damonte, Gianluca; Zegarra-Moran, Olga; Galietta, Luis J. V.			Dual Activity of Aminoarylthiazoles on the Trafficking and Gating Defects of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Caused by Cystic Fibrosis Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL MONOLAYERS; ION-CHANNEL; WILD-TYPE; CFTR; RESCUE; DELTA-F508; G551D; CORRECTORS; GENISTEIN; AFFINITY	A large fraction of mutations causing cystic fibrosis impair the function of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel by causing reduced channel activity (gating defect) and/or impaired exit from the endoplasmic reticulum (trafficking defect). Such defects need to be treated with separate pharmacological compounds termed potentiators and correctors, respectively. Here, we report the characterization of aminoarylthiazoles (AATs) as compounds having dual activity. Cells expressing mutant CFTR were studied with functional assays (fluorescence-based halide transport and short circuit current measurements) to assess the effect of acute and chronic treatment with compounds. We found that AATs are effective on F508del, the most frequent cystic fibrosis mutation, which is associated with both a gating and a trafficking defect. AATs are also effective on mutations like G1349D and G551D, which cause only a gating defect. Evaluation of a panel of AAT analogs identified EN277I as the most effective compound. Incubation of cells expressing mutant CFTR with EN277I caused a strong stimulation of channel activity as demonstrated by single channel recordings. Compounds with dual activity such as AATs may be useful for the development of effective drugs for the treatment of cystic fibrosis.	[Pedemonte, Nicoletta; Tomati, Valeria; Sondo, Elvira; Caci, Emanuela; Zegarra-Moran, Olga; Galietta, Luis J. V.] Ist Giannina Gaslini, Genet Mol Lab, I-16100 Genoa, Italy; [Tomati, Valeria; Sondo, Elvira; Armirotti, Andrea] Ctr Biotecnol Avanzate, I-16100 Genoa, Italy; [Millo, Enrico; Damonte, Gianluca] Dipartimento Med Sperimentale, Sez Biochim, I-16100 Genoa, Italy; [Millo, Enrico; Damonte, Gianluca] Ctr Eccellenza Ric Biomed, I-16100 Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini	Galietta, LJV (corresponding author), Ist Giannina Gaslini, Genet Mol Lab, Largo Gerolamo Gaslini 5, I-16147 Genoa, Italy.	galietta@unige.it	Millo, Enrico/K-3218-2018; Sondo, Elvira/K-3789-2018; Armirotti, Andrea/AAB-3284-2019; Tomati, Valeria/AAB-4543-2021; Pedemonte, Nicoletta/B-3607-2010; Galietta, Luis JV/HCG-8692-2022	Millo, Enrico/0000-0002-4019-0051; Sondo, Elvira/0000-0003-0971-2082; Tomati, Valeria/0000-0003-3761-1916; Pedemonte, Nicoletta/0000-0002-5161-1720; Galietta, Luis/0000-0001-8686-3461; Armirotti, Andrea/0000-0002-3766-8755	Cystic Fibrosis Foundation Therapeutics; Telethon Foundation [GGP10026]; Fondazione Italiana Fibrosi Cistica [2/2009, 3/2009]; Delegazione FFC di Vicenza, Anna Iacomini, Gruppo di Sostegno FFC "Rita" Verona, Delegazione FFC di Como	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Telethon Foundation(Fondazione Telethon); Fondazione Italiana Fibrosi Cistica(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Delegazione FFC di Vicenza, Anna Iacomini, Gruppo di Sostegno FFC "Rita" Verona, Delegazione FFC di Como	This work was supported by funds from Cystic Fibrosis Foundation Therapeutics, Telethon Foundation Grant GGP10026, and Fondazione Italiana Fibrosi Cistica Grants FFC#2/2009 and FFC#3/2009 with the contribution of Delegazione FFC di Vicenza, Anna Iacomini, Gruppo di Sostegno FFC "Rita" Verona, Delegazione FFC di Como.	Ai T, 2004, MOL PHARMACOL, V65, P1415, DOI 10.1124/mol.65.6.1415; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bilodeau MT, 2004, J MED CHEM, V47, P6363, DOI 10.1021/jm049697f; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; Cai ZW, 2002, J BIOL CHEM, V277, P19546, DOI 10.1074/jbc.M108023200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Haws CM, 1996, AM J PHYSIOL-CELL PH, V270, pC1544, DOI 10.1152/ajpcell.1996.270.5.C1544; HORN R, 1991, BIOPHYS J, V60, P433, DOI 10.1016/S0006-3495(91)82069-0; Hosoya Y, 1996, J GEN PHYSIOL, V108, P485, DOI 10.1085/jgp.108.6.485; Lansdell KA, 2000, J PHYSIOL-LONDON, V524, P317, DOI 10.1111/j.1469-7793.2000.t01-1-00317.x; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; McAuley D F, 2000, Paediatr Respir Rev, V1, P93, DOI 10.1053/prrv.2000.0029; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Noel S, 2006, J PHARMACOL EXP THER, V319, P349, DOI 10.1124/jpet.106.104521; Pedemonte N, 2005, MOL PHARMACOL, V68, P1736, DOI 10.1124/mol.105.015149; Pedemonte N, 2005, MOL PHARMACOL, V67, P1797, DOI 10.1124/mol.105.010959; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pedemonte N, 2007, MOL PHARMACOL, V72, P197, DOI 10.1124/mol.107.034702; Pedemonte N, 2010, AM J PHYSIOL-CELL PH, V298, pC866, DOI 10.1152/ajpcell.00404.2009; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Taddei A, 2004, FEBS LETT, V558, P52, DOI 10.1016/S0014-5793(04)00011-0; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Wang F, 1998, J GEN PHYSIOL, V111, P477, DOI 10.1085/jgp.111.3.477; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608; Zegarra-Moran O, 2002, BRIT J PHARMACOL, V137, P504, DOI 10.1038/sj.bjp.0704882	36	50	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15215	15226		10.1074/jbc.M110.184267	http://dx.doi.org/10.1074/jbc.M110.184267			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21383017	Green Published, hybrid			2022-12-25	WOS:000289788300053
J	Oz, S; Tsemakhovich, V; Christel, CJ; Lee, A; Dascal, N				Oz, Shimrit; Tsemakhovich, Vladimir; Christel, Carl J.; Lee, Amy; Dascal, Nathan			CaBP1 Regulates Voltage-dependent Inactivation and Activation of Ca(V)1.2 (L-type) Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CA2+ CHANNELS; PROTEIN-KINASE-C; VISININ-LIKE PROTEIN-2; AUDITORY HAIR-CELLS; N-TERMINUS; CA2+-DEPENDENT INACTIVATION; CA(V)2.1 CHANNELS; ALPHA(1C) SUBUNIT; MOLECULAR DETERMINANTS; CA2+-BINDING PROTEIN-1	CaBP1 is a Ca2+-binding protein that regulates the gating of voltage-gated (Ca-V) Ca2+ channels. In the Ca(V)1.2 channel alpha(1)-subunit (alpha(1C)), CaBP1 interacts with cytosolic N- and C-terminal domains and blunts Ca2+-dependent inactivation. To clarify the role of the alpha(1C) N-terminal domain in CaBP1 regulation, we compared the effects of CaBP1 on two alternatively spliced variants of alpha(1C) containing a long or short N-terminal domain. In both isoforms, CaBP1 inhibited Ca2+-dependent inactivation but also caused a depolarizing shift in voltage-dependent activation and enhanced voltage-dependent inactivation (VDI). In binding assays, CaBP1 interacted with the distal third of the N-terminal domain in a Ca2+-independent manner. This segment is distinct from the previously identified calmodulin-binding site in the N terminus. However, deletion of a segment in the proximal N-terminal domain of both alpha(1C) isoforms, which spared the CaBP1-binding site, inhibited the effect of CaBP1 on VDI. This result suggests a modular organization of the alpha(1C) N-terminal domain, with separate determinants for CaBP1 binding and transduction of the effect on VDI. Our findings expand the diversity and mechanisms of Ca-V channel regulation by CaBP1 and define a novel modulatory function for the initial segment of the N terminus of alpha(1C).	[Oz, Shimrit; Tsemakhovich, Vladimir; Dascal, Nathan] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Christel, Carl J.; Lee, Amy] Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA	Tel Aviv University; Sackler Faculty of Medicine; University of Iowa	Dascal, N (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	dascaln@post.tau.ac.il	Dascal, Nathan/O-3915-2015	Dascal, Nathan/0000-0002-5397-4146; Oz, Shimrit/0000-0001-5110-3833; Lee, Amy/0000-0001-8021-0443	National Institutes of Health [HL087120, DC009433, T32 HL07121]; United States-Israel Binational Science Foundation [2005340]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121, R01HL087120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC009433, R01DC009433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants HL087120 and DC009433 (to A.L.) and T32 HL07121 (to C.J.C.). This work was also supported by United States-Israel Binational Science Foundation Grant 2005340 (to N.D. and A.L.).	Abernethy DR, 2002, J PHARMACOL EXP THER, V300, P724, DOI 10.1124/jpet.300.3.724; Babich O, 2007, J GEN PHYSIOL, V129, P477, DOI 10.1085/jgp.200709734; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Benmocha A, 2009, CHANNELS, V3, P337, DOI 10.4161/chan.3.5.9686; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; Blumenstein Y, 2002, J BIOL CHEM, V277, P3419, DOI 10.1074/jbc.C100642200; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Calin-Jageman I, 2008, J NEUROCHEM, V105, P573, DOI 10.1111/j.1471-4159.2008.05286.x; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cens T, 2006, PROG BIOPHYS MOL BIO, V90, P104, DOI 10.1016/j.pbiomolbio.2005.05.013; Cens T, 1999, J BIOL CHEM, V274, P5483, DOI 10.1074/jbc.274.9.5483; Cheng XY, 2007, J BIOL CHEM, V282, P29211, DOI 10.1074/jbc.M610623200; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; Dai BS, 2002, BIOCHEM BIOPH RES CO, V296, P429, DOI 10.1016/S0006-291X(02)00894-X; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Few AP, 2005, J NEUROSCI, V25, P7071, DOI 10.1523/JNEUROSCI.0452-05.2005; Findeisen F, 2010, STRUCTURE, V18, P1617, DOI 10.1016/j.str.2010.09.012; Findlay I, 2004, J PHYSIOL-LONDON, V554, P275, DOI 10.1113/jphysiol.2003.047902; Findlay I, 2002, J PHYSIOL-LONDON, V541, P741, DOI 10.1113/jphysiol.2002.019737; Fowler MR, 2009, PFLUG ARCH EUR J PHY, V457, P1049, DOI 10.1007/s00424-008-0575-5; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; HALLING DB, 2006, SCI STKE, pER1, DOI DOI 10.1126/STKE.3152005RE15; Hering S, 2000, J PHYSIOL-LONDON, V528, P237, DOI 10.1111/j.1469-7793.2000.t01-1-00237.x; Herzig S, 2007, FASEB J, V21, P1527, DOI 10.1096/fj.06-7377com; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Jangsangthong W, 2010, PFLUG ARCH EUR J PHY, V459, P399, DOI 10.1007/s00424-009-0738-z; Kanevsky N, 2006, J GEN PHYSIOL, V128, P15, DOI 10.1085/jgp.200609485; Kobrinsky E, 2005, J BIOL CHEM, V280, P12474, DOI 10.1074/jbc.M412140200; Kobrinsky E, 2003, J BIOL CHEM, V278, P5021, DOI 10.1074/jbc.M211254200; Lautermilch NJ, 2005, J NEUROSCI, V25, P7062, DOI 10.1523/JNEUROSCI.0447-05.2005; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Lee D, 2006, CELL CALCIUM, V39, P475, DOI 10.1016/j.ceca.2006.01.010; Meyers MB, 1998, J BIOL CHEM, V273, P18930, DOI 10.1074/jbc.273.30.18930; Morad M, 2005, CELL CALCIUM, V38, P223, DOI 10.1016/j.ceca.2005.06.027; Pang L, 2003, FEBS LETT, V546, P349, DOI 10.1016/S0014-5793(03)00629-X; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Shistik E, 1999, J BIOL CHEM, V274, P31145, DOI 10.1074/jbc.274.44.31145; Shistik E, 1998, J BIOL CHEM, V273, P17901, DOI 10.1074/jbc.273.28.17901; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; Soldatov MM, 2003, TRENDS PHARMACOL SCI, V24, P167, DOI 10.1016/S0165-6147(03)00065-8; SOLDATOV NM, 1994, GENOMICS, V22, P77, DOI 10.1006/geno.1994.1347; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Stotz SC, 2004, J PHYSIOL-LONDON, V554, P263, DOI 10.1113/jphysiol.2003.047068; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200; Zhou H, 2004, J NEUROSCI, V24, P4698, DOI 10.1523/JNEUROSCI.5523-03.2004; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	54	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13945	13953		10.1074/jbc.M110.198424	http://dx.doi.org/10.1074/jbc.M110.198424			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21383011	Green Published, hybrid			2022-12-25	WOS:000289556200017
J	Gollo, LL; Mirasso, CR; Atienza, M; Crespo-Garcia, M; Cantero, JL				Gollo, Leonardo L.; Mirasso, Claudio R.; Atienza, Mercedes; Crespo-Garcia, Maite; Cantero, Jose L.			Theta Band Zero-Lag Long-Range Cortical Synchronization via Hippocampal Dynamical Relaying	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; ENTORHINAL CORTEX; VISUAL-CORTEX; TIME-DELAY; OSCILLATIONS; RHYTHM; MODEL; BRAIN; PLASTICITY; NETWORKS	Growing evidence suggests that synchronization among distributed neuronal networks underlie functional integration in the brain. Neural synchronization is typically revealed by a consistent phase delay between neural responses generated in two separated sources. But the influence of a third neuronal assembly in that synchrony pattern remains largely unexplored. We investigate here the potential role of the hippocampus in determining cortico-cortical theta synchronization in different behavioral states during motor quiescent and while animals actively explore the environment. To achieve this goal, the two states were modeled with a recurrent network involving the hippocampus, as a relay element, and two distant neocortical sites. We found that cortico-cortical neural coupling accompanied higher hippocampal theta oscillations in both behavioral states, although the highest level of synchronization between cortical regions emerged during motor exploration. Local field potentials recorded from the same brain regions qualitatively confirm these findings in the two behavioral states. These results suggest that zero-lag long-range cortico-cortical synchronization is likely mediated by hippocampal theta oscillations in lower mammals as a function of cognitive demands and motor acts.	[Gollo, Leonardo L.; Mirasso, Claudio R.] CSIC UIB, IFISC, Palma de Mallorca, Spain; [Atienza, Mercedes; Crespo-Garcia, Maite; Cantero, Jose L.] Univ Pablo Olavide, Spanish Network Excellence Res Neurodegenerat Dis, Lab Funct Neurosci, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Barcelona; Universidad Pablo de Olavide	Gollo, LL (corresponding author), CSIC UIB, IFISC, Campus Univ Illes Balears, Palma de Mallorca, Spain.	claudio@ifisc.uib-csic.es	Gollo, Leonardo/K-6971-2014; Atienza, Mercedes/L-1805-2014; Crespo Garcia, Maite/K-9059-2014; Cantero, Jose L./ABG-6447-2020; Mirasso, Claudio R/B-8661-2008	Gollo, Leonardo/0000-0003-3505-9259; Atienza, Mercedes/0000-0002-6760-1252; Crespo Garcia, Maite/0000-0002-1170-0382; Mirasso, Claudio/0000-0003-2980-7038	European Commission [FP6-NEST, 043309]; Ministerio de Educacion y Ciencia (Spain); Fondo Europeo de Desarrollo Regional (FEDER) [FIS2007-60327]; Spanish Ministry of Science and Innovation [SAF2008-03300, PSI2008-06141]; Regional Ministry of Innovation, Science and Enterprise, Junta de Andalucia [CTS-4604]	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Ministry of Innovation, Science and Enterprise, Junta de Andalucia(Junta de Andalucia)	The authors acknowledge the financial support from the European Commission Project GABA (FP6-NEST Contract 043309). LLG and CM also acknowledge the Ministerio de Educacion y Ciencia (Spain) and Fondo Europeo de Desarrollo Regional (FEDER) under project FIS2007-60327 (FISICOS). This research was also supported by grants from the Spanish Ministry of Science and Innovation (SAF2008-03300, PSI2008-06141) to JLC and MA, respectively, and from the Regional Ministry of Innovation, Science and Enterprise, Junta de Andalucia (CTS-4604) to JLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO A, 1987, EXP BRAIN RES, V67, P493, DOI 10.1007/BF00247282; Atay FM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.144101; Atay FM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.094101; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Budd JML, 2005, P ROY SOC B-BIOL SCI, V272, P101, DOI 10.1098/rspb.2004.2927; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2006, RHYTHMS BRAIN; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Cantero JL, 2005, REV NEUROSCIENCE, V16, P69, DOI 10.1515/REVNEURO.2005.16.1.69; Cantero JL, 2003, J NEUROSCI, V23, P10897; Chawla D, 2001, NEURAL NETWORKS, V14, P727, DOI 10.1016/S0893-6080(01)00043-0; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Crespo-Garcia M, 2010, NEUROIMAGE, V50, P1258, DOI 10.1016/j.neuroimage.2010.01.018; D'Huys O, 2008, CHAOS, V18, DOI 10.1063/1.2953582; Dayan P., 2001, THEORETICAL NEUROSCI; Dhamala M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.074104; DOYERE V, 1993, NEUROPSYCHOLOGIA, V31, P1031, DOI 10.1016/0028-3932(93)90031-T; Ermentrout GB, 1998, P NATL ACAD SCI USA, V95, P1259, DOI 10.1073/pnas.95.3.1259; ERNST U, 1995, PHYS REV LETT, V74, P1570, DOI 10.1103/PhysRevLett.74.1570; Fischer I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.123902; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gollo LL, 2010, NEUROIMAGE, V52, P947, DOI 10.1016/j.neuroimage.2009.11.058; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Guderian S, 2005, HIPPOCAMPUS, V15, P901, DOI 10.1002/hipo.20125; Gutierrez R, 2010, J NEUROSCI, V30, P287, DOI 10.1523/JNEUROSCI.0855-09.2010; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Hyman JM, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/neuro.07.002.2010; Hyman JM, 2005, HIPPOCAMPUS, V15, P739, DOI 10.1002/hipo.20106; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jones MW, 2005, HIPPOCAMPUS, V15, P867, DOI 10.1002/hipo.20119; Kahana MJ, 2006, J NEUROSCI, V26, P1669, DOI 10.1523/JNEUROSCI.3737-05c.2006; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Knoblauch A, 2003, NEUROCOMPUTING, V52-4, P301, DOI 10.1016/S0925-2312(02)00792-0; Koene RA, 2003, NEURAL NETWORKS, V16, P577, DOI 10.1016/S0893-6080(03)00106-0; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Leung LS, 1998, NEUROSCI BIOBEHAV R, V22, P275; LEUNG LWS, 1987, BRAIN RES, V407, P68, DOI 10.1016/0006-8993(87)91220-0; Masquelier T, 2009, J NEUROSCI, V29, P13484, DOI 10.1523/JNEUROSCI.2207-09.2009; McIntosh AR, 1999, MEMORY, V7, P523, DOI 10.1080/096582199387733; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; MITCHELL SJ, 1980, BRAIN RES, V189, P49, DOI 10.1016/0006-8993(80)90006-2; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; NIEBUR E, 1991, PHYS REV LETT, V67, P2753, DOI 10.1103/PhysRevLett.67.2753; Paz R, 2008, LEARN MEMORY, V15, P524, DOI 10.1101/lm.932408; Pesaran B, 2010, CURR OPIN NEUROBIOL, V20, P166, DOI 10.1016/j.conb.2010.03.003; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Ranganath C, 2005, CURR OPIN NEUROBIOL, V15, P175, DOI 10.1016/j.conb.2005.03.017; Reddy DVR, 1998, PHYS REV LETT, V80, P5109, DOI 10.1103/PhysRevLett.80.5109; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Roxin A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.238103; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Soteropoulos DS, 2006, J NEUROPHYSIOL, V95, P1194, DOI 10.1152/jn.00935.2005; Strogatz S. H., 2003, SYNC; Su HL, 2001, J NEUROSCI, V21, P4173, DOI 10.1523/JNEUROSCI.21-12-04173.2001; Tejada S, 2010, NEUROSCIENCE, V165, P621, DOI 10.1016/j.neuroscience.2009.10.031; Tsanov M, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.032.2009; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Vicente R, 2008, P NATL ACAD SCI USA, V105, P17157, DOI 10.1073/pnas.0809353105; Vyazovskiy VV, 2005, BRAIN RES, V1050, P64, DOI 10.1016/j.brainres.2005.05.022; Wall PM, 2001, BEHAV BRAIN RES, V127, P99, DOI 10.1016/S0166-4328(01)00355-2; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang QY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026206; Wang QY, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/50008; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Yamaguchi Yoko, 2004, Journal of Integrative Neuroscience, V3, P143, DOI 10.1142/S0219635204000488; Yeung MKS, 1999, PHYS REV LETT, V82, P648, DOI 10.1103/PhysRevLett.82.648; Young CK, 2009, CEREB CORTEX, V19, P24, DOI 10.1093/cercor/bhn055; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	82	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17756	10.1371/journal.pone.0017756	http://dx.doi.org/10.1371/journal.pone.0017756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408082	gold, Green Published, Green Submitted			2022-12-25	WOS:000288170000058
J	Gosalbes, MJ; Durban, A; Pignatelli, M; Abellan, JJ; Jimenez-Hernandez, N; Perez-Cobas, AE; Latorre, A; Moya, A				Jose Gosalbes, Maria; Durban, Ana; Pignatelli, Miguel; Jose Abellan, Juan; Jimenez-Hernandez, Nuria; Elena Perez-Cobas, Ana; Latorre, Amparo; Moya, Andres			Metatranscriptomic Approach to Analyze the Functional Human Gut Microbiota	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; HUMAN GASTROINTESTINAL-TRACT; METAGENOMIC ANALYSIS; BACTERIAL DIVERSITY; VIRAL COMMUNITY; NONCODING RNAS; MUCOSA; GROWTH; BIFIDOBACTERIA; METABOLISM	The human gut is the natural habitat for a large and dynamic bacterial community that has a great relevance for health. Metagenomics is increasing our knowledge of gene content as well as of functional and genetic variability in this microbiome. However, little is known about the active bacteria and their function(s) in the gastrointestinal tract. We performed a metatranscriptomic study on ten healthy volunteers to elucidate the active members of the gut microbiome and their functionality under conditions of health. First, the microbial cDNAs obtained from each sample were sequenced using 454 technology. The analysis of 16S transcripts showed the phylogenetic structure of the active microbial community. Lachnospiraceae, Ruminococcaceae, Bacteroidaceae, Prevotellaceae, and Rickenellaceae were the predominant families detected in the active microbiota. The characterization of mRNAs revealed a uniform functional pattern in healthy individuals. The main functional roles of the gut microbiota were carbohydrate metabolism, energy production and synthesis of cellular components. In contrast, housekeeping activities such as amino acid and lipid metabolism were underrepresented in the metatranscriptome. Our results provide new insights into the functionality of the complex gut microbiota in healthy individuals. In this RNA-based survey, we also detected small RNAs, which are important regulatory elements in prokaryotic physiology and pathogenicity.	[Jose Gosalbes, Maria; Durban, Ana; Pignatelli, Miguel; Jose Abellan, Juan; Jimenez-Hernandez, Nuria; Elena Perez-Cobas, Ana; Latorre, Amparo; Moya, Andres] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolutiva, Unidad Mixta Invest Genom & Salud, Ctr Super Invest Salud Publ Generalitat Valencian, Valencia, Spain; [Jose Gosalbes, Maria; Durban, Ana; Pignatelli, Miguel; Jose Abellan, Juan; Jimenez-Hernandez, Nuria; Latorre, Amparo; Moya, Andres] CIBER Epidemiol & Salud Publ, Valencia, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Gosalbes, MJ (corresponding author), Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolutiva, Unidad Mixta Invest Genom & Salud, Ctr Super Invest Salud Publ Generalitat Valencian, Valencia, Spain.	andres.moya@uv.es	Hernández, Nuria Jiménez/H-1982-2015; Latorre, Amparo/E-4997-2015; Pérez Cobas, Ana Elena/GRY-4537-2022; Pérez-Cobas, Ana Elena/A-9471-2019; Moya, Andrés/A-8190-2008; Pérez-Cobas, Ana Elena/K-7881-2019; Gosalbes, Maria Jose/C-7194-2011	Hernández, Nuria Jiménez/0000-0002-9107-056X; Latorre, Amparo/0000-0002-9146-7284; Pérez-Cobas, Ana Elena/0000-0002-3995-5571; Moya, Andrés/0000-0002-2867-1119; Pérez-Cobas, Ana Elena/0000-0002-3995-5571; Gosalbes, Maria Jose/0000-0003-0460-1105; Abellan-Andres, Juan Jose/0000-0002-6517-0786	Ministerio de Ciencia e Innovacion, Spain [BFU2008-04501-E/BMC, SAF2009-13032-C02-01]; Instituto de Salud Carlos III, Spain; 'CIBER en Epidemiologia y Salud Publica' (CIBEResp), Spain	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); 'CIBER en Epidemiologia y Salud Publica' (CIBEResp), Spain	This work has been funded by grant BFU2008-04501-E/BMC and SAF2009-13032-C02-01 from Ministerio de Ciencia e Innovacion, Spain. AD and AEPC are recipients of a fellowship from the Instituto de Salud Carlos III, Spain. MJG is recipient of a post-doctoral contract from 'CIBER en Epidemiologia y Salud Publica' (CIBEResp), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2007, APPL ENVIRON MICROB, V73, P7435, DOI 10.1128/AEM.01143-07; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; Bejerano-Sagie M, 2007, CURR OPIN MICROBIOL, V10, P189, DOI 10.1016/j.mib.2007.03.009; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; Booijink CCGM, 2010, APPL ENVIRON MICROB, V76, P5533, DOI 10.1128/AEM.00502-10; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; CHAO A, 1984, SCAND J STAT, V11, P265; Chao A, 2000, STAT SINICA, V10, P227; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; GIBSON GR, 1994, J APPL BACTERIOL, V77, P412, DOI 10.1111/j.1365-2672.1994.tb03443.x; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gottesman S, 2002, GENE DEV, V16, P2829, DOI 10.1101/gad.1030302; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; KEMP PF, 1993, APPL ENVIRON MICROB, V59, P2594, DOI 10.1128/AEM.59.8.2594-2601.1993; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Klaassens ES, 2009, APPL ENVIRON MICROB, V75, P2668, DOI 10.1128/AEM.02492-08; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lay C, 2005, ENVIRON MICROBIOL, V7, P933, DOI 10.1111/j.1462-2920.2005.00763.x; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Marounek M, 1999, LETT APPL MICROBIOL, V29, P429, DOI 10.1046/j.1472-765X.1999.00671.x; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; O'Sullivan DJ, 2001, J AGR FOOD CHEM, V49, P1751, DOI 10.1021/jf0012244; Papineau D, 2005, APPL ENVIRON MICROB, V71, P4822, DOI 10.1128/AEM.71.8.4822-4832.2005; Pignatelli M, 2009, ENV MICROBIOL REP, V1, P191, DOI 10.1111/j.1758-2229.2009.00030.x; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Poretsky RS, 2005, APPL ENVIRON MICROB, V71, P4121, DOI 10.1128/AEM.71.7.4121-4126.2005; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; RODE LM, 1981, APPL ENVIRON MICROB, V42, P20, DOI 10.1128/AEM.42.1.20-22.1981; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Takada T, 2004, J MICROBIOL METH, V58, P413, DOI 10.1016/j.mimet.2004.05.006; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Wang X, 2003, J APPL MICROBIOL, V95, P508, DOI 10.1046/j.1365-2672.2003.02005.x; Warnecke F, 2009, J BIOTECHNOL, V142, P91, DOI 10.1016/j.jbiotec.2009.03.022; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603; Zoetendal EG, 2006, MOL MICROBIOL, V59, P1639, DOI 10.1111/j.1365-2958.2006.05056.x; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	67	234	261	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17447	10.1371/journal.pone.0017447	http://dx.doi.org/10.1371/journal.pone.0017447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408168	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170000031
J	McMains, E; Krishnan, V; Prasad, S; Gleason, E				McMains, Emily; Krishnan, Vijai; Prasad, Sujitha; Gleason, Evanna			Expression and Localization of CLC Chloride Transport Proteins in the Avian Retina	PLOS ONE			English	Article							LYSOSOMAL STORAGE DISEASE; DEVELOPING CHICK RETINA; SUBCELLULAR-LOCALIZATION; GLUTAMINE-SYNTHETASE; AMACRINE CELLS; HORIZONTAL CELLS; CHANNEL; KIDNEY; IMMUNOLOCALIZATION; LEADS	Members of the ubiquitously expressed CLC protein family of chloride channels and transporters play important roles in regulating cellular chloride and pH. The CLCs that function as Cl-/H+ antiporters, ClCs 3-7, are essential in particular for the acidification of endosomal compartments and protein degradation. These proteins are broadly expressed in the nervous system, and mutations that disrupt their expression are responsible for several human genetic diseases. Furthermore, knockout of ClC3 and ClC7 in the mouse result in the degeneration of the hippocampus and the retina. Despite this evidence of their importance in retinal function, the expression patterns of different CLC transporters in different retinal cell types are as yet undescribed. Previous work in our lab has shown that in chicken amacrine cells, internal Cl- can be dynamic. To determine whether CLCs have the potential to participate, we used PCR and immunohistochemical techniques to examine CLC transporter expression in the chicken retina. We observed a high level of variation in the retinal expression levels and patterns among the different CLC proteins examined. These findings, which represent the first systematic investigation of CLC transporter expression in the retina, support diverse functions for the different CLCs in this tissue.	[McMains, Emily; Krishnan, Vijai; Prasad, Sujitha; Gleason, Evanna] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	McMains, E (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	egleaso@lsu.edu	Gleason, Evanna/C-2778-2011	, Vijai/0000-0001-5979-1255; Abdulmagomedov, Suleiman/0000-0001-9162-5062	National Eye Institute, NIH [EY012204]; NATIONAL EYE INSTITUTE [R01EY012204, R29EY012204] Funding Source: NIH RePORTER	National Eye Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute, NIH, EY012204 (nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; Bergmann M, 2002, J COMP NEUROL, V449, P231, DOI 10.1002/cne.10302; Bergmann M, 2000, J COMP NEUROL, V418, P361; Caldwell RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r6; Caminos E, 1999, DEV BRAIN RES, V118, P227, DOI 10.1016/S0165-3806(99)00156-X; Crousillac S, 2003, VISUAL NEUROSCI, V20, P453, DOI 10.1017/S0952523803204107; ELLIS JH, 1991, CELL TISSUE RES, V264, P197, DOI 10.1007/BF00313956; Faundez Victor, 2004, Sci STKE, V2004, pre8, DOI 10.1126/stke.2332004re8; Fischer AJ, 1999, J COMP NEUROL, V405, P1, DOI 10.1002/(SICI)1096-9861(19990301)405:1<1::AID-CNE1>3.0.CO;2-U; Fischer AJ, 1998, J COMP NEUROL, V393, P1; Fischer AJ, 1998, J COMP NEUROL, V392, P273; Fischer AJ, 2007, J COMP NEUROL, V500, P1154, DOI 10.1002/cne.21236; Gavrikov KE, 2006, P NATL ACAD SCI USA, V103, P18793, DOI 10.1073/pnas.0604551103; GLEASON E, 1993, J NEUROSCI, V13, P2359, DOI 10.1523/JNEUROSCI.13-06-02359.1993; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Hirano AA, 2005, J COMP NEUROL, V488, P70, DOI 10.1002/cne.20577; Hoffpauir B, 2006, J NEUROPHYSIOL, V95, P2866, DOI 10.1152/jn.01317.2005; Huang LQ, 2005, J BIOL CHEM, V280, P36150, DOI 10.1074/jbc.M507706200; Isnard-Bagnis C, 2003, AM J PHYSIOL-CELL PH, V284, pC220, DOI 10.1152/ajpcell.00374.2001; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2005, CURR OPIN NEUROBIOL, V15, P319, DOI 10.1016/j.conb.2005.05.002; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Koulen P, 1997, J COMP NEUROL, V380, P520, DOI 10.1002/(SICI)1096-9861(19970421)380:4<520::AID-CNE8>3.0.CO;2-3; LINSER P, 1979, P NATL ACAD SCI USA, V76, P6476, DOI 10.1073/pnas.76.12.6476; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Luyckx VA, 1998, AM J PHYSIOL-RENAL, V275, pF761, DOI 10.1152/ajprenal.1998.275.5.F761; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; Matsuda JJ, 2008, AM J PHYSIOL-CELL PH, V294, pC251, DOI 10.1152/ajpcell.00338.2007; MILLAR T, 1985, NEUROSCI LETT, V61, P311, DOI 10.1016/0304-3940(85)90482-3; Neagoe I, 2010, J BIOL CHEM, V285, P21689, DOI 10.1074/jbc.M110.125971; NEGISHI K, 1988, NEUROSCI LETT, V94, P247, DOI 10.1016/0304-3940(88)90025-0; NORENBERG MD, 1980, J CELL BIOL, V84, P803, DOI 10.1083/jcb.84.3.803; Novarino G, 2010, SCIENCE, V328, P1398, DOI 10.1126/science.1188070; Okkenhaug H, 2006, FASEB J, V20, P2390, DOI 10.1096/fj.05-5588fje; Omri S, 2010, CLIN OPHTHALMOL, V4, P183; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Plans V, 2009, PFLUG ARCH EUR J PHY, V458, P23, DOI 10.1007/s00424-008-0597-z; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Prada FA, 1998, GLIA, V22, P221, DOI 10.1002/(SICI)1098-1136(199803)22:3<221::AID-GLIA2>3.0.CO;2-8; Sakamoto H, 1999, AM J PHYSIOL-RENAL, V277, pF957, DOI 10.1152/ajprenal.1999.277.6.F957; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Sen M, 2006, VISUAL NEUROSCI, V23, P221, DOI 10.1017/S0952523806232073; Sherry DM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-54; Smith AJ, 2010, J PHYSIOL-LONDON, V588, P2033, DOI 10.1113/jphysiol.2010.188540; STAUBER T, 2010, J BIOL CHEM; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; Vandewalle A, 2001, AM J PHYSIOL-CELL PH, V280, pC373, DOI 10.1152/ajpcell.2001.280.2.C373; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200	57	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17647	10.1371/journal.pone.0017647	http://dx.doi.org/10.1371/journal.pone.0017647			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408174	gold, Green Published, Green Submitted			2022-12-25	WOS:000288099800031
J	Nehme, NT; Quintin, J; Cho, JH; Lee, J; Lafarge, MC; Kocks, C; Ferrandon, D				Nehme, Nadine T.; Quintin, Jessica; Cho, Ju Hyun; Lee, Janice; Lafarge, Marie-Celine; Kocks, Christine; Ferrandon, Dominique			Relative Roles of the Cellular and Humoral Responses in the Drosophila Host Defense against Three Gram-Positive Bacterial Infections	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTOR; IMMUNE-RESPONSE; TOLL-PATHWAY; ANTIMICROBIAL PEPTIDES; IMD PATHWAYS; PGRP-SD; PHAGOCYTOSIS; PROTEIN; RESISTANCE; ACTIVATION	Background: Two NF-kappaB signaling pathways, Toll and immune deficiency (imd), are required for survival to bacterial infections in Drosophila. In response to septic injury, these pathways mediate rapid transcriptional activation of distinct sets of effector molecules, including antimicrobial peptides, which are important components of a humoral defense response. However, it is less clear to what extent macrophage-like hemocytes contribute to host defense. Methodology/Principal Findings: In order to dissect the relative importance of humoral and cellular defenses after septic injury with three different Gram-positive bacteria (Micrococcus luteus, Enterococcus faecalis, Staphylococcus aureus), we used latex bead pre-injection to ablate macrophage function in flies wildtype or mutant for various Toll and imd pathway components. We found that in all three infection models a compromised phagocytic system impaired fly survival independently of concomitant Toll or imd pathway activation. Our data failed to confirm a role of the PGRP-SA and GNBP1 Pattern Recognition Receptors for phagocytosis of S. aureus. The Drosophila scavenger receptor Eater mediates the phagocytosis by hemocytes or S2 cells of E. faecalis and S. aureus, but not of M. luteus. In the case of M. luteus and E. faecalis, but not S. aureus, decreased survival due to defective phagocytosis could be compensated for by genetically enhancing the humoral immune response. Conclusions/Significance: Our results underscore the fundamental importance of both cellular and humoral mechanisms in Drosophila immunity and shed light on the balance between these two arms of host defense depending on the invading pathogen.	[Nehme, Nadine T.; Quintin, Jessica; Cho, Ju Hyun; Lee, Janice; Lafarge, Marie-Celine; Kocks, Christine; Ferrandon, Dominique] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Equipe Fdn Rech Med,UPR 9022, Strasbourg, France; [Cho, Ju Hyun; Lee, Janice; Kocks, Christine] Harvard Univ, Sch Med, Dept Pediat, Massachusetts Gen Hosp, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Harvard Medical School; Massachusetts General Hospital	Nehme, NT (corresponding author), Hop Necker Enfants Malad, INSERM, U768, Paris, France.	D.Ferrandon@ibmc.u-strasbg.fr		FERRANDON, Dominique/0000-0001-7680-7773	Conseil National de la Recherche Scientifique du Liban; CNRS; NIH [PO1 AI44220]; Fondation pour la Recherche Medicale; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER	Conseil National de la Recherche Scientifique du Liban; CNRS(Centre National de la Recherche Scientifique (CNRS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	N.N. was partially supported by a fellowship from the Conseil National de la Recherche Scientifique du Liban. This work was supported financially by the CNRS, a NIH Program grant PO1 AI44220, and a DROSELEGANS grant from the Agence Nationale de la Recherche. The Strasbourg team is an "Equipe FRM", a label awarded by the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; Avet-Rochex A, 2005, CELL MICROBIOL, V7, P799, DOI 10.1111/j.1462-5822.2005.00512.x; Avet-Rochex A, 2007, GENES CELLS, V12, P1193, DOI 10.1111/j.1365-2443.2007.01121.x; Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Braun A, 1998, P NATL ACAD SCI USA, V95, P14337, DOI 10.1073/pnas.95.24.14337; Brennan CA, 2007, CURR BIOL, V17, P67, DOI 10.1016/j.cub.2006.11.026; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Chang CI, 2004, PLOS BIOL, V2, P1293, DOI 10.1371/journal.pbio.0020277; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Defaye A, 2009, J INNATE IMMUN, V1, P322, DOI 10.1159/000210264; DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106; DIMARCQ JL, 1994, EUR J BIOCHEM, V221, P201, DOI 10.1111/j.1432-1033.1994.tb18730.x; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Garver LS, 2006, P NATL ACAD SCI USA, V103, P660, DOI 10.1073/pnas.0506182103; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Hashimoto Y, 2009, J IMMUNOL, V183, P7451, DOI 10.4049/jimmunol.0901032; HOFFMANN D, 1976, CR ACAD SCI D NAT, V282, P1021; HOFFMANN JA, 1992, IMMUNOL TODAY, V13, P411, DOI 10.1016/0167-5699(92)90092-L; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; Jung AC, 2001, BIOTECHNIQUES, V30, P594, DOI 10.2144/01303rr04; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leone P, 2008, MOL IMMUNOL, V45, P2521, DOI 10.1016/j.molimm.2008.01.015; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Matova N, 2006, P NATL ACAD SCI USA, V103, P16424, DOI 10.1073/pnas.0605721103; Matskevich AA, 2010, EUR J IMMUNOL, V40, P1244, DOI 10.1002/eji.200940164; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Pluddemann Annette, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000159; POWELL DA, 1975, BIOCHEM J, V151, P387, DOI 10.1042/bj1510387; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Wang L, 2008, P NATL ACAD SCI USA, V105, P11881, DOI 10.1073/pnas.0710092105; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861	58	71	73	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e14743	10.1371/journal.pone.0014743	http://dx.doi.org/10.1371/journal.pone.0014743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390224	Green Published, gold, Green Submitted			2022-12-25	WOS:000287965200003
J	Yuan, SH; Martin, J; Elia, J; Flippin, J; Paramban, RI; Hefferan, MP; Vidal, JG; Mu, YL; Killian, RL; Israel, MA; Emre, N; Marsala, S; Marsala, M; Gage, FH; Goldstein, LSB; Carson, CT				Yuan, Shauna H.; Martin, Jody; Elia, Jeanne; Flippin, Jessica; Paramban, Rosanto I.; Hefferan, Mike P.; Vidal, Jason G.; Mu, Yangling; Killian, Rhiannon L.; Israel, Mason A.; Emre, Nil; Marsala, Silvia; Marsala, Martin; Gage, Fred H.; Goldstein, Lawrence S. B.; Carson, Christian T.			Cell-Surface Marker Signatures for the Isolation of Neural Stem Cells, Glia and Neurons Derived from Human Pluripotent Stem Cells	PLOS ONE			English	Article							FLOW-CYTOMETRIC ANALYSIS; PROGENITOR CELLS; SPINAL-CORD; DOPAMINERGIC-NEURONS; NERVOUS-SYSTEM; HUMAN ES; HUMAN BLASTOCYSTS; SELF-RENEWAL; DIFFERENTIATION; FETAL	Background: Neural induction of human pluripotent stem cells often yields heterogeneous cell populations that can hamper quantitative and comparative analyses. There is a need for improved differentiation and enrichment procedures that generate highly pure populations of neural stem cells (NSC), glia and neurons. One way to address this problem is to identify cell-surface signatures that enable the isolation of these cell types from heterogeneous cell populations by fluorescence activated cell sorting (FACS). Methodology/Principal Findings: We performed an unbiased FACS- and image-based immunophenotyping analysis using 190 antibodies to cell surface markers on naive human embryonic stem cells (hESC) and cell derivatives from neural differentiation cultures. From this analysis we identified prospective cell surface signatures for the isolation of NSC, glia and neurons. We isolated a population of NSC that was CD184(+)/CD271(-)/CD44(-)/CD24(+) from neural induction cultures of hESC and human induced pluripotent stem cells (hiPSC). Sorted NSC could be propagated for many passages and could differentiate to mixed cultures of neurons and glia in vitro and in vivo. A population of neurons that was CD184(-)/CD44(-)/CD15(LOW)/CD24(+) and a population of glia that was CD184(+)/CD44(+) were subsequently purified from cultures of differentiating NSC. Purified neurons were viable, expressed mature and subtype-specific neuronal markers, and could fire action potentials. Purified glia were mitotic and could mature to GFAP-expressing astrocytes in vitro and in vivo. Conclusions/Significance: These findings illustrate the utility of immunophenotyping screens for the identification of cell surface signatures of neural cells derived from human pluripotent stem cells. These signatures can be used for isolating highly pure populations of viable NSC, glia and neurons by FACS. The methods described here will enable downstream studies that require consistent and defined neural cell populations.	[Yuan, Shauna H.; Flippin, Jessica; Killian, Rhiannon L.; Israel, Mason A.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Yuan, Shauna H.; Flippin, Jessica; Killian, Rhiannon L.; Israel, Mason A.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Yuan, Shauna H.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Martin, Jody; Elia, Jeanne; Paramban, Rosanto I.; Vidal, Jason G.; Emre, Nil; Carson, Christian T.] BD Biosci, La Jolla, CA USA; [Hefferan, Mike P.; Marsala, Silvia; Marsala, Martin] Univ Calif San Diego, Dept Anesthesiol, Anesthesiol Res Lab, La Jolla, CA 92093 USA; [Mu, Yangling; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Killian, Rhiannon L.; Israel, Mason A.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Marsala, Martin] Slovak Acad Sci, Inst Neurobiol, Kosice 04001, Slovakia	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; Slovak Academy of Sciences	Yuan, SH (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	christian_carson@bd.com		Israel, Mason/0000-0003-0867-0626; Yuan, Shauna/0000-0003-4058-4146	UCSD [T1-00003]; CIRM [RC1-00116-1, RC1-00131-1]; HHMI; Becton Dickinson Biosciences	UCSD; CIRM(California Institute for Regenerative Medicine); HHMI(Howard Hughes Medical Institute); Becton Dickinson Biosciences	SHY, RLN and MAI were partially supported by the CIRM Interdisciplinary Stem Cell Training Program at UCSD (grant T1-00003 Larry Goldstein, PD). LSBG is a Howard Hughes Investigator. This work was partially supported by a grant from CIRM to LSBG (RC1-00116-1) and to MM (RC1-00131-1) and HHMI. CTC, NE, RP, JM, JE and JGV were supported by Becton Dickinson Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DK, 1995, BRAIN PATHOL, V5, P451, DOI 10.1111/j.1750-3639.1995.tb00624.x; Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Bucay N, 2009, STEM CELLS, V27, P68, DOI 10.1634/stemcells.2007-1018; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carson CT, 2006, NAT MED, V12, P1237, DOI 10.1038/nm1106-1237; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cizkova D, 2007, NEUROSCIENCE, V147, P546, DOI 10.1016/j.neuroscience.2007.02.065; Corti S, 2005, FASEB J, V19, P1860, DOI 10.1096/fj.05-4170fje; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; GERDES J, 1984, J IMMUNOL, V133, P1710; Giovanini MA, 1997, EXP NEUROL, V148, P523, DOI 10.1006/exnr.1997.6703; Golebiewska A, 2009, STEM CELLS, V27, P1298, DOI 10.1002/stem.59; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Kakinohana O, 2004, EXP NEUROL, V190, P122, DOI 10.1016/j.expneurol.2004.07.014; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Keyoung HM, 2001, NAT BIOTECHNOL, V19, P843, DOI 10.1038/nbt0901-843; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Leschik J, 2008, NAT PROTOC, V3, P1381, DOI 10.1038/nprot.2008.116; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Luo YQ, 2002, J NEUROCHEM, V83, P1481, DOI 10.1046/j.1471-4159.2002.01260.x; Maric D, 2003, J NEUROSCI, V23, P240; Marsala M, 2004, EUR J NEUROSCI, V20, P2401, DOI 10.1111/j.1460-9568.2004.03702.x; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Nelson TJ, 2008, STEM CELLS, V26, P1464, DOI 10.1634/stemcells.2007-0808; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Peh GSL, 2009, STEM CELLS DEV, V18, P269, DOI 10.1089/scd.2008.0124; Peng H, 2007, J NEUROIMMUNE PHARM, V2, P251, DOI 10.1007/s11481-007-9081-3; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; PRUSZAK J, 2009, STEM CELLS; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Rebetz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001936; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Roy NS, 2000, NAT MED, V6, P271; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Sundberg M, 2009, STEM CELL RES, V2, P113, DOI 10.1016/j.scr.2008.08.001; Taira Y, 1996, STROKE, V27, P1850, DOI 10.1161/01.STR.27.10.1850; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; USVALD D, 2010, CELL TRANSPLANT; Vinuela A, 2008, BRAIN, V131, P3361, DOI 10.1093/brain/awn192; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	56	258	276	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17540	10.1371/journal.pone.0017540	http://dx.doi.org/10.1371/journal.pone.0017540			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407814	Green Submitted, gold, Green Published			2022-12-25	WOS:000287933300032
J	Ristic, N; Zukurov, J; Alkmim, W; Diaz, RS; Janini, LM; Chin, MPS				Ristic, Natalia; Zukurov, Jean; Alkmim, Wagner; Diaz, Ricardo Sobhie; Janini, Luiz Mario; Chin, Mario P. S.			Analysis of the Origin and Evolutionary History of HIV-1 CRF28_BF and CRF29_BF Reveals a Decreasing Prevalence in the AIDS Epidemic of Brazil	PLOS ONE			English	Article							INTERSUBTYPE RECOMBINANT VIRUSES; RIO-DE-JANEIRO; SUBTYPE-B; BLOOD-DONORS; SAO-PAULO; TYPE-1; IDENTIFICATION; INDIVIDUALS; INFECTIONS; ARGENTINA	Background: HIV-1 subtype B and subtype F are prevalent in the AIDS epidemic of Brazil. Recombinations between these subtypes have generated at least four BF circulating recombinant forms (CRFs). CRF28_BF and CRF29_BF are among the first two BF recombinants being identified in Brazil and they contributed significantly to the epidemic. However, the evolution and demographic histories of the CRFs are unclear. Methodology/Principal Findings: A collection of gag and pol sequences sampled within Brazil was screened for CRF28_BF-like and CRF29_BF-like recombination patterns. A Bayesian coalescent framework was employed to delineate the phylogenetic, divergence time and population dynamics of the virus having CRF28_BF-like and CRF29_BF-like genotype. These recombinants were phylogenetically related to each other and formed a well-supported monophyletic clade dated to 1988-1989. The effective number of infections by these recombinants grew exponentially over a five-year period after their emergence, but then decreased toward the present following a logistic model of population growth. The demographic pattern of both recombinants closely resembles those previously reported for CRF31_BC. Conclusions: We revealed that HIV-1 recombinants of the CRF28_BF/CRF29_BF clade are still circulating in the Brazilian population. These recombinants did not exhibit a strong founder effect and showed a decreasing prevalence in the AIDS epidemic of Brazil. Our data suggested that multiple URFs may also play a role in shaping the epidemic of recombinant BF HIV-1 in the region.	[Ristic, Natalia; Chin, Mario P. S.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Zukurov, Jean; Diaz, Ricardo Sobhie] Univ Fed Sao Paulo, Dept Med, Sao Paulo, Brazil; [Alkmim, Wagner; Janini, Luiz Mario] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil	Rockefeller University; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Ristic, N (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 1230 York Ave, New York, NY 10021 USA.	mchin@adarc.org	Diaz, Ricardo/K-3978-2012; Janini, Luiz Mario R/E-9700-2012	Janini, Luiz Mario/0000-0002-6186-6284	Aaron Diamond AIDS Research Center; National Institutes of Health [DA026293]; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA026293, K99DA026293] Funding Source: NIH RePORTER	Aaron Diamond AIDS Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by internal funds of Aaron Diamond AIDS Research Center and National Institutes of Health grant DA026293. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulicino PC, 2007, AIDS RES HUM RETROV, V23, P1176, DOI 10.1089/aid.2007.0038; AULICINO PC, 2010, INFECT GENET EVOL; Bello G, 2006, AIDS, V20, P763, DOI 10.1097/01.aids.0000216377.84313.52; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bello G, 2007, INFECT GENET EVOL, V7, P263, DOI 10.1016/j.meegid.2006.11.002; Bello G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-22; Bello G, 2009, AIDS RES HUM RETROV, V25, P1065, DOI 10.1089/aid.2009.0106; Passaes CPB, 2009, INFECT GENET EVOL, V9, P474, DOI 10.1016/j.meegid.2009.01.008; *BRAZ MIN HLTH, 2009, AIDS EP B; Brennan CA, 2007, AIDS RES HUM RETROV, V23, P1434, DOI 10.1089/aid.2007.0121; Brigido LFM, 2005, AIDS RES HUM RETROV, V21, P673, DOI 10.1089/aid.2005.21.673; Carr JK, 2001, AIDS, V15, pF41, DOI 10.1097/00002030-200110190-00002; Chin MPS, 2007, VIROLOGY, V363, P437, DOI 10.1016/j.virol.2007.01.034; Chin MPS, 2005, P NATL ACAD SCI USA, V102, P9002, DOI 10.1073/pnas.0502522102; De Sa DJ, 2005, AIDS RES HUM RETROV, V21, P145, DOI 10.1089/aid.2005.21.145; De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1; Deng W, 2009, AIDS, V23, P977, DOI 10.1097/QAD.0b013e328329217d; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; FELSENSTEIN J, 1973, AM J HUM GENET, V25, P471; Galli A, 2010, J VIROL, V84, P7651, DOI 10.1128/JVI.00276-10; Guimaraes ML, 2008, AIDS, V22, P433, DOI 10.1097/QAD.0b013e3282f47ad0; Guiniaraes ML, 2002, AIDS RES HUM RETROV, V18, P1261, DOI 10.1089/088922202320886307; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Leal E, 2008, RETROVIROLOGY RES TR, V1, P1; Lemey P, 2004, GENETICS, V167, P1059, DOI 10.1534/genetics.104.026666; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Moore Michael D., 2009, V485, P87, DOI 10.1007/978-1-59745-170-3_7; MORGADO MG, 1994, AIDS RES HUM RETROV, V10, P569, DOI 10.1089/aid.1994.10.569; Ramos A, 1999, EMERG INFECT DIS, V5, P65, DOI 10.3201/eid0501.990108; Rhodes T, 2003, J VIROL, V77, P11193, DOI 10.1128/JVI.77.20.11193-11200.2003; Robbins KE, 2003, J VIROL, V77, P6359, DOI 10.1128/JVI.77.11.6359-6366.2003; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Sa D, 2007, AIDS RES HUM RETROV, V23, P1087, DOI 10.1089/aid.2006.0173; SABINO EC, 1994, J VIROL, V68, P6340, DOI 10.1128/JVI.68.10.6340-6346.1994; Sanabani S, 2006, INFECT GENET EVOL, V6, P368, DOI 10.1016/j.meegid.2006.01.003; Sanabani SS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-74; Schierup MH, 2000, GENETICS, V156, P879; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tanuri A, 1999, J ACQ IMMUN DEF SYND, V20, P60, DOI 10.1097/00042560-199901010-00009; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomson MM, 2000, AIDS, V14, P897, DOI 10.1097/00002030-200005050-00020; Thomson MM, 2004, AIDS RES HUM RETROV, V20, P1126, DOI 10.1089/aid.2004.20.1126; Thomson MM, 2002, J GEN VIROL, V83, P107, DOI 10.1099/0022-1317-83-1-107; Walker Polly R., 2005, Infection Genetics and Evolution, V5, P199, DOI 10.1016/j.meegid.2004.06.011; Worobey M, 2001, MOL BIOL EVOL, V18, P1425, DOI 10.1093/oxfordjournals.molbev.a003928	50	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17485	10.1371/journal.pone.0017485	http://dx.doi.org/10.1371/journal.pone.0017485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390250	gold, Green Published, Green Submitted			2022-12-25	WOS:000287932100020
J	Dong, GY; Luo, J; Zhang, H; Wang, CM; Duan, MX; Deliberto, TJ; Nolte, DL; Ji, GJ; He, HX				Dong, Guoying; Luo, Jing; Zhang, Hong; Wang, Chengmin; Duan, Mingxing; Deliberto, Thomas Jude; Nolte, Dale Louis; Ji, Guangju; He, Hongxuan			Phylogenetic Diversity and Genotypical Complexity of H9N2 Influenza A Viruses Revealed by Genomic Sequence Analysis	PLOS ONE			English	Article							AVIAN INFLUENZA; SOUTHERN CHINA; MOLECULAR EPIDEMIOLOGY; HUMAN INFECTION; EVOLUTION; POULTRY; HEMAGGLUTININ; GENES; TRANSMISSION; ECOLOGY	H9N2 influenza A viruses have become established worldwide in terrestrial poultry and wild birds, and are occasionally transmitted to mammals including humans and pigs. To comprehensively elucidate the genetic and evolutionary characteristics of H9N2 influenza viruses, we performed a large-scale sequence analysis of 571 viral genomes from the NCBI Influenza Virus Resource Database, representing the spectrum of H9N2 influenza viruses isolated from 1966 to 2009. Our study provides a panoramic framework for better understanding the genesis and evolution of H9N2 influenza viruses, and for describing the history of H9N2 viruses circulating in diverse hosts. Panorama phylogenetic analysis of the eight viral gene segments revealed the complexity and diversity of H9N2 influenza viruses. The 571 H9N2 viral genomes were classified into 74 separate lineages, which had marked host and geographical differences in phylogeny. Panorama genotypical analysis also revealed that H9N2 viruses include at least 98 genotypes, which were further divided according to their HA lineages into seven series (A-G). Phylogenetic analysis of the internal genes showed that H9N2 viruses are closely related to H3, H4, H5, H7, H10, and H14 subtype influenza viruses. Our results indicate that H9N2 viruses have undergone extensive reassortments to generate multiple reassortants and genotypes, suggesting that the continued circulation of multiple genotypical H9N2 viruses throughout the world in diverse hosts has the potential to cause future influenza outbreaks in poultry and epidemics in humans. We propose a nomenclature system for identifying and unifying all lineages and genotypes of H9N2 influenza viruses in order to facilitate international communication on the evolution, ecology and epidemiology of H9N2 influenza viruses.	[Dong, Guoying; Luo, Jing; Zhang, Hong; Wang, Chengmin; He, Hongxuan] Chinese Acad Sci, Inst Zool, Natl Res Ctr Wildlife Born Dis, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Dong, Guoying; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Ctr Computat & Syst Biol, Beijing 100080, Peoples R China; [Duan, Mingxing] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Deliberto, Thomas Jude; Nolte, Dale Louis] US Anim & Plant Hlth Inspect Serv, Natl Wildlife Dis Program, Wildlife Serv, USDA, Ft Collins, CO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Tsinghua University; United States Department of Agriculture (USDA)	Dong, GY (corresponding author), Chinese Acad Sci, Inst Zool, Natl Res Ctr Wildlife Born Dis, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	gj28@ibp.ac.cn; hehx@ioz.ac.cn		Ji, Guangju/0000-0001-8626-3490	Science & Technology Support Project of the eleventh-five-year plan of China [2009BAI83B01]; National Key Basic Research and Development Program of China [2007BC109103]; National Department of Science and Technology [2009ZX10004-109]; NWDP USDA-IOZ CAS joint project [0760621234]	Science & Technology Support Project of the eleventh-five-year plan of China; National Key Basic Research and Development Program of China(National Basic Research Program of China); National Department of Science and Technology; NWDP USDA-IOZ CAS joint project	This work was supported by grants from the Science & Technology Support Project of the eleventh-five-year plan of China (2009BAI83B01), the National Key Basic Research and Development Program of China (Grant No. 2007BC109103), the Special Major Project of the National Department of Science and Technology (2009ZX10004-109) and NWDP USDA-IOZ CAS joint project (0760621234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2007, VIROLOGY, V361, P45, DOI 10.1016/j.virol.2006.10.037; Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Banks J, 2000, AVIAN PATHOL, V29, P353, DOI 10.1080/03079450050118485; Brown IH, 1997, J GEN VIROL, V78, P553, DOI 10.1099/0022-1317-78-3-553; Brown IH, 2006, DEV BIOLOGICALS, V124, P45; Cameron KR, 2000, VIROLOGY, V278, P36, DOI 10.1006/viro.2000.0585; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; HOMME P J, 1970, Avian Diseases, V14, P66, DOI 10.2307/1588557; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Kawaoka Y, 1998, VIRUS RES, V55, P143, DOI 10.1016/S0168-1702(98)00038-0; Lee CW, 2000, AVIAN DIS, V44, P527, DOI 10.2307/1593091; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li KS, 2003, J VIROL, V77, P6988, DOI 10.1128/JVI.77.12.6988-6994.2003; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Liu JH, 2003, VIRUS GENES, V27, P291, DOI 10.1023/A:1026304117797; Liu S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005022; Lu JH, 2005, VIRUS GENES, V31, P163, DOI 10.1007/s11262-005-1790-1; Macken CA, 2006, J GEN VIROL, V87, P2803, DOI 10.1099/vir.0.81454-0; MUNIR I, 2009, PLOS ONE, V4, pE5788; Naeem K, 1999, VET REC, V145, P560, DOI 10.1136/vr.145.19.560; Nili H, 2002, AVIAN PATHOL, V31, P247, DOI 10.1080/03079450220136567; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; Perk S, 2006, DEV BIOLOGICALS, V124, P201; Shaw M, 2002, J MED VIROL, V66, P107, DOI 10.1002/jmv.2118; Wahlgren J, 2008, VECTOR-BORNE ZOONOT, V8, P783, DOI 10.1089/vbz.2007.0274; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Xu KM, 2007, J VIROL, V81, P2635, DOI 10.1128/JVI.02316-06	36	62	73	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17212	10.1371/journal.pone.0017212	http://dx.doi.org/10.1371/journal.pone.0017212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386964	gold, Green Published			2022-12-25	WOS:000287931400037
J	McHugh, PC; Wright, JA; Brown, DR				McHugh, Patrick C.; Wright, Josephine A.; Brown, David R.			Transcriptional Regulation of the Beta-Synuclein 5 '-Promoter Metal Response Element by Metal Transcription Factor-1	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; MESSENGER-RNA; PROTEASOMAL FUNCTION; ALZHEIMERS-DISEASE; GAMMA-SYNUCLEIN; GENE-EXPRESSION; FACTOR MTF-1; LEWY BODY; PROTEIN	The progression of many human neurodegenerative disorders is associated with an accumulation of alpha-synuclein. Alpha-synuclein belongs to the homologous synuclein family, which includes beta-synuclein. It has been proposed that beta-synuclein may be a natural regulator of alpha-synuclein. Therefore controlling beta-synuclein expression may control the accumulation of alpha-synuclein and ultimately prevent disease progression. The regulation of synucleins is poorly understood. We investigated the transcriptional regulation of beta-synuclein, with the aim of identifying molecules that differentially control beta-synuclein expression levels. To investigate transcriptional regulation of beta-synuclein, we used reporter gene assays and bioinformatics. We identified a region -1.1/-0.6 kb upstream of the beta-synuclein translational start site to be a key regulatory region of beta-synuclein 5'-promoter activity in human dopaminergic cells (SH-SY5Y). Within this key promoter region we identified a metal response element pertaining to a putative Metal Transcription Factor-1 (MTF1) binding site. We demonstrated that MTF-1 binds to this 5'-promoter region using EMSA analysis. Moreover, we showed that MTF-1 differentially regulates beta-synuclein promoter binding site, as well as beta-synuclein mRNA and protein expression. This effect of MTF-1 on expression was found to be specific to beta-synuclein when compared to alpha-synuclein. Understanding the regulation of synucleins and how they interact may point to molecular targets that could be manipulated for therapeutic benefit. In this study we showed that MTF-1 differentially controls the expression of beta-synuclein when compared to its homolog alpha-synuclein. This could potentially provide a novel targets or pathways for therapeutic intervention and/or treatment of synucleinopathies.	[McHugh, Patrick C.; Wright, Josephine A.; Brown, David R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	McHugh, PC (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssdrb@bath.ac.uk		Wright, Josephine/0000-0003-4588-8827; McHugh, Patrick/0000-0003-0661-919X	Alzheimer's Research Trust [PG2007/1]; Alzheimers Research UK [ART-PG2007-1] Funding Source: researchfish	Alzheimer's Research Trust; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported by Alzheimer's Research Trust/PG2007/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Bahadorani S, 2010, NEUROBIOL AGING, V31, P1215, DOI 10.1016/j.neurobiolaging.2008.08.001; Bellingham SA, 2009, J BIOL CHEM, V284, P1291, DOI 10.1074/jbc.M804755200; Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Binolfi A, 2008, J AM CHEM SOC, V130, P11801, DOI 10.1021/ja803494v; Bolognin S, 2009, NEUROMOL MED, V11, P223, DOI 10.1007/s12017-009-8102-1; Brown DR, 2004, NEUROBIOL DIS, V15, P534, DOI 10.1016/j.nbd.2003.11.009; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; DAVIES P, 2010, BIOCHEMISTRY-US, DOI DOI 10.1021/BI101582; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; Fan Y, 2006, HUM MOL GENET, V15, P3002, DOI 10.1093/hmg/ddl242; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Kruger R, 1999, ANN NEUROL, V45, P611, DOI 10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X; LaRochelle O, 2008, J BIOL CHEM, V283, P8190, DOI 10.1074/jbc.M800640200; Lavedan C, 1998, GENOMICS, V54, P173, DOI 10.1006/geno.1998.5556; Lee JC, 2008, J AM CHEM SOC, V130, P6898, DOI 10.1021/ja711415b; Li WX, 2004, J NEUROSCI, V24, P7400, DOI 10.1523/JNEUROSCI.1370-04.2004; Lichtlen P, 2001, SWISS MED WKLY, V131, P647; McHugh PC, 2008, J NEUROSCI RES, V86, P306, DOI 10.1002/jnr.21482; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Mori F, 2003, NEUROREPORT, V14, P1783, DOI 10.1097/00001756-200310060-00005; Nishioka K, 2006, ANN NEUROL, V59, P298, DOI 10.1002/ana.20753; Ohtake H, 2004, NEUROLOGY, V63, P805, DOI 10.1212/01.WNL.0000139870.14385.3C; Paik SR, 1999, BIOCHEM J, V340, P821, DOI 10.1042/0264-6021:3400821; Park JY, 2003, BIOCHEMISTRY-US, V42, P3696, DOI 10.1021/bi020604a; Pradet-Balade B, 2001, BIOTECHNIQUES, V30, P1352, DOI 10.2144/01306rr03; Rockenstein E, 2001, BRAIN RES, V914, P48, DOI 10.1016/S0006-8993(01)02772-X; Roth S, 2010, J TRACE ELEM MED BIO, V24, P130, DOI 10.1016/j.jtemb.2010.01.007; Saini N, 2010, BIOL CHEM, V391, P513, DOI 10.1515/BC.2010.052; Saydam N, 2001, J BIOL CHEM, V276, P25487, DOI 10.1074/jbc.M009154200; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; SERFLING E, 1985, EMBO J, V4, P3851, DOI 10.1002/j.1460-2075.1985.tb04157.x; SHEN Q, 2006, NAT NEUROSCI; Shinyashiki M, 2000, P NATL ACAD SCI USA, V97, P2491, DOI 10.1073/pnas.050586597; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; Tabner BJ, 2002, FREE RADICAL BIO MED, V32, P1076, DOI 10.1016/S0891-5849(02)00801-8; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; Wang XY, 2010, J NEUROCHEM, V113, P704, DOI 10.1111/j.1471-4159.2010.06638.x; West AB, 2001, EUR J HUM GENET, V9, P659, DOI 10.1038/sj.ejhg.5200698; Wright JA, 2009, CELL MOL LIFE SCI, V66, P3809, DOI 10.1007/s00018-009-0154-8; Wright JA, 2009, FASEB J, V23, P2384, DOI 10.1096/fj.09-130039; Xia Z, 1996, J Biochem Toxicol, V11, P203, DOI 10.1002/(SICI)1522-7146(1996)11:4<203::AID-JBT6>3.3.CO;2-F; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021	50	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17354	10.1371/journal.pone.0017354	http://dx.doi.org/10.1371/journal.pone.0017354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386983	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000287931400060
J	Varshney, A; Rehan, M; Subbarao, N; Rabbani, G; Khan, RH				Varshney, Ankita; Rehan, Mohd; Subbarao, Naidu; Rabbani, Gulam; Khan, Rizwan Hasan			Elimination of Endogenous Toxin, Creatinine from Blood Plasma Depends on Albumin Conformation: Site Specific Uremic Toxicity & Impaired Drug Binding	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; RENAL-FAILURE; HEMODIALYSIS-PATIENTS; GUANIDINO COMPOUNDS; MOLECULAR DOCKING; HYPERTENSION; MICROALBUMINURIA; POPULATION; MORTALITY; REMOVAL	Uremic syndrome results from malfunctioning of various organ systems due to the retention of uremic toxins which, under normal conditions, would be excreted into the urine and/or metabolized by the kidneys. The aim of this study was to elucidate the mechanisms underlying the renal elimination of uremic toxin creatinine that accumulate in chronic renal failure. Quantitative investigation of the plausible correlations was performed by spectroscopy, calorimetry, molecular docking and accessibility of surface area. Alkalinization of normal plasma from pH 7.0 to 9.0 modifies the distribution of toxin in the body and therefore may affect both the accumulation and the rate of toxin elimination. The ligand loading of HSA with uremic toxin predicts several key side chain interactions of site I that presumably have the potential to impact the specificity and impaired drug binding. These findings provide useful information for elucidating the complicated mechanism of toxin disposition in renal disease state.	[Varshney, Ankita; Rabbani, Gulam; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Rehan, Mohd; Subbarao, Naidu] Jawaharlal Nehru Univ, Sch Informat Technol, Ctr Computat Biol & Bioinformat, New Delhi 110067, India	Aligarh Muslim University; Jawaharlal Nehru University, New Delhi	Varshney, A (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	rizwanhkhan@hotmail.com	Subbarao, Prof Naidu/AAZ-1832-2020; Rehan, Mohd/H-9835-2012; Khan, Rizwan Hasan/F-8276-2014; Khan, Rizwan/GXZ-5789-2022; Rabbani, Gulam/AAE-5629-2022	Subbarao, Prof Naidu/0000-0002-1720-2165; Khan, Rizwan Hasan/0000-0002-9965-8982; Rabbani, Gulam/0000-0002-5293-8231; Rehan, Mohd/0000-0003-4898-6043	Council of Scientific and Industrial Research, New Delhi [37/1278/06 EMR-II]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research, New Delhi [37/1278/06 EMR-II]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2006, BIOMACROMOLECULES, V7, P1350, DOI 10.1021/bm050996b; Ahmad B, 2005, ARCH BIOCHEM BIOPHYS, V437, P159, DOI 10.1016/j.abb.2005.03.013; Berge-Lefranc D, 2009, MICROPOR MESOPOR MAT, V119, P186, DOI 10.1016/j.micromeso.2008.10.016; Brantsma AH, 2006, J AM SOC NEPHROL, V17, P331, DOI 10.1681/ASN.2005111153; Celej MS, 2005, BBA-PROTEINS PROTEOM, V1750, P122, DOI 10.1016/j.bbapap.2005.05.003; Cheema MA, 2007, BIOMACROMOLECULES, V8, P2576, DOI 10.1021/bm070354j; De Deyn PP, 2009, SEMIN DIALYSIS, V22, P340, DOI 10.1111/j.1525-139X.2009.00577.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Forman JP, 2006, KIDNEY INT, V69, P22, DOI 10.1038/sj.ki.5000056; Gao HW, 2008, BIOPHYS J, V94, P906, DOI 10.1529/biophysj.107.120865; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Ghosh KS, 2009, BIOPOLYMERS, V91, P737, DOI 10.1002/bip.21220; Glorieux GL, 2004, KIDNEY INT, V65, P2184, DOI 10.1111/j.1523-1755.2004.00631.x; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Ivanov AI, 2002, ARCH BIOCHEM BIOPHYS, V408, P69, DOI 10.1016/S0003-9861(02)00533-7; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kanakis CD, 2007, J AGR FOOD CHEM, V55, P970, DOI 10.1021/jf062638l; Kang J, 2004, BBA-GEN SUBJECTS, V1674, P205, DOI 10.1016/j.bbagen.2004.06.021; Kestenbaum B, 2008, ANN INTERN MED, V148, P501, DOI 10.7326/0003-4819-148-7-200804010-00006; Kosa T, 2007, J PHARM SCI-US, V96, P3117, DOI 10.1002/jps.20887; Mattix HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341034; Mingrone G, 1997, CLIN CHIM ACTA, V260, P27, DOI 10.1016/S0009-8981(96)06504-7; Perna AF, 2004, J AM SOC NEPHROL, V15, P2747, DOI 10.1097/01.ASN.0000141041.71717.11; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sarnatskaya VV, 2007, ARTIF CELL BLOOD SUB, V35, P287, DOI 10.1080/10731190701378618; Sarnatskaya VV, 2002, BIOCHEM PHARMACOL, V63, P1287, DOI 10.1016/S0006-2952(02)00869-9; Sarnatskaya VV, 1998, ARTIF ORGANS, V22, P107; Sun H, 2006, PHARMACOL THERAPEUT, V109, P1, DOI 10.1016/j.pharmthera.2005.05.010; Taes YEC, 2008, NEPHROL DIAL TRANSPL, V23, P1330, DOI 10.1093/ndt/gfm793; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; Vaidya VS, 2009, KIDNEY INT, V76, P108, DOI 10.1038/ki.2009.96; Van Biesen W, 2007, EUR HEART J, V28, P478, DOI 10.1093/eurheartj/ehl455; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Vanholder R, 2003, ARTIF ORGANS, V27, P218, DOI 10.1046/j.1525-1594.2003.07212.x; VANHOLDER R, 1994, SEMIN NEPHROL, V14, P205; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2001, INT J ARTIF ORGANS, V24, P695, DOI 10.1177/039139880102401004; Varshney A, 2008, INT J BIOL MACROMOL, V42, P483, DOI 10.1016/j.ijbiomac.2008.03.004; Varshney A, 2010, CHIRALITY, V22, P77, DOI 10.1002/chir.20709; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; YANG M, 1998, J BEIJING MED U, V30, P97	43	83	83	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17230	10.1371/journal.pone.0017230	http://dx.doi.org/10.1371/journal.pone.0017230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386972	Green Submitted, Green Published, gold			2022-12-25	WOS:000287931400038
J	Van Cutsem, G; Ford, N; Hildebrand, K; Goemaere, E; Mathee, S; Abrahams, M; Coetzee, D; Boulle, A				Van Cutsem, Gilles; Ford, Nathan; Hildebrand, Katherine; Goemaere, Eric; Mathee, Shaheed; Abrahams, Musaed; Coetzee, David; Boulle, Andrew			Correcting for Mortality Among Patients Lost to Follow Up on Antiretroviral Therapy in South Africa: A Cohort Analysis	PLOS ONE			English	Article							OUTCOMES; CARE; KHAYELITSHA; EXPERIENCE; PROGRAMS; RETENTION; ADHERENCE; INCOME	Background: Loss to follow-up (LTF) challenges the reporting of antiretroviral treatment (ART) programmes, since it encompasses patients alive but lost to programme and deaths misclassified as LTF. We describe LTF before and after correction for mortality in a primary care ART programme with linkages to the national vital registration system. Methods and Findings: We included 6411 patients enrolled on ART between March 2001 and June 2007. Patients LTF with available civil identification numbers were matched with the national vital registration system to ascertain vital status. Corrected mortality and true LTF were determined by weighting these patients to represent all patients LTF. We used Kaplan-Meier estimates and Cox regression to describe LTF, mortality among those LTF, and true LTF. Of 627 patients LTF, 85 (28.8%) had died within 3 months after their last clinic visits. Respective estimates of LTF before and after correction for mortality were 6.9% (95% confidence interval [ CI] 6.2-7.6) and 4.3% (95% CI 3.5-5.3) at one year on ART, and 23.9% (95% CI 21.0-27.2) and 19.7% (95% CI 16.1-23.7) at 5 years. After correction for mortality, the hazard of LTF was reversed from decreasing to increasing with time on ART. Younger age, higher baseline CD4 count, pregnancy and increasing calendar year were associated with higher true LTF. Mortality of patients LTF at 1, 12 and 24 months after their last visits was respectively 23.1%, 30.9% and 43.8%; 78.0% of deaths occurred during the first 3 months after last visit and 45.0% in patients on ART for 0 to 3 months. Conclusions: Mortality of patients LTF was high and occurred early after last clinic visit, especially in patients recently started on ART. Correction for these misclassified deaths revealed that the risk of true LTF increased over time. Research targeting groups at higher risk of LTF (youth, pregnant women and patients with higher CD4 counts) is needed.	[Van Cutsem, Gilles; Ford, Nathan; Hildebrand, Katherine; Goemaere, Eric; Abrahams, Musaed] Med Sans Frontieres, Cape Town, South Africa; [Van Cutsem, Gilles; Ford, Nathan; Hildebrand, Katherine; Coetzee, David; Boulle, Andrew] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Mathee, Shaheed] Prov Govt Western Cape, Dept Hlth, Cape Town, South Africa	University of Cape Town	Van Cutsem, G (corresponding author), Med Sans Frontieres, Cape Town, South Africa.	gillesvancutsem@gmail.com	Boulle, Andrew/C-1413-2008; Van Cutsem, Gilles/ABB-1171-2021	Boulle, Andrew/0000-0002-7713-8062; Van Cutsem, Gilles/0000-0002-8972-4480	M�decins Sans Fronti�res [09_NAT_ERB_013] Funding Source: researchfish	M�decins Sans Fronti�res		Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; CHI B, 2010, 18 INT AIDS C; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Coetzee D, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406003-00006; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Deribe K, 2008, TROP MED INT HEALTH, V13, P328, DOI 10.1111/j.1365-3156.2008.02006.x; Ford N, 2010, AIDS, V24, P2645, DOI 10.1097/QAD.0b013e32833ec5b2; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; Fox RC, 2006, CAMB Q HEALTHC ETHIC, V15, P302; GENG EH, J ACQUIR IMMUNE DEFI, V53, P405; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Ingle SM, 2010, AIDS, V24, P2717, DOI 10.1097/QAD.0b013e32833fb71f; Jerene D, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-136; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; Kranzer K, 2010, JAIDS-J ACQ IMM DEF, V55, pE17, DOI 10.1097/QAI.0b013e3181f275fd; Losina E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000173; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Nachega JB, 2010, CURR OPIN HIV AIDS, V5, P70, DOI 10.1097/COH.0b013e328333ad61; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; *STAT S AFR, 2009, MOR CAUS DEATH S AFR; World Health Organization, 2009, RAP ADV ANT THER HIV; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zachariah R, 2008, T ROY SOC TROP MED H, V102, P288, DOI 10.1016/j.trstmh.2007.12.007	30	69	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e14684	10.1371/journal.pone.0014684	http://dx.doi.org/10.1371/journal.pone.0014684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379378	Green Published, Green Submitted, gold			2022-12-25	WOS:000287482300003
J	Tomita, T; Sakurai, Y; Ishibashi, S; Maru, Y				Tomita, T.; Sakurai, Y.; Ishibashi, S.; Maru, Y.			Imbalance of Clara cell-mediated homeostatic inflammation is involved in lung metastasis	ONCOGENE			English	Article						Clara cell; lung metastasis; serum amyloid A3; Toll-like receptor 4	TUMOR-NECROSIS-FACTOR; ALLERGIC PULMONARY INFLAMMATION; SERUM AMYLOID A3; NF-KAPPA-B; TRANSENDOTHELIAL MIGRATION; NEGATIVE REGULATOR; EPITHELIAL-CELLS; DANGER SIGNAL; MYELOID CELLS; PROTEIN	We have previously shown that tumor necrosis factor (TNF)alpha produced from primary tumor-induced expression of two endogenous Toll-like receptor 4 (TLR4) ligands, S100A8 and serum amyloid A3 (SAA3), in pre-metastatic lungs. However, mechanistic details of the signaling network and relevance to pulmonary physiology are poorly understood. Here, we identify Clara cells as a control tower of the network. Clara cell ablation by naphthalene suppressed pulmonary recruitment of CD11b+ TLR4+ cells and spontaneous lung metastasis. Clara cells turned out to express TLR4 through which SAA3 was auto-amplified. Reciprocal bone marrow transplantation between wild-type and TLR4 knockout mice demonstrated that pulmonary TLR4+ Clara cells could be derived from bone marrow. SAA3-induced TNF alpha expression in both alveolar type II cells and macrophages. Primary co-cultures of alveolar type II cells and Clara cells revealed that the induction of TNF alpha in alveolar type II cells was dependent on the Clara cell-mediated amplification of SAA3. SAA3 induction by bacterial endotoxin also required both Clara cells and TLR4. Thus, pulmonary metastatic soil may feature deregulation of homeostatic inflammatory responses to constant assaults of microbes with endotoxin. Oncogene (2011) 30, 3429-3439; doi:10.1038/onc.2011.53; published online 14 March 2011	[Maru, Y.] Tokyo Womens Med Univ, Dept Pharmacol, Shinjuku Ku, Tokyo 1628666, Japan	Tokyo Women's Medical University	Maru, Y (corresponding author), Tokyo Womens Med Univ, Dept Pharmacol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	ymaru@research.twmu.ac.jp	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943; Tomita, Takeshi/0000-0001-6815-2244	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21117008, 21790330]; Sato Memorial Foundation for Cancer Research; Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM), from MEXT, Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sato Memorial Foundation for Cancer Research; Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM), from MEXT, Japan	We thank Dr Shioko Kimura at National Institute of Health for providing resources including cell lines. This work was supported by Grant-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, 21117008 (YM) and 21790330 (TT), Sato Memorial Foundation for Cancer Research (TT), and the Global COE program, Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM), from MEXT, Japan.	Armstrong L, 2004, AM J RESP CELL MOL, V31, P241, DOI 10.1165/rcmb.2004-0078OC; Arsalane K, 2000, AM J RESP CRIT CARE, V161, P1624, DOI 10.1164/ajrccm.161.5.9812157; Atkinson JJ, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-1; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bing ZY, 2000, J BIOL CHEM, V275, P31616, DOI 10.1074/jbc.M005378200; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Devoogdt N, 2003, P NATL ACAD SCI USA, V100, P5778, DOI 10.1073/pnas.1037154100; DOBBS LG, 1978, AM REV RESPIR DIS, V134, P141; Franklin GA, 2003, AM J SURG, V186, P493, DOI 10.1016/j.amjsurg.2003.07.012; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilchrist M, 2008, J EXP MED, V205, P2349, DOI 10.1084/jem.20072254; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Kerkhoff C, 2005, FASEB J, V19, P467, DOI 10.1096/fj.04-2377fje; Kerkhoff C, 1999, PATHOBIOLOGY, V67, P230, DOI 10.1159/000028098; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019; Maru Y, 2010, CELL MOL IMMUNOL, V7, P94, DOI 10.1038/cmi.2009.113; Maru Yoshiro, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P337; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Passey RJ, 1999, J IMMUNOL, V163, P2209; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Saha A, 2010, J BIOL CHEM, V285, P10822, DOI 10.1074/jbc.M109.083550; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Son DS, 2004, ENDOCRINOLOGY, V145, P2245, DOI 10.1210/en.2003-1261; Taranova AG, 2008, CANCER RES, V68, P8582, DOI 10.1158/0008-5472.CAN-08-1673; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wong AP, 2009, J CLIN INVEST, V119, P336, DOI 10.1172/JCI36882; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yao XL, 1998, AM J RESP CELL MOL, V19, P629, DOI 10.1165/ajrcmb.19.4.3129; Yatera K, 2001, ENVIRON HEALTH PERSP, V109, P795, DOI 10.2307/3454821; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139; ZUGMAIER G, 1991, CANCER RES, V51, P3590	43	44	47	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2011	30	31					3429	3439		10.1038/onc.2011.53	http://dx.doi.org/10.1038/onc.2011.53			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	802KA	21399660				2022-12-25	WOS:000293508100004
J	Avale, ME; Chabout, J; Pons, S; Serreau, P; De Chaumont, F; Olivo-Marin, JC; Bourgeois, JP; Maskos, U; Changeux, JP; Granon, S				Avale, Maria Elena; Chabout, Jonathan; Pons, Stephanie; Serreau, Pierre; De Chaumont, Fabrice; Olivo-Marin, Jean-Christophe; Bourgeois, Jean-Pierre; Maskos, Uwe; Changeux, Jean-Pierre; Granon, Sylvie			Prefrontal nicotinic receptors control novel social interaction between mice	FASEB JOURNAL			English	Article						acetylcholine; prelimbic cortex; executive behavior; gene rescue	MEDIAL FRONTAL-CORTEX; BEHAVIORAL FLEXIBILITY; COGNITIVE FUNCTIONS; RAT; ACETYLCHOLINE; EXPRESSION; LACKING; SYSTEM; STIMULATION; INVOLVEMENT	Social behavior is a defining mammalian feature that integrates emotional and motivational processes with external rewarding stimuli. It is thus an appropriate readout for complex behaviors, yet its neuronal and molecular bases remain poorly understood. In this study, we investigated the role of the mouse prefrontal area, particularly the involvement of beta 2-subunit nicotinic receptors (beta 2*-nAChRs) in a paradigm of social behavior with concurrent motivations. We previously observed that mice lacking beta 2*-nAChRs (beta 2(-/-)) display increased time in social contact and exaggerated approach movements toward the novel conspecific. Here, combining behavioral analysis, localized brain lesions, and lentiviral gene rescue, we found that c-Fos expression is specifically activated in the prelimbic (PrL) area of the prefrontal cortex (PFC) of mice exposed to a novel conspecific; lesions of the PrL area in wild-type mice produce the same social pattern as in beta 2(-/-) mice; and virally mediated reexpression of the beta 2-subunit in the PrL area of beta 2(-/-) mice rescues behavioral components in the social interaction task up to normal levels. Together, these data reveal that social interactions particularly mobilize the PrL area of the mouse PFC and that the presence of functional PrL beta 2*-nAChRs is necessary for this integrated behavior to emerge.-Avale, M. E., Chabout, J., Pons, S., Serreau, P., De Chauont, F., Olivo-Marin, J-C., Bourgeois, J-P., Maskos, U., Changeux, J-P., Granon, S. Prefrontal nicotinic receptors control novel social interaction between mice. FASEB J. 25, 2145-2155 (2011). www.fasebj.org	[Chabout, Jonathan; Serreau, Pierre; Granon, Sylvie] Univ Paris 11, Team Neurobiol Prise Decis, F-91405 Orsay, France; [Chabout, Jonathan; Serreau, Pierre; Granon, Sylvie] CNRS, Ctr Neurosci Paris Sud, UMR 8620, F-91405 Orsay, France; [Avale, Maria Elena; Pons, Stephanie; Serreau, Pierre; Bourgeois, Jean-Pierre; Maskos, Uwe; Changeux, Jean-Pierre; Granon, Sylvie] CNRS, Unite Neurobiol Integrat Syst Cholinerg, URA 2182, Paris, France; [De Chaumont, Fabrice; Olivo-Marin, Jean-Christophe] Inst Pasteur, Lab Anal Imagerie Dynam, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Granon, S (corresponding author), Univ Paris 11, Team Neurobiol Prise Decis, Bat 425, F-91405 Orsay, France.	sylvie.granon@u-psud.fr	Granon, Sylvie/J-9224-2019; Olivo-Marin, Jean-Christophe/K-4428-2015	Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; de Chaumont, Fabrice/0000-0001-7613-7204; Granon, sylvie/0000-0001-9384-3119; Avale, Maria Elena/0000-0002-0251-0093	Institut Pasteur; Centre National de la Recherche Scientifique; Universite Paris Sud XI; Agence Nationale de la Recherche [NT09_446810]; Biocortech master grant	Institut Pasteur(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Sud XI; Agence Nationale de la Recherche(French National Research Agency (ANR)); Biocortech master grant	The authors thank Martine Soudant for excellent technical assistance. This work was supported by the Institut Pasteur, the Centre National de la Recherche Scientifique, and the Universite Paris Sud XI (excellence chair to S. G.). Part of the work was funded by an Agence Nationale de la Recherche grant to S. G. (NT09_446810) and a Biocortech master grant to J.C.	ADOLPHS R, NEURON, V65, P752; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Avale ME, 2008, P NATL ACAD SCI USA, V105, P15991, DOI 10.1073/pnas.0807635105; BALLESTEROSYANE.I, P NATL ACAD SCI US, V107, P11567; Besson M, 2008, BEHAV GENET, V38, P503, DOI 10.1007/s10519-008-9216-1; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bisler S, 2002, J CHEM NEUROANAT, V23, P187, DOI 10.1016/S0891-0618(01)00155-7; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Couey JJ, 2007, NEURON, V54, P73, DOI 10.1016/j.neuron.2007.03.006; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Del Arco A, 2009, J NEURAL TRANSM, V116, P941, DOI 10.1007/s00702-009-0243-8; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Floresco SB, 2009, BEHAV BRAIN RES, V204, P396, DOI 10.1016/j.bbr.2008.12.001; Gorelova N, 1997, NEUROSCIENCE, V76, P689, DOI 10.1016/S0306-4522(96)00380-6; Granon S, 1996, BEHAV BRAIN RES, V78, P147, DOI 10.1016/0166-4328(95)00242-1; Granon S, 2000, PSYCHOBIOLOGY, V28, P229; Granon S, 2003, P NATL ACAD SCI USA, V100, P9596, DOI 10.1073/pnas.1533498100; GRANON S, 1995, PSYCHOPHARMACOLOGY, V119, P139, DOI 10.1007/BF02246154; HILL JA, 1993, J NEUROSCI, V13, P1551; Howe WM, 2010, NEUROPSYCHOPHARMACOL, V35, P1391, DOI 10.1038/npp.2010.9; Ito M, 2009, J NEUROSCI, V29, P9861, DOI 10.1523/JNEUROSCI.6157-08.2009; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Kording K, 2007, SCIENCE, V318, P606, DOI 10.1126/science.1142998; Lambe EK, 2003, NEUROPSYCHOPHARMACOL, V28, P216, DOI 10.1038/sj.npp.1300032; Mameli-Engvall M, 2006, NEURON, V50, P911, DOI 10.1016/j.neuron.2006.05.007; Mansvelder HD, 2009, SEMIN CELL DEV BIOL, V20, P432, DOI 10.1016/j.semcdb.2009.01.007; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Maskos U, 2007, J NEUROCHEM, V100, P596, DOI 10.1111/j.1471-4159.2006.04224.x; Mogensen J, 2004, BRAIN RES BULL, V63, P217, DOI 10.1016/j.brainresbull.2004.02.008; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Panksepp JB, 2007, GENES BRAIN BEHAV, V6, P661, DOI 10.1111/j.1601-183X.2006.00295.x; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Ragozzino ME, 1999, J NEUROSCI, V19, P4585; Rasband W., 2006, IMAGEJ; Rich EL, 2009, J NEUROSCI, V29, P7208, DOI 10.1523/JNEUROSCI.6068-08.2009; Robbins TW, 1996, PHILOS T ROY SOC B, V351, P1463, DOI 10.1098/rstb.1996.0131; Ross RS, 2005, LEARN MEMORY, V12, P302, DOI 10.1101/lm.91605; Sarter M, 1997, BRAIN RES REV, V23, P28, DOI 10.1016/S0165-0173(96)00009-4; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; SMITH DV, J NEUROSCI, V30, P2490; Tolu S, 2010, FASEB J, V24, P723, DOI 10.1096/fj.09-139790; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Wiklund A, 2008, ANESTHESIOLOGY, V109, P790, DOI 10.1097/ALN.0b013e31818a379a; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006; Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080; Zoli M, 1999, EMBO J, V18, P1235, DOI 10.1093/emboj/18.5.1235	51	73	73	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2011	25	7					2145	2155		10.1096/fj.10-178558	http://dx.doi.org/10.1096/fj.10-178558			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21402717				2022-12-25	WOS:000292242200007
J	Lecosnier, S; Cordier, C; Simon, P; Francois, JC; Saison-Behmoaras, TE				Lecosnier, Sabine; Cordier, Celine; Simon, Philippe; Francois, Jean-Christophe; Saison-Behmoaras, Tula E.			A steric blocker of translation elongation inhibits IGF-1R expression and cell transformation	FASEB JOURNAL			English	Article						peptide nucleic acid; IGF signaling; triplex structure; prostate cancer	FACTOR-I RECEPTOR; GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; PEPTIDE NUCLEIC-ACIDS; PROSTATE-CANCER; TUMOR-GROWTH; ANTISENSE OLIGONUCLEOTIDES; PANCREATIC-CANCER; KINASE INHIBITOR; GENE-EXPRESSION	The insulin-like growth factor 1 receptor (IGF-1R) is involved in transformation, survival, mitogenesis and differentiation. It is overexpressed in many tumors and a validated target for anticancer therapy. In cell-free systems, polypyrimidic peptide nucleic acids (PNAs) can form triplex-like structures with messenger RNAs and halt the ribosomal machinery during the translation elongation. A 17-mer PNA that formed a PNA(2): mRNA complex with a purine-rich sequence located in the coding region of IGF-1R mRNA induced the synthesis of a truncated IGF-1R in vitro. This PNA down-regulated expression of the receptor by 70-80% in prostate cancer cells without affecting insulin receptor expression that exhibits high homology with IGF-1R. Inhibition occurs at the translational level, since the IGF-1R mRNA level measured by quantitative RT-PCR was not affected by PNA treatment. In addition, IGF-1R knockdown by PNA led to an attenuation of phosphorylation of downstream signaling pathways, PI3K/AKT and MAPK, involved in survival and mitogenesis and also to a decrease in cell transformation. Of the steric blockers tested, which included phosphorodiamidate morpholino oligomers and locked nucleic acids, PNA was unique in its ability to form triplex structures with mRNA and to arrest translation elongation.-Lecosnier, S., Cordier, C., Simon, P., Francois, J.-C., Saison-Behmoaras, T. E. A steric blocker of translation elongation inhibits IGF-1R expression and cell transformation. FASEB J. 25, 2201-2210 (2011). www.fasebj.org	[Lecosnier, Sabine; Cordier, Celine; Simon, Philippe; Francois, Jean-Christophe; Saison-Behmoaras, Tula E.] Museum Natl Hist Nat, CNRS, UMR7196, F-75231 Paris 05, France; [Lecosnier, Sabine; Cordier, Celine; Simon, Philippe; Francois, Jean-Christophe; Saison-Behmoaras, Tula E.] INSERM, U565, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Museum National d'Histoire Naturelle (MNHN); Institut National de la Sante et de la Recherche Medicale (Inserm)	Saison-Behmoaras, TE (corresponding author), Museum Natl Hist Nat, CNRS, UMR7196, 57 Rue Cuvier,CP 26, F-75231 Paris 05, France.	francois@mnhn.fr; tula@mnhn.fr	SIMON, Philippe/GXZ-4688-2022; FRANCOIS, Jean-Christophe/O-1659-2018	FRANCOIS, Jean-Christophe/0000-0003-4480-1822	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; French Ministry for Research	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French Ministry for Research(Ministry of Research, France)	The authors thank Loic Perrouault and Karen Haug for their technical assistance. The authors are grateful to Dr. Renato Baserga (Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA) for providing human IGF-IR cDNA. This work was supported by the Institut National de la Sante et de la Recherche Medicale and the Centre National de la Recherche Scientifique. S.L. and C.C. are doctoral fellows supported by the French Ministry for Research.	Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Armitage BA, 2003, DRUG DISCOV TODAY, V8, P222, DOI 10.1016/S1359-6446(03)02611-4; Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; Bendifallah N, 2006, BIOCONJUGATE CHEM, V17, P750, DOI 10.1021/bc050283q; Boudvillain M, 1997, BIOCHEMISTRY-US, V36, P2925, DOI 10.1021/bi962695f; Boutimah-Hamoudi F, 2007, NUCLEIC ACIDS RES, V35, P3907, DOI 10.1093/nar/gkm374; Burfeind P, 1996, P NATL ACAD SCI USA, V93, P7263, DOI 10.1073/pnas.93.14.7263; Chernicky CL, 2002, J CLIN PATHOL-MOL PA, V55, P102, DOI 10.1136/mp.55.2.102; CROOKE ST, 1995, BIOCHEM J, V312, P599, DOI 10.1042/bj3120599; D'cunja J, 2007, EUR J CANCER, V43, P1581, DOI 10.1016/j.ejca.2007.03.003; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Dias N, 1999, J MOL BIOL, V294, P403, DOI 10.1006/jmbi.1999.3277; Dias N, 2002, J MOL BIOL, V320, P489, DOI 10.1016/S0022-2836(02)00474-6; EGHOLM M, 1995, NUCLEIC ACIDS RES, V23, P217, DOI 10.1093/nar/23.2.217; Faria M, 2001, NAT BIOTECHNOL, V19, P40, DOI 10.1038/83489; Francois JC, 2000, METHOD ENZYMOL, V313, P74; Furukawa J, 2010, PROSTATE, V70, P206, DOI 10.1002/pros.21054; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Gee JE, 1998, ANTISENSE NUCLEIC A, V8, P103, DOI 10.1089/oli.1.1998.8.103; Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172; Hellawell GO, 2002, CANCER RES, V62, P2942; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Ji QS, 2007, MOL CANCER THER, V6, P2158, DOI 10.1158/1535-7163.MCT-07-0070; Knudsen H, 1996, NUCLEIC ACIDS RES, V24, P494, DOI 10.1093/nar/24.3.494; Kwon J, 2009, CANCER RES, V69, P1350, DOI 10.1158/0008-5472.CAN-08-1328; Mayfield LD, 1999, ANAL BIOCHEM, V268, P401, DOI 10.1006/abio.1998.3052; Min YF, 2003, CANCER RES, V63, P6432; Moser C, 2008, EUR J CANCER, V44, P1577, DOI 10.1016/j.ejca.2008.04.003; Nickerson T, 2001, CANCER RES, V61, P6276; Nielsen Peter E, 2002, Methods Mol Biol, V208, P3; Nulf CJ, 2004, NUCLEIC ACIDS RES, V32, P3792, DOI 10.1093/nar/gkh706; Oussedik K, 2010, FASEB J, V24, P2235, DOI 10.1096/fj.09-132324; Reinmuth N, 2002, LAB INVEST, V82, P1377, DOI 10.1097/01.LAB.0000032411.41603.C2; Reiss K, 1998, CLIN CANCER RES, V4, P2647; Resnik JL, 1998, CANCER RES, V58, P1159; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Roberts J, 2006, MOL THER, V14, P471, DOI 10.1016/j.ymthe.2006.05.017; Rochester MA, 2005, CANCER GENE THER, V12, P90, DOI 10.1038/sj.cgt.7700775; Rogers FA, 2002, P NATL ACAD SCI USA, V99, P16695, DOI 10.1073/pnas.262556899; Sachdev D, 2003, CANCER RES, V63, P627; Sazani P, 2002, NAT BIOTECHNOL, V20, P1228, DOI 10.1038/nbt759; Senamaud-Beaufort C, 2003, OLIGONUCLEOTIDES, V13, P465, DOI 10.1089/154545703322860780; Shiraishi T, 2008, NUCLEIC ACIDS RES, V36, P4424, DOI 10.1093/nar/gkn401; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Steller MA, 1996, CANCER RES, V56, P1761; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Wu B, 2008, P NATL ACAD SCI USA, V105, P14814, DOI 10.1073/pnas.0805676105; Yin HF, 2010, MOL THER, V18, P819, DOI 10.1038/mt.2009.310; Zhang H, 2007, CANCER RES, V67, P391, DOI 10.1158/0008-5472.CAN-06-1712	52	9	9	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2011	25	7					2201	2210		10.1096/fj.10-169540	http://dx.doi.org/10.1096/fj.10-169540			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21402719				2022-12-25	WOS:000292242200012
J	Rossini, L; Hashimoto, Y; Suzuki, H; Kurita, M; Gianfriddo, M; Scali, C; Roncarati, R; Franceschini, D; Pollio, G; Trabalzini, L; Terstappen, GC; Matsuoka, M; Caricasole, A				Rossini, Lara; Hashimoto, Yuichi; Suzuki, Hiroaki; Kurita, Megumi; Gianfriddo, Marco; Scali, Carla; Roncarati, Renza; Franceschini, Davide; Pollio, Giuseppe; Trabalzini, Lorenza; Terstappen, Georg C.; Matsuoka, Masaaki; Caricasole, Andrea			VSTM2L is a novel secreted antagonist of the neuroprotective peptide Humanin	FASEB JOURNAL			English	Article						protein-protein interaction; neurodegenerative disease; neurotrophic factor	NEURONAL CELL-DEATH; RESCUE FACTOR HUMANIN; ALZHEIMERS-DISEASE; ACTIVATION DOMAIN; BINDS; APOPTOSIS; PROTEINS; SURVIVAL; NETWORK; ATAXIAS	Humanin (HN) is a 24-residue peptide displaying a protective activity in vitro against a range of cytotoxic and neurotoxic insults, as well as mediating in vivo amelioration of Alzheimer disease (AD)-related memory impairment in experimental models. Published evidence suggests that the mechanisms through which HN exerts its cyto- and neuroprotective activity may include its secretion and binding to membrane-associated receptors. Here, we describe the identification of a new modulator of HN neuroprotective activity, V-set and transmembrane domain containing 2 like (VSTM2L), previously known as C20orf102. VSTM2L interacts with HN in both yeast and mammalian cells, is secreted in cultured cells, is present in serum, and is selectively expressed in the central nervous system. VSTM2L colocalizes with HN in distinct brain areas as well as in primary cultured neurons, where it plays a role in the modulation of neuronal viability. When tested in HN neuroprotection bioassays, VSTM2L acts as a strong antagonist of HN neuroprotective activity. In summary, VSTM2L is the first example of a secreted antagonist of HN and may play a role in the modulation of HN biological functions-Rossini, L., Hashimoto, Y., Suzuki, H., Kurita, M., Gianfriddo, M., Scali, C., Roncarati, R., Franceschini, D., Pollio, G., Trabalzini, L., Terstappen, G. C., Matsuoka, M., Caricasole, A. VSTM2L is a novel secreted antagonist of the neuroprotective peptide Humanin. FASEB J. 25, 1983-2000 (2011). www.fasebj.org	[Caricasole, Andrea] Siena Biotech SpA, Dept Neurosci, I-53100 Siena, Italy; [Hashimoto, Yuichi; Suzuki, Hiroaki; Kurita, Megumi; Matsuoka, Masaaki] Tokyo Med Univ, Dept Pharmacol, Tokyo 1608402, Japan; [Trabalzini, Lorenza] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy	Siena Biotech; Tokyo Medical University; University of Siena	Caricasole, A (corresponding author), Siena Biotech SpA, Dept Neurosci, Str Petriccio Belriguardo 35, I-53100 Siena, Italy.	sakimatu@tokyo-med.ac.jp; acaricasole@sienabiotech.it	Hashimoto, Yuichi/N-1508-2015	Hashimoto, Yuichi/0000-0001-5863-3618; Trabalzini, Lorenza/0000-0002-0850-7186	Grants-in-Aid for Scientific Research [22590247] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aho S, 1997, ANAL BIOCHEM, V253, P270, DOI 10.1006/abio.1997.2394; Arakawa T, 2008, CURR MED CHEM, V15, P2086, DOI 10.2174/092986708785747616; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Caricasole A, 2002, FASEB J, V16, P1331, DOI 10.1096/fj.02-0018fje; Chan KC., 2004, CLIN PROTEOM, V1, P101, DOI [DOI 10.1385/CP:1:2:101, 10.1385/CP:1:2:101]; Copani A, 1999, FASEB J, V13, P2225, DOI 10.1096/fasebj.13.15.2225; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6; FARROW SN, 1995, NATURE, V374, P731, DOI 10.1038/374731a0; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Halsey TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r104; Hashimoto Y, 2005, LIFE SCI, V77, P3092, DOI 10.1016/j.lfs.2005.03.031; Hashimoto Y, 2001, J NEUROSCI, V21, P9235, DOI 10.1523/JNEUROSCI.21-23-09235.2001; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Kariya S, 2005, ACTA NEUROPATHOL, V109, P367, DOI 10.1007/s00401-004-0965-5; Kariya S, 2005, J MOL NEUROSCI, V25, P165, DOI 10.1385/JMN:25:2:165; Kariya S, 2005, NEUROPEPTIDES, V39, P97, DOI 10.1016/j.npep.2004.11.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; LIU X, 1993, MOL CELL BIOL, V13, P3291, DOI 10.1128/MCB.13.6.3291; Luciano F, 2005, J BIOL CHEM, V280, P15825, DOI 10.1074/jbc.M413062200; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334; Niikura T, 2006, CURR NEUROPHARMACOL, V4, P139, DOI 10.2174/157015906776359577; Niikura T, 2004, MOL NEUROBIOL, V30, P327, DOI 10.1385/MN:30:3:327; Niikura T, 2003, EUR J NEUROSCI, V17, P1150, DOI 10.1046/j.1460-9568.2003.02553.x; Nishimoto I, 2004, TRENDS MOL MED, V10, P102, DOI 10.1016/j.molmed.2004.01.001; PLATIKA D, 1985, P NATL ACAD SCI USA, V82, P3499, DOI 10.1073/pnas.82.10.3499; Pollio G, 2008, J NEUROSCI METH, V172, P34, DOI 10.1016/j.jneumeth.2008.03.018; Saille C, 1999, NEUROSCIENCE, V92, P1455, DOI 10.1016/S0306-4522(99)00089-5; Staub E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-37; Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4; Terashita K, 2003, J NEUROCHEM, V85, P1521, DOI 10.1046/j.1471-4159.2003.01797.x; TRUANT R, 1993, J BIOL CHEM, V268, P2284; Xu XS, 2008, BRAIN RES, V1227, P12, DOI 10.1016/j.brainres.2008.06.018; Yamagishi Y, 2003, PEPTIDES, V24, P585, DOI 10.1016/S0196-9781(03)00106-2; YAVIN Z, 1980, DEV BIOL, V75, P454, DOI 10.1016/0012-1606(80)90176-1; Ying GG, 2004, J IMMUNOL, V172, P7078, DOI 10.4049/jimmunol.172.11.7078; Zambrano A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-82	43	17	20	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					1983	2000		10.1096/fj.10-163535	http://dx.doi.org/10.1096/fj.10-163535			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21393573				2022-12-25	WOS:000291023800021
J	Mejias, JF; Torres, JJ				Mejias, Jorge F.; Torres, Joaquin J.			Emergence of Resonances in Neural Systems: The Interplay between Adaptive Threshold and Short-Term Synaptic Plasticity	PLOS ONE			English	Article							STOCHASTIC RESONANCE; COINCIDENCE DETECTION; FIRE MODEL; NOISE; NEURONS; DEPRESSION; INFORMATION; ADAPTATION; RELEASE; HETEROGENEITY	In this work we study the detection of weak stimuli by spiking (integrate-and-fire) neurons in the presence of certain level of noisy background neural activity. Our study has focused in the realistic assumption that the synapses in the network present activity-dependent processes, such as short-term synaptic depression and facilitation. Employing mean-field techniques as well as numerical simulations, we found that there are two possible noise levels which optimize signal transmission. This new finding is in contrast with the classical theory of stochastic resonance which is able to predict only one optimal level of noise. We found that the complex interplay between adaptive neuron threshold and activity-dependent synaptic mechanisms is responsible for this new phenomenology. Our main results are confirmed by employing a more realistic FitzHugh-Nagumo neuron model, which displays threshold variability, as well as by considering more realistic stochastic synaptic models and realistic signals such as poissonian spike trains.	[Mejias, Jorge F.] Univ Ottawa, Ctr Neural Dynam, Ottawa, ON, Canada; [Mejias, Jorge F.; Torres, Joaquin J.] Univ Granada, Dept Electromagnetism & Phys Matter, Granada, Spain	University of Ottawa; University of Granada	Mejias, JF (corresponding author), Univ Ottawa, Ctr Neural Dynam, Ottawa, ON, Canada.	jmejias@uottawa.ca	Torres, Joaquín J./AAE-6228-2019; Torres, Joaquín J./C-1385-2012	Torres, Joaquín J./0000-0001-6175-9676; Mejias, Jorge/0000-0002-8096-4891	MEyC-FEDER [FIS2009-08451]; Junta de Andalucia [P06-FQM-01505, P07-FQM-02725]	MEyC-FEDER; Junta de Andalucia(Junta de Andalucia)	This work was supported by the MEyC-FEDER project FIS2009-08451 and the Junta de Andalucia projects P06-FQM-01505 and P07-FQM-02725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Bertram R, 1996, J NEUROPHYSIOL, V75, P1919, DOI 10.1152/jn.1996.75.5.1919; BEZRUKOV SM, 1995, NATURE, V378, P362, DOI 10.1038/378362a0; Bulsara AR, 1996, PHYS REV E, V53, P3958, DOI 10.1103/PhysRevE.53.3958; Cardin JA, 2008, NEURON, V59, P150, DOI 10.1016/j.neuron.2008.05.002; Chacron MJ, 2004, PHYSICA D, V192, P138, DOI 10.1016/j.physd.2003.12.009; CHIALVO DR, 1993, J STAT PHYS, V70, P375, DOI 10.1007/BF01053974; COLLINS JJ, 1995, PHYS REV E, V52, pR3321, DOI 10.1103/PhysRevE.52.R3321; de la Rocha J, 2005, J NEUROSCI, V25, P8416, DOI 10.1523/JNEUROSCI.0631-05.2005; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; FAUVE S, 1983, PHYS LETT A, V97, P5, DOI 10.1016/0375-9601(83)90086-5; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; Fricker D, 1999, J PHYSIOL-LONDON, V517, P791, DOI 10.1111/j.1469-7793.1999.0791s.x; Fuentes MA, 2003, FLUCT NOISE LETT, V3, pL365, DOI 10.1142/S0219477503001440; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Garcia-Lazaro JA, 2007, EUR J NEUROSCI, V26, P2359, DOI 10.1111/j.1460-9568.2007.05847.x; Greenwood PE, 2000, PHYS REV LETT, V84, P4773, DOI 10.1103/PhysRevLett.84.4773; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P497, DOI 10.1113/jphysiol.1952.sp004719; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hou ZH, 1999, J CHEM PHYS, V111, P1592, DOI 10.1063/1.479419; Ibanes M, 2000, EUR PHYS J B, V18, P663, DOI 10.1007/s100510070015; Kobayashi R, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.009.2009; Koch Christof, 1999, P1; Krawiecki A, 2009, EUR PHYS J B, V69, P81, DOI 10.1140/epjb/e2009-00082-x; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Lindner B, 2009, J NEUROSCI, V29, P2076, DOI 10.1523/JNEUROSCI.3702-08.2009; Liu YH, 2001, J COMPUT NEUROSCI, V10, P25, DOI 10.1023/A:1008916026143; LONGTIN A, 1991, PHYS REV LETT, V67, P656, DOI 10.1103/PhysRevLett.67.656; Lugo E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002860; Manjarrez E, 2002, NEUROSCI LETT, V324, P213, DOI 10.1016/S0304-3940(02)00212-4; Mankin R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031120; Mato G, 1998, PHYS REV E, V58, P876, DOI 10.1103/PhysRevE.58.876; Mato G, 1999, PHYS REV E, V59, P3339, DOI 10.1103/PhysRevE.59.3339; MCNAMARA B, 1988, PHYS REV LETT, V60, P2626, DOI 10.1103/PhysRevLett.60.2626; MCNAMARA B, 1989, PHYS REV A, V39, P4854, DOI 10.1103/PhysRevA.39.4854; Mejias JF, 2008, J COMPUT NEUROSCI, V24, P222, DOI 10.1007/s10827-007-0052-8; Mejias JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013651; Mejias JF, 2009, NEURAL COMPUT, V21, P851, DOI 10.1162/neco.2008.02-08-719; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; NOBLE D, 1966, PHYSIOL REV, V46, P1; PALM G, 1988, BIOL CYBERN, V59, P1, DOI 10.1007/BF00336885; Rudolph M, 2001, J COMPUT NEUROSCI, V11, P19, DOI 10.1023/A:1011200713411; STANCEY WC, 2000, J NEUROPHYSIOL, V83, P1394; Stemmler M, 1996, NETWORK-COMP NEURAL, V7, P687, DOI 10.1088/0954-898X/7/4/005; Tessone CJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.194101; Torres JJ, 2007, NEURAL COMPUT, V19, P2739, DOI 10.1162/neco.2007.19.10.2739; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; VANDENBROECK C, 1994, PHYS REV LETT, V73, P3395, DOI 10.1103/PhysRevLett.73.3395; VandenBroeck C, 1997, PHYS REV E, V55, P4084, DOI 10.1103/PhysRevE.55.4084; Vilar JMG, 1997, PHYS REV LETT, V78, P2882, DOI 10.1103/PhysRevLett.78.2882; Volkov EI, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061112; Wang J, 2002, EUR PHYS J B, V29, P123, DOI 10.1140/epjb/e2002-00269-7; Wang XJ, 2003, J NEUROPHYSIOL, V89, P3279, DOI 10.1152/jn.00242.2003; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WIESENFELD K, 1994, PHYS REV LETT, V72, P2125, DOI 10.1103/PhysRevLett.72.2125; Yasuda H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118103; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219; Zalanyi L, 2001, NEUROCOMPUTING, V38, P459, DOI 10.1016/S0925-2312(01)00383-6	62	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17255	10.1371/journal.pone.0017255	http://dx.doi.org/10.1371/journal.pone.0017255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408148	gold, Green Submitted, Green Published			2022-12-25	WOS:000288170000018
J	Ouellette, SP; Dorsey, FC; Moshiach, S; Cleveland, JL; Carabeo, RA				Ouellette, Scot P.; Dorsey, Frank C.; Moshiach, Simon; Cleveland, John L.; Carabeo, Rey A.			Chlamydia Species-Dependent Differences in the Growth Requirement for Lysosomes	PLOS ONE			English	Article							TRACHOMATIS SEROVAR L2; COXIELLA-BURNETII; EPITHELIAL-CELLS; GENOME SEQUENCE; PNEUMONIAE; TRAFFICKING; INCLUSION; PHAGOSOMES; INFECTION; TRANSPORT	Genome reduction is a hallmark of obligate intracellular pathogens such as Chlamydia, where adaptation to intracellular growth has resulted in the elimination of genes encoding biosynthetic enzymes. Accordingly, chlamydiae rely heavily on the host cell for nutrients yet their specific source is unclear. Interestingly, chlamydiae grow within a pathogen-defined vacuole that is in close apposition to lysosomes. Metabolically-labeled uninfected host cell proteins were provided as an exogenous nutrient source to chlamydiae-infected cells, and uptake and subsequent labeling of chlamydiae suggested lysosomal degradation as a source of amino acids for the pathogen. Indeed, Bafilomycin A1 (BafA1), an inhibitor of the vacuolar H(+)/ATPase that blocks lysosomal acidification and functions, impairs the growth of C. trachomatis and C. pneumoniae, and these effects are especially profound in C. pneumoniae. BafA1 induced the marked accumulation of material within the lysosomal lumen, which was due to the inhibition of proteolytic activities, and this response inhibits chlamydiae rather than changes in lysosomal acidification per se, as cathepsin inhibitors also inhibit the growth of chlamydiae. Finally, the addition of cycloheximide, an inhibitor of eukaryotic protein synthesis, compromises the ability of lysosomal inhibitors to block chlamydial growth, suggesting chlamydiae directly access free amino acids in the host cytosol as a preferred source of these nutrients. Thus, chlamydiae co-opt the functions of lysosomes to acquire essential amino acids.	[Ouellette, Scot P.; Carabeo, Rey A.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, Div Cell & Mol Biol, London, England; [Dorsey, Frank C.; Cleveland, John L.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Moshiach, Simon] St Jude Childrens Hosp, Dept Tumor Cell Biol & Genet, Memphis, TN 38105 USA	Imperial College London; Scripps Research Institute; St Jude Children's Research Hospital	Ouellette, SP (corresponding author), Inst Pasteur, Unite Biochim Interact Macromol, Paris, France.	r.carabeo@imperial.ac.uk		O, Scot/0000-0002-3721-6839; CARABEO, REY/0000-0002-5708-5493	National Institutes of Health [AI052252, AI065545, CA123777]; Medical Research Council [G0900213] Funding Source: researchfish; MRC [G0900213] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [F32CA123777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065545, K22AI052252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI052252 and AI065545 to R. A. C. and CA123777 to F. C. D. from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Al-Younes HM, 2004, INFECT IMMUN, V72, P4751, DOI 10.1128/IAI.72.8.4751-4762.2004; Al-Younes HM, 1999, CELL MICROBIOL, V1, P237, DOI 10.1046/j.1462-5822.1999.00024.x; Balin BJ, 1998, MED MICROBIOL IMMUN, V187, P23, DOI 10.1007/s004300050071; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; BRUNHAM RC, 1985, J INFECT DIS, V152, P1275, DOI 10.1093/infdis/152.6.1275; BUCHMEIER NA, 1991, INFECT IMMUN, V59, P2232, DOI 10.1128/IAI.59.7.2232-2238.1991; Byrne GI, 2001, INFECT IMMUN, V69, P5423, DOI 10.1128/IAI.69.9.5423-5429.2001; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; *CDCP, 2007, SEX TRANSM DIS SURV; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Doeven MK, 2008, BIOPHYS J, V94, P3956, DOI 10.1529/biophysj.107.120964; Dorsey FC, 2009, METHOD ENZYMOL, V453, P251, DOI 10.1016/S0076-6879(08)04012-3; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Gieffers J, 2002, INFECT IMMUN, V70, P5827, DOI 10.1128/IAI.70.10.5827-5834.2002; GRAYSTON JT, 1992, CLIN INFECT DIS, V15, P757, DOI 10.1093/clind/15.5.757; Grieshaber S, 2002, CELL MICROBIOL, V4, P273, DOI 10.1046/j.1462-5822.2002.00191.x; Grieshaber SS, 2003, J CELL SCI, V116, P3793, DOI 10.1242/jcs.00695; HACKSTADT T, 1981, P NATL ACAD SCI-BIOL, V78, P3240, DOI 10.1073/pnas.78.5.3240; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; HAHN DL, 1995, J FAM PRACTICE, V41, P345; HATCH TP, 1975, INFECT IMMUN, V12, P211, DOI 10.1128/IAI.12.1.211-220.1975; Heinzen RA, 1997, INFECT IMMUN, V65, P1088, DOI 10.1128/IAI.65.3.1088-1094.1997; Heinzen RA, 1996, INFECT IMMUN, V64, P796, DOI 10.1128/IAI.64.3.796-809.1996; HIGH N, 1992, EMBO J, V11, P1991, DOI 10.1002/j.1460-2075.1992.tb05253.x; Ishidoh K, 2002, BIOL CHEM, V383, P1827, DOI 10.1515/BC.2002.206; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Mabey DCW, 2003, LANCET, V362, P223, DOI 10.1016/S0140-6736(03)13914-1; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; Miyairi I, 2006, J INFECT DIS, V194, P350, DOI 10.1086/505432; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Ouellette SP, 2006, MOL MICROBIOL, V62, P1387, DOI 10.1111/j.1365-2958.2006.05465.x; Pachikara N, 2009, FEMS MICROBIOL LETT, V292, P240, DOI 10.1111/j.1574-6968.2009.01494.x; PISONI RL, 1991, BIOCHIM BIOPHYS ACTA, V1071, P351, DOI 10.1016/0304-4157(91)90002-E; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; RIPA KT, 1977, J CLIN MICROBIOL, V6, P328; Rossi A, 2004, BIOL CHEM, V385, P363, DOI 10.1515/BC.2004.040; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schramm N, 1996, INFECT IMMUN, V64, P1208, DOI 10.1128/IAI.64.4.1208-1214.1996; Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Skipp P, 2005, PROTEOMICS, V5, P1558, DOI 10.1002/pmic.200401044; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; TAYLORROBINSON D, 1992, LANCET, V340, P81, DOI 10.1016/0140-6736(92)90399-N; Thamotharan M, 1997, J BIOL CHEM, V272, P11786, DOI 10.1074/jbc.272.18.11786; WINKLER HH, 1982, INFECT IMMUN, V38, P109, DOI 10.1128/IAI.38.1.109-113.1982	53	51	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e16783	10.1371/journal.pone.0016783	http://dx.doi.org/10.1371/journal.pone.0016783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408144	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170000010
J	Shoval, Y; Berissi, H; Kimchi, A; Pietrokovski, S				Shoval, Yishay; Berissi, Hanna; Kimchi, Adi; Pietrokovski, Shmuel			New Modularity of DAP-Kinases: Alternative Splicing of the DRP-1 Gene Produces a ZIPk-Like Isoform	PLOS ONE			English	Article							INTERACTING PROTEIN-KINASE; REGULATORY LIGHT-CHAIN; CELL-DEATH; SERINE/THREONINE KINASE; APOPTOTIC ACTIVITY; TUMOR-SUPPRESSOR; REORGANIZATION; PHOSPHORYLATES; SIGNALS; GENOME	DRP-1 and ZIPk are two members of the Death Associated Protein Ser/Thr Kinase (DAP-kinase) family, which function in different settings of cell death including autophagy. DAP kinases are very similar in their catalytic domains but differ substantially in their extra-catalytic domains. This difference is crucial for the significantly different modes of regulation and function among DAP kinases. Here we report the identification of a novel alternatively spliced kinase isoform of the DRP-1 gene, termed DRP-1 beta. The alternative splicing event replaces the whole extra catalytic domain of DRP-1 with a single coding exon that is closely related to the sequence of the extra catalytic domain of ZIPk. As a consequence, DRP-1 beta lacks the calmodulin regulatory domain of DRP-1, and instead contains a leucine zipper-like motif similar to the protein binding region of ZIPk. Several functional assays proved that this new isoform retained the biochemical and cellular properties that are common to DRP-1 and ZIPk, including myosin light chain phosphorylation, and activation of membrane blebbing and autophagy. In addition, DRP-1 beta also acquired binding to the ATF4 transcription factor, a feature characteristic of ZIPk but not DRP-1. Thus, a splicing event of the DRP-1 produces a ZIPk like isoform. DRP-1 beta is highly conserved in evolution, present in all known vertebrate DRP-1 loci. We detected the corresponding mRNA and protein in embryonic mouse brains and in human embryonic stem cells thus confirming the in vivo utilization of this isoform. The discovery of module conservation within the DAPk family members illustrates a parsimonious way to increase the functional complexity within protein families. It also provides crucial data for modeling the expansion and evolution of DAP kinase proteins within vertebrates, suggesting that DRP-1 and ZIPk most likely evolved from their ancient ancestor gene DAPk by two gene duplication events that occurred close to the emergence of vertebrates.	[Shoval, Yishay; Berissi, Hanna; Kimchi, Adi; Pietrokovski, Shmuel] Weizmann Inst Sci, Dept Mol Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shoval, Y (corresponding author), Weizmann Inst Sci, Dept Mol Biol, IL-76100 Rehovot, Israel.	Adi.Kimchi@weizmann.ac.il; Shmuel.Pietrokovski@weizmann.ac.il		Pietrokovski, Shmuel/0000-0001-8573-5863	Flight Attendant Medical Research Institute (FAMRI); European Union; Israel Science Foundation (ISF)	Flight Attendant Medical Research Institute (FAMRI); European Union(European Commission); Israel Science Foundation (ISF)(Israel Science Foundation)	This work was supported by the Center of Excellence grant from the Flight Attendant Medical Research Institute (FAMRI), by a grant from the European Union FP7 consortium (APO-SYS), and by a grant from the Israel Science Foundation (ISF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Bialik S, 2004, SEMIN CANCER BIOL, V14, P283, DOI 10.1016/j.semcancer.2004.04.008; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Chen RH, 2006, J BIOMED SCI, V13, P193, DOI 10.1007/s11373-005-9063-5; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Esteller M, 2003, LANCET ONCOL, V4, P351, DOI 10.1016/S1470-2045(03)01115-X; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Graves PR, 2005, J BIOL CHEM, V280, P9363, DOI 10.1074/jbc.M412538200; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Haystead TAJ, 2005, CELL SIGNAL, V17, P1313, DOI 10.1016/j.cellsig.2005.05.008; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; Inbal B, 2000, MOL CELL BIOL, V20, P1044, DOI 10.1128/MCB.20.3.1044-1054.2000; Kawai T, 2003, MOL CELL BIOL, V23, P6174, DOI 10.1128/MCB.23.17.6174-6186.2003; Kawai T, 1999, ONCOGENE, V18, P3471, DOI 10.1038/sj.onc.1202701; Kawai T, 1998, MOL CELL BIOL, V18, P1642, DOI 10.1128/MCB.18.3.1642; Kogel D, 2001, BRIT J CANCER, V85, P1801, DOI 10.1054/bjoc.2001.2158; Kogel D, 1999, ONCOGENE, V18, P7212, DOI 10.1038/sj.onc.1203169; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Murata-Hori M, 1999, FEBS LETT, V451, P81, DOI 10.1016/S0014-5793(99)00550-5; Murata-Hori M, 2001, ONCOGENE, V20, P8175, DOI 10.1038/sj.onc.1205055; Pietrokovski S, 1996, NUCLEIC ACIDS RES, V24, P3836, DOI 10.1093/nar/24.19.3836; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Raveh T, 2001, EXP CELL RES, V264, P185, DOI 10.1006/excr.2000.5134; Sanjo H, 1998, J BIOL CHEM, V273, P29066, DOI 10.1074/jbc.273.44.29066; Shani G, 2004, MOL CELL BIOL, V24, P8611, DOI 10.1128/MCB.24.19.8611-8626.2004; Shani G, 2001, EMBO J, V20, P1099, DOI 10.1093/emboj/20.5.1099; Shohat G, 2002, BBA-PROTEINS PROTEOM, V1600, P45, DOI 10.1016/S1570-9639(02)00443-0; Shoval Y, 2007, PLOS GENET, V3, P1884, DOI 10.1371/journal.pgen.0030180; TANG HW, EMBO J; Tong A, 2009, P NATL ACAD SCI USA, V106, P1457, DOI 10.1073/pnas.0809339106; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Wang WJ, 2002, J CELL BIOL, V159, P169, DOI 10.1083/jcb.200204050	35	14	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17344	10.1371/journal.pone.0017344	http://dx.doi.org/10.1371/journal.pone.0017344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408167	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170000023
J	Tong, JS; Zhang, QH; Huang, X; Fu, XQ; Qi, ST; Wang, YP; Hou, Y; Sheng, J; Sun, QY				Tong, Jing-Shan; Zhang, Qing-Hua; Huang, Xin; Fu, Xue-Qi; Qi, Shu-Tao; Wang, Ya-Peng; Hou, Yi; Sheng, Jun; Sun, Qing-Yuan			Icaritin Causes Sustained ERK1/2 Activation and Induces Apoptosis in Human Endometrial Cancer Cells	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; EMBRYONIC STEM-CELLS; SIGNALING PATHWAYS; ESTROGEN-RECEPTOR; MAP KINASES; DEATH; INHIBITION; TRANSIENT; STRESS; PHOSPHORYLATION	Icaritin, a compound from Epimedium Genus, has selective estrogen receptor (ER) modulating activities, and posses antitumor activity. Here, we examined icaritin effect on cell growth of human endometrial cancer Hec1A cells and found that icaritin potently inhibited proliferation of Hec1A cells. Icaritin-inhibited cell growth was associated with increased levels of p21 and p27 expression and reduced cyclinD1 and cdk 4 expression. Icaritin also induced cell apoptosis accompanied by activation of caspases as evidenced by the cleavage of endogenous substrate Poly (ADP-ribose) polymerase (PARP) and cytochrome c release, which was abrogated by pretreatment with the pan-caspase inhibitor z-VAD-fmk. Icaritin treatment also induced expression of pro-apoptotic protein Bax with a concomitant decrease of Bcl-2 expression. Furthermore, icaritin induced sustained phosphorylation of extracellular signal-regulated kinase1/2 (the MAPK/ERK1/2) in Hec1A cells and U0126, a specific MAP kinase kinase (MEK1/2) inhibitor, blocked the ERK1/2 activation by icaritin and abolished the icaritin-induced growth inhibition and apoptosis. Our results demonstrated that icaritin induced sustained ERK 1/2 activation and inhibited growth of endometrial cancer Hec1A cells, and provided a rational for preclinical and clinical evaluation of icaritin for endometrial cancer therapy.	[Tong, Jing-Shan; Zhang, Qing-Hua; Huang, Xin; Qi, Shu-Tao; Wang, Ya-Peng; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Tong, Jing-Shan; Fu, Xue-Qi; Sheng, Jun] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Sheng, Jun] Yunnan Agr Univ, Kunming, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Jilin University; Yunnan Agricultural University	Tong, JS (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	shengjunpuer@qq.com; sunqy@ioz.ac.cn		Qi, Shutao/0000-0002-4073-1161; Tong, Jingshan/0000-0003-1640-5769	Major State Basic Research Program of China [2011CB94451]; NIH [DK070016]; Nebraska Tobacco Settlement Biomedical Research Program [LB-595, LB692]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070016] Funding Source: NIH RePORTER	Major State Basic Research Program of China(National Basic Research Program of China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Tobacco Settlement Biomedical Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Major State Basic Research Program of China to Q.Y. Sun (2011CB94451). This work was also supported by the NIH grant DK070016 to Z.Y. Wang and the Nebraska Tobacco Settlement Biomedical Research Program Awards (LB-595 and LB692) to Z.Y. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2002, J CELL PHYSIOL, V192, P151, DOI 10.1002/jcp.10124; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Brown J, 2010, CANCER-AM CANCER SOC, V116, P4973, DOI 10.1002/cncr.25498; Chaudhry P, 2009, ENDOCR-RELAT CANCER, V16, P363, DOI 10.1677/ERC-08-0266; Chen JR, 2005, J BIOL CHEM, V280, P4632, DOI 10.1074/jbc.M411530200; Chen MF, 2010, AMINO ACIDS, V38, P1505, DOI 10.1007/s00726-009-0366-0; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Fan YM, 2007, MOL CELLS, V23, P30; Gehrig PA, 2010, GYNECOL ONCOL, V116, P187, DOI 10.1016/j.ygyno.2009.10.041; He J, 2010, PLANTA MED, V76, P1834, DOI 10.1055/s-0030-1250042; Heinrich A, 2009, TOXICOL LETT, V191, P260, DOI 10.1016/j.toxlet.2009.09.008; Holdenrieder S, 2001, CLIN CHEM LAB MED, V39, P596, DOI 10.1515/CCLM.2001.095; Huang J, 2007, LIFE SCI, V81, P832, DOI 10.1016/j.lfs.2007.07.015; Huang X, 2007, EUR J PHARMACOL, V564, P26, DOI 10.1016/j.ejphar.2007.02.039; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jeon ES, 2007, J CELL BIOCHEM, V100, P1536, DOI 10.1002/jcb.21141; Kim BW, 2008, CANCER BIOL THER, V7, P1080, DOI 10.4161/cbt.7.7.6164; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; Lin SL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-102; Loo DT, 2011, METHODS MOL BIOL, V682, P3, DOI 10.1007/978-1-60327-409-8_1; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Plataniotis G, 2010, ANN ONCOL, V21, pv41, DOI 10.1093/annonc/mdq245; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Shang YF, 2006, NAT REV CANCER, V6, P360, DOI 10.1038/nrc1879; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shtil AA, 1999, ONCOGENE, V18, P377, DOI 10.1038/sj.onc.1202305; Sorosky JI, 2008, OBSTET GYNECOL, V111, P436, DOI 10.1097/AOG.0b013e318162f690; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Stone AA, 2000, EXP CELL RES, V254, P110, DOI 10.1006/excr.1999.4731; Susnow N, 2009, SEMIN CANCER BIOL, V19, P42, DOI 10.1016/j.semcancer.2008.12.002; Tada-Oikawa S, 2009, PHOTOCHEM PHOTOBIOL, V85, P1391, DOI 10.1111/j.1751-1097.2009.00600.x; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tong JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015408; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Wang XD, 2001, GENE DEV, V15, P2922; Wang Z, 2007, NEUROSCIENCE, V145, P911, DOI 10.1016/j.neuroscience.2006.12.059; Wang ZQ, 2009, CHEM-BIOL INTERACT, V179, P375, DOI 10.1016/j.cbi.2008.12.007; Wang ZQ, 2004, EUR J PHARMACOL, V504, P147, DOI 10.1016/j.ejphar.2004.10.002; Wo YB, 2008, J CELL BIOCHEM, V103, P1536, DOI 10.1002/jcb.21541; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yu CR, 2004, ONCOGENE, V23, P1364, DOI 10.1038/sj.onc.1207248; Zhang G, 2009, BONE, V44, P345, DOI 10.1016/j.bone.2008.10.035	48	121	132	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e16781	10.1371/journal.pone.0016781	http://dx.doi.org/10.1371/journal.pone.0016781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408143	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170000009
J	Nagabhushana, A; Bansal, M; Swarup, G				Nagabhushana, Ananthamurthy; Bansal, Megha; Swarup, Ghanshyam			Optineurin Is Required for CYLD-Dependent Inhibition of TNF alpha-Induced NF-kappa B Activation	PLOS ONE			English	Article							DEUBIQUITINATING ENZYME; OPTIC NEUROPATHY; UBIQUITINATION; BINDING; NEMO; A20; IDENTIFICATION; NEUROBIOLOGY; MUTATIONS; APOPTOSIS	The nuclear factor kappa B (NF-kappa B) regulates genes that function in diverse cellular processes like inflammation, immunity and cell survival. The activation of NF-kappa B is tightly controlled and the deubiquitinase CYLD has emerged as a key negative regulator of NF-kappa B signalling. Optineurin, mutated in certain glaucomas and amyotrophic lateral sclerosis, is also a negative regulator of NF-kappa B activation. It competes with NEMO (NF-kappa B essential modulator) for binding to ubiquitinated RIP (receptor interacting protein) to prevent NF-kappa B activation. Recently we identified CYLD as optineurin-interacting protein. Here we have analysed the functional significance of interaction of optineurin with CYLD. Our results show that a glaucoma-associated mutant of optineurin, H486R, is altered in its interaction with CYLD. Unlike wild-type optineurin, the H486R mutant did not inhibit tumour necrosis factor alpha (TNF alpha)-induced NF-kappa B activation. CYLD mediated inhibition of TNF alpha-induced NF-kappa B activation was abrogated by expression of the H486R mutant. Upon knockdown of optineurin, CYLD was unable to inhibit TNF alpha-induced NF-kappa B activation and showed drastically reduced interaction with ubiquitinated RIP. The level of ubiquitinated RIP was increased in optineurin knockdown cells. Deubiquitination of RIP by over-expressed CYLD was abrogated in optineurin knockdown cells. These results suggest that optineurin regulates NF-kappa B activation by mediating interaction of CYLD with ubiquitinated RIP thus facilitating deubiquitination of RIP.	[Nagabhushana, Ananthamurthy; Bansal, Megha; Swarup, Ghanshyam] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Nagabhushana, A (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	gshyam@ccmb.res.in		Swarup, Ghanshyam/0000-0002-8098-0509	Department of Biotechnology, Government of India [BT/PR10130/BRB/10/614/2008]; UGC, India; CSIR, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); UGC, India(University Grants Commission, India); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by grant BT/PR10130/BRB/10/614/2008 from the Department of Biotechnology, Government of India, to GS. AN is recipient of Senior Research Fellowship of UGC, India. MB is recipient of Research Fellowship of CSIR, India. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chalasani ML, 2007, INVEST OPHTH VIS SCI, V48, P1607, DOI 10.1167/iovs.06-0834; Chalasani ML, 2009, OPHTHALMIC RES, V42, P176, DOI 10.1159/000232400; Chi ZL, 2010, HUM MOL GENET, V19, P2606, DOI 10.1093/hmg/ddq146; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Evans PC, 2004, BIOCHEM J, V378, P727, DOI 10.1042/BJ20031377; Grus FH, 2008, J GLAUCOMA, V17, P79, DOI 10.1097/IJG.0b013e318156a592; Gupta V, 2006, J CELL SCI, V119, P1703, DOI 10.1242/jcs.02885; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jain N, 2007, FEBS J, V274, P4396, DOI 10.1111/j.1742-4658.2007.05969.x; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Journo C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000521; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kumar Y, 2010, BIOCHEM J, V427, P91, DOI 10.1042/BJ20091349; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Leung YF, 2003, INVEST OPHTH VIS SCI, V44, P3880, DOI 10.1167/iovs.02-0693; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; Mrowka R, 2008, FEBS J, V275, P3178, DOI 10.1111/j.1742-4658.2008.06471.x; Nagabhushana A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-4; Park BC, 2007, GENES CELLS, V12, P969, DOI 10.1111/j.1365-2443.2007.01102.x; Park B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011547; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Takahashi Y, 2007, NEUROPATH APPL NEURO, V33, P692, DOI 10.1111/j.1365-2990.2007.00862.x; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Vrabec JP, 2007, EYE, V21, pS11, DOI 10.1038/sj.eye.6702880; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Wax MB, 2002, MOL NEUROBIOL, V26, P45, DOI 10.1385/MN:26:1:045; Weisschuh N, 2007, EXP EYE RES, V85, P450, DOI 10.1016/j.exer.2007.06.012; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Willoughby CE, 2004, INVEST OPHTH VIS SCI, V45, P3122, DOI 10.1167/iovs.04-0107; Wooten MW, 2008, J BIOL CHEM, V283, P6783, DOI 10.1074/jbc.M709496200; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Ying HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009168; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	47	83	85	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17477	10.1371/journal.pone.0017477	http://dx.doi.org/10.1371/journal.pone.0017477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408173	Green Published, Green Submitted, gold			2022-12-25	WOS:000288099800017
J	Razanajatovo, NH; Richard, V; Hoffmann, J; Reynes, JM; Razafitrimo, GM; Randremanana, RV; Heraud, JM				Razanajatovo, Norosoa Harline; Richard, Vincent; Hoffmann, Jonathan; Reynes, Jean-Marc; Razafitrimo, Girard Marcellin; Randremanana, Rindra Vatosoa; Heraud, Jean-Michel			Viral Etiology of Influenza-Like Illnesses in Antananarivo, Madagascar, July 2008 to June 2009	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; REAL-TIME PCR; HOSPITALIZED CHILDREN; HUMAN METAPNEUMOVIRUS; SEASONAL INFLUENZA; TRACT INFECTIONS; CORONAVIRUS; DIAGNOSIS; DISEASE; ASSAY	Background: In Madagascar, despite an influenza surveillance established since 1978, little is known about the etiology and prevalence of viruses other than influenza causing influenza-like illnesses (ILIs). Methodology/Principal Findings: From July 2008 to June 2009, we collected respiratory specimens from patients who presented ILIs symptoms in public and private clinics in Antananarivo (the capital city of Madagascar). ILIs were defined as body temperature >= 38 degrees C and cough and at least two of the following symptoms: sore throat, rhinorrhea, headache and muscular pain, for a maximum duration of 3 days. We screened these specimens using five multiplex real time Reverse Transcription and/or Polymerase Chain Reaction assays for detection of 14 respiratory viruses. We detected respiratory viruses in 235/313 (75.1%) samples. Overall influenza virus A (27.3%) was the most common virus followed by rhinovirus (24.8%), RSV (21.2%), adenovirus (6.1%), coronavirus OC43 (6.1%), influenza virus B (3.9%), parainfluenza virus-3 (2.9%), and parainfluenza virus-1 (2.3%). Co-infections occurred in 29.4% (69/235) of infected patients and rhinovirus was the most detected virus (27.5%). Children under 5 years were more likely to have one or more detectable virus associated with their ILI. In this age group, compared to those >= 5 years, the risk of detecting more than one virus was higher (OR = 1.9), as was the risk of detecting of RSV (OR = 10.1) and adenovirus (OR = 4.7). While rhinovirus and adenovirus infections occurred year round, RSV, influenza virus A and coronavirus OC43 had defined period of circulation. Conclusions: In our study, we found that respiratory viruses play an important role in ILIs in the Malagasy community, particularly in children under 5 years old. These data provide a better understanding of the viral etiology of outpatients with ILI and describe for the first time importance of these viruses in different age group and their period of circulation.	[Razanajatovo, Norosoa Harline; Hoffmann, Jonathan; Reynes, Jean-Marc; Razafitrimo, Girard Marcellin; Heraud, Jean-Michel] Inst Pasteur Madagascar, Virol Unit, Natl Influenza Ctr, Antananarivo, Madagascar; [Richard, Vincent; Randremanana, Rindra Vatosoa] IPM, Epidemiol Unit, Antananarivo, Madagascar	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Heraud, JM (corresponding author), Inst Pasteur Madagascar, Virol Unit, Natl Influenza Ctr, Antananarivo, Madagascar.	jmheraud@pasteur.mg	Reynes, Jean-Marc/M-6108-2014; Heraud, Jean-Michel/O-1464-2013	Heraud, Jean-Michel/0000-0003-1107-0859; Reynes, Jean-Marc/0000-0002-3712-941X; Vincent, RICHARD/0000-0002-6961-1753; HOFFMANN, JONATHAN/0000-0002-2400-8862	WHO Geneva [OD/AP-08-02451]; Sanofi-Pasteur; French Ministry of Health; US Centers for Disease Control and Prevention [U51/IP000327-01]; US Department of Health and Human Service via the International Network of Pasteur Institutes [6 IDSEP060001-01-01]; National Center for Immunization and Respiratory Diseases (NCIRD) [U51IP000327] Funding Source: NIH RePORTER	WHO Geneva(World Health Organization); Sanofi-Pasteur; French Ministry of Health; US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); US Department of Health and Human Service via the International Network of Pasteur Institutes; National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by WHO Geneva (APW/Ref. OD/AP-08-02451), Sanofi-Pasteur, the French Ministry of Health, the US Centers for Disease Control and Prevention (Cooperative Agreement Number: U51/IP000327-01) and the US Department of Health and Human Service (Grant Number 6 IDSEP060001-01-01) via the International Network of Pasteur Institutes. The authors are therefore grateful to Wenqing Zhang from WHO Geneva, Beatrice Barret and Myriam Beigeaud from Sanofi Pasteur and Kathleen Victoir and Marc Jouan from the International Network of Pasteur Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Laguna-Torres VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006118; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Chan PKS, 2009, J MED VIROL, V81, P1797, DOI 10.1002/jmv.21551; Chen HL, 2004, J TROP PEDIATRICS, V50, P279, DOI 10.1093/tropej/50.5.279; Di Carlo P, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-11; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; El-Hajje MJ, 2008, PRESSE MED, V37, P37, DOI 10.1016/j.lpm.2007.06.023; Hindiyeh M, 2001, AM J CLIN PATHOL, V116, P218; Jartti T, 2004, J MED VIROL, V72, P695, DOI 10.1002/jmv.20027; Kehl SC, 2001, J CLIN MICROBIOL, V39, P1696, DOI 10.1128/JCM.39.5.1696-1701.2001; Mathisen M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-35; Matthew J, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-16; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nokes DJ, 2004, J INFECT DIS, V190, P1828, DOI 10.1086/425040; Pabbaraju K, 2007, J CLIN VIROL, V40, P186, DOI 10.1016/j.jcv.2007.08.004; Pierangeli A, 2007, J MED VIROL, V79, P463, DOI 10.1002/jmv.20832; Puzelli S, 2009, J MED VIROL, V81, P2066, DOI 10.1002/jmv.21610; Rabarijaona L. P., 2003, Archives de l'Institut Pasteur de Madagascar, V69, P20; Randrianasolo L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-31; Raobijaona H., 1999, Archives de l'Institut Pasteur de Madagascar, V65, P107; Rasamoelisoa J. M., 1999, Archives de l'Institut Pasteur de Madagascar, V65, P127; RAVAOARINORO M, 1986, Archives de l'Institut Pasteur de Madagascar, V52, P147; Sapin G, 2001, B SOC PATHOL EXOT, V94, P3; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Soares J. L., 2003, Archives de l'Institut Pasteur de Madagascar, V69, P12; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Williams JV, 2006, J INFECT DIS, V193, P387, DOI 10.1086/499274; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; World Health Organization, 2010, AC RESP INF CHILDR; World Health Organization, 1999, WHOCDSCSRISR992	35	60	62	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17579	10.1371/journal.pone.0017579	http://dx.doi.org/10.1371/journal.pone.0017579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390235	Green Published, gold			2022-12-25	WOS:000287965200029
J	Granadeiro, JP; Phillips, RA; Brickle, P; Catry, P				Granadeiro, Jose P.; Phillips, Richard A.; Brickle, Paul; Catry, Paulo			Albatrosses Following Fishing Vessels: How Badly Hooked Are They on an Easy Meal?	PLOS ONE			English	Article							PELAGIC LONGLINE FISHERY; BLACK-BROWED ALBATROSS; DIOMEDEA-EXULANS; FALKLAND ISLANDS; GPS TRACKING; SEABIRDS; PETRELS; RESPONSES; TRAWLERS; RATES	Fisheries have major impacts on seabirds, both by changing food availability and by causing direct mortality of birds during trawling and longline setting. However, little is known about the nature and the spatial-temporal extent of the interactions between individual birds and vessels. By studying a system in which we had fine-scale data on bird movements and activity, and near real-time information on vessel distribution, we provide new insights on the association of a threatened albatross with fisheries. During early chick-rearing, black-browed albatrosses Thalassarche melanophris from two different colonies (separated by only 75 km) showed significant differences in the degree of association with fisheries, despite being nearly equidistant to the Falklands fishing fleet. Most foraging trips from either colony did not bring tracked individuals close to vessels, and proportionally little time and foraging effort was spent near ships. Nevertheless, a few individuals repeatedly visited fishing vessels, which may indicate they specialise on fisheries-linked food sources and so are potentially more vulnerable to bycatch. The evidence suggests that this population has little reliance on fisheries discards at a critical stage of its nesting cycle, and hence measures to limit fisheries waste on the Patagonian shelf that also reduce vessel attractiveness and the risk of incidental mortality, would be of high overall conservation benefit.	[Granadeiro, Jose P.] Univ Lisbon, Museu Nacl Hist Nat, CESAM, Lisbon, Portugal; [Phillips, Richard A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England; [Catry, Paulo] ISPA, Ecoethol Res Unit, Lisbon, Portugal	Universidade de Lisboa; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Instituto Superior Psicologia Aplicada (ISPA)	Granadeiro, JP (corresponding author), Univ Lisbon, Museu Nacl Hist Nat, CESAM, Lisbon, Portugal.	jpgranadeiro@fc.ul.pt	Granadeiro, José Pedro/E-8060-2011; Catry, Paulo/I-5408-2013	Granadeiro, José Pedro/0000-0002-7207-3474; Catry, Paulo/0000-0003-3000-0522; Brickle, Paul/0000-0002-9870-3518	Fundacao para a Ciencia e Tecnologia [PTDC/MAR/099366/2008]; Programa Plurianual [UID 331/94]; Falkland Islands Government; Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Plurianual; Falkland Islands Government; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was financed by Fundacao para a Ciencia e Tecnologia (www.fct.mctes.pt, Portugal) through Project PTDC/MAR/099366/2008 and as part of the Programa Plurianual (UI&D 331/94) and by the Falkland Islands Government (http://www.falklands.gov.fk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACAP, 2009, ACAP SPEC ASS BLACK; Arata J, 2003, POLAR BIOL, V26, P638, DOI 10.1007/s00300-003-0530-z; Bartumeus F, 2010, CURR BIOL, V20, P215, DOI 10.1016/j.cub.2009.11.073; Batschelet E, 1981, CIRCULAR STAT BIOL; Brothers N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012491; Brothers NP, 1999, FAO FISHERIES CIRCUL; Bugoni Leandro, 2008, Endangered Species Research, V5, P137, DOI 10.3354/esr00115; Bugoni L, 2010, J EXP MAR BIOL ECOL, V391, P190, DOI 10.1016/j.jembe.2010.06.027; Catry P, 2006, ANIM BEHAV, V72, P383, DOI 10.1016/j.anbehav.2005.10.030; Cuthbert R, 2005, BIOL CONSERV, V121, P345, DOI 10.1016/j.biocon.2004.05.007; FAVERO M, 2010, ANIM CONSER IN PRESS; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Furness RW, 2003, SCI MAR, V67, P33, DOI 10.3989/scimar.2003.67s233; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Huin N, 2002, AQUAT CONSERV, V12, P89, DOI 10.1002/aqc.479; Hyrenbach KD, 2003, BIOL CONSERV, V112, P391, DOI 10.1016/S0006-3207(02)00337-3; Jimenez S, 2010, AQUAT LIVING RESOUR, V23, P49, DOI 10.1051/alr/2010002; Leuteritz T., 2008, IUCN RED LIST THREAT; Montevecchi William A., 2002, P527; Nel DC, 2002, IBIS, V144, pE141, DOI 10.1046/j.1474-919X.2002.00092.x; Osterblom H, 2008, OIKOS, V117, P967, DOI 10.1111/j.2008.0030-1299.16501.x; Otley H, 2007, POLAR BIOL, V30, P359, DOI 10.1007/s00300-006-0192-8; Petersen Samantha L., 2008, Endangered Species Research, V5, P117, DOI 10.3354/esr00132; Phalan B, 2007, MAR ECOL PROG SER, V340, P271, DOI 10.3354/meps340271; Phillips RA, 2006, BIOL CONSERV, V129, P336, DOI 10.1016/j.biocon.2005.10.046; Pierre JP, 2010, BIOL CONSERV, V143, P2779, DOI 10.1016/j.biocon.2010.07.026; Skov H, 2001, MAR ECOL PROG SER, V214, P289, DOI 10.3354/meps214289; Sullivan BJ, 2006, BIOL CONSERV, V131, P495, DOI 10.1016/j.biocon.2006.02.007; THOMPSON KR, 1995, IBIS, V137, P198, DOI 10.1111/j.1474-919X.1995.tb03240.x; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Witt MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001111; Xavier JC, 2004, FISH OCEANOGR, V13, P324, DOI 10.1111/j.1365-2419.2004.00298.x	34	51	53	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17467	10.1371/journal.pone.0017467	http://dx.doi.org/10.1371/journal.pone.0017467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399696	Green Submitted, gold, Green Published			2022-12-25	WOS:000287933300025
J	Rigamonti, A; Brennand, K; Lau, F; Cowan, CA				Rigamonti, Alessandra; Brennand, Kristen; Lau, Frank; Cowan, Chad A.			Rapid Cellular Turnover in Adipose Tissue	PLOS ONE			English	Article							CHILDHOOD OBESITY; PROGENITOR CELLS; PPAR-GAMMA; LONG-TERM; IN-VIVO; OB GENE; EXPRESSION; PROLIFERATION; MOUSE; FAT	It was recently shown that cellular turnover occurs within the human adipocyte population. Through three independent experimental approaches - dilution of an inducible histone 2B-green fluorescent protein (H2BGFP), labeling with the cell cycle marker Ki67 and incorporation of BrdU - we characterized the degree of cellular turnover in murine adipose tissue. We observed rapid turnover of the adipocyte population, finding that 4.8% of preadipocytes are replicating at any time and that between 1-5% of adipocytes are replaced each day. In light of these findings, we suggest that adipose tissue turnover represents a possible new avenue of therapeutic intervention against obesity.	[Rigamonti, Alessandra; Lau, Frank; Cowan, Chad A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Rigamonti, Alessandra] Univ Milan, Milan, Italy; [Brennand, Kristen] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Harvard University; University of Milan; Salk Institute	Rigamonti, A (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Boston, MA 02115 USA.	ccowan1@partners.org	Brennand, Kristen J/U-5470-2019; Brennand, Kristen J/J-8704-2012	Brennand, Kristen J/0000-0003-0993-5956	Stowers Medical Institute	Stowers Medical Institute	This work was funded by the Stowers Medical Institute and departmental resources from the Massachusetts General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; BJORNTORP P, 1974, METABOLISM, V23, P1091, DOI 10.1016/0026-0495(74)90076-6; BJORNTORP P, 1975, AM J CLIN NUTR, V28, P445; BJORNTORP P, 1971, ACTA MED SCAND, V190, P363; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; FRIEDMAN JM, 1991, GENOMICS, V11, P1054, DOI 10.1016/0888-7543(91)90032-A; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Hutley LJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1037, DOI 10.1152/ajpendo.2001.281.5.E1037; LALOR PA, 1987, RHEUMATOL INT, V7, P183, DOI 10.1007/BF00541375; Leroy P, 1996, J BIOL CHEM, V271, P2365, DOI 10.1074/jbc.271.5.2365; LLOYD JK, 1961, BRIT MED J, V2, P145, DOI 10.1136/bmj.2.5245.145; Maumus M, 2008, J CLIN ENDOCR METAB, V93, P4098, DOI 10.1210/jc.2008-0044; Miller SG, 1996, P NATL ACAD SCI USA, V93, P5507, DOI 10.1073/pnas.93.11.5507; MILLER WH, 1984, J LIPID RES, V25, P336; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; NEWMAN PJ, 1994, ANN NY ACAD SCI, V714, P165, DOI 10.1111/j.1749-6632.1994.tb12041.x; Prins JB, 1997, CLIN SCI, V92, P3, DOI 10.1042/cs0920003; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2000, GENE DEV, V14, P1293; SASAKI K, 1988, CANCER, V62, P989, DOI 10.1002/1097-0142(19880901)62:5<989::AID-CNCR2820620525>3.0.CO;2-U; SASAKI K, 1987, J CELL PHYSIOL, V133, P579, DOI 10.1002/jcp.1041330321; SJOSTROM L, 1974, ACTA MED SCAND, V195, P201; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; STASZKIEWICZ J, 2008, BIOCH BIOPHYS RES CO; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; TANG W, 2008, SCIENCE; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhang HH, 2000, J ENDOCRINOL, V164, P119, DOI 10.1677/joe.0.1640119	38	92	94	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17637	10.1371/journal.pone.0017637	http://dx.doi.org/10.1371/journal.pone.0017637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407813	Green Submitted, Green Published, gold			2022-12-25	WOS:000287933300039
J	Hewitt, KJ; Shamis, Y; Hayman, RB; Margvelashvili, M; Dong, SM; Carlson, MW; Garlick, JA				Hewitt, Kyle J.; Shamis, Yulia; Hayman, Ryan B.; Margvelashvili, Mariam; Dong, Shumin; Carlson, Mark W.; Garlick, Jonathan A.			Epigenetic and Phenotypic Profile of Fibroblasts Derived from Induced Pluripotent Stem Cells	PLOS ONE			English	Article							FUNCTIONAL-PROPERTIES; TISSUE; DIFFERENTIATION; METHYLATION; BIOLOGY	Human induced pluripotent stem (hiPS) cells offer a novel source of patient-specific cells for regenerative medicine. However, the biological potential of iPS-derived cells and their similarities to cells differentiated from human embryonic stem (hES) cells remain unclear. We derived fibroblast-like cells from two hiPS cell lines and show that their phenotypic properties and patterns of DNA methylation were similar to that of mature fibroblasts and to fibroblasts derived from hES cells. iPS-derived fibroblasts (iPDK) and their hES-derived counterparts (EDK) showed similar cell morphology throughout differentiation, and patterns of gene expression and cell surface markers were characteristic of mature fibroblasts. Array-based methylation analysis was performed for EDK, iPDK and their parental hES and iPS cell lines, and hierarchical clustering revealed that EDK and iPDK had closely-related methylation profiles. DNA methylation analysis of promoter regions associated with extracellular matrix (ECM)-production (COL1A1) by iPS- and hESC-derived fibroblasts and fibroblast lineage commitment (PDGFR beta), revealed promoter demethylation linked to their expression, and patterns of transcription and methylation of genes related to the functional properties of mature stromal cells were seen in both hiPS- and hES-derived fibroblasts. iPDK cells also showed functional properties analogous to those of hES-derived and mature fibroblasts, as seen by their capacity to direct the morphogenesis of engineered human skin equivalents. Characterization of the functional behavior of ES- and iPS-derived fibroblasts in engineered 3D tissues demonstrates the utility of this tissue platform to predict the capacity of iPS-derived cells before their therapeutic application.	[Hewitt, Kyle J.; Shamis, Yulia; Garlick, Jonathan A.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Cell Mol & Dev Biol, Boston, MA 02111 USA; [Hayman, Ryan B.] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [Margvelashvili, Mariam; Dong, Shumin; Carlson, Mark W.; Garlick, Jonathan A.] Tufts Univ, Dept Oral & Maxillofacial Pathol, Boston, MA 02111 USA; [Margvelashvili, Mariam] Univ Siena, Sch Dent, Dept Dent Mat, I-53100 Siena, Italy	Tufts University; Tufts University; Tufts University; University of Siena	Hewitt, KJ (corresponding author), Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Cell Mol & Dev Biol, Boston, MA 02111 USA.	jonathan.garlick@tufts.edu	Hewitt, Kyle/S-6512-2019		National Institutes of Health [R01 DE017413-01A1]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grant number R01 DE017413-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alappat S, 2003, CELL RES, V13, P429, DOI 10.1038/sj.cr.7290185; Andriani F, 2003, J INVEST DERMATOL, V120, P923, DOI 10.1046/j.1523-1747.2003.12235.x; Aranda P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007809; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Boyd NL, 2009, TISSUE ENG PT A, V15, P1897, DOI 10.1089/ten.tea.2008.0351; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hewitt KJ, 2009, TISSUE ENG PT A, V15, P3417, DOI [10.1089/ten.tea.2009.0060, 10.1089/ten.TEA.2009.0060]; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang K, 2010, REGEN MED, V5, P531, DOI [10.2217/rme.10.35, 10.2217/RME.10.35]; Izadpanah R, 2008, CANCER RES, V68, P4229, DOI 10.1158/0008-5472.CAN-07-5272; Jahoda CAB, 1996, DERMATOL CLIN, V14, P573, DOI 10.1016/S0733-8635(05)70385-5; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; Lin N, 2010, CELL PROLIFERAT, V43, P427, DOI 10.1111/j.1365-2184.2010.00692.x; Liu YP, 2009, J CEREBR BLOOD F MET, V29, P780, DOI 10.1038/jcbfm.2009.1; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Margulis A, 2004, METH MOL B, V289, P61; Metallo CM, 2008, J CELL MOL MED, V12, P709, DOI 10.1111/j.1582-4934.2008.00228.x; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Phan Sem H, 2008, Proc Am Thorac Soc, V5, P334, DOI 10.1513/pats.200708-146DR; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taura D, 2009, FEBS LETT, V583, P1029, DOI 10.1016/j.febslet.2009.02.031; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tigli RS, 2009, J TISSUE ENG REGEN M, V3, P348, DOI 10.1002/term.169; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhong SP, 2010, WIRES NANOMED NANOBI, V2, P510, DOI 10.1002/wnan.100; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	39	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17128	10.1371/journal.pone.0017128	http://dx.doi.org/10.1371/journal.pone.0017128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386890	Green Submitted, gold, Green Published			2022-12-25	WOS:000287931400031
J	Santini, SM; Lapenta, C; Donati, S; Spadaro, F; Belardelli, F; Ferrantini, M				Santini, Stefano M.; Lapenta, Caterina; Donati, Simona; Spadaro, Francesca; Belardelli, Filippo; Ferrantini, Maria			Interferon-alpha-Conditioned Human Monocytes Combine a Th1-Orienting Attitude with the Induction of Autologous Th17 Responses: Role of IL-23 and IL-12	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HUMAN T-CELLS; DENDRITIC CELLS; I INTERFERON; IFN-ALPHA; CROHNS-DISEASE; CUTTING EDGE; DIFFERENTIATION; AUTOIMMUNITY; CYTOKINES	IFN-alpha exerts multiple effects leading to immune protection against pathogens and cancer as well to autoimmune reactions by acting on monocytes and dendritic cells. We analyzed the versatility of human monocytes conditioned by IFN-alpha towards dendritic cell differentiation (IFN-DC) in shaping the autologous T-helper response. Priming of naive CD4 T cells with autologous IFN-DC in the presence of either SEA or anti-CD3, resulted, in addition to a prominent expansion of CXCR3+ IFN-gamma-producing CD4 Th1 cells, in the emergence of two distinct subsets of IL-17-producing CD4 T cells: i) a predominant Th17 population selectively producing IL-17 and expressing CCR6; ii) a minor Th1/Th17 population, producing both IL-17 and IFN-gamma. After phagocytosis of apoptotic cells, IFN-DC induced Th17 cell expansion and IL-17 release. Notably, the use of neutralizing antibodies revealed that IL-23 was an essential cytokine in mediating Th17 cell development by IFN-DC. The demonstration of the IFN-DC-induced expansion of both Th1 and Th17 cell populations reveals the intrinsic plasticity of these DC in orienting the immune response and provides a mechanistic link between IFN-alpha and the onset of autoimmune phenomena, which have been correlated with both IL-17 production and exposure to IFN-alpha.	[Santini, Stefano M.; Lapenta, Caterina; Donati, Simona; Spadaro, Francesca; Belardelli, Filippo; Ferrantini, Maria] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS)	Santini, SM (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	maria.ferrantini@iss.it	Lapenta, Caterina cu/K-6009-2016; Santini, Stefano Maria/K-5907-2016; Spadaro, Francesca/M-7512-2017; Donati, Simona/M-7936-2017	Lapenta, Caterina cu/0000-0002-2771-6813; Santini, Stefano Maria/0000-0002-7580-5589; Spadaro, Francesca/0000-0002-6610-350X; Donati, Simona/0000-0001-5214-9913; Belardelli, Filippo/0000-0002-3082-3169; Ferrantini, Maria/0000-0002-6979-0149	Italian Ministry of Health [7OAF1/4, ACC2-WP2.2]; Italian Association for Research against Cancer	Italian Ministry of Health(Ministry of Health, Italy); Italian Association for Research against Cancer(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from Italian Ministry of Health (www.salute.gov.it) ["Progetto Integrato Oncologia" (7OAF1/4), "Progetto ISS per ACC" (ACC2-WP2.2)] and from the Italian Association for Research against Cancer (www.airc.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Annunziato F, 2009, BLOOD, V114, P2213, DOI 10.1182/blood-2009-03-209189; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Belardelli F, 1996, IMMUNOL TODAY, V17, P369, DOI 10.1016/0167-5699(96)10027-X; Benwell RK, 2010, CLIN IMMUNOL, V134, P178, DOI 10.1016/j.clim.2009.09.013; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Dhodapkar KM, 2008, BLOOD, V112, P2878, DOI 10.1182/blood-2008-03-143222; Ferrantini M, 2008, CYTOKINE GROWTH F R, V19, P93, DOI 10.1016/j.cytogfr.2007.10.003; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Gilliet M, 2008, CURR OPIN IMMUNOL, V20, P401, DOI 10.1016/j.coi.2008.06.008; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hoeve MA, 2006, EUR J IMMUNOL, V36, P661, DOI 10.1002/eji.200535239; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Iezzi G, 2009, P NATL ACAD SCI USA, V106, P876, DOI 10.1073/pnas.0810769106; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; Koon H, 2006, NEW ENGL J MED, V354, P758, DOI 10.1056/NEJMe058307; Kryczek I, 2008, J IMMUNOL, V181, P5842, DOI 10.4049/jimmunol.181.9.5842; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Lapenta C, 2006, EUR J IMMUNOL, V36, P2046, DOI 10.1002/eji.200535579; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Lebre MC, 2008, AM J PATHOL, V172, P940, DOI 10.2353/ajpath.2008.070703; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Parlato S, 2010, BLOOD, V115, P1554, DOI 10.1182/blood-2009-07-234468; Salim SY, 2009, AM J PATHOL, V174, P82, DOI 10.2353/ajpath.2009.080273; Sallusto F, 2009, MICROBES INFECT, V11, P620, DOI 10.1016/j.micinf.2009.04.004; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Santini Stefano Maria, 2009, Handb Exp Pharmacol, P295, DOI 10.1007/978-3-540-71029-5_14; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613	41	44	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17364	10.1371/journal.pone.0017364	http://dx.doi.org/10.1371/journal.pone.0017364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387004	Green Submitted, Green Published, gold			2022-12-25	WOS:000287931400063
J	Carriconde, F; Gilgado, F; Arthur, I; Ellis, D; Malik, R; van de Wiele, N; Robert, V; Currie, BJ; Meyer, W				Carriconde, Fabian; Gilgado, Felix; Arthur, Ian; Ellis, David; Malik, Richard; van de Wiele, Nathalie; Robert, Vincent; Currie, Bart J.; Meyer, Wieland			Clonality and alpha-a Recombination in the Australian Cryptococcus gattii VGII Population - An Emerging Outbreak in Australia	PLOS ONE			English	Article							NEOFORMANS VAR. GATTII; VANCOUVER-ISLAND; NORTHERN AUSTRALIA; STATISTICAL TESTS; BRITISH-COLUMBIA; NATURAL HABITAT; MATING-TYPE; EPIDEMIOLOGY; DISPERSAL; INFECTION	Background: Cryptococcus gattii is a basidiomycetous yeast that causes life-threatening disease in humans and animals. Within C. gattii, four molecular types are recognized (VGI to VGIV). The Australian VGII population has been in the spotlight since 2005, when it was suggested as the possible origin for the ongoing outbreak at Vancouver Island (British Columbia, Canada), with same-sex mating being suggested as the driving force behind the emergence of this outbreak, and is nowadays hypothesized as a widespread phenomenon in C. gattii. However, an in-depth characterization of the Australian VGII population is still lacking. The present work aimed to define the genetic variability within the Australian VGII population and determine processes shaping its population structure. Methodology/Principal Findings: A total of 54 clinical, veterinary and environmental VGII isolates from different parts of the Australian continent were studied. To place the Australian population in a global context, 17 isolates from North America, Europe, Asia and South America were included. Genetic variability was assessed using the newly adopted international consensus multi-locus sequence typing (MLST) scheme, including seven genetic loci: CAP59, GPD1, LAC1, PLB1, SOD1, URA5 and IGS1. Despite the overall clonality observed, the presence of MATa VGII isolates in Australia was demonstrated for the first time in association with recombination in MAT alpha-MATa populations. Our results also support the hypothesis of a "smouldering" outbreak throughout the Australian continent, involving a limited number of VGII genotypes, which is possibly caused by a founder effect followed by a clonal expansion. Conclusions/Significance: The detection of sexual recombination in MAT alpha-MATa population in Australia is in accordance with the natural life cycle of C. gattii involving opposite mating types and presents an alternative to the same-sex mating strategy suggested elsewhere. The potential for an Australian wide outbreak highlights the crucial issue to develop active surveillance procedures.	[Carriconde, Fabian; Gilgado, Felix; van de Wiele, Nathalie; Meyer, Wieland] Univ Sydney, Mol Mycol Res Lab, Sydney Med Sch,Westmead Millennium Inst, Westmead Hosp,Ctr Infect Dis & Microbiol,Sydney E, Sydney, NSW 2006, Australia; [Arthur, Ian] QEII Med Ctr, PathW Lab Med WA, Nedlands, WA, Australia; [Ellis, David] Womens & Childrens Hosp, SA Pathol, Adelaide, SA, Australia; [Malik, Richard] Univ Sydney, Ctr Vet Educ, Sydney, NSW 2006, Australia; [van de Wiele, Nathalie] Hogesch, Leiden, Netherlands; [Robert, Vincent] CBS Fungal Biodivers Ctr, Utrecht, Netherlands; [Currie, Bart J.] Royal Darwin Hosp, Trop & Emerging Infect Dis Div, Menzies Sch Hlth Res, No Terr Clin Sch, Casuarina, NT, Australia; [Currie, Bart J.] Royal Darwin Hosp, Dept Infect Dis, Casuarina, NT, Australia	University of Sydney; Westmead Institute for Medical Research; University of Western Australia; SA Pathology; Womens & Childrens Hospital Australia; University of Sydney; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Charles Darwin University; Menzies School of Health Research; Northern Territory Government	Carriconde, F (corresponding author), Univ Sydney, Mol Mycol Res Lab, Sydney Med Sch,Westmead Millennium Inst, Westmead Hosp,Ctr Infect Dis & Microbiol,Sydney E, Sydney, NSW 2006, Australia.	w.meyer@usyd.edu.au	Malik, Richard/I-2009-2019; Meyer, Wieland/G-1204-2015	Meyer, Wieland/0000-0001-9933-8340	Valentine Charlton Bequest; University of Sydney [100124681]	Valentine Charlton Bequest; University of Sydney(University of Sydney)	Richard Malik is supported by the Valentine Charlton Bequest administered by the Centre for Veterinary Education of the University of Sydney. This work was supported by a University of Sydney Bridging grant #100124681 to WM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; BURNETT J, 2003, FUNGAL POPULATION SP, P47; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; Callejas A, 1998, MED MYCOL, V36, P341, DOI 10.1080/02681219880000531; Campbell LT, 2006, FEMS YEAST RES, V6, P588, DOI 10.1111/j.1567-1364.2006.00087.x; Campbell LT, 2005, EUKARYOT CELL, V4, P1403, DOI 10.1128/EC.4.8.1403-1409.2005; CARTER D, 2007, SEX FUNGI MOL DETERM; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Chen SCA, 1997, T ROY SOC TROP MED H, V91, P547, DOI 10.1016/S0035-9203(97)90021-3; Choi YH, 2010, FEMS YEAST RES, V10, P769, DOI 10.1111/j.1567-1364.2010.00648.x; ELLIS DH, 1990, LANCET, V336, P923, DOI 10.1016/0140-6736(90)92283-N; ELLIS DH, 1990, J CLIN MICROBIOL, V28, P1642, DOI 10.1128/JCM.28.7.1642-1644.1990; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferrer C, 2001, J CLIN MICROBIOL, V39, P2873, DOI 10.1128/JCM.39.8.2873-2879.2001; FISHER D, 1993, AUST NZ J MED, V23, P678, DOI 10.1111/j.1445-5994.1993.tb04726.x; Fisher MC, 2005, PLOS PATHOG, V1, P159, DOI 10.1371/journal.ppat.0010020; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Galanis E, 2010, EMERG INFECT DIS, V16, P251, DOI [10.3201/eid1602.090900, 10.3201/eid1601.090900]; Georgi A, 2009, INFECTION, V37, P370, DOI 10.1007/s15010-008-8211-z; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Halliday CL, 1999, J CLIN MICROBIOL, V37, P2920, DOI 10.1128/JCM.37.9.2920-2926.1999; Hiremath SS, 2008, MICROBIOL-SGM, V154, P1513, DOI 10.1099/mic.0.2007/015594-0; Jenney A, 2004, J CLIN MICROBIOL, V42, P3865, DOI 10.1128/JCM.42.8.3865-3868.2004; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Krockenberger MB, 2002, MED MYCOL, V40, P263, DOI 10.1080/mmy.40.3.263.272; KWONCHUNG KJ, 1984, AM J EPIDEMIOL, V120, P123, DOI 10.1093/oxfordjournals.aje.a113861; Lazera MS, 1998, MED MYCOL, V36, P119, DOI 10.1080/02681219880000191; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; Lindberg J, 2007, EMERG INFECT DIS, V13, P178, DOI 10.3201/eid1301.060945; McGill S, 2009, MED MYCOL, V47, P625, DOI 10.1080/13693780802512519; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; NAGARAJAN S, 1990, ANNU REV PHYTOPATHOL, V28, P139, DOI 10.1146/annurev.py.28.090190.001035; NGAMSKULRUNGROJ P, 2010, CLIN MICROBIOL INFEC, DOI DOI 10.1111/J.1469-0691.2010.03222.X; Ngamskulrungroj P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005862; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Rees JR, 1998, CLIN INFECT DIS, V27, P1138, DOI 10.1093/clinids/27.5.1138; RILEY CB, 1992, AUST VET J, V69, P135, DOI 10.1111/j.1751-0813.1992.tb07482.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Saul N, 2008, EUKARYOT CELL, V7, P727, DOI 10.1128/EC.00020-08; Schneider S, 1999, GENETICS, V152, P1079; SLATKIN M, 1991, GENETICS, V129, P555; Sorrell Tania C., 1997, Revista Iberoamericana de Micologia, V14, P42; Sorrell TC, 1996, J CLIN MICROBIOL, V34, P1261, DOI 10.1128/JCM.34.5.1261-1263.1996; SPEED BR, 2002, MICRO AUST, V23, P5; Stern H, 2000, AUST METEOROL MAG, V49, P87; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wilson LS, 2002, VALUE HEALTH, V5, P26, DOI 10.1046/j.1524-4733.2002.51108.x	60	61	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16936	10.1371/journal.pone.0016936	http://dx.doi.org/10.1371/journal.pone.0016936			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383989	Green Published, gold, Green Submitted			2022-12-25	WOS:000287761700019
J	Ojha, J; Karmegam, RV; Masilamoni, JG; Terry, AV; Cashikar, AG				Ojha, Juhi; Karmegam, Rajalakshmi V.; Masilamoni, J. Gunasingh; Terry, Alvin V., Jr.; Cashikar, Anil G.			Behavioral Defects in Chaperone-Deficient Alzheimer's Disease Model Mice	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; HEAT-SHOCK PROTEINS; DESMIN-RELATED MYOPATHY; AMYLOID-BETA PROTEIN; ALEXANDERS-DISEASE; MISSENSE MUTATION; MOUSE MODEL; EXPRESSION; GENE; BRAINS	Molecular chaperones protect cells from the deleterious effects of protein misfolding and aggregation. Neurotoxicity of amyloid-beta (A beta) aggregates and their deposition in senile plaques are hallmarks of Alzheimer's disease (AD). We observed that the overall content of alpha B-crystallin, a small heat shock protein molecular chaperone, decreased in AD model mice in an age-dependent manner. We hypothesized that alpha B-crystallin protects cells against A beta toxicity. To test this, we crossed alpha B-crystallin/HspB2 deficient (CRYAB(-/-) HSPB2(-/-)) mice with AD model transgenic mice expressing mutant human amyloid precursor protein. Transgenic and non-transgenic mice in chaperone-sufficient or deficient backgrounds were examined for representative behavioral paradigms for locomotion and memory network functions: (i) spatial orientation and locomotion was monitored by open field test; (ii) sequential organization and associative learning was monitored by fear conditioning; and (iii) evoked behavioral response was tested by hot plate method. Interestingly, alpha B-crystallin/HspB2 deficient transgenic mice were severely impaired in locomotion compared to each genetic model separately. Our results highlight a synergistic effect of combining chaperone deficiency in a transgenic mouse model for AD underscoring an important role for chaperones in protein misfolding diseases.	[Ojha, Juhi; Karmegam, Rajalakshmi V.; Masilamoni, J. Gunasingh; Cashikar, Anil G.] Med Coll Georgia, Ctr Mol Chaperones & Radiobiol, Augusta, GA 30912 USA; [Terry, Alvin V., Jr.] Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Ojha, J (corresponding author), Med Coll Georgia, Ctr Mol Chaperones & Radiobiol, Augusta, GA 30912 USA.	acashikar@mcg.edu	Cashikar, Anil G/F-5968-2011	Cashikar, Anil/0000-0002-3671-684X; Terry, Alvin/0000-0003-2071-4767	Medical College of Georgia	Medical College of Georgia	This work was funded by the Medical College of Georgia faculty startup funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony SG, 2003, J ALZHEIMERS DIS, V5, P171, DOI 10.3233/JAD-2003-5301; ARRIGO AP, 1994, BIOL HEAT SHOCK PROT; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Chen QH, 2005, CIRC RES, V97, P1018, DOI 10.1161/01.RES.0000189262.92896.0b; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; Cottrell BA, 2005, ANN NEUROL, V58, P277, DOI 10.1002/ana.20554; Dabir DV, 2004, AM J PATHOL, V164, P155, DOI 10.1016/S0002-9440(10)63106-9; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fonte V, 2002, P NATL ACAD SCI USA, V99, P9439, DOI 10.1073/pnas.152313999; Franck E, 2004, J MOL EVOL, V59, P792, DOI 10.1007/s00239-004-0013-z; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Haslbeck M, 2002, CELL MOL LIFE SCI, V59, P1649, DOI 10.1007/PL00012492; Head MW, 2000, NEUROPATH APPL NEURO, V26, P304, DOI 10.1046/j.1365-2990.2000.00269.x; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Iwaki A, 1997, GENOMICS, V45, P386, DOI 10.1006/geno.1997.4956; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Kato K, 2001, J NEUROCHEM, V76, P730, DOI 10.1046/j.1471-4159.2001.00038.x; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Liao PC, 2008, BIOCHEM BIOPH RES CO, V376, P637, DOI 10.1016/j.bbrc.2008.08.161; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; LOWE J, 1992, J PATHOL, V166, P61, DOI 10.1002/path.1711660110; MacRae TH, 2000, CELL MOL LIFE SCI, V57, P899, DOI 10.1007/PL00000733; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; RENKAWEK K, 1992, ACTA NEUROPATHOL, V83, P324, DOI 10.1007/BF00296796; Renkawek K, 1999, NEUROREPORT, V10, P2273, DOI 10.1097/00001756-199908020-00009; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P155, DOI 10.1007/BF00296185; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Rustay NR, 2010, BRAIN RES, V1311, P136, DOI 10.1016/j.brainres.2009.11.040; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; SHINOHARA H, 1993, J NEUROL SCI, V119, P203, DOI 10.1016/0022-510X(93)90135-L; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Treweek TM, 2005, FEBS J, V272, P711, DOI 10.1111/j.1742-4658.2004.04507.x; van Rijk AF, 2000, OPHTHALMOLOGICA, V214, P7, DOI 10.1159/000027468; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Wilhelmus MMM, 2006, NEUROPATH APPL NEURO, V32, P119, DOI 10.1111/j.1365-2990.2006.00689.x; WILSON RC, 1976, BEHAV BIOL, V17, P495, DOI 10.1016/S0091-6773(76)90901-9; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Yoo BC, 2001, BIOCHEM BIOPH RES CO, V280, P249, DOI 10.1006/bbrc.2000.4109; Zourlidou A, 2004, J NEUROCHEM, V88, P1439, DOI 10.1046/j.1471-4159.2003.02273.x	47	33	33	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16550	10.1371/journal.pone.0016550	http://dx.doi.org/10.1371/journal.pone.0016550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379584	Green Submitted, Green Published, gold			2022-12-25	WOS:000287482300018
J	Simanek, AM; Dowd, JB; Pawelec, G; Melzer, D; Dutta, A; Aiello, AE				Simanek, Amanda M.; Dowd, Jennifer Beam; Pawelec, Graham; Melzer, David; Dutta, Ambarish; Aiello, Allison E.			Seropositivity to Cytomegalovirus, Inflammation, All-Cause and Cardiovascular Disease-Related Mortality in the United States	PLOS ONE			English	Article							C-REACTIVE PROTEIN; IMMUNE RISK PHENOTYPE; HERPES-SIMPLEX-VIRUS; SMOOTH-MUSCLE-CELLS; SOCIOECONOMIC POSITION; HIGH PREVALENCE; ARTERIAL-WALLS; LATE-LIFE; T-CELLS; INFECTION	Background: Studies have suggested that CMV infection may influence cardiovascular disease (CVD) risk and mortality. However, there have been no large-scale examinations of these relationships among demographically diverse populations. The inflammatory marker C-reactive protein (CRP) is also linked with CVD outcomes and mortality and may play an important role in the pathway between CMV and mortality. We utilized a U. S. nationally representative study to examine whether CMV infection is associated with all-cause and CVD-related mortality. We also assessed whether CRP level mediated or modified these relationships. Methodology/Principal Findings: Data come from subjects >= 25 years of age who were tested for CMV and CRP level and were eligible for mortality follow-up on December 31(st), 2006 (N = 14153) in the National Health and Nutrition Examination Survey (NHANES) III (1988-1994). Cox proportional hazard models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for all-cause and CVD-related mortality by CMV serostatus. After adjusting for multiple confounders, CMV seropositivity remained statistically significantly associated with all-cause mortality (HR 1.19, 95% CI: 1.01, 1.41). The association between CMV and CVD-related mortality did not achieve statistical significance after confounder adjustment. CRP did not mediate these associations. However, CMV seropositive individuals with high CRP levels showed a 30.1% higher risk for all-cause mortality and 29.5% higher risk for CVD-related mortality compared to CMV seropositive individuals with low CRP levels. Conclusions/Significance: CMV was associated with a significant increased risk for all-cause mortality and CMV seropositive subjects who also had high CRP levels were at substantially higher risk for both for all-cause and CVD-related mortality than subjects with low CRP levels. Future work should target the mechanisms by which CMV infection and low-level inflammation interact to yield significant impact on mortality.	[Simanek, Amanda M.; Aiello, Allison E.] Univ Michigan, Sch Publ Hlth, Ctr Social Epidemiol & Populat Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Dowd, Jennifer Beam] CUNY, CUNY Inst Demog Res, Hunter Coll, Sch Publ Hlth, New York, NY 10021 USA; [Pawelec, Graham] Univ Tubingen, Sch Med, ZMF, Med Res Ctr,Dept Internal Med 2, Tubingen, Germany; [Melzer, David; Dutta, Ambarish] Peninsula Med Sch, Epidemiol & Publ Hlth Grp, Exeter, Devon, England	University of Michigan System; University of Michigan; City University of New York (CUNY) System; Hunter College (CUNY); Eberhard Karls University of Tubingen; University of Exeter	Simanek, AM (corresponding author), Univ Michigan, Sch Publ Hlth, Ctr Social Epidemiol & Populat Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	aielloa@umich.edu	Dowd, Jennifer B/C-1127-2012; Pawelec, Graham/H-2713-2019; Simanek, Amanda/AAC-1426-2019	Dowd, Jennifer B/0000-0003-2006-5656; Pawelec, Graham/0000-0002-3600-0163; Dutta, Ambarish/0000-0002-4019-7472	Rackham Graduate School, University of Michigan; National Institutes of Health [R21 NR011181]; Stanley Medical Research Institute; European Commission [EU-LSHG-CT-2007-036894]; NATIONAL INSTITUTE OF NURSING RESEARCH [R21NR011181] Funding Source: NIH RePORTER	Rackham Graduate School, University of Michigan(University of Michigan System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Medical Research Institute; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	AMS was supported by Rackham Graduate School Predoctoral Fellowship, University of Michigan. JBD and AEA were funded by National Institutes of Health grant (R21 NR011181). AEA was funded by the Stanley Medical Research Institute. GP was supported by the European Commission (EU-LSHG-CT-2007-036894 "LifeSpan"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2008, J GERONTOL A-BIOL, V63, P610, DOI 10.1093/gerona/63.6.610; Aiello AE, 2006, J AM GERIATR SOC, V54, P1046, DOI 10.1111/j.1532-5415.2006.00796.x; Albert LJ, 1999, NEW ENGL J MED, V341, P2068, DOI 10.1056/NEJM199912303412707; ALMEIDA GD, 1994, BLOOD, V83, P370; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Bajpai A, 2010, CLIN CARDIOL, V33, P190, DOI 10.1002/clc.20681; Bason C, 2003, LANCET, V362, P1971, DOI 10.1016/S0140-6736(03)15016-7; Berencsi K, 1998, CELL ADHES COMMUN, V5, P39, DOI 10.3109/15419069809005597; Bertoni AG, 2001, DIABETES CARE, V24, P1044, DOI 10.2337/diacare.24.6.1044; Blankenberg S, 2001, CIRCULATION, V103, P2915, DOI 10.1161/01.CIR.103.24.2915; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; Chan D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-34; Chidrawar S, 2009, CLIN EXP IMMUNOL, V155, P423, DOI 10.1111/j.1365-2249.2008.03785.x; Colugnati FAB, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-71; Costalonga EC, 2009, CLIN TRANSPLANT, V23, P710, DOI 10.1111/j.1399-0012.2009.01030.x; Dowd JB, 2009, EPIDEMIOL INFECT, V137, P58, DOI 10.1017/S0950268808000551; Epstein SE, 2000, ARTERIOSCL THROM VAS, V20, P1417, DOI 10.1161/01.ATV.20.6.1417; Epstein SE, 2002, CIRC RES, V90, P2, DOI 10.1161/res.90.1.2; Epstein SE, 2009, CIRCULATION, V119, P3133, DOI 10.1161/CIRCULATIONAHA.109.849455; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guetta E, 1997, CIRC RES, V81, P8, DOI 10.1161/01.RES.81.1.8; Gunter EW, 1996, LAB PROCEDURES USED; Hadrup SR, 2006, J IMMUNOL, V176, P2645, DOI 10.4049/jimmunol.176.4.2645; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Harkins L, 2002, LANCET, V360, P1557, DOI 10.1016/S0140-6736(02)11524-8; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; He LP, 2010, HEART, V96, P339, DOI 10.1136/hrt.2009.174912; HENDRIX MGR, 1990, AM J PATHOL, V136, P23; Hsich E, 2001, ATHEROSCLEROSIS, V156, P23, DOI 10.1016/S0021-9150(00)00608-0; Knosel T, 2004, CANCER LETT, V211, P243, DOI 10.1016/j.canlet.2004.02.011; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Kuper H, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4265; Lee TA, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.03.003; Lin WR, 2002, NEUROBIOL DIS, V9, P82, DOI 10.1006/nbdi.2001.0465; Lunardi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000473; MELNICK JL, 1983, LANCET, V2, P644; MELNICK JL, 1994, J MED VIROL, V42, P170, DOI 10.1002/jmv.1890420213; Mendall MA, 2000, EUR HEART J, V21, P1584, DOI 10.1053/euhj.1999.1982; Mocarski ES, 2006, CYTOMEGALOVIRUSES: MOLECULAR BIOLOGY AND IMMUNOLOGY, P465; Muhlestein JB, 2000, CIRCULATION, V102, P1917, DOI 10.1161/01.CIR.102.16.1917; National Center for Health Statistics, 1998, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 2010, COMP AN NHANES 3 PUB; National Center for Health Statistics. Centers for Disease Control and Prevention, 2010, NAT HLTH NUTR EX SUR; National Center for Health Statistics. Office of Analysis and Epidemiology, 2009, 3 NAT HLTH NUTR EX S; Nieto FJ, 1996, CIRCULATION, V94, P922, DOI 10.1161/01.CIR.94.5.922; Olsson J, 2000, MECH AGEING DEV, V121, P187; OONEY RJ, 1999, CLIN IMMUNOL, V90, P213; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; Pawelec G, 2009, REV MED VIROL, V19, P47, DOI 10.1002/rmv.598; Prasad K, 2006, CARDIOVASC DRUG REV, V24, P33, DOI 10.1111/j.1527-3466.2006.00033.x; Rask K, 2009, J PUBLIC HEALTH-UK, V31, P231, DOI 10.1093/pubmed/fdp015; Reinhardt B, 2005, CARDIOVASC RES, V67, P151, DOI 10.1016/j.cardiores.2005.03.012; *RES TRIANGL I, 2008, SUDAAN LANG MAN REL; Ridker PM, 2003, CIRCULATION, V108, pE81, DOI 10.1161/01.CIR.0000093381.57779.67; Ridker PM, 1998, CIRCULATION, V98, P2796, DOI 10.1161/01.CIR.98.25.2796; Roberts ET, 2010, AM J EPIDEMIOL, V172, P363, DOI 10.1093/aje/kwq177; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Rothman K., 1998, MODERN EPIDEMIOLOGY; Samanta M, 2003, J UROLOGY, V170, P998, DOI 10.1097/01.ju.0000080263.46164.97; Sathiakumar N, 1998, J OCCUP ENVIRON MED, V40, P808, DOI 10.1097/00043764-199809000-00010; Schmaltz HN, 2005, J AM GERIATR SOC, V53, P747, DOI 10.1111/j.1532-5415.2005.53250.x; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; Simanek AM, 2009, INT J EPIDEMIOL, V38, P775, DOI 10.1093/ije/dyn273; Singh GK, 2006, INT J EPIDEMIOL, V35, P903, DOI 10.1093/ije/dyl089; Smieja M, 2003, CIRCULATION, V107, P251, DOI 10.1161/01.CIR.0000044940.65226.1F; SMITH PD, 1992, J CLIN INVEST, V90, P1642, DOI 10.1172/JCI116035; Sorlie PD, 2000, ARCH INTERN MED, V160, P2027, DOI 10.1001/archinte.160.13.2027; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Stassen FR, 2006, J CLIN VIROL, V35, P349, DOI 10.1016/j.jcv.2005.11.007; Stassen FR, 2008, PHARMACOL REP, V60, P85; Strandberg TE, 2009, JAMA-J AM MED ASSOC, V301, P380, DOI 10.1001/jama.2009.4; Tice JA, 2003, AM J MED, V114, P199, DOI 10.1016/S0002-9343(02)01497-3; United States National Center for Health Statistics, 2005, NAT HLTH NUTR EX SUR; VANDAMMIERAS MCE, 1992, THROMB HAEMOSTASIS, V68, P364; Wang GC, 2010, AM J EPIDEMIOL, V171, P1144, DOI 10.1093/aje/kwq062; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; WIKBY A, 1994, EXP GERONTOL, V29, P531, DOI 10.1016/0531-5565(94)90036-1; Wikby A, 2006, MECH AGEING DEV, V127, P695, DOI 10.1016/j.mad.2006.04.003; Zhu JH, 1999, J AM COLL CARDIOL, V34, P1738, DOI 10.1016/S0735-1097(99)00410-6	80	268	271	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16103	10.1371/journal.pone.0016103	http://dx.doi.org/10.1371/journal.pone.0016103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379581	Green Published, gold			2022-12-25	WOS:000287482300014
J	Moller, AP; Bonisoli-Alquati, A; Rudolfsen, G; Mousseau, TA				Moller, Anders Pape; Bonisoli-Alquati, Andea; Rudolfsen, Geir; Mousseau, Timothy A.			Chernobyl Birds Have Smaller Brains	PLOS ONE			English	Article							BARN SWALLOWS; OXIDATIVE STRESS; EYE SIZE; RADIATION; MALFORMATIONS; ANTIOXIDANTS; GLUTATHIONE; DISPERSAL; DISASTER	Background: Animals living in areas contaminated by radioactive material from Chernobyl suffer from increased oxidative stress and low levels of antioxidants. Therefore, normal development of the nervous system is jeopardized as reflected by high frequencies of developmental errors, reduced brain size and impaired cognitive abilities in humans. Alternatively, associations between psychological effects and radiation have been attributed to post-traumatic stress in humans. Methodology/Principal Finding: Here we used an extensive sample of 550 birds belonging to 48 species to test the prediction that even in the absence of post-traumatic stress, there is a negative association between relative brain size and level of background radiation. We found a negative association between brain size as reflected by external head volume and level of background radiation, independent of structural body size and body mass. The observed reduction in brain size in relation to background radiation amounted to 5% across the range of almost a factor 5,000 in radiation level. Species differed significantly in reduction in brain size with increasing background radiation, and brain size was the only morphological character that showed a negative relationship with radiation. Brain size was significantly smaller in yearlings than in older individuals. Conclusions/Significance: Low dose radiation can have significant effects on normal brain development as reflected by brain size and therefore potentially cognitive ability. The fact that brain size was smaller in yearlings than in older individuals implies that there was significant directional selection on brain size with individuals with larger brains experiencing a viability advantage.	[Moller, Anders Pape] Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France; [Bonisoli-Alquati, Andea; Mousseau, Timothy A.] NRPA, Dept Environm Radioact, Polar Environm Ctr, Tromso, Norway; [Rudolfsen, Geir] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Moller, AP (corresponding author), Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France.	anders.moller@u-psud.fr	Mousseau, Timothy A/A-1253-2011; Alquati, Andrea Bonisoli/S-2082-2017; Moller, Anders/O-6665-2016; Bonisoli Alquati, Andrea/A-6409-2008; Rudolfsen, Geir/ABD-7777-2020	Alquati, Andrea Bonisoli/0000-0002-9255-7556; Moller, Anders/0000-0003-3739-4675; Rudolfsen, Geir/0000-0001-7984-8458; Mousseau, Timothy/0000-0002-2235-4868	University of South Carolina School of the Environment; Bill Murray and the Samuel Freeman Charitable Trust; National Science Foundation; NATO; Fulbright Program; CRDF; National Geographic Society	University of South Carolina School of the Environment; Bill Murray and the Samuel Freeman Charitable Trust; National Science Foundation(National Science Foundation (NSF)); NATO(NATO (North Atlantic Treaty Organisation)); Fulbright Program; CRDF; National Geographic Society(National Geographic Society)	The authors received funding from the University of South Carolina School of the Environment, Bill Murray and the Samuel Freeman Charitable Trust, the National Science Foundation, NATO, the Fulbright Program, CRDF and the National Geographic Society to conduct their research. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOND D, 2007, NATL BUREAU EC RES, V1334, P1; Bains JS, 1997, BRAIN RES REV, V25, P335, DOI 10.1016/S0165-0173(97)00045-3; Battley PF, 2000, P ROY SOC B-BIOL SCI, V267, P191, DOI 10.1098/rspb.2000.0986; Bazhan K V, 1998, Lik Sprava, P47; Ben-Amotz A, 1998, RADIAT ENVIRON BIOPH, V37, P187, DOI 10.1007/s004110050116; Bonisoli-Alquati A, 2010, COMP BIOCHEM PHYS A, V155, P205, DOI 10.1016/j.cbpa.2009.10.041; Burnham KP, 2001, MODEL SELECTION MULT; Chaialo P P, 1991, Med Radiol (Mosk), V36, P20; CHUPRYKOV AP, 1992, MENTAL DISORDERS RAD; Cohen J., 1988, STAT POWER ANAL BEHA; Dukas R, 2004, ANNU REV ECOL EVOL S, V35, P347, DOI 10.1146/annurev.ecolsys.35.112202.130152; DZYKOVICH IB, 1996, MED BIOL ASPECTS CHE, V1, P16; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; Gaschak S. P., 2008, Radiatsionnaya Biologiya Radioekologiya, V48, P28; Havenaar JM, 1997, AM J PSYCHIAT, V154, P1605, DOI 10.1176/ajp.154.11.1605; Heiervang KS, 2010, SCAND J PSYCHOL, V51, P210, DOI 10.1111/j.1467-9450.2010.00814.x; Hoffman DJ, 1998, ENVIRON TOXICOL CHEM, V17, P161, DOI 10.1002/etc.5620170204; Hoffmann W, 2001, ARCH ENVIRON HEALTH, V56, P478, DOI 10.1080/00039890109602895; Ivanyuta L. I., 1998, Ukrainskii Biokhimicheskii Zhurnal, V70, P132; Iwaniuk AN, 2004, P ROY SOC B-BIOL SCI, V271, pS148, DOI 10.1098/rsbl.2003.0127; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; Kimler BF, 1998, INT J RADIAT BIOL, V73, P423, DOI 10.1080/095530098142266; Kumerova AO, 2000, BIOL TRACE ELEM RES, V77, P1, DOI 10.1385/BTER:77:1:1; Lykholat E. A., 1999, Ukrainskii Biokhimicheskii Zhurnal, V71, P82; Moller AP, 2007, BIOL LETTERS, V3, P414, DOI 10.1098/rsbl.2007.0136; Moller AP, 2007, P ROY SOC B-BIOL SCI, V274, P1443, DOI 10.1098/rspb.2007.0005; Moller AP, 2006, ECOL APPL, V16, P1696, DOI 10.1890/1051-0761(2006)016[1696:CAAPSF]2.0.CO;2; Moller AP, 2010, J EVOLUTION BIOL, V23, P625, DOI 10.1111/j.1420-9101.2009.01928.x; Moller AP, 2010, ETHOLOGY, V116, P458, DOI 10.1111/j.1439-0310.2010.01754.x; Moller AP, 2008, J COMP PHYSIOL B, V178, P735, DOI 10.1007/s00360-008-0262-z; Moller AP, 2005, P ROY SOC B-BIOL SCI, V272, P247, DOI 10.1098/rspb.2004.2914; Moller AP, 2005, J EVOLUTION BIOL, V18, P223, DOI 10.1111/j.1420-9101.2004.00805.x; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; MOLLER AP, 2010, ECOL INDICA IN PRESS; Moller AP., 1994, SEXUAL SELECTION BAR; MOLLER AP, 2007, BIOL LETT, V5, P356; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Neyfakh EA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P1138; Neyfakh EA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P977; Nyagu AI, 1998, INT J PSYCHOPHYSIOL, V30, P303, DOI 10.1016/S0167-8760(98)00022-1; NYAGU AI, 2003, HLTH PHYS, V89; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; Rosenthal Robert., 1991, META ANALYTIC PROCED; *SAS I INC, 2000, JMP VERS 7; Sewalk CJ, 2000, J TOXICOL ENV HEAL A, V62, P33, DOI 10.1080/00984100050201659; Shestopalov V. M., 1996, ATLAS CHERNOBYL EXCL; Svensson L.A., 2006, IDENTIFICATION GUIDE; Timmermans S, 2000, BRAIN BEHAV EVOLUT, V56, P196, DOI 10.1159/000047204; Wertelecki W, 2010, PEDIATRICS, V125, pE836, DOI 10.1542/peds.2009-2219; YABLOKOV A. V., 2009, CHERNOBYL CONSEQUENC; Zhavoronkova L A, 2002, Dokl Biol Sci, V386, P410, DOI 10.1023/A:1020702015207	51	41	42	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16862	10.1371/journal.pone.0016862	http://dx.doi.org/10.1371/journal.pone.0016862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21390202	gold, Green Submitted, Green Published			2022-12-25	WOS:000287037000028
J	Bist, P; Leow, SC; Phua, QH; Shu, S; Zhuang, Q; Loh, WT; Nguyen, TH; Zhou, JB; Hooi, SC; Lim, LHK				Bist, P.; Leow, S. C.; Phua, Q. H.; Shu, S.; Zhuang, Q.; Loh, W. T.; Nguyen, T. H.; Zhou, J. B.; Hooi, S. C.; Lim, L. H. K.			Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-kappa B: implication in breast cancer metastasis	ONCOGENE			English	Article						metastasis; transcription factor; NF-kappa B; CXCR4	CHEMOKINE RECEPTOR CXCR4; A1 EXPRESSION; TUMOR-CELLS; BONE-MARROW; IN-VITRO; PROTEIN; PROGRESSION; PATHWAY; DOMAIN; MIGRATION	The molecular mechanisms underlying constitutive nuclear factor-kappa B (NF-kappa B) activation in solid tumors has not been elucidated. We show that Annexin-1 (ANXA1) is involved in this process, and suppression of ANXA1 in highly metastatic breast cancer cells impedes migration and metastasis capabilities in vitro and in vivo. ANXA1 expression correlates with NF-kappa B activity, suggesting that ANXA1 may be required for the constitutive activity of I kappa B kinase (IKK) and NF-kappa B in highly metatstatic breast cancer. Gel-filtration analysis demonstrated that ANXA1 co-elutes with the members of the IKK complex and NF-kappa B signaling pathway, and immunoprecipitation confirmed that ANXA1 can bind to and interact with IKK gamma or NEMO, but not IKK alpha or IKK beta. Importantly, silencing of ANXA1 prevents the interaction of NEMO and RIP1, which indicates that ANXA1 is required for the recruitment of RIP1 to the IKK complex, which may be important for the activation of NF-kappa B. Downstream targets of NF-kappa B include uPA and CXCR4, which can be modulated by ANXA1 silencing. CXCR4-mediated migration of breast cancer cell lines in response to CXCL12 was significantly modulated by ANXA1, indicating its importance in the tissue-specific migration of breast cancer cells. Chromatin immunoprecipitation experiments confirmed that in ANXA1 overexpressed cells, NF-kappa B was recruited to CXCR4 promoter without external stimulation, indicating that ANXA1 is critical for the constitutive activation of NF-kappa B in breast cancer to promote metastasis. Finally, we show that ANXA1 overexpression enhances metastasis and reduces survival in an intracardiac metastasis model, while ANXA1-deficient mice crossed with MMTV-PyMT mice display significantly less metastasis than their heterozygous littermates, indicating that ANXA1 is an important gene in breast cancer metastasis. Our data reveal that ANXA1 can constitutively activate NF-kappa B in breast cancer cells through the interaction with the IKK complex, and suggests that modulating ANXA1 levels has therapeutic potential to suppress breast cancer metastasis. Oncogene (2011) 30, 3174-3185; doi:10.1038/onc.2011.28; published online 7 March 2011	[Lim, L. H. K.] Natl Univ Singapore, Dept Physiol, Inflammat & Canc Lab, Yong Loo Lin Sch Med,Ctr Life Sci, Singapore 117456, Singapore; [Bist, P.; Leow, S. C.; Phua, Q. H.; Shu, S.; Zhuang, Q.; Loh, W. T.; Nguyen, T. H.; Lim, L. H. K.] Natl Univ Singapore, NUS Immunol Program, Inflammat & Canc Lab, Singapore 117456, Singapore; [Zhou, J. B.] Natl Univ Singapore, Oncol Res Inst, Singapore 117456, Singapore; [Lim, L. H. K.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Lim, LHK (corresponding author), Natl Univ Singapore, Dept Physiol, Inflammat & Canc Lab, Yong Loo Lin Sch Med,Ctr Life Sci, Level 3,28 Med Dr, Singapore 117456, Singapore.	linalim@nus.edu.sg	Nguyen, Hung/M-8118-2014; Hooi, Shing/C-8588-2012; BIST, PRADEEP/AAG-7986-2019	Nguyen, Hung/0000-0001-8378-555X; Lim, Lina/0000-0002-2935-2275; Hooi, Shing Chuan/0000-0003-3249-903X	Biomedical Research Council of Singapore [07/1/21/19/507, 04/1/21/19/319]; A*Star [SIgN 07-011]	Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); A*Star(Agency for Science Technology & Research (A*STAR))	This work was supported by grants from the Biomedical Research Council of Singapore (07/1/21/19/507) and A*Star (SIgN 07-011) to LL and Biomedical Research Council of Singapore (04/1/21/19/319) to SCH. We thank Professor Rod Flower (William Harvey Research Institute, Queen Mary's School of Medicine and Dentistry, London) for generously providing us with the pCDNA3.1-V5 ANXA1 construct and Professor Michael Karin (University of California San Diego, CA, USA) for the HA-IKK alpha, HA-IKK beta and HA-IKK gamma plasmid constructs.	Ahn SH, 1997, CLIN EXP METASTAS, V15, P151, DOI 10.1023/A:1018452810915; Ang EZF, 2009, MOL CANCER RES, V7, P266, DOI 10.1158/1541-7786.MCR-08-0147; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Cabioglu N, 2005, CLIN EXP METASTAS, V22, P39, DOI 10.1007/s10585-005-3222-y; Cao Y, 2008, APPL IMMUNOHISTO M M, V16, P530, DOI 10.1097/PAI.0b013e31817432c3; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Cicek M, 2004, CLIN EXP METASTAS, V21, P149, DOI 10.1023/B:CLIN.0000024729.19084.f0; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Johnstone PAS, 2002, CURR PROB CANCER, V26, P282, DOI 10.1067/mcn.2002.129997; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kreunin P, 2007, PROTEOMICS, V7, P299, DOI 10.1002/pmic.200600272; Kukreja P, 2005, CANCER RES, V65, P9891, DOI 10.1158/0008-5472.CAN-05-1293; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Mehta SA, 2007, ONCOGENE, V26, P3329, DOI 10.1038/sj.onc.1210120; Monks NR, 2006, J CELL BIOCHEM, V98, P221, DOI 10.1002/jcb.20789; Mukhina S, 2000, J BIOL CHEM, V275, P16450, DOI 10.1074/jbc.M909080199; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Palkowitsch L, 2008, J BIOL CHEM, V283, P76, DOI 10.1074/jbc.M708856200; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Patel NM, 2000, ONCOGENE, V19, P4159, DOI 10.1038/sj.onc.1203768; Pencil SD, 1998, CLIN EXP METASTAS, V16, P113, DOI 10.1023/A:1021917017109; Perretti M, 2003, NEWS PHYSIOL SCI, V18, P60, DOI 10.1152/nips.01424.2002; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Shen DJ, 2006, HUM PATHOL, V37, P1583, DOI 10.1016/j.humpath.2006.06.001; Shen DJ, 2005, BIOCHEM BIOPH RES CO, V326, P218, DOI 10.1016/j.bbrc.2004.10.214; Strieter RM, 2001, NAT IMMUNOL, V2, P285, DOI 10.1038/86286; Wetterwald A, 2002, AM J PATHOL, V160, P1143, DOI 10.1016/S0002-9440(10)64934-6; Zhang ZQ, 2010, CANCER RES, V70, P2379, DOI 10.1158/0008-5472.CAN-09-4204	37	91	93	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2011	30	28					3174	3185		10.1038/onc.2011.28	http://dx.doi.org/10.1038/onc.2011.28			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	792FQ	21383699				2022-12-25	WOS:000292726300006
J	Jiang, Y; Scott, KL; Kwak, SJ; Chen, R; Mardon, G				Jiang, Y.; Scott, K. L.; Kwak, S-J; Chen, R.; Mardon, G.			Sds22/PP1 links epithelial integrity and tumor suppression via regulation of myosin II and JNK signaling	ONCOGENE			English	Article						tumor suppressor; epithelial integrity; cell invasion; sds22; protein phosphatase 1	PROTEIN PHOSPHATASE-1; CELL POLARITY; NONMUSCLE MYOSIN; MATRIX METALLOPROTEINASES; DROSOPHILA-MELANOGASTER; NEURAL DEVELOPMENT; INDUCED APOPTOSIS; GENETIC MOSAICS; IMAGINAL DISCS; CANCER	Loss of epithelial integrity often correlates with the progression of malignant tumors. Sds22, a regulatory subunit of protein phosphatase 1 (PP1), has recently been linked to regulation of epithelial polarity in Drosophila. However, its role in tumorigenesis remains obscure. In this study, using Drosophila imaginal tissue as an in vivo model system, we show that sds22 is a new potential tumor suppressor gene in Drosophila. Without sds22, cells lose epithelial architecture, and become invasive and tumorigenic when combined with Ras overexpression; conversely, sds22 overexpression can largely suppress tumorigenic growth of Ras(V12)scrib(-/-) mutant cells. Mechanistically, we show that sds22 prevents cell invasion and metastasis by inhibiting myosin II and Jun N-terminal kinase (JNK) activity downstream of PP1. Loss of this inhibition causes cells to lose epithelial organization and promotes cell invasion. Finally, human Sds22 is focally deleted and downregulated in multiple carcinomas, and this downregulation correlates with tumor progression, suggesting that sds22 inactivation may contribute to tumorigenesis and metastatic potential in human cancers via a similar mechanism. Oncogene (2011) 30, 3248-3260; doi:10.1038/onc.2011.46; published online 14 March 2011	[Jiang, Y.; Scott, K. L.; Chen, R.; Mardon, G.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Kwak, S-J; Mardon, G.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Chen, R.; Mardon, G.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Chen, R.; Mardon, G.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Mardon, G.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Mardon, G.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Mardon, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	gmardon@bcm.edu			National Eye Institute [R01 EY011232, EY016853]; Retina Research Foundation; NATIONAL EYE INSTITUTE [R01EY016853, R01EY011232] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Retina Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Andreas Bergmann, Yasuyoshi Nishida, Tian Xu, the Bloomington Stock Center, VDRC, and the DSHB for stocks and antibodies. We especially thank Georg Halder, Rui Chen, Mardelle Atkins, Umesh Karandikar, and Nicholas Justice for helpful comments on the manuscript. This work was supported by the National Eye Institute (R01 EY011232 [GM] and EY016853 [RC]) and the Retina Research Foundation (GM).	AGRAWAL N, 1995, DEV BIOL, V172, P218, DOI 10.1006/dbio.1995.0017; Beaucher M, 2007, DEV BIOL, V303, P625, DOI 10.1016/j.ydbio.2006.12.001; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bennett D, 2006, J MOL BIOL, V364, P196, DOI 10.1016/j.jmb.2006.08.094; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Cengiz B, 2007, ORAL ONCOL, V43, P241, DOI 10.1016/j.oraloncology.2006.03.004; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Ceulemans H, 2002, J BIOL CHEM, V277, P47331, DOI 10.1074/jbc.M206838200; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; DOMBRADI V, 1990, EUR J BIOCHEM, V194, P739, DOI 10.1111/j.1432-1033.1990.tb19464.x; DOMBRADI V, 1993, EUR J BIOCHEM, V212, P177, DOI 10.1111/j.1432-1033.1993.tb17648.x; Dow LE, 2007, INT REV CYTOL, V262, P253, DOI 10.1016/S0074-7696(07)62006-3; Grusche FA, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-14; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Jasper H, 2001, DEV CELL, V1, P579, DOI 10.1016/S1534-5807(01)00045-4; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; Kirchner J, 2007, GENETICS, V175, P1741, DOI 10.1534/genetics.106.067488; Kirchner J, 2007, GENETICS, V176, P273, DOI 10.1534/genetics.106.069914; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Llano E, 2000, J BIOL CHEM, V275, P35978, DOI 10.1074/jbc.M006045200; MACKELVIE SH, 1995, MOL CELL BIOL, V15, P3777; Martin FA, 2009, INT J DEV BIOL, V53, P1341, DOI 10.1387/ijdb.072447fm; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; Narayan G, 2003, ONCOGENE, V22, P3489, DOI 10.1038/sj.onc.1206432; Newsome TP, 2000, DEVELOPMENT, V127, P851; OHKURA H, 1991, CELL, V64, P149, DOI 10.1016/0092-8674(91)90216-L; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pepple KL, 2008, DEVELOPMENT, V135, P4071, DOI 10.1242/dev.028951; Pohar N, 1999, GENOMICS, V57, P293, DOI 10.1006/geno.1999.5776; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Shao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009938; Singh J, 2010, ONCOGENE, V29, P4033, DOI 10.1038/onc.2010.155; Smith DP, 1999, NEURON, V22, P203, DOI 10.1016/S0896-6273(00)81078-8; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; STONE EM, 1993, CURR BIOL, V3, P13, DOI 10.1016/0960-9822(93)90140-J; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Traweger A, 2008, P NATL ACAD SCI USA, V105, P10402, DOI 10.1073/pnas.0804102105; Uhlirova M, 2005, P NATL ACAD SCI USA, V102, P13123, DOI 10.1073/pnas.0504170102; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Vereshchagina N, 2004, MOL BIOL CELL, V15, P4395, DOI 10.1091/mbc.E04-02-0139; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Winter SL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-85; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; XU T, 1993, DEVELOPMENT, V117, P1223; Young MRI, 1997, ADV EXP MED BIOL, V407, P311; Zhu MW, 2010, CELL RES, V20, P242, DOI 10.1038/cr.2010.2	64	24	24	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2011	30	29					3248	3260		10.1038/onc.2011.46	http://dx.doi.org/10.1038/onc.2011.46			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	795VW	21399659	Green Accepted			2022-12-25	WOS:000293006800004
J	Jiffar, T; Yilmaz, T; Lee, J; Hanna, E; El-Naggar, A; Yu, D; Myers, JN; Kupferman, ME				Jiffar, T.; Yilmaz, T.; Lee, J.; Hanna, E.; El-Naggar, A.; Yu, D.; Myers, J. N.; Kupferman, M. E.			KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma	ONCOGENE			English	Article						head and neck squamous cell carcinoma; KiSS1; chemotherapy resistance; cisplatin; metastasis	NF-KAPPA-B; CISPLATIN-INDUCED APOPTOSIS; S-TRANSFERASE-PI; GENE-EXPRESSION; OVARIAN-CANCER; IMMUNOHISTOCHEMICAL EXPRESSION; POLY(ADP-RIBOSE) POLYMERASE; FUNCTIONAL-CHARACTERIZATION; LUNG-CANCER; P53 GENE	Although surgery and radiotherapy have been the standard treatment modalities for head and neck squamous cell carcinoma (HNSCC), the integration of cisplatin (CDDP)-based therapy has led to improvements in local and regional control of disease for patients. However, many trials show that only 10-20% of patients benefit from this treatment intensification, which can result in profound treatment-associated morbidity and mortality. Moreover, the marginal survival improvement suggests that CDDP resistance is an innate characteristic of HNSCC. To elucidate the biological mechanisms underpinning CDDP resistance in HNSCC, we utilized an experimental model of CDDP resistance in this disease. We first observed significant enhancements in local tumor growth and metastasis, as well as adverse survival, in CDDP-resistant (CR) tumors compared with sensitive tumors. To elucidate the molecular mechanisms of this phenotype, we undertook a systems biology-based approach utilizing high-throughput PCR arrays, and we identified a significant suppression of KiSS1 mRNA and protein expression in the CR cells, but no significant regions of genomic loss with array comparative genomic hybridization. Genetic suppression of KiSS1 in CDDP-sensitive cell lines rendered them CR, an observation that was mechanistically linked to alterations in glutathione S-transferase-pi expression and function. We next confirmed that, in human HNSCC tumors, loss of KiSS1 expression was associated with metastatic human HNSCC tumors compared with non-metastatic tumors. Genetic reconstitution of KiSS1 in CR cells abrogated cellular migration and induced CDDP sensitivity. To confirm these findings in a murine model, either CR or KiSS1-transfected CR cells were studied in an orthotopic model of HNSCC, or survival studies revealed significant improvement in survival of the mice bearing CR-KiSS1 tumors. Mechanistically, alterations in apoptotic pathways and CDDP metabolism contributed to KiSS1-associated chemotherapy sensitization. These studies provided further direct evidence for the role of KiSS1 loss in biologically aggressive HNSCC and suggest potential targets for therapy in CR cancers. Oncogene (2011) 30, 3163-3173; doi:10.1038/onc.2011.39; published online 7 March 2011	[Jiffar, T.; Yilmaz, T.; Lee, J.; Hanna, E.; Myers, J. N.; Kupferman, M. E.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surgery Holcombe 1515, Houston, TX 77030 USA; [El-Naggar, A.] Dept Pathol 1515 Holcombe, Houston, TX USA; [Yu, D.] Dept Mol & Cellular Oncol 1515 Holcombe, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center	Kupferman, ME (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surgery Holcombe 1515, 1400 Pressler St,Unit 1445, Houston, TX 77030 USA.	mekupfer@mdanderson.org	Lee, Jack/P-7331-2019; Hanna, Ehab Y/B-1593-2017	Lee, Jack/0000-0002-4584-929X; Hanna, Ehab Y/0000-0003-3241-2440; Lee, J. Jack/0000-0001-5469-9214; Yu, Dihua/0000-0001-6231-9381	NIH [K08-DE019185]; Triological Society; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE019185] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Triological Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Yongxiang Li BS for technical assistance and Terri Astin for administrative assistance. We also thank the members of the Small Animal Imaging Facility for their assistance with the mouse studies, Taylor Appleberry for assistance with the array CGH studies and Dr Douglas Boyd (MDACC) for providing the KiSS1 construct. This work is supported by the following funding sources: NIH Grant K08-DE019185 (MEK), Triological Society Career Development Award (MEK), MD Anderson	Antoun G, 2000, J CELL BIOCHEM, V77, P372, DOI 10.1002/(SICI)1097-4644(20000601)77:3<372::AID-JCB3>3.0.CO;2-P; Arai T, 2000, CANCER DETECT PREV, V24, P252; Bai F, 1996, CANCER, V78, P416; Chanvorachote P, 2006, CANCER RES, V66, P6353, DOI 10.1158/0008-5472.CAN-05-4533; Cho SG, 2009, CANCER RES, V69, P7062, DOI 10.1158/0008-5472.CAN-09-0476; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Cullen KJ, 2003, CANCER RES, V63, P8097; Di Pietro G, 2010, EXPERT OPIN DRUG MET, V6, P153, DOI 10.1517/17425250903427980; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Ganjavi H, 2005, CANCER GENE THER, V12, P397, DOI 10.1038/sj.cgt.7700798; Goldberg SF, 2003, CANCER RES, V63, P432; HAMAGUCHI K, 1993, CANCER RES, V53, P5225; Hu HB, 2005, CLIN CANCER RES, V11, P2379, DOI 10.1158/1078-0432.CCR-04-2084; Jiang Y, 2005, CLIN EXP METASTAS, V22, P369, DOI 10.1007/s10585-005-8186-4; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Khan K, 2010, HEAD NECK-J SCI SPEC, V32, P381, DOI 10.1002/hed.21195; Kigawa J, 2000, ADV EXP MED BIOL, V465, P207; Kim SJ, 2010, J MOL MED, V88, P1123, DOI 10.1007/s00109-010-0652-z; Kupferman ME, 2010, ONCOGENE, V29, P2047, DOI 10.1038/onc.2009.486; Kupferman Michael E, 2009, J Exp Ther Oncol, V8, P117; Lee JH, 1997, CANCER RES, V57, P2384; Li XX, 2002, EXP HEMATOL, V30, P285, DOI 10.1016/S0301-472X(02)00777-4; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Lo HW, 2008, MOL CANCER RES, V6, P843, DOI 10.1158/1541-7786.MCR-07-2105; Marot D, 2007, ENDOCR-RELAT CANCER, V14, P691, DOI 10.1677/ERC-07-0012; Masanek U, 1997, ANTI-CANCER DRUG, V8, P189, DOI 10.1097/00001813-199702000-00010; Michaud WA, 2009, CLIN CANCER RES, V15, P1645, DOI 10.1158/1078-0432.CCR-08-2581; Mitchell DC, 2007, ONCOGENE, V26, P1739, DOI 10.1038/sj.onc.1209963; Moffat GJ, 1996, J BIOL CHEM, V271, P20740, DOI 10.1074/jbc.271.34.20740; Morceau F, 2004, BIOCHEM PHARMACOL, V67, P1227, DOI 10.1016/j.bcp.2003.10.036; Nash KT, 2007, JNCI-J NATL CANCER I, V99, P309, DOI 10.1093/jnci/djk053; Nash KT, 2006, FRONT BIOSCI-LANDMRK, V11, P647, DOI 10.2741/1824; Navenot JM, 2009, MOL PHARMACOL, V75, P1300, DOI 10.1124/mol.109.055095; Navenot JM, 2009, MOL PHARMACOL, V75, P1074, DOI 10.1124/mol.108.054270; Niedner H, 2001, MOL PHARMACOL, V60, P1153, DOI 10.1124/mol.60.6.1153; O'Donnell RK, 2005, ONCOGENE, V24, P1244, DOI 10.1038/sj.onc.1208285; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Soussi T, 2007, ONCOGENE, V26, P2145, DOI 10.1038/sj.onc.1210280; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Stewart DJ, 2007, CRIT REV ONCOL HEMAT, V63, P12, DOI 10.1016/j.critrevonc.2007.02.001; SUNGGOOK C, 2009, J CELL BIOCHEM, V107, P1139; WELCH DR, 1994, ONCOGENE, V9, P255; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Yazlovitskaya EM, 2001, BIOCHEM BIOPH RES CO, V283, P732, DOI 10.1006/bbrc.2001.4849; Yilmaz T, 2010, CANCER BIOL THER, V10, P644, DOI 10.4161/cbt.10.6.12782	49	26	28	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2011	30	28					3163	3173		10.1038/onc.2011.39	http://dx.doi.org/10.1038/onc.2011.39			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	792FQ	21383688	Green Accepted			2022-12-25	WOS:000292726300005
J	Knauf, JA; Sartor, MA; Medvedovic, M; Lundsmith, E; Ryder, M; Salzano, M; Nikiforov, YE; Giordano, TJ; Ghossein, RA; Fagin, JA				Knauf, J. A.; Sartor, M. A.; Medvedovic, M.; Lundsmith, E.; Ryder, M.; Salzano, M.; Nikiforov, Y. E.; Giordano, T. J.; Ghossein, R. A.; Fagin, J. A.			Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGF beta signaling	ONCOGENE			English	Article						BRAF; TGF beta; epithelial-mesenchymal transition; thyroid	GROWTH-FACTOR-BETA; GENE-EXPRESSION DATA; FALSE DISCOVERY RATE; BRAF(V600E) MUTATION; HIGH PREVALENCE; CARCINOMA; CELLS; METASTASIS; ACTIVATION; MICE	Mice with thyroid-specific expression of oncogenic BRAF (Tg-Braf) develop papillary thyroid cancers (PTCs) that are locally invasive and have well-defined foci of poorly differentiated thyroid carcinoma (PDTC). To investigate the PTC-PDTC progression, we performed a microarray analysis using RNA from paired samples of PDTC and PTC collected from the same animals by laser capture microdissection. Analysis of eight paired samples revealed a profound deregulation of genes involved in cell adhesion and intracellular junctions, with changes consistent with an epithelial-mesenchymal transition (EMT). This was confirmed by immunohistochemistry, as vimentin expression was increased and E-cadherin lost in PDTC compared with adjacent PTC. Moreover, PDTC stained positively for phospho-Smad2, suggesting a role for transforming growth factor (TGF)beta in mediating this process. Accordingly, TGF beta-induced EMT in primary cultures of thyroid cells from Tg-Braf mice, whereas wild-type thyroid cells retained their epithelial features. TGF beta-induced Smad2 phosphorylation, transcriptional activity and induction of EMT required mitogen-activated protein kinase (MAPK) pathway activation in Tg-Braf thyrocytes. Hence, tumor initiation by oncogenic BRAF renders thyroid cells susceptible to TGF beta-induced EMT, through a MAPK-dependent process. Oncogene (2011) 30, 3153-3162; doi:10.1038/onc.2011.44; published online 7 March 2011	[Knauf, J. A.; Lundsmith, E.; Ryder, M.; Salzano, M.; Fagin, J. A.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Knauf, J. A.; Lundsmith, E.; Ryder, M.; Salzano, M.; Fagin, J. A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Sartor, M. A.; Medvedovic, M.] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA; [Nikiforov, Y. E.] Univ Cincinnati, Dept Pathol, Cincinnati, OH USA; [Giordano, T. J.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Ghossein, R. A.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center	Knauf, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10065 USA.	knaufj@mskcc.org	Sartor, Maureen/L-2902-2019	Salzano, Marcella/0000-0002-1856-8281; Giordano, Thomas/0000-0003-0641-8873; Knauf, Jeffrey/0000-0003-4456-8792	NIH [CA 50706]; Margot Rosenberg Pulitzer Foundation; NATIONAL CANCER INSTITUTE [R01CA050706, R29CA050706, R01CA072597] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Margot Rosenberg Pulitzer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH CA 50706, and a grant from the Margot Rosenberg Pulitzer Foundation. We are grateful to the MSKCC Genetically Engineered Mouse Phenotyping core facility and Dr Katia Manova of the MSKCC Molecular Cytology core for help with immunohistochemical experiments.	Ball DW, 2007, J CLIN ENDOCR METAB, V92, P4712, DOI 10.1210/jc.2007-1184; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bravo SB, 2003, ONCOGENE, V22, P7819, DOI 10.1038/sj.onc.1207029; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Depoortere F, 2000, MOL BIOL CELL, V11, P1061, DOI 10.1091/mbc.11.3.1061; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P3943, DOI 10.1210/jc.2008-0607; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; Franco AT, 2011, P NATL ACAD SCI USA, V108, P1615, DOI 10.1073/pnas.1015557108; Funaba M, 2002, J BIOL CHEM, V277, P41361, DOI 10.1074/jbc.M204597200; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Guo JH, 2004, TOXICOL APPL PHARM, V194, P79, DOI 10.1016/j.taap.2003.09.002; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Jechlinger M, 2002, J MAMMARY GLAND BIOL, V7, P415, DOI 10.1023/A:1024090116451; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kimura ET, 2003, CANCER RES, V63, P1454; Knauf JA, 2005, CANCER RES, V65, P4238, DOI 10.1158/0008-5472.CAN-05-0047; Leboeuf R, 2008, J CLIN ENDOCR METAB, V93, P2194, DOI 10.1210/jc.2007-2825; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Montero-Conde C, 2008, ONCOGENE, V27, P1554, DOI 10.1038/sj.onc.1210792; MORRIS JC, 1988, ENDOCRINOLOGY, V123, P1385, DOI 10.1210/endo-123-3-1385; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Namba H, 2003, J CLIN ENDOCR METAB, V88, P4393, DOI 10.1210/jc.2003-030305; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P5399, DOI 10.1210/jc.2003-030838; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Riesco-Eizaguirre G, 2009, CANCER RES, V69, P8317, DOI 10.1158/0008-5472.CAN-09-1248; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Saltman B, 2006, SURGERY, V140, P899, DOI 10.1016/j.surg.2006.07.027; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Sartor MA, 2010, BIOINFORMATICS, V26, P456, DOI 10.1093/bioinformatics/btp683; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Soares P, 2003, ONCOGENE, V22, P4578, DOI 10.1038/sj.onc.1206706; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; TSUSHIMA T, 1988, ENDOCRINOLOGY, V123, P1187, DOI 10.1210/endo-123-2-1187; Vasko V, 2007, P NATL ACAD SCI USA, V104, P2803, DOI 10.1073/pnas.0610733104; Weinberg RA, 2008, NAT CELL BIOL, V10, P1021, DOI 10.1038/ncb0908-1021; Wiseman SM, 2007, ARCH SURG-CHICAGO, V142, P717, DOI 10.1001/archsurg.142.8.717; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5	53	132	135	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2011	30	28					3153	3162		10.1038/onc.2011.44	http://dx.doi.org/10.1038/onc.2011.44			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	792FQ	21383698	Green Accepted			2022-12-25	WOS:000292726300004
J	de la Pena, FA; Kanasaki, K; Kanasaki, M; Tangirala, N; Maeda, G; Kalluri, R				de la Pena, Francisco Ayala; Kanasaki, Keizo; Kanasaki, Megumi; Tangirala, Neelima; Maeda, Genta; Kalluri, Raghu			Loss of p53 and Acquisition of Angiogenic MicroRNA Profile Are Insufficient to Facilitate Progression of Bladder Urothelial Carcinoma in Situ to Invasive Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITIONAL-CELL CARCINOMA; ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; MESENCHYMAL TRANSITION; CANCER; EXPRESSION; METASTASIS; VEGF; IDENTIFICATION; TUMORIGENESIS	Activation of oncogenes or inactivation of tumor suppressors in urothelium is considered critical for development of urothelial cancer. Here we report cloning of the urothelium-specific promoter uroplakin-II (UPK II) and generation of transgenic mice in which expression of SV40 large T antigen is driven by UPKII promoter. Inactivation of tumor suppressor p53 and pRb in urothelium by SV40 T antigen resulted in urothelial carcinoma, resembling human high-grade carcinoma in situ. Specific deletion of p53 in urothelial cells using the newly generated UPK II-Cre mice results in normal bladders without any evidence of cancer. The high-grade carcinoma in situ in the UPK II-SV40 mice is associated with significant activation of angiogenic signals consisting of hypoxia-inducible factor-1 alpha (HIF-1 alpha) and VEGF and a down-regulation of thrombospondin-1. Interestingly, such pro-angiogenic activity was not associated with progression to invasive cancer. Analysis of bladder-associated microRNAs in carcinoma in situ lesions reveals a pro-angiogenic profile, with specific overexpression of miR-18a and miR-19a and down-regulation of miR-107. A group of microRNAs (miRs) identified as associated with invasive human urothelial cancer remained unchanged in this mouse model. Collectively, our results support the notion that activation of angiogenesis and loss of p53 are not sufficient for progression to invasive cancer. Our studies identify a new mouse model for bladder cancer that can be used to study factors that determine progression to an invasive phenotype of bladder cancer.	[de la Pena, Francisco Ayala; Kanasaki, Keizo; Kanasaki, Megumi; Tangirala, Neelima; Maeda, Genta; Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; [Kalluri, Raghu] Harvard Univ, Sch Med, Harvard Mit Div Hlth Sci & Technol, Boston, MA 02215 USA; [Kalluri, Raghu] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kalluri, R (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA.	rkalluri@bidmc.harvard.edu	Ayala, Francisco/C-5280-2011; Kalluri, Raghu/E-2677-2015	Ayala, Francisco/0000-0001-6311-920X; Kalluri, Raghu/0000-0002-2190-547X	National Institutes of Health [DK62987, DK55001, AA13913, DK61688, CA125550]; Champalimaud Metastasis Program; Department of Medicine for the Division of Matrix Biology at Beth Israel Deaconess Medical Center; Ministry of Health, Spain; Health Service (SMS) from the Comunidad Autonoma of Murcia, Spain; NATIONAL CANCER INSTITUTE [R01CA125550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061688, R01DK055001, R01DK062987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Champalimaud Metastasis Program; Department of Medicine for the Division of Matrix Biology at Beth Israel Deaconess Medical Center; Ministry of Health, Spain(Spanish Government); Health Service (SMS) from the Comunidad Autonoma of Murcia, Spain; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK62987, DK55001, AA13913, DK61688, and CA125550 (to R. K.), the Champalimaud Metastasis Program, and funds from the Department of Medicine for the Division of Matrix Biology at Beth Israel Deaconess Medical Center.; Supported by Grant BAE-90057 from the Health Research Fund (FIS), Ministry of Health, Spain, and by the Health Service (SMS) from the Comunidad Autonoma of Murcia, Spain.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bochner BH, 1997, CLIN CANCER RES, V3, P1615; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Catalano A, 2002, ONCOGENE, V21, P2896, DOI 10.1038/sj.onc.1205382; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng J, 2003, CANCER RES, V63, P179; Cordon-Cardo C, 2008, SCAND J UROL NEPHROL, V42, P154, DOI 10.1080/03008880802291915; Crew JP, 1999, J UROLOGY, V161, P799, DOI 10.1016/S0022-5347(01)61772-5; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; Fauconnet S, 2009, ONCOL REP, V21, P1495, DOI 10.3892/or_00000380; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; Gao J, 2004, ONCOGENE, V23, P687, DOI 10.1038/sj.onc.1207169; Grossfeld GD, 1997, J NATL CANCER I, V89, P219, DOI 10.1093/jnci/89.3.219; He F, 2009, CANCER RES, V69, P9413, DOI 10.1158/0008-5472.CAN-09-2158; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Ioachim E, 2006, UROL INT, V77, P255, DOI 10.1159/000094819; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Izawa JI, 2001, ONCOL REP, V8, P9; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson Aimee M, 2008, BMC Urol, V8, P7, DOI 10.1186/1471-2490-8-7; Jones A, 2001, CLIN CANCER RES, V7, P1263; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Mitra AP, 2006, J CLIN ONCOL, V24, P5552, DOI 10.1200/JCO.2006.08.2073; Mo L, 2005, AM J PHYSIOL-RENAL, V289, pF562, DOI 10.1152/ajprenal.00368.2004; Neely LA, 2010, UROL ONCOL-SEMIN ORI, V28, P39, DOI 10.1016/j.urolonc.2008.06.006; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Ostenfeld MS, 2010, ONCOGENE, V29, P1073, DOI 10.1038/onc.2009.395; Palit V, 2005, ONCOL REP, V14, P909; Pasin Erik, 2008, Rev Urol, V10, P31; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; Sagol O, 2001, UROLOGY, V57, P895, DOI 10.1016/S0090-4295(01)00905-0; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stavropoulos NE, 2004, INT UROL NEPHROL, V36, P163, DOI 10.1023/B:UROL.0000034676.50636.e0; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Turner KJ, 2002, BRIT J CANCER, V86, P1276, DOI 10.1038/sj.bjc.6600215; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Zhang ZT, 1999, CANCER RES, V59, P3512	52	52	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20778	20787		10.1074/jbc.M110.198069	http://dx.doi.org/10.1074/jbc.M110.198069			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21388952	hybrid, Green Published			2022-12-25	WOS:000291267600063
J	Heise, RL; Stober, V; Cheluvaraju, C; Hollingsworth, JW; Garantziotis, S				Heise, Rebecca L.; Stober, Vandy; Cheluvaraju, Chaitra; Hollingsworth, John W.; Garantziotis, Stavros			Mechanical Stretch Induces Epithelial-Mesenchymal Transition in Alveolar Epithelia via Hyaluronan Activation of Innate Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; PULMONARY-FIBROSIS; TARGETED DISRUPTION; IN-VIVO; CELLS; MATRIX; CD44; DIFFERENTIATION; VENTILATION	Epithelial injury is a central event in the pathogenesis of many inflammatory and fibrotic lung diseases like acute respiratory distress syndrome, pulmonary fibrosis, and iatrogenic lung injury. Mechanical stress is an often underappreciated contributor to lung epithelial injury. Following injury, differentiated epithelia can assume a myofibroblast phenotype in a process termed epithelial to mesenchymal transition (EMT), which contributes to aberrant wound healing and fibrosis. We demonstrate that cyclic mechanical stretch induces EMT in alveolar type II epithelial cells, associated with increased expression of low molecular mass hyaluronan (sHA). We show that sHA is sufficient for induction of EMT in statically cultured alveolar type II epithelial cells and necessary for EMT during cell stretch. Furthermore, stretch-induced EMT requires the innate immune adaptor molecule MyD88. We examined the Wnt/beta-catenin pathway, which is known to mediate EMT. The Wnt target gene Wnt-inducible signaling protein 1 (wisp-1) is significantly up-regulated in stretched cells in hyaluronan- and MyD88-dependent fashion, and blockade of WISP-1 prevents EMT in stretched cells. In conclusion, we show for the first time that innate immunity transduces mechanical stress responses through the matrix component hyaluronan, and activation of the Wnt/beta-catenin pathway.	[Heise, Rebecca L.; Stober, Vandy; Cheluvaraju, Chaitra; Garantziotis, Stavros] NIEHS, Lab Resp Biol, NIH, Res Triangle Pk, NC 27709 USA; [Hollingsworth, John W.] Duke Univ, Dept Med, Med Ctr, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University	Garantziotis, S (corresponding author), NIEHS, Lab Resp Biol, NIH, POB 12233,MD CU01, Res Triangle Pk, NC 27709 USA.	garantziotis@niehs.nih.gov	Garantziotis, Stavros/A-6903-2009; Heise, Rebecca/N-7797-2016	Garantziotis, Stavros/0000-0003-4007-375X; Heise, Rebecca/0000-0002-6602-6700	National Institutes of Health [ES016126]; Division of Intramural Research, NIEHS/National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZIAES102605, R01ES016126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, NIEHS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES016126 (to J. W. H.). This work was also supported by intramural funds from the Division of Intramural Research, NIEHS/National Institutes of Health (to S. G.).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akimoto T, 2005, BIOCHEM BIOPH RES CO, V329, P381, DOI 10.1016/j.bbrc.2005.01.136; Arnsdorf EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005388; Aytekin M, 2008, AM J PHYSIOL-LUNG C, V295, pL789, DOI 10.1152/ajplung.90306.2008; Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; Bannerman DD, 2003, AM J PHYSIOL-LUNG C, V284, pL899, DOI 10.1152/ajplung.00338.2002; Berthiaume Y, 1999, THORAX, V54, P150, DOI 10.1136/thx.54.2.150; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; BRENNAN NJ, 1983, THORAX, V38, P62, DOI 10.1136/thx.38.1.62; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Camara J, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-2; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Corvol H, 2009, INT J BIOCHEM CELL B, V41, P1643, DOI 10.1016/j.biocel.2009.02.009; Crapo J D, 1982, Am Rev Respir Dis, V125, P740; Dell'Accio F, 2003, EXP CELL RES, V287, P16, DOI 10.1016/S0014-4827(03)00036-3; Garantziotis S, 2008, AM J RESP CRIT CARE, V178, P939, DOI 10.1164/rccm.200803-386OC; Garantziotis S, 2010, AM J RESP CRIT CARE, V181, P666, DOI 10.1164/rccm.200903-0381OC; Garantziotis S, 2009, J BIOL CHEM, V284, P11309, DOI 10.1074/jbc.M802400200; Jansen JHW, 2010, J ORTHOP RES, V28, P390, DOI 10.1002/jor.20991; Janssens S, 2003, FEBS LETT, V548, P103, DOI 10.1016/S0014-5793(03)00747-6; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Lauer ME, 2008, J BIOL CHEM, V283, P26283, DOI 10.1074/jbc.M803350200; Lionetti V, 2005, CURR OPIN CRIT CARE, V11, P82, DOI 10.1097/00075198-200502000-00013; LWEBUGAMUKASA JS, 1991, AM REV RESPIR DIS, V144, P452, DOI 10.1164/ajrccm/144.2.452; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P403, DOI 10.1513/pats.200508-090JS; Mascarenhas MM, 2004, AM J RESP CELL MOL, V30, P51, DOI 10.1165/rcmb.2002-0167OC; Mummert ME, 2000, J EXP MED, V192, P769, DOI 10.1084/jem.192.6.769; Muto J, 2009, MOL IMMUNOL, V47, P449, DOI 10.1016/j.molimm.2009.08.026; Pedreira PR, 2008, AM J PHYSIOL-LUNG C, V295, pL820, DOI 10.1152/ajplung.90211.2008; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Savani RC, 2000, AM J RESP CELL MOL, V23, P475, DOI 10.1165/ajrcmb.23.4.3944; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Taliana L, 2006, MOL VIS, V12, P1233; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Toole BP, 2005, CELLS TISSUES ORGANS, V179, P66, DOI 10.1159/000084510; Treggiari MM, 2007, AM J RESP CRIT CARE, V176, P685, DOI 10.1164/rccm.200701-165OC; Tremblay LN, 2002, CRIT CARE MED, V30, P1693, DOI 10.1097/00003246-200208000-00003; Tschumperlin DJ, 1999, J APPL PHYSIOL, V86, P2026, DOI 10.1152/jappl.1999.86.6.2026; Vaneker M, 2008, ANESTHESIOLOGY, V109, P465, DOI 10.1097/ALN.0b013e318182aef1; Wang HX, 2008, MOL BIOL CELL, V19, P1519, DOI 10.1091/mbc.E07-08-0817; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wurfel Mark M, 2007, Proc Am Thorac Soc, V4, P77, DOI 10.1513/pats.200608-149JG; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	54	103	113	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17435	17444		10.1074/jbc.M110.137273	http://dx.doi.org/10.1074/jbc.M110.137273			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21398522	Green Published, hybrid			2022-12-25	WOS:000290585200005
J	Mitra, R; Guo, ZJ; Milani, M; Mesaros, C; Rodriguez, M; Nguyen, J; Luo, XH; Clarke, D; Lamba, J; Schuetz, E; Donner, DB; Puli, N; Falck, JR; Capdevila, J; Gupta, K; Blair, IA; Potter, DA				Mitra, Ranjana; Guo, Zhijun; Milani, Monica; Mesaros, Clementina; Rodriguez, Mariangellys; Nguyen, Julia; Luo, Xianghua; Clarke, Duncan; Lamba, Jatinder; Schuetz, Erin; Donner, David B.; Puli, Narender; Falck, John R.; Capdevila, Jorge; Gupta, Kalpna; Blair, Ian A.; Potter, David A.			CYP3A4 Mediates Growth of Estrogen Receptor-positive Breast Cancer Cells in Part by Inducing Nuclear Translocation of Phospho-Stat3 through Biosynthesis of (+/-)-14, 15-Epoxyeicosatrienoic Acid (EET)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; EPOXYEICOSATRIENOIC ACIDS; RECOMBINANT ENZYMES; EPOXIDE HYDROLASE; MOLECULAR-CLONING; CELLULAR FUNCTION; LIVER-MICROSOMES; CARCINOMA LINES; C-SRC; CYTOCHROME-P450	CYP3A4 expression in breast cancer correlates with decreased overall survival, but the mechanisms are unknown. Cytochrome P450 gene profiling by RNAi silencing demonstrates that CYP3A or 2C8 gene expression is specifically required for growth of the breast cancer lines MCF7, T47D, and MDA-MB-231. CYP3A4 silencing blocks the cell cycle at the G(2)/M checkpoint and induces apoptosis in the MCF7 line, thereby inhibiting anchorage-dependent growth and survival. CYP3A4 was profiled for NADPH-dependent arachidonic acid (AA) metabolism and synthesized AA epoxygenase products (+/-)-8,9-, (+/-)-11,12-, and (+/-)-14,15-epoxyeicosatrienoic acid (EET) (total turnover of similar to 2 pmol/pmol CYP3A4/min) but not hydroxylase products (+/-)-15-, (+/-)-19-, or 20-hydroxyeicosatetraenoic acid. Furthermore, eicosanoid profiling revealed that MCF7 cells synthesize EETs in a CYP3A4-dependent manner. The (+/-)-14,15-EET regioisomer selectively rescues breast cancer cells from CYP3A4 silencing in a concentration-dependent fashion and promotes mitogenesis and anchorage-dependent cloning. Stat3 (Tyr-705) phosphorylation was inhibited by CYP3A4 silencing, providing a potential mechanism for CYP3A4 involvement in breast cancer cell growth. Silencing Stat3 blocks breast cancer cell growth and abrogates (+/-)-14,15-EET-induced proliferation, indicating a Stat3 requirement for (+/-)-14,15-EET-mediated cell growth. Although silencing of CYP3A4 reduces nuclear Tyr(P)-705-Stat3, (+/-)-14,15-EET restores this signaling process and promotes Tyr(P)-705-Stat3 translocation to the nucleus, suggesting that (+/-)-14,15-EET may be involved in an autocrine/paracrine pathway driving cell growth. These studies indicate that CYP3A4 is a highly active AA epoxygenase that promotes Stat3-mediated breast cancer cell growth in part through (+/-)-14,15-EET biosynthesis. Furthermore, these studies indicate an essential role for Stat3 as a mediator of epoxygenase activity in breast cancer.	[Potter, David A.] Univ Minnesota, Div Hematol Oncol & Transplantat, Dept Med, Minneapolis, MN 55455 USA; [Mitra, Ranjana; Guo, Zhijun; Milani, Monica; Rodriguez, Mariangellys; Nguyen, Julia; Luo, Xianghua; Gupta, Kalpna; Potter, David A.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Mesaros, Clementina; Blair, Ian A.] Univ Penn, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Mesaros, Clementina; Blair, Ian A.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Luo, Xianghua] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Clarke, Duncan] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Lamba, Jatinder] Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Schuetz, Erin] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Donner, David B.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Puli, Narender; Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Biochem & Pharmacol, Dallas, TX 75390 USA; [Capdevila, Jorge] Vanderbilt Univ, Dept Med, Nashville, TN 37240 USA; [Capdevila, Jorge] Vanderbilt Ingram Canc Ctr, Nashville, TN 37240 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; Vanderbilt University	Potter, DA (corresponding author), Univ Minnesota, Div Hematol Oncol & Transplantat, Dept Med, 420 Delaware St SE,MMC 480, Minneapolis, MN 55455 USA.	dapotter@umn.edu	Falck, John R/B-3030-2011	Falck, John R/0000-0002-9219-7845; Mitra, Ranjana/0000-0001-9421-3610; Clarke, Duncan/0000-0002-7795-3294	National Institutes of Health [R01CA113570, R01CA091016, P30ES013508, P01DK038226, R01-GM31278, 1S10RR024618-01A1, R01 CA109582, P30CA077598]; Masonic Cancer Center, Flight Attendant Medical Research Institute [042257]; Susan G. Komen for the Cure Grants [BCTR0504012, KG090861]; Robert A. Welch Foundation; Fairview Foundation; NATIONAL CANCER INSTITUTE [R01CA091016, P30CA077598, R01CA113570, R01CA109582] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Masonic Cancer Center, Flight Attendant Medical Research Institute; Susan G. Komen for the Cure Grants(Susan G. Komen Breast Cancer Foundation); Robert A. Welch Foundation(The Welch Foundation); Fairview Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA113570, R01CA091016, P30ES013508, P01DK038226, R01-GM31278, and 1S10RR024618-01A1. This work was also supported by the Cancer Experimental Therapeutics Program of the Masonic Cancer Center, Flight Attendant Medical Research Institute Grant 042257, Susan G. Komen for the Cure Grants BCTR0504012 and KG090861, the Robert A. Welch Foundation, and a grant from the Dr. Barbara Bowers Oncology Fund of the Fairview Foundation.; Supported by National Institutes of Health Grant R01 CA109582.; Dr. Philip McGlave and the Division of Hematology/Oncology and Transplantation are gratefully acknowledged. We acknowledge the expert help of Drs. Stephen Hecht and Peter Villalta and the Analytical Biochemistry Core of the Masonic Cancer Center, University of Minnesota. We thank Drs. Bruce Hammock and Sung Hee Hwang for the epoxide hydrolase inhibitor 1471. We thank Drs. Carol Lange, Douglas Yee, Rory Remmel, David Flockhart, George Sledge, Harikrishna Nakshatri, Christy Orschell, Jacqueline Bromberg, and Faris Farassati for helpful advice on the studies. We are grateful to Michael Franklin for outstanding help with editing. The Masonic Cancer Center, University of Minnesota, was recipient of National Institutes of Health Grant P30CA077598.	Ayajiki K, 2003, HYPERTENS RES, V26, P237, DOI 10.1291/hypres.26.237; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bylund J, 1998, J PHARMACOL EXP THER, V284, P51; CAPDEVILA JH, 1991, METHOD ENZYMOL, V206, P441; Chen C, 2006, CURR NEUROVASC RES, V3, P171, DOI 10.2174/156720206778018767; Chen JK, 1999, J BIOL CHEM, V274, P4764, DOI 10.1074/jbc.274.8.4764; Chen JK, 1998, J BIOL CHEM, V273, P29254, DOI 10.1074/jbc.273.44.29254; Cheranov SY, 2008, BLOOD, V111, P5581, DOI 10.1182/blood-2007-11-126680; Dieudonne MN, 2002, BIOCHEM BIOPH RES CO, V293, P622, DOI 10.1016/S0006-291X(02)00205-X; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Enayetallah AE, 2006, J MOL HISTOL, V37, P133, DOI 10.1007/s10735-006-9050-9; Ernest CS, 2005, J PHARMACOL EXP THER, V312, P583, DOI 10.1124/jpet.104.075416; Gauthier KM, 2004, PHARMACOL RES, V49, P515, DOI 10.1016/j.phrs.2003.09.014; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Guo M, 2005, J PHARMACOL EXP THER, V315, P526, DOI 10.1124/jpet.105.088567; Haas S, 2006, INT J CANCER, V119, P1785, DOI 10.1002/ijc.21915; Jiang JG, 2005, CANCER RES, V65, P4707, DOI 10.1158/0008-5472.CAN-04-4173; Klaassen I, 2001, CLIN CANCER RES, V7, P1017; Lee SH, 2003, RAPID COMMUN MASS SP, V17, P2168, DOI 10.1002/rcm.1170; Li L, 2002, J BIOL CHEM, V277, P17397, DOI 10.1074/jbc.M109962200; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Ma J, 2003, J BIOL CHEM, V278, P29252, DOI 10.1074/jbc.M304196200; Mesaros C, 2009, J CHROMATOGR B, V877, P2736, DOI 10.1016/j.jchromb.2009.03.011; Murray GI, 2010, HISTOPATHOLOGY, V57, P202, DOI 10.1111/j.1365-2559.2010.03606.x; Nakano M, 2009, DRUG METAB DISPOS, V37, P2119, DOI 10.1124/dmd.109.028530; Nilsson UK, 2003, LIPIDS, V38, P1057, DOI 10.1007/s11745-006-1161-2; Pincheira R, 2008, J IMMUNOL, V181, P1288, DOI 10.4049/jimmunol.181.2.1288; RIFKIND AB, 1995, ARCH BIOCHEM BIOPHYS, V320, P380, DOI 10.1016/0003-9861(95)90023-3; Sevrioukova IF, 2010, P NATL ACAD SCI USA, V107, P18422, DOI 10.1073/pnas.1010693107; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Sirvent A, 2007, ONCOGENE, V26, P7313, DOI 10.1038/sj.onc.1210543; Smirnova IV, 2000, J BIOL CHEM, V275, P9377, DOI 10.1074/jbc.275.13.9377; Smith G, 2003, LANCET, V361, P1336, DOI 10.1016/S0140-6736(03)13081-4; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Srirangam A, 2006, CLIN CANCER RES, V12, P1883, DOI 10.1158/1078-0432.CCR-05-1167; Stark K, 2008, FEBS J, V275, P3706, DOI 10.1111/j.1742-4658.2008.06518.x; Walsky RL, 2005, J CLIN PHARMACOL, V45, P68, DOI 10.1177/0091270004270642; Wu S, 1996, J BIOL CHEM, V271, P3460; Wu ZL, 2006, MOL PHARMACOL, V69, P2007, DOI 10.1124/mol.106.023648; ZELDIN DC, 1993, J BIOL CHEM, V268, P6402; ZELDIN DC, 1995, ARCH BIOCHEM BIOPHYS, V322, P76, DOI 10.1006/abbi.1995.1438; Zhang JH, 2007, ANAL BIOCHEM, V365, P40, DOI 10.1016/j.ab.2007.03.001; Zhao W, 2010, J BIOL CHEM, V285, P35855, DOI 10.1074/jbc.M110.154088	44	77	78	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17543	17559		10.1074/jbc.M110.198515	http://dx.doi.org/10.1074/jbc.M110.198515			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21402692	hybrid, Green Published			2022-12-25	WOS:000290585200017
J	Pryde, KR; Hirst, J				Pryde, Kenneth R.; Hirst, Judy			Superoxide Is Produced by the Reduced Flavin in Mitochondrial Complex I A SINGLE, UNIFIED MECHANISM THAT APPLIES DURING BOTH FORWARD AND REVERSE ELECTRON TRANSFER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN SPECIES GENERATION; IRON-SULFUR CLUSTERS; UBIQUINONE-OXIDOREDUCTASE; OXIDATIVE PHOSPHORYLATION; HEART-MITOCHONDRIA; HYDROGEN-PEROXIDE; SUBMITOCHONDRIAL PARTICLES; NADH; REDUCTION; DEHYDROGENASE	NADH:ubiquinone oxidoreductase (complex I) is a major source of reactive oxygen species in mitochondria and a contributor to cellular oxidative stress. In isolated complex I the reduced flavin is known to react with molecular oxygen to form predominantly superoxide, but studies using intact mitochondria contend that superoxide may result from a semiquinone species that responds to the proton-motive force (Delta p) also. Here, we use bovine heart submitochondrial particles to show that a single mechanism describes superoxide production by complex I under all conditions (during both NADH oxidation and reverse electron transfer). NADH-induced superoxide production is inhibited by complex I flavin-site inhibitors but not by inhibitors of ubiquinone reduction, and it is independent of Delta p. Reverse electron transfer (RET) through complex I in submitochondrial particles, driven by succinate oxidation and the Delta p created by ATP hydrolysis, reduces the flavin, leading to NAD(+) and O-2 reduction. RET-induced superoxide production is inhibited by both flavin-site and ubiquinone-reduction inhibitors. The potential dependence of NADH-induced superoxide production (set by the NAD(+) potential) matches that of RET-induced superoxide production (set by the succinate potential and Delta p), and they both match the potential dependence of the flavin. Therefore, both NADH- and RET-induced superoxide are produced by the flavin, according to the same molecular mechanism. The unified mechanism describes how reactive oxygen species production by complex I responds to changes in cellular conditions. It establishes a route to understanding causative connections between the enzyme and its pathological effects and to developing rational strategies for addressing them.	[Pryde, Kenneth R.; Hirst, Judy] Med Res Council Mitochondrial Biol Unit, Cambridge CB2 0XY, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Hirst, J (corresponding author), Med Res Council Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	jh@mrc-mbu.cam.ac.uk	Hirst, Judy/F-4803-2011	Hirst, Judy/0000-0001-8667-6797	Medical Research Council; Medical Research Council [MC_U105663141] Funding Source: researchfish; MRC [MC_U105663141] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council.	Aon MA, 2010, BBA-BIOENERGETICS, V1797, P865, DOI 10.1016/j.bbabio.2010.02.016; AZZI A, 1975, BIOCHEM BIOPH RES CO, V65, P597, DOI 10.1016/S0006-291X(75)80188-4; BASHFORD CL, 1977, J BIOL CHEM, V252, P8459; BELTRAN C, 1984, EUR J BIOCHEM, V144, P151, DOI 10.1111/j.1432-1033.1984.tb08443.x; Biason JV, 2011, J MOL BIOL, V406, P443, DOI 10.1016/j.jmb.2010.12.025; Birrell JA, 2009, BIOCHEMISTRY-US, V48, P12005, DOI 10.1021/bi901706w; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; CHANCE B, 1960, NATURE, V185, P666, DOI 10.1038/185666a0; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Grivennikova VG, 2010, BBA-BIOENERGETICS, V1797, P939, DOI 10.1016/j.bbabio.2010.02.013; HANSEN M, 1964, BIOCHIM BIOPHYS ACTA, V81, P214, DOI 10.1016/0926-6569(64)90036-7; HILLE R, 1981, J BIOL CHEM, V256, P9090; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Hirst J, 2010, BIOCHEM J, V425, P327, DOI 10.1042/BJ20091382; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; JAULT JM, 1993, J BIOL CHEM, V268, P1558; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; Kotlyar AB, 2005, FEBS LETT, V579, P4861, DOI 10.1016/j.febslet.2005.07.076; KOTLYAR AB, 1984, BIOCHIM BIOPHYS ACTA, V784, P24, DOI 10.1016/0167-4838(84)90168-7; KSENZENKO M, 1983, FEBS LETT, V155, P19, DOI 10.1016/0014-5793(83)80200-2; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lambert AJ, 2008, BBA-BIOENERGETICS, V1777, P397, DOI 10.1016/j.bbabio.2008.03.005; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; LINNANE AW, 1958, BIOCHIM BIOPHYS ACTA, V29, P630, DOI 10.1016/0006-3002(58)90021-0; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; MAJANDER A, 1994, J BIOL CHEM, V269, P21037; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; ORR GA, 1984, ANAL BIOCHEM, V142, P232, DOI 10.1016/0003-2697(84)90544-X; PULLMAN ME, 1960, J BIOL CHEM, V235, P3322; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Reda T, 2008, BIOCHEMISTRY-US, V47, P8885, DOI 10.1021/bi800437g; ROTTENBERG H, 1975, BIOCHEMISTRY-US, V14, P2675, DOI 10.1021/bi00683a017; Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107; Selivanov VA, 2008, J BIOL CHEM, V283, P29292, DOI 10.1074/jbc.M801019200; SLED VD, 1994, BIOCHEMISTRY-US, V33, P10069, DOI 10.1021/bi00199a034; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; SORGATO MC, 1978, BIOCHEM J, V174, P237, DOI 10.1042/bj1740237; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Treberg JR, 2010, FEBS J, V277, P2766, DOI 10.1111/j.1742-4658.2010.07693.x; Vinogradov AD, 2005, BIOCHEMISTRY-MOSCOW+, V70, P120, DOI 10.1007/s10541-005-0090-7; Votyakova TV, 2004, ARCH BIOCHEM BIOPHYS, V431, P138, DOI 10.1016/j.abb.2004.07.025; Yakovlev G, 2007, BIOCHEMISTRY-US, V46, P14250, DOI 10.1021/bi7017915; Zharova TV, 1997, BBA-BIOENERGETICS, V1320, P256, DOI 10.1016/S0005-2728(97)00029-7; Zoccarato F, 2007, BIOCHEM J, V406, P125, DOI 10.1042/BJ20070215	48	198	207	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18056	18065		10.1074/jbc.M110.186841	http://dx.doi.org/10.1074/jbc.M110.186841			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21393237	Green Published, hybrid			2022-12-25	WOS:000290585200067
J	Alvarez, Y; Municio, C; Hugo, E; Zhu, J; Alonso, S; Hu, XY; Fernandez, N; Crespo, MS				Alvarez, Yolanda; Municio, Cristina; Hugo, Etzel; Zhu, Jimmy; Alonso, Sara; Hu, Xiaoyu; Fernandez, Nieves; Sanchez Crespo, Mariano			Notch- and Transducin-like Enhancer of Split (TLE)-dependent Histone Deacetylation Explain Interleukin 12 (IL-12) p70 Inhibition by Zymosan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROTEIN KINASE-1 MSK1; HUMAN DENDRITIC CELLS; TOLL-LIKE RECEPTOR-2; C-REL; GENE-EXPRESSION; BETA-GLUCANS; IL-23 P19; TRANSCRIPTIONAL ACTIVITY; DEPENDENT TRANSCRIPTION	The fungal analog zymosan induces IL-23 and low amounts of IL-12 p70. This study addresses the molecular mechanisms underlying this cytokine pattern in human monocyte-derived dendritic cells. The transcriptional regulation of il23a, one of the chains of IL-23, depended on the activation of c-Rel and histone H3 phosphorylation, as judged from the association of c-Rel with the il23a promoter and the correlation between IL-23 production and Ser-10-histone H3 phosphorylation. Consistent with its reduced ability to produce IL-12 p70, zymosan induced a transient occupancy of the il12a promoter by c-Rel, blocked the production of IL-12 p70 and the transcription of il12a induced by other stimuli, and triggered the expression and nuclear translocation of the transcriptional repressors of the Notch family hairy and enhancer of split (Hes)-1, Hes5, hairy/enhancer-of-split related with YRPW motif protein (Hey)-1, and transducin-like enhancer of split (TLE). Zymosan also induced the interaction of Hes1 and TLE with histone H3 phosphorylated on Ser-10 and deacetylated on Lys-14. Inhibition of class III histone deacetylases increased the production of IL-12 p70 and partially blunted the inhibitory effect of zymosan on the production of IL-12 p70 elicited by LPS and IFN-gamma. These results indicate that the selective induction of IL-23 by beta-glucans is explained by the activation of c-Rel associated with Ser-10-histone H3 phosphorylation in the il23a promoter mediated by mitogen-and stress-activated kinase and/or protein kinase A and inhibition of il12a transcription by a mechanism involving activation of several corepressors with the ability to bind TLE and to promote histone deacetylation.	[Alvarez, Yolanda; Municio, Cristina; Hugo, Etzel; Alonso, Sara; Sanchez Crespo, Mariano] Inst Biol & Genet Mol, Consejo Super Invest Cientif, Valladolid 47003, Spain; [Zhu, Jimmy; Hu, Xiaoyu] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Fernandez, Nieves] Univ Valladolid, Dept Bioquim & Biol Mol, Fac Med, E-47005 Valladolid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid	Crespo, MS (corresponding author), Inst Biol & Genet Mol, Consejo Super Invest Cientif, C Sanz & Fores 3, Valladolid 47003, Spain.	mscres@ibgm.uva.es	Hu, Xiaoyu/D-5403-2017; Fernández, Nieves/N-5426-2018; Alvarez, Yolanda/AAD-4964-2021; Municio, Cristina/D-2916-2019	Hu, Xiaoyu/0000-0002-4289-6998; Fernández, Nieves/0000-0002-9141-3956; Municio, Cristina/0000-0002-8552-8183; Alvarez, Yolanda/0000-0002-4851-8277; Sanchez Crespo, Mariano/0000-0002-6149-154X; zhu, jimmy/0000-0003-4957-8885	Plan Nacional de Salud y Farmacia [SAF2007-60446, SAF2010-15070]; Fundacion Ramon Areces, Red Tematica de Investigacion Cardiovascular; Junta de Castilla y Leon [GR230]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056729] Funding Source: NIH RePORTER	Plan Nacional de Salud y Farmacia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces, Red Tematica de Investigacion Cardiovascular; Junta de Castilla y Leon(Junta de Castilla y Leon); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Plan Nacional de Salud y Farmacia Grants SAF2007-60446 and SAF2010-15070, Fundacion Ramon Areces, Red Tematica de Investigacion Cardiovascular, and Junta de Castilla y Leon Grant GR230.	Al-Salleeh F, 2008, J IMMUNOL, V181, P4523, DOI 10.4049/jimmunol.181.7.4523; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Bode KA, 2007, IMMUNOLOGY, V122, P596, DOI 10.1111/j.1365-2567.2007.02678.x; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Cinnamon E, 2008, CURR OPIN GENET DEV, V18, P435, DOI 10.1016/j.gde.2008.07.010; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; DeManno DA, 1999, MOL ENDOCRINOL, V13, P91, DOI 10.1210/me.13.1.91; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Du ZM, 2006, J IMMUNOL, V176, P4785, DOI 10.4049/jimmunol.176.8.4785; Du ZM, 2005, P NATL ACAD SCI USA, V102, P10267, DOI 10.1073/pnas.0408854102; Feng D, 2010, J IMMUNOL, V185, P6003, DOI 10.4049/jimmunol.1000482; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Ghosh HS, 2007, BIOCHEM J, V408, P105, DOI 10.1042/BJ20070817; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Goriely S, 2006, BLOOD, V107, P1078, DOI 10.1182/blood-2005-06-2416; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Harokopakis E, 2005, EUR J IMMUNOL, V35, P1201, DOI 10.1002/eji.200425883; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09; Huang ZY, 2011, J BIOL CHEM, V286, P160, DOI 10.1074/jbc.M110.163030; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Ivashkiv LB, 2010, CELL HOST MICROBE, V8, P132, DOI 10.1016/j.chom.2010.07.011; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kollet JI, 2006, MOL IMMUNOL, V43, P623, DOI 10.1016/j.molimm.2005.04.004; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lemos HP, 2009, P NATL ACAD SCI USA, V106, P5954, DOI 10.1073/pnas.0812782106; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Liu WC, 2009, J BIOL CHEM, V284, P24006, DOI 10.1074/jbc.M109.025528; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Palaparti A, 1997, J BIOL CHEM, V272, P26604, DOI 10.1074/jbc.272.42.26604; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Smeekens SP, 2010, INT IMMUNOL, V22, P889, DOI 10.1093/intimm/dxq442; Snijders A, 1998, INT IMMUNOL, V10, P1593, DOI 10.1093/intimm/10.11.1593; Spooren A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/275892; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727; van Bruggen R, 2009, MOL IMMUNOL, V47, P575, DOI 10.1016/j.molimm.2009.09.018; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang JM, 2007, J IMMUNOL, V178, P6777, DOI 10.4049/jimmunol.178.11.6777; Wenink MH, 2009, J IMMUNOL, V183, P6960, DOI 10.4049/jimmunol.0900713; Yarmus M, 2006, P NATL ACAD SCI USA, V103, P7384, DOI 10.1073/pnas.0602470103; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoon C, 2008, J NEUROSCI, V28, P3738, DOI 10.1523/JNEUROSCI.4439-07.2008; Yu SH, 2004, J MOL MED, V82, P621, DOI 10.1007/s00109-004-0559-7; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	70	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16583	16595		10.1074/jbc.M111.222158	http://dx.doi.org/10.1074/jbc.M111.222158			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21402701	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000290301900007
J	Bimboese, P; Gibson, CJ; Schmidt, S; Xiang, WQ; Ehrlich, BE				Bimboese, Patricia; Gibson, Craig J.; Schmidt, Stefan; Xiang, Wanqing; Ehrlich, Barbara E.			Isoform-specific Regulation of the Inositol 1,4,5-Trisphosphate Receptor by O-Linked Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ACINAR-CELLS; III INSP(3) RECEPTOR; PROTEIN-KINASE-A; N-ACETYLGLUCOSAMINE; INSULIN-RESISTANCE; GLCNAC TRANSFERASE; HEXOSAMINE BIOSYNTHESIS; DIABETIC-RATS; BETA-CELLS; CALCIUM	The inositol 1,4,5-trisphosphate receptor (InsP(3)R), an intracellular calcium channel, has three isoforms with >65% sequence homology, yet the isoforms differ in their function and regulation by post-translational modifications. We showed previously that InsP(3)R-1 is functionally modified by O-linked beta-N-acetylglucosamine glycosylation (O-GlcNAcylation) (Rengifo, J., Gibson, C. J., Winkler, E., Collin, T., and Ehrlich, B. E. (2007) J. Neurosci. 27, 13813-13821). We now report the effect of O-GlcNAcylation on InsP(3)R-2 and InsP(3)R-3. Analysis of AR4-2J cells, a rat pancreatoma cell line expressing predominantly InsP(3)R-2, showed no detectable O-GlcNAcylation of InsP(3)R-2 and no significant functional changes despite the presence of the enzymes for addition (O-beta-N-acetylglucosaminyltransferase) and removal (O-beta-N-acetylglucosaminidase) of the monosaccharide. In contrast, InsP(3)R-3 in Mz-ChA-1 cells, a human cholangiocarcinoma cell line expressing predominantly InsP(3)R-3, was functionally modified by O-GlcNAcylation. Interestingly, the functional impact of O-GlcNAcylation on the InsP(3)R-3 channel was opposite the effect measured with InsP(3)R-1. Addition of O-GlcNAc by O-beta-N-acetylglucosaminyltransferase increased InsP(3)R-3 single channel open probability. Incubation of Mz-ChA-1 cells in hyperglycemic medium caused an increase in the InsP(3)-dependent calcium release from the endoplasmic reticulum. The dynamic and inducible nature of O-GlcNAcylation and the InsP(3)R isoform specificity suggest that this form of modification of InsP(3)R and subsequent changes in intracellular calcium transients are important in physiological and pathophysiological processes.	[Ehrlich, Barbara E.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University; Yale University	Ehrlich, BE (corresponding author), Yale Univ, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	barbara.ehrlich@yale.edu	/AAX-8408-2021; Bimboese, Patricia/ABA-1227-2021	/0000-0001-9657-9704; Bimboese, Patricia/0000-0003-3282-1762; Schmidt, Stefan/0000-0001-8590-6319	National Institutes of Health [DK57751, DK61747]; German National Merit Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057751, R01DK061747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German National Merit Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57751 and DK61747. This work was also supported by scholarships from the German National Merit Foundation (to P. B., S. S., and W. X.).	Akimoto Yoshihiro, 2005, Medical Molecular Morphology, V38, P84, DOI 10.1007/s00795-004-0264-1; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; DANIELS MC, 1993, MOL ENDOCRINOL, V7, P1041, DOI 10.1210/me.7.8.1041; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Forrest ARR, 2003, GENOME RES, V13, P1443, DOI 10.1101/gr.954803; FURUICHI T, 1995, J NEUROCHEM, V64, P953, DOI 10.1046/j.1471-4159.1995.64030953.x; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Futatsugi A, 1998, BIOCHEM J, V334, P559, DOI 10.1042/bj3340559; Gibson CJ, 2008, CELL CALCIUM, V43, P228, DOI 10.1016/j.ceca.2007.05.008; Hagar RE, 1998, NATURE, V396, P81, DOI 10.1038/23954; Hagar RE, 2000, BIOPHYS J, V79, P271, DOI 10.1016/S0006-3495(00)76289-8; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Kaznacheyeva E, 1998, J GEN PHYSIOL, V111, P847, DOI 10.1085/jgp.111.6.847; KORNFELD R, 1967, J BIOL CHEM, V242, P3135; Lee B, 1999, ENDOCRINOLOGY, V140, P2173, DOI 10.1210/en.140.5.2173; Lee B, 1998, J MOL ENDOCRINOL, V21, P31, DOI 10.1677/jme.0.0210031; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Marshall S, 2003, ANAL BIOCHEM, V314, P169, DOI 10.1016/S0003-2697(02)00686-3; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Minagawa N, 2005, J BIOL CHEM, V280, P33637, DOI 10.1074/jbc.M503210200; NATHANSON MH, 1994, J BIOL CHEM, V269, P4693; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Perez PJ, 1997, J BIOL CHEM, V272, P23961, DOI 10.1074/jbc.272.38.23961; Rengifo J, 2007, J NEUROSCI, V27, P13813, DOI 10.1523/JNEUROSCI.2069-07.2007; ROBINSON KA, 1995, DIABETES, V44, P1438, DOI 10.2337/diabetes.44.12.1438; Ryu Gyeong Ryul, 2004, Pancreas, V29, pe106, DOI 10.1097/00006676-200411000-00164; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sharma K, 1999, AM J PHYSIOL-RENAL, V276, pF54, DOI 10.1152/ajprenal.1999.276.1.F54; Slawson C, 2003, CURR OPIN STRUC BIOL, V13, P631, DOI 10.1016/j.sbi.2003.08.003; Sliter DA, 2011, J BIOL CHEM, V286, P1074, DOI 10.1074/jbc.M110.188383; Sliter DA, 2008, J BIOL CHEM, V283, P35319, DOI 10.1074/jbc.M807288200; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; Straub SV, 2002, J BIOL CHEM, V277, P31949, DOI 10.1074/jbc.M204318200; Tang TS, 2003, J NEUROSCI, V23, P403, DOI 10.1523/JNEUROSCI.23-02-00403.2003; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Vermassen E, 2004, BIOL CELL, V96, P3, DOI 10.1016/j.biolcel.2003.11.004; Wagner LE, 2008, J PHYSIOL-LONDON, V586, P3577, DOI 10.1113/jphysiol.2008.152314; Wagner LE, 2004, J BIOL CHEM, V279, P46242, DOI 10.1074/jbc.M405849200; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; WATRAS J, 1991, J NEUROSCI, V11, P3239; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; WOJCIKIEWICZ RJH, 1994, J BIOL CHEM, V269, P7963; Yamazaki H, 2010, J NUTR SCI VITAMINOL, V56, P1, DOI 10.3177/jnsv.56.1; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; YU Z, 1994, AM J PHYSIOL, V266, pH2334, DOI 10.1152/ajpheart.1994.266.6.H2334; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	67	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.206482	http://dx.doi.org/10.1074/jbc.M110.206482			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21383013	Green Published, hybrid			2022-12-25	WOS:000290022800008
J	Cappell, SD; Dohlman, HG				Cappell, Steven D.; Dohlman, Henrik G.			Selective Regulation of MAP Kinase Signaling by an Endomembrane Phosphatidylinositol 4-Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PHEROMONE RESPONSE PATHWAY; G-BETA-GAMMA; G-PROTEIN SUBUNITS; FILAMENTOUS GROWTH; PLASMA-MEMBRANE; ADAPTER PROTEIN; TRANSDUCTION PATHWAY; SCAFFOLD PROTEIN; BINDING DOMAINS	Multiple MAP kinase pathways share components yet initiate distinct biological processes. Signaling fidelity can be maintained by scaffold proteins and restriction of signaling complexes to discreet subcellular locations. For example, the yeast MAP kinase scaffold Ste5 binds to phospholipids produced at the plasma membrane and promotes selective MAP kinase activation. Here we show that Pik1, a phosphatidylinositol 4-kinase that localizes primarily to the Golgi, also regulates MAP kinase specificity but does so independently of Ste5. Pik1 is required for full activation of the MAP kinases Fus3 and Hog1 and represses activation of Kss1. Further, we show by genetic epistasis analysis that Pik1 likely regulates Ste11 and Ste50, components shared by all three MAP kinase pathways, through their interaction with the scaffold protein Opy2. These findings reveal a new regulator of signaling specificity functioning at endomembranes rather than at the plasma membrane.	[Dohlman, Henrik G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Cappell, Steven D.; Dohlman, Henrik G.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu	Cappell, Steven/O-4072-2018	Cappell, Steven/0000-0002-2885-7327; Dohlman, Henrik/0000-0003-2443-0729	National Institutes of Health [R01 GM059167, GM080739]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059167, R01GM080739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM059167 and GM080739.	Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cappell SD, 2010, MOL CELL, V38, P746, DOI 10.1016/j.molcel.2010.05.026; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; CHOI KY, 1994, CELL, V78, P499; COLE GM, 1990, MOL CELL BIOL, V10, P510, DOI 10.1128/MCB.10.2.510; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DORER R, 1995, J CELL BIOL, V131, P845, DOI 10.1083/jcb.131.4.845; Edwards MC, 1997, GENETICS, V147, P1063; Elion EA, 2001, J CELL SCI, V114, P3967; Erdman S, 2001, GENETICS, V159, P919; Galperin E, 2008, TRAFFIC, V9, P1776, DOI 10.1111/j.1600-0854.2008.00788.x; Garrenton LS, 2006, GENE DEV, V20, P1946, DOI 10.1101/gad.1413706; Garrenton LS, 2010, P NATL ACAD SCI USA, V107, P11805, DOI 10.1073/pnas.1005817107; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Hao N, 2008, J BIOL CHEM, V283, P33798, DOI 10.1074/jbc.C800179200; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Hirschman JE, 1999, MOL CELL BIOL, V19, P7705; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Homma K, 1998, J BIOL CHEM, V273, P15779, DOI 10.1074/jbc.273.25.15779; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; MARCUS S, 1994, P NATL ACAD SCI USA, V91, P7762, DOI 10.1073/pnas.91.16.7762; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; NOMOTO S, 1990, EMBO J, V9, P691, DOI 10.1002/j.1460-2075.1990.tb08161.x; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Posas F, 1998, MOL CELL BIOL, V18, P5788, DOI 10.1128/MCB.18.10.5788; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; RAD MR, 1992, MOL GEN GENET, V236, P145; Rad MR, 1998, MOL GEN GENET, V259, P29, DOI 10.1007/s004380050785; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; STEVENSON BJ, 1992, GENE DEV, V6, P1293, DOI 10.1101/gad.6.7.1293; STONE DE, 1991, GENE DEV, V5, P1969, DOI 10.1101/gad.5.11.1969; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Takahashi S, 2007, MOL BIOL CELL, V18, P4945, DOI 10.1091/mbc.E07-07-0676; Tatebayashi K, 2006, EMBO J, V25, P3033, DOI 10.1038/sj.emboj.7601192; Truckses DM, 2006, MOL CELL BIOL, V26, P912, DOI 10.1128/MCB.26.3.912-928.2006; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; van Drogen F, 2001, NAT CELL BIOL, V3, P1051, DOI 10.1038/ncb1201-1051; WHITEWAY M, 1990, MOL CELL BIOL, V10, P217, DOI 10.1128/MCB.10.1.217; Wild AC, 2004, J BIOL CHEM, V279, P17101, DOI 10.1074/jbc.M314035200; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Wu CL, 1999, MOL BIOL CELL, V10, P2425, DOI 10.1091/mbc.10.7.2425; Wu CL, 2006, GENE DEV, V20, P734, DOI 10.1101/gad.1375706; Xu G, 1996, MOL MICROBIOL, V20, P773, DOI 10.1111/j.1365-2958.1996.tb02516.x; Yamamoto K, 2010, MOL CELL, V40, P87, DOI 10.1016/j.molcel.2010.09.011; Yang HY, 2009, EMBO J, V28, P1380, DOI 10.1038/emboj.2009.104; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	65	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14852	14860		10.1074/jbc.M110.195073	http://dx.doi.org/10.1074/jbc.M110.195073			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388955	Green Published, hybrid			2022-12-25	WOS:000289788300015
J	Lee, DE; Lee, KW; Byun, S; Jung, SK; Song, N; Lim, SH; Heo, YS; Kim, JE; Kang, NJ; Kim, BY; Bowden, GT; Bode, AM; Lee, HJ; Dong, Z				Lee, Dong Eun; Lee, Ki Won; Byun, Sanguine; Jung, Sung Keun; Song, Nury; Lim, Sung Hwan; Heo, Yong-Seok; Kim, Jong Eun; Kang, Nam Joo; Kim, Bo Yeon; Bowden, G. Tim; Bode, Ann M.; Lee, Hyong Joo; Dong, Zigang			7,3 ',4 '-Trihydroxyisoflavone, a Metabolite of the Soy Isoflavone Daidzein, Suppresses Ultraviolet B-induced Skin Cancer by Targeting Cot and MKK4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE KINASE; MOUSE SKIN; OXIDATIVE-METABOLISM; COX-2 EXPRESSION; IN-VITRO; ACTIVATION; CARCINOGENESIS; GENISTEIN; PHOSPHORYLATION; PHYTOESTROGENS	Nonmelanoma skin cancer is one of the most frequently occurring cancers in the United States. Chronic exposure to UVB irradiation is a major cause of this cancer. Daidzein, along with genistein, is a major isoflavone found in soybeans; however, little is known about the chemopreventive effects of daidzein and its metabolites in UVB-induced skin cancer. Here, we found that 7,3',4'-trihydroxyisoflavone (THIF), a major metabolite of daidzein, effectively inhibits UVB-induced cyclooxygenase 2 (COX-2) expression through the inhibition of NF-kappa B transcription activity in mouse skin epidermal JB6 P+ cells. In contrast, daidzein had no effect on COX-2 expression levels. Data from Western blot and kinase assays showed that 7,3',4'-THIF inhibited Cot and MKK4 activity, thereby suppressing UVB-induced phosphorylation of mitogen-activated protein kinases. Pull-down assays indicated that 7,3',4' -THIF competed with ATP to inhibit Cot or MKK4 activity. Topical application of 7,3',4'-THIF clearly suppressed the incidence and multiplicity of UVB-induced tumors in hairless mouse skin. Hairless mouse skin results also showed that 7,3',4'-THIF inhibits Cot or MKK4 kinase activity directly, resulting in suppressed UVB-induced COX-2 expression. A docking study revealed that 7,3',4'-THIF, but not daidzein, easily docked to the ATP binding site of Cot and MKK4, which is located between the N-and C-lobes of the kinase domain. Collectively, these results provide insight into the biological actions of 7,3',4'-THIF, a potential skin cancer chemopreventive agent.	[Lee, Dong Eun; Lee, Ki Won; Byun, Sanguine; Jung, Sung Keun; Song, Nury; Kim, Jong Eun; Bode, Ann M.; Dong, Zigang] Seoul Natl Univ, Food Sci & Biotechnol Program, Seoul 151921, South Korea; [Lee, Dong Eun; Byun, Sanguine; Jung, Sung Keun; Song, Nury; Kim, Jong Eun] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Heo, Yong-Seok] Konkuk Univ, Dept Chem, Seoul 143701, South Korea; [Kang, Nam Joo] Kyungpook Natl Univ, Sch Food Sci & Biotechnol, Coll Agr & Life Sci, Taegu 702701, South Korea; [Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol, Choongbuk 363883, South Korea; [Bowden, G. Tim] Univ Arizona, Ctr Canc, Tucson, AZ 85724 USA	Seoul National University (SNU); University of Minnesota System; Konkuk University; Kyungpook National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Arizona	Lee, HJ (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151742, South Korea.	leehyjo@snu.ac.kr; zgdong@hi.umn.edu	Byun, Sanguine/AAR-5451-2021; kim, jong-eun/B-3550-2017; Heo, Yong-Seok/D-8244-2011; Lee, Ki Won/M-4114-2018	kim, jong-eun/0000-0002-5030-6126; Byun, Sanguine/0000-0003-3903-5887	Hormel Foundation; National Institutes of Health [CA077646, CA027502, CA111536, CA120388, R37CA081064, ES016548]; World Class University [R31-2008-00-10056-0]; World Class Institute [2009-0093824]; Leap Research Program [2010-0029233]; National Research Foundation of Korea [2009-0090797]; NATIONAL CANCER INSTITUTE [P01CA027502, R01CA120388, R37CA081064, R01CA111536, R01CA077646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class University; World Class Institute; Leap Research Program; National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported, in whole or in part, by The Hormel Foundation and National Institutes of Health Grants CA077646, CA027502, CA111536, CA120388, R37CA081064, and ES016548. This work was also supported by World Class University Program Grant R31-2008-00-10056-0, World Class Institute Program Grant 2009-0093824, Leap Research Program Grant 2010-0029233, and Basic Science Research Program Grant 2009-0090797 through the National Research Foundation of Korea.	Athar M, 2001, BIOCHEM BIOPH RES CO, V280, P1042, DOI 10.1006/bbrc.2000.4201; Babu G, 2006, J BIOL CHEM, V281, P14041, DOI 10.1074/jbc.M512375200; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Buckman SY, 1998, CARCINOGENESIS, V19, P723, DOI 10.1093/carcin/19.5.723; Chen N, 2008, PHOTOCHEM PHOTOBIOL, V84, P1551, DOI 10.1111/j.1751-1097.2008.00383.x; Choi HS, 2008, FASEB J, V22, P113, DOI 10.1096/fj.07-9078com; Cuenda A, 2000, INT J BIOCHEM CELL B, V32, P581, DOI 10.1016/S1357-2725(00)00003-0; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Jung SK, 2008, CANCER RES, V68, P6021, DOI 10.1158/0008-5472.CAN-08-0899; Kang NJ, 2008, J BIOL CHEM, V283, P20664, DOI 10.1074/jbc.M800263200; Katiyar SK, 1997, JNCI-J NATL CANCER I, V89, P556, DOI 10.1093/jnci/89.8.556; Krcova Z, 2008, BIOMED PAP, V152, P21, DOI 10.5507/bp.2008.003; Kulling SE, 2000, J AGR FOOD CHEM, V48, P4963, DOI 10.1021/jf000524i; Kulling SE, 2002, J CHROMATOGR B, V777, P211, DOI 10.1016/S1570-0232(02)00215-5; Kulling SE, 2001, J AGR FOOD CHEM, V49, P3024, DOI 10.1021/jf0012695; Lee HJ, 2009, PHYTOTHER RES, V23, P399, DOI 10.1002/ptr.2640; Mantena SK, 2006, FREE RADICAL BIO MED, V40, P1603, DOI 10.1016/j.freeradbiomed.2005.12.032; Marwaha V, 2005, J BIOL CHEM, V280, P32379, DOI 10.1074/jbc.M503245200; Moore JO, 2006, CARCINOGENESIS, V27, P1627, DOI 10.1093/carcin/bgi367; Muller-Decker K, 2007, MOL CARCINOGEN, V46, P705, DOI 10.1002/mc.20326; Muller-Decker K, 2002, P NATL ACAD SCI USA, V99, P12483, DOI 10.1073/pnas.192323799; Ouyang WM, 2007, ENVIRON HEALTH PERSP, V115, P513, DOI 10.1289/ehp.9588; Rundhaug JE, 2008, PHOTOCHEM PHOTOBIOL, V84, P322, DOI 10.1111/j.1751-1097.2007.00261.x; Stafford MJ, 2006, FEBS LETT, V580, P4010, DOI 10.1016/j.febslet.2006.06.004; Tiano HF, 2002, CANCER RES, V62, P3395; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Wittwer T, 2008, BIOCHEM BIOPH RES CO, V371, P294, DOI 10.1016/j.bbrc.2008.04.069; Yaomura T, 2008, NEPHROLOGY, V13, P397, DOI 10.1111/j.1440-1797.2008.00959.x	31	54	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14246	14256		10.1074/jbc.M110.147348	http://dx.doi.org/10.1074/jbc.M110.147348			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21378167	Green Published, hybrid			2022-12-25	WOS:000289556200048
J	Chiew, KS; Braver, TS				Chiew, Kimberly S.; Braver, Todd S.			Neural Circuitry of Emotional and Cognitive Conflict Revealed through Facial Expressions	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; EVENT-RELATED FMRI; PREFRONTAL CORTEX; SIGNIFICANT ACTIVATION; RELEVANCE DETECTION; WORKING-MEMORY; HUMAN AMYGDALA; VALENCE; REGIONS; SCHIZOPHRENIA	Background: Neural systems underlying conflict processing have been well studied in the cognitive realm, but the extent to which these overlap with those underlying emotional conflict processing remains unclear. A novel adaptation of the AX Continuous Performance Task (AX-CPT), a stimulus-response incompatibility paradigm, was examined that permits close comparison of emotional and cognitive conflict conditions, through the use of affectively-valenced facial expressions as the response modality. Methodology/Principal Findings: Brain activity was monitored with functional magnetic resonance imaging (fMRI) during performance of the emotional AX-CPT. Emotional conflict was manipulated on a trial-by-trial basis, by requiring contextually pre-cued facial expressions to emotional probe stimuli (IAPS images) that were either affectively compatible (low-conflict) or incompatible (high-conflict). The emotion condition was contrasted against a matched cognitive condition that was identical in all respects, except that probe stimuli were emotionally neutral. Components of the brain cognitive control network, including dorsal anterior cingulate cortex (ACC) and lateral prefrontal cortex (PFC), showed conflict-related activation increases in both conditions, but with higher activity during emotion conditions. In contrast, emotion conflict effects were not found in regions associated with affective processing, such as rostral ACC. Conclusions/Significance: These activation patterns provide evidence for a domain-general neural system that is active for both emotional and cognitive conflict processing. In line with previous behavioural evidence, greatest activity in these brain regions occurred when both emotional and cognitive influences additively combined to produce increased interference.	[Chiew, Kimberly S.; Braver, Todd S.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA	Washington University (WUSTL)	Chiew, KS (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	kschiew@wustl.edu		Chiew, Kimberly/0000-0003-3049-4059; Braver, Todd/0000-0002-2631-3393	National Institutes of Health [RO1 MH66078]; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grant RO1 MH66078 from the National Institutes of Health to T. S. B. and a Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship to K. S. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan RL, 2007, NEUROIMAGE, V38, P261, DOI 10.1016/j.neuroimage.2007.06.004; Algom D, 2004, J EXP PSYCHOL GEN, V133, P323, DOI 10.1037/0096-3445.133.3.323; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Braver TS., 2002, PRINCIPLES FRONTAL L, P428, DOI [10.1093/acprof:oso/9780195134971.003.0027, DOI 10.1093/ACPROF:OSO/9780195134971.003.0027]; BRAVER TS, 2007, NEUROSCIENCE RULE GU, P255; Buhle J., 2010, SELF CONTROL SOC MIN, P93, DOI DOI 10.1093/ACPROF:OSO/9780195391381.003.0006; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Chiew KS, 2010, EMOTION, V10, P842, DOI 10.1037/a0019704; Cohen JD, 1996, PHILOS T R SOC B, V351, P1515, DOI 10.1098/rstb.1996.0138; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Compton RJ, 2003, COGN AFFECT BEHAV NE, V3, P81, DOI 10.3758/CABN.3.2.81; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; Dolcos F, 2006, J NEUROSCI, V26, P2072, DOI 10.1523/JNEUROSCI.5042-05.2006; Eastwood JD, 2001, PERCEPT PSYCHOPHYS, V63, P1004, DOI 10.3758/BF03194519; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Haas BW, 2006, COGN AFFECT BEHAV NE, V6, P152, DOI 10.3758/CABN.6.2.152; Holland PC, 2006, J NEUROSCI, V26, P3791, DOI 10.1523/JNEUROSCI.0390-06.2006; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Jensen J, 2007, HUM BRAIN MAPP, V28, P294, DOI 10.1002/hbm.20274; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Krug MK, 2010, COGN AFFECT BEHAV NE, V10, P357, DOI 10.3758/CABN.10.3.357; Lang P. J., 1999, INT AFFECTIVE PICTUR; Larsen RJ, 2006, EMOTION, V6, P62, DOI 10.1037/1528-3542.6.1.62; Lee TW, 2008, CEREB CORTEX, V18, P104, DOI 10.1093/cercor/bhm035; MacDonald AW, 2003, J ABNORM PSYCHOL, V112, P689, DOI 10.1037/0021-843X.112.4.689; MATHEWS A, 1985, BEHAV RES THER, V23, P563, DOI 10.1016/0005-7967(85)90104-4; McAvoy MP, 2001, NEUROIMAGE, V13, pS198; Nitschke JB, 2006, NAT NEUROSCI, V9, P435, DOI 10.1038/nn1645; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; OCHSNER KN, 2008, J COGN NEUROSCI; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ousdal OT, 2008, NEUROSCIENCE, V156, P450, DOI 10.1016/j.neuroscience.2008.07.066; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Schaefer A, 2006, J NEUROSCI, V26, P10120, DOI 10.1523/JNEUROSCI.2567-06.2006; Sohn MH, 2007, P NATL ACAD SCI USA, V104, P10330, DOI 10.1073/pnas.0703225104; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TALAIRAICH J, 1988, COPLANAR STEREOTAXIC; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Ward D.B., 2000, SIMULTANEOUS INFEREN; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Wittfoth M, 2010, CEREB CORTEX, V20, P383, DOI 10.1093/cercor/bhp106	61	25	25	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17635	10.1371/journal.pone.0017635	http://dx.doi.org/10.1371/journal.pone.0017635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FR	21408006	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170900033
J	Schmieder, R; Edwards, R				Schmieder, Robert; Edwards, Robert			Fast Identification and Removal of Sequence Contamination from Genomic and Metagenomic Datasets	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; HUMAN MICROBIOME PROJECT; SHORT READ ALIGNMENT; GENERATION; TOOL; BLAST	High-throughput sequencing technologies have strongly impacted microbiology, providing a rapid and cost-effective way of generating draft genomes and exploring microbial diversity. However, sequences obtained from impure nucleic acid preparations may contain DNA from sources other than the sample. Those sequence contaminations are a serious concern to the quality of the data used for downstream analysis, causing misassembly of sequence contigs and erroneous conclusions. Therefore, the removal of sequence contaminants is a necessary and required step for all sequencing projects. We developed DeconSeq, a robust framework for the rapid, automated identification and removal of sequence contamination in longer-read datasets (>150 bp mean read length). DeconSeq is publicly available as standalone and web-based versions. The results can be exported for subsequent analysis, and the databases used for the web-based version are automatically updated on a regular basis. DeconSeq categorizes possible contamination sequences, eliminates redundant hits with higher similarity to non-contaminant genomes, and provides graphical visualizations of the alignment results and classifications. Using DeconSeq, we conducted an analysis of possible human DNA contamination in 202 previously published microbial and viral metagenomes and found possible contamination in 145 (72%) metagenomes with as high as 64% contaminating sequences. This new framework allows scientists to automatically detect and efficiently remove unwanted sequence contamination from their datasets while eliminating critical limitations of current methods. DeconSeq's web interface is simple and user-friendly. The standalone version allows offline analysis and integration into existing data processing pipelines. DeconSeq's results reveal whether the sequencing experiment has succeeded, whether the correct sample was sequenced, and whether the sample contains any sequence contamination from DNA preparation or host. In addition, the analysis of 202 metagenomes demonstrated significant contamination of the non-human associated metagenomes, suggesting that this method is appropriate for screening all metagenomes. DeconSeq is available at http://deconseq.sourceforge.net/.	[Schmieder, Robert; Edwards, Robert] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Schmieder, Robert] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Edwards, Robert] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA	California State University System; San Diego State University; California State University System; San Diego State University; United States Department of Energy (DOE); Argonne National Laboratory	Schmieder, R (corresponding author), San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA.	rschmied@sciences.sdsu.edu; redwards@cs.sdsu.edu	Edwards, Robert/Q-1691-2019	Edwards, Robert/0000-0001-8383-8949	National Science Foundation [DBI 0850356]	National Science Foundation(National Science Foundation (NSF))	This work was supported by grant DBI 0850356 Advances in Bioinformatics from the National Science Foundation (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YR, 2009, NAT BIOTECHNOL, V27, P820, DOI 10.1038/nbt0909-820; Manzini G, 2000, P 41 ANN S FDN COMP; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; McCarthy A, 2010, CHEM BIOL, V17, P675, DOI 10.1016/j.chembiol.2010.07.004; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rosen GL, 2009, CURR GENOMICS, V10, P493, DOI 10.2174/138920209789208255; Schmieder R, 2011, BIOINFORMATICS; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Smith AD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-128; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turner DJ, 2009, MAMM GENOME, V20, P327, DOI 10.1007/s00335-009-9187-4; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667	51	468	516	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17288	10.1371/journal.pone.0017288	http://dx.doi.org/10.1371/journal.pone.0017288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408061	Green Submitted, Green Published, gold			2022-12-25	WOS:000288170900009
J	Gutteling, TP; Kenemans, JL; Neggers, SFW				Gutteling, Tjerk P.; Kenemans, J. Leon; Neggers, Sebastiaan F. W.			Grasping Preparation Enhances Orientation Change Detection	PLOS ONE			English	Article							EYE-MOVEMENTS; VISUOSPATIAL ATTENTION; VISUAL-SEARCH; SELECTION; FMRI; TMS; PERCEPTION; MECHANISM; FEEDBACK; FIELDS	Preparing a goal directed movement often requires detailed analysis of our environment. When picking up an object, its orientation, size and relative distance are relevant parameters when preparing a successful grasp. It would therefore be beneficial if the motor system is able to influence early perception such that information processing needs for action control are met at the earliest possible stage. However, only a few studies reported (indirect) evidence for action-induced visual perception improvements. We therefore aimed to provide direct evidence for a feature-specific perceptual modulation during the planning phase of a grasping action. Human subjects were instructed to either grasp or point to a bar while simultaneously performing an orientation discrimination task. The bar could slightly change its orientation during grasping preparation. By analyzing discrimination response probabilities, we found increased perceptual sensitivity to orientation changes when subjects were instructed to grasp the bar, rather than point to it. As a control experiment, the same experiment was repeated using bar luminance changes, a feature that is not relevant for either grasping or pointing. Here, no differences in visual sensitivity between grasping and pointing were found. The present results constitute first direct evidence for increased perceptual sensitivity to a visual feature that is relevant for a certain skeletomotor act during the movement preparation phase. We speculate that such action-induced perception improvements are controlled by neuronal feedback mechanisms from cortical motor planning areas to early visual cortex, similar to what was recently established for spatial perception improvements shortly before eye movements.	[Gutteling, Tjerk P.; Neggers, Sebastiaan F. W.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Kenemans, J. Leon] Univ Utrecht, Dept Expt Psychol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University	Gutteling, TP (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands.	T.Gutteling@umcutrecht.nl	Gutteling, Tjerk/J-3440-2012	Gutteling, Tjerk/0000-0002-0934-418X	Netherlands Foundation for Scientific Research (NWO) [NWO 400-05-134]	Netherlands Foundation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a Netherlands Foundation for Scientific Research (NWO, http://www.nwo.nl/) Open Competition Grant NWO 400-05-134. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLPORT A, 1987, SELECTION ACTION SOM, P395; Bekkering H, 2002, PSYCHOL SCI, V13, P370, DOI 10.1111/1467-9280.00466; Cohen NR, 2009, NEUROPSYCHOLOGIA, V47, P1553, DOI 10.1016/j.neuropsychologia.2008.12.034; Craighero L, 1999, J EXP PSYCHOL HUMAN, V25, P1673, DOI 10.1037/0096-1523.25.6.1673; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Fagioli S, 2007, PSYCHOL RES-PSYCH FO, V71, P22, DOI 10.1007/s00426-005-0033-3; Grabowska A, 1996, PSYCHOL BULL, V120, P434, DOI 10.1037/0033-2909.120.3.434; Gutteling TP, 2010, J COGNITIVE NEUROSCI, V22, P1931, DOI 10.1162/jocn.2009.21342; Hannus A, 2005, ACTA PSYCHOL, V118, P171, DOI 10.1016/j.actpsy.2004.10.010; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Macmillan N.A, DETECTION THEORY USE; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Neggers SFW, 2007, J NEUROPHYSIOL, V98, P2765, DOI 10.1152/jn.00357.2007; Neggers SFW, 1999, EXP BRAIN RES, V125, P97, DOI 10.1007/s002210050663; Neuman O., 1987, PERSPECTIVES PERCEPT, P361; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; PRINZ W, 1997, EUROPEAN J COGNITIVE, P129; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Ruff CC, 2006, CURR BIOL, V16, P1479, DOI 10.1016/j.cub.2006.06.057; Symes E, 2008, J EXP PSYCHOL HUMAN, V34, P854, DOI 10.1037/0096-1523.34.4.854; van Elk M, 2010, J NEUROPHYSIOL, V104, P972, DOI 10.1152/jn.01079.2009; Van Ettinger-Veenstra HM, 2009, J NEUROPHYSIOL, V102, P3469, DOI 10.1152/jn.00350.2009	24	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17675	10.1371/journal.pone.0017675	http://dx.doi.org/10.1371/journal.pone.0017675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FI	21408131	Green Published, gold			2022-12-25	WOS:000288170000052
J	Ataera, H; Hyde, E; Price, KM; Stoitzner, P; Ronchese, F				Ataera, Haley; Hyde, Evelyn; Price, Kylie M.; Stoitzner, Patrizia; Ronchese, Franca			Murine Melanoma-Infiltrating Dendritic Cells Are Defective in Antigen Presenting Function Regardless of the Presence of CD4(+)CD25(+) Regulatory T Cells	PLOS ONE			English	Article							TUMOR-DERIVED ANTIGEN; IN-VIVO; TGF-BETA; PROGNOSTIC VALUE; II PRESENTATION; CUTTING EDGE; LYMPH-NODES; EFFECTOR; ACTIVATION; IMMUNITY	Tumor-infiltrating dendritic cells are often ineffective at presenting tumor-derived antigen in vivo, a defect usually ascribed to the suppressive tumor environment. We investigated the effects of depleting CD4(+)CD25(+) "natural" regulatory T cells (Treg) on the frequency, phenotype and function of total dendritic cell populations in B16.OVA tumors and in tumor-draining lymph nodes. Intraperitoneal injection of the anti-CD25 monoclonal antibody PC61 reduced Treg frequency in blood and tumors, but did not affect the frequency of tumor-infiltrating dendritic cells, or their expression of CD40, CD86 and MHCII. Tumor-infiltrating dendritic cells from PC61-treated or untreated mice induced the proliferation of allogeneic T cells in vitro, but could not induce proliferation of OVA-specific OTI and OTIIT cells unless specific peptide antigen was added in culture. Some proliferation of naive, OVA-specific OTI T cells, but not OTII T cells, was observed in the tumor-draining LN of mice carrying B16.OVA tumors, however, this was not improved by PC61 treatment. Experiments using RAG1(-/-) hosts adoptively transferred with OTI and CD25-depleted OTII cells also failed to show improved OTI and OTII T cell proliferation in vivo compared to C57BL/6 hosts. We conclude that the defective presentation of B16.OVA tumor antigen by tumor-infiltrating dendritic cells and in the tumor-draining lymph node is not due to the presence of "natural" CD4(+)CD25(+) Treg.	[Ataera, Haley; Hyde, Evelyn; Price, Kylie M.; Stoitzner, Patrizia; Ronchese, Franca] Malaghan Inst Med Res, Wellington, New Zealand	Malaghan Institute; Victoria University Wellington	Ataera, H (corresponding author), Baylor Coll Med, Ctr Gene Therapy, Houston, TX 77030 USA.	fronchese@malaghan.org.nz	Price, Kylie/AAO-4061-2020; Ronchese, Franca/M-9618-2019	Price, Kylie/0000-0002-1446-6958; Ronchese, Franca/0000-0001-5835-8230; stoitzner, patrizia/0000-0002-8488-6704	Health Research Council of NZ; Cancer Society of NZ [HRC 04/249]; Austrian Science Fund [FWF-J2479]	Health Research Council of NZ(Health Research Council of New Zealand); Cancer Society of NZ; Austrian Science Fund(Austrian Science Fund (FWF))	This work was funded by a research grant from the Health Research Council of NZ and Cancer Society of NZ to FR (HRC 04/249). HA was funded by a PhD scholarship from the Health Research Council of NZ and by the Wellington division of the Cancer Society. PS was supported by the Erwin Schroedinger Auslandsstipendium from the Austrian Science Fund (FWF-J2479). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Billiard F, 2006, J IMMUNOL, V177, P2167, DOI 10.4049/jimmunol.177.4.2167; Biollaz G, 2009, EUR J IMMUNOL, V39, P1323, DOI 10.1002/eji.200838921; Boissonnas A, 2010, IMMUNITY, V32, P266, DOI 10.1016/j.immuni.2009.11.015; Bui JD, 2006, CANCER RES, V66, P7301, DOI 10.1158/0008-5472.CAN-06-0556; Carbone FR, 2004, TRENDS IMMUNOL, V25, P655, DOI 10.1016/j.it.2004.09.013; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Chaux P, 1997, INT J CANCER, V72, P619, DOI 10.1002/(SICI)1097-0215(19970807)72:4<619::AID-IJC12>3.3.CO;2-Y; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chiodoni C, 1999, J EXP MED, V190, P125, DOI 10.1084/jem.190.1.125; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; ENGLEMAN EG, 2004, SCI STKE, pPE28; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gerner MY, 2008, J IMMUNOL, V181, P155, DOI 10.4049/jimmunol.181.1.155; Gerner MY, 2009, J IMMUNOL, V182, P2726, DOI 10.4049/jimmunol.0803479; Grauer OM, 2007, INT J CANCER, V121, P95, DOI 10.1002/ijc.22607; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Iwamoto M, 2003, INT J CANCER, V104, P92, DOI 10.1002/ijc.10915; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Lugade AA, 2005, J IMMUNOL, V174, P7516, DOI 10.4049/jimmunol.174.12.7516; Marincola FM, 2003, TRENDS IMMUNOL, V24, P335, DOI 10.1016/S1471-4906(03)00116-9; Matsushita N, 2008, J IMMUNOL METHODS, V333, P167, DOI 10.1016/j.jim.2008.01.012; McDonnell AM, 2010, EUR J IMMUNOL, V40, P1617, DOI 10.1002/eji.200940153; McLachlan JB, 2009, IMMUNITY, V30, P277, DOI 10.1016/j.immuni.2008.11.013; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; Oberle N, 2007, J IMMUNOL, V179, P3578, DOI 10.4049/jimmunol.179.6.3578; Pinzon-Charry A, 2005, IMMUNOL CELL BIOL, V83, P451, DOI 10.1111/j.1440-1711.2005.01371.x; Prasad SJ, 2005, J IMMUNOL, V174, P90, DOI 10.4049/jimmunol.174.1.90; Preynat-Seauve O, 2006, J IMMUNOL, V176, P61, DOI 10.4049/jimmunol.176.1.61; Qin FXF, 2009, CELL MOL IMMUNOL, V6, P3, DOI 10.1038/cmi.2009.2; Sandel MH, 2005, CLIN CANCER RES, V11, P2576, DOI 10.1158/1078-0432.CCR-04-1448; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shimizu J, 1999, J IMMUNOL, V163, P5211; Shreedhar V, 1999, IMMUNITY, V11, P625, DOI 10.1016/S1074-7613(00)80137-5; Stoitzner P, 2008, CANCER IMMUNOL IMMUN, V57, P1665, DOI 10.1007/s00262-008-0487-4; Stumbles PA, 2004, J IMMUNOL, V173, P5923, DOI 10.4049/jimmunol.173.10.5923; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Thompson ED, 2010, J EXP MED, V207, P1791, DOI 10.1084/jem.20092454; van Mierlo GJD, 2008, J IMMUNOL, V180, P2747, DOI 10.4049/jimmunol.180.5.2747; van Mierlo GJD, 2004, J IMMUNOL, V173, P6753, DOI 10.4049/jimmunol.173.11.6753; Vicari AP, 2002, J EXP MED, V196, P541, DOI 10.1084/jem.20020732; Vicari AP, 2002, SEMIN CANCER BIOL, V12, P33, DOI 10.1006/scbi.2001.0400; Yang ZZ, 2006, CANCER RES, V66, P10145, DOI 10.1158/0008-5472.CAN-06-1822	55	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17515	10.1371/journal.pone.0017515	http://dx.doi.org/10.1371/journal.pone.0017515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390236	Green Submitted, Green Published, gold			2022-12-25	WOS:000287965200019
J	Creekmore, AL; Silkworth, WT; Cimini, D; Jensen, RV; Roberts, PC; Schmelz, EM				Creekmore, Amy L.; Silkworth, William T.; Cimini, Daniela; Jensen, Roderick V.; Roberts, Paul C.; Schmelz, Eva M.			Changes in Gene Expression and Cellular Architecture in an Ovarian Cancer Progression Model	PLOS ONE			English	Article							PROTEIN-KINASE-C; FOCAL ADHESION KINASE; EPITHELIAL-CELLS; MEMBRANE ASSOCIATION; RECYCLING ENDOSOMES; ACTIN CYTOSKELETON; TUMOR-SUPPRESSOR; ONTO-TOOLS; BETA-II; APC	Background: Ovarian cancer is the fifth leading cause of cancer deaths among women. Early stage disease often remains undetected due the lack of symptoms and reliable biomarkers. The identification of early genetic changes could provide insights into novel signaling pathways that may be exploited for early detection and treatment. Methodology/Principal Findings: Mouse ovarian surface epithelial (MOSE) cells were used to identify stage-dependent changes in gene expression levels and signal transduction pathways by mouse whole genome microarray analyses and gene ontology. These cells have undergone spontaneous transformation in cell culture and transitioned from non-tumorigenic to intermediate and aggressive, malignant phenotypes. Significantly changed genes were overrepresented in a number of pathways, most notably the cytoskeleton functional category. Concurrent with gene expression changes, the cytoskeletal architecture became progressively disorganized, resulting in aberrant expression or subcellular distribution of key cytoskeletal regulatory proteins (focal adhesion kinase, alpha-actinin, and vinculin). The cytoskeletal disorganization was accompanied by altered patterns of serine and tyrosine phosphorylation as well as changed expression and subcellular localization of integral signaling intermediates APC and PKC beta II. Conclusions/Significance: Our studies have identified genes that are aberrantly expressed during MOSE cell neoplastic progression. We show that early stage dysregulation of actin microfilaments is followed by progressive disorganization of microtubules and intermediate filaments at later stages. These stage-specific, step-wise changes provide further insights into the time and spatial sequence of events that lead to the fully transformed state since these changes are also observed in aggressive human ovarian cancer cell lines independent of their histological type. Moreover, our studies support a link between aberrant cytoskeleton organization and regulation of important downstream signaling events that may be involved in cancer progression. Thus, our MOSE-derived cell model represents a unique model for in depth mechanistic studies of ovarian cancer progression.	[Roberts, Paul C.] Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Creekmore, Amy L.; Schmelz, Eva M.] Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA; [Silkworth, William T.; Cimini, Daniela; Jensen, Roderick V.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Roberts, PC (corresponding author), Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.	pcroberts@vt.edu; eschmelz@vt.edu	Schmelz, Eva M/E-6579-2012; Cimini, Daniela/A-3039-2016	Cimini, Daniela/0000-0002-4082-4894; Creekmore, Amy/0000-0002-7092-823X	NIH [R01 CA118846]; AICR [04B071]; NATIONAL CANCER INSTITUTE [R01CA118846] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AICR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The studies were supported by NIH R01 CA118846 (to EMS, PCR) and AICR grant 04B071 (EMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; Alvi F, 2007, CELL MOL LIFE SCI, V64, P263, DOI 10.1007/s00018-006-6363-5; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Basu R, 2007, CURR OPIN CELL BIOL, V19, P88, DOI 10.1016/j.ceb.2006.12.012; Becker KP, 2003, J BIOL CHEM, V278, P52747, DOI 10.1074/jbc.M305228200; Bevington P. R, 2003, DATA REDUCTION ERROR, pxi; Bijman MNA, 2008, BIOCHEM PHARMACOL, V76, P707, DOI 10.1016/j.bcp.2008.06.014; Blobe GC, 1996, J BIOL CHEM, V271, P15823, DOI 10.1074/jbc.271.26.15823; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Brautigam K, 2009, TRANSL ONCOL, V2, P164, DOI 10.1593/tlo.09121; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; BURRIDGE K, 1981, NATURE, V294, P691, DOI 10.1038/294691a0; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Collin L, 2008, BIOL CELL, V100, P243, DOI 10.1042/BC20070123; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Dikovskaya D, 2010, J CELL SCI, V123, P736, DOI 10.1242/jcs.060806; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; DwyerNield LD, 1996, AM J PHYSIOL-LUNG C, V270, pL526, DOI 10.1152/ajplung.1996.270.4.L526; Earley S, 2008, BIOCHEM BIOPH RES CO, V366, P476, DOI 10.1016/j.bbrc.2007.11.181; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Gagne JP, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-16; Gatcliffe TA, 2008, INT J GYNECOL CANCER, V18, P954, DOI 10.1111/j.1525-1438.2007.01127.x; Goicoechea SM, 2009, ONCOGENE, V28, P587, DOI 10.1038/onc.2008.408; GOODNIGHT J, 1995, J BIOL CHEM, V270, P9991, DOI 10.1074/jbc.270.17.9991; Halder J, 2007, CANCER RES, V67, P10976, DOI 10.1158/0008-5472.CAN-07-2667; Halder J, 2006, CLIN CANCER RES, V12, P4916, DOI 10.1158/1078-0432.CCR-06-0021; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Honore S, 2005, CELL MOL LIFE SCI, V62, P3039, DOI 10.1007/s00018-005-5330-x; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Iorio E, CANC RES, V70, P2126; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Kedrin D, 2007, J MAMMARY GLAND BIOL, V12, P143, DOI 10.1007/s10911-007-9046-4; Keller A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-290; Khatri P, 2004, NUCLEIC ACIDS RES, V32, pW449, DOI 10.1093/nar/gkh409; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Kurman RJ, 2008, INT J GYNECOL PATHOL, V27, P151, DOI 10.1097/PGP.0b013e318161e4f5; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Lindberg U, 2008, SEMIN CANCER BIOL, V18, P2, DOI 10.1016/j.semcancer.2007.10.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meinhold-Heerlein I, 2005, ONCOGENE, V24, P1053, DOI 10.1038/sj.onc.1208298; Menendez L, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-10; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Nathke I, 2006, NAT REV CANCER, V6, P967, DOI 10.1038/nrc2010; Neufeld KL, 2009, ADV EXP MED BIOL, V656, P13, DOI 10.1007/978-1-4419-1145-2_2; Ogura T, 2006, CLIN CANCER RES, V12, P5216, DOI 10.1158/1078-0432.CCR-06-0674; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Ouellet V, 2005, ONCOGENE, V24, P4672, DOI 10.1038/sj.onc.1208214; Pascale A, 2004, GLIA, V46, P169, DOI 10.1002/glia.10354; Rai K, 2010, CELL, V142, P930, DOI 10.1016/j.cell.2010.08.030; Raul U, 2004, INT J CANCER, V111, P662, DOI 10.1002/ijc.20349; Roberts PC, 2005, NEOPLASIA, V7, P944, DOI 10.1593/neo.05358; Rosin-Arbesfeld R, 2001, EMBO J, V20, P5929, DOI 10.1093/emboj/20.21.5929; Sakamoto M, 2001, Hum Cell, V14, P305; Sarrio D, 2006, HUM PATHOL, V37, P1042, DOI 10.1016/j.humpath.2006.03.003; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schwartz DR, 2002, CANCER RES, V62, P4722; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Sodek KL, 2008, MOL BIOSYST, V4, P762, DOI 10.1039/b717542f; Taniguchi S, 2005, CANCER SCI, V96, P738, DOI 10.1111/j.1349-7006.2005.00118.x; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Xiao H, 2009, J CELL PHYSIOL, V218, P366, DOI 10.1002/jcp.21609; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Zhao Y, 2009, EXPERT OPIN THER PAT, V19, P607, DOI 10.1517/13543770902775713	74	70	70	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17676	10.1371/journal.pone.0017676	http://dx.doi.org/10.1371/journal.pone.0017676			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390237	gold, Green Published, Green Submitted			2022-12-25	WOS:000287965200035
J	Hensel, M; Steurer, R; Fichtl, J; Elger, C; Wedekind, F; Petzold, A; Schlothauer, T; Molhoj, M; Reusch, D; Bulau, P				Hensel, Miriam; Steurer, Rebecca; Fichtl, Juergen; Elger, Carsten; Wedekind, Frank; Petzold, Andreas; Schlothauer, Tilman; Molhoj, Michael; Reusch, Dietmar; Bulau, Patrick			Identification of Potential Sites for Tryptophan Oxidation in Recombinant Antibodies Using tert-Butylhydroperoxide and Quantitative LC-MS	PLOS ONE			English	Article							METHIONINE OXIDATION; MONOCLONAL-ANTIBODY; HUMAN IGG1; PROTEIN; BINDING; FC; PHARMACEUTICALS; DEGRADATION; MECHANISMS	Amino acid oxidation is known to affect the structure, activity, and rate of degradation of proteins. Methionine oxidation is one of the several chemical degradation pathways for recombinant antibodies. In this study, we have identified for the first time a solvent accessible tryptophan residue (Trp-32) in the complementary-determining region (CDR) of a recombinant IgG1 antibody susceptible to oxidation under real-time storage and elevated temperature conditions. The degree of light chain Trp-32 oxidation was found to be higher than the oxidation level of the conserved heavy chain Met-429 and the heavy chain Met-107 of the recombinant IgG1 antibody HER2, which have already been identified as being solvent accessible and sensitive to chemical oxidation. In order to reduce the time for simultaneous identification and functional evaluation of potential methionine and tryptophan oxidation sites, a test system employing tert-butylhydroperoxide (TBHP) and quantitative LC-MS was developed. The optimized oxidizing conditions allowed us to specifically oxidize the solvent accessible methionine and tryptophan residues that displayed significant oxidation in the real-time stability and elevated temperature study. The achieved degree of tryptophan oxidation was adequate to identify the functional consequence of the tryptophan oxidation by binding studies. In summary, the here presented approach of employing TBHP as oxidizing reagent combined with quantitative LC-MS and binding studies greatly facilitates the efficient identification and functional evaluation of methionine and tryptophan oxidation sites in the CDR of recombinant antibodies.	[Hensel, Miriam; Steurer, Rebecca; Fichtl, Juergen; Elger, Carsten; Wedekind, Frank; Molhoj, Michael; Reusch, Dietmar; Bulau, Patrick] Roche Diagnost GmbH, Pharma Dev Penzberg, Penzberg, Germany; [Petzold, Andreas; Schlothauer, Tilman] Roche Diagnost GmbH, Pharma Res Penzberg, Penzberg, Germany	Roche Holding; Roche Holding	Bulau, P (corresponding author), Roche Diagnost GmbH, Pharma Dev Penzberg, Penzberg, Germany.	patrick.bulau@roche.com		Bulau, Patrick/0000-0002-7121-2954				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bertolotti-Ciarlet A, 2009, MOL IMMUNOL, V46, P1878, DOI 10.1016/j.molimm.2009.02.002; Churnsae C, 2007, J CHROMATOGR B, V850, P285, DOI 10.1016/j.jchromb.2006.11.050; DAVIES KJA, 1987, J BIOL CHEM, V262, P9902; Houde D, 2006, J CHROMATOGR A, V1123, P189, DOI 10.1016/j.chroma.2006.04.046; Hovorka SW, 2001, J PHARM SCI-US, V90, P253, DOI 10.1002/1520-6017(200103)90:3<253::AID-JPS1>3.0.CO;2-W; Ji JA, 2009, J PHARM SCI-US, V98, P4485, DOI 10.1002/jps.21746; Lam XM, 1997, J PHARM SCI, V86, P1250, DOI 10.1021/js970143s; LI SH, 1995, BIOTECHNOL BIOENG, V48, P490, DOI 10.1002/bit.260480511; Liu D, 2008, BIOCHEMISTRY-US, V47, P5088, DOI 10.1021/bi702238b; Liu HC, 2008, MOL IMMUNOL, V45, P701, DOI 10.1016/j.molimm.2007.07.012; NGUYEN TH, 1993, PHARMACEUT RES, V10, P1563, DOI 10.1023/A:1018908316698; Pan H, 2009, PROTEIN SCI, V18, P424, DOI 10.1002/pro.45; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Shen FJ., 1996, TECHNIQUES PROTEIN C, V7, P275; Timm V, 2010, J CHROMATOGR B, V878, P777, DOI 10.1016/j.jchromb.2010.01.036; UCHIDA K, 1989, AGR BIOL CHEM TOKYO, V53, P3285, DOI 10.1080/00021369.1989.10869852; Wei ZP, 2007, ANAL CHEM, V79, P2797, DOI 10.1021/ac062311j; Yang J, 2007, J CHROMATOGR A, V1156, P174, DOI 10.1016/j.chroma.2007.01.140	19	43	43	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17708	10.1371/journal.pone.0017708	http://dx.doi.org/10.1371/journal.pone.0017708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390239	Green Submitted, Green Published, gold			2022-12-25	WOS:000287965200038
J	Kawasaki, H; Kosugi, I; Arai, Y; Iwashita, T; Tsutsui, Y				Kawasaki, Hideya; Kosugi, Isao; Arai, Yoshifumi; Iwashita, Toshihide; Tsutsui, Yoshihiro			Mouse Embryonic Stem Cells Inhibit Murine Cytomegalovirus Infection through a Multi-Step Process	PLOS ONE			English	Article							IMMEDIATE-EARLY PROMOTER; HUMAN TERATOCARCINOMA CELLS; GROWTH-FACTOR RECEPTOR; TRANSGENIC MICE; TRANSCRIPTIONAL REGULATION; ENDOTHELIAL-CELLS; RETINOIC ACID; IN-VITRO; PROTEIN EXPRESSION; EPITHELIAL-CELLS	In humans, cytomegalovirus (CMV) is the most significant infectious cause of intrauterine infections that cause congenital anomalies of the central nervous system. Currently, it is not known how this process is affected by the timing of infection and the susceptibility of early-gestational-period cells. Embryonic stem (ES) cells are more resistant to CMV than most other cell types, although the mechanism responsible for this resistance is not well understood. Using a plaque assay and evaluation of immediate-early 1 mRNA and protein expression, we found that mouse ES cells were resistant to murine CMV (MCMV) at the point of transcription. In ES cells infected with MCMV, treatment with forskolin and trichostatin A did not confer full permissiveness to MCMV. In ES cultures infected with elongation factor-1 alpha (EF-1 alpha) promoter-green fluorescent protein (GFP) recombinant MCMV at a multiplicity of infection of 10, less than 5% of cells were GFP-positive, despite the fact that ES cells have relatively high EF-1 alpha promoter activity. Quantitative PCR analysis of the MCMV genome showed that ES cells allow approximately 20-fold less MCMV DNA to enter the nucleus than mouse embryonic fibroblasts (MEFs) do, and that this inhibition occurs in a multi-step manner. In situ hybridization revealed that ES cell nuclei have significantly less MCMV DNA than MEF nuclei. This appears to be facilitated by the fact that ES cells express less heparan sulfate, beta 1 integrin, and vimentin, and have fewer nuclear pores, than MEF. This may reduce the ability of MCMV to attach to and enter through the cellular membrane, translocate to the nucleus, and cross the nuclear membrane in pluripotent stem cells (ES/induced pluripotent stem cells). The results presented here provide perspective on the relationship between CMV susceptibility and cell differentiation.	[Kawasaki, Hideya; Kosugi, Isao; Arai, Yoshifumi; Iwashita, Toshihide] Hamamatsu Univ Sch Med, Dept Pathol 2, Hamamatsu, Shizuoka 4313192, Japan; [Tsutsui, Yoshihiro] Hamamatsu Univ, Fac Hlth Sci, Hamamatsu, Shizuoka 4312102, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Kawasaki, H (corresponding author), Hamamatsu Univ Sch Med, Dept Pathol 2, Hamamatsu, Shizuoka 4313192, Japan.	gloria@hama-med.ac.jp			Ministry of Education, Science and Culture, Japan [20790301]; Hamamatsu University School of Medicine	Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hamamatsu University School of Medicine	This work has been supported by a grant (#20790301) from the Ministry of Education, Science and Culture, Japan and through funding from Hamamatsu University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba-Masago S, 1999, AM J PATHOL, V154, P735, DOI 10.1016/S0002-9440(10)65320-5; Bouhon IA, 2006, STEM CELLS, V24, P1908, DOI 10.1634/stemcells.2006-0031; CARDIN RD, 1995, VIROLOGY, V209, P236, DOI 10.1006/viro.1995.1249; COMPTON T, 1993, VIROLOGY, V193, P834, DOI 10.1006/viro.1993.1192; COONEN E, 1993, HISTOCHEMISTRY, V99, P141, DOI 10.1007/BF00571875; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; EBIHARA K, 1984, J VIROL, V51, P117, DOI 10.1128/JVI.51.1.117-122.1984; Feire AL, 2004, P NATL ACAD SCI USA, V101, P15470, DOI 10.1073/pnas.0406821101; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; GHAZAL P, 1992, P NATL ACAD SCI USA, V89, P7630, DOI 10.1073/pnas.89.16.7630; GONCZOL E, 1985, J GEN VIROL, V66, P509, DOI 10.1099/0022-1317-66-3-509; GONCZOL E, 1984, SCIENCE, V224, P159, DOI 10.1126/science.6322309; Harel A, 2001, NAT CELL BIOL, V3, pE267, DOI 10.1038/ncb1201-e267; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; Huber MT, 2002, J VIROL, V76, P5748, DOI 10.1128/JVI.76.11.5748-5758.2002; Isaacson MK, 2007, J VIROL, V81, P6241, DOI 10.1128/JVI.00169-07; Ishiguro K, 2004, EUR J BIOCHEM, V271, P2379, DOI 10.1111/j.1432-1033.2004.04157.x; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Jurak I, 2006, EMBO J, V25, P2634, DOI 10.1038/sj.emboj.7601133; KASHIWAI A, 1992, ARCH VIROL, V127, P37, DOI 10.1007/BF01309573; Kawabata K, 2005, MOL THER, V12, P547, DOI 10.1016/j.ymthe.2005.04.015; Kawasaki H, 2002, LAB INVEST, V82, P1347, DOI 10.1097/01.LAB.0000032376.58688.D4; Kawasaki H, 2007, J VIROL, V81, P9013, DOI 10.1128/JVI.00261-07; Keller MJ, 2007, J VIROL, V81, P6669, DOI 10.1128/JVI.01524-06; Kim S, 2007, STEM CELLS DEV, V16, P537, DOI 10.1089/scd.2006.0088; Kosugi I, 2000, LAB INVEST, V80, P1373, DOI 10.1038/labinvest.3780145; Krmpotic A, 2003, MICROBES INFECT, V5, P1263, DOI 10.1016/j.micinf.2003.09.007; LAFEMINA R, 1986, J VIROL, V58, P434, DOI 10.1128/JVI.58.2.434-440.1986; Lentz BR, 1999, MOL MEMBR BIOL, V16, P279, DOI 10.1080/096876899294508; Li RY, 2001, GLIA, V35, P41, DOI 10.1002/glia.1069; LIGAS MW, 1988, J VIROL, V62, P1486, DOI 10.1128/JVI.62.5.1486-1494.1988; Matsukage S, 2006, BIRTH DEFECTS RES A, V76, P115, DOI 10.1002/bdra.20233; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; Meier JL, 1997, J VIROL, V71, P1246, DOI 10.1128/JVI.71.2.1246-1255.1997; Meier JL, 2001, J VIROL, V75, P1581, DOI 10.1128/JVI.75.4.1581-1593.2001; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; Miller MS, 2009, J VIROL, V83, P7015, DOI 10.1128/JVI.00398-09; MILLER N, 1992, J VIROL, V66, P3409, DOI 10.1128/JVI.66.6.3409-3414.1992; Mocarski E.S, 2007, FIELDS VIROLOGY, P2702; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Murphy JC, 2002, EMBO J, V21, P1112, DOI 10.1093/emboj/21.5.1112; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; NELSON JA, 1986, MOL CELL BIOL, V6, P452, DOI 10.1128/MCB.6.2.452; Nicola AV, 2003, J VIROL, V77, P5324, DOI 10.1128/JVI.77.9.5324-5332.2003; Odeberg J, 2006, J VIROL, V80, P8929, DOI 10.1128/JVI.00676-06; Ojala PM, 2000, MOL CELL BIOL, V20, P4922, DOI 10.1128/MCB.20.13.4922-4931.2000; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Patrone M, 2007, J VIROL, V81, P11479, DOI 10.1128/JVI.00788-07; Perez-Terzic Carmen, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS68, DOI 10.1038/ncpcardio0763; RAUB TJ, 1990, J CELL PHYSIOL, V144, P52, DOI 10.1002/jcp.1041440108; Reeves MB, 2005, J GEN VIROL, V86, P2949, DOI 10.1099/vir.0.81161-0; Schleiss MR, 2002, J CLIN VIROL, V25, pS37; Scrivano L, 2010, J VIROL, V84, P4469, DOI 10.1128/JVI.02441-09; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shinmura Y, 1997, AM J PATHOL, V151, P1331; Simon CO, 2006, J VIROL, V80, P10436, DOI 10.1128/JVI.01248-06; Simon CO, 2005, J VIROL, V79, P326, DOI 10.1128/JVI.79.1.326-340.2005; Sinzger C, 2008, J CLIN VIROL, V41, P174, DOI 10.1016/j.jcv.2007.12.002; Slobbe-van Drunen MEP, 1998, VIRUS RES, V56, P149, DOI 10.1016/S0168-1702(98)00064-1; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; Soroceanu L, 2008, NATURE, V455, P391, DOI 10.1038/nature07209; STENBERG RM, 1990, J VIROL, V64, P1556, DOI 10.1128/JVI.64.4.1556-1565.1990; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang QY, 2006, J VIROL, V80, P7510, DOI 10.1128/JVI.00684-06; Tang QY, 2000, J VIROL, V74, P9694, DOI 10.1128/JVI.74.20.9694-9700.2000; TSUTSUI Y, 1995, PATHOL INT, V45, P91, DOI 10.1111/j.1440-1827.1995.tb03428.x; Tsutsui Y, 2005, REV MED VIROL, V15, P327, DOI 10.1002/rmv.475; Tsutsui Yoshihiro, 2009, Congenital Anomalies, V49, P47, DOI 10.1111/j.1741-4520.2009.00222.x; van den Pol AN, 1999, J NEUROSCI, V19, P10948, DOI 10.1523/JNEUROSCI.19-24-10948.1999; Vanarsdall AL, 2008, J VIROL, V82, P11837, DOI 10.1128/JVI.01623-08; Wang D, 2007, P NATL ACAD SCI USA, V104, P20037, DOI 10.1073/pnas.0709704104; Wang R, 2008, STEM CELLS DEV, V17, P279, DOI 10.1089/scd.2007.0084; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818; Wang XQ, 2003, J VIROL, V77, P7182, DOI 10.1128/JVI.77.13.7182-7192.2003; Wang YM, 2006, METHODS, V39, P356, DOI 10.1016/j.ymeth.2006.06.010; WENTHWOR.BB, 1970, P SOC EXP BIOL MED, V135, P253, DOI 10.3181/00379727-135-35031; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; 1991, CONGENITAL PERINATAL, P205	81	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17492	10.1371/journal.pone.0017492	http://dx.doi.org/10.1371/journal.pone.0017492			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407806	Green Submitted, gold, Green Published			2022-12-25	WOS:000287933300028
J	Lopez-Lopez, P; Ferrer, M; Madero, A; Casado, E; McGrady, M				Lopez-Lopez, Pascual; Ferrer, Miguel; Madero, Agustin; Casado, Eva; McGrady, Michael			Solving Man-Induced Large-Scale Conservation Problems: The Spanish Imperial Eagle and Power Lines	PLOS ONE			English	Article							AQUILA-ADALBERTI; RAPTOR ELECTROCUTION; HIERAAETUS-FASCIATUS; MORTALITY; SPAIN; COLLISION; STOCHASTICITY; POPULATIONS; MANAGEMENT; RECOVERY	Background: Man-induced mortality of birds caused by electrocution with poorly-designed pylons and power lines has been reported to be an important mortality factor that could become a major cause of population decline of one of the world rarest raptors, the Spanish imperial eagle (Aquila adalberti). Consequently it has resulted in an increasing awareness of this problem amongst land managers and the public at large, as well as increased research into the distribution of electrocution events and likely mitigation measures. Methodology/Principal Findings: We provide information of how mitigation measures implemented on a regional level under the conservation program of the Spanish imperial eagle have resulted in a positive shift of demographic trends in Spain. A 35 years temporal data set (1974-2009) on mortality of Spanish imperial eagle was recorded, including population censuses, and data on electrocution and non-electrocution of birds. Additional information was obtained from 32 radio-tracked young eagles and specific field surveys. Data were divided into two periods, before and after the approval of a regional regulation of power line design in 1990 which established mandatory rules aimed at minimizing or eliminating the negative impacts of power lines facilities on avian populations. Our results show how population size and the average annual percentage of population change have increased between the two periods, whereas the number of electrocuted birds has been reduced in spite of the continuous growing of the wiring network. Conclusions: Our results demonstrate that solving bird electrocution is an affordable problem if political interest is shown and financial investment is made. The combination of an adequate spatial planning with a sustainable development of human infrastructures will contribute positively to the conservation of the Spanish imperial eagle and may underpin population growth and range expansion, with positive side effects on other endangered species.	[Lopez-Lopez, Pascual] Univ Valencia, Terr Vertebrates Grp, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Lopez-Lopez, Pascual; Ferrer, Miguel] Spanish Natl Res Council, Donana Biol Stn, Biodivers Conservat Grp, Seville, Spain; [Madero, Agustin] Junta de Andalucia, Consejeria Medio Ambiente, Seville, Spain; [Casado, Eva] Fdn Migres, Seville, Spain; [McGrady, Michael] Nat Res Ltd, Krems, Austria	University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Lopez-Lopez, P (corresponding author), Univ Valencia, Terr Vertebrates Grp, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain.	Pascual.Lopez@uv.es	Ferrer, Miguel/G-3519-2015; López-López, Pascual/C-1039-2011; Ferrer, Miguel/AFU-8286-2022; Casado, Eva/F-8211-2016	Ferrer, Miguel/0000-0003-0092-8450; López-López, Pascual/0000-0001-5269-652X; 	Spanish Ministerio de Educacion [AP2005-0874]; Spanish Ministry of Education; Natural Research Ltd.; Junta de Andalucia	Spanish Ministerio de Educacion(Spanish Government); Spanish Ministry of Education(Spanish Government); Natural Research Ltd.; Junta de Andalucia(Junta de Andalucia)	P. Lopez-Lopez was supported by FPU grant of the Spanish Ministerio de Educacion (reference AP2005-0874) and wrote this paper during a pre-doctoral stay at Donana Biological Station (CSIC) in Sevilla, Spain. The funders of this study (Spanish Ministry of Education, Natural Research Ltd. and Junta de Andalucia) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson PC., 1981, THESIS B YOUNG U PRO; Bevanger K, 1998, BIOL CONSERV, V86, P67, DOI 10.1016/S0006-3207(97)00176-6; BEVANGER K, 1994, IBIS, V136, P412, DOI 10.1111/j.1474-919X.1994.tb01116.x; *BIRDLIFE INT, 2010, SPEC FACTSH AQ AD; Boeker EL, 1975, WILDLIFE SOC B, V3, P79; CLAVE AT, 1992, IBERDROLA CONSEJO SU, P50; FERRER M, 1991, WILDLIFE SOC B, V19, P436; FERRER M, 1991, J FIELD ORNITHOL, V62, P181; FERRER M, 1990, BIOL CONSERV, V51, P151, DOI 10.1016/0006-3207(90)90109-3; FERRER M, 1992, BIOL CONSERV, V60, P57, DOI 10.1016/0006-3207(92)90799-S; FERRER M, 1987, RICH BIOL SELVAG, V12, P97; FERRER M, 2001, SPANISH IMPERIAL EAG; FERRER M, 1999, BIRDS POWER LINES CO, P145; Ferrer M, 2008, J APPL ECOL, V45, P1453, DOI 10.1111/j.1365-2664.2008.01497.x; Ferrer M, 2009, CONSERV BIOL, V23, P1017, DOI 10.1111/j.1523-1739.2009.01215.x; GONZALEZ LM, 2004, LIBRO ROJO AVES ESPA, P145; Gonzalez LM, 2007, ORYX, V41, P495, DOI 10.1017/S0030605307414119; Janss G.F.E., 1999, BIRDS POWER LINES CO, p145e159; Janss GFE, 1999, WILDLIFE SOC B, V27, P263; Janss GFE, 1999, J RAPTOR RES, V33, P154; Janss GFE, 1998, J FIELD ORNITHOL, V69, P8; Janss GFE, 2001, BIRD CONSERV INT, V11, P3, DOI 10.1017/S0959270901001022; JANSS GFE, 2001, THESIS UTRECHT U, P175; Katzner TE, 2006, BIOL CONSERV, V132, P322, DOI 10.1016/j.biocon.2006.04.024; Lehman RN, 2007, BIOL CONSERV, V136, P159, DOI 10.1016/j.biocon.2006.09.015; MESTEL R, 1993, NEW SCI, V1901, P4; Ortega E, 2009, ORYX, V43, P113, DOI 10.1017/S0030605307991048; Penteriani V, 2005, OIKOS, V108, P523, DOI 10.1111/j.0030-1299.2005.13514.x; Real J, 2001, BIRD STUDY, V48, P221, DOI 10.1080/00063650109461221; Rollan A, 2010, BIRD CONSERV INT, V20, P279, DOI 10.1017/S0959270910000250; Schaub M, 2010, BIOL CONSERV, V143, P1911, DOI 10.1016/j.biocon.2010.04.047; Sergio F, 2004, J APPL ECOL, V41, P836, DOI 10.1111/j.0021-8901.2004.00946.x; Soutullo A, 2008, BIOL CONSERV, V141, P1013, DOI 10.1016/j.biocon.2008.01.011; *STATSOFT INC, 2004, STATISTICA DAT AN SO; *UNESA, 2005, SECT EL TRAV UNESA 1; Zar JH, 1999, BIOSTATISTICAL ANAL	36	58	60	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17196	10.1371/journal.pone.0017196	http://dx.doi.org/10.1371/journal.pone.0017196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399692	gold, Green Published, Green Submitted			2022-12-25	WOS:000287933300013
J	Rutledge, RG				Rutledge, Robert G.			A Java Program for LRE-Based Real-Time qPCR that Enables Large-Scale Absolute Quantification	PLOS ONE			English	Article							PCR; STANDARD	Background: Linear regression of efficiency (LRE) introduced a new paradigm for real-time qPCR that enables large-scale absolute quantification by eliminating the need for standard curves. Developed through the application of sigmoidal mathematics to SYBR Green I-based assays, target quantity is derived directly from fluorescence readings within the central region of an amplification profile. However, a major challenge of implementing LRE quantification is the labor intensive nature of the analysis. Findings: Utilizing the extensive resources that are available for developing Java-based software, the LRE Analyzer was written using the NetBeans IDE, and is built on top of the modular architecture and windowing system provided by the NetBeans Platform. This fully featured desktop application determines the number of target molecules within a sample with little or no intervention by the user, in addition to providing extensive database capabilities. MS Excel is used to import data, allowing LRE quantification to be conducted with any real-time PCR instrument that provides access to the raw fluorescence readings. An extensive help set also provides an in-depth introduction to LRE, in addition to guidelines on how to implement LRE quantification. Conclusions: The LRE Analyzer provides the automated analysis and data storage capabilities required by large-scale qPCR projects wanting to exploit the many advantages of absolute quantification. Foremost is the universal perspective afforded by absolute quantification, which among other attributes, provides the ability to directly compare quantitative data produced by different assays and/or instruments. Furthermore, absolute quantification has important implications for gene expression profiling in that it provides the foundation for comparing transcript quantities produced by any gene with any other gene, within and between samples.	Nat Resources Canada, Canadian Forest Serv, Quebec City, PQ, Canada	Natural Resources Canada; Canadian Forest Service	Rutledge, RG (corresponding author), Nat Resources Canada, Canadian Forest Serv, Quebec City, PQ, Canada.	Bob.Rutledge@NRCan.gc.ca			Canadian Biotechnology Strategy	Canadian Biotechnology Strategy	The research was supported in part by a grant to RGR from the Canadian Biotechnology Strategy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding were received for this study.	Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Murphy J, 2009, EXPERT REV MOL DIAGN, V9, P187, DOI 10.1586/14737159.9.2.187; Pfaffl MW, 2010, METHODS, V50, P215, DOI 10.1016/j.ymeth.2010.02.005; Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Rutledge RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009731; Rutledge RG, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-96; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Vermeulen J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp721	11	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17636	10.1371/journal.pone.0017636	http://dx.doi.org/10.1371/journal.pone.0017636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407812	Green Published, Green Submitted, gold			2022-12-25	WOS:000287933300038
J	Jurat-Fuentes, JL; Karumbaiah, L; Jakka, SRK; Ning, CM; Liu, CX; Wu, KM; Jackson, J; Gould, F; Blanco, C; Portilla, M; Perera, O; Adang, M				Jurat-Fuentes, Juan Luis; Karumbaiah, Lohitash; Jakka, Siva Rama Krishna; Ning, Changming; Liu, Chenxi; Wu, Kongming; Jackson, Jerreme; Gould, Fred; Blanco, Carlos; Portilla, Maribel; Perera, Omaththage; Adang, Michael			Reduced Levels of Membrane-Bound Alkaline Phosphatase Are Common to Lepidopteran Strains Resistant to Cry Toxins from Bacillus thuringiensis	PLOS ONE			English	Article							HELIOTHIS-VIRESCENS LEPIDOPTERA; ARMIGERA HUBNER LEPIDOPTERA; P38 MAP KINASE; DELTA-ENDOTOXIN; MANDUCA-SEXTA; BINDING-PROTEINS; BT COTTON; CONFERRING RESISTANCE; INSECT RESISTANCE; TRANSGENIC COTTON	Development of insect resistance is one of the main concerns with the use of transgenic crops expressing Cry toxins from the bacterium Bacillus thuringiensis. Identification of biomarkers would assist in the development of sensitive DNA-based methods to monitor evolution of resistance to Bt toxins in natural populations. We report on the proteomic and genomic detection of reduced levels of midgut membrane-bound alkaline phosphatase (mALP) as a common feature in strains of Cry-resistant Heliothis virescens, Helicoverpa armigera and Spodoptera frugiperda when compared to susceptible larvae. Reduced levels of H. virescens mALP protein (HvmALP) were detected by two dimensional differential in-gel electrophoresis (2D-DIGE) analysis in Cry-resistant compared to susceptible larvae, further supported by alkaline phosphatase activity assays and Western blotting. Through quantitative real-time polymerase chain reaction (qRT-PCR) we demonstrate that the reduction in HvmALP protein levels in resistant larvae are the result of reduced transcript amounts. Similar reductions in ALP activity and mALP transcript levels were also detected for a Cry1Ac-resistant strain of H. armigera and field-derived strains of S. frugiperda resistant to Cry1Fa. Considering the unique resistance and cross-resistance phenotypes of the insect strains used in this work, our data suggest that reduced mALP expression should be targeted for development of effective biomarkers for resistance to Cry toxins in lepidopteran pests.	[Jurat-Fuentes, Juan Luis; Jakka, Siva Rama Krishna] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Karumbaiah, Lohitash; Adang, Michael] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Ning, Changming; Liu, Chenxi; Wu, Kongming] Chinese Acad Agr Sci, State Key Lab Plant Dis & Insect Pests, Inst Plant Protect, Beijing, Peoples R China; [Jackson, Jerreme] Univ Tennessee, Genome Sci & Technol Program, Knoxville, TN 37901 USA; [Gould, Fred] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Blanco, Carlos] US Anim & Plant Hlth Inspect Serv, Biotechnol Regulatory Serv, USDA, Riverdale, MD USA; [Portilla, Maribel; Perera, Omaththage] ARS, So Insect Management Res Unit, USDA, Stoneville, MS USA; [Adang, Michael] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University System of Georgia; University of Georgia; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University of Tennessee System; University of Tennessee Knoxville; University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University System of Georgia; University of Georgia	Jurat-Fuentes, JL (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA.	jurat@utk.edu	Jurat-Fuentes, Juan Luis/A-5104-2014; Portilla, Maribel/AAJ-9247-2020; Blanco, Carlos/AAE-9032-2022	Jurat-Fuentes, Juan Luis/0000-0002-8945-1814; Karumbaiah, Lohitash/0000-0001-7969-417X	Cooperative State Research, Education, and Extension Service, U.S. Department of Agriculture [2004-35607-14936, 2008-39211-19577]	Cooperative State Research, Education, and Extension Service, U.S. Department of Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This material is based upon work supported by Cooperative State Research, Education, and Extension Service, U.S. Department of Agriculture, under National Research Initiative Award No. 2004-35607-14936 to M.J.A. and J.L.J.-F., and Biotechnology Risk Assessment Grant Award No. 2008-39211-19577 to J.L.J.-F. and O.P.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture.	Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Baxter SW, 2005, INSECT MOL BIOL, V14, P327, DOI 10.1111/j.1365-2583.2005.00563.x; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Blanco CA, 2010, SOUTHWEST ENTOMOL, V35, P409, DOI 10.3958/059.035.0325; Blanco CA, 2009, J ECON ENTOMOL, V102, P381, DOI 10.1603/029.102.0149; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Cancino-Rodezno A, 2010, INSECT BIOCHEM MOLEC, V40, P58, DOI 10.1016/j.ibmb.2009.12.010; Ding QM, 2001, BIOCHEM BIOPH RES CO, V284, P282, DOI 10.1006/bbrc.2001.4969; EGUCHI M, 1995, COMP BIOCHEM PHYS B, V111, P151, DOI 10.1016/0305-0491(94)00248-S; ENGLISH LH, 1989, INSECT BIOCHEM, V19, P145, DOI 10.1016/0020-1790(89)90085-1; Fernandez LE, 2006, BIOCHEM J, V394, P77, DOI 10.1042/BJ20051517; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Forcada C, 1999, ARCH INSECT BIOCHEM, V42, P51, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;51::AID-ARCH6&gt;3.0.CO;2-6; Gahan LJ, 2007, J ECON ENTOMOL, V100, P187, DOI 10.1603/0022-0493(2007)100[187:APCRSO]2.0.CO;2; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gahan LJ, 2005, J ECON ENTOMOL, V98, P1357, DOI 10.1603/0022-0493-98.4.1357; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; GOULD F, 1995, J ECON ENTOMOL, V88, P1545, DOI 10.1093/jee/88.6.1545; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Hua G, 2009, BIOCHEMISTRY-US, V48, P9785, DOI 10.1021/bi9014538; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Jurat-Fuentes JL, 2004, BIOCHEMISTRY-US, V43, P14299, DOI 10.1021/bi048500i; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Jurat-Fuentes JL, 2003, APPL ENVIRON MICROB, V69, P5898, DOI 10.1128/AEM.69.10.5898-5906.2003; Jurat-Fuentes JL, 2002, APPL ENVIRON MICROB, V68, P5711, DOI 10.1128/AEM.68.11.5711-5717.2002; Jurat-Fuentes JL, 2001, APPL ENVIRON MICROB, V67, P323, DOI 10.1128/AEM.67.1.323-329.2001; Jurat-Fuentes JL, 2007, J INVERTEBR PATHOL, V95, P187, DOI 10.1016/j.jip.2007.01.008; Jurat-Fuentes JL, 2006, J INVERTEBR PATHOL, V92, P166, DOI 10.1016/j.jip.2006.01.010; Karumbaiah L, 2007, COMP BIOCHEM PHYS B, V146, P139, DOI 10.1016/j.cbpb.2006.10.104; Kaur M, 2009, J ENVIRON BIOL, V30, P1019; Krishnamoorthy M, 2007, INSECT BIOCHEM MOLEC, V37, P189, DOI 10.1016/j.ibmb.2006.10.004; KUCERA M, 1974, ACTA ENTOMOL BOHEMOS, V71, P289; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liang GM, 2008, J INVERTEBR PATHOL, V97, P142, DOI 10.1016/j.jip.2007.09.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu MG, 2004, PEST MANAG SCI, V60, P887, DOI 10.1002/ps.882; Luo K, 1997, INSECT BIOCHEM MOLEC, V27, P735, DOI 10.1016/S0965-1748(97)00052-0; Martinez-Ramirez AC, 1999, BIOCONTROL SCI TECHN, V9, P239, DOI 10.1080/09583159929811; Martins ES, 2010, INSECT BIOCHEM MOLEC, V40, P138, DOI 10.1016/j.ibmb.2010.01.005; McNall RJ, 2003, INSECT BIOCHEM MOLEC, V33, P999, DOI 10.1016/S0965-1748(03)00114-0; Meng FX, 2004, PEST MANAG SCI, V60, P167, DOI 10.1002/ps.806; Miao YG, 2002, J APPL ENTOMOL, V126, P138, DOI 10.1046/j.1439-0418.2002.00625.x; Morin S, 2004, INSECT BIOCHEM MOLEC, V34, P1225, DOI 10.1016/j.ibmb.2004.08.003; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Ning CM, 2010, J INSECT PHYSIOL, V56, P666, DOI 10.1016/j.jinsphys.2010.02.003; Pardo-Lopez L, 2006, BIOCHEMISTRY-US, V45, P10329, DOI 10.1021/bi060297z; Perera OP, 2009, INSECT BIOCHEM MOLEC, V39, P294, DOI 10.1016/j.ibmb.2009.01.006; Rahman MM, 2004, P NATL ACAD SCI USA, V101, P2696, DOI 10.1073/pnas.0306669101; Raymond B, 2010, TRENDS MICROBIOL, V18, P189, DOI 10.1016/j.tim.2010.02.006; SANGADALA S, 1994, J BIOL CHEM, V269, P10088; Hernandez-Rodriguez CS, 2008, APPL ENVIRON MICROB, V74, P7654, DOI 10.1128/AEM.01373-08; Sarkar A, 2009, J PROTEOME RES, V8, P1838, DOI 10.1021/pr8006528; Soberon M, 2009, CELL MOL LIFE SCI, V66, P1337, DOI 10.1007/s00018-008-8330-9; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Suzuki A, 1999, ENDOCRINOLOGY, V140, P3177, DOI 10.1210/en.140.7.3177; Suzuki A, 2002, BONE, V30, P91, DOI 10.1016/S8756-3282(01)00660-3; Tabashnik BE, 2005, J ECON ENTOMOL, V98, P635, DOI 10.1603/0022-0493-98.3.635; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P2125, DOI 10.1603/0022-0493-99.6.2125; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P1525, DOI 10.1603/0022-0493-99.5.1525; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Xu ZP, 2009, PEST MANAG SCI, V65, P391, DOI 10.1002/ps.1703; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103; Zhao J, 2010, INSECT BIOCHEM MOLEC, V40, P113, DOI 10.1016/j.ibmb.2010.01.001; Zhuang MB, 2002, J BIOL CHEM, V277, P13863, DOI 10.1074/jbc.M110057200	69	119	134	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17606	10.1371/journal.pone.0017606	http://dx.doi.org/10.1371/journal.pone.0017606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390253	Green Submitted, Green Published, gold			2022-12-25	WOS:000287932100025
J	Gomila, RC; Martin, GW; Gehrke, L				Gomila, Raul C.; Martin, Glover W., III; Gehrke, Lee			NF90 Binds the Dengue Virus RNA 3 ' Terminus and Is a Positive Regulator of Dengue Virus Replication	PLOS ONE			English	Article							3'-TERMINAL STEM-LOOP; 3'-UNTRANSLATED REGION; MESSENGER-RNA; GENOMIC RNA; SECONDARY STRUCTURE; CYCLIZATION SEQUENCES; BREAST-CANCER; DC-SIGN; PROTEIN; TRANSLATION	Background: Viral RNA translation and replication are regulated by sequence and structural elements in the 5' and 3' untranslated regions (UTR) and by host cell and/or viral proteins that bind them. Dengue virus has a single-stranded RNA genome with positive polarity, a 5' m7GpppG cap, and a conserved 3'-terminal stem loop (SL) that is linked to proposed functions in viral RNA transcription and translation. Mechanisms explaining the contributions of host proteins to viral RNA translation and replication are poorly defined, yet understanding host protein-viral RNA interactions may identify new targets for therapeutic intervention. This study was directed at identifying functionally significant host proteins that bind the conserved dengue virus RNA 3' terminus. Methodology/Principal Findings: Proteins eluted from a dengue 3' SL RNA affinity column at increasing ionic strength included two with double-strand RNA binding motifs (NF90/DRBP76 and DEAH box polypeptide 9/RNA helicase A (RHA)), in addition to NF45, which forms a heterodimer with NF90. Although detectable NF90 and RHA proteins localized to the nucleus of uninfected cells, immunofluorescence revealed cytoplasmic NF90 in dengue virus-infected cells, leading us to hypothesize that NF90 has a functional role(s) in dengue infections. Cells depleted of NF90 were used to quantify viral RNA transcript levels and production of infectious dengue virus. NF90 depletion was accompanied by a 50%-70% decrease in dengue RNA levels and in production of infectious viral progeny. Conclusions/Significance: The results indicate that NF90 interacts with the 3' SL structure of the dengue RNA and is a positive regulator of dengue virus replication. NF90 depletion diminished the production of infectious dengue virus by more than 50%, which may have important significance for identifying therapeutic targets to limit a virus that threatens more than a billion people worldwide.	Harvard Univ, Sch Med, Div Hlth Sci, Boston, MA USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gomila, RC (corresponding author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.	lee_gehrke@hms.harvard.edu			Ruth L. Kirschstein National Research Service Award; NIH-NRSA [GM64985]; UNCF-Merck; NIAID New England Regional Center for Excellence in Biodefense and Emerging Infectious Disease (NERCE-BEID); Ellison Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042504, F31GM064985] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNCF-Merck(Merck & Company); NIAID New England Regional Center for Excellence in Biodefense and Emerging Infectious Disease (NERCE-BEID); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Ruth L. Kirschstein National Research Service Award Predoctoral Fellowship, NIH-NRSA GM64985, to RCG; a UNCF-Merck Postdoctoral Fellowship and NIAID New England Regional Center for Excellence in Biodefense and Emerging Infectious Disease (NERCE-BEID) Career Development Fellowship to GWM; and an award to LG from the Ellison Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2004, AM J PATHOL, V164, P1683, DOI 10.1016/S0002-9440(10)63727-3; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014; BAKER PR, CLAUSER KR MS FIT; Balliet JW, 1999, J VIROL, V73, P3054, DOI 10.1128/JVI.73.4.3054-3061.1999; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; BLACKWELL JL, 1995, J VIROL, V69, P5650, DOI 10.1128/JVI.69.9.5650-5658.1995; BRAY M, 1991, P NATL ACAD SCI USA, V88, P10342, DOI 10.1073/pnas.88.22.10342; Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0; BRINTON MA, 1986, VIROLOGY, V153, P113, DOI 10.1016/0042-6822(86)90012-7; CALNAN BJ, 1991, GENE DEV, V5, P201, DOI 10.1101/gad.5.2.201; Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997; Copeland PR, 2002, METHOD ENZYMOL, V347, P40; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; DENG RT, 1993, NUCLEIC ACIDS RES, V21, P1949, DOI 10.1093/nar/21.8.1949; Dibbens JA, 1999, MOL BIOL CELL, V10, P907, DOI 10.1091/mbc.10.4.907; Elghonemy S, 2005, VIROLOGY, V331, P238, DOI 10.1016/j.virol.2004.11.008; GRANGE T, 1985, FEBS LETT, V188, P159, DOI 10.1016/0014-5793(85)80895-4; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Heukelbach J, 2001, TROP MED INT HEALTH, V6, P635, DOI 10.1046/j.1365-3156.2001.00762.x; Holden KL, 2006, VIROLOGY, V344, P439, DOI 10.1016/j.virol.2005.08.034; Holden KL, 2004, VIROLOGY, V329, P119, DOI 10.1016/j.virol.2004.08.004; HOUSERSCOTT F, 1994, J VIROL, V68, P2194, DOI 10.1128/JVI.68.4.2194-2205.1994; Isken O, 2003, EMBO J, V22, P5655, DOI 10.1093/emboj/cdg562; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Ito T, 1997, J VIROL, V71, P8698, DOI 10.1128/JVI.71.11.8698-8706.1997; JOBLING SA, 1988, NUCLEIC ACIDS RES, V16, P4483, DOI 10.1093/nar/16.10.4483; Kaminski A, 1995, RNA, V1, P924; Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001; Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005; Larcher JC, 2004, FASEB J, V18, P1761, DOI 10.1096/fj.04-1763fje; Lawrence P, 2009, J VIROL, V83, P11356, DOI 10.1128/JVI.02677-08; Liao HJ, 1998, P NATL ACAD SCI USA, V95, P8514, DOI 10.1073/pnas.95.15.8514; Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996; Merrill MK, 2006, J VIROL, V80, P3147, DOI 10.1128/JVI.80.7.3147-3156.2006; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200; Parrott AM, 2005, J MOL BIOL, V348, P281, DOI 10.1016/j.jmb.2005.02.047; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfeifer I, 2008, P NATL ACAD SCI USA, V105, P4173, DOI 10.1073/pnas.0711222105; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; Shi LF, 2005, J BIOL CHEM, V280, P18981, DOI 10.1074/jbc.M411034200; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Tilgner M, 2005, VIROLOGY, V331, P375, DOI 10.1016/j.virol.2004.07.022; Vumbaca F, 2008, MOL CELL BIOL, V28, P772, DOI 10.1128/MCB.02078-06; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; You SY, 2001, J BIOL CHEM, V276, P15581, DOI 10.1074/jbc.M010923200; Yu L, 2005, J VIROL, V79, P2309, DOI 10.1128/JVI.79.4.2309-2324.2005; Zeng LL, 1998, J VIROL, V72, P7510, DOI 10.1128/JVI.72.9.7510-7522.1998	56	71	72	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16687	10.1371/journal.pone.0016687	http://dx.doi.org/10.1371/journal.pone.0016687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386893	gold, Green Published, Green Submitted			2022-12-25	WOS:000287931400009
J	Narbonne-Reveau, K; Charroux, B; Royet, J				Narbonne-Reveau, Karine; Charroux, Bernard; Royet, Julien			Lack of an Antibacterial Response Defect in Drosophila Toll-9 Mutant	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION RECEPTORS; ANTIMICROBIAL PEPTIDE GENES; DORSAL-VENTRAL POLARITY; GENOME-WIDE ANALYSIS; IMMUNE-RESPONSE; HOST-DEFENSE; NEGATIVE REGULATOR; EXPRESSION; INDUCTION	Toll and Toll-like receptors represent families of receptors involved in mediating innate immunity response in insects and mammals. Although Drosophila proteome contains multiple Toll paralogs, Toll-1 is, so far, the only receptor to which an immune role has been attributed. In contrast, every single mammalian TLR is a key membrane receptor upstream of the vertebrate immune signaling cascades. The prevailing view is that TLR-mediated immunity is ancient. Structural analysis reveals that Drosophila Toll-9 is the most closely related to vertebrate TLRs and utilizes similar signaling components as Toll-1. This suggests that Toll-9 could be an ancestor of TLR-like receptors and could have immune function. Consistently, it has been reported that over-expression of Toll-9 in immune tissues is sufficient to induce the expression of some antimicrobial peptides in flies. These results have led to the idea that Toll-9 could be a constitutively active receptor that maintain significant levels of antimicrobial molecules and therefore provide constant basal protection against micro-organisms. To test theses hypotheses, we generated and analyzed phenotypes associated with a complete loss-of-function allele of Toll-9. Our results suggest that Toll-9 is neither required to maintain a basal anti-microbial response nor to mount an efficient immune response to bacterial infection.	[Narbonne-Reveau, Karine; Charroux, Bernard; Royet, Julien] Univ Aix Marseille 2, CNRS, UMR 6216, IBDML, F-13284 Marseille 07, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Narbonne-Reveau, K (corresponding author), Univ Aix Marseille 2, CNRS, UMR 6216, IBDML, Campus Luminy, F-13284 Marseille 07, France.	royet@ibdml.univmed.fr		Narbonne-Reveau, Karine/0000-0002-4650-4576	Centre National de la Recherche Scientifique, Agence Nationale de la Recherche; Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique, Agence Nationale de la Recherche(French National Research Agency (ANR)Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by Centre National de la Recherche Scientifique, Agence Nationale de la Recherche and Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KV, 1985, CELL, V42, P791, DOI 10.1016/0092-8674(85)90275-2; Armant MA, 2002, GENOME BIOL, V3; Bergmann A, 1996, MECH DEVELOP, V60, P109, DOI 10.1016/S0925-4773(96)00607-7; Bettencourt R, 2004, J ENDOTOXIN RES, V10, P261, DOI 10.1179/096805104225004897; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bilak H, 2003, BIOCHEM SOC T, V31, P648, DOI 10.1042/bst0310648; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007; Charroux B, 2010, FLY, V4, P40, DOI 10.4161/fly.4.1.10810; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Defaye A, 2009, J INNATE IMMUN, V1, P322, DOI 10.1159/000210264; DEV A, 2010, CURR TOP MICROBIOL I; Du X, 2000, EUR CYTOKINE NETW, V11, P362; ELDON E, 1994, DEVELOPMENT, V120, P885; Fernandez NQ, 2001, DEVELOPMENT, V128, P2963; Gangloff M, 2008, J BIOL CHEM, V283, P14629, DOI 10.1074/jbc.M800112200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Halfon MS, 1998, DEV BIOL, V199, P164, DOI 10.1006/dbio.1998.8915; HALFON MS, 1995, DEV BIOL, V169, P151, DOI 10.1006/dbio.1995.1134; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Hetru C, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000232; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hoshino K, 1999, J IMMUNOL, V162, P3749; Imler JL, 2004, J LEUKOCYTE BIOL, V75, P18, DOI 10.1189/jlb.0403160; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Kambris Zakaria, 2002, Gene Expression Patterns, V2, P311, DOI 10.1016/S1567-133X(02)00020-0; Kanzok SM, 2004, J MOL EVOL, V58, P442, DOI 10.1007/s00239-003-2565-8; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kim S, 2006, GENESIS, V44, P541, DOI 10.1002/dvg.20245; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2008, NAT REV GENET, V9, P165, DOI 10.1038/nrg2303; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Luo CH, 2000, IMMUNOGENETICS, V51, P92, DOI 10.1007/s002510050017; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Moncrieffe MC, 2008, J BIOL CHEM, V283, P33447, DOI 10.1074/jbc.M805427200; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Okun E, 2010, P NATL ACAD SCI USA, V107, P15625, DOI 10.1073/pnas.1005807107; Ooi JY, 2002, EMBO REP, V3, P82, DOI 10.1093/embo-reports/kvf004; Pal S, 2009, ADV EXP MED BIOL, V653, P162; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006; Rehorn KP, 1996, DEVELOPMENT, V122, P4023; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rose D, 1997, DEVELOPMENT, V124, P1561; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Seppo A, 2003, DEVELOPMENT, V130, P1439, DOI 10.1242/dev.00347; Shechter R, 2008, J CELL BIOL, V183, P393, DOI 10.1083/jcb.200804010; Sun HY, 2004, EMBO J, V23, P100, DOI 10.1038/sj.emboj.7600033; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202; Wu S, 2010, DEV COMP IMMUNOL, V34, P93, DOI 10.1016/j.dci.2009.08.010; Yagi Y, 2010, DEV GROWTH DIFFER, V52, P771, DOI 10.1111/j.1440-169X.2010.01213.x	71	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17470	10.1371/journal.pone.0017470	http://dx.doi.org/10.1371/journal.pone.0017470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386906	Green Published, Green Submitted, gold			2022-12-25	WOS:000287931400080
J	Stoks, R; De Block, M				Stoks, Robby; De Block, Marjan			Rapid Growth Reduces Cold Resistance: Evidence from Latitudinal Variation in Growth Rate, Cold Resistance and Stress Proteins	PLOS ONE			English	Article							LIFE-HISTORY VARIATION; COMPENSATORY GROWTH; TIME CONSTRAINTS; PHOSPHOGLUCOSE ISOMERASE; DROSOPHILA-MELANOGASTER; PHYSIOLOGICAL COSTS; GENETIC-VARIATION; OXIDATIVE STRESS; TRADE-OFF; EXPRESSION	Background: Physiological costs of rapid growth may contribute to the observation that organisms typically grow at submaximal rates. Although, it has been hypothesized that faster growing individuals would do worse in dealing with suboptimal temperatures, this type of cost has never been explored empirically. Furthermore, the mechanistic basis of the physiological costs of rapid growth is largely unexplored. Methodology/Principal Finding: Larvae of the damselfly Ischnura elegans from two univoltine northern and two multivoltine southern populations were reared at three temperatures and after emergence given a cold shock. Cold resistance, measured by chill coma recovery times in the adult stage, was lower in the southern populations. The faster larval growth rates in the southern populations contributed to this latitudinal pattern in cold resistance. In accordance with their assumed role in cold resistance, Hsp70 levels were lower in the southern populations, and faster growing larvae had lower Hsp70 levels. Yet, individual variation in Hsp70 levels did not explain variation in cold resistance. Conclusions/Significance: We provide evidence for a novel cost of rapid growth: reduced cold resistance. Our results indicate that the reduced cold resistance in southern populations of animals that change voltinism along the latitudinal gradient may not entirely be explained by thermal selection per se but also by the costs of time constraint-induced higher growth rates. This also illustrates that stressors imposed in the larval stage may carry over and shape fitness in the adult stage and highlights the importance of physiological costs in the evolution of life-histories at macro-scales.	[Stoks, Robby; De Block, Marjan] Katholieke Univ Leuven, Lab Aquat Ecol & Evolutionary Biol, Louvain, Belgium	KU Leuven	Stoks, R (corresponding author), Katholieke Univ Leuven, Lab Aquat Ecol & Evolutionary Biol, Louvain, Belgium.	robby.stoks@bio.kuleuven.be	Stoks, Robby/AAK-1227-2020	Stoks, Robby/0000-0003-4130-0459	Fund for Scientific Research - Flanders [G.0419.08]; KULeuven Research Fund [GOA/2008/06, PF/10/007]	Fund for Scientific Research - Flanders(FWO); KULeuven Research Fund(KU Leuven)	This research was supported by a research grant of the Fund for Scientific Research - Flanders (G.0419.08) and research grants from the KULeuven Research Fund (GOA/2008/06 and PF/10/007). M. De Block is postdoctoral researcher of the Fund for Scientific Research - Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, AM NAT, V147, P381, DOI 10.1086/285857; Altermatt F, 2010, P ROY SOC B-BIOL SCI, V277, P1281, DOI 10.1098/rspb.2009.1910; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; AYRES MP, 1994, ECOL MONOGR, V64, P465, DOI 10.2307/2937146; Chown SL, 1999, BIOL REV, V74, P87, DOI 10.1017/S000632319800526X; Clowers KJ, 2010, GENET RES, V92, P103, DOI 10.1017/S0016672310000108; Colinet H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010925; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Corbet Philip S., 2006, International Journal of Odonatology, V9, P1; Dahlhoff EP, 2000, P NATL ACAD SCI USA, V97, P10056, DOI 10.1073/pnas.160277697; De Block M, 2004, OECOLOGIA, V140, P68, DOI 10.1007/s00442-004-1575-6; De Block M, 2005, ECOLOGY, V86, P185, DOI 10.1890/04-0116; De Block M, 2008, ECOL ENTOMOL, V33, P796, DOI 10.1111/j.1365-2311.2008.01024.x; De Block M, 2008, P ROY SOC B-BIOL SCI, V275, P781, DOI 10.1098/rspb.2007.1515; Dijkstra K.-D.-B., 2006, FIELD GUIDE DRAGONFL; Fischer K, 2004, EVOL ECOL, V18, P343, DOI 10.1007/s10682-004-2004-3; Gaston KJ, 2009, AM NAT, V174, P595, DOI 10.1086/605982; Gotthard K, 2000, J ANIM ECOL, V69, P896, DOI 10.1046/j.1365-2656.2000.00432.x; Gotthard K, 2001, EXPTL BIOL REV, P287; GOTTHARD K, 1994, OECOLOGIA, V99, P281, DOI 10.1007/BF00627740; Hall ME, 2010, FUNCT ECOL, V24, P365, DOI 10.1111/j.1365-2435.2009.01635.x; Hoffmann AA, 2005, FUNCT ECOL, V19, P222, DOI 10.1111/j.1365-2435.2005.00959.x; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Johansson F, 1999, ECOLOGY, V80, P1242, DOI 10.2307/177071; Johansson F, 2001, ECOLOGY, V82, P1857, DOI 10.1890/0012-9658(2001)082[1857:LHPIAD]2.0.CO;2; Karl I, 2008, FUNCT ECOL, V22, P887, DOI 10.1111/j.1365-2435.2008.01438.x; Karl I, 2009, J EVOLUTION BIOL, V22, P172, DOI 10.1111/j.1420-9101.2008.01630.x; Karl I, 2008, OIKOS, V117, P778, DOI 10.1111/j.0030-1299.2008.16522.x; Kostal V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004546; Krebs RA, 1997, CELL STRESS CHAPERON, V2, P60, DOI 10.1379/1466-1268(1997)002<0060:DCOHOI>2.3.CO;2; Nygren GH, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.4701; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Ragland GJ, 2007, J EVOLUTION BIOL, V20, P2144, DOI 10.1111/j.1420-9101.2007.01428.x; Ragland GJ, 2008, EVOLUTION, V62, P1345, DOI 10.1111/j.1558-5646.2008.00367.x; Richter-Boix A, 2010, MOL ECOL, V19, P716, DOI 10.1111/j.1365-294X.2009.04502.x; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Roff Derek A., 1992; Rolff J, 2004, AM NAT, V164, P559, DOI 10.1086/423715; Slos S, 2008, FUNCT ECOL, V22, P637, DOI 10.1111/j.1365-2435.2008.01424.x; Soler JJ, 2003, P ROY SOC B-BIOL SCI, V270, P241, DOI 10.1098/rspb.2002.2217; Sonoda S, 2006, ARCH INSECT BIOCHEM, V63, P36, DOI 10.1002/arch.20138; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Stearns S.C., 1992, pi; Stoks R, 2005, J ANIM ECOL, V74, P708, DOI 10.1111/j.1365-2656.2005.00969.x; Stoks R, 2006, ECOLOGY, V87, P1566, DOI 10.1890/0012-9658(2006)87[1566:PCOCGI]2.0.CO;2; Tammaru T, 2004, OIKOS, V107, P352, DOI 10.1111/j.0030-1299.2004.13363.x; Turnbull LA, 2008, ECOLOGY, V89, P1352, DOI 10.1890/07-1531.1; Van Doorslaer W, 2005, OIKOS, V111, P599, DOI 10.1111/j.1600-0706.2005.14335.x	51	64	66	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16935	10.1371/journal.pone.0016935	http://dx.doi.org/10.1371/journal.pone.0016935			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390210	Green Published, gold, Green Submitted			2022-12-25	WOS:000287761700018
J	Arsenault, D; Julien, C; Tremblay, C; Calon, F				Arsenault, Dany; Julien, Carl; Tremblay, Cyntia; Calon, Frederic			DHA Improves Cognition and Prevents Dysfunction of Entorhinal Cortex Neurons in 3xTg-AD Mice	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; DIETARY DOCOSAHEXAENOIC ACID; BETA-AMYLOID ACCUMULATION; TRIPLE-TRANSGENIC MODEL; ALZHEIMERS-DISEASE; SYNAPTIC NOISE; MOUSE MODEL; MEMBRANE CAPACITANCE; RECOGNITION MEMORY; PREFRONTAL CORTEX	Defects in neuronal activity of the entorhinal cortex (EC) are suspected to underlie the symptoms of Alzheimer's disease (AD). Whereas neuroprotective effects of docosahexaenoic acid (DHA) have been described, the effects of DHA on the physiology of EC neurons remain unexplored in animal models of AD. Here, we show that DHA consumption improved object recognition (up arrow 12%), preventing deficits observed in old 3xTg-AD mice (down arrow 12%). Moreover, 3xTg-AD mice displayed seizure-like akinetic episodes, not detected in NonTg littermates and partly prevented by DHA (down arrow 50%). Patch-clamp recording revealed that 3xTg-AD EC neurons displayed (i) loss of cell capacitance (CC), suggesting reduced membrane surface area; (ii) increase of firing rate versus injected current (F-I) curve associated with modified action potentials, and (iii) overactivation of glutamatergic synapses, without changes in synaptophysin levels. DHA consumption increased CC (up arrow 12%) and decreased F-I slopes (down arrow 21%), thereby preventing the opposite alterations observed in 3xTg-AD mice. Our results indicate that cognitive performance and basic physiology of EC neurons depend on DHA intake in a mouse model of AD.	[Arsenault, Dany; Julien, Carl; Calon, Frederic] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Arsenault, Dany; Julien, Carl; Tremblay, Cyntia; Calon, Frederic] CHUL CHUQ Quebec, Ctr Rech, Quebec City, PQ, Canada	Laval University; Laval University	Arsenault, D (corresponding author), Univ Laval, Fac Pharm, Quebec City, PQ, Canada.	Frederic.Calon@crchul.ulaval.ca	Calon, Frederic/AAF-4390-2020; Julien, Carl/AAU-5309-2021	Calon, Frederic/0000-0002-4203-0887	Canadian Institutes of Health Research (CIHR) [FC - MOP74443]; Alzheimer Society Canada [FC - ASC 0516]; Canada Foundation for Innovation [10307]; "Fonds d'Enseignement and de Recherche" from the faculty of pharmacy of Laval University; "Fonds de la recherche en sante du Quebec (FRSQ)"; Clinical Research Initiative; CIHR Institute of Aging [CAN-76833]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alzheimer Society Canada; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); "Fonds d'Enseignement and de Recherche" from the faculty of pharmacy of Laval University; "Fonds de la recherche en sante du Quebec (FRSQ)"(Fonds de la Recherche en Sante du Quebec); Clinical Research Initiative; CIHR Institute of Aging(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) (FC - MOP74443), the Alzheimer Society Canada (FC - ASC 0516) and the Canada Foundation for Innovation (10307). D. Arsenault held studentships from the CIHR and "Fonds d'Enseignement and de Recherche" from the faculty of pharmacy of Laval University. C. Julien is supported by the Alzheimer Society Canada, "Fonds de la recherche en sante du Quebec (FRSQ)" and the "Fonds d'Enseignement and de Recherche" from the faculty of pharmacy of Laval University. The work of F. Calon was supported by a New Investigator Award from the Clinical Research Initiative and the CIHR Institute of Aging (CAN-76833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav I, 2006, CEREB CORTEX, V16, P1759, DOI 10.1093/cercor/bhj114; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Arsenault D, 2006, J PHYSIOL-LONDON, V573, P121, DOI 10.1113/jphysiol.2006.106542; Balderas I, 2008, LEARN MEMORY, V15, P618, DOI 10.1101/lm.1028008; Boston PF, 2004, PROSTAG LEUKOTR ESS, V71, P341, DOI 10.1016/j.plefa.2004.07.001; Boudrault C, 2009, J NUTR BIOCHEM, V20, P1, DOI 10.1016/j.jnutbio.2008.05.016; Bousquet M, 2008, FASEB J, V22, P1213, DOI 10.1096/fj.07-9677com; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brenna JT, 2007, PROSTAG LEUKOTR ESS, V77, P247, DOI 10.1016/j.plefa.2007.10.016; Brunel N, 2001, PHYS REV LETT, V86, P2186, DOI 10.1103/PhysRevLett.86.2186; Bruno MJ, 2007, P NATL ACAD SCI USA, V104, P9638, DOI 10.1073/pnas.0701015104; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Calon F, 2005, EUR J NEUROSCI, V22, P617, DOI 10.1111/j.1460-9568.2005.04253.x; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Calon F, 2007, PROSTAG LEUKOTR ESS, V77, P287, DOI 10.1016/j.plefa.2007.10.019; Cao DH, 2009, J NEUROCHEM, V111, P510, DOI 10.1111/j.1471-4159.2009.06335.x; Chang YM, 2005, CEREB CORTEX, V15, P409, DOI 10.1093/cercor/bhh144; Chen CT, 2009, PROSTAG LEUKOTR ESS, V80, P157, DOI 10.1016/j.plefa.2009.01.005; Chiu CC, 2008, PROG NEURO-PSYCHOPH, V32, P1538, DOI 10.1016/j.pnpbp.2008.05.015; Clinton LK, 2007, NEUROBIOL DIS, V28, P76, DOI 10.1016/j.nbd.2007.06.013; Counts SE, 2006, J NEUROPATH EXP NEUR, V65, P592, DOI 10.1097/00005072-200606000-00007; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; de Lima MN, 2006, NEUROSCI LETT, V405, P142, DOI 10.1016/j.neulet.2006.06.044; Devore EE, 2009, AM J CLIN NUTR, V90, P170, DOI 10.3945/ajcn.2008.27037; Diau GY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-11; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Dong HX, 2007, J COMP NEUROL, V500, P311, DOI 10.1002/cne.21176; Dullemeijer C, 2008, BRIT J NUTR, V100, P794, DOI 10.1017/S0007114508943737; Duyckaerts C, 2004, NEUROBIOL AGING, V25, P735, DOI 10.1016/neurobiolaging.2003.12.014; Faumont S, 2006, J NEUROPHYSIOL, V95, P3665, DOI 10.1152/jn.00052.2006; FERRER I, 1990, ACTA NEUROPATHOL, V79, P680, DOI 10.1007/BF00294247; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fotuhi M, 2009, NAT CLIN PRACT NEURO, V5, P140, DOI 10.1038/ncpneuro1044; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; Golowasch J, 2009, J NEUROPHYSIOL, V102, P2161, DOI 10.1152/jn.00160.2009; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Haag M, 2003, CAN J PSYCHIAT, V48, P195, DOI 10.1177/070674370304800308; Hamilton JA, 2002, MOL CELL BIOCHEM, V239, P17, DOI 10.1023/A:1020542220599; Hamilton JA, 2007, J MOL NEUROSCI, V33, P12, DOI 10.1007/s12031-007-0050-3; Haroutunian V, 1998, ARCH NEUROL-CHICAGO, V55, P1185, DOI 10.1001/archneur.55.9.1185; Haroutunian V, 1999, ARCH NEUROL-CHICAGO, V56, P713, DOI 10.1001/archneur.56.6.713; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Heude B, 2003, AM J CLIN NUTR, V77, P803, DOI 10.1093/ajcn/77.4.803; Hogan SA, 2003, J MICROENCAPSUL, V20, P675, DOI 10.1080/0265204031000151974; Hooijmans CR, 2009, NEUROBIOL DIS, V33, P482, DOI 10.1016/j.nbd.2008.12.002; Hsieh AT, 2009, PROSTAG LEUKOTR ESS, V81, P105, DOI 10.1016/j.plefa.2009.05.012; Huang TL, 2005, NEUROLOGY, V65, P1409, DOI 10.1212/01.wnl.0000183148.34197.2e; Hunt CA, 1996, J NEUROSCI, V16, P1380; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; Julien C, 2010, NEUROBIOL AGING, V31, P1516, DOI 10.1016/j.neurobiolaging.2008.08.022; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; King DL, 2002, BRAIN RES, V926, P58, DOI 10.1016/S0006-8993(01)03294-2; Kohn AF, 1998, BIOSYSTEMS, V48, P113; Kolanowski W, 2004, INT J FOOD SCI NUTR, V55, P333, DOI 10.1080/09637480410001725157; Kotani S, 2006, NEUROSCI RES, V56, P159, DOI 10.1016/j.neures.2006.06.010; Kroger E, 2009, AM J CLIN NUTR, V90, P184, DOI 10.3945/ajcn.2008.26987; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lipton P. A., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/258467; Martin RE, 2000, NEUROCHEM RES, V25, P715, DOI 10.1023/A:1007575406896; Martinez-Coria H, 2010, AM J PATHOL, V176, P870, DOI 10.2353/ajpath.2010.090452; Masood A, 2005, J LIPID RES, V46, P2299, DOI 10.1194/jlr.D500022-JLR200; Matthews EA, 2008, P NATL ACAD SCI USA, V105, P15154, DOI 10.1073/pnas.0805855105; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mitchell JH, 2001, CLIN SCI, V100, P613, DOI 10.1042/CS20000212; MIZUSHIMA Y, 1984, EXPERIENTIA, V40, P359, DOI 10.1007/BF01952551; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Namani T, 2007, COLLOID SURFACE B, V54, P118, DOI 10.1016/j.colsurfb.2006.05.022; Nejak-Bowen KN, 2009, J BIOL CHEM, V284, P28115, DOI 10.1074/jbc.M109.047258; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Perez SE, 2010, J NEUROSCI RES, V88, P1026, DOI 10.1002/jnr.22266; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Prescott SA, 2003, P NATL ACAD SCI USA, V100, P2076, DOI 10.1073/pnas.0337591100; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Rao SC, 2009, EPILEPSY BEHAV, V14, P118, DOI 10.1016/j.yebeh.2008.08.012; Robson LG, 2010, NEUROBIOL AGING, V31, P678, DOI 10.1016/j.neurobiolaging.2008.05.027; ROBSON LG, 2008, NEUROBIOL AGING; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Sah P, 2000, CLIN EXP PHARMACOL P, V27, P657, DOI 10.1046/j.1440-1681.2000.03317.x; Sakamoto T, 2007, BRAIN RES, V1182, P50, DOI 10.1016/j.brainres.2007.08.089; SALEM N, 1989, OMEGA 3 FATTY ACIDS, P109; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Scheff SW, 2006, J ALZHEIMERS DIS, V9, P101; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; SERTH J, 1991, EMBO J, V10, P1325, DOI 10.1002/j.1460-2075.1991.tb07651.x; Sewards TV, 2003, BRAIN RES REV, V42, P243, DOI 10.1016/S0165-0173(03)00175-9; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Stacey WC, 2009, J NEUROPHYSIOL, V102, P2342, DOI 10.1152/jn.00397.2009; Sterniczuk R, 2010, BRAIN RES, V1348, P149, DOI 10.1016/j.brainres.2010.06.011; Sun XD, 2003, NEUROBIOL DIS, V14, P567, DOI 10.1016/j.nbd.2003.08.007; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; TAHA AY, 2010, EPILEPSIA; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thid D, 2007, LANGMUIR, V23, P5878, DOI 10.1021/la700523x; VANDERHEYDEN MJ, 1994, BIOL CYBERN, V72, P133, DOI 10.1007/BF00205977; Voskuyl RA, 1998, EUR J PHARMACOL, V341, P145, DOI 10.1016/S0014-2999(97)01467-2; Wang HB, 2005, P NATL ACAD SCI USA, V102, P9960, DOI 10.1073/pnas.0501632102; Whelan J, 2006, ANNU REV NUTR, V26, P75, DOI 10.1146/annurev.nutr.25.050304.092605; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Woodhall GL, 2005, HIPPOCAMPUS, V15, P232, DOI 10.1002/hipo.20047; Wurtman RJ, 2009, J NUTR HEALTH AGING, V13, P189, DOI 10.1007/s12603-009-0056-3; Xiao YF, 1999, BRAIN RES, V846, P112, DOI 10.1016/S0006-8993(99)01997-6; Young C, 2000, SYNAPSE, V37, P90, DOI 10.1002/1098-2396(200008)37:2&lt;90::AID-SYN2&gt;3.0.CO;2-Z; Yuen AWC, 2005, EPILEPSY BEHAV, V7, P253, DOI 10.1016/j.yebeh.2005.04.014; Yurko-Mauro K, 2010, ALZHEIMERS DEMENT; Zhang ZW, 2005, J PHYSIOL-LONDON, V566, P379, DOI 10.1113/jphysiol.2005.086066; Zhou FM, 1996, J NEUROPHYSIOL, V76, P651, DOI 10.1152/jn.1996.76.2.651	119	123	126	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17397	10.1371/journal.pone.0017397	http://dx.doi.org/10.1371/journal.pone.0017397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383850	Green Published, gold, Green Submitted			2022-12-25	WOS:000287657500054
J	Maier, E; Nord, H; von Hofsten, J; Gunhaga, L				Maier, Esther; Nord, Hanna; von Hofsten, Jonas; Gunhaga, Lena			A Balance of BMP and Notch Activity Regulates Neurogenesis and Olfactory Nerve Formation	PLOS ONE			English	Article							CHICK-EMBRYO; STEM-CELLS; ENDOTHELIAL-CELLS; NEURON LINEAGE; SPINAL-CORD; EXPRESSION; DIFFERENTIATION; EPITHELIUM; PLACODE; SPECIFICATION	Although the function of the adult olfactory system has been thoroughly studied, the molecular mechanisms regulating the initial formation of the olfactory nerve, the first cranial nerve, remain poorly defined. Here, we provide evidence that both modulated Notch and bone morphogenetic protein (BMP) signaling affect the generation of neurons in the olfactory epithelium and reduce the number of migratory neurons, so called epithelioid cells. We show that this reduction of epithelial and migratory neurons is followed by a subsequent failure or complete absence of olfactory nerve formation. These data provide new insights into the early generation of neurons in the olfactory epithelium and the initial formation of the olfactory nerve tract. Our results present a novel mechanism in which BMP signals negatively affect Notch activity in a dominant manner in the olfactory epithelium, thereby regulating neurogenesis and explain why a balance of BMP and Notch activity is critical for the generation of neurons and proper development of the olfactory nerve.	[Maier, Esther; Nord, Hanna; von Hofsten, Jonas; Gunhaga, Lena] Umea Univ, Umea Ctr Mol Med, Umea, Sweden	Umea University	Maier, E (corresponding author), Umea Univ, Umea Ctr Mol Med, Umea, Sweden.	lena.gunhaga@ucmm.umu.se	Maier, Esther/AAR-6123-2020	von Hofsten, Jonas/0000-0003-3730-1790	Magnus Bergvalls Foundation; Umea University, Sweden; O.E. and Edla Johanssons Foundation; Ake Wibergs Foundation	Magnus Bergvalls Foundation; Umea University, Sweden; O.E. and Edla Johanssons Foundation; Ake Wibergs Foundation	J.v.H. is supported by Magnus Bergvalls Foundation, and L. G. is supported by Umea University, Sweden, O.E. and Edla Johanssons Foundation, and Ake Wibergs Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akai J, 2005, GENE DEV, V19, P2877, DOI 10.1101/gad.357705; Alanentalo T, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3000430; Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cau E, 2000, DEVELOPMENT, V127, P2323; Cau E, 2002, DEVELOPMENT, V129, P1871; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; CROUCHER SJ, 1989, DEVELOPMENT, V106, P493; Drapkin PT, 1999, DEV DYNAM, V214, P349, DOI 10.1002/(SICI)1097-0177(199904)214:4<349::AID-AJA7>3.3.CO;2-5; Fior R, 2005, DEV BIOL, V281, P318, DOI 10.1016/j.ydbio.2005.03.017; Fornaro M, 2003, NEUROSCIENCE, V122, P123, DOI 10.1016/j.neuroscience.2003.07.004; Fornaro M, 2001, NEUROSCIENCE, V107, P191, DOI 10.1016/S0306-4522(01)00334-7; GEISERT EE, 1989, NEUROSCI LETT, V102, P137, DOI 10.1016/0304-3940(89)90068-2; Haddon C, 1998, DEVELOPMENT, V125, P359; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; James RG, 2005, DEV BIOL, V288, P113, DOI 10.1016/j.ydbio.2005.09.025; Kee Y, 2001, MECH DEVELOP, V109, P337, DOI 10.1016/S0925-4773(01)00575-5; Lassiter RNT, 2010, DEV BIOL, V344, P836, DOI 10.1016/j.ydbio.2010.05.514; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; Le Roux I, 2003, INT J DEV BIOL, V47, P263; Machold RP, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-5; Maier E, 2010, DEVELOPMENT, V137, P1601, DOI 10.1242/dev.051219; Maier E, 2009, DEV DYNAM, V238, P1617, DOI 10.1002/dvdy.21966; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; MENDOZA AS, 1982, J EMBRYOL EXP MORPH, V69, P47; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Orita Y, 2006, ACTA OTO-LARYNGOL, V126, P498, DOI 10.1080/00016480500437419; Perez SE, 1999, DEVELOPMENT, V126, P1715; Schwarting GA, 2007, J MOL HISTOL, V38, P543, DOI 10.1007/s10735-007-9110-9; Shou J, 1999, NAT NEUROSCI, V2, P339, DOI 10.1038/7251; Shou JY, 2000, DEVELOPMENT, V127, P5403; Sjodal M, 2007, DEV CELL, V13, P141, DOI 10.1016/j.devcel.2007.04.020; Tang LS, 2006, DEVELOPMENT, V133, P3683, DOI 10.1242/dev.02536; Tian GC, 2003, J BIOL CHEM, V278, P28968, DOI 10.1074/jbc.M300905200; Timmer JR, 2002, DEVELOPMENT, V129, P2459; Tsarovina K, 2008, MOL CELL NEUROSCI, V37, P20, DOI 10.1016/j.mcn.2007.08.010; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; VALVERDE F, 1992, NEUROSCIENCE, V49, P255, DOI 10.1016/0306-4522(92)90094-I; Vargesson N, 1998, MECH DEVELOP, V77, P197, DOI 10.1016/S0925-4773(98)00138-5; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	45	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17379	10.1371/journal.pone.0017379	http://dx.doi.org/10.1371/journal.pone.0017379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383851	Green Submitted, Green Published, gold			2022-12-25	WOS:000287657500052
J	Kettle, CJ; Maycock, CR; Ghazoul, J; Hollingsworth, PM; Khoo, E; Sukri, RSH; Burslem, DFRP				Kettle, Chris J.; Maycock, Colin R.; Ghazoul, Jaboury; Hollingsworth, Pete M.; Khoo, Eyen; Sukri, Rahayu Sukmaria Haji; Burslem, David F. R. P.			Ecological Implications of a Flower Size/Number Trade-Off in Tropical Forest Trees	PLOS ONE			English	Article							SPATIAL GENETIC-STRUCTURE; EICHHORNIA-PANICULATA PONTEDERIACEAE; EARLY-LIFE STAGES; POLLEN DISPERSAL; FLORAL DISPLAY; COMPUTER-PROGRAM; SEED DISPERSAL; DIPTEROCARPACEAE; SHOREA; SIZE	Background: In angiosperms, flower size commonly scales negatively with number. The ecological consequences of this trade-off for tropical trees remain poorly resolved, despite their potential importance for tropical forest conservation. We investigated the flower size number trade-off and its implications for fecundity in a sample of tree species from the Dipterocarpaceae on Borneo. Methodology/Principal Findings: We combined experimental exclusion of pollinators in 11 species, with direct and indirect estimates of contemporary pollen dispersal in two study species and published estimates of pollen dispersal in a further three species to explore the relationship between flower size, pollinator size and mean pollen dispersal distance. Maximum flower production was two orders of magnitude greater in small-flowered than large-flowered species of Dipterocarpaceae. In contrast, fruit production was unrelated to flower size and did not differ significantly among species. Small-flowered species had both smaller-sized pollinators and lower mean pollination success than large-flowered species. Average pollen dispersal distances were lower and frequency of mating between related individuals was higher in a smaller-flowered species than a larger-flowered confamilial. Our synthesis of pollen dispersal estimates across five species of dipterocarp suggests that pollen dispersal scales positively with flower size. Conclusions and Their Significance: Trade-offs embedded in the relationship between flower size and pollination success contribute to a reduction in the variance of fecundity among species. It is therefore plausible that these processes could delay competitive exclusion and contribute to maintenance of species coexistence in this ecologically and economically important family of tropical trees. These results have practical implications for tree species conservation and restoration. Seed collection from small-flowered species may be especially vulnerable to cryptic genetic erosion. Our findings also highlight the potential for differential vulnerability of tropical tree species to the deleterious consequences of forest fragmentation.	[Kettle, Chris J.; Ghazoul, Jaboury] ETH, Inst Terr Ecosyst, Zurich, Switzerland; [Kettle, Chris J.; Maycock, Colin R.; Sukri, Rahayu Sukmaria Haji; Burslem, David F. R. P.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Hollingsworth, Pete M.] Royal Bot Gardens, Edinburgh, Midlothian, Scotland; [Khoo, Eyen] Sabah Forest Dept, Forest Res Ctr, Sabah, Malaysia	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Aberdeen; Royal Botanic Gardens, Kew; Pusat Penyelidikan Hutan	Kettle, CJ (corresponding author), ETH, Inst Terr Ecosyst, Zurich, Switzerland.	chris.kettle@env.ethz.ch	Sukri, Rahayu/AAJ-9640-2020; Burslem, David FRP/F-1204-2019; Maycock, Colin Ruzelion/H-3556-2013; Kettle, Chris/A-6160-2011; Ghazoul, Jaboury/B-2121-2018	Sukri, Rahayu/0000-0002-2662-399X; Burslem, David FRP/0000-0001-6033-0990; Maycock, Colin Ruzelion/0000-0002-4368-2545; Hollingsworth, Peter/0000-0003-0602-0654	British Ecological Society; Natural Environment Research Council [NER/A/S/2001/00835, NE/D003822/1]; NERC [NE/D003822/1] Funding Source: UKRI	British Ecological Society; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Financial support was provided by the British Ecological Society (http://www.britishecologicalsociety.org/) "Overseas Research Programme" and the Natural Environment Research Council (http://www.nerc.ac.uk/) grant numbers NER/A/S/2001/00835 and NE/D003822/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2008, MOL ECOL, V17, P5177, DOI 10.1111/j.1365-294X.2008.03971.x; Aldrich PR, 1998, MOL ECOL, V7, P933, DOI 10.1046/j.1365-294x.1998.00396.x; ASHTON PS, 1988, AM NAT, V132, P44, DOI 10.1086/284837; Ashton PS., 2004, TREE FLORA SABAH SAR, P63; Austerlitz F, 2007, HEREDITY, V99, P193, DOI 10.1038/sj.hdy.6800983; BAGCHI R, 2009, ECOLOGY LETT, V9999; BAWA KS, 1998, REV DIPTEROCARPS TAX; de Lacerda AEB, 2008, BIOTROPICA, V40, P462, DOI 10.1111/j.1744-7429.2008.00402.x; Blundell AG, 1998, OECOLOGIA, V117, P151, DOI 10.1007/s004420050643; Blundell AG, 2004, J TROP ECOL, V20, P229, DOI 10.1017/S0266467403001123; Born C, 2008, MOL ECOL, V17, P2041, DOI 10.1111/j.1365-294X.2007.03685.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chambers J, 2009, EVOL ECOL, V23, P737, DOI 10.1007/s10682-008-9269-x; CHARLESWORTH D, 1989, TRENDS ECOL EVOL, V4, P289, DOI 10.1016/0169-5347(89)90023-2; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cloutier D, 2007, MOL ECOL, V16, P797, DOI 10.1111/j.1365-294X.2006.03193.x; Colpaert N, 2005, SILVAE GENET, V54, P265, DOI 10.1515/sg-2005-0038; Curran LM, 2000, ECOL MONOGR, V70, P129, DOI 10.1890/0012-9615(2000)070[0129:ETOTSS]2.0.CO;2; Dayanandan S.C, 1990, REPROD ECOLOGY TROPI; Dick CW, 2003, MOL ECOL, V12, P753, DOI 10.1046/j.1365-294X.2003.01760.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; FOX JED, 1973, HDB KABILI SEPILOK; Fukue Y, 2007, J PLANT RES, V120, P413, DOI 10.1007/s10265-007-0078-z; Gamage DT, 2006, GENES GENET SYST, V81, P1, DOI 10.1266/ggs.81.1; Ghazoul J, 1998, J ECOL, V86, P462, DOI 10.1046/j.1365-2745.1998.00270.x; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Ghazoul J, 1997, J NAT HIST, V31, P901, DOI 10.1080/00222939700770441; Ghazoul J, 2009, ECOLOGY, V90, P369, DOI 10.1890/07-1436.1; Goodwillie C, 2010, NEW PHYTOL, V185, P311, DOI 10.1111/j.1469-8137.2009.03043.x; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Harder LD, 2010, PHILOS T R SOC B, V365, P529, DOI 10.1098/rstb.2009.0226; HARDER LD, 1995, NATURE, V373, P512, DOI 10.1038/373512a0; Hardy OJ, 2006, MOL ECOL, V15, P559, DOI 10.1111/j.1365-294X.2005.02785.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hardy OJ, 2008, BIOL J LINN SOC, V93, P465, DOI 10.1111/j.1095-8312.2007.00898.x; Harrison Rhett D., 2005, Malayan Nature Journal, V57, P67; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Haskell JP, 2002, NATURE, V418, P527, DOI 10.1038/nature00840; Honnay O, 2007, CONSERV BIOL, V21, P823, DOI 10.1111/j.1523-1739.2006.00646.x; Hubbell S.P., 2001, MG POP BIOL, V32; Hufford KM, 2003, EVOLUTION, V57, P518, DOI 10.1111/j.0014-3820.2003.tb01543.x; Hufford KM, 2009, INT J PLANT SCI, V170, P724, DOI 10.1086/599075; Jones FA, 2008, P ROY SOC B-BIOL SCI, V275, P2759, DOI 10.1098/rspb.2008.0894; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kamiya K, 2005, AM J BOT, V92, P775, DOI 10.3732/ajb.92.5.775; Kenta T, 2004, MOL ECOL, V13, P3575, DOI 10.1111/j.1365-294X.2004.02345.x; Kettle CJ, 2008, BIOL CONSERV, V141, P1953, DOI 10.1016/j.biocon.2008.05.008; KETTLE CJ, PERSPECTIVE IN PRESS; Kohyama T, 2009, J ECOL, V97, P463, DOI 10.1111/j.1365-2745.2009.01490.x; Konuma A, 2000, MOL ECOL, V9, P1843, DOI 10.1046/j.1365-294x.2000.01081.x; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Lee SL, 2006, BIOL CONSERV, V131, P72, DOI 10.1016/j.biocon.2006.02.005; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MARTIN EP, 2004, COMPARE VERSION 4 6B; Maycock CR, 2005, J VEG SCI, V16, P635, DOI 10.1111/j.1654-1103.2005.tb02406.x; Momose Kuniyasu, 1996, Plant Species Biology, V11, P189, DOI 10.1111/j.1442-1984.1996.tb00145.x; Naito Y, 2005, J PLANT RES, V118, P423, DOI 10.1007/s10265-005-0245-z; Naito Y, 2008, FOREST ECOL MANAG, V256, P375, DOI 10.1016/j.foreco.2008.04.031; Ng KKS, 2006, TREE GENET GENOMES, V2, P121, DOI 10.1007/s11295-006-0035-3; Ng KKS, 2004, MOL ECOL, V13, P657, DOI 10.1046/j.1365-294X.2004.02094.x; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Osada N, 2001, J TROP ECOL, V17, P911, DOI 10.1017/S0266467401001687; PRIMACK RB, 1987, ANNU REV ECOL SYST, V18, P409, DOI 10.1146/annurev.ecolsys.18.1.409; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Richards SA, 2009, AM NAT, V174, P382, DOI 10.1086/603626; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Robledo-Arnuncio JJ, 2007, MOL ECOL NOTES, V7, P763, DOI 10.1111/j.1471-8286.2007.01706.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Russo SE, 2008, J ECOL, V96, P192, DOI 10.1111/j.1365-2745.2007.01330.x; Sakai S, 1999, AM J BOT, V86, P62, DOI 10.2307/2656955; SAKAI S, 1995, AM NAT, V145, P918, DOI 10.1086/285776; Sakai S, 2002, BIOL J LINN SOC, V75, P233, DOI 10.1111/j.1095-8312.2002.tb01424.x; Sakai Satoki, 2000, Plant Species Biology, V15, P261, DOI 10.1046/j.1442-1984.2000.00045.x; Sargent RD, 2008, INT J PLANT SCI, V169, P39, DOI 10.1086/523359; Sargent RD, 2007, AM J BOT, V94, P2059, DOI 10.3732/ajb.94.12.2059; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Smouse PE, 2001, EVOLUTION, V55, P260; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; Stone GN, 1998, ECOLOGY, V79, P2808, DOI 10.1890/0012-9658(1998)079[2808:POPDFI]2.0.CO;2; Takeuchi Y, 2004, HEREDITY, V92, P323, DOI 10.1038/sj.hdy.6800411; Vamosi JC, 2006, P NATL ACAD SCI USA, V103, P956, DOI 10.1073/pnas.0507165103; Verhulst J, 2008, OECOLOGIA, V156, P95, DOI 10.1007/s00442-008-0980-7; Wells K, 2005, RAFFLES B ZOOL, V53, P281; WOOD GHS, 1964, DIPTEROCARPS SABAH; Worley AC, 2000, EVOLUTION, V54, P1533, DOI 10.1111/j.0014-3820.2000.tb00699.x; Worley AC, 2001, J EVOLUTION BIOL, V14, P469, DOI 10.1046/j.1420-9101.2001.00296.x; Worley AC, 2000, INT J PLANT SCI, V161, P69, DOI 10.1086/314225	91	31	32	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2011	6	2							e16111	10.1371/journal.pone.0016111	http://dx.doi.org/10.1371/journal.pone.0016111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UR	21408110	Green Submitted, Green Published, gold			2022-12-25	WOS:000286835000003
J	Grandinetti, KB; Stevens, TA; Ha, S; Salamone, RJ; Walker, JR; Zhang, J; Agarwalla, S; Tenen, DG; Peters, EC; Reddy, VA				Grandinetti, K. B.; Stevens, T. A.; Ha, S.; Salamone, R. J.; Walker, J. R.; Zhang, J.; Agarwalla, S.; Tenen, D. G.; Peters, E. C.; Reddy, V. A.			Overexpression of TRIB2 in human lung cancers contributes to tumorigenesis through downregulation of C/EBP alpha	ONCOGENE			English	Article						tribbles; lung; C/EBP alpha; TRIM21	STEM-CELLS; PROSPECTIVE IDENTIFICATION; TRIBBLES; MORPHOGENESIS; DIFFERENTIATION; PROLIFERATION; DEGRADATION; EXPRESSION; DROSOPHILA; PROTEINS	Lung cancer is the most common cause of cancer-related mortality worldwide. Here, we report elevated expression of tribbles homolog 2 (TRIB2) in primary human lung tumors and in non-small cell lung cancer cells that express low levels of differentiation-inducing transcription factor CCAAT/enhancer-binding protein alpha (C/EBP alpha). In approximately 10-20% of cases, elevated TRIB2 expression resulted from gene amplification. TRIB2 knockdown was found to inhibit cell proliferation and in vivo tumor growth. In addition, TRIB2 knockdown led to morphological changes similar to C/EBP alpha overexpression and correlated with increased expression and activity of C/EBP alpha. TRIB2-mediated regulation of C/EBP alpha was found to occur through the association of TRIB2 with the E3 ligase TRIM21. Together, these data identify TRIB2 as a potential driver of lung tumorigenesis through a mechanism that involves downregulation of C/EBP alpha. Oncogene (2011) 30, 3328-3335; doi:10.1038/onc.2011.57; published online 14 March 2011	[Grandinetti, K. B.; Stevens, T. A.; Ha, S.; Salamone, R. J.; Walker, J. R.; Zhang, J.; Agarwalla, S.; Peters, E. C.; Reddy, V. A.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Grandinetti, K. B.] Scripps Res Inst, San Diego, CA USA; [Tenen, D. G.] Natl Univ Singapore, Canc Sci Inst, Singapore, Singapore; [Tenen, D. G.] Harvard Stem Cell Inst, Ctr Life Sci, Boston, MA USA	Novartis; Scripps Research Institute; National University of Singapore; Harvard University	Grandinetti, KB (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John Jay Hopkins Dr, San Diego, CA 92121 USA.	bgrandinetti@gnf.org	Peters, Eric/W-2739-2019	Tenen, Daniel/0000-0002-6423-3888	NIH [HL56745, CA90578]; NATIONAL CANCER INSTITUTE [P50CA090578, P20CA090578] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056745] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the NIH (HL56745 and CA90578) to DGT.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Behre G, 2002, J BIOL CHEM, V277, P26293, DOI 10.1074/jbc.M202301200; Cassel TN, 2003, AM J PHYSIOL-LUNG C, V285, pL773, DOI 10.1152/ajplung.00023.2003; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Costa DB, 2007, LUNG CANCER, V56, P97, DOI 10.1016/j.lungcan.2006.11.023; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dedhia PH, 2010, BLOOD, V116, P1321, DOI 10.1182/blood-2009-07-229450; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Halmos B, 2002, CANCER RES, V62, P528; Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Keeshan K, 2006, CANCER CELL, V10, P401, DOI 10.1016/j.ccr.2006.09.012; Keeshan K, 2010, BLOOD, V116, P4948, DOI 10.1182/blood-2009-10-247361; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Naiki T, 2007, J BIOL CHEM, V282, P24075, DOI 10.1074/jbc.M701409200; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oelgeschlager M, 1996, MOL CELL BIOL, V16, P4717; Pan H, 2008, J IMMUNOL METHODS, V329, P31, DOI 10.1016/j.jim.2007.09.009; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sabile A, 2006, MOL CELL BIOL, V26, P5994, DOI 10.1128/MCB.01630-05; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Singh SK, 2003, CANCER RES, V63, P5821; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; TIMCHENKO N, 1995, MOL CELL BIOL, V15, P1192; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Wada K, 2006, BIOCHEM BIOPH RES CO, V339, P415, DOI 10.1016/j.bbrc.2005.11.029; Wada K, 2009, J BIOCHEM, V146, P821, DOI 10.1093/jb/mvp127; Yoshimi R, 2009, J IMMUNOL, V182, P7527, DOI 10.4049/jimmunol.0804121; Zanella F, 2010, ONCOGENE, V29, P2973, DOI 10.1038/onc.2010.58	41	68	72	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2011	30	30					3328	3335		10.1038/onc.2011.57	http://dx.doi.org/10.1038/onc.2011.57			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	798NO	21399661	Green Accepted			2022-12-25	WOS:000293215700003
J	Escobar-Cabrera, E; Okon, M; Lau, DKW; Dart, CF; Bonvin, AMJJ; McIntosh, LP				Escobar-Cabrera, Eric; Okon, Mark; Lau, Desmond K. W.; Dart, Christopher F.; Bonvin, Alexandre M. J. J.; McIntosh, Lawrence P.			Characterizing the N- and C-terminal Small Ubiquitin-like Modifier (SUMO)-interacting Motifs of the Scaffold Protein DAXX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO-BINDING-MOTIF; THYMINE-DNA GLYCOSYLASE; TRANSCRIPTIONAL ACTIVITY; STRUCTURAL-CHARACTERIZATION; INTERACTING MOTIFS; CRYSTAL-STRUCTURE; NMR; SUMOYLATION; COMPLEX; PML	DAXX is a scaffold protein with diverse roles that often depend upon binding SUMO via its N- and/or C-terminal SUMO-interacting motifs (SIM-N and SIM-C). Using NMR spectroscopy, we characterized the in vitro binding properties of peptide models of SIM-N and SIM-C to SUMO-1 and SUMO-2. In each case, binding was mediated by hydrophobic and electrostatic interactions and weakened with increasing ionic strength. Neither isolated SIM showed any significant paralog specificity, and the measured mu M range K-D values of SIM-N toward both SUMO-1 and SUMO-2 were similar to 4-fold lower than those of SIM-C. Furthermore, SIM-N bound SUMO-1 predominantly in a parallel orientation, whereas SIM-C interconverted between parallel and antiparallel binding modes on an ms to mu s time scale. The differences in affinities and binding modes are attributed to the differences in charged residues that flank the otherwise identical hydrophobic core sequences of the two SIMs. In addition, within its native context, SIM-N bound intramolecularly to the adjacent N-terminal helical bundle domain of DAXX, thus reducing its apparent affinity for SUMO. This behavior suggests a possible autoregulatory mechanism for DAXX. The interaction of a C-terminal fragment of DAXX with an N-terminal fragment of the sumoylated Ets1 transcription factor was mediated by SIM-C. Importantly, this interaction did not involve any direct contacts between DAXX and Ets1, but rather was derived from the non-covalent binding of SIM-C to SUMO-1, which in turn was covalently linked to the unstructured N-terminal segment of Ets1. These results provide insights into the binding mechanisms and hence biological roles of the DAXX SUMO-interacting motifs.	[McIntosh, Lawrence P.] Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada; [Escobar-Cabrera, Eric; Okon, Mark; Lau, Desmond K. W.; McIntosh, Lawrence P.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z3, Canada; [Escobar-Cabrera, Eric; Okon, Mark; Lau, Desmond K. W.; McIntosh, Lawrence P.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z3, Canada; [Bonvin, Alexandre M. J. J.] Univ Utrecht, Bijvoet Ctr Biomol Res, Fac Sci, NL-3584 CH Utrecht, Netherlands	University of British Columbia; University of British Columbia; University of British Columbia; Utrecht University	McIntosh, LP (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mcintosh@chem.ubc.ca	Bonvin, Alexandre M.J.J./A-5420-2009	Bonvin, Alexandre M.J.J./0000-0001-7369-1322	Canadian Cancer Society [017308]; Netherlands Organization for Scientific Research [700.56.442]; British Columbia Knowledge Development Fund; University of British Columbia Blusson Fund	Canadian Cancer Society(Canadian Cancer Society (CCS)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); British Columbia Knowledge Development Fund; University of British Columbia Blusson Fund	This work was supported in part by the Canadian Cancer Society (Grant 017308 to L. P. M.).; Supported by Netherlands Organization for Scientific Research VICI Grant 700.56.442.; We thank Pitter Huesgen, Alexander Ishov, Lewis Kay, and Cameron Mackereth for advice and helpful ideas. Instrument support was provided by the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, the British Columbia Knowledge Development Fund, the University of British Columbia Blusson Fund, and the Michael Smith Foundation for Health Research.	Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Baba D, 2006, J MOL BIOL, V359, P137, DOI 10.1016/j.jmb.2006.03.036; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chupreta S, 2005, MOL CELL BIOL, V25, P4272, DOI 10.1128/MCB.25.10.4272-4282.2005; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donaldson LW, 2001, J AM CHEM SOC, V123, P9843, DOI 10.1021/ja011241p; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Escobar-Cabrera E, 2010, STRUCTURE, V18, P1642, DOI 10.1016/j.str.2010.09.016; Fukuyo Y, 2009, CANCER RES, V69, P7512, DOI 10.1158/0008-5472.CAN-09-2148; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; GODDARD TD, 2004, SPARKY 3 VERSION 3; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hollenbach AD, 2002, J CELL SCI, V115, P3319; HOLLENHORST P, 2011, ANNU REV BI IN PRESS; Huang YS, 2009, BIOCHEM BIOPH RES CO, V386, P762, DOI 10.1016/j.bbrc.2009.06.126; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Ishov AM, 2004, J CELL SCI, V117, P3807, DOI 10.1242/jcs.01230; Ji Z, 2007, ONCOGENE, V26, P395, DOI 10.1038/sj.onc.1209789; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson PE, 1996, BIOCHEMISTRY-US, V35, P13895, DOI 10.1021/bi961186a; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; KOSEN PA, 1989, METHOD ENZYMOL, V177, P86; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Lehembre F, 2001, ONCOGENE, V20, P1, DOI 10.1038/sj.onc.1204063; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Lindsay CR, 2008, FRONT BIOSCI-LANDMRK, V13, P7132, DOI 10.2741/3216; Macauley MS, 2006, J BIOL CHEM, V281, P4164, DOI 10.1074/jbc.M510488200; Macauley MS, 2004, J BIOL CHEM, V279, P49131, DOI 10.1074/jbc.M408705200; Matunis MJ, 2006, DEV CELL, V11, P596, DOI 10.1016/j.devcel.2006.10.011; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Muromoto R, 2004, J IMMUNOL, V172, P2985, DOI 10.4049/jimmunol.172.5.2985; Naik MT, 2011, BIOMOL NMR ASSIGN, V5, P75, DOI 10.1007/s12104-010-9271-4; Nelson ML, 2010, P NATL ACAD SCI USA, V107, P10026, DOI 10.1073/pnas.0915137107; Nishida T, 2006, BIOCHEM BIOPH RES CO, V345, P1536, DOI 10.1016/j.bbrc.2006.05.065; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; Puto LA, 2008, GENE DEV, V22, P998, DOI 10.1101/gad.1632208; Reibarkh M, 2006, J AM CHEM SOC, V128, P2160, DOI 10.1021/ja055971z; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Ryu SW, 2000, BIOCHEM BIOPH RES CO, V279, P6, DOI 10.1006/bbrc.2000.3882; Santiago A, 2009, CELL CYCLE, V8, P76, DOI 10.4161/cc.8.1.7493; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Shih HM, 2007, BIOCHEM SOC T, V35, P1397, DOI 10.1042/BST0351397; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Su XC, 2010, J BIOMOL NMR, V46, P101, DOI 10.1007/s10858-009-9331-1; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	69	24	26	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19816	19829		10.1074/jbc.M111.231647	http://dx.doi.org/10.1074/jbc.M111.231647			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21383010	hybrid, Green Published			2022-12-25	WOS:000291027700063
J	Brodrick, B; Vidrich, A; Porter, E; Bradley, L; Buzan, JM; Cohn, SM				Brodrick, Brooks; Vidrich, Alda; Porter, Edith; Bradley, Leigh; Buzan, Jenny M.; Cohn, Steven M.			Fibroblast Growth Factor Receptor-3 (FGFR-3) Regulates Expression of Paneth Cell Lineage-specific Genes in Intestinal Epithelial Cells through both TCF4/beta-Catenin-dependent and -independent Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; STEM-CELLS; WNT/BETA-CATENIN; HUMAN DEFENSIN-5; ALPHA-DEFENSINS; INNATE IMMUNITY; COLON-CANCER; IN-VITRO; SPONTANEOUS DIFFERENTIATION; GASTROINTESTINAL-TRACT	Fibroblast growth factor receptor-3 (FGFR-3) expression in the developing intestine is restricted to the undifferentiated epithelial cells within the lower portion of the crypt. We previously showed that mice lacking functional FGFR-3 have a significant decrease in the number of Paneth cells in the small intestine. Here, we used Caco2 cells to investigate whether FGFR-3 signaling can directly modulate expression of Paneth cell differentiation markers through its effects on TCF4/beta-catenin or through other signaling pathways downstream of this receptor. Caco2 cells treated with FGFR-3 ligands or expressing FGFR-3(K650E), a constitutively active mutant, resulted in a significantly increased expression of genes characteristic of mature Paneth cells, including human alpha-defensins 5 and 6 (HD5 and HD6) and Paneth cell lysozyme, whereas enterocytic differentiation markers were reduced. Activation of FGFR-3 signaling sustained high levels of beta-catenin mRNA expression, leading to increased TCF4/beta-catenin-regulated transcriptional activity in Caco2 cells. Sustained activity of the TCF4/beta-catenin pathway was required for the induction of Paneth cell markers. Activation of the MAPK pathway by FGFR-3 is also required for the induction of Paneth cell markers in addition to and independent of the effect of FGFR-3 on TCF4/beta-catenin activity. These studies suggest that coordinate activation of multiple independent signaling pathways downstream of FGFR-3 is involved in regulation of Paneth cell differentiation.	[Brodrick, Brooks; Vidrich, Alda; Bradley, Leigh; Buzan, Jenny M.; Cohn, Steven M.] Univ Virginia, Div Gastroenterol & Hepatol, Charlottesville, VA 22908 USA; [Porter, Edith] Univ Calif Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA	University of Virginia; University of California System; University of California Los Angeles	Cohn, SM (corresponding author), Univ Virginia Hlth Syst, Digest Hlth Ctr, Box 800708, Charlottesville, VA 22908 USA.	SC6W@virginia.edu			National Institutes of Health [R01 DK064751, P20 MD001824]; Molecular Biology and Morphology Cores of the University of Virginia National Institutes of Health/NIDDK Digestive Diseases Research Core Center [DK50306]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, P30DK067629, R01DK064751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Biology and Morphology Cores of the University of Virginia National Institutes of Health/NIDDK Digestive Diseases Research Core Center; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK064751 (to S. M. C.) and through the Molecular Biology and Morphology Cores of the University of Virginia National Institutes of Health/NIDDK Digestive Diseases Research Core Center Grant (Grant DK50306).; Supported by National Institutes of Health Grant P20 MD001824.	Aliaga JC, 1999, AM J PHYSIOL-GASTR L, V277, pG631, DOI 10.1152/ajpgi.1999.277.3.G631; Andreu P, 2008, DEV BIOL, V324, P288, DOI 10.1016/j.ydbio.2008.09.027; *APPL BIOS, 1997, US B APPL BIOS, V2; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Bevins CL, 2005, AM J PHYSIOL-GASTR L, V289, pG173, DOI 10.1152/ajpgi.00079.2005; Brock P, 1999, CYTOMETRY, V35, P353, DOI 10.1002/(SICI)1097-0320(19990401)35:4<353::AID-CYTO8>3.0.CO;2-M; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cunliffe RN, 2004, J LEUKOCYTE BIOL, V75, P49, DOI 10.1189/jlb.0503249; Cunliffe RN, 2001, GUT, V48, P176, DOI 10.1136/gut.48.2.176; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Ducroc R, 2002, LIFE SCI, V70, P1359, DOI 10.1016/S0024-3205(01)01519-3; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; HARA A, 1993, JPN J CANCER RES, V84, P625, DOI 10.1111/j.1349-7006.1993.tb02022.x; Hart KC, 2001, MOL BIOL CELL, V12, P931, DOI 10.1091/mbc.12.4.931; HOLLINGSWORTH MA, 1994, INT J CANCER, V57, P198, DOI 10.1002/ijc.2910570212; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Houchen CW, 1999, AM J PHYSIOL-GASTR L, V276, pG249, DOI 10.1152/ajpgi.1999.276.1.G249; Kanai M, 1997, AM J PHYSIOL-GASTR L, V272, pG885, DOI 10.1152/ajpgi.1997.272.4.G885; Kannan K, 2000, IUBMB LIFE, V49, P197; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mariadason JM, 2002, CANCER RES, V62, P4791; Mariadason JM, 2001, CANCER RES, V61, P3465; Mariadason JM, 2000, J CELL PHYSIOL, V183, P347, DOI 10.1002/(SICI)1097-4652(200006)183:3<347::AID-JCP7>3.0.CO;2-W; MOLMENTI EP, 1993, J CLIN INVEST, V92, P2022, DOI 10.1172/JCI116797; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; NIV Y, 1992, INT J CANCER, V50, P147, DOI 10.1002/ijc.2910500129; Ogle CK, 2002, CRIT CARE MED, V30, P428, DOI 10.1097/00003246-200202000-00027; Ouellette AJ, 2001, INFLAMM BOWEL DIS, V7, P43, DOI 10.1097/00054725-200102000-00007; PODOLSKY DK, 1993, AM J PHYSIOL, V264, pG179, DOI 10.1152/ajpgi.1993.264.2.G179; Porter E, 2005, INFECT IMMUN, V73, P4823, DOI 10.1128/IAI.73.8.4823-4833.2005; Porter EM, 1997, INFECT IMMUN, V65, P2396, DOI 10.1128/IAI.65.6.2396-2401.1997; Porter EM, 1998, FEBS LETT, V434, P272, DOI 10.1016/S0014-5793(98)00994-6; Quayle AJ, 1998, AM J PATHOL, V152, P1247; Saaf AM, 2007, MOL BIOL CELL, V18, P4245, DOI 10.1091/mbc.E07-04-0309; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sturgill TW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-104; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; VANBEERS EH, 1995, BIOCHEM J, V308, P769, DOI 10.1042/bj3080769; Varnat F, 2006, GASTROENTEROLOGY, V131, P538, DOI 10.1053/j.gastro.2006.05.004; Vidrich A, 2005, AM J PATHOL, V166, P1055, DOI 10.1016/S0002-9440(10)62326-7; Vidrich A, 2004, DEV DYNAM, V230, P114, DOI 10.1002/dvdy.20018; Vidrich A, 2009, AM J PHYSIOL-GASTR L, V297, pG168, DOI 10.1152/ajpgi.90589.2008; Vreugdenhil ACE, 2000, J IMMUNOL, V165, P4561, DOI 10.4049/jimmunol.165.8.4561; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wehkamp J, 2005, J LEUKOCYTE BIOL, V77, P460, DOI 10.1189/jlb.0904543; Wehkamp J, 2002, DIGEST DIS SCI, V47, P1349, DOI 10.1023/A:1015334917273; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	60	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18515	18525		10.1074/jbc.M111.229252	http://dx.doi.org/10.1074/jbc.M111.229252			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21388956	Green Published, hybrid			2022-12-25	WOS:000290785700024
J	Suzuki, K; Oneyama, C; Kimura, H; Tajima, S; Okada, M				Suzuki, Kei; Oneyama, Chitose; Kimura, Hironobu; Tajima, Shoji; Okada, Masato			Down-regulation of the Tumor Suppressor C-terminal Src Kinase (Csk)-binding Protein (Cbp)/PAG1 Is Mediated by Epigenetic Histone Modifications via the Mitogen-activated Protein Kinase (MAPK)/Phosphatidylinositol 3-Kinase (PI3K) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY TYROSINE KINASES; T-CELL-ACTIVATION; V-SRC; TRANSMEMBRANE ADAPTER; CANCER; CSK; TRANSFORMATION; COMPLEX; GENE; METHYLATION	The transmembrane adaptor protein Cbp (or PAG1) functions as a suppressor of Src-mediated tumor progression by promoting the inactivation of Src. The expression of Cbp is down-regulated in Src-transformed cells and in various human cancer cells, suggesting a potential role for Cbp as a tumor suppressor. However, the mechanisms underlying the down-regulation of Cbp remain unknown. The present study shows that Cbp expression is down-regulated by epigenetic histone modifications via the MAPK/PI3K pathway. In mouse embryonic fibroblasts, transformation by oncogenic Src and Ras induced a marked down-regulation of Cbp expression. The levels of Cbp expression were inversely correlated with the activity of MEK and Akt, and Cbp down-regulation was suppressed by inhibiting MEK and PI3K. Src transformation did not affect the stability of Cbp mRNA, the transcriptional activity of the cbp promoter, or the DNA methylation status of the cbp promoter CpG islands. However, Cbp expression was restored by treatment with histone deacetylase (HDAC) inhibitors and by siRNA-mediated knockdown of HDAC1/2. Src transformation significantly decreased the acetylation levels of histone H4 and increased the trimethylation levels of histone H3 lysine 27 in the cbp promoter. EGF-induced Cbp down-regulation was also suppressed by inhibiting MEK and HDAC. Furthermore, the inhibition of MEK or HDAC restored Cbp expression in human cancer cells harboring Cbp down-regulation through promoter hypomethylation. These findings suggest that Cbp down-regulation is primarily mediated by epigenetic histone modifications via oncogenic MAPK/PI3K pathways in a subset of cancer cells.	[Suzuki, Kei; Oneyama, Chitose; Okada, Masato] Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 5650871, Japan; [Kimura, Hironobu; Tajima, Shoji] Osaka Univ, Inst Prot Res, Lab Epigenet, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Okada, M (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	okadam@biken.osaka-u.ac.jp	Kimura, Hironobu/B-3731-2010		Uehara Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22689009] Funding Source: KAKEN	Uehara Foundation(Uehara Memorial Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Uehara Foundation and a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Baylin S, 2001, Dev Biol (Basel), V106, P85; Baylin S, 2001, DEV BIOL BASEL, V106, P143; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Jiang LQ, 2006, ONCOGENE, V25, P5495, DOI 10.1038/sj.onc.1209554; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Oneyama C, 2008, GENES CELLS, V13, P1, DOI 10.1111/j.1365-2443.2007.01145.x; Oneyama C, 2009, MOL CELL BIOL, V29, P6462, DOI 10.1128/MCB.00941-09; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; PIERANI A, 1993, MOL CELL BIOL, V13, P3401, DOI 10.1128/MCB.13.6.3401; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shima T, 2003, P NATL ACAD SCI USA, V100, P14897, DOI 10.1073/pnas.2432139100; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Sung J, 2005, CARCINOGENESIS, V26, P487, DOI 10.1093/carcin/bgh318; Yagi R, 2007, EMBO J, V26, P1234, DOI 10.1038/sj.emboj.7601595; Yan PS, 2001, CANCER RES, V61, P8375	28	26	27	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.195362	http://dx.doi.org/10.1074/jbc.M110.195362			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21388951	hybrid, Green Published			2022-12-25	WOS:000290022800009
J	Park, H; Cox, D				Park, Haein; Cox, Dianne			Syk Regulates Multiple Signaling Pathways Leading to CX3CL1 Chemotaxis in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WISKOTT-ALDRICH-SYNDROME; TYROSINE KINASE SYK; ATHEROSCLEROTIC LESION FORMATION; RECEPTOR-MEDIATED PHAGOCYTOSIS; SYNDROME PROTEIN; RHEUMATOID-ARTHRITIS; ACTIN POLYMERIZATION; LEUKOCYTE MIGRATION; CELL-MIGRATION; MAST-CELLS	Several studies have clearly established the importance of the interaction between macrophages and CX3CL1 in the progression of disease. A previous study demonstrated that Syk was required for CX3CL1-mediated actin polymerization and chemotaxis. Here, we delineated the signaling cascade of Syk-mediated cell migration in response to CX3CL1. Inhibition of Syk in bone marrow-derived macrophages or reduction of Syk expression using siRNA in RAW/LR5 cells indicated that Syk was required for the activation of PI3K, Cdc42, and Rac1. Also, reduction in WASP or WAVE2 levels, common downstream effectors of Cdc42 or Rac1, resulted in impaired cell migration to CX3CL1. Syk indirectly regulated WASP tyrosine phosphorylation through Cdc42 activation. Altogether, our data identify that Syk mediated chemotaxis toward CX3CL1 by regulating both Rac1/WAVE2 and Cdc42/WASP pathways, whereas Src family kinases were required for proper WASP tyrosine phosphorylation.	[Park, Haein; Cox, Dianne] Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Cox, Dianne] Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Park, H (corresponding author), 1300 Morris Pk Ave,MRRC306, Bronx, NY 10461 USA.	hapark@aecom.yu.edu; dianne.cox@einstein.yu.edu		Cox, Dianne/0000-0002-0591-9767	National Institutes of Health [GM071828]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071828 (to D.C.).	Abou Kheir W, 2005, J CELL SCI, V118, P5369, DOI 10.1242/jcs.02638; Abou-Kheir W, 2008, J CELL SCI, V121, P379, DOI 10.1242/jcs.010272; Allen LAH, 1996, CURR OPIN IMMUNOL, V8, P36, DOI 10.1016/S0952-7915(96)80102-6; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Allen WE, 1997, J CELL SCI, V110, P707; Badolato R, 1998, J IMMUNOL, V161, P1026; Cambien B, 2001, BLOOD, V97, P2031, DOI 10.1182/blood.V97.7.2031; Cammer M, 2009, J BIOL CHEM, V284, P23302, DOI 10.1074/jbc.M109.036384; CLARK EA, 1994, J BIOL CHEM, V269, P28859; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Cory GOC, 2002, J BIOL CHEM, V277, P45115, DOI 10.1074/jbc.M203346200; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Cox D, 2001, SEMIN IMMUNOL, V13, P339, DOI 10.1006/smim.2001.0330; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Dovas A, 2009, J CELL SCI, V122, P3873, DOI 10.1242/jcs.051755; Fraticelli P, 2001, J CLIN INVEST, V107, P1173, DOI 10.1172/JCI11517; Ganju RK, 2000, J BIOL CHEM, V275, P17263, DOI 10.1074/jbc.M000689200; Gevrey JC, 2005, J IMMUNOL, V175, P3737, DOI 10.4049/jimmunol.175.6.3737; Goda S, 2000, J IMMUNOL, V164, P4313, DOI 10.4049/jimmunol.164.8.4313; Greenberg S, 1999, J LEUKOCYTE BIOL, V66, P712, DOI 10.1002/jlb.66.5.712; Greenberg S, 1996, P NATL ACAD SCI USA, V93, P1103, DOI 10.1073/pnas.93.3.1103; Haddad E, 2001, BLOOD, V97, P33, DOI 10.1182/blood.V97.1.33; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Jones GE, 2002, INT J BIOCHEM CELL B, V34, P806, DOI 10.1016/S1357-2725(01)00162-5; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; McDermott DH, 2001, CIRC RES, V89, P401, DOI 10.1161/hh1701.095642; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miki H, 2002, BIOCHEM BIOPH RES CO, V293, P93, DOI 10.1016/S0006-291X(02)00218-8; Millard TH, 2004, BIOCHEM J, V380, P1, DOI 10.1042/BJ20040176; Moatti D, 2001, BLOOD, V97, P1925, DOI 10.1182/blood.V97.7.1925; Mocsai A, 2003, BLOOD, V101, P4155, DOI 10.1182/blood-2002-07-2346; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Nanki T, 2002, ARTHRITIS RHEUM, V46, P2878, DOI 10.1002/art.10622; Navara CS, 2004, CURR PHARM DESIGN, V10, P1739, DOI 10.2174/1381612043384493; Oda A, 2005, BLOOD, V105, P3141, DOI 10.1182/blood-2003-04-1319; Oda A, 2001, BLOOD, V97, P2633, DOI 10.1182/blood.V97.9.2633; Park H, 2009, MOL BIOL CELL, V20, P4500, DOI 10.1091/mbc.E09-03-0230; Raffaghello L, 2009, SEMIN CANCER BIOL, V19, P97, DOI 10.1016/j.semcancer.2008.10.003; Ruth JH, 2001, ARTHRITIS RHEUM, V44, P1568, DOI 10.1002/1529-0131(200107)44:7<1568::AID-ART280>3.0.CO;2-1; Saederup N, 2008, CIRCULATION, V117, P1642, DOI 10.1161/CIRCULATIONAHA.107.743872; Sawai H, 2005, ARTHRITIS RHEUM-US, V52, P1392, DOI 10.1002/art.21140; Schmitz U, 2001, J BIOL CHEM, V276, P22003, DOI 10.1074/jbc.M102450200; Schymeinsky J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001132; Schymeinsky J, 2006, BLOOD, V108, P3919, DOI 10.1182/blood-2005-12-030387; Sheffer I, 2001, J IMMUNOL, V167, P475, DOI 10.4049/jimmunol.167.1.475; Shi J, 2005, J BIOL CHEM, V280, P29849, DOI 10.1074/jbc.M500617200; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Stabile H, 2010, BLOOD, V115, P2818, DOI 10.1182/blood-2009-07-235804; Stanley E R, 1997, Methods Mol Biol, V75, P301; Strzelecka A, 1997, CELL MOTIL CYTOSKEL, V38, P287, DOI 10.1002/(SICI)1097-0169(1997)38:3<287::AID-CM7>3.0.CO;2-2; Suen PW, 1999, J CELL SCI, V112, P4067; Takenawa T, 2001, J CELL SCI, V114, P1801; Torres E, 2006, J BIOL CHEM, V281, P3513, DOI 10.1074/jbc.M509416200; Torres E, 2003, MOL CELL, V11, P1215, DOI 10.1016/S1097-2765(03)00139-4; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404; Tsuboi S, 2007, J BIOL CHEM, V282, P34194, DOI 10.1074/jbc.M705999200; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Umehara H, 2004, ARTERIOSCL THROM VAS, V24, P34, DOI 10.1161/01.ATV.0000095360.62479.1F; Wan Y, 1996, NATURE, V380, P541, DOI 10.1038/380541a0; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Zicha D, 1998, BRIT J HAEMATOL, V101, P659, DOI 10.1046/j.1365-2141.1998.00767.x	66	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14762	14769		10.1074/jbc.M110.185181	http://dx.doi.org/10.1074/jbc.M110.185181			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388954	hybrid, Green Published			2022-12-25	WOS:000289788300005
J	Syeda, F; Fagan, RL; Wean, M; Avvakumov, GV; Walker, JR; Xue, S; Dhe-Paganon, S; Brenner, C				Syeda, Farisa; Fagan, Rebecca L.; Wean, Matthew; Avvakumov, George V.; Walker, John R.; Xue, Sheng; Dhe-Paganon, Sirano; Brenner, Charles			The Replication Focus Targeting Sequence (RFTS) Domain Is a DNA-competitive Inhibitor of Dnmt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMI-METHYLATED DNA; SRA DOMAIN; METHYLTRANSFERASE; UHRF1; COMPLEX; ENZYME; RECOGNITION; ACTIVATION; MECHANISM; INSIGHTS	Dnmt1 (DNA methyltransferase 1) is the principal enzyme responsible for maintenance of cytosine methylation at CpG dinucleotides in the mammalian genome. The N-terminal replication focus targeting sequence (RFTS) domain of Dnmt1 has been implicated in subcellular localization, protein association, and catalytic function. However, progress in understanding its function has been limited by the lack of assays for and a structure of this domain. Here, we show that the naked DNA-and polynucleosome- binding activities of Dnmt1 are inhibited by the RFTS domain, which functions by virtue of binding the catalytic domain to the exclusion of DNA. Kinetic analysis with a fluorogenic DNA substrate established the RFTS domain as a 600-fold inhibitor of Dnmt1 enzymatic activity. The crystal structure of the RFTS domain reveals a novel fold and supports a mechanism in which an RFTS-targeted Dnmt1-binding protein, such as Uhrf1, may activate Dnmt1 for DNA binding.	[Syeda, Farisa; Avvakumov, George V.; Walker, John R.; Xue, Sheng; Dhe-Paganon, Sirano] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Syeda, Farisa; Avvakumov, George V.; Walker, John R.; Xue, Sheng; Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada; [Fagan, Rebecca L.; Wean, Matthew; Brenner, Charles] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA	University of Toronto; Structural Genomics Consortium; University of Toronto; University of Iowa	Dhe-Paganon, S (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.	sirano.dhepaganon@utoronto.ca	Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226; /0000-0002-5255-895X; Switzer, Rebecca/0000-0003-0591-2538	National Institutes of Health [CA075954]; NCI [HHSN261200433000C]; United States Department of Energy Office of Basic Energy Sciences [DE-AC02-06CH11357]; Canadian Institutes of Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA075954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work performed at the University of Iowa was supported by National Institutes of Health Grant CA075954 and Contract HHSN261200433000C from NCI and a generous gift from the Roy J. Carver Foundation. Use of the Advanced Photon Source was supported by United States Department of Energy Office of Basic Energy Sciences Contract DE-AC02-06CH11357. The Structural Genomics Consortium is a registered charity (1097737) supported by the Canadian Institutes of Health Research, the Canadian Foundation for Innovation, and Genome Canada through the Ontario Genomics Institute.; Supported by an American Cancer Society postdoctoral fellowship.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Bacik JP, 2010, J BIOL CHEM, V285, P20273, DOI 10.1074/jbc.M110.102921; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Callebaut I, 1999, FEBS LETT, V446, P189, DOI 10.1016/S0014-5793(99)00132-5; CHA S, 1970, J BIOL CHEM, V245, P4814; CHAN S, 1988, J BIOL CHEM, V263, P15643; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Goldstein A, 1944, J GEN PHYSIOL, V27, P529, DOI 10.1085/jgp.27.6.529; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jeltsch A, 2006, EPIGENETICS-US, V1, P63, DOI 10.4161/epi.1.2.2767; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pradhan M, 2008, BIOCHEMISTRY-US, V47, P10000, DOI 10.1021/bi8011725; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Svedruzic ZM, 2005, BIOCHEMISTRY-US, V44, P9472, DOI 10.1021/bi050295z; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wood RJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq047; Yokochi T, 2002, J BIOL CHEM, V277, P11735, DOI 10.1074/jbc.M106590200	29	83	86	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15344	15351		10.1074/jbc.M110.209882	http://dx.doi.org/10.1074/jbc.M110.209882			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21389349	Green Published, hybrid			2022-12-25	WOS:000289788300065
J	Xie, WB; Li, ZG; Miano, JM; Long, XC; Chen, SY				Xie, Wei-Bing; Li, Zuguo; Miano, Joseph M.; Long, Xiaochun; Chen, Shi-You			Smad3-mediated Myocardin Silencing A NOVEL MECHANISM GOVERNING THE INITIATION OF SMOOTH MUSCLE DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; TGF-BETA; CELL-DIFFERENTIATION; EXPRESSION; TRANSCRIPTION; SIGNALS; MARKER; SMAD3; GENE; SUFFICIENT	Both TGF-beta and myocardin (MYOCD) are important for smooth muscle cell (SMC) differentiation, but their precise role in regulating the initiation of SMC development is less clear. In TGF-beta-induced SMC differentiation of pluripotent C3H10T1/2 progenitors, we found that TGF-beta did not significantly induce Myocd mRNA expression until 18 h of stimulation. On the other hand, early SMC markers such as SM alpha-actin, SM22 alpha, and SM calponin were detectable beginning 2 or 4 h after TGF-beta treatment. These results suggest that Myocd expression is blocked during the initiation of TGF-beta-induced SMC differentiation. Consistent with its endogenous expression, Myocd promoter activity was not elevated until 18 h following TGF-beta stimulation. Surprisingly, Smad signaling was inhibitory to Myocd expression because blockade of Smad signaling enhanced Myocd promoter activity. Overexpression of Smad3, but not Smad2, inhibited Myocd promoter activity. Conversely, shRNA knockdown of Smad3 allowed TGF-beta to activate the Myocd promoter in the initial phase of induction. Myocd was activated by PI3 kinase signaling and its downstream target Nkx2.5. Interestingly, Smad3 did not affect PI3 kinase activity. However, Smad3 physically interacted with Nkx2.5. This interaction blocked Nkx2.5 binding to the Myocd promoter in the early stage of TGF-beta induction, leading to inhibition of Myocd mRNA expression. Moreover, Smad3 inhibited Nkx2.5-activated Myocd promoter activity in a dose-dependent manner. Taken together, our results reveal a novel mechanism for Smad3-mediated inhibition of Myocd in the initiation phase of SMC differentiation.	[Xie, Wei-Bing; Li, Zuguo; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA; [Miano, Joseph M.; Long, Xiaochun] Univ Rochester, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA	University System of Georgia; University of Georgia; University of Rochester	Chen, SY (corresponding author), 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu	; Miano, Joseph/L-5634-2018	Long, Xiaochun/0000-0001-9714-0023; Miano, Joseph/0000-0001-7522-3207	National Institutes of Health [HL093429, HL091168]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091168, R01HL093429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL093429 (to S.-Y.C.) and HL091168 (to J.M.M.).	ARCINIEGAS E, 1992, J CELL SCI, V103, P521; Briones VR, 2006, BIOCHEM BIOPH RES CO, V345, P595, DOI 10.1016/j.bbrc.2006.04.052; Chang H, 1999, DEVELOPMENT, V126, P1631; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; De Caestecker M, 2001, RESPIR RES, V2, P193; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; de Caestecker MP, 2000, J BIOL CHEM, V275, P2115, DOI 10.1074/jbc.275.3.2115; deCaestecker MP, 1997, J BIOL CHEM, V272, P13690, DOI 10.1074/jbc.272.21.13690; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; HOOFNAGLE MH, 2011, AM J PHYSL IN PRESS; Kawai-Kowase K, 2005, MOL CELL BIOL, V25, P8009, DOI 10.1128/MCB.25.18.8009-8023.2005; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Masszi A, 2010, J CELL BIOL, V188, P383, DOI 10.1083/jcb.200906155; Naito AT, 2003, EXP CELL RES, V291, P56, DOI 10.1016/S0014-4827(03)00378-1; Nicolas FJ, 2004, J CELL SCI, V117, P4113, DOI 10.1242/jcs.01289; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Owens Gary K, 2007, Novartis Found Symp, V283, P174; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Qiu P, 2003, J MOL CELL CARDIOL, V35, P1407, DOI 10.1016/j.yjmcc.2003.09.002; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Sun Q, 2009, J BIOL CHEM, V284, P32582, DOI 10.1074/jbc.M109.033910; Ueyama T, 2003, MOL CELL BIOL, V23, P9222, DOI 10.1128/MCB.23.24.9222-9232.2003; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yang X, 1999, DEVELOPMENT, V126, P1571; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhang JCL, 2001, MOL CELL BIOL, V21, P1336, DOI 10.1128/MCB.2001.21.4.1336-1344.2001; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	44	41	41	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15050	15057		10.1074/jbc.M110.202747	http://dx.doi.org/10.1074/jbc.M110.202747			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21402709	Green Published, hybrid			2022-12-25	WOS:000289788300035
J	Dai, DH; Beck, B; Wang, XF; Howk, C; Li, Y				Dai, Donghai; Beck, Brandon; Wang, Xiaofang; Howk, Cory; Li, Yi			Quantitative Interpretation of a Genetic Model of Carcinogenesis Using Computer Simulations	PLOS ONE			English	Article							METASTATIC INEFFICIENCY; CELL-POPULATIONS; STEM-CELLS; CANCER; GROWTH; EVOLUTIONARY; DISEASE	The genetic model of tumorigenesis by Vogelstein et al. (V theory) and the molecular definition of cancer hallmarks by Hanahan and Weinberg (W theory) represent two of the most comprehensive and systemic understandings of cancer. Here, we develop a mathematical model that quantitatively interprets these seminal cancer theories, starting from a set of equations describing the short life cycle of an individual cell in uterine epithelium during tissue regeneration. The process of malignant transformation of an individual cell is followed and the tissue (or tumor) is described as a composite of individual cells in order to quantitatively account for intra-tumor heterogeneity. Our model describes normal tissue regeneration, malignant transformation, cancer incidence including dormant/transient tumors, and tumor evolution. Further, a novel mechanism for the initiation of metastasis resulting from substantial cell death is proposed. Finally, model simulations suggest two different mechanisms of metastatic inefficiency for aggressive and less aggressive cancer cells. Our work suggests that cellular de-differentiation is one major oncogenic pathway, a hypothesis based on a numerical description of a cell's differentiation status that can effectively and mathematically interpret some major concepts in V/W theories such as progressive transformation of normal cells, tumor evolution, and cancer hallmarks. Our model is a mathematical interpretation of cancer phenotypes that complements the well developed V/W theories based upon description of causal biological and molecular events. It is possible that further developments incorporating patient-and tissue-specific variables may build an even more comprehensive model to explain clinical observations and provide some novel insights for understanding cancer.	[Dai, Donghai; Beck, Brandon; Wang, Xiaofang; Howk, Cory] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; [Li, Yi] Univ Iowa, Dept Math, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Dai, DH (corresponding author), Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA.	donghai-dai@uiowa.edu	Li, Yi/D-5381-2017	Li, Yi/0000-0002-7148-0019; Dai, Donghai/0000-0002-9670-7822	ACS [RSG-06-105-01-CCE]; UI College of Medicine	ACS(American Cancer Society); UI College of Medicine	This work is supported by ACS Research Scholar Award RSG-06-105-01-CCE (DD) and UI College of Medicine Basic Reproductive Science Research Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM CANC SOC, 2010, CANC FACTS FIG; Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Bru A, 2006, J THEOR BIOL, V243, P171, DOI 10.1016/j.jtbi.2006.05.020; Byrne H, 2009, J MATH BIOL, V58, P657, DOI 10.1007/s00285-008-0212-0; Byrne HM, 2010, NAT REV CANCER, V10, P221, DOI 10.1038/nrc2808; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Enderling H, 2009, CANCER RES, V69, P8814, DOI 10.1158/0008-5472.CAN-09-2115; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061; Gatenby RA, 2003, CANCER RES, V63, P6212; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; LAIRD AK, 1969, NATL CANCER I MONOGR, P15; Lloyd, 1979, ADV CANCER CHEMOTHER, V1, P205; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Michor F, 2004, NAT REV CANCER, V4, P197, DOI 10.1038/nrc1295; NIELSEN M, 1987, BRIT J CANCER, V56, P814, DOI 10.1038/bjc.1987.296; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Paget S, 1889, LANCET, V133, P571, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Riester M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000777; SMITH JR, 1974, J CELL BIOL, V62, P48, DOI 10.1083/jcb.62.1.48; SMITH JR, 1980, SCIENCE, V207, P82; Spencer SL, 2004, J THEOR BIOL, V231, P515, DOI 10.1016/j.jtbi.2004.07.006; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; SWEENEY E, 1995, HUM PATHOL, V26, P691, DOI 10.1016/0046-8177(95)90180-9; Weinberg RA, 2007, BIOL CANC; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1; Wong CW, 2001, CANCER RES, V61, P333; ZHANG G, 2011, ONCOLOGY RE IN PRESS	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e16859	10.1371/journal.pone.0016859	http://dx.doi.org/10.1371/journal.pone.0016859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408146	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170000011
J	Reyes, LH; Almario, MP; Kao, KC				Reyes, Luis H.; Almario, Maria P.; Kao, Katy C.			Genomic Library Screens for Genes Involved in n-Butanol Tolerance in Escherichia coli	PLOS ONE			English	Article							ORGANIC-SOLVENT TOLERANCE; CLOSTRIDIUM-ACETOBUTYLICUM; STRESS; IDENTIFICATION; RESISTANCE; EXPRESSION; BACTERIA; PROTEIN; MECHANISMS; REGULON	Background: n-Butanol is a promising emerging biofuel, and recent metabolic engineering efforts have demonstrated the use of several microbial hosts for its production. However, most organisms have very low tolerance to n-butanol (up to 2% (v/v)), limiting the economic viability of this biofuel. The rational engineering of more robust n-butanol production hosts relies upon understanding the mechanisms involved in tolerance. However, the existing knowledge of genes involved in n-butanol tolerance is limited. The goal of this study is therefore to identify E. coli genes that are involved in n-butanol tolerance. Methodology/Principal Findings: Using a genomic library enrichment strategy, we identified approximately 270 genes that were enriched or depleted in n-butanol challenge. The effects of these candidate genes on n-butanol tolerance were experimentally determined using overexpression or deletion libraries. Among the 55 enriched genes tested, 11 were experimentally shown to confer enhanced tolerance to n-butanol when overexpressed compared to the wild-type. Among the 84 depleted genes tested, three conferred increased n-butanol resistance when deleted. The overexpressed genes that conferred the largest increase in n-butanol tolerance were related to iron transport and metabolism, entC and feoA, which increased the n-butanol tolerance by 32.8 +/- 4.0% and 49.1 +/- 3.3%, respectively. The deleted gene that resulted in the largest increase in resistance to n-butanol was astE, which enhanced n-butanol tolerance by 48.7 +/- 6.3%. Conclusions/Significance: We identified and experimentally verified 14 genes that decreased the inhibitory effect of n-butanol tolerance on E. coli. From the data, we were able to expand the current knowledge on the genes involved in n-butanol tolerance; the results suggest that an increased iron transport and metabolism and decreased acid resistance may enhance n-butanol tolerance. The genes and mechanisms identified in this study will be helpful in the rational engineering of more robust biofuel producers.	[Reyes, Luis H.; Almario, Maria P.; Kao, Katy C.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Reyes, LH (corresponding author), Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.	katy@chemail.tamu.edu	Reyes, Luis/J-8334-2017	Reyes, Luis/0000-0001-7251-5298; Kao, Katy/0000-0002-1184-276X	US NSF [CBET-1032487]; Texas Engineering Experimental Station (TEES); Div Of Chem, Bioeng, Env, & Transp Sys [1032487] Funding Source: National Science Foundation	US NSF(National Science Foundation (NSF)); Texas Engineering Experimental Station (TEES); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The authors wish to acknowledge financial support from US NSF grant CBET-1032487 and the Texas Engineering Experimental Station (TEES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BEESCH SC, 1953, APPL MICROBIOL, V1, P85, DOI 10.1128/AEM.1.2.85-95.1953; BEESCH SC, 1952, IND ENG CHEM, V44, P1677, DOI 10.1021/ie50511a054; Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; Berezina OV, 2010, APPL MICROBIOL BIOT, V87, P635, DOI 10.1007/s00253-010-2480-z; Borden JR, 2007, APPL ENVIRON MICROB, V73, P3061, DOI 10.1128/AEM.02296-06; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; BOWLES LK, 1985, APPL ENVIRON MICROB, V50, P1165, DOI 10.1128/AEM.50.5.1165-1170.1985; Brynildsen MP, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.34; BURTON K, 1977, BIOCHEM J, V168, P195, DOI 10.1042/bj1680195; BURTON K, 1994, P ROY SOC B-BIOL SCI, V255, P153, DOI 10.1098/rspb.1994.0022; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Demple B, 1996, GENE, V179, P53, DOI 10.1016/S0378-1119(96)00329-0; Dupont M, 2007, ANTIMICROB AGENTS CH, V51, P3190, DOI 10.1128/AAC.01481-06; Fajardo DA, 1998, J BACTERIOL, V180, P4452, DOI 10.1128/JB.180.17.4452-4459.1998; Galbe M, 2002, APPL MICROBIOL BIOT, V59, P618, DOI 10.1007/s00253-002-1058-9; GAVIN JJ, 1965, J BACTERIOL, V89, P437, DOI 10.1128/JB.89.2.437-443.1965; Han XL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-35; HEIPIEPER HJ, 1994, TRENDS BIOTECHNOL, V12, P409, DOI 10.1016/0167-7799(94)90029-9; Inui M, 2008, APPL MICROBIOL BIOT, V77, P1305, DOI 10.1007/s00253-007-1257-5; Isken S, 1998, EXTREMOPHILES, V2, P229, DOI 10.1007/s007920050065; Kieboom J, 1998, J BIOL CHEM, V273, P85, DOI 10.1074/jbc.273.1.85; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Knoshaug EP, 2009, APPL BIOCHEM BIOTECH, V153, P13, DOI 10.1007/s12010-008-8460-4; Lee J, 2010, J APPL MICROBIOL, V108, P2088, DOI 10.1111/j.1365-2672.2009.04611.x; Lee JH, 2009, J BACTERIOL, V191, P4441, DOI 10.1128/JB.01474-08; Lewis C, 2008, MICROBIOL-SGM, V154, P979, DOI 10.1099/mic.0.2007/011999-0; LIN YL, 1983, APPL ENVIRON MICROB, V45, P966, DOI 10.1128/AEM.45.3.966-973.1983; Ma Z, 2002, J BACTERIOL, V184, P7001, DOI 10.1128/JB.184.24.7001-7012.2002; Nagakubo S, 2002, J BACTERIOL, V184, P4161, DOI 10.1128/JB.184.15.4161-4167.2002; Ng B, 2008, ANAL BIOCHEM, V376, P131, DOI 10.1016/j.ab.2008.01.026; Nielsen DR, 2009, METAB ENG, V11, P262, DOI 10.1016/j.ymben.2009.05.003; Nielsen LE, 2005, APPL ENVIRON MICROB, V71, P5171, DOI 10.1128/AEM.71.9.5171-5176.2005; Pinkart HC, 1996, APPL ENVIRON MICROB, V62, P1129, DOI 10.1128/AEM.62.3.1129-1132.1996; Qin ZHS, 2003, NAT BIOTECHNOL, V21, P435, DOI 10.1038/nbt802; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ramos JL, 1997, J BIOL CHEM, V272, P3887, DOI 10.1074/jbc.272.7.3887; RON EZ, 1990, ANTON LEEUW INT J G, V58, P169, DOI 10.1007/BF00548929; Rowbury RJ, 1999, J APPL MICROBIOL, V86, P325, DOI 10.1046/j.1365-2672.1999.00676.x; Ruhl J, 2009, APPL ENVIRON MICROB, V75, P4653, DOI 10.1128/AEM.00225-09; Rutherford BJ, 2010, APPL ENVIRON MICROB, V76, P1935, DOI 10.1128/AEM.02323-09; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sambrook J, 2001, MOL CLONING LAB MANU; Sardessai Y, 2002, RES MICROBIOL, V153, P263, DOI 10.1016/S0923-2508(02)01319-0; Semchyshyn H, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1238, DOI 10.1007/s10541-005-0253-6; Shimizu K, 2005, J BIOSCI BIOENG, V99, P72, DOI 10.1263/jbb.99.72; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Sugai R, 2001, J BACTERIOL, V183, P5523, DOI 10.1128/JB.183.19.5523-5528.2001; SUPPMANN B, 1994, MOL MICROBIOL, V11, P965, DOI 10.1111/j.1365-2958.1994.tb00375.x; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Tomas CA, 2004, J BACTERIOL, V186, P2006, DOI 10.1128/JB.186.7.2006-2018.2004; Tomas Christopher A., 2005, P813; Tsukagoshi N, 2000, J BACTERIOL, V182, P4803, DOI 10.1128/JB.182.17.4803-4810.2000; Weber FJ, 1996, BBA-REV BIOMEMBRANES, V1286, P225, DOI 10.1016/S0304-4157(96)00010-X; WHITE CB, 1995, J BIOL CHEM, V270, P12990, DOI 10.1074/jbc.270.22.12990; White DG, 1997, J BACTERIOL, V179, P6122, DOI 10.1128/jb.179.19.6122-6126.1997; WINKLER J, 2010, TRANSCRIPTIONA UNPUB; Xu Y, 1995, BIOCHEMISTRY-US, V34, P16624, DOI 10.1021/bi00051a010; Yang YH, 2001, PROC SPIE, V4266, P141, DOI 10.1117/12.427982; Yoshimura M, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-69; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	63	103	118	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17678	10.1371/journal.pone.0017678	http://dx.doi.org/10.1371/journal.pone.0017678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408113	Green Submitted, gold, Green Published			2022-12-25	WOS:000288170000053
J	Sesti, G; Folli, F; Perego, L; Hribal, ML; Pontiroli, AE				Sesti, Giorgio; Folli, Franco; Perego, Lucia; Hribal, Marta Letizia; Pontiroli, Antonio E.			Effects of Weight Loss in Metabolically Healthy Obese Subjects after Laparoscopic Adjustable Gastric Banding and Hypocaloric Diet	PLOS ONE			English	Article							RISK; INFLAMMATION; INDIVIDUALS; PREVALENCE; PROFILE; WOMEN	Weight loss in metabolically healthy obese (MHO) subjects may result in deterioration of cardio-metabolic risk profile. We analyzed the effects of weight loss induced by laparoscopic adjustable gastric banding (LAGB) on cardio-metabolic risk factors in MHO and insulin resistant obese (IRO) individuals. This study included 190 morbidly obese non-diabetic subjects. Obese individuals were stratified on the basis of their insulin sensitivity index (ISI), estimated from an OGTT, into MHO (ISI index in the upper quartile) and IRO (ISI in the three lower quartiles). Anthropometric and cardio-metabolic variables were measured at baseline and 6-months after LAGB. Six months after LAGB, anthropometric measures were significantly reduced in both MHO and IRO. Percent changes in body weight, BMI, and waist circumference did not differ between the two groups. Fasting glucose and insulin levels, triglycerides, AST, and ALT were significantly reduced, and HDL cholesterol significantly increased, in both MHO and IRO subjects with no differences in percent changes from baseline. Insulin sensitivity increased in both MHO and IRO group. Insulin secretion was significantly reduced in the IRO group only. However, the disposition index significantly increased in both MHO and IRO individuals with no differences in percent changes from baseline between the two groups. The change in insulin sensitivity correlated with the change in BMI (r = -0.43; P< 0.0001). In conclusion, our findings reinforce the recommendation that weight loss in response to LAGB intervention should be considered an appropriate treatment option for morbidly obese individuals regardless of their metabolic status, i.e. MHO vs. IRO subjects.	[Sesti, Giorgio; Hribal, Marta Letizia] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Folli, Franco] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA; [Perego, Lucia; Pontiroli, Antonio E.] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Milan, Italy	Magna Graecia University of Catanzaro; University of Texas System; University of Texas Health San Antonio; University of Milan	Sesti, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy.	folli@uthscsa.edu	folli, franco/J-2795-2018; Sesti, Giorgio/B-1509-2012; pontiroli, antonio e/AAI-5575-2020	folli, franco/0000-0001-9824-5222; Sesti, Giorgio/0000-0002-1618-7688				Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Calori G, 2011, DIABETES CARE, V34, P210, DOI 10.2337/dc10-0665; Janiszewski PM, 2010, DIABETES CARE, V33, P1957, DOI 10.2337/dc10-0547; Kantartzis K, 2011, DIABETOLOGIA, V54, P864, DOI 10.1007/s00125-010-2006-3; Karelis AD, 2008, DIABETOLOGIA, V51, P1752, DOI 10.1007/s00125-008-1038-4; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Kuk JL, 2009, DIABETES CARE, V32, P2297, DOI 10.2337/dc09-0574; Marini MA, 2007, DIABETES CARE, V30, P2145, DOI 10.2337/dc07-0419; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Pontiroli AE, 2005, DIABETES CARE, V28, P2703, DOI 10.2337/diacare.28.11.2703; Pontiroli AE, 2002, J CLIN ENDOCR METAB, V87, P3555, DOI 10.1210/jc.87.8.3555; Sesti G, 2005, J CLIN ENDOCR METAB, V90, P5064, DOI 10.1210/jc.2005-0404; Sesti G, 2011, NUTR METAB CARDIOVAS, V21, P933, DOI 10.1016/j.numecd.2010.02.008; Shin MJ, 2006, INT J OBESITY, V30, P1529, DOI 10.1038/sj.ijo.0803304; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Succurro E, 2009, ATHEROSCLEROSIS, V207, P245, DOI 10.1016/j.atherosclerosis.2009.04.006; Succurro E, 2008, OBESITY, V16, P1881, DOI 10.1038/oby.2008.308; Succurro E, 2010, CLIN J AM SOC NEPHRO, V5, P1922, DOI 10.2215/CJN.03240410; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617	22	38	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17737	10.1371/journal.pone.0017737	http://dx.doi.org/10.1371/journal.pone.0017737			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408112	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170000056
J	Clegg, NJ; Couto, SS; Wongvipat, J; Hieronymus, H; Carver, BS; Taylor, BS; Ellwood-Yen, K; Gerald, WL; Sander, C; Sawyers, CL				Clegg, Nicola J.; Couto, Suzana S.; Wongvipat, John; Hieronymus, Haley; Carver, Brett S.; Taylor, Barry S.; Ellwood-Yen, Katharine; Gerald, William L.; Sander, Chris; Sawyers, Charles L.			MYC Cooperates with AKT in Prostate Tumorigenesis and Alters Sensitivity to mTOR Inhibitors	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; CANCER PROGRESSION; MAMMALIAN TARGET; RAPAMYCIN; ACTIVATION; PATHWAYS; PTEN; CARCINOGENESIS; EIF4E; CELLS	MYC and phosphoinositide 3-kinase (PI3K)-pathway deregulation are common in human prostate cancer. Through examination of 194 human prostate tumors, we observed statistically significant co-occurrence of MYC amplification and PI3K-pathway alteration, raising the possibility that these two lesions cooperate in prostate cancer progression. To investigate this, we generated bigenic mice in which both activated human AKT1 and human MYC are expressed in the prostate (MPAKT/Hi-MYC model). In contrast to mice expressing AKT1 alone (MPAKT model) or MYC alone (Hi-MYC model), the bigenic phenotype demonstrates accelerated progression of mouse prostate intraepithelial neoplasia (mPIN) to microinvasive disease with disruption of basement membrane, significant stromal remodeling and infiltration of macrophages, B- and T-lymphocytes, similar to inflammation observed in human prostate tumors. In contrast to the reversibility of mPIN lesions in young MPAKT mice after treatment with mTOR inhibitors, Hi-MYC and bigenic MPAKT/HiMYC mice were resistant. Additionally, older MPAKT mice showed reduced sensitivity to mTOR inhibition, suggesting that additional genetic events may dampen mTOR dependence. Since increased MYC expression is an early feature of many human prostate cancers, these data have implications for treatment of human prostate cancers with PI3K-pathway alterations using mTOR inhibitors.	[Clegg, Nicola J.; Wongvipat, John; Hieronymus, Haley; Carver, Brett S.; Gerald, William L.; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Couto, Suzana S.] Mem Sloan Kettering Canc Ctr, Lab Comparat Pathol, New York, NY 10021 USA; [Wongvipat, John; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Carver, Brett S.] Mem Sloan Kettering Canc Ctr, Urol Serv, New York, NY 10021 USA; [Carver, Brett S.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Taylor, Barry S.; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Ellwood-Yen, Katharine] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Clegg, NJ (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	sawyersc@mskcc.org	Sander, Chris/H-1452-2011; Sawyers, Charles/G-5327-2016	Sander, Chris/0000-0001-6059-6270; 	Charles H. Revson Senior Fellowship in Life Sciences; David H. Koch Fellowship in Cancer Genomics; Howard Hughes Medical Institute; NCI [5P01CA089021]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [P01CA089021] Funding Source: NIH RePORTER	Charles H. Revson Senior Fellowship in Life Sciences; David H. Koch Fellowship in Cancer Genomics; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Charles H. Revson Senior Fellowship in Life Sciences (www. revsonfoundation. org) (NJC); David H. Koch Fellowship in Cancer Genomics (www.kochfamilyfoundations.org/FoundationsDHK.asp) (BST); Howard Hughes Medical Institute (www.hhmi.org) (CLS); NCI 5P01CA089021 (www.cancer.gov) (CLS); and the Prostate Cancer Foundation (www.pcf.org) (CLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Amato RJ, 2008, CLIN GENITOURIN CANC, V6, P97, DOI 10.3816/CGC.2008.n.015; Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Balakumaran BS, 2009, CANCER RES, V69, P7803, DOI 10.1158/0008-5472.CAN-09-0910; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Brachmann S, 2009, CURR OPIN CELL BIOL, V21, P194, DOI 10.1016/j.ceb.2008.12.011; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chen Y, 2009, LANCET ONCOL, V10, P981, DOI 10.1016/S1470-2045(09)70229-3; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Jenkins RB, 1997, CANCER RES, V57, P524; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kim J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000542; Kuczyk M, 1998, BRIT J UROL, V81, P406; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sato K, 1999, JNCI-J NATL CANCER I, V91, P1574, DOI 10.1093/jnci/91.18.1574; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Sfanos KS, 2008, CLIN CANCER RES, V14, P3254, DOI 10.1158/1078-0432.CCR-07-5164; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Wu LC, 2005, CANCER RES, V65, P2825, DOI 10.1158/0008-5472.CAN-04-3137; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7	47	66	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17449	10.1371/journal.pone.0017449	http://dx.doi.org/10.1371/journal.pone.0017449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394210	gold, Green Published, Green Submitted			2022-12-25	WOS:000288025500014
J	Das, S; Dutta, K; Kumawat, KL; Ghoshal, A; Adhya, D; Basu, A				Das, Sulagna; Dutta, Kallol; Kumawat, Kanhaiya Lal; Ghoshal, Ayan; Adhya, Dwaipayan; Basu, Anirban			Abrogated Inflammatory Response Promotes Neurogenesis in a Murine Model of Japanese Encephalitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; NECROSIS-FACTOR-ALPHA; SUBVENTRICULAR ZONE NEUROGENESIS; ADULT HIPPOCAMPAL NEUROGENESIS; FOCAL CEREBRAL-ISCHEMIA; BLOOD-BRAIN-BARRIER; NITRIC-OXIDE; PROGENITOR CELLS; NEURONAL DEATH	Background: Japanese encephalitis virus (JEV) induces neuroinflammation with typical features of viral encephalitis, including inflammatory cell infiltration, activation of microglia, and neuronal degeneration. The detrimental effects of inflammation on neurogenesis have been reported in various models of acute and chronic inflammation. We investigated whether JEV-induced inflammation has similar adverse effects on neurogenesis and whether those effects can be reversed using an anti-inflammatory compound minocycline. Methodology/Principal Findings: Here, using in vitro studies and mouse models, we observed that an acute inflammatory milieu is created in the subventricular neurogenic niche following Japanese encephalitis ( JE) and a resultant impairment in neurogenesis occurs, which can be reversed with minocycline treatment. Immunohistological studies showed that proliferating cells were replenished and the population of migrating neuroblasts was restored in the niche following minocycline treatment. In vitro, we checked for the efficacy of minocycline as an anti-inflammatory compound and cytokine bead array showed that production of cyto/chemokines decreased in JEV-activated BV2 cells. Furthermore, mouse neurospheres grown in the conditioned media from JEV-activated microglia exhibit arrest in both proliferation and differentiation of the spheres compared to conditioned media from control microglia. These effects were completely reversed when conditioned media from JEV-activated and minocycline treated microglia was used. Conclusion/Significance: This study provides conclusive evidence that JEV-activated microglia and the resultant inflammatory molecules are anti-proliferative and anti-neurogenic for NSPCs growth and development, and therefore contribute to the viral neuropathogenesis. The role of minocycline in restoring neurogenesis may implicate enhanced neuronal repair and attenuation of the neuropsychiatric sequelae in JE survivors.	[Das, Sulagna; Dutta, Kallol; Kumawat, Kanhaiya Lal; Ghoshal, Ayan; Adhya, Dwaipayan; Basu, Anirban] Natl Brain Res Ctr, Manesar, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Das, S (corresponding author), Natl Brain Res Ctr, Manesar, Haryana, India.	anirban@nbrc.ac.in	Dutta, Kallol/J-5827-2019	Dutta, Kallol/0000-0001-6402-1300; Basu, Anirban/0000-0002-5200-2054; Das, Sulagna/0000-0002-8495-3153	Department of Biotechnology, Government of India [BT/PR8682/Med/14/1273/2007]; Council of Scientific and Industrial Research [27(0173)/07/EMR-II]; University Grants Commission, Government of India; Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, Government of India(University Grants Commission, India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work is funded by grants to A. B. from the Department of Biotechnology, Government of India (BT/PR8682/Med/14/1273/2007), and the Council of Scientific and Industrial Research (27(0173)/07/EMR-II); S.D. is the recipient of a Senior Research Fellowship from the University Grants Commission, Government of India; K.D. is a recipient of a Research Associateship in Biotechnology and Life Sciences from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Bernardino L, 2008, STEM CELLS, V26, P2361, DOI 10.1634/stemcells.2007-0914; Buckner CM, 2006, J NEUROIMMUNE PHARM, V1, P160, DOI 10.1007/s11481-006-9017-3; Cacci E, 2005, J NEUROSCI RES, V80, P789, DOI 10.1002/jnr.20531; Cacci E, 2008, GLIA, V56, P412, DOI 10.1002/glia.20616; CHATURVEDI UC, 1979, CLIN EXP IMMUNOL, V38, P492; Covacu R, 2006, STEM CELLS, V24, P2792, DOI 10.1634/stemcells.2005-0640; Das S, 2008, J NEUROCHEM, V106, P1624, DOI 10.1111/j.1471-4159.2008.05511.x; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Das S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008134; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Heldmann U, 2005, EXP NEUROL, V196, P204, DOI 10.1016/j.expneurol.2005.07.024; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Krathwohl MD, 2004, STEM CELLS, V22, P109, DOI 10.1634/stemcells.22-1-109; Kuzumaki N, 2010, SYNAPSE, V64, P721, DOI 10.1002/syn.20800; Lazarini F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007017; Liu YP, 2005, BRAIN RES, V1054, P152, DOI 10.1016/j.brainres.2005.06.085; Liu ZY, 2007, STROKE, V38, P146, DOI 10.1161/01.STR.0000251791.64910.cd; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Marchetti B, 2005, TRENDS PHARMACOL SCI, V26, P517, DOI 10.1016/j.tips.2005.08.007; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Matarredona ER, 2005, BRAIN RES REV, V49, P355, DOI 10.1016/j.brainresrev.2005.01.001; MATHUR A, 1992, INT J EXP PATHOL, V73, P603; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mishra MK, 2008, J NEUROCHEM, V105, P1582, DOI 10.1111/j.1471-4159.2008.05238.x; Mishra MK, 2007, NEUROCHEM INT, V50, P764, DOI 10.1016/j.neuint.2007.01.014; Mishra MK, 2009, NEUROCHEM INT, V55, P717, DOI 10.1016/j.neuint.2009.07.006; MISRA UK, PROG NEUROBIOL, V91, P108; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Monnet FP, 2003, EUR PSYCHIAT, V18, P269, DOI 10.1016/j.eurpsy.2003.09.001; MORI K, NEUROSCI LETT; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Peng H, 2008, GLIA, V56, P903, DOI 10.1002/glia.20665; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Poluektova L, 2005, GLIA, V52, P344, DOI 10.1002/glia.20253; Reyes TM, 1998, AM J PHYSIOL-REG I, V274, pR139, DOI 10.1152/ajpregu.1998.274.1.R139; RICHTER RW, 1961, NEUROLOGY, V11, P553, DOI 10.1212/WNL.11.7.553; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Romero-Grimaldi C, 2006, EUR J NEUROSCI, V24, P2461, DOI 10.1111/j.1460-9568.2006.05127.x; Strassburger M, 2008, EUR J PHARMACOL, V592, P55, DOI 10.1016/j.ejphar.2008.06.099; Swarup V, 2008, NEUROCHEM INT, V52, P1310, DOI 10.1016/j.neuint.2008.01.014; Swarup V, 2007, J NEUROCHEM, V103, P771, DOI 10.1111/j.1471-4159.2007.04790.x; Tanapat P, 1998, INT J DEV NEUROSCI, V16, P235, DOI 10.1016/S0736-5748(98)00029-X; Tewari R, 2008, J NEUROCHEM, V107, P616, DOI 10.1111/j.1471-4159.2008.05625.x; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; Tran PB, 2005, NEUROTOX RES, V8, P149, DOI 10.1007/BF03033826; Vrati S, 1999, J GEN VIROL, V80, P1665, DOI 10.1099/0022-1317-80-7-1665; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003; Ziv Y, 2008, BRAIN BEHAV IMMUN, V22, P167, DOI 10.1016/j.bbi.2007.08.006; Ziv Y, 2008, TRENDS MOL MED, V14, P471, DOI 10.1016/j.molmed.2008.09.004	65	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17225	10.1371/journal.pone.0017225	http://dx.doi.org/10.1371/journal.pone.0017225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390230	Green Published, gold, Green Submitted			2022-12-25	WOS:000287965200012
J	Liu, SJ; Madiai, F; Hackshaw, KV; Allen, CE; Carl, J; Huschart, E; Karanfilov, C; Litsky, A; Hickey, CJ; Marcucci, G; Huja, S; Agarwal, S; Yu, JH; Caligiuri, MA; Wu, LC				Liu, Shujun; Madiai, Francesca; Hackshaw, Kevin V.; Allen, Carl E.; Carl, Joseph; Huschart, Emily; Karanfilov, Chris; Litsky, Alan; Hickey, Christopher J.; Marcucci, Guido; Huja, Sarandeep; Agarwal, Sudha; Yu, Jianhua; Caligiuri, Michael A.; Wu, Lai-Chu			The Large Zinc Finger Protein ZAS3 Is a Critical Modulator of Osteoclastogenesis	PLOS ONE			English	Article							NF-KAPPA-B; BINDING-PROTEIN; C-JUN; V(D)J RECOMBINATION; SIGNALING PATHWAY; MYELOID-LEUKEMIA; DNA-BINDING; T-CELLS; TRANSCRIPTION; RECEPTOR	Background: Mice deficient in the large zinc finger protein, ZAS3, show postnatal increase in bone mass suggesting that ZAS3 is critical in the regulation of bone homeostasis. Although ZAS3 has been shown to inhibit osteoblast differentiation, its role on osteoclastogenesis has not been determined. In this report we demonstrated the role of ZAS3 in bone resorption by examining the signaling mechanisms involved in osteoclastogenesis. Methodology/Principal Findings: Comparison of adult wild-type and ZAS3 knockout (ZAS32/2) mice showed that ZAS3 deficiency led to thicker bones that are more resistant to mechanical fracture. Additionally, ZAS32/2 bones showed fewer osteoclasts and inefficient M-CSF/sRANKL-mediated osteoclastogenesis ex vivo. Utilizing RAW 264.7 pre-osteoclasts, we demonstrated that overexpression of ZAS3 promoted osteoclastogenesis and the expression of crucial osteoclastic molecules, including phospho-p38, c-Jun, NFATc1, TRAP and CTSK. Contrarily, ZAS3 silencing by siRNA inhibited osteoclastogenesis. Co-immunoprecipitation experiments demonstrated that ZAS3 associated with TRAF6, the major receptor associated molecule in RANK signaling. Furthermore, EMSA suggested that nuclear ZAS3 could regulate transcription by binding to gene regulatory elements. Conclusion/Significance: Collectively, the data suggested a novel role of ZAS3 as a positive regulator of osteoclast differentiation. ZAS3 deficiency caused increased bone mass, at least in part due to decreased osteoclast formation and bone resorption. These functions of ZAS3 were mediated via activation of multiple intracellular targets. In the cytoplasmic compartment, ZAS3 associated with TRAF6 to control NF-kB and MAP kinase signaling cascades. Nuclear ZAS3 acted as a transcriptional regulator for osteoclast-associated genes. Additionally, ZAS3 activated NFATc1 required for the integration of RANK signaling in the terminal differentiation of osteoclasts. Thus, ZAS3 was a crucial molecule in osteoclast differentiation, which might potentially serve as a target in the design of therapeutic interventions for the treatment of bone diseases related to increased osteoclast activity such as postmenopausal osteoporosis, Paget's disease, and rheumatoid arthritis.	[Liu, Shujun; Madiai, Francesca; Hackshaw, Kevin V.; Marcucci, Guido; Wu, Lai-Chu] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Liu, Shujun; Hickey, Christopher J.; Marcucci, Guido; Yu, Jianhua; Caligiuri, Michael A.; Wu, Lai-Chu] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Allen, Carl E.; Hickey, Christopher J.; Wu, Lai-Chu] Ohio State Univ, Mol & Cellular Dev Biol Grad Program, Columbus, OH 43210 USA; [Carl, Joseph; Huschart, Emily; Wu, Lai-Chu] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Karanfilov, Chris] Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Litsky, Alan] Ohio State Univ, Dept Orthopaed, Columbus, OH 43210 USA; [Litsky, Alan] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Huja, Sarandeep] Ohio State Univ, Div Orthodont, Columbus, OH 43210 USA; [Agarwal, Sudha] Ohio State Univ, Div Oral Biol, Biomech & Tissue Engn Lab, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Liu, SJ (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	laichu.wu@osumc.edu	Litsky, Alan S/E-3523-2011; Wu, Lai-Chu/E-4328-2011; Huja, Sarandeep/I-6234-2016	Wu, Lai-Chu/0000-0002-1348-269X; Huja, Sarandeep/0000-0002-4617-5055	National Cancer Institute [P30 CA16058]; Columbus Medical Research Foundation; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Columbus Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by a grant P30 CA16058 from the National Cancer Institute and by grants from the Columbus Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CE, 2007, GENE EXPRESSION, V14, P83, DOI 10.3727/105221607783417574; ALLEN CE, 2004, ZINC FINGER PROTEINS, P233; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Baldridge D, 2010, ANNU REV GENOM HUM G, V11, P189, DOI 10.1146/annurev-genom-082908-150158; Dai H, 2000, DEV BIOL, V227, P373, DOI 10.1006/dbio.2000.9901; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; Dorflinger U, 1999, MOL CELL BIOL, V19, P3736; FAN CM, 1990, GENE DEV, V4, P29, DOI 10.1101/gad.4.1.29; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Hjelmsoe I, 2000, J BIOL CHEM, V275, P913, DOI 10.1074/jbc.275.2.913; Hong JW, 2003, P NATL ACAD SCI USA, V100, P12301, DOI 10.1073/pnas.2133048100; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Jones DC, 2010, P NATL ACAD SCI USA, V107, P8254, DOI 10.1073/pnas.1003727107; Liang J, 2003, DEVELOPMENT, V130, P6453, DOI 10.1242/dev.00863; Liu SJ, 2008, BLOOD, V111, P2364, DOI 10.1182/blood-2007-08-110171; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; MAKINO R, 1994, NUCLEIC ACIDS RES, V22, P5679, DOI 10.1093/nar/22.25.5679; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Nakabayashi Y, 1994, J Arthroplasty, V9, P307, DOI 10.1016/0883-5403(94)90086-8; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Oukka M, 2002, MOL CELL, V9, P121, DOI 10.1016/S1097-2765(01)00434-8; Oukka M, 2004, J EXP MED, V199, P15, DOI 10.1084/jem.20030421; Saita Y, 2007, J BIOL CHEM, V282, P12907, DOI 10.1074/jbc.M611203200; Shukla A, 2009, NAT CELL BIOL, V11, P777, DOI 10.1038/ncb1885; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Wu LC, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-4; Wu LC, 2002, GENE EXPRESSION, V10, P137, DOI 10.3727/000000002783992479; WU LC, 1993, NUCLEIC ACIDS RES, V21, P5067, DOI 10.1093/nar/21.22.5067; Yakovich AJ, 2011, CELL SIGNAL, V23, P105, DOI 10.1016/j.cellsig.2010.08.009; Yang X, 2005, J BIOL CHEM, V280, P18710, DOI 10.1074/jbc.M500859200; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	36	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17161	10.1371/journal.pone.0017161	http://dx.doi.org/10.1371/journal.pone.0017161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390242	gold, Green Published, Green Submitted			2022-12-25	WOS:000287965200010
J	Stankiewicz, E; Prowse, DM; Ng, M; Cuzick, J; Mesher, D; Hiscock, F; Lu, YJ; Watkin, N; Corbishley, C; Lam, W; Berney, DM				Stankiewicz, Elzbieta; Prowse, David M.; Ng, Mansum; Cuzick, Jack; Mesher, David; Hiscock, Frances; Lu, Yong-Jie; Watkin, Nicholas; Corbishley, Catherine; Lam, Wayne; Berney, Daniel M.			Alternative HER/PTEN/Akt Pathway Activation in HPV Positive and Negative Penile Carcinomas	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMAS; HUMAN-PAPILLOMAVIRUS; RECEPTOR FAMILY; CANCER PATIENTS; IN-SITU; EXPRESSION; EGFR; CARCINOGENESIS; THERAPY	Background: The pathogenesis of penile squamous cell carcinoma (PSCC) is not well understood, though risk factors include human papillomavirus (HPV). Disruption of HER/PTEN/Akt pathway is present in many cancers; however there is little information on its function in PSCC. We investigated HER family receptors and phosphatase and tension homolog (PTEN) in HPV-positive and negative PSCC and its impact on Akt activation using immunohistochemistry and fluorescent in situ hybridisation (FISH). Methodology/Principal Findings: 148 PSCCs were microarrayed and immunostained for phosphorylated EGFR (pEGFR), HER2, HER3, HER4, phosphorylated Akt (pAkt), Akt1 and PTEN proteins. EGFR and PTEN gene status were also evaluated using FISH. HPV presence was assessed by PCR. pEGFR expression was detected significantly less frequently in HPV-positive than HPV-negative tumours (p = 0.0143). Conversely, HER3 expression was significantly more common in HPV-positive cases (p = 0.0128). HER4, pAkt, Akt and PTEN protein expression were not related to HPV. HER3 (p = 0.0054) and HER4 (p = 0.0002) receptors significantly correlated with cytoplasmic Akt1 immunostaining. All three proteins positively correlated with tumour grade (HER3, p = 0.0029; HER4, p = 0.0118; Akt1, p = 0.0001). pEGFR expression correlated with pAkt but not with tumour grade or stage. There was no EGFR gene amplification. HER2 was not detected. PTEN protein expression was reduced or absent in 62% of tumours but PTEN gene copy loss was present only in 4% of PSCCs. Conclusions/Significance: EGFR, HER3 and HER4 but not HER2 are associated with penile carcinogenesis. HPV-negative tumours tend to express significantly more pEGFR than HPV-positive cancers and this expression correlates with pAkt protein, indicating EGFR as an upstream regulator of Akt signalling in PSCC. Conversely, HER3 expression is significantly more common in HPV-positive cases and positively correlates with cytoplasmic Akt1 expression. HER4 and PTEN protein expression are not related to HPV infection. Our results suggest that PSCC patients could benefit from therapies developed to target HER receptors.	[Stankiewicz, Elzbieta; Prowse, David M.; Ng, Mansum; Hiscock, Frances; Lu, Yong-Jie; Berney, Daniel M.] Queen Mary Univ London, Ctr Mol Oncol & Imaging, Inst Canc, Barts & London Sch Med & Dent, London, England; [Cuzick, Jack; Mesher, David] Queen Mary Univ London, Canc Res UK Ctr Epidemiol Math & Stat, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London, England; [Watkin, Nicholas] St George Hosp, Dept Urol, London, England; [Corbishley, Catherine; Lam, Wayne] St George Hosp, Dept Cellular Pathol, London, England	University of London; Queen Mary University London; Cancer Research UK; University of London; Queen Mary University London; St Georges University London; St Georges University London	Stankiewicz, E (corresponding author), Queen Mary Univ London, Ctr Mol Oncol & Imaging, Inst Canc, Barts & London Sch Med & Dent, London, England.	e.stankiewicz@qmul.ac.uk		Stankiewicz, Elzbieta/0000-0003-0812-4086; Berney, Daniel/0000-0001-5474-8696; Lu, Yong-Jie/0000-0001-6174-6621; Mesher, David/0000-0001-9163-6757	Jean Shanks Foundation; Orchid Cancer Appeal	Jean Shanks Foundation; Orchid Cancer Appeal	This work was funded by a grant from the Jean Shanks Foundation, http://www.jeanshanksfoundation.org and Orchid Cancer Appeal, http://www.orchid-cancer.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson P, 2008, J UROLOGY, V179, P2030, DOI 10.1016/j.juro.2007.12.040; Arteaga CL, 2003, CLIN CANCER RES, V9, P1579; Backes DM, 2009, CANCER CAUSE CONTROL, V20, P449, DOI 10.1007/s10552-008-9276-9; Bleeker MCG, 2009, WORLD J UROL, V27, P141, DOI 10.1007/s00345-008-0302-z; Borgermann C, 2009, UROLOGE, V48, P1483, DOI 10.1007/s00120-009-2101-6; Bose S, 2002, HUM PATHOL, V33, P405, DOI 10.1053/hupa.2002.124721; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chow NH, 2001, CLIN CANCER RES, V7, P1957; CUBILLA LC, 2004, STERNBERGS DIAGNOSTI, P2233; Daling JR, 2005, INT J CANCER, V116, P606, DOI 10.1002/ijc.21009; Earp H Shelton 3rd, 2003, Trans Am Clin Climatol Assoc, V114, P315; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Hafner N, 2008, ONCOGENE, V27, P1610, DOI 10.1038/sj.onc.1210791; Hirsch FR, 2008, J CLIN ONCOL, V26, P3351, DOI 10.1200/JCO.2007.14.0111; Hsieh AC, 2007, BRIT J CANCER, V97, P453, DOI 10.1038/sj.bjc.6603910; Kane LP, 2003, IMMUNOL REV, V192, P7, DOI 10.1034/j.1600-065X.2003.00008.x; Kong CS, 2009, INT J RADIAT ONCOL, V74, P553, DOI 10.1016/j.ijrobp.2009.02.015; Koseoglu S, 2007, CANCER BIOL THER, V6, P755, DOI 10.4161/cbt.6.5.3995; Kountourakis P, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-46; Kruser TJ, 2010, EXP CELL RES, V316, P1083, DOI 10.1016/j.yexcr.2010.01.009; Lavens N, 2010, CURR ONCOL, V17, P8; Le Page C, 2006, BRIT J CANCER, V94, P1906, DOI 10.1038/sj.bjc.6603184; Lee CM, 2005, GYNECOL ONCOL, V99, P415, DOI 10.1016/j.ygyno.2005.05.045; Mao XY, 2010, CANCER RES, V70, P5207, DOI 10.1158/0008-5472.CAN-09-4074; Mayer TJ, 2000, IN VITRO CELL DEV-AN, V36, P667; Ming M, 2009, J INVEST DERMATOL, V129, P2109, DOI 10.1038/jid.2009.79; NARAYANA AS, 1982, CANCER, V49, P2185, DOI 10.1002/1097-0142(19820515)49:10<2185::AID-CNCR2820491034>3.0.CO;2-M; Narisawa-Saito M, 2007, ONCOGENE, V26, P2988, DOI 10.1038/sj.onc.1210118; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Prowse DM, 2008, BRIT J DERMATOL, V158, P261, DOI 10.1111/j.1365-2133.2007.08305.x; QUINN AG, 1994, CANCER RES, V54, P4756; Razis E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-234; Reimers N, 2007, INT J CANCER, V120, P1731, DOI 10.1002/ijc.22355; Robinson D, 2009, BRIT J CANCER, V100, P527, DOI 10.1038/sj.bjc.6604871; Rubin MA, 2001, AM J PATHOL, V159, P1211, DOI 10.1016/S0002-9440(10)62506-0; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Sobin, 2009, UICC TNM CLASSIFICAT; STANKIEWICZ E, 2010, HISTOPATHOLOGY; Stankiewicz E, 2009, MODERN PATHOL, V22, P1160, DOI 10.1038/modpathol.2009.77; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Vivanco I, 2010, P NATL ACAD SCI USA, V107, P6459, DOI 10.1073/pnas.0911188107; Webster KA, 2004, CIRC RES, V94, P856, DOI 10.1161/01.RES.0000126699.49835.5D; Zhang BY, 2005, ONCOGENE, V24, P2585, DOI 10.1038/sj.onc.1208453	44	63	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17517	10.1371/journal.pone.0017517	http://dx.doi.org/10.1371/journal.pone.0017517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407808	Green Published, Green Submitted, gold			2022-12-25	WOS:000287933300031
J	Cheung, HH; Davis, AJ; Lee, TL; Pang, AL; Nagrani, S; Rennert, OM; Chan, WY				Cheung, H-H; Davis, A. J.; Lee, T-L; Pang, A. L.; Nagrani, S.; Rennert, O. M.; Chan, W-Y			Methylation of an intronic region regulates miR-199a in testicular tumor malignancy	ONCOGENE			English	Article						intronic methylation; miR-199a; testicular tumor; PODXL; malignancy	GERM-CELL TUMORS; OVARIAN-CANCER CELLS; DNA METHYLATION; MICRORNA EXPRESSION; PROSTATE-CANCER; BLADDER-CANCER; IDENTIFICATION; PODOCALYXIN; METASTASIS; CARCINOMA	In the testicular cancer cell line, NT2, we previously demonstrated that differentially methylated regions were located in introns or intergenic regions, and postulated these might regulate non-coding RNAs. Three microRNAs and three small nucleolar RNAs were differentially methylated; one, miR-199a, was associated with the progression and prognosis of gastric and ovarian cancers. In this report we document, by epigenomic profiling of testicular tissue, that miR-199a is transcribed as antisense of dynamin 3 (chromosome 1q24.3), and hypermethylation of this region is correlated with miR-199a-5p/3p repression and tumor malignancy. Re-expression of miR-199a in testicular cancer cells led to suppression of cell growth, cancer migration, invasion and metastasis. The miR-199a-5p, one of two mature miRNA species derived from miR-199a, is associated with tumor malignancy. We further identified the embryonal carcinoma antigen podocalyxin-like protein 1 (PODXL), an anti-adhesive protein expressed in aggressive tumors, as a target of miR-199a-5p. We demonstrated PODXL is overexpressed in malignant testicular tumor, and cellular depletion of PODXL resulted in suppression of cancer invasion. The inverse relationship between PODXL and miR-199a-5p expression suggests PODXL is a downstream effector mediating the action of miR199a-5p. This report identifies DNA methylation, miR-199a dysregulation and PODXL as critical factors in tumor malignancy. Oncogene (2011) 30, 3404-3415; doi:10.1038/onc.2011.60; published online 7 March 2011	[Cheung, H-H; Chan, W-Y] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Shatin, Hong Kong, Peoples R China; [Cheung, H-H; Davis, A. J.; Lee, T-L; Pang, A. L.; Nagrani, S.; Rennert, O. M.; Chan, W-Y] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Clin & Dev Genom, NIH, Bethesda, MD USA	Chinese University of Hong Kong; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Chan, WY (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Room 518B,Choh Ming Li Basic Med Sci Bldg, Shatin, Hong Kong, Peoples R China.	chanwy@cuhk.edu.hk	Chan, Wai Yee/R-7442-2018; Rennert, owen/AAI-7374-2020; Lee, Tin-Lap/A-7853-2009; Lee, Tin-Lap/W-6595-2019; Cheung, Hoi-Hung/G-7605-2011; Cheung, Hoi-Hung/AAE-2670-2020	Chan, Wai Yee/0000-0002-9714-0936; Lee, Tin-Lap/0000-0002-6654-0988; Lee, Tin-Lap/0000-0002-6654-0988; Cheung, Hoi-Hung/0000-0001-7178-9289; Davis, Andrew/0000-0001-9556-4498	National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development; Chinese University of Hong Kong; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008820, ZIAHD008817] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Chinese University of Hong Kong(Chinese University of Hong Kong); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Dr Yun-Fai Chris Lau for providing the 833K cell line. This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Chinese University of Hong Kong.	Aleman A, 2008, CLIN CANCER RES, V14, P8236, DOI 10.1158/1078-0432.CCR-08-0778; ANDREWS PW, 1984, LAB INVEST, V50, P147; Casey G, 2006, HUM MOL GENET, V15, P735, DOI 10.1093/hmg/ddi487; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Cheung HH, 2010, BRIT J CANCER, V102, P419, DOI 10.1038/sj.bjc.6605505; Cheung HH, 2009, BIRTH DEFECTS RES C, V87, P335, DOI 10.1002/bdrc.20163; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Hayatsu N, 2008, BIOCHEM BIOPH RES CO, V374, P394, DOI 10.1016/j.bbrc.2008.07.049; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kim S, 2008, J BIOL CHEM, V283, P18158, DOI 10.1074/jbc.M800186200; Koch LK, 2008, HUM PATHOL, V39, P1597, DOI 10.1016/j.humpath.2008.03.008; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Li LC, 2001, J UROLOGY, V166, P705, DOI 10.1016/S0022-5347(05)66047-8; Li YM, 2007, HUM PATHOL, V38, P1470, DOI 10.1016/j.humpath.2007.03.011; Lin EA, 2009, J BIOL CHEM, V284, P11326, DOI 10.1074/jbc.M807709200; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Netto GJ, 2008, MODERN PATHOL, V21, P1337, DOI 10.1038/modpathol.2008.127; Pang ALY, 2009, BIOL REPROD, V81, P302, DOI 10.1095/biolreprod.108.073221; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Santhakumar D, 2010, P NATL ACAD SCI USA, V107, P13830, DOI 10.1073/pnas.1008861107; Schopperle WM, 2003, BIOCHEM BIOPH RES CO, V300, P285; Singal R, 1997, P NATL ACAD SCI USA, V94, P13724, DOI 10.1073/pnas.94.25.13724; Smiraglia DJ, 2002, ONCOGENE, V21, P3909, DOI 10.1038/sj.onc.1205488; Somasiri A, 2004, CANCER RES, V64, P5068, DOI 10.1158/0008-5472.CAN-04-0240; Takeda T, 2000, MOL BIOL CELL, V11, P3219, DOI 10.1091/mbc.11.9.3219; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Tsai ZY, 2010, J CELL BIOCHEM, V109, P93, DOI 10.1002/jcb.22385; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Watts GS, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-47; Worley LA, 2008, MELANOMA RES, V18, P184, DOI 10.1097/CMR.0b013e3282feeac6; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	45	108	115	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2011	30	31					3404	3415		10.1038/onc.2011.60	http://dx.doi.org/10.1038/onc.2011.60			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	802KA	21383689	Green Accepted			2022-12-25	WOS:000293508100002
J	Ohnishi, M; Kato, S; Akiyoshi, J; Atfi, A; Razzaque, MS				Ohnishi, Mutsuko; Kato, Shigeko; Akiyoshi, Junko; Atfi, Azeddine; Razzaque, M. Shawkat			Dietary and genetic evidence for enhancing glucose metabolism and reducing obesity by inhibiting klotho functions	FASEB JOURNAL			English	Article						insulin; liver; vitamin D	HIGH-FAT-DIET; SOFT-TISSUE CALCIFICATION; ENDOTHELIAL DYSFUNCTION; PHOSPHATE HOMEOSTASIS; INSULIN-RESISTANCE; MICE LEADS; OB/OB MICE; NULL MICE; EXPRESSION; MOUSE	Klotho is a multifunctional protein involved in numerous biological functions, ranging from mineral ion metabolism to signaling activities. Recent studies have identified klotho as a target gene for peroxisome proliferator-activated receptor-gamma (PPAR-gamma), a master regulator of adipocyte differentiation, and an adipogenesis-promoting factor. In a similar line of observation, eliminating klotho function from mice resulted in the generation of lean mice with almost no detectable fat tissue. In contrast to the klotho-knockout mice (11.7 +/- 0.3 g at 9 wk), leptin-deficient (ob/ob) mice are severely obese (49.3 +/- 0.6 g at 9 wk), due to excessive fat accumulation. To study the in vivo role of klotho in obesity, we have generated and characterized ob/ob mice lacking klotho activity [ob/ob-klotho double-knockout (DKO) mice]. The ob/ob mice started to get bigger from 3 wk onward and gained almost 2 times more weight than their wild-type (WT) counterparts (WT vs. ob/ob: 34.8 +/- 1.3 vs. 65.5 +/- 1.2 g at 21 wk). The generated ob/ob-klotho DKO mice were not only viable throughout their adulthood but also showed markedly reduced fat tissue accumulation compared to their ob/ob littermates. The ob/ob-klotho DKO mice had significantly (P<0.01) less retroperitoneal, mesenteric, and epididymal fat accumulation, compared to their ob/ob counterparts. Similarly, the fatty liver that was consistently observed in the ob/ob mice was eliminated in the ob/ob-klotho DKO mice. Such structural improvement in the liver was also evident from markedly reduced fasting blood glucose levels in ob/ob-klotho DKO mice, compared to their ob/ob counterparts (ob/ob vs. ob/ob-klotho DKO: 266 +/- 36 vs. 65 +/- 2 mg/dl). Finally, to study whether the absence of klotho can induce resistance to high-fat-diet-induced obesity, we provided a high-fat (60%) diet to klotho-knockout mice and compared them with normal-fat (20%) diet-fed klotho-knockout mice. No significant difference in body weight was detected in klotho-knockout mice fed either the normal-fat diet or high-fat diet, while WT mice fed the high-fat diet gradually gained body weight, compared to the normal-fat-diet-fed counterparts. The results of our dietary and genetic manipulation studies provide in vivo evidence for a role of klotho in obesity and offer a novel target to manipulate obesity and associated complications.-Ohnishi, M., Kato, S., Akiyoshi, J., Atfi, A., Razzaque, M. S. Dietary and genetic evidence for enhancing glucose metabolism and reducing obesity by inhibiting klotho functions. FASEB J. 25, 2031-2039 (2011). www.fasebj.org	[Ohnishi, Mutsuko; Kato, Shigeko; Akiyoshi, Junko; Atfi, Azeddine; Razzaque, M. Shawkat] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	Harvard University; Harvard School of Dental Medicine	Razzaque, MS (corresponding author), Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Res & Educ Bldg,Rm 304,190 Longwood Ave, Boston, MA 02115 USA.	mrazzaque@hms.harvard.edu	Razzaque, Mohammed S./K-4282-2019		U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [R01-DK077276]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077276] Funding Source: NIH RePORTER	U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Part of the research is supported by grant R01-DK077276 to M.S.R. from the U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases).	Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chihara Y, 2006, ENDOCRINOLOGY, V147, P3835, DOI 10.1210/en.2005-1529; Cioffi F, 2010, FASEB J, V24, P3451, DOI 10.1096/fj.10-157115; Flicker L, 2010, J AM GERIATR SOC, V58, P234, DOI 10.1111/j.1532-5415.2009.02677.x; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Haluzik M, 2004, ENDOCRINOLOGY, V145, P3258, DOI 10.1210/en.2004-0219; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Kawaguchi H, 1999, J CLIN INVEST, V104, P229, DOI 10.1172/JCI5705; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Matsunuma A, 2004, ENDOCRINOLOGY, V145, P1367, DOI 10.1210/en.2003-1010; Mizuno I, 2001, LIFE SCI, V68, P2917, DOI 10.1016/S0024-3205(01)01092-X; Moon BC, 1997, GENOMICS, V42, P152, DOI 10.1006/geno.1997.4701; Mori K, 2000, BIOCHEM BIOPH RES CO, V278, P665, DOI 10.1006/bbrc.2000.3864; Nabeshima Y, 2002, AGEING RES REV, V1, P627, DOI 10.1016/S1568-1637(02)00027-2; Nagai R, 2000, CELL MOL LIFE SCI, V57, P738, DOI 10.1007/s000180050038; Nakatani T, 2009, FASEB J, V23, P3702, DOI 10.1096/fj.08-123992; Nakatani T, 2009, FASEB J, V23, P433, DOI 10.1096/fj.08-114397; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Ohnishi M, 2009, CIRC-CARDIOVASC GENE, V2, P583, DOI 10.1161/CIRCGENETICS.108.847814; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Rabot S, 2010, FASEB J, V24, P4948, DOI 10.1096/fj.10-164921; Razzaque MS, 2011, KIDNEY INT, V79, P708, DOI 10.1038/ki.2010.432; Razzaque MS, 2011, CLIN SCI, V120, P91, DOI 10.1042/CS20100377; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Razzaque MS, 2009, AM J PHYSIOL-RENAL, V296, pF470, DOI 10.1152/ajprenal.90538.2008; Razzaque MS, 2011, IUBMB LIFE, V63, P240, DOI 10.1002/iub.437; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Saito Y, 2000, BIOCHEM BIOPH RES CO, V276, P767, DOI 10.1006/bbrc.2000.3470; Saito Y, 1998, BIOCHEM BIOPH RES CO, V248, P324, DOI 10.1006/bbrc.1998.8943; Sato M, 2010, FASEB J, V24, P2375, DOI 10.1096/fj.09-145466; Tozuka Y, 2009, FASEB J, V23, P1920, DOI 10.1096/fj.08-124784; Utsugi T, 2000, METABOLISM, V49, P1118, DOI 10.1053/meta.2000.8606; Yamagishi T, 2001, HYPERTENS RES, V24, P705, DOI 10.1291/hypres.24.705; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Zadravec D, 2010, FASEB J, V24, P4366, DOI 10.1096/fj.09-152298; Zha Y, 2006, ENDOCRINOLOGY, V147, P5690, DOI 10.1210/en.2006-0302; Zhang H, 2008, KIDNEY INT, V74, P732, DOI 10.1038/ki.2008.244	39	32	34	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2011	25	6					2031	2039		10.1096/fj.10-167056	http://dx.doi.org/10.1096/fj.10-167056			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21382979	Green Published			2022-12-25	WOS:000291023800025
J	Ganesh, K; Adam, S; Taylor, B; Simpson, P; Rada, C; Neuberger, M				Ganesh, Karuna; Adam, Salome; Taylor, Benjamin; Simpson, Paul; Rada, Cristina; Neuberger, Michael			CTNNBL1 Is a Novel Nuclear Localization Sequence-binding Protein That Recognizes RNA-splicing Factors CDC5L and Prp31	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-SWITCH RECOMBINATION; IMPORTIN-ALPHA; RETINITIS-PIGMENTOSA; STRUCTURAL BASIS; GENE PRPF31; AID; SPLICEOSOME; IDENTIFICATION; KARYOPHERINS; RECEPTOR	Nuclear proteins typically contain short stretches of basic amino acids (nuclear localization sequences; NLSs) that bind karyopherin alpha family members, directing nuclear import. Here, we identify CTNNBL1 (catenin-beta-like 1), an armadillo motifcontaining nuclear protein that exhibits no detectable primary sequence homology to karyopherin alpha, as a novel, selective NLS-binding protein. CTNNBL1 (a single-copy gene conserved from fission yeast to man) was previously found associated with Prp19-containing RNA-splicing complexes as well as with the antibody-diversifying enzyme AID. We find that CTNNBL1 association with the Prp19 complex is mediated by recognition of the NLS of the CDC5L component of the complex and show that CTNNBL1 also interacts with Prp31 (another U4/U6. U5 tri-snRNP-associated splicing factor) through its NLS. As with karyopherin alpha s, CTNNBL1 binds NLSs via its armadillo (ARM) domain, but displays a separate, more selective NLS binding specificity. Furthermore, the CTNNBL1/AID interaction depends on amino acids forming the AID conformational NLS with CTNNBL1-deficient cells showing a partial defect in AID nuclear accumulation. However, in further contrast to karyopherin alpha s, the CTNNBL1 N-terminal region itself binds karyopherin alpha s (rather than karyopherin beta), suggesting a function divergent from canonical nuclear transport. Thus, CTNNBL1 is a novel NLS-binding protein, distinct from karyopherin alpha s, with the results suggesting a possible role in the selective intranuclear targeting or interactions of some splicing-associated complexes.	[Ganesh, Karuna; Adam, Salome; Taylor, Benjamin; Simpson, Paul; Rada, Cristina; Neuberger, Michael] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Neuberger, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	msn@mrc-lmb.cam.ac.uk		Taylor, Benjamin/0000-0001-6101-3786; Simpson, Paul/0000-0002-5069-8588	Laboratory of Molecular Biology; James Baird Fund; Ecole Normale Superieure de Cachan; Medical Research Council [MC_U105178806] Funding Source: researchfish; MRC [MC_U105178806] Funding Source: UKRI	Laboratory of Molecular Biology; James Baird Fund; Ecole Normale Superieure de Cachan; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a Laboratory of Molecular Biology International Scholarship and the James Baird Fund.; Supported by the Ecole Normale Superieure de Cachan.	Aoufouchi S, 2008, J EXP MED, V205, P1357, DOI 10.1084/jem.20070950; Bernstein HS, 1997, J BIOL CHEM, V272, P5833, DOI 10.1074/jbc.272.9.5833; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; Deery EC, 2002, HUM MOL GENET, V11, P3209, DOI 10.1093/hmg/11.25.3209; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Geisberger R, 2009, P NATL ACAD SCI USA, V106, P6736, DOI 10.1073/pnas.0810808106; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Grote M, 2010, MOL CELL BIOL, V30, P2105, DOI 10.1128/MCB.01505-09; Han L, 2010, J IMMUNOL, V185, P1379, DOI 10.4049/jimmunol.1001643; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Jabbour L, 2003, GENOMICS, V81, P292, DOI 10.1016/S0888-7543(02)00038-1; Jensen ON, 1997, ANAL CHEM, V69, P4741, DOI 10.1021/ac970896z; Liu LS, 2003, CELL BIOCHEM BIOPHYS, V39, P119, DOI 10.1385/CBB:39:2:119; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; Mason DA, 2002, GENETICS, V161, P157; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Ordinario EC, 2009, J IMMUNOL, V183, P4545, DOI 10.4049/jimmunol.0900673; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Randow Felix, 2006, Subcell Biochem, V40, P383; Schaffert N, 2004, EMBO J, V23, P3000, DOI 10.1038/sj.emboj.7600296; Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Stanek D, 2006, CHROMOSOMA, V115, P343, DOI 10.1007/s00412-006-0056-6; Tsai WY, 1999, J BIOL CHEM, V274, P9455, DOI 10.1074/jbc.274.14.9455; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521	30	35	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17091	17102		10.1074/jbc.M110.208769	http://dx.doi.org/10.1074/jbc.M110.208769			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21385873	Green Published, hybrid			2022-12-25	WOS:000290301900059
J	Zhang, L; Jouret, F; Rinehart, J; Sfakianos, J; Mellman, I; Lifton, RP; Young, LH; Caplan, MJ				Zhang, Li; Jouret, Francois; Rinehart, Jesse; Sfakianos, Jeff; Mellman, Ira; Lifton, Richard P.; Young, Lawrence H.; Caplan, Michael J.			AMP-activated Protein Kinase (AMPK) Activation and Glycogen Synthase Kinase-3 beta (GSK-3 beta) Inhibition Induce Ca2+-independent Deposition of Tight Junction Components at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE UVOMORULIN; INTESTINAL EPITHELIAL-CELLS; PANCREATIC ACINAR-CELLS; OCCLUDING JUNCTIONS; BETA-CATENIN; NEURONAL POLARITY; ADHERENS JUNCTION; ALPHA-CATENIN; ACTIN-BINDING; CADHERIN	Extracellular Ca2+ is essential for the development of stable epithelial tight junctions. We find that in the absence of extracellular Ca2+, AMP-activated protein kinase (AMPK) activation and glycogen synthase kinase (GSK)-3 beta inhibition independently induce the localization of epithelial tight junction components to the plasma membrane. The Ca2+-independent deposition of junctional proteins induced by AMPK activation and GSK-3 beta inhibition is independent of E-cadherin. Furthermore, the nectin-afadin system is required for the deposition of tight junction components induced by AMPK activation, but it is not required for that induced by GSK-3 beta inhibition. Phosphorylation studies demonstrate that afadin is a substrate for AMPK. These data demonstrate that two kinases involved in regulating cell growth and metabolism act through distinct pathways to influence the deposition of the components of epithelial tight junctions.	[Jouret, Francois; Young, Lawrence H.; Caplan, Michael J.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Zhang, Li; Sfakianos, Jeff; Mellman, Ira; Caplan, Michael J.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Rinehart, Jesse; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Young, Lawrence H.] Yale Univ, Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT 06520 USA; [Sfakianos, Jeff; Mellman, Ira] Genentech Inc, San Francisco, CA 94080 USA	Yale University; Yale University; Yale University; Yale University; Roche Holding; Genentech	Caplan, MJ (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, POB 208026, New Haven, CT 06520 USA.	michael.caplan@yale.edu	Zhang, Li/N-3674-2013; Mellman, Ira/ABG-5896-2020	Caplan, Michael/0000-0001-5768-4405	National Institutes of Health [DK17433, 072614]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433, R01DK072614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK17433 and 072614.	ABERLE H, 1994, J CELL SCI, V107, P3655; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; BIRCHMEIER C, 1993, ANNU REV CELL BIOL, V9, P511, DOI 10.1146/annurev.cb.09.110193.002455; BOLLER K, 1985, J CELL BIOL, V100, P327, DOI 10.1083/jcb.100.1.327; Brakeman PR, 2009, AM J PHYSIOL-RENAL, V296, pF564, DOI 10.1152/ajprenal.90328.2008; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; CEREIJIDO M, 1981, AM J PHYSIOL, V240, pC96, DOI 10.1152/ajpcell.1981.240.3.C96; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; Chen XY, 2006, METHOD ENZYMOL, V406, P362, DOI 10.1016/S0076-6879(06)06026-5; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; GALLI P, 1976, EXP CELL RES, V99, P178, DOI 10.1016/0014-4827(76)90694-7; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; GUMBINER B, 1988, TRENDS BIOCHEM SCI, V13, P75, DOI 10.1016/0968-0004(88)90040-0; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; HAYS RM, 1965, J CELL BIOL, V25, P195, DOI 10.1083/jcb.25.3.195; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; MARRS JA, 1995, J CELL BIOL, V129, P507, DOI 10.1083/jcb.129.2.507; MARTINEZPALOMO A, 1980, J CELL BIOL, V87, P736, DOI 10.1083/jcb.87.3.736; MCNEILL H, 1990, CELL, V62, P309, DOI 10.1016/0092-8674(90)90368-O; MELDOLESI J, 1978, J CELL BIOL, V79, P156, DOI 10.1083/jcb.79.1.156; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; PALANT CE, 1983, AM J PHYSIOL, V245, pC203, DOI 10.1152/ajpcell.1983.245.3.C203; PITELKA DR, 1983, J CELL BIOL, V96, P606, DOI 10.1083/jcb.96.3.606; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Rajasekaran AK, 1996, J CELL BIOL, V132, P451, DOI 10.1083/jcb.132.3.451; Reymond N, 2000, GENE, V255, P347, DOI 10.1016/S0378-1119(00)00316-4; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; RINGWALD M, 1987, EMBO J, V6, P3647, DOI 10.1002/j.1460-2075.1987.tb02697.x; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; SEDAR AW, 1964, J CELL BIOL, V22, P173, DOI 10.1083/jcb.22.1.173; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Tsukamoto T, 1999, AM J PHYSIOL-RENAL, V276, pF737, DOI 10.1152/ajprenal.1999.276.5.F737; Van Itallie CM, 2004, PHYSIOLOGY, V19, P331, DOI 10.1152/physiol.00027.2004; Vleminckx K, 1999, BIOESSAYS, V21, P211, DOI 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.3.CO;2-G; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Yamada A, 2006, ONCOGENE, V25, P5085, DOI 10.1038/sj.onc.1209525; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; YONEMURA S, 1995, J CELL SCI, V108, P127; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103	59	44	45	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16879	16890		10.1074/jbc.M110.186932	http://dx.doi.org/10.1074/jbc.M110.186932			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21383016	hybrid, Green Published			2022-12-25	WOS:000290301900037
J	Bouillot, S; Tillet, E; Carmona, G; Prandini, MH; Gauchez, AS; Hoffmann, P; Alfaidy, N; Cand, F; Huber, P				Bouillot, Stephanie; Tillet, Emmanuelle; Carmona, Guillaume; Prandini, Marie-Helene; Gauchez, Anne-Sophie; Hoffmann, Pascale; Alfaidy, Nadia; Cand, Francine; Huber, Philippe			Protocadherin-12 Cleavage Is a Regulated Process Mediated by ADAM10 Protein EVIDENCE OF SHEDDING UP-REGULATION IN PRE-ECLAMPSIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; VASCULAR ENDOTHELIAL-CADHERIN; GAMMA-PROTOCADHERINS; TUMOR-SUPPRESSOR; HUMAN PLACENTA; LARGE FAMILY; MIGRATION; PREECLAMPSIA; EXPRESSION; ADAM-10	Protocadherins are a group of transmembrane proteins with homophilic binding activity, members of the cadherin superfamily. Apart from their role in adhesion, the cellular functions of protocadherins are essentially unknown. Protocadherin (PCDH) 12 was previously identified in invasive trophoblasts and endothelial and mesangial cells in the mouse. Invalidation studies revealed that the protein was required for optimal placental development. In this article, we show that its human homolog is abundantly expressed in various trophoblast subtypes of the human placenta and at lower levels in endothelial cells. We demonstrate that PCDH12 is shed at high rates in vitro. The shedding mechanism depends on ADAM10 and results in reduced cellular adhesion in a cell migration assay. PCDH12 is subsequently cleaved by the gamma-secretase complex, and its cytoplasmic domain is rapidly degraded by the proteasome. PCDH12 shedding is regulated by interlinked intracellular pathways, including those involving protein kinase C, PI3K, and cAMP, that either increase or inhibit cleavage. In endothelial cells, VEGF, prostaglandin E-2, or histamine regulates PCDH12 shedding. The extracellular domain of PCDH12 was also detected in human serum and urine, thus providing evidence of PCDH12 shedding in vivo. Importantly, we observed an increase in circulating PCDH12 in pregnant women who later developed a pre-eclampsia, a frequent pregnancy syndrome and a major cause of maternal and fetal morbidity and mortality. In conclusion, we speculate that, like in mice, PCDH12 may play an important role in human placental development and that proteolytic cleavage in response to external factors, such as cytokines and pathological settings, regulates its activity.	[Huber, Philippe] CEA, iRTSV LAPV U882, Lab Angiogenese & Physiopathol Vasc, F-38054 Grenoble, France; [Bouillot, Stephanie; Tillet, Emmanuelle; Carmona, Guillaume; Prandini, Marie-Helene; Cand, Francine; Huber, Philippe] INSERM, U882, F-38054 Grenoble, France; [Alfaidy, Nadia] INSERM, U878, F-38054 Grenoble, France; [Bouillot, Stephanie; Tillet, Emmanuelle; Carmona, Guillaume; Prandini, Marie-Helene; Alfaidy, Nadia; Cand, Francine; Huber, Philippe] Univ Grenoble 1, F-38041 Grenoble, France; [Gauchez, Anne-Sophie] CHR Univ Grenoble, Dept Biol Integrat, F-38043 Grenoble, France; [Hoffmann, Pascale] CHR Univ Grenoble, Dept Gynecol Obstet & Med Reprod, F-38043 Grenoble, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Huber, P (corresponding author), CEA, iRTSV LAPV U882, Lab Angiogenese & Physiopathol Vasc, 17 Rue Martyrs, F-38054 Grenoble, France.	phuber@cea.fr	Alfaidy, N./I-2972-2016; GAUCHEZ, Anne-Sophie/M-5534-2014; Huber, Philippe/C-7971-2019	Alfaidy, N./0000-0002-0718-2447; GAUCHEZ, Anne-Sophie/0000-0003-2332-0966; Huber, Philippe/0000-0002-4153-7694; Tillet, Emmanuelle/0000-0002-0076-8007; Hoffmann, Pascale/0000-0003-3305-5414; BOUILLOT, Stephanie/0000-0001-7567-557X	CEA; INSERM; Universite Grenoble 1	CEA(French Atomic Energy Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Grenoble 1	This work was supported by the CEA, INSERM, and Universite Grenoble 1.	Aamar E, 2008, DEV BIOL, V318, P335, DOI 10.1016/j.ydbio.2008.03.040; Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Bass KE, 1997, DEV GENET, V21, P61, DOI 10.1002/(SICI)1520-6408(1997)21:1<61::AID-DVG7>3.0.CO;2-6; Bononi J, 2008, MECH DEVELOP, V125, P1033, DOI 10.1016/j.mod.2008.07.007; Bouillot S, 2006, PLACENTA, V27, P882, DOI 10.1016/j.placenta.2005.09.009; Cetin I, 2011, PLACENTA, V32, pS4, DOI 10.1016/j.placenta.2010.11.022; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dibbens LM, 2008, NAT GENET, V40, P776, DOI 10.1038/ng.149; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Emond MR, 2008, DEV BIOL, V321, P175, DOI 10.1016/j.ydbio.2008.06.011; Haas IG, 2005, J BIOL CHEM, V280, P9313, DOI 10.1074/jbc.M412909200; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Junghans D, 2005, CURR OPIN CELL BIOL, V17, P446, DOI 10.1016/j.ceb.2005.08.008; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kuroda H, 2002, DEV BIOL, V244, P267, DOI 10.1006/dbio.2002.0589; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Medina A, 2004, EMBO J, V23, P3249, DOI 10.1038/sj.emboj.7600329; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Morishita H, 2007, CURR OPIN CELL BIOL, V19, P584, DOI 10.1016/j.ceb.2007.09.006; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nakao S, 2008, J CELL BIOL, V182, P395, DOI 10.1083/jcb.200802069; Okazaki N, 2002, CARCINOGENESIS, V23, P1139, DOI 10.1093/carcin/23.7.1139; POLETTE M, 1994, LAB INVEST, V71, P838; Rampon C, 2005, EXP CELL RES, V302, P48, DOI 10.1016/j.yexcr.2004.08.024; Rampon C, 2008, PHYSIOL GENOMICS, V34, P193, DOI 10.1152/physiolgenomics.00220.2007; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Reiners J, 2005, MOL VIS, V11, P347; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Reiss K, 2006, J BIOL CHEM, V281, P21735, DOI 10.1074/jbc.M602663200; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Telo P, 1998, J BIOL CHEM, V273, P17565, DOI 10.1074/jbc.273.28.17565; Tillet E, 1997, J BIOL CHEM, V272, P10769; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yu JS, 2008, ONCOGENE, V27, P4657, DOI 10.1038/onc.2008.101; Zhao S, 2010, PLACENTA, V31, P512, DOI 10.1016/j.placenta.2010.03.014	45	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15195	15204		10.1074/jbc.M111.230045	http://dx.doi.org/10.1074/jbc.M111.230045			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21402705	hybrid, Green Published			2022-12-25	WOS:000289788300051
J	Kato, A; Okamoto, O; Ishikawa, K; Sumiyoshi, H; Matsuo, N; Yoshioka, H; Nomizu, M; Shimada, T; Fujiwara, S				Kato, Aiko; Okamoto, Osamu; Ishikawa, Kazushi; Sumiyoshi, Hideaki; Matsuo, Noritaka; Yoshioka, Hidekatsu; Nomizu, Motoyoshi; Shimada, Tatsuo; Fujiwara, Sakuhei			Dermatopontin Interacts with Fibronectin, Promotes Fibronectin Fibril Formation, and Enhances Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEIN; SELF-ASSOCIATION; BINDING-SITE; IN-VITRO; FIBRILLOGENESIS; COLLAGEN; SKIN; IDENTIFICATION; SUPERFIBRONECTIN; LOCALIZATION	We report that dermatopontin (DP), an abundant dermal extracellular matrix protein, is found in the fibrin clot and in the wound fluid, which comprise the provisional matrix at the initial stage of wound healing. DP was also found in the serum but at a lower concentration than that in wound fluid. DP co-localized with both fibrin and fibronectin on fibrin fibers and interacted with both proteins. Both normal fibroblast and HT1080 cell adhesion to the fibrin-fibronectin matrix were dose-dependently enhanced by DP, and the adhesion was mediated by alpha 5 beta 1 integrin. The cytoskeleton was more organized in the cells that adhered to the fibrin-fibronectin-DP complex. When incubated with DP, fibronectin formed an insoluble complex of fibronectin fibrils as visualized by electron microscopy. The interacting sites of fibronectin with DP were the first, thirteenth, and fourteenth type III repeats (III1, III13, and III14), with III13 and III14 assumed to be the major sites. The interaction between III2-3 and III12-14 was inhibited by DP, whereas the interaction between I1-5 and III12-14 was specifically and strongly enhanced by DP. Because the interaction between III2-3 and III12-14 is involved in forming a globular conformation of fibronectin, and that between I1-5 and III12-14 is required for forming fibronectin fibrils, DP promotes fibronectin fibril formation probably by changing the fibronectin conformation. These results suggest that DP has an accelerating role in fibroblast cell adhesion to the provisional matrix in the initial stage of wound healing.	[Okamoto, Osamu; Ishikawa, Kazushi; Fujiwara, Sakuhei] Oita Univ, Dept Dermatol, Yufu, Oita 8795593, Japan; [Kato, Aiko] Oita Univ, Dept Plast Surg, Yufu, Oita 8795593, Japan; [Sumiyoshi, Hideaki; Matsuo, Noritaka; Yoshioka, Hidekatsu] Oita Univ, Dept Biochem, Yufu, Oita 8795593, Japan; [Shimada, Tatsuo] Oita Univ, Fac Med, Yufu, Oita 8795593, Japan; [Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Clin Biochem, Tokyo 1920392, Japan	Oita University; Oita University; Oita University; Oita University; Tokyo University of Pharmacy & Life Sciences	Okamoto, O (corresponding author), Oita Univ, Dept Dermatol, 1-1 Idaigaoka,Hasama Machi, Yufu, Oita 8795593, Japan.	ookamoto@oita-u.ac.jp			Ministry of Education, Culture, Science, Sports, and Technology of Japan	Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Ministry of Education, Culture, Science, Sports, and Technology of Japan (to A.K.).	AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; Bultmann H, 1998, J BIOL CHEM, V273, P2601, DOI 10.1074/jbc.273.5.2601; CRONSHAW AD, 1993, MATRIX, V13, P255, DOI 10.1016/S0934-8832(11)80009-0; DICKINSON CD, 1994, J MOL BIOL, V236, P1079, DOI 10.1016/0022-2836(94)90013-2; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; FOGERTY FJ, 1990, J CELL BIOL, V111, P699, DOI 10.1083/jcb.111.2.699; FUJII N, 1992, J BIOL CHEM, V267, P22452; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Hynes RO, 1990, FIBRONECTINS; Ingham KC, 1997, J BIOL CHEM, V272, P1718, DOI 10.1074/jbc.272.3.1718; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Koblinski JE, 2005, J CELL SCI, V118, P2965, DOI 10.1242/jcs.02411; LEWANDOWSKA K, 1991, J CELL SCI, V99, P657; MACBEATH JRE, 1993, J BIOL CHEM, V268, P19826; Makogonenko E, 2002, BIOCHEMISTRY-US, V41, P7907, DOI 10.1021/bi025770x; Makogonenko E, 2007, BIOCHEMISTRY-US, V46, P5418, DOI 10.1021/bi7001373; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Midwood KS, 2006, J INVEST DERM SYMP P, V11, P73, DOI 10.1038/sj.jidsymp.5650005; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; NEAME PJ, 1989, J BIOL CHEM, V264, P5474; Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200; Okamoto O, 1996, J BIOCHEM-TOKYO, V119, P106; Okamoto O, 1999, BIOCHEM J, V337, P537, DOI 10.1042/0264-6021:3370537; Okamoto O, 2006, CONNECT TISSUE RES, V47, P177, DOI 10.1080/03008200600846564; Okamoto O, 2010, BIOCHEMISTRY-US, V49, P147, DOI 10.1021/bi901066f; PETERS DMP, 1990, J CELL BIOL, V111, P249, DOI 10.1083/jcb.111.1.249; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Sechler JL, 2000, J CELL SCI, V113, P1491; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; SUPERTIFURGA A, 1993, GENOMICS, V17, P463, DOI 10.1006/geno.1993.1348; Takeda U, 2002, J INVEST DERMATOL, V119, P678, DOI 10.1046/j.1523-1747.2002.01863.x; Takemoto S, 2002, BASIC RES CARDIOL, V97, P461, DOI 10.1007/s00395-002-0371-x; Tzen CY, 2004, EXP CELL RES, V294, P30, DOI 10.1016/j.yexcr.2003.10.026; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Viglio S, 2008, J INVEST DERMATOL, V128, P1915, DOI 10.1038/jid.2008.33; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Wu CY, 1996, CELL ADHES COMMUN, V4, P149, DOI 10.3109/15419069609014219	39	47	50	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14861	14869		10.1074/jbc.M110.179762	http://dx.doi.org/10.1074/jbc.M110.179762			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21398523	Green Published, hybrid			2022-12-25	WOS:000289788300016
J	Pena, J; Harris, E				Pena, Jose; Harris, Eva			Dengue Virus Modulates the Unfolded Protein Response in a Time-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH PROGRAM; ER STRESS; TRANSLATIONAL CONTROL; KINASE; INITIATION; INFECTION; REPLICATION; RNA; PATHWAY	Flaviviruses, such as dengue virus (DENV), depend on the host endoplasmic reticulum for translation, replication, and packaging of their genomes. Here we report that DENV-2 infection modulates the unfolded protein response in a time-dependent manner. We show that early DENV-2 infection triggers and then suppresses PERK-mediated eIF2 alpha phosphorylation and that in mid and late DENV-2 infection, the IRE1-XBP1 and ATF6 pathways are activated, respectively. Activation of IRE1-XBP1 correlated with induction of downstream targets GRP78, CHOP, and GADD34. Furthermore, induction of CHOP did not induce apoptoticmarkers, such as suppression of anti-apoptotic protein Bcl-2, activation of caspase-9 or caspase-3, and cleavage of poly(ADPribose) polymerase. Finally, we show that DENV-2 replication is affected inPERK(-/-) and IRE1(-/-) mouse embryo fibroblasts when compared with wild-type mouse embryo fibroblasts. These results demonstrate that time-dependent activation of the unfolded protein response by DENV-2 can override inhibition of translation, prevent apoptosis, and prolong the viral life cycle.	[Pena, Jose; Harris, Eva] Univ Calif Berkeley, Div Infect Dis & Vaccinol, Sch Publ Hlth, Berkeley, CA 94720 USA; Univ Calif Berkeley, Grad Grp Microbiol, Dept Plant & Microbial Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Pena, J (corresponding author), Univ Calif Berkeley, Div Infect Dis & Vaccinol, Sch Publ Hlth, 1 Barker Hall, Berkeley, CA 94720 USA.	jpena360@yahoo.com; eharris@berkeley.edu			National Institutes of Health [AI052324]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI052324 (to E. H.) and a supplemental National Institutes of Health grant (to J. P.).	Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625; Ceballos-Olvera I, 2010, VIROLOGY, V396, P30, DOI 10.1016/j.virol.2009.10.019; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hetz CA, 2007, ANTIOXID REDOX SIGN, V9, P2345, DOI 10.1089/ars.2007.1793; Huerta-Zepeda A, 2008, THROMB HAEMOSTASIS, V99, P936, DOI [10.1160/TH07-08-0483, 10.1160/TH07-08-0438]; Jordan R, 2002, J VIROL, V76, P9588, DOI 10.1128/JVI.76.19.9588-9599.2002; Krishnamoorthy J, 2008, CELL CYCLE, V7, P2346, DOI 10.4161/cc.6323; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pavio N, 2003, J VIROL, V77, P3578, DOI 10.1128/JVI.77.6.3578-3585.2003; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shen JS, 2005, METHODS, V35, P382, DOI 10.1016/j.ymeth.2004.10.011; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200; Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06	46	134	138	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14226	14236		10.1074/jbc.M111.222703	http://dx.doi.org/10.1074/jbc.M111.222703			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21385877	Green Published, hybrid			2022-12-25	WOS:000289556200046
J	Lee, TY; Chen, SA; Hung, HY; Ou, YY				Lee, Tzong-Yi; Chen, Shu-An; Hung, Hsin-Yi; Ou, Yu-Yen			Incorporating Distant Sequence Features and Radial Basis Function Networks to Identify Ubiquitin Conjugation Sites	PLOS ONE			English	Article							FUNCTION NEURAL-NETWORK; PROTEIN; PREDICTION; IDENTIFICATION; DEGRADATION; DATABASE; BLAST; LOGO	Ubiquitin (Ub) is a small protein that consists of 76 amino acids about 8.5 kDa. In ubiquitin conjugation, the ubiquitin is majorly conjugated on the lysine residue of protein by Ub-ligating (E3) enzymes. Three major enzymes participate in ubiquitin conjugation. They are - E1, E2 and E3 which are responsible for activating, conjugating and ligating ubiquitin, respectively. Ubiquitin conjugation in eukaryotes is an important mechanism of the proteasome-mediated degradation of a protein and regulating the activity of transcription factors. Motivated by the importance of ubiquitin conjugation in biological processes, this investigation develops a method, UbSite, which uses utilizes an efficient radial basis function (RBF) network to identify protein ubiquitin conjugation (ubiquitylation) sites. This work not only investigates the amino acid composition but also the structural characteristics, physicochemical properties, and evolutionary information of amino acids around ubiquitylation (Ub) sites. With reference to the pathway of ubiquitin conjugation, the substrate sites for E3 recognition, which are distant from ubiquitylation sites, are investigated. The measurement of F-score in a large window size (-20 similar to+20) revealed a statistically significant amino acid composition and position-specific scoring matrix (evolutionary information), which are mainly located distant from Ub sites. The distant information can be used effectively to differentiate Ub sites from non-Ub sites. As determined by five-fold cross-validation, the model that was trained using the combination of amino acid composition and evolutionary information performs best in identifying ubiquitin conjugation sites. The prediction sensitivity, specificity, and accuracy are 65.5%, 74.8%, and 74.5%, respectively. Although the amino acid sequences around the ubiquitin conjugation sites do not contain conserved motifs, the cross-validation result indicates that the integration of distant sequence features of Ub sites can improve predictive performance. Additionally, the independent test demonstrates that the proposed method can outperform other ubiquitylation prediction tools.	[Lee, Tzong-Yi; Chen, Shu-An; Hung, Hsin-Yi; Ou, Yu-Yen] Yuan Ze Univ, Dept Comp Sci & Engn, Chungli, Taiwan	Yuan Ze University	Lee, TY (corresponding author), Yuan Ze Univ, Dept Comp Sci & Engn, Chungli, Taiwan.	francis@saturn.yzu.edu.tw; yien@csie.org	Ou, Yu-Yen/AAA-1716-2022	Ou, Yu-Yen/0000-0002-9894-926X	National Science Council (NSC) of Taiwan [NSC99-2320-B155-001, NSC99-2221-E155-073]	National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan)	This work was partially supported by National Science Council (NSC) of Taiwan, NSC99-2320-B155-001 to TYL, and NSC99-2221-E155-073 to YYO. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2003, BIOINFORMATICS, V19, P1849, DOI 10.1093/bioinformatics/btg249; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; CHARTON M, 1982, J THEOR BIOL, V99, P629, DOI 10.1016/0022-5193(82)90191-6; Chen SA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-536; Chernorudskiy AL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-126; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hu ZJ, 2004, NUCLEIC ACIDS RES, V32, pW235, DOI 10.1093/nar/gkh483; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Lin C-J, 2003, NIPS 2003 FEATURE SE, P1; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Ou CY, 2003, TRENDS GENET, V19, P382, DOI 10.1016/S0168-9525(03)00146-X; Ou YY, 2008, COMPUT BIOL CHEM, V32, P227, DOI 10.1016/j.compbiolchem.2008.03.002; OU YY, 2005, P IEEE INT C NEURAL, V3, P1383; Pang CNI, 2007, J PROTEOME RES, V6, P1833, DOI 10.1021/pr060674u; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shien DM, 2009, J COMPUT CHEM, V30, P1532, DOI 10.1002/jcc.21232; Su CT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-319; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tung CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-310; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359; Yang ZR, 2005, IEEE T NEURAL NETWOR, V16, P263, DOI 10.1109/TNN.2004.836196; Zanzoni A, 2007, NUCLEIC ACIDS RES, V35, pD229, DOI 10.1093/nar/gkl922; Zhang GZ, 2004, J COMPUT AID MOL DES, V18, P797, DOI 10.1007/s10822-005-0578-7	38	63	63	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17331	10.1371/journal.pone.0017331	http://dx.doi.org/10.1371/journal.pone.0017331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408064	Green Submitted, Green Published, gold			2022-12-25	WOS:000288170900010
J	Carola, V; Mirabeau, O; Gross, CT				Carola, Valeria; Mirabeau, Olivier; Gross, Cornelius T.			Hidden Markov Model Analysis of Maternal Behavior Patterns in Inbred and Reciprocal Hybrid Mice	PLOS ONE			English	Article							EMOTIONAL REACTIVITY; RESPONSES; ANXIETY; STRESS; MOUSE; ENVIRONMENT; EXPRESSION; STRAINS; MAZE; CARE	Individual variation in maternal care in mammals shows a significant heritable component, with the maternal behavior of daughters resembling that of their mothers. In laboratory mice, genetically distinct inbred strains show stable differences in maternal care during the first postnatal week. Moreover, cross fostering and reciprocal breeding studies demonstrate that differences in maternal care between inbred strains persist in the absence of genetic differences, demonstrating a nongenetic or epigenetic contribution to maternal behavior. In this study we applied a mathematical tool, called hidden Markov model (HMM), to analyze the behavior of female mice in the presence of their young. The frequency of several maternal behaviors in mice has been previously described, including nursing/grooming pups and tending to the nest. However, the ordering, clustering, and transitions between these behaviors have not been systematically described and thus a global description of maternal behavior is lacking. Here we used HMM to describe maternal behavior patterns in two genetically distinct mouse strains, C57BL/6 and BALB/c, and their genetically identical reciprocal hybrid female offspring. HMM analysis is a powerful tool to identify patterns of events that cluster in time and to determine transitions between these clusters, or hidden states. For the HMM analysis we defined seven states: arched-backed nursing, blanket nursing, licking/grooming pups, grooming, activity, eating, and sleeping. By quantifying the frequency, duration, composition, and transition probabilities of these states we were able to describe the pattern of maternal behavior in mouse and identify aspects of these patterns that are under genetic and nongenetic inheritance. Differences in these patterns observed in the experimental groups (inbred and hybrid females) were detected only after the application of HMM analysis whereas classical statistical methods and analyses were not able to highlight them.	[Carola, Valeria; Mirabeau, Olivier; Gross, Cornelius T.] EMBL, Mouse Biol Unit, Monterotondo, Italy; [Carola, Valeria] European Ctr Brain Res CERC, Santa Lucia Fdn, Rome, Italy	European Molecular Biology Laboratory (EMBL); IRCCS Santa Lucia	Carola, V (corresponding author), EMBL, Mouse Biol Unit, Monterotondo, Italy.	carola@embl.it; gross@embl.it	carola, valeria/J-9724-2014		Santa Lucia Foundation; Fritz Thyssen Stiftung; NARSAD; European Molecular Biology Laboratory	Santa Lucia Foundation; Fritz Thyssen Stiftung; NARSAD(NARSAD); European Molecular Biology Laboratory	This work was supported by grants from the Santa Lucia Foundation (V. C.), Fritz Thyssen Stiftung (C. G.), NARSAD (C. G.), and funds from European Molecular Biology Laboratory (O.M. and C. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; Benjamini Y, 2001, ANN STAT, V29, P1165; Calatayud F, 2004, PHYSIOL BEHAV, V80, P465, DOI 10.1016/j.physbeh.2003.10.001; Calatayud F, 2001, PHYSIOL BEHAV, V74, P355, DOI 10.1016/S0031-9384(01)00566-2; Caldji C, 2003, NEUROPSYCHOPHARMACOL, V28, P1950, DOI 10.1038/sj.npp.1300237; Carola V, 2006, GENES BRAIN BEHAV, V5, P189, DOI 10.1111/j.1601-183X.2005.00152.x; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Carola V, 2008, BIOL PSYCHIAT, V63, P840, DOI 10.1016/j.biopsych.2007.08.013; CHEVALET P, 1989, BEHAV PROCESS, V20, P93, DOI 10.1016/0376-6357(89)90015-6; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1315, DOI 10.1038/nbt1004-1315; Hastie T., 2009, UNSUPERVISED LEARNIN; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Maubourguet N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000229; Mirabeau O, 2007, GENOME RES, V17, P320, DOI 10.1101/gr.5755407; Prakash P, 2006, BRAIN RES, V1111, P122, DOI 10.1016/j.brainres.2006.06.089; Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Roy V, 2007, BEHAV BRAIN RES, V185, P49, DOI 10.1016/j.bbr.2007.07.008; Sargin ME, 2008, IEEE T PATTERN ANAL, V30, P1330, DOI 10.1109/TPAMI.2007.70797; Shoji H, 2006, PHYSIOL BEHAV, V89, P320, DOI 10.1016/j.physbeh.2006.06.012; VETROV D, 2008, P 6 INT C METH TECHN; Weaver ICG, 2002, ENDOCR RES, V28, P699, DOI 10.1081/ERC-120016989; Zaharia MD, 1996, PSYCHOPHARMACOLOGY, V128, P227, DOI 10.1007/s002130050130; Zhang TY, 2004, ANN NY ACAD SCI, V1032, P85, DOI 10.1196/annals.1314.007	25	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e14753	10.1371/journal.pone.0014753	http://dx.doi.org/10.1371/journal.pone.0014753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408086	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170000002
J	Feng, Y; Cao, CM; Vikram, M; Park, S; Kim, HJ; Hong, JC; Cisneros-Zevallos, L; Koiwa, H				Feng, Yue; Cao, Cong-Mei; Vikram, Meenu; Park, Sunghun; Kim, Hye Jin; Hong, Jong Chan; Cisneros-Zevallos, Luis; Koiwa, Hisashi			A Three-Component Gene Expression System and Its Application for Inducible Flavonoid Overproduction in Transgenic Arabidopsis thaliana	PLOS ONE			English	Article							MYB TRANSCRIPTION FACTOR; FUNCTIONAL GENOMICS; ROOT DEVELOPMENT; OVER-EXPRESSION; HUMAN HEALTH; STRESS; ANTHOCYANIN; BIOSYNTHESIS; TOBACCO; PLANTS	Inducible gene expression is a powerful tool to study and engineer genes whose overexpression could be detrimental for the host organisms. However, only limited systems have been adopted in plant biotechnology. We have developed an osmotically inducible system using three components of plant origin, RD29a (Responsive to Dehydration 29A) promoter, CBF3 (C-repeat Binding Factor 3) transcription factor and cpl1-2 (CTD phosphatase-like 1) mutation. The osmotic stress responsible RD29a promoter contains the CBF3 binding sites and thus RD29A-CBF3 feedforward cassette enhances induction of RD29a promoter under stress. The cpl1-2 mutation in a host repressor CPL1 promotes stress responsible RD29a promoter expression. The efficacy of this system was tested using PAP1 (Production of Anthocyanin Pigment 1) transgene, a model transcription factor that regulates the anthocyanin pathway in Arabidopsis. While transgenic plants with only one or two of three components did not reproducibly accumulate anthocyanin pigments above the control level, transgenic cpl1 plants containing homozygous RD29a-PAP1 and RD29a-CBF3 transgenes produced 30-fold higher level of total anthocyanins than control plants upon cold treatment. Growth retardation and phytochemical production of transgenic plants were minimum under normal conditions. The flavonoid profile in cold-induced transgenic plants was determined by LC/MS/MS, which resembled that of previously reported pap1-D plants but enriched for kaempferol derivatives. These results establish the functionality of the inducible three-component gene expression system in plant metabolic engineering. Furthermore, we show that PAP1 and environmental signals synergistically regulate the flavonoid pathway to produce a unique flavonoid blend that has not been produced by PAP1 overexpression or cold treatment alone.	[Feng, Yue; Cao, Cong-Mei; Vikram, Meenu; Cisneros-Zevallos, Luis; Koiwa, Hisashi] Texas A&M Univ, Dept Hort Sci, Vegetable & Fruit Improvement Ctr, College Stn, TX 77843 USA; [Park, Sunghun] Kansas State Univ, Dept Hort Forestry & Recreat Sources, Manhattan, KS 66506 USA; [Kim, Hye Jin; Hong, Jong Chan] Gyeongsang Natl Univ, Grad Sch, Div Appl Life Sci & Plant Mol Biol, Program BK21, Jinju, South Korea; [Kim, Hye Jin; Hong, Jong Chan] Gyeongsang Natl Univ, Grad Sch, Biotechnol Res Ctr, Jinju, South Korea	Texas A&M University System; Texas A&M University College Station; Kansas State University; Gyeongsang National University; Gyeongsang National University	Feng, Y (corresponding author), Texas A&M Univ, Dept Hort Sci, Vegetable & Fruit Improvement Ctr, College Stn, TX 77843 USA.	koiwa@neo.tamu.edu	Cao, Congmei/M-5720-2014; Koiwa, Hisashi/AAO-6512-2020; Koiwa, Hisashi/AAA-8182-2019	Koiwa, Hisashi/0000-0002-7421-340X; 	National Science Foundation [MCB0421889, MCB0950459]; USDA-CSREES [2008-34402-19195, 2009-34402-19831]; National Research Foundation of Korea, MEST [2010-0012801]	National Science Foundation(National Science Foundation (NSF)); USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Research Foundation of Korea, MEST(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by the National Science Foundation (http://www.nsf.gov, MCB0421889 and MCB0950459), USDA-CSREES (http://www.csrees.usda.gov, 2008-34402-19195 and 2009-34402-19831) "Designing Food for Health'', and a Basic Science Research Program through the National Research Foundation of Korea (http://www.nrf.go.kr/html/en/) MEST (2010-0012801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Endt DV, 2002, PHYTOCHEMISTRY, V61, P107, DOI 10.1016/S0031-9422(02)00185-1; FULEKI T, 1968, J FOOD SCI, V33, P78, DOI 10.1111/j.1365-2621.1968.tb00888.x; Geekiyanage S, 2007, PLANT BIOTECHNOL REP, V1, P11, DOI 10.1007/s11816-006-0001-4; Goderis IJWM, 2002, PLANT MOL BIOL, V50, P17, DOI 10.1023/A:1016052416053; Guo HS, 2003, PLANT J, V34, P383, DOI 10.1046/j.1365-313X.2003.01723.x; Iriti M, 2009, NAT PROD COMMUN, V4, P611; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Koiwa H, 2002, P NATL ACAD SCI USA, V99, P10893, DOI 10.1073/pnas.112276199; Korkina LG, 2007, CELL MOL BIOL, V53, P15, DOI 10.1170/T772; Kubo H, 1999, PLANT CELL, V11, P1217, DOI 10.1105/tpc.11.7.1217; Li X, 2010, J AGR FOOD CHEM, V58, P1639, DOI 10.1021/jf903527y; Liu CJ, 2002, P NATL ACAD SCI USA, V99, P14578, DOI 10.1073/pnas.212522099; Marczak L, 2008, RAPID COMMUN MASS SP, V22, P3949, DOI 10.1002/rcm.3819; Matsuda O, 2009, PLANT J, V57, P96, DOI 10.1111/j.1365-313X.2008.03663.x; Peel GJ, 2009, PLANT J, V59, P136, DOI 10.1111/j.1365-313X.2009.03885.x; Piao HL, 2001, PLANT J, V27, P305, DOI 10.1046/j.1365-313x.2001.01099.x; Sanchez-Calderon L, 2006, PLANT PHYSIOL, V140, P879, DOI 10.1104/pp.105.073825; Shadle GL, 2003, PHYTOCHEMISTRY, V64, P153, DOI 10.1016/S0031-9422(03)00151-1; Shi MZ, 2010, PLANTA, V231, P1385, DOI 10.1007/s00425-010-1142-9; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Ueda A, 2008, PLANT MOL BIOL, V67, P683, DOI 10.1007/s11103-008-9348-y; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Xiong LM, 2002, P NATL ACAD SCI USA, V99, P10899, DOI 10.1073/pnas.162111599; Zhou LL, 2008, PLANTA, V229, P37, DOI 10.1007/s00425-008-0809-y; Zuo Jianru, 2006, V323, P329	30	5	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17603	10.1371/journal.pone.0017603	http://dx.doi.org/10.1371/journal.pone.0017603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408135	gold, Green Published, Green Submitted			2022-12-25	WOS:000288170000044
J	Hsing, CH; Lin, MC; Choi, PC; Huang, WC; Kai, JI; Tsai, CC; Cheng, YL; Hsieh, CY; Wang, CY; Chang, YP; Chen, YH; Chen, CL; Lin, CF				Hsing, Chung-Hsi; Lin, Ming-Chung; Choi, Pui-Ching; Huang, Wei-Ching; Kai, Jui-In; Tsai, Cheng-Chieh; Cheng, Yi-Lin; Hsieh, Chia-Yuan; Wang, Chi-Yun; Chang, Yu-Ping; Chen, Yu-Hong; Chen, Chia-Ling; Lin, Chiou-Feng			Anesthetic Propofol Reduces Endotoxic Inflammation by Inhibiting Reactive Oxygen Species-regulated Akt/IKK beta/NF-kappa B Signaling	PLOS ONE			English	Article							ACUTE LUNG INJURY; OXIDATIVE STRESS; INFUSION SYNDROME; GENE-EXPRESSION; CONSCIOUS RATS; LIPOPOLYSACCHARIDE; ACTIVATION; SEPSIS; CELLS; PATHOPHYSIOLOGY	Background: Anesthetic propofol has immunomodulatory effects, particularly in the area of anti-inflammation. Bacterial endotoxin lipopolysaccharide (LPS) induces inflammation through toll-like receptor (TLR) 4 signaling. We investigated the molecular actions of propofol against LPS/TLR4-induced inflammatory activation in murine RAW264.7 macrophages. Methodology/Principal Findings: Non-cytotoxic levels of propofol reduced LPS-induced inducible nitric oxide synthase (iNOS) and NO as determined by western blotting and the Griess reaction, respectively. Propofol also reduced the production of tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-6, and IL-10 as detected by enzyme-linked immunosorbent assays. Western blot analysis showed propofol inhibited LPS-induced activation and phosphorylation of IKK beta (Ser180) and nuclear factor (NF)-kappa B (Ser536); the subsequent nuclear translocation of NF-kappa B p65 was also reduced. Additionally, propofol inhibited LPS-induced Akt activation and phosphorylation (Ser473) partly by reducing reactive oxygen species (ROS) generation; inter-regulation that ROS regulated Akt followed by NF-kappa B activation was found to be crucial for LPS-induced inflammatory responses in macrophages. An in vivo study using C57BL/6 mice also demonstrated the anti-inflammatory properties against LPS in peritoneal macrophages. Conclusions/Significance: These results suggest that propofol reduces LPS-induced inflammatory responses in macrophages by inhibiting the interconnected ROS/Akt/IKK beta/NF-kappa B signaling pathways.	[Hsing, Chung-Hsi; Lin, Ming-Chung] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Hsing, Chung-Hsi] Taipei Med Univ, Coll Med, Dept Anesthesiol, Taipei, Taiwan; [Lin, Ming-Chung; Choi, Pui-Ching; Huang, Wei-Ching; Kai, Jui-In; Tsai, Cheng-Chieh; Cheng, Yi-Lin; Hsieh, Chia-Yuan; Wang, Chi-Yun; Lin, Chiou-Feng] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan; [Huang, Wei-Ching; Tsai, Cheng-Chieh; Wang, Chi-Yun; Lin, Chiou-Feng] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Tsai, Cheng-Chieh] Chung Hwa Univ Med Technol, Dept Nursing, Tainan, Taiwan; [Cheng, Yi-Lin] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Chen, Yu-Hong; Chen, Chia-Ling; Lin, Chiou-Feng] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan	Chi Mei Hospital; Taipei Medical University; National Cheng Kung University; National Cheng Kung University; Chung Hua University; National Cheng Kung University; National Cheng Kung University	Hsing, CH (corresponding author), Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan.	hsing@mail.chimei.org.tw; cflin@mail.ncku.edu.tw		Wang, Chi-Yun/0000-0003-0317-5378	National Cheng Kung University [CMNCKU9809]; Chi Mei Medical Center, Taiwan; National Science Council, Taiwan [NSC 96-2320-B-006-018-MY3]	National Cheng Kung University; Chi Mei Medical Center, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the cooperation project CMNCKU9809 of National Cheng Kung University and Chi Mei Medical Center, Taiwan and by grant NSC 96-2320-B-006-018-MY3 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Brasil LJ, 2006, TOXICOLOGY, V227, P53, DOI 10.1016/j.tox.2006.07.013; Chen HI, 2008, CRIT CARE MED, V36, P1214, DOI 10.1097/CCM.0b013e31816a0607; Chen RM, 2005, ANN NY ACAD SCI, V1042, P262, DOI 10.1196/annals.1338.030; Chiu WT, 2009, CHEM-BIOL INTERACT, V181, P430, DOI 10.1016/j.cbi.2009.06.011; Fudickar A, 2009, MINERVA ANESTESIOL, V75, P339; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Haddad JJ, 2002, CYTOKINES CELL MOL T, V7, P1, DOI 10.1080/13684730216401; HSING CH, 2010, NEPHROL DIA IN PRESS; Hsu BG, 2005, CLIN EXP PHARMACOL P, V32, P24, DOI 10.1111/j.1440-1681.2005.04155.x; Huang WC, 2009, IMMUNOLOGY, V128, pe275, DOI 10.1111/j.1365-2567.2008.02959.x; Inada T, 2009, CAN J ANAESTH, V56, P222, DOI 10.1007/s12630-008-9035-0; Jang SI, 2006, EUR J PHARMACOL, V542, P1, DOI 10.1016/j.ejphar.2006.04.044; Jawan B, 2008, TOXICOL APPL PHARM, V229, P362, DOI 10.1016/j.taap.2008.01.044; Kim JH, 2008, FREE RADICAL BIO MED, V45, P885, DOI 10.1016/j.freeradbiomed.2008.06.019; Koay MA, 2001, INFECT IMMUN, V69, P5991, DOI 10.1128/IAI.69.10.5991-5996.2001; Kwak SH, 2004, J KOREAN MED SCI, V19, P55, DOI 10.3346/jkms.2004.19.1.55; Lawton JA, 2003, CURR OPIN CHEM BIOL, V7, P446, DOI 10.1016/S1367-5931(03)00077-2; Lin CF, 2007, J CELL SCI, V120, P2935, DOI 10.1242/jcs.03473; Ma L, 2010, ACTA ANAESTH SCAND, V54, P362, DOI 10.1111/j.1399-6576.2009.02127.x; Macdonald J, 2003, BRIT J ANAESTH, V90, P221, DOI 10.1093/bja/aeg034; MACKENZIE N, 1987, ANAESTHESIA, V42, P3, DOI 10.1111/j.1365-2044.1987.tb02936.x; Marik PE, 2005, PHARMACOTHERAPY, V25, p28S, DOI 10.1592/phco.2005.25.5_Part_2.28S; Nomellini V, 2009, SHOCK, V31, P11, DOI 10.1097/SHK.0b013e318180f508; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Poli-De-Figueiredo LF, 2008, SHOCK, V30, P53, DOI 10.1097/SHK.0b013e318181a343; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rinaldi S, 2009, CURR DRUG TARGETS, V10, P872, DOI 10.2174/138945009789108774; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Song XM, 2009, MOL BIOL REP, V36, P2345, DOI 10.1007/s11033-009-9456-z; Takaono M, 2002, ACTA ANAESTH SCAND, V46, P176, DOI 10.1034/j.1399-6576.2002.460209.x; Takemoto Yasuhiro, 2005, J Anesth, V19, P40, DOI 10.1007/s00540-004-0267-z; Taniguchi T, 2003, TOHOKU J EXP MED, V200, P85, DOI 10.1620/tjem.200.85; Tsao CM, 2008, CRIT CARE MED, V36, P887, DOI 10.1097/CCM.0B013E318165395E; Vasile B, 2003, INTENS CARE MED, V29, P1417, DOI 10.1007/s00134-003-1905-x; Victor Victor M., 2009, Infectious Disorders - Drug Targets, V9, P376; Wu GJ, 2009, CHEM-BIOL INTERACT, V180, P465, DOI 10.1016/j.cbi.2009.05.003; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630	38	75	86	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17598	10.1371/journal.pone.0017598	http://dx.doi.org/10.1371/journal.pone.0017598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408125	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170000043
J	Burkett-Cadena, ND; McClure, CJW; Ligon, RA; Graham, SP; Guyer, C; Hill, GE; Ditchkoff, SS; Eubanks, MD; Hassan, HK; Unnasch, TR				Burkett-Cadena, Nathan D.; McClure, Christopher J. W.; Ligon, Russell A.; Graham, Sean P.; Guyer, Craig; Hill, Geoffrey E.; Ditchkoff, Stephen S.; Eubanks, Micky D.; Hassan, Hassan K.; Unnasch, Thomas R.			Host Reproductive Phenology Drives Seasonal Patterns of Host Use in Mosquitoes	PLOS ONE			English	Article							EQUINE ENCEPHALOMYELITIS VIRUS; WHITE-TAILED DEER; BLOOD-FEEDING PATTERNS; VERTEBRATE HOSTS; CENTRAL ALABAMA; CULEX-TARSALIS; VECTORS; IDENTIFICATION; TRANSMISSION; ENCEPHALITIS	Seasonal shifts in host use by mosquitoes from birds to mammals drive the timing and intensity of annual epidemics of mosquito-borne viruses, such as West Nile virus, in North America. The biological mechanism underlying these shifts has been a matter of debate, with hypotheses falling into two camps: (1) the shift is driven by changes in host abundance, or (2) the shift is driven by seasonal changes in the foraging behavior of mosquitoes. Here we explored the idea that seasonal changes in host use by mosquitoes are driven by temporal patterns of host reproduction. We investigated the relationship between seasonal patterns of host use by mosquitoes and host reproductive phenology by examining a seven-year dataset of blood meal identifications from a site in Tuskegee National Forest, Alabama USA and data on reproduction from the most commonly utilized endothermic (white-tailed deer, great blue heron, yellow-crowned night heron) and ectothermic (frogs) hosts. Our analysis revealed that feeding on each host peaked during periods of reproductive activity. Specifically, mosquitoes utilized herons in the spring and early summer, during periods of peak nest occupancy, whereas deer were fed upon most during the late summer and fall, the period corresponding to the peak in births for deer. For frogs, however, feeding on early-and late-season breeders paralleled peaks in male vocalization. We demonstrate for the first time that seasonal patterns of host use by mosquitoes track the reproductive phenology of the hosts. Peaks in relative mosquito feeding on each host during reproductive phases are likely the result of increased tolerance and decreased vigilance to attacking mosquitoes by nestlings and brooding adults (avian hosts), quiescent young (avian and mammalian hosts), and mate-seeking males (frogs).	[Burkett-Cadena, Nathan D.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [McClure, Christopher J. W.; Ligon, Russell A.; Graham, Sean P.; Guyer, Craig; Hill, Geoffrey E.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Ditchkoff, Stephen S.] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA; [Eubanks, Micky D.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Hassan, Hassan K.; Unnasch, Thomas R.] Univ S Florida, Dept Global Hlth, Tampa, FL USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; Texas A&M University System; Texas A&M University College Station; State University System of Florida; University of South Florida	Burkett-Cadena, ND (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	urkend@auburn.edu	McClure, Christopher/J-2712-2019; Hill, Geoffrey E./R-7354-2019; Ligon, Russell/M-1233-2013	McClure, Christopher/0000-0003-1216-7425; Hill, Geoffrey E./0000-0001-8864-6495; Ligon, Russell/0000-0002-0195-8275; Burkett-Cadena, Nathan/0000-0001-6168-1637; Ditchkoff, Stephen/0000-0002-7414-5777	National Institute of Allergy and Infectious Diseases [R01AI049724]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049724] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a grant from the National Institute of Allergy and Infectious Diseases, Project # R01AI049724. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander K, 1997, J AVIAN BIOL, V28, P325, DOI 10.2307/3676946; Bernal XE, 2006, BEHAV ECOL, V17, P709, DOI 10.1093/beheco/arl003; BLACKMORE JOHN S., 1958, MOSQUITO NEWS, V18, P15; Burkett-Cadena ND, 2008, AM J TROP MED HYG, V79, P809, DOI 10.4269/ajtmh.2008.79.809; Burkett-Cadena ND, 2008, J AM MOSQUITO CONTR, V24, P228, DOI 10.2987/5662.1; BURKETTCADENA ND, 2010, AM J TROP MED HYG, P10, DOI DOI 10.4269/AJTMH.PP; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chaves LF, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-3; Cohen SB, 2009, AM J TROP MED HYG, V81, P452, DOI 10.4269/ajtmh.2009.81.452; CUNNINGHAM R. A., 2006, CANBERRA BIRD NOTES, V31, P73; Cupp EW, 2004, AM J TROP MED HYG, V71, P272, DOI 10.4269/ajtmh.2004.71.272; Cupp EW, 2003, AM J TROP MED HYG, V68, P495, DOI 10.4269/ajtmh.2003.68.495; DALRYMPLE JM, 1972, AM J EPIDEMIOL, V96, P129, DOI 10.1093/oxfordjournals.aje.a121439; EDMAN JD, 1968, SCIENCE, V161, P67, DOI 10.1126/science.161.3836.67; EDMAN JD, 1974, J MED ENTOMOL, V11, P95, DOI 10.1093/jmedent/11.1.95; Hamilton R.J., 1985, PROC ANN CONF SOUTHE, V9, P389; Hassan HK, 2003, AM J TROP MED HYG, V69, P641, DOI 10.4269/ajtmh.2003.69.641; JACKSON RM, 1972, ECOLOGY, V53, P262, DOI 10.2307/1934080; KALE HW, 1972, MOSQ NEWS, V32, P343; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Lee JH, 2002, AM J TROP MED HYG, V66, P599, DOI 10.4269/ajtmh.2002.66.599; Ligon JD, 1999, EVOLUTION AVIAN BREE; Linnell JDC, 1995, WILDLIFE BIOL, V1, P209, DOI 10.2981/wlb.1995.0026; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MCKEEVER S, 1977, MOSQ NEWS, V37, P522; MILLER AJ, 1992, SUBSET SELECTION REG; NELSON RL, 1976, AM J TROP MED HYG, V25, P644, DOI 10.4269/ajtmh.1976.25.644; Pyle P, 2004, WILSON BULL, V116, P287, DOI 10.1676/04-012; R Core Team, 2022, R LANG ENV STAT COMP; Rohm JH, 2007, J WILDLIFE MANAGE, V71, P851, DOI 10.2193/2006-027; RYAN MJ, 1988, AM ZOOL, V28, P885; Saalfeld ST, 2007, J WILDLIFE MANAGE, V71, P940, DOI 10.2193/2006-116; TEMPELIS CH, 1965, AM J TROP MED HYG, V14, P170, DOI 10.4269/ajtmh.1965.14.170; Toma Takako, 2005, Medical Entomology and Zoology, V56, P65; TUTTLE ND, 1981, SCIENCE, V214, P677; WALKER ED, 1985, J MED ENTOMOL, V22, P4370; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; WEINMANN CJ, 1975, J PARASITOL, V61, P317, DOI 10.2307/3279012; WRIGHT RE, 1970, ANN ENTOMOL SOC AM, V63, P777, DOI 10.1093/aesa/63.3.777; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	40	29	29	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17681	10.1371/journal.pone.0017681	http://dx.doi.org/10.1371/journal.pone.0017681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408172	gold, Green Published			2022-12-25	WOS:000288099800032
J	Tonnesen, J; Parish, CL; Sorensen, AT; Andersson, A; Lundberg, C; Deisseroth, K; Arenas, E; Lindvall, O; Kokaia, M				Tonnesen, Jan; Parish, Clare L.; Sorensen, Andreas T.; Andersson, Angelica; Lundberg, Cecilia; Deisseroth, Karl; Arenas, Ernest; Lindvall, Olle; Kokaia, Merab			Functional Integration of Grafted Neural Stem Cell-Derived Dopaminergic Neurons Monitored by Optogenetics in an In Vitro Parkinson Model	PLOS ONE			English	Article							OPTICAL CONTROL; MIDBRAIN; RECEPTORS; COMPACTA; DISEASE; CULTURE; REPAIR; BRAIN; GABA; MICE	Intrastriatal grafts of stem cell-derived dopamine (DA) neurons induce behavioral recovery in animal models of Parkinson's disease (PD), but how they functionally integrate in host neural circuitries is poorly understood. Here, Wnt5a-overexpressing neural stem cells derived from embryonic ventral mesencephalon of tyrosine hydroxylase-GFP transgenic mice were expanded as neurospheres and transplanted into organotypic cultures of wild type mouse striatum. Differentiated GFP-labeled DA neurons in the grafts exhibited mature neuronal properties, including spontaneous firing of action potentials, presence of post-synaptic currents, and functional expression of DA D-2 autoreceptors. These properties resembled those recorded from identical cells in acute slices of intrastriatal grafts in the 6-hydroxy-DA-induced mouse PD model and from DA neurons in intact substantia nigra. Optogenetic activation or inhibition of grafted cells and host neurons using channelrhodopsin-2 (ChR2) and halorhodopsin (NpHR), respectively, revealed complex, bi-directional synaptic interactions between grafted cells and host neurons and extensive synaptic connectivity within the graft. Our data demonstrate for the first time using optogenetics that ectopically grafted stem cell-derived DA neurons become functionally integrated in the DA-denervated striatum. Further optogenetic dissection of the synaptic wiring between grafted and host neurons will be crucial to clarify the cellular and synaptic mechanisms underlying behavioral recovery as well as adverse effects following stem cell-based DA cell replacement strategies in PD.	[Tonnesen, Jan; Sorensen, Andreas T.; Andersson, Angelica; Kokaia, Merab] Univ Lund Hosp, Wallenberg Neurosci Ctr, Expt Epilepsy Grp, S-22185 Lund, Sweden; [Parish, Clare L.; Arenas, Ernest] Ctr Dev Biol & Regenerat Med, Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, Stockholm, Sweden; [Lundberg, Cecilia] Univ Lund Hosp, Wallenberg Neurosci Ctr, CNS Gene Therapy Unit, S-22185 Lund, Sweden; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Lindvall, Olle] Univ Lund Hosp, Wallenberg Neurosci Ctr, Lab Neurogenesis & Cell Therapy, S-22185 Lund, Sweden	Lund University; Skane University Hospital; Karolinska Institutet; Lund University; Skane University Hospital; Stanford University; Lund University; Skane University Hospital	Tonnesen, J (corresponding author), Univ Lund Hosp, Wallenberg Neurosci Ctr, Expt Epilepsy Grp, S-22185 Lund, Sweden.	Merab.Kokaia@med.lu.se	Tonnesen, Jan/C-7464-2011; Parish, Clare/A-3380-2014; Sørensen, Andreas Toft/P-4745-2018; Arenas, Ernest/AAO-5231-2020	Tonnesen, Jan/0000-0003-3663-8463; Sørensen, Andreas Toft/0000-0001-5887-9247; Arenas, Ernest/0000-0003-0197-6577; Lundberg, Cecilia/0000-0002-6959-2564; Parish, Clare/0000-0001-8212-9884	European Community [22943]; Excell [214706]; Swedish Research Council; Royal Physiographic Society; Lars Hierta's Memorial and Kock Foundations; National Health & Medical Research Council	European Community(European Commission); Excell; Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society; Lars Hierta's Memorial and Kock Foundations; National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study is supported by grants from the European Community's Seventh Framework Programme through NeuroStemcell (nr. 22943) and Excell (nr. 214706), The Swedish Research Council, The Royal Physiographic Society, and Lars Hierta's Memorial and Kock Foundations. CLP is supported by a National Health & Medical Research Council Career Development Award Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenius H, 2009, J NEUROSCI, V29, P4408, DOI 10.1523/JNEUROSCI.6003-08.2009; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Cronberg T, 2004, STROKE, V35, P753, DOI 10.1161/01.STR.0000117576.09512.32; Fasano C., 2008, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301.NS0321S44; FISHER LJ, 1991, NEUROSCIENCE, V40, P109, DOI 10.1016/0306-4522(91)90178-Q; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; GRACE AA, 1989, J NEUROSCI, V9, P3463; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Iversen L. L., 2010, DOPAMINE HDB; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; Jomphe C, 2005, J NEUROSCI METH, V146, P1, DOI 10.1016/j.jneumeth.2005.01.014; Joyce MP, 2000, NEUROSCIENCE, V99, P445, DOI 10.1016/S0306-4522(00)00219-0; Kearns SM, 2006, J NEUROSCI METH, V157, P1, DOI 10.1016/j.jneumeth.2006.03.020; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; LACEY MG, 1989, J NEUROSCI, V9, P1233; Leinekugel X, 1999, Adv Neurol, V79, P189; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Lindvall Olle, 2004, NeuroRx, V1, P382; Lindvall O, 2009, TRENDS PHARMACOL SCI, V30, P260, DOI 10.1016/j.tips.2009.03.001; MERCURI NB, 1992, LIFE SCI, V51, P711, DOI 10.1016/0024-3205(92)90479-9; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; NISENBAUM ES, 1992, J NEUROPHYSIOL, V67, P477, DOI 10.1152/jn.1992.67.2.477; NISENBAUM ES, 1993, SYNAPSE, V14, P221, DOI 10.1002/syn.890140306; Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273; Piccini P, 2000, ANN NEUROL, V48, P689, DOI 10.1002/1531-8249(200011)48:5<689::AID-ANA1>3.0.CO;2-N; Plenz D, 1996, NEUROSCIENCE, V70, P893, DOI 10.1016/0306-4522(95)00405-X; Politis M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000976; Sarkis C, 2000, P NATL ACAD SCI USA, V97, P14638, DOI 10.1073/pnas.260472897; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Sorensen AT, 2005, EUR J NEUROSCI, V21, P2793, DOI 10.1111/j.1460-9568.2005.04116.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; Tepper JM, 2007, PROG BRAIN RES, V160, P189, DOI 10.1016/S0079-6123(06)60011-3; Tonnesen J, 2009, P NATL ACAD SCI USA, V106, P12162, DOI 10.1073/pnas.0901915106; Uchida K, 2005, NEUROSCI RES, V52, P276, DOI 10.1016/j.neures.2005.03.015; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	38	77	79	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17560	10.1371/journal.pone.0017560	http://dx.doi.org/10.1371/journal.pone.0017560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394212	Green Published, Green Submitted, gold			2022-12-25	WOS:000288025500016
J	Purushothaman, S; Annamalai, K; Tyagi, AK; Surolia, A				Purushothaman, Sudha; Annamalai, Karthikeyan; Tyagi, Anil K.; Surolia, Avadhesha			Diversity in Functional Organization of Class I and Class II Biotin Protein Ligase	PLOS ONE			English	Article							ESCHERICHIA-COLI REPRESSOR; CARBOXYL CARRIER SUBUNIT; AQUIFEX-AEOLICUS; COA CARBOXYLASE; TERMINAL DOMAIN; CELL-WALL; BIOSYNTHESIS; BIOTINYLATION; TUBERCULOSIS; APO	The cell envelope of Mycobacterium tuberculosis (M. tuberculosis) is composed of a variety of lipids including mycolic acids, sulpholipids, lipoarabinomannans, etc., which impart rigidity crucial for its survival and pathogenesis. Acyl CoA carboxylase (ACC) provides malonyl-CoA and methylmalonyl-CoA, committed precursors for fatty acid and essential for mycolic acid synthesis respectively. Biotin Protein Ligase (BPL/BirA) activates apo-biotin carboxyl carrier protein (BCCP) by biotinylating it to an active holo-BCCP. A minimal peptide (Schatz), an efficient substrate for Escherichia coli BirA, failed to serve as substrate for M. tuberculosis Biotin Protein Ligase (MtBPL). MtBPL specifically biotinylates homologous BCCP domain, MtBCCP87, but not EcBCCP87. This is a unique feature of MtBPL as EcBirA lacks such a stringent substrate specificity. This feature is also reflected in the lack of self/promiscuous biotinylation by MtBPL. The N-terminus/HTH domain of EcBirA has the selfbiotinable lysine residue that is inhibited in the presence of Schatz peptide, a peptide designed to act as a universal acceptor for EcBirA. This suggests that when biotin is limiting, EcBirA preferentially catalyzes, biotinylation of BCCP over selfbiotinylation. R118G mutant of EcBirA showed enhanced self and promiscuous biotinylation but its homologue, R69A MtBPL did not exhibit these properties. The catalytic domain of MtBPL was characterized further by limited proteolysis. Holo-MtBPL is protected from proteolysis by biotinyl-59 AMP, an intermediate of MtBPL catalyzed reaction. In contrast, apo-MtBPL is completely digested by trypsin within 20 min of co-incubation. Substrate selectivity and inability to promote self biotinylation are exquisite features of MtBPL and are a consequence of the unique molecular mechanism of an enzyme adapted for the high turnover of fatty acid biosynthesis.	[Purushothaman, Sudha; Annamalai, Karthikeyan; Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Surolia, Avadhesha] Natl Inst Immunol, New Delhi 110067, India; [Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); University of Delhi	Purushothaman, S (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	surolia@nii.res.in			Department of Biotechnology (DBT), Government of India; Department of Science & Technology (DST), Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Department of Science & Technology (DST), Government of India(Department of Science & Technology (India))	This work was supported by Centre of Excellence grant from the Department of Biotechnology (DBT), Government of India to A. S. and by another Department of Science & Technology (DST), Government of India grant to A.S. A.S. is also a J.C. Bose Fellow of the Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT J, 1993, BIOCHEMISTRY-US, V32, P9649, DOI 10.1021/bi00088a017; Athappilly FK, 1995, STRUCTURE, V3, P1407, DOI 10.1016/S0969-2126(01)00277-5; Bagautdinov B, 2005, J MOL BIOL, V353, P322, DOI 10.1016/j.jmb.2005.08.032; Bagautdinov B, 2008, J BIOL CHEM, V283, P14739, DOI 10.1074/jbc.M709116200; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Beckett D, 2009, J NUTR, V139, P167, DOI 10.3945/jn.108.095760; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Brennan PJ, 2009, TUBERCULOSIS, V89, P329, DOI 10.1016/j.tube.2009.08.003; Chapman-Smith A, 1999, TRENDS BIOCHEM SCI, V24, P359, DOI 10.1016/S0968-0004(99)01438-3; Chapman-Smith A, 1999, J NUTR, V129, p477S, DOI 10.1093/jn/129.2.477S; ChapmanSmith A, 1997, J BIOL CHEM, V272, P26017, DOI 10.1074/jbc.272.41.26017; Chatterjee D, 1997, CURR OPIN CHEM BIOL, V1, P579, DOI 10.1016/S1367-5931(97)80055-5; Choi-Rhee E, 2004, PROTEIN SCI, V13, P3043, DOI 10.1110/ps.04911804; Clarke DJ, 2003, EUR J BIOCHEM, V270, P1277, DOI 10.1046/j.1432-1033.2003.03493.x; Cole ST, 2007, BIOCHEM SOC T, V35, P1321, DOI 10.1042/BST0351321; Cronan JE, 2001, J BIOL CHEM, V276, P37355, DOI 10.1074/jbc.M106353200; DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Goude R, 2008, FUTURE MICROBIOL, V3, P299, DOI 10.2217/17460913.3.3.299; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Li YQ, 2006, FEBS LETT, V580, P1536, DOI 10.1016/j.febslet.2006.01.083; Oh TJ, 2006, J BIOL CHEM, V281, P3899, DOI 10.1074/jbc.M511761200; Orme IM, 2001, TRENDS MICROBIOL, V9, P115, DOI 10.1016/S0966-842X(00)01949-1; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Purushothaman S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002320; Reyda MR, 2008, ARCH BIOCHEM BIOPHYS, V471, P32, DOI 10.1016/j.abb.2007.12.001; Roberts EL, 1999, BIOCHEMISTRY-US, V38, P5045, DOI 10.1021/bi982466o; Streaker ED, 2006, BIOCHEMISTRY-US, V45, P6417, DOI 10.1021/bi052599r; Streit WR, 2003, APPL MICROBIOL BIOT, V61, P21, DOI 10.1007/s00253-002-1186-2; Sueda S, 2006, BIOCHEM BIOPH RES CO, V344, P155, DOI 10.1016/j.bbrc.2006.03.118; Tron CM, 2009, J MOL BIOL, V387, P129, DOI 10.1016/j.jmb.2008.12.086; Wagenfuhr K, 2007, J MOL BIOL, V366, P93, DOI 10.1016/j.jmb.2006.10.087; Xu Y, 1995, BIOCHEMISTRY-US, V34, P16624, DOI 10.1021/bi00051a010; Xu Y, 1996, BIOCHEMISTRY-US, V35, P1783, DOI 10.1021/bi952269e; Yao X, 1997, BIOCHEMISTRY-US, V36, P15089, DOI 10.1021/bi971485f; Yao X, 1999, PROTEIN SCI, V8, P307	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e16850	10.1371/journal.pone.0016850	http://dx.doi.org/10.1371/journal.pone.0016850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390227	gold, Green Published, Green Accepted			2022-12-25	WOS:000287965200006
J	Eulalio, A; Frohlich, KS; Mano, M; Giacca, M; Vogel, J				Eulalio, Ana; Froehlich, Kathrin S.; Mano, Miguel; Giacca, Mauro; Vogel, Joerg			A Candidate Approach Implicates the Secreted Salmonella Effector Protein SpvB in P-Body Disassembly	PLOS ONE			English	Article							STRESS GRANULE FORMATION; RNA-DECAPPING FACTORS; GW/P BODIES; VIRULENCE PLASMID; EUKARYOTIC CELLS; INFECTED-CELLS; IN-VIVO; TRANSLATION; ENTERICA; DEADENYLATION	P-bodies are dynamic aggregates of RNA and proteins involved in several post-transcriptional regulation processes. P-bodies have been shown to play important roles in regulating viral infection, whereas their interplay with bacterial pathogens, specifically intracellular bacteria that extensively manipulate host cell pathways, remains unknown. Here, we report that Salmonella infection induces P-body disassembly in a cell type-specific manner, and independently of previously characterized pathways such as inhibition of host cell RNA synthesis or microRNA-mediated gene silencing. We show that the Salmonella-induced P-body disassembly depends on the activation of the SPI-2 encoded type 3 secretion system, and that the secreted effector protein SpvB plays a major role in this process. P-body disruption is also induced by the related pathogen, Shigella flexneri, arguing that this might be a new mechanism by which intracellular bacterial pathogens subvert host cell function.	[Eulalio, Ana; Vogel, Joerg] Max Planck Inst Infect Biol, RNA Biol Grp, Berlin, Germany; [Froehlich, Kathrin S.; Vogel, Joerg] Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany; [Eulalio, Ana; Mano, Miguel; Giacca, Mauro] Int Ctr Genet Engn & Biotechnol, Mol Med Lab, I-34012 Trieste, Italy	Max Planck Society; University of Wurzburg; International Center for Genetic Engineering & Biotechnology (ICGEB)	Eulalio, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Med Lab, Padriciano 99, I-34012 Trieste, Italy.	ana.eulalio@icgeb.org; joerg.vogel@uni-wuerzburg.de	Giacca, Mauro/J-9287-2016; Eulalio, Ana/D-3083-2013; Vogel, Jörg/D-5574-2011; Mano, Miguel/A-4462-2013	Giacca, Mauro/0000-0003-2927-7225; Eulalio, Ana/0000-0002-7355-0674; Vogel, Jörg/0000-0003-2220-1404; Mano, Miguel/0000-0003-1922-4824; Frohlich, Kathrin/0000-0003-2352-9751	NGFN; European Commission; Region Friuli Venezia Giulia; Region Friuli Venezia Giulia, Italy; German Research Foundation (DFG)	NGFN; European Commission(European CommissionEuropean Commission Joint Research Centre); Region Friuli Venezia Giulia(Regione Friuli Venezia Giulia); Region Friuli Venezia Giulia, Italy; German Research Foundation (DFG)(German Research Foundation (DFG))	Work in the Vogel lab is supported by NGFN and by the Sixth Framework Programme of the European Commission through the SIROCCO Integrated Project. M.M. was supported by Project "SeND - Search for New Drugs," funded by Region Friuli Venezia Giulia and III supplementary contract of Framework Programme on Scientific Research in Region Friuli Venezia Giulia, Italy. This publication was funded by the German Research Foundation (DFG) in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004; Bhanji RA, 2007, CLIN IMMUNOL, V125, P247, DOI 10.1016/j.clim.2007.07.016; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; Browne SH, 2002, INFECT IMMUN, V70, P7126, DOI 10.1128/IAI.70.12.7126-7135.2002; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diez J, 2000, P NATL ACAD SCI USA, V97, P3913, DOI 10.1073/pnas.080072997; DOUGHERTY JD, J VIROL; Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; FIERER J, 1993, INFECT IMMUN, V61, P5231, DOI 10.1128/IAI.61.12.5231-5236.1993; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kurita A, 2003, MICROB PATHOGENESIS, V35, P43, DOI 10.1016/S0882-4010(03)00066-4; Lesnick ML, 2001, MOL MICROBIOL, V39, P1464, DOI 10.1046/j.1365-2958.2001.02360.x; Lian S, 2007, MOL BIOL CELL, V18, P3375, DOI 10.1091/mbc.E07-01-0070; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Mas A, 2006, J VIROL, V80, P246, DOI 10.1128/JVI.80.1.246-251.2006; Mastroeni P, 2009, NAT REV MICROBIOL, V7, P73, DOI 10.1038/nrmicro2034; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Noueiry AO, 2003, MOL CELL BIOL, V23, P4094, DOI 10.1128/MCB.23.12.4094-4106.2003; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; Otto H, 2000, MOL MICROBIOL, V37, P1106, DOI 10.1046/j.1365-2958.2000.02064.x; Pauley KM, 2006, EMBO REP, V7, P904, DOI 10.1038/sj.embor.7400783; Pauley KM, 2010, IMMUNOL CELL BIOL, V88, P205, DOI 10.1038/icb.2009.84; Piotrowska J, 2010, J VIROL, V84, P3654, DOI 10.1128/JVI.01320-09; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Scheller N, 2009, P NATL ACAD SCI USA, V106, P13517, DOI 10.1073/pnas.0906413106; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Smith JA, 2006, J VIROL, V80, P2019, DOI 10.1128/JVI.80.4.2019-2033.2006; Sweet TJ, 2007, RNA, V13, P493, DOI 10.1261/rna.355807; Tezcan-Merdol D, 2001, MOL MICROBIOL, V39, P606, DOI 10.1046/j.1365-2958.2001.02258.x; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006; Wyllie DH, 2000, J IMMUNOL, V165, P7125, DOI 10.4049/jimmunol.165.12.7125; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000; Yu XJ, 2004, MOL MICROBIOL, V54, P604, DOI 10.1111/j.1365-2958.2004.04297.x; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196	53	18	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17296	10.1371/journal.pone.0017296	http://dx.doi.org/10.1371/journal.pone.0017296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390246	Green Submitted, Green Published, gold			2022-12-25	WOS:000287932100011
J	Gaunt, ER; Jansen, RR; Poovorawan, Y; Templeton, KE; Toms, GL; Simmonds, P				Gaunt, Eleanor R.; Jansen, Rogier R.; Poovorawan, Yong; Templeton, Kate E.; Toms, Geoffrey L.; Simmonds, Peter			Molecular Epidemiology and Evolution of Human Respiratory Syncytial Virus and Human Metapneumovirus	PLOS ONE			English	Article							ATTACHMENT G PROTEIN; G-GLYCOPROTEIN; SUBGROUP-A; GENETIC DIVERSITY; CLINICAL-MANIFESTATIONS; STRAIN VARIATION; NEUTRALIZING EPITOPES; ANTIGENIC RELATEDNESS; CIRCULATION PATTERNS; NUCLEOTIDE-SEQUENCE	Human respiratory syncytial virus (HRSV) and human metapneumovirus (HMPV) are ubiquitous respiratory pathogens of the Pneumovirinae subfamily of the Paramyxoviridae. Two major surface antigens are expressed by both viruses; the highly conserved fusion (F) protein, and the extremely diverse attachment (G) glycoprotein. Both viruses comprise two genetic groups, A and B. Circulation frequencies of the two genetic groups fluctuate for both viruses, giving rise to frequently observed switching of the predominantly circulating group. Nucleotide sequence data for the F and G gene regions of HRSV and HMPV variants from the UK, the Netherlands, Bangkok and data available from Genbank were used to identify clades of both viruses. Several contemporary circulating clades of HRSV and HMPV were identified by phylogenetic reconstructions. The molecular epidemiology and evolutionary dynamics of clades were modelled in parallel. Times of origin were determined and positively selected sites were identified. Sustained circulation of contemporary clades of both viruses for decades and their global dissemination demonstrated that switching of the predominant genetic group did not arise through the emergence of novel lineages each respiratory season, but through the fluctuating circulation frequencies of pre-existing lineages which undergo proliferative and eclipse phases. An abundance of sites were identified as positively selected within the G protein but not the F protein of both viruses. For HRSV, these were discordant with previously identified residues under selection, suggesting the virus can evade immune responses by generating diversity at multiple sites within linear epitopes. For both viruses, different sites were identified as positively selected between genetic groups.	[Gaunt, Eleanor R.; Simmonds, Peter] Univ Edinburgh, Ctr Infect Dis, Edinburgh, Midlothian, Scotland; [Jansen, Rogier R.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Poovorawan, Yong] Chulalongkorn Univ, Ctr Excellence Clin Virol, Bangkok, Thailand; [Toms, Geoffrey L.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Templeton, Kate E.] Royal Infirm Edinburgh NHS Trust, Specialist Virol Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Amsterdam; Academic Medical Center Amsterdam; Chulalongkorn University; Newcastle University - UK; Royal Infirmary of Edinburgh; University of Edinburgh	Gaunt, ER (corresponding author), Univ Edinburgh, Ctr Infect Dis, Edinburgh, Midlothian, Scotland.	e.gaunt@sms.ed.ac.uk	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Templeton, Kate/0000-0001-7414-1277; Poovorawan, Yong/0000-0002-2337-6807; Simmonds, Peter/0000-0002-7964-4700	BBSRC; Thailand Research Fund; Commission on Higher Education, King Chulalongkorn Memorial Hospital; Center of Excellence in Clinical Virology; Chulalongkorn University	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Thailand Research Fund(Thailand Research Fund (TRF)); Commission on Higher Education, King Chulalongkorn Memorial Hospital(Office of Higher Education Commission (OHEC)); Center of Excellence in Clinical Virology; Chulalongkorn University(Chulalongkorn University)	This research was supported by a studentship awarded to E.G. by the BBSRC, the Thailand Research Fund, the Commission on Higher Education, King Chulalongkorn Memorial Hospital, the Center of Excellence in Clinical Virology and CU Centenary Academic Development Project, Chulalongkorn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapov E, 2006, J INFECT DIS, V193, P396, DOI 10.1086/499310; AKERLIND B, 1986, J MED VIROL, V19, P241, DOI 10.1002/jmv.1890190306; ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Bastien N, 2003, J CLIN MICROBIOL, V41, P4642, DOI 10.1128/JCM.41.10.4642-4646.2003; Biacchesi S, 2003, VIROLOGY, V315, P1, DOI 10.1016/S0042-6822(03)00528-2; Boivin G, 2004, EMERG INFECT DIS, V10, P1154, DOI 10.3201/eid1006.031097; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; BUKREYEV A, 2008, J VIROL; CANE PA, 1995, J VIROL, V69, P2918, DOI 10.1128/JVI.69.5.2918-2925.1995; Cane PA, 1997, J MED VIROL, V51, P297, DOI 10.1002/(SICI)1096-9071(199704)51:4<297::AID-JMV7>3.0.CO;2-0; CANE PA, 1994, J CLIN MICROBIOL, V32, P1; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chieochansin T, 2008, J INFECTION, V56, P137, DOI 10.1016/j.jinf.2007.11.006; de Graaf M, 2008, J GEN VIROL, V89, P2933, DOI 10.1099/vir.0.2008/006957-0; Deng Jie, 2006, Zhonghua Er Ke Za Zhi, V44, P924; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Endo R, 2008, J GEN VIROL, V89, P1970, DOI 10.1099/vir.0.83679-0; Esper F, 2003, PEDIATRICS, V111, P1407, DOI 10.1542/peds.111.6.1407; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; Feldman SA, 1999, J VIROL, V73, P6610, DOI 10.1128/JVI.73.8.6610-6617.1999; FREYMUTH F, 1991, J CLIN MICROBIOL, V29, P653, DOI 10.1128/JCM.29.3.653-655.1991; GARCIA O, 1994, J VIROL, V68, P5448; GARCIABARRENO B, 1990, EMBO J, V9, P4181, DOI 10.1002/j.1460-2075.1990.tb07642.x; Gaunt E, 2009, J CLIN VIROL, V46, P318, DOI 10.1016/j.jcv.2009.09.016; Gorman JJ, 2001, J BIOL CHEM, V276, P38988, DOI 10.1074/jbc.M106288200; HENDRY RM, 1988, J INFECT DIS, V157, P640, DOI 10.1093/infdis/157.4.640; HENDRY RM, 1989, J INFECT DIS, V160, P185, DOI 10.1093/infdis/160.2.185; Herd KA, 2006, J VIROL, V80, P2034, DOI 10.1128/JVI.80.4.2034-2044.2006; Herfst S, 2007, J GEN VIROL, V88, P2702, DOI 10.1099/vir.0.83084-0; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Ishiguro N, 2004, J CLIN MICROBIOL, V42, P3406, DOI 10.1128/JCM.42.8.3406-3414.2004; JOHNSON PR, 1987, J VIROL, V61, P3163, DOI 10.1128/JVI.61.10.3163-3166.1987; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Langedijk JPM, 1996, J GEN VIROL, V77, P1249, DOI 10.1099/0022-1317-77-6-1249; LEITCH ECM, 2010, J VIROL; LERCH RA, 1990, J VIROL, V64, P5559, DOI 10.1128/JVI.64.11.5559-5569.1990; LOPEZ JA, 1993, J GEN VIROL, V74, P2567, DOI 10.1099/0022-1317-74-12-2567; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Martinez I, 1997, J GEN VIROL, V78, P2419, DOI 10.1099/0022-1317-78-10-2419; Martinez I, 1999, J GEN VIROL, V80, P125, DOI 10.1099/0022-1317-80-1-125; Matsuzaki Y, 2008, J MED VIROL, V80, P1084, DOI 10.1002/jmv.21194; McGill A, 2004, J MED VIROL, V74, P492, DOI 10.1002/jmv.20203; Melero JA, 1997, J GEN VIROL, V78, P2411, DOI 10.1099/0022-1317-78-10-2411; MONTO AS, 1990, J INFECT DIS, V161, P781, DOI 10.1093/infdis/161.4.781; MORGAN LA, 1987, J GEN VIROL, V68, P2781, DOI 10.1099/0022-1317-68-11-2781; MUFSON MA, 1988, J INFECT DIS, V157, P143, DOI 10.1093/infdis/157.1.143; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Murata Y, 2010, CLIN VACCINE IMMUNOL, V17, P695, DOI 10.1128/CVI.00432-09; OLMSTED RA, 1989, J VIROL, V63, P411, DOI 10.1128/JVI.63.1.411-420.1989; OLMSTED RA, 1986, P NATL ACAD SCI USA, V83, P7462, DOI 10.1073/pnas.83.19.7462; Padhi A, 2008, VIRUS RES, V131, P121, DOI 10.1016/j.virusres.2007.08.014; Palomo C, 2000, J MED VIROL, V60, P468, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;468::AID-JMV16&gt;3.0.CO;2-E; Peret TCT, 2004, J GEN VIROL, V85, P679, DOI 10.1099/vir.0.19504-0; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; RUEDA P, 1995, VIRAL IMMUNOL, V8, P37, DOI 10.1089/vim.1995.8.37; Santibanez S, 2002, J GEN VIROL, V83, P2699, DOI 10.1099/0022-1317-83-11-2699; Scott PD, 2006, J INFECT DIS, V193, P59, DOI 10.1086/498246; Skiadopoulos MH, 2004, J VIROL, V78, P6927, DOI 10.1128/JVI.78.13.6927-6937.2004; Stockton J, 2002, EMERG INFECT DIS, V8, P897, DOI 10.3201/eid0809.020084; Sullender WM, 1998, J INFECT DIS, V178, P925, DOI 10.1086/515697; SULLENDER WM, 1991, J VIROL, V65, P5425, DOI 10.1128/JVI.65.10.5425-5434.1991; TAYLOR CE, 1989, LANCET, V1, P777; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; van den Hoogen BG, 2007, J GEN VIROL, V88, P1251, DOI 10.1099/vir.0.82663-0; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Vicente D, 2006, CLIN INFECT DIS, V42, pE111, DOI 10.1086/504378; Walsh EE, 1998, J GEN VIROL, V79, P479, DOI 10.1099/0022-1317-79-3-479; WERTZ GW, 1985, P NATL ACAD SCI USA, V82, P4075, DOI 10.1073/pnas.82.12.4075; White LJ, 2005, EPIDEMIOL INFECT, V133, P279, DOI 10.1017/S0950268804003450; Woelk CH, 2001, J MOL EVOL, V52, P182, DOI 10.1007/s002390010147; Yang CF, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-138; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005; Zlateva KT, 2004, J VIROL, V78, P4675, DOI 10.1128/JVI.78.9.4675-4683.2004; ZLATEVA KT, 2007, J CLIN MICROBIOL	79	42	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17427	10.1371/journal.pone.0017427	http://dx.doi.org/10.1371/journal.pone.0017427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390255	Green Submitted, Green Published, gold			2022-12-25	WOS:000287932100016
J	Cheng, D; Jenner, AM; Shui, GH; Cheong, WF; Mitchell, TW; Nealon, JR; Kim, WS; McCann, H; Wenk, MR; Halliday, GM; Garner, B				Cheng, Danni; Jenner, Andrew M.; Shui, Guanghou; Cheong, Wei Fun; Mitchell, Todd W.; Nealon, Jessica R.; Kim, Woojin S.; McCann, Heather; Wenk, Markus R.; Halliday, Glenda M.; Garner, Brett			Lipid Pathway Alterations in Parkinson's Disease Primary Visual Cortex	PLOS ONE			English	Article							LEWY BODY DISEASE; APOLIPOPROTEIN-D EXPRESSION; TANDEM MASS-SPECTROMETRY; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; LIVER X RECEPTORS; ALPHA-SYNUCLEIN; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA	Background: We present a lipidomics analysis of human Parkinson's disease tissues. We have focused on the primary visual cortex, a region that is devoid of pathological changes and Lewy bodies; and two additional regions, the amygdala and anterior cingulate cortex which contain Lewy bodies at different disease stages but do not have as severe degeneration as the substantia nigra. Methodology/Principal Findings: Using liquid chromatography mass spectrometry lipidomics techniques for an initial screen of 200 lipid species, significant changes in 79 sphingolipid, glycerophospholipid and cholesterol species were detected in the visual cortex of Parkinson's disease patients (n = 10) compared to controls (n = 10) as assessed by two-sided unpaired t-test (p-value <0.05). False discovery rate analysis confirmed that 73 of these 79 lipid species were significantly changed in the visual cortex (q-value < 0.05). By contrast, changes in 17 and 12 lipid species were identified in the Parkinson's disease amygdala and anterior cingulate cortex, respectively, compared to controls; none of which remained significant after false discovery rate analysis. Using gas chromatography mass spectrometry techniques, 6 out of 7 oxysterols analysed from both non-enzymatic and enzymatic pathways were also selectively increased in the Parkinson's disease visual cortex. Many of these changes in visual cortex lipids were correlated with relevant changes in the expression of genes involved in lipid metabolism and an oxidative stress response as determined by quantitative polymerase chain reaction techniques. Conclusions/Significance: The data indicate that changes in lipid metabolism occur in the Parkinson's disease visual cortex in the absence of obvious pathology. This suggests that normalization of lipid metabolism and/or oxidative stress status in the visual cortex may represent a novel route for treatment of non-motor symptoms, such as visual hallucinations, that are experienced by a majority of Parkinson's disease patients.	[Cheng, Danni; Kim, Woojin S.; McCann, Heather; Halliday, Glenda M.; Garner, Brett] Neurosci Res Australia, Sydney, NSW, Australia; [Jenner, Andrew M.; Shui, Guanghou; Cheong, Wei Fun; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Shui, Guanghou] Natl Univ Singapore, Inst Life Sci, Singapore 117548, Singapore; [Mitchell, Todd W.] Univ Wollongong, Sch Hlth Sci, Wollongong, NSW, Australia; [Mitchell, Todd W.; Garner, Brett] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Nealon, Jessica R.] Univ Wollongong, Sch Chem, Wollongong, NSW, Australia; [Kim, Woojin S.; Halliday, Glenda M.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Wenk, Markus R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Garner, Brett] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia	Neuroscience Research Australia; National University of Singapore; National University of Singapore; University of Wollongong; University of Wollongong; University of Wollongong; University of New South Wales Sydney; National University of Singapore; University of Wollongong	Cheng, D (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	brettg@uow.edu.au	Halliday, Glenda M/E-8555-2011; jenner, andrew M/H-4791-2016; jenner, andrew/AGZ-2767-2022; Wenk, Markus Rene/D-1441-2014; McCann, Heather/I-3815-2012; Mitchell, Todd/G-7044-2012	Halliday, Glenda M/0000-0003-0422-8398; jenner, andrew M/0000-0003-1767-2033; jenner, andrew/0000-0003-1767-2033; McCann, Heather/0000-0002-8474-8969; Mitchell, Todd/0000-0002-1372-9963; Shui, Guanghou/0000-0002-1621-9643	Australian Brain Foundation; Australian Research Council; Singapore National Research Foundation [2007-04]; Biomedical Research Council of Singapore [R-183-000-211-305]; National Medical Research Council [R-183-000-224-213]; SystemsX.ch RTD project LipidX; Neuroscience Research Australia; University of New South Wales; National Health and Medical Research Council of Australia (NHMRC); University of Sydney; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism	Australian Brain Foundation; Australian Research Council(Australian Research Council); Singapore National Research Foundation(National Research Foundation, Singapore); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SystemsX.ch RTD project LipidX; Neuroscience Research Australia; University of New South Wales; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney); Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	DC is supported by a PhD scholarship from the Australian Brain Foundation. GH and BG are Fellows of the NHMRC. BG holds an Australian Research Council Future Fellowship. Work at the NUS lipidomics laboratory (MRW) is supported by grants from the Singapore National Research Foundation under CRP Award No. 2007-04, the Biomedical Research Council of Singapore (R-183-000-211-305), the National Medical Research Council (R-183-000-224-213) and the SystemsX.ch RTD project LipidX. The Sydney Brain Bank is supported by Neuroscience Research Australia, the University of New South Wales and the National Health and Medical Research Council of Australia (NHMRC). The NSW Tissue Resource Centre is supported by the University of Sydney, the NHMRC, the Schizophrenia Research Institute and the National Institute of Alcohol Abuse and Alcoholism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; Barcelo-Coblijn G, 2007, J NEUROCHEM, V101, P132, DOI 10.1111/j.1471-4159.2006.04348.x; Barnes J, 2001, J NEUROL NEUROSUR PS, V70, P727, DOI 10.1136/jnnp.70.6.727; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bosco DA, 2006, NAT CHEM BIOL, V2, P249, DOI 10.1038/nchembio782; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bras J, 2008, FEBS J, V275, P5767, DOI 10.1111/j.1742-4658.2008.06709.x; Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Burke RE, 2008, ANN NEUROL, V64, P485, DOI 10.1002/ana.21541; Caesar R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011525; Cartagena CM, 2010, BRAIN RES, V1319, P1, DOI 10.1016/j.brainres.2009.12.080; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Cheng D, 2008, NEUROREPORT, V19, P1685, DOI 10.1097/WNR.0b013e32831578b2; DAMIER P, 1993, NEUROSCIENCE, V52, P1, DOI 10.1016/0306-4522(93)90175-F; De Haan EH, 2007, NEUROREPORT, V18, P1177, DOI 10.1097/WNR.0b013e32820049d3; Deeley JM, 2008, BBA-MOL CELL BIOL L, V1781, P288, DOI 10.1016/j.bbalip.2008.04.002; DEXTER DT, 1994, MOVEMENT DISORD, V9, P92, DOI 10.1002/mds.870090115; Dickson DW, 2009, PARKINSONISM RELAT D, V15, pS1, DOI 10.1016/S1353-8020(09)70769-2; Diederich NJ, 2009, NAT REV NEUROL, V5, P331, DOI 10.1038/nrneurol.2009.62; EBERLING JL, 1994, NEUROBIOL AGING, V15, P329, DOI 10.1016/0197-4580(94)90028-0; Elliott DA, 2011, NEUROBIOL AGING, V32, P257, DOI 10.1016/j.neurobiolaging.2009.02.006; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Farooqui AA, 2007, J NEUROSCI RES, V85, P1834, DOI 10.1002/jnr.21268; Fasano C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000612; Fedorow H, 2005, J NEUROCHEM, V92, P990, DOI 10.1111/j.1471-4159.2004.02975.x; Forsaa EB, 2010, ARCH NEUROL-CHICAGO, V67, P996, DOI 10.1001/archneurol.2010.166; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Guerrera IC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007735; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Halliday G, 2002, ACTA NEUROPATHOL, V104, P72, DOI 10.1007/s00401-002-0529-5; Halliday GM, 2010, ANN NY ACAD SCI, V1184, P188, DOI 10.1111/j.1749-6632.2009.05118.x; Halliday GM, 2005, BRAIN, V128, P2654, DOI 10.1093/brain/awh584; Han XL, 2010, BBA-MOL CELL BIOL L, V1801, P774, DOI 10.1016/j.bbalip.2010.01.010; Han XL, 2002, ANAL BIOCHEM, V302, P199, DOI 10.1006/abio.2001.5536; Harding AJ, 2002, BRAIN, V125, P2431, DOI 10.1093/brain/awf251; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Heverin M, 2005, J LIPID RES, V46, P1047, DOI 10.1194/jlr.M500024-JLR200; Heverin M, 2004, J LIPID RES, V45, P186, DOI 10.1194/jlr.M300320-JLR200; Holroyd S, 2006, J NEUROPSYCH CLIN N, V18, P402, DOI 10.1176/appi.neuropsych.18.3.402; Hu CX, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013318, 10.1371/journal.pone.0015542]; Huang Q, 2006, CANCER RES, V66, P5807, DOI 10.1158/0008-5472.CAN-06-0077; Ibarretxe-Bilbao N, 2009, MOVEMENT DISORD, V24, pS748, DOI 10.1002/mds.22670; Jellinger KA, 2008, ACTA NEUROPATHOL, V116, P1, DOI 10.1007/s00401-008-0406-y; JENNER P, 1992, ANN NEUROL, V32, pS82, DOI 10.1002/ana.410320714; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P2094, DOI 10.1073/pnas.0711599105; Kim WS, 2009, J NEUROCHEM, V109, P1053, DOI 10.1111/j.1471-4159.2009.06031.x; Kolsch H, 1999, BRAIN RES, V818, P171, DOI 10.1016/S0006-8993(98)01274-8; Kolsch H, 2000, NEUROCHEM INT, V36, P507, DOI 10.1016/S0197-0186(99)00157-6; Le Lay S, 2009, J LIPID RES, V50, P1609, DOI 10.1194/jlr.M800601-JLR200; Lee CYJ, 2009, ANTIOXID REDOX SIGN, V11, P407, DOI [10.1089/ars.2008.2179, 10.1089/ARS.2008.2179]; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; Meppelink AM, 2009, BRAIN, V132, P2980, DOI 10.1093/brain/awp223; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Ordonez C, 2006, HISTOL HISTOPATHOL, V21, P361, DOI 10.14670/HH-21.361; Owen AD, 1996, ANN NY ACAD SCI, V786, P217, DOI 10.1111/j.1749-6632.1996.tb39064.x; Power JHT, 2009, ACTA NEUROPATHOL, V117, P63, DOI 10.1007/s00401-008-0438-3; Prabhakara JPR, 2008, J NEUROCHEM, V107, P1722, DOI 10.1111/j.1471-4159.2008.05736.x; Ramirez-Ruiz B, 2007, EUR J NEUROL, V14, P750, DOI 10.1111/j.1468-1331.2007.01768.x; Ramirez-Ruiz B, 2008, MOVEMENT DISORD, V23, P2335, DOI 10.1002/mds.22258; Rappley I, 2009, J NEUROCHEM, V111, P15, DOI 10.1111/j.1471-4159.2009.06290.x; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; RUIPEREZ V, 2010, PROG LIPID RES; Sacchetti P, 2009, CELL STEM CELL, V5, P409, DOI 10.1016/j.stem.2009.08.019; Sanchez-Castaneda C, 2010, MOVEMENT DISORD, V25, P615, DOI 10.1002/mds.22873; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Scholpp J, 2004, J NEUROTRAUM, V21, P667, DOI 10.1089/0897715041269632; Schwab U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002630; Seet RCS, 2010, FREE RADICAL BIO MED, V48, P560, DOI 10.1016/j.freeradbiomed.2009.11.026; Shui G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011956; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; Sparvero LJ, 2010, J NEUROCHEM, V115, P1322, DOI 10.1111/j.1471-4159.2010.07055.x; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; STALLBER.S, 1965, J LIPID RES, V6, P146; STOMMEL A, 1989, MECH AGEING DEV, V48, P1, DOI 10.1016/0047-6374(89)90021-3; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; SVENNERHOLM L, 1994, J NEUROCHEM, V63, P1802; Tong JC, 2010, BRAIN, V133, P172, DOI 10.1093/brain/awp282; Wang L, 2002, P NATL ACAD SCI USA, V99, P13878, DOI 10.1073/pnas.172510899; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Williams DR, 2008, J NEUROL NEUROSUR PS, V79, P652, DOI 10.1136/jnnp.2007.124677; Williams DR, 2005, LANCET NEUROL, V4, P605, DOI 10.1016/S1474-4422(05)70146-0; Wilson RS, 2000, J NEUROL NEUROSUR PS, V69, P172, DOI 10.1136/jnnp.69.2.172; Zhang Qingchen, 2003, Curr Psychiatry Rep, V5, P197, DOI 10.1007/s11920-003-0042-0	88	106	106	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17299	10.1371/journal.pone.0017299	http://dx.doi.org/10.1371/journal.pone.0017299			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387008	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000287931400051
J	Lage, GM; Malloy-Diniz, LF; Matos, LO; Bastos, MAR; Abrantes, SSC; Correa, H				Lage, Guilherme M.; Malloy-Diniz, Leandro F.; Matos, Lorena O.; Bastos, Marisa A. R.; Abrantes, Suzana S. C.; Correa, Humberto			Impulsivity and the 5-HTTLPR Polymorphism in a Non-Clinical Sample	PLOS ONE			English	Article							SEROTONIN TRANSPORTER POLYMORPHISM; TRYPTOPHAN DEPLETION; PERSONALITY-TRAITS; DECISION-MAKING; BEHAVIOR; ASSOCIATION	Background: Impulsivity has been associated with serotonergic system functions. However, few researchers have investigated the relationship between a polymorphism in the promoter of the serotonin transporter gene (5-HTTLPR) and the different components of impulsivity in a non-clinical population. The aim of this study was to investigate the relationship between a polymorphism in the promoter region of the serotonin transporter gene (5-HTTLPR) and the different components of impulsivity in a non-clinical population. Methodology/Principal Findings: We administered two neuropsychological tests, the Continuous Performance Task and the Iowa Gambling Task, to 127 healthy participants to measure their levels of motor, attentional and non-planning impulsivity. Then, these participants were grouped by genotype and gender, and their scores on impulsivity measures were compared. There were no significant differences between group scores on attentional, motor and non-planning impulsivity. Conclusions/Significance: Our results suggest that 5-HTTLPR genotype is not significantly associated with subsets of impulsive behavior in a non-clinical sample when measured by neuropsychological tests. These findings are discussed in terms of the sensitivity of neuropsychological tests to detect impulsivity in a non-clinical population and the role of gender and race in the relationship between the 5-HTTLPR and impulsivity.	[Lage, Guilherme M.; Matos, Lorena O.; Bastos, Marisa A. R.; Abrantes, Suzana S. C.] FUMEC Univ, Coll Human Social & Hlth Sci, Belo Horizonte, MG, Brazil; [Lage, Guilherme M.] Univ Fed Minas Gerais, Inst Biol Sci, Grad Program Neurosci, Belo Horizonte, MG, Brazil; [Malloy-Diniz, Leandro F.] Univ Fed Minas Gerais, Dept Psychol, Coll Philosophy & Human Sci, Belo Horizonte, MG, Brazil; [Correa, Humberto] Univ Fed Minas Gerais, Dept Mental Hlth, Coll Med, Belo Horizonte, MG, Brazil; [Correa, Humberto] Univ Paris Decartes, St Anne Hosp, Paris, Ile De France, France	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite	Lage, GM (corresponding author), FUMEC Univ, Coll Human Social & Hlth Sci, Belo Horizonte, MG, Brazil.	menezeslage@gmail.com	Malloy-Diniz, Leandro/D-7829-2013; Correa, Humberto/B-6497-2009; Lage, Guilherme/F-4355-2011; Malloy-Diniz, Leandro Fernandes/AAR-4025-2021	Malloy-Diniz, Leandro/0000-0002-6606-1354; Correa, Humberto/0000-0003-4327-6413; Lage, Guilherme/0000-0001-8296-3676; Malloy-Diniz, Leandro Fernandes/0000-0002-6606-1354	Instituto Nacional de Ciencia e Tecnologia de Medicina Molecular (INCT/CNPq/MCT, FAPEMIG); CNPq [473674/2009-2]; FAPEMIG [PPM 00141-10]	Instituto Nacional de Ciencia e Tecnologia de Medicina Molecular (INCT/CNPq/MCT, FAPEMIG)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by Instituto Nacional de Ciencia e Tecnologia de Medicina Molecular (INCT/CNPq/MCT, FAPEMIG; http://www.medicina.ufmg.br/molecular/), CNPq grant #473674/2009-2 (http://www.cnpq.br/) and FAPEMIG Project PPM 00141-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; Booij L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011255; Clark L, 2005, PSYCHOPHARMACOLOGY, V182, P570, DOI 10.1007/s00213-005-0104-6; Correa H, 2004, ACTA PSYCHIAT SCAND, V110, P459, DOI 10.1111/j.1600-0447.2004.00340.x; Enticott PG, 2006, PERS INDIV DIFFER, V41, P285, DOI 10.1016/j.paid.2006.01.011; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Hu XZ, 2004, BIOL PSYCHIAT, V55, p191S; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Malloy-Diniz L, 2007, J INT NEUROPSYCH SOC, V13, P693, DOI 10.1017/S1355617707070889; Malloy-Diniz LF, 2008, REV BRAS PSIQUIATR, V30, P144, DOI 10.1590/S1516-44462008005000009; Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068; Paaver M, 2007, PSYCHOPHARMACOLOGY, V194, P545, DOI 10.1007/s00213-007-0867-z; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Roiser JP, 2007, INT J NEUROPSYCHOPH, V10, P449, DOI 10.1017/S146114570600705X; Sakado K, 2003, AM J MED GENET B, V121B, P71, DOI 10.1002/ajmg.b.20063; Salgado JV, 2009, REV BRAS PSIQUIATR, V31, P4, DOI 10.1590/S1516-44462009000100003; Swann AC, 2002, BIOL PSYCHIAT, V51, P988, DOI 10.1016/S0006-3223(01)01357-9; Umekage T, 2003, NEUROSCI LETT, V337, P13, DOI 10.1016/S0304-3940(02)01291-0; Walderhaug E, 2008, J CLIN EXP NEUROPSYC, V30, P204, DOI 10.1080/13803390701346311; Walderhaug E, 2007, BIOL PSYCHIAT, V62, P593, DOI 10.1016/j.biopsych.2007.02.012; Walderhaug E, 2010, NEUROSCI LETT, V473, P208, DOI 10.1016/j.neulet.2010.02.048	23	27	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16927	10.1371/journal.pone.0016927	http://dx.doi.org/10.1371/journal.pone.0016927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386887	Green Published, Green Submitted, gold			2022-12-25	WOS:000287931400014
J	Muturi, CN; Ouma, JO; Malele, II; Ngure, RM; Rutto, JJ; Mithofer, KM; Enyaru, J; Masiga, DK				Muturi, Catherine N.; Ouma, Johnson O.; Malele, Imna I.; Ngure, Raphael M.; Rutto, Jane J.; Mithoefer, Klaus M.; Enyaru, John; Masiga, Daniel K.			Tracking the Feeding Patterns of Tsetse Flies (Glossina Genus) by Analysis of Bloodmeals Using Mitochondrial Cytochromes Genes	PLOS ONE			English	Article							G-LONGIPENNIS DIPTERA; SPECIES IDENTIFICATION; PALLIDIPES; NGURUMAN; MEALS	Tsetse flies are notoriously difficult to observe in nature, particularly when populations densities are low. It is therefore difficult to observe them on their hosts in nature; hence their vertebrate species can very often only be determined indirectly by analysis of their gut contents. This knowledge is a critical component of the information on which control tactics can be developed. The objective of this study was to determine the sources of tsetse bloodmeals, hence investigate their feeding preferences. We used mitochondrial cytochrome c oxidase 1 (COI) and cytochrome b (cytb) gene sequences for identification of tsetse fly blood meals, in order to provide a foundation for rational decisions to guide control of trypanosomiasis, and their vectors. Glossina swynnertoni were sampled from Serengeti (Tanzania) and G. pallidipes from Kenya (Nguruman and Busia), and Uganda. Sequences were used to query public databases, and the percentage identities obtained used to identify hosts. An initial assay showed that the feeds were from single sources. Hosts identified from blood fed flies collected in Serengeti ecosystem, included buffaloes (25/40), giraffes (8/40), warthogs (3/40), elephants (3/40) and one spotted hyena. In Nguruman, where G. pallidipes flies were analyzed, the feeds were from elephants (6/13) and warthogs (5/13), while buffaloes and baboons accounted for one bloodmeal each. Only cattle blood was detected in flies caught in Busia and Uganda. Out of four flies tested in Mbita Point, Suba District in western Kenya, one had fed on cattle, the other three on the Nile monitor lizard. These results demonstrate that cattle will form an integral part of a control strategy for trypanosomiasis in Busia and Uganda, while different approaches are required for Serengeti and Nguruman ecosystems, where wildlife abound and are the major component of the tsetse fly food source.	[Muturi, Catherine N.; Mithoefer, Klaus M.; Masiga, Daniel K.] Int Ctr Insect Physiol & Ecol, Mol Biol & Biotechnol Dept, Nairobi, Kenya; [Ouma, Johnson O.; Rutto, Jane J.] Trypanosomiasis Res Ctr, Kenya Agr Res Inst, Kikuyu, Kenya; [Malele, Imna I.] Tsetse & Trypanosomiasis Res Inst, Tanga, Tanzania; [Ngure, Raphael M.] Egerton Univ, Dept Biochem & Mol Biol, Egerton, Kenya; [Enyaru, John] Makerere Univ, Dept Biochem, Kampala, Uganda	International Centre of Insect Physiology & Ecology (ICIPE); Egerton University; Makerere University	Muturi, CN (corresponding author), Int Ctr Insect Physiol & Ecol, Mol Biol & Biotechnol Dept, POB 30772, Nairobi, Kenya.	dmasiga@icipe.org	Ouma, Johnson/AAS-5044-2020	Masiga, Daniel/0000-0001-7513-0887; Malele, Imna/0000-0002-9343-7150	Bill & Melinda Gates Foundation [49042.01]; International Atomic Energy Agency [15617]; Biosciences East and Central Africa Network, BecANET [BecA 2/2007]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); International Atomic Energy Agency(International Atomic Energy Agency); Biosciences East and Central Africa Network, BecANET	This study was funded by the Bill & Melinda Gates Foundation (www.gatesfoundation.org) Grant Number 49042.01; the International Atomic Energy Agency (www.iaea.org) Research Contract Number 15617; and Biosciences East and Central Africa Network, BecANET (hub.africabiosciences.org), Grant Number BecA 2/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy S, 2003, VET PARASITOL, V115, P125, DOI 10.1016/S0304-4017(03)00203-6; Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAYLIS M, 1993, B ENTOMOL RES, V83, P145, DOI 10.1017/S0007485300034635; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Brightwell R, 1997, B ENTOMOL RES, V87, P349, DOI 10.1017/S0007485300037378; Burkett-Cadena ND, 2008, AM J TROP MED HYG, V79, P809, DOI 10.4269/ajtmh.2008.79.809; CHALLIER A, 1973, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V11, P251; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Clausen PH, 1998, MED VET ENTOMOL, V12, P169, DOI 10.1046/j.1365-2915.1998.00097.x; DRANSFIELD RD, 1992, TSETSE CONTROL TRAIN, V4; Drummond A.J, 2010, GENEIOUS, V5, P3; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; JORDAN AM, 1995, J AM MOSQUITO CONTR, V11, P249; KAARE TM, 2007, TRAVEL MED INFECT DI, V5, P117; Kgori PM, 2006, ACTA TROP, V99, P184, DOI 10.1016/j.actatropica.2006.07.007; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Lindh JM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000474; Ng'ayo Musa O, 2005, Kinetoplastid Biol Dis, V4, P5, DOI 10.1186/1475-9292-4-5; Njiokou F, 2004, ACTA TROP, V91, P117, DOI 10.1016/j.actatropica.2004.03.006; Omolo MO, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000435; Ouma JO, 2006, MED VET ENTOMOL, V20, P138, DOI 10.1111/j.1365-2915.2006.00609.x; Pepin J, 2001, ADV PARASIT, V49, P71, DOI 10.1016/S0065-308X(01)49038-5; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rayaisse JB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000632; REINHARDT E, 2002, TRAVAILLER ENSEMBLE; ROGERS D, 1973, Acta Tropica, V30, P24; RURANGIRWA FR, 1986, ACTA TROP, V43, P379; Sambrook J., 2001, MOL CLONING LAB MANU; SASAKI H, 1995, J MED ENTOMOL, V32, P390, DOI 10.1093/jmedent/32.3.390; Schofield CJ, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-24; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; STAAK C, 1986, TROP MED PARASITOL, V37, P59; Steuber S, 2005, PARASITOL RES, V97, P247, DOI 10.1007/s00436-005-1410-y; Tarimo-Nesbitt RA, 1999, VET PARASITOL, V81, P107, DOI 10.1016/S0304-4017(98)00194-0; TEMPELIS CH, 1975, J MED ENTOMOL, V11, P635, DOI 10.1093/jmedent/11.6.635; TORBJORN E, 2007, MOL PHYLOGENET EVOL, V43, P530; Wamwiri FN, 2007, ANN TROP MED PARASIT, V101, P225, DOI 10.1179/136485907X156979; WEITZ B, 1963, B WORLD HEALTH ORGAN, V28, P711; WILLEMSE LPM, 1994, J MED ENTOMOL, V31, P775, DOI 10.1093/jmedent/31.6.775	42	48	51	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17284	10.1371/journal.pone.0017284	http://dx.doi.org/10.1371/journal.pone.0017284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386971	Green Published, Green Submitted, gold			2022-12-25	WOS:000287931400048
J	Yao, S; Sucheston, LE; Millen, AE; Johnson, CS; Trump, DL; Nesline, MK; Davis, W; Hong, CC; McCann, SE; Hwang, H; Kulkarni, S; Edge, SB; O'Connor, TL; Ambrosone, CB				Yao, Song; Sucheston, Lara E.; Millen, Amy E.; Johnson, Candace S.; Trump, Donald L.; Nesline, Mary K.; Davis, Warren; Hong, Chi-Chen; McCann, Susan E.; Hwang, Helena; Kulkarni, Swati; Edge, Stephen B.; O'Connor, Tracey L.; Ambrosone, Christine B.			Pretreatment Serum Concentrations of 25-Hydroxyvitamin D and Breast Cancer Prognostic Characteristics: A Case-Control and a Case-Series Study	PLOS ONE			English	Article							DIETARY VITAMIN-D; RISK; EXPRESSION; CELLS; CALCIUM; WOMEN; PREVENTION; PHENOTYPE; PATHWAYS; SUBTYPES	Background: Results from epidemiologic studies on the relationship between vitamin D and breast cancer risk are inconclusive. It is possible that vitamin D may be effective in reducing risk only of specific subtypes due to disease heterogeneity. Methods and Findings: In case-control and case-series analyses, we examined serum concentrations of 25-hydroxyvitamin D (25OHD) in relation to breast cancer prognostic characteristics, including histologic grade, estrogen receptor (ER), and molecular subtypes defined by ER, progesterone receptor (PR) and HER2, among 579 women with incident breast cancer and 574 controls matched on age and time of blood draw enrolled in the Roswell Park Cancer Institute from 2003 to 2008. We found that breast cancer cases had significantly lower 25OHD concentrations than controls (adjusted mean, 22.8 versus 26.2 ng/mL, p < 0.001). Among premenopausal women, 25OHD concentrations were lower in those with high-versus low-grade tumors, and ER negative versus ER positive tumors (p <= 0.03). Levels were lowest among women with triple-negative cancer (17.5 ng/mL), significantly different from those with luminal A cancer (24.5 ng/mL, p = 0.002). In case-control analyses, premenopausal women with 25OHD concentrations above the median had significantly lower odds of having triple-negative cancer (OR = 0.21, 95% CI = 0.08-0.53) than those with levels below the median; and every 10 ng/mL increase in serum 25OHD concentrations was associated with a 64% lower odds of having triple-negative cancer (OR = 0.36, 95% CI = 0.22-0.56). The differential associations by tumor subtypes among premenopausal women were confirmed in case-series analyses. Conclusion: In our analyses, higher serum levels of 25OHD were associated with reduced risk of breast cancer, with associations strongest for high grade, ER negative or triple negative cancers in premenopausal women. With further confirmation in large prospective studies, these findings could warrant vitamin D supplementation for reducing breast cancer risk, particularly those with poor prognostic characteristics among premenopausal women.	[Yao, Song; Sucheston, Lara E.; Nesline, Mary K.; Davis, Warren; Hong, Chi-Chen; McCann, Susan E.; Ambrosone, Christine B.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Millen, Amy E.] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA; [Johnson, Candace S.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Trump, Donald L.; O'Connor, Tracey L.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Hwang, Helena] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Kulkarni, Swati; Edge, Stephen B.] Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Yao, S (corresponding author), Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA.	song.yao@roswellpark.org	Yao, Song/A-2534-2012	Yao, Song/0000-0001-9442-1313	Breast Cancer Research Foundation; Department of Defense [W81XWH-08-1-0223]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by the Breast Cancer Research Foundation (C. B. A.), and a fellowship from the Department of Defense Breast Cancer Research Program (W81XWH-08-1-0223) (S.Y.). The Roswell Park Cancer Institute DataBank and Biorepository is a CCSG Shared Resource (NIH P30 CA016056-27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, INT J CANCER, V124, P250, DOI 10.1002/ijc.23904; Abbas S, 2008, CARCINOGENESIS, V29, P93, DOI 10.1093/carcin/bgm240; Abbas S, 2007, NUTR CANCER, V59, P54, DOI 10.1080/01635580701390223; Ahn J, 2008, JNCI-J NATL CANCER I, V100, P796, DOI 10.1093/jnci/djn152; Ambrosone CB, 2006, CANCER EPIDEM BIOMAR, V15, P1575, DOI 10.1158/1055-9965.EPI-06-0628; Artaza JN, 2009, J ENDOCRINOL, V200, P207, DOI 10.1677/JOE-08-0241; Banwell CM, 2006, CLIN CANCER RES, V12, P2004, DOI 10.1158/1078-0432.CCR-05-1218; Bertone-Johnson ER, 2009, ANN EPIDEMIOL, V19, P462, DOI 10.1016/j.annepidem.2009.01.003; Bertone-Johnson ER, 2005, CANCER EPIDEM BIOMAR, V14, P1991, DOI 10.1158/1055-9965.EPI-04-0722; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen PZ, 2010, BREAST CANCER RES TR, V121, P469, DOI 10.1007/s10549-009-0593-9; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Gandini S., 2010, INT J CANC; Giovannucci E, 2010, J STEROID BIOCHEM, V121, P349, DOI 10.1016/j.jsbmb.2010.03.085; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3757, DOI 10.1200/JCO.2008.20.0725; IARC, 2008, VIT D CANC; Knight JA, 2010, CANCER CAUSE CONTROL, V21, P479, DOI 10.1007/s10552-009-9466-0; Kuper H, 2009, CANCER EPIDEM BIOMAR, V18, P2558, DOI 10.1158/1055-9965.EPI-09-0449; Kwan ML, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2261; Li HJ, 2007, PLOS MED, V4, P562, DOI 10.1371/journal.pmed.0040103; Lin J, 2007, ARCH INTERN MED, V167, P1050, DOI 10.1001/archinte.167.10.1050; Lopes N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-483; Ma HY, 2010, CANCER RES, V70, P575, DOI 10.1158/0008-5472.CAN-09-3460; Matthews D, 2010, J STEROID BIOCHEM, V121, P362, DOI 10.1016/j.jsbmb.2010.03.061; McCullough ML, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2356; McCullough ML, 2005, CANCER EPIDEM BIOMAR, V14, P2898, DOI 10.1158/1055-9965.EPI-05-0611; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Neuhouser ML, 2008, AM J CLIN NUTR, V88, P133, DOI 10.1093/ajcn/88.1.133; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Palmieri C, 2006, J CLIN PATHOL, V59, P1334, DOI 10.1136/jcp.2006.042747; Pendas-Franco N, 2007, DIFFERENTIATION, V75, P193, DOI 10.1111/j.1432-0436.2006.00131.x; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rainville Christa, 2009, Cases J, V2, P8390, DOI 10.4076/1757-1626-2-8390; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Swami S, 2000, CLIN CANCER RES, V6, P3371; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Welsh J, 2004, AM J CLIN NUTR, V80, p1721S, DOI 10.1093/ajcn/80.6.1721S; Welsh J, 2007, ACTA PHARMACOL SIN, V28, P1373, DOI 10.1111/j.1745-7254.2007.00700.x; Yin L, 2010, EUR J CANCER, V46, P2196, DOI 10.1016/j.ejca.2010.03.037; Zinser GM, 2005, J STEROID BIOCHEM, V97, P153, DOI 10.1016/j.jsbmb.2005.06.024	41	78	78	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17251	10.1371/journal.pone.0017251	http://dx.doi.org/10.1371/journal.pone.0017251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386992	Green Published, Green Submitted, gold			2022-12-25	WOS:000287931400044
J	Fan, B; Onteru, SK; Du, ZQ; Garrick, DJ; Stalder, KJ; Rothschild, MF				Fan, Bin; Onteru, Suneel K.; Du, Zhi-Qiang; Garrick, Dorian J.; Stalder, Kenneth J.; Rothschild, Max F.			Genome-Wide Association Study Identifies Loci for Body Composition and Structural Soundness Traits in Pigs	PLOS ONE			English	Article							DIVERGENT SELECTION; GENETIC VALUE; MUSCLE; GROWTH; PREDICTION; FATNESS; BONE; EXPRESSION; SKELETAL; SEQUENCE	Background: The recent completion of the swine genome sequencing project and development of a high density porcine SNP array has made genome-wide association (GWA) studies feasible in pigs. Methodology/Principal Findings: Using Illumina's PorcineSNP60 BeadChip, we performed a pilot GWA study in 820 commercial female pigs phenotyped for backfat, loin muscle area, body conformation in addition to feet and leg (FL) structural soundness traits. A total of 51,385 SNPs were jointly fitted using Bayesian techniques as random effects in a mixture model that assumed a known large proportion (99.5%) of SNPs had zero effect. SNP annotations were implemented through the Sus scrofa Build 9 available from pig Ensembl. We discovered a number of candidate chromosomal regions, and some of them corresponded to QTL regions previously reported. We not only have identified some well-known candidate genes for the traits of interest, such as MC4R (for backfat) and IGF2 (for loin muscle area), but also obtained novel promising genes, including CHCHD3 (for backfat), BMP2 (for loin muscle area, body size and several FL structure traits), and some HOXA family genes (for overall leg action). The candidate regions responsible for body conformation and FL structure soundness did not overlap greatly which implied that these traits were controlled by different genes. Functional clustering analyses classified the genes into categories related to bone and cartilage development, muscle growth and development or the insulin pathway suggesting the traits are regulated by common pathways or gene networks that exert roles at different spatial and temporal stages. Conclusions/Significance: This study is one of the earliest GWA reports on important quantitative traits in pigs, and the findings will contribute to the further biological function analysis of the identified candidate genes and potential utilization of them in marker assisted selection.	[Fan, Bin; Onteru, Suneel K.; Du, Zhi-Qiang; Garrick, Dorian J.; Stalder, Kenneth J.; Rothschild, Max F.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Fan, Bin; Onteru, Suneel K.; Du, Zhi-Qiang; Garrick, Dorian J.; Stalder, Kenneth J.; Rothschild, Max F.] Iowa State Univ, Ctr Integrated Anim Genom, Ames, IA USA; [Fan, Bin] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China; [Fan, Bin] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan, Peoples R China	Iowa State University; Iowa State University; Huazhong Agricultural University; Huazhong Agricultural University	Fan, B (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	mfrothsc@iastate.edu	Garrick, Dorian/Q-3239-2019; Garrick, Dorian/P-9628-2019; STALDER, Kenneth/I-3781-2019	Garrick, Dorian/0000-0001-8640-5372; STALDER, Kenneth/0000-0001-9540-681X	National Pork Board and Newsham Choice Genetics, State of Iowa and Hatch	National Pork Board and Newsham Choice Genetics, State of Iowa and Hatch	This work was supported in part by the National Pork Board and Newsham Choice Genetics, State of Iowa and Hatch funding, and The College of Agriculture and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S2-S2; ALBARELLA U, 2007, PIGS HUMAN 10 000 YE; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berg F, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-17; Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; Dayton W R, 2008, J Anim Sci, V86, pE217, DOI 10.2527/jas.2007-0456; DRAPER DD, 1992, GENET SEL EVOL, V24, P363, DOI 10.1051/gse:19920406; DRAPER DD, 1991, AM J VET RES, V52, P164; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fan B, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-14; Favier B, 1997, MOL HUM REPROD, V3, P115, DOI 10.1093/molehr/3.2.115; Fernando RL, 2004, GENETICS, V166, P611, DOI 10.1534/genetics.166.1.611; Fernando RL, 2008, GENSEL USER MANUAL P; Feugang JM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-176; Gianola D, 2006, GENETICS, V173, P1761, DOI 10.1534/genetics.105.049510; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006676; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ibanez-Escriche N, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-12; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Kim CH, 2005, MOL CELL BIOL, V25, P5329, DOI 10.1128/MCB.25.13.5329-5338.2005; Kim KS, 2000, MAMM GENOME, V11, P131, DOI 10.1007/s003350010025; Kirk RK, 2005, J VET MED A, V52, P423, DOI 10.1111/j.1439-0442.2005.00747.x; Kizilkaya K, 2010, J ANIM SCI, V88, P544, DOI 10.2527/jas.2009-2064; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Meshkani R, 2007, CLIN CHEM, V53, P1585, DOI 10.1373/clinchem.2007.088146; Meuwissen THE, 2001, GENETICS, V157, P1819; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P678, DOI 10.1006/bbrc.2001.4379; NIKKILA M, 2008, HERITABILITIES GENET; Park HB, 2002, ANIM GENET, V33, P155, DOI 10.1046/j.1365-2052.2002.00824.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian J, 1999, BIOCHEM J, V341, P315, DOI 10.1042/0264-6021:3410315; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rothschild MF, 2007, INT J BIOL SCI, V3, P192; Settles M, 2009, ANIM GENET, V40, P655, DOI 10.1111/j.1365-2052.2009.01896.x; Snelling WM, 2010, J ANIM SCI, V88, P837, DOI 10.2527/jas.2009-2257; Solberg TR, 2008, J ANIM SCI, V86, P2447, DOI 10.2527/jas.2007-0010; Stalder K. J., 2004, Pig News and Information, V25, p53N; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; SUN X, 2010, BMC P IN PRESS; Toosi A, 2010, J ANIM SCI, V88, P32, DOI 10.2527/jas.2009-1975; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Verbyla KL, 2009, GENET RES, V91, P307, DOI 10.1017/S0016672309990243; VERHAEGHE J, 2002, PRINCIPLES BONE BIOL, P549; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wood SH, 2009, IMMUNOGENETICS, V61, P765, DOI 10.1007/s00251-009-0402-y	54	149	164	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e14726	10.1371/journal.pone.0014726	http://dx.doi.org/10.1371/journal.pone.0014726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383979	gold, Green Published, Green Submitted			2022-12-25	WOS:000287761700004
J	Mannes, AM; Seiler, A; Bosello, V; Maiorino, M; Conrad, M				Mannes, Alexander M.; Seiler, Alexander; Bosello, Valentina; Maiorino, Matilde; Conrad, Marcus			Cysteine mutant of mammalian GPx4 rescues cell death induced by disruption of the wild-type selenoenzyme	FASEB JOURNAL			English	Article						PHGPx; apoptosis; proliferation; redox regulation; selenocysteine	HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; THIOREDOXIN REDUCTASE; TARGETED DISRUPTION; OXIDATIVE DAMAGE; MOUSE; MECHANISMS; GENE; PEROXIREDOXINS; PURIFICATION; SPECIFICITY	Selenoproteins are expressed in many organisms, including bacteria, insects, fish, and mammals. Yet, it has remained obscure why some organisms rely on selenoproteins while others, like yeast and plants, express Cys-containing homologues. This study addressed the possible advantage of selenocysteine (Sec) vs. Cys in the essential selenoprotein glutathione peroxidase 4 (GPx4), using 4-hydroxy-tamoxifen-inducible Cre-excision of loxP-flanked GPx4 alleles in murine cells. Previously, it was shown that GPx4 disruption caused rapid cell death, which was prevented by alpha-tocopherol. Results presented herein demonstrate that the expression of wild-type (WT) GPx4 and its Sec/Cys (U46C) mutant rescued cell death of GPx4(-/-) cells, whereas the Sec/Ser (U46S) mutant failed. Notably, the specific activity of U46C was decreased by similar to 90% and was indistinguishable from U46S-expressing and mock-transfected cells. Hence, the U46C mutant prevented apoptosis despite hardly measurable in vitro activity. Doxycycline-inducible expression revealed that minute amounts of either U46C or WT GPx4 prevented cell death, albeit WT GPx4 was more efficient. Interestingly, at the same expression level, proliferation was promoted in U46C-expressing cells but attenuated in WT-expressing cells. In summary, both catalytic efficiency and the expression level of GPx4 control the balance between cell survival and proliferation.-Mannes, A. M., Seiler, A., Bosello, V., Maiorino, M., Conrad, M. Cysteine mutant of mammalian GPx4 rescues cell death induced by disruption of the wild-type selenoenzyme. FASEB J. 25, 2135-2144 (2011). www.fasebj.org	[Conrad, Marcus] Helmholtz Zentrum Munchen, Inst Dev Genet, D-85764 Neuherberg, Germany; [Mannes, Alexander M.; Seiler, Alexander; Conrad, Marcus] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Clin Mol Biol & Tumor Genet, Munich, Germany; [Bosello, Valentina; Maiorino, Matilde] Univ Padua, Dept Biol Chem, Padua, Italy; [Conrad, Marcus] German Ctr Neurodegenerat Dis, DZNE, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Padua; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Conrad, M (corresponding author), Helmholtz Zentrum Munchen, Inst Dev Genet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	marcus.conrad@helmholtz-muenchen.de	Conrad, Marcus/E-8792-2015	Conrad, Marcus/0000-0003-1140-5612; bosello travain, valentina/0000-0003-4659-1873	Deutsche Forschungsgemeinschaft (DFG) [CO 291/2-3, SPP1190]; Universita' di Padova Progetto di Ateneo [CPDA087343/08]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Universita' di Padova Progetto di Ateneo	The authors thank Georg W. Bornkamm and Fulvio Ursini for fruitful discussions and Heidi Forster for excellent technical assistance. The authors are grateful to Drs. Rob Chapman and Simon Laws for critically reading the manuscript. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) CO 291/2-3 (to M. C.), by the DFG-Priority Programme SPP1190 (to M. C.), and by Universita' di Padova Progetto di Ateneo CPDA087343/08 (to M.M.).	Allmang C, 2009, BBA-GEN SUBJECTS, V1790, P1415, DOI 10.1016/j.bbagen.2009.03.003; Arner ESJ, 2010, EXP CELL RES, V316, P1296, DOI 10.1016/j.yexcr.2010.02.032; Bornkamm GW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni137; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Conrad M, 2005, MOL CELL BIOL, V25, P7637, DOI 10.1128/MCB.25.17.7637-7644.2005; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Conrad M, 2010, P NATL ACAD SCI USA, V107, P15774, DOI 10.1073/pnas.1007909107; Conrad M, 2010, ANTIOXID REDOX SIGN, V12, P851, DOI 10.1089/ars.2009.2912; Conrad M, 2009, BBA-GEN SUBJECTS, V1790, P1575, DOI 10.1016/j.bbagen.2009.05.001; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Fomenko DE, 2008, MOL CELLS, V26, P228; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Handy DE, 2009, J BIOL CHEM, V284, P11913, DOI 10.1074/jbc.M900392200; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Hondal RJ, 2011, AMINO ACIDS, V41, P73, DOI 10.1007/s00726-010-0494-6; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Kim IY, 1997, P NATL ACAD SCI USA, V94, P418, DOI 10.1073/pnas.94.2.418; Liang HY, 2009, J BIOL CHEM, V284, P30836, DOI 10.1074/jbc.M109.032839; Loscalzo J, 2008, CELL METAB, V8, P182, DOI 10.1016/j.cmet.2008.08.004; Lu J, 2009, FASEB J, V23, P2394, DOI 10.1096/fj.08-127662; MAIORINO M, 1990, METHOD ENZYMOL, V186, P448; MAIORINO M, 1995, BIOL CHEM H-S, V376, P651, DOI 10.1515/bchm3.1995.376.11.651; Maiorino M, 2007, J MOL BIOL, V365, P1033, DOI 10.1016/j.jmb.2006.10.033; ROCHER C, 1992, EUR J BIOCHEM, V205, P955, DOI 10.1111/j.1432-1033.1992.tb16862.x; ROVERI A, 1994, METHOD ENZYMOL, V233, P202; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; THOMAS JP, 1990, J BIOL CHEM, V265, P454; Toppo S, 2008, ANTIOXID REDOX SIGN, V10, P1501, DOI 10.1089/ars.2008.2057; Toppo S, 2009, BBA-GEN SUBJECTS, V1790, P1486, DOI 10.1016/j.bbagen.2009.04.007; Tosatto SCE, 2008, ANTIOXID REDOX SIGN, V10, P1515, DOI 10.1089/ars.2008.2055; Trujillo M, 2006, J BIOL CHEM, V281, P20555, DOI 10.1074/jbc.M601008200; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; URSINI F, 1987, CHEM PHYS LIPIDS, V44, P255, DOI 10.1016/0009-3084(87)90053-3; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6	39	30	30	2	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2011	25	7					2135	2144		10.1096/fj.10-177147	http://dx.doi.org/10.1096/fj.10-177147			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21402720				2022-12-25	WOS:000292242200006
J	Lee, BC; Lobanov, AV; Marino, SM; Kaya, A; Seravalli, J; Hatfield, DL; Gladyshev, VN				Lee, Byung Cheon; Lobanov, Alexey V.; Marino, Stefano M.; Kaya, Alaattin; Seravalli, Javier; Hatfield, Dolph L.; Gladyshev, Vadim N.			A 4-Selenocysteine, 2-Selenocysteine Insertion Sequence (SECIS) Element Methionine Sulfoxide Reductase from Metridium senile Reveals a Non-catalytic Function of Selenocysteines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMATE DEHYDROGENASE; ESCHERICHIA-COLI; SELENOPROTEIN SYNTHESIS; GLYCINE REDUCTASE; IDENTIFICATION; SELENIUM; GENE; EXPRESSION; PROTEINS; FAMILY	Selenocysteine (Sec) residues occur in thiol oxidoreductase families, and functionally characterized selenoenzymes typically have a single Sec residue used directly for redox catalysis. However, how new Sec residues evolve and whether non-catalytic Sec residues exist in proteins is not known. Here, we computationally identified several genes with multiple Sec insertion sequence (SECIS) elements, one of which was a methionine-R-sulfoxide reductase (MsrB) homolog from Metridium senile that has four in-frame UGA codons and two nearly identical SECIS elements. One of the UGA codons corresponded to the conserved catalytic Sec or Cys in MsrBs, whereas the three other UGA codons evolved recently and had no homologs with Sec or Cys in these positions. Metabolic Se-75 labeling showed that all four in-frame UGA codons supported Sec insertion and that both SECIS elements were functional and collaborated in Sec insertion at each UGA codon. Interestingly, recombinant M. senile MsrB bound iron, and further analyses suggested the possibility of binding an iron-sulfur cluster by the protein. These data show that Sec residues may appear transiently in genes containing SECIS elements and be adapted for non-catalytic functions.	[Lee, Byung Cheon; Lobanov, Alexey V.; Marino, Stefano M.; Kaya, Alaattin; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, Boston, MA 02115 USA; [Kaya, Alaattin; Seravalli, Javier] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Kaya, Alaattin; Seravalli, Javier] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gladyshev, VN (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, New Res Bldg,Rm 435,77 Ave Louis Pasteur, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Gladyshev, Vadim N/J-6187-2013; Kaya, Alaattin/T-6427-2017; Gladyshev, Vadim N/A-9894-2013	Kaya, Alaattin/0000-0002-6132-5197; Gladyshev, Vadim/0000-0002-0372-7016; Lee, Byung Cheon/0000-0003-1467-1940	National Institutes of Health [AG021518, GM061603]; Center for Cancer Research, NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010767, ZIABC010889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants AG021518 and GM061603 (to V. N. G.) and by the Intramural Research Program at the Center for Cancer Research, NCI, National Institutes of Health (to D. L. H.).	Almendra MJ, 1999, BIOCHEMISTRY-US, V38, P16366, DOI 10.1021/bi990069n; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Berry SM, 2002, J AM CHEM SOC, V124, P2084, DOI 10.1021/ja0169163; CONE JE, 1976, P NATL ACAD SCI USA, V73, P2659, DOI 10.1073/pnas.73.8.2659; Conrad M, 2010, ANTIOXID REDOX SIGN, V12, P851, DOI 10.1089/ars.2009.2912; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Fletcher JE, 2001, RNA, V7, P1442; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Fomenko DE, 2009, J BIOL CHEM, V284, P5986, DOI 10.1074/jbc.M805770200; GARCIA GE, 1992, J BACTERIOL, V174, P7080, DOI 10.1128/jb.174.22.7080-7089.1992; GLADYSHEV VN, 1994, P NATL ACAD SCI USA, V91, P7708, DOI 10.1073/pnas.91.16.7708; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hoffmann PR, 2005, THYROID, V15, P769, DOI 10.1089/thy.2005.15.769; Hubert N, 1996, NUCLEIC ACIDS RES, V24, P464, DOI 10.1093/nar/24.3.464; Hubert N, 1996, BIOCHIMIE, V78, P590, DOI 10.1016/S0300-9084(96)80005-8; Jiang L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-289; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Kryukov GV, 1999, J BIOL CHEM, V274, P33888, DOI 10.1074/jbc.274.48.33888; Kryukov GV, 2002, METHOD ENZYMOL, V347, P84; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kumaraswamy E, 2000, J BIOL CHEM, V275, P35540, DOI 10.1074/jbc.M004014200; LEE BJ, 1989, J BIOL CHEM, V264, P9724; Lee BC, 2009, BBA-GEN SUBJECTS, V1790, P1471, DOI 10.1016/j.bbagen.2009.04.014; Lobanov AV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r198; Lobanov AV, 2006, NUCLEIC ACIDS RES, V34, P4012, DOI 10.1093/nar/gkl541; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Lobanov AV, 2006, NUCLEIC ACIDS RES, V34, P496, DOI 10.1093/nar/gkj450; ROCHER C, 1992, EUR J BIOCHEM, V205, P955, DOI 10.1111/j.1432-1033.1992.tb16862.x; Shchedrina VA, 2007, P NATL ACAD SCI USA, V104, P13919, DOI 10.1073/pnas.0703448104; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; STADTMAN TC, 1991, BIOFACTORS, V3, P21; Taskov K, 2005, NUCLEIC ACIDS RES, V33, P2227, DOI 10.1093/nar/gki507; URSINI F, 1995, METHOD ENZYMOL, V252, P38; Wessjohann LA, 2007, BIOL CHEM, V388, P997, DOI 10.1515/BC.2007.138; Zhang Y, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r37; ZINONI F, 1986, P NATL ACAD SCI USA, V83, P4650, DOI 10.1073/pnas.83.13.4650	40	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18747	18755		10.1074/jbc.M111.229807	http://dx.doi.org/10.1074/jbc.M111.229807			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21393246	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000290785700047
J	Fukunaka, A; Kurokawa, Y; Teranishi, F; Sekler, I; Oda, K; Ackland, ML; Faundez, V; Hiromura, M; Masuda, S; Nagao, M; Enomoto, S; Kambe, T				Fukunaka, Ayako; Kurokawa, Yayoi; Teranishi, Fumie; Sekler, Israel; Oda, Kimimitsu; Ackland, M. Leigh; Faundez, Victor; Hiromura, Makoto; Masuda, Seiji; Nagao, Masaya; Enomoto, Shuichi; Kambe, Taiho			Tissue Nonspecific Alkaline Phosphatase Is Activated via a Two-step Mechanism by Zinc Transport Complexes in the Early Secretory Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE CELLS; ENDOPLASMIC-RETICULUM; FUNCTIONAL-CHARACTERIZATION; QUALITY-CONTROL; PROTEIN; HYPOPHOSPHATASIA; DEGRADATION; HOMEOSTASIS; EXPRESSION; MEMBRANE	A number of enzymes become functional by binding to zinc during their journey through the early secretory pathway. The zinc transporters (ZnTs) located there play important roles in this step. We have previously shown that two zinc transport complexes, ZnT5/ZnT6 heterodimers and ZnT7 homo-oligomers, are required for the activation of alkaline phosphatases, by converting them from the apo- to the holo-form. Here, we investigated the molecular mechanisms of this activation. ZnT1 and ZnT4 expressed in chicken DT40 cells did not contribute to the activation of tissue nonspecific alkaline phosphatase ( TNAP). The reduced activity of TNAP in DT40 cells deficient in both ZnT complexes was not restored by zinc supplementation nor by exogenous expression of other ZnTs that increase the zinc content in the secretory pathway. Moreover, we showed that expression of ZnT5/ZnT6 heterodimers reconstituted with zinc transport-incompetent ZnT5 mutant failed to restore TNAP activity but could stabilize the TNAP protein as the apo- form, regardless of zinc status. These findings demonstrate that TNAP is activated not simply by passive zinc binding but by an elaborate two-step mechanism via protein stabilization followed by enzyme conversion from the apo- to the holo-form with zinc loaded by ZnT complexes in the early secretory pathway.	[Fukunaka, Ayako; Hiromura, Makoto; Enomoto, Shuichi] RIKEN Kobe Inst, Ctr Mol Imaging Sci, Kobe, Hyogo 6500047, Japan; [Sekler, Israel] Ben Gurion Univ Negev, Dept Physiol, IL-84105 Beer Sheva, Israel; [Oda, Kimimitsu] Niigata Univ, Grad Sch Med & Dent Sci, Div Biochem, Niigata 9518514, Japan; [Ackland, M. Leigh] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic 3125, Australia; [Faundez, Victor] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Fukunaka, Ayako; Kurokawa, Yayoi; Teranishi, Fumie; Masuda, Seiji; Nagao, Masaya; Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan; [Enomoto, Shuichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	RIKEN; Ben Gurion University; Niigata University; Deakin University; Emory University; Kyoto University; Okayama University	Kambe, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan.	kambe1@kais.kyoto-u.ac.jp	Ackland, M Leigh/L-5086-2018; Enomoto, Shuichi/G-8524-2012; ENOMOTO, Shuichi/B-2333-2011	Ackland, M Leigh/0000-0002-7474-6556; Kambe, Taiho/0000-0001-9757-063X; Faundez, Victor/0000-0002-2114-5271	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Nestle Nutrition Council, Japan; Danone Institute of Japan; Central Miso Research Institute; Kieikai Research Foundation; Yamada Bee Farm grant for Honeybee Research; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Fuji Foundation for Protein Research; Grants-in-Aid for Scientific Research [23380059] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Nestle Nutrition Council, Japan; Danone Institute of Japan(Danone Nutricia); Central Miso Research Institute; Kieikai Research Foundation(Kieikai Research Foundation); Yamada Bee Farm grant for Honeybee Research; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Fuji Foundation for Protein Research(Fuji Foundation for Protein Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to A. F. and T. K.), grants-in-aid for scientific research from the Ministry of Health, Labor, and Welfare of Japan (to S. E.), Nestle Nutrition Council, Japan, 2010 research grant from Danone Institute of Japan, Central Miso Research Institute, Kieikai Research Foundation, Yamada Bee Farm grant for Honeybee Research, Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Fuji Foundation for Protein Research (to T. K.).	Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ellis CD, 2005, J BIOL CHEM, V280, P28811, DOI 10.1074/jbc.M505500200; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Fang Y, 2008, MOL BIOL CELL, V19, P1295, DOI 10.1091/mbc.E07-08-0805; Fujimori A, 2001, EMBO J, V20, P5513, DOI 10.1093/emboj/20.19.5513; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Fukushi M, 1998, BIOCHEM BIOPH RES CO, V246, P613, DOI 10.1006/bbrc.1998.8674; Fukushi-Irie M, 2000, BIOCHEM J, V348, P633, DOI 10.1042/0264-6021:3480633; Haremaki T, 2007, P NATL ACAD SCI USA, V104, P12029, DOI 10.1073/pnas.0701413104; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Inoue K, 2002, HUM MOL GENET, V11, P1775, DOI 10.1093/hmg/11.15.1775; Ishida Y, 2003, J BIOCHEM, V134, P63, DOI 10.1093/jb/mvg114; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Jirakulaporn T, 2004, J BIOL CHEM, V279, P27807, DOI 10.1074/jbc.M401210200; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Lazarczyk M, 2008, J EXP MED, V205, P35, DOI 10.1084/jem.20071311; Levy S, 2009, J BIOL CHEM, V284, P32434, DOI 10.1074/jbc.M109.058842; Matsuura W, 2009, BIOSCI BIOTECH BIOCH, V73, P1142, DOI 10.1271/bbb.80910; Michalczyk AA, 2002, BIOCHEM J, V364, P105, DOI 10.1042/bj3640105; MILLAN JL, 1995, CRIT REV CL LAB SCI, V32, P1, DOI 10.3109/10408369509084680; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; Purkerson JM, 2007, KIDNEY INT, V71, P103, DOI 10.1038/sj.ki.5002020; Qiao W, 2009, MOL MICROBIOL, V72, P320, DOI 10.1111/j.1365-2958.2009.06644.x; Qin ZY, 2006, FASEB J, V20, P334, DOI 10.1096/fj.05-4564fje; Ranaldi G, 2002, AM J PHYSIOL-RENAL, V283, pF1365, DOI 10.1152/ajprenal.00094.2002; Salazar G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005896; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Szigeti R, 2006, J INVEST DERMATOL, V126, P2370, DOI 10.1038/sj.jid.5700447; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Turner AJ, 1997, FASEB J, V11, P355, DOI 10.1096/fasebj.11.5.9141502; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Whyte MP, 2010, ANN NY ACAD SCI, V1192, P190, DOI 10.1111/j.1749-6632.2010.05387.x	46	51	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.227173	http://dx.doi.org/10.1074/jbc.M111.227173			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21402707	hybrid, Green Published			2022-12-25	WOS:000290022800074
J	Hakvoort, TBM; Moerland, PD; Frijters, R; Sokolovic, A; Labruyere, WT; Vermeulen, JLM; van Themaat, EVL; Breit, TM; Wittink, FRA; van Kampen, AHC; Verhoeven, AJ; Lamers, WH; Sokolovic, M				Hakvoort, Theodorus B. M.; Moerland, Perry D.; Frijters, Raoul; Sokolovic, Aleksandar; Labruyere, Wilhelmina T.; Vermeulen, Jacqueline L. M.; van Themaat, Emiel Ver Loren; Breit, Timo M.; Wittink, Floyd R. A.; van Kampen, Antoine H. C.; Verhoeven, Arthur J.; Lamers, Wouter H.; Sokolovic, Milka			Interorgan Coordination of the Murine Adaptive Response to Fasting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; SKELETAL-MUSCLE ATROPHY; AMINO ACID METABOLISM; GENE-EXPRESSION; ADIPONECTIN RECEPTORS; PROLONGED STARVATION; KETONE-BODIES; PROTEIN; CHOLESTEROL; HOMEOSTASIS	Starvation elicits a complex adaptive response in an organism. No information on transcriptional regulation of metabolic adaptations is available. We, therefore, studied the gene expression profiles of brain, small intestine, kidney, liver, and skeletal muscle in mice that were subjected to 0-72 h of fasting. Functional-category enrichment, text mining, and network analyses were employed to scrutinize the overall adaptation, aiming to identify responsive pathways, processes, and networks, and their regulation. The observed transcriptomics response did not follow the accepted "carbohydrate-lipid-protein" succession of expenditure of energy substrates. Instead, these processes were activated simultaneously in different organs during the entire period. The most prominent changes occurred in lipid and steroid metabolism, especially in the liver and kidney. They were accompanied by suppression of the immune response and cell turnover, particularly in the small intestine, and by increased proteolysis in the muscle. The brain was extremely well protected from the sequels of starvation. 60% of the identified overconnected transcription factors were organ-specific, 6% were common for 4 organs, with nuclear receptors as protagonists, accounting for almost 40% of all transcriptional regulators during fasting. The common transcription factors were PPAR alpha, HNF4 alpha, GCR alpha, AR (androgen receptor), SREBP1 and -2, FOXOs, EGR1, c-JUN, c-MYC, SP1, YY1, and ETS1. Our data strongly suggest that the control of metabolism in four metabolically active organs is exerted by transcription factors that are activated by nutrient signals and serves, at least partly, to prevent irreversible brain damage.	[Hakvoort, Theodorus B. M.; Sokolovic, Aleksandar; Labruyere, Wilhelmina T.; Vermeulen, Jacqueline L. M.; Lamers, Wouter H.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 BK Amsterdam, Netherlands; [Moerland, Perry D.; van Themaat, Emiel Ver Loren; van Kampen, Antoine H. C.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands; [Moerland, Perry D.; Breit, Timo M.; van Kampen, Antoine H. C.] Netherlands Bioinformat Ctr, NL-1105 AZ Amsterdam, Netherlands; [Frijters, Raoul] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, Computat Drug Discovery Grp, NL-6525 GA Nijmegen, Netherlands; [Breit, Timo M.; Wittink, Floyd R. A.] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, MicroArray Dept, NL-1090 GE Amsterdam, Netherlands; [Breit, Timo M.; Wittink, Floyd R. A.] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, Integrat Bioinformat Unit, NL-1090 GE Amsterdam, Netherlands; [van Kampen, Antoine H. C.] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1105 AZ Amsterdam, Netherlands; [Verhoeven, Arthur J.; Sokolovic, Milka] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; University of Amsterdam; University of Amsterdam; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Sokolovic, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, POB 22700, NL-1100 DE Amsterdam, Netherlands.	m.sokolovic@amc.uva.nl	Ver Loren van Themaat, Emiel/F-2564-2012; Lamers, Wouter H./D-2965-2012; Sokolovic, Milka/C-2115-2009; Sokolovic, Milka/AAY-1618-2020; Moerland, Perry/AAG-1425-2020	Sokolovic, Milka/0000-0002-3957-4656; Moerland, Perry/0000-0002-2357-3659	Dutch Ministry of Economic Affairs [IGE01016]; Top Institute Pharma [T2-110]; Netherlands Genomics Initiative; John Emmett Foundation for Urology	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Top Institute Pharma; Netherlands Genomics Initiative; John Emmett Foundation for Urology	This study was supported by Dutch Ministry of Economic Affairs through the Innovative Oriented Research Program on Genomics (IOP Genomics IGE01016) and by a grant T2-110 from Top Institute Pharma.; Bioinformatics was part of the BioRange program of the Netherlands Bioinformatics Center, supported by an Investment Grants for Knowledge Infrastructure grant through the Netherlands Genomics Initiative. The microarrays were provided and hybridizations were performed by MicroArray Department, Swammerdam Institute for Life Sciences, Faculty of Science, University of Amsterdam. We are indebted to Dr. N. Dabhoiwala (Department of Urology, Academic Medical Center, University of Amsterdam) and the John Emmett Foundation for Urology for financing a part of the microarray analysis. We thank D. Wehkamp and Dr. L. Gilhuijs-Pederson for input into the initial design of the experiment, Dr. M. Swat for useful suggestions for data visualization, Dr. Y. Nikolsky for support with MetaCore analyses, Dr. S. M. Houten for beta-hydroxybutyrate measurement, and Prof. Dr. A. K. Groen and Dr. C. A. Argmann for constructive discussions.	Alako BTF, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-51; Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auer RN, 2004, METAB BRAIN DIS, V19, P169, DOI 10.1023/B:MEBR.0000043967.78763.5b; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Caloin M, 2004, AM J PHYSIOL-ENDOC M, V287, pE790, DOI 10.1152/ajpendo.00414.2003; Cao PR, 2005, INT J BIOCHEM CELL B, V37, P2088, DOI 10.1016/j.biocel.2004.11.010; Carter ME, 2007, CURR BIOL, V17, pR113, DOI 10.1016/j.cub.2007.01.008; CHEREL Y, 1991, CLIN SCI, V81, P611, DOI 10.1042/cs0810611; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Dobbin K, 2002, BIOINFORMATICS, V18, P1438, DOI 10.1093/bioinformatics/18.11.1438; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ekins S, 2005, DRUG METAB DISPOS, V33, P474, DOI 10.1124/dmd.104.002717; FELIG P, 1969, J CLIN INVEST, V48, P584, DOI 10.1172/JCI106017; FELIG P, 1970, AM J CLIN NUTR, V23, P986; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Freeman MR, 2007, STEROIDS, V72, P210, DOI 10.1016/j.steroids.2006.11.012; Frijters R, 2008, NUCLEIC ACIDS RES, V36, pW406, DOI 10.1093/nar/gkn215; Frijters R, 2007, PHARMACOGENOMICS, V8, P1521, DOI 10.2217/14622416.8.11.1521; GARBER AJ, 1974, J CLIN INVEST, V54, P981, DOI 10.1172/JCI107839; Gatti D, 2007, HEPATOLOGY, V46, P548, DOI 10.1002/hep.21682; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guillod-Maximin E, 2009, J ENDOCRINOL, V200, P93, DOI 10.1677/JOE-08-0348; Habold C, 2006, PFLUG ARCH EUR J PHY, V451, P749, DOI 10.1007/s00424-005-1506-3; Habold C, 2005, J PHYSIOL-LONDON, V566, P575, DOI 10.1113/jphysiol.2005.085217; Hagen RM, 2010, FEBS LETT, V584, P2689, DOI 10.1016/j.febslet.2010.04.004; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; HANNAFORD MC, 1982, AM J PHYSIOL, V243, pE251, DOI 10.1152/ajpendo.1982.243.3.E251; He YJ, 2010, J BIOL CHEM, V285, P9516, DOI 10.1074/jbc.M109.092429; Hegardt FG, 1998, BIOCHIMIE, V80, P803, DOI 10.1016/S0300-9084(00)88874-4; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; HENRIKSSON J, 1990, EUR J CLIN NUTR, V44, P55; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Jonker MJ, 2009, CARCINOGENESIS, V30, P1805, DOI 10.1093/carcin/bgp190; JUREVICS H, 1995, J NEUROCHEM, V64, P895; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Korade Z, 2009, J NEUROSCI RES, V87, P866, DOI 10.1002/jnr.21917; Koutnikova H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000591; Lamont KR, 2010, ADV CANCER RES, V107, P137, DOI 10.1016/S0065-230X(10)07005-3; Langeveld M, 2009, PROG LIPID RES, V48, P196, DOI 10.1016/j.plipres.2009.03.002; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; LEMAHO Y, 1981, AM J PHYSIOL, V241, pE342, DOI 10.1152/ajpendo.1981.241.5.E342; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mithieux G, 2005, CURR OPIN CLIN NUTR, V8, P445, DOI 10.1097/01.mco.0000172587.17385.aa; Mounier C, 2006, CAN J PHYSIOL PHARM, V84, P713, DOI 10.1139/Y05-152; Nikolsky Y, 2005, DRUG DISCOV TODAY, V10, P653, DOI 10.1016/S1359-6446(05)03420-3; Nikolsky Y, 2009, METHODS MOL BIOL, V563, P177, DOI 10.1007/978-1-60761-175-2_10; Ning YX, 2009, ATHEROSCLEROSIS, V204, P114, DOI 10.1016/j.atherosclerosis.2008.09.006; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; OWEN OE, 1969, J CLIN INVEST, V48, P574, DOI 10.1172/JCI106016; Owen OE, 1998, AM J CLIN NUTR, V68, P12, DOI 10.1093/ajcn/68.1.12; Piruzian E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-41; RANDLE PJ, 1994, J CELL BIOCHEM, V55, P1, DOI 10.1002/jcb.240550002; REICHARD GA, 1974, J CLIN INVEST, V53, P508, DOI 10.1172/JCI107584; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rogatsky I, 2006, TISSUE ANTIGENS, V68, P1, DOI 10.1111/j.1399-0039.2006.00599.x; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; SCHREIBER RA, 1984, DRUG ALCOHOL DEPEN, V13, P151, DOI 10.1016/0376-8716(84)90055-3; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SIGLER MH, 1975, J CLIN INVEST, V55, P377, DOI 10.1172/JCI107941; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sodersten P, 2006, HORM BEHAV, V50, P572, DOI 10.1016/j.yhbeh.2006.06.030; Sokolovic M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-361; Sokolovic M, 2010, J HEPATOL, V52, P737, DOI 10.1016/j.jhep.2009.11.028; Sokolovic M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-528; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; VanItallie TB, 2003, NUTR REV, V61, P327, DOI 10.1301/nr.2003.oct.327-341; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Vesely PW, 2009, MUTAT RES-REV MUTAT, V682, P7, DOI 10.1016/j.mrrev.2009.01.001; Wallner B, 2009, PROG NEURO-PSYCHOPH, V33, P391, DOI 10.1016/j.pnpbp.2009.02.006; Xiao XQ, 2004, ENDOCRINOLOGY, V145, P5344, DOI 10.1210/en.2004-0721; Yang G, 2009, J BIOL CHEM, V284, P3719, DOI 10.1074/jbc.M804965200; Zajac-Kaye M, 2001, LUNG CANCER-J IASLC, V34, pS43, DOI 10.1016/S0169-5002(01)00343-9	84	38	38	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.216986	http://dx.doi.org/10.1074/jbc.M110.216986			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21393243	Green Published, hybrid			2022-12-25	WOS:000290022800071
J	Wilson, LS; Baillie, GS; Pritchard, LM; Umana, B; Terrin, A; Zaccolo, M; Houslay, MD; Maurice, DH				Wilson, Lindsay S.; Baillie, George S.; Pritchard, Lisa M.; Umana, Bibiana; Terrin, Anna; Zaccolo, Manuela; Houslay, Miles D.; Maurice, Donald H.			A Phosphodiesterase 3B-based Signaling Complex Integrates Exchange Protein Activated by cAMP 1 and Phosphatidylinositol 3-Kinase Signals in Human Arterial Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; PHOSPHOINOSITIDE 3-KINASE; REGULATORY SUBUNIT; PROGENITOR CELLS; KINASE-A; PATHWAYS; PI3K; RAS; ANGIOGENESIS; STIMULATION	Enzymes of the phosphodiesterase 3 (PDE3) and PDE4 families each regulate the activities of both protein kinases A (PKAs) and exchange proteins activated by cAMP (EPACs) in cells of the cardiovascular system. At present, the mechanisms that allow selected PDEs to individually regulate the activities of these two effectors are ill understood. The objective of this study was to determine how a specific PDE3 variant, namely PDE3B, interacts with and regulates EPAC1-based signaling in human arterial endothelial cells (HAECs). Using several biochemical approaches, we show that PDE3B and EPAC1 bind directly through protein-protein interactions. By knocking down PDE3B expression or by antagonizing EPAC1 binding with PDE3B, we show that PDE3B regulates cAMP binding by its tethered EPAC1. Interestingly, we also show that PDE3B binds directly to p84, a PI3K gamma regulatory subunit, and that this interaction allows PI3K gamma recruitment to the PDE3B-EPAC1 complex. Of potential cardiovascular importance, we demonstrate that PDE3B-tethered EPAC1 regulates HAEC PI3K gamma activity and that this allows dynamic cAMP-dependent regulation of HAEC adhesion, spreading, and tubule formation. We identify and molecularly characterize a PDE3B-based "signalosome" that integrates cAMP-and PI3K gamma-encoded signals and show how this signal integration regulates HAEC functions of importance in angiogenesis.	[Umana, Bibiana; Maurice, Donald H.] Queens Univ, Dept Pharmacol & Toxicol, Kingston, ON K7L 3N6, Canada; [Wilson, Lindsay S.; Pritchard, Lisa M.; Maurice, Donald H.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada; [Baillie, George S.; Terrin, Anna; Zaccolo, Manuela; Houslay, Miles D.] Univ Glasgow, Inst Biomed & Life Sci, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland	Queens University - Canada; McMaster University; Queens University - Canada; University of Glasgow	Maurice, DH (corresponding author), Queens Univ, Dept Pharmacol & Toxicol, Botterell Hall,A208, Kingston, ON K7L 3N6, Canada.	mauriced@queensu.ca	Zaccolo, Manuela/B-3802-2011; Zaccolo, Manuela/AAP-6706-2020; Houslay, Miles/AAM-5281-2020; Maurice, Donald/AAE-9332-2019; Houslay, Miles D/A-6825-2011	Zaccolo, Manuela/0000-0002-0934-3662; Houslay, Miles/0000-0002-3826-8091	Canadian Institutes of Health Research [MOP57699]; Medical Research Council [G0600765]; Fondation Leducq [06CVD02]; MRC [G0600765] Funding Source: UKRI	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fondation Leducq(Leducq Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Canadian Institutes of Health Research Grant MOP57699 (to D. H. M.), Medical Research Council Grant G0600765 (to M. D. H. and G. S. B.), and Fondation Leducq Grant 06CVD02.	Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Bjorgo E, 2010, MOL CELL BIOL, V30, P1660, DOI 10.1128/MCB.00696-09; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Carmona G, 2008, BLOOD, V111, P2640, DOI 10.1182/blood-2007-04-086231; Chavakis E, 2008, CIRC RES, V102, P942, DOI 10.1161/CIRCRESAHA.107.164376; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Damilano F, 2010, ANN NY ACAD SCI, V1188, P39, DOI 10.1111/j.1749-6632.2009.05081.x; De Jesus ML, 2006, J BIOL CHEM, V281, P21837, DOI 10.1074/jbc.M604156200; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Johnson C, 2007, ONCOGENE, V26, P7049, DOI 10.1038/sj.onc.1210504; Kurig B, 2009, P NATL ACAD SCI USA, V106, P20312, DOI 10.1073/pnas.0905506106; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; McCahill A, 2005, CELL SIGNAL, V17, P1158, DOI 10.1016/j.cellsig.2005.04.003; Netherton SJ, 2005, MOL PHARMACOL, V67, P263, DOI 10.1124/mol.104.004853; Netherton SJ, 2007, CIRC RES, V101, P768, DOI 10.1161/CIRCRESAHA.106.146159; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Pawson CT, 2010, NAT STRUCT MOL BIOL, V17, P653, DOI 10.1038/nsmb.1843; Rampersad SN, 2010, J BIOL CHEM, V285, P33614, DOI 10.1074/jbc.M110.140004; Raymond DR, 2007, CELL SIGNAL, V19, P2507, DOI 10.1016/j.cellsig.2007.08.005; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020; Suire S, 2002, CURR BIOL, V12, P1068, DOI 10.1016/S0960-9822(02)00933-8; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Voigt P, 2006, J BIOL CHEM, V281, P9977, DOI 10.1074/jbc.M512502200; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	32	42	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.217026	http://dx.doi.org/10.1074/jbc.M110.217026			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21393242	hybrid, Green Published			2022-12-25	WOS:000290022800067
J	Guo, LW; Ruoho, AE				Guo, Lian-Wang; Ruoho, Arnold E.			N-terminal Half of the cGMP Phosphodiesterase gamma-Subunit Contributes to Stabilization of the GTPase-accelerating Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSDUCIN ALPHA-SUBUNIT; CYCLIC-GMP PHOSPHODIESTERASE; ROD OUTER SEGMENTS; PHOTORECEPTOR G-PROTEIN; CATALYTIC SUBUNITS; CRYSTAL-STRUCTURE; STRUCTURAL DETERMINANTS; EFFECTOR-BINDING; HIGH-AFFINITY; SITES	In the visual signal terminating transition state, the cyclic GMP phosphodiesterase (PDE6) inhibitory gamma-subunit (PDE gamma) stimulates GTPase activity of the alpha-subunit of transducin (alpha t) by enhancing the interaction between alpha t and its regulator of G protein signaling (RGS9), which is constitutively bound to the type 5 G protein beta-subunit (beta 5). Although it is known from a crystal structure of partial molecules that the PDE gamma C terminus contacts with both alpha t and RGS9, contributions from the intrinsically disordered PDE gamma N-terminal half remain unclear. In this study, we were able to investigate this issue using a photolabel transfer strategy that allows for mapping the interface of full-length proteins. We observed label transfer from PDE gamma N-terminal positions 50, 30, and 16 to RGS9 center dot beta 5 in the GTPase-accelerating protein (GAP) complex composed of PDE gamma center dot alpha t center dot RGS9 center dot beta 5. In support of a direct PDE gamma N-terminal interaction with RGS9 center dot beta 5, the PDE gamma N-terminal peptide PDE gamma(1-61) abolished label transfer to RGS9 center dot beta 5, and another N-terminal peptide, PDE gamma (10-30), disassembled the GAP complex in label transfer and pulldown experiments. Furthermore, we determined that the PDE gamma C-terminal interaction with alpha t was enhanced whereas the N-terminal interaction was weakened upon changing the alpha t conformation from the signaling state to the transition state. This "rearrangement" of PDE gamma domain interactions with alpha t appears to facilitate the interaction of the PDE gamma N-terminal half with RGS9 center dot beta 5 and hence its contribution to optimal stabilization of the GAP complex.	[Guo, Lian-Wang; Ruoho, Arnold E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Guo, LW (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, 1300 Univ Ave, Madison, WI 53706 USA.	lianwangguo@wisc.edu			National Institutes of Health [GM-33138]; Retina Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Retina Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-33138 (to A. E. R. and L.-W. G. and a Retina Research Foundation Edwin and Dorothy Gamewell Professorship (to A. E. R.).	Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; ARTEMYEV NO, 1992, BIOCHEM J, V283, P273, DOI 10.1042/bj2830273; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; Artemyev NO, 1997, BIOCHEMISTRY-US, V36, P4188, DOI 10.1021/bi963002y; BAEHR W, 1979, J BIOL CHEM, V254, P1669; Baker SA, 2006, BIOCHEMISTRY-US, V45, P10690, DOI 10.1021/bi060376a; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; BROWN RL, 1992, BIOCHEMISTRY-US, V31, P5918, DOI 10.1021/bi00140a031; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Cote R. H., 2008, VISUAL TRANSDUCTION, P141; FAUROBERT E, 1993, EMBO J, V12, P4191, DOI 10.1002/j.1460-2075.1993.tb06103.x; FUNG BKK, 1983, J BIOL CHEM, V258, P503; Grant JE, 2006, J BIOL CHEM, V281, P6194, DOI 10.1074/jbc.M509511200; Guo LW, 2007, PROTEIN EXPRES PURIF, V51, P187, DOI 10.1016/j.pep.2006.07.012; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; Guo LW, 2010, J BIOL CHEM, V285, P15209, DOI 10.1074/jbc.M109.086116; Guo LW, 2008, CURR PROTEIN PEPT SC, V9, P611, DOI 10.2174/138920308786733930; Guo LW, 2005, BIOCONJUGATE CHEM, V16, P685, DOI 10.1021/bc050016k; Guo LW, 2005, J BIOL CHEM, V280, P12585, DOI 10.1074/jbc.M410380200; He W, 2000, J BIOL CHEM, V275, P37093, DOI 10.1074/jbc.M006982200; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; Martemyanov KA, 2004, METHOD ENZYMOL, V390, P196; Martemyanov KA, 2002, J BIOL CHEM, V277, P32843, DOI 10.1074/jbc.M205170200; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; McEntaffer RL, 1999, BIOCHEMISTRY-US, V38, P4931, DOI 10.1021/bi982636x; Mittal R, 1996, SCIENCE, V271, P1413, DOI 10.1126/science.271.5254.1413; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov H, 2004, VISION RES, V44, P2437, DOI 10.1016/j.visres.2004.05.013; Natochin M, 1998, J BIOL CHEM, V273, P21808, DOI 10.1074/jbc.273.34.21808; Natochin M, 1997, J BIOL CHEM, V272, P17444, DOI 10.1074/jbc.272.28.17444; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Shankaranarayanan A, 2008, J BIOL CHEM, V283, P34923, DOI 10.1074/jbc.M805860200; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; SKIBA NP, 1995, J BIOL CHEM, V270, P13210, DOI 10.1074/jbc.270.22.13210; Skiba NP, 1999, J BIOL CHEM, V274, P8770, DOI 10.1074/jbc.274.13.8770; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Skiba NP, 2001, J BIOL CHEM, V276, P37365, DOI 10.1074/jbc.M106431200; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SLEPAK VZ, 1995, J BIOL CHEM, V270, P14319, DOI 10.1074/jbc.270.24.14319; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105; Sowa ME, 2000, P NATL ACAD SCI USA, V97, P1483, DOI 10.1073/pnas.030409597; Sowa ME, 2001, NAT STRUCT BIOL, V8, P234, DOI 10.1038/84974; Tsang SH, 2007, J PHYSIOL-LONDON, V579, P303, DOI 10.1113/jphysiol.2006.121772; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010; Zhang XJ, 2010, J BIOL CHEM, V285, P4455, DOI 10.1074/jbc.M109.057406	49	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15260	15267		10.1074/jbc.M110.210567	http://dx.doi.org/10.1074/jbc.M110.210567			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21393250	Green Published, hybrid			2022-12-25	WOS:000289788300057
J	Depinay, N; Franetich, JF; Gruner, AC; Mauduit, M; Chavatte, JM; Luty, AJF; van Gemert, GJ; Sauerwein, RW; Siksik, JM; Hannoun, L; Mazier, D; Snounou, G; Renia, L				Depinay, Nadya; Franetich, Jean Francois; Gruener, Anne Charlotte; Mauduit, Marjorie; Chavatte, Jean-Marc; Luty, Adrian J. F.; van Gemert, Geert-Jan; Sauerwein, Robert W.; Siksik, Jean-Michel; Hannoun, Laurent; Mazier, Dominique; Snounou, Georges; Renia, Laurent			Inhibitory Effect of TNF-alpha on Malaria Pre-Erythrocytic Stage Development: Influence of Host Hepatocyte/Parasite Combinations	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PLASMODIUM CIRCUMSPOROZOITE PROTEIN; RECOMBINANT INTERFERON-GAMMA; IN-VITRO; PLASMA-PROTEINS; FACTOR RECEPTOR; HEPATIC PHASE; LIVER STAGES; SERUM-LEVELS; CRUCIAL ROLE	Background: The liver stages of malaria parasites are inhibited by cytokines such as interferon-gamma or Interleukin (IL)-6. Binding of these cytokines to their receptors at the surface of the infected hepatocytes leads to the production of nitric oxide (NO) and radical oxygen intermediates (ROI), which kill hepatic parasites. However, conflicting results were obtained with TNF-alpha possibly because of differences in the models used. We have reassessed the role of TNF-alpha in the different cellular systems used to study the Plasmodium pre-erythrocytic stages. Methods and Findings: Human or mouse TNF-alpha were tested against human and rodent malaria parasites grown in vitro in human or rodent primary hepatocytes, or in hepatoma cell lines. Our data demonstrated that TNF-alpha treatment prevents the development of malaria pre-erythrocytic stages. This inhibitory effect however varies with the infecting parasite species and with the nature and origin of the cytokine and hepatocytes. Inhibition was only observed for all parasite species tested when hepatocytes were pre-incubated 24 or 48 hrs before infection and activity was directed only against early hepatic parasite. We further showed that TNF-alpha a inhibition was mediated by a soluble factor present in the supernatant of TNF-alpha stimulated hepatocytes but it was not related to NO or ROI. Treatment TNF-alpha prevents the development of human and rodent malaria pre-erythrocytic stages through the activity of a mediator that remains to be identified. Conclusions: Treatment TNF-alpha prevents the development of human and rodent malaria pre-erythrocytic stages through the activity of a mediator that remains to be identified. However, the nature of the cytokine-host cell-parasite combination must be carefully considered for extrapolation to the human infection.	[Depinay, Nadya; Gruener, Anne Charlotte; Mauduit, Marjorie; Renia, Laurent] Univ Paris 05, CNRS, Inst Cochin, Dept Immunol,UMR 8104, Paris, France; [Depinay, Nadya; Gruener, Anne Charlotte; Mauduit, Marjorie; Renia, Laurent] INSERM, U567, Paris, France; [Franetich, Jean Francois; Mazier, Dominique; Snounou, Georges] INSERM, UMRS 945, Paris, France; [Franetich, Jean Francois; Mazier, Dominique; Snounou, Georges] Univ Paris 06, Fac Med Pitie Salpetriere, Paris, France; [Gruener, Anne Charlotte; Mauduit, Marjorie; Renia, Laurent] Biopolis, Singapore Immunol Network, Agcy Sci Technol & Res A STAR, Singapore, Singapore; [Chavatte, Jean-Marc; Snounou, Georges] Museum Natl Hist Nat, CNRS, Equipe Parasitol Comparee & Modeles Expt USM0307, IFR101, Paris, France; [Luty, Adrian J. F.; van Gemert, Geert-Jan; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Siksik, Jean-Michel; Hannoun, Laurent] Univ Pitie Salpetriere, AP HP, Ctr Hosp, Serv Chirurg Digest,Hepatobilio Pancreat & Transp, Paris, France; [Mazier, Dominique; Snounou, Georges] Univ Pitie Salpetriere, AP HP, Ctr Hosp, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Depinay, N (corresponding author), Univ Paris 05, CNRS, Inst Cochin, Dept Immunol,UMR 8104, Paris, France.	renia_laurent@immunol.a-star.edu.sg	Luty, Adrian/CAH-2547-2022; Snounou, Georges/F-3352-2011; Franetich, Jean-François/GZA-9674-2022; Renia, Laurent/E-2117-2011; Gruner, Anne Charlotte/C-1841-2012; Sauerwein, Robert/C-8519-2013	Snounou, Georges/0000-0002-6133-6398; Renia, Laurent/0000-0003-0349-1557; Luty, Adrian John Frederick/0000-0001-8830-3425; Chavatte, Jean-Marc/0000-0002-0003-541X	Agency for Science, Technology and Research (A*STAR); Institut National de la Sante et de la Recherche Medicale (INSERM); European community [LSH-CT-2005-01299]	Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); European community(European Commission)	This work was supported by intramural grants from the Agency for Science, Technology and Research (A*STAR) and Institut National de la Sante et de la Recherche Medicale (INSERM), and by a grant from the European community (MALINV contract number LSH-CT-2005-01299) (L.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amani V, 2000, EUR J IMMUNOL, V30, P1646, DOI 10.1002/1521-4141(200006)30:6&lt;1646::AID-IMMU1646&gt;3.0.CO;2-0; BAUMANN H, 1987, J IMMUNOL, V139, P4122; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; CALVOCALLE JM, 1994, EXP PARASITOL, V79, P362, DOI 10.1006/expr.1994.1098; CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4; CLARK IA, 1987, J IMMUNOL, V139, P3493; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Cotgreave I A, 1997, Adv Pharmacol, V38, P205; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Fey G H, 1990, Prog Liver Dis, V9, P89; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Gego A, 2006, ANTIMICROB AGENTS CH, V50, P1586, DOI 10.1128/AAC.50.4.1586-1589.2006; GHEZZI P, 1988, LYMPHOKINE RES, V7, P157; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Hernandez-Valladares M, 2006, EXP PARASITOL, V114, P271, DOI 10.1016/j.exppara.2006.04.003; HOLLINGDALE MR, 1983, AM J TROP MED HYG, V32, P682, DOI 10.4269/ajtmh.1983.32.682; KARUNAWEERA ND, 1992, P NATL ACAD SCI USA, V89, P3200, DOI 10.1073/pnas.89.8.3200; KERN P, 1989, AM J MED, V87, P139, DOI 10.1016/S0002-9343(89)80688-6; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; Lee HJ, 2007, J MOL BIOL, V369, P967, DOI 10.1016/j.jmb.2007.03.072; MAGIELSKAZERO D, 1988, BIOCHEM INT, V17, P17; Marussig M, 1997, INT IMMUNOL, V9, P1817, DOI 10.1093/intimm/9.12.1817; MAZIER D, 1990, IMMUNOL LETT, V25, P65, DOI 10.1016/0165-2478(90)90093-6; MAZIER D, 1990, B WORLD HEALTH ORGAN, V68, P126; Mordmuller BG, 1997, EUR CYTOKINE NETW, V8, P29; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mota MM, 2000, EXP PARASITOL, V96, P257, DOI 10.1006/expr.2000.4570; NUDELMAN S, 1989, J IMMUNOL, V143, P996; NUSSLER A, 1991, INT IMMUNOL, V3, P317, DOI 10.1093/intimm/3.4.317; NUSSLER A, 1991, EUR J IMMUNOL, V21, P227, DOI 10.1002/eji.1830210134; NUSSLER A, 1991, EXP PARASITOL, V72, P1, DOI 10.1016/0014-4894(91)90114-C; PIED S, 1989, INFECT IMMUN, V57, P278, DOI 10.1128/IAI.57.1.278-282.1989; PIED S, 1991, PARASITE IMMUNOL, V13, P211, DOI 10.1111/j.1365-3024.1991.tb00276.x; PIED S, 1995, PARASITE, V2, P263, DOI 10.1051/parasite/1995023263; PONNUDURAI T, 1983, PARASITOLOGY, V87, P439, DOI 10.1017/S0031182000082962; RENIA L, 1990, EUR J IMMUNOL, V20, P1445, DOI 10.1002/eji.1830200706; SCHOFIELD L, 1988, 10TH M SCI WORK GROU, P17; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Silvie O, 2006, CELL MICROBIOL, V8, P1134, DOI 10.1111/j.1462-5822.2006.00697.x; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; SOUTHAN GJ, 1995, BRIT J PHARMACOL, V114, P510, DOI 10.1111/j.1476-5381.1995.tb13256.x; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; van de Sand C, 2005, MOL MICROBIOL, V58, P731, DOI 10.1111/j.1365-2958.2005.04888.x; Yamada Y, 1998, HEPATOLOGY, V28, P959, DOI 10.1002/hep.510280410; YAP SH, 1991, BIOCHIM BIOPHYS ACTA, V1091, P405, DOI 10.1016/0167-4889(91)90207-E	49	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17464	10.1371/journal.pone.0017464	http://dx.doi.org/10.1371/journal.pone.0017464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394207	Green Published, Green Submitted, gold			2022-12-25	WOS:000288025500015
J	Chan, JYH; Tsai, CY; Wu, CHY; Li, FCH; Dai, KY; Sun, EYH; Chan, SHH; Chang, AYW				Chan, Julie Y. H.; Tsai, Ching-Yi; Wu, Carol H. Y.; Li, Faith C. H.; Dai, Kuang-Yu; Sun, Enya Y. H.; Chan, Samuel H. H.; Chang, Alice Y. W.			Sumoylation of Hypoxia-Inducible Factor-1 alpha Ameliorates Failure of Brain Stem Cardiovascular Regulation in Experimental Brain Death	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; SYSTEMIC ARTERIAL-PRESSURE; NITRIC-OXIDE SYNTHASE; ACUTE MEVINPHOS INTOXICATION; HEART-RATE SIGNALS; FACTOR-I; VASOMOTOR COMPONENT; SPECTRAL-ANALYSIS; SUMO CONJUGATION; GENE-EXPRESSION	Background: One aspect of brain death is cardiovascular deregulation because asystole invariably occurs shortly after its diagnosis. A suitable neural substrate for mechanistic delineation of this aspect of brain death resides in the rostral ventrolateral medulla (RVLM). RVLM is the origin of a life-and-death signal that our laboratory detected from blood pressure of comatose patients that disappears before brain death ensues. At the same time, transcriptional upregulation of heme oxygenase-1 in RVLM by hypoxia-inducible factor-1 alpha (HIF-1a) plays a pro-life role in experimental brain death, and HIF-1a is subject to sumoylation activated by transient cerebral ischemia. It follows that sumoylation of HIF-1a in RVLM in response to hypoxia may play a modulatory role on brain stem cardiovascular regulation during experimental brain death. Methodology/Principal Findings: A clinically relevant animal model that employed mevinphos as the experimental insult in Sprague-Dawley rat was used. Biochemical changes in RVLM during distinct phenotypes in systemic arterial pressure spectrum that reflect maintained or defunct brain stem cardiovascular regulation were studied. Western blot analysis, EMSA, ELISA, confocal microscopy and immunoprecipitation demonstrated that drastic tissue hypoxia, elevated levels of proteins conjugated by small ubiquitin-related modifier-1 (SUMO-1), Ubc9 (the only known conjugating enzyme for the sumoylation pathway) or HIF-1 alpha, augmented sumoylation of HIF-1 alpha, nucleus-bound translocation and enhanced transcriptional activity of HIF-1 alpha in RVLM neurons took place preferentially during the pro-life phase of experimental brain death. Furthermore, loss-of-function manipulations by immunoneutralization of SUMO-1, Ubc9 or HIF-1 alpha in RVLM blunted the upregulated nitric oxide synthase I/protein kinase G signaling cascade, which sustains the brain stem cardiovascular regulatory machinery during the pro-life phase. Conclusions/Significance: We conclude that sumoylation of HIF-1 alpha in RVLM ameliorates brain stem cardiovascular regulatory failure during experimental brain death via upregulation of nitric oxide synthase I/protein kinase G signaling. This information should offer new therapeutic initiatives against this fatal eventuality.	[Chan, Julie Y. H.] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Chan, Julie Y. H.; Tsai, Ching-Yi; Wu, Carol H. Y.; Li, Faith C. H.; Dai, Kuang-Yu; Sun, Enya Y. H.; Chan, Samuel H. H.; Chang, Alice Y. W.] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital; Chang Gung Memorial Hospital	Chan, JYH (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan.	shhchan@adm.cgmh.org.tw; cgmf.kmc@gmail.com	Chan, Julie/X-5253-2019; Tsai, CY/AAV-9723-2021	Tsai, CY/0000-0002-9548-9851	National Science Council, Taiwan, Republic of China [NSC98-2321-B075-B-001, NSC97-2320-B-182A-007-MY3, NSC97-2321-B-182A-006, NSC98-2321-B-182A-003, NSC99-2321-B-182A-006]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council, Taiwan, Republic of China (NSC98-2321-B075-B-001 to J.Y.H.C.; NSC97-2320-B-182A-007-MY3 to S.H.H.C.; and NSC97-2321-B-182A-006, NSC98-2321-B-182A-003 and NSC99-2321-B-182A-006 (A.Y.W.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Beetz N, 2009, J CLIN INVEST, V119, P3597, DOI 10.1172/JCI38433; Bernhardt WM, 2007, METHOD ENZYMOL, V435, P221, DOI 10.1016/S0076-6879(07)35012-X; Berta MA, 2007, BIOCHEM BIOPH RES CO, V360, P646, DOI 10.1016/j.bbrc.2007.06.103; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Chan JYH, 2007, J PHYSIOL-LONDON, V581, P1293, DOI 10.1113/jphysiol.2007.130872; Chan JYH, 2007, J BIOL CHEM, V282, P4585, DOI 10.1074/jbc.M603394200; Chan JYH, 2005, PROG NEUROBIOL, V77, P396, DOI 10.1016/j.pneurobio.2005.11.004; Chan JYH, 2005, NEUROPHARMACOLOGY, V48, P161, DOI 10.1016/j.neuropharm.2004.08.012; Chan JYH, 2004, NEUROPHARMACOLOGY, V46, P1184, DOI 10.1016/j.neuropharm.2004.01.017; Chang AYW, 2009, SHOCK, V32, P651, DOI 10.1097/SHK.0b013e3181a71027; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Chi NC, 2004, CARDIOVASC RES, V61, P437, DOI 10.1016/j.cardiores.2003.11.033; Cimarosti H, 2008, NEUROPHARMACOLOGY, V54, P280, DOI 10.1016/j.neuropharm.2007.09.010; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Dai KY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-72; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; GILL G, 2009, GENE DEV, V18, P2046; Haupt WF, 1999, J NEUROL, V246, P432, DOI 10.1007/s004150050378; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hellwig-Burgel T, 2005, J INTERF CYTOK RES, V25, P297, DOI 10.1089/jir.2005.25.297; HUNG TP, 1995, J NEUROL NEUROSUR PS, V58, P75, DOI 10.1136/jnnp.58.1.75; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Jung F, 2000, CIRC RES, V86, P319, DOI 10.1161/01.RES.86.3.319; Kuo TBJ, 1997, AM J PHYSIOL-HEART C, V272, pH485, DOI 10.1152/ajpheart.1997.272.1.H485; Kuo TBJ, 1997, AM J PHYSIOL-HEART C, V273, pH1291, DOI 10.1152/ajpheart.1997.273.3.H1291; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Louapre P, 2005, CELL STRESS CHAPERON, V10, P17, DOI 10.1379/CSC-74R.1; LYNN J, 1981, JAMA-J AM MED ASSOC, V246, P2184; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; McLaren AT, 2007, AM J PHYSIOL-REG I, V292, pR403, DOI 10.1152/ajpregu.00403.2006; MELILLO G, 1995, J EXP MED, V182, P1683, DOI 10.1084/jem.182.6.1683; Natarajan R, 2005, BIOCHEM CELL BIOL, V83, P597, DOI 10.1139/o05-047; Pallis CA, 1983, ABC BRAIN STEM DEATH; Palmer LA, 1998, AM J PHYSIOL-LUNG C, V274, pL212, DOI 10.1152/ajplung.1998.274.2.L212; Pouyssegur J, 2006, BIOL CHEM, V387, P1337, DOI 10.1515/BC.2006.167; Rapino C, 2005, AGING CELL, V4, P177, DOI 10.1111/j.1474-9726.2005.00161.x; Rosenberger C, 2005, KIDNEY INT, V67, P531, DOI 10.1111/j.1523-1755.2005.67110.x; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; SPYER KM, 1994, J PHYSIOL-LONDON, V474, P1; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Yang CH, 1995, J PHARMACOL EXP THER, V275, P1568; Yang W, 2008, J NEUROCHEM, V106, P989, DOI 10.1111/j.1471-4159.2008.05404.x; Yen DHT, 2005, SHOCK, V23, P353, DOI 10.1097/01.shk.0000156673.44063.e8; Yen DHT, 2001, SHOCK, V15, P35, DOI 10.1097/00024382-200115010-00006; Yen DHT, 2000, CRIT CARE MED, V28, P2805, DOI 10.1097/00003246-200008000-00021; Yien HW, 1997, CRIT CARE MED, V25, P258, DOI 10.1097/00003246-199702000-00011; Yin JH, 2000, BIOCHEM BIOPH RES CO, V279, P30, DOI 10.1006/bbrc.2000.3896	54	22	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17375	10.1371/journal.pone.0017375	http://dx.doi.org/10.1371/journal.pone.0017375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390240	Green Submitted, gold, Green Published			2022-12-25	WOS:000287965200015
J	Martins, R; Silva, B; Proenca, D; Faustino, P				Martins, Rute; Silva, Bruno; Proenca, Daniela; Faustino, Paula			Differential HFE Gene Expression Is Regulated by Alternative Splicing in Human Tissues	PLOS ONE			English	Article							HEMOCHROMATOSIS PROTEIN HFE; TRANSFERRIN RECEPTOR 2; HEREDITARY HEMOCHROMATOSIS; MESSENGER-RNA; HLA-H; HEPCIDIN; LOCALIZATION; VARIANTS; CELLS	Background: The pathophysiology of HFE-derived Hereditary Hemochromatosis and the function of HFE protein in iron homeostasis remain uncertain. Also, the role of alternative splicing in HFE gene expression regulation and the possible function of the corresponding protein isoforms are still unknown. The aim of this study was to gain insights into the physiological significance of these alternative HFE variants. Methodology/Principal Findings: Alternatively spliced HFE transcripts in diverse human tissues were identified by RT-PCR, cloning and sequencing. Total HFE transcripts, as well as two alternative splicing transcripts were quantified using a realtime PCR methodology. Intracellular localization, trafficking and protein association of GFP-tagged HFE protein variants were analysed in transiently transfected HepG2 cells by immunoprecipitation and immunofluorescence assays. Alternatively spliced HFE transcripts present both level-and tissue-specificity. Concerning the exon 2 skipping and intron 4 inclusion transcripts, the liver presents the lowest relative level, while duodenum presents one of the highest amounts. The protein resulting from exon 2 skipping transcript is unable to associate with b2M and TfR1 and reveals an ER retention. Conversely, the intron 4 inclusion transcript gives rise to a truncated, soluble protein (sHFE) that is mostly secreted by cells to the medium in association with beta 2M. Conclusions/Significance: HFE gene post-transcriptional regulation is clearly affected by a tissue-dependent alternative splicing mechanism. Among the corresponding proteins, a sHFE isoform stands out, which upon being secreted into the bloodstream, may act in remote tissues. It could be either an agonist or antagonist of the full length HFE, through hepcidin expression regulation in the liver or by controlling dietary iron absorption in the duodenum.	[Martins, Rute; Silva, Bruno; Proenca, Daniela; Faustino, Paula] Inst Nacl Saude Dr Ricardo Jorge, Dept Genet, Lisbon, Portugal	Instituto Nacional de Saude Dr. Ricardo Jorge	Martins, R (corresponding author), Inst Nacl Saude Dr Ricardo Jorge, Dept Genet, Lisbon, Portugal.	paula.faustino@insa.min-saude.pt	Faustino, Paula/E-4546-2010	Faustino, Paula/0000-0002-6269-4867; Silva, Bruno/0000-0002-1452-9779	Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/SAU/GMG/64494/2006, SFRH/BD/21340/2005, SFRH/BD/60718/2009]; Programa de Financiamento Plurianual do CIGMH	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa de Financiamento Plurianual do CIGMH	This work was partially supported by Fundacao para a Ciencia e a Tecnologia (FCT; grant PTDC/SAU/GMG/64494/2006) and Programa de Financiamento Plurianual do CIGMH. RM and BS were supported by FCT fellowships (SFRH/BD/21340/2005 and SFRH/BD/60718/2009). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastin JM, 1998, BRIT J HAEMATOL, V103, P931, DOI 10.1046/j.1365-2141.1998.01102.x; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; CARTWRIGHT GE, 1979, NEW ENGL J MED, V301, P175, DOI 10.1056/NEJM197907263010402; Chen JX, 2007, J BIOL CHEM, V282, P36862, DOI 10.1074/jbc.M706720200; Chen JX, 2009, TRAFFIC, V10, P1488, DOI 10.1111/j.1600-0854.2009.00961.x; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Fleming RE, 2006, AM J PHYSIOL-GASTR L, V290, pG590, DOI 10.1152/ajpgi.00486.2005; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Griffiths WJH, 2000, QJM-MON J ASSOC PHYS, V93, P575, DOI 10.1093/qjmed/93.9.575; Gross CN, 1998, J BIOL CHEM, V273, P22068, DOI 10.1074/jbc.273.34.22068; Hviid TVF, 2006, HUM REPROD UPDATE, V12, P209, DOI 10.1093/humupd/dmi048; Jeffrey GP, 1999, BLOOD CELL MOL DIS, V25, P61, DOI 10.1006/bcmd.1999.0227; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Laham N, 2004, J CELL BIOCHEM, V91, P1130, DOI 10.1002/jcb.20015; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P2534, DOI 10.1073/pnas.94.6.2534; Parkkila S, 2000, HAEMATOLOGICA, V85, P340; Ramalingam TS, 2000, NAT CELL BIOL, V2, P953, DOI 10.1038/35046611; Rhodes DA, 1999, IMMUNOGENETICS, V49, P357, DOI 10.1007/s002510050505; Sanchez M, 2001, BLOOD CELL MOL DIS, V27, P35, DOI 10.1006/bcmd.2000.0346; Sangrouber D, 2007, J IMMUNOL METHODS, V326, P54, DOI 10.1016/j.jim.2007.07.001; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Spasic MV, 2007, BLOOD, V109, P4511, DOI 10.1182/blood-2006-07-036186; Thenie A, 2000, BLOOD CELL MOL DIS, V26, P155, DOI 10.1006/bcmd.2000.0291; Wallace DF, 2009, HEPATOLOGY, V50, P1992, DOI 10.1002/hep.23198; Walton HS, 2007, J NEUROSCI METH, V160, P294, DOI 10.1016/j.jneumeth.2006.09.022	29	16	16	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17542	10.1371/journal.pone.0017542	http://dx.doi.org/10.1371/journal.pone.0017542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21407826	gold, Green Submitted, Green Published			2022-12-25	WOS:000287965200022
J	Gu, YQ; Rospars, JP				Gu, Yuqiao; Rospars, Jean-Pierre			Dynamical Modeling of the Moth Pheromone-Sensitive Olfactory Receptor Neuron within Its Sensillar Environment	PLOS ONE			English	Article							PHOSPHOLIPASE-C-BETA; ELECTRICAL CIRCUITRY; ODOR TRANSDUCTION; ANTHERAEA-PERNYI; BOMBYX-MORI; ACTIVATION; IDENTIFICATION; MOLECULES; ANTENNAE; CURRENTS	In insects, olfactory receptor neurons (ORNs), surrounded with auxiliary cells and protected by a cuticular wall, form small discrete sensory organs - the sensilla. The moth pheromone-sensitive sensillum is a well studied example of hair-like sensillum that is favorable to both experimental and modeling investigations. The model presented takes into account both the molecular processes of ORNs, i.e. the biochemical reactions and ionic currents giving rise to the receptor potential, and the cellular organization and compartmentalization of the organ represented by an electrical circuit. The number of isopotential compartments needed to describe the long dendrite bearing pheromone receptors was determined. The transduction parameters that must be modified when the number of compartments is increased were identified. This model reproduces the amplitude and time course of the experimentally recorded receptor potential. A first complete version of the model was analyzed in response to pheromone pulses of various strengths. It provided a quantitative description of the spatial and temporal evolution of the pheromone-dependent conductances, currents and potentials along the outer dendrite and served to determine the contribution of the various steps in the cascade to its global sensitivity. A second simplified version of the model, utilizing a single depolarizing conductance and leak conductances for repolarizing the ORN, was derived from the first version. It served to analyze the effects on the sensory properties of varying the electrical parameters and the size of the main sensillum parts. The consequences of the results obtained on the still uncertain mechanisms of olfactory transduction in moth ORNs - involvement or not of G-proteins, role of chloride and potassium currents - are discussed as well as the optimality of the sensillum organization, the dependence of biochemical parameters on the neuron spatial extension and the respective contributions of the biochemical and electrical parameters to the overall neuron response.	[Gu, Yuqiao; Rospars, Jean-Pierre] INRA, UMR 1272, F-78026 Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Gu, YQ (corresponding author), INRA, UMR 1272, F-78026 Versailles, France.	rospars@versailles.inra.fr			French-British ANR BBSRC SysBio [006 01]; European FP7-ICT	French-British ANR BBSRC SysBio(French National Research Agency (ANR)); European FP7-ICT	This work was supported by French-British ANR BBSRC SysBio 006 01 "Pherosys'' (http://www.informatics.sussex.ac.uk/research/projects/PheroSys/index.php/Main_Page) and European FP7-ICT 2007 STREP Bio-ICT convergence "Neurochem'' (http://www.neurochem-project.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; BOEKHOFF I, 1990, CELL SIGNAL, V2, P49, DOI 10.1016/0898-6568(90)90032-6; BOEKHOFF I, 1990, J COMP PHYSIOL B, V160, P99, DOI 10.1007/BF00258768; BOEKHOFF I, 1993, INSECT BIOCHEM MOLEC, V23, P757, DOI 10.1016/0965-1748(93)90063-X; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chouquet B, 2010, CHEM SENSES, V35, P363, DOI 10.1093/chemse/bjq024; Cole K. S., 1972, MEMBRANE IONS IMPULS; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; DEKRAMER JJ, 1985, J NEUROSCI, V5, P2484; DEKRAMER JJ, 1984, CHEM SENSES, V8, P289, DOI 10.1093/chemse/8.3.289; DEKRAMER JJ, 1982, REGENSBURG; Fabre J-H., 1882, NOUVEAUX SOUVENIRS E; FUTRELLE RP, 1984, TRENDS NEUROSCI, V7, P116, DOI 10.1016/S0166-2236(84)80238-6; GNATZY W, 1984, CELL TISSUE RES, V235, P35; Gu YQ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000321; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Jacquin-Joly E., 2005, CURR TOP NEUROCHEM, V4, P75; Kain P, 2008, J NEUROSCI, V28, P4745, DOI 10.1523/JNEUROSCI.5306-07.2008; Kaissling K.-E., 1971, Handbook of sensory physiology, Vol. IV, P351; Kaissling K-E, 1987, RH WRIGHT LECT INSEC; Kaissling KE, 2009, J COMP PHYSIOL A, V195, P895, DOI 10.1007/s00359-009-0461-4; Kaissling KE, 2001, CHEM SENSES, V26, P125, DOI 10.1093/chemse/26.2.125; Kaissling KE, 2004, CHEM SENSES, V29, P529, DOI 10.1093/chemse/bjh057; Kaissling KE, 1998, CHEM SENSES, V23, P99, DOI 10.1093/chemse/23.1.99; Kaissling KE, 1998, CHEM SENSES, V23, P385, DOI 10.1093/chemse/23.4.385; Kaissling KE, 2004, ANIR, V6, P73, DOI DOI 10.1371/journal.pone.0152147; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Keil T.A., 1984, P477; KEIL TA, 1984, ZOOMORPHOLOGY, V104, P147, DOI 10.1007/BF00312133; Keil Thomas A., 1999, P5; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Laue M, 1997, CELL TISSUE RES, V288, P149, DOI 10.1007/s004410050802; Laue M, 1997, INT J INSECT MORPHOL, V26, P217, DOI 10.1016/S0020-7322(97)00023-8; Lucas P, 2002, CHEM SENSES, V27, P599, DOI 10.1093/chemse/27.7.599; Maida R, 2000, NEUROREPORT, V11, P1773, DOI 10.1097/00001756-200006050-00035; Minor AV, 2003, J COMP PHYSIOL A, V189, P221, DOI 10.1007/s00359-003-0394-2; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; PAIN J, 1961, ANN ABEILLE, V4, P1; Pezier A, 2007, CHEM SENSES, V32, P305, DOI 10.1093/chemse/bjl059; Pezier A, 2010, J NEUROSCI, V30, P6323, DOI 10.1523/JNEUROSCI.0261-10.2010; Pophof B, 2002, CHEM SENSES, V27, P435, DOI 10.1093/chemse/27.5.435; Rospars JP, 2007, BIOSYSTEMS, V89, P101, DOI 10.1016/j.biosystems.2006.05.015; Rospars JP, 2010, CHINESE J PHYSIOL, V53, P364, DOI 10.4077/CJP.2010.AMM038; Rospars JP, 2003, CHEM SENSES, V28, P509, DOI 10.1093/chemse/28.6.509; Rospars JP, 1996, J COMPUT NEUROSCI, V3, P51, DOI 10.1007/BF00158337; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; SCHNEIDER D, 1968, NATURWISSENSCHAFTEN, V55, P395, DOI 10.1007/BF00593307; Silbering AF, 2010, EMBO REP, V11, P173, DOI 10.1038/embor.2010.8; STENGL M, 1994, J COMP PHYSIOL A, V174, P187; Stengl M, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00133; Thurm U., 1980, P735; Tuckwell H. C, 1988, INTRO THEORETICAL NE, V1; Tuckwell H. C., 1988, INTRO THEORETICAL NE, V2; Tuckwell HC, 1996, J THEOR BIOL, V181, P25, DOI 10.1006/jtbi.1996.0111; Vermeulen A, 1996, B MATH BIOL, V58, P493, DOI 10.1007/BF02460594; Vermeulen A, 2004, EUR BIOPHYS J BIOPHY, V33, P633, DOI 10.1007/s00249-004-0405-4; Vermeulen A, 2001, NEUROCOMPUTING, V38, P1011, DOI 10.1016/S0925-2312(01)00368-X; Vermeulen A, 2001, EUR BIOPHYS J BIOPHY, V29, P587, DOI 10.1007/s002490000116; Vermeulen A, 1998, J COMPUT NEUROSCI, V5, P243, DOI 10.1023/A:1008826827728; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010; ZACK C, 1979, THESIS LUDWIGMAXIMIL; ZUFALL F, 1991, J NEUROSCI, V11, P956; ZUFALL F, 1991, P NATL ACAD SCI USA, V88, P8520, DOI 10.1073/pnas.88.19.8520	70	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17422	10.1371/journal.pone.0017422	http://dx.doi.org/10.1371/journal.pone.0017422			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399691	Green Published, gold, Green Submitted			2022-12-25	WOS:000287933300023
J	Fischer, H; Scherz, J; Szabo, S; Mildner, M; Benarafa, C; Torriglia, A; Tschachler, E; Eckhart, L				Fischer, Heinz; Scherz, Jennifer; Szabo, Sandra; Mildner, Michael; Benarafa, Charaf; Torriglia, Alicia; Tschachler, Erwin; Eckhart, Leopold			DNase 2 Is the Main DNA-Degrading Enzyme of the Stratum Corneum	PLOS ONE			English	Article							DEOXYRIBONUCLEASE-II; PSEUDOMONAS-AERUGINOSA; SALINE EXTRACTS; HUMAN EPIDERMIS; INHIBITOR; DEGRADATION; APOPTOSIS; SKIN; CASPASE-14; DIFFERENTIATION	The cornified layer, the stratum corneum, of the epidermis is an efficient barrier to the passage of genetic material, i.e. nucleic acids. It contains enzymes that degrade RNA and DNA which originate from either the living part of the epidermis or from infectious agents of the environment. However, the molecular identities of these nucleases are only incompletely known at present. Here we performed biochemical and genetic experiments to determine the main DNase activity of the stratum corneum. DNA degradation assays and zymographic analyses identified the acid endonucleases L-DNase II, which is derived from serpinB1, and DNase 2 as candidate DNases of the cornified layer of the epidermis. siRNA-mediated knockdown of serpinB1 in human in vitro skin models and the investigation of mice deficient in serpinB1a demonstrated that serpinB1-derived L-DNase II is dispensable for epidermal DNase activity. By contrast, knockdown of DNase 2, also known as DNase 2a, reduced DNase activity in human in vitro skin models. Moreover, the genetic ablation of DNase 2a in the mouse was associated with the lack of acid DNase activity in the stratum corneum in vivo. The degradation of endogenous DNA in the course of cornification of keratinocytes was not impaired by the absence of DNase 2. Taken together, these data identify DNase 2 as the predominant DNase on the mammalian skin surface and indicate that its activity is primarily targeted to exogenous DNA.	[Fischer, Heinz; Scherz, Jennifer; Szabo, Sandra; Mildner, Michael; Tschachler, Erwin; Eckhart, Leopold] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Benarafa, Charaf] Univ Bern, Theodor Kocher Inst, Bern, Switzerland; [Torriglia, Alicia] Ctr Rech Cordeliers, INSERM, UMR 872, Paris, France; [Tschachler, Erwin] Ctr Rech & Invest Epiderm & Sensorielle, Neuilly Sur Seine, France	Medical University of Vienna; University of Bern; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Fischer, H (corresponding author), Med Univ Vienna, Dept Dermatol, Vienna, Austria.	leopold.eckhart@meduniwien.ac.at	Torriglia, Alicia/L-6957-2017; Torriglia, Alicia/Q-3509-2019; Fischer, Heinz/AAD-9950-2020	Torriglia, Alicia/0000-0003-1181-6710; Eckhart, Leopold/0000-0002-5645-2036; Fischer, Heinz/0000-0003-1280-0200; Tschachler, Erwin/0000-0002-0248-1798; Mildner, Michael/0000-0002-6892-925X; Benarafa, Charaf/0000-0002-2049-7769	Austrian Science Fund (FWF) [P20043, P21312]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants to LE (Austrian Science Fund (FWF): P20043 and P21312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtin A, 2009, J INVEST DERMATOL, V129, P2193, DOI 10.1038/jid.2009.35; Altairac S, 2003, CELL DEATH DIFFER, V10, P548, DOI 10.1038/sj.cdd.4401195; Benarafa C, 2002, J BIOL CHEM, V277, P42028, DOI 10.1074/jbc.M207080200; Benarafa C, 2007, J EXP MED, V204, P1901, DOI 10.1084/jem.20070494; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Counis MF, 2006, BIOCHIMIE, V88, P1851, DOI 10.1016/j.biochi.2006.07.008; DIKSTEIN S, 1994, ACTA DERM-VENEREOL, P18; Eckhart L, 2007, BRIT J DERMATOL, V156, P1342, DOI 10.1111/j.1365-2133.2007.07886.x; Eckhart L, 1999, J BIOL CHEM, V274, P2613, DOI 10.1074/jbc.274.5.2613; Elias PM, 2005, J INVEST DERMATOL, V125, P183, DOI 10.1111/j.0022-202X.2005.23668.x; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fischer H, 2004, FEBS LETT, V577, P446, DOI 10.1016/j.febslet.2004.10.046; Fischer H, 2007, J INVEST DERMATOL, V127, P24, DOI 10.1038/sj.jid.5700503; Fischer H, 2011, J INVEST DERMATOL, V131, P1208, DOI 10.1038/jid.2011.13; FORSTER FJ, 1975, ARCH DERMATOL FORSCH, V253, P213, DOI 10.1007/BF00561146; Gazel A, 2006, J INVEST DERMATOL, V126, P2647, DOI 10.1038/sj.jid.5700461; Howell DPG, 2003, MOL THER, V8, P957, DOI 10.1016/j.ymthe.2003.09.011; Jager K, 2007, DIFFERENTIATION, V75, P939; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Krieser RJ, 2002, CELL DEATH DIFFER, V9, P956, DOI 10.1038/sj.cdd.4401056; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; Mildner M, 2006, BIOCHEM BIOPH RES CO, V348, P76, DOI 10.1016/j.bbrc.2006.07.035; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; OHMAN H, 1994, ACTA DERM-VENEREOL, V74, P375; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Pandey S, 1997, BIOCHEMISTRY-US, V36, P711, DOI 10.1021/bi962387h; Parra D, 2009, CANCER RES, V69, P6676, DOI 10.1158/0008-5472.CAN-09-1208; PARRISH JE, 1995, HUM MOL GENET, V4, P1557, DOI 10.1093/hmg/4.9.1557; Raymond AA, 2008, MOL CELL PROTEOMICS, V7, P2151, DOI 10.1074/mcp.M700334-MCP200; Rees DD, 1999, AM J RESP CELL MOL, V20, P69, DOI 10.1165/ajrcmb.20.1.3306; Rendl M, 2002, J INVEST DERMATOL, V119, P1150, DOI 10.1046/j.1523-1747.2002.19532.x; Rossol M, 2009, ANN RHEUM DIS, V68, P1498, DOI 10.1136/ard.2008.092239; SANTOIANNI P, 1961, J INVEST DERMATOL, V37, P489, DOI 10.1038/jid.1961.149; Shiokawa D, 2001, BIOCHEMISTRY-US, V40, P143, DOI 10.1021/bi001041a; TABACHNICK J, 1961, NATURE, V190, P921, DOI 10.1038/190921a0; TABACHNICK J, 1964, J INVEST DERMATOL, V42, P471, DOI 10.1038/jid.1964.100; Torriglia A, 1998, MOL CELL BIOL, V18, P3612, DOI 10.1128/MCB.18.6.3612; Torriglia A, 2009, FRONT BIOSCI-LANDMRK, V14, P4836, DOI 10.2741/3572; Torriglia A, 2008, BIOCHEM PHARMACOL, V76, P1490, DOI 10.1016/j.bcp.2008.07.039; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Widlak P, 2005, J CELL BIOCHEM, V94, P1078, DOI 10.1002/jcb.20409; Yasuda T, 2000, FEBS LETT, V467, P231, DOI 10.1016/S0014-5793(00)01162-5; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	48	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17581	10.1371/journal.pone.0017581	http://dx.doi.org/10.1371/journal.pone.0017581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390259	Green Published, Green Submitted, gold			2022-12-25	WOS:000287932100024
J	Talbot, K; Louneva, N; Cohen, JW; Kazi, H; Blake, DJ; Arnold, SE				Talbot, Konrad; Louneva, Natalia; Cohen, Julia W.; Kazi, Hala; Blake, Derek J.; Arnold, Steven E.			Synaptic Dysbindin-1 Reductions in Schizophrenia Occur in an Isoform-Specific Manner Indicating Their Subsynaptic Location	PLOS ONE			English	Article							SUPERIOR TEMPORAL GYRUS; DORSOLATERAL PREFRONTAL CORTEX; HIPPOCAMPAL-FORMATION; SUSCEPTIBILITY GENE; AUDITORY-CORTEX; NEGATIVE SYMPTOMS; EPISODIC MEMORY; MOOD DISORDERS; MESSENGER-RNA; SPINE DENSITY	Background: An increasing number of studies report associations between variation in DTNBP1, a top candidate gene in schizophrenia, and both the clinical symptoms of the disorder and its cognitive deficits. DTNBP1 encodes dysbindin-1, reduced levels of which have been found in synaptic fields of schizophrenia cases. This study determined whether such synaptic reductions are isoform-specific. Methodology/Principal Findings: Using Western blotting of tissue fractions, we first determined the synaptic localization of the three major dysbindin-1 isoforms (A, B, and C). All three were concentrated in synaptosomes of multiple brain areas, including auditory association cortices in the posterior half of the superior temporal gyrus (pSTG) and the hippocampal formation (HF). Tests on the subsynaptic tissue fractions revealed that each isoform is predominantly, if not exclusively, associated with synaptic vesicles (dysbindin-1B) or with postsynaptic densities (dysbindin-1A and -1C). Using Western blotting on pSTG (n = 15) and HF (n = 15) synaptosomal fractions from schizophrenia cases and their matched controls, we discovered that synaptic dysbindin-1 is reduced in an isoform-specific manner in schizophrenia without changes in levels of synaptophysin or PSD-95. In pSTG, about 92% of the schizophrenia cases displayed synaptic dysbindin-1A reductions averaging 48% (p = 0.0007) without alterations in other dysbindin-1 isoforms. In the HF, by contrast, schizophrenia cases displayed normal levels of synaptic dysbindin-1A, but 67% showed synaptic reductions in dysbindin-1B averaging 33% (p = 0.0256), while 80% showed synaptic reductions in dysbindin-1C averaging 35% (p = 0.0171). Conclusions/Significance: Given the distinctive subsynaptic localization of dysbindin-1A, -1B, and -1C across brain regions, the observed pSTG reductions in dysbindin-1A are postsynaptic and may promote dendritic spine loss with consequent disruption of auditory information processing, while the noted HF reductions in dysbindin-1B and -1C are both presynaptic and postsynaptic and could promote deficits in spatial working memory.	[Talbot, Konrad; Louneva, Natalia; Cohen, Julia W.; Kazi, Hala; Arnold, Steven E.] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; [Blake, Derek J.] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales; [Blake, Derek J.] Cardiff Univ, Dept Psychol Med & Neurol, Cardiff, S Glam, Wales	University of Pennsylvania; Pennsylvania Medicine; Cardiff University; Cardiff University	Talbot, K (corresponding author), Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA.	talbotk2@mail.med.upenn.edu	Arnold, Steven E/J-7546-2012	Talbot, Konrad/0000-0003-4549-0835	National Institutes of Health [RO1 MH072880, P50 MH064045]; MRC [G0800509] Funding Source: UKRI; Medical Research Council [G0800509, G0801418B] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072880, P50MH064045] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health grants RO1 MH072880 and P50 MH064045 (SEA). The funders had no role in the study design, data collection, data analysis, the decision to publish, or preparation of the manuscript.	Albert KA, 2002, ARCH GEN PSYCHIAT, V59, P705, DOI 10.1001/archpsyc.59.8.705; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; ARNOLD SE, 1995, AM J PSYCHIAT, V152, P731; Barch DM, 2005, ANNU REV CLIN PSYCHO, V1, P321, DOI 10.1146/annurev.clinpsy.1.102803.143959; Bhardwaj SK, 2009, BEHAV BRAIN RES, V197, P435, DOI 10.1016/j.bbr.2008.10.011; Bramon E, 2004, SCHIZOPHR RES, V70, P315, DOI 10.1016/j.schres.2004.01.004; Brugge JF, 2008, HEARING RES, V238, P12, DOI 10.1016/j.heares.2007.11.012; Burdick KE, 2007, SCHIZOPHR RES, V89, P169, DOI 10.1016/j.schres.2006.09.008; Burdick KE, 2006, HUM MOL GENET, V15, P1563, DOI 10.1093/hmg/ddi481; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Chance SA, 2008, BRAIN, V131, P3178, DOI 10.1093/brain/awn211; Chen XW, 2008, J CELL BIOL, V181, P791, DOI 10.1083/jcb.200711021; Chiba S, 2006, J NEURAL TRANSM, V113, P1337, DOI 10.1007/s00702-005-0414-1; Cox MM, 2009, GENES BRAIN BEHAV, V8, P390, DOI 10.1111/j.1601-183X.2009.00477.x; Deng C, 2006, EXP BRAIN RES, V168, P587, DOI 10.1007/s00221-005-0290-9; Deng C, 2005, J NEUROSCI RES, V81, P883, DOI 10.1002/jnr.20600; DeRosse P, 2006, AM J PSYCHIAT, V163, P532, DOI 10.1176/appi.ajp.163.3.532; Diagnostic A, 1994, DIAGN STAT MAN MENT, P886; Dickman DK, 2009, SCIENCE, V326, P1127, DOI 10.1126/science.1179685; Donohoe G, 2007, NEUROPSYCHOLOGIA, V45, P454, DOI 10.1016/j.neuropsychologia.2006.06.016; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Falcon-Perez JM, 2002, PIGM CELL RES, V15, P82, DOI 10.1034/j.1600-0749.2002.1r082.x; Fanous AH, 2005, AM J PSYCHIAT, V162, P1824, DOI 10.1176/appi.ajp.162.10.1824; Fountoulakis M, 2001, EXP NEUROL, V167, P86, DOI 10.1006/exnr.2000.7529; Garcia-Marti G, 2008, PROG NEURO-PSYCHOPH, V32, P72, DOI 10.1016/j.pnpbp.2007.07.014; Hahn CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005251; Hanlon FM, 2006, SCHIZOPHR RES, V87, P67, DOI 10.1016/j.schres.2006.05.021; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; HECKERS S, 2009, HDB NEUROCHEMISTRY M, V27, P315; Howard MA, 2000, J COMP NEUROL, V416, P79, DOI 10.1002/(SICI)1096-9861(20000103)416:1<79::AID-CNE6>3.0.CO;2-2; Jentsch JD, 2009, NEUROPSYCHOPHARMACOL, V34, P2601, DOI 10.1038/npp.2009.90; Aguilar EJ, 2008, EUR J RADIOL, V67, P434, DOI 10.1016/j.ejrad.2008.02.046; Karlsgodt KH, 2011, BIOL PSYCHIAT, V69, P28, DOI 10.1016/j.biopsych.2010.09.012; Kasai K, 2003, AM J PSYCHIAT, V160, P156, DOI 10.1176/appi.ajp.160.1.156; Konopaske GT, 2006, NEUROSCIENCE, V138, P189, DOI 10.1016/j.neuroscience.2005.10.070; Kraus MS, 2007, BRIT J PSYCHIAT, V191, pS46, DOI 10.1192/bjp.191.50.s46; Law AJ, 2004, AM J PSYCHIAT, V161, P1848, DOI 10.1176/appi.ajp.161.10.1848; LI YT, 1994, NEUROBIOL AGING, V15, P1, DOI 10.1016/0197-4580(94)90139-2; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; LOUNEVA N, 2009, SOC NEUR ANN M CHIC; Louneva N, 2008, AM J PATHOL, V173, P1488, DOI 10.2353/ajpath.2008.080434; Naatanen R, 2009, INT J NEUROPSYCHOPH, V12, P125, DOI 10.1017/S1461145708009322; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; Neckelmann G, 2006, INT J NEUROSCI, V116, P9, DOI 10.1080/00207450690962244; Nestor PG, 2007, PSYCHIAT RES-NEUROIM, V155, P21, DOI 10.1016/j.pscychresns.2006.12.020; Nieuwenhuys R., 2008, HUMAN CENTRAL NERVOU; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Pae CU, 2008, NEUROSCI LETT, V440, P150, DOI 10.1016/j.neulet.2008.05.069; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Phillips GR, 2005, J NEUROSCI RES, V81, P762, DOI 10.1002/jnr.20614; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Reichenberg A, 2007, PSYCHOL BULL, V133, P833, DOI 10.1037/0033-2909.133.5.833; Rethelyi JM, 2010, AM J MED GENET B, V153B, P792, DOI 10.1002/ajmg.b.31049; Riley B, 2009, SCHIZOPHR RES, V115, P245, DOI 10.1016/j.schres.2009.09.008; Rosoklija G, 2000, ARCH GEN PSYCHIAT, V57, P349, DOI 10.1001/archpsyc.57.4.349; Ryder PV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293pe66; SMILEY JF, 2009, HDB NEUROCHEMISTRY M, V27, P353; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Sumich A, 2005, BIOL PSYCHIAT, V57, P947, DOI 10.1016/j.biopsych.2004.12.041; Sun J, 2008, AM J MED GENET B, V147B, P1173, DOI 10.1002/ajmg.b.30743; Sun JH, 2009, BRAIN RES REV, V61, P14, DOI 10.1016/j.brainresrev.2009.03.004; Sweet RA, 2005, J COMP NEUROL, V491, P270, DOI 10.1002/cne.20702; Sweet RA, 2004, BIOL PSYCHIAT, V55, P1128, DOI 10.1016/j.biopsych.2004.03.002; Sweet RA, 2007, BIOL PSYCHIAT, V61, P854, DOI 10.1016/j.biopsych.2006.07.033; Sweet RA, 2009, NEUROPSYCHOPHARMACOL, V34, P374, DOI 10.1038/npp.2008.67; Szeszko PR, 2002, AM J PSYCHIAT, V159, P217, DOI 10.1176/appi.ajp.159.2.217; Takahashi T, 2006, SCHIZOPHR RES, V83, P131, DOI 10.1016/j.schres.2006.01.016; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; TALBOT K, 2009, HDB NEUROCHEMISTRY M, V27, P107; Talbot K, 2006, HUM MOL GENET, V15, P3041, DOI 10.1093/hmg/ddl246; Talbot K, 2009, PROG BRAIN RES, V179, P87, DOI 10.1016/S0079-6123(09)17910-4; Tang JX, 2009, HUM MOL GENET, V18, P3851, DOI 10.1093/hmg/ddp329; Thoma RJ, 2009, J INT NEUROPSYCH SOC, V15, P182, DOI 10.1017/S1355617709090225; Toulopoulou T, 2004, BIOL PSYCHIAT, V56, P447, DOI 10.1016/j.biopsych.2004.06.026; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Velakoulis D, 2006, ARCH GEN PSYCHIAT, V63, P139, DOI 10.1001/archpsyc.63.2.139; Weickert CS, 2008, SCHIZOPHR RES, V98, P105, DOI 10.1016/j.schres.2007.05.041; Wessman J, 2009, BIOL PSYCHIAT, V66, P990, DOI 10.1016/j.biopsych.2009.05.034; Wirgenes KV, 2009, NEUROPSYCHOBIOLOGY, V60, P31, DOI 10.1159/000235799; Zinkstok JR, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-19; Zuo LJ, 2009, PSYCHIAT GENET, V19, P292, DOI 10.1097/YPG.0b013e32832a50bc	85	65	66	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e16886	10.1371/journal.pone.0016886	http://dx.doi.org/10.1371/journal.pone.0016886			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390302	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000287932100006
J	Roghmann, MC; Johnson, JK; Stine, OC; Lydecker, AD; Ryan, KA; Mitchell, BD; Shuldiner, AR				Roghmann, Mary-Claire; Johnson, J. Kristie; Stine, O. Colin; Lydecker, Alison D.; Ryan, Kathleen A.; Mitchell, Braxton D.; Shuldiner, Alan R.			Persistent Staphylococcus aureus Colonization Is Not a Strongly Heritable Trait in Amish Families	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; OLD-ORDER AMISH; NASAL CARRIAGE; RECEPTOR GENE; UNITED-STATES; POLYMORPHISMS; POPULATION; PREVALENCE; HOSPITALS; SAMPLES	About 20% of adults are persistently colonized with S. aureus in the anterior nares. Host genetic factors could contribute susceptibility to this phenotype. The objective of this study was to determine whether the phenotype of persistent S. aureus colonization aggregates in family members who live in different households. Healthy adults and their eligible same sex siblings who lived in different households were recruited from the Old Order Amish of Lancaster, Pennsylvania. All participants had two cultures of the anterior nares to determine if they were persistently colonized with S. aureus. Three hundred and ninety eight participants finished the study, of whom 166 were index cases and 232 were siblings of index cases. Eighteen per cent (71/398) of all participants and 17% (29/166) of index cases were persistently colonized with S. aureus. Twenty two per cent (8/36) of siblings of persistently colonized index cases were persistently colonized with S. aureus compared to 17% (34/196) of siblings of non-persistently colonized index cases, yielding a prevalence rate ratio of 1.28 (95% CI: 0.65-2.54, p = 0.64) and sibling relative risk of 1.25 (95% CI: 0.65-2.38, p = 0.51). The heritability of persistent colonization was 0.19 +/- 0.21 (p = 0.31). Persistent S. aureus colonization does not strongly aggregate in Amish family members in different households and heritability is low, suggesting that environmental factors or acquired host factors are more important than host genetic factors in determining persistent S. aureus colonization in this community.	[Roghmann, Mary-Claire; Johnson, J. Kristie; Stine, O. Colin; Lydecker, Alison D.; Ryan, Kathleen A.; Mitchell, Braxton D.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Roghmann, Mary-Claire; Shuldiner, Alan R.] VA Maryland Hlth Care Syst, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore	Roghmann, MC (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.	mroghman@epi.umaryland.edu	Mitchell, Braxton/CAF-0876-2022	Mitchell, Braxton/0000-0003-4920-4744; Shuldiner, Alan/0000-0001-9921-4305; Roghmann, Mary-Claire/0000-0003-1063-9257	National Center for Research Resources at the National Institutes of Health [1K12RR023250]; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023250] Funding Source: NIH RePORTER	National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	M-C. R., J.K.J., and A. R. S. were supported by grant 1K12RR023250 from the National Center for Research Resources at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; ALY R, 1977, INFECT IMMUN, V17, P546, DOI 10.1128/IAI.17.3.546-549.1977; ALY R, 1974, AM J DIS CHILD, V127, P486, DOI 10.1001/archpedi.1974.02110230032004; Bancroft EA, 2007, JAMA-J AM MED ASSOC, V298, P1803, DOI 10.1001/jama.298.15.1803; Blangero J, 2001, ADV GENET, V42, P151, DOI 10.1016/S0065-2660(01)42021-9; Calfee DP, 2003, INFECT CONT HOSP EP, V24, P422, DOI 10.1086/502225; Claassen M, 2005, FEMS IMMUNOL MED MIC, V43, P173, DOI 10.1016/j.femsim.2004.08.002; Cole AM, 1999, INFECT IMMUN, V67, P3267, DOI 10.1128/IAI.67.7.3267-3275.1999; Emonts M, 2008, J INFECT DIS, V197, P1244, DOI 10.1086/533501; Emonts M, 2007, FEMS IMMUNOL MED MIC, V50, P330, DOI 10.1111/j.1574-695X.2007.00250.x; Eveillard M, 2004, INFECT CONT HOSP EP, V25, P114, DOI 10.1086/502360; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; HOEKSMA A, 1963, Acta Leiden, V32, P123; Johnson JK, 2007, EMERG INFECT DIS, V13, P1195, DOI 10.3201/eid1308.061575; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Lautenbach E, 2009, INFECT CONT HOSP EP, V30, P380, DOI 10.1086/596045; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Morrison MA, 2006, J HOSP INFECT, V62, P241, DOI 10.1016/j.jhin.2005.07.011; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; NOBLE WC, 1967, J HYG-CAMB, V65, P567, DOI 10.1017/S002217240004609X; Nouwen J, 2004, INFECT IMMUN, V72, P6685, DOI 10.1128/IAI.72.11.6685-6688.2004; Nouwen JL, 2004, CLIN INFECT DIS, V39, P806, DOI 10.1086/423376; Pallin DJ, 2008, ANN EMERG MED, V51, P291, DOI 10.1016/j.annemergmed.2007.12.004; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; Pollin TI, 2008, HUM HERED, V65, P91, DOI 10.1159/000108941; van Belkum A, 2007, MICROBES INFECT, V9, P1471, DOI 10.1016/j.micinf.2007.08.003; van den Akker ELT, 2006, J INFECT DIS, V194, P814, DOI 10.1086/506367; Van Hout CV, 2010, GENET EPIDEMIOL, V34, P146, DOI 10.1002/gepi.20444; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17368	10.1371/journal.pone.0017368	http://dx.doi.org/10.1371/journal.pone.0017368			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386985	Green Published, gold, Green Submitted			2022-12-25	WOS:000287931400065
J	Li, XS; Wu, XP; Camacho, R; Schwartz, GJ; LeRoith, D				Li, Xiaosong; Wu, Xhiping; Camacho, Raul; Schwartz, Gary J.; LeRoith, Derek			Intracerebroventricular Leptin Infusion Improves Glucose Homeostasis in Lean Type 2 Diabetic MKR Mice via Hepatic Vagal and Non-Vagal Mechanisms	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; THERAPY; RATS; MUSCLE	MKR mice, lacking insulin-like growth factor 1 receptor (IGF-1R) signaling in skeletal muscle, are lean yet hyperlipidemic, hyperinsulinemic, and hyperglycemic, with severe insulin resistance and elevated hepatic and skeletal muscle levels of triglycerides. We have previously shown that chronic peripheral administration of the adipokine leptin improves hepatic insulin sensitivity in these mice independently of its effects on food intake. As central leptin signaling has been implicated in the control of peripheral glucose homeostasis, here we examined the ability of central intracerebroventricular leptin administration to affect energy balance and peripheral glucose homeostasis in non-obese diabetic male MKR mice. Central leptin significantly reduced food intake, body weight gain and adiposity, as well as serum glucose, insulin, leptin, free fatty acid and triglyceride levels relative to ACSF treated controls. These reductions were accompanied by increased fat oxidation as measured by indirect calorimetry, as well as increased oxygen consumption. Central leptin also improved glucose tolerance and hepatic insulin sensitivity determined using the euglycemic-hyperinsulinemic clamps relative to pair fed vehicle treated controls, as well as increasing the rate of glucose disappearance. Hepatic vagotomy only partially reversed the ability of central leptin to improve glucose tolerance. These results demonstrate that central leptin dramatically improves insulin sensitivity independently of its effects on food intake, in a lean mouse model of type 2 diabetes. The findings also suggest that: 1) both hepatic vagal and non-vagal pathways contribute to this improvement, and 2) central leptin alters glucose disposal in skeletal muscle in this model.	[Li, Xiaosong; Wu, Xhiping; Camacho, Raul; Schwartz, Gary J.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Li, Xiaosong; Wu, Xhiping; Camacho, Raul; Schwartz, Gary J.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [LeRoith, Derek] Mt Sinai Sch Med, Dept Med, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai	Li, XS (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	derek.leroith@mssm.edu			American Diabetes Association [7-08-MN-33]; National Institutes of Health, New York Obesity Center [NIH-DK-26687]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health, New York Obesity Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by an American Diabetes Association Mentor grant (7-08-MN-33) awarded to DLR and by the National Institutes of Health grant NIH-DK-26687, New York Obesity Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babic T, 2010, BRAIN RES, V1345, P146, DOI 10.1016/j.brainres.2010.05.042; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Fujikawa T, 2010, P NATL ACAD SCI USA, V107, P17391, DOI 10.1073/pnas.1008025107; German J, 2009, ENDOCRINOLOGY, V150, P4502, DOI 10.1210/en.2009-0445; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Kim H, 2006, AM J PHYSIOL-ENDOC M, V290, pE1227, DOI 10.1152/ajpendo.00344.2005; Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Minokoshi Y, 2003, BIOCHEM SOC T, V31, P196, DOI 10.1042/bst0310196; Minokoshi Y, 1999, DIABETES, V48, P287, DOI 10.2337/diabetes.48.2.287; Morton GJ, 2003, ENDOCRINOLOGY, V144, P2016, DOI 10.1210/en.2002-0115; Pocai A, 2005, DIABETES, V54, P3182, DOI 10.2337/diabetes.54.11.3182; Rahmouni K, 2009, DIABETES, V58, P536, DOI 10.2337/db08-0822; Roman EAFR, 2010, MOL CELL ENDOCRINOL, V314, P62, DOI 10.1016/j.mce.2009.08.007; Shen J, 2007, NEUROSCI LETT, V416, P193, DOI 10.1016/j.neulet.2007.02.003; Toda C, 2009, DIABETES, V58, P2757, DOI 10.2337/db09-0638; Toyoshima Y, 2005, ENDOCRINOLOGY, V146, P4024, DOI 10.1210/en.2005-0087; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; Yakar Shoshana, 2005, Pediatr Endocrinol Rev, V3, P11	20	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17058	10.1371/journal.pone.0017058	http://dx.doi.org/10.1371/journal.pone.0017058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379576	Green Published, Green Submitted, gold			2022-12-25	WOS:000287482300027
J	Ibey, BL; Roth, CC; Pakhomov, AG; Bernhard, JA; Wilmink, GJ; Pakhomova, ON				Ibey, Bennett L.; Roth, Caleb C.; Pakhomov, Andrei G.; Bernhard, Joshua A.; Wilmink, Gerald J.; Pakhomova, Olga N.			Dose-Dependent Thresholds of 10-ns Electric Pulse Induced Plasma Membrane Disruption and Cytotoxicity in Multiple Cell Lines	PLOS ONE			English	Article							COLON-CARCINOMA CELLS; IRREVERSIBLE ELECTROPORATION; HIGH-INTENSITY; PHOSPHOLIPID TRANSLOCATION; FIELD NSPEF; IN-VITRO; NANOSECOND; APOPTOSIS; ELECTROPERMEABILIZATION; ELECTROCHEMOTHERAPY	In this study, we determined the LD50 (50% lethal dose) for cell death, and the ED50 (50% of cell population staining positive) for propidium (Pr) iodide uptake, and phosphatidylserine (PS) externalization for several commonly studied cell lines (HeLa, Jurkat, U937, CHO-K1, and GH3) exposed to 10-ns electric pulses (EP). We found that the LD50 varied substantially across the cell lines studied, increasing from 51 J/g for Jurkat to 1861 J/g for HeLa. PS externalized at doses equal or lower than that required for death in all cell lines ranging from 51 J/g in Jurkat, to 199 J/g in CHO-K1. Pr uptake occurred at doses lower than required for death in three of the cell lines: 656 J/g for CHO-K1, 634 J/g for HeLa, and 142 J/g for GH3. Both Jurkat and U937 had a LD50 lower than the ED50 for Pr uptake at 780 J/g and 1274 J/g, respectively. The mechanism responsible for these differences was explored by evaluating cell size, calcium concentration in the exposure medium, and effect of trypsin treatment prior to exposure. None of the studied parameters correlated with the observed results suggesting that cellular susceptibility to injury and death by 10-ns EP was largely determined by cell physiology. In contrast to previous studies, our findings suggest that permeabilization of internal membranes may not necessarily be responsible for cell death by 10-ns EP. Additionally, a mixture of Jurkat and HeLa cells was exposed to 10-ns EP at a dose of 280 J/g. Death was observed only in Jurkat cells suggesting that 10-ns EP may selectively kill cells within a heterogeneous tissue.	[Ibey, Bennett L.; Bernhard, Joshua A.; Wilmink, Gerald J.] USAF, Radio Frequency Radiat Branch, Res Lab, Brooks City Base, San Antonio, TX USA; [Pakhomov, Andrei G.; Pakhomova, Olga N.] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA	United States Department of Defense; United States Air Force; Old Dominion University	Ibey, BL (corresponding author), USAF, Radio Frequency Radiat Branch, Res Lab, Brooks City Base, 711th Human Performance Wing, San Antonio, TX USA.	Bennett.Ibey@brooks.af.mil	Roth, Caleb/Y-1487-2019	Roth, Caleb/0000-0001-8962-1097; Pakhomov, Andrei/0000-0003-3816-3860	Air Force Office of Scientific Research; Air Force Surgeon General Clinical Investigation Program; National Cancer Institute [R01CA125482]; National Institute of General Medical Sciences [R01GM088303]; NATIONAL CANCER INSTITUTE [R01CA125482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088303] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Air Force Surgeon General Clinical Investigation Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported in part by the Air Force Office of Scientific Research, by Air Force Surgeon General Clinical Investigation Program, by the National Cancer Institute R01CA125482, and by the National Institute of General Medical Sciences R01GM088303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2007, ANAL CHEM, V79, P3589, DOI 10.1021/ac062049e; Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; Beebe SJ, 2002, IEEE T PLASMA SCI, V30, P286, DOI 10.1109/TPS.2002.1003872; Cemazar M, 1998, ELECTRO MAGNETOBIOL, V17, P263; Cemazar M, 2003, DNA CELL BIOL, V22, P765, DOI 10.1089/104454903322624975; Chang D.C., 1992, GUIDE ELECTROPORATIO; CHEN G, 2007, 15 INT S HIGH VOLT E; [程先忠 Chen Xianzhong], 2008, [分析仪器, Analytical Instrumentation], P28; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Deng JD, 2003, BIOPHYS J, V84, P2709, DOI 10.1016/S0006-3495(03)75076-0; Garon EB, 2007, INT J CANCER, V121, P675, DOI 10.1002/ijc.22723; GROSSE C, 1992, BIOPHYS J, V63, P1632, DOI 10.1016/S0006-3495(92)81740-X; Hall EH, 2005, DNA CELL BIOL, V24, P283, DOI 10.1089/dna.2005.24.283; Hall EH, 2007, APOPTOSIS, V12, P1721, DOI 10.1007/s10495-007-0083-7; Hampton MB, 1996, FEBS LETT, V399, P277, DOI 10.1016/S0014-5793(96)01341-5; Heller R, 1998, CANCER-AM CANCER SOC, V83, P148, DOI 10.1002/(SICI)1097-0142(19980701)83:1<148::AID-CNCR20>3.0.CO;2-W; Ibey BL, 2010, BBA-GEN SUBJECTS, V1800, P1210, DOI 10.1016/j.bbagen.2010.07.008; Ibey BL, 2010, BIOELECTROCHEMISTRY, V79, P114, DOI 10.1016/j.bioelechem.2010.01.001; Ibey BL, 2009, BIOELECTROMAGNETICS, V30, P92, DOI 10.1002/bem.20451; Kennedy SM, 2008, BIOPHYS J, V94, P5018, DOI 10.1529/biophysj.106.103218; Kolb JF, 2006, BIOELECTROMAGNETICS, V27, P172, DOI 10.1002/bem.20185; Kotnik T, 2006, BIOPHYS J, V90, P480, DOI 10.1529/biophysj.105.070771; Landstrom FJ, 2010, DERMATOL SURG, V36, P1245, DOI 10.1111/j.1524-4725.2010.01617.x; LORENZ A, 1988, J VIROL, V62, P3050, DOI 10.1128/JVI.62.8.3050-3052.1988; Miller L, 2005, TECHNOL CANCER RES T, V4, P699, DOI 10.1177/153303460500400615; MIR LM, 1991, EUR J CANCER, V27, P68, DOI 10.1016/0277-5379(91)90064-K; Mir LM, 1998, BRIT J CANCER, V77, P2336, DOI 10.1038/bjc.1998.388; Neal RE, 2009, ANN BIOMED ENG, V37, P2615, DOI 10.1007/s10439-009-9796-9; Neumann E., 1989, ELECTROPORATION ELEC; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345; Pakhomov AG, 2004, IEEE T PLASMA SCI, V32, P1579, DOI 10.1109/TPS.2004.831773; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2007, ARCH BIOCHEM BIOPHYS, V465, P109, DOI 10.1016/j.abb.2007.05.003; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Rubinsky B, 2010, SER BIOMED ENG, P1, DOI 10.1007/978-3-642-05420-4; Rubinsky J, 2008, J UROLOGY, V180, P2668, DOI 10.1016/j.juro.2008.08.003; Saulis G, 1999, Biomed Sci Instrum, V35, P409; Saulis G, 1997, BIOPHYS J, V73, P1299, DOI 10.1016/S0006-3495(97)78163-3; Schoenbach KH, 2007, IEEE T DIELECT EL IN, V14, P1088, DOI 10.1109/TDEI.2007.4339468; Schoenbach KH, 2008, IEEE INT POWER MODUL, P60, DOI 10.1109/IPMC.2008.4743576; Smith KC, 2008, BIOPHYS J, V95, P1547, DOI 10.1529/biophysj.107.121921; Stacey M, 2003, MUTAT RES-GEN TOX EN, V542, P65, DOI 10.1016/j.mrgentox.2003.08.006; Teissie J, 1999, ADV DRUG DELIVER REV, V35, P3, DOI 10.1016/S0169-409X(98)00060-X; Vasilkoski Z, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021904; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Vernier PT, 2005, P ANN INT IEEE EMBS, P5850, DOI 10.1109/IEMBS.2005.1615820; Vernier PT, 2006, J AM CHEM SOC, V128, P6288, DOI 10.1021/ja0588306; Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945; Vernier PT, 2003, IEEE T DIELECT EL IN, V10, P795, DOI 10.1109/TDEI.2003.1237329; Weaver JC, 2003, IEEE T DIELECT EL IN, V10, P754, DOI 10.1109/TDEI.2003.1237325; WINTERBOURNE DJ, 1998, BIOCHEM J, V251, P427; XIAO S, 2007, PULS POW C 2007 16 I, V1, P744; Xiao S, 2010, IEEE ANTENN WIREL PR, V9, P12, DOI 10.1109/LAWP.2010.2041027	55	66	68	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e15642	10.1371/journal.pone.0015642	http://dx.doi.org/10.1371/journal.pone.0015642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21390200	Green Published, gold, Green Submitted			2022-12-25	WOS:000286662800010
J	Sivertsen, B; Lang, MJ; Frimurer, TM; Holliday, ND; Bach, A; Els, S; Engelstoft, MS; Petersen, PS; Madsen, AN; Schwartz, TW; Beck-Sickinger, AG; Holst, B				Sivertsen, Bjorn; Lang, Manja; Frimurer, Thomas M.; Holliday, Nicholas D.; Bach, Anders; Els, Sylvia; Engelstoft, Maja S.; Petersen, Pia S.; Madsen, Andreas N.; Schwartz, Thue W.; Beck-Sickinger, Annette G.; Holst, Birgitte			Unique Interaction Pattern for a Functionally Biased Ghrelin Receptor Agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE SECRETAGOGUE; HETEROTRIMERIC G-PROTEINS; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; INVERSE AGONISTS; STRUCTURAL BASIS; LIGAND; IDENTIFICATION; ACTIVATION; PEPTIDE	Based on the conformationally constrained D-Trp-Phe-D-Trp (wFw) core of the prototype inverse agonist [D-Arg(1), D-Phe(5), D-Trp(7,9), Leu(11)] substance P, a series of novel, small, peptide-mimetic agonists for the ghrelin receptor were generated. By using various simple, ring-constrained spacers connecting the D-Trp-Phe-D-Trp motif with the important C-terminal carboxyamide group, 40 nM agonism potency was obtained and also in one case (wFw-Isn-NH2, where Isn is isonipecotic acid) similar to 80% efficacy. However, in contrast to all previously reported ghrelin receptor agonists, the piperidine-constrained wFw-Isn-NH2 was found to be a functionally biased agonist. Thus, wFw-Isn-NH2 mediated potent and efficacious signaling through the G alpha(q) and ERK1/2 signaling pathways, but in contrast to all previous ghrelin receptor agonists it did not signal through the serum response element, conceivably the G alpha(12/13) pathway. The recognition pattern of wFw-Isn-NH2 with the ghrelin receptor also differed significantly from that of all previously characterized unbiased agonists. Most importantly, wFw-Isn-NH2 was not dependent on GluIII:09 (Glu3.33), which otherwise is an obligatory TM III anchor point residue for ghrelin agonists. Molecular modeling and docking experiments indicated that wFw-Isn-NH2 binds in the classical agonist binding site between the extracellular segments of TMs III, VI, and VII, interacting closely with the aromatic cluster between TMs VI and VII, but that it does so in an opposite orientation as compared with, for example, the wFw peptide agonists. It is concluded that the novel peptide-mimetic ligand wFw-Isn-NH2 is a biased ghrelin receptor agonist and that the selective signaling pattern presumably is due to its unique receptor recognition pattern lacking interaction with key residues especially in TM III.	[Sivertsen, Bjorn; Bach, Anders; Engelstoft, Maja S.; Petersen, Pia S.; Madsen, Andreas N.; Schwartz, Thue W.; Holst, Birgitte] Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Lang, Manja; Els, Sylvia; Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, D-04103 Leipzig, Germany; [Frimurer, Thomas M.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Holliday, Nicholas D.] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2UH, England	University of Copenhagen; Leipzig University; University of Copenhagen; University of Nottingham	Holst, B (corresponding author), Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	holst@sund.ku.dk		Schwartz, Thue W./0000-0002-0261-6904; Holliday, Nicholas/0000-0002-2900-828X; Holst, Birgitte/0000-0001-7432-097X; Bach, Anders/0000-0003-4305-9910; Frimruer, Thomas/0000-0002-9682-8245	Danish Medical Research Council; NovoNordisk Foundation; Lundbeck Foundation; Alfred Benzon Foundation; German Science Foundation [KFO 152]; Danish Ministry of Science, Technology, and Innovation; Medical Research Council [G0700049]; MRC [G0700049] Funding Source: UKRI	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Alfred Benzon Foundation; German Science Foundation(German Research Foundation (DFG)); Danish Ministry of Science, Technology, and Innovation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from the Danish Medical Research Council, the NovoNordisk Foundation, the Lundbeck Foundation, the Alfred Benzon Foundation, and the German Science Foundation for Financial Support (KFO 152). This work was carried out as part of the "Food, Fitness & Pharma for Health and Disease" research program of the UNIK project, supported by the Danish Ministry of Science, Technology, and Innovation.; Supported by Medical Research Council Grant G0700049.	Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Bach MA, 2004, J AM GERIATR SOC, V52, P516, DOI 10.1111/j.1532-5415.2004.52156.x; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Chu KM, 2007, INT J BIOCHEM CELL B, V39, P752, DOI 10.1016/j.biocel.2006.11.007; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; Falls HD, 2006, J MOL ENDOCRINOL, V37, P51, DOI 10.1677/jme.1.01943; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Galandrin S, 2008, MOL PHARMACOL, V74, P162, DOI 10.1124/mol.107.043893; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Gbahou F, 2003, P NATL ACAD SCI USA, V100, P11086, DOI 10.1073/pnas.1932276100; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Holst B, 2004, TRENDS PHARMACOL SCI, V25, P113, DOI 10.1016/j.tips.2004.01.010; Holst B, 2001, J BIOL CHEM, V276, P19793, DOI 10.1074/jbc.M100621200; Holst B, 2007, J BIOL CHEM, V282, P15799, DOI 10.1074/jbc.M609796200; Holst B, 2006, MOL PHARMACOL, V70, P936, DOI 10.1124/mol.106.024422; Holst B, 2009, MOL PHARMACOL, V75, P44, DOI 10.1124/mol.108.049189; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2001, TRENDS ENDOCRIN MET, V12, P118, DOI 10.1016/S1043-2760(00)00362-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang MJ, 2004, J MED CHEM, V47, P1153, DOI 10.1021/jm030982t; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Lundholm K, 2010, CANCER-AM CANCER SOC, V116, P2044, DOI 10.1002/cncr.24917; MATTOS C, 1995, STRUCT BIOL, V1, P55; Michel MC, 2007, MOL PHARMACOL, V72, P1097, DOI 10.1124/mol.107.040923; Mousseaux D, 2006, BRIT J PHARMACOL, V148, P350, DOI 10.1038/sj.bjp.0706727; Murphy MG, 2001, J CLIN ENDOCR METAB, V86, P1116, DOI 10.1210/jc.86.3.1116; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Petersen PS, 2009, ENDOCRINOLOGY, V150, P4920, DOI 10.1210/en.2008-1638; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Reis RI, 2007, REGUL PEPTIDES, V140, P32, DOI 10.1016/j.regpep.2006.11.028; Richman JG, 2007, J BIOL CHEM, V282, P18028, DOI 10.1074/jbc.M701866200; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Yang J, 2008, P NATL ACAD SCI USA, V105, P10750, DOI 10.1073/pnas.0805353105; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Zhang L, 2009, MOL PHARMACOL, V75, P235, DOI 10.1124/mol.108.050906	55	38	38	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20845	20860		10.1074/jbc.M110.173237	http://dx.doi.org/10.1074/jbc.M110.173237			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21402696	Green Published, hybrid			2022-12-25	WOS:000291267600069
J	Formenti, F; Beer, PA; Croft, QPP; Dorrington, KL; Gale, DP; Lappin, TRJ; Lucas, GS; Maher, ER; Maxwell, PH; McMullin, MF; O'Connor, DF; Percy, MJ; Pugh, CW; Ratcliffe, PJ; Smith, TG; Talbot, NP; Robbins, PA				Formenti, Federico; Beer, Philip A.; Croft, Quentin P. P.; Dorrington, Keith L.; Gale, Daniel P.; Lappin, Terence R. J.; Lucas, Guy S.; Maher, Eamonn R.; Maxwell, Patrick H.; McMullin, Mary F.; O'Connor, David F.; Percy, Melanie J.; Pugh, Christopher W.; Ratcliffe, Peter J.; Smith, Thomas G.; Talbot, Nick P.; Robbins, Peter A.			Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2 alpha gain-of-function mutation	FASEB JOURNAL			English	Article						pulmonary hypertension; ventilation; metabolism; polycythemia	PULMONARY-ARTERY PRESSURE; DOPPLER-ECHOCARDIOGRAPHY; TUMOR-SUPPRESSOR; CARDIAC-OUTPUT; NONINVASIVE ESTIMATION; PROLYL HYDROXYLASES; SYSTOLIC PRESSURE; PROTEIN; GENE; ALPHA	The hypoxia-inducible factors (HIFs; isoforms HIF-1 alpha, HIF-2 alpha, HIF-3 alpha) mediate many responses to hypoxia. Their regulation is principally by oxygen-dependent degradation, which is initiated by hydroxylation of specific proline residues followed by binding of von Hippel-Lindau (VHL) protein. Chuvash polycythemia is a disorder with elevated HIF. It arises through germline homozygosity for hypomorphic VHL alleles and has a phenotype of hematological, cardiopulmonary, and metabolic abnormalities. This study explores the phenotype of two other HIF pathway diseases: classic VHL disease and HIF-2 alpha gain-of-function mutation. No cardiopulmonary abnormalities were detected in classic VHL disease. HIF-2 alpha gain-of-function mutations were associated with pulmonary hypertension, increased cardiac output, increased heart rate, and increased pulmonary ventilation relative to metabolism. Comparison of the HIF-2 alpha gain-of-function responses with data from studies of Chuvash polycythemia suggested that other aspects of the Chuvash phenotype were diminished or absent. In classic VHL disease, patients are germline heterozygous for mutations in VHL, and the present results suggest that a single wild-type allele for VHL is sufficient to maintain normal cardiopulmonary function. The HIF-2 alpha gain-of-function phenotype may be more limited than the Chuvash phenotype either because HIF-1 alpha is not elevated in the former condition, or because other HIF-independent functions of VHL are perturbed in Chuvash polycythemia.-Formenti, F., Beer, P. A., Croft, Q. P. P., Dorrington, K. L., Gale, D. P., Lappin, T. R. J., Lucas, G. S., Maher, E. R., Maxwell, P. H., McMullin, M. F., O'Connor, D. F., Percy, M. J., Pugh, C. W., Ratcliffe, P. J., Smith, T. G., Talbot, N. P., Robbins, P. A. Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2 alpha gain-of-function mutation. FASEB J. 25, 2001-2011 (2011). www.fasebj.org	[Formenti, Federico; Croft, Quentin P. P.; Dorrington, Keith L.; O'Connor, David F.; Smith, Thomas G.; Talbot, Nick P.; Robbins, Peter A.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Pugh, Christopher W.; Ratcliffe, Peter J.] Univ Oxford, Nuffield Dept Clin Med, Oxford OX1 3PT, England; [Beer, Philip A.] Univ Cambridge, Cambridge, England; [Beer, Philip A.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England; [Gale, Daniel P.; Maxwell, Patrick H.] UCL, Div Med, Rayne Inst, London, England; [Lappin, Terence R. J.] Queens Univ, Belfast City Hosp, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [McMullin, Mary F.; Percy, Melanie J.] Queens Univ, Belfast City Hosp, Dept Haematol, Belfast, Antrim, North Ireland; [Lucas, Guy S.] Manchester Royal Infirm, Dept Haematol, Manchester M13 9WL, Lancs, England; [Maher, Eamonn R.] Univ Birmingham, Ctr Rare Dis & Personalised Med, Sch Clin & Expt Med, Birmingham, W Midlands, England	University of Oxford; University of Oxford; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; King's College London; University College London; Belfast City Hospital; Queens University Belfast; Belfast City Hospital; Queens University Belfast; University of Manchester; University of Birmingham	Formenti, F (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	federico.formenti@dpag.ox.ac.uk; peter.robbins@dpag.ox.ac.uk	Maxwell, Patrick H/C-5557-2008; MAHER, EAMONN R/A-9507-2008; Gale, Daniel/D-5594-2013; McMullin, Mary Frances/AAG-6078-2021; McMullin, Mary F/AAF-6472-2020; Formenti, Federico/F-3501-2012; Robbins, Peter/C-7846-2016	Maxwell, Patrick H/0000-0002-0338-2679; MAHER, EAMONN R/0000-0002-6226-6918; Gale, Daniel/0000-0002-9170-1579; McMullin, Mary Frances/0000-0002-0773-0204; Formenti, Federico/0000-0003-4289-0761; Robbins, Peter/0000-0002-4975-0609; Smith, Thomas/0000-0002-5197-5030; Pugh, Chris/0000-0002-5170-1662; Ratcliffe, Peter/0000-0002-2853-806X; Beer, Philip/0000-0003-3056-5419; Talbot, Nick/0000-0002-9186-8950	University College Oxford; Department of Physiology, Anatomy, and Genetics; University of Oxford, Oxford, UK; Wellcome Trust [075876]; Dunhill Medical Trust; Royal Society [TG092416]; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; British Heart Foundation [RG/11/1/28684] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish	University College Oxford; Department of Physiology, Anatomy, and Genetics; University of Oxford, Oxford, UK; Wellcome Trust(Wellcome Trust); Dunhill Medical Trust(Dunhill Medical Trust); Royal Society(Royal Society of London); NIHR Cambridge Biomedical Research Centre, Cambridge, UK(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors thank the patients and volunteers who took part in the studies. F.F. was funded by a University College Oxford postdoctoral research scholarship and by the Fell Fund from the Department of Physiology, Anatomy, and Genetics, University of Oxford, Oxford, UK. This work was supported by the Wellcome Trust (grant 075876 to P.A.R.), by the Dunhill Medical Trust (to K.L.D.), by the Royal Society (grant TG092416 to F.F.), and by the NIHR Cambridge Biomedical Research Centre, Cambridge, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. F.F., P.A.B., Q.P.P.C., K.L.D., D.P.G., T.R.J.L., G.S.L., E.R.M., P.H.M., M.F.M., D.F.O., M.J.P., C.W.P., P.J.R., T.G.S., N.P.T., and P.A.R. agree with the manuscript's results and conclusions; F.F., C.W.P., and P.A.R. designed the experiments and the study; F.F. analyzed the data; F.F., Q.P.P.C., K.L.D., D.F.O., T.G.S., and N.P.T. collected data and conducted experiments for the study; F.F., P.A.B., D.P.G., T.R.J.L., G.S.L., E.R.M., P.H.M., M.F.M., M.J.P., T.G.S., and P.A.R. enrolled patients; F.F., P.J.R., and P.A.R. wrote the manuscript; K.L.D. and P.A.R. supervised and obtained funding. P.J.R., P.H.M., and C.W.P. are scientific cofounders of, and hold equity in, ReOx Ltd, a university spinoff company that is seeking to make HIF hydroxylase inhibitors. The other authors declare no competing financial interests.	Allemann Y, 2000, AM J PHYSIOL-HEART C, V279, pH2013, DOI 10.1152/ajpheart.2000.279.4.H2013; Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bushuev VI, 2006, HAEMATOLOGICA, V91, P744; Chemla D, 2004, CHEST, V126, P1313, DOI 10.1378/chest.126.4.1313; CHRISTIE J, 1987, CIRCULATION, V76, P539, DOI 10.1161/01.CIR.76.3.539; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; ERIKSEN M, 1990, MED BIOL ENG COMPUT, V28, P555, DOI 10.1007/BF02442607; Formenti F, 2010, P NATL ACAD SCI USA, V107, P12722, DOI 10.1073/pnas.1002339107; Frew IJ, 2007, CURR OPIN CELL BIOL, V19, P685, DOI 10.1016/j.ceb.2007.10.001; Gale DP, 2008, BLOOD, V112, P919, DOI 10.1182/blood-2008-04-153718; Gordeuk VR, 2006, SEMIN THROMB HEMOST, V32, P289, DOI 10.1055/s-2006-939441; Gordeuk VR, 2004, BLOOD, V103, P3924, DOI 10.1182/blood-2003-07-2535; GROVES BM, 1987, J APPL PHYSIOL, V63, P521, DOI 10.1152/jappl.1987.63.2.521; Grunig E, 2000, J AM COLL CARDIOL, V35, P980, DOI 10.1016/S0735-1097(99)00633-6; Hickey MM, 2010, J CLIN INVEST, V120, P827, DOI 10.1172/JCI36362; HOWSON MG, 1986, J PHYSIOL-LONDON, V382, pP12; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; KNUDSON AG, 1972, AM J HUM GENET, V24, P514; KNUDSON AG, 1986, ANNU REV GENET, V20, P231; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Martini M, 2008, HAEMATOL-HEMATOL J, V93, P1068, DOI 10.3324/haematol.13210; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; PEACOCK AJ, 1990, RESP MED, V84, P335, DOI 10.1016/S0954-6111(08)80063-7; Percy MJ, 2008, BLOOD, V111, P5400, DOI 10.1182/blood-2008-02-137703; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Prowse AH, 1997, AM J HUM GENET, V60, P765; ROBBINS PA, 1982, J APPL PHYSIOL, V52, P1353, DOI 10.1152/jappl.1982.52.5.1353; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Sergeyeva A, 1997, BLOOD, V89, P2148, DOI 10.1182/blood.V89.6.2148; SKJAERPE T, 1986, EUR HEART J, V7, P704, DOI 10.1093/oxfordjournals.eurheartj.a062126; Smith TG, 2006, PLOS MED, V3, P1178, DOI 10.1371/journal.pmed.0030290; Smith TG, 2009, JAMA-J AM MED ASSOC, V302, P1444, DOI 10.1001/jama.2009.1404; Sugawara J, 2003, ACTA PHYSIOL SCAND, V179, P361, DOI 10.1046/j.0001-6772.2003.01211.x; Walmsley SR, 2006, BLOOD, V108, P3176, DOI 10.1182/blood-2006-04-018796; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wasserman K, 2005, PRINCIPLES EXERCISE; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; YOCK PG, 1984, CIRCULATION, V70, P657, DOI 10.1161/01.CIR.70.4.657	51	70	70	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					2001	2011		10.1096/fj.10-177378	http://dx.doi.org/10.1096/fj.10-177378			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21389259	Green Published, hybrid			2022-12-25	WOS:000291023800022
J	Lu, KF; Li, P; Zhang, MH; Xing, GC; Li, X; Zhou, WH; Bartlam, M; Zhang, LQ; Rao, ZH; He, FC				Lu, Kefeng; Li, Ping; Zhang, Minghua; Xing, Guichun; Li, Xin; Zhou, Weihong; Bartlam, Mark; Zhang, Lingqiang; Rao, Zihe; He, Fuchu			Pivotal Role of the C2 Domain of the Smurf1 Ubiquitin Ligase in Substrate Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL DIVERSITY; CELL POLARITY; NEDD4 FAMILY; DEGRADATION; RECEPTOR; TARGETS; SMAD7	The C2-WW-HECT-type ubiquitin ligases Smurf1 and Smurf2 play a critical role in embryogenesis and adult bone homeostasis via regulation of bone morphogenetic protein, Wnt, and RhoA signaling pathways. The intramolecular interaction between C2 and HECT domains autoinhibits the ligase activity of Smurf2. However, the role of the Smurf1 C2 domain remains elusive. Here, we show that the C2-HECT autoinhibition mechanism is not observed in Smurf1, and instead its C2 domain functions in substrate selection. The Smurf1 C2 domain exerts a key role in localization to the plasma membrane and endows Smurf1 with differential activity toward RhoA versus Smad5 and Runx2. Crystal structure analysis reveals that the Smurf1 C2 domain possesses a typical anti-parallel beta-sandwich fold. Examination of the sulfate-binding site analysis reveals two key lysine residues, Lys-28 and Lys-85, within the C2 domain that are important for Smurf1 localization at the plasma membrane, regulation on cell migration, and robust ligase activity toward RhoA, which further supports a Ca2+-independent localization mechanism for Smurf1. These findings demonstrate a previously unidentified role of the Smurf1 C2 domain in substrate selection and cellular localization.	[Lu, Kefeng; Zhang, Minghua; Xing, Guichun; Zhang, Lingqiang; He, Fuchu] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China; [Li, Ping; Li, Xin; Zhou, Weihong; Bartlam, Mark; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China	Academy of Military Medical Sciences - China; Nankai University	Zhang, LQ (corresponding author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China.	zhanglq@nic.bmi.ac.cn; raozh@nankai.edu.cn	Zhang, Minghua/AAC-4782-2020; Rao, Zihe/HCH-6944-2022	Bartlam, Mark/0000-0001-5173-5080; Lu, Kefeng/0000-0001-8200-9380	National Basic Research Program [2011CB910602, 2007CB914601, 2007CB914301]; National Natural Science Foundation [30830029, 30970601]; National Key Technologies R&D Program for New Drugs [2009ZX09503-002, 2009ZX09301-002]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program for New Drugs(National Key Technology R&D Program)	This work was supported by National Basic Research Program Grants 2011CB910602, 2007CB914601, and 2007CB914301, National Natural Science Foundation Project Grants 30830029 and 30970601, and National Key Technologies R&D Program for New Drugs Grants 2009ZX09503-002 and 2009ZX09301-002.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Chong PA, 2010, P NATL ACAD SCI USA, V107, P18404, DOI 10.1073/pnas.1003023107; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Kalkan T, 2009, MOL BIOL CELL, V20, P3436, DOI 10.1091/mbc.E08-03-0325; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li S, 2010, MOL CELL BIOCHEM, V338, P11, DOI 10.1007/s11010-009-0315-y; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ogunjimi AA, 2010, J BIOL CHEM, V285, P6308, DOI 10.1074/jbc.M109.044537; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang Q, 2007, J BIOL CHEM, V282, P10742, DOI 10.1074/jbc.M610997200; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yamaguchi K, 2008, BIOL CHEM, V389, P405, DOI 10.1515/BC.2008.036; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Ying SX, 2003, J BIOL CHEM, V278, P39029, DOI 10.1074/jbc.M301193200; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	40	35	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16861	16870		10.1074/jbc.M110.211979	http://dx.doi.org/10.1074/jbc.M110.211979			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21402695	Green Published, hybrid			2022-12-25	WOS:000290301900035
J	Chen, XF; Overcash, R; Green, T; Hoffman, D; Asch, AS; Ruiz-Echevarra, MJ				Chen, Xiaofei; Overcash, Ryan; Green, Thomas; Hoffman, Donald; Asch, Adam S.; Ruiz-Echevarra, Maria J.			The Tumor Suppressor Activity of the Transmembrane Protein with Epidermal Growth Factor and Two Follistatin Motifs 2 (TMEFF2) Correlates with Its Ability to Modulate Sarcosine Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAUROSPORINE INDUCES APOPTOSIS; PROSTATE-CANCER; NERVOUS-SYSTEM; METHYLATION; IDENTIFICATION; PROMOTER; EXPRESSION; RECEPTOR; ISOFORM; GLYCINE	The type I transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2) is expressed in brain and prostate and overexpressed in prostate cancer, but its role in this disease is unclear. Several studies have suggested that TMEFF2 plays a role in suppressing the growth and invasive potential of human cancer cells, whereas others suggest that the shed portion of TMEFF2, which lacks the cytoplasmic region, has a growth-promoting activity. Here we show that TMEFF2 has a dual mode of action. Ectopic expression of wild-type full-length TMEFF2 inhibits soft agar colony formation, cellular invasion, and migration and increases cellular sensitivity to apoptosis. However, expression of the ectodomain portion of TMEFF2 increases cell proliferation. Using affinity chromatography and mass spectrometry, we identify sarcosine dehydrogenase (SARDH), the enzyme that converts sarcosine to glycine, as a TMEFF2-interacting protein. Co-immunoprecipitation and immunofluorescence analysis confirms the interaction of SARDH with full-length TMEFF2. The ectodomain does not bind to SARDH. Moreover, expression of the full-length TMEFF2 but not the ectodomain results in a decreased level of sarcosine in the cells. These results suggest that the tumor suppressor activity of TMEFF2 requires the cytoplasmic/transmembrane portion of the protein and correlates with its ability to bind to SARDH and to modulate the level of sarcosine.	[Green, Thomas; Asch, Adam S.; Ruiz-Echevarra, Maria J.] Brody Sch Med, Dept Med Hematol Oncol, Greenville, NC 27834 USA; [Chen, Xiaofei; Overcash, Ryan] Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27834 USA; [Hoffman, Donald] Brody Sch Med, Dept Pathol, Greenville, NC 27834 USA; [Asch, Adam S.; Ruiz-Echevarra, Maria J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Ruiz-Echevarra, MJ (corresponding author), Brody Sch Med, Dept Med Hematol Oncol, Greenville, NC 27834 USA.	ruizechevarriam@ecu.edu		Ruiz Echevarria, Maria Jesus/0000-0001-7133-9982	Division of Research and Graduate Studies at East Carolina University; Brody Brothers Foundation	Division of Research and Graduate Studies at East Carolina University; Brody Brothers Foundation	This work was supported in part by contributions from the Division of Research and Graduate Studies at East Carolina University and the Brody Brothers Foundation fund (to M. J. R.- E.).	Afar DEH, 2004, MOL CANCER THER, V3, P921; Ali N, 2007, J BIOL CHEM, V282, P37378, DOI 10.1074/jbc.M702170200; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Belouchi A., 2008, [No title captured], Patent No. [PCT/US2008/003125, 2008003125]; Belouchi A., 2008, World Intellectual Property Organization Patent, Patent No. [WO/2008/112177, 2008112177]; Bergeron F, 1998, EUR J BIOCHEM, V257, P556, DOI 10.1046/j.1432-1327.1998.2570556.x; Brucher BLDM, 2006, INT J CANCER, V119, P1298, DOI 10.1002/ijc.21990; Chang CB, 2003, DEV BIOL, V255, P1, DOI 10.1016/S0012-1606(02)00075-1; Elahi A, 2008, INT J CANCER, V122, P1567, DOI 10.1002/ijc.23202; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Gery S, 2003, J MOL BIOL, V328, P977, DOI 10.1016/S0022-2836(03)00404-2; Gery S, 2002, ONCOGENE, V21, P4739, DOI 10.1038/sj.onc.1205142; Glynne-Jones E, 2001, INT J CANCER, V94, P178, DOI 10.1002/ijc.1450; Gonzalo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008777; Harms PW, 2003, GENE DEV, V17, P2624, DOI 10.1101/gad.1127703; Heanue TA, 2006, P NATL ACAD SCI USA, V103, P6919, DOI 10.1073/pnas.0602152103; Hellwinkel OJC, 2008, BJU INT, V101, P753, DOI 10.1111/j.1464-410X.2007.07322.x; Horie M, 2000, GENOMICS, V67, P146, DOI 10.1006/geno.2000.6228; Ivanauskas A, 2008, DIGEST LIVER DIS, V40, P920, DOI 10.1016/j.dld.2008.05.004; Javitt DC, 2009, CURR OPIN DRUG DISC, V12, P468; Kanemoto N, 2001, MOL BRAIN RES, V86, P48, DOI 10.1016/S0169-328X(00)00257-6; Kang YK, 2008, CANCER RES, V68, P7887, DOI 10.1158/0008-5472.CAN-08-1734; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Lim SO, 2002, BIOCHEM BIOPH RES CO, V291, P1031, DOI 10.1006/bbrc.2002.6547; Lin H, 2003, LIFE SCI, V73, P1617, DOI 10.1016/S0024-3205(03)00514-9; Mohler JL, 2002, PROSTATE, V51, P247, DOI 10.1002/pros.10086; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Pan D, 2009, EMBO J, V28, P3500, DOI 10.1038/emboj.2009.250; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Quayle SN, 2006, GENOMICS, V87, P633, DOI 10.1016/j.ygeno.2005.12.004; Rodriguez Luis G., 2004, V294, P23; Siegel DA, 2002, INT J DEV NEUROSCI, V20, P373, DOI 10.1016/S0736-5748(02)00055-2; Siegel DA, 2006, J NEUROCHEM, V98, P34, DOI 10.1111/j.1471-4159.2006.03801.x; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stover PJ, 2009, J NUTR, V139, P2402, DOI 10.3945/jn.109.113670; Suzuki M, 2005, BRIT J CANCER, V93, P1029, DOI 10.1038/sj.bjc.6602837; Tsunoda S, 2009, ONCOL REP, V21, P1067, DOI 10.3892/or_00000325; Uchida T, 1999, BIOCHEM BIOPH RES CO, V266, P593, DOI 10.1006/bbrc.1999.1873; Zhang HX, 2009, J PHYSIOL-LONDON, V587, P3207, DOI 10.1113/jphysiol.2009.168757; Zhang XD, 2004, MOL CANCER THER, V3, P187	43	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.193805	http://dx.doi.org/10.1074/jbc.M110.193805			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21393249	Green Published, hybrid			2022-12-25	WOS:000290022800049
J	Grechi, J; Marinho-Carvalho, M; Zancan, P; Cinelli, LP; Gomes, AMO; Rodrigues, ML; Nimrichter, L; Sola-Penna, M				Grechi, Juliana; Marinho-Carvalho, Monica; Zancan, Patricia; Cinelli, Leonardo Paes; Gomes, Andre M. O.; Rodrigues, Marcio L.; Nimrichter, Leonardo; Sola-Penna, Mauro			Glucuronoxylomannan from Cryptococcus neoformans Down-regulates the Enzyme 6-Phosphofructo-1-kinase of Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT MUSCLE PHOSPHOFRUCTOKINASE; BREAST-CANCER CELLS; SKELETAL-MUSCLE; CAPSULAR POLYSACCHARIDES; CELLULAR-DISTRIBUTION; EXTRACELLULAR VESICLES; ALVEOLAR MACROPHAGES; GLYCOLYTIC-ENZYMES; SELF-ASSOCIATION; IN-VIVO	The encapsulated yeast Cryptococcus neoformans is the causative agent of cryptococosis, an opportunistic life-threatening infection. C. neoformans is coated by a polysaccharide capsule mainly composed of glucuronoxylomannan (GXM). GXM is considered a key virulence factor of this pathogen. The present work aimed at evaluating the effects of GXM on the key glycolytic enzyme, 6-phosphofructo-1-kinase (PFK). GXM inhibited PFK activity in cultured murine macrophages in both dose-and time-dependent manners, which occurred in parallel to cell viability decrease. The polysaccharide also inhibited purified PFK, promoting a decrease on the enzyme affinity for its substrates. In macrophages GXM and PFK partially co-localized, suggesting that internalized polysaccharide directly may interact with this enzyme. The mechanism of PFK inhibition involved dissociation of tetramers into weakly active dimers, as revealed by fluorescence spectroscopy. Allosteric modulators of the enzyme able to stabilize its tetrameric conformation attenuated the inhibition promoted by GXM. Altogether, our results suggest that the mechanism of GXM-induced cell death involves the inhibition of the glycolytic flux.	[Grechi, Juliana; Rodrigues, Marcio L.; Nimrichter, Leonardo] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Lab Estudos Integrados Bioquim Microbiana, BR-21941590 Rio De Janeiro, Brazil; [Grechi, Juliana; Marinho-Carvalho, Monica; Sola-Penna, Mauro] Univ Fed Rio de Janeiro, Fac Farm, Lab Enzimol & Controle Metab, BR-21941590 Rio De Janeiro, Brazil; [Zancan, Patricia] Univ Fed Rio de Janeiro, Fac Farm, Lab Oncobiol Mol, BR-21941590 Rio De Janeiro, Brazil; [Gomes, Andre M. O.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil; [Cinelli, Leonardo Paes] Univ Fed Rio de Janeiro, Fac Farm, BR-27930560 Macae, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Nimrichter, L (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Lab Estudos Integrados Bioquim Microbiana, BR-21941590 Rio De Janeiro, Brazil.	nimrichter1@yahoo.com; maurosp@ufrj.br	Zancan, Patricia/Q-6281-2016; Rodrigues, Marcio/J-3727-2013; de Carvalho, Mônica Mesquita Marinho/ABC-7373-2020; Sola-Penna, Mauro/E-8221-2011; Gomes, Andre M.O./C-4009-2014; Nimrichter, Leonardo/L-3545-2014	Zancan, Patricia/0000-0002-0503-028X; Rodrigues, Marcio/0000-0002-6081-3439; Sola-Penna, Mauro/0000-0001-9796-6829; Gomes, Andre M.O./0000-0003-1052-8004; Nimrichter, Leonardo/0000-0001-9281-6856	Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Companhade Aperfeicoamento de Pessoal de Nivel Superior/Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ	Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Companhade Aperfeicoamento de Pessoal de Nivel Superior/Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (to L.N., M.L.R., M.S.-P., and P.Z.).; Supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.; Supported by Companhade Aperfeicoamento de Pessoal de Nivel Superior/Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ.	Alvarez M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-16; Alvarez M, 2006, CURR BIOL, V16, P2161, DOI 10.1016/j.cub.2006.09.061; Alves GG, 2003, MOL GENET METAB, V78, P302, DOI 10.1016/S1096-7192(03)00037-4; Barbosa FM, 2007, CLIN VACCINE IMMUNOL, V14, P94, DOI 10.1128/CVI.00296-06; BOLANOS B, 1989, J LEUKOCYTE BIOL, V46, P521, DOI 10.1002/jlb.46.6.521; BULMER GS, 1975, INFECT IMMUN, V11, P73, DOI 10.1128/IAI.11.1.73-79.1975; Cai GZ, 1997, BIOPHYS CHEM, V64, P199, DOI 10.1016/S0301-4622(96)02232-6; CASADEVALL A, 1992, J IMMUNOL METHODS, V154, P27, DOI 10.1016/0022-1759(92)90209-C; CEPPI ED, 1992, BIOCHEM J, V284, P761, DOI 10.1042/bj2840761; Chang ZL, 2006, INFECT IMMUN, V74, P144, DOI 10.1128/IAI.74.1.144-151.2006; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; Chiapello LS, 2008, INT IMMUNOL, V20, P1527, DOI 10.1093/intimm/dxn112; Coelho WS, 2007, MOL GENET METAB, V92, P364, DOI 10.1016/j.ymgme.2007.07.010; Da Silva D, 2010, ARCH BIOCHEM BIOPHYS, V496, P53, DOI 10.1016/j.abb.2010.01.013; DISCHE Z, 1947, J BIOL CHEM, V167, P189; Ellerbroek PM, 2004, CURR MED CHEM, V11, P253, DOI 10.2174/0929867043456188; Fonseca FL, 2009, FUNGAL GENET BIOL, V46, P496, DOI 10.1016/j.fgb.2009.03.003; Frases S, 2009, P NATL ACAD SCI USA, V106, P1228, DOI 10.1073/pnas.0808995106; Grijpstra J, 2009, EUKARYOT CELL, V8, P1165, DOI 10.1128/EC.00013-09; Heiss C, 2009, CARBOHYD RES, V344, P915, DOI 10.1016/j.carres.2009.03.003; HESTERBERG LK, 1981, BIOCHEMISTRY-US, V20, P2974, DOI 10.1021/bi00513a040; HESTERBERG LK, 1980, BIOCHEMISTRY-US, V19, P2030, DOI 10.1021/bi00551a004; KOZEL TR, 1988, REV INFECT DIS, V10, pS436; KOZEL TR, 1982, J IMMUNOL, V129, P1675; KOZEL TR, 1976, INFECT IMMUN, V14, P62, DOI 10.1128/IAI.14.1.62-67.1976; Leite TC, 2007, BIOCHEM J, V408, P123, DOI 10.1042/BJ20070687; Li Shu Shun, 2010, Proc Am Thorac Soc, V7, P186, DOI 10.1513/pats.200907-063AL; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTHER MA, 1986, J BIOL CHEM, V261, P1753; LUTHER MA, 1983, BIOCHEMISTRY-US, V22, P5494, DOI 10.1021/bi00293a007; LUTHER MA, 1986, BIOCHEMISTRY-US, V25, P7931, DOI 10.1021/bi00372a022; Maia J.C.C., 1983, GENES ANTIGENES PARA, P146; Marcondes MC, 2010, ARCH BIOCHEM BIOPHYS, V497, P62, DOI 10.1016/j.abb.2010.03.013; Marinho-Carvalho MM, 2006, MOL GENET METAB, V87, P253, DOI 10.1016/j.ymgme.2005.11.002; Marinho-Carvalho MM, 2009, BBA-PROTEINS PROTEOM, V1794, P1175, DOI 10.1016/j.bbapap.2009.02.006; McClelland EE, 2006, INFECT IMMUN, V74, P1500, DOI 10.1128/IAI.74.3.1500-1504.2006; McFadden DC, 2006, J BIOL CHEM, V281, P1868, DOI 10.1074/jbc.M509465200; Meira DD, 2005, MOL GENET METAB, V84, P354, DOI 10.1016/j.ymgme.2004.11.012; MITCHELL TG, 1972, INFECT IMMUN, V5, P491, DOI 10.1128/IAI.5.4.491-498.1972; Monari C, 2005, J INFECT DIS, V191, P127, DOI 10.1086/426511; Monari C, 2008, CELL MICROBIOL, V10, P2129, DOI 10.1111/j.1462-5822.2008.01196.x; Monari C, 2009, J IMMUNOL, V183, P191, DOI 10.4049/jimmunol.0804144; Mukherjee S, 1996, J INFECT DIS, V173, P1222, DOI 10.1093/infdis/173.5.1222; Nimrichter L, 2007, EUKARYOT CELL, V6, P1400, DOI 10.1128/EC.00122-07; Nosanchuk Joshua D, 2008, Commun Integr Biol, V1, P37; Oliveira DL, 2010, INFECT IMMUN, V78, P1601, DOI 10.1128/IAI.01171-09; OROSZ F, 1988, MOL PHARMACOL, V33, P678; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pelli AA, 2010, MICRON, V41, P660, DOI 10.1016/j.micron.2010.03.001; Penso J, 1998, EUR J PHARMACOL, V342, P113, DOI 10.1016/S0014-2999(97)01507-0; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Prado M, 2009, MEM I OSWALDO CRUZ, V104, P513, DOI 10.1590/S0074-02762009000300019; Rais B, 2000, BBA-PROTEIN STRUCT M, V1479, P303, DOI 10.1016/S0167-4838(00)00047-9; Real-Hohn A, 2010, BIOCHIMIE, V92, P538, DOI 10.1016/j.biochi.2010.01.023; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; Rodrigues ML, 2009, MED MYCOL, V47, P783, DOI 10.3109/13693780902788621; Silva APP, 2004, AN ACAD BRAS CIENC, V76, P541, DOI 10.1590/S0001-37652004000300008; Sola-Penna M, 2002, J BIOCHEM BIOPH METH, V50, P129, DOI 10.1016/S0165-022X(01)00180-4; Sola-Penna M, 2008, IUBMB LIFE, V60, P605, DOI 10.1002/iub.97; Sola-Penna M, 2010, IUBMB LIFE, V62, P791, DOI 10.1002/iub.393; Spitz GA, 2009, BIOCHEM PHARMACOL, V77, P46, DOI 10.1016/j.bcp.2008.09.020; TAYLOR RL, 1972, BIOCHEMISTRY-US, V11, P1383, DOI 10.1021/bi00758a009; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; Vecchiarelli A, 2000, MED MYCOL, V38, P407, DOI 10.1080/mmy.38.6.407.417; Vecchiarelli Anna, 2010, Front Biosci (Schol Ed), V2, P256; Vertessy BG, 1997, BIOCHEMISTRY-US, V36, P2051, DOI 10.1021/bi9623441; Villena SN, 2008, CELL MICROBIOL, V10, P1274, DOI 10.1111/j.1462-5822.2008.01125.x; Yauch LE, 2006, PLOS PATHOG, V2, P1060, DOI 10.1371/journal.ppat.0020120; Yauch LE, 2005, INFECT IMMUN, V73, P8429, DOI 10.1128/IAI.73.12.8429-8432.2005; Zancan P, 2005, MOL GENET METAB, V86, P401, DOI 10.1016/j.ymgme.2005.06.011; Zancan P, 2005, MOL GENET METAB, V86, P392, DOI 10.1016/j.ymgme.2005.07.005; Zancan P, 2008, IUBMB LIFE, V60, P526, DOI 10.1002/iub.58; Zancan P, 2007, ARCH BIOCHEM BIOPHYS, V467, P275, DOI 10.1016/j.abb.2007.08.032; Zancan P, 2007, BIOCHEM PHARMACOL, V73, P1520, DOI 10.1016/j.bcp.2007.01.018; Zancan P, 2010, MOL GENET METAB, V100, P372, DOI 10.1016/j.ymgme.2010.04.006; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0	77	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14820	14829		10.1074/jbc.M110.177030	http://dx.doi.org/10.1074/jbc.M110.177030			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388964	hybrid, Green Published			2022-12-25	WOS:000289788300012
J	Venkatesha, SH; Yu, H; Rajaiah, R; Tong, L; Moudgil, KD				Venkatesha, Shivaprasad H.; Yu, Hua; Rajaiah, Rajesh; Tong, Li; Moudgil, Kamal D.			Celastrus-derived Celastrol Suppresses Autoimmune Arthritis by Modulating Antigen-induced Cellular and Humoral Effector Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATOID-ARTHRITIS; TERMINAL DETERMINANTS; T-H-17 CELLS; HEAT-SHOCK-PROTEIN-65; MYCOBACTERIAL; ANGIOGENESIS; DISABILITY; ANTIBODIES; INDUCTION; CYTOKINES	Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial inflammation and articular damage. Proinflammatory cytokines, antibodies, and matrix-degrading enzymes orchestrate the pathogenic events in autoimmune arthritis. Accordingly, these mediators of inflammation are the targets of several anti-arthritic drugs. However, the prolonged use of such drugs is associated with severe adverse reactions. This limitation has necessitated the search for less toxic natural plant products that possess anti-arthritic activity. Furthermore, it is imperative that the mechanism of action of such products be explored before they can be recommended for further preclinical testing. Using the rat adjuvant-induced arthritis model of human RA, we demonstrate that celastrol derived from Celastrus has potent anti-arthritic activity. This suppression of arthritis is mediated via modulation of the key proinflammatory cytokines (IL-17, IL-6, and IFN-gamma) in response to the disease-related antigens, of the IL-6/IL-17-related transcription factor STAT3, of antibodies directed against cyclic citrullinated peptides and Bhsp65, and of the activity of matrix metalloproteinase-9 and phospho-ERK. Most of the clinical and mechanistic attributes of celastrol are similar to those of Celastrus extract. Several studies have addressed the antitumor activity of celastrol. Our study highlights the anti-arthritic activity of Celastrus-derived celastrol and the underlying mechanisms. These results provide a strong rationale for further testing and validation of the use of celastrol and the natural plant extract from Celastrus as an adjunct (with conventional drugs) or alternative modality for the treatment of RA.	[Venkatesha, Shivaprasad H.; Yu, Hua; Rajaiah, Rajesh; Moudgil, Kamal D.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Moudgil, Kamal D.] Univ Maryland, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21201 USA; [Tong, Li] So Med Univ, Sch Tradit Chinese Med, Guangzhou 510510, Guangdong, Peoples R China	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Southern Medical University - China	Moudgil, KD (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 W Baltimore St,HSF-1,Suite 380, Baltimore, MD 21201 USA.	kmoud001@umaryland.edu	Venkatesha, Shivaprasad/S-3141-2016; Rajaiah, Rajesh/A-3403-2012; Rajaiah, rajesh/ABA-5509-2021; yu, hua/F-8948-2012		National Institutes of Health [R01AT004321]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported, in whole or in part, by National Institutes of Health Grant R01AT004321.	Backman CL, 2004, CURR OPIN RHEUMATOL, V16, P148, DOI 10.1097/00002281-200403000-00014; Barnes Patricia M, 2004, Adv Data, P1; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Chang YH, 2008, CLIN BIOCHEM, V41, P955, DOI 10.1016/j.clinbiochem.2008.04.012; Durai M, 2004, J IMMUNOL, V172, P2795, DOI 10.4049/jimmunol.172.5.2795; Eck SM, 2009, J AUTOIMMUN, V33, P214, DOI 10.1016/j.jaut.2009.09.011; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; Gaffen Sarah L, 2009, Curr Rheumatol Rep, V11, P365; Gorman CL, 2008, BEST PRACT RES CL RH, V22, P221, DOI 10.1016/j.berh.2008.01.003; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hembry Rosalind M., 2007, V135, P227; Hu HY, 2009, J CARDIOVASC PHARM, V54, P240, DOI 10.1097/FJC.0b013e3181b21472; Jung HW, 2007, EXP MOL MED, V39, P715, DOI 10.1038/emm.2007.78; Kageyama-Yahara N, 2010, BIOL PHARM BULL, V33, P142, DOI 10.1248/bpb.33.142; Kim DH, 2009, EUR J CLIN INVEST, V39, P819, DOI 10.1111/j.1365-2362.2009.02186.x; Kim HR, 2006, J IMMUNOL, V177, P6634, DOI 10.4049/jimmunol.177.10.6634; Kim Y, 2009, EUR J PHARMACOL, V612, P131, DOI 10.1016/j.ejphar.2009.03.071; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kremers HM, 2004, J RHEUMATOL, V31, P2366; Lainer-Carr D, 2007, NAT CLIN PRACT RHEUM, V3, P434, DOI 10.1038/ncprheum0559; Lipsky PE, 2005, HARRISONS PRINCIPLES, P1968; Luo DQ, 2005, PEST MANAG SCI, V61, P85, DOI 10.1002/ps.953; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Moudgil KD, 1997, J EXP MED, V185, P1307, DOI 10.1084/jem.185.7.1307; Pajulo OT, 1999, WOUND REPAIR REGEN, V7, P453, DOI 10.1046/j.1524-475X.1999.00453.x; Pruijn GJM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2903; Quiding-Jarbrink M, 2001, INFECT IMMUN, V69, P5661, DOI 10.1128/IAI.69.9.5661-5670.2001; Rajaiah R, 2011, J BIOL CHEM, V286, P2817, DOI 10.1074/jbc.M110.187013; Scott DL, 2003, CLIN EXP RHEUMATOL, V21, pS20; Shen CL, 2011, OSTEOPOROSIS INT, V22, P327, DOI 10.1007/s00198-010-1209-2; Song YW, 2010, QJM-INT J MED, V103, P139, DOI 10.1093/qjmed/hcp165; Stiel D, 2000, Am J Ther, V7, P91, DOI 10.1097/00045391-200007020-00006; Taibi DM, 2003, FAM COMMUNITY HEALTH, V26, P41, DOI 10.1097/00003727-200301000-00006; Tong L, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2268; Uysal H, 2010, IMMUNOL REV, V233, P9, DOI 10.1111/j.0105-2896.2009.00853.x; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Venkatesha SH, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/986797; Venkatesha SH, 2011, BIOORGAN MED CHEM, V19, P21, DOI 10.1016/j.bmc.2010.10.053; Weir MR, 2002, CLEV CLIN J MED, V69, P53; WOOLEY PH, 1988, METHOD ENZYMOL, V162, P361; Wu SH, 2004, J CHROMATOGR A, V1028, P171, DOI 10.1016/j.chroma.2003.11.072; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yu H, 2011, ARTHRITIS RHEUM-US, V63, P981, DOI 10.1002/art.30219	45	89	93	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15138	15146		10.1074/jbc.M111.226365	http://dx.doi.org/10.1074/jbc.M111.226365			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21402700	hybrid, Green Published			2022-12-25	WOS:000289788300045
J	Solomon, IH; Khatri, N; Biasini, E; Massignan, T; Huettner, JE; Harris, DA				Solomon, Isaac H.; Khatri, Natasha; Biasini, Emiliano; Massignan, Tania; Huettner, James E.; Harris, David A.			An N-terminal Polybasic Domain and Cell Surface Localization Are Required for Mutant Prion Protein Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; CULTURED-CELLS; SYNAPTIC PLASTICITY; ANCHORED PROTEINS; SCRAPIE ISOFORM; TRANSGENIC MICE; BETA OLIGOMERS; WILD-TYPE; PRP; DISEASE	There is evidence that alterations in the normal physiological activity of PrPC contribute to prion-induced neurotoxicity. This mechanism has been difficult to investigate, however, because the normal function of PrPC has remained obscure, and there are no assays available to measure it. We recently reported that cells expressing PrP deleted for residues 105-125 exhibit spontaneous ionic currents and hypersensitivity to certain classes of cationic drugs. Here, we utilize cell culture assays based on these two phenomena to test how changes in PrP sequence and/or cellular localization affect the functional activity of the protein. We report that the toxic activity of Delta 105-125 PrP requires localization to the plasma membrane and depends on the presence of a polybasic amino acid segment at the N terminus of PrP. Several different deletions spanning the central region as well as three disease-associated point mutations also confer toxic activity on PrP. The sequence domains identified in our study are also critical for PrPSc formation, suggesting that common structural features may govern both the functional activity of PrPC and its conversion to PrPSc.	[Solomon, Isaac H.; Khatri, Natasha; Biasini, Emiliano; Massignan, Tania; Harris, David A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Huettner, James E.] Washington Univ, Dept Cell Biol & Physiol, Sch Med, St Louis, MO 63110 USA	Boston University; Washington University (WUSTL)	Harris, DA (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,K225, Boston, MA 02118 USA.	daharris@bu.edu	Huettner, James E/C-5219-2012; Biasini, Emiliano/A-3147-2011	Biasini, Emiliano/0000-0002-3927-6341; massignan, tania/0000-0002-6176-2696; Harris, David/0000-0002-6985-5790	National Institutes of Health [NS052526, NS040975, NS30888, NS063547]; Washington University [T32GM007200]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200, T32GM008541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS063547, R01NS030888, R01NS040975, R01NS065244, R01NS052526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS052526 and NS040975 (to D. A. H.) and NS30888 (to J. E. H.).; Supported by National Institutes of Health Pre-doctoral Fellowship NS063547 and the Medical Scientist Training Program at Washington University (National Institutes of Health Grant T32GM007200).	Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Baumann F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006707; Biasini E, 2010, BIOCHEM J, V430, P477, DOI 10.1042/BJ20100615; BOLTON DC, 1991, J VIROL, V65, P3667, DOI 10.1128/JVI.65.7.3667-3675.1991; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Christensen HM, 2009, J NEUROCHEM, V108, P44, DOI 10.1111/j.1471-4159.2008.05719.x; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Fuhrmann M, 2006, J NEUROCHEM, V98, P1876, DOI 10.1111/j.1471-4159.2006.04011.x; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; Hajj GNM, 2007, J CELL SCI, V120, P1915, DOI 10.1242/jcs.03459; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; HAY B, 1987, MOL CELL BIOL, V7, P914, DOI 10.1128/MCB.7.2.914; Herms JW, 2001, NEUROBIOL DIS, V8, P324, DOI 10.1006/nbdi.2000.0369; HOBMAN TC, 1995, MOL BIOL CELL, V6, P7, DOI 10.1091/mbc.6.1.7; Hooper NM, 2008, BIOCHEM SOC T, V36, P1272, DOI 10.1042/BST0361272; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V207, P621, DOI 10.1006/bbrc.1995.1233; Huettner JE, 2006, STEM CELLS, V24, P1654, DOI 10.1634/stemcells.2005-0003; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Kourie JI, 2003, J MEMBRANE BIOL, V193, P35, DOI 10.1007/s00232-002-2005-5; Kourie JI, 2002, EUR BIOPHYS J BIOPHY, V31, P409, DOI 10.1007/s00249-002-0242-2; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Lorenz H, 2002, J BIOL CHEM, V277, P8508, DOI 10.1074/jbc.M110197200; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Maglio LE, 2004, MOL BRAIN RES, V131, P58, DOI 10.1016/j.molbrainres.2004.08.004; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Massignan T, 2011, METHODS, V53, P214, DOI 10.1016/j.ymeth.2010.11.005; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Myrdal SE, 2005, HEARING RES, V204, P170, DOI 10.1016/j.heares.2005.02.005; Myrdal SE, 2005, HEARING RES, V204, P156, DOI 10.1016/j.heares.2005.02.002; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005285; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2004, PRION BIOL DIS; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Rodriguez MM, 2005, NEUROLOGY, V64, P1455, DOI 10.1212/01.WNL.0000158618.39527.93; Sandoval RM, 2000, AM J PHYSIOL-RENAL, V279, pF884, DOI 10.1152/ajprenal.2000.279.5.F884; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SHYNG SL, 1995, J BIOL CHEM, V270, P14793, DOI 10.1074/jbc.270.24.14793; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; Wadia JS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003314; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Wilding TJ, 2005, J NEUROSCI, V25, P9470, DOI 10.1523/JNEUROSCI.2826-05.2005; YOST CS, 1990, NATURE, V343, P669, DOI 10.1038/343669a0; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200	72	45	45	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14724	14736		10.1074/jbc.M110.214973	http://dx.doi.org/10.1074/jbc.M110.214973			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21385869	Green Published, hybrid			2022-12-25	WOS:000289556200091
J	Goni, J; Aznarez-Sanado, M; Arrondo, G; Fernandez-Seara, M; Loayza, FR; Heukamp, FH; Pastor, MA				Goni, Joaquin; Aznarez-Sanado, Maite; Arrondo, Gonzalo; Fernandez-Seara, Maria; Loayza, Francis R.; Heukamp, Franz H.; Pastor, Maria A.			The Neural Substrate and Functional Integration of Uncertainty in Decision Making: An Information Theory Approach	PLOS ONE			English	Article							PREFRONTAL CORTEX; ANTERIOR CINGULATE; INSULAR CORTEX; PROBABILITY; VALIDATION; ACTIVATION; NETWORKS; PARIETAL; CONTEXT	Decision making can be regarded as the outcome of cognitive processes leading to the selection of a course of action among several alternatives. Borrowing a central measurement from information theory, Shannon entropy, we quantified the uncertainties produced by decisions of participants within an economic decision task under different configurations of reward probability and time. These descriptors were used to obtain blood oxygen level-dependent (BOLD) signal correlates of uncertainty and two clusters codifying the Shannon entropy of task configurations were identified: a large cluster including parts of the right middle cingulate cortex (MCC) and left and right pre-supplementary motor areas (pre-SMA) and a small cluster at the left anterior thalamus. Subsequent functional connectivity analyses using the psycho-physiological interactions model identified areas involved in the functional integration of uncertainty. Results indicate that clusters mostly located at frontal and temporal cortices experienced an increased connectivity with the right MCC and left and right pre-SMA as the uncertainty was higher. Furthermore, pre-SMA was also functionally connected to a rich set of areas, most of them associative areas located at occipital and parietal lobes. This study provides a map of the human brain segregation and integration (i.e., neural substrate and functional connectivity respectively) of the uncertainty associated to an economic decision making paradigm.	[Goni, Joaquin; Aznarez-Sanado, Maite; Arrondo, Gonzalo; Fernandez-Seara, Maria; Loayza, Francis R.; Pastor, Maria A.] Univ Navarra, Neuroimaging Lab, Dept Neurosci, Ctr Appl Med Res, E-31080 Pamplona, Spain; [Arrondo, Gonzalo; Heukamp, Franz H.] Univ Navarra, IESE Business Sch, Barcelona, Spain	University of Navarra; University of Navarra; IESE Business School	Goni, J (corresponding author), Univ Navarra, Neuroimaging Lab, Dept Neurosci, Ctr Appl Med Res, E-31080 Pamplona, Spain.	mapastor@unav.es	Loayza, Francis R./AAR-7985-2021; Fernandez-Seara, Maria A./K-1246-2014; Pastor, Maria A./C-7851-2009; Arrondo, Gonzalo/U-9534-2017	Loayza, Francis R./0000-0002-6283-3679; Fernandez-Seara, Maria A./0000-0001-8536-6295; Pastor, Maria A./0000-0003-2404-9346; Arrondo, Gonzalo/0000-0003-3085-8959; Aznarez-Sanado, Maite/0000-0002-4368-548X	FIMA of the University of Navarra; IESE Business School of the University of Navarra; CIBERNED	FIMA of the University of Navarra; IESE Business School of the University of Navarra; CIBERNED(Instituto de Salud Carlos III)	This work was funded by FIMA of the University of Navarra, IESE Business School of the University of Navarra and by CIBERNED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Aziz-Zadeh L, 2009, HUM BRAIN MAPP, V30, P908, DOI 10.1002/hbm.20554; BAUCELLS M, 2007, PROBABILITY TIME TRA; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bischoff-Grethe A, 2001, J COGNITIVE NEUROSCI, V13, P986, DOI 10.1162/089892901753165881; Blackwood N, 2004, COGNITIVE BRAIN RES, V20, P46, DOI 10.1016/j.cogbrainres.2003.12.009; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Elliott R, 1999, NEUROPSYCHOLOGIA, V37, P403, DOI 10.1016/S0028-3932(98)00107-9; Fan J, 2008, CEREB CORTEX, V18, P796, DOI 10.1093/cercor/bhm125; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; FORTSMANN BU, 2008, P NATL ACAD SCI USA, V105, P17538; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Harrison LM, 2006, NEURAL NETWORKS, V19, P535, DOI 10.1016/j.neunet.2005.11.002; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; Nachev P, 2007, NEUROIMAGE, V36, pT155, DOI 10.1016/j.neuroimage.2007.03.034; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Paulus MP, 2002, NEUROIMAGE, V15, P836, DOI 10.1006/nimg.2001.1031; Paulus MP, 2001, NEUROIMAGE, V13, P91, DOI 10.1006/nimg.2000.0667; Penny W., 2003, HUMAN BRAIN FUNCTION; Pochon JB, 2008, J NEUROSCI, V28, P3468, DOI 10.1523/JNEUROSCI.4195-07.2008; Reynolds SM, 2005, J NEUROSCI, V25, P11757, DOI 10.1523/JNEUROSCI.3432-05.2005; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Stephan KE, 2004, J ANAT, V205, P443, DOI 10.1111/j.0021-8782.2004.00359.x; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025; STOODLEY C, 2010, CORTEX IN PRESS; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; STRANGE BA, 1999, NEUROIMAGE, V9, P36; Volz KG, 2005, BRAIN RES BULL, V67, P403, DOI 10.1016/j.brainresbull.2005.06.011; Volz KG, 2004, NEUROIMAGE, V21, P848, DOI 10.1016/j.neuroimage.2003.10.028; Volz KG, 2003, NEUROIMAGE, V19, P271, DOI 10.1016/S1053-8119(03)00122-8; Wittmann M, 2007, EXP BRAIN RES, V179, P643, DOI 10.1007/s00221-006-0822-y	38	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17408	10.1371/journal.pone.0017408	http://dx.doi.org/10.1371/journal.pone.0017408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408065	Green Submitted, Green Published, gold			2022-12-25	WOS:000288170900015
J	Jardri, R; Pins, D; Lafargue, G; Very, E; Ameller, A; Delmaire, C; Thomas, P				Jardri, Renaud; Pins, Delphine; Lafargue, Gilles; Very, Etienne; Ameller, Aurely; Delmaire, Christine; Thomas, Pierre			Increased Overlap between the Brain Areas Involved in Self-Other Distinction in Schizophrenia	PLOS ONE			English	Article							MIRROR NEURONS; PARIETAL; AGENCY; HALLUCINATIONS; SYMPTOMS; REPRESENTATIONS; SYSTEM; BODY; PET; RECOGNITION	Self-awareness impairments are frequently mentioned as being responsible for the positive symptoms of schizophrenia spectrum disorders. However, the neural correlates of self-other distinction in this pathology are still poorly understood. In the present study, we developed an fMRI procedure in order to examine self-other distinction during speech exchange situations. Fifteen subjects with schizophrenia were compared to 15 matched controls. The results revealed an increased overlap between the self and non-self cortical maps in schizophrenia, in the medial frontal and medial parietal cortices, as well as in the right middle temporal cortex and the right inferior parietal lobule. Moreover, these neural structures showed less BOLD amplitude differences between the self and non-self conditions in the patients. These activation patterns were judged to be independent of mirror-like properties, familiarity or body-ownership processing. Significantly, the increase in the right IPL signal was found to correlate positively with the severity of first-rank symptoms, and thus could be considered a "state-marker" of schizophrenia, whereas temporal and medial parieto-frontal differences appear to be "trait-markers" of the disease. Such an increased overlap between self and non-self cortical maps might be considered a neuro-physiological signature of the well established self-awareness impairment in people suffering from schizophrenia.	[Jardri, Renaud; Pins, Delphine; Lafargue, Gilles; Delmaire, Christine; Thomas, Pierre] Univ Lille Nord de France, Lab Neurosci Fonct & Pathol, EA 4559, Lille, France; [Jardri, Renaud] CHRU Lille, Hop Fontan, Serv Psychiat Infanto Juvenile, Lille, France; [Pins, Delphine] CNRS, Paris, France; [Very, Etienne] Hop Purpan, Serv Urgences Psychiat Univ, Toulouse, France; [Ameller, Aurely; Thomas, Pierre] CHRU Lille, Hop Fontan, Psychiat Serv, Lille, France; [Delmaire, Christine] CHRU Lille, Hop Salengro, Serv Neuroradiol, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Jardri, R (corresponding author), Univ Lille Nord de France, Lab Neurosci Fonct & Pathol, EA 4559, Lille, France.	renaud.jardri@chru-lille.fr	Jardri, Renaud/J-9202-2012; Jardri, Renaud/ABE-5841-2021	Jardri, Renaud/0000-0003-4596-1502; Pins, Delphine/0000-0001-9158-8425				Agnew Z, 2008, J NEUROSCI, V28, P12268, DOI 10.1523/JNEUROSCI.2836-08.2008; Allen PP, 2004, SCHIZOPHR RES, V69, P277, DOI 10.1016/j.schres.2003.09.008; [Anonymous], 2000, DIAGNOSTIC STAT MANU, V4th; Blanke O, 2005, J NEUROSCI, V25, P550, DOI 10.1523/JNEUROSCI.2612-04.2005; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2008, CURR OPIN PSYCHIATR, V21, P281, DOI 10.1097/YCO.0b013e3282fbcd32; Bulot V, 2007, EXP BRAIN RES, V183, P115, DOI 10.1007/s00221-007-1027-8; Charney DS, 2002, RESEARCH AGENDA FOR DSM-V, P31; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Crow TJ, 1998, BRIT J PSYCHIAT, V173, P303, DOI 10.1192/bjp.173.4.303; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Dubois J, 2008, HUM BRAIN MAPP, V29, P14, DOI 10.1002/hbm.20363; Farrer C, 2004, PSYCHIAT RES-NEUROIM, V131, P31, DOI 10.1016/j.pscychresns.2004.02.004; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; FEINBERG I, 1978, SCHIZOPHRENIA BULL, V4, P636, DOI 10.1093/schbul/4.4.636; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Franck N, 2001, AM J PSYCHIAT, V158, P454, DOI 10.1176/appi.ajp.158.3.454; Frith C, 2005, CONSCIOUS COGN, V14, P752, DOI 10.1016/j.concog.2005.04.002; FRITH CD, 1989, PSYCHOL MED, V19, P359, DOI 10.1017/S003329170001240X; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Georgieff N, 1998, CONSCIOUS COGN, V7, P465, DOI 10.1006/ccog.1998.0367; Hesling I, 2005, NEUROIMAGE, V24, P937, DOI 10.1016/j.neuroimage.2004.11.003; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Jardri R, 2007, NEUROIMAGE, V35, P1645, DOI 10.1016/j.neuroimage.2007.02.002; Jardri R, 2009, NEUROPSYCHOLOGIA, V47, P132, DOI 10.1016/j.neuropsychologia.2008.08.006; Jeannerod M, 2009, EXP BRAIN RES, V192, P527, DOI 10.1007/s00221-008-1533-3; Johns LC, 2001, PSYCHOL MED, V31, P705, DOI 10.1017/S0033291701003774; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kiebel S., 2003, HUMAN BRAIN FUNCTION, P725; Lafargue G, 2009, CONSCIOUS COGN, V18, P277, DOI 10.1016/j.concog.2008.05.004; Lindner A, 2005, CURR BIOL, V15, P1119, DOI 10.1016/j.cub.2005.05.049; Maruff P, 2005, PSYCHOL MED, V35, P783, DOI 10.1017/S0033291704003113; MELLOR CS, 1970, BRIT J PSYCHIAT, V117, P15, DOI 10.1192/S0007125000192116; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Plaze M, 2011, SCHIZOPHRENIA BULL, V37, P212, DOI 10.1093/schbul/sbp081; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; SCHNEIDER K, 1955, KLIN PSYCHOPATHOLOGI; Spence SA, 1997, BRAIN, V120, P1997, DOI 10.1093/brain/120.11.1997; Talairach I., 1988, COPLANAR STEREOTACTI; Torrey EF, 2007, SCHIZOPHR RES, V97, P215, DOI 10.1016/j.schres.2007.08.023; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Uddin LQ, 2006, SOC COGN AFFECT NEUR, V1, P65, DOI 10.1093/scan/nsl003; van den Bos E, 2002, COGNITION, V85, P177, DOI 10.1016/S0010-0277(02)00100-2; Waters FAV, 2010, SCHIZOPHRENIA BULL, V36, P510, DOI 10.1093/schbul/sbn112; Wible CG, 2009, BRAIN IMAGING BEHAV, V3, P85, DOI 10.1007/s11682-008-9052-1; Wilke M, 2001, NEUROIMAGE, V13, P814, DOI 10.1006/nimg.2001.0751	51	45	46	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17500	10.1371/journal.pone.0017500	http://dx.doi.org/10.1371/journal.pone.0017500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408008	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170900023
J	Pan, YQ; Ouyang, ZQ; Wong, WH; Baker, JC				Pan, Yuqiong; Ouyang, Zhengqing; Wong, Wing Hung; Baker, Julie C.			A New FACS Approach Isolates hESC Derived Endoderm Using Transcription Factors	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; EXPRESSION ANALYSIS; FLOW-CYTOMETRY; DIFFERENTIATION; RNA; FIXATION; MOUSE	We show that high quality microarray gene expression profiles can be obtained following FACS sorting of cells using combinations of transcription factors. We use this transcription factor FACS (tfFACS) methodology to perform a genomic analysis of hESC-derived endodermal lineages marked by combinations of SOX17, GATA4, and CXCR4, and find that triple positive cells have a much stronger definitive endoderm signature than other combinations of these markers. Additionally, SOX17(+) GATA4(+) cells can be obtained at a much earlier stage of differentiation, prior to expression of CXCR4(+) cells, providing an important new tool to isolate this earlier definitive endoderm subtype. Overall, tfFACS represents an advancement in FACS technology which broadly crosses multiple disciplines, most notably in regenerative medicine to redefine cellular populations.	[Pan, Yuqiong; Wong, Wing Hung] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Pan, Yuqiong; Baker, Julie C.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Pan, Yuqiong] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Ouyang, Zhengqing; Wong, Wing Hung] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Wong, Wing Hung] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Pan, YQ (corresponding author), Stanford Univ, Dept Stat, Stanford, CA 94305 USA.	whwong@stanford.edu; jbaker@stanford.edu			California Institute of Regenerative Medicine (CIRM) [RC1-00100, RC1-00133]; National Institutes of Health [1U01HL100397]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the California Institute of Regenerative Medicine (CIRM) Grants RC1-00100 (J.C.B., W.H.W.) and RC1-00133 (W.H.W.), National Institutes of Health grant 1U01HL100397 (W.H.W.). Z.O. was supported by a CIRM predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afouda BA, 2005, DEVELOPMENT, V132, P763, DOI 10.1242/dev.01647; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Chiao E, 2008, STEM CELLS, V26, P2032, DOI 10.1634/stemcells.2007-0964; Cox ML, 2006, EXP MOL PATHOL, V80, P183, DOI 10.1016/j.yexmp.2005.10.002; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; De Rosa SC, 2003, NAT MED, V9, P112, DOI 10.1038/nm0103-112; Goldsworthy SM, 1999, MOL CARCINOGEN, V25, P86, DOI 10.1002/(SICI)1098-2744(199906)25:2<86::AID-MC2>3.3.CO;2-W; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Krutzik PO, 2004, CLIN IMMUNOL, V110, P206, DOI 10.1016/j.clim.2003.11.009; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li JX, 2000, GENE DEV, V14, P464; LIU H, 2007, P LSS COMPUT SYST BI, V6, P79; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Medeiros F, 2007, ARCH PATHOL LAB MED, V131, P1805; Mossman AK, 2005, STEM CELLS DEV, V14, P656, DOI 10.1089/scd.2005.14.656; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Preffer F, 2009, CYTOM PART B-CLIN CY, V76B, P295, DOI 10.1002/cyto.b.20480; Ravo M, 2008, LAB INVEST, V88, P430, DOI 10.1038/labinvest.2008.11; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szaniszlo P, 2004, CYTOM PART A, V59A, P191, DOI 10.1002/cyto.a.20055; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167	29	18	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17536	10.1371/journal.pone.0017536	http://dx.doi.org/10.1371/journal.pone.0017536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408072	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170900026
J	Schmidt, AJ; Rockstroh, JK; Vogel, M; Heiden, MAD; Baillot, A; Krznaric, I; Radun, D				Schmidt, Axel J.; Rockstroh, Juergen K.; Vogel, Martin; Heiden, Matthias An Der; Baillot, Armin; Krznaric, Ivanka; Radun, Doris			Trouble with Bleeding: Risk Factors for Acute Hepatitis C among HIV-Positive Gay Men from Germany-A Case-Control Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUALLY-TRANSMITTED INFECTION; HOMOSEXUAL-MEN; HETEROSEXUAL TRANSMISSION; COINFECTED PATIENTS; SEMINAL PLASMA; SEX; HCV; PREVALENCE; INCREASE	Objectives: To identify risk factors for hepatitis C among HIV-positive men who have sex with men (MSM), focusing on potential sexual, nosocomial, and other non-sexual determinants. Background: Outbreaks of hepatitis C virus (HCV) infections among HIV-positive MSM have been reported by clinicians in post-industrialized countries since 2000. The sexual acquisition of HCV by gay men who are HIV positive is not, however, fully understood. Methods: Between 2006 and 2008, a case-control study was embedded into a behavioural survey of MSM in Germany. Cases were HIV-positive and acutely HCV-co-infected, with no history of injection drug use. HIV-positive MSM without known HCV infection, matched for age group, served as controls. The HCV-serostatus of controls was assessed by serological testing of dried blood specimens. Univariable and multivariable regression analyses were used to identify factors independently associated with HCV-co-infection. Results: 34 cases and 67 controls were included. Sex-associated rectal bleeding, receptive fisting and snorting cocaine/amphetamines, combined with group sex, were independently associated with case status. Among cases, surgical interventions overlapped with sex-associated rectal bleeding. Conclusions: Sexual practices leading to rectal bleeding, and snorting drugs in settings of increased HCV-prevalence are risk factors for acute hepatitis C. We suggest that sharing snorting equipment as well as sharing sexual partners might be modes of sexual transmission. Condoms and gloves may not provide adequate protection if they are contaminated with blood. Public health interventions for HIV-positive gay men should address the role of blood in sexual risk behaviour. Further research is needed into the interplay of proctosurgery and sex-associated rectal bleeding.	[Schmidt, Axel J.; Heiden, Matthias An Der; Radun, Doris] Robert Koch Inst, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany; [Rockstroh, Juergen K.; Vogel, Martin] Univ Bonn, Med Clin 1, D-5300 Bonn, Germany; [Baillot, Armin] Govt Inst Publ Hlth Lower Saxony, Hannover, Germany	Robert Koch Institute; University of Bonn	Schmidt, AJ (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany.	a.j.schmidt@rki.de	Schmidt, Axel J/J-1855-2019	Schmidt, Axel J/0000-0002-6910-4399; an der Heiden, Matthias/0000-0001-5863-4549	Robert Koch Institute; University of Bonn; German MOH; Roche; Essex; Abbott; Gilead; Boehringer Ingelheim; GSK; ViiV; Pfizer; MSD; Tibotec; BMS	Robert Koch Institute; University of Bonn; German MOH; Roche(Roche Holding); Essex; Abbott(Abbott Laboratories); Gilead(Gilead Sciences); Boehringer Ingelheim(Boehringer Ingelheim); GSK(GlaxoSmithKline); ViiV; Pfizer(Pfizer); MSD; Tibotec; BMS(Bristol-Myers Squibb)	The embedded case-control study was funded by the Robert Koch Institute and the University of Bonn; the KABaSTI study was supported by the German MOH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Axel J. Schmidt, Matthias An der Heiden, Armin Baillot, Ivanka Krznaric, and Doris Radun do not have any financial disclosures. Jurgen K. Rockstroh and Martin Vogel have received lecture fees and congress travel grants from Roche, Essex, Abbott, Gilead, Boehringer Ingelheim, GSK, ViiV, Pfizer, MSD, Tibotec, and BMS, but none of these were related to the case-control-study presented here.	Aaron S, 2008, CLIN INFECT DIS, V47, P931, DOI 10.1086/591699; Alary M, 2005, AM J PUBLIC HEALTH, V95, P502, DOI 10.2105/AJPH.2003.020388; Aral SO, 2002, SEX TRANSM INFECT, V78, pI3, DOI 10.1136/sti.78.suppl_1.i3; Blaise G, 2007, J EUR ACAD DERMATOL, V21, P1262, DOI 10.1111/j.1468-3083.2007.02155.x; BOCHOW M, 2004, GAY MEN AIDS RISK MA, V48; BOCHOW M, 2010, GAY MEN AIDS SEXUAL, V55; Bollepalli S, 2007, SEX TRANSM DIS, V34, P367, DOI 10.1097/01.olq.0000240295.35457.b1; Bourlet T, 2003, J CLIN MICROBIOL, V41, P789, DOI 10.1128/JCM.41.2.789-793.2003; Bourlet T, 2002, J CLIN MICROBIOL, V40, P3252, DOI 10.1128/JCM.40.9.3252-3255.2002; Bouvet Elisabeth, 2005, Euro Surveill, V10, P74; Briat A, 2005, AIDS, V19, P1827, DOI 10.1097/01.aids.0000189847.98569.2d; Browne R, 2004, SEX TRANSM INFECT, V80, P326, DOI 10.1136/sti.2003.008532; Butler DM, 2007, AIDS, V21, P1218, DOI 10.1097/QAD.0b013e32814db7bf; Carey JW, 2009, AIDS BEHAV, V13, P1084, DOI 10.1007/s10461-008-9403-3; Cassuto NG, 2002, HUM REPROD, V17, P3153, DOI 10.1093/humrep/17.12.3153; Clarke A, 2006, INT J STD AIDS, V17, P74, DOI 10.1258/095646206775455685; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; *EACS, 2007, GUID CLIN MAN TREAT; Farias A, 2010, HEPATO-GASTROENTEROL, V57, P300; Fierer D, 2009, 16 C RETR OPP INF MO; Filippini P, 2001, SEX TRANSM DIS, V28, P725, DOI 10.1097/00007435-200112000-00010; GAMBOTTI L, 2005, EUROSURVEILLANCE, V10, P74; Ghosn J, 2006, SEX TRANSM INFECT, V82, P458, DOI 10.1136/sti.2006.021493; Ghosn J, 2004, HIV MED, V5, P303, DOI 10.1111/j.1468-1293.2004.00225.x; GHOSN J, 2009, 16 C RETR OPP INF MO; Ghosn J, 2008, AIDS, V22, P658, DOI 10.1097/QAD.0b013e3282f4e86f; Giuliani M, 1997, SEX TRANSM DIS, V24, P533, DOI 10.1097/00007435-199710000-00007; Gotz HM, 2005, AIDS, V19, P969, DOI 10.1097/01.aids.0000171412.61360.f8; Hisada M, 2000, J INFECT DIS, V181, P1475, DOI 10.1086/315396; Jin FY, 2007, JAIDS-J ACQ IMM DEF, V46, P245, DOI 10.1097/QAI.0b013e3181565db5; Jin FY, 2007, SEX TRANSM INFECT, V83, P397, DOI 10.1136/sti.2007.025684; Jin FY, 2010, SEX TRANSM INFECT, V86, P25, DOI 10.1136/sti.2009.038182; Jin FY, 2005, AUST NZ J PUBL HEAL, V29, P536, DOI 10.1111/j.1467-842X.2005.tb00246.x; Kamili S, 2007, INFECT CONT HOSP EP, V28, P519, DOI 10.1086/513727; Kent CK, 2005, CLIN INFECT DIS, V41, P67, DOI 10.1086/430704; Leruez-Ville M, 2000, LANCET, V356, P42, DOI 10.1016/S0140-6736(00)02435-1; Mao LM, 2006, AIDS, V20, P1204, DOI 10.1097/01.aids.0000226964.17966.75; MARCUS U, 2011, SEX HLTH IN PRESS; Marcus U, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-180; Minola E, 2006, EUR J EPIDEMIOL, V21, P293, DOI 10.1007/s10654-006-0016-8; Mocroft A, 2005, AIDS, V19, P2117, DOI 10.1097/01.aids.0000194799.43799.ea; Mudrikova T, 2008, NETH J MED, V66, P98; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Neumayr G, 1999, QJM-INT J MED, V92, P505, DOI 10.1093/qjmed/92.9.505; Nowicki MJ, 2005, J INFECT DIS, V192, P1557, DOI 10.1086/491742; Onland-Moret NC, 2007, J CLIN EPIDEMIOL, V60, P350, DOI 10.1016/j.jclinepi.2006.06.022; Owen G, 2008, CULT HEALTH SEX, V10, P601, DOI 10.1080/13691050802061673; Page-Shafer KA, 2002, AM J PUBLIC HEALTH, V92, P670, DOI 10.2105/AJPH.92.4.670; Parsons JT, 2005, AIDS, V19, pS13, DOI 10.1097/01.aids.0000167348.15750.9a; Pasquier C, 2003, J MED VIROL, V69, P344, DOI 10.1002/jmv.10295; *R KOCH I, 2009, EP B, V20, P197; Rauch A, 2005, CLIN INFECT DIS, V41, P395, DOI 10.1086/431486; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Rockstroh JK, 2004, LANCET INFECT DIS, V4, P437, DOI 10.1016/S1473-3099(04)01059-X; Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P112; Ruys Th A, 2004, Ned Tijdschr Geneeskd, V148, P2309; Schmidt A.J., 2007, KABASTI STUDY KNOWLE; SCHMIDT AJ, 2009, 16 C RETR OPP INF MO; Serpaggi J, 2006, AIDS, V20, P233, DOI 10.1097/01.aids.0000200541.40633.56; Tahan V, 2005, AM J GASTROENTEROL, V100, P821, DOI 10.1111/j.1572-0241.2005.40879.x; Terrault NA, 2002, HEPATOLOGY, V36, pS99, DOI 10.1053/jhep.2002.36797; Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808; Tortu S, 2004, SUBST USE MISUSE, V39, P211, DOI 10.1081/JA-120028488; Trimarchi M, 2006, AM J RHINOL, V20, P160, DOI 10.1177/194589240602000207; Tuaillon E, 2010, HEPATOLOGY, V51, P752, DOI 10.1002/hep.23407; Turner J, 2010, 2 JOINT BHIVA BASHH; Urbanus AT, 2009, AIDS, V23, pF1, DOI 10.1097/QAD.0b013e32832e5631; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; van Kesteren NMC, 2007, PATIENT EDUC COUNS, V65, P5, DOI 10.1016/j.pec.2006.09.003; Vandelli C, 2004, AM J GASTROENTEROL, V99, P855, DOI 10.1111/j.1572-0241.2004.04150.x; VANDENBERG G, 2009, 16 C RETR OPP INF MO; Vogel M, 2009, CLIN INFECT DIS, V49, DOI 10.1086/600058; Walter J, 2005, GESUNDHEITSWESEN, V67, P441, DOI 10.1055/s-2005-858519; Wienecke R, 2006, HAUTARZT, V57, P994, DOI 10.1007/s00105-006-1236-2; Wyld R, 1997, J INFECTION, V35, P163, DOI 10.1016/S0163-4453(97)91677-7; Young RM, 2005, AM J PUBLIC HEALTH, V95, P1144, DOI 10.2105/AJPH.2004.046714	79	109	111	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17781	10.1371/journal.pone.0017781	http://dx.doi.org/10.1371/journal.pone.0017781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408083	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000288170000059
J	Cheng, LA; Wang, J; Li, XZ; Xing, QA; Du, PS; Su, LS; Wang, SD				Cheng, Liang; Wang, Jun; Li, Xiaozhu; Xing, Qiao; Du, Peishuang; Su, Lishan; Wang, Shengdian			Interleukin-6 Induces Gr-1+CD11b+Myeloid Cells to Suppress CD8+T Cell-Mediated Liver Injury in Mice	PLOS ONE			English	Article							VIRUS-TRANSGENIC MICE; T-CELL; HEPATOCELLULAR-CARCINOMA; HEPATITIS-B; INDUCED ARTHRITIS; IN-VIVO; IL-6; ACTIVATION; INFLAMMATION; PATHOGENESIS	Background: Agonist antibodies against CD137 (4-1BB) on T lymphocytes are used to increase host anti-tumor immunity, but often leading to severe liver injury in treated mice or in patients during clinical trials. Interleukin-6 (IL-6) has been reported to protect hepatocyte death, but the role of IL-6 in protecting chronic T cell-induced liver diseases is not clearly defined due to lack of relevant animal models. We aimed to define the role of IL-6 in CD8+ T cell-mediated liver injury induced by a CD137 agonistic mAb (clone 2A) in mice. Methods/Principal Findings: We expressed IL-6 in the liver by hydrodynamic gene delivery in mice treated with 2A or control mAb and studied how IL-6 treatment affected host immunity and T cell-mediated liver injury. We found that ectopic IL-6 expression in the liver elevated intrahepatic leukocyte infiltration but prevented CD8+ T cell-mediated liver injury. In IL-6 treated mice, CD8+ T cells proliferation and IFN-gamma expression were inhibited in the liver. We discovered that IL-6 increased accumulation of Gr-1+CD11b+ myeloid derived suppressor cells (MDSCs) in the liver and spleen. These MDSCs had the ability to inhibit T cells proliferation and activation. Finally, we showed that the MDSCs were sufficient and essential for IL-6-mediated protection of anti-CD137 mAb-induced liver injury. Conclusions/Significance: We concluded that IL-6 induced Gr-1+CD11b+ MDSCs in the liver to inhibit T cell-mediated liver injury. The findings have defined a novel mechanism of IL-6 in protecting liver from CD8+ T cell-mediated injury.	[Cheng, Liang; Wang, Jun; Li, Xiaozhu; Xing, Qiao; Du, Peishuang; Su, Lishan; Wang, Shengdian] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China; [Cheng, Liang; Wang, Jun] Grad Univ, Chinese Acad Sci, Beijing, Peoples R China; [Su, Lishan] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Cheng, LA (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China.	lsu@med.unc.edu; sdwang@moon.ibp.ac.cn	Wang, Jun/G-8361-2011	Wang, Jun/0000-0002-6346-2929	Ministry of Science and Technology of China [2006AA02A410]; National Key Technologies Research and Development Program of China [2008ZX10002-006, 2009ZX10004-309, 2008ZX10002-001]; Chinese Academy of Sciences [KSCX1-YW-10-02]; National Institutes of Health of USA [AA018372, AI076142, AA018009]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA018009, R21AA018372] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Key Technologies Research and Development Program of China(National Key Technology R&D Program); Chinese Academy of Sciences(Chinese Academy of Sciences); National Institutes of Health of USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The project was supported in part by grants from the Ministry of Science and Technology of China's 863 programs (2006AA02A410 to S.W.), the National Key Technologies Research and Development Program of China (2008ZX10002-006, 2009ZX10004-309, 2008ZX10002-001 and 2009ZX10004-309 to S. W.), the Innovative Program of Chinese Academy of Sciences (KSCX1-YW-10-02 to S.W.) and from National Institutes of Health of USA (AA018372, AI076142 and AA018009 to L.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Blindenbacher A, 2003, HEPATOLOGY, V38, P674, DOI 10.1053/jhep.2003.50378; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Chen YY, 2007, HEPATOLOGY, V46, P706, DOI 10.1002/hep.21872; *CLINICALTRIALS GO, 2011, PHAS 2 2 LIN MEL RAN; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Dubrot J, 2010, CANCER IMMUNOL IMMUN, V59, P1223, DOI 10.1007/s00262-010-0846-9; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Halstead ES, 2002, NAT IMMUNOL, V3, P536, DOI 10.1038/ni798; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; Hong F, 2002, ONCOGENE, V21, P32, DOI 10.1038/sj.onc.1205016; HWU WJ, 2010, TARGETED THERAPY MET; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; Kovalovich K, 2000, HEPATOLOGY, V31, P149, DOI 10.1002/hep.510310123; Kovalovich K, 2001, J BIOL CHEM, V276, P26605, DOI 10.1074/jbc.M100740200; Masubachi Y, 2003, BIOCHEM BIOPH RES CO, V304, P207, DOI 10.1016/S0006-291X(03)00572-2; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Mizuhara H, 1996, HEPATOLOGY, V23, P1608, DOI 10.1002/hep.510230643; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Myers LM, 2005, TRENDS IMMUNOL, V26, P440, DOI 10.1016/j.it.2005.06.003; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Streetz KL, 2003, HEPATOLOGY, V38, P218, DOI 10.1053/jhep.2003.50268; Sun R, 2004, J IMMUNOL, V172, P5648, DOI 10.4049/jimmunol.172.9.5648; Taub R, 2003, J CLIN INVEST, V112, P978, DOI 10.1172/JCI20031200319974; Wang J, 2010, J IMMUNOL, V185, P7654, DOI 10.4049/jimmunol.1000927; Wilcox RA, 2002, J CLIN INVEST, V109, P651, DOI 10.1172/JCI200214184; Wong VWS, 2009, INT J CANCER, V124, P2766, DOI 10.1002/ijc.24281; Wuestefeld T, 2003, J BIOL CHEM, V278, P11281, DOI 10.1074/jbc.M208470200; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878; Zhu YW, 2007, BLOOD, V109, P4882, DOI 10.1182/blood-2006-10-043463	40	39	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17631	10.1371/journal.pone.0017631	http://dx.doi.org/10.1371/journal.pone.0017631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394214	Green Published, gold, Green Submitted			2022-12-25	WOS:000288025500019
J	Kwakman, PHS; Velde, AAT; de Boer, L; Vandenbroucke-Grauls, CMJE; Zaat, SAJ				Kwakman, Paulus H. S.; Velde, Anje A. Te; de Boer, Leonie; Vandenbroucke-Grauls, Christina M. J. E.; Zaat, Sebastian A. J.			Two Major Medicinal Honeys Have Different Mechanisms of Bactericidal Activity	PLOS ONE			English	Article							LEPTOSPERMUM-SCOPARIUM HONEY; ZEALAND MANUKA HONEY; HYDROGEN-PEROXIDE; ANTIBACTERIAL ACTIVITY; FOODBORNE PATHOGENS; POLYACRYLAMIDE-GEL; GROWTH-INHIBITION; IDENTIFICATION; METHYLGLYOXAL; ORIGIN	Honey is increasingly valued for its antibacterial activity, but knowledge regarding the mechanism of action is still incomplete. We assessed the bactericidal activity and mechanism of action of Revamil (R) source (RS) honey and manuka honey, the sources of two major medical-grade honeys. RS honey killed Bacillus subtilis, Escherichia coli and Pseudomonas aeruginosa within 2 hours, whereas manuka honey had such rapid activity only against B. subtilis. After 24 hours of incubation, both honeys killed all tested bacteria, including methicillin-resistant Staphylococcus aureus, but manuka honey retained activity up to higher dilutions than RS honey. Bee defensin-1 and H(2)O(2) were the major factors involved in rapid bactericidal activity of RS honey. These factors were absent in manuka honey, but this honey contained 44-fold higher concentrations of methylglyoxal than RS honey. Methylglyoxal was a major bactericidal factor in manuka honey, but after neutralization of this compound manuka honey retained bactericidal activity due to several unknown factors. RS and manuka honey have highly distinct compositions of bactericidal factors, resulting in large differences in bactericidal activity.	[Kwakman, Paulus H. S.; de Boer, Leonie; Vandenbroucke-Grauls, Christina M. J. E.; Zaat, Sebastian A. J.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Velde, Anje A. Te] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Vandenbroucke-Grauls, Christina M. J. E.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Dis, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Kwakman, PHS (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.a.zaat@amc.uva.nl	Vandenbroucke-Grauls, Christina/AAO-7953-2020	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597				Adams CJ, 2008, CARBOHYD RES, V343, P651, DOI 10.1016/j.carres.2007.12.011; Adams CJ, 2009, CARBOHYD RES, V344, P1050, DOI 10.1016/j.carres.2009.03.020; ALLEN KL, 1991, J PHARM PHARMACOL, V43, P817, DOI 10.1111/j.2042-7158.1991.tb03186.x; Bachanova K, 2002, APIDOLOGIE, V33, P259, DOI 10.1051/apido:2002015; Bang LM, 2003, J ALTERN COMPLEM MED, V9, P267, DOI 10.1089/10755530360623383; Bogdanov S, 1997, FOOD SCI TECHNOL-LEB, V30, P748, DOI 10.1006/fstl.1997.0259; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Cooper RA, 2002, J APPL MICROBIOL, V93, P857, DOI 10.1046/j.1365-2672.2002.01761.x; EFEM SEE, 1988, BRIT J SURG, V75, P679, DOI 10.1002/bjs.1800750718; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; HARWIG SSL, 1993, ANAL BIOCHEM, V208, P382, DOI 10.1006/abio.1993.1065; Kalapos MP, 2008, CHEM-BIOL INTERACT, V171, P251, DOI 10.1016/j.cbi.2007.11.009; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; KNECHT D, 1990, APIDOLOGIE, V21, P457, DOI 10.1051/apido:19900507; Krushna NSA, 2007, INDIAN J EXP BIOL, V45, P459; Kwakman PHS, 2008, CLIN INFECT DIS, V46, P1677, DOI 10.1086/587892; Kwakman PHS, 2010, FASEB J, V24, P2576, DOI 10.1096/fj.09-150789; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; LENSKY Y, 1983, COMP BIOCHEM PHYS B, V75, P607, DOI 10.1016/0305-0491(83)90104-9; Majno G., 1975, MAN WOUND ANCIENT WO; Majtan J, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq013; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; McEwen SA, 2002, CLIN INFECT DIS, V34, pS93, DOI 10.1086/340246; MOLAN PC, 1992, BEE WORLD, V73, P59, DOI 10.1080/0005772X.1992.11099118; Mundo MA, 2004, INT J FOOD MICROBIOL, V97, P1, DOI 10.1016/j.ijfoodmicro.2004.03.025; RACKER E, 1951, J BIOL CHEM, V190, P685; RUSSELL KM, 1990, J AGR FOOD CHEM, V38, P10, DOI 10.1021/jf00091a002; SCHEPARTZ A I, 1966, Journal of Apicultural Research, V5, P167; Taormina PJ, 2001, INT J FOOD MICROBIOL, V69, P217, DOI 10.1016/S0168-1605(01)00505-0; Walsh C., 2003, ANTIBIOTICS ACTIONS; Weigel KU, 2004, EUR FOOD RES TECHNOL, V218, P147, DOI 10.1007/s00217-003-0814-0; Weston RJ, 2000, FOOD CHEM, V70, P427, DOI 10.1016/S0308-8146(00)00127-8; Weston RJ, 1999, FOOD CHEM, V64, P295, DOI 10.1016/S0308-8146(98)00100-9; White J. W., 1963, J APICULT RES, V2, P93, DOI [10.1080/00218839.1963.11100066, DOI 10.1080/00218839.1963.11100066]; WHITE JONATHAN W., 1964, J APICULT RES, V3, P45; WHITE JW, 1963, BIOCHIM BIOPHYS ACTA, V73, P57; WHITE JW, 1964, J FOOD SCI, V29, P819, DOI 10.1111/j.1365-2621.1964.tb00455.x; ZUMLA A, 1989, J ROY SOC MED, V82, P384, DOI 10.1177/014107688908200704	38	151	167	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17709	10.1371/journal.pone.0017709	http://dx.doi.org/10.1371/journal.pone.0017709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394213	Green Published, Green Submitted, gold			2022-12-25	WOS:000288025500021
J	Chaturvedi, S; Rajkumar, SS; Li, X; Hurteau, GJ; Shtutman, M; Chaturvedi, V				Chaturvedi, Sudha; Rajkumar, Sunanda S.; Li, Xiaojiang; Hurteau, Gregory J.; Shtutman, Michael; Chaturvedi, Vishnu			Antifungal Testing and High-Throughput Screening of Compound Library against Geomyces destructans, the Etiologic Agent of Geomycosis (WNS) in Bats	PLOS ONE			English	Article							ASPERGILLUS; 5-FLUOROCYTOSINE; 5-FLUOROURACIL; ITRACONAZOLE; ETEST; MODE; CAVE	Bats in the northeastern U.S. are affected by geomycosis caused by the fungus Geomyces destructans (Gd). This infection is commonly referred to as White Nose Syndrome (WNS). Over a million hibernating bats have died since the fungus was first discovered in 2006 in a cave near Albany, New York. A population viability analysis conducted on little brown bats (Myotis lucifugus), one of six bat species infected with Gd, suggests regional extinction of this species within 20 years. The fungus Gd is a psychrophile ("cold loving''), but nothing is known about how it thrives at low temperatures and what pathogenic attributes allow it to infect bats. This study aimed to determine if currently available antifungal drugs and biocides are effective against Gd. We tested five Gd strains for their susceptibility to antifungal drugs and high-throughput screened (HTS) one representative strain with SpectrumPlus compound library containing 1,920 compounds. The results indicated that Gd is susceptible to a number of antifungal drugs at concentrations similar to the susceptibility range of human pathogenic fungi. Strains of Gd were susceptible to amphotericin B, fluconazole, itraconazole, ketoconazole and voriconazole. In contrast, very high MICs (minimum inhibitory concentrations) of flucytosine and echinocandins were needed for growth inhibition, which were suggestive of fungal resistance to these drugs. Of the1,920 compounds in the library, a few caused 50% - to greater than 90% inhibition of Gd growth. A number of azole antifungals, a fungicide, and some biocides caused prominent growth inhibition. Our results could provide a theoretical basis for future strategies aimed at the rehabilitation of most affected bat species and for decontamination of Gd in the cave environment.	[Chaturvedi, Sudha; Rajkumar, Sunanda S.; Li, Xiaojiang; Chaturvedi, Vishnu] New York State Dept Hlth, Wadsworth Ctr, Mycol Lab, Albany, NY 12237 USA; [Chaturvedi, Sudha; Chaturvedi, Vishnu] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA; [Shtutman, Michael] Ordway Res Inst, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Ordway Research Institute	Chaturvedi, S (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Mycol Lab, Albany, NY 12237 USA.	vishnu@wadsworth.org	Shtutman, Michael/AAB-8391-2020	Shtutman, Michael/0000-0002-2458-3226; Chaturvedi, Vishnu/0000-0002-3922-9676				Arikan S, 2001, ANTIMICROB AGENTS CH, V45, P327, DOI 10.1128/AAC.45.1.327-330.2001; Bastian F, 2009, NATURWISSENSCHAFTEN, V96, P863, DOI 10.1007/s00114-009-0540-y; Bending GD, 2007, CHEMOSPHERE, V69, P82, DOI 10.1016/j.chemosphere.2007.04.042; Berger L, 2009, RES VET SCI, V87, P106, DOI 10.1016/j.rvsc.2008.11.005; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; CLSI, 2008, M38A2 CLSI, V28; CLSI, 2008, M27A3 CLSI, V28; CUNNINGHAM KI, 1995, ENVIRON GEOL, V25, P2, DOI 10.1007/BF01061824; Espinel-Ingroff Ana, 2003, Revista Iberoamericana de Micologia, V20, P121; *EUCAST, 2008, CLIN MICROBIOL INFEC, P982; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Garner TWJ, 2009, DIS AQUAT ORGAN, V83, P257, DOI 10.3354/dao02008; Hoskins J, 2007, YEAST, V24, P861, DOI 10.1002/yea.1516; Katiyar SK, 2009, ANTIMICROB AGENTS CH, V53, P1772, DOI 10.1128/AAC.00020-09; Li H, 2008, J LIPID RES, V49, P230, DOI 10.1194/jlr.D700015-JLR200; Maltby L, 2009, ENVIRON SCI TECHNOL, V43, P7556, DOI 10.1021/es901461c; Marchetti V, 2006, VET RES COMMUN, V30, P255, DOI 10.1007/s11259-006-3199-2; Martel A, 2011, MED MYCOL, V49, P143, DOI 10.3109/13693786.2010.508185; Martin-Mazuelos E, 2003, J ANTIMICROB CHEMOTH, V52, P365, DOI 10.1093/jac/dkg384; Martos AI, 2010, MED MYCOL, V48, P858, DOI 10.3109/13693781003586943; Okoli I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007025; POLAK A, 1983, SABOURAUDIA, V21, P15; Shapiro J, 2010, AM MIDL NAT, V163, P76, DOI 10.1674/0003-0031-163.1.76; Tamukai K, 2010, J VET MED SCI; TOSH FE, 1966, AM J EPIDEMIOL, V83, P262, DOI 10.1093/oxfordjournals.aje.a120582; Urzi C, 2010, MICROB ECOL, V60, P116, DOI 10.1007/s00248-010-9710-x; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; WAGNER GE, 1979, CHEMOTHERAPY, V25, P61, DOI 10.1159/000237824; Zhang LX, 2007, P NATL ACAD SCI USA, V104, P4606, DOI 10.1073/pnas.0609370104	30	25	26	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17032	10.1371/journal.pone.0017032	http://dx.doi.org/10.1371/journal.pone.0017032			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399675	Green Published, gold, Green Submitted			2022-12-25	WOS:000287933300008
J	Montoro, AG; Ramirez, SC; Quiroga, R; Taubas, JV				Gonzalez Montoro, Ayelen; Chumpen Ramirez, Sabrina; Quiroga, Rodrigo; Valdez Taubas, Javier			Specificity of Transmembrane Protein Palmitoylation in Yeast	PLOS ONE			English	Article							CYSTEINE-RICH DOMAIN; DHHC; IDENTIFICATION; PALMITOYLTRANSFERASES; ACYLTRANSFERASE; UBIQUITINATION; MECHANISM; ALIGNMENT; RESIDUES; REVEALS	Many proteins are modified after their synthesis, by the addition of a lipid molecule to one or more cysteine residues, through a thioester bond. This modification is called S-acylation, and more commonly palmitoylation. This reaction is carried out by a family of enzymes, called palmitoyltransferases (PATs), characterized by the presence of a conserved 50-aminoacids domain called LAsp-His-His-Cys-Cysteine Rich Domain" (DHHC-CRD). There are 7 members of this family in the yeast Saccharomyces cerevisiae, and each of these proteins is thought to be responsible for the palmitoylation of a subset of substrates. Substrate specificity of PATs, however, is not yet fully understood. Several yeast PATs seem to have overlapping specificity, and it has been proposed that the machinery responsible for palmitoylating peripheral membrane proteins in mammalian cells, lacks specificity altogether. Here we investigate the specificity of transmembrane protein palmitoylation in S. cerevisiae, which is carried out predominantly by two PATs, Swf1 and Pfa4. We show that palmitoylation of transmembrane substrates requires dedicated PATs, since other yeast PATs are mostly unable to perform Swf1 or Pfa4 functions, even when overexpressed. Furthermore, we find that Swf1 is highly specific for its substrates, as it is unable to substitute for other PATs. To identify where Swf1 specificity lies, we carried out a bioinformatics survey to identify amino acids responsible for the determination of specificity or Specificity Determination Positions (SDPs) and showed experimentally, that mutation of the two best SDP candidates, A145 and K148, results in complete and partial loss of function, respectively. These residues are located within the conserved catalytic DHHC domain suggesting that it could also be involved in the determination of specificity. Finally, we show that modifying the position of the cysteines in Tlg1, a Swf1 substrate, results in lack of palmitoylation, as expected for a highly specific enzymatic reaction.	[Gonzalez Montoro, Ayelen; Chumpen Ramirez, Sabrina; Quiroga, Rodrigo; Valdez Taubas, Javier] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, CIQUIBIC UNC CONICET, Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Montoro, AG (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, CIQUIBIC UNC CONICET, Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina.	jvaldezt@dqb.fcq.unc.edu.ar	Quiroga, Rodrigo/GLT-7145-2022	Quiroga, Rodrigo/0000-0001-5015-0531; Gonzalez Montoro, Ayelen/0000-0002-6978-8284; Valdez Taubas, Javier/0000-0002-2806-9419	Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba (Secyt UNC) [RES214/10]; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (ANPCyT) [PICT 2006 1239, PICT 2005 32937]; CONICET	Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba (Secyt UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (ANPCyT)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba (Secyt UNC 2007 and 2010 to JVT RES214/10; http://www.secyt.unc.edu.ar/nuevo/) and Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (ANPCyT) (PICT 2006 1239 to Hugo Maccioni and JVT, and PICT 2005 32937 to JVT; http://www.agencia.mincyt.gov.ar/). JVT is a Career Investigator of CONICET (Argentina). AGM and SC have fellowships from CONICET. RQ is a FONCyT fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Capra JA, 2008, BIOINFORMATICS, V24, P1473, DOI 10.1093/bioinformatics/btn214; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; COUVE A, 1995, P NATL ACAD SCI USA, V92, P5987, DOI 10.1073/pnas.92.13.5987; DeMar JC, 1997, J BIOL CHEM, V272, P31362, DOI 10.1074/jbc.272.50.31362; Dighe SA, 2008, MOL BIOL CELL, V19, P4454, DOI 10.1091/mbc.E08-03-0252; Ducker CE, 2004, ONCOGENE, V23, P9230, DOI 10.1038/sj.onc.1208171; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Montoro AG, 2009, BIOCHEM J, V419, P301, DOI 10.1042/BJ20080921; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Harlow L, 1988, ANTIBODIES LAB MANUA; HE Y, 2008, J LIPID RES; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hou HT, 2009, TRAFFIC, V10, P1061, DOI 10.1111/j.1600-0854.2009.00925.x; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Lam KKY, 2006, J CELL BIOL, V174, P19, DOI 10.1083/jcb.200602049; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Mill P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000748; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; Nadolski MJ, 2009, J BIOL CHEM, V284, P17720, DOI 10.1074/jbc.M109.005447; PRESCOTT GR, 2009, J NEUROCHEM; Putilina T, 1999, MOL CELL BIOCHEM, V195, P219, DOI 10.1023/A:1006932522197; Rausell A, 2010, P NATL ACAD SCI USA, V107, P1995, DOI 10.1073/pnas.0908044107; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Smotrys JE, 2005, J CELL BIOL, V170, P1091, DOI 10.1083/jcb.200507048; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wang YX, 1998, J CELL BIOL, V140, P1063, DOI 10.1083/jcb.140.5.1063; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Washbourne P, 2004, NEURON, V44, P901, DOI 10.1016/S0896-6273(04)00799-8; Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016; Yik JHN, 2002, J BIOL CHEM, V277, P47305, DOI 10.1074/jbc.M208751200	46	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16969	10.1371/journal.pone.0016969	http://dx.doi.org/10.1371/journal.pone.0016969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383992	Green Published, gold, Green Submitted			2022-12-25	WOS:000287761700022
J	Nader, IW; Pietschnig, J; Niederkrotenthaler, T; Kapusta, ND; Sonneck, G; Voracek, M				Nader, Ingo W.; Pietschnig, Jakob; Niederkrotenthaler, Thomas; Kapusta, Nestor D.; Sonneck, Gernot; Voracek, Martin			Suicide Seasonality: Complex Demodulation as a Novel Approach in Epidemiologic Analysis	PLOS ONE			English	Article							RATES; FINLAND; EXPERIENCE; AUSTRALIA; AMPLITUDE; SLOVENIA; TIME; SEX	Background: Seasonality of suicides is well-known and nearly ubiquitous, but recent evidence showed inconsistent patterns of decreasing or increasing seasonality in different countries. Furthermore, strength of seasonality was hypothesized to be associated with suicide prevalence. This study aimed at pointing out methodological difficulties in examining changes in suicide seasonality. Methododology/Principal Findings: The present study examines the hypothesis of decreasing seasonality with a superior method that allows continuous modeling of seasonality. Suicides in Austria (1970-2008, N = 67,741) were analyzed with complex demodulation, a local (point-in-time specific) version of harmonic analysis. This avoids the need to arbitrarily split the time series, as is common practice in the field of suicide seasonality research, and facilitates incorporating the association with suicide prevalence. Regression models were used to assess time trends and association of amplitude and absolute suicide numbers. Results showed that strength of seasonality was associated with absolute suicide numbers, and that strength of seasonality was stable during the study period when this association was taken into account. Conclusion/Significance: Continuous modeling of suicide seasonality with complex demodulation avoids spurious findings that can result when time series are segmented and analyzed piecewise or when the association with suicide prevalence is disregarded.	[Nader, Ingo W.; Pietschnig, Jakob; Voracek, Martin] Univ Vienna, Sch Psychol, Dept Basic Psychol Res, Vienna, Austria; [Niederkrotenthaler, Thomas] Med Univ Vienna, Ctr Publ Hlth, Dept Gen Practice & Family Med, Vienna, Austria; [Niederkrotenthaler, Thomas; Sonneck, Gernot] Med Univ Vienna, Ctr Publ Hlth, Dept Med Psychol, Vienna, Austria; [Kapusta, Nestor D.] Med Univ Vienna, Dept Psychoanal & Psychotherapy, Vienna, Austria; [Sonneck, Gernot] Ludwig Boltzmann Inst Social Psychiat, Vienna, Austria	University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Ludwig Boltzmann Institute	Nader, IW (corresponding author), Univ Vienna, Sch Psychol, Dept Basic Psychol Res, Vienna, Austria.	ingo.nader@univie.ac.at	Voracek, Martin/S-5865-2016; Pietschnig, Jakob/AAE-8913-2020; Kapusta, Nestor D/C-9368-2009	Voracek, Martin/0000-0001-6109-6155; Pietschnig, Jakob/0000-0003-0222-9557; Kapusta, Nestor D/0000-0002-0970-4341; Nader, Ingo/0000-0002-9673-0360; Niederkrotenthaler, Thomas/0000-0001-9550-628X				Ajdacic-Gross V, 2005, J EPIDEMIOL COMMUN H, V59, P967, DOI 10.1136/jech.2004.030981; Ajdacic-Gross V, 2003, SOC SCI MED, V57, P1173, DOI 10.1016/S0277-9536(02)00493-8; Ajdacic-Gross V, 2007, AM J EPIDEMIOL, V165, P561, DOI 10.1093/aje/kwk034; Bloomfield P., 2000, FOURIER ANAL TIME SE, P261; Bridges FS, 2005, PERCEPT MOTOR SKILL, V100, P920, DOI 10.2466/pms.100.3c.920-924; CHEW KSY, 1995, SOC SCI MED, V40, P223, DOI 10.1016/0277-9536(94)E0070-9; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Fisher RA, 1929, P R SOC LOND A-CONTA, V125, P54, DOI 10.1098/rspa.1929.0151; Hakko H, 1998, J AFFECT DISORDERS, V50, P49, DOI 10.1016/S0165-0327(98)00031-7; Hakko H, 2002, SUICIDE LIFE-THREAT, V32, P191, DOI 10.1521/suli.32.2.191.24403; Jessen G, 1998, ARCH SUICIDE RES, V4, P263, DOI 10.1080/13811119808258301; Kapusta ND, 2009, ACTA PSYCHIAT SCAND, V119, P236, DOI 10.1111/j.1600-0447.2008.01314.x; KEVAN SM, 1980, SOC SCI MED-MED GEOG, V14, P369, DOI 10.1016/0160-8002(80)90005-2; MEARES R, 1981, BRIT J PSYCHIAT, V138, P321, DOI 10.1192/bjp.138.4.321; NAYHA S, 1983, ACTA PSYCHIAT SCAND, V67, P32, DOI 10.1111/j.1600-0447.1983.tb00328.x; NAYHA S, 1982, BRIT J PSYCHIAT, V141, P512, DOI 10.1192/bjp.141.5.512; NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610; Oravecz R, 2007, J AFFECT DISORDERS, V104, P211, DOI 10.1016/j.jad.2007.03.009; Oravecz R, 2006, J AFFECT DISORDERS, V95, P135, DOI 10.1016/j.jad.2006.04.027; Preti A, 2002, ACTA NEUROPSYCHIATR, V14, P17, DOI 10.1034/j.1601-5215.2002.140103.x; Preti A, 2000, Crisis, V21, P59, DOI 10.1027//0227-5910.21.2.59; R Development Core Team, 2010, LANG ENV STAT COMP V; Rihmer Z, 1998, PSYCHIAT RES, V81, P233, DOI 10.1016/S0165-1781(98)00106-1; Rocchi MBL, 2007, NEUROPSYCHOBIOLOGY, V56, P86, DOI 10.1159/000111538; Rocchi MBL, 2007, J AFFECT DISORDERS, V100, P129, DOI 10.1016/j.jad.2006.10.003; Rock D, 2003, PSYCHIAT RES, V120, P43, DOI 10.1016/S0165-1781(03)00165-3; RUSSELL RJH, 1985, BRIT J MATH STAT PSY, V38, P116, DOI 10.1111/j.2044-8317.1985.tb00820.x; Voracek M, 2004, PERCEPT MOTOR SKILL, V99, P17, DOI 10.2466/pms.99.1.17-18; Warner R.M., 1998, SPECTRAL ANAL TIME S; Yip PSF, 2006, J AFFECT DISORDERS, V96, P117, DOI 10.1016/j.jad.2006.05.012; Yip PSF, 2000, BRIT J PSYCHIAT, V177, P366, DOI 10.1192/bjp.177.4.366; Yip PSF, 1998, J AFFECT DISORDERS, V47, P141, DOI 10.1016/S0165-0327(97)00135-3; Zeileis A., 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]; [No title captured]	34	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17413	10.1371/journal.pone.0017413	http://dx.doi.org/10.1371/journal.pone.0017413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	726XY	21390315	Green Submitted, gold, Green Published			2022-12-25	WOS:000287761700052
J	Alter, MD; Kharkar, R; Ramsey, KE; Craig, DW; Melmed, RD; Grebe, TA; Bay, RC; Ober-Reynolds, S; Kirwan, J; Jones, JJ; Turner, JB; Hen, R; Stephan, DA				Alter, Mark D.; Kharkar, Rutwik; Ramsey, Keri E.; Craig, David W.; Melmed, Raun D.; Grebe, Theresa A.; Bay, R. Curtis; Ober-Reynolds, Sharman; Kirwan, Janet; Jones, Josh J.; Turner, J. Blake; Hen, Rene; Stephan, Dietrich A.			Autism and Increased Paternal Age Related Changes in Global Levels of Gene Expression Regulation	PLOS ONE			English	Article							DE-NOVO MUTATIONS; SPECTRUM DISORDERS; SYNAPTIC PLASTICITY; VALPROIC ACID; ANIMAL-MODEL; MOUSE MODEL; CHILDREN; MEMORY; SCHIZOPHRENIA; RESPONSES	A causal role of mutations in multiple general transcription factors in neurodevelopmental disorders including autism suggested that alterations in global levels of gene expression regulation might also relate to disease risk in sporadic cases of autism. This premise can be tested by evaluating for changes in the overall distribution of gene expression levels. For instance, in mice, variability in hippocampal-dependent behaviors was associated with variability in the pattern of the overall distribution of gene expression levels, as assessed by variance in the distribution of gene expression levels in the hippocampus. We hypothesized that a similar change in variance might be found in children with autism. Gene expression microarrays covering greater than 47,000 unique RNA transcripts were done on RNA from peripheral blood lymphocytes (PBL) of children with autism (n = 82) and controls (n = 64). Variance in the distribution of gene expression levels from each microarray was compared between groups of children. Also tested was whether a risk factor for autism, increased paternal age, was associated with variance. A decrease in the variance in the distribution of gene expression levels in PBL was associated with the diagnosis of autism and a risk factor for autism, increased paternal age. Traditional approaches to microarray analysis of gene expression suggested a possible mechanism for decreased variance in gene expression. Gene expression pathways involved in transcriptional regulation were down-regulated in the blood of children with autism and children of older fathers. Thus, results from global and gene specific approaches to studying microarray data were complimentary and supported the hypothesis that alterations at the global level of gene expression regulation are related to autism and increased paternal age. Global regulation of transcription, thus, represents a possible point of convergence for multiple etiologies of autism and other neurodevelopmental disorders.	[Alter, Mark D.; Kharkar, Rutwik] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; [Ramsey, Keri E.; Craig, David W.; Stephan, Dietrich A.] Translat Gen Res Inst, Neurogen Div, Phoenix, AZ USA; [Melmed, Raun D.; Grebe, Theresa A.; Bay, R. Curtis; Ober-Reynolds, Sharman; Kirwan, Janet; Jones, Josh J.] SW Autism Res & Resource Ctr, Phoenix, AZ USA; [Turner, J. Blake] Columbia Univ, Dept Psychiat, Div Child & Adolescent Psychiat, New York, NY USA; [Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY USA; [Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; Translational Genomics Research Institute; Columbia University; Columbia University; Columbia University	Alter, MD (corresponding author), Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA.	markalter1968@gmail.com	Craig, David Wesley/K-6961-2019	Craig, David Wesley/0000-0003-2040-1955	NARSAD; state of Arizona; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH080228] Funding Source: NIH RePORTER	NARSAD(NARSAD); state of Arizona; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research support: Dr. Alter's salary was paid in part through a NARSAD Young Investigator Award (http://www.narsad.org/?q = node/124/apply_for_grants/124); sample collection and processing, microarrays, and salary support provided through a grant from the state of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo AM, 2010, BIOFACTORS, V36, P117, DOI 10.1002/biof.91; AIMO L, 2010, J NUTR BIOCH; Alter MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003344; ALTER MD, 2009, BIOL PSYCHIAT; Ashwood Paul, 2004, Clin Dev Immunol, V11, P165, DOI 10.1080/10446670410001722096; Aso T, 1996, J CLIN INVEST, V97, P1561, DOI 10.1172/JCI118580; Bading H, 2000, EUR J BIOCHEM, V267, P5280, DOI 10.1046/j.1432-1327.2000.01565.x; Cantor RM, 2007, MOL PSYCHIATR, V12, P419, DOI 10.1038/sj.mp.4001966; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DREXHAGE RC, EXPERT REV NEUROTHER, V10, P59; Enstrom AM, 2009, BRAIN BEHAV IMMUN, V23, P124, DOI 10.1016/j.bbi.2008.08.001; Faber S, 2009, BIOMARKERS, V14, P171, DOI 10.1080/13547500902783747; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Gregg JP, 2008, GENOMICS, V91, P22, DOI 10.1016/j.ygeno.2007.09.003; Hu VW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-118; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jyonouchi H, 2001, J NEUROIMMUNOL, V120, P170, DOI 10.1016/S0165-5728(01)00421-0; Kimura M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040037; Lattal KM, 2007, BEHAV NEUROSCI, V121, P1125, DOI 10.1037/0735-7044.121.5.1125; Levenson JM, 2006, CELL MOL LIFE SCI, V63, P1009, DOI 10.1007/s00018-006-6026-6; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mackenzie GG, 2007, IUBMB LIFE, V59, P299, DOI 10.1080/15216540701225966; Malaspina D, 2005, PSYCHIAT GENET, V15, P117, DOI 10.1097/00041444-200506000-00008; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; Malaspina D, 2002, AM J MED GENET, V114, P299, DOI 10.1002/ajmg.1701; Malaspina D, 2001, SCHIZOPHRENIA BULL, V27, P379, DOI 10.1093/oxfordjournals.schbul.a006882; MILLER MC, 2006, HARV MENT HLTH LETT, V23, P8; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Ornoy A, 2009, REPROD TOXICOL, V28, P1, DOI 10.1016/j.reprotox.2009.02.014; Puleo CM, 2008, MOL PSYCHIATR, V13, P243, DOI 10.1038/sj.mp.4002102; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Saha S, 2009, SCHIZOPHR RES, V115, P130, DOI 10.1016/j.schres.2009.09.012; Saha S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000040; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Schneider T, 2007, PSYCHOPHARMACOLOGY, V193, P547, DOI 10.1007/s00213-007-0795-y; Stephan DA, 2008, AM J HUM GENET, V82, P7, DOI 10.1016/j.ajhg.2007.12.003; Sykes Nuala H., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000452; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Tsuchiya KJ, 2008, BRIT J PSYCHIAT, V193, P316, DOI 10.1192/bjp.bp.107.045120; Unryn BM, 2005, AGING CELL, V4, P97, DOI 10.1111/j.1474-9728.2005.00144.x; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wagner GC, 2006, J AUTISM DEV DISORD, V36, P779, DOI 10.1007/s10803-006-0117-y; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wang Z, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-9; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Wiech NL, 2009, CURR TOP MED CHEM, V9, P257, DOI 10.2174/156802609788085241; Wiegert JS, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-124; Williams G, 2001, DEV MED CHILD NEUROL, V43, P202, DOI 10.1017/S001216220100038X; Zoghbi HY, 2005, J CHILD NEUROL, V20, P736, DOI 10.1177/08830738050200090701	53	72	72	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16715	10.1371/journal.pone.0016715	http://dx.doi.org/10.1371/journal.pone.0016715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379579	Green Published, Green Submitted, gold			2022-12-25	WOS:000287482300020
J	Smalley, JW; Byrne, DP; Birss, AJ; Wojtowicz, H; Sroka, A; Potempa, J; Olczak, T				Smalley, John W.; Byrne, Dominic P.; Birss, Andrew J.; Wojtowicz, Halina; Sroka, Aneta; Potempa, Jan; Olczak, Teresa			HmuY Haemophore and Gingipain Proteases Constitute a Unique Syntrophic System of Haem Acquisition by Porphyromonas gingivalis	PLOS ONE			English	Article							LYSINE-SPECIFIC GINGIPAIN; CONTAINING PIGMENT; PROTOPORPHYRIN-IX; CREVICULAR FLUID; ISOLATED CHAINS; GLOBIN LINKAGE; HEMOGLOBIN; MECHANISM; OXYHEMOGLOBIN; PROTEINS	Haem (iron protoporphyrin IX) is both an essential growth factor and virulence regulator for the periodontal pathogen Porphyromonas gingivalis, which acquires it mainly from haemoglobin via the sequential actions of the R-and K-specific gingipain proteases. The haem-binding lipoprotein haemophore HmuY and its cognate receptor HmuR of P. gingivalis, are responsible for capture and internalisation of haem. This study examined the role of the HmuY in acquisition of haem from haemoglobin and the cooperation between HmuY and gingipain proteases in this process. Using UV-visible spectroscopy and polyacrylamide gel electrophoresis, HmuY was demonstrated to wrest haem from immobilised methaemoglobin and deoxyhaemoglobin. Haem extraction from oxyhaemoglobin was facilitated after oxidation to methaemoglobin by pretreatment with the P. gingivalis R-gingipain A (HRgpA). HmuY was also capable of scavenging haem from oxyhaemoglobin pre-treated with the K-gingipain (Kgp). This is the first demonstration of a haemophore working in conjunction with proteases to acquire haem from haemoglobin. In addition, HmuY was able to extract haem from methaemalbumin, and could bind haem, either free in solution or from methaemoglobin, even in the presence of serum albumin.	[Smalley, John W.; Byrne, Dominic P.; Birss, Andrew J.] Univ Liverpool, Sch Dent Sci, Liverpool L69 3BX, Merseyside, England; [Wojtowicz, Halina; Olczak, Teresa] Univ Wroclaw, Biochem Lab, Fac Biotechnol, PL-50138 Wroclaw, Poland; [Sroka, Aneta; Potempa, Jan] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Potempa, Jan] Univ Louisville, Sch Dent, Dept Oral Hlth & Rehabil, Louisville, KY 40292 USA	University of Liverpool; University of Wroclaw; Jagiellonian University; University of Louisville	Smalley, JW (corresponding author), Univ Liverpool, Sch Dent Sci, Liverpool L69 3BX, Merseyside, England.	josmall@liv.ac.uk	Potempa, Jan/AAA-6850-2021	Sroka, Aneta/0000-0002-3386-5364; Potempa, Jan/0000-0002-3600-7461	Ministry of Science and Higher Education, Poland [N N303 406136, 1642/B/P01/2008/35]; Jagiellonian University [DS/9/WBBiB]; National Institutes of Health [DE 09761]; Foundation for Polish Science [Team/2009-4/8]; European Union [POIG.02.01.00-12-064/08]; School of Dental Science, University of Liverpool; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761] Funding Source: NIH RePORTER	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); Jagiellonian University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union(European Commission); School of Dental Science, University of Liverpool; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in parts by the Ministry of Science and Higher Education, Poland (grant No. N N303 406136 and 1642/B/P01/2008/35 to T.O. and J.P.,respectively), the Jagiellonian University (statutory funds DS/9/WBBIB), the National Institutes of Health (Grant DE 09761) and the Foundation for Polish Science (Team/2009-4/8). The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union (grant No. POIG.02.01.00-12-064/08 -" Molecular biotechnology for health"). J.W.S. is grateful to the School of Dental Science, University of Liverpool, for financial support for D. P. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PA, 1980, BIOCHEM J, V191, P95, DOI 10.1042/bj1910095; BENESCH RE, 1990, J BIOL CHEM, V265, P14881; BICKEL M, 1985, J PERIODONTAL RES, V20, P35, DOI 10.1111/j.1600-0765.1985.tb00408.x; BUNN HF, 1968, J BIOL CHEM, V243, P465; Byrne DP, 2010, BIOCHEM J, V425, P257, DOI 10.1042/BJ20090343; CURTIS MA, 1988, J CLIN PERIODONTOL, V15, P628, DOI 10.1111/j.1600-051X.1988.tb02263.x; EGGERT FM, 1991, ARCH ORAL BIOL, V36, P233, DOI 10.1016/0003-9969(91)90091-8; Gattoni M, 1996, J BIOL CHEM, V271, P10130, DOI 10.1074/jbc.271.17.10130; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; HRKAL Z, 1974, EUR J BIOCHEM, V43, P73, DOI 10.1111/j.1432-1033.1974.tb03386.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; Lewis JP, 2006, MICROBIOL-SGM, V152, P3367, DOI 10.1099/mic.0.29011-0; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; MARSH PD, 1994, MICROBIOL-UK, V140, P861, DOI 10.1099/00221287-140-4-861; MCKEE AS, 1986, INFECT IMMUN, V52, P349, DOI 10.1128/IAI.52.2.349-355.1986; MONZANI E, BIOCH BIOPHYS ACTA, V1547, P302; Olczak T, 2001, J BACTERIOL, V183, P5599, DOI 10.1128/JB.183.19.5599-5608.2001; Olczak T, 2005, FEMS MICROBIOL REV, V29, P119, DOI 10.1016/j.femsre.2004.09.001; Olczak T, 2008, ARCH MICROBIOL, V189, P197, DOI 10.1007/s00203-007-0309-7; Olczak T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-134; PIKE R, 1994, J BIOL CHEM, V269, P406; Potempa J, 1998, J BIOL CHEM, V273, P21648, DOI 10.1074/jbc.273.34.21648; Smalley JW, 2006, MICROBIOL-SGM, V152, P1839, DOI 10.1099/mic.0.28835-0; Smalley JW, 2008, BIOL CHEM, V389, P1235, DOI 10.1515/BC.2008.140; Smalley JW, 2007, ARCH BIOCHEM BIOPHYS, V465, P44, DOI 10.1016/j.abb.2007.05.011; SMALLEY JW, 1993, J GEN MICROBIOL, V139, P2145, DOI 10.1099/00221287-139-9-2145; SMALLEY JW, 1991, FEMS MICROBIOL LETT, V90, P63, DOI 10.1016/0378-1097(91)90647-S; Smalley JW, 1998, BIOCHEM J, V331, P681, DOI 10.1042/bj3310681; Smalley JW, 2004, BIOCHEM J, V379, P833, DOI 10.1042/BJ20031221; Smalley JW, 2002, BIOCHEM J, V362, P239, DOI 10.1042/0264-6021:3620239; Tsuruga M, 1998, J BIOL CHEM, V273, P8607, DOI 10.1074/jbc.273.15.8607; Wojtowicz H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000419; Wojtowicz H, 2009, BIOCHEM BIOPH RES CO, V383, P178, DOI 10.1016/j.bbrc.2009.03.148	34	60	62	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17182	10.1371/journal.pone.0017182	http://dx.doi.org/10.1371/journal.pone.0017182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21390208	gold, Green Published			2022-12-25	WOS:000287482300035
J	Buhler, S; Sanchez-Mazas, A				Buhler, Stephane; Sanchez-Mazas, Alicia			HLA DNA Sequence Variation among Human Populations: Molecular Signatures of Demographic and Selective Events	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I LOCI; HUMAN MITOCHONDRIAL-DNA; GENE CONVERSION; OVERDOMINANT SELECTION; NUCLEOTIDE SUBSTITUTION; BALANCING SELECTION; NATURAL-SELECTION; HLA-DRB1 ALLELES; MHC EVOLUTION	Molecular differences between HLA alleles vary up to 57 nucleotides within the peptide binding coding region of human Major Histocompatibility Complex (MHC) genes, but it is still unclear whether this variation results from a stochastic process or from selective constraints related to functional differences among HLA molecules. Although HLA alleles are generally treated as equidistant molecular units in population genetic studies, DNA sequence diversity among populations is also crucial to interpret the observed HLA polymorphism. In this study, we used a large dataset of 2,062 DNA sequences defined for the different HLA alleles to analyze nucleotide diversity of seven HLA genes in 23,500 individuals of about 200 populations spread worldwide. We first analyzed the HLA molecular structure and diversity of these populations in relation to geographic variation and we further investigated possible departures from selective neutrality through Tajima's tests and mismatch distributions. All results were compared to those obtained by classical approaches applied to HLA allele frequencies. Our study shows that the global patterns of HLA nucleotide diversity among populations are significantly correlated to geography, although in some specific cases the molecular information reveals unexpected genetic relationships. At all loci except HLA-DPB1, populations have accumulated a high proportion of very divergent alleles, suggesting an advantage of heterozygotes expressing molecularly distant HLA molecules (asymmetric overdominant selection model). However, both different intensities of selection and unequal levels of gene conversion may explain the heterogeneous mismatch distributions observed among the loci. Also, distinctive patterns of sequence divergence observed at the HLA-DPB1 locus suggest current neutrality but old selective pressures on this gene. We conclude that HLA DNA sequences advantageously complement HLA allele frequencies as a source of data used to explore the genetic history of human populations, and that their analysis allows a more thorough investigation of human MHC molecular evolution.	[Buhler, Stephane; Sanchez-Mazas, Alicia] Univ Geneva, Lab Anthropol Genet & Peopling Hist, Dept Anthropol, Geneva, Switzerland	University of Geneva	Buhler, S (corresponding author), Univ Geneva, Lab Anthropol Genet & Peopling Hist, Dept Anthropol, Geneva, Switzerland.	stephane.buhler@unige.ch		Buhler, Stephane/0000-0001-6675-5287; SANCHEZ-MAZAS, Alicia/0000-0002-7714-2432	Swiss National Science Foundation [FNS 3100-49771.96, 3100A0-112651]; European Science Foundation [ESF COST Action BM0803 HLA-NET]; Swiss State Secretariat for Education and Research (SER) [C08.0131];  [PBGEA-119280]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Science Foundation(European Science Foundation (ESF)European Commission); Swiss State Secretariat for Education and Research (SER); 	This work was supported by grants from the Swiss National Science Foundation (FNS 3100-49771.96 and 3100A0-112651 to A. Sanchez-Mazas and fellowship for prospective researcher PBGEA-119280 to S. Buhler) and by the European Science Foundation (ESF COST Action BM0803 HLA-NET) and the Swiss State Secretariat for Education and Research (SER grant C08.0131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2001, IMMUNOL REV, V183, P41, DOI 10.1034/j.1600-065x.2001.1830104.x; Arnaiz-Villena A, 2000, TISSUE ANTIGENS, V56, P405, DOI 10.1034/j.1399-0039.2000.560503.x; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Beck S, 2000, ANNU REV GENOM HUM G, V1, P117, DOI 10.1146/annurev.genom.1.1.117; BELICH MP, 1992, NATURE, V357, P326, DOI 10.1038/357326a0; Bergstrom TF, 1999, IMMUNOL REV, V167, P351, DOI 10.1111/j.1600-065X.1999.tb01404.x; Bergstrom TF, 1998, NAT GENET, V18, P237, DOI 10.1038/ng0398-237; BODMER J, 1997, P 12 INT HIST WORKSH, P269; Bontrop RE, 2006, HUM IMMUNOL, V67, P388, DOI 10.1016/j.humimm.2006.03.007; Bradshaw D, 2002, TISSUE ANTIGENS, V59, P325, DOI 10.1034/j.1399-0039.2002.590413.x; Buhler S, 2006, TISSUE ANTIGENS, V68, P44, DOI 10.1111/j.1399-0039.2006.00621.x; Buhler S, 2002, TISSUE ANTIGENS, V59, P525, DOI 10.1034/j.1399-0039.2002.590611.x; Buhler S, 2010, TISSUE ANTIGENS, V75, P500, DOI 10.1111/j.1399-0039.2010.01469.x; Bunce M, 1997, TRANSPLANTATION, V64, P1505, DOI 10.1097/00007890-199712150-00001; Bunce M., 1997, Tissue Antigens, V50, P100, DOI 10.1111/j.1399-0039.1997.tb02847.x; Cadavid LF, 1997, TISSUE ANTIGENS, V50, P209, DOI 10.1111/j.1399-0039.1997.tb02865.x; Cao K, 2004, TISSUE ANTIGENS, V63, P293, DOI 10.1111/j.0001-2815.2004.00192.x; Cereb N, 1997, IMMUNOGENETICS, V47, P30, DOI 10.1007/s002510050323; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; DI D, AM J PHYS A IN PRESS; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fukami-Kobayashi K, 2005, P NATL ACAD SCI USA, V102, P9230, DOI 10.1073/pnas.0500770102; GAO X, 1997, P 12 INT HIST WORKSH, P298; Garrigan D, 2003, EVOLUTION, V57, P1707; Gaudieri S, 2000, GENOME RES, V10, P1579, DOI 10.1101/gr.127200; Gibert M, 2003, EUR J IMMUNOGENET, V30, P361, DOI 10.1046/j.1365-2370.2003.00418.x; Grundschober C, 1997, TISSUE ANTIGENS, V49, P612, DOI 10.1111/j.1399-0039.1997.tb02809.x; Guenounou BA, 2006, INT J IMMUNOGENET, V33, P93, DOI 10.1111/j.1744-313X.2006.00577.x; Hao L, 2005, GENE, V347, P149, DOI 10.1016/j.gene.2004.12.012; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Hedrick PW, 1998, GENETICA, V104, P207, DOI 10.1023/A:1026494212540; HOLLENBACH JA, 2010, ANTHR COMP 15 INT HI; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Jakobsen IB, 1998, IMMUNOGENETICS, V48, P312, DOI 10.1007/s002510050438; Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [10.1016/0304-4149(82)90011-4, DOI 10.1016/0304-4149(82)90011-4]; Kulski JK, 2002, IMMUNOL REV, V190, P95, DOI 10.1034/j.1600-065X.2002.19008.x; KWOK WW, 1993, J IMMUNOL, V150, P2263; KWOK WW, 1995, J IMMUNOL, V155, P2468; Little AM, 1996, TISSUE ANTIGENS, V48, P113, DOI 10.1111/j.1399-0039.1996.tb02615.x; MACK S, 2006, IMMUNOBIOLOGY HUMAN, P747; Mack S. J., 2006, IMMUNOBIOLOGY HUMAN, P580; Mack SJ, 2006, IMMUNOBIOLOGY HUMAN, P564; Marsh S. G. E., 2000, HLA FACTSBOOK; MARSH SG, 2008, HUM IMMUNOL; Marsh SGE, 2005, TISSUE ANTIGENS, V65, P301, DOI 10.1111/j.1399-0039.2005.00379.x; Martinsohn JT, 1999, IMMUNOGENETICS, V50, P168, DOI 10.1007/s002510050593; MEDHI SQ, 1997, P 12 INT HIST WORKSH, P321; Meyer D, 2006, IMMUNOBIOLOGY HUMAN, P653; Meyer D, 2006, GENETICS, V173, P2121, DOI 10.1534/genetics.105.052837; Middleton D, 2010, IMMUNOLOGY, V129, P8, DOI 10.1111/j.1365-2567.2009.03208.x; Mytilineos J, 1997, TISSUE ANTIGENS, V50, P395, DOI 10.1111/j.1399-0039.1997.tb02893.x; Nei M., 1987, MOL EVOLUTIONARY GEN; NUNES J, HUM BIOL IN PRESS; Nunes J, 2006, IMMUNOBIOLOGY HUMAN, P143; Nunes J, 2005, THESIS U PORTO; Nunes JM, 2006, GENERATE TOOLS ANAL; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Parham P, 1997, TISSUE ANTIGENS, V50, P219, DOI 10.1111/j.1399-0039.1997.tb02866.x; PARHAM P, 1995, IMMUNOL REV, V143, P141, DOI 10.1111/j.1600-065X.1995.tb00674.x; Perrier P, 2000, TISSUE ANTIGENS, V56, P556, DOI 10.1034/j.1399-0039.2000.560612.x; PETZLERLER ML, 1997, P 12 IHWC HLA GEN HI, P337; PIAZZA A, 1997, P 12 INT HIST WORKSH, P374; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Ray N., 2002, GEODIST; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; REYNOLDS J, 1983, GENETICS, V105, P767; RICCIO M, HUM BIOL IN PRESS; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]; Robinson James, 2007, V409, P43, DOI 10.1007/978-1-60327-118-9_3; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rohlf F.J., 2000, NTSYSPC NUMERICAL TA; Salamon H, 1999, GENETICS, V152, P393; Sanchez-Mazas A, 2000, TISSUE ANTIGENS, V56, P303, DOI 10.1034/j.1399-0039.2000.560402.x; Sanchez-Mazas A, 2001, HUM IMMUNOL, V62, P937, DOI 10.1016/S0198-8859(01)00293-2; Sanchez-Mazas A., 2006, IMMUNOBIOLOGY HUMAN, P758; Sanchez-Mazas A, 2007, TISSUE ANTIGENS, V69, P198, DOI 10.1111/j.1399-0039.2006.00802.x; Satta Y, 1997, HEREDITAS, V127, P105, DOI 10.1111/j.1601-5223.1997.00105.x; SATTA Y, 1994, P NATL ACAD SCI USA, V91, P7184, DOI 10.1073/pnas.91.15.7184; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; SAWYER S, 1999, GENECONVC COMPUTER P; Schierup MH, 2000, GENETICS, V156, P879; Schierup MH, 2001, GENETICS, V159, P1833; Schneider S, 1999, GENETICS, V152, P1079; Silvera-Redondo C, 2000, IMMUNOGENETICS, V51, P1053, DOI 10.1007/s002510000238; Slatkin M, 2000, GENETICS, V156, P2119; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Solberg OD, 2008, HUM IMMUNOL, V69, P443, DOI 10.1016/j.humimm.2008.05.001; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Takahata N, 1998, GENETICA, V102-3, P157, DOI 10.1023/A:1017029613342; Tavoularis S, 2001, TISSUE ANTIGENS, V57, P390, DOI 10.1034/j.1399-0039.2001.570420.x; TIERCY JM, 1992, AM J HUM GENET, V51, P592; TSAI Y, 2006, IMMUNOBIOLOGY HUMAN, P199; Turner S, 1998, J IMMUNOL, V161, P1406; Valdes AM, 1999, ANN HUM GENET, V63, P27, DOI 10.1046/j.1469-1809.1999.6310027.x; van Oosterhout Cock, 2009, Communicative & Integrative Biology, V2, P408; van Oosterhout C, 2009, P ROY SOC B-BIOL SCI, V276, P657, DOI 10.1098/rspb.2008.1299; von Salome J, 2007, IMMUNOGENETICS, V59, P261, DOI 10.1007/s00251-007-0196-8; Wang H, 1997, TISSUE ANTIGENS, V49, P134, DOI 10.1111/j.1399-0039.1997.tb02727.x; WATKINS DI, 1992, NATURE, V357, P329, DOI 10.1038/357329a0; WATTERSON GA, 1978, GENETICS, V88, P405; Wiuf C, 2000, GENETICS, V155, P451; Wiuf C, 2000, THEOR POPUL BIOL, V57, P357, DOI 10.1006/tpbi.2000.1462; WRIGHT S, 1951, ANN EUGENIC, V15, P323	109	94	96	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2011	6	2							e14643	10.1371/journal.pone.0014643	http://dx.doi.org/10.1371/journal.pone.0014643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UR	21408106	Green Published, Green Submitted, gold			2022-12-25	WOS:000286835000002
J	Nazeer, FI; Devany, E; Mohammed, S; Fonseca, D; Akukwe, B; Taveras, C; Kleiman, FE				Nazeer, F. I.; Devany, E.; Mohammed, S.; Fonseca, D.; Akukwe, B.; Taveras, C.; Kleiman, F. E.			p53 inhibits mRNA 3 ' processing through its interaction with the CstF/BARD1 complex	ONCOGENE			English	Article						p53; cleavage-stimulation factor; BARD1; DNA damage; RNA processing	DNA-DAMAGE; POLYMERASE-II; POLYADENYLATION FACTOR; UNTRANSLATED REGIONS; EXPRESSION; IDENTIFICATION; APOPTOSIS; PROTEIN; CELLS; PHOSPHORYLATION	The mechanisms involved in the p53-dependent control of gene expression following DNA damage have not been completely elucidated. Here, we show that the p53 C terminus associates with factors that are required for the ultraviolet (UV)-induced inhibition of the mRNA 3' cleavage step of the polyadenylation reaction, such as the tumor suppressor BARD1 and the 3' processing factor cleavage-stimulation factor 1 (CstF1). We found that p53 can coexist in complexes with CstF and BARD1 in extracts of UV-treated cells, suggesting a role for p53 in mRNA 3' cleavage following DNA damage. Consistent with this, we found that p53 inhibits 3' cleavage in vitro and that there is a reverse correlation between the levels of p53 expression and the levels of mRNA 3' cleavage under different cellular conditions. Supporting these results, a tumor-associated mutation in p53 not only decreases the interaction with BARD1 and CstF, but also decreases the UV-induced inhibition of 3' processing, all of which is restored by wild-type-p53 expression. We also found that p53 expression levels affect the polyadenylation levels of housekeeping genes, but not of p21 and c-fos genes, which are involved in the DNA damage response (DDR). Here, we identify a novel 3' RNA processing inhibitory function of p53, adding a new level of complexity to the DDR by linking RNA processing to the p53 network. Oncogene (2011) 3', 3'73-3'83; doi: 10.1038/onc.2011.29; published online 7 March 2011	[Nazeer, F. I.; Devany, E.; Mohammed, S.; Fonseca, D.; Akukwe, B.; Taveras, C.; Kleiman, F. E.] CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Kleiman, FE (corresponding author), CUNY Hunter Coll, Dept Chem, 695 Pk Ave, New York, NY 10065 USA.	fkleiman@hunter.cuny.edu		Mathmann, Carmen/0000-0002-7406-2285	National Institute of General Medical Sciences [SC1GM083806]; Minority Access to Research Careers Program (MARC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM083806] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Minority Access to Research Careers Program (MARC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr JL Manley for anti-CstF2 antibodies, Dr B Vogelstein and Dr J Bargonetti for cell lines DLD-1 and D-A2, Dr EK Boamah for technical advice, Dr C Prives for p53 encoding plasmids, Dr R Baer for BARD1 encoding plasmids and Dr S Pinol-Roma and Dr MA Cevher for advice and discussion. This work is supported by National Institute of General Medical Sciences Grant SC1GM083806 to FEK and by Minority Access to Research Careers Program (MARC) to BA and CT.	Akeo K, 2007, TISSUE CULT RES COMM, V26, P149; CEVHER MA, 2010, CONNECTIONS 3 END PR; Cevher MA, 2010, EMBO J, V29, P1674, DOI 10.1038/emboj.2010.59; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Fabbro M, 2004, J BIOL CHEM, V279, P31251, DOI 10.1074/jbc.M405372200; Feki A, 2005, ONCOGENE, V24, P3726, DOI 10.1038/sj.onc.1208491; Fong S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-23; Fox JT, 2009, J BIOL CHEM, V284, P31097, DOI 10.1074/jbc.M109.015800; Fu N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000216; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; Irminger-Finger I, 2001, MOL CELL, V8, P1255, DOI 10.1016/S1097-2765(01)00406-3; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; KESSIS TD, 1993, P NATL ACAD SCI USA, V90, P3988, DOI 10.1073/pnas.90.9.3988; Kleiman FE, 2005, GENE DEV, V19, P1227, DOI 10.1101/gad.1309505; Kleiman FE, 1999, SCIENCE, V285, P1576, DOI 10.1126/science.285.5433.1576; Kleiman FE, 2001, CELL, V104, P743, DOI 10.1016/S0092-8674(02)07059-9; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Ljungman M, 1999, ONCOGENE, V18, P583, DOI 10.1038/sj.onc.1202356; Maccoux LJ, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-62; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; McKay BC, 2001, ONCOGENE, V20, P6805, DOI 10.1038/sj.onc.1204901; McKay Bruce C., 1999, Neoplasia (New York), V1, P276, DOI 10.1038/sj.neo.7900028; Mirkin N, 2008, NUCLEIC ACIDS RES, V36, P1792, DOI 10.1093/nar/gkn005; Noda A, 2000, ONCOGENE, V19, P21, DOI 10.1038/sj.onc.1203230; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sauer M, 2008, NUCLEIC ACIDS RES, V36, P1900, DOI 10.1093/nar/gkn044; Scorilas A, 2002, CRIT REV CL LAB SCI, V39, P193, DOI 10.1080/10408360290795510; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Singh P, 2009, CANCER RES, V69, P9422, DOI 10.1158/0008-5472.CAN-09-2236; TAKAGAKI Y, 1989, GENE DEV, V3, P1711, DOI 10.1101/gad.3.11.1711; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Takwi A, 2009, CURR GENOMICS, V10, P194, DOI 10.2174/138920209788185270; Topalian SL, 2001, MOL CELL BIOL, V21, P5614, DOI 10.1128/MCB.21.16.5614-5623.2001; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1242/jcs.03293; Wei QZ, 2005, J BIOL CHEM, V280, P37790, DOI 10.1074/jbc.M502974200; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Zhu ZH, 2009, ONCOGENE, V28, P41, DOI 10.1038/onc.2008.359; Zlotorynski E, 2008, CELL, V134, P208, DOI 10.1016/j.cell.2008.07.003	46	30	30	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2011	30	27					3073	3083		10.1038/onc.2011.29	http://dx.doi.org/10.1038/onc.2011.29			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	789IW	21383700				2022-12-25	WOS:000292510100007
J	Omori, E; Matsumoto, K; Ninomiya-Tsuji, J				Omori, E.; Matsumoto, K.; Ninomiya-Tsuji, J.			Non-canonical beta-catenin degradation mediates reactive oxygen species-induced epidermal cell death	ONCOGENE			English	Article						apoptosis; beta-catenin; caspase; epidermis; reactive oxygen species	TUMOR-NECROSIS-FACTOR; IL-1 SIGNALING PATHWAY; PROTEOLYTIC CLEAVAGE; FACTOR-ALPHA; KINASE TAK1; HELA-CELLS; TNF-ALPHA; KAPPA-B; ACTIVATION; APOPTOSIS	beta-Catenin is constantly degraded through the ubiquitin-proteasomal pathway. In this study, we report that a different type of beta-catenin degradation is causally involved in epidermal cell death. We observed that reactive oxygen species (ROS) caused beta-catenin degradation in the epidermal cells through a caspase-dependent mechanism, which results in disruption of cell adhesion. Disruption of cell adhesion increased ROS and activated caspases. Upregulation of the intact beta-catenin blocked ROS accumulation and caspase activation. These results indicate that a feed-forward loop consisting of ROS, caspases activation and beta-catenin degradation induces epidermal cell death. Oncogene (2011) 30, 3336-3344; doi:10.1038/onc.2011.49; published online 7 March 2011	[Omori, E.; Ninomiya-Tsuji, J.] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Matsumoto, K.] Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648601, Japan	University of North Carolina; North Carolina State University; Nagoya University	Ninomiya-Tsuji, J (corresponding author), N Carolina State Univ, Dept Environm & Mol Toxicol, Campus Box 7633, Raleigh, NC 27695 USA.	Jun_Tsuji@ncsu.edu		Ninomiya-Tsuji, Jun/0000-0002-5584-0176	National Institutes of Health [GM068812, GM084406]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068812, R01GM084406] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22020016] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S Akira for tak1-floxed mice, ER Fearon for beta-catenin cDNAs, J Dow, BJ Welker and M Mattmuler for support. This work was supported by National Institutes of Health Grant GM068812 and GM084406 (to J N-T).	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Bannerman DD, 1998, J BIOL CHEM, V273, P35371, DOI 10.1074/jbc.273.52.35371; Brancolini C, 1998, CELL DEATH DIFFER, V5, P1042, DOI 10.1038/sj.cdd.4400443; Brancolini C, 1997, J CELL BIOL, V139, P759, DOI 10.1083/jcb.139.3.759; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Go YM, 2004, J BIOL CHEM, V279, P5837, DOI 10.1074/jbc.M307547200; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Kitamura T, 1998, INT J HEMATOL, V67, P351; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Li G, 2002, P NATL ACAD SCI USA, V99, P13254, DOI 10.1073/pnas.202355799; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2008, J BIOL CHEM, V283, P26161, DOI 10.1074/jbc.M804513200; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Pasparakis M, 1997, P NATL ACAD SCI USA, V94, P6319, DOI 10.1073/pnas.94.12.6319; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Steinhusen U, 2000, J BIOL CHEM, V275, P16345, DOI 10.1074/jbc.M001458200; Tafani M, 2002, J BIOL CHEM, V277, P49569, DOI 10.1074/jbc.M208915200; Tafani M, 2001, CANCER RES, V61, P2459; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Van de Craen M, 1999, FEBS LETT, V458, P167, DOI 10.1016/S0014-5793(99)01153-9; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Yang HP, 2005, BIOCHEM J, V391, P399, DOI 10.1042/BJ20050795	30	9	10	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2011	30	30					3336	3344		10.1038/onc.2011.49	http://dx.doi.org/10.1038/onc.2011.49			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	798NO	21383695	Green Accepted			2022-12-25	WOS:000293215700004
J	Piao, JH; Hasegawa, M; Heissig, B; Hattori, K; Takeda, K; Iwakura, Y; Okumura, K; Inohara, N; Nakano, H				Piao, Jiang-Hu; Hasegawa, Mizuho; Heissig, Beate; Hattori, Koichi; Takeda, Kazuyoshi; Iwakura, Yoichiro; Okumura, Ko; Inohara, Naohiro; Nakano, Hiroyasu			Tumor Necrosis Factor Receptor-associated Factor (TRAF) 2 Controls Homeostasis of the Colon to Prevent Spontaneous Development of Murine Inflammatory Bowel Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTESTINAL INFLAMMATION; CELL-DEATH; ACTIVATION; MICE; PATHWAY; DEFICIENCY; DEFENSINS; RESPONSES; COLITIS	Fine-tuning of host cell responses to commensal bacteria plays a crucial role in maintaining homeostasis of the gut. Here, we show that tumor necrosis factor receptor-associated factor (Traf)2(-/-) mice spontaneously developed severe colitis and succumbed within 3 weeks after birth. Histological analysis revealed that apoptosis of colonic epithelial cells was enhanced, and B cells diffusely infiltrated into the submucosal layer of the colon of Traf2(-/-) mice. Expression of proinflammatory cytokines, including Tnfa, Il17a, and Ifng, was up-regulated, whereas expression of antimicrobial peptides was down-regulated in the colon of Traf2(-/-) mice. Moreover, a number of IL-17-producing helper T cells were increased in the colonic lamina propria of Traf2(-/-) mice. These cellular alterations resulted in drastic changes in the colonic microbiota of Traf2(-/-) mice compared with Traf2(+/+) mice. Treatment of Traf2(-/-) mice with antibiotics ameliorated colitis along with down-regulation of proinflammatory cytokines and prolonged survival, suggesting that the altered colonic microbiota might contribute to exacerbation of colitis. Finally, deletion of Tnfr1, but not Il17a, dramatically ameliorated colitis in Traf2(-/-) mice by preventing apoptosis of colonic epithelial cells, down-regulation of proinflammatory cytokines, and restoration of wild-type commensal bacteria. Together, TRAF2 plays a crucial role in controlling homeostasis of the colon.	[Piao, Jiang-Hu; Takeda, Kazuyoshi; Okumura, Ko; Nakano, Hiroyasu] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan; [Piao, Jiang-Hu] Juntendo Univ, Sch Med, Sportol Ctr, Bunkyo Ku, Tokyo 1138421, Japan; [Okumura, Ko] Juntendo Univ, Sch Med, Atopy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan; [Piao, Jiang-Hu] Ningxia Med Univ, Basic Med Sci Coll, Dept Immunol, Xingqing Qu 750004, Yinchuan, Peoples R China; [Hasegawa, Mizuho; Inohara, Naohiro] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Heissig, Beate] Univ Tokyo, Frontier Res Initiat, Minato Ku, Tokyo 1088639, Japan; [Heissig, Beate; Hattori, Koichi] Univ Tokyo, Dept Stem Cell Regulat, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Tokyo 1088639, Japan; [Iwakura, Yoichiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Juntendo University; Juntendo University; Juntendo University; Ningxia Medical University; University of Michigan System; University of Michigan; University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Nakano, H (corresponding author), Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	hnakano@juntendo.ac.jp	Heissig, Beate/AAF-6771-2021; Hattori, Koichi/AAF-6862-2021; Iwakura, Yoichiro/E-5457-2011	Heissig, Beate/0000-0002-0348-5934; Iwakura, Yoichiro/0000-0002-9934-5775; Nakano, Hiroyasu/0000-0003-4843-1427	Ministry of Education, Culture, Sports, Science and Technology; Promotion and Mutual Aid Corporation for Private Schools of Japan; Japan Society for the Promotion of Science; Scientific Research on Innovative Areas, Ministry of Education, Culture, Sports, Science and Technology, Japan; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [23659404, 23300355] Funding Source: KAKEN; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018503] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Scientific Research on Innovative Areas, Ministry of Education, Culture, Sports, Science and Technology, Japan; Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by grants-in-aid for "High-Tech Research Center" project for private universities, matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology, the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan, Scientific Research B and C from Japan Society for the Promotion of Science, Scientific Research on Innovative Areas, Ministry of Education, Culture, Sports, Science and Technology, Japan, Takeda Science Foundation, and Astellas Foundation for Research on Metabolic Disorders.	Broglie P, 2010, J BIOL CHEM, V285, P2333, DOI 10.1074/jbc.M109.090522; Corthesy B, 2007, J IMMUNOL, V178, P27, DOI 10.4049/jimmunol.178.1.27; De Jong YP, 2000, GASTROENTEROLOGY, V119, P715, DOI 10.1053/gast.2000.16485; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Hasegawa M, 2010, INFECT IMMUN, V78, P639, DOI 10.1128/IAI.01043-09; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; Nakano H, 1999, P NATL ACAD SCI USA, V96, P9803, DOI 10.1073/pnas.96.17.9803; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Piao JH, 2007, J IMMUNOL, V178, P2272, DOI 10.4049/jimmunol.178.4.2272; Shi JS, 2007, J IMMUNOL, V179, P1245, DOI 10.4049/jimmunol.179.2.1245; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wehkamp J, 2005, NAT CLIN PRACT GASTR, V2, P406, DOI 10.1038/ncpgasthep0265; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	28	24	25	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17879	17888		10.1074/jbc.M111.221853	http://dx.doi.org/10.1074/jbc.M111.221853			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21393251	Green Published, hybrid			2022-12-25	WOS:000290585200051
J	Liu, JY; Zhang, DY; Luo, WJ; Yu, YH; Yu, JX; Li, JX; Zhang, XH; Zhang, BL; Chen, JY; Wu, XR; Rosas-Acosta, G; Huang, CS				Liu, Jinyi; Zhang, Dongyun; Luo, Wenjing; Yu, Yonghui; Yu, Jianxiu; Li, Jingxia; Zhang, Xinhai; Zhang, Baolin; Chen, Jingyuan; Wu, Xue-Ru; Rosas-Acosta, German; Huang, Chuanshu			X-linked Inhibitor of Apoptosis Protein (XIAP) Mediates Cancer Cell Motility via Rho GDP Dissociation Inhibitor (RhoGDI)-dependent Regulation of the Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOHISTOCHEMICAL DETECTION; ACTIN POLYMERIZATION; EXPRESSION; DEGRADATION; METASTASIS; IAPS; MIGRATION; RECEPTOR; GTPASES; TARGET	X-linked inhibitor of apoptosis protein (XIAP) overexpression has been found to be associated with malignant cancer progression and aggression in individuals with many types of cancers. However, the molecular basis of XIAP in the regulation of cancer cell biological behavior remains largely unknown. In this study, we found that a deficiency of XIAP expression in human cancer cells by either knock-out or knockdown leads to a marked reduction in beta-actin polymerization and cytoskeleton formation. Consistently, cell migration and invasion were also decreased in XIAP-deficient cells compared with parental wildtype cells. Subsequent studies demonstrated that the regulation of cell motility by XIAP depends on its interaction with the Rho GDP dissociation inhibitor (RhoGDI) via the XIAP RING domain. Furthermore, XIAP was found to negatively regulate RhoGDI SUMOylation, which might affect its activity in controlling cell motility. Collectively, our studies provide novel insights into the molecular mechanisms by which XIAP regulates cancer invasion and offer a further theoretical basis for setting XIAP as a potential prognostic marker and specific target for treatment of cancers with metastatic properties.	[Liu, Jinyi; Zhang, Dongyun; Yu, Yonghui; Yu, Jianxiu; Li, Jingxia; Zhang, Xinhai; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA; [Liu, Jinyi] Third Mil Med Univ, Prevent Med Coll, Dept Hyg Toxicol, Chongqing 400038, Peoples R China; [Luo, Wenjing; Chen, Jingyuan] Fourth Mil Med Univ, Dept Occupat & Environm Hlth Sci, Xian 710032, Shanxi, Peoples R China; [Zhang, Baolin] US FDA, Div Therapeut Prot, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Rosas-Acosta, German] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Liu, Jinyi] Third Mil Med Univ, Prevent Med Coll, Toxicogenom Lab, Chongqing 400038, Peoples R China	New York University; Army Medical University; Air Force Military Medical University; US Food & Drug Administration (FDA); New York University; New York University; University of Texas System; University of Texas El Paso; Army Medical University	Huang, CS (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	chuanshu.huang@nyumc.org	Yu, Jianxiu/A-7214-2012; Yu, Yonghui/AAZ-4093-2021	Wu, Xue-Ru/0000-0001-6058-6291; Huang, Chuanshu/0000-0003-4133-5096	National Institutes of Health, NCI [CA112557]; NIEHS [ES000260]; New York University Urology Center of Excellence;  [ES012451];  [ES010344]; NATIONAL CANCER INSTITUTE [R01CA112557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI098976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010344, P30ES000260, R01ES012451] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); New York University Urology Center of Excellence; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA112557 from NCI and Grants ES012451, ES010344, and ES000260 from NIEHS. This work was also supported by the New York University Urology Center of Excellence.	Akyurek N, 2006, CANCER-AM CANCER SOC, V107, P1844, DOI 10.1002/cncr.22219; Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; Burstein DE, 2008, ANN DIAGN PATHOL, V12, P85, DOI 10.1016/j.anndiagpath.2007.04.008; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Chan AY, 1998, J CELL SCI, V111, P199; Cummins JM, 2004, CANCER RES, V64, P3006, DOI 10.1158/0008-5472.CAN-04-0046; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DIAKONOVA M, 1995, J CELL SCI, V108, P2499; Disanza A, 2005, CELL MOL LIFE SCI, V62, P955, DOI 10.1007/s00018-004-4472-6; Dogan T, 2008, NAT CELL BIOL, V10, P1447, DOI 10.1038/ncb1804; Entschladen F, 2004, LANCET ONCOL, V5, P254, DOI 10.1016/S1470-2045(04)01431-7; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fong WG, 2000, GENOMICS, V70, P113, DOI 10.1006/geno.2000.6364; Gordon GJ, 2007, J PATHOL, V211, P447, DOI 10.1002/path.2121; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Jordan BWM, 2001, J BIOL CHEM, V276, P39985, DOI 10.1074/jbc.C100171200; Kleinberg L, 2007, HUM PATHOL, V38, P986, DOI 10.1016/j.humpath.2006.12.013; Kleinberg L, 2007, CANCER, V109, P228, DOI 10.1002/cncr.22426; Kluger HM, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-6; LEE HK, 1994, INT REV EXP PATHOL, V35, P39; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Li Bin, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1746; Li M, 2007, CHINESE MED J-PEKING, V120, P469, DOI 10.1097/00029330-200703020-00007; Luo WJ, 2008, J BIOL CHEM, V283, P8624, DOI 10.1074/jbc.M707860200; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Mizutani Y, 2007, INT J ONCOL, V30, P919; Morizane Y, 2005, J BIOCHEM, V137, P125, DOI 10.1093/jb/mvi029; Nagi C, 2007, ANN DIAGN PATHOL, V11, P402, DOI 10.1016/j.anndiagpath.2006.12.012; Nemoto T, 2004, EXP MOL PATHOL, V76, P253, DOI 10.1016/j.yexmp.2004.01.001; Ouyang WM, 2009, J CELL PHYSIOL, V218, P205, DOI 10.1002/jcp.21590; Pal S, 2010, J VIROL METHODS, V163, P498, DOI 10.1016/j.jviromet.2009.11.010; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Rouleau C, 2006, MOL CANCER THER, V5, P219, DOI 10.1158/1535-7163.MCT-05-0289; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Shi YH, 2008, HEPATOLOGY, V48, P497, DOI 10.1002/hep.22393; Song L, 2007, MOL CELL BIOL, V27, P2713, DOI 10.1128/MCB.00657-06; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Staiger CJ, 2006, CURR OPIN PLANT BIOL, V9, P554, DOI 10.1016/j.pbi.2006.09.013; Taniuchi S, 1999, PEDIATR INT, V41, P37; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Wilkinson JC, 2008, MOL CELL BIOL, V28, P237, DOI 10.1128/MCB.01065-07; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yang L, 2003, CANCER RES, V63, P6815; Zhang BL, 2006, DRUG RESIST UPDATE, V9, P134, DOI 10.1016/j.drup.2006.06.001; Zhang BL, 2005, CANCER RES, V65, P6054, DOI 10.1158/0008-5472.CAN-05-0175; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448	51	65	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.176982	http://dx.doi.org/10.1074/jbc.M110.176982			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21402697	Green Published, hybrid			2022-12-25	WOS:000290022800003
J	Makino, R; Park, S; Obayashi, E; Iizuka, T; Hori, H; Shiro, Y				Makino, Ryu; Park, Sam-yon; Obayashi, Eiji; Iizuka, Tetsutaro; Hori, Hiroshi; Shiro, Yoshitugu			Oxygen Binding and Redox Properties of the Heme in Soluble Guanylate Cyclase IMPLICATIONS FOR THE MECHANISM OF LIGAND DISCRIMINATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; ABSORPTION FINE-STRUCTURE; SPERM WHALE MYOGLOBIN; NITRIC-OXIDE; CARBON-MONOXIDE; BOVINE LUNG; COBALT MYOGLOBINS; SMOOTH-MUSCLE; CYCLIC-GMP; ACTIVATION	Soluble guanylate cyclase is an NO-sensing hemoprotein that serves as a NO receptor in NO-mediated signaling pathways. It has been believed that this enzyme displays no measurable affinity for O-2, thereby enabling the selective NO sensing in aerobic environments. Despite the physiological significance, the reactivity of the enzyme-heme for O-2 has not been examined in detail. In this paper we demonstrated that the high spin heme of the ferrous enzyme converted to a low spin oxyheme (Fe2+-O-2) when frozen at 77 K in the presence of O-2. The ligation of O-2 was confirmed by EPR analyses using cobalt-substituted enzyme. The oxy form was produced also under solution conditions at -7 degrees C, with the extremely low affinity for O-2. The low O-2 affinity was not caused by a distal steric protein effect and by rupture of the Fe2+-proximal His bond as revealed by extended x-ray absorption fine structure. The midpoint potential of the enzyme-heme was +187 mV, which is the most positive among high spin protoheme-hemoproteins. This observation implies that the electron density of the ferrous heme iron is relatively low by comparison to those of other hemoproteins, presumably due to the weak Fe2+-proximal His bond. Based on our results, we propose that the weak Fe2+-proximal His bond is a key determinant for the low O-2 affinity of the heme moiety of soluble guanylate cyclase.	[Makino, Ryu] Rikkyo Univ, Coll Sci, Dept Life Sci, Toshima Ku, Tokyo 1718501, Japan; [Park, Sam-yon; Obayashi, Eiji] Yokohama City Univ, Prot Design Lab, Yokohama, Kanagawa 2300045, Japan; [Iizuka, Tetsutaro; Shiro, Yoshitugu] RIKEN, Harima Inst Spring 8, Mikazuki, Hyogo 6795148, Japan; [Hori, Hiroshi] Osaka Univ, Ctr Quantum Sci & Technol Extreme Condit, Osaka 5608531, Japan	Rikkyo University; Yokohama City University; RIKEN; Osaka University	Makino, R (corresponding author), Rikkyo St Pauls Univ, Coll Sci, Dept Life Sci, Toshima Ku, Nishi Ikebukuro 3-34-1, Tokyo 1718501, Japan.	rmakino@rikkyo.ne.jp	Shiro, Yoshitsugu Y/J-3757-2014	Shiro, Yoshitsugu Y/0000-0003-0695-8327	Rikkyo University; Ministry of Culture, Education, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [21245041] Funding Source: KAKEN	Rikkyo University(Rikkyo University); Ministry of Culture, Education, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Frontier Project "Life Adaptation Strategies to Environmental Changes" of Rikkyo University and grants-in-aid from the Ministry of Culture, Education, Sports, Science, and Technology of Japan (to R. M.).	BINSTED N, 1992, BIOCHEMISTRY-US, V31, P12117, DOI 10.1021/bi00163a021; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; COLLMAN JP, 1983, J AM CHEM SOC, V105, P3052, DOI 10.1021/ja00348a019; Deinum G, 1996, BIOCHEMISTRY-US, V35, P1540; Derbyshire ER, 2007, J BIOL CHEM, V282, P35741, DOI 10.1074/jbc.M705557200; Derbyshire ER, 2010, J BIOL CHEM, V285, P17471, DOI 10.1074/jbc.M109.098269; Derbyshire ER, 2005, BIOCHEMISTRY-US, V44, P16257, DOI 10.1021/bi0515671; EISENBERGER P, 1978, NATURE, V274, P30, DOI 10.1038/274030a0; Evans JP, 2009, BIOCHEMISTRY-US, V48, P8920, DOI 10.1021/bi9011258; FALK JE, 1964, PORPHYRINS METALLOPO, P67; FAULKNER KM, 1995, J BIOL CHEM, V270, P13604, DOI 10.1074/jbc.270.23.13604; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GERZER R, 1981, EUR J BIOCHEM, V116, P479, DOI 10.1111/j.1432-1033.1981.tb05361.x; Gullotti M, 2007, INORG CHEM, V46, P8971, DOI 10.1021/ic700852c; HAGIHARA B, 1971, J BIOCHEM-TOKYO, V69, P355, DOI 10.1093/oxfordjournals.jbchem.a129474; HORI H, 1982, J BIOL CHEM, V257, P3636; Hu XH, 2008, J BIOL CHEM, V283, P20968, DOI 10.1074/jbc.M801501200; Huang SH, 2007, BIOCHEMISTRY-US, V46, P15115, DOI 10.1021/bi701771r; HUMBERT P, 1990, EUR J BIOCHEM, V190, P273, DOI 10.1111/j.1432-1033.1990.tb15572.x; IGNARRO LJ, 1985, ANNU REV PHARMACOL, V25, P171, DOI 10.1146/annurev.pharmtox.25.1.171; IGNARRO LJ, 1982, P NATL ACAD SCI-BIOL, V79, P2870, DOI 10.1073/pnas.79.9.2870; IKEDASAITO M, 1977, J BIOL CHEM, V252, P4882; KAMISAKI Y, 1986, J BIOL CHEM, V261, P7236; LI TS, 1994, BIOCHEMISTRY-US, V33, P1433, DOI 10.1021/bi00172a021; Makino R, 2003, J BIOL CHEM, V278, P11130, DOI 10.1074/jbc.M209026200; Makino R, 1999, J BIOL CHEM, V274, P7714, DOI 10.1074/jbc.274.12.7714; MAKINO R, 1974, ARCH BIOCHEM BIOPHYS, V165, P485, DOI 10.1016/0003-9861(74)90274-4; Marti MA, 2006, J INORG BIOCHEM, V100, P761, DOI 10.1016/j.jinorgbio.2005.12.009; Martin E, 2006, J BIOL CHEM, V281, P27836, DOI 10.1074/jbc.M601078200; MIMS MP, 1983, J BIOL CHEM, V258, P4219; Miyatake H, 1999, J BIOL CHEM, V274, P23176, DOI 10.1074/jbc.274.33.23176; MONCADA S, 1991, EUR J CLIN INVEST, V21, P361, DOI 10.1111/j.1365-2362.1991.tb01383.x; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Obayashi E, 1997, J AM CHEM SOC, V119, P7807, DOI 10.1021/ja9637816; OBERTING WA, 1990, INORG CHEM, V29, P2633; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Rich AM, 1998, J AM CHEM SOC, V120, P10827, DOI 10.1021/ja980253g; SEYBERT DW, 1977, J BIOL CHEM, V252, P4225; STETZKOWSKI F, 1979, J BIOL CHEM, V254, P1351; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; STONE JR, 1995, BIOCHEM BIOPH RES CO, V207, P572, DOI 10.1006/bbrc.1995.1226; TRAYLOR TG, 1993, J AM CHEM SOC, V115, P810, DOI 10.1021/ja00055a075; Tsujimura S, 2005, ANAL BIOCHEM, V337, P325, DOI 10.1016/j.ab.2004.11.017; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; WALDMAN SA, 1987, PHARMACOL REV, V39, P163; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; Yang F, 1996, J MOL BIOL, V256, P762, DOI 10.1006/jmbi.1996.0123; Yazawa S, 2006, J BIOL CHEM, V281, P21763, DOI 10.1074/jbc.M508983200; YONETANI T, 1974, J BIOL CHEM, V249, P682; Zhao Y, 1997, BIOCHEMISTRY-US, V36, P15959, DOI 10.1021/bi971825x	52	26	26	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.177576	http://dx.doi.org/10.1074/jbc.M110.177576			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21385878	hybrid, Green Published			2022-12-25	WOS:000290022800007
J	Sandoval, CJ; Martinez-Claros, M; Bello-Medina, PC; Perez, O; Ramirez-Amaya, V				Jimena Sandoval, C.; Martinez-Claros, Marisela; Bello-Medina, Paola C.; Perez, Oswaldo; Ramirez-Amaya, Victor			When Are New Hippocampal Neurons, Born in the Adult Brain, Integrated into the Network That Processes Spatial Information?	PLOS ONE			English	Article							GENERATED GRANULE CELLS; DENTATE GYRUS; SYNAPTIC PLASTICITY; PROTEIN EXPRESSION; CRITICAL PERIOD; RAT; NEUROGENESIS; MATURATION; DIFFERENTIATION; SURVIVAL	Adult-born neurons in the dentate gyrus (DG) functionally integrate into the behaviorally relevant hippocampal networks, showing a specific Arc-expression response to spatial exploration when mature. However, it is not clear when, during the 4- to 6-week interval that is critical for survival and maturation of these neurons, this specific response develops. Therefore, we characterized Arc expression after spatial exploration or cage control conditions in adult-born neurons from rats that were injected with BrdU on one day and were sacrificed 1, 7, 15, 30, and 45 days post-BrdU injection (PBI). Triple immunostaining for NeuN, Arc, and BrdU was analyzed through the different DG layers. Arc protein expression in BrdU-positive cells was observed from day 1 to day 15 PBI but was not related to behavioral stimulation. The specific Arc-expression response to spatial exploration was observed from day 30 and 45 in about 5% of the BrdU-positive cell population. Most of the BrdU-positive neurons expressing Arc in response to spatial exploration(similar to 90%) were located in DG layer 1, and no Arc expression was observed in cells located in the subgranular zone (SGZ). Using the current data and that obtained previously, we propose a mathematical model suggesting that new neurons are unlikely to respond to exploration by expressing Arc after they are 301 days old, and also that in a 7-month-old rat the majority (60%) of the neurons that respond to exploration must have been born during adulthood; thus, suggesting that adult neurogenesis in the DG is highly relevant for spatial information processing.	[Jimena Sandoval, C.; Martinez-Claros, Marisela; Bello-Medina, Paola C.; Ramirez-Amaya, Victor] Univ Nacl Autonoma Mexico, Lab Redes Neuronales Plast, Dept Neurobiol Conductual & Cognit, Inst Neurobiol, Queretaro Qro, Mexico; [Perez, Oswaldo] Univ Nacl Autonoma Mexico, Lab Neurofisiol Percepc, Dept Neurobiol Conductual & Cognit, Inst Neurobiol, Queretaro Qro, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Sandoval, CJ (corresponding author), Univ Nacl Autonoma Mexico, Lab Redes Neuronales Plast, Dept Neurobiol Conductual & Cognit, Inst Neurobiol, Campus Juriquilla, Queretaro Qro, Mexico.	vramirez@unam.mx	Bello-Medina, Paola C./AAS-2330-2021	Bello-Medina, Paola C./0000-0003-3815-4956; Perez, Oswaldo/0000-0002-1888-7434	CONACyT [51028]; PAPIIT [IN213907, IN216510-21]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This work was funded by CONACyT 51028 and PAPIIT IN213907 and IN216510-21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ADAMS N, 1983, J COMP PSYCHOL, V97, P24, DOI 10.1037/0735-7036.97.1.24; Alme CB, 2010, HIPPOCAMPUS, V20, P1109, DOI 10.1002/hipo.20810; Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; Ambrogini P, 2004, BRAIN RES, V1017, P21, DOI 10.1016/j.brainres.2004.05.039; Babu H, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.001.2009; Bischofberger J, 2007, NAT NEUROSCI, V10, P273, DOI 10.1038/nn0307-273; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; DRICKAMER L C, 1977, Laboratory Animals (London), V11, P159, DOI 10.1258/002367777780936639; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Jones SP, 2003, HIPPOCAMPUS, V13, P413, DOI 10.1002/hipo.10121; Karten YJG, 2006, HIPPOCAMPUS, V16, P312, DOI 10.1002/hipo.20165; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuipers SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004885; Lee E, 2009, BMB REP, V42, P239, DOI 10.5483/BMBRep.2009.42.5.239; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Piatti VC, 2006, NEUROSCIENTIST, V12, P463, DOI 10.1177/1073858406293538; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Rao MS, 2005, EUR J NEUROSCI, V21, P464, DOI 10.1111/j.1460-9568.2005.03853.x; Rapp PR, 1996, P NATL ACAD SCI USA, V93, P9926, DOI 10.1073/pnas.93.18.9926; RIHN LL, 1990, DEV BRAIN RES, V54, P115, DOI 10.1016/0165-3806(90)90071-6; Rosi S, 2005, J NEUROSCI, V25, P723, DOI 10.1523/JNEUROSCI.4469-04.2005; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Scharfman HE, 2007, PROG BRAIN RES, V163, P627, DOI 10.1016/S0079-6123(07)63034-9; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; SNYDER JS, 2009, ADULT BORN HIPPOCAMP; STONE SSD, 2010, FUNCTIONAL CONVERGEN; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	49	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17689	10.1371/journal.pone.0017689	http://dx.doi.org/10.1371/journal.pone.0017689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408012	Green Submitted, Green Published, gold			2022-12-25	WOS:000288170900041
J	Poza, DJ; Santos, JI; Galan, JM; Lopez-Paredes, A				Poza, David J.; Santos, Jose I.; Galan, Jose M.; Lopez-Paredes, Adolfo			Mesoscopic Effects in an Agent-Based Bargaining Model in Regular Lattices	PLOS ONE			English	Article							COMMUNITY STRUCTURE; EVOLUTIONARY GAMES; PRISONERS-DILEMMA; COOPERATION; NETWORK; DYNAMICS	The effect of spatial structure has been proved very relevant in repeated games. In this work we propose an agent based model where a fixed finite population of tagged agents play iteratively the Nash demand game in a regular lattice. The model extends the multiagent bargaining model by Axtell, Epstein and Young [1] modifying the assumption of global interaction. Each agent is endowed with a memory and plays the best reply against the opponent's most frequent demand. We focus our analysis on the transient dynamics of the system, studying by computer simulation the set of states in which the system spends a considerable fraction of the time. The results show that all the possible persistent regimes in the global interaction model can also be observed in this spatial version. We also find that the mesoscopic properties of the interaction networks that the spatial distribution induces in the model have a significant impact on the diffusion of strategies, and can lead to new persistent regimes different from those found in previous research. In particular, community structure in the intratype interaction networks may cause that communities reach different persistent regimes as a consequence of the hindering diffusion effect of fluctuating agents at their borders.	[Poza, David J.; Lopez-Paredes, Adolfo] Social Syst Engn Ctr INSISOC, Valladolid, Spain; [Santos, Jose I.; Galan, Jose M.] Univ Burgos, Dept Ingn Civil, Area Org Empresas, Burgos, Spain	Universidad de Burgos	Poza, DJ (corresponding author), Social Syst Engn Ctr INSISOC, Valladolid, Spain.	djpoza@gmail.com	Poza, David/AFF-8145-2022; Santos, José I/K-5924-2014; lopez-paredes, adolfo/B-9900-2009; Poza, David/D-5529-2016; Galán, José Manuel/B-9782-2009	Santos, José I/0000-0002-6653-043X; Poza, David/0000-0002-9878-221X; Galán, José Manuel/0000-0003-3360-7602; lopez-paredes, adolfo/0000-0001-5748-8308	Spanish Ministry of Science and Innovation [TIN2008-06464-C03-02, CSD2010-00034]; Junta de Castilla y Leon [VA006A009, BU034A08, GREX251-2009]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work stems from the participation of the authors in research projects funded by the Spanish Ministry of Science and Innovation, references TIN2008-06464-C03-02 and CSD2010-00034 (CONSOLIDER-INGENIO 2010), and by the Junta de Castilla y Leon, references VA006A009, BU034A08 and GREX251-2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 1999, J PHILOS, V96, P588, DOI 10.2307/2564625; Axtell RL, 2001, SOCIAL DYNAMICS, P191; Castello X, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/66006; Charness G, 2007, J ECON THEORY, V136, P28, DOI 10.1016/j.jet.2005.06.009; Chen JL, 2009, PHYSICA A, V388, P945, DOI 10.1016/j.physa.2008.11.039; Coleman J.S., 1990, FDN SOCIAL THEORY, P761; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Floria LM, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026106; Fort H, 2005, JASSS-J ARTIF SOC S, V8; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Fu F, 2007, EUR PHYS J B, V56, P367, DOI 10.1140/epjb/e2007-00124-5; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026117; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gleiser PM, 2003, ADV COMPLEX SYST, V6, P565, DOI 10.1142/S0219525903001067; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Guimera R, 2006, J ECON BEHAV ORGAN, V61, P653, DOI 10.1016/j.jebo.2004.07.021; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Helbing D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057104; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Izquierdo LR, 2009, JASSS-J ARTIF SOC S, V12; Izquierdo SS, 2010, J THEOR BIOL, V267, P76, DOI 10.1016/j.jtbi.2010.07.039; KANDORI M, 1992, REV ECON STUD, V59, P63, DOI 10.2307/2297925; Kirley M, 2006, PHYSICA A, V365, P521, DOI 10.1016/j.physa.2005.10.002; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Lozano S, 2008, J ECON INTERACT COOR, V3, P183, DOI 10.1007/s11403-008-0041-7; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Nash JF, 1950, ECONOMETRICA, V18, P155, DOI 10.2307/1907266; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Ohtsuki H, 2007, J THEOR BIOL, V246, P681, DOI 10.1016/j.jtbi.2007.01.024; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Poncela J, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/38003; Porter MA., 2009, NOT AM MATH SOC, V56, P1082, DOI DOI 10.1103/PHYSREVE.69.066133; Porter MA, 2007, PHYSICA A, V386, P414, DOI 10.1016/j.physa.2007.07.039; Poza DJ, 2011, DISCRETE DYN NAT SOC, V2011, DOI 10.1155/2011/915279; Roca CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015210; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Skyrms B, 2000, P NATL ACAD SCI USA, V97, P9340, DOI 10.1073/pnas.97.16.9340; Skyrms B, 2014, EVOLUTION SOCIAL CON, DOI 10.1017/CBO9781139924825; Sysi-Aho M, 2005, EUR PHYS J B, V44, P129, DOI 10.1140/epjb/e2005-00108-5; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Szolnoki A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30007; Toivonen R, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016109; Tomassini M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016132; Tomassini M, 2010, INT J MOD PHYS C, V21, P1277, DOI 10.1142/S012918311001583X; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Yamashita T, 2005, LECT NOTES COMPUT SC, V3415, P185; YAMASHITA T, 2004, LNCS LNAI, V3012, P137, DOI DOI 10.1007/978-3-540-24666-4_9; Yang HX, 2008, CHINESE PHYS B, V17, P2759, DOI 10.1088/1674-1056/17/8/002; Young H.P., 1998, INDIVIDUAL STRATEGY, DOI DOI 10.1515/9780691214252; YOUNG HP, 1993, J ECON THEORY, V59, P145, DOI 10.1006/jeth.1993.1009	63	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17661	10.1371/journal.pone.0017661	http://dx.doi.org/10.1371/journal.pone.0017661			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408019	Green Published, gold			2022-12-25	WOS:000288170900037
J	Warren, RJ; Skelly, DK; Schmitz, OJ; Bradford, MA				Warren, Robert J., II; Skelly, David K.; Schmitz, Oswald J.; Bradford, Mark A.			Universal Ecological Patterns in College Basketball Communities	PLOS ONE			English	Article							SPECIES ABUNDANCE DISTRIBUTIONS; NEUTRAL THEORY; RELATIVE ABUNDANCE; DIVERSITY	The rank abundance of common and rare species within ecological communities is remarkably consistent from the tropics to the tundra. This invariant patterning provides one of ecology's most enduring and unified tenets: most species rare and a few very common. Increasingly, attention is focused upon elucidating biological mechanisms that explain these species abundance distributions (SADs), but these evaluations remain controversial. We show that college basketball wins generate SADs just like those observed in ecological communities. Whereas college basketball wins are structured by competitive interactions, the result produces a SAD pattern indistinguishable from random wins. We also show that species abundance data for tropical trees exhibits a significant-digit pattern consistent with data derived from complex structuring forces. These results cast doubt upon the ability of SAD analysis to resolve ecological mechanism, and their patterning may reflect statistical artifact as much as biological processes.	[Warren, Robert J., II; Skelly, David K.; Schmitz, Oswald J.; Bradford, Mark A.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	Yale University	Warren, RJ (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	hexastylis@gmail.com	Bradford, Mark A/G-3850-2012; Skelly, David/D-3878-2013	Bradford, Mark A/0000-0002-2022-8331; 	National Science Foundation [DEB-0823293]; Yale School of Forestry and Environmental Studies	National Science Foundation(National Science Foundation (NSF)); Yale School of Forestry and Environmental Studies	This work was supported by funds from the National Science Foundation (award DEB-0823293) to the Coweeta Long Term Ecological Research Program and by the Yale School of Forestry and Environmental Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Bates D., 1988, NONLINEAR REGRESSION; Benford F, 1938, P AM PHILOS SOC, V78, P551, DOI DOI 10.2307/984802; Clark JS, 2010, SCIENCE, V327, P1129, DOI 10.1126/science.1183506; Clark JS, 2009, TRENDS ECOL EVOL, V24, P8, DOI 10.1016/j.tree.2008.09.004; FIZEL J, 2004, EC COLL SPORTS, P3; Hill TP, 1995, STAT SCI, V10, P354, DOI 10.1214/ss/1177009869; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; HUBBELL SP, 2006, BARRO COLORADO ISLAN; Hubbell Stephen P., 2001, V32, pi; Leigh EG, 2007, J EVOLUTION BIOL, V20, P2075, DOI 10.1111/j.1420-9101.2007.01410.x; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; MACARTHUR R, 1960, AM NAT, V94, P25, DOI 10.1086/282106; MACARTHUR RH, 1957, P NATL ACAD SCI USA, V43, P293, DOI 10.1073/pnas.43.3.293; MACARTHUR RH, 1966, ECOLOGY, V47, P1074; Magurran A.E, 2004, MEASURING BIOL DIVER; Magurran A E, 1988, ECOLOGICAL DIVERSITY; Magurran AE, 2005, FUNCT ECOL, V19, P177, DOI 10.1111/j.0269-8463.2005.00930.x; May R.M., 1975, P81; McGill BJ, 2003, ECOL LETT, V6, P766, DOI 10.1046/j.1461-0248.2003.00491.x; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; MILLER M, 2010, GREATEST PROGRAMS AL; Morlon H, 2009, ECOL LETT, V12, P488, DOI 10.1111/j.1461-0248.2009.01318.x; NEE S, 1991, P ROY SOC B-BIOL SCI, V243, P161, DOI 10.1098/rspb.1991.0026; Nekola JC, 2007, ECOL LETT, V10, P188, DOI 10.1111/j.1461-0248.2006.01003.x; Newcomb S., 1881, AM J MATH, V4, P39, DOI [10.2307/2369148, DOI 10.2307/2369148]; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; R Development Core Team, 2005, R LANG ENV STAT COMP; Rosindell J, 2010, ECOL LETT, V13, P716, DOI 10.1111/j.1461-0248.2010.01463.x; STAUDOHAR PD, 2004, EC COLL SPORTS; Tokeshi M., 2009, SPECIES COEXISTENCE; VANRIPER T, 2010, HIGHEST PAID COLL BA; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Williams C. B., 1964, PATTERNS BALANCE NAT	34	22	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17342	10.1371/journal.pone.0017342	http://dx.doi.org/10.1371/journal.pone.0017342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408063	gold, Green Published			2022-12-25	WOS:000288170900011
J	Li, XT; Wang, QJ; Pan, N; Lee, S; Zhao, YM; Chait, BT; Yue, ZY				Li, Xianting; Wang, Qing Jun; Pan, Nina; Lee, Sangkyu; Zhao, Yingming; Chait, Brian T.; Yue, Zhenyu			Phosphorylation-Dependent 14-3-3 Binding to LRRK2 Is Impaired by Common Mutations of Familial Parkinson's Disease	PLOS ONE			English	Article							PROTEIN-KINASE-A; LEUCINE-RICH-REPEAT-KINASE-2 LRRK2; IN-VIVO; RECEPTOR; GTPASE; GENE; NEUROTRANSMISSION; 14-3-3-PROTEINS; RIM1-ALPHA; PLASTICITY	Background: Recent studies show that mutations in Leucine Rich Repeat Kinase 2 (LRRK2) are the cause of the most common inherited and some sporadic forms of Parkinson's disease (PD). The molecular mechanism underlying the pathogenic role of LRRK2 mutations in PD remains unknown. Methodology/Principal Findings: Using affinity purification and mass spectrometric analysis, we investigated phosphorylation sites and binding proteins of LRRK2 purified from mouse brain. We identified multiple phosphorylation sites at N-terminus of LRRK2 including S910, S912, S935 and S973. Focusing on the high stoichiometry S935 phosphorylation site, we developed an anti-pS935 specific antibody and showed that LRRK2 is constitutively phosphorylated at S935 in various tissues (including brain) and at different ages in mice. We find that 14-3-3 proteins (especially isoforms gamma and eta) bind LRRK2 and this binding depends on phosphorylation of S935. The binding of 14-3-3, with little effect on dimer formation of LRRK2, confers protection of the phosphorylation status of S935. Furthermore, we show that protein kinase A (PKA), but not LRRK2 kinase itself, can cause the phosphorylation of LRRK2 at S935 in vitro and in cell culture, suggesting that PKA is a potential upstream kinase that regulates LRRK2 function. Finally, our study indicates that the common PD-related mutations of LRRK2, R1441G, Y1699C and G2019S, decrease homeostatic phosphorylation levels of S935 and impair 14-3-3 binding of LRRK2. Conclusions/Significance: LRRK2 is extensively phosphorylated in vivo, and the phosphorylation of specific sites (e.g. S935) determines 14-3-3 binding of LRRK2. We propose that 14-3-3 is an important regulator of LRRK2-mediated cellular functions. Our study suggests that PKA, a cAMP-dependent kinase involved in regulating dopamine physiology, is a potential upstream kinase that phosphorylates LRRK2 at S935. Furthermore, the reduction of phosphorylation/14-3-3 binding of LRRK2 due to the common familial PD-related mutations provides novel insight into the pathogenic mechanism of LRRK2-linked PD.	[Li, Xianting; Pan, Nina; Yue, Zhenyu] Mt Sinai Sch Med, Dept Neurol & Neurosci, New York, NY 10029 USA; [Wang, Qing Jun; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA; [Lee, Sangkyu; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	Icahn School of Medicine at Mount Sinai; Rockefeller University; University of Chicago	Li, XT (corresponding author), Mt Sinai Sch Med, Dept Neurol & Neurosci, New York, NY 10029 USA.	zhenyu.yue@mssm.edu		Wang, Qingjun/0000-0002-1959-4107; Li, Xianting/0000-0002-3153-0931	US National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [NS061152, NS060809, RNS055683A]; Michael J. Fox Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220, P20RR020171, P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS061152, R01NS060809, R21NS055683] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael J. Fox Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the US National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) NS061152 (Z.Y.), NS060809 (Z.Y.), RNS055683A (Z.Y.), Michael J. Fox Foundation (Z.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRASELMANN S, 1995, EMBO J, V14, P4839, DOI 10.1002/j.1460-2075.1995.tb00165.x; Chen Y, 2005, J PROTEOME RES, V4, P998, DOI 10.1021/pr049754t; Cheng ZY, 2009, MOL CELL PROTEOMICS, V8, P45, DOI 10.1074/mcp.M800224-MCP200; Craparo A, 1997, J BIOL CHEM, V272, P11663; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Dubois T, 1997, J BIOL CHEM, V272, P28882, DOI 10.1074/jbc.272.46.28882; DZAMKO N, BIOCH J, V430, P405; Feng LP, 2004, FEBS LETT, V557, P275, DOI 10.1016/S0014-5793(03)01507-2; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Kaeser PS, 2008, P NATL ACAD SCI USA, V105, P14680, DOI 10.1073/pnas.0806679105; LEE BD, NAT MED, V16, P998; LI X, J NEUROSCI, V30, P1788; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Meller N, 1996, MOL CELL BIOL, V16, P5782; MELROSE HL, NEUROBIOL DIS, V40, P503; NICHOLS RJ, BIOCH J, V430, P393; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Palmer D, 2007, J BIOL CHEM, V282, P9411, DOI 10.1074/jbc.M606936200; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Thomas D, 2005, CURR TOP DEV BIOL, V67, P285, DOI 10.1016/S0070-2153(05)67009-3; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Wakui H, 1997, J BIOL CHEM, V272, P8153, DOI 10.1074/jbc.272.13.8153; Wang HN, 1998, J BIOL CHEM, V273, P16297, DOI 10.1074/jbc.273.26.16297; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Wolf ME, 2003, ANN NY ACAD SCI, V1003, P241, DOI 10.1196/annals.1300.015; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	45	119	121	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17153	10.1371/journal.pone.0017153	http://dx.doi.org/10.1371/journal.pone.0017153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390248	Green Submitted, gold, Green Published			2022-12-25	WOS:000287932100010
J	Grillon, E; Farion, R; Fablet, K; De Waard, M; Tse, CM; Donowitz, M; Remy, C; Coles, JA				Grillon, Emmanuelle; Farion, Regine; Fablet, Katell; De Waard, Michel; Tse, Chung Ming; Donowitz, Mark; Remy, Chantal; Coles, Jonathan A.			The Spatial Organization of Proton and Lactate Transport in a Rat Brain Tumor	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-IX; IN-VIVO; NA+/H+ EXCHANGER; EXTRACELLULAR PH; INTRACELLULAR PH; MONOCARBOXYLATE TRANSPORTERS; MATRIX METALLOPROTEINASES; ANTIPORT ACTIVITY; CELL-MIGRATION; ACIDIC PH	Tumors create a heterogeneous acidic microenvironment which assists their growth and which must be taken into account in the design of drugs and their delivery. In addition, the acidic extracellular pH (pHe) is itself exploited in several experimental techniques for drug delivery. The way the acidity is created is not clear. We report here the spatial organization of key proton-handling proteins in C6 gliomas in rat brain. The mean profiles across the tumor rim of the Na+/H+ exchanger NHE1, and the lactate-H+ cotransporter MCT1, both showed peaks. NHE1, which is important for extension and migration of cells in vitro, showed a peak 1.55 times higher than in extratumoural tissue at 0.33 mm from the edge. MCT1 had a broader peak, further into the tumor (maximum 1.76 fold at 1.0 mm from the edge). In contrast, MCT4 and the carbonic anhydrase CAIX, which are associated with hypoxia, were not significantly upregulated in the rim. The spatial distribution of MCT4 was highly correlated with that of CAIX, suggesting that their expression is regulated by the same factors. Since protons extruded by NHE1 diffuse away through extracellular clefts, NHE1 requires a continuous source of intracellular protons. From the stoichiometries of metabolic pathways that produce or consume H+, and the greater availability of glucose compared to oxygen in most parts of a tumor, we support the classic view that most of the net proton efflux from C6 gliomas originates in glycolytic formation of lactate and H+ inside the tumor, but add that some lactate is taken up into cells in the rim on MCT1, and some lactate diffuses away, leaving its associated protons available to re-enter cells for extrusion on NHE1. Therapeutic inhibition of NHE1, MCT1 or CAIX is predicted to affect different parts of a tumor.	[Grillon, Emmanuelle; Farion, Regine; Fablet, Katell; De Waard, Michel; Remy, Chantal; Coles, Jonathan A.] INSERM, U836, La Tronche, Isere, France; [Grillon, Emmanuelle; Farion, Regine; Fablet, Katell; De Waard, Michel; Remy, Chantal; Coles, Jonathan A.] Univ Grenoble 1, Grenoble Inst Neurosci, Grenoble, France; [Tse, Chung Ming; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Div Gastroenterol, Baltimore, MD 21205 USA; [Tse, Chung Ming; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA; [Coles, Jonathan A.] Univ Strathclyde, Ctr Biophoton, Glasgow, Lanark, Scotland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Johns Hopkins University; Johns Hopkins University; University of Strathclyde	Grillon, E (corresponding author), INSERM, U836, La Tronche, Isere, France.	Jonathan.Coles@glasgow.ac.uk	De Waard, Michel/G-7406-2014; Remy, Chantal/L-9459-2014	De Waard, Michel/0000-0002-2782-9615; 	INSERM [U836]; NIDDK [R01 DK26523, DK61765]; Hopkins Basic Research Digestive Diseases Development Core Center [R24 DK 64388]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064388, R01DK061765, R01DK026523] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hopkins Basic Research Digestive Diseases Development Core Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by program grant U836 of INSERM and Action Concertee Incitative 2008-2009 INCa (C.R.), NIDDK R01 DK26523 and DK61765 and Hopkins Basic Research Digestive Diseases Development Core Center R24 DK 64388 (M.D.). Some imaging and expenses of JAC were supported by the Sir David Anderson Bequest from the University of Strathclyde. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev OA, 2007, P NATL ACAD SCI USA, V104, P7893, DOI 10.1073/pnas.0702439104; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; BENDA P, 1971, J NEUROSURG, V34, P310, DOI 10.3171/jns.1971.34.3.0310; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Busco G, 2010, FASEB J; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chiang YH, 2008, J CELL PHYSIOL, V214, P810, DOI 10.1002/jcp.21277; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; De Milito A, 2010, INT J CANCER, V127, P207, DOI 10.1002/ijc.25009; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; ENGASSER JM, 1974, PHYSIOL CHEM PHYS M, V6, P541; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Froberg MK, 2001, NEUROREPORT, V12, P761, DOI 10.1097/00001756-200103260-00030; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; Garcia-Martin ML, 2001, CANCER RES, V61, P6524; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gerweck LE, 2006, MOL CANCER THER, V5, P1275, DOI 10.1158/1535-7163.MCT-06-0024; Gerweck LE, 1996, CANCER RES, V56, P1194; Gillies RJ, 2004, IEEE ENG MED BIOL, V23, P57, DOI 10.1109/MEMB.2004.1360409; GILLIES RJ, 1994, AM J PHYSIOL, V267, pC195, DOI 10.1152/ajpcell.1994.267.1.C195; GIOIA M, 2010, J BIOL INORG CHEM, V12; Haapasalo JA, 2006, CLIN CANCER RES, V12, P473, DOI 10.1158/1078-0432.CCR-05-0848; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOLM E, 1995, CANCER RES, V55, P1373; Hunter T, 2010, CURR OPIN GENET DEV, V20, P1, DOI 10.1016/j.gde.2010.01.001; Julien C, 2004, BRIT J CANCER, V91, P374, DOI 10.1038/sj.bjc.6601908; Kallio H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-22; Kersh AE, 2009, AM J PHYSIOL-REG I, V297, pR1409, DOI 10.1152/ajpregu.91038.2008; Korkolopoulou P, 2007, HUM PATHOL, V38, P629, DOI 10.1016/j.humpath.2006.07.020; LAGARDE AE, 1988, J CELL BIOCHEM, V36, P249, DOI 10.1002/jcb.240360306; Lane AN, 2009, METABOLOMICS, V5, P163, DOI 10.1007/s11306-008-0142-2; Lee GH, 2010, ONCOGENE, V29, P2130, DOI 10.1038/onc.2009.491; Loncaster JA, 2001, CANCER RES, V61, P6394; MAJUMDAR D, 2010, NEUROSCIENCE; Mathupala SP, 2004, NEUROSURGERY, V55, P1410, DOI 10.1227/01.NEU.0000143034.62913.59; McLean LA, 2000, AM J PHYSIOL-CELL PH, V278, pC676, DOI 10.1152/ajpcell.2000.278.4.C676; Min KH, 2010, J CONTROL RELEASE, V144, P259, DOI 10.1016/j.jconrel.2010.02.024; Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200; Moulin P, 2007, J MOL ENDOCRINOL, V38, P409, DOI 10.1677/jme.1.02164; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Ojugo ASE, 1999, NMR BIOMED, V12, P495, DOI 10.1002/(SICI)1099-1492(199912)12:8<495::AID-NBM594>3.0.CO;2-K; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Ord JJ, 2005, BRIT J CANCER, V93, P346, DOI 10.1038/sj.bjc.6602666; Parkkila S, 2000, J HISTOCHEM CYTOCHEM, V48, P1601, DOI 10.1177/002215540004801203; Pinheiro C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/427694; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Proescholdt MA, 2005, NEURO-ONCOLOGY, V7, P465, DOI 10.1215/S1152851705000025; Provent P, 2007, CANCER RES, V67, P7638, DOI 10.1158/0008-5472.CAN-06-3459; Raghunand N, 2001, NEOPLASIA, V3, P227, DOI 10.1038/sj.neo.7900151; ROTIN D, 1989, CANCER RES, V49, P205; Segala J, 2009, INT J MOL SCI, V10, P3478, DOI 10.3390/ijms10083478; Sennoune SR, 2007, J BIOENERG BIOMEMBR, V39, P427, DOI 10.1007/s10863-007-9108-8; Sier CFM, 1996, BRIT J CANCER, V74, P413, DOI 10.1038/bjc.1996.374; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Stock C, 2008, EUR J CELL BIOL, V87, P591, DOI 10.1016/j.ejcb.2008.01.007; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Stuwe L, 2007, J PHYSIOL-LONDON, V585, P351, DOI 10.1113/jphysiol.2007.145185; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; SWIETACH P, 2010, NEW INSIGHTS PHYSIOL; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; THOMAS RC, 1984, J PHYSIOL-LONDON, V354, pP3; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Voegtlin C, 1933, SCIENCE, V77, P567, DOI 10.1126/science.77.2006.567; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Webb S.D., 2001, NOVART FDN SYMP, V240, P181; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; Zhang XM, 2010, J NUCL MED, V51, P1167, DOI 10.2967/jnumed.109.068981; Zoula S, 2003, BRIT J CANCER, V88, P1439, DOI 10.1038/sj.bjc.6600837	77	34	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17416	10.1371/journal.pone.0017416	http://dx.doi.org/10.1371/journal.pone.0017416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390324	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000287761700053
J	Iwata, A; de Claro, RA; Morgan-Stevenson, VL; Tupper, JC; Schwartz, BR; Liu, L; Zhu, XD; Jordan, KC; Winn, RK; Harlan, JM				Iwata, Akiko; de Claro, R. Angelo; Morgan-Stevenson, Vicki L.; Tupper, Joan C.; Schwartz, Barbara R.; Liu, Li; Zhu, Xiaodong; Jordan, Katherine C.; Winn, Robert K.; Harlan, John M.			Extracellular Administration of BCL2 Protein Reduces Apoptosis and Improves Survival in a Murine Model of Sepsis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INNATE IMMUNE-RESPONSES; CELL-DEATH; SEPTIC MICE; RECEPTOR; HMGB1; EXPRESSION; INJURY; DANGER; PLASMA	Background: Severe sepsis and septic shock are major causes of morbidity and mortality worldwide. In experimental sepsis there is prominent apoptosis of various cell types, and genetic manipulation of death and survival pathways has been shown to modulate organ injury and survival. Methodology/Principal Findings: We investigated the effect of extracellular administration of two anti-apoptotic members of the BCL2 (B-cell lymphoma 2) family of intracellular regulators of cell death in a murine model of sepsis induced by cecal ligation and puncture (CLP). We show that intraperitoneal injection of picomole range doses of recombinant human (rh) BCL2 or rhBCL2A1 protein markedly improved survival as assessed by surrogate markers of death. Treatment with rhBCL2 or rhBCL2A1 protein significantly reduced the number of apoptotic cells in the intestine and heart following CLP, and this was accompanied by increased expression of endogenous mouse BCL2 protein. Further, mice treated with rhBCL2A1 protein showed an increase in the total number of neutrophils in the peritoneum following CLP with reduced neutrophil apoptosis. Finally, although neither BCL2 nor BCL2A1 are a direct TLR2 ligand, TLR2-null mice were not protected by rhBCL2A1 protein, indicating that TLR2 signaling was required for the protective activity of extracellularly adminsitered BCL2A1 protein in vivo. Conclusions/Significance: Treatment with rhBCL2A1 or rhBCL2 protein protects mice from sepsis by reducing apoptosis in multiple target tissues, demonstrating an unexpected, potent activity of extracellularly administered BCL2 BH4-domain proteins.	[Iwata, Akiko; Morgan-Stevenson, Vicki L.; Winn, Robert K.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [de Claro, R. Angelo; Tupper, Joan C.; Schwartz, Barbara R.; Liu, Li; Zhu, Xiaodong; Jordan, Katherine C.; Harlan, John M.] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Iwata, A (corresponding author), Univ Washington, Dept Surg, Seattle, WA 98195 USA.	jharlan@uw.edu			National Institutes of Health [GM042686, GM071398]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042686, R01GM071398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health grants GM042686 (RKW, JMH) and GM071398 (JMH) supported this work. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ahn T, 2010, CELL CALCIUM, V47, P387, DOI 10.1016/j.ceca.2010.02.003; Akanda N, 2008, CELL CYCLE, V7, P3225, DOI 10.4161/cc.7.20.6831; Ayala A, 2008, CURR PHARM DESIGN, V14, P1853, DOI 10.2174/138161208784980617; Baier PK, 2006, HEPATO-GASTROENTEROL, V53, P747; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Buerke U, 2008, SHOCK, V29, P497, DOI 10.1097/SHK.0b013e318142c434; Chang KC, 2007, FASEB J, V21, P708, DOI 10.1096/fj.06-6805com; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Coopersmith CM, 2002, CRIT CARE MED, V30, P195, DOI 10.1097/00003246-200201000-00028; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Fathi NA, 2006, CLIN EXP IMMUNOL, V146, P339, DOI 10.1111/j.1365-2249.2006.03219.x; Fialkow L, 2006, CRIT CARE, V10, DOI 10.1186/cc5090; Hagiwara S, 2008, INTENS CARE MED, V34, P1812, DOI 10.1007/s00134-008-1161-1; Hajishengallis G, 2008, P NATL ACAD SCI USA, V105, P13532, DOI 10.1073/pnas.0803852105; Hatada T, 2005, THROMB HAEMOSTASIS, V94, P975, DOI 10.1160/TH05-05-0316; Hotchkiss RS, 2005, J IMMUNOL, V174, P5110, DOI 10.4049/jimmunol.174.8.5110; Hotchkiss RS, 1999, J IMMUNOL, V162, P4148; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 2003, P NATL ACAD SCI USA, V100, P6724, DOI 10.1073/pnas.1031788100; Hotchkiss RS, 2002, CRIT CARE MED, V30, pS225, DOI 10.1097/00003246-200205001-00009; Houston G, 2009, CLIN MICROBIOL INFEC, V15, P319, DOI 10.1111/j.1469-0691.2009.02751.x; Hreggvidsdottir HS, 2009, J LEUKOCYTE BIOL, V86, P655, DOI 10.1189/jlb.0908548; Iwata A, 2003, J IMMUNOL, V171, P3136, DOI 10.4049/jimmunol.171.6.3136; Iwata A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009103; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; McCarthy BA, 2008, MOL MED, V14, P618, DOI 10.2119/2008.00061.McCarthy; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; Mzayek F, 2008, CRIT CARE MED, V36, P2690, DOI 10.1097/CCM.0b013e3181833c6f; Oberholzer C, 2001, P NATL ACAD SCI USA, V98, P11503, DOI 10.1073/pnas.181338198; Osman H G, 2007, Indian J Med Microbiol, V25, P323; Protopsaltis J, 2007, MED PRIN PRACT, V16, P222, DOI 10.1159/000100394; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Reed JC, 2008, BLOOD, V111, P3322, DOI 10.1182/blood-2007-09-078162; Reimers K, 2007, INT J BIOL SCI, V3, P471; Rice TW, 2005, ANNU REV MED, V56, P225, DOI 10.1146/annurev.med.56.082103.104356; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Rouhiainen A, 2007, J LEUKOCYTE BIOL, V81, P49, DOI 10.1189/jlb.0306200; Sakai T, 1999, J INTERF CYTOK RES, V19, P999, DOI 10.1089/107999099313208; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]; Vyas D, 2007, HISTOL HISTOPATHOL, V22, P623, DOI 10.14670/HH-22.623; Walsh M, 2002, BLOOD, V99, P3439, DOI 10.1182/blood.V99.9.3439; Wesche DE, 2005, J LEUKOCYTE BIOL, V78, P325, DOI 10.1189/jlb.0105017; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996	51	23	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e14729	10.1371/journal.pone.0014729	http://dx.doi.org/10.1371/journal.pone.0014729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390214	Green Published, gold, Green Submitted			2022-12-25	WOS:000287761700007
J	Tanabe, Y; Watanabe, MM				Tanabe, Yuuhiko; Watanabe, Makoto M.			Local Expansion of a Panmictic Lineage of Water Bloom-Forming Cyanobacterium Microcystis aeruginosa	PLOS ONE			English	Article							NATURAL-POPULATIONS; GENETIC EXCHANGE; TOXIC CYANOBACTERIA; DNA POLYMORPHISM; RECOMBINATION; DIVERSITY; SPECIATION; BACTERIA	In previous studies, we have demonstrated that the population structure of the bloom-forming cyanobacterium Microcystis aeruginosa is clonal. Expanded multilocus sequence typing analysis of M. aeruginosa using 412 isolates identified five intraspecific lineages suggested to be panmictic while maintaining overall clonal structure probably due to a reduced recombination rate between lineages. Interestingly, since 2005 most strains belonging to one of these panmictic clusters (group G) have been found in a particular locality (Lake Kasumigaura Basin) in Japan. In this locality, multiple, similar but distinct genotypes of this lineage predominated in the bloom, a pattern that is unprecedented for M. aeruginosa. The population structure underlying blooms associated with this lineage is comparable to epidemics of pathogens. Our results may reveal an expansion of the possible adaptive lineage in a localized aquatic environment, providing us with a unique opportunity to investigate its ecological and biogeographical consequences.	[Tanabe, Yuuhiko; Watanabe, Makoto M.] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba	Tanabe, Y (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	y_tanabe@sakura.cc.tsukuba.ac.jp		Tanabe, Yuuhiko/0000-0003-0841-4569	Institute for Fermentation, Osaka (IFO); Ministry of the Environment, Japan [D-0905]	Institute for Fermentation, Osaka (IFO)(Institute for Fermentation (IFO)); Ministry of the Environment, Japan(Ministry of the Environment, Japan)	This work was supported by a grant of the Institute for Fermentation, Osaka (IFO) (http://www.ifo.or.jp/) to YT, and by the Global Environment Research Fund (D-0905) (http://www.env.go.jp/earth/suishinhi/english/index.html) of the Ministry of the Environment, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Barker GLA, 2000, MICROBIOL-UK, V146, P2865, DOI 10.1099/00221287-146-11-2865; BEASLEY VR, 1989, VET CLIN N AM-FOOD A, V5, P345, DOI 10.1016/S0749-0720(15)30980-4; Carmichael WW, 1996, TOXIC MICROCYSTIS, P1; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; den Bakker HC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-277; Deng L, 2008, FRESHWATER BIOL, V53, P1240, DOI 10.1111/j.1365-2427.2007.01947.x; Falush D, 2006, PHILOS T R SOC B, V361, P2045, DOI 10.1098/rstb.2006.1925; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Fewer DP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-183; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Goss EM, 2005, GENETICS, V169, P21, DOI 10.1534/genetics.104.031351; Hanage WP, 2006, PHILOS T R SOC B, V361, P2039, DOI 10.1098/rstb.2006.1926; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hoen AG, 2009, P NATL ACAD SCI USA, V106, P15013, DOI 10.1073/pnas.0903810106; Ionescu D, 2010, FEMS MICROBIOL ECOL, V72, P103, DOI 10.1111/j.1574-6941.2010.00835.x; Janse I, 2004, APPL ENVIRON MICROB, V70, P3979, DOI 10.1128/AEM.70.7.3979-3987.2004; Jing HM, 2005, EXTREMOPHILES, V9, P325, DOI 10.1007/s00792-005-0456-1; Jochimsen EM, 1998, NEW ENGL J MED, V338, P873, DOI 10.1056/NEJM199803263381304; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kasai F, 2004, NIES COLLECTION LIST, V7; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Kurmayer R, 2005, MICROBIOL-SGM, V151, P1525, DOI 10.1099/mic.0.27779-0; Lawrence JG, 2002, THEOR POPUL BIOL, V61, P449, DOI 10.1006/tpbi.2002.1587; Lodders N, 2005, ENVIRON MICROBIOL, V7, P434, DOI 10.1111/j.1462-2920.2005.00730.x; Majewski J, 2000, J BACTERIOL, V182, P1016, DOI 10.1128/JB.182.4.1016-1023.2000; Nei M, 1987, MOL EVOLUTIONARY GEN; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Perez-Losada M, 2006, INFECT GENET EVOL, V6, P97, DOI 10.1016/j.meegid.2005.02.003; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; SOUZA V, 1992, P NATL ACAD SCI USA, V89, P8389, DOI 10.1073/pnas.89.17.8389; Spratt BG, 2001, CURR OPIN MICROBIOL, V4, P602, DOI 10.1016/S1369-5274(00)00257-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanabe Y, 2004, J MOL EVOL, V58, P633, DOI 10.1007/s00239-004-2583-1; Tanabe Y, 2007, MICROBIOL-SGM, V153, P3695, DOI 10.1099/mic.0.2007/010645-0; Tanabe Y, 2009, ENV MICROBIOL REP, V1, P575, DOI 10.1111/j.1758-2229.2009.00088.x; Tanabe Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-115; Vulic M, 1997, P NATL ACAD SCI USA, V94, P9763, DOI 10.1073/pnas.94.18.9763	45	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17085	10.1371/journal.pone.0017085	http://dx.doi.org/10.1371/journal.pone.0017085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390221	Green Published, Green Submitted, gold			2022-12-25	WOS:000287761700028
J	Sharathchandra, RG; Stander, C; Jacobson, D; Ndimba, B; Vivier, MA				Sharathchandra, Ramaschandra G.; Stander, Charmaine; Jacobson, Dan; Ndimba, Bongani; Vivier, Melane A.			Proteomic Analysis of Grape Berry Cell Cultures Reveals that Developmentally Regulated Ripening Related Processes Can Be Studied Using Cultured Cells	PLOS ONE			English	Article							LIQUID-PHASE IEF; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; PROTEIN; OXIDOREDUCTASE; ARABIDOPSIS; ISOFORMS; NITROGEN; BINDING; PLANTS	Background: This work describes a proteomics profiling method, optimized and applied to berry cell suspensions to organ-specific cultures as a platform to study grape berry ripening. Variations in berry ripening within a cluster(s) a vine and in a vineyard are a major impediment towards complete understanding of the functional processes that ripening, specifically when a characterized and homogenous sample is required. Berry cell suspensions could some of these problems, but their suitability as a model system for berry development and ripening needs to be first. Methodology/Principal Findings: In this study we report on the proteomic evaluation of the cytosolic proteins obtained synchronized cell suspension cultures that were established from callus lines originating from green, veraison and ripe vinifera berry explants. The proteins were separated using liquid phase IEF in a Microrotofor cell and SDS PAGE. This proved superior to gel-based 2DE. Principal component analysis confirmed that biological and technical repeats tightly and importantly, showed that the proteomes of berry cultures originating from the different growth/stages were distinct. A total of twenty six common bands were selected after band matching between different stages and twenty two of these bands were positively identified. Thirty two % of the identified proteins are currently as hypothetical. The differential expression profile of the identified proteins, when compared with published on grape berry ripening, suggested common trends in terms of relative abundance in the different developmental between real berries and cell suspensions. Conclusions: The advantages of having suspension cultures that accurately mimic specific developmental stages are and could significantly contribute to the study of the intricate regulatory and signaling networks responsible for development and ripening.	[Sharathchandra, Ramaschandra G.; Stander, Charmaine; Jacobson, Dan; Vivier, Melane A.] Univ Stellenbosch, Inst Wine Biotechnol, Dept Viticulture & Oenol, ZA-7600 Stellenbosch, South Africa; [Ndimba, Bongani] Univ Western Cape, Dept Biotechnol, Prote Res Lab, ZA-7535 Bellville, South Africa	Stellenbosch University; University of the Western Cape	Sharathchandra, RG (corresponding author), Univ Stellenbosch, Inst Wine Biotechnol, Dept Viticulture & Oenol, ZA-7600 Stellenbosch, South Africa.	mav@sun.ac.za		Ramasandra Govind, Sharathchandra/0000-0002-1156-9986; Jacobson, Daniel/0000-0002-9822-8251	Wine Industry Network of Expertise and Technology (Winetech); Table Grape Industry (SATI); National Research Foundation of South Africa; South African Technology and Human Resources for Industry Programme (THRIP); Claude Leon Foundation	Wine Industry Network of Expertise and Technology (Winetech); Table Grape Industry (SATI); National Research Foundation of South Africa(National Research Foundation - South Africa); South African Technology and Human Resources for Industry Programme (THRIP); Claude Leon Foundation	The work was financially supported by the Wine Industry Network of Expertise and Technology (Winetech) and the Table Grape Industry (SATI), the National Research Foundation of South Africa, the South African Technology and Human Resources for Industry Programme (THRIP) and the Claude Leon Foundation. Winetech and SATI are the official overarching coordinators of all research funding of the Wine Industry and Table Grape Industry respectively. None of the funders had any role in the study design, data collection and analysis, or the decision to publish, or the preparation of the manuscript.	Agasse A, 2009, GRAPEVINE MOL PHYSL, P105; Brobey RKB, 2007, PROTEOMICS, V7, P116, DOI 10.1002/pmic.200600587; Buchner P, 2002, PLANT MOL BIOL, V49, P171, DOI 10.1023/A:1014910900312; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; CALDERON AA, 1994, PLANT CELL TISS ORG, V37, P121, DOI 10.1007/BF00043605; Conde C, 2006, PLANT PHYSIOL, V141, P1563, DOI 10.1104/pp.106.080804; Coombe B. G., 2000, Australian Journal of Grape and Wine Research, V6, P131, DOI 10.1111/j.1755-0238.2000.tb00171.x; COOMBE BG, 1992, AM J ENOL VITICULT, V43, P101; Davies C, 2000, PLANT PHYSIOL, V122, P803, DOI 10.1104/pp.122.3.803; Deluc LG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-429; Deytieux C, 2007, J EXP BOT, V58, P1851, DOI 10.1093/jxb/erm049; Faurie B, 2009, J PLANT PHYSIOL, V166, P1863, DOI 10.1016/j.jplph.2009.05.015; Ferri M, 2009, PROTEOMICS, V9, P610, DOI 10.1002/pmic.200800386; Garavaglia BS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-51; Garavaglia BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008950; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gazzana G, 2007, J PROTEOME RES, V6, P3143, DOI 10.1021/pr070097p; GHISI R, 1984, VITIS, V23, P257; Giribaldi M, 2007, PROTEOMICS, V7, P3154, DOI 10.1002/pmic.200600974; Grimplet J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-187; Gummadova JO, 2007, J EXP BOT, V58, P3971, DOI 10.1093/jxb/erm252; Hanke GT, 2005, PLANT CELL ENVIRON, V28, P1146, DOI 10.1111/j.1365-3040.2005.01352.x; HAWKER J S, 1973, Hortscience, V8, P398; Hey Julie, 2008, V424, P225, DOI 10.1007/978-1-60327-064-9_19; Hiratsuka S, 2001, SCI HORTIC-AMSTERDAM, V90, P121, DOI 10.1016/S0304-4238(00)00264-8; Iizasa E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.027540; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Lashbrooke JG, 2010, AUST J GRAPE WINE R, V16, P349, DOI 10.1111/j.1755-0238.2010.00097.x; Lintala M, 2009, PLANT J, V57, P1103, DOI 10.1111/j.1365-313X.2008.03753.x; Lucker J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-50; Lund ST, 2008, PLANT MOL BIOL, V68, P301, DOI 10.1007/s11103-008-9371-z; Martinez-Esteso MJ, 2009, J PROTEOMICS, V73, P331, DOI 10.1016/j.jprot.2009.10.001; Mechin V, 2004, PHYTOCHEMISTRY, V65, P1609, DOI 10.1016/j.phytochem.2004.04.035; METZGER GH, 2000, PATHOGENESIS RELATED, P48; Miller RNG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-15; Monteiro S, 2007, PHYTOCHEMISTRY, V68, P416, DOI 10.1016/j.phytochem.2006.11.014; Moser C., 2005, Functional & Integrative Genomics, V5, P208, DOI 10.1007/s10142-005-0143-4; Negri AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-378; Rao SR, 2002, BIOTECHNOL ADV, V20, P101, DOI 10.1016/S0734-9750(02)00007-1; Robinson S. P., 2000, Australian Journal of Grape and Wine Research, V6, P175, DOI 10.1111/j.1755-0238.2000.tb00177.x; Rogalski M, 2008, PLANT CELL, V20, P2221, DOI 10.1105/tpc.108.060392; Sarry JE, 2004, PROTEOMICS, V4, P201, DOI 10.1002/pmic.200300499; Seshi B, 2007, PROTEOMICS, V7, P1984, DOI 10.1002/pmic.200600868; Sormo CG, 2006, PHYTOCHEMISTRY, V67, P2332, DOI 10.1016/j.phytochem.2006.08.011; Sweetman C, 2009, PHYTOCHEMISTRY, V70, P1329, DOI 10.1016/j.phytochem.2009.08.006; Takabayashi A, 2005, P NATL ACAD SCI USA, V102, P16898, DOI 10.1073/pnas.0507095102; TAUREILLESSAUREL C, 1995, AM J ENOL VITICULT, V46, P29; Terrier N, 2005, PLANTA, V222, P832, DOI 10.1007/s00425-005-0017-y; Thelen JJ, 2007, PLANT CELL, V19, P3339, DOI 10.1105/tpc.107.053991; Vincent D, 2006, ELECTROPHORESIS, V27, P1853, DOI 10.1002/elps.200500698; Vincent D, 2009, ELECTROPHORESIS, V30, P4118, DOI 10.1002/elps.200900415; Vitrac X, 2000, PHYTOCHEMISTRY, V53, P659, DOI 10.1016/S0031-9422(99)00620-2; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang W, 2009, ACTA PHYSIOL PLANT, V31, P597, DOI 10.1007/s11738-008-0269-9; Yuksel B, 2008, J EXP BOT, V59, P3831, DOI 10.1093/jxb/ern223; Zhang JW, 2008, J EXP BOT, V59, P2979, DOI 10.1093/jxb/ern156; Zuo X, 2000, ANAL BIOCHEM, V284, P266, DOI 10.1006/abio.2000.4714	57	19	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e14708	10.1371/journal.pone.0014708	http://dx.doi.org/10.1371/journal.pone.0014708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379583	Green Published, gold			2022-12-25	WOS:000287482300009
J	Mireuta, M; Hancock, MA; Pollak, M				Mireuta, Matei; Hancock, Mark A.; Pollak, Michael			Binding between Insulin-like Growth Factor 1 and Insulin-like Growth Factor-binding Protein 3 Is Not Influenced by Glucose or 2-Deoxy-D-glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOF MASS-SPECTROMETRY; NONCOVALENT COMPLEXES; METABOLIC BLOCK; 2-DEOXYGLUCOSE; BIOSENSOR; INHIBITION; SYSTEM; CANCER	A recent report (Zhong, D., Xiong, L., Liu, T., Liu, X., Liu, X., Chen, J., Sun, S. Y., Khuri, F. R., Zong, Y., Zhou, Q., and Zhou, W. (2009) J. Biol. Chem. 284, 23225-23233) details that 2-deoxy-D-glucose (2-DG), a well known inhibitor of glycolysis and a candidate antineoplastic agent, also induces insulin-like growth factor 1 receptor (IGF-1R) signaling through the inhibition of insulin-like growth factor 1-insulin-like growth factor-binding protein 3 (IGF-1-IGFBP-3) complex formation. Zhong et al. hypothesized that disrupted IGF-1/IGFBP-3 binding by 2-DG led to increased free IGF-1 concentrations and, consequently, activation of IGF-1R downstream pathways. Because their report suggests unprecedented off-target effects of 2-DG, this has profound implications for the fields of metabolism and oncology. Using ELISA, surface plasmon resonance, and novel "intensity-fading" mass spectrometry, we now provide a detailed characterization of complex formation between IGF-1 and IGFBP-3. All three of these independent methods demonstrated that there was no effect of glucose or 2-DG on the interaction between IGF-1 and IGFBP-3. Furthermore, we show examples of 2-DG exposure associated with reduced rather than increased IGF-1R and AKT activation, providing further evidence against a 2-DG increase in IGF-1R activation by IGF-1-IGFBP-3 complex disruption.	[Mireuta, Matei; Pollak, Michael] Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Mireuta, Matei; Pollak, Michael] Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Hancock, Mark A.] McGill Univ, Sheldon Biotechnol Ctr, Montreal, PQ H3A 2B4, Canada	McGill University; Lady Davis Institute; McGill University; McGill University	Pollak, M (corresponding author), 3755 Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	michael.pollak@mcgill.ca	Pollak, Michael/G-9094-2011	Pollak, Michael/0000-0003-3047-0604	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank the Genome Quebec and Lady Davis Institute Clinical Proteomics Facility for their assistance with mass spectrometry experiments. Sheldon Biotechnology Centre is supported by a research resource grant from the Canadian Institutes of Health Research.	Beattie J, 2008, MOL CELL BIOCHEM, V307, P221, DOI 10.1007/s11010-007-9601-8; Bolbach G, 2005, CURR PHARM DESIGN, V11, P2535, DOI 10.2174/1381612054546923; CHEN W, 1992, BIOCHIMIE, V74, P867, DOI 10.1016/0300-9084(92)90070-U; Collett-Solberg PF, 2000, ENDOCRINE, V12, P121, DOI 10.1385/ENDO:12:2:121; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Laviola L, 2007, CURR PHARM DESIGN, V13, P663, DOI 10.2174/138161207780249146; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Levitt RJ, 2005, BIOCHEM BIOPH RES CO, V336, P1056, DOI 10.1016/j.bbrc.2005.08.229; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Singh DH, 2005, STRAHLENTHER ONKOL, V181, P507, DOI 10.1007/s00066-005-1320-z; Vorwerk P, 2002, ENDOCRINOLOGY, V143, P1677, DOI 10.1210/en.143.5.1677; WICK AN, 1955, P SOC EXP BIOL MED, V89, P579; WICK AN, 1957, J BIOL CHEM, V224, P963; Yanes O, 2007, NAT PROTOC, V2, P119, DOI 10.1038/nprot.2006.487; Yanes O, 2006, J PROTEOME RES, V5, P2711, DOI 10.1021/pr060202f; Zhong DS, 2008, MOL CANCER THER, V7, P809, DOI 10.1158/1535-7163.MCT-07-0559; Zhong DS, 2009, J BIOL CHEM, V284, P23225, DOI 10.1074/jbc.M109.005280	21	8	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16567	16573		10.1074/jbc.M110.213033	http://dx.doi.org/10.1074/jbc.M110.213033			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21388950	Green Published, hybrid			2022-12-25	WOS:000290301900005
J	Kitano, E; Hayashi, A; Kanai, D; Shinmyozu, K; Nakayama, J				Kitano, Erina; Hayashi, Aki; Kanai, Daigo; Shinmyozu, Kaori; Nakayama, Jun-ichi			Roles of Fission Yeast Grc3 Protein in Ribosomal RNA Processing and Heterochromatic Gene Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMODOMAIN PROTEIN; HISTONE H3; LOCALIZATION; TRANSCRIPTION; ORGANIZATION; METHYLATION; INTERACT; EXPORT; DAMAGE; HCLP1	Grc3 is an evolutionarily conserved protein. Genome-wide budding yeast studies suggest that Grc3 is involved in rRNA processing. In the fission yeast Schizosaccharomyces pombe, Grc3 was identified as a factor exhibiting distinct nuclear dot localization, yet its exact physiological function remains unknown. Here, we show that S. pombe Grc3 is required for both rRNA processing and heterochromatic gene silencing. Cytological analysis revealed that Grc3 nuclear dots correspond to heterochromatic regions and that some Grc3 is also present in the nucleolar peripheral region. Depleting the heterochromatic proteins Swi6 or Clr4 abolished heterochromatic localization of Grc3 and resulted in its preferential accumulation in the peri-nucleolar region, suggesting its dynamic association with these nuclear compartments. Cells expressing mutant grc3 showed defects in 25 S rRNA maturation and in heterochromatic gene silencing. Protein analysis of Grc3-containing complexes led to the identification of Las1 and components of the IPI complex (Rix1, Ipi1, and Crb3). All of these Grc3-interacting proteins showed a dynamic nuclear localization similar to that observed for Grc3, and those conditional mutants showed defects in both rRNA processing and silencing of centromeric transcripts. Our data suggest that Grc3 functions cooperatively with Las1 and the IPI complex in both ribosome biogenesis and heterochromatin assembly.	[Nakayama, Jun-ichi] RIKEN, Ctr Dev Biol, Lab Chromatin Dynam, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Shinmyozu, Kaori] RIKEN, Ctr Dev Biol, Prote Support Unit, Kobe, Hyogo 6500047, Japan; [Kitano, Erina] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 6578501, Japan; [Kanai, Daigo; Nakayama, Jun-ichi] Kwansei Gakuin Univ, Grad Sch Sci & Technol, Dept Biosci, Sanda 6691337, Japan	RIKEN; RIKEN; Kobe University; Kwansei Gakuin University	Nakayama, J (corresponding author), RIKEN, Ctr Dev Biol, Lab Chromatin Dynam, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	jnakayam@cdb.riken.jp	Nakayama, Jun-ichi/C-6003-2011	Nakayama, Jun-ichi/0000-0002-5597-8239; Hayashi, Aki/0000-0003-1953-1664	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kobe University; Grants-in-Aid for Scientific Research [22115513] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobe University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.; Supported by the Global Center of Excellence (G-COE) program of Kobe University.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Braglia P, 2010, EMBO REP, V11, P758, DOI 10.1038/embor.2010.130; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Castle CD, 2010, MOL CELL BIOL, V30, P4404, DOI 10.1128/MCB.00358-10; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; Ding DQ, 2000, GENES CELLS, V5, P169, DOI 10.1046/j.1365-2443.2000.00317.x; DOSEFF AI, 1995, GENETICS, V141, P857; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; El-Moghazy AN, 2000, YEAST, V16, P277, DOI 10.1002/(SICI)1097-0061(200002)16:3<277::AID-YEA524>3.0.CO;2-G; Galani K, 2004, J BIOL CHEM, V279, P55411, DOI 10.1074/jbc.M406876200; Gould KL, 2004, METHODS, V33, P239, DOI 10.1016/j.ymeth.2003.11.019; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hayashi A, 2009, GENES CELLS, V14, P217, DOI 10.1111/j.1365-2443.2008.01264.x; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Jain R, 2009, RNA, V15, P923, DOI 10.1261/rna.1492809; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noble CG, 2007, NUCLEIC ACIDS RES, V35, P87, DOI 10.1093/nar/gkl1010; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Ramirez A, 2008, RNA, V14, P1737, DOI 10.1261/rna.1142908; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Sadaie M, 2008, MOL CELL BIOL, V28, P6973, DOI 10.1128/MCB.00791-08; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Sydorskyy Y, 2003, MOL CELL BIOL, V23, P2042, DOI 10.1128/MCB.23.6.2042-2054.2003; Taricani L, 2006, MOL BIOL CELL, V17, P3456, DOI 10.1091/mbc.E06-01-0056; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777	44	19	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15391	15402		10.1074/jbc.M110.201343	http://dx.doi.org/10.1074/jbc.M110.201343			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21385875	hybrid, Green Published			2022-12-25	WOS:000289788300069
J	Li, YY; Sun, LY; Zhang, Y; Wang, DD; Wang, F; Liang, J; Gui, B; Shang, YF				Li, Yanyan; Sun, Luyang; Zhang, Yu; Wang, Dandan; Wang, Feng; Liang, Jing; Gui, Bin; Shang, Yongfeng			The Histone Modifications Governing TFF1 Transcription Mediated by Estrogen Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ACTIVATED PROTEIN-KINASE; ALPHA-AMANITIN; GENE-EXPRESSION; REGULATED TRANSCRIPTION; NUCLEAR RECEPTORS; TERMINAL DOMAIN; TFIIH KINASE; SRC FAMILY; PHOSPHORYLATION	Transcription regulation by histone modifications is a major contributing factor to the structural and functional diversity in biology. These modifications are encrypted as histone codes or histone languages and function to establish and maintain heritable epigenetic codes that define the identity and the fate of the cell. Despite recent advances revealing numerous histone modifications associated with transcription regulation, how such modifications dictate the process of transcription is not fully understood. Here we describe spatial and temporal analyses of the histone modifications that are introduced during estrogen receptor alpha (ER alpha)-activated transcription. We demonstrated that aborting RNA polymerase II caused a disruption of the histone modifications that are associated with transcription elongation but had a minimal effect on modifications deposited during transcription initiation. We also found that the histone H3S10 phosphorylation mark is catalyzed by mitogen-and stress-activated protein kinase 1 (MSK1) and is recognized by a 14-3-3 zeta/14-3-3 epsilon heterodimer through its interaction with H3K4 trimethyltransferase SMYD3 and the p52 subunit of TFIIH. We showed that H3S10 phosphorylation is a prerequisite for H3K4 trimethylation. In addition, we demonstrated that SET8/PR-Set7/KMT5A is required for ER alpha-regulated transcription and its catalyzed H4K20 monomethylation is implicated in both transcription initiation and elongation. Our experiments provide a relatively comprehensive analysis of histone modifications associated with ER alpha-regulated transcription and define the biological meaning of several key components of the histone code that governs ER alpha-regulated transcription.	[Li, Yanyan; Sun, Luyang; Zhang, Yu; Wang, Dandan; Wang, Feng; Liang, Jing; Gui, Bin; Shang, Yongfeng] Peking Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China; [Shang, Yongfeng] Tianjin Med Univ, Tianjin 300070, Peoples R China	Peking University; Tianjin Medical University	Shang, YF (corresponding author), Peking Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Key Lab Carcinogenesis & Translat Res,Minist Educ, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.				National Natural Science Foundation of China [30830032, 30921062]; Ministry of Science and Technology of China [2011CB504204, 2007CB914503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Grants 30830032 and 30921062 (to Y.S.) from the National Natural Science Foundation of China and Grants 2011CB504204 and 2007CB914503 (973 Program) (to Y.S.) from the Ministry of Science and Technology of China.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Benvenisti-Zarom L, 2006, NEUROSCI LETT, V398, P230, DOI 10.1016/j.neulet.2006.01.003; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Carascossa S, 2010, GENE DEV, V24, P708, DOI 10.1101/gad.568410; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Couture JF, 2006, CURR OPIN STRUC BIOL, V16, P753, DOI 10.1016/j.sbi.2006.10.002; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Duan Q, 2008, J BIOL CHEM, V283, P33585, DOI 10.1074/jbc.M803312200; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Frigo DE, 2006, MOL ENDOCRINOL, V20, P971, DOI 10.1210/me.2004-0075; Fukuda A, 2000, Tanpakushitsu Kakusan Koso, V45, P1505; Glass CK, 2000, GENE DEV, V14, P121; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; HANSEN JC, 1992, BIOCHEMISTRY-US, V31, P7977, DOI 10.1021/bi00149a032; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hong SW, 2009, P NATL ACAD SCI USA, V106, P14276, DOI 10.1073/pnas.0903642106; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Jones PA, 2008, NATURE, V454, P711, DOI 10.1038/454711a; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Ke QD, 2008, CARCINOGENESIS, V29, P1276, DOI 10.1093/carcin/bgn084; KEDINGER C, 1970, BIOCHEM BIOPH RES CO, V38, P165, DOI 10.1016/0006-291X(70)91099-5; Kim HG, 2008, CANCER RES, V68, P2538, DOI 10.1158/0008-5472.CAN-07-6597; Kim H, 2009, J BIOL CHEM, V284, P19867, DOI 10.1074/jbc.M109.021485; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Lee DY, 2006, J BIOL CHEM, V281, P8476, DOI 10.1074/jbc.M511093200; Lee JS, 2007, MUTAT RES-FUND MOL M, V618, P130, DOI 10.1016/j.mrfmmm.2006.08.014; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Qi C, 2002, J BIOL CHEM, V277, P28624, DOI 10.1074/jbc.M201053200; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Rodicker F, 1999, GENE EXPRESSION, V8, P165; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Seval Y, 2006, J CLIN ENDOCR METAB, V91, P2349, DOI 10.1210/jc.2005-2132; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Sun XJ, 2004, J BIOL CHEM, V279, P32839, DOI 10.1074/jbc.M402522200; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Tshuikina M, 2008, GENE, V410, P259, DOI 10.1016/j.gene.2007.12.013; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wilson BJ, 2010, MOL ENDOCRINOL, V24, P1349, DOI 10.1210/me.2009-0441; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhang Y, 2007, EMBO J, V26, P2645, DOI 10.1038/sj.emboj.7601710; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	79	44	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13925	13936		10.1074/jbc.M111.223198	http://dx.doi.org/10.1074/jbc.M111.223198			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21378170	hybrid, Green Published			2022-12-25	WOS:000289556200015
J	Belo, NO; Pinheiro, RT; Reis, ES; Ricklefs, RE; Braga, EM				Belo, Nayara O.; Pinheiro, Renato T.; Reis, Elivania S.; Ricklefs, Robert E.; Braga, Erika M.			Prevalence and Lineage Diversity of Avian Haemosporidians from Three Distinct Cerrado Habitats in Brazil	PLOS ONE			English	Article							BLOOD PARASITES; ANOPHELES-DARLINGI; MALARIA PARASITES; HOST; PLASMODIUM; FOREST; VECTOR; RISK; INFECTION; BIRDS	Habitat alteration can disrupt host-parasite interactions and lead to the emergence of new diseases in wild populations. The cerrado habitat of Brazil is being fragmented and degraded rapidly by agriculture and urbanization. We screened 676 wild birds from three habitats (intact cerrado, disturbed cerrado and transition area Amazonian rainforest-cerrado) for the presence of haemosporidian parasites (Plasmodium and Haemoproteus) to determine whether different habitats were associated with differences in the prevalence and diversity of infectious diseases in natural populations. Twenty one mitochondrial lineages, including 11 from Plasmodium and 10 from Haemoproteus were identified. Neither prevalence nor diversity of infections by Plasmodium spp. or Haemoproteus spp. differed significantly among the three habitats. However, 15 of the parasite lineages had not been previously described and might be restricted to these habitats or to the region. Six haemosporidian lineages previously known from other regions, particularly the Caribbean Basin, comprised 50-80% of the infections in each of the samples, indicating a regional relationship between parasite distribution and abundance.	[Belo, Nayara O.; Braga, Erika M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Pinheiro, Renato T.; Reis, Elivania S.] Univ Fed Tocantins, Palmas, Brazil; [Ricklefs, Robert E.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	Universidade Federal de Minas Gerais; Universidade Federal do Tocantins (UFT); University of Missouri System; University of Missouri Saint Louis	Belo, NO (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.	embraga@icb.ufmg.br	Braga, Erika Martins/A-6776-2008; Belo, Nayara/ABE-3106-2021; Belo, nayara Oliveira/H-1657-2012; Pinheiro, Renato/D-9567-2013	Braga, Erika Martins/0000-0001-5550-7157; , nayara/0000-0003-1719-7404	Conselho Nacional de Pesquisa e Tecnologia (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); CNPQ; Curators of the University of Missouri	Conselho Nacional de Pesquisa e Tecnologia (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Curators of the University of Missouri	This work was supported by Conselho Nacional de Pesquisa e Tecnologia (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The CNPQ granted a scholarship to Ms. Nayara O. Belo. Some laboratory work was supported by funds from the Curators of the University of Missouri to R. E. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AA, 2002, CONSERVATION MEDICINE, P79; Atkinson CT, 1991, BIRD PARASITE INTERA, P19; Balls MJ, 2004, T ROY SOC TROP MED H, V98, P400, DOI 10.1016/j.trstmh.2003.11.005; Beadell JS, 2009, INT J PARASITOL, V39, P257, DOI 10.1016/j.ijpara.2008.06.005; Belo NO, 2009, PREV VET MED, V88, P220, DOI 10.1016/j.prevetmed.2008.09.007; Bensch S, 2000, P ROY SOC B-BIOL SCI, V267, P1583, DOI 10.1098/rspb.2000.1181; Bensch S, 2003, J PARASITOL, V89, P388, DOI 10.1645/0022-3395(2003)089[0388:TASVOH]2.0.CO;2; Bonneaud C, 2009, J TROP ECOL, V25, P439, DOI 10.1017/S0266467409006178; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Chasar A, 2009, MOL ECOL, V18, P4121, DOI 10.1111/j.1365-294X.2009.04346.x; COLWELL R. K., 2008, ESTIMATES STAT ESTIM; Cottontail VM, 2009, PARASITOLOGY, V136, P1133, DOI 10.1017/S0031182009990485; Cunha RV, 1999, T ROY SOC TROP MED H, V93, P247, DOI 10.1016/S0035-9203(99)90008-1; de Morais SA, 2010, MEM I OSWALDO CRUZ, V105, P672, DOI 10.1590/S0074-02762010000500012; Fallon SM, 2005, AM NAT, V165, P466, DOI 10.1086/428430; Fallon SM, 2003, EVOLUTION, V57, P606, DOI 10.1111/j.0014-3820.2003.tb01552.x; Gratz NG, 1999, ANNU REV ENTOMOL, V44, P51, DOI 10.1146/annurev.ento.44.1.51; Jarvi SI, 2002, J PARASITOL, V88, P153, DOI 10.1645/0022-3395(2002)088[0153:PDUTPO]2.0.CO;2; KNOWLES SC, 2010, MOL ECOL IN PRESS; Kotze DJ, 2001, BIODIVERS CONSERV, V10, P443, DOI 10.1023/A:1016606209906; Lafferty KD, 1997, PARASITOL TODAY, V13, P251, DOI 10.1016/S0169-4758(97)01072-7; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Omumbo JA, 2005, TROP MED INT HEALTH, V10, P557, DOI 10.1111/j.1365-3156.2005.01424.x; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; Povoa MM, 2003, J MED ENTOMOL, V40, P379, DOI 10.1603/0022-2585-40.4.379; Ribeiro SF, 2005, PARASITOLOGY, V130, P261, DOI 10.1017/S0031182004006596; Richard FA, 2002, J PARASITOL, V88, P819, DOI 10.1645/0022-3395(2002)088[0819:ACAOPB]2.0.CO;2; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; Ricklefs RE, 2005, ECOL MONOGR, V75, P543, DOI 10.1890/04-1820; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; SCHALL JJ, 1995, J ANIM ECOL, V64, P177, DOI 10.2307/5753; SCOTT TW, 1991, BIRD PARASITE INTERA, P179; Sehgal RNM, 2005, J VET MED SCI, V67, P295, DOI 10.1292/jvms.67.295; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; *UN FAO, 2007, STAT WORLDS FOR 2007; van der Hoek W, 2003, INT J EPIDEMIOL, V32, P280, DOI 10.1093/ije/dyg055; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; Wood MJ, 2007, MOL ECOL, V16, P3263, DOI 10.1111/j.1365-294X.2007.03362.x; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; ENV SITUATION	45	60	63	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17654	10.1371/journal.pone.0017654	http://dx.doi.org/10.1371/journal.pone.0017654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408114	Green Published, gold			2022-12-25	WOS:000288170000051
J	Konyukh, M; Delorme, R; Chaste, P; Leblond, C; Lemiere, N; Nygren, G; Anckarsater, H; Rastam, M; Stahlberg, O; Amsellem, F; Gillberg, C; Mouren-Simeoni, MC; Herbrecht, E; Fauchereau, F; Toro, R; Gillberg, C; Leboyer, M; Bourgeron, T				Konyukh, Marina; Delorme, Richard; Chaste, Pauline; Leblond, Claire; Lemiere, Nathalie; Nygren, Gudrun; Anckarsater, Henrik; Rastam, Maria; Stahlberg, Ola; Amsellem, Frederique; Gillberg, Carina; Mouren-Simeoni, Marie Christine; Herbrecht, Evelyn; Fauchereau, Fabien; Toro, Roberto; Gillberg, Christopher; Leboyer, Marion; Bourgeron, Thomas			Variations of the Candidate SEZ6L2 Gene on Chromosome 16p11.2 in Patients with Autism Spectrum Disorders and in Human Populations	PLOS ONE			English	Article							MICRODELETION; MUTATIONS	Background: Autism spectrum disorders (ASD) are a group of severe childhood neurodevelopmental disorders with still unknown etiology. One of the most frequently reported associations is the presence of recurrent de novo or inherited microdeletions and microduplications on chromosome 16p11.2. The analysis of rare variations of 8 candidate genes among the 27 genes located in this region suggested SEZ6L2 as a compelling candidate. Methodology/Principal Findings: We further explored the role of SEZ6L2 variations by screening its coding part in a group of 452 individuals, including 170 patients with ASD and 282 individuals from different ethnic backgrounds of the Human Genome Diversity Panel (HGDP), complementing the previously reported screening. We detected 7 previously unidentified non-synonymous variations of SEZ6L2 in ASD patients. We also identified 6 non-synonymous variations present only in HGDP. When we merged our results with the previously published, no enrichment of non-synonymous variation in SEZ6L2 was observed in the ASD group compared with controls. Conclusions/Significance: Our results provide an extensive ascertainment of the genetic variability of SEZ6L2 in human populations and do not support a major role for SEZ6L2 sequence variations in the susceptibility to ASD.	[Konyukh, Marina; Delorme, Richard; Chaste, Pauline; Leblond, Claire; Lemiere, Nathalie; Fauchereau, Fabien; Toro, Roberto; Bourgeron, Thomas] Inst Pasteur, Paris, France; [Konyukh, Marina; Delorme, Richard; Chaste, Pauline; Leblond, Claire; Lemiere, Nathalie; Fauchereau, Fabien; Toro, Roberto; Bourgeron, Thomas] Inst Pasteur, CNRS, URA 2182, Paris, France; [Delorme, Richard; Chaste, Pauline; Amsellem, Frederique; Mouren-Simeoni, Marie Christine] Hop Robert Debre, Serv Psychopathol Enfant & Adolescent, F-75019 Paris, France; [Delorme, Richard; Chaste, Pauline; Amsellem, Frederique; Gillberg, Christopher] INSERM, IMRB, Dept Med Genom, Psychiat Genet team,U 995, Creteil, France; [Nygren, Gudrun; Anckarsater, Henrik; Stahlberg, Ola; Gillberg, Carina] Univ Gothenburg, Dept Child & Adolescent Psychiat, Gothenburg, Sweden; [Anckarsater, Henrik] Lund Univ, Inst Clin Sci, Malmo, Sweden; [Rastam, Maria] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Herbrecht, Evelyn; Leboyer, Marion] Univ Paris Est Creteil, Fac Med, IFR10, Creteil, France; [Herbrecht, Evelyn; Leboyer, Marion] Henri Mondor Albert Chenevier Hosp, AP HP, Creteil, France; [Herbrecht, Evelyn; Leboyer, Marion; Bourgeron, Thomas] French Natl Sci Fdn, Creteil, France; [Fauchereau, Fabien; Bourgeron, Thomas] Univ Denis Diderot Paris 7, Paris, France; [Gillberg, Christopher] St Georges Hosp Med Sch, London, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Gothenburg; Lund University; Lund University; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Universite Paris Cite; St Georges University London	Konyukh, M (corresponding author), Inst Pasteur, Paris, France.	thomasb@pasteur.fr	Leboyer, Marion/AAW-3648-2021	Leboyer, Marion/0000-0001-5473-3697; Bourgeron, Thomas/0000-0001-8164-9220; Delorme, Richard/0000-0002-5614-3663; Toro, Roberto/0000-0002-6671-858X	Institut Pasteur; INSERM; CNRS; University Denis Diderot Paris 7; ANR; Fondation FondaMentale; PHRC; Fondation Orange	Institut Pasteur(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University Denis Diderot Paris 7; ANR(French National Research Agency (ANR)); Fondation FondaMentale; PHRC; Fondation Orange	The Institut Pasteur, INSERM, CNRS, University Denis Diderot Paris 7, ANR, Fondation FondaMentale, PHRC and Fondation Orange supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Cann HM, 2002, SCIENCE, V296, P261; Fernell E, 2010, RES DEV DISABIL, V31, P680, DOI 10.1016/j.ridd.2010.01.007; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; GILLBERG C, 2009, J AUTISM DEV DISORD; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Kumar RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004582; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Toro R, 2010, TRENDS GENE IN PRESS; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9	17	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17289	10.1371/journal.pone.0017289	http://dx.doi.org/10.1371/journal.pone.0017289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394203	Green Published, Green Submitted, gold			2022-12-25	WOS:000288025500007
J	Ochola, LB; Siddondo, BR; Ocholla, H; Nkya, S; Kimani, EN; Williams, TN; Makale, JO; Liljander, A; Urban, BC; Bull, PC; Szestak, T; Marsh, K; Craig, AG				Ochola, Lucy B.; Siddondo, Bethsheba R.; Ocholla, Harold; Nkya, Siana; Kimani, Eva N.; Williams, Thomas N.; Makale, Johnstone O.; Liljander, Anne; Urban, Britta C.; Bull, Pete C.; Szestak, Tadge; Marsh, Kevin; Craig, Alister G.			Specific Receptor Usage in Plasmodium falciparum Cytoadherence Is Associated with Disease Outcome	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; INFECTED ERYTHROCYTES; SEVERE MALARIA; CHONDROITIN SULFATE; CEREBRAL MALARIA; PARASITIZED ERYTHROCYTES; RHINOVIRUS SEROTYPES; CLINICAL-DISEASE; SURFACE-ANTIGENS; IN-VITRO	Our understanding of the basis of severe disease in malaria is incomplete. It is clear that pathology is in part related to the pro-inflammatory nature of the host response but a number of other factors are also thought to be involved, including the interaction between infected erythrocytes and endothelium. This is a complex system involving several host receptors and a major parasite-derived variant antigen (PfEMP1) expressed on the surface of the infected erythrocyte membrane. Previous studies have suggested a role for ICAM-1 in the pathology of cerebral malaria, although these have been inconclusive. In this study we have examined the cytoadherence patterns of 101 patient isolates from varying clinical syndromes to CD36 and ICAM-1, and have used variant ICAM-1 proteins to further characterise this adhesive phenotype. Our results show that increased binding to CD36 is associated with uncomplicated malaria while ICAM-1 adhesion is raised in parasites from cerebral malaria cases.	[Ochola, Lucy B.; Siddondo, Bethsheba R.; Ocholla, Harold; Kimani, Eva N.; Williams, Thomas N.; Makale, Johnstone O.; Urban, Britta C.; Bull, Pete C.; Marsh, Kevin] Ctr Geog Med Res, KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Urban, Britta C.; Szestak, Tadge; Craig, Alister G.] Univ Liverpool, Liverpool Sch Trop Med, Dept Mol Parasitol, Liverpool L3 5QA, Merseyside, England; [Nkya, Siana] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Liljander, Anne] Karolinska Inst, Dept Med, Stockholm, Sweden; [Bull, Pete C.; Marsh, Kevin] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Williams, Thomas N.] Univ Oxford, Dept Pediat, Oxford, England	Liverpool School of Tropical Medicine; University of Liverpool; Muhimbili University of Health & Allied Sciences; Karolinska Institutet; University of Oxford; University of Oxford	Ochola, LB (corresponding author), Ctr Geog Med Res, KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.	laochola@gmail.com	Urban, Britta/W-6087-2018	Urban, Britta/0000-0002-4197-8393; Bull, Peter/0000-0002-7674-6752; Ochola, Lucy/0000-0003-0264-5526; Craig, Alister/0000-0003-0914-6164; Nkya, Siana/0000-0001-7576-6279	UK Medical Research Council [70959]; Wellcome Trust [084535]; MRC [G0400417] Funding Source: UKRI; Medical Research Council [G0400417] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (Research Grant 70959) and the Wellcome Trust (Research Grant 084535). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams S, 2000, INFECT IMMUN, V68, P264, DOI 10.1128/IAI.68.1.264-269.2000; Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Akech SO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-256; AlYaman F, 1997, PARASITE IMMUNOL, V19, P207, DOI 10.1046/j.1365-3024.1997.d01-198.x; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Beeson JG, 2005, CURR TOP MICROBIOL, V297, P187; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; Bellamy R, 1998, T ROY SOC TROP MED H, V92, P312, DOI 10.1016/S0035-9203(98)91026-4; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Biswas AK, 2007, PLOS PATHOG, V3, P1271, DOI 10.1371/journal.ppat.0030130; Blomqvist K, 2010, MOL BIOCHEM PARASIT, V170, P74, DOI 10.1016/j.molbiopara.2009.12.002; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; Bull PC, 2000, J INFECT DIS, V182, P252, DOI 10.1086/315652; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; CHAIYAROJ SC, 1994, P NATL ACAD SCI USA, V91, P10805, DOI 10.1073/pnas.91.23.10805; Chakravorty SJ, 2005, EUR J CELL BIOL, V84, P15, DOI 10.1016/j.ejcb.2004.09.002; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Chilongola J, 2009, TROP MED INT HEALTH, V14, P810, DOI 10.1111/j.1365-3156.2009.02298.x; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; Chong SS, 2000, BLOOD, V95, P360; Cojean S, 2008, PARASITE, V15, P163, DOI 10.1051/parasite/2008152163; COOKE BM, 1994, BRIT J HAEMATOL, V87, P162, DOI 10.1111/j.1365-2141.1994.tb04887.x; Craig A, 2000, HUM MOL GENET, V9, P525, DOI 10.1093/hmg/9.4.525; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; Degen R, 2000, EXP PARASITOL, V95, P113, DOI 10.1006/expr.2000.4512; Elliott SR, 2007, INFECT IMMUN, V75, P3621, DOI 10.1128/IAI.00095-07; ENGELBRECHT F, 1995, EXP PARASITOL, V81, P90, DOI 10.1006/expr.1995.1096; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Farnert A, 1999, J INFECT DIS, V179, P989, DOI 10.1086/314652; Farnert A, 2009, J INFECT DIS, V200, P1166, DOI 10.1086/605652; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Feng GQ, 2009, J INFECT DIS, V200, P299, DOI 10.1086/599841; FernandezReyes D, 1997, HUM MOL GENET, V6, P1357, DOI 10.1093/hmg/6.8.1357; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gray C, 2003, MOL BIOCHEM PARASIT, V128, P187, DOI 10.1016/S0166-6851(03)00075-6; Gray C, 2002, INFECT IMMUN, V70, P3962, DOI 10.1128/IAI.70.7.3962-3964.2002; GREENWALT DE, 1992, BLOOD, V80, P1105; Heddini A, 2001, INFECT IMMUN, V69, P5849, DOI 10.1128/IAI.69.9.5849-5856.2001; Ho M, 1998, BLOOD, V91, P4803, DOI 10.1182/blood.V91.12.4803.412k30_4803_4809; HO M, 1991, INFECT IMMUN, V59, P873, DOI 10.1128/IAI.59.3.873-878.1991; Ho M, 1999, AM J PHYSIOL-CELL PH, V276, pC1231, DOI 10.1152/ajpcell.1999.276.6.C1231; Horata N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-184; Jenkins NE, 2005, CLIN INFECT DIS, V41, P1817, DOI 10.1086/498156; Klein MM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000147; Kolatkar PR, 1999, EMBO J, V18, P6249, DOI 10.1093/emboj/18.22.6249; Kun JFJ, 1999, AM J TROP MED HYG, V61, P776, DOI 10.4269/ajtmh.1999.61.776; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Liljander A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-78; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Marsh K, 1997, PHILOS T R SOC B, V352, P1385, DOI 10.1098/rstb.1997.0124; MARSH K, 1988, EXP PARASITOL, V65, P202, DOI 10.1016/0014-4894(88)90123-3; Maubert B, 2000, PARASITE IMMUNOL, V22, P191, DOI 10.1046/j.1365-3024.2000.00292.x; McCormick CJ, 1997, J CLIN INVEST, V100, P2521, DOI 10.1172/JCI119794; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Meerman L, 2005, J INFECT DIS, V192, P1651, DOI 10.1086/496887; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mo M, 2008, INFECT IMMUN, V76, P1837, DOI 10.1128/IAI.00480-07; MOLYNEUX ME, 1989, Q J MED, V71, P441; Montgomery J, 2007, MOL MICROBIOL, V65, P959, DOI 10.1111/j.1365-2958.2007.05837.x; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; OCKENHOUSE CF, 1992, CELL, V68, P63, DOI 10.1016/0092-8674(92)90206-R; OCKENHOUSE CF, 1989, J CLIN INVEST, V84, P468, DOI 10.1172/JCI114188; Pain A, 2001, LANCET, V357, P1502, DOI 10.1016/S0140-6736(00)04662-6; Pradhan P, 2009, J VECTOR DIS, V46, P100; REEDER JC, 1994, AM J TROP MED HYG, V51, P45, DOI 10.4269/ajtmh.1994.51.45; Reeder JC, 1999, P NATL ACAD SCI USA, V96, P5198, DOI 10.1073/pnas.96.9.5198; Roberts DJ, 2003, REDOX REP, V8, P304, DOI 10.1179/135100003225002998; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rogerson SJ, 1999, AM J TROP MED HYG, V61, P467, DOI 10.4269/ajtmh.1999.61.467; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Rowe JA, 2000, J IMMUNOL, V165, P6341, DOI 10.4049/jimmunol.165.11.6341; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Serghides L, 2001, J IMMUNOL, V166, P6742, DOI 10.4049/jimmunol.166.11.6742; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; Smith TG, 2003, INFECT IMMUN, V71, P393, DOI 10.1128/IAI.71.1.393-400.2003; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Staalsoe T, 2001, J INFECT DIS, V184, P618, DOI 10.1086/322809; Toure FS, 2007, CLIN MED RES, V5, P106, DOI 10.3121/cmr.2007.696; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tse MT, 2004, MOL MICROBIOL, V51, P1039, DOI 10.1046/j.1365-2958.2003.03895.x; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; Veenemans J, 2008, J INFECT DIS, V198, P401, DOI 10.1086/589884; Waitumbi JN, 2000, BLOOD, V95, P1481, DOI 10.1182/blood.V95.4.1481.004k15_1481_1486; Waterfall CM, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.23.e119; Xiao C, 2004, J VIROL, V78, P10034, DOI 10.1128/JVI.78.18.10034-10044.2004	95	88	88	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e14741	10.1371/journal.pone.0014741	http://dx.doi.org/10.1371/journal.pone.0014741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390226	Green Published, Green Accepted, gold			2022-12-25	WOS:000287965200001
J	Lai, YL; Qiao, M; Song, MH; Weintraub, ST; Shiio, Y				Lai, Yanlai; Qiao, Mei; Song, Meihua; Weintraub, Susan T.; Shiio, Yuzuru			Quantitative Proteomics Identifies the Myb-Binding Protein p160 as a Novel Target of the von Hippel-Lindau Tumor Suppressor	PLOS ONE			English	Article							CODED AFFINITY TAGS; RNA-POLYMERASE-II; TANDEM MASS-SPECTROMETRY; CELL CARCINOMA-CELLS; STATISTICAL-MODEL; LARGE SUBUNIT; HIF2A GENE; APOPTOSIS; TRANSACTIVATION; UBIQUITINATION	Background: The von Hippel-Lindau (VHL) tumor suppressor gene encodes a component of a ubiquitin ligase complex, which is best understood as a negative regulator of hypoxia inducible factor (HIF). VHL ubiquitinates and degrades the a subunits of HIF, and this is proposed to suppress tumorigenesis and tumor angiogenesis. However, several lines of evidence suggest that there are unidentified substrates or targets for VHL that play important roles in tumor suppression. Methodology/Principal Findings: Employing quantitative proteomics, we developed an approach to systematically identify the substrates of ubiquitin ligases and using this method, we identified the Myb-binding protein p160 as a novel substrate of VHL. Conclusions/Significance: A major barrier to understanding the functions of ubiquitin ligases has been the difficulty in pinpointing their ubiquitination substrates. The quantitative proteomics approach we devised for the identification of VHL substrates will be widely applicable to other ubiquitin ligases.	[Lai, Yanlai; Qiao, Mei; Song, Meihua; Shiio, Yuzuru] Greehey Childrens Canc Res Inst, San Antonio, TX USA; [Weintraub, Susan T.; Shiio, Yuzuru] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Lai, YL (corresponding author), Greehey Childrens Canc Res Inst, San Antonio, TX USA.	shiio@uthscsa.edu			National Institutes of Health [R01CA125020, P30CA54174]; National Heart, Blood, and Lung Institute [N01-HV-28179]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028179] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA054174, R01CA125020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health grants R01CA125020 (to YS) and P30CA54174 (San Antonio Cancer Institute - Mass Spectrometry Core) and by federal funding from the National Heart, Blood, and Lung Institute under Contract N01-HV-28179 (Seattle Proteome Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry RE, 2004, TRENDS MOL MED, V10, P466, DOI 10.1016/j.molmed.2004.07.008; Bishop T, 2004, PLOS BIOL, V2, P1549, DOI 10.1371/journal.pbio.0020289; CHOI SM, 2006, J BIOL CHEM; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Czyzyk-Krzeska MF, 2004, TRENDS MOL MED, V10, P146, DOI 10.1016/j.molmed.2004.02.004; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Hervouet E, 2005, CARCINOGENESIS, V26, P531, DOI 10.1093/carcin/bgi001; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Juin P, 1999, GENE DEV, V13, P1367, DOI 10.1101/gad.13.11.1367; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim M, 2004, BIOCHEM BIOPH RES CO, V320, P945, DOI 10.1016/j.bbrc.2004.06.042; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kuznetsova AV, 2003, P NATL ACAD SCI USA, V100, P2706, DOI 10.1073/pnas.0436037100; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Li XJ, 2003, ANAL CHEM, V75, P6648, DOI 10.1021/ac034633i; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Morrish F, 2003, GENE DEV, V17, P240, DOI 10.1101/gad.1032503; Na X, 2003, EMBO J, V22, P4249, DOI 10.1093/emboj/cdg410; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Percy MJ, 2008, BLOOD, V111, P5400, DOI 10.1182/blood-2008-02-137703; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Qi H, 2003, CANCER RES, V63, P7076; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Shiio Y, 2003, J AM SOC MASS SPECTR, V14, P696, DOI 10.1016/S1044-0305(03)00204-6; Shiio Y, 2002, EMBO J, V21, P5088, DOI 10.1093/emboj/cdf525; Shiio Y, 2006, NAT PROTOC, V1, P139, DOI 10.1038/nprot.2006.22; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Tavner FJ, 1998, MOL CELL BIOL, V18, P989, DOI 10.1128/MCB.18.2.989	37	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16975	10.1371/journal.pone.0016975	http://dx.doi.org/10.1371/journal.pone.0016975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386990	Green Published, Green Submitted, gold			2022-12-25	WOS:000287931400016
J	Wheeler, DW; Thompson, AJ; Corletto, F; Reckless, J; Loke, JCT; Lapaque, N; Grant, AJ; Mastroeni, P; Grainger, DJ; Padgett, CL; O'Brien, JA; Miller, NGA; Trowsdale, J; Lummis, SCR; Menon, DK; Beech, JS				Wheeler, Daniel W.; Thompson, Andrew J.; Corletto, Federico; Reckless, Jill; Loke, Justin C. T.; Lapaque, Nicolas; Grant, Andrew J.; Mastroeni, Pietro; Grainger, David J.; Padgett, Claire L.; O'Brien, John A.; Miller, Nigel G. A.; Trowsdale, John; Lummis, Sarah C. R.; Menon, David K.; Beech, John S.			Anaesthetic Impairment of Immune Function Is Mediated via GABA(A) Receptors	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; OF-THE-LITERATURE; MECHANICAL VENTILATION; BINDING-SITE; IN-VITRO; PROPOFOL; BENZODIAZEPINES; PHAGOCYTOSIS; SUPPRESSION; INHIBITION	Background: GABA(A) receptors are members of the Cys-loop family of neurotransmitter receptors, proteins which are responsible for fast synaptic transmission, and are the site of action of wide range of drugs [1]. Recent work has shown that Cys-loop receptors are present on immune cells, but their physiological roles and the effects of drugs that modify their function in the innate immune system are currently unclear [2]. We are interested in how and why anaesthetics increase infections in intensive care patients; a serious problem as more than 50% of patients with severe sepsis will die [3-6]. As many anaesthetics act via GABA(A) receptors [7], the aim of this study was to determine if these receptors are present on immune cells, and could play a role in immunocompromising patients. Principal Findings: We demonstrate, using RT-PCR, that monocytes express GABA(A) receptors constructed of alpha 1, alpha 4, beta 2, gamma 1 and/or delta subunits. Whole cell patch clamp electrophysiological studies show that GABA can activate these receptors, resulting in the opening of a chloride-selective channel; activation is inhibited by the GABA(A) receptor antagonists bicuculline and picrotoxin, but not enhanced by the positive modulator diazepam. The anaesthetic drugs propofol and thiopental, which can act via GABA(A) receptors, impaired monocyte function in classic immunological chemotaxis and phagocytosis assays, an effect reversed by bicuculline and picrotoxin. Significance: Our results show that functional GABA(A) receptors are present on monocytes with properties similar to CNS GABA(A) receptors. The functional data provide a possible explanation as to why chronic propofol and thiopental administration can increase the risk of infection in critically ill patients: their action on GABA(A) receptors inhibits normal monocyte behaviour. The data also suggest a potential solution: monocyte GABA(A) receptors are insensitive to diazepam, thus the use of benzodiazepines as an alternative anesthetising agent may be advantageous where infection is a life threatening problem.	[Wheeler, Daniel W.; Corletto, Federico; Loke, Justin C. T.; Menon, David K.; Beech, John S.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 2QQ, England; [Thompson, Andrew J.; Padgett, Claire L.; Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Cambridge CB2 2QQ, England; [Reckless, Jill; Grainger, David J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Lapaque, Nicolas; Miller, Nigel G. A.; Trowsdale, John] Univ Cambridge, Dept Pathol, Cambridge CB2 2QQ, England; [Grant, Andrew J.; Mastroeni, Pietro] Univ Cambridge, Dept Vet Med, Cambridge CB2 2QQ, England; [O'Brien, John A.; Lummis, Sarah C. R.] MRC Lab Mol Biol, Div Neurobiol, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; MRC Laboratory Molecular Biology	Wheeler, DW (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 2QQ, England.	sl120@mole.bio.cam.ac.uk	Lapaque, Nicolas/D-5377-2014; Wheeler, Daniel/A-8690-2008; Lapaque, Nicolas/AAB-4530-2021; Wheeler, Daniel/L-8609-2019	Lapaque, Nicolas/0000-0003-0824-0108; Lapaque, Nicolas/0000-0003-0824-0108; Loke, Justin/0000-0002-0725-069X; Mastroeni, Pietro/0000-0003-3838-4962; Thompson, Andrew/0000-0002-7046-6792; Wheeler, Daniel/0000-0001-7692-6887; Corletto, Federico/0000-0003-2396-4278	Medical Research Council [79588]; Wellcome Trust [08195]; Association of Anaesthetists of Ireland; Biotechnology and Biological Sciences Research Council; Royal College of Anaesthetists; Queen's College, Cambridge; Evelyn Trust; Association of Anaesthetists of Great Britain; Medical Research Council [G84/6409, G9800943, G0001354B, G0401569, G1000183B, G0001354, G0801161, MC_U105184294] Funding Source: researchfish; MRC [G9800943, G84/6409, G0801161, MC_U105184294, G0401569] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Association of Anaesthetists of Ireland; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal College of Anaesthetists; Queen's College, Cambridge; Evelyn Trust; Association of Anaesthetists of Great Britain; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (DW, JAOB, DKM, JSB): JSB, DKM: grant number 79588, the Wellcome Trust (FC, AJT, PM, SCRL, DKM) SCRL: grant number 08195, the Association of Anaesthetists of Great Britain and Ireland (DWW), Biotechnology and Biological Sciences Research Council (AJG), Royal College of Anaesthetists (DKM), Queen's College, Cambridge (DKM), the Evelyn Trust (DKM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2006, MOL IMMUNOL, V43, P1432, DOI 10.1016/j.molimm.2005.07.025; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Cestari IN, 1996, NEUROREPORT, V7, P943, DOI 10.1097/00001756-199603220-00023; Cordato DJ, 2001, ANAESTH INTENS CARE, V29, P339, DOI 10.1177/0310057X0102900403; Dawidowicz AL, 2006, CHEM-BIOL INTERACT, V159, P149, DOI 10.1016/j.cbi.2005.10.108; DENEYNDEN JV, 2009, FRONT MOL NEUROSCI, V2, P9; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Ferrer NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012978; Fraser GL, 2007, CURR OPIN ANESTHESIO, V20, P119, DOI 10.1097/ACO.0b013e32808255b4; Frow EK, 2004, MED RES REV, V24, P267, DOI 10.1002/med.10062; GOLDFARB G, 1984, ANESTHESIOLOGY, V60, P57, DOI 10.1097/00000542-198401000-00011; Gramlich L, 2004, NUTRITION, V20, P843, DOI 10.1016/j.nut.2004.06.003; HASLETT C, 1985, AM J PATHOL, V119, P101; Hofbauer R, 1999, CRIT CARE MED, V27, P1843, DOI 10.1097/00003246-199909000-00023; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; KRUMHOLZ W, 1995, BRIT J ANAESTH, V75, P66, DOI 10.1093/bja/75.1.66; Krumholz W, 1999, EUR J ANAESTH, V16, P547, DOI 10.1046/j.1365-2346.1999.00537.x; Lubick K, 2007, J LEUKOCYTE BIOL, V82, P1062, DOI 10.1189/jlb.0407255; Maddox FN, 2004, DEV BRAIN RES, V149, P143, DOI 10.1016/j.devbrainres.2004.01.001; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; MORISAKI H, 1991, BRIT J ANAESTH, V66, P97, DOI 10.1093/bja/66.1.97; Nadal P, 1995, Eur J Emerg Med, V2, P14, DOI 10.1097/00063110-199503000-00004; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Shiratsuchi H, 2009, AM J PHYSIOL-CELL PH, V296, pC1400, DOI 10.1152/ajpcell.00345.2008; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; Stankevicius D, 2008, NEUROPHARMACOLOGY, V54, P300, DOI 10.1016/j.neuropharm.2007.09.011; Stover JF, 1998, EUR J CLIN PHARMACOL, V54, P529, DOI 10.1007/s002280050508; Strom T, 2010, LANCET, V375, P475, DOI 10.1016/S0140-6736(09)62072-9; Stuart PC, 2000, BRIT J ANAESTH, V84, P638, DOI 10.1093/bja/84.5.638; Stuckey DJ, 2005, J LEUKOCYTE BIOL, V78, P393, DOI 10.1189/jlb.1203604; Tian J, 1999, J NEUROIMMUNOL, V96, P21, DOI 10.1016/S0165-5728(98)00264-1; Tian JD, 2004, J IMMUNOL, V173, P5298, DOI 10.4049/jimmunol.173.8.5298; Vansant G, 2007, AUTOIMMUNITY, V40, P180, DOI 10.1080/08916930701204467; VOLAKLI E, CRIT CARE, V14, pR32; WEISS M, 1993, BRIT J ANAESTH, V70, P317, DOI 10.1093/bja/70.3.317	41	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17152	10.1371/journal.pone.0017152	http://dx.doi.org/10.1371/journal.pone.0017152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390329	Green Published, gold, Green Submitted			2022-12-25	WOS:000287761700033
J	Ying, M; Wang, S; Sang, Y; Sun, P; Lal, B; Goodwin, CR; Guerrero-Cazares, H; Quinones-Hinojosa, A; Laterra, J; Xia, S				Ying, M.; Wang, S.; Sang, Y.; Sun, P.; Lal, B.; Goodwin, C. R.; Guerrero-Cazares, H.; Quinones-Hinojosa, A.; Laterra, J.; Xia, S.			Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition	ONCOGENE			English	Article						glioblastoma; cancer stem cell; retinoic acid; differentiation; Notch	HEPATOCYTE GROWTH-FACTOR; 13-CIS-RETINOIC ACID; EMBRYONAL CARCINOMA; DIFFERENTIATION THERAPY; NEURAL DIFFERENTIATION; U87MG CELLS; PHASE-II; CANCER; APOPTOSIS; GLIOMA	It is necessary to understand mechanisms by which differentiating agents influence tumor-initiating cancer stem cells. Toward this end, we investigated the cellular and molecular responses of glioblastoma stem-like cells (GBM-SCs) to all-trans retinoic acid (RA). GBM-SCs were grown as non-adherent neurospheres in growth factor supplemented serum-free medium. RA treatment rapidly induced morphology changes, induced growth arrest at G1/G0 to S transition, decreased cyclin D1 expression and increased p27 expression. Immunofluorescence and western blot analysis indicated that RA induced the expression of lineage-specific differentiation markers Tuj1 and GFAP and reduced the expression of neural stem cell markers such as CD133, Msi-1, nestin and Sox-2. RA treatment dramatically decreased neurosphere-forming capacity, inhibited the ability of neurospheres to form colonies in soft agar and inhibited their capacity to propagate subcutaneous and intracranial xenografts. Expression microarray analysis identified similar to 350 genes that were altered within 48 h of RA treatment. Affected pathways included retinoid signaling and metabolism, cell-cycle regulation, lineage determination, cell adhesion, cell-matrix interaction and cytoskeleton remodeling. Notch signaling was the most prominent of these RA-responsive pathways. Notch pathway downregulation was confirmed based on the downregulation of HES and HEY family members. Constitutive activation of Notch signaling with the Notch intracellular domain rescued GBM neurospheres from the RA-induced differentiation and stem cell depletion. Our findings identify mechanisms by which RA targets GBM-derived stem-like tumor-initiating cells and novel targets applicable to differentiation therapies for glioblastoma. Oncogene (2011) 30, 3454-3467; doi:10.1038/onc.2011.58; published online 7 March 2011	[Xia, S.] Hugo W Moser Res Inst Kennedy Krieger, Johns Hopkins Sch Med, Dept Neurooncol, Baltimore, MD 21205 USA; [Ying, M.; Sun, P.; Lal, B.; Laterra, J.; Xia, S.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Guerrero-Cazares, H.; Quinones-Hinojosa, A.; Laterra, J.] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA; [Guerrero-Cazares, H.] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD USA; [Laterra, J.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Xia, S (corresponding author), Hugo W Moser Res Inst Kennedy Krieger, Johns Hopkins Sch Med, Dept Neurooncol, 707 N Broadway,Room 400K, Baltimore, MD 21205 USA.	xia@kennedykrieger.org		Guerrero-Cazares, Hugo/0000-0003-1307-719X; Goodwin, C. Rory/0000-0002-6540-2751	Maryland Stem Cell Research Fund (MSCRFE) [2009-0126-00]; MSCRF; NIH [NS43987, KO8]; James McDonnell Foundation; HHMI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043987] Funding Source: NIH RePORTER	Maryland Stem Cell Research Fund (MSCRFE); MSCRF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James McDonnell Foundation; HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by the Maryland Stem Cell Research Fund (MSCRFE) 2009-0126-00 (SX); MSCRF (MY, HG); NIH NS43987 and the James McDonnell Foundation (JL); as well as NIH KO8 and HHMI grants (AQ). Dr CR Goodwin is a UNCF-Merck Science postdoc fellow. We thank Dr Jiang Qian and Ms Yanqing Yang from Wilmer Eye Institute, Johns Hopkins University, for their assistance with microarray analysis.	Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; An J, 2005, PROTEOMICS, V5, P1656, DOI 10.1002/pmic.200401049; Bain G., 2000, Functional and Integrative Genomics, V1, P127, DOI 10.1007/s101420000014; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Butowski N, 2005, INT J RADIAT ONCOL, V61, P1454, DOI 10.1016/j.ijrobp.2004.08.023; Chalmers AJ, 2007, DNA REPAIR, V6, P1391, DOI 10.1016/j.dnarep.2007.03.019; Chearwae W, 2008, BRIT J CANCER, V99, P2044, DOI 10.1038/sj.bjc.6604786; Das A, 2008, J NEURO-ONCOL, V87, P9, DOI 10.1007/s11060-007-9485-1; Dragnev KH, 2003, CANCER BIOL THER, V2, pS150; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Ginestier C, 2009, CELL CYCLE, V8, P3297, DOI 10.4161/cc.8.20.9761; Goodwin CR, 2010, CANCER RES, V70, P2932, DOI 10.1158/0008-5472.CAN-09-3570; Harris Thomas M, 2002, Funct Integr Genomics, V2, P105, DOI 10.1007/s10142-002-0062-6; Jaeckle KA, 2003, J CLIN ONCOL, V21, P2305, DOI 10.1200/JCO.2003.12.097; Johannessen TCA, 2008, CANCER TREAT REV, V34, P558, DOI 10.1016/j.ctrv.2008.03.125; Jurcic Joseph G, 2007, Curr Oncol Rep, V9, P337, DOI 10.1007/s11912-007-0045-9; Kageyama R, 2009, CURR OPIN CELL BIOL, V21, P733, DOI 10.1016/j.ceb.2009.08.009; Karmakar S, 2008, CANCER, V112, P596, DOI 10.1002/cncr.23223; Kumar Hari R, 2008, Expert Rev Neurother, V8, P1497, DOI 10.1586/14737175.8.10.1497; Lal BC, 2005, CLIN CANCER RES, V11, P4479, DOI 10.1158/1078-0432.CCR-05-0166; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Massard C, 2006, ANN ONCOL, V17, P1620, DOI 10.1093/annonc/mdl074; Mongan NP, 2007, DIFFERENTIATION, V75, P853, DOI 10.1111/j.1432-0436.2007.00206.x; Murata-Ohsawa M, 2005, LEUKEMIA RES, V29, P197, DOI 10.1016/j.leukres.2004.05.020; Nasr R, 2009, CLIN CANCER RES, V15, P6321, DOI 10.1158/1078-0432.CCR-09-0209; Niles RM, 2004, MUTAT RES-FUND MOL M, V555, P81, DOI 10.1016/j.mrfmmm.2004.05.020; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piccirillo SGM, 2007, EXPERT OPIN BIOL TH, V7, P1129, DOI 10.1517/14712598.7.8.1129; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Reznik TE, 2008, MOL CANCER RES, V6, P139, DOI 10.1158/1541-7786.MCR-07-0236; Sangster-Guity N, 2004, CANCER BIOL THER, V3, P1109, DOI 10.4161/cbt.3.11.1190; See SJ, 2004, NEURO-ONCOLOGY, V6, P253, DOI 10.1215/S1152851703000607; Sell S, 2006, TUMOR BIOL, V27, P59, DOI 10.1159/000092323; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Shih AH, 2006, NEOPLASIA, V8, P1072, DOI 10.1593/neo.06526; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sivasankaran B, 2009, CANCER RES, V69, P458, DOI 10.1158/0008-5472.CAN-08-2610; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun P, 2009, STEM CELLS, V27, P1473, DOI 10.1002/stem.89; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Walsh J, 2003, APMIS, V111, P197, DOI 10.1034/j.1600-0463.2003.1110124.x; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wei Y, 2002, DIFFERENTIATION, V70, P204, DOI 10.1046/j.1432-0436.2002.700409.x; Wilson A, 2006, FEBS LETT, V580, P2860, DOI 10.1016/j.febslet.2006.03.024; Yu XB, 2008, CELL STEM CELL, V2, P461, DOI 10.1016/j.stem.2008.03.001; Yung WKA, 1996, CLIN CANCER RES, V2, P1931; Zhang R, 2007, NEUROCHEM RES, V32, P2194, DOI 10.1007/s11064-007-9417-7	54	132	136	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2011	30	31					3454	3467		10.1038/onc.2011.58	http://dx.doi.org/10.1038/onc.2011.58			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	802KA	21383690	Green Accepted			2022-12-25	WOS:000293508100006
J	Andrikopoulos, P; Fraser, SP; Patterson, L; Ahmad, Z; Burcu, H; Ottaviani, D; Diss, JKJ; Box, C; Eccles, SA; Djamgoz, MBA				Andrikopoulos, Petros; Fraser, Scott P.; Patterson, Lisa; Ahmad, Zahida; Burcu, Hakan; Ottaviani, Diego; Diss, James K. J.; Box, Carol; Eccles, Suzanne A.; Djamgoz, Mustafa B. A.			Angiogenic Functions of Voltage-gated Na+ Channels in Human Endothelial Cells MODULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; HUMAN UMBILICAL VEIN; BREAST-CANCER CELLS; RAT PROSTATE-CANCER; SODIUM-CHANNEL; IN-VITRO; NA+-CA2+ EXCHANGE; SPLICE VARIANT; CA2+ CHANNELS; DNA-SYNTHESIS	Voltage-gated sodium channel (VGSC) activity has previously been reported in endothelial cells (ECs). However, the exact isoforms of VGSCs present, their mode(s) of action, and potential role(s) in angiogenesis have not been investigated. The main aims of this study were to determine the role of VGSC activity in angiogenic functions and to elucidate the potentially associated signaling mechanisms using human umbilical vein endothelial cells (HUVECs) as a model system. Real-time PCR showed that the primary functional VGSC alpha- and beta-subunit isoforms in HUVECs were Nav1.5, Nav1.7, VGSC beta 1, and VGSC beta 3. Western blots verified that VGSC alpha proteins were expressed in HUVECs, and immunohistochemistry revealed VGSC alpha expression in mouse aortic ECs in vivo. Electrophysiological recordings showed that the channels were functional and suppressed by tetrodotoxin (TTX). VGSC activity modulated the following angiogenic properties of HUVECs: VEGF-induced proliferation or chemotaxis, tubular differentiation, and substrate adhesion. Interestingly, different aspects of angiogenesis were controlled by the different VGSC isoforms based on TTX sensitivity and effects of siRNA-mediated gene silencing. Additionally, we show for the first time that TTX-resistant (TTX-R) VGSCs (Nav1.5) potentiate VEGF-induced ERK1/2 activation through the PKC alpha-B-RAF signaling axis. We postulate that this potentiation occurs through modulation of VEGF-induced HUVEC depolarization and [Ca2+](i). We conclude that VGSCs regulate multiple angiogenic functions and VEGF signaling in HUVECs. Our results imply that targeting VGSC expression/activity could be a novel strategy for controlling angiogenesis.	[Diss, James K. J.; Djamgoz, Mustafa B. A.] Univ London Imperial Coll Sci Technol & Med, Neurosci Solut Canc Res Grp, Div Cell & Mol Biol, London SW7 2AZ, England; [Andrikopoulos, Petros; Patterson, Lisa; Ahmad, Zahida; Burcu, Hakan; Ottaviani, Diego; Box, Carol; Eccles, Suzanne A.] Inst Canc Res, McElwain Labs, Canc Res UK Canc Therapeut Unit, Sutton SM2 5NG, Surrey, England	Imperial College London; Cancer Research UK; University of London; Institute of Cancer Research - UK	Andrikopoulos, P (corresponding author), Queen Marys Univ London, Barts & London Sch Med, William Harvey Res Inst, London EC1M 6BQ, England.	p.andrikopoulos@qmul.ac.uk; m.djamgoz@imperial.ac.uk	Andrikopoulos, Petros/G-2519-2011; Andrikopoulos, Petros/N-7724-2019; Diss, James K/C-5994-2008	Andrikopoulos, Petros/0000-0002-1555-3498; Diss, James K/0000-0003-4988-257X; Box, Carol/0000-0002-8919-8724	British Heart Foundation [FS/06/22]; National Health Service; Royal Marsden Hospital Head and Neck Cancer Research Trust; Cancer Research UK [C309/A8274]; Institute of Cancer Research; Cancer Research UK [11566] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Health Service; Royal Marsden Hospital Head and Neck Cancer Research Trust; Cancer Research UK(Cancer Research UK); Institute of Cancer Research; Cancer Research UK(Cancer Research UK)	This work was supported by British Heart Foundation Studentship FS/06/22 (to P. A.). Additional support was provided by the Pro Cancer Research Fund. The NIHR Biomedical Research Centre was supported by the National Health Service.; Supported by the Royal Marsden Hospital Head and Neck Cancer Research Trust.; Supported by Cancer Research UK Grant C309/A8274 and The Institute of Cancer Research.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Black JA, 2008, ANN NEUROL, V64, P644, DOI 10.1002/ana.21527; Borg JJ, 2002, J PHARMACOL EXP THER, V303, P282, DOI 10.1124/jpet.102.038901; Brackenbury WJ, 2007, BREAST CANCER RES TR, V101, P149, DOI 10.1007/s10549-006-9281-1; Brackenbury WJ, 2006, J PHYSIOL-LONDON, V573, P343, DOI 10.1113/jphysiol.2006.106906; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chen CH, 2006, CIRC RES, V99, P787, DOI 10.1161/01.RES.0000247758.34085.a6; Chioni AM, 2009, INT J BIOCHEM CELL B, V41, P1216, DOI 10.1016/j.biocel.2008.11.001; Dawson NS, 2006, FASEB J, V20, P991, DOI 10.1096/fj.05-3923fje; Diss JKJ, 2001, PROSTATE, V48, P165, DOI 10.1002/pros.1095; Doanes AM, 1999, BIOCHEM BIOPH RES CO, V255, P545, DOI 10.1006/bbrc.1999.0227; Eccles SA, 2004, INT J DEV BIOL, V48, P583, DOI 10.1387/ijdb.041820se; Eccles Suzanne A., 2009, V467, P159, DOI 10.1007/978-1-59745-241-0_9; EPPS DE, 1994, CHEM PHYS LIPIDS, V69, P137, DOI 10.1016/0009-3084(94)90035-3; Fraser SP, 2003, J CELL PHYSIOL, V195, P479, DOI 10.1002/jcp.10312; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gillet L, 2009, J BIOL CHEM, V284, P8671, DOI 10.1074/jbc.M806891200; Gliki G, 2001, BIOCHEM J, V353, P503, DOI 10.1042/0264-6021:3530503; GORDIENKO DV, 1994, PFLUG ARCH EUR J PHY, V428, P91, DOI 10.1007/BF00374756; Gosling M, 1998, J BIOL CHEM, V273, P21084, DOI 10.1074/jbc.273.33.21084; HE P, 1994, J APPL PHYSIOL, V76, P2288, DOI 10.1152/jappl.1994.76.6.2288; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; House CD, 2010, CANCER RES, V70, P6957, DOI 10.1158/0008-5472.CAN-10-1169; Isner JM, 2002, NATURE, V415, P234, DOI 10.1038/415234a; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Larbig R, 2010, J PHYSIOL-LONDON, V588, P3266, DOI 10.1113/jphysiol.2010.187708; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Liang GH, 2008, PFLUG ARCH EUR J PHY, V457, P67, DOI 10.1007/s00424-008-0490-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier SKG, 2003, P NATL ACAD SCI USA, V100, P3507, DOI 10.1073/pnas.2627986100; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Meadows KN, 2001, J BIOL CHEM, V276, P49289, DOI 10.1074/jbc.M108069200; Ng SW, 2008, J BIOL CHEM, V283, P31348, DOI 10.1074/jbc.M804942200; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Palmer CP, 2008, EUR BIOPHYS J BIOPHY, V37, P359, DOI 10.1007/s00249-007-0219-2; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Platel JC, 2005, P NATL ACAD SCI USA, V102, P19174, DOI 10.1073/pnas.0504540102; Putney J W Jr, 2001, Mol Interv, V1, P84; Qu YS, 1996, J GEN PHYSIOL, V108, P375, DOI 10.1085/jgp.108.5.375; Sanderson S, 2006, MOL CANCER THER, V5, P522, DOI 10.1158/1535-7163.MCT-05-0439; Semenza GL, 2006, CIRC RES, V98, P1115, DOI 10.1161/01.RES.0000223485.43020.9e; Shigekawa M, 2001, CIRC RES, V88, P864, DOI 10.1161/hh0901.090298; Smitherman KA, 2001, J MEMBRANE BIOL, V181, P125, DOI 10.1007/s00232-001-0016-2; Stamboulian S, 2010, J NEUROSCI, V30, P1637, DOI 10.1523/JNEUROSCI.4872-09.2010; Szewczyk MM, 2007, J CELL MOL MED, V11, P129, DOI 10.1111/j.1582-4934.2007.00010.x; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Teubl M, 1999, J BIOL CHEM, V274, P29529, DOI 10.1074/jbc.274.41.29529; Traub O, 1999, J BIOL CHEM, V274, P20144, DOI 10.1074/jbc.274.29.20144; Walsh KB, 1998, AM J PHYSIOL-HEART C, V274, pH506, DOI 10.1152/ajpheart.1998.274.2.H506; Wang AH, 2002, CIRC RES, V90, P609, DOI 10.1161/01.RES.0000012503.30315.E8; Wilsher N, 2007, DRUG METAB DISPOS, V35, P1017, DOI 10.1124/dmd.106.014498; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006; Zeng HY, 2001, J BIOL CHEM, V276, P32714, DOI 10.1074/jbc.M103130200	60	73	79	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16846	16860		10.1074/jbc.M110.187559	http://dx.doi.org/10.1074/jbc.M110.187559			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21385874	Green Published, hybrid			2022-12-25	WOS:000290301900034
J	Masui, S; Vavassori, S; Fagioli, C; Sitia, R; Inaba, K				Masui, Shoji; Vavassori, Stefano; Fagioli, Claudio; Sitia, Roberto; Inaba, Kenji			Molecular Bases of Cyclic and Specific Disulfide Interchange between Human ERO1 alpha Protein and Protein-disulfide Isomerase (PDI)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; BOND FORMATION; GENERATING DISULFIDES; MISFOLDED PROTEINS; OXIDATIVE ACTIVITY; CRYSTAL-STRUCTURE; PEROXIREDOXIN-IV; HUMAN-CELLS; ERP44; FAMILY	In the endoplasmic reticulum (ER) of human cells, ERO1 alpha and protein-disulfide isomerase (PDI) constitute one of the major electron flow pathways that catalyze oxidative folding of secretory proteins. Specific and limited PDI oxidation by ERO1 alpha is essential to avoid ER hyperoxidation. To investigate how ERO1 alpha oxidizes PDI selectively among more than 20 ER-resident PDI family member proteins, we performed docking simulations and systematic biochemical analyses. Our findings reveal that a protruding beta-hairpin of ERO1 alpha specifically interacts with the hydrophobic pocket present in the redox-inactive PDI b'-domain through the stacks between their aromatic residues, leading to preferred oxidation of the C-terminal PDI a'-domain. ERO1 alpha associated preferentially with reduced PDI, explaining the stepwise disulfide shuttle mechanism, first from ERO1 alpha to PDI and then from oxidized PDI to an unfolded polypeptide bound to its hydrophobic pocket. The interaction of ERO1 alpha with ERp44, another PDI family member protein, was also analyzed. Notably, ERO1 alpha-dependent PDI oxidation was inhibited by a hyperactive ERp44 mutant that lacks the C-terminal tail concealing the substrate-binding hydrophobic regions. The potential ability of ERp44 to inhibit ERO1 alpha activity may suggest its physiological role in ER redox and protein homeostasis.	[Masui, Shoji; Inaba, Kenji] Kyushu Univ, Med Inst Bioregulat, Postgenome Sci Ctr, Div Prot Chem,Higashi Ku, Fukuoka 8128582, Japan; [Vavassori, Stefano; Fagioli, Claudio; Sitia, Roberto] Univ Vita Salute, San Raffaele Sci Inst, Div Genet & Cell Biol, I-20132 Milan, Italy	Kyushu University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Inaba, K (corresponding author), Kyushu Univ, Med Inst Bioregulat, Postgenome Sci Ctr, Div Prot Chem,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	inaba-k@bioreg.kyushu-u.ac.jp	Fagioli, Claudio/AAN-4147-2020; Sitia, Roberto/AAB-5005-2019	Fagioli, Claudio/0000-0001-9889-4695; Sitia, Roberto/0000-0001-7086-4152; Inaba, Kenji/0000-0001-8229-0467	MEXT; Yamada Science Foundation; Regione Lombardia (ASTIL); Associazione Italiana Ricerca Cancro (AIRC)	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Science Foundation; Regione Lombardia (ASTIL)(Regione Lombardia); Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by a Grant-in-aid for Young Scientists (A) from MEXT and the Yamada Science Foundation (to K. I.) and grants from Regione Lombardia (ASTIL) and Associazione Italiana Ricerca Cancro (AIRC) (to R. S.).	Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Bertoli G, 2004, J BIOL CHEM, V279, P30047, DOI 10.1074/jbc.M403192200; Byrne LJ, 2009, BIOCHEM J, V423, P209, DOI 10.1042/BJ20090565; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Chambers JE, 2010, J BIOL CHEM, V285, P29200, DOI 10.1074/jbc.M110.156596; Cortini M, 2010, TRAFFIC, V11, P651, DOI 10.1111/j.1600-0854.2010.01043.x; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; Depuydt M., 2011, ANTIOXID RE IN PRESS; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Fraldi A, 2008, HUM MOL GENET, V17, P2610, DOI 10.1093/hmg/ddn161; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Inaba K, 2010, GENES CELLS, V15, P935, DOI 10.1111/j.1365-2443.2010.01434.x; Kanamori E, 2007, PROTEINS, V69, P832, DOI 10.1002/prot.21737; Karala AR, 2009, ANTIOXID REDOX SIGN, V11, P963, DOI 10.1089/ARS.2008.2326; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kodali VK, 2010, ANTIOXID REDOX SIGN, V13, P1217, DOI 10.1089/ars.2010.3098; Li WK, 2010, NATURE, V463, P507, DOI 10.1038/nature08720; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mariappan M, 2008, J BIOL CHEM, V283, P6375, DOI 10.1074/jbc.M709171200; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Nakasako M, 2010, BIOCHEMISTRY-US, V49, P6953, DOI 10.1021/bi1006089; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Saaranen MJ, 2010, ANTIOXID REDOX SIGN, V12, P15, DOI 10.1089/ars.2009.2674; Serve O, 2010, J MOL BIOL, V396, P361, DOI 10.1016/j.jmb.2009.11.049; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Thorpe C, 2007, J BIOL CHEM, V282, P13929, DOI 10.1074/jbc.R600037200; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tsuchiya Y, 2006, PROTEIN ENG DES SEL, V19, P421, DOI 10.1093/protein/gzl026; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Vitu E, 2010, J BIOL CHEM, V285, P18155, DOI 10.1074/jbc.M109.064931; Wang C, 2010, J BIOL CHEM, V285, P26788, DOI 10.1074/jbc.M110.107839; Wang L, 2011, BIOCHEM J, V434, P113, DOI 10.1042/BJ20101357; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Wang LK, 2008, EMBO REP, V9, P642, DOI 10.1038/embor.2008.88; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	54	53	54	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.231357	http://dx.doi.org/10.1074/jbc.M111.231357			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21398518	Green Published, hybrid			2022-12-25	WOS:000290022800065
J	Munoz, E; Valero, RA; Quintana, A; Hoth, M; Nunez, L; Villalobos, C				Munoz, Eva; Valero, Ruth A.; Quintana, Ariel; Hoth, Markus; Nunez, Lucia; Villalobos, Carlos			Nonsteroidal Anti-inflammatory Drugs Inhibit Vascular Smooth Muscle Cell Proliferation by Enabling the Ca2+-dependent Inactivation of Calcium Release-activated Calcium/Orai Channels Normally Prevented by Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STROMAL INTERACTION MOLECULE-1; CAPACITATIVE CA2+ ENTRY; NEOINTIMA FORMATION; T-LYMPHOCYTES; TRPC CHANNELS; I-CRAC; INFLUX; STIM1; SALICYLATE; STIMULATION	Abnormal vascular smooth muscle cell (VSMC) proliferation contributes to occlusive and proliferative disorders of the vessel wall. Salicylate and other nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit VSMC proliferation by an unknown mechanism unrelated to anti-inflammatory activity. In search for this mechanism, we have studied the effects of salicylate and other NSAIDs on subcellular Ca2+ homeostasis and Ca2+-dependent cell proliferation in rat aortic A10 cells, a model of neointimal VSMCs. We found that A10 cells displayed both store-operated Ca2+ entry (SOCE) and voltage-operated Ca2+ entry (VOCE), the former being more important quantitatively than the latter. Inhibition of SOCE by specific Ca2+ released-activated Ca2+ (CRAC/Orai) channels antagonists prevented A10 cell proliferation. Salicylate and other NSAIDs, including ibuprofen, indomethacin, and sulindac, inhibited SOCE and thereby Ca2+-dependent, A10 cell proliferation. SOCE, but not VOCE, induced mitochondrial Ca2+ uptake in A10 cells, and mitochondrial depolarization prevented SOCE, thus suggesting that mitochondrial Ca2+ uptake controls SOCE (but not VOCE) in A10 cells. NSAIDs depolarized mitochondria and prevented mitochondrial Ca2+ uptake, suggesting that they favor the Ca2+-dependent inactivation of CRAC/Orai channels. NSAIDs also inhibited SOCE in rat basophilic leukemia cells where mitochondrial control of CRAC/Orai is well established. NSAIDs accelerate slow inactivation of CRAC currents in rat basophilic leukemia cells under weak Ca2+ buffering conditions but not in strong Ca2+ buffer, thus excluding that NSAIDs inhibit SOCE directly. Taken together, our results indicate that NSAIDs inhibit VSMC proliferation by facilitating the Ca2+-dependent inactivation of CRAC/Orai channels which normally is prevented by mitochondria clearing of entering Ca2+.	[Munoz, Eva; Valero, Ruth A.; Nunez, Lucia; Villalobos, Carlos] Univ Valladolid, Inst Mol Biol & Genet, Toyota 47003, Japan; [Munoz, Eva; Valero, Ruth A.; Nunez, Lucia; Villalobos, Carlos] Spanish Res Council, Toyota 47003, Japan; [Quintana, Ariel; Hoth, Markus] Univ Saarland, Dept Biophys, D-66421 Homburg, Germany	Saarland University	Villalobos, C (corresponding author), Univ Valladolid, Inst Mol Biol & Genet, Toyota 47003, Japan.	carlosv@ibgm.uva.es	nunez, lucia/AAG-8018-2019; Villalobos, Carlos/M-9839-2017	Villalobos, Carlos/0000-0002-0429-3846; Hoth, Markus/0000-0001-7080-4643; Nunez, Lucia/0000-0002-9638-5747	Junta de Castilla y Leon, Spain [SAN191/VA1806, CSI12A08]; Ministerio de Ciencia e Innovacion, Spain [BFU2009-0867]; Instituto de Salud Carlos III, Spain [PI07/0766]; Deutsche Forschungsgemeinschaft [A3, Sonderforschungsbereich 530]	Junta de Castilla y Leon, Spain(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grants SAN191/VA1806, CSI12A08 from Junta de Castilla y Leon, Spain, BFU2009-0867 from Ministerio de Ciencia e Innovacion, Spain, and PI07/0766 from Instituto de Salud Carlos III, Spain, and Deutsche Forschungsgemeinschaft Grant A3 in the Sonderforschungsbereich 530.	Anderson HV, 2001, CIRCULATION, V104, P2331, DOI 10.1161/hc4401.098434; Aubart FC, 2009, MOL THER, V17, P455, DOI 10.1038/mt.2008.291; Beech DJ, 2007, BIOCHEM SOC T, V35, P890, DOI 10.1042/BST0350890; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Brooks G, 2003, J PHARM PHARMACOL, V55, P519, DOI 10.1211/002235702775; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Dietrich A, 2007, PFLUG ARCH EUR J PHY, V455, P465, DOI 10.1007/s00424-007-0314-3; Fantozzi I, 2003, AM J PHYSIOL-LUNG C, V285, pL1233, DOI 10.1152/ajplung.00445.2002; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gilabert JA, 2000, EMBO J, V19, P6401, DOI 10.1093/emboj/19.23.6401; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; Gu Qing, 2005, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V27, P87; Guibert C, 2008, PROG BIOPHYS MOL BIO, V98, P10, DOI 10.1016/j.pbiomolbio.2008.05.001; Guo RW, 2009, CARDIOVASC RES, V81, P660, DOI 10.1093/cvr/cvn338; GUTKNECHT J, 1990, J MEMBRANE BIOL, V115, P253, DOI 10.1007/BF01868640; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Khan Q, 2005, J ATHEROSCLER THROMB, V12, P185, DOI 10.5551/jat.12.185; Li J, 2008, CIRC RES, V103, pE97, DOI 10.1161/CIRCRESAHA.108.182931; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Marra DE, 2000, CIRCULATION, V102, P2124, DOI 10.1161/01.CIR.102.17.2124; Marra DE, 2001, TRENDS CARDIOVAS MED, V11, P339, DOI 10.1016/S1050-1738(01)00133-5; Montalvo GB, 2006, J BIOL CHEM, V281, P35616, DOI 10.1074/jbc.M603518200; Ng LC, 2009, J PHYSIOL-LONDON, V587, P2429, DOI 10.1113/jphysiol.2009.172254; Nunez L, 2006, J PHYSIOL-LONDON, V571, P57, DOI 10.1113/jphysiol.2005.100586; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peel SE, 2008, AM J RESP CELL MOL, V38, P744, DOI 10.1165/rcmb.2007-0395OC; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Rao RS, 1997, CARDIOVASC RES, V36, P118, DOI 10.1016/S0008-6363(97)00156-9; Ren JL, 2010, J BIOL CHEM, V285, P31829, DOI 10.1074/jbc.M109.097576; Schwarz EC, 2007, EUR J IMMUNOL, V37, P2723, DOI 10.1002/eji.200737039; Sonkusare S, 2006, VASC PHARMACOL, V44, P131, DOI 10.1016/j.vph.2005.10.005; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V361, P934, DOI 10.1016/j.bbrc.2007.07.096; Valero RA, 2008, CELL CALCIUM, V44, P259, DOI 10.1016/j.ceca.2007.12.002; Villalobos C, 2002, FASEB J, V16, DOI 10.1096/fj.01-0630com; Villalobos C, 2009, METHODS MOL BIOL, V574, P203, DOI 10.1007/978-1-60327-321-3_17; Wang YJ, 2008, CLIN EXP PHARMACOL P, V35, P1127, DOI 10.1111/j.1440-1681.2008.05018.x; Weber AA, 2000, EUR J PHARMACOL, V389, P67, DOI 10.1016/S0014-2999(99)00868-7; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	43	37	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.198952	http://dx.doi.org/10.1074/jbc.M110.198952			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21402693	Green Published, hybrid			2022-12-25	WOS:000290022800058
J	Yu, Y; Richardson, DR				Yu, Yu; Richardson, Des R.			Cellular Iron Depletion Stimulates the JNK and p38 MAPK Signaling Transduction Pathways, Dissociation of ASK1-Thioredoxin, and Activation of ASK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EFFECTIVE ANTIPROLIFERATIVE AGENTS; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; STRESS-INDUCED PHOSPHORYLATION; ISONICOTINOYL HYDRAZONE CLASS; SELECTIVE ANTITUMOR-ACTIVITY; PROTEIN-KINASE; MOLECULAR-MECHANISMS; CYCLE PROGRESSION; GENE-EXPRESSION; UP-REGULATION	The role of signaling pathways in the regulation of cellular iron metabolism is becoming increasingly recognized. Iron chelation is used for the treatment of iron overload but also as a potential strategy for cancer therapy, because iron depletion results in cell cycle arrest and apoptosis. This study examined potential signaling pathways affected by iron depletion induced by desferrioxamine (DFO) or di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT). Both chelators affected multiple molecules in the mitogen-activated protein kinase (MAPK) pathway, including a number of dual specificity phosphatases that directly de-phosphorylate MAPKs. Examination of the phosphorylation of major MAPKs revealed that DFO and Dp44mT markedly increased phosphorylation of stress-activated protein kinases, JNK and p38, without significantly affecting the extracellular signal-regulated kinase (ERK). Redox-inactive DFO-iron complexes did not affect phosphorylation of JNK or p38, whereas the redox-active Dp44mT-iron complex significantly increased the phosphorylation of these kinases similarly to Dp44mT alone. Iron or N-acetylcysteine supplementation reversed Dp44mT-induced up-regulation of phospho-JNK, but only iron was able to reverse the effect of DFO on JNK. Both iron chelators significantly reduced ASK1-thioredoxin complex formation, resulting in the increased phosphorylation of ASK1, which activates the JNK and p38 pathways. Thus, dissociation of ASK1 could serve as an important signal for the phosphorylation of JNK and p38 activation observed after iron chelation. Phosphorylation of JNK and p38 likely play an important role in mediating the cell cycle arrest and apoptosis induced by iron depletion.	[Richardson, Des R.] Univ Sydney, Dept Pathol, Iron Metab & Chelat Program, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Iron Metab & Chelat Program, Blackburn Bldg,D06, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au	Yu, Yu/AAD-7947-2019	Yu, Yu/0000-0002-0209-0586; Richardson, Des/0000-0003-0960-6415; Richardson, Des/0000-0002-5506-3274	National Health and Medical Research Council of Australia; Australian Research Council; University of Sydney; Cancer Institute New South Wales	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); University of Sydney(University of Sydney); Cancer Institute New South Wales	This work was supported in part by a Senior Principal Research Fellowship, Project Grants from the National Health and Medical Research Council of Australia, and a Discovery Grant from the Australian Research Council (to D. R. R.).; Supported by Ph.D. scholarships from the University of Sydney (University Postgraduate Award) and Cancer Institute New South Wales.	Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Antosiewicz J, 2007, FREE RADICAL BIO MED, V43, P265, DOI 10.1016/j.freeradbiomed.2007.04.023; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bardwell L, 2006, METHODS, V40, P213, DOI 10.1016/j.ymeth.2006.06.008; Beerepoot LV, 1996, CANCER RES, V56, P3747; BLATT J, 1987, CANCER RES, V47, P1749; BRODIE C, 1993, CANCER RES, V53, P3968; Buss JL, 2003, CURR MED CHEM, V10, P1021, DOI 10.2174/0929867033457638; CANO E, 1994, MOL CELL BIOL, V14, P7352, DOI 10.1128/MCB.14.11.7352; Choi SC, 2003, FREE RADICAL BIO MED, V35, P1171, DOI 10.1016/S0891-5849(03)00503-3; Clerk A, 1997, BIOCHEM J, V325, P801, DOI 10.1042/bj3250801; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; Darnell G, 1999, BLOOD, V94, P781, DOI 10.1182/blood.V94.2.781.414k32_781_792; Deb S, 2009, BIOMETALS, V22, P855, DOI 10.1007/s10534-009-9214-7; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; DONFRANCESCO A, 1990, CANCER RES, V50, P4929; ESTROV Z, 1987, BLOOD, V69, P757; Fu D, 2007, BLOOD, V110, P752, DOI 10.1182/blood-2007-03-076737; FUKUCHI K, 1994, FEBS LETT, V350, P139, DOI 10.1016/0014-5793(94)00755-1; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Gomez MA, 2010, J BIOL CHEM, V285, P24620, DOI 10.1074/jbc.M110.107037; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HILETI D, 1995, BRIT J HAEMATOL, V89, P181, DOI 10.1111/j.1365-2141.1995.tb08927.x; Jansson PJ, 2010, J INORG BIOCHEM, V104, P1224, DOI 10.1016/j.jinorgbio.2010.07.012; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kalinowski DS, 2007, J MED CHEM, V50, P3716, DOI 10.1021/jm070445z; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kim BS, 2002, CELL IMMUNOL, V220, P96, DOI 10.1016/S0008-8749(03)00031-5; Kim BM, 2008, TOXICOL APPL PHARM, V228, P24, DOI 10.1016/j.taap.2007.11.022; Kulp KS, 1996, EXP CELL RES, V229, P60, DOI 10.1006/excr.1996.0343; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; LUCAS JJ, 1995, BLOOD, V86, P2268, DOI 10.1182/blood.V86.6.2268.bloodjournal8662268; Mardini L, 2010, BIOCHEM J, V432, P145, DOI 10.1042/BJ20100541; Matsuzawa A, 2001, J BIOCHEM-TOKYO, V130, P1; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Noulsri E, 2009, AM J HEMATOL, V84, P170, DOI 10.1002/ajh.21350; Nurtjahja-Tjendraputra E, 2007, BLOOD, V109, P4045, DOI 10.1182/blood-2006-10-047753; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; Rahmanto YS, 2007, CARCINOGENESIS, V28, P2172, DOI 10.1093/carcin/bgm096; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rao VA, 2009, CANCER RES, V69, P948, DOI 10.1158/0008-5472.CAN-08-1437; RICHARDSON D, 1994, CANCER RES, V54, P685; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; RICHARDSON DR, 1990, BIOCHIM BIOPHYS ACTA, V1053, P1, DOI 10.1016/0167-4889(90)90018-9; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Saletta F, 2010, MOL PHARMACOL, V77, P443, DOI 10.1124/mol.109.061028; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SELIG RA, 1993, ANTICANCER RES, V13, P721; Seo GS, 2006, FREE RADICAL BIO MED, V40, P1502, DOI 10.1016/j.freeradbiomed.2005.12.020; Simonart T, 2000, J INVEST DERMATOL, V115, P893, DOI 10.1046/j.1523-1747.2000.00119.x; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wenger RH, 1998, CANCER RES, V58, P5678; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; YU Y, 2011, MOL PHARM IN PRESS; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zhong DS, 2008, CANCER RES, V68, P7270, DOI 10.1158/0008-5472.CAN-08-1484; Zhu T, 2000, J BIOL CHEM, V275, P2103, DOI 10.1074/jbc.275.3.2103	64	78	78	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15413	15427		10.1074/jbc.M111.225946	http://dx.doi.org/10.1074/jbc.M111.225946			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21378396	Green Published, hybrid			2022-12-25	WOS:000289788300071
J	Barney, JN; DiTomaso, JM				Barney, Jacob N.; DiTomaso, Joseph M.			Global Climate Niche Estimates for Bioenergy Crops and Invasive Species of Agronomic Origin: Potential Problems and Opportunities	PLOS ONE			English	Article							BIOFUELS; PREDICTIONS; FEEDSTOCK; US	The global push towards a more biomass-based energy sector is ramping up efforts to adopt regionally appropriate high-yielding crops. As potential bioenergy crops are being moved around the world an assessment of the climatic suitability would be a prudent first step in identifying suitable areas of productivity and risk. Additionally, this assessment also provides a necessary step in evaluating the invasive potential of bioenergy crops, which present a possible negative externality to the bioeconomy. Therefore, we provide the first global climate niche assessment for the major graminaceous (9), herbaceous (3), and woody (4) bioenergy crops. Additionally, we contrast these with climate niche assessments for North American invasive species that were originally introduced for agronomic purposes as examples of well-intentioned introductions gone awry. With few exceptions (e. g., Saccharum officinarum, Pennisetum purpureum), the bioenergy crops exhibit broad climatic tolerance, which allows tremendous flexibility in choosing crops, especially in areas with high summer rainfall and long growing seasons (e. g., southeastern US, Amazon Basin, eastern Australia). Unsurprisingly, the invasive species of agronomic origin have very similar global climate niche profiles as the proposed bioenergy crops, also demonstrating broad climatic tolerance. The ecoregional evaluation of bioenergy crops and known invasive species demonstrates tremendous overlap at both high (EI >= 30) and moderate (EI >= 20) climate suitability. The southern and western US ecoregions support the greatest number of invasive species of agronomic origin, especially the Southeastern USA Plains, Mixed Woods Plains, and Mediterranean California. Many regions of the world have a suitable climate for several bioenergy crops allowing selection of agro-ecoregionally appropriate crops. This model knowingly ignores the complex biotic interactions and edaphic conditions, but provides a robust assessment of the climate niche, which is valuable for agronomists, crop developers, and regulators seeking to choose agro-ecoregionally appropriate crops while minimizing the risk of invasive species.	[Barney, Jacob N.] Virginia Polytech Inst & State Univ, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [DiTomaso, Joseph M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Virginia Polytechnic Institute & State University; University of California System; University of California Davis	Barney, JN (corresponding author), Virginia Polytech Inst & State Univ, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA.	jnbarney@vt.edu	Barney, Jacob/C-2412-2008	Barney, Jacob/0000-0003-2949-5003				Angelini LG, 2009, BIOMASS BIOENERG, V33, P635, DOI 10.1016/j.biombioe.2008.10.005; Barney JN, 2008, BIOL INVASIONS, V10, P259, DOI 10.1007/s10530-007-9127-8; Barney JN, 2008, BIOSCIENCE, V58, P64, DOI 10.1641/B580111; Barney JN, 2010, BIOMASS BIOENERG, V34, P124, DOI 10.1016/j.biombioe.2009.10.009; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Buddenhagen CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005261; Crosti R, 2010, BIOL INVASIONS, V12, P1607, DOI 10.1007/s10530-009-9573-6; DiTomaso J.M., 2007, WEEDS CALIFORNIA OTH, V3488; Evans JM, 2010, GCB BIOENERGY, V2, P63, DOI 10.1111/j.1757-1707.2010.01040.x; Forseth IN, 2004, CRIT REV PLANT SCI, V23, P401, DOI 10.1080/07352680490505150; Gordon DR, 2011, BIOMASS BIOENERG, V35, P74, DOI 10.1016/j.biombioe.2010.08.029; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Karp A, 2008, NEW PHYTOL, V179, P15, DOI 10.1111/j.1469-8137.2008.02432.x; Lemus R, 2005, CRIT REV PLANT SCI, V24, P1, DOI 10.1080/07352680590910393; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; Low T., 2007, WEEDY TRUTH BIOFUELS; Mack R.N., 2000, BIOL INVASIONS, V2, P111, DOI DOI 10.1023/A:1010088422771; Mika AM, 2008, GLOBAL CHANGE BIOL, V14, P1721, DOI 10.1111/j.1365-2486.2008.01620.x; Olfert O, 2004, CAN ENTOMOL, V136, P277; Omernik JM, 2004, ENVIRON MANAGE, V34, pS27, DOI 10.1007/s00267-003-5197-2; Pattison RR, 2008, GLOBAL CHANGE BIOL, V14, P813, DOI 10.1111/j.1365-2486.2007.01528.x; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Quinn LD, 2010, GCB BIOENERGY, V2, P310, DOI 10.1111/j.1757-1707.2010.01062.x; Raghu S, 2006, SCIENCE, V313, P1742, DOI 10.1126/science.1129313; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Sanderson MA, 2006, CAN J PLANT SCI, V86, P1315, DOI 10.4141/P06-136; Schnoor J, 2008, WATER IMPLICATIONS B; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Sutherst RW, 2003, J BIOGEOGR, V30, P805, DOI 10.1046/j.1365-2699.2003.00861.x; SUTHERST RW, 2007, CLIMEX VERSION 3 0; U.S. Department of Agriculture, 2010, USDA REG ROADM M BIO	32	56	57	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17222	10.1371/journal.pone.0017222	http://dx.doi.org/10.1371/journal.pone.0017222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408056	gold, Green Published, Green Submitted			2022-12-25	WOS:000288170900008
J	Diaz-Albiter, H; Mitford, R; Genta, FA; Sant'Anna, MRV; Dillon, RJ				Diaz-Albiter, Hector; Mitford, Roanna; Genta, Fernando A.; Sant'Anna, Mauricio R. V.; Dillon, Rod J.			Reactive Oxygen Species Scavenging by Catalase Is Important for Female Lutzomyia longipalpis Fecundity and Mortality	PLOS ONE			English	Article							PROTEIN OXIDATIVE DAMAGE; LIFE-SPAN; VISCERAL LEISHMANIASIS; SUPEROXIDE-DISMUTASE; INORGANIC PEROXIDES; PEROXIREDOXIN GENE; ASCORBIC-ACID; CATTLE TICK; SAND FLIES; STRESS	The phlebotomine sand fly Lutzomyia longipalpis is the most important vector of American visceral leishmaniasis (AVL), the disseminated and most serious form of the disease in Central and South America. In the natural environment, most female L. longipalpis are thought to survive for less than 10 days and will feed on blood only once or twice during their lifetime. Successful transmission of parasites occurs when a Leishmania-infected female sand fly feeds on a new host. Knowledge of factors affecting sand fly longevity that lead to a reduction in lifespan could result in a decrease in parasite transmission. Catalase has been found to play a major role in survival and fecundity in many insect species. It is a strong antioxidant enzyme that breaks down toxic reactive oxygen species (ROS). Ovarian catalase was found to accumulate in the developing sand fly oocyte from 12 to 48 hours after blood feeding. Catalase expression in ovaries as well as oocyte numbers was found to decrease with age. This reduction was not found in flies when fed on the antioxidant ascorbic acid in the sugar meal, a condition that increased mortality and activation of the prophenoloxidase cascade. RNA interference was used to silence catalase gene expression in female Lu. longipalpis. Depletion of catalase led to a significant increase of mortality and a reduction in the number of developing oocytes produced after blood feeding. These results demonstrate the central role that catalase and ROS play in the longevity and fecundity of phlebotomine sand flies.	[Diaz-Albiter, Hector; Mitford, Roanna; Sant'Anna, Mauricio R. V.; Dillon, Rod J.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Genta, Fernando A.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Genta, Fernando A.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil	Liverpool School of Tropical Medicine; University of Liverpool; Fundacao Oswaldo Cruz	Diaz-Albiter, H (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England.	r.j.dillon@liv.ac.uk	Genta, Fernando/F-1791-2011; Sant'Anna, Mauricio Roberto Via/AAQ-6084-2021; DIAZ-ALBITER, HECTOR/G-4327-2012; Sant'Anna, Mauricio Roberto Viana/AAQ-4093-2021	Genta, Fernando/0000-0001-9558-1116; Sant'Anna, Mauricio Roberto Viana/0000-0002-2504-0979; Dillon, Rod/0000-0002-3551-0030; Diaz-Albiter, Hector/0000-0003-2937-0569	Consejo Nacional de Ciencia y Tecnologia [207646]; Leverhulme Trust [F/00 808/C]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Leverhulme Trust(Leverhulme Trust)	This work was funded by Consejo Nacional de Ciencia y Tecnologia (www.conacyt.mx) Fellow ref 207646; The Leverhulme Trust (www.leverhulme.co.uk) ref F/00 808/C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2002, OIKOS, V97, P371, DOI 10.1034/j.1600-0706.2002.970307.x; ALLEN RG, 1983, BIOCHEM J, V216, P503, DOI 10.1042/bj2160503; Bayne ACV, 2005, BIOCHEM J, V391, P277, DOI 10.1042/BJ20041872; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Citelli M, 2007, MOL BIOCHEM PARASIT, V151, P81, DOI 10.1016/j.molbiopara.2006.10.008; CORBYHARRIS V, PLOS PATHOGENS, V6; Coutinho-Abreu IV, 2010, MEM I OSWALDO CRUZ, V105, P1, DOI 10.1590/S0074-02762010000100001; Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209; DeJong RJ, 2007, P NATL ACAD SCI USA, V104, P2121, DOI 10.1073/pnas.0608407104; Dillon RJ, 2006, GENOMICS, V88, P831, DOI 10.1016/j.ygeno.2006.06.011; Emanuelsson O, 2003, J MOL BIOL, V330, P443, DOI 10.1016/S0022-2836(03)00553-9; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; FREEMAN BA, 1982, LAB INVEST, V47, P412; Freitas DRJ, 2007, COMP BIOCHEM PHYS A, V146, P688, DOI 10.1016/j.cbpa.2006.04.032; GENTA F, 2010, J INSECT PHYSL; GILLESPIE S, 2004, MICROBEVECTOR INTERA; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; GRIMALDI G, 1993, CLIN MICROBIOL REV, V6, P230, DOI 10.1128/CMR.6.3.230-250.1993; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; HU Z, 2009, COMP BIOCH PHYSL B; JARAMILLOGUTIER.G, ANOPHELES GAMBIAE OX; Jochim RC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-15; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kang MA, 2008, J EXP BIOL, V211, P741, DOI 10.1242/jeb.012955; Kim I, 2005, COMP BIOCHEM PHYS B, V140, P579, DOI 10.1016/j.cbpc.2004.12.005; KOUA D, 2008, NUCL ACIDS RES; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Levick MP, 1998, MOL BIOCHEM PARASIT, V96, P125, DOI 10.1016/S0166-6851(98)00122-4; LOFT S, 1992, CARCINOGENESIS, V13, P2241, DOI 10.1093/carcin/13.12.2241; Logullo C, 2002, INSECT BIOCHEM MOLEC, V32, P1805, DOI 10.1016/S0965-1748(02)00162-5; MACKAY WJ, 1989, GENETICS, V122, P643; MAGALHAES DEBT, 2008, PHYSIOLOGY, V68, P134; Magwere T, 2006, MECH AGEING DEV, V127, P356, DOI 10.1016/j.mad.2005.12.009; Mandal G, 2007, PARASITOLOGY, V134, P1679, DOI 10.1017/S0031182007003150; Mehta A, 2006, FREE RADICAL BIO MED, V40, P1857, DOI 10.1016/j.freeradbiomed.2006.01.024; Miller MA, 2000, J BIOL CHEM, V275, P33883, DOI 10.1074/jbc.M003671200; MODI G, CARE MAINTENANCE PHL; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Morey M, 2003, J CELL SCI, V116, P4597, DOI 10.1242/jcs.00783; Myskova J, 2007, MICROBES INFECT, V9, P317, DOI 10.1016/j.micinf.2006.12.010; Costa CHN, 2008, CAD SAUDE PUBLICA, V24, P2959, DOI 10.1590/S0102-311X2008001200027; Neuberger G, 2003, J MOL BIOL, V328, P567, DOI 10.1016/S0022-2836(03)00318-8; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; ORR CWM, 1967, BIOCHEMISTRY-US, V6, P2995, DOI 10.1021/bi00862a004; ORR CWM, 1967, BIOCHEMISTRY-US, V6, P3000, DOI 10.1021/bi00862a005; Paes MC, 2001, ARCH INSECT BIOCHEM, V48, P63, DOI 10.1002/arch.1058; POMERANTZ SH, 1963, J BIOL CHEM, V238, P2351; Radyuk SN, 2001, FREE RADICAL BIO MED, V31, P1090, DOI 10.1016/S0891-5849(01)00692-X; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Sant'Anna MRV, 2008, INSECT BIOCHEM MOLEC, V38, P652, DOI 10.1016/j.ibmb.2008.03.012; Soares RPP, 2003, AN ACAD BRAS CIENC, V75, P301, DOI 10.1590/S0001-37652003000300005; SOHAL RS, 1990, MECH AGEING DEV, V56, P223, DOI 10.1016/0047-6374(90)90084-S; SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Walker J. M, 2005, PROTEOMICS PROTOCOLS; WALSHE DP, 2009, ENEMY WITHIN INTERAC, P119; Wang Q, 2008, COMP BIOCHEM PHYS B, V149, P176, DOI 10.1016/j.cbpb.2007.09.005; Wheeler D, 1996, ANNU REV ENTOMOL, V41, P407, DOI 10.1146/annurev.en.41.010196.002203; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yan LJ, 2000, FREE RADICAL BIO MED, V29, P1143, DOI 10.1016/S0891-5849(00)00423-8; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046	64	57	63	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17486	10.1371/journal.pone.0017486	http://dx.doi.org/10.1371/journal.pone.0017486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408075	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000288170900021
J	Tjalsma, H; Laarakkers, CMM; van Swelm, RPL; Theurl, M; Theurl, I; Kemna, EH; van der Burgt, YEM; Venselaar, H; Dutilh, BE; Russel, FGM; Weiss, G; Masereeuw, R; Fleming, RE; Swinkels, DW				Tjalsma, Harold; Laarakkers, Coby M. M.; van Swelm, Rachel P. L.; Theurl, Milan; Theurl, Igor; Kemna, Erwin H.; van der Burgt, Yuri E. M.; Venselaar, Hanka; Dutilh, Bas E.; Russel, Frans G. M.; Weiss, Guenter; Masereeuw, Rosalinde; Fleming, Robert E.; Swinkels, Dorine W.			Mass Spectrometry Analysis of Hepcidin Peptides in Experimental Mouse Models	PLOS ONE			English	Article							HEREDITARY HEMOCHROMATOSIS; GENE-EXPRESSION; IRON; LIVER; SERUM; HFE; URINE; BMP6; FERROPORTIN; REGULATOR	The mouse is a valuable model for unravelling the role of hepcidin in iron homeostasis, however, such studies still report hepcidin mRNA levels as a surrogate marker for bioactive hepcidin in its pivotal function to block ferroportin-mediated iron transport. Here, we aimed to assess bioactive mouse Hepcidin-1 (Hep-1) and its paralogue Hepcidin-2 (Hep-2) at the peptide level. To this purpose, fourier transform ion cyclotron resonance (FTICR) and tandem-MS was used for hepcidin identification, after which a time-of-flight (TOF) MS-based methodology was exploited to routinely determine Hep-1 and -2 levels in mouse serum and urine. This method was biologically validated by hepcidin assessment in: i) 3 mouse strains (C57Bl/6; DBA/2 and BABL/c) upon stimulation with intravenous iron and LPS, ii) homozygous Hfe knock out, homozygous transferrin receptor 2 (Y245X) mutated mice and double affected mice, and iii) mice treated with a sublethal hepatotoxic dose of paracetamol. The results showed that detection of Hep-1 was restricted to serum, whereas Hep-2 and its presumed isoforms were predominantly present in urine. Elevations in serum Hep-1 and urine Hep-2 upon intravenous iron or LPS were only moderate and varied considerably between mouse strains. Serum Hep-1 was decreased in all three hemochromatosis models, being lowest in the double affected mice. Serum Hep-1 levels correlated with liver hepcidin-1 gene expression, while acute liver damage by paracetamol depleted Hep-1 from serum. Furthermore, serum Hep-1 appeared to be an excellent indicator of splenic iron accumulation. In conclusion, Hep-1 and Hep-2 peptide responses in experimental mouse agree with the known biology of hepcidin mRNA regulators, and their measurement can now be implemented in experimental mouse models to provide novel insights in post-transcriptional regulation, hepcidin function, and kinetics.	[Tjalsma, Harold; Laarakkers, Coby M. M.; Kemna, Erwin H.; Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Genet Endocrine & Metab Dis, NL-6525 ED Nijmegen, Netherlands; [van Swelm, Rachel P. L.; Russel, Frans G. M.; Masereeuw, Rosalinde] Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol & Toxicol, NL-6525 ED Nijmegen, Netherlands; [Theurl, Milan; Theurl, Igor; Weiss, Guenter] Med Univ Innsbruck, Dept Internal Med Clin Immunol & Infect Dis, Innsbruck, Austria; [Theurl, Milan] Innsbruck Med Univ, Dept Ophthalmol & Optometry, Innsbruck, Austria; [van der Burgt, Yuri E. M.] Leiden Univ, Med Ctr, Dept Parasitol, Biomol Mass Spectrometry Unit, Leiden, Netherlands; [Venselaar, Hanka; Dutilh, Bas E.] Ctr Mol & Biomol Informat NCMLS, Nijmegen, Netherlands; [Fleming, Robert E.] St Louis Univ, Sch Med, Dept Pediat, Ctr Liver, St Louis, MO 63104 USA	Radboud University Nijmegen; Radboud University Nijmegen; Medical University of Innsbruck; Medical University of Innsbruck; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Saint Louis University	Tjalsma, H (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Genet Endocrine & Metab Dis, NL-6525 ED Nijmegen, Netherlands.	d.swinkels@labgk.umcn.nl	Swinkels, Dorine W./H-8098-2014; Masereeuw, Roos/I-5276-2016; van der Burgt, Yuri/I-1149-2016; van Swelm, Rachel PL/P-6063-2015; Venselaar, Hanka/D-2009-2016; Dutilh, Bas E./B-9719-2011; Tjalsma, Harold/I-7146-2012; Russel, Frans G.M./B-3184-2014; Masereeuw, Roos/N-3582-2014	Swinkels, Dorine W./0000-0002-1040-9446; Masereeuw, Roos/0000-0002-1560-1074; van der Burgt, Yuri/0000-0003-0556-5564; Venselaar, Hanka/0000-0001-9824-6559; Dutilh, Bas E./0000-0003-2329-7890; Russel, Frans G.M./0000-0002-7959-2314; Weiss, Guenter/0000-0003-0709-2158; Theurl, Igor/0000-0003-3180-4784				Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Courselaud B, 2004, BLOOD CELL MOL DIS, V32, P283, DOI 10.1016/j.bcmd.2003.11.003; De Domenico I, 2008, CELL METAB, V8, P146, DOI 10.1016/j.cmet.2008.07.002; Fleming RE, 2002, P NATL ACAD SCI USA, V99, P10653, DOI 10.1073/pnas.162360699; Ilyin G, 2003, FEBS LETT, V542, P22, DOI 10.1016/S0014-5793(03)00329-6; Jordan JB, 2009, J BIOL CHEM, V284, P24155, DOI 10.1074/jbc.M109.017764; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; Kemna EHJM, 2007, HAEMATOLOGICA, V93, P90, DOI 10.3324/haematol.11705; Kemna EHJM, 2007, CLIN CHEM, V53, P620, DOI 10.1373/clinchem.2006.079186; Koening CL, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-33; Krijt J, 2004, J HEPATOL, V40, P891, DOI 10.1016/j.jhep.2004.02.029; Kulaksiz H, 2005, J ENDOCRINOL, V184, P361, DOI 10.1677/joe.1.05729; LEBOEUF RC, 1995, J LAB CLIN MED, V126, P128; Lesbordes-Brion JC, 2006, BLOOD, V108, P1402, DOI 10.1182/blood-2006-02-003376; Lou DQ, 2004, BLOOD, V103, P2816, DOI 10.1182/blood-2003-07-2524; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Pietrangelo A, 2005, GASTROENTEROLOGY, V128, P470, DOI 10.1053/j.gastro.2004.11.057; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Roy CN, 2007, BLOOD, V109, P4038, DOI 10.1182/blood-2006-10-051755; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Swinkels DW, 2006, CLIN CHEM, V52, P950, DOI 10.1373/clinchem.2006.068684; Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019; van Dijk BAC, 2008, BRIT J HAEMATOL, V142, P979, DOI 10.1111/j.1365-2141.2008.07273.x; Wallace DF, 2009, HEPATOLOGY, V50, P1992, DOI 10.1002/hep.23198; Wenderfer SE, 2009, AM J NEPHROL, V30, P450, DOI 10.1159/000242430; Zasloff M, 2006, NAT MED, V12, P606, DOI 10.1038/nm0606-607; Zhang XL, 2008, KIDNEY INT, V74, P799, DOI 10.1038/ki.2008.316	36	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e16762	10.1371/journal.pone.0016762	http://dx.doi.org/10.1371/journal.pone.0016762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408141	Green Submitted, Green Published, gold			2022-12-25	WOS:000288170000008
J	Stamatakos, GS; Georgiadi, EC; Graf, N; Kolokotroni, EA; Dionysiou, DD				Stamatakos, Georgios S.; Georgiadi, Eleni C.; Graf, Norbert; Kolokotroni, Eleni A.; Dionysiou, Dimitra D.			Exploiting Clinical Trial Data Drastically Narrows the Window of Possible Solutions to the Problem of Clinical Adaptation of a Multiscale Cancer Model	PLOS ONE			English	Article							IN-SILICO ONCOLOGY; WILMS-TUMOR; SIMULATION-MODEL; LYMPHOBLASTIC-LEUKEMIA; MATHEMATICAL-MODEL; SOLID TUMOR; GROWTH-RATE; CHEMOTHERAPY; RADIOTHERAPY; THERAPY	The development of computational models for simulating tumor growth and response to treatment has gained significant momentum during the last few decades. At the dawn of the era of personalized medicine, providing insight into complex mechanisms involved in cancer and contributing to patient-specific therapy optimization constitute particularly inspiring pursuits. The in silico oncology community is facing the great challenge of effectively translating simulation models into clinical practice, which presupposes a thorough sensitivity analysis, adaptation and validation process based on real clinical data. In this paper, the behavior of a clinically-oriented, multiscale model of solid tumor response to chemotherapy is investigated, using the paradigm of nephroblastoma response to preoperative chemotherapy in the context of the SIOP/GPOH clinical trial. A sorting of the model's parameters according to the magnitude of their effect on the output has unveiled the relative importance of the corresponding biological mechanisms; major impact on the result of therapy is credited to the oxygenation and nutrient availability status of the tumor and the balance between the symmetric and asymmetric modes of stem cell division. The effect of a number of parameter combinations on the extent of chemotherapy-induced tumor shrinkage and on the tumor's growth rate are discussed. A real clinical case of nephroblastoma has served as a proof of principle study case, demonstrating the basics of an ongoing clinical adaptation and validation process. By using clinical data in conjunction with plausible values of model parameters, an excellent fit of the model to the available medical data of the selected nephroblastoma case has been achieved, in terms of both volume reduction and histological constitution of the tumor. In this context, the exploitation of multiscale clinical data drastically narrows the window of possible solutions to the clinical adaptation problem.	[Stamatakos, Georgios S.; Georgiadi, Eleni C.; Kolokotroni, Eleni A.; Dionysiou, Dimitra D.] Natl Tech Univ Athens, Silico Oncol Grp, Inst Commun & Comp Syst, Sch Elect & Comp Engn, Athens, Greece; [Graf, Norbert] Univ Saarland, Klin Pad Onkol & Hamatol, Homburg, Germany	National Technical University of Athens; Saarland University	Stamatakos, GS (corresponding author), Natl Tech Univ Athens, Silico Oncol Grp, Inst Commun & Comp Syst, Sch Elect & Comp Engn, Athens, Greece.	gestam@central.ntua.gr	Graf, Norbert/H-1328-2011	Graf, Norbert/0000-0002-2248-323X	European Commission [FP6-2005-IST-026996, FP7-ICT-2007-2-223979]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported in part by the European Commission under the projects "ACGT: Advancing Clinicogenomic Trials on Cancer" (FP6-2005-IST-026996, http://eu-acgt.org/) and "ContraCancrum: Clinically OrientedTranslationalCancerMultilevel Modeling" (FP7-ICT-2007-2-223979, http://contracancrum.eu/?q = node/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Beck W, 2000, CANC MED; Berrebi D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002216; Carre A, 2005, AM J MED GENET A, V139A, P165, DOI 10.1002/ajmg.a.31004; Castorina P, 2009, CANCER RES, V69, P8507, DOI 10.1158/0008-5472.CAN-09-0653; Craft AW, 1999, LANCET, V354, P1127, DOI 10.1016/S0140-6736(05)76925-7; DAHL WN, 1976, CANCER RES, V36, P3101; Deisboeck TS, 2009, NAT CLIN PRACT ONCOL, V6, P34, DOI 10.1038/ncponc1237; DEWEY WC, 1995, INT J RADIAT ONCOL, V33, P781, DOI 10.1016/0360-3016(95)00214-8; Dionysiou D D, 2008, Open Biomed Eng J, V2, P43, DOI 10.2174/1874120700802010043; Dionysiou DD, 2004, J THEOR BIOL, V230, P1, DOI 10.1016/j.jtbi.2004.03.024; Dionysiou DD, 2006, CANCER INFORM, V2, P113; DUECHTING W, 1992, Strahlentherapie und Onkologie, V168, P354; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Frieboes HB, 2006, CANCER RES, V66, P1597, DOI 10.1158/0008-5472.CAN-05-3166; GEORGIADI EC, 2008, P 8 IEEE INT C BIO B; Graf N, 2000, UROL CLIN N AM, V27, P443, DOI 10.1016/S0094-0143(05)70092-6; Graf N, 2009, KLIN PADIATR, V221, P141, DOI 10.1055/s-0029-1216368; Groninger E, 2002, PEDIATR RES, V52, P113, DOI 10.1203/00006450-200207000-00021; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Kaste SC, 2008, PEDIATR RADIOL, V38, P2, DOI 10.1007/s00247-007-0687-7; Kobayashi H, 1998, BIOCHEM PHARMACOL, V55, P1229, DOI 10.1016/S0006-2952(97)00615-1; LUNZER A, 2010, P 4 INT ADV IN PRESS; MARIAS K, 2009, IFMBE P, V25, P2124; Marias K, 2007, LECT NOTES COMPUT SC, V4561, P703; Maseide K, 2000, RADIOTHER ONCOL, V54, P171, DOI 10.1016/S0167-8140(99)00154-1; PINKERTON CR, 1988, CANCER CHEMOTH PHARM, V22, P271, DOI 10.1007/BF00273423; Powathil G, 2007, PHYS MED BIOL, V52, P3291, DOI 10.1088/0031-9155/52/11/023; REVAZOVA E S, 1981, Byulleten' Eksperimental'noi Biologii i Meditsiny, V92, P335; Ribba B, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-7; Rockne Russell, 2008, P207, DOI 10.1007/978-0-8176-4713-1_8; SALMON SE, 2001, BASIC CLIN PHARM, P923; Sawada K, 2005, BIOL PHARM BULL, V28, P1202, DOI 10.1248/bpb.28.1202; SHACKNEY SE, 1978, ANN INTERN MED, V89, P107, DOI 10.7326/0003-4819-89-1-107; Sottoriva A, 2010, CANCER RES, V70, P46, DOI 10.1158/0008-5472.CAN-09-3663; Stamatakos GS, 2010, J THEOR BIOL, V266, P124, DOI 10.1016/j.jtbi.2010.05.019; Stamatakos GS, 2007, P ANN INT IEEE EMBS, P6629; Stamatakos GS, 2006, IEEE T BIO-MED ENG, V53, P1467, DOI 10.1109/TBME.2006.873761; Stamatakos GS, 2002, P IEEE, V90, P1764, DOI 10.1109/JPROC.2002.804685; Steel G.G., 2002, BASIC CLIN RADIOBIOL, P9; Tan TY, 2006, J PAEDIATR CHILD H, V42, P486, DOI 10.1111/j.1440-1754.2006.00908.x; Titz B, 2008, PHYS MED BIOL, V53, P4471, DOI 10.1088/0031-9155/53/17/001; Veal GJ, 2005, CLIN CANCER RES, V11, P5893, DOI 10.1158/1078-0432.CCR-04-2546; Ventura AC, 2009, CANCER RES, V69, P400, DOI 10.1158/0008-5472.CAN-08-4422; Wein LM, 2000, INT J RADIAT ONCOL, V47, P1073, DOI 10.1016/S0360-3016(00)00534-4; Wood Kenneth W., 2001, Current Opinion in Pharmacology, V1, P370, DOI 10.1016/S1471-4892(01)00064-9; Zoubek A, 1999, LANCET, V354, P344, DOI 10.1016/S0140-6736(05)75257-0; [No title captured]	49	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17594	10.1371/journal.pone.0017594	http://dx.doi.org/10.1371/journal.pone.0017594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21407827	gold, Green Published, Green Submitted			2022-12-25	WOS:000287965200030
J	Bland, DM; Eisele, NA; Keleher, LL; Anderson, PE; Anderson, DM				Bland, David M.; Eisele, Nicholas A.; Keleher, Lauren L.; Anderson, Paul E.; Anderson, Deborah M.			Novel Genetic Tools for Diaminopimelic Acid Selection in Virulence Studies of Yersinia pestis	PLOS ONE			English	Article							SALMONELLA VACCINE STRAINS; ESCHERICHIA-COLI; TRANSFERABLE PLASMID; PASTEURELLA PESTIS; STABLE MAINTENANCE; BUBONIC PLAGUE; EXPRESSION; RESISTANCE; CLONING; PSEUDOTUBERCULOSIS	Molecular studies of bacterial virulence are enhanced by expression of recombinant DNA during infection to allow complementation of mutants and expression of reporter proteins in vivo. For highly pathogenic bacteria, such as Yersinia pestis, these studies are currently limited because deliberate introduction of antibiotic resistance is restricted to those few which are not human treatment options. In this work, we report the development of alternatives to antibiotics as tools for host-pathogen research during Yersinia pestis infections focusing on the diaminopimelic acid (DAP) pathway, a requirement for cell wall synthesis in eubacteria. We generated a mutation in the dapA-nlpB(dapX) operon of Yersinia pestis KIM D27 and CO92 which eliminated the expression of both genes. The resulting strains were auxotrophic for diaminopimelic acid and this phenotype was complemented in trans by expressing dapA in single and multi-copy. In vivo, we found that plasmids derived from the p15a replicon were cured without selection, while selection for DAP enhanced stability without detectable loss of any of the three resident virulence plasmids. The dapAX mutation rendered Y. pestis avirulent in mouse models of bubonic and septicemic plague which could be complemented when dapAX was inserted in single or multi-copy, restoring development of disease that was indistinguishable from the wild type parent strain. We further identified a high level, constitutive promoter in Y. pestis that could be used to drive expression of fluorescent reporters in dapAX strains that had minimal impact to virulence in mouse models while enabling sensitive detection of bacteria during infection. Thus, diaminopimelic acid selection for single or multi-copy genetic systems in Yersinia pestis offers an improved alternative to antibiotics for in vivo studies that causes minimal disruption to virulence.	[Bland, David M.; Eisele, Nicholas A.; Keleher, Lauren L.; Anderson, Paul E.; Anderson, Deborah M.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Bland, David M.; Eisele, Nicholas A.] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Bland, DM (corresponding author), Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.	andersondeb@missouri.edu		Bland, David/0000-0002-5052-5599	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases; American Recovery and Reinvestment Act [R21AI074635]; NIH/National Institute of General Medical Sciences Cell and Molecular Biology [T32 GM008396]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI074603, U01AI074635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008396] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Recovery and Reinvestment Act; NIH/National Institute of General Medical Sciences Cell and Molecular Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases PHS award and the American Recovery and Reinvestment Act (R21AI074635) to DMA. NAE is supported by the NIH/National Institute of General Medical Sciences Cell and Molecular Biology training grant (T32 GM008396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Anderson GW, 1996, INFECT IMMUN, V64, P4580, DOI 10.1128/IAI.64.11.4580-4585.1996; Auerbach RK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000770; BOUVIER J, 1991, J BACTERIOL, V173, P5523, DOI 10.1128/jb.173.17.5523-5531.1991; BRUBAKER RR, 1965, SCIENCE, V149, P422, DOI 10.1126/science.149.3682.422; BUKHARI AI, 1971, J BACTERIOL, V105, P844, DOI 10.1128/JB.105.3.844-854.1971; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; CURTISS R, 1989, IMMUNOL INVEST, V18, P583, DOI 10.3109/08820138909112265; DeBord KL, 2006, INFECT IMMUN, V74, P4910, DOI 10.1128/IAI.01860-05; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Eisele NA, 2009, CLIN VACCINE IMMUNOL, V16, P1720, DOI 10.1128/CVI.00333-09; GALAN JE, 1990, GENE, V94, P29, DOI 10.1016/0378-1119(90)90464-3; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Guiyoule A, 2001, EMERG INFECT DIS, V7, P43, DOI 10.3201/eid0701.010106; Hanahan D, 1985, DNA CLONING PRACTICA; Hutton CA, 2003, MINI-REV MED CHEM, V3, P115, DOI 10.2174/1389557033405359; Lee-Lewis H, 2010, INFECT IMMUN, V78, P220, DOI 10.1128/IAI.00559-09; Logsdon LK, 2003, INFECT IMMUN, V71, P4595, DOI 10.1128/IAI.71.8.4595-4607.2003; Lorange EA, 2005, J INFECT DIS, V191, P1907, DOI 10.1086/429931; Norris MH, 2009, APPL ENVIRON MICROB, V75, P6062, DOI 10.1128/AEM.00820-09; Overheim KA, 2005, INFECT IMMUN, V73, P5152, DOI 10.1128/IAI.73.8.5152-5159.2005; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; PARRA F, 1983, J GEN MICROBIOL, V129, P337; Peters JE, 2001, NAT REV MOL CELL BIO, V2, P806, DOI 10.1038/35099006; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Pollitzer R., 1954, PLAGUE; Rediers H, 2003, APPL ENVIRON MICROB, V69, P6864, DOI 10.1128/AEM.69.11.6864-6874.2003; REED L. J., 1938, AMER JOUR HYG, V27, P493; RICHAUD F, 1986, J BACTERIOL, V166, P297, DOI 10.1128/jb.166.1.297-300.1986; Ruckert C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-121; SIMON R, 1983, BIOTECHNOLOGY, V1; SURGALLA MJ, 1969, APPL MICROBIOL, V18, P834, DOI 10.1128/AEM.18.5.834-837.1969; Team RDC, 2008, COMP RFFS; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	36	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17352	10.1371/journal.pone.0017352	http://dx.doi.org/10.1371/journal.pone.0017352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399698	Green Published, Green Submitted, gold			2022-12-25	WOS:000287933300019
J	Xu, WY; Yang, RD; Li, MM; Xing, Z; Yang, WQ; Chen, GA; Guo, H; Gong, XJ; Du, Z; Zhang, ZH; Hu, XM; Wang, D; Qian, QA; Wang, T; Su, Z; Xue, YB				Xu, Wenying; Yang, Rendong; Li, Meina; Xing, Zhuo; Yang, Wenqiang; Chen, Guang; Guo, Han; Gong, Xiaojie; Du, Zhou; Zhang, Zhenhai; Hu, Xingming; Wang, Dong; Qian, Qian; Wang, Tai; Su, Zhen; Xue, Yongbiao			Transcriptome Phase Distribution Analysis Reveals Diurnal Regulated Biological Processes and Key Pathways in Rice Flag Leaves and Seedling Leaves	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; GENE-EXPRESSION; STARCH BIOSYNTHESIS; PERIODIC PATTERNS; ARABIDOPSIS; METABOLISM; LIGHT; PROTEIN; SUGARS; ACCUMULATION	Plant diurnal oscillation is a 24-hour period based variation. The correlation between diurnal genes and biological pathways was widely revealed by microarray analysis in different species. Rice (Oryza sativa) is the major food staple for about half of the world's population. The rice flag leaf is essential in providing photosynthates to the grain filling. However, there is still no comprehensive view about the diurnal transcriptome for rice leaves. In this study, we applied rice microarray to monitor the rhythmically expressed genes in rice seedling and flag leaves. We developed a new computational analysis approach and identified 6,266 (10.96%) diurnal probe sets in seedling leaves, 13,773 (24.08%) diurnal probe sets in flag leaves. About 65% of overall transcription factors were identified as flag leaf preferred. In seedling leaves, the peak of phase distribution was from 2: 00am to 4: 00am, whereas in flag leaves, the peak was from 8: 00pm to 2: 00am. The diurnal phase distribution analysis of gene ontology (GO) and cis-element enrichment indicated that, some important processes were waken by the light, such as photosynthesis and abiotic stimulus, while some genes related to the nuclear and ribosome involved processes were active mostly during the switch time of light to dark. The starch and sucrose metabolism pathway genes also showed diurnal phase. We conducted comparison analysis between Arabidopsis and rice leaf transcriptome throughout the diurnal cycle. In summary, our analysis approach is feasible for relatively unbiased identification of diurnal transcripts, efficiently detecting some special periodic patterns with non-sinusoidal periodic patterns. Compared to the rice flag leaves, the gene transcription levels of seedling leaves were relatively limited to the diurnal rhythm. Our comprehensive microarray analysis of seedling and flag leaves of rice provided an overview of the rice diurnal transcriptome and indicated some diurnal regulated biological processes and key functional pathways in rice.	[Xu, Wenying; Li, Meina; Xing, Zhuo; Yang, Wenqiang; Chen, Guang; Guo, Han; Gong, Xiaojie; Hu, Xingming; Wang, Dong; Xue, Yongbiao] Chinese Acad Sci, Lab Mol & Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China; [Xu, Wenying; Li, Meina; Xing, Zhuo; Yang, Wenqiang; Chen, Guang; Guo, Han; Gong, Xiaojie; Hu, Xingming; Wang, Dong; Xue, Yongbiao] Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Yang, Rendong; Du, Zhou; Zhang, Zhenhai; Su, Zhen] China Agr Univ, State Key Lab Plant Physiol & Biochem, Coll Biol Sci, Beijing 100094, Peoples R China; [Qian, Qian] Chinese Acad Agr Sci, State Key Lab Rice Biol, China Natl Rice Res Inst, Hangzhou, Zhejiang, Peoples R China; [Wang, Tai] Chinese Acad Sci, Res Ctr Mol & Dev Biol, Key Lab Photosynth & Environm Mol Physiol, Inst Bot, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; China Agricultural University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Chinese Academy of Sciences; Institute of Botany, CAS	Xu, WY (corresponding author), Chinese Acad Sci, Lab Mol & Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China.	zhensu@cau.edu.cn; ybxue@genetics.ac.cn	xing, zhuo/L-7165-2016; qian, qian/AAH-8708-2021; du, zhou/E-5358-2011; Wang, Tai/G-2544-2010	xing, zhuo/0000-0002-4635-6630; Guo, Han/0000-0001-9118-9897	Ministry of Science and Technology of China [2005CB120804, 90817006]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the Ministry of Science and Technology of China (2005CB120804 and 90817006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chudova D, 2009, BIOINFORMATICS, V25, P3114, DOI 10.1093/bioinformatics/btp547; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; Dietrich P, 2001, J EXP BOT, V52, P1959, DOI 10.1093/jexbot/52.363.1959; Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Geigenberger P, 2000, PLANT J, V23, P795, DOI 10.1046/j.1365-313x.2000.00848.x; GEIGER DR, 1994, ANNU REV PLANT PHYS, V45, P235, DOI 10.1146/annurev.pp.45.060194.001315; Gibon Y, 2004, PLANT CELL, V16, P3304, DOI 10.1105/tpc.104.025973; Gibon Y, 2004, PLANT J, V39, P847, DOI 10.1111/j.1365-313X.2004.02173.x; Gibon Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r76; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; Hannah LC, 2008, CURR OPIN BIOTECH, V19, P160, DOI 10.1016/j.copbio.2008.02.013; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hudson KA, 2010, PLANT GENOME-US, V3, P3, DOI 10.3835/plantgenome2009.08.0025; James MG, 2003, CURR OPIN PLANT BIOL, V6, P215, DOI 10.1016/S1369-5266(03)00042-6; KEVIN RMB, 2010, PLOS ONE, V5; Khan S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-126; Langmead CJ, 2003, J COMPUT BIOL, V10, P521, DOI 10.1089/10665270360688165; Lans H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000941; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; Lu Y, 2005, PLANT PHYSIOL, V138, P2280, DOI 10.1104/pp.105.061903; Mach J, 2009, PLANT CELL, V21, P14, DOI 10.1105/tpc.108.210111; Mangelsen E, 2010, PLANT PHYSIOL, V153, P14, DOI 10.1104/pp.110.154856; Matt P, 1998, PLANTA, V207, P27, DOI 10.1007/s004250050452; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Michael TP, 2008, PLOS BIOL, V6, P1887, DOI 10.1371/journal.pbio.0060225; Mizuno T, 2008, PLANT CELL PHYSIOL, V49, P481, DOI 10.1093/pcp/pcn008; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Mutisya J, 2009, J PLANT PHYSIOL, V166, P428, DOI 10.1016/j.jplph.2008.06.017; Orzechowski S, 2008, ACTA BIOCHIM POL, V55, P435, DOI 10.18388/abp.2008_3049; Park JH, 2009, DNA REPAIR, V8, P29, DOI 10.1016/j.dnarep.2008.08.011; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Roelfsema MRG, 2005, NEW PHYTOL, V167, P665, DOI 10.1111/j.1469-8137.2005.01460.x; Salamone PR, 2000, FEBS LETT, V482, P113, DOI 10.1016/S0014-5793(00)01985-2; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Shaked H, 2006, GENETICS, V173, P985, DOI 10.1534/genetics.105.051664; Shimazaki K, 2007, ANNU REV PLANT BIOL, V58, P219, DOI 10.1146/annurev.arplant.57.032905.105434; STEER BT, 1974, PLANT PHYSIOL, V54, P758, DOI 10.1104/pp.54.5.758; STITT M, 1978, BIOCHIM BIOPHYS ACTA, V544, P200, DOI 10.1016/0304-4165(78)90223-4; STITT M, 1983, PLANT PHYSIOL, V72, P1139, DOI 10.1104/pp.72.4.1139; Straume M, 2004, METHOD ENZYMOL, V383, P149; Tabata M, 2000, HEADACHE, V40, P457, DOI 10.1046/j.1526-4610.2000.00068.x; Tallman G, 2004, J EXP BOT, V55, P1963, DOI 10.1093/jxb/erh212; Tetlow IJ, 2008, PLANT PHYSIOL, V146, P1878, DOI 10.1104/pp.108.116244; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Turner JG, 2007, CURR BIOL, V17, pR847, DOI 10.1016/j.cub.2007.08.014; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Yamada Rikuhiro, 2007, Methods Mol Biol, V362, P245; Yang R, 2010, BIOINFORMATICS, V26, pi168, DOI 10.1093/bioinformatics/btq189; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zhao Q, 2009, J BIOL CHEM, V284, P30424, DOI 10.1074/jbc.M109.044982	57	21	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17613	10.1371/journal.pone.0017613	http://dx.doi.org/10.1371/journal.pone.0017613			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407816	gold, Green Published, Green Submitted			2022-12-25	WOS:000287933300035
J	Zhu, L; Wang, LD; Wang, X; Luo, XL; Yang, L; Zhang, R; Yin, HK; Xie, D; Pan, Y; Chen, Y				Zhu, Lu; Wang, Lingdi; Wang, Xiao; Luo, Xiaolin; Yang, Ling; Zhang, Rui; Yin, Hongkun; Xie, Dong; Pan, Yi; Chen, Yan			Hepatic Deletion of Smad7 in Mouse Leads to Spontaneous Liver Dysfunction and Aggravates Alcoholic Liver Injury	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; MUTANT MICE; EXTRAEMBRYONIC TISSUES; SIGNAL TRANSDUCER; TRANSGENIC MICE; TRANSCRIPTION 3; DISRUPTION; EXPRESSION; DAMAGE	Background: TGF-beta has been known to play an important role in various liver diseases including fibrosis and alcohol-induced fatty liver. Smad7 is an intracellular negative regulator of TGF-b signaling. It is currently unclear whether endogenous Smad7 has an effect on liver function and alcoholic liver damage. Methodology/Principal Findings: We used Cre/loxP system by crossing Alb-Cre mice with Smad7(loxP/loxP) mice to generate liver-specific deletion of Smad7 with loss of the indispensable MH2 domain. Alcoholic liver injury was achieved by feeding mice with a liquid diet containing 5% ethanol for 6 weeks, followed by a single dose of ethanol gavage. Deletion of Smad7 in the liver was associated with increased Smad2/3 phosphorylation in the liver or upon TGF-b treatment in primary hepatocytes. The majority of mice with liver specific deletion of Smad7 (Smad7(liver-KO)) were viable and phenotypically normal, accompanied by only slight or no reduction of Smad7 expression in the liver. However, about 30% of Smad7(liver-KO) mice with high efficiency of Smad7 deletion had spontaneous liver dysfunction, demonstrated as low body weight, overall deterioration, and increased serum levels of AST and ALT. Degeneration and elevated apoptosis of liver cells were observed with these mice. TGF-b-induced epithelial to mesenchymal transition (EMT) was accelerated in Smad7-deleted primary hepatocytes. In addition, alcohol-induced liver injury and steatosis were profoundly aggravated in Smad7 deficient mice, associated with upregulation of critical genes involved in lipogenesis and inflammation. Furthermore, alcohol-induced ADH1 expression was significantly abrogated by Smad7 deletion in hepatocytes. Conclusion/Significance: In this study, we provided in vivo evidence revealing that endogenous Smad7 plays an important role in liver function and alcohol-induced liver injury.	[Zhu, Lu; Wang, Lingdi; Wang, Xiao; Luo, Xiaolin; Yang, Ling; Zhang, Rui; Yin, Hongkun; Xie, Dong; Pan, Yi; Chen, Yan] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Grad Sch, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhu, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Grad Sch, Shanghai, Peoples R China.	ychen3@sibs.ac.cn	Luo, Xiaolin/D-7159-2014; Yang, Ling/F-4404-2016; Zhu, Lu/N-1073-2017	Luo, Xiaolin/0000-0003-3215-8112; Zhu, Lu/0000-0003-2716-4649; yin, hongkun/0000-0002-8595-4270; Xie, Dong/0000-0002-1150-8657; Yang, Ling/0000-0002-7586-3922	National Natural Science Foundation of China [30830037, 81021002, 30971660]; Ministry of Science and Technology of China [2007CB947100, 2006CB943900, 2010CB529506]; Shanghai Institutes for Biological Sciences [2009KIP207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences)	This work was supported by research grants from National Natural Science Foundation of China ( 30830037 and 81021002) and the Ministry of Science and Technology of China (2007CB947100 and 2006CB943900) to Y.C. The work was also supported by Ministry of Science and Technology of China (2010CB529506), National Natural Science Foundation of China ( 30971660) and a grant from Shanghai Institutes for Biological Sciences (2009KIP207) to YP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottinger EP, 1996, P NATL ACAD SCI USA, V93, P5877, DOI 10.1073/pnas.93.12.5877; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; CASTILLA A, 1991, NEW ENGL J MED, V324, P933, DOI 10.1056/NEJM199104043241401; Chang H, 1999, DEVELOPMENT, V126, P1631; Chen Q, 2009, J BIOL CHEM, V284, P292, DOI 10.1074/jbc.M807233200; Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196; Ciuclan L, 2010, J HEPATOL, V52, P407, DOI 10.1016/j.jhep.2009.12.003; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Hamzavi J, 2008, J CELL MOL MED, V12, P2130, DOI 10.1111/j.1582-4934.2008.00262.x; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Horiguchi N, 2008, GASTROENTEROLOGY, V134, P1148, DOI 10.1053/j.gastro.2008.01.016; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang Z, 2009, HUM MOL GENET, V18, P2791, DOI 10.1093/hmg/ddp214; Ji C, 2006, J HEPATOL, V45, P717, DOI 10.1016/j.jhep.2006.05.009; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837; Li RG, 2006, J IMMUNOL, V176, P6777, DOI 10.4049/jimmunol.176.11.6777; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Murray KF, 2008, J PEDIATR GASTR NUTR, V47, P395, DOI 10.1097/MPG.0b013e3181709464; Neufeld D S, 1997, Methods Mol Biol, V75, P145; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Scholten D, 2010, GASTROENTEROLOGY, V139, P987, DOI 10.1053/j.gastro.2010.05.005; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Weinstein M, 2000, CYTOKINE GROWTH F R, V11, P49, DOI 10.1016/S1359-6101(99)00028-3; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang L, 2010, J HEPATOL, V53, P339, DOI 10.1016/j.jhep.2010.03.004; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	37	27	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17415	10.1371/journal.pone.0017415	http://dx.doi.org/10.1371/journal.pone.0017415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386907	Green Submitted, gold, Green Published			2022-12-25	WOS:000287931400072
J	Lindstrom, S; Schumacher, F; Siddiq, A; Travis, RC; Campa, D; Berndt, SI; Diver, WR; Severi, G; Allen, N; Andriole, G; Bueno-de-Mesquita, B; Chanock, SJ; Crawford, D; Gaziano, JM; Giles, GG; Giovannucci, E; Guo, C; Haiman, CA; Hayes, RB; Halkjaer, J; Hunter, DJ; Johansson, M; Kaaks, R; Kolonel, LN; Navarro, C; Riboli, E; Sacerdote, C; Stampfer, M; Stram, DO; Thun, MJ; Trichopoulos, D; Virtamo, J; Weinstein, SJ; Yeager, M; Henderson, B; Ma, J; Le Marchand, L; Albanes, D; Kraft, P				Lindstrom, Sara; Schumacher, Fredrick; Siddiq, Afshan; Travis, Ruth C.; Campa, Daniele; Berndt, Sonja I.; Diver, W. Ryan; Severi, Gianluca; Allen, Naomi; Andriole, Gerald; Bueno-de-Mesquita, Bas; Chanock, Stephen J.; Crawford, David; Gaziano, J. Michael; Giles, Graham G.; Giovannucci, Edward; Guo, Carolyn; Haiman, Christopher A.; Hayes, Richard B.; Halkjaer, Jytte; Hunter, David J.; Johansson, Mattias; Kaaks, Rudolf; Kolonel, Laurence N.; Navarro, Carmen; Riboli, Elio; Sacerdote, Carlotta; Stampfer, Meir; Stram, Daniel O.; Thun, Michael J.; Trichopoulos, Dimitrios; Virtamo, Jarmo; Weinstein, Stephanie J.; Yeager, Meredith; Henderson, Brian; Ma, Jing; Le Marchand, Loic; Albanes, Demetrius; Kraft, Peter			Characterizing Associations and SNP-Environment Interactions for GWAS-Identified Prostate Cancer Risk Markers-Results from BPC3	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GROWTH-FACTOR-I; SUSCEPTIBILITY LOCI; SEQUENCE VARIANTS; BINDING PROTEIN-3; PSA LEVELS; GENES; METAANALYSIS; MULTIPLE; REPLICATION	Genome-wide association studies (GWAS) have identified multiple single nucleotide polymorphisms (SNPs) associated with prostate cancer risk. However, whether these associations can be consistently replicated, vary with disease aggressiveness (tumor stage and grade) and/or interact with non-genetic potential risk factors or other SNPs is unknown. We therefore genotyped 39 SNPs from regions identified by several prostate cancer GWAS in 10,501 prostate cancer cases and 10,831 controls from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). We replicated 36 out of 39 SNPs (P-values ranging from 0.01 to 10(-28)). Two SNPs located near KLK3 associated with PSA levels showed differential association with Gleason grade (rs2735839, P = 0.0001 and rs266849, P = 0.0004; case-only test), where the alleles associated with decreasing PSA levels were inversely associated with low-grade (as defined by Gleason grade,8) tumors but positively associated with high-grade tumors. No other SNP showed differential associations according to disease stage or grade. We observed no effect modification by SNP for association with age at diagnosis, family history of prostate cancer, diabetes, BMI, height, smoking or alcohol intake. Moreover, we found no evidence of pair-wise SNP-SNP interactions. While these SNPs represent new independent risk factors for prostate cancer, we saw little evidence for effect modification by other SNPs or by the environmental factors examined.	[Lindstrom, Sara; Guo, Carolyn; Hunter, David J.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Lindstrom, Sara; Guo, Carolyn; Stampfer, Meir; Trichopoulos, Dimitrios; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Schumacher, Fredrick; Haiman, Christopher A.; Stram, Daniel O.; Henderson, Brian] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA; [Siddiq, Afshan; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Travis, Ruth C.; Allen, Naomi] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England; [Campa, Daniele] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Berndt, Sonja I.; Chanock, Stephen J.; Hayes, Richard B.; Weinstein, Stephanie J.; Yeager, Meredith; Albanes, Demetrius] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Diver, W. Ryan; Thun, Michael J.] Amer Canc Soc, Dept Epidemiol, Atlanta, GA 30329 USA; [Severi, Gianluca; Giles, Graham G.] Univ Melbourne, Canc Epidemiol Ctr, Canc Council Victoria, Melbourne, Vic, Australia; [Severi, Gianluca; Giles, Graham G.] Univ Melbourne, Ctr Mol Genet Environm & Analyt Epidemiol, Melbourne, Vic, Australia; [Andriole, Gerald] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA; [Bueno-de-Mesquita, Bas] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Crawford, David] Univ Colorado, Denver Hlth Sci Ctr, Denver, CO 80202 USA; [Gaziano, J. Michael] Boston Vet Affairs Healthcare Syst, Massachusetts Vet Epidemiol & Res Informat Ctr MA, Boston, MA USA; [Gaziano, J. Michael] Boston Vet Affairs Healthcare Syst, GRECC, Boston, MA USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Div Aging, Dept Med, Boston, MA 02115 USA; [Giles, Graham G.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Giovannucci, Edward; Stampfer, Meir] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hayes, Richard B.] NYU Langone Med Ctr, Div Epidemiol, New York, NY USA; [Halkjaer, Jytte] Inst Canc Epidemiol, Danish Canc Soc, Copenhagen, Denmark; [Hunter, David J.; Stampfer, Meir; Ma, Jing] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Hunter, David J.; Stampfer, Meir; Ma, Jing] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Johansson, Mattias] Int Agcy Res Canc, F-69372 Lyon, France; [Johansson, Mattias] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden; [Kaaks, Rudolf] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Program Epidemiol, Canc Res Ctr, Honolulu, HI 96822 USA; [Navarro, Carmen] Reg Hlth Author, Dept Epidemiol, Murcia, Spain; [Navarro, Carmen] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Sacerdote, Carlotta] CPO Piemonte Torino, Turin, Italy; [Sacerdote, Carlotta] Human Genet Fdn, Turin, Italy; [Trichopoulos, Dimitrios] Ctr Food & Nutr Policies, Athens, Greece; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Southern California; Imperial College London; University of Oxford; Helmholtz Association; German Cancer Research Center (DKFZ); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Cancer Society; Cancer Council Victoria; University of Melbourne; University of Melbourne; Washington University (WUSTL); Netherlands National Institute for Public Health & the Environment; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Geriatric Research Education & Clinical Center; Harvard University; Brigham & Women's Hospital; Monash University; Harvard University; Harvard T.H. Chan School of Public Health; NYU Langone Medical Center; Danish Cancer Society; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; World Health Organization; International Agency for Research on Cancer (IARC); Umea University; Helmholtz Association; German Cancer Research Center (DKFZ); Cancer Research Center of Hawaii; University of Hawaii System; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Finland National Institute for Health & Welfare; Harvard University; Harvard T.H. Chan School of Public Health	Lindstrom, S (corresponding author), Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA.	pkraft@hsph.harvard.edu	Severi, Gianluca/Q-1824-2019; Weinstein, Stephanie J/P-1627-2017; Johansson, Mattias/ABF-3365-2020; Berndt, Sonja I/J-8423-2016; Diver, Ryan/AAG-3469-2019; Albanes, Demetrius/B-9749-2015; Yeager, Meredith/AAA-5322-2020; Campa, Daniele/K-1617-2016; Schumacher, Fredrick/R-6043-2019; Severi, Gianluca/H-3774-2018	Severi, Gianluca/0000-0001-7157-419X; Weinstein, Stephanie J/0000-0002-3834-1535; Diver, Ryan/0000-0002-5418-9000; Campa, Daniele/0000-0003-3220-9944; Schumacher, Fredrick/0000-0002-3073-7463; Severi, Gianluca/0000-0001-7157-419X; Johansson, Mattias/0000-0002-3116-5081; Giles, Graham/0000-0003-4946-9099; Navarro, Carmen/0000-0001-8896-7483; Hayes, Richard/0000-0002-0918-661X; Riboli, Elio/0000-0001-6795-6080; Siddiq, Afshan/0000-0002-9110-1434; Sacerdote, Carlotta/0000-0002-8008-5096	US National Institutes of Health, National Cancer Institute [U01-CA98233-07, U01-CA98710-06, U01-CA98216-06, U01-CA98758-07]; NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics; NATIONAL CANCER INSTITUTE [ZIACP010201] Funding Source: NIH RePORTER	US National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the US National Institutes of Health, National Cancer Institute [cooperative agreements U01-CA98233-07 to David J. Hunter, U01-CA98710-06 to Michael J. Thun, U01-CA98216-06 to Elio Riboli and Rudolf Kaaks, and U01-CA98758-07 to Brian E. Henderson, and Intramural Research Program of NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSSON PA, 1988, PROSTATE, V12, P39, DOI 10.1002/pros.2990120106; Ahn J, 2008, NAT GENET, V40, P1032, DOI 10.1038/ng0908-1032; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Bagnardi V, 2001, BRIT J CANCER, V85, P1700, DOI 10.1054/bjoc.2001.2140; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Chan JM, 2002, J NATL CANCER I, V94, P1099; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; FitzGerald LM, 2009, CLIN CANCER RES, V15, P3231, DOI 10.1158/1078-0432.CCR-08-2190; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Giovannucci E, 2003, CANCER EPIDEM BIOMAR, V12, P84; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001513; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Hayes RB, 2000, CONTROL CLIN TRIALS, V21, p349S, DOI 10.1016/S0197-2456(00)00101-X; Hsu FC, 2009, CANCER RES, V69, P2720, DOI 10.1158/0008-5472.CAN-08-3347; Huncharek M, 2010, AM J PUBLIC HEALTH, V100, P693, DOI 10.2105/AJPH.2008.150508; Hunter DJ, 2005, NAT REV CANCER, V5, P977, DOI 10.1038/nrc1754; Kader AK, 2009, PROSTATE, V69, P1195, DOI 10.1002/pros.20970; Kolonel LN, 2004, NAT REV CANCER, V4, P519, DOI 10.1038/nrc1389; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183; Lilja H, 2008, NAT REV CANCER, V8, P268, DOI 10.1038/nrc2351; MacInnis RJ, 2006, CANCER CAUSE CONTROL, V17, P989, DOI 10.1007/s10552-006-0049-z; R Core Team, 2022, R LANG ENV STAT COMP; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Severi G, 2006, CANCER EPIDEM BIOMAR, V15, P1137, DOI 10.1158/1055-9965.EPI-05-0823; SIEMIATYCKI J, 1981, INT J EPIDEMIOL, V10, P383, DOI 10.1093/ije/10.4.383; Skolarus TA, 2007, NAT CLIN PRACT UROL, V4, P605, DOI 10.1038/ncpuro0944; Stevens VL, 2010, PROSTATE, V70, P601, DOI 10.1002/pros.21094; Sun JL, 2009, CANCER RES, V69, P10, DOI 10.1158/0008-5472.CAN-08-3464; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Wiklund F, 2009, PROSTATE, V69, P419, DOI 10.1002/pros.20908; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zheng SL, 2007, JNCI-J NATL CANCER I, V99, P1525, DOI 10.1093/jnci/djm169; Zheng SL, 2009, CANCER EPIDEM BIOMAR, V18, P1815, DOI 10.1158/1055-9965.EPI-08-0983	43	53	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17142	10.1371/journal.pone.0017142	http://dx.doi.org/10.1371/journal.pone.0017142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390317	Green Published, Green Submitted, gold			2022-12-25	WOS:000287761700031
J	Dave, RK; Ellis, T; Toumpas, MC; Robson, JP; Julian, E; Adolphe, C; Bartlett, PF; Cooper, HM; Reynolds, BA; Wainwright, BJ				Dave, Richa K.; Ellis, Tammy; Toumpas, Melissa C.; Robson, Jonathan P.; Julian, Elaine; Adolphe, Christelle; Bartlett, Perry F.; Cooper, Helen M.; Reynolds, Brent A.; Wainwright, Brandon J.			Sonic Hedgehog and Notch Signaling Can Cooperate to Regulate Neurogenic Divisions of Neocortical Progenitors	PLOS ONE			English	Article							NEURAL STEM-CELLS; RADIAL GLIAL-CELLS; NERVOUS-SYSTEM; ASYMMETRIC DIVISION; CEREBRAL-CORTEX; NEURONS; PATHWAY; GROWTH; DIFFERENTIATION; PRECURSORS	Background: Hedgehog (Hh) signaling is crucial for the generation and maintenance of both embryonic and adult stem cells, thereby regulating development and tissue homeostasis. In the developing neocortex, Sonic Hedgehog (Shh) regulates neural progenitor cell proliferation. During neurogenesis, radial glial cells of the ventricular zone (VZ) are the predominant neocortical progenitors that generate neurons through both symmetric and asymmetric divisions. Despite its importance, relatively little is known of the molecular pathways that control the switch from symmetric proliferative to differentiative/neurogenic divisions in neural progenitors. Principal Findings: Here, we report that conditional inactivation of Patched1, a negative regulator of the Shh pathway, in Nestin positive neural progenitors of the neocortex leads to lamination defects due to improper corticogenesis and an increase in the number of symmetric proliferative divisions of the radial glial cells. Hedgehog-activated VZ progenitor cells demonstrated a concomitant upregulation of Hes1 and Blbp, downstream targets of Notch signaling. The Notch signaling pathway plays a pivotal role in the maintenance of stem/progenitor cells and the regulation of glial versus neuronal identity. To study the effect of Notch signaling on Hh-activated neural progenitors, we inactivated both Patched1 and Rbpj, a transcriptional mediator of Notch signaling, in Nestin positive cells of the neocortex. Conclusions: Our data indicate that by mid neurogenesis (embryonic day 14.5), attenuation of Notch signaling reverses the effect of Patched1 deletion on neurogenesis by restoring the balance between symmetric proliferative and neurogenic divisions. Hence, our results demonstrate that correct corticogenesis is an outcome of the interplay between the Hh and Notch signaling pathways.	[Dave, Richa K.; Ellis, Tammy; Toumpas, Melissa C.; Robson, Jonathan P.; Julian, Elaine; Adolphe, Christelle; Wainwright, Brandon J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Bartlett, Perry F.; Cooper, Helen M.; Reynolds, Brent A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Cooper, Helen M.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Dave, RK (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	b.wainwright@imb.uq.edu.au	Cooper, Helen/G-3505-2010; Cooper, Helen M/AAA-2182-2019; Bartlett, Perry/F-3813-2012	Cooper, Helen M/0000-0001-9838-5743; Adolphe, Christelle/0000-0002-3908-1843; Wainwright, Brandon/0000-0003-0406-2092	Australian National Health and Medical Research Council; ARC Special Research Centre for Functional and Applied Genomics; ACRF; Queensland Cancer Fund; John Trivett Foundation	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC Special Research Centre for Functional and Applied Genomics(Australian Research Council); ACRF; Queensland Cancer Fund; John Trivett Foundation	This work was supported by grants from the Australian National Health and Medical Research Council and the ARC Special Research Centre for Functional and Applied Genomics. Confocal microscopy was performed at the Australian Cancer Research Foundation (ACRF)/Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology, which was established with the support of the ACRF. R. Dave is supported by the Queensland Cancer Fund. T. Ellis is supported by The John Trivett Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphe C, 2004, DEVELOPMENT, V131, P5009, DOI 10.1242/dev.01367; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Androutsellis-Theotokis A, 2009, P NATL ACAD SCI USA, V106, P13570, DOI 10.1073/pnas.0905125106; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Blaess S, 2006, DEVELOPMENT, V133, P1799, DOI 10.1242/dev.02339; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825; Campbell K, 2002, TRENDS NEUROSCI, V25, P235, DOI 10.1016/S0166-2236(02)02156-2; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Corbin JG, 2008, J NEUROCHEM, V106, P2272, DOI 10.1111/j.1471-4159.2008.05522.x; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Ellis T, 2003, DEV BIOL, V263, P203, DOI 10.1016/S0012-1606(03)00394-4; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Ever L, 2005, CURR OPIN NEUROBIOL, V15, P29, DOI 10.1016/j.conb.2005.01.005; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Fujimoto M, 2009, DEV BIOL, V332, P339, DOI 10.1016/j.ydbio.2009.06.001; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gaiano N, 2008, NEURON, V60, P189, DOI 10.1016/j.neuron.2008.10.009; Gao F, 2009, MOL CELL NEUROSCI, V40, P442, DOI 10.1016/j.mcn.2008.12.008; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Gotz M, 2002, BRAIN RES BULL, V57, P777, DOI 10.1016/S0361-9230(01)00777-8; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; HANSEN DV, NATURE; Hashimoto-Torii K, 2008, NEURON, V60, P273, DOI 10.1016/j.neuron.2008.09.026; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hatakeyama J, 2006, CEREB CORTEX, V16, pI132, DOI 10.1093/cercor/bhj166; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; INGRAM WJ, 2007, ONCOGENE; Julian E, 2010, ONCOGENE, V29, P3465, DOI 10.1038/onc.2010.101; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Kawaguchi D, 2008, DEVELOPMENT, V135, P3849, DOI 10.1242/dev.024570; KOMADA M, 2008, DEVELOPMENT; Komine O, 2007, DEV BIOL, V311, P238, DOI 10.1016/j.ydbio.2007.08.042; LIU SL, 2005, P AM ASS CANC RES, V46; Lutolf S, 2002, DEVELOPMENT, V129, P373; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Mo ZC, 2007, J NEUROSCI, V27, P4132, DOI 10.1523/JNEUROSCI.0111-07.2007; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; Pevny L, 2005, CURR OPIN NEUROBIOL, V15, P7, DOI 10.1016/j.conb.2005.01.016; Pierfelice TJ, 2008, COLD SH Q B, V73, P367, DOI 10.1101/sqb.2008.73.013; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Qian XM, 1998, DEVELOPMENT, V125, P3143; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Shen Q, 2002, DEVELOPMENT, V129, P4843; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wall DS, 2009, J CELL BIOL, V184, P101, DOI 10.1083/jcb.200805155; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004	69	67	73	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e14680	10.1371/journal.pone.0014680	http://dx.doi.org/10.1371/journal.pone.0014680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379383	Green Submitted, Green Published, gold			2022-12-25	WOS:000287482300002
J	Dmitriev, OY; Bhattacharjee, A; Nokhrin, S; Uhlemann, EME; Lutsenko, S				Dmitriev, Oleg Y.; Bhattacharjee, Ashima; Nokhrin, Sergiy; Uhlemann, Eva-Maria E.; Lutsenko, Svetlana			Difference in Stability of the N-domain Underlies Distinct Intracellular Properties of the E1064A and H1069Q Mutants of Copper-transporting ATPase ATP7B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSON-DISEASE PROTEIN; NUCLEOTIDE-BINDING DOMAIN; MUTATIONS; EXPRESSION	Wilson disease (WD) is a disorder of copper metabolism caused by mutations in the Cu-transporting ATPase ATP7B. WD is characterized by significant phenotypic variability, the molecular basis of which is poorly understood. The E1064A mutation in the N-domain of ATP7B was previously shown to disrupt ATP binding. We have now determined, by NMR, the structure of the N-domain containing this mutation and compared properties of E1064A and H1069Q, another mutant with impaired ATP binding. The E1064A mutation does not change the overall fold of the N-domain. However, the position of the alpha 1,alpha 2-helical hairpin (alpha-HH) that houses Glu(1064) and His(1069) is altered. The alpha-HH movement produces a more open structure compared with the wild-type ATP-bound form and misaligns ATP coordinating residues, thus explaining complete loss of ATP binding. In the cell, neither the stability nor targeting of ATP7B-E1064A to the trans-Golgi network differs significantly from the wild type. This is in a contrast to the H1069Q mutation within the same alpha-HH, which greatly destabilizes protein both in vitro and in cells. The difference between two mutants can be linked to a lower stability of the alpha-HH in the H1069Q variant at the physiological temperature. We conclude that the structural stability of the N-domain rather than the loss of ATP binding plays a defining role in the ability of ATP7B to reach the trans-Golgi network, thus contributing to phenotypic variability in WD.	[Dmitriev, Oleg Y.; Nokhrin, Sergiy; Uhlemann, Eva-Maria E.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Bhattacharjee, Ashima; Lutsenko, Svetlana] Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21205 USA	University of Saskatchewan; Johns Hopkins University	Dmitriev, OY (corresponding author), 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	oleg.dmitriev@usask.ca; lutsenko@jhmi.edu	Dmitriev, Oleg/AAB-7830-2019		Canadian Institutes of Health Research; Saskatchewan Health Research Foundation; National Institutes of Health [R01 DK071865, P01GM067166]; NSF; United States Department of Agriculture; University of Wisconsin; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); University of Wisconsin; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from Canadian Institutes of Health Research and Saskatchewan Health Research Foundation (to O. Y. D.). This work was also supported in part by National Institutes of Health Grants R01 DK071865 and P01GM067166 (to S. L.). The study also made use of the National Magnetic Resonance Facility at Madison, which is supported by funding from National Institutes of Health, NSF, United States Department of Agriculture, and the University of Wisconsin.	Banci L, 2010, J BIOL CHEM, V285, P2537, DOI 10.1074/jbc.M109.054262; Caca K, 2001, J HEPATOL, V35, P575, DOI 10.1016/S0168-8278(01)00219-7; Cauza E, 2000, WIEN KLIN WOCHENSCHR, V112, P576; Das SK, 2006, NAT CLIN PRACT NEURO, V2, P482, DOI 10.1038/ncpneuro0291; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; Folhoffer Aniko, 2003, Orvosi Hetilap, V144, P2509; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Huster D, 2003, GASTROENTEROLOGY, V124, P335, DOI 10.1053/gast.2003.50066; Kalinsky H, 1998, HUM MUTAT, V11, P145, DOI 10.1002/(SICI)1098-1004(1998)11:2<145::AID-HUMU7>3.3.CO;2-F; Liu L, 2009, ACTA CRYSTALLOGR E, V65, pO2776, DOI 10.1107/S1600536809039646; Lubben M, 2007, J MOL BIOL, V369, P368, DOI 10.1016/j.jmb.2007.03.029; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Morgan CT, 2004, J BIOL CHEM, V279, P36363, DOI 10.1074/jbc.M404553200; Payne AS, 1998, P NATL ACAD SCI USA, V95, P10854, DOI 10.1073/pnas.95.18.10854; Rodriguez-Granillo A, 2008, J MOL BIOL, V383, P1097, DOI 10.1016/j.jmb.2008.07.065; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Stapelbroek JM, 2004, J HEPATOL, V41, P758, DOI 10.1016/j.jhep.2004.07.017; Tsivkovskii R, 2003, J BIOL CHEM, V278, P13302, DOI 10.1074/jbc.M300034200; Tsuda T, 2009, EMBO J, V28, P1782, DOI 10.1038/emboj.2009.143; van den Berghe PVE, 2009, HEPATOLOGY, V50, P1783, DOI 10.1002/hep.23209	20	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.198101	http://dx.doi.org/10.1074/jbc.M110.198101			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21398519	Green Published, hybrid			2022-12-25	WOS:000290022800073
J	Tolino, LA; Okumura, S; Kashlan, OB; Carattino, MD				Tolino, Lindsey A.; Okumura, Sora; Kashlan, Ossama B.; Carattino, Marcelo D.			Insights into the Mechanism of Pore Opening of Acid-sensing Ion Channel 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGE; EXTRACELLULAR DOMAIN; DESENSITIZATION; KINETICS; SITES	Acid-sensing ion channels (ASICs) are trimeric cation channels that undergo activation and desensitization in response to extracellular acidification. The underlying mechanism coupling proton binding in the extracellular region to pore gating is unknown. Here we probed the reactivity toward methanethiosulfonate (MTS) reagents of channels with cysteine-substituted residues in the outer vestibule of the pore of ASIC1a. We found that positively-charged MTS reagents trigger pore opening of G428C. Scanning mutagenesis of residues in the region preceding the second transmembrane spanning domain indicated that the MTSET-modified side chain of Cys at position 428 interacts with Tyr-424. This interaction was confirmed by double-mutant cycle analysis. Strikingly, Y424C-G428C monomers were associated by intersubunit disulfide bonds and were insensitive to MTSET. Despite the spatial constraints introduced by these intersubunit disulfide bonds in the outer vestibule of the pore, Y424C-G428C transitions between the resting, open, and desensitized states in response to extracellular acidification. This finding suggests that the opening of the ion conductive pathway involves coordinated rotation of the second transmembrane-spanning domains.	[Tolino, Lindsey A.; Okumura, Sora; Kashlan, Ossama B.; Carattino, Marcelo D.] Univ Pittsburgh, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carattino, MD (corresponding author), S828 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	mdc4@pitt.edu			National Institutes of Health [R01 DK084060, DK078734]; American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084060, K01DK078734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants R01 DK084060 (to M. D. C.) and DK078734 (to O. B. K.) from the National Institutes of Health.; Supported by a Carl W. Gottschalk award from the American Society of Nephrology.	Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Kusama N, 2010, J BIOL CHEM, V285, P17425, DOI 10.1074/jbc.M109.091561; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Sluka KA, 2009, CURR OPIN DRUG DISC, V12, P693; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Vemana S, 2004, J GEN PHYSIOL, V123, P21, DOI 10.1085/jgp.200308916; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yu MJ, 2006, MOL CELL PROTEOMICS, V5, P2131, DOI 10.1074/mcp.M600177-MCP200; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106	29	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.202366	http://dx.doi.org/10.1074/jbc.M110.202366			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21388961	hybrid, Green Published			2022-12-25	WOS:000290022800068
J	Sato, K; Miyoshi, F; Yokota, K; Araki, Y; Asanuma, Y; Akiyama, Y; Yoh, K; Takahashi, S; Aburatani, H; Mimura, T				Sato, Kojiro; Miyoshi, Fumihiko; Yokota, Kazuhiro; Araki, Yasuto; Asanuma, Yu; Akiyama, Yuji; Yoh, Keigyou; Takahashi, Satoru; Aburatani, Hiroyuki; Mimura, Toshihide			Marked Induction of c-Maf Protein during Th17 Cell Differentiation and Its Implication in Memory Th Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; ROR-GAMMA-T; TGF-BETA; CUTTING EDGE; T-H-17 CELLS; INTESTINAL INFLAMMATION; HELPER-CELLS; T(H)17 CELLS; IFN-GAMMA; EXPRESSION	Until recently, effector T helper (Th) cells have been classified into two subsets, Th1 and Th2 cells. Since the discovery of Th17 cells, which produce IL-17, much attention has been given to Th17 cells, mainly because they have been implicated in the pathogenesis of various inflammatory diseases. We have performed transcriptome analysis combined with factor analysis and revealed that the expression level of c-Maf, which is considered to be important for Th2 differentiation, increases significantly during the course of Th17 differentiation. The IL-23 receptor (IL-23R), which is important for Th17 cells, is among putative transcriptional targets of c-Maf. Interestingly, the analysis of c-Maf transgenic Th cells revealed that the overexpression of c-Maf did not lead to the acceleration of the early stage of Th17 differentiation but rather to the expansion of memory phenotype cells, particularly with Th1 and Th17 traits. Consistently, mouse wild-type memory Th cells expressed higher mRNA levels of c-Maf, IL-23R, IL-17, and IFN-gamma than control cells; in contrast, Maf(-/-) memory Th cells expressed lower mRNA levels of those molecules. Thus, we propose that c-Maf is important for the development of memory Th cells, particularly memory Th17 cells and Th1 cells.	[Sato, Kojiro; Miyoshi, Fumihiko; Yokota, Kazuhiro; Araki, Yasuto; Asanuma, Yu; Akiyama, Yuji; Mimura, Toshihide] Saitama Med Univ, Fac Med, Dept Rheumatol & Appl Immunol, Saitama 3500495, Japan; [Yoh, Keigyou] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Clin Sci, Tsukuba, Ibaraki 3058575, Japan; [Takahashi, Satoru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan; [Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Dept Canc Syst Biol, Tokyo 1538904, Japan	Saitama Medical University; University of Tsukuba; University of Tsukuba; University of Tokyo	Sato, K (corresponding author), Morohongo 38, Moroyama, Saitama 3500495, Japan.	satok@saitama-med.ac.jp	Mimura, Toshihide/AAV-2844-2020	Sato, Kojiro/0000-0003-4105-3726	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation; Kanae Foundation for the Promotion of Medical Science; Uehara Memorial Foundation; Kato Memorial Bioscience Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation(Naito Memorial Foundation); Kanae Foundation for the Promotion of Medical Science; Uehara Memorial Foundation(Uehara Memorial Foundation); Kato Memorial Bioscience Foundation	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and grants from the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Naito Foundation, the Kanae Foundation for the Promotion of Medical Science, Uehara Memorial Foundation, and the Kato Memorial Bioscience Foundation.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Boniface K, 2010, J IMMUNOL, V185, P679, DOI 10.4049/jimmunol.1000366; GAJEWSKI TF, 1988, J IMMUNOL, V140, P4245; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Kajihara M, 2003, BIOCHEM BIOPH RES CO, V312, P831, DOI 10.1016/j.bbrc.2003.10.196; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Kim Y, 2005, J BIOL CHEM, V280, P32905, DOI 10.1074/jbc.M505820200; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Morito N, 2006, CANCER RES, V66, P812, DOI 10.1158/0008-5472.CAN-05-2154; Nishihara M, 2007, INT IMMUNOL, V19, P695, DOI 10.1093/intimm/dxm045; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Shin HCK, 1999, CYTOKINE, V11, P257, DOI 10.1006/cyto.1998.0433; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Takatori H, 2005, J IMMUNOL, V174, P3734, DOI 10.4049/jimmunol.174.6.3734; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Weigmann B, 2004, J IMMUNOL, V173, P3446, DOI 10.4049/jimmunol.173.5.3446; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123; Yamamoto T, 2006, GENES CELLS, V11, P575, DOI 10.1111/j.1365-2443.2006.00965.x; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yang Y, 2005, J IMMUNOL, V174, P2720, DOI 10.4049/jimmunol.174.5.2720; Zhu YC, 2004, J IMMUNOL, V173, P2918, DOI 10.4049/jimmunol.173.5.2918	42	33	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14963	14971		10.1074/jbc.M111.218867	http://dx.doi.org/10.1074/jbc.M111.218867			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21402704	Green Published, hybrid			2022-12-25	WOS:000289788300026
J	Oh, CS; Martin, GB				Oh, Chang-Sik; Martin, Gregory B.			Tomato 14-3-3 Protein TFT7 Interacts with a MAP Kinase Kinase to Regulate Immunity-associated Programmed Cell Death Mediated by Diverse Disease Resistance Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE REGULATOR; DOCKING SITES; RECOGNITION; CASCADES; PATHWAY; SYSTEM; GENES; FORM	Programmed cell death (PCD) associated with immunity is triggered when a plant disease resistance (R) protein recognizes a corresponding pathogen virulence protein. In tomato, detection by the host Pto kinase of the Pseudomonas syringae proteins AvrPto or AvrPtoB causes localized PCD. Previously, we reported that both MAPKKK alpha (mitogen-activated protein kinase kinase kinase) and the tomato 14-3-3 protein 7 (TFT7) positively regulate Pto-mediated PCD in tomato and Nicotiana benthamiana. In addition, in contrast to MAPKKK alpha, TFT7 is required for PCD mediated by four other R proteins. Here we investigate why TFT7 is required for PCD induced by diverse R proteins in plants. We discovered that a MAPKK, SlMKK2, which acts downstream of SlMAPKKK alpha, also interacts with TFT7 in plant cells. Gene silencing experiments revealed that the orthologous genes of both SlMKK2 and TFT7 in N. benthamiana are required for PCD mediated by the same set of R proteins. SlMKK2 and its orthologs contain a 14-3-3 binding site in their N terminus, and Thr(33) in this site is required for interaction with TFT7 in vivo. Like the structurally similar human 14-3-3 is an element of protein, TFT7 forms a homodimer in vivo. Because TFT7 interacts with both SlMAPKKK alpha and SlMKK2 and also forms a homodimer, we propose that TFT7 may coordinately recruit these client proteins for efficient signal transfer, leading to PCD induction.	[Oh, Chang-Sik; Martin, Gregory B.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Oh, Chang-Sik] Kyung Hee Univ, Dept Hort Biotechnol, Yongin 446701, South Korea; [Martin, Gregory B.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research; Kyung Hee University; Cornell University	Martin, GB (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	gbm7@cornell.edu	Martin, Gregory B/F-6262-2011	Martin, Gregory B/0000-0003-0044-6830	Israel-USA Binational Agriculture Research and Development Fund [IS-4159-08C]	Israel-USA Binational Agriculture Research and Development Fund	This work was supported by grant IS-4159-08C from the Israel-USA Binational Agriculture Research and Development Fund.	Bardwell AJ, 2009, J BIOL CHEM, V284, P13165, DOI 10.1074/jbc.M900080200; Bendahmane A, 2000, PLANT J, V21, P73, DOI 10.1046/j.1365-313x.2000.00654.x; BRIDGES D, 2005, SCI STKE RE, V10, P2; Brigneti G, 2004, PLANT J, V39, P264, DOI 10.1111/j.1365-313X.2004.02122.x; Chaudhri M, 2003, BIOCHEM BIOPH RES CO, V300, P679, DOI 10.1016/S0006-291X(02)02902-9; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; Day B, 2005, PLANT CELL, V17, P1292, DOI 10.1105/tpc.104.030163; del Pozo O, 2004, EMBO J, V23, P3072, DOI 10.1038/sj.emboj.7600283; Ekengren SK, 2003, PLANT J, V36, P905, DOI 10.1046/j.1365-313X.2003.01944.x; Fritz A, 2006, J BIOL CHEM, V281, P6236, DOI 10.1074/jbc.M509249200; Gutierrez JR, 2010, PLANT J, V61, P507, DOI 10.1111/j.1365-313X.2009.04078.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jin HL, 2002, DEV CELL, V3, P291, DOI 10.1016/S1534-5807(02)00205-8; Jin HL, 2003, PLANT J, V33, P719, DOI 10.1046/j.1365-313X.2003.01664.x; Kang HG, 2010, PLANT CELL, V22, P918, DOI 10.1105/tpc.109.071662; Kiegerl S, 2000, PLANT CELL, V12, P2247, DOI 10.1105/tpc.12.11.2247; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Oh CS, 2011, TRENDS PLANT SCI, V16, P132, DOI 10.1016/j.tplants.2010.11.001; Oh CS, 2010, PLANT CELL, V22, P260, DOI 10.1105/tpc.109.070664; Oh CS, 2010, PLANT PATHOLOGY J, V26, P1, DOI 10.5423/PPJ.2010.26.1.001; Peart JR, 2002, P NATL ACAD SCI USA, V99, P10865, DOI 10.1073/pnas.152330599; Pedley KF, 2005, CURR OPIN PLANT BIOL, V8, P541, DOI 10.1016/j.pbi.2005.07.006; Pedley KF, 2004, J BIOL CHEM, V279, P49229, DOI 10.1074/jbc.M410323200; Rentel MC, 2008, P NATL ACAD SCI USA, V105, P1091, DOI 10.1073/pnas.0711215105; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Sacco MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000564; Sehnke PC, 2002, PLANT CELL, V14, pS339, DOI 10.1105/tpc.010430; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; van Doorn WG, 2005, TRENDS PLANT SCI, V10, P117, DOI 10.1016/j.tplants.2005.01.006; Velasquez A.C., 2009, J VIS EXP, V28, P1292; Yang KY, 2001, P NATL ACAD SCI USA, V98, P741, DOI 10.1073/pnas.98.2.741; Yang XH, 2009, PLANT J, V60, P539, DOI 10.1111/j.1365-313X.2009.03978.x; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103	42	57	59	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14129	14136		10.1074/jbc.M111.225086	http://dx.doi.org/10.1074/jbc.M111.225086			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21378171	hybrid, Green Published			2022-12-25	WOS:000289556200036
J	Bollazzi, M; Roces, F				Bollazzi, Martin; Roces, Flavio			Information Needs at the Beginning of Foraging: Grass-Cutting Ants Trade Off Load Size for a Faster Return to the Nest	PLOS ONE			English	Article							ATTA-CEPHALOTES L; HARVESTER ANTS; ACROMYRMEX-LUNDI; LEAF; SELECTION; COLOMBICA; STRATEGIES; BEHAVIOR; FORMICIDAE; DISTANCE	Background: Acquisition of information about food sources is essential for animals that forage collectively like social insects. Foragers deliver two commodities to the nest, food and information, and they may favor the delivery of one at the expenses of the other. We predict that information needs should be particularly high at the beginning of foraging: the decision to return faster to the nest will motivate a grass-cutting ant worker to reduce its loading time, and so to leave the source with a partial load. Principal Findings: Field results showed that at the initial foraging phase, most grass-cutting ant foragers (Acromyrmex heyeri) returned unladen to the nest, and experienced head-on encounters with outgoing workers. Ant encounters were not simply collisions in a probabilistic sense: outgoing workers contacted in average 70% of the returning foragers at the initial foraging phase, and only 20% at the established phase. At the initial foraging phase, workers cut fragments that were shorter, narrower, lighter and tenderer than those harvested at the established one. Foragers walked at the initial phase significantly faster than expected for the observed temperatures, yet not at the established phase. Moreover, when controlling for differences in the fragment-size carried, workers still walked faster at the initial phase. Despite the higher speed, their individual transport rate of vegetable tissue was lower than that of similarly-sized workers foraging later at the same patch. Conclusions/Significance: At the initial foraging phase, workers compromised their individual transport rates of material in order to return faster to the colony. We suggest that the observed flexible cutting rules and the selection of partial loads at the beginning of foraging are driven by the need of information transfer, crucial for the establishment and maintenance of a foraging process to monopolize a discovered resource.	[Bollazzi, Martin; Roces, Flavio] Univ Wurzburg, Dept Behav Physiol & Sociobiol, Bioctr, Wurzburg, Germany; [Bollazzi, Martin] Univ Republica, Fac Agron, Dept Entomol, Montevideo, Uruguay; [Bollazzi, Martin] Univ Republ, Ctr Univ Rivera, Rivera, Uruguay	University of Wurzburg; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Bollazzi, M (corresponding author), Univ Wurzburg, Dept Behav Physiol & Sociobiol, Bioctr, Wurzburg, Germany.	roces@biozentrum.uni-wuerzburg.de		Bollazzi, Martin/0000-0003-3361-5602; Roces, Flavio/0000-0001-9258-3079	German Academic Exchange Service (DAAD); German Research Foundation [DFG - SFB 567]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation(German Research Foundation (DFG))	This research was supported by the German Academic Exchange Service (DAAD, fellowship granted to MB) and the German Research Foundation (DFG - SFB 567 "Mechanisms of Interspecific Interactions of Organisms''). The publications costs were covered by the German Research Foundation (DFG) in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes TC, 1932, BIOL BULL-US, V62, P306, DOI 10.2307/1537511; BERTSCH A, 1984, OECOLOGIA, V62, P325, DOI 10.1007/BF00384264; Burd M, 2000, BEHAV ECOL, V11, P125, DOI 10.1093/beheco/11.2.125; Burd M, 2003, INSECT SOC, V50, P3, DOI 10.1007/s000400300001; Burd M, 2000, ANIM BEHAV, V60, P781, DOI 10.1006/anbe.2000.1537; BURD M, 1995, J INSECT BEHAV, V8, P715, DOI 10.1007/BF01997240; CHERRETT JM, 1972, J ANIM ECOL, V41, P647, DOI 10.2307/3200; Daguerre J. B., 1945, REV SOC ENT ARGENTINA, V12, P438; Detrain C, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P331; Detrain C, 2009, CONTEMP TOP ENTOMOL, P29; Dornhaus A, 2006, BEHAV ECOL SOCIOBIOL, V61, P151, DOI 10.1007/s00265-006-0246-5; Dussutour A, 2007, INSECT SOC, V54, P158, DOI 10.1007/s00040-007-0926-9; Farji-Brener AG, 2010, ANIM BEHAV, V79, P343, DOI 10.1016/j.anbehav.2009.11.009; Gordon D. M., 2010, ANT ENCOUNTERS INTER, P167; Gordon DM, 2008, BEHAV ECOL, V19, P217, DOI 10.1093/beheco/arm125; GORDON DM, 1993, ANIM BEHAV, V45, P1083, DOI 10.1006/anbe.1993.1134; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Gordon DM, 1999, BEHAV ECOL SOCIOBIOL, V45, P370, DOI 10.1007/s002650050573; Greene MJ, 2007, BEHAV ECOL, V18, P451, DOI 10.1093/beheco/arl105; HODGSON ES, 1955, ECOLOGY, V36, P293, DOI 10.2307/1933235; HOWARD JJ, 1987, ECOLOGY, V68, P503, DOI 10.2307/1938455; Howard JJ, 1996, ANIM BEHAV, V52, P299, DOI 10.1006/anbe.1996.0175; JAFFE K, 1979, ANIM BEHAV, V27, P930, DOI 10.1016/0003-3472(79)90031-9; JAFFE K, 1985, INSECT SOC, V32, P257, DOI 10.1007/BF02224915; LEWIS T, 1974, J ANIM ECOL, V43, P129, DOI 10.2307/3162; LUGO AE, 1973, ECOLOGY, V54, P1292, DOI 10.2307/1934191; Lutz FE, 1929, AM MUS NOVIT, V388, P1, DOI DOI 10.1206/0003-0082(2006)502[0001:NSAFRS]2.0.CO;2; Moll K, 2010, J COMP PHYSIOL A, V196, P471, DOI 10.1007/s00359-010-0535-3; NUNEZ J A, 1970, Animal Behaviour, V18, P527, DOI 10.1016/0003-3472(70)90049-7; NUNEZ JA, 1966, Z VERGL PHYSIOL, V53, P142; Nunez JA, 1996, BEE WORLD, V77, P182, DOI 10.1080/0005772X.1996.11099313; NUNEZ JA, 1982, J APICULT RES, V21, P139, DOI 10.1080/00218839.1982.11100531; PFLUMM W, 1986, ETHOLOGY, V72, P15; ROCES F, 1993, BEHAV ECOL SOCIOBIOL, V33, P183, DOI 10.1007/BF00216599; ROCES F, 1994, OECOLOGIA, V97, P1, DOI 10.1007/BF00317902; ROCES F, 1990, OECOLOGIA, V83, P261, DOI 10.1007/BF00317762; ROCES F, 1993, ANIM BEHAV, V45, P135, DOI 10.1006/anbe.1993.1012; ROCES F, 1994, INSECT SOC, V41, P235, DOI 10.1007/BF01242294; ROCES F, 1990, ANIM BEHAV, V40, P1181, DOI 10.1016/S0003-3472(05)80185-X; Roces Flavio, 2009, P289; Roces F, 2009, CONTEMP TOP ENTOMOL, P261; Roschard J, 2003, J TROP ECOL, V19, P647, DOI 10.1017/S0266467403006047; Roschard J, 2002, OECOLOGIA, V131, P319, DOI 10.1007/s00442-002-0882-z; RUDOLPH SG, 1986, ECOL ENTOMOL, V11, P401, DOI 10.1111/j.1365-2311.1986.tb00319.x; Saverschek N, 2010, ANIM BEHAV, V79, P689, DOI 10.1016/j.anbehav.2009.12.021; Schafer RJ, 2006, ANIM BEHAV, V71, P815, DOI 10.1016/j.anbehav.2005.05.024; Shapley H, 1924, P NATL ACAD SCI USA, V10, P436, DOI 10.1073/pnas.10.10.436; STRADLING DJ, 1978, J ANIM ECOL, V47, P173, DOI 10.2307/3930; Torres-Contreras H, 2007, ETHOLOGY, V113, P76, DOI 10.1111/j.1439-0310.2006.01302.x; TRANIELLO JFA, 1989, ANNU REV ENTOMOL, V34, P191, DOI 10.1146/annurev.en.34.010189.001203; Whitehouse MEA, 1996, ANIM BEHAV, V51, P1207, DOI 10.1006/anbe.1996.0126; YDENBERG R, 1994, TRENDS ECOL EVOL, V9, P491, DOI 10.1016/0169-5347(94)90321-2	52	41	41	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17667	10.1371/journal.pone.0017667	http://dx.doi.org/10.1371/journal.pone.0017667			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408014	Green Submitted, Green Published, gold			2022-12-25	WOS:000288170900038
J	John, S; Weiss, JN; Ribalet, B				John, Scott; Weiss, James N.; Ribalet, Bernard			Subcellular Localization of Hexokinases I and II Directs the Metabolic Fate of Glucose	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; HUMAN BRAIN HEXOKINASE; GLYCOGEN-SYNTHASE; MITOCHONDRIAL HEXOKINASE; MAMMALIAN HEXOKINASE; HUMAN MUSCLE; PROTEIN; CELLS; GLUCOSE-6-PHOSPHATE; BINDING	Background: The first step in glucose metabolism is conversion of glucose to glucose 6-phosphate (G-6-P) by hexokinases (HKs), a family with 4 isoforms. The two most common isoforms, HKI and HKII, have overlapping tissue expression, but different subcellular distributions, with HKI associated mainly with mitochondria and HKII associated with both mitochondrial and cytoplasmic compartments. Here we tested the hypothesis that these different subcellular distributions are associated with different metabolic roles, with mitochondrially-bound HK's channeling G-6-P towards glycolysis (catabolic use), and cytoplasmic HKII regulating glycogen formation (anabolic use). Methodology/Principal Findings: To study subcellular translocation of HKs in living cells, we expressed HKI and HKII linked to YFP in CHO cells. We concomitantly recorded the effects on glucose handling using the FRET based intracellular glucose biosensor, FLIPglu-600 mM, and glycogen formation using a glycogen-associated protein, PTG, tagged with GFP. Our results demonstrate that HKI remains strongly bound to mitochondria, whereas HKII translocates between mitochondria and the cytosol in response to glucose, G-6-P and Akt, but not ATP. Metabolic measurements suggest that HKI exclusively promotes glycolysis, whereas HKII has a more complex role, promoting glycolysis when bound to mitochondria and glycogen synthesis when located in the cytosol. Glycogen breakdown upon glucose removal leads to HKII inhibition and dissociation from mitochondria, probably mediated by increases in glycogen-derived G-6-P. Conclusions/Significance: These findings show that the catabolic versus anabolic fate of glucose is dynamically regulated by extracellular glucose via signaling molecules such as intracellular glucose, G-6-P and Akt through regulation and subcellular translocation of HKII. In contrast, HKI, which activity and regulation is much less sensitive to these factors, is mainly committed to glycolysis. This may be an important mechanism by which HK's allow cells to adapt to changing metabolic conditions to maintain energy balance and avoid injury.	[Weiss, James N.; Ribalet, Bernard] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Lab, Dept Physiol, Los Angeles, CA 90095 USA; [John, Scott; Weiss, James N.] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Lab, Dept Med Cardiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	John, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Lab, Dept Med Cardiol, Los Angeles, CA 90095 USA.	bribalet@mednet.ucla.edu		John, Scott/0000-0002-1232-9140	NIH [R37HL60025, P01 HL071870]; Laubisch and Kawata Endowments; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071870, R37HL060025] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laubisch and Kawata Endowments; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants R37HL60025 and P01 HL071870, Laubisch and Kawata Endowments to J.N.W. and a Laubsich endowment to S.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin AE, 1998, J MOL BIOL, V282, P345, DOI 10.1006/jmbi.1998.2017; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Cesar MD, 2002, ARCH BIOCHEM BIOPHYS, V397, P106, DOI 10.1006/abbi.2001.2639; Cifuentes D, 2008, J BIOL CHEM, V283, P5642, DOI 10.1074/jbc.M706334200; Depre C, 1999, CIRCULATION, V99, P578, DOI 10.1161/01.CIR.99.4.578; ELLISON WR, 1975, J BIOL CHEM, V250, P1864; Fang TY, 1998, J BIOL CHEM, V273, P19548, DOI 10.1074/jbc.273.31.19548; Fehr M, 2003, J BIOL CHEM, V278, P19127, DOI 10.1074/jbc.M301333200; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; Galluzzi L, 2008, ONCOGENE, V27, P4633, DOI 10.1038/onc.2008.114; Gimenez-Cassina A, 2009, J BIOL CHEM, V284, P3001, DOI 10.1074/jbc.M808698200; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; John SA, 2008, PFLUG ARCH EUR J PHY, V456, P307, DOI 10.1007/s00424-007-0395-z; Jurczak MJ, 2008, J CELL BIOCHEM, V104, P435, DOI 10.1002/jcb.21634; Lerin C, 2000, J BIOL CHEM, V275, P39991, DOI 10.1074/jbc.M006251200; LOWRY OH, 1964, J BIOL CHEM, V239, P31; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; MANDARINO LJ, 1995, AM J PHYSIOL-ENDOC M, V269, pE701; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; POSTIC C, 1994, AM J PHYSIOL, V266, pE548, DOI 10.1152/ajpendo.1994.266.4.E548; PURICH DL, 1971, J BIOL CHEM, V246, P3456; ROSE IA, 1967, J BIOL CHEM, V242, P1635; Schulz AR, 1998, ARCH BIOCHEM BIOPHYS, V353, P172, DOI 10.1006/abbi.1998.0643; Skaff DA, 2005, J BIOL CHEM, V280, P38403, DOI 10.1074/jbc.M506943200; Sui DX, 1997, ARCH BIOCHEM BIOPHYS, V345, P111, DOI 10.1006/abbi.1997.0241; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Syed NA, 2000, MOL CELL BIOCHEM, V211, P123, DOI 10.1023/A:1007159422667; Taylor AJ, 2006, J ENDOCRINOL, V188, P11, DOI 10.1677/joe.1.06381; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241	30	145	153	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17674	10.1371/journal.pone.0017674	http://dx.doi.org/10.1371/journal.pone.0017674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408025	Green Submitted, gold, Green Published			2022-12-25	WOS:000288170900039
J	Dang, TNH; Thi, PTL; Wolbers, M; Quang, TC; Van, MHN; Vu, TNT; Thi, PTL; Hoan, PN; Thi, HCT; Xuan, SD; Song, DT; Thi, THH; Truong, H; Campbell, J; Van, VCN; Tran, CN; Van, DN; Thi, HN; Spratt, BG; Tinh, HT; Farrar, J; Schultsz, C				Dang Trung Nghia Ho; Thi Phuong Tu Le; Wolbers, Marcel; Quang Thai Cao; Van Minh Hoang Nguyen; Vu Thieu Nga Tran; Thi Phuong Thao Le; Hoan Phu Nguyen; Thi Hong Chau Tran; Xuan Sinh Dinh; Song Diep To; Thi Thanh Hang Hoang; Truong Hoang; Campbell, James; Van Vinh Chau Nguyen; Tran Chinh Nguyen; Van Dung Nguyen; Thi Hoa Ngo; Spratt, Brian G.; Tinh Hien Tran; Farrar, Jeremy; Schultsz, Constance			Risk Factors of Streptococcus suis Infection in Vietnam. A Case-Control Study	PLOS ONE			English	Article							MENINGITIS	Background: Streptococcus suis infection, an emerging zoonosis, is an increasing public health problem across South East Asia and the most common cause of acute bacterial meningitis in adults in Vietnam. Little is known of the risk factors underlying the disease. Methods and Findings: A case-control study with appropriate hospital and matched community controls for each patient was conducted between May 2006 and June 2009. Potential risk factors were assessed using a standardized questionnaire and investigation of throat and rectal S. suis carriage in cases, controls and their pigs, using real-time PCR and culture of swab samples. We recruited 101 cases of S. suis meningitis, 303 hospital controls and 300 community controls. By multivariate analysis, risk factors identified for S. suis infection as compared to either control group included eating "high risk" dishes, including such dishes as undercooked pig blood and pig intestine (OR1 = 2.22; 95% CI = [1.15-4.28] and OR2 = 4.44; 95% CI = [2.15-9.15]), occupations related to pigs (OR1 = 3.84; 95% CI = [1.32-11.11] and OR2 = 5.52; 95% CI = [1.49-20.39]), and exposures to pigs or pork in the presence of skin injuries (OR1 = 7.48; 95% CI = [1.97-28.44] and OR2 = 15.96; 95% CI = [2.97-85.72]). S. suis specific DNA was detected in rectal and throat swabs of 6 patients and was cultured from 2 rectal samples, but was not detected in such samples of 1522 healthy individuals or patients without S. suis infection. Conclusions: This case control study, the largest prospective epidemiological assessment of this disease, has identified the most important risk factors associated with S. suis bacterial meningitis to be eating 'high risk' dishes popular in parts of Asia, occupational exposure to pigs and pig products, and preparation of pork in the presence of skin lesions. These risk factors can be addressed in public health campaigns aimed at preventing S. suis infection.	[Dang Trung Nghia Ho; Thi Phuong Tu Le; Wolbers, Marcel; Quang Thai Cao; Van Minh Hoang Nguyen; Vu Thieu Nga Tran; Thi Phuong Thao Le; Thi Thanh Hang Hoang; Campbell, James; Thi Hoa Ngo; Tinh Hien Tran; Farrar, Jeremy; Schultsz, Constance] Univ Oxford, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Clin Res Unit, Ho Chi Minh City, Vietnam; [Dang Trung Nghia Ho; Thi Thanh Hang Hoang; Truong Hoang] Pham Ngoc Thach Univ Med, Ho Chi Minh City, Vietnam; [Van Dung Nguyen] Subdept Anim Hlth Ho Chi Minh City, Ho Chi Minh City, Vietnam; [Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Ctr Poverty Related Communicable Dis, NL-1105 AZ Amsterdam, Netherlands; [Spratt, Brian G.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London	Dang, TNH (corresponding author), Univ Oxford, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Clin Res Unit, Ho Chi Minh City, Vietnam.	schultsz@gmail.com	Farrar, Jeremy J./HGA-7610-2022	Farrar, Jeremy/0000-0002-2700-623X; Ngo, Hoa/0000-0001-9320-4050; Van Nguyen, Dung/0000-0002-0590-0679	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by the Wellcome Trust Major Overseas Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDS JP, 1988, REV INFECT DIS, V10, P131; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Harrell FE, 2001, REGRESSION MODELING; Ip M, 2007, DIAGN MICR INFEC DIS, V57, P15, DOI 10.1016/j.diagmicrobio.2006.05.011; KAY R, 1995, QJM-INT J MED, V88, P39; KHADTHASRIMA HTN, 2007, HUMAN STREPTOCOCCUS; Ma Y, 2009, PHILOS T R SOC B, V364, P2725, DOI 10.1098/rstb.2009.0093; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; NGA TVT, DIAGN MICRO IN PRESS; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Strangmann E, 2002, INT J HYG ENVIR HEAL, V205, P385, DOI 10.1078/1438-4639-00165; Walsh B., 1992, Reviews in Medical Microbiology, V3, P65; Wertheim HFL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005973; Wisselink HJ, 1999, VET MICROBIOL, V67, P143, DOI 10.1016/S0378-1135(99)00036-X; Yu Hong-jie, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P636; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; STAT YB VIET NAM 200	17	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17604	10.1371/journal.pone.0017604	http://dx.doi.org/10.1371/journal.pone.0017604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408132	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170000045
J	Trulsson, M; Yu, H; Gisselsson, L; Chao, YX; Urbano, A; Aits, S; Mossberg, AK; Svanborg, C				Trulsson, Maria; Yu, Hao; Gisselsson, Lennart; Chao, Yinxia; Urbano, Alexander; Aits, Sonja; Mossberg, Ann-Kristin; Svanborg, Catharina			HAMLET Binding to alpha-Actinin Facilitates Tumor Cell Detachment	PLOS ONE			English	Article							APOPTOSIS-LIKE MECHANISM; GENE AMPLIFICATION; FOURIER HOLOGRAPHY; ALPHA-ACTININ-4; LACTALBUMIN; PROTEIN; CANCER; ANOIKIS; SITE; TUMORIGENICITY	Cell adhesion is tightly regulated by specific molecular interactions and detachment from the extracellular matrix modifies proliferation and survival. HAMLET (Human Alpha-lactalbumin Made LEthal to Tumor cells) is a protein-lipid complex with tumoricidal activity that also triggers tumor cell detachment in vitro and in vivo, suggesting that molecular interactions defining detachment are perturbed in cancer cells. To identify such interactions, cell membrane extracts were used in Far-western blots and HAMLET was shown to bind alpha-actinins; major F-actin cross-linking proteins and focal adhesion constituents. Synthetic peptide mapping revealed that HAMLET binds to the N-terminal actin-binding domain as well as the integrin-binding domain of alpha-actinin-4. By co-immunoprecipitation of extracts from HAMLET-treated cancer cells, an interaction with alpha-actinin-1 and -4 was observed. Inhibition of alpha-actinin-1 and alpha-actinin-4 expression by siRNA transfection increased detachment, while alpha-actinin-4-GFP over-expression significantly delayed rounding up and detachment of tumor cells in response to HAMLET. In response to HAMLET, adherent tumor cells rounded up and detached, suggesting a loss of the actin cytoskeletal organization. These changes were accompanied by a reduction in beta 1 integrin staining and a decrease in FAK and ERK1/2 phosphorylation, consistent with a disruption of integrin-dependent cell adhesion signaling. Detachment per se did not increase cell death during the 22 hour experimental period, regardless of alpha-actinin-4 and alpha-actinin-1 expression levels but adherent cells with low alpha-actinin levels showed increased death in response to HAMLET. The results suggest that the interaction between HAMLET and alpha-actinins promotes tumor cell detachment. As alpha-actinins also associate with signaling molecules, cytoplasmic domains of transmembrane receptors and ion channels, additional alpha-actinin-dependent mechanisms are discussed.	[Trulsson, Maria; Yu, Hao; Aits, Sonja; Mossberg, Ann-Kristin; Svanborg, Catharina] Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, Lund, Sweden; [Gisselsson, Lennart] Phase Holog Imaging AB, Lund, Sweden; [Chao, Yinxia; Urbano, Alexander] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore	Lund University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Trulsson, M (corresponding author), Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, Lund, Sweden.	catharina.svanborg@med.lu.se	Aits, Sonja/D-1496-2011	Aits, Sonja/0000-0002-1321-0678; Chao, Yinxia/0000-0003-1185-3511	Sharon D. Lund Foundation; American Cancer Society; Swedish Cancer Society; Swedish Pediatric Cancer Foundation; Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation; Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society	Sharon D. Lund Foundation; American Cancer Society(American Cancer Society); Swedish Cancer Society(Swedish Cancer Society); Swedish Pediatric Cancer Foundation; Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society	This study was supported by the Sharon D. Lund Foundation grant and the American Cancer Society, the Swedish Cancer Society, the Swedish Pediatric Cancer Foundation, the Medical Faculty (Lund University), the Soderberg Foundation, the Segerfalk Foundation, the Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research, the Knut and Alice Wallenberg Foundation, the Lund City Jubileumsfond, the John and Augusta Persson Foundation for Medical Research, the Maggie Stephens Foundation, the Gunnar Nilsson Cancer Foundation, the Inga-Britt and Arne Lundberg Foundation, the HJ Forssman Foundation for Medical Research and the Royal Physiographic Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aits S, 2009, INT J CANCER, V124, P1008, DOI 10.1002/ijc.24076; BARON MD, 1987, BIOCHEM SOC T, V15, P796, DOI 10.1042/bst0150796; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Craig DH, 2008, NEOPLASIA, V10, P217, DOI 10.1593/neo.07945; Cuche E, 1999, OPT LETT, V24, P291, DOI 10.1364/OL.24.000291; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; Dubois F, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2357174; Duringer C, 2003, J BIOL CHEM, V278, P42131, DOI 10.1074/jbc.M306462200; ENDO T, 1982, J BIOCHEM, V92, P1457, DOI 10.1093/oxfordjournals.jbchem.a134070; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; Franzot G, 2005, J MOL BIOL, V348, P151, DOI 10.1016/j.jmb.2005.01.002; Fu L, 2007, CANCER-AM CANCER SOC, V110, P2672, DOI 10.1002/cncr.23110; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GLUCK U, 1993, P NATL ACAD SCI USA, V90, P383, DOI 10.1073/pnas.90.2.383; Gonzalez AM, 2001, J CELL SCI, V114, P4197; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Gustafsson M, 2004, OPT LASER ENG, V41, P553, DOI 10.1016/S0143-8166(02)00214-2; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hallgren O, 2006, APOPTOSIS, V11, P221, DOI 10.1007/s10495-006-3607-7; Hara T, 2007, MOL CELL PROTEOMICS, V6, P479, DOI 10.1074/mcp.M600129-MCP200; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Karpman D, 1998, INFECT IMMUN, V66, P636, DOI 10.1128/IAI.66.2.636-644.1998; Kelly DF, 2005, J STRUCT BIOL, V149, P290, DOI 10.1016/j.jsb.2004.11.010; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; Kohler C, 1999, EXP CELL RES, V249, P260, DOI 10.1006/excr.1999.4472; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Liu J, 2004, J MOL BIOL, V338, P115, DOI 10.1016/j.jmb.2004.02.034; Martin SS, 2004, BBA-MOL CELL RES, V1692, P145, DOI 10.1016/j.bbamcr.2004.02.008; Menez J, 2004, ONCOGENE, V23, P2630, DOI 10.1038/sj.onc.1207347; MONTEIRO J, EUR J CANC, V46, P1198; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; Nikolopoulos SN, 2000, ONCOGENE, V19, P380, DOI 10.1038/sj.onc.1203310; OTEY CA, 1993, J BIOL CHEM, V268, P21193; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Quick Q, 2010, EXP CELL RES, V316, P1137, DOI 10.1016/j.yexcr.2010.02.011; REN JS, 1993, J BIOL CHEM, V268, P19292; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; SCHNARS U, 2005, DIGITAL HOLOGRAPHY D, V9, P164; Sebesta M, 2005, OPT LETT, V30, P471, DOI 10.1364/OL.30.000471; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Svanborg C, 2003, ADV CANCER RES, V88, P1; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thorne RF, 2000, J BIOL CHEM, V275, P35264, DOI 10.1074/jbc.M003969200; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107	56	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17179	10.1371/journal.pone.0017179	http://dx.doi.org/10.1371/journal.pone.0017179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408150	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170000014
J	Achan, J; Tibenderana, J; Kyabayinze, D; Mawejje, H; Mugizi, R; Mpeka, B; Talisuna, A; D'Alessandro, U				Achan, Jane; Tibenderana, James; Kyabayinze, Daniel; Mawejje, Henry; Mugizi, Rukaaka; Mpeka, Betty; Talisuna, Ambrose; D'Alessandro, Umberto			Case Management of Severe Malaria - A Forgotten Practice: Experiences from Health Facilities in Uganda	PLOS ONE			English	Article							AFRICAN CHILDREN; INPATIENT MORTALITY; FALCIPARUM-MALARIA; PEDIATRIC CARE; HOSPITALS; QUALITY; TRIAGE	Introduction: Severe malaria is a life-threatening medical emergency and requires prompt and effective treatment to prevent death. There is paucity of published information on current practices of severe malaria case management in sub-Saharan Africa; we evaluated the management practices for severe malaria in Ugandan health facilities Methods and Findings: We did a cross sectional survey, using multi-stage sampling methods, of health facilities in 11 districts in the eastern and mid-western parts of Uganda. The study instruments were adapted from the WHO hospital care assessment tools. Between June and August 2009, 105 health facilities were surveyed and 181 health workers and 868 patients/caretakers interviewed. None of the inpatient facilities had all seven components of a basic care package for the management of severe malaria consistently available during the 3 months prior to the survey. Referral practices were appropriate for < 10% (18/196) of the patients. Prompt care at any health facility was reported by 29% (247/868) of patients. Severe malaria was correctly diagnosed in 27% of patients (233). Though the quinine dose and regimen was correct in the majority (611/868, 70.4%) of patients, it was administered in the correct volumes of 5% dextrose in only 18% (147/815). Most patients (80.1%) had several doses of quinine administered in one single 500 ml bottle of 5% dextrose. Medications were purchased by 385 (44%) patients and medical supplies by 478 patients (70.6%). Conclusions: Management of severe malaria in Ugandan health facilities was sub-optimal. These findings highlight the challenges of correctly managing severe malaria in resource limited settings. Priority areas for improvement include triage and emergency care, referral practises, quality of diagnosis and treatment, availability of medicines and supplies, training and support supervision.	[Achan, Jane] Makerere Univ, Dept Paediat & Child Hlth, Coll Hlth Sci, Kampala, Uganda; [Tibenderana, James; Mawejje, Henry; Mugizi, Rukaaka; Mpeka, Betty] Malaria Consortium Africa, Kampala, Uganda; [Tibenderana, James] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Kyabayinze, Daniel] Malaria Consortium, Communicable Dis Res Programme Consortium, Kampala, Uganda; [Talisuna, Ambrose] Makerere Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Kampala, Uganda; [D'Alessandro, Umberto] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium	Makerere University; University of London; London School of Hygiene & Tropical Medicine; Makerere University; Institute of Tropical Medicine (ITM)	Achan, J (corresponding author), Makerere Univ, Dept Paediat & Child Hlth, Coll Hlth Sci, Kampala, Uganda.	achanj@yahoo.co.uk	Tibenderana, James Kananura/M-2272-2018; D'Alessandro, Umberto/D-3457-2015	Tibenderana, James Kananura/0000-0002-0755-4597; D'Alessandro, Umberto/0000-0001-6341-5009; Kyabayinze, Daniel/0000-0002-0539-1341	Irish Aid	Irish Aid(CGIAR)	Financial support for this study was provided by the Irish Aid through a regional programme in the Malaria Consortium on Health Systems Strengthening for Equitable Access to Malaria and Other Communicable Disease Control. The funders of the study had no role in study design, data collection, data analysis, data interpretation, decision to publish or preparation of the manuscript.	[Anonymous], CDC GROWTH CHARTS; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Day N, 2007, AM J TROP MED HYG, V77, P29; Dondorp AM, 2007, T ROY SOC TROP MED H, V101, P633, DOI 10.1016/j.trstmh.2007.03.011; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Duke T, 2003, ARCH DIS CHILD, V88, P563, DOI 10.1136/adc.88.7.563; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; Faiz MA, 2005, LANCET, V366, P717; Gwer S, 2007, AM J TROP MED HYG, V77, P6, DOI 10.4269/ajtmh.2007.77.6; James CD, 2006, APPL HEALTH ECON HEA, V5, P137, DOI 10.2165/00148365-200605030-00001; *MMV, 2010, MED MAL VENT ACH CHA; Molyneux E, 2006, B WORLD HEALTH ORGAN, V84, P314, DOI 10.2471/BLT.04.019505; NEWTON CR, 1998, PHARMACOL THERAPEUT, V79, P153; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Opoka RO, 2008, PEDIATR INFECT DIS J, V27, P319, DOI 10.1097/INF.0b013e31815d74dd; Planche T, 2003, CLIN INFECT DIS, V37, P890, DOI 10.1086/377536; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Ssekabira U, 2008, AM J TROP MED HYG, V79, P826, DOI 10.4269/ajtmh.2008.79.826; Tamburlini G, 1999, ARCH DIS CHILD, V81, P478, DOI 10.1136/adc.81.6.478; *UG MIN HLTH, UG MAL CONTR STR 200; *UG MIN HLTH, 2003, NAT TREATM GUID; UNICEF, 2014, UG STAT; *USAID, 2003, HLTH SECT HUM RES CR; WHO, 2010, GUID TREATM MAL, V2nd; Winstanley P, 2004, CLIN MICROBIOL REV, V17, P612, DOI 10.1128/CMR.17.3.612-637.2004	25	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17053	10.1371/journal.pone.0017053	http://dx.doi.org/10.1371/journal.pone.0017053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390301	Green Published, gold			2022-12-25	WOS:000287932100009
J	Zhang, JY; Zou, ZS; Huang, A; Zhang, Z; Fu, JL; Xu, XS; Chen, LM; Li, BS; Wang, FS				Zhang, Ji-Yuan; Zou, Zheng-Sheng; Huang, Ang; Zhang, Zheng; Fu, Jun-Liang; Xu, Xiang-Sheng; Chen, Li-Ming; Li, Bao-Sen; Wang, Fu-Sheng			Hyper-Activated Pro-Inflammatory CD16(+) Monocytes Correlate with the Severity of Liver Injury and Fibrosis in Patients with Chronic Hepatitis B	PLOS ONE			English	Article							T-CELLS; DISEASE PROGRESSION; VIRUS; DAMAGE; CD14	Background: Extensive mononuclear cell infiltration is strongly correlated with liver damage in patients with chronic hepatitis B virus (CHB) infection. Macrophages and infiltrating monocytes also participate in the development of liver damage and fibrosis in animal models. However, little is known regarding the immunopathogenic role of peripheral blood monocytes and intrahepatic macrophages. Methodology/Principal Findings: The frequencies, phenotypes, and functions of peripheral blood and intrahepatic monocyte/macrophage subsets were analyzed in 110 HBeAg positive CHB patients, including 32 immune tolerant (IT) carriers and 78 immune activated (IA) patients. Liver biopsies from 20 IA patients undergoing diagnosis were collected for immunohistochemical analysis. IA patients displayed significant increases in peripheral blood monocytes and intrahepatic macrophages as well as CD16(+) subsets, which were closely associated with serum alanine aminotransferase (ALT) levels and the liver histological activity index (HAI) scores. In addition, the increased CD16(+) monocytes/macrophages expressed higher levels of the activation marker HLA-DR compared with CD16(-) monocytes/macrophages. Furthermore, peripheral blood CD16(+) monocytes preferentially released inflammatory cytokines and hold higher potency in inducing the expansion of Th17 cells. Of note, hepatic neutrophils also positively correlated with HAI scores. Conclusions: These distinct properties of monocyte/macrophage subpopulations participate in fostering the inflammatory microenvironment and liver damage in CHB patients and further represent a collaborative scenario among different cell types contributing to the pathogenesis of HBV-induced liver disease.	[Zhang, Ji-Yuan; Zhang, Zheng; Fu, Jun-Liang; Xu, Xiang-Sheng; Chen, Li-Ming; Wang, Fu-Sheng] Beijing 302 Hosp, Res Ctr Biol Therapy, Beijing, Peoples R China; [Zou, Zheng-Sheng; Huang, Ang; Li, Bao-Sen] Beijing 302 Hosp, Dept Infect Dis, Beijing, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital	Zhang, JY (corresponding author), Beijing 302 Hosp, Res Ctr Biol Therapy, Beijing, Peoples R China.	libaosen16@sina.com; fswang@public.bta.net.cn		Huang, Ang/0000-0001-8876-9903	National Grand Program on Key Infectious Disease [2009ZX10004-103, 2009ZX10004-309, 2008ZX10002-007]; National Natural Science Foundation of China [30801039]	National Grand Program on Key Infectious Disease; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Grand Program on Key Infectious Disease (No. 2009ZX10004-103, No. 2009ZX10004-309 and 2008ZX10002-007) and the National Natural Science Foundation of China (No. 30801039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Dolganiuc A, 2004, GASTROENTEROLOGY, V127, P1513, DOI 10.1053/j.gastro.2004.08.067; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; Fouser LA, 2008, IMMUNOL REV, V226, P87, DOI 10.1111/j.1600-065X.2008.00712.x; Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341; Han JY, 2009, JAIDS-J ACQ IMM DEF, V52, P553, DOI 10.1097/QAI.0b013e3181c1d4fe; Kuang DM, 2010, HEPATOLOGY, V51, P154, DOI 10.1002/hep.23291; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Matsuzaki G, 2007, MICROBIOL IMMUNOL, V51, P1139, DOI 10.1111/j.1348-0421.2007.tb04008.x; MIROSLAVABLAHOV, 2010, HEPATOLOGY, V51, P2030; O'Quinn DB, 2008, ADV IMMUNOL, V99, P115, DOI 10.1016/S0065-2776(08)00605-6; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Sitia G, 2004, J CLIN INVEST, V113, P1158, DOI 10.1172/JCI200421087; WANG FS, 2009, GASTROENTEROL HEPATO, V3, P499; Xu DP, 2006, J IMMUNOL, V177, P739, DOI 10.4049/jimmunol.177.1.739; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107; Zhang JY, 2008, J IMMUNOL, V181, P3741, DOI 10.4049/jimmunol.181.6.3741; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273; Zhang Z, 2008, J HEPATOL, V49, P396, DOI 10.1016/j.jhep.2008.05.017; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Zou ZS, 2009, J CLIN GASTROENTEROL, V43, P182, DOI 10.1097/MCG.0b013e3181624464	28	83	109	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17484	10.1371/journal.pone.0017484	http://dx.doi.org/10.1371/journal.pone.0017484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390263	gold, Green Published, Green Submitted			2022-12-25	WOS:000287932100019
J	Du, JA; Miura, E; Robischon, M; Martinez, C; Groover, A				Du, Juan; Miura, Eriko; Robischon, Marcel; Martinez, Ciera; Groover, Andrew			The Populus Class III HD ZIP Transcription Factor POPCORONA Affects Cell Differentiation during Secondary Growth of Woody Stems	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; GENE FAMILY; LATERAL ORGANS; HOMEOBOX GENE; ARABIDOPSIS; MICRORNAS; BIOSYNTHESIS; GIBBERELLIN; EVOLUTION; POLARITY	The developmental mechanisms regulating cell differentiation and patterning during the secondary growth of woody tissues are poorly understood. Class III HD ZIP transcription factors are evolutionarily ancient and play fundamental roles in various aspects of plant development. Here we investigate the role of a Class III HD ZIP transcription factor, POPCORONA, during secondary growth of woody stems. Transgenic Populus (poplar) trees expressing either a miRNA-resistant POPCORONA or a synthetic miRNA targeting POPCORONA were used to infer function of POPCORONA during secondary growth. Whole plant, histological, and gene expression changes were compared for transgenic and wild-type control plants. Synthetic miRNA knock down of POPCORONA results in abnormal lignification in cells of the pith, while overexpression of a miRNA-resistant POPCORONA results in delayed lignification of xylem and phloem fibers during secondary growth. POPCORONA misexpression also results in coordinated changes in expression of genes within a previously described transcriptional network regulating cell differentiation and cell wall biosynthesis, and hormone-related genes associated with fiber differentiation. POPCORONA illustrates another function of Class III HD ZIPs: regulating cell differentiation during secondary growth.	[Du, Juan; Miura, Eriko; Robischon, Marcel; Groover, Andrew] US Forest Serv, Pacific SW Res Stn, Inst Forest Genet, Davis, CA USA; [Martinez, Ciera; Groover, Andrew] Univ Calif Davis, Plant Biol Grad Grp, Davis, CA 95616 USA	United States Department of Agriculture (USDA); United States Forest Service; University of California System; University of California Davis	Du, JA (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	agroover@fs.fed.us	Du, Juan/AAQ-5466-2020	DU, JUAN/0000-0001-8263-5189	DOE [DE-A102-05ER64115]	DOE(United States Department of Energy (DOE))	This work was supported by DOE grant DE-A102-05ER64115 to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONI R, 1982, PLANT PHYSIOL, V70, P1631, DOI 10.1104/pp.70.6.1631; ALONI R, 1979, PLANT PHYSIOL, V63, P609, DOI 10.1104/pp.63.4.609; Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Baima S, 1995, DEVELOPMENT, V121, P4171; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Du J, 2009, PLANT J, V60, P1000, DOI 10.1111/j.1365-313X.2009.04017.x; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Floyd SK, 2007, INT J PLANT SCI, V168, P1, DOI 10.1086/509079; Floyd SK, 2006, GENETICS, V173, P373, DOI 10.1534/genetics.105.054239; Green KA, 2005, PLANT CELL, V17, P691, DOI 10.1105/tpc.104.026179; Groover AT, 2006, PLANT MOL BIOL, V61, P917, DOI 10.1007/s11103-006-0059-y; Groover AT, 2010, PLANT GENET GENOMICS, V8, P201, DOI 10.1007/978-1-4419-1541-2_10; Groover AT, 2005, TRENDS PLANT SCI, V10, P210, DOI 10.1016/j.tplants.2005.03.001; Han KH, 2000, PLANT CELL REP, V19, P315, DOI 10.1007/s002990050019; Hertzberg M, 2001, P NATL ACAD SCI USA, V98, P14732, DOI 10.1073/pnas.261293398; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Izhaki A, 2007, PLANT CELL, V19, P495, DOI 10.1105/tpc.106.047472; Kerstetter RA, 2001, NATURE, V411, P706, DOI 10.1038/35079629; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kim YS, 2008, PLANT CELL, V20, P920, DOI 10.1105/tpc.107.057448; Ko JH, 2006, NEW PHYTOL, V169, P469, DOI 10.1111/j.1469-8137.2005.01623.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson, 1994, VASCULAR CAMBIUM; MADDISON WP, 1999, MACGLADE VERSION 3 0; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; McConnell JR, 1998, DEVELOPMENT, V125, P2935; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Nylander J. A. A., 2004, MRAIC; Ochando I, 2008, INT J DEV BIOL, V52, P953, DOI 10.1387/ijdb.072306io; Ochando I, 2006, PLANT PHYSIOL, V141, P607, DOI 10.1104/pp.106.077149; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Ohashi-Ito K, 2003, PLANT CELL PHYSIOL, V44, P1350, DOI 10.1093/pcp/pcg164; Prigge MJ, 2006, EVOL DEV, V8, P350, DOI 10.1111/j.1525-142X.2006.00107.x; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rieu I, 2008, PLANT CELL, V20, P2420, DOI 10.1105/tpc.108.058818; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Serrano-Cartagena J, 2000, GENETICS, V156, P1363; Spicer R, 2010, NEW PHYTOL, V186, P577, DOI 10.1111/j.1469-8137.2010.03236.x; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; TALBERT PB, 1995, DEVELOPMENT, V121, P2723; Thiel T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-209; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Wenkel S, 2007, PLANT CELL, V19, P3379, DOI 10.1105/tpc.107.055772; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; YAMAGUCHI M, 2010, PLANT PHYSIOL, V110; Yamaguchi M, 2008, PLANT J, V55, P652, DOI 10.1111/j.1365-313X.2008.03533.x; Zhong RQ, 1999, PLANT CELL, V11, P2139, DOI 10.1105/tpc.11.11.2139; Zhong RQ, 2001, PLANT PHYSIOL, V126, P549, DOI 10.1104/pp.126.2.549; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875	60	77	83	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17458	10.1371/journal.pone.0017458	http://dx.doi.org/10.1371/journal.pone.0017458			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386988	Green Published, gold, Green Submitted			2022-12-25	WOS:000287931400079
J	Letang, E; Miro, JM; Nhampossa, T; Ayala, E; Gascon, J; Menendez, C; Alonso, PL; Naniche, D				Letang, Emilio; Miro, Jose M.; Nhampossa, Tacilta; Ayala, Edgar; Gascon, Joaquim; Menendez, Clara; Alonso, Pedro L.; Naniche, Denise			Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome in a Rural Area of Mozambique	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; RISK-FACTORS; KAPOSIS-SARCOMA; RESTORATION DISEASE; INITIATION; TUBERCULOSIS; MORTALITY; AFRICA; EUROPE	Background: There is limited data on the epidemiology of Immune Reconstitution Inflammatory Syndrome (IRIS) in rural sub-Saharan Africa. A prospective observational cohort study was conducted to assess the incidence, clinical characteristics, outcome and predictors of IRIS in rural Mozambique. Methods: One hundred and thirty-six consecutive antiretroviral treatment (ART)-naive HIV-1-infected patients initiating ART at the Manhic, a district hospital were prospectively followed for development of IRIS over 16 months. Survival analysis by Cox regression was performed to identify pre-ART predictors of IRIS development. Results: Thirty-six patients developed IRIS [26.5%, incidence rate 3.1 cases/100 persons-month of ART (95% CI 2.2-4.3)]. Median time to IRIS onset was 62 days from ART initiation (IQR 35.5-93.5). Twenty-five cases (69.4%) were "unmasking", 10 (27.8%) were "paradoxical", and 1 (2.8%) developed a paradoxical worsening followed by the unmasking of another condition. Systemic OI (OI-IRIS) accounted for 47% (17/36) of IRIS cases, predominantly of KS (8 cases) and TB (6 cases) IRIS. Mucocutaneous IRIS manifestations (MC-IRIS) accounted for 53% (19/36) of IRIS events, mostly tinea (9 cases) and herpes simplex infection (3 cases). Multivariate analysis identified two independent predictors of IRIS development: pre-ART CD4 count < 50 cells/mu l (HR 2.3, 95% CI 1.19-4.44, p = 0.01) and body mass index (BMI) < 18.5 (HR 2.15, 95% CI 1.07-4.3, p = 0.03). The pre-cART proportion of activated T-cells, as well as the immunologic and virologic response to ART were not associated with IRIS development. All patients continued on ART, 7 (19.4%) required hospitalization and there were 3 deaths (8.3%) attributable to IRIS. Conclusions: IRIS is common in patients initiating ART in rural Mozambique. Pre-ART CD4 counts and BMI can easily be assessed at ART initiation in rural sub-Saharan Africa to identify patients at high risk of IRIS, for whom close supervision is warranted.	[Letang, Emilio; Nhampossa, Tacilta; Menendez, Clara; Alonso, Pedro L.; Naniche, Denise] CISM, Manhica, Maputo, Mozambique; [Miro, Jose M.] Univ Barcelona, Infect Dis Serv, Hosp Clin IDIBAPS, Barcelona, Spain; [Letang, Emilio; Ayala, Edgar; Gascon, Joaquim; Menendez, Clara; Alonso, Pedro L.; Naniche, Denise] Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin IDIBAPS, Barcelona, Spain	Centro de Investigacao em Saude de Manhica; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Letang, E (corresponding author), CISM, Manhica, Maputo, Mozambique.	emili.letang@cresib.cat; dsuzanne@clinic.ub.es	Gascon, Joaquim/M-3598-2015; Alonso, Pedro L/AAZ-3645-2020; Menéndez, Clara/Q-3446-2016; Naniche, Denise S/S-1814-2018	Gascon, Joaquim/0000-0002-5045-1585; Alonso, Pedro L/0000-0003-3292-3443; Menéndez, Clara/0000-0002-2641-6907; Naniche, Denise S/0000-0002-4495-6325	Fundacio "la Caixa"; Agencia Catalana de Cooperacio al Desenvolupament (ACCD); Spanish Agency for International Cooperation and Development; Agencia Catalana de Cooperacio al Desenvolupament; Spanish Ministry of Education and Science (Rio Hortega); Spanish Ministry of Education and Science (Ramon y Cajal); Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona (Spain); Spanish Network for AIDS Research (RIS) [ISCIII-RETIC RD06/006]; Madrid (Spain)	Fundacio "la Caixa"(La Caixa FoundationEuropean Commission); Agencia Catalana de Cooperacio al Desenvolupament (ACCD); Spanish Agency for International Cooperation and Development(Spanish Government); Agencia Catalana de Cooperacio al Desenvolupament; Spanish Ministry of Education and Science (Rio Hortega)(Spanish Government); Spanish Ministry of Education and Science (Ramon y Cajal)(Spanish Government); Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona (Spain); Spanish Network for AIDS Research (RIS); Madrid (Spain)	Financial support was received from the Fundacio "la Caixa", and the Agencia Catalana de Cooperacio al Desenvolupament (ACCD). The "Centro de Investigacao em Saude de Manhica" receives core funding from the Spanish Agency for International Cooperation and Development. The VCT center is supported by the Agencia Catalana de Cooperacio al Desenvolupament. E. L. is supported by a grant from the Spanish Ministry of Education and Science (Rio Hortega). D.N. was supported by a grant from the Spanish Ministry of Education and Science (Ramon y Cajal). J.M.M. received a Research Grant from the "Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona (Spain), and the Spanish Network for AIDS Research (RIS; ISCIII-RETIC RD06/006), Madrid (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli LRV, 2010, BLOOD, V116, P3818, DOI 10.1182/blood-2010-05-285080; Bonham S, 2008, BIOMARK MED, V2, P349, DOI 10.2217/17520363.2.4.349; Bower M, 2005, J CLIN ONCOL, V23, P5224, DOI 10.1200/JCO.2005.14.597; Breton G, 2004, CLIN INFECT DIS, V39, P1709, DOI 10.1086/425742; Cook PM, 1999, AIDS, V13, P1165, DOI 10.1097/00002030-199907090-00004; DeSimone JA, 2000, ANN INTERN MED, V133, P447, DOI 10.7326/0003-4819-133-6-200009190-00013; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Funk M, 2010, 18 INT AIDS C VIENN; Geng EH, 2009, CLIN INFECT DIS, V48, P362, DOI 10.1086/595889; Grant PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011416; Haddow LJ, 2009, CLIN INFECT DIS, V49, P1424, DOI 10.1086/630208; Hirsch HH, 2004, CLIN INFECT DIS, V38, P1159, DOI 10.1086/383034; Jevtovic D, 2005, HIV MED, V6, P140, DOI 10.1111/j.1468-1293.2005.00277.x; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lehloenya R, 2006, DERMATOL CLIN, V24, P549, DOI 10.1016/j.det.2006.06.007; Leidner RS, 2005, AIDS PATIENT CARE ST, V19, P635, DOI 10.1089/apc.2005.19.635; Letang E, 2010, JAIDS-J ACQ IMM DEF, V53, P589, DOI 10.1097/QAI.0b013e3181bc476f; Lortholary O, 2005, AIDS, V19, P1043, DOI 10.1097/01.aids.0000174450.70874.30; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2010, AIDS, V24, P2381, DOI 10.1097/QAD.0b013e32833dfc68; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Murdoch DA, 2008, AIDS, V22, P601, DOI 10.1097/QAD.0b013e3282f4a607; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Nweze EI, 2001, MED MYCOL, V39, P181, DOI 10.1080/714031015; Osei-Sekyere B, 2010, CLIN EXP DERMATOL, V35, P477, DOI 10.1111/j.1365-2230.2009.03620.x; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Price P, 2009, CLIN MICROBIOL REV, V22, P651, DOI 10.1128/CMR.00015-09; Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356; Seebacher C, 2008, MYCOPATHOLOGIA, V166, P335, DOI 10.1007/s11046-008-9100-9; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; Shelburne SA, 2002, MEDICINE, V81, P213, DOI 10.1097/00005792-200205000-00005; Shelburne SA, 2005, CLIN INFECT DIS, V40, P1049, DOI 10.1086/428618; van Hal SJ, 2005, CLIN INFECT DIS, V40, P113; WHO, 2009, TREATM TUB GUID	36	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16946	10.1371/journal.pone.0016946	http://dx.doi.org/10.1371/journal.pone.0016946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386993	gold, Green Published, Green Submitted			2022-12-25	WOS:000287931400015
J	Yao, I; Takao, K; Miyakawa, T; Ito, S; Setou, M				Yao, Ikuko; Takao, Keizo; Miyakawa, Tsuyoshi; Ito, Seiji; Setou, Mitsutoshi			Synaptic E3 Ligase SCRAPPER in Contextual Fear Conditioning: Extensive Behavioral Phenotyping of Scrapper Heterozygote and Overexpressing Mutant Mice	PLOS ONE			English	Article							ACTIVE ZONE; PROTEIN-DEGRADATION; INTERACTING PROTEIN; LATERAL AMYGDALA; CIRCADIAN CLOCK; GENE-EXPRESSION; MEMORY; HIPPOCAMPUS; UBIQUITIN; RIM1-ALPHA	SCRAPPER, an F-box protein coded by FBXL20, is a subunit of SCF type E3 ubiquitin ligase. SCRAPPER localizes synapses and directly binds to Rab3-interacting molecule 1 (RIM1), an essential factor for synaptic vesicle release, thus it regulates neural transmission via RIM1 degradation. A defect in SCRAPPER leads to neurotransmission abnormalities, which could subsequently result in neurodegenerative phenotypes. Because it is likely that the alteration of neural transmission in Scrapper mutant mice affect their systemic condition, we have analyzed the behavioral phenotypes of mice with decreased or increased the amount of SCRAPPER. We carried out a series of behavioral test batteries for Scrapper mutant mice. Scrapper transgenic mice overexpressing SCRAPPER in the hippocampus did not show any significant difference in every test argued in this manuscript by comparison with wild-type mice. On the other hand, heterozygotes of Scrapper knockout [SCR (+/-)] mice showed significant difference in the contextual but not cued fear conditioning test. In addition, SCR (+/-) mice altered in some tests reflecting anxiety, which implies the loss of functions of SCRAPPER in the hippocampus. The behavioral phenotypes of Scrapper mutant mice suggest that molecular degradation conferred by SCRAPPER play important roles in hippocampal-dependent fear memory formation.	[Yao, Ikuko; Ito, Seiji] Kansai Med Univ, Dept Med Chem, Osaka, Japan; [Yao, Ikuko; Setou, Mitsutoshi] Mitsubishi Kagaku Inst Life Sci, Tokyo, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Kyoto Univ, Genet Engn & Funct Genom Grp, Frontier Technol Ctr, Grad Sch Med, Kyoto, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Sect Behav Anal, Aichi, Japan; [Miyakawa, Tsuyoshi] Fujita Hlth Univ, Div Syst Med Sci, Inst Comprehens Med Sci, Aichi, Japan; [Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Mol Anat, Shizuoka, Japan	Kansai Medical University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Fujita Health University; Hamamatsu University School of Medicine	Yao, I (corresponding author), Kansai Med Univ, Dept Med Chem, Osaka, Japan.	yaoik@takii.kmu.ac.jp; setou@hama-med.ac.jp	Takao, Keizo/B-9527-2008; Miyakawa, Tsuyoshi/A-7741-2008	Takao, Keizo/0000-0002-4734-3583; Miyakawa, Tsuyoshi/0000-0003-0137-8200; ito, Seiji/0000-0002-0942-1624	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study is supported by: Grant-in-Aid for Scientific Research on Priority Areas (Research on Pathomechanisms on Brain Disorders) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to IY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Ageta H, 2001, J BIOL CHEM, V276, P15893, DOI 10.1074/jbc.M011097200; AGETA H, LEARN MEM, V17, P176; Ageta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001869; Amorapanth P, 2000, NAT NEUROSCI, V3, P74, DOI 10.1038/71145; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dardente H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003530; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; File SE, 1998, BEHAV NEUROSCI, V112, P352, DOI 10.1037/0735-7044.112.2.352; Fourcaudot E, 2009, NAT NEUROSCI, V12, P1093, DOI 10.1038/nn.2378; Gatfield D, 2007, SCIENCE, V316, P1135, DOI 10.1126/science.1144165; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Godsil BP, 2005, BEHAV NEUROSCI, V119, P1339, DOI 10.1037/0735-7044.119.5.1339; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Harrison FE, 2006, LEARN MEMORY, V13, P809, DOI 10.1101/lm.334306; Hashimoto-Gotoh T, 2009, FRONT NEUROSCI-SWITZ, V3, P15, DOI 10.3389/neuro.01.004.2009; Hata Y, 1999, CELL MOL LIFE SCI, V56, P461, DOI 10.1007/s000180050445; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kaang BK, 2009, NEUROSCIENTIST, V15, P430, DOI 10.1177/1073858408331374; Kaeser PS, 2008, P NATL ACAD SCI USA, V105, P14680, DOI 10.1073/pnas.0806679105; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Levin ED, 2006; Li M, 2008, NAT CELL BIOL, V10, P1083, DOI 10.1038/ncb1768; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; MARKHAM CM, LEARN MEM, V17, P109; Marschner A, 2008, J NEUROSCI, V28, P9030, DOI 10.1523/JNEUROSCI.1651-08.2008; Maruyama Y, 2008, BIOCHEM BIOPH RES CO, V374, P737, DOI 10.1016/j.bbrc.2008.07.126; Matsumoto M, 2007, NEUROSCI RES, V57, P411, DOI 10.1016/j.neures.2006.11.015; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Miyakawa T, 2001, HIPPOCAMPUS, V11, P763, DOI 10.1002/hipo.1092; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nakajima R, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-7; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; PAPE HC, PHYSL REV, V90, P419; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Powell CM, 2004, NEURON, V42, P143, DOI 10.1016/S0896-6273(04)00146-1; Quirk GJ, 1996, COLD SPRING HARB SYM, V61, P247; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rogan MT, 1996, CELL, V85, P469, DOI 10.1016/S0092-8674(00)81247-7; Sakurai M, 2008, EUR J NEUROSCI, V27, P691, DOI 10.1111/j.1460-9568.2008.06047.x; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2004, J NEUROBIOL, V58, P201, DOI 10.1002/neu.10324; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stork O, 2001, LEARN MEMORY, V8, P209, DOI 10.1101/lm.39401; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Szyndler J, 2005, PHARMACOL BIOCHEM BE, V81, P15, DOI 10.1016/j.pbb.2005.01.020; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Tanda K, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-19; Tsujimura A, 2008, FRONT BEHAV NEUROSCI, V2, DOI 10.3389/neuro.08.004.2008; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Virshup DM, 2007, CELL, V129, P857, DOI 10.1016/j.cell.2007.05.015; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Wood MA, 2005, HIPPOCAMPUS, V15, P610, DOI 10.1002/hipo.20082; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Yao I, 1999, J BIOL CHEM, V274, P27463, DOI 10.1074/jbc.274.39.27463; Yao I, 1999, J BIOL CHEM, V274, P11889, DOI 10.1074/jbc.274.17.11889; Yao I, 2008, PROTEOMICS, V8, P3692, DOI 10.1002/pmic.200701121; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Yasojima K, 1997, BIOCHEM BIOPH RES CO, V231, P481, DOI 10.1006/bbrc.1996.6033; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008	78	23	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17317	10.1371/journal.pone.0017317	http://dx.doi.org/10.1371/journal.pone.0017317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390313	gold, Green Submitted, Green Published			2022-12-25	WOS:000287761700044
J	Cudaback, E; Li, XW; Montine, KS; Montine, TJ; Keene, CD				Cudaback, Eiron; Li, Xianwu; Montine, Kathleen S.; Montine, Thomas J.; Keene, C. Dirk			Apolipoprotein E isoform-dependent microglia migration	FASEB JOURNAL			English	Article						C5a; ATP; ERK; receptor associated protein; targeted replacement	GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; LIPOPROTEIN RECEPTOR; TARGETED REPLACEMENT; NERVOUS-SYSTEM; SENILE PLAQUES; APOE GENOTYPE; MOUSE MODEL; E GENE; ACTIVATION	Complement component C5a and ATP are potent effectors of microglial movement and are increased in diverse neurodegenerative diseases and at sites of injury. Apolipoprotein E (apoE) influences microglial function, and different human apoE isoforms confer variable risk for development of neurodegenerative disorders, especially Alzheimer's disease. The purpose of this investigation was to test the hypothesis that mouse apoE and human apoE isoforms influence microglial migration. Using primary wild-type and apoE-deficient microglia, we show that C5a- and ATP-stimulated chemotaxis are largely apoE-dependent processes with different molecular bases. Although the C5a-dependent chemotaxis of wild-type microglia was completely blocked by receptor-associated protein (RAP), suggesting apoE receptor involvement, ATP-stimulated migration was unaffected by RAP but was associated with differential ERK phosphorylation. Studies using primary microglia derived from targeted replacement mice "humanized" for the coding exons (protein isoform) of human epsilon 2 (apoE2), epsilon 3 (apoE3), or epsilon 4 (apoE4) allele of APOE revealed that primary mouse microglia expressing apoE4 or apoE2 exhibited significantly reduced C5a- and ATP-stimulated migration compared with microglia expressing human apoE3. This study, for the first time, demonstrates apoE dependence and apoE isoform-specific modulation of microglial migration in response to distinct chemotactic stimuli commonly associated with neurodegenerative disease.-Cudaback, E., Li, X., Montine, K. S., Montine, T. J., Keene, C. D. Apolipoprotein E isoform-dependent microglia migration. FASEB J. 25, 2082-2091 (2011). www.fasebj.org	[Keene, C. Dirk] Univ Washington, Harborview Med Ctr, Dept Pathol, Div Neuropathol, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle	Keene, CD (corresponding author), Univ Washington, Harborview Med Ctr, Dept Pathol, Div Neuropathol, Box 359645,325 9th Ave, Seattle, WA 98104 USA.	cdkeene@uw.edu	Keene, Christopher D/N-1806-2015	Keene, Christopher/0000-0002-5291-1469; Montine, Kathleen/0000-0003-2110-8363	U.S. National Institutes of Health [AG05136, ES16754, 5T32 AG000258]; Nancy and Buster Alvord Endowment; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136, T32AG000258] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy and Buster Alvord Endowment; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Yue Yang, Meilany Wijaya, Amy Look, and Lisa Keene for technical assistance and Carol Arnold for managerial support. We also thank Dr. Nobuyo Maeda for the generous gift of apoE2-, apoE3-, and apoE4-targeted replacement mice. This work was supported by U.S. National Institutes of Health grants AG05136 and ES16754 as well as 5T32 AG000258 (Dr. Suzanne Craft) and the Nancy and Buster Alvord Endowment.	Ager RR, 2010, J NEUROCHEM, V113, P389, DOI 10.1111/j.1471-4159.2010.06595.x; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Belinson H, 2009, J NEURAL TRANSM, V116, P1427, DOI 10.1007/s00702-009-0218-9; Bradt BM, 1998, J EXP MED, V188, P431, DOI 10.1084/jem.188.3.431; Calvo M, 2010, J NEUROSCI, V30, P5437, DOI 10.1523/JNEUROSCI.5169-09.2010; Choi MS, 2010, ARCH PHARM RES, V33, P257, DOI 10.1007/s12272-010-0211-8; Christie RH, 1996, AM J PATHOL, V148, P399; Cimino PJ, 2009, AM J PATHOL, V175, P1622, DOI 10.2353/ajpath.2009.090443; Colton CA, 2004, J NEUROIMMUNOL, V147, P62, DOI 10.1016/j.jneuroim.2003.10.015; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DEGRELL I, 1988, ARCH GERONTOL GERIAT, V7, P173, DOI 10.1016/0167-4943(88)90029-5; Egensperger R, 1998, BRAIN PATHOL, V8, P439; Egger M, 2008, EUR J PHARMACOL, V598, P104, DOI 10.1016/j.ejphar.2008.09.016; EIKELENBOOM P, 1982, ACTA NEUROPATHOL, V57, P239, DOI 10.1007/BF00685397; Festoff BW, 2006, J NEUROCHEM, V97, P1314, DOI 10.1111/j.1471-4159.2006.03799.x; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Garrett MC, 2009, BRAIN RES, V1298, P171, DOI 10.1016/j.brainres.2009.04.047; Gyoneva S, 2009, PARKINSONISM RELAT D, V15, pS195, DOI 10.1016/S1353-8020(09)70813-2; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hickman SE, 2010, CNS NEUROL DISORD-DR, V9, P168, DOI 10.2174/187152710791011982; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Horvath RJ, 2009, J NEUROSCI, V29, P998, DOI 10.1523/JNEUROSCI.4595-08.2009; HOWELL OW, J NEUROPATHOL EXP NE, V69, P1017; Inoue K, 2008, CELL MOL LIFE SCI, V65, P3074, DOI 10.1007/s00018-008-8210-3; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Irino Y, 2008, J NEUROSCI RES, V86, P1511, DOI 10.1002/jnr.21610; JAKOB A, 2010, J NEUROINFLAMM, V221, P46; James G, 2002, EUR J PHARMACOL, V447, P247, DOI 10.1016/S0014-2999(02)01756-9; Keene CD, 2010, AM J PATHOL, V177, P346, DOI 10.2353/ajpath.2010.090840; Kim GH, 2008, NEUROSURGERY, V63, P122, DOI 10.1227/01.NEU.0000335079.70222.8D; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kurpius D, 2007, GLIA, V55, P873, DOI 10.1002/glia.20509; Lambert C, 2010, BRAIN BEHAV IMMUN, V24, P1241, DOI 10.1016/j.bbi.2010.02.010; LEE CY, J NEURAL TRANSM, V117, P949; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Maezawa I, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-21; Maezawa I, 2006, FASEB J, V20, P797, DOI 10.1096/fj.05-5423fje; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Malm TM, 2008, GLIA, V56, P1767, DOI 10.1002/glia.20726; Marzolo MP, 2000, J NEUROSCI RES, V60, P401, DOI 10.1002/(SICI)1097-4547(20000501)60:3<401::AID-JNR15>3.3.CO;2-C; MCGEER PL, 1989, NEUROSCI LETT, V107, P341, DOI 10.1016/0304-3940(89)90843-4; Miller AM, 2009, GLIA, V57, P875, DOI 10.1002/glia.20813; Morgan BP, 1996, IMMUNOL TODAY, V17, P461, DOI 10.1016/0167-5699(96)20028-F; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Pocivavsek A, 2009, GLIA, V57, P444, DOI 10.1002/glia.20772; SAMUELS SE, J GEN PHYSL, V136, P425; Sanz JM, 2009, J IMMUNOL, V182, P4378, DOI 10.4049/jimmunol.0803612; Seabrook TJ, 2006, GLIA, V53, P776, DOI 10.1002/glia.20338; Seshadri S, JAMA, V303, P1832; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Valazquez P, 1997, NAT MED, V3, P77, DOI 10.1038/nm0197-77; Van Den Bosch L, 2002, NEUROREPORT, V13, P1067, DOI 10.1097/00001756-200206120-00018; Venneti S, 2009, J NEUROIMMUNE PHARM, V4, P227, DOI 10.1007/s11481-008-9142-2; WANG Y, J NEUROINFLAMMATION, V7, P24; Ward PA, 2009, J MOL MED, V87, P375, DOI 10.1007/s00109-009-0442-7; Woodruff TM, 2010, NEUROMOL MED, V12, P179, DOI 10.1007/s12017-009-8085-y; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Xu PT, 1996, NEUROBIOL DIS, V3, P229, DOI 10.1006/nbdi.1996.0023; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zhang C, 2009, AM J PATHOL, V174, P586, DOI 10.2353/ajpath.2009.080661	67	36	36	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					2082	2091		10.1096/fj.10-176891	http://dx.doi.org/10.1096/fj.10-176891			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21385991	Green Published			2022-12-25	WOS:000291023800030
J	Shiose, S; Chen, Y; Okano, K; Roy, S; Kohno, H; Tang, J; Pearlman, E; Maeda, T; Palczewski, K; Maeda, A				Shiose, Satomi; Chen, Yu; Okano, Kiichiro; Roy, Sanhita; Kohno, Hideo; Tang, Johnny; Pearlman, Eric; Maeda, Tadao; Palczewski, Krzysztof; Maeda, Akiko			Toll-like Receptor 3 Is Required for Development of Retinopathy Caused by Impaired All-trans-retinal Clearance in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT FACTOR-H; MACULAR DEGENERATION; GEOGRAPHIC ATROPHY; INNATE IMMUNITY; MESSENGER-RNA; AGE; RISK; VARIANT; SUSCEPTIBILITY; COMMON	Chronic inflammation is an important component that contributes to many age-related neurodegenerative diseases, including macular degeneration. Here, we report a role for toll-like receptor 3 (TLR3) in cone-rod dystrophy (CORD) of mice lacking ATP-binding cassette transporter 4 (ABCA4) and retinol dehydrogenase 8 (RDH8), proteins critical for all-trans-retinal clearance in the retina. Increased expression of toll-like receptor-signaling elements and inflammatory changes were observed in Rdh8(-/-) Abca4(-/-) eyes by RNA expression analysis. Unlike 3-month-old Rdh8(-/-) Abca4(-/-) mice that developed CORD, 6-month-old Tlr3(-/-) Rdh8(-/-) Abca4(-/-) mice did not evidence an abnormal retinal phenotype. Light-induced retinal degeneration in Tlr3(-/-) Rdh8(-/-) Abca4(-/-) mice was milder than that in Rdh8(-/-) Abca4(-/-) mice, and a 2-fold increased TLR3 expression was detected in light-illuminated retinas of Rdh8(-/-) Abca4(-/-) mice compared with nonilluminated retinas. Poly(I-C), a TLR3 ligand, caused caspase-8-independent cellular apoptosis. Whereas poly(I-C) induced retinal cell death in Rdh8(-/-) Abca4(-/-) and WT mice both in vivo and ex vivo, this was not seen in mice lacking Tlr3. Far fewer invasive macrophage/microglialcells in the subretinal space and weaker activation of Muller glial cells were exhibited by Tlr3(-/-) Rdh8(-/-) Abca4(-/-) mice compared with Rdh8(-/-) Abca4(-/-) mice at 3 and 6 months of age, indicating that loss of TLR3 inhibits local inflammation in the retina. Both poly(I-C) and endogenous products emanating from dying/dead retinal cells induced NF-kappa B and IRF3 activation. These findings demonstrate that endogenous products from degenerating retina stimulate TLR3 that causes cellular apoptosis and retinal inflammation and that loss of TLR3 protects mice from CORD.	[Palczewski, Krzysztof; Maeda, Akiko] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Akiko] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Sch Med, Cleveland, OH 44106 USA; [Tang, Johnny] Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu; aam19@case.edu		ROY, SANHITA/0000-0002-0407-8177	National Institutes of Health [K08EY019031, K08EY019880, EY009339, EY021126, P30 EY11373]; Veterans Affairs Medical Center; Research to Prevent Blindness Foundation; Foundation Fighting Blindness; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [R24EY021126, P30EY011373, K08EY019031, K08EY019880, R01EY009339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Medical Center; Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness(European Commission); Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants K08EY019031, K08EY019880, EY009339, EY021126, and P30 EY11373. This work was also supported by a Veterans Affairs Medical Center career development grant, Research to Prevent Blindness Foundation, Foundation Fighting Blindness, and the Ohio Lions Eye Research Foundation.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 2009, NEW ENGL J MED, V360, P2252; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Arora A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-1; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Cho YE, 2009, INVEST OPHTH VIS SCI, V50, P5614, DOI 10.1167/iovs.09-3688; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Deleidi M, 2010, J NEUROSCI, V30, P16091, DOI 10.1523/JNEUROSCI.2400-10.2010; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Edwards AO, 2008, INVEST OPHTH VIS SCI, V49, P1652, DOI 10.1167/iovs.07-1378; Edwards AO, 2009, NEW ENGL J MED, V360, P2254; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; EILAT D, 1994, MOL IMMUNOL, V31, P1377, DOI 10.1016/0161-5890(94)90154-6; Fiala M, 2007, P NATL ACAD SCI USA, V104, P12849, DOI 10.1073/pnas.0701267104; Ginsberg SD, 1999, ANN NEUROL, V45, P174, DOI 10.1002/1531-8249(199902)45:2<174::AID-ANA7>3.0.CO;2-E; Glenn JV, 2009, INVEST OPHTH VIS SCI, V50, P441, DOI 10.1167/iovs.08-1724; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Johnson AC, 2008, J BIOL CHEM, V283, P3988, DOI 10.1074/jbc.M707264200; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Kam JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013127; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kumar MV, 2004, J NEUROIMMUNOL, V153, P7, DOI 10.1016/j.jneuroim.2004.04.018; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lewin AS, 2009, NEW ENGL J MED, V360, P2251, DOI 10.1056/NEJMc082233; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liew G, 2009, NEW ENGL J MED, V360, P2252; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2010, P NATL ACAD SCI USA, V107, P8428, DOI 10.1073/pnas.1000640107; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Ryan D, 2006, MOL VIS, V12, P1175; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Shen DF, 2006, OPHTHALMIC RES, V38, P71, DOI 10.1159/000090266; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Sparrow JR, 2001, INVEST OPHTH VIS SCI, V42, P1356; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Vives-Bauza C, 2008, J BIOL CHEM, V283, P24770, DOI 10.1074/jbc.M800706200; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Weber A, 2010, CELL DEATH DIFFER, V17, P942, DOI 10.1038/cdd.2009.190; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yoneda K, 2008, INT J ONCOL, V33, P929, DOI 10.3892/ijo_00000080; Zareparsi S, 2005, HUM MOL GENET, V14, P1449, DOI 10.1093/hmg/ddi154	68	44	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15543	15555		10.1074/jbc.M111.228551	http://dx.doi.org/10.1074/jbc.M111.228551			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21383019	Green Published, hybrid			2022-12-25	WOS:000289788300082
J	Angulo, S; Morales, A; Danese, S; Llacuna, L; Masamunt, MC; Pultz, N; Cifone, MG; De Simone, C; Delgado, S; Vila, J; Panes, J; Donskey, C; Fernandez-Checa, JC; Fiocchi, C; Sans, M				Angulo, Sandra; Morales, Albert; Danese, Silvio; Llacuna, Laura; Carme Masamunt, Maria; Pultz, Nicole; Cifone, Maria Grazia; De Simone, Claudio; Delgado, Salvadora; Vila, Jordi; Panes, Julian; Donskey, Curtis; Fernandez-Checa, Jose C.; Fiocchi, Claudio; Sans, Miquel			Probiotic Sonicates Selectively Induce Mucosal Immune Cells Apoptosis through Ceramide Generation via Neutral Sphingomyelinase	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ESCHERICHIA-COLI NISSLE-1917; ELECTRON-TRANSPORT CHAIN; CROHNS-DISEASE; T-CELLS; ULCERATIVE-COLITIS; LYMPHOPROLIFERATIVE SYNDROME; MITOCHONDRIAL GLUTATHIONE; ALKALINE SPHINGOMYELINASE; MAINTAINING REMISSION	Background: Probiotics appear to be beneficial in inflammatory bowel disease, but their mechanism of action is incompletely understood. We investigated whether probiotic-derived sphingomyelinase mediates this beneficial effect. Methodology/Principal Findings: Neutral sphingomyelinase (NSMase) activity was measured in sonicates of the probiotic L. brevis (LB) and S. thermophilus (ST) and the non-probiotic E. coli (EC) and E. faecalis (EF). Lamina propria mononuclear cells (LPMC) were obtained from patients with Crohn's disease (CD) and Ulcerative Colitis (UC), and peripheral blood mononuclear cells (PBMC) from healthy volunteers, analysing LPMC and PBMC apoptosis susceptibility, reactive oxygen species (ROS) generation and JNK activation. In some experiments, sonicates were preincubated with GSH or GW4869, a specific NSMase inhibitor. NSMase activity of LB and ST was 10-fold that of EC and EF sonicates. LB and ST sonicates induced significantly more apoptosis of CD and UC than control LPMC, whereas EC and EF sonicates failed to induce apoptosis. Pre-stimulation with anti-CD3/CD28 induced a significant and time-dependent increase in LB-induced apoptosis of LPMC and PBMC. Exposure to LB sonicates resulted in JNK activation and ROS production by LPMC. NSMase activity of LB sonicates was completely abrogated by GW4869, causing a dose-dependent reduction of LB-induced apoptosis. LB and ST selectively induced immune cell apoptosis, an effect dependent on the degree of cell activation and mediated by bacterial NSMase. Conclusions: These results suggest that induction of immune cell apoptosis is a mechanism of action of some probiotics, and that NSMase-mediated ceramide generation contributes to the therapeutic effects of probiotics.	[Angulo, Sandra; Carme Masamunt, Maria; Panes, Julian; Sans, Miquel] CIBERehd, Dept Gastroenterol, Hosp Clin, IDIBAPS, Barcelona, Spain; [Morales, Albert; Llacuna, Laura; Fernandez-Checa, Jose C.] CIBERehd, Liver Unit, Hosp Clin, IDIBAPS, Barcelona, Spain; [Morales, Albert; Llacuna, Laura; Fernandez-Checa, Jose C.] CSIC, Dept Cell Death & Proliferat, IIBB, Barcelona, Spain; [Danese, Silvio] Ist Clin Humanitas, Div Gastroenterol, Milan, Italy; [Pultz, Nicole; Donskey, Curtis] VA Med Ctr, Infect Dis Sect, Louis Stokes Cleveland Dept, Cleveland, OH USA; [Cifone, Maria Grazia; De Simone, Claudio] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; [Delgado, Salvadora] CIBERehd, Dept Gastrointestinal Surg, Hosp Clin, IDIBAPS, Barcelona, Spain; [Vila, Jordi] CIBERehd, Dept Clin Microbiol, Hosp Clin, IDIBAPS, Barcelona, Spain; [Fernandez-Checa, Jose C.] Univ So Calif, Keck Sch Med, Res Ctr Alcohol Liver & Pancreat Dis, Los Angeles, CA 90033 USA; [Fiocchi, Claudio] Cleveland Clin Fdn, Dept Gastroenterol & Hepatol, Cleveland, OH 44195 USA	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); IRCCS Humanitas Research Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of L'Aquila; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Southern California; Cleveland Clinic Foundation	Angulo, S (corresponding author), CIBERehd, Dept Gastroenterol, Hosp Clin, IDIBAPS, Barcelona, Spain.	checa229@yahoo.com; msans@clinic.ub.es	Danese, Silvio/ABH-9571-2020; Morales, Albert/E-2988-2013; Fernández-Checa, José Carlos/L-8342-2014; Cifone, Maria Grazia/I-3750-2019; Cifone, Maria Grazia/ABH-1984-2021; Vila, Jordi/P-3613-2016; Panes, Julian/H-5991-2015	Danese, Silvio/0000-0001-7341-1351; Morales, Albert/0000-0001-8702-2269; Fernández-Checa, José Carlos/0000-0003-3422-2990; Cifone, Maria Grazia/0000-0002-9923-5445; Vila, Jordi/0000-0002-8025-3926; Masamunt, M Carme/0000-0001-8736-1623; Panes, Julian/0000-0002-4971-6902	Ministerio de Ciencia e Innovacion [SAF2005-00280, SAF2008-03676, FIS2009-00056, SAF2009-11417]; Fundacion Ramon Areces; National Institutes of Health [DK30399, DK50984]; United States National Institute for Alcohol Abuse and Alcoholism [P50 AA 11999]; Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050984, R37DK030399, R01DK030399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Ramon Areces; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States National Institute for Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The funding sources included grants from Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd), Ministerio de Ciencia e Innovacion (SAF2005-00280 and SAF2008-03676 to MS, FIS2009-00056 to AM, SAF2009-11417 to JCF), Fundacion Ramon Areces (to MS), the National Institutes of Health (DK30399 and DK50984 to CF) and the Research Center for Liver and Pancreatic Diseases funded by the United States National Institute for Alcohol Abuse and Alcoholism (P50 AA 11999 to JCF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; Boirivant M, 1999, GASTROENTEROLOGY, V116, P557, DOI 10.1016/S0016-5085(99)70177-0; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Coll O, 2007, J LIPID RES, V48, P1924, DOI 10.1194/jlr.M700069-JLR200; Di Marzio L, 2001, NUTR CANCER, V40, P185, DOI 10.1207/S15327914NC402_16; Doering J, 2004, GUT, V53, P1632, DOI 10.1136/gut.2003.037911; Dotan I, 2005, CURR OPIN GASTROEN, V21, P426; Duan RD, 2006, BBA-MOL CELL BIOL L, V1761, P281, DOI 10.1016/j.bbalip.2006.03.007; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Frustaci A, 2006, MODERN PATHOL, V19, P755, DOI 10.1038/modpathol.3800594; GARCIARUIZ C, 1995, MOL PHARMACOL, V48, P825; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Ina K, 1999, J IMMUNOL, V163, P1081; Itoh J, 2001, GUT, V49, P35, DOI 10.1136/gut.49.1.35; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Liu B, 1997, J BIOL CHEM, V272, P16281, DOI 10.1074/jbc.272.26.16281; Loidl A, 2002, J LIPID RES, V43, P815; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Martin SF, 2007, ARCH BIOCHEM BIOPHYS, V459, P295, DOI 10.1016/j.abb.2006.11.007; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Mudter J, 2007, GUT, V56, P293, DOI 10.1136/gut.2005.090464; Murosaki S, 1997, MICROBIOL IMMUNOL, V41, P139, DOI 10.1111/j.1348-0421.1997.tb01179.x; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Ruvolo PP, 2001, LEUKEMIA, V15, P1153, DOI 10.1038/sj.leu.2402197; Salinas I, 2008, VET MICROBIOL, V128, P167, DOI 10.1016/j.vetmic.2007.10.011; Sanchez AM, 2007, APOPTOSIS, V12, P2013, DOI 10.1007/s10495-007-0119-z; Schrezenmeir J, 2001, AM J CLIN NUTR, V73, p361S, DOI 10.1093/ajcn/73.2.361s; Shen C, 2005, ALIMENT PHARM THER, V21, P251, DOI 10.1111/j.1365-2036.2005.02309.x; Soo I, 2008, CAN J GASTROENTEROL, V22, P237, DOI 10.1155/2008/520383; Sturm A, 2005, INFECT IMMUN, V73, P1452, DOI 10.1128/IAI.73.3.1452-1465.2005; Sturm A, 2004, GUT, V53, P1624, DOI 10.1136/gut.2003.033613; Sturm A, 2004, J IMMUNOL, V173, P3889, DOI 10.4049/jimmunol.173.6.3889; Sturm A, 2002, J CLIN INVEST, V109, P1481, DOI 10.1172/JCI14967; Sturm A, 2002, GUT, V50, P148, DOI 10.1136/gut.50.2.148; van den Brande JMH, 2007, INFLAMM BOWEL DIS, V13, P118, DOI 10.1002/ibd.20000; Van den Brande JMH, 2006, GASTROENTEROLOGY, V131, P1362, DOI 10.1053/j.gastro.2006.08.054; Van Den Brande JMH, 2003, GASTROENTEROLOGY, V124, P1774, DOI 10.1016/S0016-5085(03)00382-2; West GA, 1996, GASTROENTEROLOGY, V110, P1683, DOI 10.1053/gast.1996.v110.pm8964392; Won JS, 2006, FREE RADICAL BIO MED, V40, P1875, DOI 10.1016/j.freeradbiomed.2006.01.035; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhang M, 2004, CELL MOL IMMUNOL, V1, P447; Zocco MA, 2006, ALIMENT PHARM THER, V23, P1567, DOI 10.1111/j.1365-2036.2006.02927.x	47	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e16953	10.1371/journal.pone.0016953	http://dx.doi.org/10.1371/journal.pone.0016953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408067	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170900006
J	El-Khatib, Z; Katzenstein, D; Marrone, G; Laher, F; Mohapi, L; Petzold, M; Morris, L; Ekstrom, AM				El-Khatib, Ziad; Katzenstein, David; Marrone, Gaetano; Laher, Fatima; Mohapi, Lerato; Petzold, Max; Morris, Lynn; Ekstrom, Anna Mia			Adherence to Drug-Refill Is a Useful Early Warning Indicator of Virologic and Immunologic Failure among HIV Patients on First-Line ART in South Africa	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; ANTIRETROVIRAL THERAPY ADHERENCE; SUB-SAHARAN AFRICA; VIRAL LOAD; RESISTANCE; ADULTS; CARE; INFECTION; LEVEL	Background: Affordable strategies to prevent treatment failure on first-line regimens among HIV patients are essential for the long-term success of antiretroviral therapy (ART) in sub-Saharan Africa. WHO recommends using routinely collected data such as adherence to drug-refill visits as early warning indicators. We examined the association between adherence to drug-refill visits and long-term virologic and immunologic failure among non-nucleoside reverse transcriptase inhibitor (NNRTI) recipients in South Africa. Methods: In 2008, 456 patients on NNRTI-based ART for a median of 44 months (range 12-99 months; 1,510 person-years) were enrolled in a retrospective cohort study in Soweto. Charts were reviewed for clinical characteristics before and during ART. Multivariable logistic regression and Kaplan-Meier survival analysis assessed associations with virologic (two repeated VL>50 copies/ml) and immunologic failure (as defined by WHO). Results: After a median of 15 months on ART, 19% (n = 88) and 19% (n = 87) had failed virologically and immunologically respectively. A cumulative adherence of <95% to drug-refill visits was significantly associated with both virologic and immunologic failure (p<0.01). In the final multivariable model, risk factors for virologic failure were incomplete adherence (OR 2.8, 95% CI 1.2-6.7), and previous exposure to single-dose nevirapine or any other antiretrovirals (adj. OR 2.1, 95% CI 1.2-3.9), adjusted for age and sex. In Kaplan-Meier analysis, the virologic failure rate by month 48 was 19% vs. 37% among adherent and non-adherent patients respectively (logrank p value = 0.02). Conclusion: One in five failed virologically after a median of 15 months on ART. Adherence to drug-refill visits works as an early warning indicator for both virologic and immunologic failure.	[El-Khatib, Ziad; Marrone, Gaetano; Petzold, Max; Ekstrom, Anna Mia] Karolinska Inst, Div Global Hlth IHCAR, Stockholm, Sweden; [El-Khatib, Ziad; Morris, Lynn] NICD, AIDS Virus Res Unit, Johannesburg, South Africa; [Katzenstein, David] Stanford Univ, Div Infect Dis, Palo Alto, CA 94304 USA; [Laher, Fatima; Mohapi, Lerato] Univ Witwatersrand, PHRU, Soweto, South Africa; [Petzold, Max] Nord Sch Publ Hlth NHV, Gothenburg, Sweden	Karolinska Institutet; National Institute for Communicable Diseases (NICD); Stanford University; University of Witwatersrand	El-Khatib, Z (corresponding author), Karolinska Inst, Div Global Hlth IHCAR, Stockholm, Sweden.	ziad.khatib@gmail.com	Franzeck, Fabian C/B-5055-2011; Morris, Lynn/V-3941-2018; El-Khatib, Ziad/B-5161-2017	Morris, Lynn/0000-0003-3961-7828; El-Khatib, Ziad/0000-0003-0756-7280; Marrone, Gaetano/0000-0002-2991-1663; El-Khatib, Ziad/0000-0002-0711-5404; katzenstein, david/0000-0002-8593-4560	Swedish International Development Cooperation Agency; Karolinska Institutet; HIV/TB Research Fogarty International Center/NIH [2 U2R TW006878]; Freeman-Spogli Institute at Stanford University; FOGARTY INTERNATIONAL CENTER [U2RTW006878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066922] Funding Source: NIH RePORTER	Swedish International Development Cooperation Agency; Karolinska Institutet(Karolinska Institutet); HIV/TB Research Fogarty International Center/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Freeman-Spogli Institute at Stanford University; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Swedish International Development Cooperation Agency to National Institute for Communicable Diseases (NICD) and Karolinska Institutet; The Karolinska Institutet (PhD student grant to ZEK and senior research grant to AME); Sven Gard's Fund for Virology Research, African Programme for Training in HIV/TB Research Fogarty International Center/NIH 2 U2R TW006878 and the Freeman-Spogli Institute at Stanford University to ZEK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badri M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-89; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; Cambiano V, 2010, HIV MED, V11, P216, DOI 10.1111/j.1468-1293.2009.00771.x; Coovadia A, 2009, CLIN INFECT DIS, V48, P462, DOI 10.1086/596486; Datay MI, 2010, JAIDS-J ACQ IMM DEF, V54, P489, DOI 10.1097/QAI.0b013e3181d91788; EGGER M, 2007, OUTCOMES ANTIRETROVI; El-Khatib Z, 2010, AIDS, V24, P1679, DOI 10.1097/QAD.0b013e32833a097b; ELKHATIB Z, 2009, MED REV S AFRICAN AD; ELKHATIB Z, 2004, QUESTIONNAIRE DESIGN; ELKHATIB Z, 2010, DRUG RESIST IN PRESS; *EPIDATA FDN, 2008, EPIDATA DAT ENTR DOC; Eshleman SH, 2005, AIDS, V19, P2167, DOI 10.1097/01.aids.0000194800.43799.94; Ford N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010460; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Harries AD, 2010, LANCET INFECT DIS, V10, P60, DOI 10.1016/S1473-3099(09)70321-4; HATANO H, 2010, AIDS; Hedt BL, 2008, ANTIVIR THER, V13, P69; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Jackson JB, 2000, AIDS, V14, pF111, DOI 10.1097/00002030-200007280-00001; Kagee A, 2010, GLOB PUBLIC HEALTH, V1-15; Kantor R, 2009, CLIN INFECT DIS, V49, P454, DOI 10.1086/600396; Keiser O, 2008, PLOS MED, V5, P1102, DOI 10.1371/journal.pmed.0050148; Kuritzkes DR, 2004, AIDS PATIENT CARE ST, V18, P259, DOI 10.1089/108729104323076007; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P360; Madge S, 2008, HIV MED, V9, P208, DOI 10.1111/j.1468-1293.2008.00548.x; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Martinson NA, 2009, AIDS, V23, P809, DOI 10.1097/QAD.0b013e328323ad49; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Nachega JB, 2010, CURR OPIN HIV AIDS, V5, P70, DOI 10.1097/COH.0b013e328333ad61; NATTRASS N, 2006, SO AFRICAN J HIV MED; Paredes R, 2004, MIL DRUG TH, P53; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Phillips AN, 2001, AIDS, V15, P2385, DOI 10.1097/00002030-200112070-00006; PRISM G, 2005, VERSION 4 0C; REWARI BB, 2010, J ACQUIR IMMUNE 1001; RICHARD T, 2010, LANCET, DOI DOI 10.1016/S0140-6736(10)61997-6; Rothman KJ., 1982, EPIDEMIOLOGIC ANAL P; Sanne IM, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-38; Shuter J, 2007, JAIDS-J ACQ IMM DEF, V45, P4, DOI 10.1097/QAI.0b013e318050d8c2; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; *STATACORP LP, 2008, STAT SE 10 1; Unge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013613; WHO, 2010, ANT THER HIV INF AD; *WHO, 2006, HIV DRUG RES EARL WA; World Health Organization, 2008, PRIM HLTH CAR MOR NE, P1; World Health Organization, 2004, SCAL ANT THER RES LT	53	66	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17518	10.1371/journal.pone.0017518	http://dx.doi.org/10.1371/journal.pone.0017518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408071	gold, Green Published, Green Submitted			2022-12-25	WOS:000288170900024
J	Iser, WB; Wilson, MA; Wood, WH; Becker, K; Wolkow, CA				Iser, Wendy B.; Wilson, Mark A.; Wood, William H., III; Becker, Kevin; Wolkow, Catherine A.			Co-Regulation of the DAF-16 Target Gene, cyp-35B1/dod-13, by HSF-1 in C. elegans Dauer Larvae and daf-2 Insulin Pathway Mutants	PLOS ONE			English	Article							HEAT-SHOCK FACTOR; CAENORHABDITIS-ELEGANS; LIFE-SPAN; INTERACTING GENES; FAMILY-MEMBER; LONGEVITY; TRANSCRIPTION; RECEPTOR; PROTEIN; LONG	Insulin/IGF-I-like signaling (IIS) has both cell autonomous and non-autonomous functions. In some cases, targets through which IIS regulates cell-autonomous functions, such as cell growth and metabolism, have been identified. In contrast, targets for many non-autonomous IIS functions, such as C. elegans dauer morphogenesis, remain elusive. Here, we report the use of genomic and genetic approaches to identify potential non-autonomous targets of C. elegans IIS. First, we used transcriptional microarrays to identify target genes regulated non-autonomously by IIS in the intestine or in neurons. C. elegans IIS controls expression of a number of stress response genes, which were differentially regulated by tissue-restricted IIS. In particular, expression of sod-3, a MnSOD enzyme, was not regulated by tissue-restricted IIS on the microarrays, while expression of hsp-16 genes was rescued back to wildtype by tissue restricted IIS. One IIS target regulated non-autonomously by age-1 was cyp-35B1/dod-13, encoding a cytochrome P450. Genetic analysis of the cyp-35B1 promoter showed both DAF-16 and HSF-1 are direct regulators. Based on these findings, we propose that hsf-1 may participate in the pathways mediating non-autonomous activities of age-1 in C. elegans.	[Iser, Wendy B.; Wilson, Mark A.; Wolkow, Catherine A.] NIA Intramural Res Program, Invertebrate Mol Genet Unit, Lab Neurosci, Res Resources Branch,NIH Biomed Res Ctr, Baltimore, MD USA; [Wood, William H., III; Becker, Kevin] NIA Intramural Res Program, Gene Express & Genom Unit, Res Resources Branch, NIH Biomed Res Ctr, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Iser, WB (corresponding author), NIA Intramural Res Program, Invertebrate Mol Genet Unit, Lab Neurosci, Res Resources Branch,NIH Biomed Res Ctr, Baltimore, MD USA.	wolkowca@mail.nih.gov		Becker, Kevin/0000-0002-6794-6656	NIA [AG000320]; Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [Z01AG000320, ZICAG000616] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was carried out with funding from the NIA Intramural Research Program (AG000320) and from an Ellison Medical Foundation New Scholar in Aging award (www.ellisonfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; BRENNER S, 1974, GENETICS, V77, P71; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; Butler AA, 2001, ANNU REV PHYSIOL, V63, P141, DOI 10.1146/annurev.physiol.63.1.141; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garigan D, 2002, GENETICS, V161, P1101; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Gems D, 1998, GENETICS, V150, P129; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; GOTTLIEB S, 1994, GENETICS, V137, P107; Halaschek-Wiener J, 2005, GENOME RES, V15, P603, DOI 10.1101/gr.3274805; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Iser WB, 2007, DEV BIOL, V303, P434, DOI 10.1016/j.ydbio.2006.04.467; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim SH, 2003, J BIOL CHEM, V278, P28038, DOI 10.1074/jbc.M302192200; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; LEHMING N, 1994, NATURE, V371, P175, DOI 10.1038/371175a0; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; SCHENA M, 1991, METHOD ENZYMOL, V194, P389; SCHENA M, 1988, SCIENCE, V241, P965, DOI 10.1126/science.3043665; Shostak Y, 2004, GENE DEV, V18, P2529, DOI 10.1101/gad.1218504; THOMAS JH, 1993, GENETICS, V134, P1105; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; VOWELS JJ, 1992, GENETICS, V130, P105; Walker GA, 2001, J GERONTOL A-BIOL, V56, pB281, DOI 10.1093/gerona/56.7.B281; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	45	16	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17369	10.1371/journal.pone.0017369	http://dx.doi.org/10.1371/journal.pone.0017369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408062	gold, Green Submitted, Green Published			2022-12-25	WOS:000288170900012
J	Anselmo, A; Flori, L; Jaffrezic, F; Rutigliano, T; Cecere, M; Cortes-Perez, N; Lefevre, F; Rogel-Gaillard, C; Giuffra, E				Anselmo, Anna; Flori, Laurence; Jaffrezic, Florence; Rutigliano, Teresa; Cecere, Maria; Cortes-Perez, Naima; Lefevre, Francois; Rogel-Gaillard, Claire; Giuffra, Elisabetta			Co-Expression of Host and Viral MicroRNAs in Porcine Dendritic Cells Infected by the Pseudorabies Virus	PLOS ONE			English	Article							LATENCY-ASSOCIATED TRANSCRIPT; DEEP-SEQUENCING DATA; GENOMIC ORGANIZATION; GENE-EXPRESSION; IMMUNITY; IDENTIFICATION; ANNOTATION; PROTEINS; TARGETS; INNATE	MicroRNAs are small non-coding RNAs approximately 22 nt long that modulate gene expression in animals and plants. It has been recently demonstrated that herpesviruses encode miRNAs to control the post-transcriptional regulation of expression from their own genomes and possibly that of their host, thus adding an additional layer of complexity to the physiological cross-talk between host and pathogen. The present study focussed on the interactions between porcine dendritic cells (DCs) and the Pseudorabies virus (PRV), an alpha-herpesvirus causing Aujeszky's disease in pigs. A catalogue of porcine and viral miRNAs, expressed eight hours post-infection, was established by deep sequencing. An average of 2 million reads per sample with a size of 21-24 nucleotides was obtained from six libraries representing three biological replicates of infected and mock-infected DCs. Almost 95% of reads mapped to the draft pig genome sequence and pig miRNAs previously annotated in dedicated databases were detected by sequence alignment. In silico prediction allowed the identification of unknown porcine as well as of five miRNAs transcribed by the Large Latency Transcript (LLT) of PRV. The gene target prediction of the viral miRNAs and the Ingenuity Pathway Analysis of differentially expressed pig miRNAs were conducted to contextualize the identified small RNA molecules and functionally characterize their involvement in the post-transcriptional regulation of gene expression. The results support a role for PRV miRNAs in the maintenance of the host cell latency state through the down-regulation of immediate-early viral genes which is similar to other herpesviruses. The differentially expressed swine miRNAs identified a unique network of target genes with highly significant functions in the development and function of the nervous system and in infectious mechanisms, suggesting that the modulation of both host and viral miRNAs is necessary for the establishment of PRV latency.	[Anselmo, Anna; Rutigliano, Teresa; Cecere, Maria; Giuffra, Elisabetta] Polo Univ, Lodi, Italy; [Flori, Laurence; Jaffrezic, Florence; Rogel-Gaillard, Claire; Giuffra, Elisabetta] INRA, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France; [Flori, Laurence; Jaffrezic, Florence; Cortes-Perez, Naima; Rogel-Gaillard, Claire; Giuffra, Elisabetta] AgroParisTech, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France; [Lefevre, Francois] INRA, UR Virol & Immunol Mol 892, Jouy En Josas, France; [Rogel-Gaillard, Claire] CEA, DSV, IRCM, SREIT,Lab Radiobiol & Etud Genome, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Anselmo, A (corresponding author), Polo Univ, Lodi, Italy.	elisabetta.giuffra@jouy.inra.fr	Cortes-Perez, Naima/AAG-7100-2022; Cortes-Perez, Naima/AFL-1772-2022; Giuffra, Elisabetta/I-3201-2013; Giuffra, Elisabetta/J-8080-2014; Flori, Laurence/H-3683-2013; Cortes-Perez, Naima G/AAE-8967-2019	Cortes-Perez, Naima/0000-0003-4189-7304; Cortes-Perez, Naima/0000-0003-4189-7304; ROGEL-GAILLARD, Claire/0000-0002-2174-1962; Giuffra, Elisabetta/0000-0001-9568-2056; Anselmo, Anna/0000-0002-5279-8670	EU [FOOD-CT-2004-506416]	EU(European Commission)	Work was supported by FP6 EADGENE network of excellence (EU Contract No. FOOD-CT-2004-506416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bai Zhi-Qiang, 2008, Virol Sin, V23, P459, DOI 10.1007/s12250-008-2997-9; Bloom DC, 2010, BBA-GENE REGUL MECH, V1799, P246, DOI 10.1016/j.bbagrm.2009.12.001; Boss IW, 2009, TRENDS MICROBIOL, V17, P544, DOI 10.1016/j.tim.2009.09.002; Brukman A, 2006, J VIROL, V80, P10871, DOI 10.1128/JVI.01308-06; Burnside J, 2006, J VIROL, V80, P8778, DOI 10.1128/JVI.00831-06; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Cekaite Lina, 2010, Front Biosci (Elite Ed), V2, P818; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Das S, 2009, MOL BIOL EVOL, V26, P1179, DOI 10.1093/molbev/msp035; Derfuss T, 2002, CURR TOP MICROBIOL, V269, P257; Flori L, 2008, DEV BIOLOGICALS, V132, P99, DOI 10.1159/000317149; Flori L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-123; Freer G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000384; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Glazov EA, 2010, J GEN VIROL, V91, P32, DOI 10.1099/vir.0.014290-0; Guo XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-97; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Heidari M, 2010, VIRAL IMMUNOL, V23, P309, DOI 10.1089/vim.2009.0079; Ji J, 2008, J GEN VIROL, V89, P2761, DOI 10.1099/vir.0.2008/002923-0; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jurak I, 2010, J VIROL, V84, P4659, DOI 10.1128/JVI.02725-09; Kent JR, 2003, J NEUROVIROL, V9, P285, DOI 10.1080/13550280390200994; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Koh W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S6; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kwiatkowski DL, 2009, J VIROL, V83, P8173, DOI 10.1128/JVI.00686-09; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; McCullough KC, 2009, VET IMMUNOL IMMUNOP, V128, P7, DOI 10.1016/j.vetimm.2008.10.290; Moens U, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/419539; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Olena AF, 2010, J CELL PHYSIOL, V222, P540, DOI 10.1002/jcp.21993; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pomeranz LE, 2005, MICROBIOL MOL BIOL R, V69, P462, DOI 10.1128/MMBR.69.3.462-500.2005; Riteau B, 2006, J GEN VIROL, V87, P1109, DOI 10.1099/vir.0.81609-0; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Song WJ, 2010, CANCER SCI, V101, P1754, DOI 10.1111/j.1349-7006.2010.01577.x; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tang S, 2009, J VIROL, V83, P1433, DOI 10.1128/JVI.01723-08; Umbach JL, 2010, J VIROL, V84, P1189, DOI 10.1128/JVI.01712-09; Umbach JL, 2009, J VIROL, V83, P10677, DOI 10.1128/JVI.01185-09; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288	52	34	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17374	10.1371/journal.pone.0017374	http://dx.doi.org/10.1371/journal.pone.0017374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408164	Green Published, gold			2022-12-25	WOS:000288170000026
J	Wijsman, CA; van Heemst, D; Rozing, MP; Slagboom, PE; Beekman, M; de Craen, AJM; Maier, AB; Westendorp, RGJ; Blom, HJ; Mooijaart, SP				Wijsman, Carolien A.; van Heemst, Diana; Rozing, Maarten P.; Slagboom, P. Eline; Beekman, Marian; de Craen, Anton J. M.; Maier, Andrea B.; Westendorp, Rudi G. J.; Blom, Henk J.; Mooijaart, Simon P.			Homocysteine and Familial Longevity: The Leiden Longevity Study	PLOS ONE			English	Article							PLASMA TOTAL HOMOCYSTEINE; S-ADENOSYLHOMOCYSTEINE; GLUTATHIONE METABOLISM; CARDIOVASCULAR-DISEASE; NONAGENARIAN SIBLINGS; RISK FACTOR; LIFE-SPAN; MORTALITY; HYPERHOMOCYSTEINEMIA; DETERMINANTS	Homocysteine concentrations are a read-out of methionine metabolism and have been related to changes in lifespan in animal models. In humans, high homocysteine concentrations are an important predictor of age related disease. We aimed to explore the association of homocysteine with familial longevity by testing whether homocysteine is lower in individuals that are genetically enriched for longevity. We measured concentrations of total homocysteine in 1907 subjects from the Leiden Longevity Study consisting of 1309 offspring of nonagenarian siblings, who are enriched with familial factors promoting longevity, and 598 partners thereof as population controls. We found that homocysteine was related to age, creatinine, folate, vitamin B levels and medical history of hypertension and stroke in both groups (all p < 0.001). However, levels of homocysteine did not differ between offspring enriched for longevity and their partners, and no differences in the age-related rise in homocysteine levels were found between groups (p for interaction 0.63). The results suggest that homocysteine metabolism is not likely to predict familial longevity.	[Wijsman, Carolien A.; van Heemst, Diana; Rozing, Maarten P.; de Craen, Anton J. M.; Maier, Andrea B.; Westendorp, Rudi G. J.; Mooijaart, Simon P.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Slagboom, P. Eline; Beekman, Marian] Leiden Univ, Med Ctr, Dept Med Stat, Sect Mol Epidemiol, Leiden, Netherlands; [Slagboom, P. Eline] NCHA, Leiden, Netherlands; [Blom, Henk J.] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Clin Chem, Metab Unit, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Wijsman, CA (corresponding author), Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.	c.a.wijsman@lumc.nl	Mooijaart, Simon P./A-5306-2008; Maier, Andrea B./Q-5548-2019; Rozing, Maarten/AHC-7454-2022; Maier, Andrea/W-7060-2019; Slagboom, P. Eline/R-4790-2016; Beekman, Marian/L-3004-2019	Mooijaart, Simon P./0000-0003-3106-3568; Maier, Andrea/0000-0001-7206-1724; Slagboom, P. Eline/0000-0002-2875-4723; Beekman, Marian/0000-0003-0585-6206; Blom, Henk/0000-0001-5202-9241	SenterNovem [IGE01014, IGE5007]; Centre for Medical Systems Biology (CMSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO) [05040202]; EU [FP6 036894]	SenterNovem; Centre for Medical Systems Biology (CMSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO)(Netherlands Organization for Scientific Research (NWO)); EU(European Commission)	This study was supported by the Innovation Oriented Research Program on Genomics (SenterNovem; IGE01014 and IGE5007), the Centre for Medical Systems Biology (CMSB), the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO; 05040202), and the EU funded Network of Excellence Lifespan (FP6 036894). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 2008, ARCH GEN PSYCHIAT, V65, P1286, DOI 10.1001/archpsyc.65.11.1286; Ayyadevara S, 2005, AGING CELL, V4, P257, DOI 10.1111/j.1474-9726.2005.00168.x; Becker A, 2003, ATHEROSCLEROSIS, V169, P323, DOI 10.1016/S0021-9150(03)00199-0; Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Blom HJ, 2000, EUR J PEDIATR, V159, pS208, DOI 10.1007/PL00014405; Bostom AG, 1999, ANN INTERN MED, V131, P352, DOI 10.7326/0003-4819-131-5-199909070-00006; Brown-Borg HM, 2005, EXP GERONTOL, V40, P115, DOI 10.1016/j.exger.2004.11.004; Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348; Connolly GM, 2010, NEPHRON CLIN PRACT, V114, pC5, DOI 10.1159/000242443; Dangour AD, 2008, J NUTR, V138, P1121, DOI 10.1093/jn/138.6.1121; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; denHeijer M, 1996, NEW ENGL J MED, V334, P759, DOI 10.1056/NEJM199603213341203; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Kerins DM, 2001, AM J CLIN NUTR, V74, P723; Lewis SJ, 2005, BMJ-BRIT MED J, V331, P1053, DOI 10.1136/bmj.38611.658947.55; Marti-Carvajal AJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006786.pub2; Muntjewerff JW, 2005, AM J MED GENET B, V135B, P69, DOI 10.1002/ajmg.b.30179; Nygard O, 1998, AM J CLIN NUTR, V67, P263, DOI 10.1093/ajcn/67.2.263; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Rozing MP, 2010, J GERONTOL A-BIOL, V65, P365, DOI 10.1093/gerona/glp200; Rozing MP, 2010, J AM GERIATR SOC, V58, P564, DOI 10.1111/j.1532-5415.2010.02725.x; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Selhub J, 2006, J NUTR, V136, p1726S, DOI 10.1093/jn/136.6.1726S; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Smulders YM, 2011, J INHERIT METAB DIS, V34, P93, DOI 10.1007/s10545-010-9151-1; Uthus EO, 2006, MECH AGEING DEV, V127, P444, DOI 10.1016/j.mad.2006.01.001; van Hecke MV, 2008, CLIN SCI, V114, P479, DOI 10.1042/CS20070275; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; Vollset SE, 2001, AM J CLIN NUTR, V74, P130; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Wijsman CA, 2011, AGING CELL, V10, P114, DOI 10.1111/j.1474-9726.2010.00650.x; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Zhang WL, 2010, CLIN SCI, V118, P187, DOI 10.1042/CS20090142	35	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17543	10.1371/journal.pone.0017543	http://dx.doi.org/10.1371/journal.pone.0017543			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408159	Green Published, gold			2022-12-25	WOS:000288170000036
J	Rube, CE; Fricke, A; Widmann, TA; Furst, T; Madry, H; Pfreundschuh, M; Rube, C				Ruebe, Claudia E.; Fricke, Andreas; Widmann, Thomas A.; Fuerst, Tobias; Madry, Henning; Pfreundschuh, Michael; Ruebe, Christian			Accumulation of DNA Damage in Hematopoietic Stem and Progenitor Cells during Human Aging	PLOS ONE			English	Article							STRAND BREAK REPAIR; TELOMERE LENGTH; CELLULAR SENESCENCE; DYSFUNCTION; EXERCISE; TISSUES; AGE	Background: Accumulation of DNA damage leading to adult stem cell exhaustion has been proposed to be a principal mechanism of aging. Here we tested this hypothesis in healthy individuals of different ages by examining unrepaired DNA double-strand breaks (DSBs) in hematopoietic stem/progenitor cells matured in their physiological microenvironment. Methodology/Principal Findings: To asses DNA damage accumulation and repair capacities, gamma H2AX-foci were examined before and after exposure to ionizing irradiation. Analyzing CD34+ and CD34- stem/progenitor cells we observed an increase of endogenous gamma H2AX-foci levels with advancing donor age, associated with an age-related decline in telomere length. Using combined immunofluorescence and telomere-fluorescence in-situ hybridization we show that gamma H2AX-foci co-localize consistently with other repair factors such as pATM, MDC1 and 53BP1, but not significantly with telomeres, strongly supporting the telomere-independent origin for the majority of foci. The highest inter-individual variations for non-telomeric DNA damage were observed in middle-aged donors, whereas the individual DSB repair capacity appears to determine the extent of DNA damage accrual. However, analyzing different stem/progenitor subpopulations obtained from healthy elderly (> 70 years), we observed an only modest increase in DNA damage accrual, most pronounced in the primitive CD34+CD38--enriched subfraction, but sustained DNA repair efficiencies, suggesting that healthy lifestyle may slow down the natural aging process. Conclusions/Significance: Based on these findings we conclude that age-related non-telomeric DNA damage accrual accompanies physiological stem cell aging in humans. Moreover, aging may alter the functional capacity of human stem cells to repair DSBs, thereby deteriorating an important genome protection mechanism leading to exceeding DNA damage accumulation. However, the great inter-individual variations in middle-aged individuals suggest that additional cell-intrinsic mechanisms and/or extrinsic factors contribute to the age-associated DNA damage accumulation.	[Ruebe, Claudia E.; Fricke, Andreas; Fuerst, Tobias; Ruebe, Christian] Univ Saarland, Dept Radiat Oncol, D-6650 Homburg, Germany; [Widmann, Thomas A.; Pfreundschuh, Michael] Univ Saarland, Dept Internal Med 1, D-6650 Homburg, Germany; [Madry, Henning] Univ Saarland, Dept Orthopaed Surg, D-6650 Homburg, Germany	Saarland University; Saarland University; Saarland University	Rube, CE (corresponding author), Univ Saarland, Dept Radiat Oncol, D-6650 Homburg, Germany.	claudia.ruebe@uks.eu	Fricke, Andreas/V-7478-2018; Madry, Henning/AAP-7115-2020	Fricke, Andreas/0000-0003-4915-4564	Saarland University [HOMFOR 2006/77]; Deutsche Forschungsgemeinschaft [RU 821/3-1]	Saarland University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by research funding from Saarland University (HOMFOR 2006/77) and in part from Deutsche Forschungsgemeinschaft (RU 821/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgayer H, 2008, SCAND J GASTROENTERO, V43, P971, DOI 10.1080/00365520701766111; Baerlocher GM, 2002, CYTOMETRY, V47, P89, DOI 10.1002/cyto.10053; Banath JP, 2009, EXP CELL RES, V315, P1505, DOI 10.1016/j.yexcr.2008.12.007; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Engelhardt M, 2002, LEUKEMIA, V16, P1603, DOI 10.1038/sj.leu.2402620; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hofer T, 2008, REJUV RES, V11, P793, DOI 10.1089/rej.2008.0712; Jeggo PA, 2009, HEALTH PHYS, V97, P416, DOI 10.1097/HP.0b013e3181aff9c8; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Ju ZY, 2008, BIOCHIMIE, V90, P24, DOI 10.1016/j.biochi.2007.09.006; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Kappei D, 2008, MECH AGEING DEV, V129, P17, DOI 10.1016/j.mad.2007.10.009; Kollman C, 2001, BLOOD, V98, P2043, DOI 10.1182/blood.V98.7.2043; Lichtman MA, 2004, SEMIN ONCOL, V31, P185, DOI 10.1053/j.seminoncol.2003.12.029; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Lobrich M, 2005, P NATL ACAD SCI USA, V102, P8984, DOI 10.1073/pnas.0501895102; Niedernhofer LJ, 2008, DNA REPAIR, V7, P523, DOI 10.1016/j.dnarep.2007.11.012; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; O'Callaghan NJ, 2009, REJUV RES, V12, P169, DOI 10.1089/rej.2008.0819; ORLOWSKI C, CHROMOSOMA; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Reichenbach J, 2006, CLIN EXP IMMUNOL, V146, P381, DOI 10.1111/j.1365-2249.2006.03221.x; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rossi DJ, 2007, CELL CYCLE, V6, P2371, DOI 10.4161/cc.6.19.4759; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; RUBE CE, DNA REPAIR AMST; Rube CE, 2008, INT J RADIAT ONCOL, V72, P1180, DOI 10.1016/j.ijrobp.2008.07.017; Rube CE, 2008, CLIN CANCER RES, V14, P6546, DOI 10.1158/1078-0432.CCR-07-5147; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Song Z, AGING CELL, V9, P607; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wagner W, 2008, EXP GERONTOL, V43, P974, DOI 10.1016/j.exger.2008.04.007; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Widmann TA, 2005, EXP HEMATOL, V33, P1257, DOI 10.1016/j.exphem.2005.05.019; Widmann T, 2008, EXP HEMATOL, V36, P104, DOI 10.1016/j.exphem.2007.08.028; Xiao M, 2000, LEUKEMIA LYMPHOMA, V38, P489, DOI 10.3109/10428190009059267	40	213	215	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17487	10.1371/journal.pone.0017487	http://dx.doi.org/10.1371/journal.pone.0017487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408175	gold, Green Published, Green Submitted			2022-12-25	WOS:000288099800018
J	Martins, H; Villesen, P				Martins, Hugo; Villesen, Palle			Improved Integration Time Estimation of Endogenous Retroviruses with Phylogenetic Data	PLOS ONE			English	Article							ENVELOPE PROTEIN; HERV-W; GLYCOPROTEIN; CONSERVATION; PLACENTA; SYNCYTIN; ORIGIN	Background: Endogenous retroviruses f(ERVs) are genetic fossils of ancient retroviral integrations that remain in the genome of many organisms. Most loci are rendered non-functional by mutations, but several intact retroviral genes are known in mammalian genomes. Some have been adopted by the host species, while the beneficial roles of others remain unclear. Besides the obvious possible immunogenic impact from transcribing intact viral genes, endogenous retroviruses have also become an interesting and useful tool to study phylogenetic relationships. The determination of the integration time of these viruses has been based upon the assumption that both 59 and 39 Long Terminal Repeats (LTRs) sequences are identical at the time of integration, but evolve separately afterwards. Similar approaches have been using either a constant evolutionary rate or a range of rates for these viral loci, and only single species data. Here we show the advantages of using different approaches. Results: We show that there are strong advantages in using multiple species data and state-of-the-art phylogenetic analysis. We incorporate both simple phylogenetic information and Monte Carlo Markov Chain (MCMC) methods to date the integrations of these viruses based on a relaxed molecular clock approach over a Bayesian phylogeny model and applied them to several selected ERV sequences in primates. These methods treat each ERV locus as having a distinct evolutionary rate for each LTR, and make use of consensual speciation time intervals between primates to calibrate the relaxed molecular clocks. Conclusions: The use of a fixed rate produces results that vary considerably with ERV family and the actual evolutionary rate of the sequence, and should be avoided whenever multi-species phylogenetic data are available. For genome-wide studies, the simple phylogenetic approach constitutes a better alternative, while still being computationally feasible.	[Martins, Hugo; Villesen, Palle] Univ Aarhus, Bioinformat Res Ctr, Aarhus, Denmark; [Martins, Hugo] Inst Gulbenkian Ciencias, Computat Biol PhD Program, Oeiras, Portugal	Aarhus University; Instituto Gulbenkian de Ciencia	Martins, H (corresponding author), Univ Aarhus, Bioinformat Res Ctr, Aarhus, Denmark.	palle@birc.au.dk		Villesen, Palle/0000-0001-7589-8781	FCT, Portugal [(SFRH)/BD/33526/2008]	FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by research scholarship Servicos, Formacao e Recursos Humanos (SFRH)/BD/33526/2008 from FCT, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 2005, GENOMICS, V86, P685, DOI 10.1016/j.ygeno.2005.08.011; Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Belshaw R, 2004, P NATL ACAD SCI USA, V101, P4894, DOI 10.1073/pnas.0307800101; Blaise S, 2004, J VIROL, V78, P1050, DOI 10.1128/JVI.78.2.1050-1054.2004; Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; COFFIN JM, RETROVIRIDAE; DOOLITTLE RF, 1989, Q REV BIOL, V64, P1, DOI 10.1086/416128; Dupressoir A, 2005, P NATL ACAD SCI USA, V102, P725, DOI 10.1073/pnas.0406509102; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Herve CA, 2004, GENOMICS, V83, P940, DOI 10.1016/j.ygeno.2003.10.003; Jern P, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-50; JUNIER T, NEWICK UTILS 0 11; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Prudhomme S, 2005, CYTOGENET GENOME RES, V110, P353, DOI 10.1159/000084967; Romano CM, 2006, ARCH VIROL, V151, P2215, DOI 10.1007/s00705-006-0792-1; Romano CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001026; Ruprecht K, 2008, CELL MOL LIFE SCI, V65, P3366, DOI 10.1007/s00018-008-8496-1; Schrago CG, 2003, MOL BIOL EVOL, V20, P1620, DOI 10.1093/molbev/msg172; Sotgiu S, 2006, MULT SCLER J, V12, P698, DOI 10.1177/1352458506070773; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; DNA DOTPLOT WEB UTIL	28	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e14745	10.1371/journal.pone.0014745	http://dx.doi.org/10.1371/journal.pone.0014745			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394200	Green Submitted, gold, Green Published			2022-12-25	WOS:000288025500001
J	Bygrave, H; Kranzer, K; Hilderbrand, K; Jouquet, G; Goemaere, E; Vlahakis, N; Trivino, L; Makakole, L; Ford, N				Bygrave, Helen; Kranzer, Katharina; Hilderbrand, Katherine; Jouquet, Guillaume; Goemaere, Eric; Vlahakis, Nathalie; Trivino, Laura; Makakole, Lipontso; Ford, Nathan			Renal Safety of a Tenofovir-Containing First Line Regimen: Experience from an Antiretroviral Cohort in Rural Lesotho	PLOS ONE			English	Article							DISOPROXIL FUMARATE; THERAPY; HIV; OUTCOMES; ZAMBIA; DF	Introduction: Current guidelines contraindicate TDF use when creatinine clearance (CrCl) falls below 50 ml/min. We report prevalence of abnormal renal function at baseline and factors associated with abnormal renal function from a community cohort in Lesotho. Methods: We calculated changes in CrCl from baseline for patients initiated on TDF at 6 and 12 months and the proportion of patients initiated on TDF who developed renal impairment. Screening algorithms were developed using risk factors determined by multivariate analysis. Results: Among 933 adults for whom baseline creatinine was available, 176 (18.9%) presented with a baseline CrCl < 50 ml/min. Renal function improved during follow-up. 19 patients who developed renal toxicity during follow up remained on TDF; renal function improved (CrCl >= 50 ml/min) in all but 3 of these patients. Among 15 patients with a baseline CrCl,50 ml/min were started in error, none developed severe renal impairment. Conclusion: In this setting TDF-associated renal toxicity is rare and mainly transient. Further studies to assess TDF safety at lower CrCl thresholds are warranted.	[Bygrave, Helen; Jouquet, Guillaume; Vlahakis, Nathalie; Trivino, Laura] Med Sans Frontieres, Morija, Lesotho; [Kranzer, Katharina] London Sch Hyg & Trop Med, London WC1, England; [Hilderbrand, Katherine; Goemaere, Eric; Ford, Nathan] Med Sans Frontieres, Cape Town, South Africa; [Hilderbrand, Katherine; Ford, Nathan] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7700 Rondebosch, South Africa; [Makakole, Lipontso] Scott Hosp, Morija, Lesotho	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town	Bygrave, H (corresponding author), Med Sans Frontieres, Morija, Lesotho.	helen.bygrave@joburg.msf.org	Kranzer, Katharina/O-8845-2014	Kranzer, Katharina/0000-0001-5691-7270	M�decins Sans Fronti�res [OCA_pilot_00_Bygrave] Funding Source: researchfish	M�decins Sans Fronti�res		[Anonymous], 2009, RAPID ADVICE ANTIRET; [Anonymous], 2010, ANTIRETROVIRAL THERA; Barraclough K, 2009, NEPHRON CLIN PRACT, V111, pC39, DOI 10.1159/000178978; Chi BH, 2010, JAIDS-J ACQ IMM DEF, V54, P63, DOI 10.1097/QAI.0b013e3181c6c65c; Clinical guidelines for the management of the open abdomen with ABTheraTM, 2010, CLIN GUIDELINES MANA; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Franey C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-143; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Grim SA, 2003, ANN PHARMACOTHER, V37, P849, DOI 10.1345/aph.1C388; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Mulenga LB, 2008, AIDS, V22, P1821, DOI 10.1097/QAD.0b013e328307a051; Pozniak A, 2008, INT J CLIN PRACT, V62, P1285, DOI 10.1111/j.1742-1241.2008.01817.x; Reid A, 2005, 5 IAS C HIV PATH TRE; Schopper D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000115; STRUIK G, 2010, 18 C INT AIDS SOC C; Verhave JC, 2005, AM J KIDNEY DIS, V46, P233, DOI 10.1053/j.ajkd.2005.05.011; VROUENRAETS S, 2008, 15 C RETR OPP INF BO	19	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17609	10.1371/journal.pone.0017609	http://dx.doi.org/10.1371/journal.pone.0017609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407815	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000287933300034
J	Valbuena, A; Castro-Obregon, S; Lazo, PA				Valbuena, Alberto; Castro-Obregon, Susana; Lazo, Pedro A.			Downregulation of VRK1 by p53 in Response to DNA Damage Is Mediated by the Autophagic Pathway	PLOS ONE			English	Article							HUMAN VACCINIA-RELATED-KINASE-1 VRK1; VACCINIA-RELATED KINASE-1; P53-MDM2 FEEDBACK LOOP; AUTOREGULATORY LOOP; MDM-2 BINDING; CELL-DEATH; IN-VIVO; APOPTOSIS; PROTEIN; PHOSPHORYLATION	Human VRK1 induces a stabilization and accumulation of p53 by specific phosphorylation in Thr18. This p53 accumulation is reversed by its downregulation mediated by Hdm2, requiring a dephosphorylated p53 and therefore also needs the removal of VRK1 as stabilizer. This process requires export of VRK1 to the cytosol and is inhibited by leptomycin B. We have identified that downregulation of VRK1 protein levels requires DRAM expression, a p53-induced gene. DRAM is located in the endosomal-lysosomal compartment. Induction of DNA damage by UV, IR, etoposide and doxorubicin stabilizes p53 and induces DRAM expression, followed by VRK1 downregulation and a reduction in p53 Thr18 phosphorylation. DRAM expression is induced by wild-type p53, but not by common human p53 mutants, R175H, R248W and R273H. Overexpression of DRAM induces VRK1 downregulation and the opposite effect was observed by its knockdown. LC3 and p62 were also downregulated, like VRK1, in response to UV-induced DNA damage. The implication of the autophagic pathway was confirmed by its requirement for Beclin1. We propose a model with a double regulatory loop in response to DNA damage, the accumulated p53 is removed by induction of Hdm2 and degradation in the proteasome, and the p53-stabilizer VRK1 is eliminated by the induction of DRAM that leads to its lysosomal degradation in the autophagic pathway, and thus permitting p53 degradation by Hdm2. This VRK1 downregulation is necessary to modulate the block in cell cycle progression induced by p53 as part of its DNA damage response.	[Valbuena, Alberto; Lazo, Pedro A.] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Expt Therapeut & Translat Oncol Program, E-37008 Salamanca, Spain; [Castro-Obregon, Susana] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Dev Genet & Mol Physiol, Cuernavaca 62191, Morelos, Mexico	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Universidad Nacional Autonoma de Mexico	Valbuena, A (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Expt Therapeut & Translat Oncol Program, E-37008 Salamanca, Spain.	pedro.lazo@usal.es	Castro-Obregon, Susana/AAE-5105-2020; Lazo, Pedro A./M-6435-2014	Lazo, Pedro A./0000-0001-8997-3025; Castro-Obregon, Susana/0000-0003-0549-5690	Ministerio de Educacion, Ciencia e Innovacion [SAF2007-60242, SAF2010-14935, CSD2007-0017]; Junta de Castilla y Leon (Consejeria de Educacion) [CSI-14A08, GR15]; Consejeria de Sanidad [SAN 673/SA02/08]; Fundacion Sandra Ibarra; Fundacion Samuel Solorzano	Ministerio de Educacion, Ciencia e Innovacion; Junta de Castilla y Leon (Consejeria de Educacion)(Junta de Castilla y Leon); Consejeria de Sanidad; Fundacion Sandra Ibarra; Fundacion Samuel Solorzano	This work was supported by grants from Ministerio de Educacion, Ciencia e Innovacion (SAF2007-60242, SAF2010-14935 and CSD2007-0017), Junta de Castilla y Leon (Consejeria de Educacion, CSI-14A08 and GR15; Consejeria de Sanidad (SAN 673/SA02/08), and Fundacion Sandra Ibarra to P. A. L., and from Fundacion Samuel Solorzano to A. V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Blanco S, 2003, FEMS MICROBIOL LETT, V221, P151, DOI 10.1016/S0378-1097(03)00179-4; Blanco S, 2006, FEBS J, V273, P2487, DOI 10.1111/j.1742-4658.2006.05256.x; Brech A, 2009, MOL ONCOL, V3, P366, DOI 10.1016/j.molonc.2009.05.007; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Crighton D, 2007, AUTOPHAGY, V3, P72, DOI 10.4161/auto.3438; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Falguieres T, 2008, MOL BIOL CELL, V19, P4942, DOI 10.1091/mbc.E08-03-0239; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P6591, DOI 10.1073/pnas.0811023106; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Jabbur JR, 2002, ONCOGENE, V21, P7100, DOI 10.1038/sj.onc.1205856; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Klerkx EPF, 2009, HISTOL HISTOPATHOL, V24, P749, DOI 10.14670/HH-24.749; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Lopez-Sanchez I, 2009, MOL CELL BIOL, V29, P1189, DOI 10.1128/MCB.01341-08; Lorin S, 2010, AUTOPHAGY, V6, P153, DOI 10.4161/auto.6.1.10537; Lorin S, 2009, CANCER RES, V69, P6924, DOI 10.1158/0008-5472.CAN-09-1270; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Lu XB, 2005, CELL CYCLE, V4, P1060; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu X, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000984; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Menendez S, 2003, BRIT J CANCER, V88, P636, DOI 10.1038/sj.bjc.6600752; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Moll UM, 2003, MOL CANCER RES, V1, P1001; Mutka SC, 2009, CANCER RES, V69, P510, DOI 10.1158/0008-5472.CAN-08-0858; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Peters D, 2005, MOL CANCER THER, V4, P1605, DOI 10.1158/1535-7163.MCT-04-0311; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Pursiheimo JP, 2009, ONCOGENE, V28, P334, DOI 10.1038/onc.2008.392; Razi M, 2006, MOL BIOL CELL, V17, P3469, DOI 10.1091/mbc.E05-11-1054; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Santos CR, 2006, MOL CANCER RES, V4, P177, DOI 10.1158/1541-7786.MCR-05-0212; Sanz-Garcia M., 2010, EMERGING SIGNALING P, P135; Sanz-Garcia M, 2008, MOL CELL PROTEOMICS, V7, P2199, DOI 10.1074/mcp.M700586-MCP200; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; STUCHELL MD, 2004, J BIOL CHEM; Tasdemir E, 2008, AUTOPHAGY, V4, P810, DOI 10.4161/auto.6486; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2007, LUNG CANCER, V58, P303, DOI 10.1016/j.lungcan.2007.06.023; Valbuena A, 2007, ARCH BIOCHEM BIOPHYS, V465, P219, DOI 10.1016/j.abb.2007.06.005; Valbuena A, 2006, MOL CELL BIOL, V26, P4782, DOI 10.1128/MCB.00069-06; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002649; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004	65	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17320	10.1371/journal.pone.0017320	http://dx.doi.org/10.1371/journal.pone.0017320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386980	Green Published, Green Submitted, gold			2022-12-25	WOS:000287931400055
J	Dubash, AD; Guilluy, C; Srougi, MC; Boulter, E; Burridge, K; Garcia-Mata, R				Dubash, Adi D.; Guilluy, Christophe; Srougi, Melissa C.; Boulter, Etienne; Burridge, Keith; Garcia-Mata, Rafael			The Small GTPase RhoA Localizes to the Nucleus and Is Activated by Net1 and DNA Damage Signals	PLOS ONE			English	Article							EXCHANGE FACTOR NET1; CELL-ADHESION; HUMAN ECT2; PROTEIN; ACTIN; RAC1; CDC42; DEGRADATION; DOWNSTREAM; MECHANISM	Background: Rho GTPases control many cellular processes, including cell survival, gene expression and migration. Rho proteins reside mainly in the cytosol and are targeted to the plasma membrane (PM) upon specific activation by guanine nucleotide exchange factors (GEFs). Accordingly, most GEFs are also cytosolic or associated with the PM. However, Net1, a RhoA-specific GEF predominantly localizes to the cell nucleus at steady-state. Nuclear localization for Net1 has been seen as a mechanism for sequestering the GEF away from RhoA, effectively rendering the protein inactive. However, considering the prominence of nuclear Net1 and the fact that a biological stimulus that promotes Net1 translocation out the nucleus to the cytosol has yet to be discovered, we hypothesized that Net1 might have a previously unidentified function in the nucleus of cells. Principal Findings: Using an affinity precipitation method to pulldown the active form of Rho GEFs from different cellular fractions, we show here that nuclear Net1 does in fact exist in an active form, contrary to previous expectations. We further demonstrate that a fraction of RhoA resides in the nucleus, and can also be found in a GTP-bound active form and that Net1 plays a role in the activation of nuclear RhoA. In addition, we show that ionizing radiation (IR) specifically promotes the activation of the nuclear pool of RhoA in a Net1-dependent manner, while the cytoplasmic activity remains unchanged. Surprisingly, irradiating isolated nuclei alone also increases nuclear RhoA activity via Net1, suggesting that all the signals required for IR-induced nuclear RhoA signaling are contained within the nucleus. Conclusions/Significance: These results demonstrate the existence of a functional Net1/RhoA signaling pathway within the nucleus of the cell and implicate them in the DNA damage response.	[Dubash, Adi D.; Guilluy, Christophe; Srougi, Melissa C.; Boulter, Etienne; Burridge, Keith; Garcia-Mata, Rafael] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Srougi, Melissa C.; Burridge, Keith] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dubash, AD (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA.	rafaelgm@med.unc.edu	Boulter, Etienne/R-1737-2016; guilluy, christophe/C-6002-2014; Guilluy, Christophe/Z-1015-2019	Boulter, Etienne/0000-0001-6597-9086; guilluy, christophe/0000-0003-1141-0809; Guilluy, Christophe/0000-0003-1141-0809; Garcia-Mata, Rafael/0000-0002-7116-4411; Srougi, Melissa/0000-0003-2183-0233	National Institutes of Health [GM029860]; Department of Defense [BC051092]; AHA; Fondation pour la Recherche Medicale; Allocation INSERM InCa/AVENIR [R08227AS]; European Union [254747]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); AHA(American Heart Association); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Allocation INSERM InCa/AVENIR; European Union(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	KB was supported by a National Institutes of Health grant (GM029860), ADD by a Department of Defense Breast Cancer Predoctoral Fellowship (BC051092), RGM by an AHA Beginning Grant in Aid, EB by a Fondation pour la Recherche Medicale Fellowship, an AHA Postdoctoral Fellowship, and an Allocation INSERM InCa/AVENIR (R08227AS), and CG by a Marie Curie Outgoing International Fellowship from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 254747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts AS, 2005, J BIOL CHEM, V280, P12152, DOI 10.1074/jbc.M405073200; Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bentle MS, 2006, J MOL HISTOL, V37, P203, DOI 10.1007/s10735-006-9043-8; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chalamalasetty RB, 2006, J CELL SCI, V119, P3008, DOI 10.1242/jcs.03032; Chan AML, 1996, ONCOGENE, V12, P1259; Dellaire G, 2007, CELL CYCLE, V6, P1864, DOI 10.4161/cc.6.15.4560; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Dunford JE, 2006, J BONE MINER RES, V21, P684, DOI 10.1359/JBMR.060118; Frisan T, 2003, CELL MICROBIOL, V5, P695, DOI 10.1046/j.1462-5822.2003.00311.x; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; GARCIAMATA R, 2007, MOL CELL BIOL; Guerra L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002254; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kasai M, 2003, CANCER RES, V63, P4927; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; NISHIDA E, 1987, P NATL ACAD SCI USA, V84, P5262, DOI 10.1073/pnas.84.15.5262; Nix DA, 1997, J CELL BIOL, V138, P1139, DOI 10.1083/jcb.138.5.1139; Oceguera-Yanez F, 2005, J CELL BIOL, V168, P221, DOI 10.1083/jcb.200408085; Pederson T, 2008, J CELL BIOL, V180, P1061, DOI 10.1083/jcb.200709082; Pendleton A, 2003, J BIOL CHEM, V278, P14394, DOI 10.1074/jbc.M206393200; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Reuther GW, 2001, J BIOL CHEM, V276, P27145, DOI 10.1074/jbc.M103565200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmidt A, 2002, J BIOL CHEM, V277, P14581, DOI 10.1074/jbc.M111108200; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Shen X, 2001, J BIOL CHEM, V276, P15362, DOI 10.1074/jbc.M009534200; Tanaka T, 2006, J BIOL CHEM, V281, P15320, DOI 10.1074/jbc.M510954200; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Yokoo T, 2003, J BIOL CHEM, V278, P52919, DOI 10.1074/jbc.M309334200	42	68	72	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17380	10.1371/journal.pone.0017380	http://dx.doi.org/10.1371/journal.pone.0017380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390328	gold, Green Published, Green Submitted			2022-12-25	WOS:000287761700049
J	Macha, MA; Matta, A; Chauhan, SS; Siu, KWM; Ralhan, R				Macha, Muzafar A.; Matta, Ajay; Chauhan, Shyam Singh; Siu, K. W. Michael; Ralhan, Ranju			Guggulsterone Targets Smokeless Tobacco Induced PI3K/Akt Pathway in Head and Neck Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; JUN NH2-TERMINAL KINASE; TUMOR-SUPPRESSOR GENES; PROMOTES APOPTOSIS; RB PATHWAY; ACTIVATION; EXPRESSION; CARCINOMA; NICOTINE; PROLIFERATION	Background: Epidemiological association of head and neck cancer with smokeless tobacco (ST) emphasizes the need to unravel the molecular mechanisms implicated in cancer development, and identify pharmacologically safe agents for early intervention and prevention of disease recurrence. Guggulsterone (GS), a biosafe nutraceutical, inhibits the PI3K/Akt pathway that plays a critical role in HNSCC development. However, the potential of GS to suppress ST and nicotine (major component of ST) induced HNSCC remains unexplored. We hypothesized GS can abrogate the effects of ST and nicotine on apoptosis in HNSCC cells, in part by activation of PI3K/Akt pathway and its downstream targets, Bax and Bad. Methods and Results: Our results showed ST and nicotine treatment resulted in activation of PI3K, PDK1, Akt, and its downstream proteins - Raf, GSK3 beta and pS6 while GS induced a time dependent decrease in activation of PI3K/Akt pathway. ST and nicotine treatment also resulted in induction of Bad and Bax phosphorylation, increased the association of Bad with 14-3-3 zeta resulting in its sequestration in the cytoplasm of head and neck cancer cells, thus blocking its pro-apoptotic function. Notably, GS pre-treatment inhibited ST/nicotine induced activation of PI3K/Akt pathway, and inhibited the Akt mediated phosphorylation of Bax and Bad. Conclusions: In conclusion, GS treatment not only inhibited proliferation, but also induced apoptosis by abrogating the effects of ST / nicotine on PI3K/Akt pathway in head and neck cancer cells. These findings provide a rationale for designing future studies to evaluate the chemopreventive potential of GS in ST / nicotine associated head and neck cancer.	[Macha, Muzafar A.; Chauhan, Shyam Singh] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Matta, Ajay; Siu, K. W. Michael; Ralhan, Ranju] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada; [Matta, Ajay; Siu, K. W. Michael; Ralhan, Ranju] York Univ, Ctr Res Mass Spectrometry, Toronto, ON M3J 2R7, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Alex & Simona Shnaider Lab Mol Oncol, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Joseph & Mildred Sonshine Family Ctr Head & Neck, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	All India Institute of Medical Sciences (AIIMS) New Delhi; York University - Canada; York University - Canada; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Macha, MA (corresponding author), All India Inst Med Sci, Dept Biochem, New Delhi 110029, India.	rralhan@mtsinai.on.ca	MACHA, MUZAFAR AHMAD/AAN-5735-2020; MATTA, AJAY/AFT-2977-2022	MACHA, MUZAFAR AHMAD/0000-0003-4468-4435; 	Council of Scientific and Industrial Research (CSIR), New Delhi, India; MITACS Ontario, Canada; Joseph and Mildred Sonshine Centre for Head and Neck Diseases; Alex and Simona Shnaider Laboratory of Molecular Oncology; Temmy Latner/Dynacare; Department of Otolaryngology-Head and Neck Surgery, Mount Sinai Hospital, University of Toronto; Ontario Institute for Cancer Research (OICR); Ontario Research and Development Challenge Fund	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); MITACS Ontario, Canada; Joseph and Mildred Sonshine Centre for Head and Neck Diseases; Alex and Simona Shnaider Laboratory of Molecular Oncology; Temmy Latner/Dynacare; Department of Otolaryngology-Head and Neck Surgery, Mount Sinai Hospital, University of Toronto(University of Toronto); Ontario Institute for Cancer Research (OICR); Ontario Research and Development Challenge Fund(General Electric)	Muzafar A. Macha is a recipient of a Senior Research Fellowship of Council of Scientific and Industrial Research (CSIR), New Delhi, India. Ajay Matta is the recipient of a MITACS Accelerate Fellowship, Ontario, Canada. Ranju Ralhan gratefully acknowledges support from the Joseph and Mildred Sonshine Centre for Head and Neck Diseases, Alex and Simona Shnaider Laboratory of Molecular Oncology, Temmy Latner/Dynacare, and the Department of Otolaryngology-Head and Neck Surgery, Mount Sinai Hospital, University of Toronto. K.W. Michael Siu acknowledges funding from the Ontario Institute for Cancer Research (OICR), and infrastructural support from the Ontario Research and Development Challenge Fund and AB SCIEX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An MJ, 2009, CANCER LETT, V279, P93, DOI 10.1016/j.canlet.2009.01.026; Arora S, 2005, MOL CARCINOGEN, V42, P97, DOI 10.1002/mc.20048; Cogliano V, 2004, LANCET ONCOL, V5, P708, DOI 10.1016/S1470-2045(04)01633-X; Colilla SA, 2010, REGUL TOXICOL PHARM, V56, P197, DOI 10.1016/j.yrtph.2009.09.017; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Davis R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007524; De Gottardi A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-48; Ho R, 2005, CANCER RES, V65, P9868, DOI 10.1158/0008-5472.CAN-04-2426; Jayasurya R, 2005, MODERN PATHOL, V18, P1056, DOI 10.1038/modpathol.3800387; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kar P, 2006, CANCER LETT, V240, P306, DOI 10.1016/j.canlet.2005.09.023; Kaur J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-168; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Kim ES, 2008, ONCOL REP, V20, P1321, DOI 10.3892/or_00000147; KIM MS, 1993, ANTICANCER RES, V13, P1405; Kuhar M, 2006, ANTICANCER RES, V26, P1297; Kurinna SM, 2004, CANCER RES, V64, P7852, DOI 10.1158/0008-5472.CAN-04-1552; Leeman-Neill RJ, 2009, CARCINOGENESIS, V30, P1848, DOI 10.1093/carcin/bgp211; MACHA MA, 2009, J ORAL PATH IN PRESS; Mai HQ, 2003, J BIOL CHEM, V278, P1886, DOI 10.1074/jbc.M209044200; McClave Annette K., 2010, Morbidity and Mortality Weekly Report, V59, P1; Meselhy MR, 2003, PHYTOCHEMISTRY, V62, P213, DOI 10.1016/S0031-9422(02)00388-6; Mishra R, 2005, MOL BIOL REP, V32, P159, DOI 10.1007/s11033-005-0754-9; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Murugan AK, 2008, INT J ONCOL, V32, P101; Nishioka T, 2010, J CELL BIOCHEM, V109, P152, DOI 10.1002/jcb.22392; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rohatgi N, 2005, ORAL ONCOL, V41, P806, DOI 10.1016/j.oraloncology.2005.04.010; SAKAI E, 1992, ONCOGENE, V7, P927; Samudio I, 2005, MOL CANCER THER, V4, P1982, DOI 10.1158/1535-7163.MCT-05-0247; Sapkota AR, 2010, ENVIRON HEALTH PERSP, V118, P351, DOI 10.1289/ehp.0901201; Sarfaraz S, 2008, CARCINOGENESIS, V29, P2011, DOI 10.1093/carcin/bgn180; Sawhney M, 2009, INT J CANCER, V124, P2098, DOI 10.1002/ijc.24192; Sharma C, 2006, TOXICOLOGY, V228, P1, DOI 10.1016/j.tox.2006.07.027; Shishodia S, 2004, J BIOL CHEM, V279, P47148, DOI 10.1074/jbc.M408093200; Shishodia S, 2008, ANTICANCER RES, V28, P3647; Shishodia S, 2007, BIOCHEM PHARMACOL, V74, P118, DOI 10.1016/j.bcp.2007.03.026; Singh SV, 2007, CANCER RES, V67, P7439, DOI 10.1158/0008-5472.CAN-07-0120; Singh SV, 2005, MOL CANCER THER, V4, P1747, DOI 10.1158/1535-7163.MCT-05-0223; Soni S, 2005, ONCOLOGY-BASEL, V68, P314, DOI 10.1159/000086970; Stepanov I, 2010, CHEM RES TOXICOL, V23, P66, DOI 10.1021/tx900281u; Tzivion G, 2006, SEMIN CANCER BIOL, V16, P203, DOI 10.1016/j.semcancer.2006.03.004; Urizar NL, 2003, ANNU REV NUTR, V23, P303, DOI 10.1146/annurev.nutr.23.011702.073102; Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891; Warnakulasuriya KAAS, 2007, J ORAL PATHOL MED, V36, P63, DOI 10.1111/j.1600-0714.2007.00496.x; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; West R, 2004, BRIT DENT J, V196, P611, DOI 10.1038/sj.bdj.4811286; Xu HB, 2009, PHARMAZIE, V64, P660, DOI 10.1691/ph.2009.9619; Yamada T, 2010, ANTICANCER RES, V30, P1953; Zhang JM, 2009, AM J RESP CELL MOL, V40, P135, DOI 10.1165/rcmb.2007-0277OC	50	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e14728	10.1371/journal.pone.0014728	http://dx.doi.org/10.1371/journal.pone.0014728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383988	Green Published, Green Submitted, gold			2022-12-25	WOS:000287761700006
J	Schierack, P; Kleta, S; Tedin, K; Babila, JT; Oswald, S; Oelschlaeger, TA; Hiemann, R; Paetzold, S; Wieler, LH				Schierack, Peter; Kleta, Sylvia; Tedin, Karsten; Babila, Julius Tachu; Oswald, Sibylle; Oelschlaeger, Tobias A.; Hiemann, Rico; Paetzold, Susanne; Wieler, Lothar H.			E. coli Nissle 1917 Affects Salmonella Adhesion to Porcine Intestinal Epithelial Cells	PLOS ONE			English	Article							NONPATHOGENIC ESCHERICHIA-COLI; ENTERICA SEROVAR TYPHIMURIUM; STRAIN NISSLE-1917; IN-VITRO; INVASION GENES; DIARRHEA; GROWTH; EXPRESSION; INFECTION; PPGPP	Background: The probiotic Escherichia coli strain Nissle 1917 (EcN) has been shown to interfere in a human in vitro model with the invasion of several bacterial pathogens into epithelial cells, but the underlying molecular mechanisms are not known. Methodology/Principal Findings: In this study, we investigated the inhibitory effects of EcN on Salmonella Typhimurium invasion of porcine intestinal epithelial cells, focusing on EcN effects on the various stages of Salmonella infection including intracellular and extracellular Salmonella growth rates, virulence gene regulation, and adhesion. We show that EcN affects the initial Salmonella invasion steps by modulating Salmonella virulence gene regulation and Salmonella SiiE-mediated adhesion, but not extra-and intracellular Salmonella growth. However, the inhibitory activity of EcN against Salmonella invasion always correlated with EcN adhesion capacities. EcN mutants defective in the expression of F1C fimbriae and flagellae were less adherent and less inhibitory toward Salmonella invasion. Another E. coli strain expressing F1C fimbriae was also adherent to IPEC-J2 cells, and was similarly inhibitory against Salmonella invasion like EcN. Conclusions: We propose that EcN affects Salmonella adhesion through secretory components. This mechanism appears to be common to many E. coli strains, with strong adherence being a prerequisite for an effective reduction of SiiE-mediated Salmonella adhesion.	[Schierack, Peter; Kleta, Sylvia; Tedin, Karsten; Wieler, Lothar H.] Free Univ Berlin, Inst Mikrobiol & Tierseuchen, D-1000 Berlin, Germany; [Schierack, Peter; Hiemann, Rico] Hsch Lausitz FH, Fachbereich Bio Chem & Verfahrenstech, Senftenberg, Germany; [Kleta, Sylvia] Bundesinst Risikobewertung, Berlin, Germany; [Babila, Julius Tachu] Max Delbruck Ctr Mol Med, Dept Neuroprote, Berlin, Germany; [Oswald, Sibylle; Oelschlaeger, Tobias A.] Univ Wurzburg, Inst Mol Infektbiol, Wurzburg, Germany; [Paetzold, Susanne] Max Planck Inst Infektbiol, Berlin, Germany; [Paetzold, Susanne] Res Ctr Borstel, Borstel, Germany	Free University of Berlin; Brandenburg University of Technology Cottbus; Federal Institute for Risk Assessment; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg; Max Planck Society; Forschungszentrum Borstel	Schierack, P (corresponding author), Free Univ Berlin, Inst Mikrobiol & Tierseuchen, D-1000 Berlin, Germany.	Peter.Schierack@HS-Lausitz.de	Oelschlaeger, Tobias/B-5624-2015	Wieler, Lothar H./0000-0003-4365-3717; Tedin, Karsten/0000-0003-2109-0730	German Research Foundation (DFG) through the Collaborative Research Centre [852, SFB852/1]; DFG [FOR 438/1-1]; Bundesministerium fur Bildung und Forschung (BMBF, Germany) [InnoProfile IP 03 IP 611]	German Research Foundation (DFG) through the Collaborative Research Centre(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF, Germany)(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Research Foundation (DFG) through the Collaborative Research Centre 852 (grant no. SFB852/1), by grant FOR 438/1-1 from the DFG and by InnoProfile IP 03 IP 611 funded by the Bundesministerium fur Bildung und Forschung (BMBF, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoefer A, 2004, FEMS IMMUNOL MED MIC, V40, P223, DOI 10.1016/S0928-8244(03)00368-7; Bar F, 2009, NEUROGASTROENT MOTIL, V21, P575, DOI 10.1111/j.1365-2982.2008.01258.x; Bajaj V, 1995, MOL MICROBIOL, V18, P715, DOI 10.1111/j.1365-2958.1995.mmi_18040715.x; Bar F., 2009, NEUROGASTROENT MOTIL, V21, pe516; BernetCamard MF, 1997, APPL ENVIRON MICROB, V63, P2747, DOI 10.1128/AEM.63.7.2747-2753.1997; Bickert T, 2009, INT ARCH ALLERGY IMM, V149, P219, DOI 10.1159/000199717; Boudeau J, 2003, ALIMENT PHARM THER, V18, P45, DOI 10.1046/j.1365-2036.2003.01638.x; Chiu HH, 2008, J APPL MICROBIOL, V104, P605, DOI 10.1111/j.1365-2672.2007.03573.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ellermeier CD, 2005, MOL MICROBIOL, V57, P691, DOI 10.1111/j.1365-2958.2005.04737.x; Gerlach RG, 2007, INFECT IMMUN, V75, P4697, DOI 10.1128/IAI.00228-07; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Helwig U, 2006, WORLD J GASTROENTERO, V12, P5978, DOI 10.3748/wjg.v12.i37.5978; Henker J, 2008, PEDIATR INFECT DIS J, V27, P494, DOI 10.1097/INF.0b013e318169034c; HERNANDEZ VJ, 1990, J BIOL CHEM, V265, P11605; Hudault S, 1997, APPL ENVIRON MICROB, V63, P513, DOI 10.1128/AEM.63.2.513-518.1997; Kamada N, 2008, INFECT IMMUN, V76, P214, DOI 10.1128/IAI.01193-07; Kleta S, 2006, J APPL MICROBIOL, V101, P1357, DOI 10.1111/j.1365-2672.2006.03019.x; Krammer HJ, 2006, Z GASTROENTEROL, V44, P651, DOI 10.1055/s-2006-926909; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Lasaro MA, 2009, APPL ENVIRON MICROB, V75, P246, DOI 10.1128/AEM.01144-08; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; Main-Hester KL, 2008, INFECT IMMUN, V76, P1024, DOI 10.1128/IAI.01224-07; Monteiro C, 2009, ENVIRON MICROBIOL, V11, P1105, DOI 10.1111/j.1462-2920.2008.01840.x; Prilassnig M, 2007, WIEN KLIN WOCHENSCHR, V119, P456, DOI 10.1007/s00508-007-0808-1; Reissbrodt R, 2009, FEMS MICROBIOL LETT, V290, P62, DOI 10.1111/j.1574-6968.2008.01405.x; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Schierack P, 2009, APPL ENVIRON MICROB, V75, P695, DOI 10.1128/AEM.01650-08; Schroeder B, 2006, DIGEST DIS SCI, V51, P724, DOI 10.1007/s10620-006-3198-8; Schultz M, 2004, CLIN DIAGN LAB IMMUN, V11, P372, DOI 10.1128/CDLI.11.2.372-378.2004; Thompson A, 2006, J BIOL CHEM, V281, P30112, DOI 10.1074/jbc.M605616200; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; von Buenau R, 2005, J DAIRY SCI, V88, P317, DOI 10.3168/jds.S0022-0302(05)72690-4; Zyrek AA, 2007, CELL MICROBIOL, V9, P804, DOI 10.1111/j.1462-5822.2006.00836.x	34	41	42	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e14712	10.1371/journal.pone.0014712	http://dx.doi.org/10.1371/journal.pone.0014712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379575	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000287482300012
J	Graham, SJL; Dziadek, MA; Johnstone, LS				Graham, Sarah J. L.; Dziadek, Marie A.; Johnstone, Lorna S.			A Cytosolic STIM2 Preprotein Created by Signal Peptide Inefficiency Activates ORAI1 in a Store-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; NF-KAPPA-B; ENDOPLASMIC-RETICULUM; CRAC CHANNEL; C-REL; BIOCHEMICAL-PROPERTIES; CELL-DEVELOPMENT; FACTOR-I; T-CELLS; CALMODULIN	Calcium (Ca2+) influx through the plasma membrane store-operated Ca2+ channel ORAI1 is controlled by Ca2+ sensors of the stromal interaction molecule (STIM) family. STIM1 responds to endoplasmic reticulum (ER) Ca2+ store depletion by redistributing and activating ORAI1 from regions of the ER juxtaposed to the plasma membrane. Unlike STIM1, STIM2 can regulate ORAI1 in a store-dependent and store-independent manner, but the mechanism by which this is achieved is unknown. Here we find that STIM2 is translated from a highly conserved methionine residue and is directed to the ER by an incredibly long 101-amino acid signal peptide. We find that although the majority of the total STIM2 population resides on the ER membrane, a second population escapes ER targeting to accumulate as a full-length preprotein in the cytosol, signal peptide intact. Unlike STIM2, preSTIM2 localizes to the inner leaflet of the plasma membrane where it interacts with ORAI1 to regulate basal Ca2+ concentration and Ca2+-dependent gene transcription in a store-independent manner. Furthermore, a third protein comprising a fragment of the STIM2 signal peptide is released from the ER membrane into the cytosol where it regulates gene transcription in a Ca2+-independent manner. This study establishes a new model for STIM2-mediated regulation of ORAI1 in which two distinct proteins, STIM2 and preSTIM2, control store-dependent and store-independent modes of ORAI1 activation.	[Graham, Sarah J. L.; Johnstone, Lorna S.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Dziadek, Marie A.] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia	University of Auckland; University of New South Wales Sydney	Johnstone, LS (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1142, New Zealand.	lorna.johnstone@vodafone.co.nz		Graham, Sarah/0000-0002-3021-5542	Health Research Council; Auckland Medical Research Foundation; Lottery Health in New Zealand	Health Research Council; Auckland Medical Research Foundation; Lottery Health in New Zealand	This work was supported by the Health Research Council, Auckland Medical Research Foundation, and Lottery Health in New Zealand.	Antonsson A, 2003, MOL CELL BIOL, V23, P1418, DOI 10.1128/MCB.23.4.1418-1427.2003; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Bae JS, 2003, BIOCHEM BIOPH RES CO, V305, P1094, DOI 10.1016/S0006-291X(03)00869-6; Ballabio E, 2004, CELL MOL LIFE SCI, V61, P1069, DOI 10.1007/s00018-004-4016-0; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; Bird GS, 2009, CURR BIOL, V19, P1724, DOI 10.1016/j.cub.2009.08.022; Bopp T, 2005, J EXP MED, V201, P181, DOI 10.1084/jem.20041538; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Byun-McKay SA, 2007, TRENDS ECOL EVOL, V22, P338, DOI 10.1016/j.tree.2007.05.002; Darbellay B, 2010, J BIOL CHEM, V285, P22437, DOI 10.1074/jbc.M110.118984; Deenick EK, 2010, EUR J IMMUNOL, V40, P677, DOI 10.1002/eji.201040298; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Edin S, 2010, MOL IMMUNOL, V47, P2057, DOI 10.1016/j.molimm.2010.04.005; Ercan E, 2009, TRAFFIC, V10, P1802, DOI 10.1111/j.1600-0854.2009.00995.x; Golde TE, 2009, SEMIN CELL DEV BIOL, V20, P225, DOI 10.1016/j.semcdb.2009.02.003; Graham SJL, 2009, DIFFERENTIATION, V77, P239, DOI 10.1016/j.diff.2008.10.013; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Hughes K, 2001, J BIOL CHEM, V276, P36008, DOI 10.1074/jbc.M106125200; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Johanson RA, 2000, J NEUROSCI, V20, P2860; Johnstone LS, 2010, J CELL MOL MED, V14, P1890, DOI 10.1111/j.1582-4934.2010.01097.x; Kanazawa Y, 2008, NEUROSCIENCE, V154, P473, DOI 10.1016/j.neuroscience.2008.03.044; Kilic A, 2010, EUR J CELL BIOL, V89, P449, DOI 10.1016/j.ejcb.2010.02.001; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Lemberg MK, 2004, FEBS LETT, V564, P213, DOI 10.1016/S0014-5793(04)00192-9; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lipskaia L, 2009, PFLUG ARCH EUR J PHY, V457, P673, DOI 10.1007/s00424-007-0428-7; Malli R, 2008, J CELL SCI, V121, P3133, DOI 10.1242/jcs.034496; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; Mariotti M, 2000, J BIOL CHEM, V275, P24047, DOI 10.1074/jbc.M001928200; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; MATTILA PS, 1990, EMBO J, V9, P4425, DOI 10.1002/j.1460-2075.1990.tb07893.x; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Oritani K, 1996, J CELL BIOL, V134, P771, DOI 10.1083/jcb.134.3.771; Pani B, 2009, P NATL ACAD SCI USA, V106, P20087, DOI 10.1073/pnas.0905002106; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Rosso L, 2008, PLOS BIOL, V6, P1281, DOI 10.1371/journal.pbio.0060140; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Shaffer KL, 2005, DEV CELL, V9, P545, DOI 10.1016/j.devcel.2005.09.001; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Vang KB, 2010, J IMMUNOL, V184, P4074, DOI 10.4049/jimmunol.0903933; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Visekruna A, 2010, EUR J IMMUNOL, V40, P671, DOI 10.1002/eji.200940260; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Wedel B, 2007, J PHYSIOL-LONDON, V579, P679, DOI 10.1113/jphysiol.2006.125641; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900	63	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.206946	http://dx.doi.org/10.1074/jbc.M110.206946			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21383014	Green Published, hybrid			2022-12-25	WOS:000290022800057
J	Yu, Q; Zhang, XM; Bi, X				Yu, Qun; Zhang, Xinmin; Bi, Xin			Roles of Chromatin Remodeling Factors in the Formation and Maintenance of Heterochromatin Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONALLY SILENT CHROMATIN; POSITION-EFFECT VARIEGATION; LINKING NUMBER CHANGE; SACCHAROMYCES-CEREVISIAE; SIR COMPLEX; LOCUS HML; YEAST; ACETYLATION; PROTEIN; DNA	Heterochromatin consists of highly ordered nucleosomes with characteristic histone modifications. There is evidence implicating chromatin remodeling proteins in heterochromatin formation, but their exact roles are not clear. We demonstrate in Saccharomyces cerevisiae that the Fun30p and Isw1p chromatin remodeling factors are similarly required for transcriptional silencing at the HML locus, but they differentially contribute to the structure and stability of HML heterochromatin. In the absence of Fun30p, only a partially silenced structure is established at HML. Such a structure resembles fully silenced heterochromatin in histone modifications but differs markedly from both fully silenced and derepressed chromatin structures regarding nucleosome arrangement. This structure likely represents an intermediate state of heterochromatin that can be converted by Fun30p to the mature state. Moreover, Fun30p removal reduces the rate of de novo establishment of heterochromatin, suggesting that Fun30p assists the silencing machinery in forming heterochromatin. We also find evidence suggesting that Fun30p functions together with, or after, the action of the silencing machinery. On the other hand, Isw1p is dispensable for the formation of heterochromatin structure but is instead critically required for maintaining its stability. Therefore, chromatin remodeling proteins may rearrange nucleosomes during the formation of heterochromatin or serve to stabilize/maintain heterochromatin structure.	[Yu, Qun; Zhang, Xinmin; Bi, Xin] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Zhang, Xinmin] Jilin Univ, Sch Pharmaceut Sci, Changchun 130021, Jilin, Peoples R China	University of Rochester; Jilin University	Bi, X (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	xinbi@mail.rochester.edu			National Institutes of Health [GM62484]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62484 (to X. B.).	Awad S, 2010, J BIOL CHEM, V285, P9477, DOI 10.1074/jbc.M109.082149; Bassett AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002099; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Bi X, 1997, MOL CELL BIOL, V17, P7077, DOI 10.1128/MCB.17.12.7077; Bi X, 1999, GENE DEV, V13, P1089, DOI 10.1101/gad.13.9.1089; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; Cheng TH, 1998, P NATL ACAD SCI USA, V95, P5521, DOI 10.1073/pnas.95.10.5521; Chiu YH, 2003, GENETICS, V165, P115; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Corona DFV, 2007, PLOS BIOL, V5, P2011, DOI 10.1371/journal.pbio.0050232; Cuperus G, 2002, GENETICS, V162, P633; de la Cruz X, 2005, BIOESSAYS, V27, P164, DOI 10.1002/bies.20176; Dillon N, 2004, BIOL CELL, V96, P631, DOI 10.1016/j.biolcel.2004.06.003; Dror V, 2004, MOL CELL BIOL, V24, P8227, DOI 10.1128/MCB.24.18.8227-8235.2004; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Holmes SG, 1996, GENE DEV, V10, P1021, DOI 10.1101/gad.10.8.1021; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Katan-Khaykovich Y, 2005, EMBO J, V24, P2138, DOI 10.1038/sj.emboj.7600692; KENT NA, 1993, NUCLEIC ACIDS RES, V21, P4653, DOI 10.1093/nar/21.19.4653; Lau A, 2002, GENE DEV, V16, P2935, DOI 10.1101/gad.764102; Lejeune E, 2007, CURR BIOL, V17, P1219, DOI 10.1016/j.cub.2007.06.028; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Martins-Taylor K, 2004, GENETICS, V168, P65, DOI 10.1534/genetics.103.020149; Mellor J, 2004, BBA-GENE STRUCT EXPR, V1677, P100, DOI 10.1016/j.bbaexp.2003.10.014; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; Neves-Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008111; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; NORTON VG, 1990, J BIOL CHEM, V265, P19848; PARK EC, 1990, MOL CELL BIOL, V10, P4932, DOI 10.1128/MCB.10.9.4932; Ravindra A, 1999, MOL CELL BIOL, V19, P7944; Roy N, 2000, CURR BIOL, V10, P111, DOI 10.1016/S0960-9822(00)00298-0; Rudner AD, 2005, MOL CELL BIOL, V25, P4514, DOI 10.1128/MCB.25.11.4514-4528.2005; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Ryan MP, 1999, METHOD ENZYMOL, V304, P376; Santos-Rosa H, 2004, J BIOL CHEM, V279, P47506, DOI 10.1074/jbc.M407949200; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; THOMPSON JS, 1994, MOL CELL BIOL, V14, P446, DOI 10.1128/MCB.14.1.446; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Van Leeuwen F, 2002, METHOD ENZYMOL, V350, P165, DOI 10.1016/S0076-6879(02)50962-9; VOLKERT FC, 1986, CELL, V46, P541, DOI 10.1016/0092-8674(86)90879-2; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Weiss K, 1998, MOL CELL BIOL, V18, P5392, DOI 10.1128/MCB.18.9.5392; Yu Q, 2006, J MOL BIOL, V356, P1082, DOI 10.1016/j.jmb.2005.11.089	50	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14659	14669		10.1074/jbc.M110.183269	http://dx.doi.org/10.1074/jbc.M110.183269			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21388962	hybrid, Green Published			2022-12-25	WOS:000289556200085
J	Cappelletti, PA; dos Santos, RF; do Amaral, AM; Homem, RA; Souza, TD; Machado, MA; Farah, CS				Cappelletti, Paola A.; dos Santos, Rafael Freitas; do Amaral, Alexandre M.; Homem, Rafael Augusto; Souza, Thais dos Santos; Machado, Marcos A.; Farah, Chuck S.			Structure-Function Analysis of the HrpB2-HrcU Interaction in the Xanthomonas citri Type III Secretion System	PLOS ONE			English	Article							ENCODES 8 PROTEINS; SUBSTRATE-SPECIFICITY; FLAGELLAR HOOK; HYPERSENSITIVE RESPONSE; HOST-PLANT; SALMONELLA; PATHOGENICITY; YSCU; EXPORT; GENE	Bacterial type III secretion systems deliver protein virulence factors to host cells. Here we characterize the interaction between HrpB2, a small protein secreted by the Xanthomonas citri subsp. citri type III secretion system, and the cytosolic domain of the inner membrane protein HrcU, a paralog of the flagellar protein FlhB. We show that a recombinant fragment corresponding to the C-terminal cytosolic domain of HrcU produced in E. coli suffers cleavage within a conserved Asn264-Pro265-Thr266-His267 (NPTH) sequence. A recombinant HrcU cytosolic domain with N264A, P265A, T266A mutations at the cleavage site (HrcU(AAAH)) was not cleaved and interacted with HrpB2. Furthermore, a polypeptide corresponding to the sequence following the NPTH cleavage site also interacted with HrpB2 indicating that the site for interaction is located after the NPTH site. Non-polar deletion mutants of the hrcU and hrpB2 genes resulted in a total loss of pathogenicity in susceptible citrus plants and disease symptoms could be recovered by expression of HrpB2 and HrcU from extrachromossomal plasmids. Complementation of the Delta hrcU mutant with HrcU(AAAH) produced canker lesions similar to those observed when complemented with wild-type HrcU. HrpB2 secretion however, was significantly reduced in the Delta hrcU mutant complemented with HrcU(AAAH), suggesting that an intact and cleavable NPTH site in HrcU is necessary for total functionally of T3SS in X. citri subsp. citri. Complementation of the Delta hrpB2 X. citri subsp. citri strain with a series of hrpB2 gene mutants revealed that the highly conserved HrpB2 C-terminus is essential for T3SS-dependent development of citrus canker symptoms in planta.	[Cappelletti, Paola A.; dos Santos, Rafael Freitas; Souza, Thais dos Santos; Farah, Chuck S.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [do Amaral, Alexandre M.] EMBRAPA Recursos Genet & Biotecnol, Brasilia, DF, Brazil; [do Amaral, Alexandre M.; Homem, Rafael Augusto; Machado, Marcos A.] Ctr APTA Citros Sylvio Moreira IAC, Sao Paulo, Brazil	Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Instituto Agronomico de Campinas (IAC)	Cappelletti, PA (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	chsfarah@iq.usp.br	4, INCT/H-4499-2013; Machado, Marcos/G-3582-2012; Citros, Inct/I-2442-2013; Farah, Chuck Shaker/G-5565-2012; Inbeqmedi, Inct/I-1929-2013	Machado, Marcos/0000-0001-9780-3990; Farah, Chuck Shaker/0000-0003-3110-6302; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2005/59243-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by research grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant # 2005/59243-3) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) to C. S. F. and a graduate student scholarship to P. A. C. from FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x; Aldon D, 2000, EMBO J, V19, P2304, DOI 10.1093/emboj/19.10.2304; Alegria MC, 2004, J BACTERIOL, V186, P6186, DOI 10.1128/JB.186.18.6186-6197.2004; ALLAOUI A, 1994, J BACTERIOL, V176, P4534, DOI 10.1128/JB.176.15.4534-4542.1994; Astua-Monge G, 2005, J BACTERIOL, V187, P1201, DOI 10.1128/JB.187.3.1201-1205.2005; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; BONAS U, 1991, MOL PLANT MICROBE IN, V15, P109; Brito B, 2002, MOL PLANT MICROBE IN, V15, P109, DOI 10.1094/MPMI.2002.15.2.109; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Buttner D, 2009, PLANT PHYSIOL, V150, P1656, DOI 10.1104/pp.109.139089; Buttner D, 2006, CURR OPIN MICROBIOL, V9, P193, DOI 10.1016/j.mib.2006.02.006; Buttner D, 2006, MOL MICROBIOL, V59, P513, DOI 10.1111/j.1365-2958.2005.04924.x; COLLAZO CM, 1995, MOL MICROBIOL, V15, P25, DOI 10.1111/j.1365-2958.1995.tb02218.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Deane JE, 2008, MOL MICROBIOL, V69, P267, DOI 10.1111/j.1365-2958.2008.06293.x; DEFEYTER R, 1993, MOL PLANT MICROBE IN, V6, P225, DOI 10.1094/MPMI-6-225; DUNGER G, 2005, PLANT PATHOL, V54, P8; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Fenselau S, 1995, MOL PLANT MICROBE IN, V8, P845, DOI 10.1094/MPMI-8-0845; Ferris HU, 2005, J BIOL CHEM, V280, P41236, DOI 10.1074/jbc.M509438200; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x; Furutani A, 2009, MOL PLANT MICROBE IN, V22, P96, DOI 10.1094/MPMI-22-1-0096; Guzzo CR, 2009, J MOL BIOL, V393, P848, DOI 10.1016/j.jmb.2009.07.065; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; HIROSHI S, 2007, J BACTERIOL, V189, P3271; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; KUTSUKAKE K, 1994, J BACTERIOL, V176, P7625, DOI 10.1128/JB.176.24.7625-7629.1994; Lavander M, 2002, J BACTERIOL, V184, P4500, DOI 10.1128/JB.184.16.4500-4509.2002; Lorenz C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000094; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Macnab RM, 1999, J BACTERIOL, V181, P7149, DOI 10.1128/JB.181.23.7149-7153.1999; Marenda M, 1998, MOL MICROBIOL, V27, P437, DOI 10.1046/j.1365-2958.1998.00692.x; Marguerettaz M, 2011, MOL PLANT MICROBE IN, V24, P246, DOI 10.1094/MPMI-08-10-0188; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Minamino T, 1999, MOL MICROBIOL, V34, P295, DOI 10.1046/j.1365-2958.1999.01597.x; Moreira LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-238; Oh C, 1999, MOL PLANT MICROBE IN, V12, P633, DOI 10.1094/MPMI.1999.12.7.633; Paulucci AA, 2002, J BIOL CHEM, V277, P39574, DOI 10.1074/jbc.M204749200; Payne PL, 1999, J BACTERIOL, V181, P2852, DOI 10.1128/JB.181.9.2852-2862.1999; Pieretti I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-616; Riordan KE, 2008, J BACTERIOL, V190, P6204, DOI 10.1128/JB.00467-08; Riordan KE, 2008, MOL MICROBIOL, V68, P1485, DOI 10.1111/j.1365-2958.2008.06247.x; Rong W, 2010, MOL PLANT PATHOL, V11, P783, DOI 10.1111/j.1364-3703.2010.00642.x; Rossier O, 2000, MOL MICROBIOL, V38, P828, DOI 10.1046/j.1365-2958.2000.02173.x; SAMBROOK J, 2000, MOL CLONING LAB MANU; Song CF, 2010, MOL PLANT MICROBE IN, V23, P893, DOI 10.1094/MPMI-23-7-0893; Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUZUKI T, 1981, J BACTERIOL, V148, P973, DOI 10.1128/JB.148.3.973-979.1981; SWARUP S, 1992, MOL PLANT MICROBE IN, V5, P204, DOI 10.1094/MPMI-5-204; Szczesny R, 2010, NEW PHYTOL, V187, P1058, DOI 10.1111/j.1469-8137.2010.03346.x; Tahara ST, 2003, PROTEOMICS, V3, P95, DOI 10.1002/pmic.200390014; Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002; VANGIJSEGEM F, 1995, MOL MICROBIOL, V15, P1095, DOI 10.1111/j.1365-2958.1995.tb02284.x; Wiesand U, 2009, J MOL BIOL, V385, P854, DOI 10.1016/j.jmb.2008.10.034; Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996; Zarivach R, 2008, NATURE, V453, P124, DOI 10.1038/nature06832	63	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17614	10.1371/journal.pone.0017614	http://dx.doi.org/10.1371/journal.pone.0017614			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408079	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170900030
J	Singh, A; Beveridge, AJ; Singh, N				Singh, Ajay; Beveridge, Alim J.; Singh, Neena			Decreased CSF Transferrin in sCJD: A Potential Pre-Mortem Diagnostic Test for Prion Disorders	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; CEREBROSPINAL-FLUID; DIFFERENTIAL-DIAGNOSIS; TAU-PROTEIN; GEL-ELECTROPHORESIS; IRON; MARKERS; 14-3-3-PROTEIN; ALZHEIMERS; FERRITIN	Sporadic Creutzfeldt-Jakob-disease (sCJD) is a fatal neurodegenerative condition that escapes detection until autopsy. Recently, brain iron dyshomeostasis accompanied by increased transferrin (Tf) was reported in sCJD cases. The consequence of this abnormality on cerebrospinal-fluid (CSF) levels of Tf is uncertain. We evaluated the accuracy of CSF Tf, a 'new' biomarker, as a pre-mortem diagnostic test for sCJD when used alone or in combination with the 'current' biomarker totaltau (T-tau). Levels of total-Tf (T-Tf), isoforms of Tf (Tf-1 and Tf-b2), and iron saturation of Tf were quantified in CSF collected 0.3-36 months before death (duration) from 99 autopsy confirmed sCJD (CJD+) and 75 confirmed cases of dementia of non-CJD origin (CJD-). Diagnostic accuracy was estimated by non-parametric tests, logistic regression, and receiver operating characteristic (ROC) analysis. Area under the ROC curve (AUC), sensitivity, specificity, positive and negative predictive values (PV), and likelihood ratios (LR) of each biomarker and biomarker combination were calculated. We report that relative to CJD-, CJD+ cases had lower median CSF T-Tf (125,7093 vs. 217,7893) and higher T-tau (11530 vs. 1266) values. AUC was 0.90 (95% confidence interval (CI), 0.85-0.94) for T-Tf, and 0.93 (95% CI, 0.89-0.97) for T-Tf combined with T-tau. With cut-offs defined to achieve a sensitivity of,85%, T-Tf identified CJD+ cases with a specificity of 71.6% (95% CI, 59.1-81.7), positive LR of 3.0 (95% CI, 2.1-4.5), negative LR of 0.2 (95% CI, 0.1-0.3), and accuracy of 80.1%. The effect of patient age and duration was insignificant. T-Tf combined with T-tau identified CJD+ with improved specificity of 87.5% (95% CI, 76.3-94.1), positive LR of 6.8 (95% CI, 3.5-13.1), negative LR of 0.2 (95% CI, 0.1-0.3), positive-PV of 91.0%, negative-PV of 80.0%, and accuracy of 86.2%. Thus, CSF T-Tf, a new biomarker, when combined with the current biomarker T-tau, is a reliable pre-mortem diagnostic test for sCJD.	[Singh, Ajay; Singh, Neena] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Beveridge, Alim J.] Case Western Reserve Univ, Dept Org Behav, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Singh, A (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	neena.singh@case.edu	Beveridge, 'Alim/I-2098-2012; Beveridge, 'Alim/GRS-5863-2022	Beveridge, 'Alim/0000-0001-6454-585X	National Institutes of Health [R21AG109106]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076139, R21NS077438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by funds from National Institutes of Health grant R21AG109106 to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Aksamit AJ, 2003, ARCH NEUROL-CHICAGO, V60, P803, DOI 10.1001/archneur.60.6.803; Altman D.G., 1990, PRACTICAL STAT MED R, DOI DOI 10.1201/9780429258589; Alzheimers Assoc, 1998, NEUROBIOL AGING, V19, P109; Baldeiras IE, 2009, J NEUROL, V256, P1540, DOI 10.1007/s00415-009-5160-0; Brechlin P, 2008, PROTEOMICS, V8, P4357, DOI 10.1002/pmic.200800375; Castellani RJ, 2004, NEUROLOGY, V63, P436, DOI 10.1212/01.WNL.0000135153.96325.3B; Clardy SL, 2006, J LAB CLIN MED, V147, P67, DOI 10.1016/j.lab.2005.06.011; Collins SJ, 2006, BRAIN, V129, P2278, DOI 10.1093/brain/awl159; Connor JR, 2008, CURR NEUROL NEUROSCI, V8, P162, DOI 10.1007/s11910-008-0026-x; Cuadrado-Corrales N, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-25; DUGUID JR, 1989, P NATL ACAD SCI USA, V86, P7260, DOI 10.1073/pnas.86.18.7260; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Geschwind MD, 2003, ARCH NEUROL-CHICAGO, V60, P813, DOI 10.1001/archneur.60.6.813; Geschwind MD, 2008, ANN NEUROL, V64, P97, DOI 10.1002/ana.21430; Gmitterova K, 2009, NEUROBIOL AGING, V30, P1842, DOI 10.1016/j.neurobiolaging.2008.01.007; Gorogh T, 2005, CLIN CHEM, V51, P1704, DOI 10.1373/clinchem.2005.054916; Green AJE, 2001, NEUROLOGY, V56, P986, DOI 10.1212/WNL.56.7.986; Heinemann U, 2007, BRAIN, V130, P1350, DOI 10.1093/brain/awm063; Hsich G, 1996, NEW ENGL J MED, V335, P924, DOI 10.1056/NEJM199609263351303; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Jesse S, 2009, J ALZHEIMERS DIS, V17, P541, DOI 10.3233/JAD-2009-1075; Kapaki E, 2001, J NEUROL NEUROSUR PS, V71, P401, DOI 10.1136/jnnp.71.3.401; Kell D., 2009, NATURE, V460, P6; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Kim BH, 2007, NEUROSCI LETT, V422, P158, DOI 10.1016/j.neulet.2007.05.061; KURT S, 2002, NEUROLOGY TODAY, V2, P19; Mackenzie EL, 2008, ANTIOXID REDOX SIGN, V10, P997, DOI 10.1089/ars.2007.1893; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; Mizuno S, 2005, J SLEEP RES, V14, P43, DOI 10.1111/j.1365-2869.2004.00403.x; Moos T, 2000, CELL MOL NEUROBIOL, V20, P77, DOI 10.1023/A:1006948027674; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Otto M, 2003, RESTOR NEUROL NEUROS, V21, P191; Otto M, 2002, NEUROLOGY, V58, P192, DOI 10.1212/WNL.58.2.192; Otto M, 1997, NEUROSCI LETT, V225, P210, DOI 10.1016/S0304-3940(97)00215-2; Otto M, 2008, METHODS, V44, P289, DOI 10.1016/j.ymeth.2007.06.012; Pennington C, 2009, NEUROSCI LETT, V455, P56, DOI 10.1016/j.neulet.2009.02.067; Piubelli C, 2006, PROTEOMICS, V6, pS256, DOI 10.1002/pmic.200500294; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Sanchez-Juan P, 2006, NEUROLOGY, V67, P637, DOI 10.1212/01.wnl.0000230159.67128.00; Sanchez-Juan P, 2007, J NEUROL, V254, P901, DOI 10.1007/s00415-006-0472-9; Satoh K, 2007, DEMENT GERIATR COGN, V24, P207, DOI 10.1159/000107082; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000336; Skinningsrud Anders, 2008, Cerebrospinal Fluid Res, V5, P14, DOI 10.1186/1743-8454-5-14; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; Sussmuth SD, 2001, NEUROSCI LETT, V300, P95, DOI 10.1016/S0304-3940(01)01556-7; Tabachnick B.G., 2014, USING MULTIVARIATE S, V6th Ed., P659; Van Everbroeck B, 2005, CLIN NEUROL NEUROSUR, V107, P355, DOI 10.1016/j.clineuro.2004.12.002; Van Everbroeck B, 2004, J NEUROL, V251, P298, DOI 10.1007/s00415-004-0311-9; Van Everbroeck B, 2003, J NEUROL NEUROSUR PS, V74, P1210, DOI 10.1136/jnnp.74.9.1210; Weissmann C, 2002, P NATL ACAD SCI USA, V99, P16378, DOI 10.1073/pnas.172403799; WHO, 1998, EM OTH COMM DIS SURV, P1; Wiltfang J, 2005, WORLD J BIOL PSYCHIA, V6, P69, DOI 10.1080/15622970510029786; Zerr I, 1998, ANN NEUROL, V43, P32, DOI 10.1002/ana.410430109	55	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e16804	10.1371/journal.pone.0016804	http://dx.doi.org/10.1371/journal.pone.0016804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408069	Green Submitted, Green Published, gold			2022-12-25	WOS:000288170900004
J	Zebelo, SA; Bertea, CM; Bossi, S; Occhipinti, A; Gnavi, G; Maffei, ME				Zebelo, Simon Atsbaha; Bertea, Cinzia M.; Bossi, Simone; Occhipinti, Andrea; Gnavi, Giorgio; Maffei, Massimo E.			Chrysolina herbacea Modulates Terpenoid Biosynthesis of Mentha aquatica L.	PLOS ONE			English	Article							ESSENTIAL OIL BIOSYNTHESIS; PLANT DEFENSE; MONOTERPENE BIOSYNTHESIS; ISOPRENOID BIOSYNTHESIS; FUNCTIONAL EXPRESSION; MINTHOSTACHYS-MOLLIS; CHEMICAL-COMPOSITION; GLANDULAR TRICHOMES; VOLATILE EMISSIONS; INSECT HERBIVORY	Interactions between herbivorous insects and plants storing terpenoids are poorly understood. This study describes the ability of Chrysolina herbacea to use volatiles emitted by undamaged Mentha aquatica plants as attractants and the plant's response to herbivory, which involves the production of deterrent molecules. Emitted plant volatiles were analyzed by GC-MS. The insect's response to plant volatiles was tested by Y-tube olfactometer bioassays. Total RNA was extracted from control plants, mechanically damaged leaves, and leaves damaged by herbivores. The terpenoid quantitative gene expressions (qPCR) were then assayed. Upon herbivory, M. aquatica synthesizes and emits (+)-menthofuran, which acts as a deterrent to C. herbacea. Herbivory was found to up-regulate the expression of genes involved in terpenoid biosynthesis. The increased emission of (+)-menthofuran was correlated with the upregulation of (+)-menthofuran synthase.	[Zebelo, Simon Atsbaha; Bertea, Cinzia M.; Bossi, Simone; Occhipinti, Andrea; Gnavi, Giorgio; Maffei, Massimo E.] Univ Turin, Plant Physiol Unit, Dept Plant Biol, Innovat Ctr, Turin, Italy	University of Turin	Zebelo, SA (corresponding author), Univ Turin, Plant Physiol Unit, Dept Plant Biol, Innovat Ctr, Turin, Italy.	massimo.maffei@unito.it	Zebelo, Simon/T-7086-2017; Maffei, Massimo E/K-9593-2015; Bertea, Cinzia Margherita/AAH-6434-2019; Occhipinti, Andrea/E-4607-2017; G., Gnavi/B-8624-2014	Maffei, Massimo E/0000-0001-6814-2353; Occhipinti, Andrea/0000-0003-2723-6374; G., Gnavi/0000-0003-4725-5337; Bertea, Cinzia Margherita/0000-0003-2919-0445; Bossi, Simone/0000-0003-4736-519X	doctorate school of Pharmaceutical and Biomolecular Sciences of the University of Turin	doctorate school of Pharmaceutical and Biomolecular Sciences of the University of Turin	Financial support came from the doctorate school of Pharmaceutical and Biomolecular Sciences of the University of Turin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 2004, IDENTIFICATION ESSEN, V3rd ed.; Aharoni A, 2003, PLANT CELL, V15, P2866, DOI 10.1105/tpc.016253; Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Banchio E, 2005, J CHEM ECOL, V31, P719, DOI 10.1007/s10886-005-3540-1; Banchio E, 2007, BIOCHEM SYST ECOL, V35, P68, DOI 10.1016/j.bse.2006.08.007; Bertea CM, 2001, ARCH BIOCHEM BIOPHYS, V390, P279, DOI 10.1006/abbi.2001.2378; Bienkowski AO, 2009, ZOOL ZH, V88, P1471; Burke CC, 1999, P NATL ACAD SCI USA, V96, P13062, DOI 10.1073/pnas.96.23.13062; Burse A, 2009, PHYTOCHEMISTRY, V70, P1899, DOI 10.1016/j.phytochem.2009.08.002; Chen MS, 2008, INSECT SCI, V15, P101, DOI 10.1111/j.1744-7917.2008.00190.x; Cogni R, 2009, BIOL J LINN SOC, V97, P494, DOI 10.1111/j.1095-8312.2009.01234.x; Croteau RB, 2005, NATURWISSENSCHAFTEN, V92, P562, DOI 10.1007/s00114-005-0055-0; Dancewicz K, 2008, J CHEM ECOL, V34, P530, DOI 10.1007/s10886-008-9448-9; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dicke M, 2010, TRENDS PLANT SCI, V15, P115, DOI 10.1016/j.tplants.2010.01.007; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Estevez JM, 2001, J BIOL CHEM, V276, P22901, DOI 10.1074/jbc.M100854200; FARRELL BD, 1994, AM ZOOL, V34, P57, DOI 10.1093/icb/34.1.57; Frost CJ, 2008, NEW PHYTOL, V180, P722, DOI 10.1111/j.1469-8137.2008.02599.x; Gershenzon J, 2000, PLANT PHYSIOL, V122, P205, DOI 10.1104/pp.122.1.205; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Holopainen JK, 2010, TRENDS PLANT SCI, V15, P176, DOI 10.1016/j.tplants.2010.01.006; HORWOOD AR, BRIT WILD FLOWERS TH; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Jager AK, 2007, S AFR J BOT, V73, P518, DOI 10.1016/j.sajb.2007.04.061; Jerkovic I, 2001, CROAT CHEM ACTA, V74, P431; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Lange BM, 2000, P NATL ACAD SCI USA, V97, P2934, DOI 10.1073/pnas.97.6.2934; Lange BM, 1998, P NATL ACAD SCI USA, V95, P2100, DOI 10.1073/pnas.95.5.2100; Laurent P, 2005, TOP CURR CHEM, V240, P167; Laurent P, 2003, EUR J ORG CHEM, V2003, P2733, DOI 10.1002/ejoc.200300008; Luciano P, 2007, FORENSIC SCI INT-GEN, V1, P262, DOI 10.1016/j.fsigen.2007.06.003; Lupien S, 1999, ARCH BIOCHEM BIOPHYS, V368, P181, DOI 10.1006/abbi.1999.1298; MAFFEI M, 1989, NEW PHYTOL, V111, P707, DOI 10.1111/j.1469-8137.1989.tb02366.x; Maffei ME, 2010, S AFR J BOT, V76, P612, DOI 10.1016/j.sajb.2010.03.003; Maffei ME, 2007, PHYTOCHEMISTRY, V68, P2946, DOI 10.1016/j.phytochem.2007.07.016; Maffei ME, 2007, TRENDS PLANT SCI, V12, P310, DOI 10.1016/j.tplants.2007.06.001; Mahmoud SS, 2003, P NATL ACAD SCI USA, V100, P14481, DOI 10.1073/pnas.2436325100; Mahmoud SS, 2002, TRENDS PLANT SCI, V7, P366, DOI 10.1016/S1360-1385(02)02303-8; MALINGRE TM, 1974, PHYTOCHEMISTRY, V13, P1531, DOI 10.1016/0031-9422(74)80322-5; Mantyla E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002832; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; McConkey ME, 2000, PLANT PHYSIOL, V122, P215, DOI 10.1104/pp.122.1.215; Mithofer A, 2009, ANNU PLANT REV, V34, P261, DOI 10.1111/b.9781405175326.2009.00009.x; Mkaddem M, 2009, J FOOD SCI, V74, pM358, DOI 10.1111/j.1750-3841.2009.01272.x; Mora FD, 2009, NAT PROD COMMUN, V4, P997; Mucciarelli M, 2001, PHYTOCHEMISTRY, V57, P91, DOI 10.1016/S0031-9422(00)00393-9; Ntalli NG, 2010, J AGR FOOD CHEM, V58, P7856, DOI 10.1021/jf100797m; Olsen HT, 2008, J ETHNOPHARMACOL, V117, P500, DOI 10.1016/j.jep.2008.02.015; Pare PW, 1997, PLANT PHYSIOL, V114, P1161, DOI 10.1104/pp.114.4.1161; PASTEELS JM, 1990, J CHEM ECOL, V16, P211, DOI 10.1007/BF01021280; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Ringer KL, 2005, PLANT PHYSIOL, V137, P863, DOI 10.1104/pp.104.053298; Ringer KL, 2003, ARCH BIOCHEM BIOPHYS, V418, P80, DOI 10.1016/S0003-9861(03)00390-4; Rios-Estepa R, 2008, P NATL ACAD SCI USA, V105, P2818, DOI 10.1073/pnas.0712314105; Rozen S, 2000, Methods Mol Biol, V132, P365; Ribeiro VLS, 2010, BIORESOURCE TECHNOL, V101, P2506, DOI 10.1016/j.biortech.2009.11.016; Scharf ME, 2006, PEST MANAG SCI, V62, P655, DOI 10.1002/ps.1222; Scriber JM, 2002, ENTOMOL EXP APPL, V104, P217, DOI 10.1023/A:1021292604205; Smiseth PT, 2008, P ROY SOC B-BIOL SCI, V275, P1823, DOI 10.1098/rspb.2008.0199; STRONG DR, 1984, INSECTS PLANTS; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Unsicker SB, 2009, CURR OPIN PLANT BIOL, V12, P479, DOI 10.1016/j.pbi.2009.04.001; Valladares GR, 2002, J AGR FOOD CHEM, V50, P4059, DOI 10.1021/jf011608+; van Poecke RMP, 2004, PLANT BIOLOGY, V6, P387, DOI 10.1055/s-2004-820887; Van Staden J, 2007, PLANTA MED, V73, P928; Wang H, 2008, J CHEM ECOL, V34, P330, DOI 10.1007/s10886-008-9433-3; WARREN PH, 1993, ECOGRAPHY, V16, P11, DOI 10.1111/j.1600-0587.1993.tb00053.x; Zhao YX, 2003, J APPL ENTOMOL, V127, P80, DOI 10.1046/j.1439-0418.2003.00687.x	71	30	31	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17195	10.1371/journal.pone.0017195	http://dx.doi.org/10.1371/journal.pone.0017195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408066	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170900007
J	Zhu, WH; Banga, S; Tan, YH; Zheng, C; Stephenson, R; Gately, J; Luo, ZQ				Zhu, Wenhan; Banga, Simran; Tan, Yunhao; Zheng, Cheng; Stephenson, Robert; Gately, Jonathan; Luo, Zhao-Qing			Comprehensive Identification of Protein Substrates of the Dot/Icm Type IV Transporter of Legionella pneumophila	PLOS ONE			English	Article							LEGIONNAIRES-DISEASE; INTRACELLULAR GROWTH; HOST; SYSTEM; TRANSLOCATION; FAMILY; PATHOGENESIS; MACROPHAGES; MEMBERS; REGION	A large number of proteins transferred by the Legionella pneumophila Dot/Icm system have been identified by various strategies. With no exceptions, these strategies are based on one or more characteristics associated with the tested proteins. Given the high level of diversity exhibited by the identified proteins, it is possible that some substrates have been missed in these screenings. In this study, we took a systematic method to survey the L. pneumophila genome by testing hypothetical orfs larger than 300 base pairs for Dot/Icm-dependent translocation. 798 of the 832 analyzed orfs were successfully fused to the carboxyl end of beta-lactamase. The transfer of the fusions into mammalian cells was determined using the beta-lactamase reporter substrate CCF4-AM. These efforts led to the identification of 164 proteins positive in translocation. Among these, 70 proteins are novel substrates of the Dot/Icm system. These results brought the total number of experimentally confirmed Dot/Icm substrates to 275. Sequence analysis of the C-termini of these identified proteins revealed that Lpg2844, which contains few features known to be important for Dot/Icm-dependent protein transfer can be translocated at a high efficiency. Thus, our efforts have identified a large number of novel substrates of the Dot/Icm system and have revealed the diverse features recognizable by this protein transporter.	[Zhu, Wenhan; Banga, Simran; Tan, Yunhao; Stephenson, Robert; Gately, Jonathan; Luo, Zhao-Qing] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Zheng, Cheng] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhu, WH (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	Luoz@purdue.edu	YAN, JING/J-7233-2015; Banga, Simran/L-8806-2013; Tan, Yunhao/K-7442-2016	Tan, Yunhao/0000-0002-5516-4980; Zhu, Wenhan/0000-0003-3771-0842; Luo, Zhao-Qing/0000-0001-8890-6621	NIH-NIAID [R01AI069344, K02AI085403, R21AI092043]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069344, K02AI085403, R21AI092043] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH-NIAID grants R01AI069344, K02AI085403 and R21AI092043 (Z.-Q.L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Zant A, 2007, CELL MICROBIOL, V9, P246, DOI 10.1111/j.1462-5822.2006.00785.x; Altman E, 2008, J BACTERIOL, V190, P1985, DOI 10.1128/JB.01493-07; Banga S, 2007, P NATL ACAD SCI USA, V104, P5121, DOI 10.1073/pnas.0611030104; Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Cambronne ED, 2007, PLOS PATHOG, V3, P1837, DOI 10.1371/journal.ppat.0030188; Campodonico EM, 2005, MOL MICROBIOL, V56, P918, DOI 10.1111/j.1365-2958.2005.04595.x; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Charpentier X, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000501; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Ge JN, 2009, P NATL ACAD SCI USA, V106, P13725, DOI 10.1073/pnas.0907200106; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kubori T, 2008, MOL MICROBIOL, V67, P1307, DOI 10.1111/j.1365-2958.2008.06124.x; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Lindeberg M, 2009, MOL PLANT PATHOL, V10, P767, DOI 10.1111/j.1364-3703.2009.00587.x; Liu YC, 2008, P NATL ACAD SCI USA, V105, P9385, DOI 10.1073/pnas.0801055105; Lomma M, 2010, CELL MICROBIOL, V12, P1272, DOI 10.1111/j.1462-5822.2010.01467.x; Losick VP, 2006, J EXP MED, V203, P2177, DOI 10.1084/jem.20060766; Losick VP, 2010, CELL MICROBIOL, V12, P1083, DOI 10.1111/j.1462-5822.2010.01452.x; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nagai H, 2003, CELL MICROBIOL, V5, P373, DOI 10.1046/j.1462-5822.2003.00285.x; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; Ninio S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000278; Price CT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000704; Rasis M, 2009, MOL MICROBIOL, V72, P995, DOI 10.1111/j.1365-2958.2009.06705.x; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Shen XH, 2009, CELL MICROBIOL, V11, P911, DOI 10.1111/j.1462-5822.2009.01301.x; SMITH HO, 1995, SCIENCE, V269, P538, DOI 10.1126/science.7542802; Solomon JM, 2000, INFECT IMMUN, V68, P2939, DOI 10.1128/IAI.68.5.2939-2947.2000; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; VanRheenen SM, 2006, INFECT IMMUN, V74, P3597, DOI 10.1128/IAI.02060-05; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Zusman T, 2008, INFECT IMMUN, V76, P4581, DOI 10.1128/IAI.00337-08	48	167	172	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17638	10.1371/journal.pone.0017638	http://dx.doi.org/10.1371/journal.pone.0017638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408005	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170900034
J	Deshpande, CN; Harrop, SJ; Boucher, Y; Hassan, KA; Di Leo, R; Xu, XH; Cui, H; Savchenko, A; Chang, CS; Labbate, M; Paulsen, IT; Stokes, HW; Curmi, PMG; Mabbutt, BC				Deshpande, Chandrika N.; Harrop, Stephen J.; Boucher, Yan; Hassan, Karl A.; Di Leo, Rosa; Xu, Xiaohui; Cui, Hong; Savchenko, Alexei; Chang, Changsoo; Labbate, Maurizio; Paulsen, Ian T.; Stokes, H. W.; Curmi, Paul M. G.; Mabbutt, Bridget C.			Crystal Structure of an Integron Gene Cassette-Associated Protein from Vibrio cholerae Identifies a Cationic Drug-Binding Module	PLOS ONE			English	Article							RESPONDING TRANSCRIPTIONAL REGULATOR; LIVIDANS TIPAL PROTEIN; MULTIDRUG RECOGNITION; MERR FAMILY; BMRR; MECHANISM; ACTIVATION; DATABASE; PHENIX; TOXIN	Background: The direct isolation of integron gene cassettes from cultivated and environmental microbial sources allows an assessment of the impact of the integron/gene cassette system on the emergence of new phenotypes, such as drug resistance or virulence. A structural approach is being exploited to investigate the modularity and function of novel integron gene cassettes. Methodology/Principal Findings: We report the 1.8 A crystal structure of Cass2, an integron-associated protein derived from an environmental V. cholerae. The structure defines a monomeric beta-barrel protein with a fold related to the effector-binding portion of AraC/XylS transcription activators. The closest homologs of Cass2 are multi-drug binding proteins, such as BmrR. Consistent with this, a binding pocket made up of hydrophobic residues and a single glutamate side chain is evident in Cass2, occupied in the crystal form by polyethylene glycol. Fluorescence assays demonstrate that Cass2 is capable of binding cationic drug compounds with submicromolar affinity. The Cass2 module possesses a protein interaction surface proximal to its drug-binding cavity with features homologous to those seen in multi-domain transcriptional regulators. Conclusions/Significance: Genetic analysis identifies Cass2 to be representative of a larger family of independent effector-binding proteins associated with lateral gene transfer within Vibrio and closely-related species. We propose that the Cass2 family not only has capacity to form functional transcription regulator complexes, but represents possible evolutionary precursors to multi-domain regulators associated with cationic drug compounds.	[Deshpande, Chandrika N.; Hassan, Karl A.; Paulsen, Ian T.; Mabbutt, Bridget C.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Harrop, Stephen J.; Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW, Australia; [Harrop, Stephen J.; Curmi, Paul M. G.] St Vincents Ctr Appl Med Res, Sydney, NSW, Australia; [Boucher, Yan] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Di Leo, Rosa; Xu, Xiaohui; Cui, Hong; Savchenko, Alexei; Chang, Changsoo] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; [Labbate, Maurizio; Stokes, H. W.] Univ Technol Sydney, Inst Biotechnol Infect Dis, Sydney, NSW 2007, Australia	Macquarie University; University of New South Wales Sydney; Massachusetts Institute of Technology (MIT); University of Toronto; University of Technology Sydney	Deshpande, CN (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	bridget.mabbutt@mq.edu.au	Paulsen, Ian T/K-3832-2012; Curmi, Paul/G-7185-2011; Boucher, Yann Felix/H-4576-2019; Boucher, Yan/A-2618-2014; Chang, Changsoo/X-3271-2018; Hassan, Karl/B-2802-2013	Paulsen, Ian T/0000-0001-9015-9418; Curmi, Paul/0000-0001-5762-7638; Boucher, Yann Felix/0000-0002-0036-6083; Deshpande, Chandrika/0000-0002-5557-519X; Chang, Changsoo/0000-0003-1860-2969; Hassan, Karl/0000-0003-2031-9679; Labbate, Maurizio/0000-0003-1428-3382	NHMRC [488502]; National Institutes of Health [GM62414-0]; Ontario Research and Development Challenge Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, P50GM062414] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Research and Development Challenge Fund(General Electric); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is funded by Australian NHMRC grant 488502 (http://www.nhmrc.gov.au/) and supported by National Institutes of Health Grant GM62414-0 and the Ontario Research and Development Challenge Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2005, CCP4 NEWSL, V42; AHMED M, 1994, J BIOL CHEM, V269, P28506; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boucher Y, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-3; Boucher Y, 2007, TRENDS MICROBIOL, V15, P301, DOI 10.1016/j.tim.2007.05.004; Boucher Y, 2006, BIOLOGY OF VIBRIOS, P84; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Chakraborty S, 2000, APPL ENVIRON MICROB, V66, P4022, DOI 10.1128/AEM.66.9.4022-4028.2000; Chiu ML, 2001, BIOCHEMISTRY-US, V40, P12950, DOI 10.1021/bi010328k; Chiu ML, 1999, J BIOL CHEM, V274, P20578, DOI 10.1074/jbc.274.29.20578; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; COLLIS CM, 1993, MOL MICROBIOL, V9, P41, DOI 10.1111/j.1365-2958.1993.tb01667.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DUTTA NK, 1972, BRIT J PHARMACOL, V44, P153, DOI 10.1111/j.1476-5381.1972.tb07247.x; Egan SM, 2002, J BACTERIOL, V184, P5529, DOI 10.1128/JB.184.20.5529-5532.2002; Elsaied H, 2007, ENVIRON MICROBIOL, V9, P2298, DOI 10.1111/j.1462-2920.2007.01344.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Faruque SM, 2003, TRENDS MICROBIOL, V11, P505, DOI 10.1016/j.tim.2003.09.003; Faruque SM, 2003, INFECT IMMUN, V71, P1020, DOI 10.1128/IAI.71.2.1020-1025.2003; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Hall RM, 1998, DRUG RESIST UPDATE, V1, P109, DOI 10.1016/S1368-7646(98)80026-5; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; ISLAM MR, 1982, GASTROENTEROLOGY, V82, P1335; Kahmann JD, 2003, EMBO J, V22, P1824, DOI 10.1093/emboj/cdg181; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; KOBAYASHI TOSHIKAZU, 1963, JAPAN JOUR BACTERIOL, V18, P387; Koenig JE, 2008, ENVIRON MICROBIOL, V10, P1024, DOI 10.1111/j.1462-2920.2007.01524.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kwon HJ, 2000, NAT STRUCT BIOL, V7, P424; Labbate M, 2007, MICROBIOL-SGM, V153, P1488, DOI 10.1099/mic.0.2006/001065-0; Labbate Maurizio, 2009, V532, P103, DOI 10.1007/978-1-60327-853-9_6; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Markham PN, 1996, J BACTERIOL, V178, P1473, DOI 10.1128/jb.178.5.1473-1475.1996; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Newberry KJ, 2008, J BIOL CHEM, V283, P26795, DOI 10.1074/jbc.M804191200; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; Ramamurthy T, 2003, MICROBES INFECT, V5, P329, DOI 10.1016/S1286-4579(03)00035-2; Rhee S, 1998, P NATL ACAD SCI USA, V95, P10413, DOI 10.1073/pnas.95.18.10413; Romanowski MJ, 2002, PROTEINS, V47, P403, DOI 10.1002/prot.10102; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schumacher MA, 2002, MOL MICROBIOL, V45, P885, DOI 10.1046/j.1365-2958.2002.03039.x; SOFER A, 1995, J BIOL CHEM, V270, P12117, DOI 10.1074/jbc.270.20.12117; Stokes HW, 1997, MOL MICROBIOL, V26, P731, DOI 10.1046/j.1365-2958.1997.6091980.x; Stokes HW, 2001, APPL ENVIRON MICROB, V67, P5240, DOI 10.1128/AEM.67.11.5240-5246.2001; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vazquez-Laslop N, 1999, BIOCHEMISTRY-US, V38, P16925, DOI 10.1021/bi991988g; WEST PA, 1982, J CLIN MICROBIOL, V16, P1110, DOI 10.1128/JCM.16.6.1110-1116.1982; Westbrook J, 2003, METHOD ENZYMOL, V374, P370, DOI 10.1016/S0076-6879(03)74017-8; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Yanai I, 2001, P NATL ACAD SCI USA, V98, P7940, DOI 10.1073/pnas.141236298; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6	68	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e16934	10.1371/journal.pone.0016934	http://dx.doi.org/10.1371/journal.pone.0016934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390267	Green Published, Green Submitted, gold			2022-12-25	WOS:000287965200008
J	Farrar, CT; Kamoun, WS; Ley, CD; Kim, YR; Catana, C; Kwon, SJ; Rosen, BR; Jain, RK; Sorensen, AG				Farrar, Christian T.; Kamoun, Walid S.; Ley, Carsten D.; Kim, Young R.; Catana, Ciprian; Kwon, Seon J.; Rosen, Bruce R.; Jain, Rakesh K.; Sorensen, A. Gregory			Sensitivity of MRI Tumor Biomarkers to VEGFR Inhibitor Therapy in an Orthotopic Mouse Glioma Model	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; BRAIN-BARRIER PERMEABILITY; TYROSINE KINASE INHIBITOR; ARTERIAL INPUT FUNCTION; CONTRAST-ENHANCED MRI; IN-VIVO; GRADIENT-ECHO; VESSEL SIZE; DIFFUSION; ANGIOGENESIS	MRI biomarkers of tumor edema, vascular permeability, blood volume, and average vessel caliber are increasingly being employed to assess the efficacy of tumor therapies. However, the dependence of these biomarkers on a number of physiological factors can compromise their sensitivity and complicate the assessment of therapeutic efficacy. Here we examine the response of these MRI tumor biomarkers to cediranib, a potent vascular endothelial growth factor receptor (VEGFR) inhibitor, in an orthotopic mouse glioma model. A significant increase in the tumor volume and relative vessel caliber index (rVCI) and a slight decrease in the water apparent diffusion coefficient (ADC) were observed for both control and cediranib treated animals. This contrasts with a clinical study that observed a significant decrease in tumor rVCI, ADC and volume with cediranib therapy. While the lack of a difference between control and cediranib treated animals in these biomarker responses might suggest that cediranib has no therapeutic benefit, cediranib treated mice had a significantly increased survival. The increased survival benefit of cediranib treated animals is consistent with the significant decrease observed for cediranib treated animals in the relative cerebral blood volume (rCBV), relative microvascular blood volume (rMBV), transverse relaxation time (T2), blood vessel permeability (K-trans), and extravascular-extracellular space (v(e)). The differential response of pre-clinical and clinical tumors to cediranib therapy, along with the lack of a positive response for some biomarkers, indicates the importance of evaluating the whole spectrum of different tumor biomarkers to properly assess the therapeutic response and identify and interpret the therapy-induced changes in the tumor physiology.	[Farrar, Christian T.; Kim, Young R.; Catana, Ciprian; Kwon, Seon J.; Rosen, Bruce R.; Sorensen, A. Gregory] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Kamoun, Walid S.; Ley, Carsten D.; Jain, Rakesh K.] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Farrar, CT (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA.	cfarrar@nmr.mgh.harvard.edu	Catana, Ciprian/A-1246-2013; Jain, Rakesh K/I-1384-2017	Jain, Rakesh K/0000-0001-7571-3548; Catana, Ciprian/0000-0002-3249-5971; Ley, Carsten Dan/0000-0001-8119-2224; Farrar, Christian/0000-0001-6623-8220	National Institutes of Health [P41-RR14075, P01-CA80124, R01-CA115767]; AstraZeneca Pharmaceuticals; National Cancer Institute [T32-CA009502]; National Institute on Aging [K25-AG029415]; NATIONAL CANCER INSTITUTE [R01CA115767, P01CA080124, T32CA009502] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG029415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca Pharmaceuticals(AstraZeneca); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institutes of Health (P41-RR14075, P01-CA80124, R01-CA115767) and by AstraZeneca Pharmaceuticals. CTF gratefully acknowledges support from the National Cancer Institute (T32-CA009502) and the National Institute on Aging (K25-AG029415). WSK gratefully acknowledges support from the Susan G. Komen foundation. CDL gratefully acknowledges support from the Harboe Foundation, the A.P. Moller Foundation, and the Dagmar-Marshall Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONEN HJ, 1994, RADIOLOGY, V191, P41, DOI 10.1148/radiology.191.1.8134596; Badruddoja MA, 2003, NEURO-ONCOLOGY, V5, P235, DOI 10.1215/S1152851703000073; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Brown EB, 2001, NAT MED, V7, P864, DOI 10.1038/89997; Buckley DL, 2004, RADIOLOGY, V233, P709, DOI 10.1148/radiol.2333032098; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chenevert TL, 1997, CLIN CANCER RES, V3, P1457; Chenevert TL, 2000, JNCI-J NATL CANCER I, V92, P2029, DOI 10.1093/jnci/92.24.2029; Dennie J, 1998, MAGN RESON MED, V40, P793, DOI 10.1002/mrm.1910400602; Donahue KM, 2000, MAGNET RESON MED, V43, P845, DOI 10.1002/1522-2594(200006)43:6<845::AID-MRM10>3.0.CO;2-J; EIS M, 1995, MAGN RESON MED, V34, P835, DOI 10.1002/mrm.1910340608; Ferretti S, 2005, CLIN CANCER RES, V11, P7773, DOI 10.1158/1078-0432.CCR-05-1165; Gerstner ER, 2010, J CLIN ONCOL, V28, pE91, DOI 10.1200/JCO.2009.25.0233; Hall DE, 2004, CLIN CANCER RES, V10, P7852, DOI 10.1158/1078-0432.CCR-04-1218; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Hylton N, 2006, J CLIN ONCOL, V24, P3293, DOI 10.1200/JCO.2006.06.8080; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Jain RK, 2002, NAT REV CANCER, V2, P266, DOI 10.1038/nrc778; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; Kiselev VG, 2005, MAGNET RESON MED, V53, P553, DOI 10.1002/mrm.20383; Kono K, 2001, AM J NEURORADIOL, V22, P1081; Lyng H, 2000, MAGNET RESON MED, V43, P828, DOI 10.1002/1522-2594(200006)43:6<828::AID-MRM8>3.0.CO;2-P; McGrath DM, 2009, MAGN RESON MED, V61, P1173, DOI 10.1002/mrm.21959; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Oh J, 2005, J MAGN RESON IMAGING, V21, P701, DOI 10.1002/jmri.20335; Ostergaard L, 1999, J NEUROSURG, V90, P300, DOI 10.3171/jns.1999.90.2.0300; Packard SD, 2003, NEOPLASIA, V5, P330, DOI 10.1016/S1476-5586(03)80026-X; Padhani AR, 2002, J MAGN RESON IMAGING, V16, P407, DOI 10.1002/jmri.10176; Parker GJM, 2006, MAGN RESON MED, V56, P993, DOI 10.1002/mrm.21066; Pathak AP, 2003, J MAGN RESON IMAGING, V18, P397, DOI 10.1002/jmri.10371; Pathak AP, 2008, NEUROIMAGE, V40, P1130, DOI 10.1016/j.neuroimage.2008.01.022; Ross BD, 2003, MOL CANCER THER, V2, P581; Schmainda KM, 2004, AM J NEURORADIOL, V25, P1524; Sorensen AG, 2009, CANCER RES, V69, P5296, DOI 10.1158/0008-5472.CAN-09-0814; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; SZAFER A, 1995, MAGNET RESON MED, V33, P697, DOI 10.1002/mrm.1910330516; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Tropres I, 2004, MAGN RESON MED, V51, P533, DOI 10.1002/mrm.20017; Tropres I, 2001, MAGN RESON MED, V45, P397, DOI 10.1002/1522-2594(200103)45:3<397::AID-MRM1052>3.0.CO;2-3; Tyrrell JA, 2007, IEEE T MED IMAGING, V26, P223, DOI 10.1109/TMI.2006.889722; Valable S, 2008, NMR BIOMED, V21, P1043, DOI 10.1002/nbm.1278; Wedge SR, 2005, CANCER RES, V65, P4389, DOI 10.1158/0008-5472.CAN-04-4409; WEISSKOFF RM, 1994, MAGNET RESON MED, V31, P601, DOI 10.1002/mrm.1910310605; Yankeelov TE, 2005, MAGN RESON IMAGING, V23, P519, DOI 10.1016/j.mri.2005.02.013; Yankeelov TE, 2007, CURR MED IMAGING REV, V3, P91, DOI 10.2174/157340507780619179; YUAN F, 1994, CANCER RES, V54, P4564	50	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17228	10.1371/journal.pone.0017228	http://dx.doi.org/10.1371/journal.pone.0017228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390238	Green Published, gold, Green Submitted			2022-12-25	WOS:000287965200013
J	Yu, HH; Xie, WB; Wang, J; Xing, YZ; Xu, CG; Li, XH; Xiao, JH; Zhang, QF				Yu, Huihui; Xie, Weibo; Wang, Jia; Xing, Yongzhong; Xu, Caiguo; Li, Xianghua; Xiao, Jinghua; Zhang, Qifa			Gains in QTL Detection Using an Ultra-High Density SNP Map Based on Population Sequencing Relative to Traditional RFLP/SSR Markers	PLOS ONE			English	Article							ELITE RICE HYBRID; SINGLE-FEATURE POLYMORPHISMS; FUNCTIONAL GENOMICS; NATURAL VARIATION; EXPRESSION ATLAS; SEEDLING STAGE; GENETIC-BASIS; GRAIN WIDTH; MAJOR QTL; LOCUS	Huge efforts have been invested in the last two decades to dissect the genetic bases of complex traits including yields of many crop plants, through quantitative trait locus (QTL) analyses. However, almost all the studies were based on linkage maps constructed using low-throughput molecular markers, e. g. restriction fragment length polymorphisms (RFLPs) and simple sequence repeats (SSRs), thus are mostly of low density and not able to provide precise and complete information about the numbers and locations of the genes or QTLs controlling the traits. In this study, we constructed an ultra-high density genetic map based on high quality single nucleotide polymorphisms (SNPs) from low-coverage sequences of a recombinant inbred line (RIL) population of rice, generated using new sequencing technology. The quality of the map was assessed by validating the positions of several cloned genes including GS3 and GW5/qSW5, two major QTLs for grain length and grain width respectively, and OsC1, a qualitative trait locus for pigmentation. In all the cases the loci could be precisely resolved to the bins where the genes are located, indicating high quality and accuracy of the map. The SNP map was used to perform QTL analysis for yield and three yield-component traits, number of tillers per plant, number of grains per panicle and grain weight, using data from field trials conducted over years, in comparison to QTL mapping based on RFLPs/SSRs. The SNP map detected more QTLs especially for grain weight, with precise map locations, demonstrating advantages in detecting power and resolution relative to the RFLP/SSR map. Thus this study provided an example for ultra-high density map construction using sequencing technology. Moreover, the results obtained are helpful for understanding the genetic bases of the yield traits and for fine mapping and cloning of QTLs.	[Yu, Huihui; Xie, Weibo; Wang, Jia; Xing, Yongzhong; Xu, Caiguo; Li, Xianghua; Xiao, Jinghua; Zhang, Qifa] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Natl Ctr Plant Gene Res, Wuhan, Peoples R China	Huazhong Agricultural University	Zhang, QF (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Natl Ctr Plant Gene Res, Wuhan, Peoples R China.	qifazh@mail.hzau.edu.cn	Yu, Huihui/AAT-7595-2021; Xie, Weibo/B-3771-2008; Xie, Weibo/AAI-2412-2021	Yu, Huihui/0000-0003-2725-1937; Xie, Weibo/0000-0002-2768-3572; Xie, Weibo/0000-0002-2768-3572; Xing, Yongzhong/0000-0003-1376-1514	National Program on Key Basic Research Project; National Special Key Project on Functional Genomics of Major Plants and Animals; National Natural Science Foundation of China	National Program on Key Basic Research Project(National Basic Research Program of China); National Special Key Project on Functional Genomics of Major Plants and Animals; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Program on Key Basic Research Project, National Special Key Project on Functional Genomics of Major Plants and Animals, and National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fujita M, 2010, PLANT CELL PHYSIOL, V51, P2060, DOI 10.1093/pcp/pcq165; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Hua JP, 2002, GENETICS, V162, P1885; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Krishnan A, 2009, PLANT PHYSIOL, V149, P165, DOI 10.1104/pp.108.128918; Kumar R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000284; Lian XM, 2005, THEOR APPL GENET, V112, P85, DOI 10.1007/s00122-005-0108-y; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Potokina E, 2008, PLANT J, V53, P90, DOI 10.1111/j.1365-313X.2007.03315.x; R Development Core Team, 2009, R FDN STAT COMP; Rostoks N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r54; Saitoh K, 2004, GENETICS, V168, P997, DOI 10.1534/genetics.103.018390; Sallaud C, 2004, PLANT J, V39, P450, DOI 10.1111/j.1365-313X.2004.02145.x; Schon CC, 2004, GENETICS, V167, P485, DOI 10.1534/genetics.167.1.485; SCHUSTER S, 2008, NATURE, V200, P8; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Tan YF, 2000, THEOR APPL GENET, V101, P823, DOI 10.1007/s001220051549; Vales MI, 2005, THEOR APPL GENET, V111, P1260, DOI 10.1007/s00122-005-0043-y; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wang J, 2010, PLANT J, V63, P1063, DOI 10.1111/j.1365-313X.2010.04303.x; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wang L, 2011, THEOR APPL GENET, V122, P327, DOI 10.1007/s00122-010-1449-8; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Wu CY, 2003, PLANT J, V35, P418, DOI 10.1046/j.1365-313X.2003.01808.x; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xie WB, 2009, THEOR APPL GENET, V119, P151, DOI 10.1007/s00122-009-1025-2; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang J, 2007, PLANT J, V49, P947, DOI 10.1111/j.1365-313X.2006.03001.x	43	188	211	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17595	10.1371/journal.pone.0017595	http://dx.doi.org/10.1371/journal.pone.0017595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390234	Green Submitted, Green Published, gold			2022-12-25	WOS:000287965200031
J	Porotto, M; Yi, F; Moscona, A; LaVan, DA				Porotto, Matteo; Yi, Feng; Moscona, Anne; LaVan, David A.			Synthetic Protocells Interact with Viral Nanomachinery and Inactivate Pathogenic Human Virus	PLOS ONE			English	Article							SUPPORTED LIPID-BILAYERS; NIPAH VIRUS; PARAMYXOVIRUS; DELIVERY; FUSION; ENCEPHALITIS; INHIBITION; BANGLADESH; INFECTION; RECEPTOR	We present a new antiviral strategy and research tool that could be applied to a wide range of enveloped viruses that infect human beings via membrane fusion. We test this strategy on two emerging zoonotic henipaviruses that cause fatal encephalitis in humans, Nipah (NiV) and Hendra (HeV) viruses. In the new approach, artificial cell-like particles (protocells) presenting membrane receptors in a biomimetic manner were developed and found to attract and inactivate henipavirus envelope glycoprotein pseudovirus particles, preventing infection. The protocells do not accumulate virus during the inactivation process. The use of protocells that interact with, but do not accumulate, viruses may provide significant advantages over current antiviral drugs, and this general approach may have wide potential for antiviral development.	[Porotto, Matteo; Moscona, Anne] Cornell Univ, Dept Pediat, Weill Med Coll, New York, NY 10021 USA; [Porotto, Matteo; Moscona, Anne] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; [Yi, Feng; LaVan, David A.] NIST, Mat Measurement Lab, Gaithersburg, MD 20899 USA	Cornell University; Cornell University; National Institute of Standards & Technology (NIST) - USA	Porotto, M (corresponding author), Cornell Univ, Dept Pediat, Weill Med Coll, New York, NY 10021 USA.	anm2047@med.cornell.edu; david.lavan@nist.gov	LaVan, David/C-3943-2012	LaVan, David/0000-0002-1952-0028; POROTTO, Matteo/0000-0003-3866-9220	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) [AI076335]; National Institute of Biomedical Imaging and Bioengineering [EB011707]; NIH (NIAID) Northeast Center of Excellence for Biodefense; National Center for Design of Biomimetic Nanoconductors; National Institutes of Health through the NIH Roadmap for Medical Research [PHS 2 PN2 EY016570B]; PI of Center of Excellence [U54AI057158]; March of Dimes Research Grant [06-322]; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB011707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076385] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH (NIAID) Northeast Center of Excellence for Biodefense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Design of Biomimetic Nanoconductors; National Institutes of Health through the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PI of Center of Excellence; March of Dimes Research Grant(March of Dimes); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Public Health Service grants AI076335 from National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) to AM, EB011707 from the National Institute of Biomedical Imaging and Bioengineering to MP, NIH (NIAID) Northeast Center of Excellence for Biodefense, subcontracts to AM and to DL from the National Center for Design of Biomimetic Nanoconductors, funded by Grant Number PHS 2 PN2 EY016570B from the National Institutes of Health through the NIH Roadmap for Medical Research (PI: E. Jakobsson), Emerging Infectious Disease Research U54AI057158 grants to AM and MP (PI of Center of Excellence grant: W.I. Lipkin), by March of Dimes Research Grant 06-322 to AM, and by a Grand Challenges Exploration grant from the Bill and Melinda Gates Foundation to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buranda T, 2003, LANGMUIR, V19, P1654, DOI 10.1021/la026405+; Chemburu S, 2010, MOLECULES, V15, P1932, DOI 10.3390/molecules15031932; Conti M, 2000, ANGEW CHEM INT EDIT, V39, P215, DOI 10.1002/(SICI)1521-3773(20000103)39:1<215::AID-ANIE215>3.0.CO;2-R; Hossain MJ, 2008, CLIN INFECT DIS, V46, P977, DOI 10.1086/529147; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876; LaVan DA, 2002, NAT REV DRUG DISCOV, V1, P77, DOI 10.1038/nrd707; Leduc PR, 2007, NAT NANOTECHNOL, V2, P3, DOI 10.1038/nnano.2006.180; Liu JW, 2009, J AM CHEM SOC, V131, P1354, DOI 10.1021/ja808018y; Lu YF, 1999, NATURE, V398, P223, DOI 10.1038/18410; Lu YF, 2000, J AM CHEM SOC, V122, P5258, DOI 10.1021/ja9935862; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Nye JA, 2008, LANGMUIR, V24, P4145, DOI 10.1021/la703788h; OSullivan JD, 1997, LANCET, V349, P93, DOI 10.1016/S0140-6736(96)06162-4; Porotto M, 2007, J VIROL, V81, P10567, DOI 10.1128/JVI.01181-07; Porotto M, 2006, J VIROL, V80, P9837, DOI 10.1128/JVI.00736-06; Porotto M, 2005, J VIROL, V79, P2383, DOI 10.1128/JVI.79.4.2383-2392.2005; Porotto M, 2004, J VIROL, V78, P13911, DOI 10.1128/JVI.78.24.13911-13919.2004; Porotto M, 2009, J VIROL, V83, P5148, DOI 10.1128/JVI.00164-09; Russell CJ, 2001, EMBO J, V20, P4024, DOI 10.1093/emboj/20.15.4024; Sejvar JJ, 2007, ANN NEUROL, V62, P235, DOI 10.1002/ana.21178; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Wang LF, 2001, MICROBES INFECT, V3, P279, DOI 10.1016/S1286-4579(01)01381-8	25	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e16874	10.1371/journal.pone.0016874	http://dx.doi.org/10.1371/journal.pone.0016874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390296	gold, Green Published, Green Submitted			2022-12-25	WOS:000287932100005
J	Merrifield, MS; Hines, E; Liu, XH; Beck, MW				Merrifield, Matthew S.; Hines, Ellen; Liu, Xiaohang; Beck, Michael W.			Building Regional Threat-Based Networks for Estuaries in the Western United States	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; COASTAL WATERS; CLASSIFICATION; MANAGEMENT; LAND; RESTORATION; CALIFORNIA; NURSERIES; PATTERNS; IMPACTS	Estuaries are ecologically and economically valuable and have been highly degraded from both land and sea. Estuarine habitats in the coastal zone are under pressure from a range of human activities. In the United States and elsewhere, very few conservation plans focused on estuaries are regional in scope; fewer still address threats to estuary long term viability. We have compiled basic information about the spatial extent of threats to identify commonalities. To do this we classify estuaries into hierarchical networks that share similar threat characteristics using a spatial database (geodatabase) of threats to estuaries from land and sea in the western U. S. Our results show that very few estuaries in this region (16%) have no or minimal stresses from anthropogenic activity. Additionally, one quarter (25%) of all estuaries in this study have moderate levels of all threats. The small number of un-threatened estuaries is likely not representative of the ecological variability in the region and will require working to abate threats at others. We think the identification of these estuary groups can foster sharing best practices and coordination of conservation activities amongst estuaries in any geography.	[Merrifield, Matthew S.] Nature Conservancy, Dept Sci & Planning, San Francisco, CA USA; [Hines, Ellen; Liu, Xiaohang] San Francisco State Univ, Dept Geog & Human Environm Studies, San Francisco, CA 94132 USA; [Beck, Michael W.] Nature Conservancy, Global Marine Initiat, Santa Cruz, CA USA	Nature Conservancy; California State University System; San Francisco State University; Nature Conservancy	Merrifield, MS (corresponding author), Nature Conservancy, Dept Sci & Planning, San Francisco, CA USA.	mmerrifield@tnc.org	Beck, Michael W./AAB-2844-2019	Beck, Michael W./0000-0002-5107-9973				Adam P, 2002, ENVIRON CONSERV, V29, P39, DOI 10.1017/S0376892902000048; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Alber M, 2002, ESTUARIES, V25, P1246, DOI 10.1007/BF02692222; [Anonymous], 2006, MARINE COASTAL ECOSY; Armstrong DA, 2003, ESTUARIES, V26, P1174, DOI 10.1007/BF02803372; Beck M. W., 2003, DRAFTING CONSERVATIO, P319; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bodin O, 2006, ECOL SOC, V11; Bottom DL, 2005, ESTUAR COAST SHELF S, V64, P79, DOI 10.1016/j.ecss.2005.02.008; Brosofske KD, 1997, ECOL APPL, V7, P1188, DOI 10.1890/1051-0761(1997)007[1188:HEOMGF]2.0.CO;2; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dahl T.E., 2006, STATUS TRENDS WETLAN; Douvere F., 2009, ECOSYSTEM BASED MARI; Duffy EJ, 2008, T AM FISH SOC, V137, P165, DOI 10.1577/T07-049.1; Edgar GJ, 2000, BIOL CONSERV, V92, P383, DOI 10.1016/S0006-3207(99)00111-1; Emmett R, 2000, ESTUARIES, V23, P765, DOI 10.2307/1352998; Engle VD, 2007, ENVIRON MONIT ASSESS, V129, P397, DOI 10.1007/s10661-006-9372-9; Everitt B. S., 2001, CLUSTER ANAL; Groves CR, 2002, BIOSCIENCE, V52, P499, DOI 10.1641/0006-3568(2002)052[0499:PFBCPC]2.0.CO;2; Hale SS, 2004, ESTUARIES, V27, P283, DOI 10.1007/BF02803385; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hickey BM, 2003, ESTUARIES, V26, P1010, DOI 10.1007/BF02803360; Higgins JV, 2005, CONSERV BIOL, V19, P432, DOI 10.1111/j.1523-1739.2005.00504.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Howarth RW, 2002, ESTUARIES, V25, P656, DOI 10.1007/BF02804898; Imperial MT, 1996, COAST MANAGE, V24, P115, DOI 10.1080/08920759609362286; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; Komar PD, 2004, J GEOL, V112, P455, DOI 10.1086/421074; Kurtz JC, 2006, ESTUAR COAST, V29, P107, DOI 10.1007/BF02784703; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; MORING JR, 1982, HYDROBIOLOGIA, V88, P295, DOI 10.1007/BF00008510; Nedwell DB, 2002, ESTUAR COAST SHELF S, V54, P951, DOI 10.1006/ecss.2001.0867; *ODF, 2009, OR FOR REP 2007 2009; *OFF GOV WASH, 2008, W COAST GOV AGR OC H; Pethick J, 2001, CATENA, V42, P307, DOI 10.1016/S0341-8162(00)00143-0; POC, 2003, AM LIV OC CHART COUR; Ridgway J, 2002, ESTUAR COAST SHELF S, V55, P903, DOI 10.1006/ecss.2002.1035; Sane M, 2007, J ENVIRON MANAGE, V82, P399, DOI 10.1016/j.jenvman.2005.01.030; Schneider M, 2003, AM J POLIT SCI, V47, P143, DOI 10.2307/3186098; Sloan NA, 2007, CONSERV BIOL, V21, P897, DOI 10.1111/j.1523-1739.2007.00731.x; Stoms DM, 2005, FRONT ECOL ENVIRON, V3, P429, DOI 10.1890/1540-9295(2005)003[0429:ICRPMT]2.0.CO;2; Team. RDC, 2007, R LANG ENV STAT COMP; *USCOP, 2004, OC BLUEPR 21 CENT FI; Van Dyke E, 2005, ESTUARIES, V28, P173, DOI 10.1007/BF02732853; Vasconcelos RP, 2007, SCI TOTAL ENVIRON, V374, P199, DOI 10.1016/j.scitotenv.2006.12.048; Zacharias MA, 2000, CONSERV BIOL, V14, P1327, DOI 10.1046/j.1523-1739.2000.99191.x; Zedler JB, 1996, ECOL APPL, V6, P84, DOI 10.2307/2269555	51	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17407	10.1371/journal.pone.0017407	http://dx.doi.org/10.1371/journal.pone.0017407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387006	Green Published, Green Submitted, gold			2022-12-25	WOS:000287931400070
J	Trathan, PN; Fretwell, PT; Stonehouse, B				Trathan, Philip N.; Fretwell, Peter T.; Stonehouse, Bernard			First Recorded Loss of an Emperor Penguin Colony in the Recent Period of Antarctic Regional Warming: Implications for Other Colonies	PLOS ONE			English	Article							NORTHEAST ATLANTIC WATERS; ENDANGERED TOP PREDATOR; CLIMATE-CHANGE; APTENODYTES-FORSTERI; RANGE EXPANSION; SOUTHERN-OCEAN; ADELIE LAND; SEA-ICE; PENINSULA; POPULATION	In 1948, a small colony of emperor penguins Aptenodytes forsteri was discovered breeding on Emperor Island (67 degrees 51' 52 '' S, 68 degrees 42' 20 '' W), in the Dion Islands, close to the West Antarctic Peninsula (Stonehouse 1952). When discovered, the colony comprised approximately 150 breeding pairs; these numbers were maintained until 1970, after which time the colony showed a continuous decline. By 1999 there were fewer than 20 pairs, and in 2009 high-resolution aerial photography revealed no remaining trace of the colony. Here we relate the decline and loss of the Emperor Island colony to a well-documented rise in local mean annual air temperature and coincident decline in seasonal sea ice duration. The loss of this colony provides empirical support for recent studies (Barbraud & Weimerskirch 2001; Jenouvrier et al 2005, 2009; Ainley et al 2010; Barber-Meyer et al 2005) that have highlighted the vulnerability of emperor penguins to changes in sea ice duration and distribution. These studies suggest that continued climate change is likely to impact upon future breeding success and colony viability for this species. Furthermore, a recent circumpolar study by Fretwell & Trathan (2009) highlighted those Antarctic coastal regions where colonies appear most vulnerable to such changes. Here we examine which other colonies might be at risk, discussing various ecological factors, some previously unexplored, that may also contribute to future declines. The implications of this are important for future modelling work and for understanding which colonies actually are most vulnerable.	[Trathan, Philip N.; Fretwell, Peter T.] British Antarctic Survey, Cambridge CB3 0ET, England; [Stonehouse, Bernard] Univ Cambridge, Scott Polar Res Inst, Cambridge CB2 1ER, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Cambridge	Trathan, PN (corresponding author), British Antarctic Survey, Cambridge CB3 0ET, England.	p.trathan@bas.ac.uk			BAS; United Kingdom Overseas Territories Environment Programme [BAT601]; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	BAS; United Kingdom Overseas Territories Environment Programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported in part by the BAS Ecosystem Programme and by a United Kingdom Overseas Territories Environment Programme Grant (BAT601) to PTF and PNT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D, 2010, ECOL MONOGR, V80, P49, DOI 10.1890/08-2289.1; Barber-Meyer SM, 2008, ANTARCT SCI, V20, P3, DOI 10.1017/S0954102007000673; Barbraud C, 2001, NATURE, V411, P183, DOI 10.1038/35075554; BARLOW J, 1967, BIOL REPORT ADELAIDE; Barrett BE, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036369; Cheung WWL, 2008, 16 U BRIT COL FISH C; Cook AJ, 2010, CRYOSPHERE, V4, P77, DOI 10.5194/tc-4-77-2010; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Crawford RJM, 2007, ICES J MAR SCI, V64, P570, DOI 10.1093/icesjms/fsm009; CULIK BM, 1995, NATURE, V376, P301, DOI 10.1038/376301b0; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Emslie SD, 1998, ANTARCT SCI, V10, P257, DOI 10.1017/S0954102098000352; EVERSON I, 1977, GLOSO771 FAO SO OC F; Forcada J, 2008, GLOBAL CHANGE BIOL, V14, P2473, DOI 10.1111/j.1365-2486.2008.01678.x; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Fretwell PT, 2009, GLOBAL ECOL BIOGEOGR, V18, P543, DOI 10.1111/j.1466-8238.2009.00467.x; Giles AB, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004139; HASBROOK R, 1970, BASE J 1970 BASE T; Jenouvrier S, 2005, ECOLOGY, V86, P2889, DOI 10.1890/05-0514; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; Kerry K.R., 2009, P107; Kirkwood R, 1997, MAR ECOL PROG SER, V156, P205, DOI 10.3354/meps156205; Kock K-H., 1992, ANTARCTIC FISH FISHE; KOOYMAN GL, 1993, ANTARCTIC SCI, V5, P743; Lefebvre W, 2008, CLIM DYNAM, V30, P59, DOI 10.1007/s00382-007-0273-6; Massom RA, 2006, J CLIMATE, V19, P3544, DOI 10.1175/JCLI3805.1; Massom RA, 2010, POLAR SCI, V4, P149, DOI 10.1016/j.polar.2010.05.001; Massom RA, 2009, MAR ECOL PROG SER, V374, P243, DOI 10.3354/meps07734; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; MOUGIN JL, 1979, CR ACAD SCI D NAT, V289, P157; PONCET J, 1979, ORNITHOLOGICAL REPOR; PROCTER N, 1957, ORNITHOLOGICAL REPOR; ROTHERA JM, 1958, SLEDGING JOURNEY DIO; Sigmond M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044301; Smith RC, 1999, BIOSCIENCE, V49, P393, DOI 10.2307/1313632; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; STONEHOUSE B, 1964, NATURE, V203, P849, DOI 10.1038/203849a0; STONEHOUSE B, 1952, NATURE, V169, P760, DOI 10.1038/169760a0; Stonehouse B., 1953, FALKLAND ISLANDS DEP, V6; TAYLOR W, 1969, JOURNEY REPORT RABBL; Thomas ER, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040104; Turner J., 2009, ANTARCTIC CLIMATE CH; Turner J, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011642; Turner J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037524; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; Votier SC, 2008, BIOL LETTERS, V4, P204, DOI 10.1098/rsbl.2007.0558; WILLEY IM, 1968, ADELAIDE ISLAND BIRD; WOOLLEY WS, 1963, FIELD DIARY 1962 63; Wynn RB, 2007, BIOL LETTERS, V3, P529, DOI 10.1098/rsbl.2007.0162	50	51	52	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e14738	10.1371/journal.pone.0014738	http://dx.doi.org/10.1371/journal.pone.0014738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386883	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000287931400003
J	Swenson, LC; Pollock, G; Wynhoven, B; Mo, T; Dong, W; Hogg, RS; Montaner, JSG; Harrigan, PR				Swenson, Luke C.; Pollock, Graham; Wynhoven, Brian; Mo, Theresa; Dong, Winnie; Hogg, Robert S.; Montaner, Julio S. G.; Harrigan, P. Richard			"Dynamic Range" of Inferred Phenotypic HIV Drug Resistance Values in Clinical Practice	PLOS ONE			English	Article							FOLLOW-UP; TRIAL; SUSCEPTIBILITY; THERAPY; VIRADAPT; UTILITY	Background: 'Virtual' or inferred phenotypes (vPhenotypes) are commonly used to assess resistance to antiretroviral agents in patients failing therapy. In this study, we provide a clinical context for understanding vPhenotype values. Methods: All HIV-infected persons enrolled in the British Columbia Drug Treatment Program with a baseline plasma viral load (pVL) and follow-up genotypic resistance and pVL results were included up to October 29, 2008 (N = 5,277). Change from baseline pVL was determined as a function of Virco vPhenotype, and the "dynamic range" (defined here by the 10th and 90th percentiles for fold-change in IC50 amongst all patients) was estimated from the distribution of vPhenotye fold-changes across the cohort. Results: The distribution of vPhenotypes from a large cohort of HIV patients who have failed therapy are presented for all available antiretroviral agents. A maximum change in IC50 of at least 13-fold was observed for all drugs. The dideoxy drugs, tenofovir and most Pls exhibited small "dynamic ranges'' with values of,4-fold change observed in >99% of samples. In contrast, zidovudine, lamivudine, emtricitabine and the non-nucleoside reverse transcriptase inihibitors (excluding etravirine) had large dynamic ranges. Conclusion: We describe the populational distribution of vPhenotypes such that vPhenotype results can be interpreted relative to other patients in a drug-specific manner.	[Swenson, Luke C.; Pollock, Graham; Wynhoven, Brian; Mo, Theresa; Dong, Winnie; Hogg, Robert S.; Montaner, Julio S. G.; Harrigan, P. Richard] St Pauls Hosp, BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Montaner, Julio S. G.; Harrigan, P. Richard] Univ British Columbia, Fac Med, Div AIDS, Vancouver, BC, Canada; [Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; Simon Fraser University	Swenson, LC (corresponding author), St Pauls Hosp, BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	prharrigan@cfenet.ubc.ca	Swenson, Luke/E-8549-2014; Hogg, Robert S/B-2783-2012; Cano, Jose Maria Bellon/G-3061-2012; Berenguer, Juan/A-1347-2009; Montaner, Julio/K-7621-2012	Swenson, Luke/0000-0001-5381-7709; Hogg, Robert S/0000-0003-3463-5488; Cano, Jose Maria Bellon/0000-0002-8492-1565; Berenguer, Juan/0000-0001-8541-8200; 	Canadian Institutes of Health Research (CIHR); GSK-CIHR Research Chair	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); GSK-CIHR Research Chair(Canadian Institutes of Health Research (CIHR))	LCS is supported by a Canadian Institutes of Health Research (CIHR) Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award. PRH is supported by a GSK-CIHR Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter JD, 2000, AIDS, V14, pF83, DOI 10.1097/00002030-200006160-00001; *BRIT COL CTR EXC, 2003, HIV AIDS DRUG TREATM; BROOKS JI, 2009, 49 INT C ANT AG CHEM; Brooks JI, 2009, CAN C HIV AIDS RES V; Clevenbergh P, 2000, ANTIVIR THER, V5, P65; Dong W, 2002, 14 INT AIDS C BARC S; Dunne AL, 2001, AIDS, V15, P1471, DOI 10.1097/00002030-200108170-00003; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Harrigan PR, 2001, AIDS, V15, P1671, DOI 10.1097/00002030-200109070-00010; Haubrich R, 2001, J ACQ IMMUN DEF SYND, V26, pS51, DOI 10.1097/00126334-200103011-00006; HAUBRICH R, 2001, ADV SUDIES NURSING, V1, P486; Hoffman C, 2007, HIV MED; Huang XQ, 1996, COMPUT APPL BIOSCI, V12, P497; Johnson Victoria A, 2009, Top HIV Med, V17, P138; KELLAM P, 1994, ANTIMICROB AGENTS CH, V38, P23, DOI 10.1128/AAC.38.1.23; Meynard JL, 2002, AIDS, V16, P727, DOI 10.1097/00002030-200203290-00008; SCHUURMAN R, 1995, J INFECT DIS, V171, P1411, DOI 10.1093/infdis/171.6.1411; Sturmer M, 2003, ANTIVIR THER, V8, P239; Tural C, 2002, AIDS, V16, P209, DOI 10.1097/00002030-200201250-00010; Vandamme AM, 2001, ANTIVIR THER, V6, P21; Winters B, 2008, JAIDS-J ACQ IMM DEF, V48, P26, DOI 10.1097/QAI.0b013e31816d9bf4	22	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17402	10.1371/journal.pone.0017402	http://dx.doi.org/10.1371/journal.pone.0017402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390218	gold, Green Published, Green Submitted			2022-12-25	WOS:000287761700051
J	Garcia, SP; Pinho, AJ; Rodrigues, JMOS; Bastos, CAC; Ferreira, PJSG				Garcia, Sara P.; Pinho, Armando J.; Rodrigues, Joao M. O. S.; Bastos, Carlos A. C.; Ferreira, Paulo J. S. G.			Minimal Absent Words in Prokaryotic and Eukaryotic Genomes	PLOS ONE			English	Article								Minimal absent words have been computed in genomes of organisms from all domains of life. Here, we explore different sets of minimal absent words in the genomes of 22 organisms (one archaeota, thirteen bacteria and eight eukaryotes). We investigate if the mutational biases that may explain the deficit of the shortest absent words in vertebrates are also pervasive in other absent words, namely in minimal absent words, as well as to other organisms. We find that the compositional biases observed for the shortest absent words in vertebrates are not uniform throughout different sets of minimal absent words. We further investigate the hypothesis of the inheritance of minimal absent words through common ancestry from the similarity in dinucleotide relative abundances of different sets of minimal absent words, and find that this inheritance may be exclusive to vertebrates.	[Garcia, Sara P.; Pinho, Armando J.; Rodrigues, Joao M. O. S.; Bastos, Carlos A. C.; Ferreira, Paulo J. S. G.] Univ Aveiro, IEETA, Signal Proc Lab, P-3800 Aveiro, Portugal; [Pinho, Armando J.; Rodrigues, Joao M. O. S.; Bastos, Carlos A. C.; Ferreira, Paulo J. S. G.] Univ Aveiro, Dept Elect Telecommun & Informat, P-3800 Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro	Garcia, SP (corresponding author), Univ Aveiro, IEETA, Signal Proc Lab, P-3800 Aveiro, Portugal.	spgarcia@ua.pt	Rodrigues, João/GVU-7735-2022; Pinho, Armando J/A-2309-2012; RODRIGUES, JOÃO/AAC-6993-2019; Rodrigues, João MOS/G-4821-2011	Rodrigues, João MOS/0000-0001-9187-8094; Garcia, Sara/0000-0003-3312-6454; Pinho, Armando/0000-0002-9164-0016; Bastos, Carlos/0000-0001-6869-4713; Ferreira, Paulo/0000-0002-5147-0948	Portuguese Foundation for Science and Technology; European Social Fund; Portuguese Ministry of Science, Technology and Higher Education	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Social Fund(European Social Fund (ESF)); Portuguese Ministry of Science, Technology and Higher Education	This work was supported by the Portuguese Foundation for Science and Technology. SPG acknowledges funding from the European Social Fund and the Portuguese Ministry of Science, Technology and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouelhoda MI, 2002, LECT NOTES COMPUT SC, V2452, P449; Acquisti C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001022; BRENDEL V, 1986, J BIOMOL STRUCT DYN, V4, P11, DOI 10.1080/07391102.1986.10507643; Burrows M., 1994, BLOCK SORTING LOSSLE; GENOME A, 2010, GENOMEATLASACCESSED, P15; Gentles AJ, 2001, GENOME RES, V11, P540, DOI 10.1101/gr.163101; Gusfield D., 1997, ALGORITHMS STRINGS T; Hampikian G, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P355; Herold J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-167; KARLIN S, 1994, ANNU REV MICROBIOL, V48, P619, DOI 10.1146/annurev.mi.48.100194.003155; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; KASAI T, 2001, COMBINATORIAL PATTER, P182; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Margulies EH, 2008, GENOME RES, V18, P199, DOI 10.1101/gr.7228008; PIETROKOVSKI S, 1990, J BIOMOL STRUCT DYN, V7, P1251, DOI 10.1080/07391102.1990.10508563; Pinho AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-137; Simillion C, 2004, BIOESSAYS, V26, P1225, DOI 10.1002/bies.20127; SOKAL RR, 1958, U KANSAS SCI B, V38, P1409; Ulitsky I, 2006, J COMPUT BIOL, V13, P336, DOI 10.1089/cmb.2006.13.336; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; GENOME ATLAS WEBSITE	24	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16065	10.1371/journal.pone.0016065	http://dx.doi.org/10.1371/journal.pone.0016065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21386877	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300033
J	Gregg, KJ; Zandberg, WF; Hehemann, JH; Whitworth, GE; Deng, LH; Vocadlo, DJ; Boraston, AB				Gregg, Katie J.; Zandberg, Wesley F.; Hehemann, Jan-Hendrik; Whitworth, Garrett E.; Deng, Lehua; Vocadlo, David J.; Boraston, Alisdair B.			Analysis of a New Family of Widely Distributed Metal-independent alpha-Mannosidases Provides Unique Insight into the Processing of N-Linked Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EVOLUTIONARY CONSERVATION; SUBSTRATE-SPECIFICITY; MECHANISTIC INSIGHTS; SEQUENCE; OLIGOSACCHARIDES; ACCURACY; SOFTWARE; QUALITY; MAFFT; MEGA	The modification of N-glycans by alpha-mannosidases is a process that is relevant to a large number of biologically important processes, including infection by microbial pathogens and colonization by microbial symbionts. At present, the described mannosidases specific for alpha 1,6-mannose linkages are very limited in number. Through structural and functional analysis of two sequence-related enzymes, one from Streptococcus pneumoniae (SpGH125) and one from Clostridium perfringens (CpGH125), a new glycoside hydrolase family, GH125, is identified and characterized. Analysis of SpGH125 and CpGH125 reveal them to have exo-alpha 1,6-mannosidase activity consistent with specificity for N-linked glycans having their alpha 1,3-mannose branches removed. The x-ray crystal structures of SpGH125 and CpGH125 obtained in apo-, inhibitor-bound, and substrate-Bound forms provide both mechanistic and molecular insight into how these proteins, which adopt an (alpha/alpha)(6)-fold, recognize and hydrolyze the alpha 1,6-mannosidic bond by an inverting, metal-independent catalytic mechanism. A phylogenetic analysis of GH125 proteins reveals this to be a relatively large and widespread family found frequently in bacterial pathogens, bacterial human gut symbionts, and a variety of fungi. Based on these studies we predict this family of enzymes will primarily comprise such exo-alpha 1,6-mannosidases.	[Gregg, Katie J.; Hehemann, Jan-Hendrik; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Zandberg, Wesley F.; Whitworth, Garrett E.; Deng, Lehua; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	University of Victoria; Simon Fraser University	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca	Vocadlo, David J/E-5508-2014; Zandberg, Wesley/AAX-5568-2021	Vocadlo, David J/0000-0001-6897-5558; Boraston, Alisdair/0000-0001-6417-0592; Hehemann, Jan-Hendrik/0000-0002-8700-2564	Canadian Institutes of Health Research [FRN 86610]; Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	This work was supported in part by Canadian Institutes of Health Research Grant FRN 86610 (to D. J. V. and A. B. B.).; Supported by a doctoral fellowship from the Natural Sciences and Engineering Research Council (NSERC) of Canada.; Supported by a doctoral fellowship from the NSERC.; We thank Dr. Michael Suits for critical reading of the manuscript and Professor Geert-Jan Boons, CCRC, University of Georgia, for the kind gift of the methyl-S-(alpha-D-mannopyranosyl)-(1-6)-alpha-D-mannopyranose. We also thank the beamline staff at the Stanford Synchrotron Research Laboratory BL9-2 and the Canadian Light Source CMCF1. The Canadian Light Source is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P6240, DOI 10.1021/bi0101695; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charlwood J, 1998, ANAL BIOCHEM, V262, P197, DOI 10.1006/abio.1998.2803; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evangelista RA, 1996, ELECTROPHORESIS, V17, P347, DOI 10.1002/elps.1150170210; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Guttman A, 1996, ANAL BIOCHEM, V233, P234, DOI 10.1006/abio.1996.0034; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Higgins MA, 2009, J BIOL CHEM, V284, P26161, DOI 10.1074/jbc.M109.024067; Homer KA, 2001, J CLIN MICROBIOL, V39, P995, DOI 10.1128/JCM.39.3.995-1001.2001; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEGLER G, 1984, CARBOHYD RES, V128, P61, DOI 10.1016/0008-6215(84)85084-3; Mizuno M, 2004, J BIOL CHEM, V279, P10575, DOI 10.1074/jbc.M310771200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nei M, 2000, MOL EVOLUTION PHYLOG; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Park C, 2005, J BIOL CHEM, V280, P37204, DOI 10.1074/jbc.M508930200; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Scaman CH, 1996, GLYCOBIOLOGY, V6, P265, DOI 10.1093/glycob/6.3.265; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Suits MDL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009006; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Whitworth GE, 2010, GLYCOBIOLOGY, V20, P287, DOI 10.1093/glycob/cwp173; Zhong W, 2008, J AM CHEM SOC, V130, P8975, DOI 10.1021/ja711248y; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]; Zuckerkandl E., 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	45	49	51	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15586	15596		10.1074/jbc.M111.223172	http://dx.doi.org/10.1074/jbc.M111.223172			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388958	Green Published, hybrid			2022-12-25	WOS:000289788300086
J	Griffiths, GS; Grundl, M; Leychenko, A; Reiter, S; Young-Robbins, SS; Sulzmaier, FJ; Caliva, MJ; Ramos, JW; Matter, ML				Griffiths, Genevieve S.; Grundl, Melanie; Leychenko, Anna; Reiter, Silke; Young-Robbins, Shirley S.; Sulzmaier, Florian J.; Caliva, Maisel J.; Ramos, Joe W.; Matter, Michelle L.			Bit-1 Mediates Integrin-dependent Cell Survival through Activation of the NF kappa B Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; RIBOSOMAL S6 KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; OSTEOCLAST SURVIVAL; BCL-2 EXPRESSION; APOPTOSIS; PROTEIN; FIBRONECTIN; MECHANISMS; TRANSCRIPTION	Loss of properly regulated cell death and cell survival pathways can contribute to the development of cancer and cancer metastasis. Cell survival signals are modulated by many different receptors, including integrins. Bit-1 is an effector of anoikis (cell death due to loss of attachment) in suspended cells. The anoikis function of Bit-1 can be counteracted by integrin-mediated cell attachment. Here, we explored integrin regulation of Bit-1 in adherent cells. We show that knockdown of endogenous Bit-1 in adherent cells decreased cell survival and re-expression of Bit-1 abrogated this effect. Furthermore, reduction of Bit-1 promoted both staurosporine and serum-deprivation induced apoptosis. Indeed knockdown of Bit-1 in these cells led to increased apoptosis as determined by caspase-3 activation and positive TUNEL staining. Bit-1 expression protected cells from apoptosis by increasing phospho-I kappa B levels and subsequently bcl-2 gene transcription. Protection from apoptosis under serum-free conditions correlated with bcl-2 transcription and Bcl-2 protein expression. Finally, Bit-1-mediated regulation of bcl-2 was dependent on focal adhesion kinase, PI3K, and AKT. Thus, we have elucidated an integrin-controlled pathway in which Bit-1 is, in part, responsible for the survival effects of cell-ECM interactions.	[Griffiths, Genevieve S.; Grundl, Melanie; Leychenko, Anna; Reiter, Silke; Matter, Michelle L.] Univ Hawaii Manoa, Ctr Cardiovasc Res & Cell & Mol Biol, Honolulu, HI 96813 USA; [Leychenko, Anna; Sulzmaier, Florian J.] Univ Hawaii Manoa, John A Burns Sch Med Mol Biosci & Bioengn, Honolulu, HI 96813 USA; [Young-Robbins, Shirley S.; Sulzmaier, Florian J.; Caliva, Maisel J.; Ramos, Joe W.] Univ Hawaii Manoa, Univ Hawaii Canc Ctr, Honolulu, HI 96813 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa	Matter, ML (corresponding author), John A Burns Sch Med, Cardiovasc Res Ctr, 651 Ilalo St, Honolulu, HI 96813 USA.	matter@hawaii.edu	Ramos, Joe/G-4074-2010; Matter, Michelle/GSN-9703-2022	Ramos, Joe/0000-0002-9708-2115; Matter, Michelle/0000-0002-5988-9663	National Institutes of Health [NCRR P20-RR016453, R01-GM088266]; The Robert C. Perry Fund [20061479]; Department of Defense [05245002]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Robert C. Perry Fund; Department of Defense(United States Department of Defense); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants NCRR P20-RR016453 (to M. L. M.) and R01-GM088266 (to J. W. R.). This work was also supported by The Robert C. Perry Fund Grant 20061479 (to M. L. M.), and the Department of Defense Grant 05245002 (to J. W. R.).	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; BAUER JS, 1992, J CELL BIOL, V116, P477, DOI 10.1083/jcb.116.2.477; Biliran H, 2008, J BIOL CHEM, V283, P28029, DOI 10.1074/jbc.M803139200; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Cheresh DA, 2008, ONCOGENE, V27, P6285, DOI 10.1038/onc.2008.304; CLARKE AS, 1995, J BIOL CHEM, V270, P22673, DOI 10.1074/jbc.270.39.22673; Cohen LA, 2005, CURR CANCER DRUG TAR, V5, P629, DOI 10.2174/156800905774932798; de Pereda JM, 2004, J BIOL CHEM, V279, P8111, DOI 10.1074/jbc.M311449200; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Ghoda L, 1997, J BIOL CHEM, V272, P21281, DOI 10.1074/jbc.272.34.21281; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Grosjean J, 2006, BIOCHEM BIOPH RES CO, V340, P984, DOI 10.1016/j.bbrc.2005.12.095; Huang D, 2007, AM J PHYSIOL-CELL PH, V292, pC1339, DOI 10.1152/ajpcell.00144.2006; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Kairouz-Wahbe R, 2008, P NATL ACAD SCI USA, V105, P1528, DOI 10.1073/pnas.0711357105; Kurland JF, 2001, J BIOL CHEM, V276, P45380, DOI 10.1074/jbc.M108294200; Lee BH, 2005, J CELL BIOCHEM, V95, P1214, DOI 10.1002/jcb.20488; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; Matter ML, 1998, J CELL BIOL, V141, P1019, DOI 10.1083/jcb.141.4.1019; OBrien V, 1996, EXP CELL RES, V224, P208, DOI 10.1006/excr.1996.0130; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schouten GJ, 1997, EMBO J, V16, P3133, DOI 10.1093/emboj/16.11.3133; Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161; ZHANG ZH, 1993, J CELL BIOL, V122, P235, DOI 10.1083/jcb.122.1.235; Zhao-Yang Z, 2008, CANCER LETT, V266, P209, DOI 10.1016/j.canlet.2008.02.054	37	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14713	14723		10.1074/jbc.M111.228387	http://dx.doi.org/10.1074/jbc.M111.228387			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21383007	Green Published, hybrid			2022-12-25	WOS:000289556200090
J	Huff, TB; Shi, YZ; Sun, WJ; Wu, W; Shi, RY; Cheng, JX				Huff, Terry B.; Shi, Yunzhou; Sun, Wenjing; Wu, Wei; Shi, Riyi; Cheng, Ji-Xin			Real-Time CARS Imaging Reveals a Calpain-Dependent Pathway for Paranodal Myelin Retraction during High-Frequency Stimulation	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; POTASSIUM CHANNELS; REPETITIVE PROPAGATION; PERIPHERAL NODES; EX-VIVO; SCATTERING; MECHANISMS; RANVIER; ACTIVATION; CONDUCTION	High-frequency electrical stimulation is becoming a promising therapy for neurological disorders, however the response of the central nervous system to stimulation remains poorly understood. The current work investigates the response of myelin to electrical stimulation by laser-scanning coherent anti-Stokes Raman scattering (CARS) imaging of myelin in live spinal tissues in real time. Paranodal myelin retraction at the nodes of Ranvier was observed during 200 Hz electrical stimulation. Retraction was seen to begin minutes after the onset of stimulation and continue for up to 10 min after stimulation was ceased, but was found to reverse after a 2 h recovery period. The myelin retraction resulted in exposure of Kv 1.2 potassium channels visualized by immunofluorescence. Accordingly, treating the stimulated tissue with a potassium channel blocker, 4-aminopyridine, led to the appearance of a shoulder peak in the compound action potential curve. Label- free CARS imaging of myelin coupled with multiphoton fluorescence imaging of immuno- labeled proteins at the nodes of Ranvier revealed that high-frequency stimulation induced paranodal myelin retraction via pathologic calcium influx into axons, calpain activation, and cytoskeleton degradation through spectrin break- down.	[Huff, Terry B.; Cheng, Ji-Xin] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Shi, Yunzhou; Wu, Wei; Shi, Riyi; Cheng, Ji-Xin] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Sun, Wenjing; Shi, Riyi] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Huff, TB (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	jcheng@purdue.edu	Wu, Wei/M-9220-2014; Shi, Yunzhou/C-7500-2013	Wu, Wei/0000-0002-7835-4963; 	National Institute of Biomedical Imaging and Bioengineering (NIBIB) [EB007243]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007243] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work is supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) R01 grant EB007243. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bel S, 1991, Acta Neurochir Suppl (Wien), V52, P121; BOWE CM, 1985, PROC R SOC SER B-BIO, V224, P355, DOI 10.1098/rspb.1985.0037; Breit S, 2004, CELL TISSUE RES, V318, P275, DOI 10.1007/s00441-004-0936-0; Cheng JX, 2007, APPL SPECTROSC, V61, p197A, DOI 10.1366/000370207781746044; Cheng JX, 2004, J PHYS CHEM B, V108, P827, DOI 10.1021/jp035693v; CHIU SY, 1980, NATURE, V284, P170, DOI 10.1038/284170a0; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Fu Y, 2006, OPT EXPRESS, V14, P3942, DOI 10.1364/OE.14.003942; Fu Y, 2007, J NEUROSCI RES, V85, P2870, DOI 10.1002/jnr.21403; Fu Y, 2007, BIOPHYS J, V92, P3251, DOI 10.1529/biophysj.106.089011; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Fu Y, 2008, OPT EXPRESS, V16, P19396, DOI 10.1364/OE.16.019396; Gollan L, 2002, J CELL BIOL, V157, P1247, DOI 10.1083/jcb.200203050; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Henry FP, 2009, PLAST RECONSTR SURG, V123, p123S, DOI 10.1097/PRS.0b013e318191c5b8; HILDEBRAND C, 1978, J NEUROL SCI, V38, P421, DOI 10.1016/0022-510X(78)90147-8; Huff TB, 2007, J MICROSC-OXFORD, V225, P175, DOI 10.1111/j.1365-2818.2007.01729.x; Kemler MA, 2000, NEW ENGL J MED, V343, P618, DOI 10.1056/NEJM200008313430904; Kupsch A, 2003, J NEUROL, V250, P47, DOI 10.1007/s00415-003-1110-2; LEVRAM V, 1995, J NEUROSCI, V15, P2628; Li L, 2008, J PHYS CHEM B, V112, P1576, DOI 10.1021/jp711527v; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Mertz J, 2004, CURR OPIN NEUROBIOL, V14, P610, DOI 10.1016/j.conb.2004.08.013; Micu I, 2007, NAT MED, V13, P874, DOI 10.1038/nm1568; MORAN O, 1983, NATURE, V304, P344, DOI 10.1038/304344a0; Muller M, 2007, CHEMPHYSCHEM, V8, P2156, DOI 10.1002/cphc.200700202; Nan XL, 2003, J LIPID RES, V44, P2202, DOI 10.1194/jlr.D300022-JLR200; Oakley JC, 2002, SPINE, V27, P2574, DOI 10.1097/00007632-200211150-00034; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; PADRON R, 1982, BIOPHYS J, V39, P183, DOI 10.1016/S0006-3495(82)84506-2; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Potma EO, 2003, J RAMAN SPECTROSC, V34, P642, DOI 10.1002/jrs.1045; Rasband MN, 2001, J COMP NEUROL, V429, P166, DOI 10.1002/1096-9861(20000101)429:1<166::AID-CNE13>3.0.CO;2-Y; SCHOONHOVEN R, 1991, CRIT REV BIOMED ENG, V19, P47; SHERRATT RM, 1980, NATURE, V283, P570, DOI 10.1038/283570a0; Shi RY, 1999, J NEUROTRAUM, V16, P727, DOI 10.1089/neu.1999.16.727; Shi RY, 1997, EXP NEUROL, V148, P495, DOI 10.1006/exnr.1997.6706; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Sun WJ, 2010, J NEUROPHYSIOL, V103, P469, DOI 10.1152/jn.00154.2009; SWADLOW HA, 1978, PHYSL PATHOBIOLOGY A; Wang HF, 2005, BIOPHYS J, V89, P581, DOI 10.1529/biophysj.105.061911; WAXMAN SG, 1991, TRENDS NEUROSCI, V14, P461, DOI 10.1016/0166-2236(91)90046-W; Waxman SG, 1995, AXON STRUCTURE FUNCT; WURTZ CC, 1988, EXP NEUROL, V101, P87, DOI 10.1016/0014-4886(88)90067-2; WURTZ CC, 1986, J NEUROSCI, V6, P3133; ZAGOREN JC, 1982, BRAIN RES, V242, P27, DOI 10.1016/0006-8993(82)90492-9; Zhang CL, 2006, J NEUROPHYSIOL, V96, P695, DOI 10.1152/jn.00083.2006; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	51	39	59	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17176	10.1371/journal.pone.0017176	http://dx.doi.org/10.1371/journal.pone.0017176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390223	Green Published, Green Submitted, gold			2022-12-25	WOS:000287965200011
J	Hector, A; Bell, T; Hautier, Y; Isbell, F; Kery, M; Reich, PB; van Ruijven, J; Schmid, B				Hector, Andy; Bell, Thomas; Hautier, Yann; Isbell, Forest; Kery, Marc; Reich, Peter B.; van Ruijven, Jasper; Schmid, Bernhard			BUGS in the Analysis of Biodiversity Experiments: Species Richness and Composition Are of Similar Importance for Grassland Productivity	PLOS ONE			English	Article							PLANT DIVERSITY; ECOLOGICAL APPLICATIONS; FUNCTIONAL DIVERSITY; BAYESIAN-INFERENCE; ECOSYSTEM FUNCTION; ELEVATED CO2; VARIANCE; COMMUNITIES; STATISTICS; WINBUGS	The idea that species diversity can influence ecosystem functioning has been controversial and its importance relative to compositional effects hotly debated. Unfortunately, assessing the relative importance of different explanatory variables in complex linear models is not simple. In this paper we assess the relative importance of species richness and species composition in a multilevel model analysis of net aboveground biomass production in grassland biodiversity experiments by estimating variance components for all explanatory variables. We compare the variance components using a recently introduced graphical Bayesian ANOVA. We show that while the use of test statistics and the R-2 gives contradictory assessments, the variance components analysis reveals that species richness and composition are of roughly similar importance for primary productivity in grassland biodiversity experiments.	[Hector, Andy; Hautier, Yann; Kery, Marc; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Bell, Thomas] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Isbell, Forest] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Reich, Peter B.] Univ Minnesota, Dept Forest Resources, St Paul, MN USA; [van Ruijven, Jasper] Univ Wageningen & Res Ctr, Nat Conservat & Plant Ecol Grp, Wageningen, Netherlands; [Kery, Marc] Swiss Ornithol Inst, Ctr Populat Anal, Sempach, Switzerland	University of Zurich; University of Oxford; McGill University; University of Minnesota System; University of Minnesota Twin Cities; Wageningen University & Research; Swiss Ornithological Institute	Hector, A (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	andrew.hector@uzh.ch	van Ruijven, Jasper/D-9848-2011; Schmid, Bernhard/C-8625-2009; Hautier, Yann/I-2526-2019; van Ruijven, Jasper/ABE-7791-2020; Hautier, Yann/D-5426-2015; Hector, Andrew/H-4199-2011; Isbell, Forest/C-6915-2012	Schmid, Bernhard/0000-0002-8430-3214; Hautier, Yann/0000-0003-4347-7741; van Ruijven, Jasper/0000-0003-0003-2363; Hautier, Yann/0000-0003-4347-7741; Hector, Andrew/0000-0002-1309-7716; Isbell, Forest/0000-0001-9689-769X; Reich, Peter/0000-0003-4424-662X; Bell, Thomas/0000-0002-2615-3932	Swiss SystemsX.ch initiative [IPP-2008/23]	Swiss SystemsX.ch initiative	This project was financed by the Swiss SystemsX.ch initiative, grant IPP-2008/23 (to Bernhard Schmid, Jasmin Joshi and Prasenjit Saha). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MIXED EFFECTS MODELS; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BELL T, 2009, AM NATURALIST, V174; BOLKER BM, 2009, TRENDS ECOLOGY EVOLU; Bruno JF, 2008, FRONT ECOL ENVIRON, V6, P539, DOI 10.1890/070136; CARDINALE BJ, 2011, AM J BOT IN PRESS; CLARK JS, 2001, DESIGN ANAL ECOLOGIC; Dennis B, 1996, ECOL APPL, V6, P1095, DOI 10.2307/2269594; Dixon P, 1996, ECOL APPL, V6, P1034, DOI 10.2307/2269587; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; EFRON B, 1986, AM STAT, V40, P11, DOI 10.2307/2683111; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Ellison AM, 1996, ECOL APPL, V6, P1036, DOI 10.2307/2269588; Faraway JJ., 2005, EXTENDING LINEAR MOD; Galway N. W., 2006, INTRO MIXED MODELLIN; Gelman A, 2005, ANN STAT, V33, P1, DOI 10.1214/009053604000001048; Gelman Andrew, 2007, DATA ANAL USING MULT; GILKS WR, 1994, J R STAT SOC D-STAT, V43, P169, DOI DOI 10.2307/2348941; Graham MH, 2001, OIKOS, V93, P505, DOI 10.1034/j.1600-0706.2001.930317.x; GREEN BF, 1960, PSYCHOMETRIKA, V25, P127, DOI 10.1007/BF02288577; Grime JP, 1997, SCIENCE, V277, P1260, DOI 10.1126/science.277.5330.1260; HECTOR A, 2009, BIODIVERSITY ECOSYST; Hector A, 2010, J ANIM ECOL, V79, P308, DOI 10.1111/j.1365-2656.2009.01634.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; ISBELL FI, OECOLOGIA IN PRESS; Kery M., 2010, INTRO WINBUGS ECOLOG; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MAINDONALD J, 2010, DATA ANAL GRAPHICS U; Moore DS, 1997, AM STAT, V51, P254, DOI 10.2307/2684897; Naeem S., 2009, BIODIVERSITY ECOSYST; NELDER JA, 1995, AM STAT, V49, P382, DOI 10.2307/2684580; NELDER JA, 1994, STAT COMPUT, V4, P221, DOI 10.1007/BF00156745; Newman JA, 1997, ECOLOGY, V78, P1312; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Paul-Victor C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006917; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Qian SS, 2007, ECOLOGY, V88, P2489, DOI 10.1890/06-2041.1; Qian SS, 2010, ECOLOGY, V91, P355, DOI 10.1890/09-1043.1; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2009, R FDN STAT COMP; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Reich PB, 2009, SCIENCE, V326, P1399, DOI 10.1126/science.1178820; Robinson GK., 1991, STAT SCI, V6, P18, DOI DOI 10.1214/SS/1177011926; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Schmid B, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P61; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Spiegelhalter DJ, 1999, WINBUGS VERSION 1 2; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Tilman D, 1997, OIKOS, V80, P185, DOI 10.2307/3546532; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Turnbull LA, 2006, BIOL LETT-UK, V2, P397, DOI 10.1098/rsbl.2006.0476; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; van Ruijven J, 2003, ECOL LETT, V6, P170, DOI 10.1046/j.1461-0248.2003.00427.x; van Ruijven J, 2009, OIKOS, V118, P101, DOI 10.1111/j.1600-0706.2008.17119.x; van Ruijven J, 2007, OIKOS, V116, P1323, DOI [10.1111/j.0030-1299.2007.16005.x, 10.1111/j.2007.0030-1299.16005.x]; van Ruijven J, 2010, J ECOL, V98, P81, DOI 10.1111/j.1365-2745.2009.01603.x; Viketoft M, 2009, ECOLOGY, V90, P90, DOI 10.1890/08-0382.1; Wardle D.A., 2000, B ECOL SOC AM, V81, P235, DOI DOI 10.2307/20168451; Weigelt A., 2010, ECOLOGY, V91, P930, DOI DOI 10.1890/09-0863.1; YATES F, 1967, P 5 BERK S MATH STAT, V4, P777	64	52	54	4	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17434	10.1371/journal.pone.0017434	http://dx.doi.org/10.1371/journal.pone.0017434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399688	Green Published, Green Submitted, gold			2022-12-25	WOS:000287933300024
J	van Hoek, AJ; Underwood, A; Jit, M; Miller, E; Edmunds, WJ				van Hoek, Albert Jan; Underwood, Anthony; Jit, Mark; Miller, Elizabeth; Edmunds, W. John			The Impact of Pandemic Influenza H1N1 on Health-Related Quality of Life: A Prospective Population-Based Study	PLOS ONE			English	Article							COST-EFFECTIVENESS; VACCINATION; OSELTAMIVIR; INFECTION; ENGLAND; UTILITY; ADULTS	Background: While the H1N1v influenza pandemic in 2009 was clinically mild, with a low case-fatality rate, the overall disease burden measured in quality-adjusted life years (QALY) lost has not been estimated. Such a measure would allow comparison with other diseases and assessment of the cost-effectiveness of pandemic control measures. Methods and Findings: Cases of H1N1v confirmed by polymerase chain reaction (PCR) and PCR negative cases with similar influenza-like illness (ILI controls) in 7 regions of England were sent two questionnaires, one within a week of symptom onset and one two weeks later, requesting information on duration of illness, work loss and antiviral use together with EQ-5D questionnaires. Results were compared with those for seasonal influenza from a systematic literature review. A total QALY loss for the 2009 pandemic in England was calculated based on the estimated total clinical cases and reported deaths. A total of 655 questionnaires were sent and 296 (45%) returned. Symptoms and average illness duration were similar between confirmed cases and ILI controls (8.8 days and 8.7 days respectively). Days off work were greater for cases than ILI controls (7.3 and 4.9 days respectively, p = 0.003). The quality-adjusted life days lost was 2.92 for confirmed cases and 2.74 for ILI controls, with a reduction in QALY loss after prompt use of antivirals in confirmed cases. The overall QALY loss in the pandemic was estimated at 28,126 QALYs (22,267 discounted) of which 40% was due to deaths (24% with discounting). Conclusion: Given the global public health significance of influenza, it is remarkable that no previous prospective study of the QALY loss of influenza using standardised and well validated methods has been performed. Although the QALY loss was minor for individual patients, the estimated total burden of influenza over the pandemic was substantial when compared to other infectious diseases.	[van Hoek, Albert Jan; Miller, Elizabeth; Edmunds, W. John] Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London, England; [Underwood, Anthony] Hlth Protect Agcy, Appl Lab & Bioinformat Unit, London, England; [Jit, Mark] Hlth Protect Agcy, Modelling & Econ Unit, London, England; [Edmunds, W. John] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England	Health Protection Agency; Health Protection Agency; Health Protection Agency; University of London; London School of Hygiene & Tropical Medicine	van Hoek, AJ (corresponding author), Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London, England.	AlbertJan.vanHoek@hpa.org.uk	Jit, Mark/HDM-7797-2022	Underwood, Anthony/0000-0002-8547-4277; Jit, Mark/0000-0001-6658-8255	Health Protection Agency	Health Protection Agency	The study was funded by the Health Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GUID METH TECHN APPR; BEVAN G, 2007, ESTIMATING HLTH PROD, P45; Brisson M, 2003, ARCH DIS CHILD, V88, P862, DOI 10.1136/adc.88.10.862; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Ellis J, 2009, EUROSURVEILLANCE, V14; Griffin AD, 2001, PHARMACOECONOMICS, V19, P293, DOI 10.2165/00019053-200119030-00007; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nishiura Hiroshi, 2010, Expert Rev Respir Med, V4, P329, DOI 10.1586/ers.10.24; O'Brien BJ, 2003, VALUE HEALTH, V6, P116, DOI 10.1046/j.1524-4733.2003.00213.x; Pebody RG, 2010, EUROSURVEILLANCE, V15; Prosser Lisa A, 2005, Health Qual Life Outcomes, V3, P18, DOI 10.1186/1477-7525-3-18; Prosser LA, 2006, EMERG INFECT DIS, V12, P1548, DOI 10.3201/eid1210.051015; Rothberg MB, 2003, ANN INTERN MED, V139, P321, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00007; Sander B, 2006, PHARMACOECONOMICS, V24, P373, DOI 10.2165/00019053-200624040-00007; Sander B, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000256; Siddiqui MR, 2008, EMERG INFECT DIS, V14, P267, DOI 10.3201/eid1402.070478; Turner D, 2003, Health Technol Assess, V7, piii; VANHOEK A, 2009, RESPONSE GUEST EDITO; Wailoo AJ, 2008, VALUE HEALTH, V11, P160, DOI 10.1111/j.1524-4733.2007.00241.x; Wille N, 2010, QUAL LIFE RES, V19, P875, DOI 10.1007/s11136-010-9648-y	23	59	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17030	10.1371/journal.pone.0017030	http://dx.doi.org/10.1371/journal.pone.0017030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399678	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000287933300007
J	Hashimoto, K; Ishima, T				Hashimoto, Kenji; Ishima, Tamaki			Neurite Outgrowth Mediated by Translation Elongation Factor eEF1A1: A Target for Antiplatelet Agent Cilostazol	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; DOUBLE-BLIND; PC12 CELLS; STROKE; RECEPTORS; POTENTIATION; PREVENTION; INHIBITOR; DONEPEZIL; PLATELET	Cilostazol, a type-3 phosphodiesterase (PDE3) inhibitor, has become widely used as an antiplatelet drug worldwide. A recent second Cilostazol Stroke Prevention Study demonstrated that cilostazol is superior to aspirin for prevention of stroke after an ischemic stroke. However, its precise mechanisms of action remain to be determined. Here, we report that cilostazol, but not the PDE3 inhibitors cilostamide and milrinone, significantly potentiated nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells. Furthermore, specific inhibitors for the endoplasmic reticulum protein inositol 1,4,5-triphosphate (IP3) receptors and several common signaling pathways (PLC-gamma, PI3K, Akt, p38 MAPK, and c-Jun N-terminal kinase (JNK), and the Ras/Raf/ERK/MAPK) significantly blocked the potentiation of NGF-induced neurite outgrowth by cilostazol. Using a proteomics analysis, we identified that levels of eukaryotic translation elongation factor eEF1A1 protein were significantly increased by treatment with cilostazol, but not cilostamide, in PC12 cells. Moreover, the potentiating effects of cilostazol on NGF-induced neurite outgrowth were significantly antagonized by treatment with eEF1A1 RNAi, but not the negative control of eEF1A1. These findings suggest that eEF1A1 and several common cellular signaling pathways might play a role in the mechanism of cilostazol-induced neurite outgrowth. Therefore, agents that can increase the eEF1A1 protein may have therapeutic relevance in diverse conditions with altered neurite outgrowth.	[Hashimoto, Kenji; Ishima, Tamaki] Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan	Chiba University	Hashimoto, K (corresponding author), Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439	Japan Society for the Promotion of Science, Japan	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from the Japan Society for the Promotion of Science, Japan (to K.H.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 2009, AM J GERIAT PSYCHIAT, V17, P353, DOI 10.1097/JGP.0b013e31819431ea; Baba H, 2007, J CLIN PSYCHOPHARM, V27, P727, DOI 10.1097/JCP.0b013e31815a585e; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; CHAPMAN T, 2003, DRUGS, V3, P117; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Duttaroy A, 1998, EXP CELL RES, V238, P168, DOI 10.1006/excr.1997.3819; FUJII DK, 1982, J NEUROSCI, V2, P1157; 갠지하시모토, 2010, Clinical Psychopharmacology and Neuroscience, V8, P26; 갠지하시모토, 2010, Clinical Psychopharmacology and Neuroscience, V8, P74; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Gotoh F, 2000, J Stroke Cerebrovasc Dis, V9, P147, DOI 10.1053/jscd.2000.7216; Hankey GJ, 2008, LANCET NEUROL, V7, P469, DOI 10.1016/S1474-4422(08)70095-4; Hankey GJ, 2010, LANCET NEUROL, V9, P273, DOI 10.1016/S1474-4422(10)70038-7; Hashimoto K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015430; Hiatt WR, 2005, ATHEROSCLEROSIS SUPP, V6, P21, DOI 10.1016/j.atherosclerosissup.2005.09.004; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang YI, 2008, LANCET NEUROL, V7, P494, DOI 10.1016/S1474-4422(08)70094-2; Iketani M, 2009, NEUROSCIENCE, V161, P743, DOI 10.1016/j.neuroscience.2009.04.019; Ishima T, 2008, PROG NEURO-PSYCHOPH, V32, P1656, DOI 10.1016/j.pnpbp.2008.06.011; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; KIMURA K, 1994, J BIOL CHEM, V269, P18961; Kwon SU, 2005, STROKE, V36, P782, DOI 10.1161/01.STR.0000157667.06542.b7; Lakics V, 2010, NEUROPHARMACOLOGY, V59, P367, DOI 10.1016/j.neuropharm.2010.05.004; Liao JK, 2007, CIRCULATION, V115, P1615, DOI 10.1161/CIRCULATIONAHA.106.653741; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Matsumoto M, 2005, ATHEROSCLEROSIS SUPP, V6, P33, DOI 10.1016/j.atherosclerosissup.2005.09.003; Minase T, 2010, EUR J PHARMACOL, V648, P67, DOI 10.1016/j.ejphar.2010.09.007; Nishimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002558; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Shinohara Y, 2008, CEREBROVASC DIS, V26, P63, DOI 10.1159/000135654; Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Sudo T, 2000, BIOCHEM PHARMACOL, V59, P347, DOI 10.1016/S0006-2952(99)00346-9; Sun B, 2007, CELL SIGNAL, V19, P1765, DOI 10.1016/j.cellsig.2007.03.012; Takahashi K, 2008, PHARMACOPSYCHIATRY, V41, P37, DOI 10.1055/s-2007-993208; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; Talapatra S, 2002, CELL DEATH DIFFER, V9, P856, DOI 10.1038/sj.cdd.4401078; Uchiyama S, 2009, J STROKE CEREBROVASC, V18, P482, DOI 10.1016/j.jstrokecerebrovasdis.2009.07.010	41	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17431	10.1371/journal.pone.0017431	http://dx.doi.org/10.1371/journal.pone.0017431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390260	Green Published, Green Submitted, gold			2022-12-25	WOS:000287932100017
J	Delaune, A; Poupel, O; Mallet, A; Coic, YM; Msadek, T; Dubrac, S				Delaune, Aurelia; Poupel, Olivier; Mallet, Adeline; Coic, Yves-Marie; Msadek, Tarek; Dubrac, Sarah			Peptidoglycan Crosslinking Relaxation Plays an Important Role in Staphylococcus aureus WalKR-Dependent Cell Viability	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; L-ALANINE AMIDASE; BETA-N-ACETYLGLUCOSAMINIDASE; SIGNAL-TRANSDUCTION PATHWAY; STREPTOCOCCUS-PNEUMONIAE R6; YYCF RESPONSE REGULATOR; 2-COMPONENT SYSTEM; MOLECULAR CHARACTERIZATION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI	The WalKR two-component system is essential for viability of Staphylococcus aureus, a major pathogen. We have shown that WalKR acts as the master controller of peptidoglycan metabolism, yet none of the identified regulon genes explain its requirement for cell viability. Transmission electron micrographs revealed cell wall thickening and aberrant division septa in the absence of WalKR, suggesting its requirement may be linked to its role in coordinating cell wall metabolism and cell division. We therefore tested whether uncoupling autolysin gene expression from WalKR-dependent regulation could compensate for its essential nature. Uncoupled expression of genes encoding lytic transglycosylases or amidases did not restore growth to a WalKR-depleted strain. We identified only two WalKR-regulon genes whose expression restored cell viability in the absence of WalKR: lytM and ssaA. Neither of these two genes are essential under our conditions and a Delta lytM Delta ssaA mutant does not present any growth defect. LytM is a glycyl-glycyl endopeptidase, hydrolyzing the pentaglycine interpeptide crossbridge, and SsaA belongs to the CHAP amidase family, members of which such as LysK and LytA have been shown to have D-alanyl-glycyl endopeptidase activity, cleaving between the crossbridge and the stem peptide. Taken together, our results strongly suggest that peptidoglycan crosslinking relaxation through crossbridge hydrolysis plays a crucial role in the essential requirement of the WalKR system for cell viability.	[Delaune, Aurelia; Poupel, Olivier; Msadek, Tarek; Dubrac, Sarah] Inst Pasteur, Dept Microbiol, Paris, France; [Delaune, Aurelia; Poupel, Olivier; Msadek, Tarek; Dubrac, Sarah] CNRS, URA 2172, Paris, France; [Coic, Yves-Marie] Inst Pasteur, Dept Struct Biol & Chem, Paris, France; [Coic, Yves-Marie] CNRS, URA 2128, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Delaune, A (corresponding author), Inst Pasteur, Dept Microbiol, Paris, France.	tmsadek@pasteur.fr		Sarah, Dubrac/0000-0002-9810-5390	European Commission [LHSM-CT-2006-019064, LSHG-CT-2006-037469]; Centre National de la Recherche Scientifique [CNRS URA 2172]; Agence Nationale de la Recherche; Institut Pasteur (PTR) [256, 336]; Conseil Pasteur-Weizmann	European Commission(European CommissionEuropean Commission Joint Research Centre); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut Pasteur (PTR); Conseil Pasteur-Weizmann	This work was supported by research funds from the European Commission (StaphDynamics [LHSM-CT-2006-019064] and BaSysBio [LSHG-CT-2006-037469] grants), the Centre National de la Recherche Scientifique (CNRS URA 2172), Agence Nationale de la Recherche (ANR GrabIron and NaBab) and the Institut Pasteur (PTR N degrees 256 and PTR N degrees 336). Aurelia Delaune received a Young Scientist Fellowship from the Conseil Pasteur-Weizmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMREIN KE, 1995, P NATL ACAD SCI USA, V92, P1048, DOI 10.1073/pnas.92.4.1048; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Becker SC, 2009, FEMS MICROBIOL LETT, V294, P52, DOI 10.1111/j.1574-6968.2009.01541.x; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; Bochtler M, 2004, PROTEIN SCI, V13, P854, DOI 10.1110/ps.03515704; Burian M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010040; Burian M, 2010, J INFECT DIS, V201, P1414, DOI 10.1086/651619; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Chastanet A, 2003, MOL MICROBIOL, V47, P1061, DOI 10.1046/j.1365-2958.2003.03355.x; Chastanet A, 2003, J BACTERIOL, V185, P683, DOI 10.1128/JB.185.2.683-687.2003; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Even S, 2006, J BACTERIOL, V188, P2184, DOI 10.1128/JB.188.6.2184-2197.2006; Firczuk M, 2005, J MOL BIOL, V354, P578, DOI 10.1016/j.jmb.2005.09.082; FOSTER SJ, 1995, J BACTERIOL, V177, P5723, DOI 10.1128/jb.177.19.5723-5725.1995; Francius G, 2008, J BACTERIOL, V190, P7904, DOI 10.1128/JB.01116-08; Gardete S, 2006, ANTIMICROB AGENTS CH, V50, P3424, DOI 10.1128/AAC.00356-06; Gillaspy A.F., 2006, GRAM POSITIVE PATHOG, P381; Gotoh Y, 2010, J ANTIBIOT, V63, P127, DOI 10.1038/ja.2010.4; Herbert S, 2007, PLOS PATHOG, V3, P981, DOI 10.1371/journal.ppat.0030102; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang S, 2000, FEMS IMMUNOL MED MIC, V29, P213, DOI 10.1111/j.1574-695X.2000.tb01525.x; Layec S, 2008, J MOL MICROB BIOTECH, V14, P31, DOI 10.1159/000106080; Ling BD, 1998, ANTIMICROB AGENTS CH, V42, P936, DOI 10.1128/AAC.42.4.936; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MAIDHOF H, 1991, J BACTERIOL, V173, P3507, DOI 10.1128/jb.173.11.3507-3513.1991; Martin PK, 1999, J BACTERIOL, V181, P3666, DOI 10.1128/JB.181.12.3666-3673.1999; Martin PK, 2002, J BACTERIOL, V184, P5810, DOI 10.1128/JB.184.20.5810-5813.2002; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Mierau I, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-15; Navarre WW, 1999, J BIOL CHEM, V274, P15847, DOI 10.1074/jbc.274.22.15847; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; Ng WL, 2004, MOL MICROBIOL, V53, P1161, DOI 10.1111/j.1365-2958.2004.04196.x; Ng WL, 2003, MOL MICROBIOL, V50, P1647, DOI 10.1046/j.1365-2958.2003.03806.x; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Okada A, 2010, J ANTIBIOT, V63, P89, DOI 10.1038/ja.2009.128; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; Pragman AA, 2004, J BACTERIOL, V186, P2430, DOI 10.1128/JB.186.8.2430-2438.2004; Ramadurai L, 1997, J BACTERIOL, V179, P3625, DOI 10.1128/jb.179.11.3625-3631.1997; Ramadurai L, 1999, MICROBIOL-UK, V145, P801, DOI 10.1099/13500872-145-4-801; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; Rohrer S, 1999, P NATL ACAD SCI USA, V96, P9351, DOI 10.1073/pnas.96.16.9351; Sambrook J., 2002, MOL CLONING LAB MANU; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; Sieradzki K, 2003, J BACTERIOL, V185, P7103, DOI 10.1128/JB.185.24.7103-7110.2003; Stapleton MR, 2007, J BACTERIOL, V189, P7316, DOI 10.1128/JB.00734-07; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUGAI M, 1995, J BACTERIOL, V177, P1491, DOI 10.1128/jb.177.6.1491-1496.1995; Throup JP, 2000, MOL MICROBIOL, V35, P566, DOI 10.1046/j.1365-2958.2000.01725.x; Thumm G, 1997, MOL MICROBIOL, V23, P1251, DOI 10.1046/j.1365-2958.1997.2911657.x; Tschierske M, 1999, FEMS MICROBIOL LETT, V171, P97, DOI 10.1016/S0378-1097(98)00586-2; Ulrich LE, 2007, NUCLEIC ACIDS RES, V35, pD386, DOI 10.1093/nar/gkl932; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wagner C, 2002, INFECT IMMUN, V70, P6121, DOI 10.1128/IAI.70.11.6121-6128.2002; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Yamada S, 1996, J BACTERIOL, V178, P1565, DOI 10.1128/jb.178.6.1565-1571.1996; Yokoi KJ, 2005, GENE, V351, P97, DOI 10.1016/j.gene.2005.03.006; ZOU Y, 2010, COMPUT BIOL CHEM	69	58	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17054	10.1371/journal.pone.0017054	http://dx.doi.org/10.1371/journal.pone.0017054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386961	Green Published, Green Submitted, gold			2022-12-25	WOS:000287931400026
J	Roddy, KA; Prendergast, PJ; Murphy, P				Roddy, Karen A.; Prendergast, Patrick J.; Murphy, Paula			Mechanical Influences on Morphogenesis of the Knee Joint Revealed through Morphological, Molecular and Computational Analysis of Immobilised Embryos	PLOS ONE			English	Article							ARTICULAR-CARTILAGE FORMATION; DEVELOPING APPENDICULAR SKELETON; CHONDROCYTE PRIMARY CILIUM; MESENCHYMAL STEM-CELLS; SYNOVIAL JOINT; BONE-GROWTH; LONG BONES; DISTRACTION OSTEOGENESIS; HYDROSTATIC-PRESSURE; DYNAMIC COMPRESSION	Very little is known about the regulation of morphogenesis in synovial joints. Mechanical forces generated from muscle contractions are required for normal development of several aspects of normal skeletogenesis. Here we show that biophysical stimuli generated by muscle contractions impact multiple events during chick knee joint morphogenesis influencing differential growth of the skeletal rudiment epiphyses and patterning of the emerging tissues in the joint interzone. Immobilisation of chick embryos was achieved through treatment with the neuromuscular blocking agent Decamethonium Bromide. The effects on development of the knee joint were examined using a combination of computational modelling to predict alterations in biophysical stimuli, detailed morphometric analysis of 3D digital representations, cell proliferation assays and in situ hybridisation to examine the expression of a selected panel of genes known to regulate joint development. This work revealed the precise changes to shape, particularly in the distal femur, that occur in an altered mechanical environment, corresponding to predicted changes in the spatial and dynamic patterns of mechanical stimuli and region specific changes in cell proliferation rates. In addition, we show altered patterning of the emerging tissues of the joint interzone with the loss of clearly defined and organised cell territories revealed by loss of characteristic interzone gene expression and abnormal expression of cartilage markers. This work shows that local dynamic patterns of biophysical stimuli generated from muscle contractions in the embryo act as a source of positional information guiding patterning and morphogenesis of the developing knee joint.	[Roddy, Karen A.; Prendergast, Patrick J.; Murphy, Paula] Trinity Coll Dublin, Sch Nat Sci, Dept Zool, Dublin, Ireland; [Roddy, Karen A.; Prendergast, Patrick J.; Murphy, Paula] Trinity Coll Dublin, Sch Engn, Trinity Ctr Bioengn, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Roddy, KA (corresponding author), Trinity Coll Dublin, Sch Nat Sci, Dept Zool, Dublin, Ireland.	paula.murphy@tcd.ie		Murphy, Paula/0000-0002-8048-6850	Wellcome Trust [083539/Z/07/Z]; Science Foundation Ireland [02/IN1/B267]	Wellcome Trust(Wellcome TrustEuropean Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by a TCD Overhead Investment Plan (OIP) Interdiscipinary Award, Wellcome Trust project grant (083539/Z/07/Z) and Science Foundation Ireland (Programme Award 02/IN1/B267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele P, 2003, J ORTHOPAED RES, V21, P451, DOI 10.1016/S0736-0266(02)00230-9; Bastow ER, 2005, J BIOL CHEM, V280, P11749, DOI 10.1074/jbc.M414495200; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; BOHME K, 1995, EXP CELL RES, V216, P191, DOI 10.1006/excr.1995.1024; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; BUSCHMANN MD, 1995, J CELL SCI, V108, P1497; CARTER DR, 1988, J ORTHOPAED RES, V6, P804, DOI 10.1002/jor.1100060604; Cillo JE, 2000, ORAL SURG ORAL MED O, V90, P147, DOI 10.1067/moe.2000.107531; CRAIG FM, 1987, DEVELOPMENT, V99, P383; Davisson T, 2002, J ORTHOPAED RES, V20, P842, DOI 10.1016/S0736-0266(01)00160-7; Dickhut A, 2009, J CELL PHYSIOL, V219, P219, DOI 10.1002/jcp.21673; Dowthwaite GP, 2003, MATRIX BIOL, V22, P311, DOI 10.1016/S0945-053X(03)00037-4; Dowthwaite GP, 1999, MATRIX BIOL, V18, P523, DOI 10.1016/S0945-053X(99)00044-X; Dowthwaite GP, 1998, J HISTOCHEM CYTOCHEM, V46, P641, DOI 10.1177/002215549804600509; DRACHMAN DB, 1966, DEV BIOL, V14, P401, DOI 10.1016/0012-1606(66)90022-4; Duprez D, 1996, MECH DEVELOP, V57, P145, DOI 10.1016/0925-4773(96)00540-0; Fell HB, 1934, PROC R SOC SER B-BIO, V116, P316, DOI 10.1098/rspb.1934.0076; Francis-West PH, 1999, CELL TISSUE RES, V296, P111, DOI 10.1007/s004410051272; Fukuda K, 1997, J LAB CLIN MED, V130, P209, DOI 10.1016/S0022-2143(97)90098-6; Garciadiego-Cazares D, 2004, DEVELOPMENT, V131, P4735, DOI 10.1242/dev.01345; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gomez C, 2007, J ANAT, V210, P259, DOI 10.1111/j.1469-7580.2007.00698.x; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; HALL BK, 1990, J MORPHOL, V206, P45, DOI 10.1002/jmor.1052060105; HALL JG, 1986, AM J MED GENET, V25, P99, DOI 10.1002/ajmg.1320250112; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hamburger V., 1940, Physiological Zoology Chicago, V13, P367; Hammond E, 1995, Obstet Gynecol Surv, V50, P240, DOI 10.1097/00006254-199503000-00028; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Heegaard JH, 1999, J ORTHOPAED RES, V17, P509, DOI 10.1002/jor.1100170408; Hilton MJ, 2005, DEVELOPMENT, V132, P4339, DOI 10.1242/dev.02025; HOGG DA, 1992, COMP BIOCHEM PHYS A, V103, P25, DOI 10.1016/0300-9629(92)90237-K; Jensen CG, 2004, CELL BIOL INT, V28, P101, DOI 10.1016/j.cellbi.2003.11.007; Kahn J, 2009, DEV CELL, V16, P734, DOI 10.1016/j.devcel.2009.04.013; Kanbe Katsuaki, 2006, Mod Rheumatol, V16, P131; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kavanagh E, 2006, DEV DYNAM, V235, P826, DOI 10.1002/dvdy.20679; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Lamb KJ, 2003, INT J EXP PATHOL, V84, P55, DOI 10.1046/j.1365-2613.2003.00338.x; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lee HS, 2000, J BONE MINER RES, V15, P1501, DOI 10.1359/jbmr.2000.15.8.1501; LELKES G, 1958, J EMBRYOL EXP MORPH, V6, P183; Li CF, 2006, J BONE MINER RES, V21, P946, DOI 10.1359/JBMR.060309; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Lucchinetti E, 2004, CELL TISSUE RES, V315, P385, DOI 10.1007/s00441-003-0836-8; Macias D, 1997, DEVELOPMENT, V124, P1109; McGlashan SR, 2006, J HISTOCHEM CYTOCHEM, V54, P1005, DOI 10.1369/jhc.5A6866.2006; McMahon LA, 2008, J BIOMECH, V41, P2055, DOI 10.1016/j.jbiomech.2008.03.027; McMahon LA, 2008, ANN BIOMED ENG, V36, P185, DOI 10.1007/s10439-007-9416-5; Merino R, 1999, DEV BIOL, V206, P33, DOI 10.1006/dbio.1998.9129; Mikic B, 2000, J ORTHOPAED RES, V18, P406, DOI 10.1002/jor.1100180312; Mikic B, 2000, J REHABIL RES DEV, V37, P127; Millward-Sadler SJ, 2000, OSTEOARTHR CARTILAGE, V8, P272, DOI 10.1053/joca.1999.0301; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Minina E, 2001, DEVELOPMENT, V128, P4523; MITROVIC D, 1982, CELLS TISSUES ORGANS, V113, P313; MURRAY PDF, 1969, J EMBRYOL EXP MORPH, V22, P349; Murray PDF, 1930, ROUX ARCH DEV BIOL, V122, P629, DOI 10.1007/BF00573594; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nowlan NC, 2008, J BIOMECH, V41, P249, DOI 10.1016/j.jbiomech.2007.09.031; Nowlan NC, 2010, BIRTH DEFECTS RES C, V90, P203, DOI 10.1002/bdrc.20184; Nowlan NC, 2010, BONE, V46, P1275, DOI 10.1016/j.bone.2009.11.026; Nowlan NC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000250; Osborne A. C., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P448; PACIFICI M, 1993, DEV DYNAM, V198, P123, DOI 10.1002/aja.1001980206; Pacifici M, 2006, ANN NY ACAD SCI, V1068, P74, DOI 10.1196/annals.1346.010; Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; PERSSON M, 1983, J ANAT, V137, P591; PITSILLIDES AA, 1995, J HISTOCHEM CYTOCHEM, V43, P263, DOI 10.1177/43.3.7868856; Pitsillides AA, 2003, CELL BIOCHEM FUNCT, V21, P235, DOI 10.1002/cbf.1079; Poole CA, 1997, CELL BIOL INT, V21, P483, DOI 10.1006/cbir.1997.0177; Poole CA, 2001, J ANAT, V199, P393, DOI 10.1046/j.1469-7580.2001.19940393.x; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; REISER PJ, 1988, EXP NEUROL, V99, P59, DOI 10.1016/0014-4886(88)90127-6; Roddy KA, 2011, J BIOMECH, V44, P143, DOI 10.1016/j.jbiomech.2010.08.039; Roddy KA, 2009, J ANAT, V214, P374, DOI 10.1111/j.1469-7580.2008.01040.x; RODRIGUEZ JI, 1988, J BONE JOINT SURG AM, V70A, P1052, DOI 10.2106/00004623-198870070-00014; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rot-Nikcevic I, 2006, DEV GENES EVOL, V216, P1, DOI 10.1007/s00427-005-0024-9; RUANOGIL D, 1978, ACTA ANAT, V101, P36, DOI 10.1159/000144947; Sato M, 1999, J BONE MINER RES, V14, P1084, DOI 10.1359/jbmr.1999.14.7.1084; Shefelbine SJ, 2004, J ORTHOPAED RES, V22, P346, DOI 10.1016/j.orthres.2003.08.004; Shefelbine SJ, 2002, BONE, V30, P765, DOI 10.1016/S8756-3282(02)00700-7; Sironen RK, 2002, BBA-MOL CELL RES, V1591, P45, DOI 10.1016/S0167-4889(02)00247-1; Spater D, 2006, DEVELOPMENT, V133, P3039, DOI 10.1242/dev.02471; Spagnoli A, 2007, J CELL BIOL, V177, P1105, DOI 10.1083/jcb.200611031; Stevens SS, 1999, J ORTHOPAED RES, V17, P646, DOI 10.1002/jor.1100170505; SUMMERHURST K, 2008, GENE EXPR PATTERNS; Tanaka N, 2005, J DENT RES, V84, P64, DOI 10.1177/154405910508400111; THOROGOOD PV, 1983, CARTILAGE; Thorpe SD, 2008, BIOCHEM BIOPH RES CO, V377, P458, DOI 10.1016/j.bbrc.2008.09.154; Whitfield JF, 2008, CELL SIGNAL, V20, P1019, DOI 10.1016/j.cellsig.2007.12.001; Wilsman NJ, 1996, J ORTHOP RES, V14, P927, DOI 10.1002/jor.1100140613; WORTHAM RUBY A., 1960, JOUR MORPHOL, V106, P131, DOI 10.1002/jmor.1051060202; Wu QQ, 2000, EXP CELL RES, V256, P383, DOI 10.1006/excr.2000.4847; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491	99	86	88	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17526	10.1371/journal.pone.0017526	http://dx.doi.org/10.1371/journal.pone.0017526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386908	Green Published, gold, Green Submitted			2022-12-25	WOS:000287931400084
J	Thiagarajan, RD; Georgas, KM; Rumballe, BA; Lesieur, E; Chiu, HS; Taylor, D; Tang, DTP; Grimmond, SM; Little, MH				Thiagarajan, Rathi D.; Georgas, Kylie M.; Rumballe, Bree A.; Lesieur, Emmanuelle; Chiu, Han Sheng; Taylor, Darrin; Tang, Dave T. P.; Grimmond, Sean M.; Little, Melissa H.			Identification of Anchor Genes during Kidney Development Defines Ontological Relationships, Molecular Subcompartments and Regulatory Pathways	PLOS ONE			English	Article							MICROARRAY ANALYSIS; EXPRESSION; NEPHRON; MESENCHYME; CELLS; PROLIFERATION; EPITHELIUM; REPAIR; MICE; SIX2	The development of the mammalian kidney is well conserved from mouse to man. Despite considerable temporal and spatial data on gene expression in mammalian kidney development, primarily in rodent species, there is a paucity of genes whose expression is absolutely specific to a given anatomical compartment and/or developmental stage, defined here as 'anchor' genes. We previously generated an atlas of gene expression in the developing mouse kidney using microarray analysis of anatomical compartments collected via laser capture microdissection. Here, this data is further analysed to identify anchor genes via stringent bioinformatic filtering followed by high resolution section in situ hybridisation performed on 200 transcripts selected as specific to one of 11 anatomical compartments within the midgestation mouse kidney. A total of 37 anchor genes were identified across 6 compartments with the early proximal tubule being the compartment richest in anchor genes. Analysis of minimal and evolutionarily conserved promoter regions of this set of 25 anchor genes identified enrichment of transcription factor binding sites for Hnf4a and Hnf1b, RbpJ (Notch signalling), PPAR gamma:RxRA and COUP-TF family transcription factors. This was reinforced by GO analyses which also identified these anchor genes as targets in processes including epithelial proliferation and proximal tubular function. As well as defining anchor genes, this large scale validation of gene expression identified a further 92 compartment-enriched genes able to subcompartmentalise key processes during murine renal organogenesis spatially or ontologically. This included a cohort of 13 ureteric epithelial genes revealing previously unappreciated compartmentalisation of the collecting duct system and a series of early tubule genes suggesting that segmentation into proximal tubule, loop of Henle and distal tubule does not occur until the onset of glomerular vascularisation. Overall, this study serves to illuminate previously ill-defined stages of patterning and will enable further refinement of the lineage relationships within mammalian kidney development.	[Thiagarajan, Rathi D.; Georgas, Kylie M.; Rumballe, Bree A.; Lesieur, Emmanuelle; Chiu, Han Sheng; Taylor, Darrin; Tang, Dave T. P.; Grimmond, Sean M.; Little, Melissa H.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Thiagarajan, RD (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.	S.Grimmond@imb.uq.edu.au; M.Little@imb.uq.edu.au	Little, Melissa H/A-6170-2010; Grimmond, Sean/K-3246-2019; Grimmond, Sean M/J-5304-2016; Tang, Dave/G-9670-2014	Little, Melissa H/0000-0003-0380-2263; Grimmond, Sean/0000-0002-8102-7998; Grimmond, Sean M/0000-0002-8102-7998; Tang, Dave/0000-0002-4790-9014	National Institutes of Health, USA [NIDDK DK070136]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK070136] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the National Institutes of Health, USA (NIDDK DK070136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Awqati Q, 2002, KIDNEY INT, V61, P387, DOI 10.1046/j.1523-1755.2002.00164.x; Alcorn D, 1999, PEDIATR NEPHROL, V13, P347, DOI 10.1007/s004670050624; Ambrozewicz M, 2007, FASEB J, V21, pA901; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Brunskill EW, 2008, DEV CELL, V15, P781, DOI 10.1016/j.devcel.2008.09.007; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Caruana G, 2006, GENE EXPR PATTERNS, V6, P807, DOI 10.1016/j.modgep.2006.02.001; Challen G, 2005, PHYSIOL GENOMICS, V23, P159, DOI 10.1152/physiolgenomics.00043.2005; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Coffinier C, 1999, MECH DEVELOP, V89, P211, DOI 10.1016/S0925-4773(99)00221-X; D'Angelo A, 2010, DEVELOPMENT, V137, P1573, DOI 10.1242/dev.044420; Drummond IA, 2005, J AM SOC NEPHROL, V16, P299, DOI 10.1681/ASN.2004090754; Falahatpisheh MH, 2003, ONCOGENE, V22, P2160, DOI 10.1038/sj.onc.1206238; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Georgas K, 2008, HISTOCHEM CELL BIOL, V130, P927, DOI 10.1007/s00418-008-0454-3; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; Ghate A, 2007, NEUROSCIENCE, V146, P1182, DOI 10.1016/j.neuroscience.2007.02.040; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; JACOBSON HR, 1981, AM J PHYSIOL, V241, pF203, DOI 10.1152/ajprenal.1981.241.3.F203; Jenkins D, 2005, J AM SOC NEPHROL, V16, P2141, DOI 10.1681/ASN.2004090776; Kanazawa T, 2009, ANAT HISTOL EMBRYOL, V38, P34, DOI 10.1111/j.1439-0264.2008.00889.x; Kanazawa T, 2010, DEV DYNAM, V239, P1145, DOI 10.1002/dvdy.22276; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Kisseleva Tatiana, 2008, Proc Am Thorac Soc, V5, P338, DOI 10.1513/pats.200711-168DR; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lee CK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r23; Leimeister C, 2003, GENE EXPR PATTERNS, V3, P595, DOI 10.1016/S1567-133X(03)00114-5; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LITTLE M, 2010, KIDNEY DEV 2 TALES T, P193; Little MH, 2007, GENE EXPR PATTERNS, V7, P680, DOI 10.1016/j.modgep.2007.03.002; Little MH, 2006, J AM SOC NEPHROL, V17, P2390, DOI 10.1681/ASN.2006030218; Lucas B, 2005, ONCOGENE, V24, P6418, DOI 10.1038/sj.onc.1208794; Luyckx VA, 2005, KIDNEY INT, V68, pS68, DOI 10.1111/j.1523-1755.2005.09712.x; Maeda N, 2006, PLOS GENET, V2, P498, DOI 10.1371/journal.pgen.0020062; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; Menke AL, 2002, CANCER RES, V62, P6615; Mugford JW, 2009, DEV BIOL, V333, P312, DOI 10.1016/j.ydbio.2009.06.043; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Potter SS, 2007, GENESIS, V45, P432, DOI 10.1002/dvg.20309; Rae F, 2007, DEV BIOL, V308, P232, DOI 10.1016/j.ydbio.2007.05.027; Reich HN, 2008, KIDNEY INT, V74, P1610, DOI 10.1038/ki.2008.497; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rozen S, 2000, Methods Mol Biol, V132, P365; RUMBALLE B, 2008, CSH PROTOC, P5030; Rumballe B, 2010, PEDIATR NEPHROL, V25, P1005, DOI 10.1007/s00467-009-1392-6; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schmidt-Ott KM, 2005, J AM SOC NEPHROL, V16, P1993, DOI 10.1681/ASN.2004121127; Schwab K, 2006, DEV BIOL, V293, P540, DOI 10.1016/j.ydbio.2006.02.023; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; SIMONE MRC, 2009, GASTROENTEROLOGY, V136; Srinivas S, 1999, DEV GENET, V24, P241; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Suh JM, 2006, MOL ENDOCRINOL, V20, P3412, DOI 10.1210/me.2006-0312; Tamura M, 2007, GENOMICS, V89, P618, DOI 10.1016/j.ygeno.2007.01.003; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wertz K, 1999, MECH DEVELOP, V84, P185, DOI 10.1016/S0925-4773(99)00074-X; Zirlinger M, 2001, P NATL ACAD SCI USA, V98, P5270, DOI 10.1073/pnas.091094698	62	56	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17286	10.1371/journal.pone.0017286	http://dx.doi.org/10.1371/journal.pone.0017286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386911	Green Published, gold			2022-12-25	WOS:000287931400049
J	Feng, ZH; Zhang, C; Kang, HJ; Sun, Y; Wang, HJ; Naqvi, A; Frank, AK; Rosenwaks, Z; Murphy, ME; Levine, AJ; Hu, WW				Feng, Zhaohui; Zhang, Cen; Kang, Hey-Joo; Sun, Yvonne; Wang, Haijian; Naqvi, Asad; Frank, Amanda K.; Rosenwaks, Zev; Murphy, Maureen E.; Levine, Arnold J.; Hu, Wenwei			Regulation of female reproduction by p53 and its family members	FASEB JOURNAL			English	Article						implantation; leukemia inhibitory factor; single nucleotide polymorphism; p63; p73	LEUKEMIA INHIBITORY FACTOR; ESTROGEN-RECEPTOR; TUMOR-FORMATION; PATHWAY; MOUSE; IMPLANTATION; POLYMORPHISM; EXPRESSION; HUMANS; CELLS	Tumor suppressor p53 is crucial for embryonic implantation through transcriptional up-regulation of uterine leukemia inhibitory factor (LIF). This article reports that p53 and estrogen receptor alpha were activated in endometrial tissues during implantation to coordinately regulate LIF production. By using human p53 knockin (Hupki) mice carrying a single nucleotide polymorphism (SNP) at codon 72 (arginine/proline), the arginine allele was demonstrated to produce higher uterine LIF levels during implantation than the proline allele. In humans, the diversity of haplotypes of the p53 gene has decreased during evolution, because the arginine allele, existing in only a subset of haplotypes, is under positive selection. This observation is consistent with previous results showing that the proline allele is enriched in patients undergoing in vitro fertilization (IVF). Studies with p63- and p73-knockout mice have demonstrated the involvement of p63 and p73 in female reproduction and their roles in egg formation and apoptosis (p63) and spindle checkpoint (p73) in female mice. Here, the role of p63 and p73 in human reproduction was investigated. Selected alleles of SNPs in p63 and p73 genes were enriched in IVF patients. These findings demonstrate that the p53 family members are involved in several steps to regulate female reproduction in mice and humans.-Feng, Z., Zhang, C., Kang, H.-J., Sun, Y., Wang, H., Naqvi, A., Frank, A. K., Rosenwaks, Z., Murphy, M. E., Levine, A. J., Hu, W. Regulation of female reproduction by p53 and its family members. FASEB J. 25, 2245-2255 (2011). www.fasebj.org	[Wang, Haijian; Naqvi, Asad; Levine, Arnold J.] Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA; [Feng, Zhaohui; Zhang, Cen; Sun, Yvonne; Levine, Arnold J.; Hu, Wenwei] Univ Med & Dent New Jersey, Canc Inst New Jersey, New Brunswick, NJ USA; [Kang, Hey-Joo; Rosenwaks, Zev] Weill Cornell Med Coll, Ctr Reprod Med & Infertil, New York, NY USA; [Frank, Amanda K.; Murphy, Maureen E.] Fox Chase Canc Ctr, Div Med Sci, Philadelphia, PA 19111 USA	Institute for Advanced Study - USA; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Cornell University; Fox Chase Cancer Center	Levine, AJ (corresponding author), Inst Adv Study, Sch Nat Sci, Einstein Dr, Princeton, NJ 08540 USA.	alevine@ias.edu; huw1@umdnj.edu		Murphy, Maureen/0000-0001-7644-7296	U.S. National Institutes of Health [1P30-CA147892-01]; NATIONAL CANCER INSTITUTE [P30CA147892, R01CA102184] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by U.S. National Institutes of Health grant 1P30-CA147892-01 (to W.H. and A.J.L.).	Aghajanova L, 2004, ANN NY ACAD SCI, V1034, P176, DOI 10.1196/annals.1335.020; Atwal GS, 2007, P NATL ACAD SCI USA, V104, P4524, DOI 10.1073/pnas.0610998104; Atwal GS, 2009, P NATL ACAD SCI USA, V106, P10236, DOI 10.1073/pnas.0901298106; BELYI VA, COLD SPRING HARB PER, V2; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Cheng Jr-Gang, 2002, Rev Endocr Metab Disord, V3, P119, DOI 10.1023/A:1015402811650; DOTSCH V, COLD SPRING HARB PER, V2; Fels DR, 2005, TRENDS BIOCHEM SCI, V30, P426, DOI 10.1016/j.tibs.2005.06.009; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Hu WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001073; Ishibashi H, 2003, J CLIN ENDOCR METAB, V88, P2309, DOI 10.1210/jc.2002-021353; Jeong BS, 2010, FASEB J, V24, P1347, DOI 10.1096/fj.09-146001; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P9761, DOI 10.1073/pnas.0904280106; Kurita T, 2005, MECH DEVELOP, V122, P1043, DOI 10.1016/j.mod.2005.04.008; Laird SM, 1997, HUM REPROD, V12, P569; LANE D, COLD SPRING HARB PER, V2; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu ZP, 2004, P NATL ACAD SCI USA, V101, P2963, DOI 10.1073/pnas.0308607101; Luo JL, 2001, ONCOGENE, V20, P320, DOI 10.1038/sj.onc.1204080; Mikolajczyk M, 2007, AM J REPROD IMMUNOL, V58, P65, DOI 10.1111/j.1600-0897.2007.00492.x; Murphy ME, 2006, CELL DEATH DIFFER, V13, P916, DOI 10.1038/sj.cdd.4401907; Reinbold M, 2008, ONCOGENE, V27, P2788, DOI 10.1038/sj.onc.1210932; Robertson SA, 1996, BIOL REPROD, V54, P183, DOI 10.1095/biolreprod54.1.183; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Tibbetts TA, 1998, BIOL REPROD, V59, P1143, DOI 10.1095/biolreprod59.5.1143; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Tomasini R, 2009, P NATL ACAD SCI USA, V106, P797, DOI 10.1073/pnas.0812096106; TRANQUILLI AL, MED HYPOTHESES, V75, P38; Vernole P, 2009, CELL CYCLE, V8, P421, DOI 10.4161/cc.8.3.7623; YAMASHITA S, 1990, ENDOCRINOLOGY, V127, P2456, DOI 10.1210/endo-127-5-2456	37	61	66	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2011	25	7					2245	2255		10.1096/fj.10-180166	http://dx.doi.org/10.1096/fj.10-180166			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21402718	Green Published, Bronze			2022-12-25	WOS:000292242200016
J	Sikora, AE; Zielke, RA; Lawrence, DA; Andrews, PC; Sandkvist, M				Sikora, Aleksandra E.; Zielke, Ryszard A.; Lawrence, Daniel A.; Andrews, Philip C.; Sandkvist, Maria			Proteomic Analysis of the Vibrio cholerae Type II Secretome Reveals New Proteins, Including Three Related Serine Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; OUTER-MEMBRANE; SUBCELLULAR-LOCALIZATION; PROTEOLYTIC ACTIVATION; LEGIONELLA-PNEUMOPHILA; GENETIC-ANALYSIS; BACTERIAL; HOST; TOXIN; EXPRESSION	The type II secretion (T2S) system is responsible for extracellular secretion of a broad range of proteins, including toxins and degradative enzymes that play important roles in the pathogenesis and life cycle of many Gram-negative bacteria. In Vibrio cholerae, the etiological agent of cholera, the T2S machinery transports cholera toxin, which induces profuse watery diarrhea, a hallmark of this life-threatening disease. Besides cholera toxin, four other proteins have been shown to be transported by the T2S machinery, including hemagglutinin protease, chitinase, GbpA, and lipase. Here, for the first time, we have applied proteomic approaches, including isotope tagging for relative and absolute quantification coupled with multidimensional liquid chromatography and tandem mass spectrometry, to perform an unbiased and comprehensive analysis of proteins secreted by the T2S apparatus of the V. cholerae El Tor strain N16961 under standard laboratory growth conditions. This analysis identified 16 new putative T2S substrates, including sialidase, several proteins participating in chitin utilization, two aminopeptidases, TagA-related protein, cytolysin, RbmC, three hypothetical proteins encoded by VCA0583, VCA0738, and VC2298, and three serine proteases VesA, VesB, and VesC. Focusing on the initial characterization of VesA, VesB, and VesC, we have confirmed enzymatic activities and T2S-dependent transport for each of these proteases. In addition, analysis of single, double, and triple protease knock-out strains indicated that VesA is the primary protease responsible for processing the A subunit of cholera toxin during in vitro growth of the V. cholerae strain N16961.	[Sikora, Aleksandra E.; Sandkvist, Maria] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Zielke, Ryszard A.] Univ Michigan, Dept Mol Dev & Cellular Biol, Ann Arbor, MI 48109 USA; [Lawrence, Daniel A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Andrews, Philip C.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sandkvist, M (corresponding author), Univ Michigan, Dept Microbiol & Immunol, 1150 W Med Ctr Dr,3726 Med Sci Bldg 2, Ann Arbor, MI 48109 USA.	mariasan@umich.edu	Sikora, Aleksandra E/HGD-6641-2022	Lawrence, Daniel/0000-0003-3126-1935; Andrews, Philip/0000-0001-6843-5420	National Institutes of Health from NIAID [R01AI081705]; NHLBI [HL55374, HL54710, HL089407]; National Institutes of Health [1-U54-AI-057153]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089407, R01HL055374, P01HL054710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI081705] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI081705 from NIAID (to M. S.) and Grants HL55374, HL54710, and HL089407 from NHLBI (to D. A. L.).; We acknowledge membership within and support from the Region V "Great Lakes" Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research program supported by National Institutes of Health Award 1-U54-AI-057153.	Adav SS, 2010, J PROTEOME RES, V9, P3932, DOI 10.1021/pr100148j; Adav SS, 2010, J PROTEOME RES, V9, P3016, DOI 10.1021/pr901174z; Angelichio MJ, 1999, INFECT IMMUN, V67, P3733, DOI 10.1128/IAI.67.8.3733-3739.1999; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhowmick R, 2007, J APPL MICROBIOL, V103, P97, DOI 10.1111/j.1365-2672.2006.03253.x; BOOTH BA, 1984, INFECT IMMUN, V45, P558, DOI 10.1128/IAI.45.3.558-560.1984; Broza M, 2001, NATURE, V412, P40, DOI 10.1038/35083691; Bumann D, 2002, INFECT IMMUN, V70, P3396, DOI 10.1128/IAI.70.7.3396-3403.2002; Caldwell RB, 2004, APPL ENVIRON MICROB, V70, P610, DOI 10.1128/AEM.70.1.610-612.2004; Camberg JL, 2005, J BACTERIOL, V187, P249, DOI 10.1128/JB.187.1.249-256.2005; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Chen XQ, 2010, J PROTEOME RES, V9, P885, DOI 10.1021/pr900784c; Cianciotto NP, 2009, FUTURE MICROBIOL, V4, P797, DOI 10.2217/FMB.09.53; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Connell TD, 1998, J BACTERIOL, V180, P5591, DOI 10.1128/JB.180.21.5591-5600.1998; Cottingham KL, 2003, FRONT ECOL ENVIRON, V1, P80, DOI 10.1890/1540-9295(2003)001[0080:EMAHPT]2.0.CO;2; Coulthurst SJ, 2008, J BIOL CHEM, V283, P23739, DOI 10.1074/jbc.M801829200; Davis BM, 2000, SCIENCE, V288, P333, DOI 10.1126/science.288.5464.333; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; DENFERT C, 1989, J BIOL CHEM, V264, P17462; DENFERT C, 1987, EMBO J, V6, P3531, DOI 10.1002/j.1460-2075.1987.tb02679.x; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Evans FF, 2008, ENVIRON MICROBIOL, V10, P1101, DOI 10.1111/j.1462-2920.2007.01545.x; Evans FF, 2007, J PROTEOME RES, V6, P967, DOI 10.1021/pr060416x; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; FINKELSTEIN RA, 1983, P NATL ACAD SCI-BIOL, V80, P1092, DOI 10.1073/pnas.80.4.1092; GALEN JE, 1992, INFECT IMMUN, V60, P406, DOI 10.1128/IAI.60.2.406-415.1992; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gill D M, 1977, Adv Cyclic Nucleotide Res, V8, P85; GILL DM, 1979, J INFECT DIS, V139, P674, DOI 10.1093/infdis/139.6.674; GORDON VM, 1994, INFECT IMMUN, V62, P333, DOI 10.1128/IAI.62.2.333-340.1994; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Halpern M, 2003, APPL ENVIRON MICROB, V69, P4200, DOI 10.1128/AEM.69.7.4200-4204.2003; HEDSTROM L, 2002, CURR PROTOC PROTEIN, V21; HIRST TR, 1987, P NATL ACAD SCI USA, V84, P7418, DOI 10.1073/pnas.84.21.7418; Horstman AL, 2002, J BIOL CHEM, V277, P32538, DOI 10.1074/jbc.M203740200; IWANAGA M, 1985, J CLIN MICROBIOL, V22, P405, DOI 10.1128/JCM.22.3.405-408.1985; Jermyn WS, 2002, MICROBIOL-SGM, V148, P3681, DOI 10.1099/00221287-148-11-3681; Jha G, 2005, MOL PLANT MICROBE IN, V18, P891, DOI 10.1094/MPMI-18-0891; Johnson TL, 2007, J BACTERIOL, V189, P9082, DOI 10.1128/JB.01256-07; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Kaffarnik FAR, 2009, MOL CELL PROTEOMICS, V8, P145, DOI 10.1074/mcp.M800043-MCP200; Kanjilal S, 2010, J BACTERIOL, V192, P4300, DOI 10.1128/JB.00182-10; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Lantz MS, 1997, J PERIODONTAL RES, V32, P126, DOI 10.1111/j.1600-0765.1997.tb01393.x; Lathem WW, 2002, MOL MICROBIOL, V45, P277, DOI 10.1046/j.1365-2958.2002.02997.x; Lencer WI, 1997, J BIOL CHEM, V272, P15562, DOI 10.1074/jbc.272.24.15562; Li XB, 2007, GLYCOBIOLOGY, V17, P1377, DOI 10.1093/glycob/cwm096; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Lory S, 1998, CURR OPIN MICROBIOL, V1, P27, DOI 10.1016/S1369-5274(98)80139-2; Lybarger SR, 2009, J BACTERIOL, V191, P3149, DOI 10.1128/JB.01701-08; Maeda H, 1996, MICROBIOL IMMUNOL, V40, P685, DOI 10.1111/j.1348-0421.1996.tb01129.x; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; MENARD R, 1993, J BACTERIOL, V175, P5899; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; Moustafa I, 2004, J BIOL CHEM, V279, P40819, DOI 10.1074/jbc.M404965200; NALIN DR, 1979, INFECT IMMUN, V25, P768, DOI 10.1128/IAI.25.2.768-770.1979; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; OVERBYE LJ, 1993, GENE, V132, P101, DOI 10.1016/0378-1119(93)90520-D; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Sack DA, 2006, NEW ENGL J MED, V355, P649, DOI 10.1056/NEJMp068144; Saier MH, 2006, J MEMBRANE BIOL, V214, P75, DOI 10.1007/s00232-006-0049-7; SANDKVIST M, 1993, GENE, V123, P81, DOI 10.1016/0378-1119(93)90543-C; Sandkvist M, 1997, J BACTERIOL, V179, P6994, DOI 10.1128/jb.179.22.6994-7003.1997; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shi L, 2008, J BACTERIOL, V190, P5512, DOI 10.1128/JB.00514-08; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Sikora AE, 2007, J BACTERIOL, V189, P8484, DOI 10.1128/JB.00583-07; Sikora AE, 2009, J BACTERIOL, V191, P5398, DOI 10.1128/JB.00092-09; Silva AJ, 2006, INFECT IMMUN, V74, P2072, DOI 10.1128/IAI.74.4.2072-2079.2006; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Stewart CR, 2009, J BACTERIOL, V191, P1537, DOI 10.1128/JB.01531-08; Syngkon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013122; TAYLOR RK, 1989, J BACTERIOL, V171, P1870, DOI 10.1128/jb.171.4.1870-1878.1989; Toma C, 1996, INFECT IMMUN, V64, P4495, DOI 10.1128/IAI.64.11.4495-4500.1996; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Xicohtencatl-Cortes J, 2006, MOL CELL PROTEOMICS, V5, P2374, DOI 10.1074/mcp.M600228-MCP200; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zalewska-Piatek B, 2008, J BACTERIOL, V190, P5044, DOI 10.1128/JB.00224-08; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	86	79	79	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16555	16566		10.1074/jbc.M110.211078	http://dx.doi.org/10.1074/jbc.M110.211078			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21385872	Green Published, hybrid			2022-12-25	WOS:000290301900004
J	Gandini, MA; Sandoval, A; Gonzalez-Ramirez, R; Mori, Y; de Waard, M; Felix, R				Gandini, Mara A.; Sandoval, Alejandro; Gonzalez-Ramirez, Ricardo; Mori, Yasuo; de Waard, Michel; Felix, Ricardo			Functional Coupling of Rab3-interacting Molecule 1 (RIM1) and L-type Ca2+ Channels in Insulin Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELL; GATED CALCIUM-CHANNELS; INTERACTING MOLECULE; SUBUNIT INTERACTION; RAB3 EFFECTOR; SECRETION; EXOCYTOSIS; INACTIVATION; CA(V)1.2; SNAP-25	Insulin release by pancreatic beta-cells is regulated by diverse intracellular signals, including changes in Ca2+ concentration resulting from Ca2+ entry through voltage-gated (Ca-V) channels. It has been reported that the Rab3 effector RIM1 acts as a functional link between neuronal Ca-V channels and the machinery for exocytosis. Here, we investigated whether RIM1 regulates recombinant and native L-type Ca-V channels (that play a key role in hormone secretion) and whether this regulation affects insulin release. Whole-cell patch clamp currents were recorded from HEK-293 and insulinoma RIN-m5F cells. RIM1 and Ca-V channel expression was identified by RT-PCR and Western blot. RIM1-Ca-V channel interaction was determined by co-immunoprecipitation. Knockdown of RIM1 and Ca-V channel subunit expression were performed using small interference RNAs. Insulin release was assessed by ELISA. Co-expression of Ca(V)1.2 and Ca(V)1.3 L-type channels with RIM1 in HEK-293 cells revealed that RIM1 may not determine the availability of L-type Ca-V channels but decreases the rate of inactivation of the whole cell currents. Co-immunoprecipitation experiments showed association of the Ca-V beta auxiliary subunit with RIM1. The lack of Ca-V beta expression suppressed channel regulation by RIM1. Similar to the heterologous system, an increase of current inactivation was observed upon knockdown of endogenous RIM1. Co-immunoprecipitation showed association of Ca-V beta and RIM1 in insulin-secreting RIN-m5F cells. Knockdown of RIM1 notably impaired high K+-stimulated insulin secretion in the RIN-m5F cells. These data unveil a novel functional coupling between RIM1 and the L-type Ca-V channels via the Ca-V beta auxiliary subunit that contribute to determine insulin secretion.	[Gandini, Mara A.; Felix, Ricardo] CINVESTAV, IPN, Natl Polytech Inst, Dept Cell Biol,Ctr Res & Adv Studies, Mexico City 07300, DF, Mexico; [Sandoval, Alejandro] Univ Nacl Autonoma Mexico, Sch Med FES Iztacala, Tlalnepantla 54090, Mexico; [Gonzalez-Ramirez, Ricardo] Dr Manuel Gea Gonzalez Gen Hosp, Dept Mol Biol & Histocompatibil, Mexico City 14080, DF, Mexico; [Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan; [de Waard, Michel] INSERM, Grenoble Inst Neurosci, U836, Grenoble, France; [de Waard, Michel] Univ Grenoble 1, F-38042 Grenoble, France	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Kyoto University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Felix, R (corresponding author), CINVESTAV, IPN, Natl Polytech Inst, Dept Cell Biol,Ctr Res & Adv Studies, Ave IPN 2508, Mexico City 07300, DF, Mexico.	rfelix@cell.cinvestav.mx	De Waard, Michel/G-7406-2014; González-Ramírez, Ricardo/O-1792-2014; Felix, Ricardo/A-6989-2008	De Waard, Michel/0000-0002-2782-9615; González-Ramírez, Ricardo/0000-0003-1399-8036; Felix, Ricardo/0000-0002-5383-7176; Sandoval, Alejandro/0000-0002-8558-6033; Gandini, Maria/0000-0003-4399-1679	Consejo Nacional de Ciencia y Tenologia (Conacyt, Mexico); PAPIIT-UNAM [IN210708]; Conacyt and Instituto de Ciencia y Tecnologia del Distrito Federal (ICyTDF, Mexico)	Consejo Nacional de Ciencia y Tenologia (Conacyt, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Conacyt and Instituto de Ciencia y Tecnologia del Distrito Federal (ICyTDF, Mexico)	This work was supported in part by grants from Consejo Nacional de Ciencia y Tenologia (Conacyt, Mexico) (to R. F.) and from PAPIIT-UNAM (Grant IN210708) (to A. S.). This work was also supported by doctoral and post-doctoral fellowships from Conacyt and Instituto de Ciencia y Tecnologia del Distrito Federal (ICyTDF, Mexico) (to M. G. and R. G.-R., respectively).	Andrade A, 2009, CELL CALCIUM, V46, P282, DOI 10.1016/j.ceca.2009.08.006; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Avila G, 2004, CELL MOL NEUROBIOL, V24, P317, DOI 10.1023/B:CEMN.0000022765.52109.26; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Felix R, 2005, J RECEPT SIG TRANSD, V25, P57, DOI 10.1081/RRS-200068102; Gebhart M, 2010, MOL CELL NEUROSCI, V44, P246, DOI 10.1016/j.mcn.2010.03.011; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Hering S, 2000, J PHYSIOL-LONDON, V528, P237, DOI 10.1111/j.1469-7793.2000.t01-1-00237.x; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Hiriart M, 2008, AM J PHYSIOL-ENDOC M, V295, pE1298, DOI 10.1152/ajpendo.90493.2008; Iezzi M, 2000, FEBS LETT, V474, P66, DOI 10.1016/S0014-5793(00)01572-6; Jacobo SMP, 2009, J PHARMACOL EXP THER, V330, P283, DOI 10.1124/jpet.109.150672; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Karunasekara Y, 2009, EUR BIOPHYS J BIOPHY, V39, P75, DOI 10.1007/s00249-009-0467-4; Khanna R, 2006, NEUROSCIENCE, V140, P1201, DOI 10.1016/j.neuroscience.2006.04.053; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; Liu HY, 1996, J NEUROSCI, V16, P7557; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; Miki Takafumi, 2007, Channels (Austin), V1, P144; Safayhi H, 1997, MOL ENDOCRINOL, V11, P619, DOI 10.1210/me.11.5.619; Sandoval A, 2007, CELL MOL NEUROBIOL, V27, P901, DOI 10.1007/s10571-007-9210-9; Sandoval A, 2007, J NEUROSCI, V27, P3317, DOI 10.1523/JNEUROSCI.4566-06.2007; SATIN LS, 1995, ENDOCRINOLOGY, V136, P4589, DOI 10.1210/en.136.10.4589; Schulla V, 2003, EMBO J, V22, P3844, DOI 10.1093/emboj/cdg389; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Stanley EF, 2003, EUR J NEUROSCI, V18, P2403, DOI 10.1046/j.1460-9568.2003.02948.x; Uriu Y, 2010, J BIOL CHEM, V285, P21750, DOI 10.1074/jbc.M110.101311; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Wong FK, 2010, J NEUROCHEM, V112, P463, DOI 10.1111/j.1471-4159.2009.06466.x; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x	39	25	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.187757	http://dx.doi.org/10.1074/jbc.M110.187757			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21402706	hybrid, Green Published			2022-12-25	WOS:000290022800015
J	Obrador, E; Benlloch, M; Pellicer, JA; Asensi, M; Estrela, JM				Obrador, Elena; Benlloch, Maria; Pellicer, Jose A.; Asensi, Miguel; Estrela, Jose M.			Intertissue Flow of Glutathione (GSH) as a Tumor Growth-promoting Mechanism INTERLEUKIN 6 INDUCES GSH RELEASE FROM HEPATOCYTES IN METASTATIC B16 MELANOMA-BEARING MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B16 MELANOMA-CELLS; GAMMA-GLUTAMYL-TRANSPEPTIDASE; LIVER PARENCHYMAL-CELLS; MOUSE-LIVER; RAT-LIVER; IN-VITRO; MULTIDRUG-RESISTANCE; METASTATIC MELANOMA; CANCER-CHEMOTHERAPY; REDUCED GLUTATHIONE	B16 melanoma F10 (B16-F10) cells with high glutathione (GSH) content show high metastatic activity in vivo. An intertissue flow of GSH, where the liver is the main reservoir, can increase GSH content in metastatic cells and promote their growth. We have studied here possible tumor-derived molecular signals that could activate GSH release from hepatocytes. GSH efflux increases in hepatocytes isolated from mice bearing liver or lung metastases, thus suggesting a systemic mechanism. Fractionation of serum-free conditioned medium from cultured B16-F10 cells and monoclonal antibody-induced neutralization techniques facilitated identification of interleukin (IL)-6 as a tumor-derived molecule promoting GSH efflux in hepatocytes. IL-6 activates GSH release through a methionine-sensitive/organic anion transporter polypeptide 1- and multidrug resistance protein 1-independent channel located on the sinusoidal site of hepatocytes. Specific siRNAs were used to knock down key factors in the main signaling pathways activated by IL-6, which revealed a STAT3-dependent mechanism. Our results show that IL-6 (mainly of tumor origin in B16-F10-bearing mice) may facilitate GSH release from hepatocytes and its interorgan transport to metastatic growing foci.	[Estrela, Jose M.] Univ Valencia, Dept Physiol, Fac Med & Odontol, Valencia 46010, Spain; [Benlloch, Maria] San Vicente Martir Catholic Univ, Fac Expt Sci, Valencia, Spain	University of Valencia; Universidad Catolica de Valencia San Vicente Martir	Estrela, JM (corresponding author), Univ Valencia, Dept Physiol, Fac Med & Odontol, 15 Av Blasco Ibanez, Valencia 46010, Spain.	jose.m.estrela@uv.es	OBRADOR, ELENA/H-4069-2015; Estrela, Jose/H-4449-2015; Miralles, Miguel A Asensi/I-2756-2015; MARTINEZ, ANTONIO PELLICER/C-4832-2015	OBRADOR, ELENA/0000-0002-5934-5543; Estrela, Jose/0000-0002-2540-9190; Miralles, Miguel A Asensi/0000-0003-1922-7777; 	Ministerio de Ciencia e Innovacion, Spain [SAF2009-07729, IPT-010000-2010-21]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by Ministerio de Ciencia e Innovacion, Spain, Grants SAF2009-07729 and IPT-010000-2010-21.	Anasagasti MJ, 1998, HEPATOLOGY, V27, P1249, DOI 10.1002/hep.510270510; ANDERSON ME, 1980, J BIOL CHEM, V255, P9530; ASENSI M, 1994, ANAL BIOCHEM, V217, P323, DOI 10.1006/abio.1994.1126; Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Ballatori N, 1998, SEMIN LIVER DIS, V18, P377, DOI 10.1055/s-2007-1007171; Ballatori N, 2009, MOL ASPECTS MED, V30, P13, DOI 10.1016/j.mam.2008.08.004; BANNAI S, 1986, J MEMBRANE BIOL, V89, P1, DOI 10.1007/BF01870891; Benlloch M, 2005, J BIOL CHEM, V280, P6950, DOI 10.1074/jbc.M408531200; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carretero J, 2001, J BIOL CHEM, V276, P25775, DOI 10.1074/jbc.M101148200; Carretero J, 1999, CLIN EXP METASTAS, V17, P567, DOI 10.1023/A:1006725226078; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DENEKE SM, 1989, AM J PHYSIOL, V257, pL163, DOI 10.1152/ajplung.1989.257.4.L163; Emmenegger U, 2010, NATURE, V468, P637, DOI 10.1038/468637a; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; FernandezCheca JC, 1996, AM J PHYSIOL-GASTR L, V270, pG969, DOI 10.1152/ajpgi.1996.270.6.G969; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; FIDLER IJ, 1990, CANCER RES, V50, P6130; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; GARDELL SJ, 1980, FEBS LETT, V122, P171, DOI 10.1016/0014-5793(80)80430-3; Garibotto G, 2003, AM J PHYSIOL-ENDOC M, V284, pE757, DOI 10.1152/ajpendo.00403.2002; Geier A, 2005, AM J PHYSIOL-GASTR L, V289, pG831, DOI 10.1152/ajpgi.00307.2004; Green RM, 1996, GASTROENTEROLOGY, V111, P193, DOI 10.1053/gast.1996.v111.pm8698199; GRIFFITH OW, 1979, P NATL ACAD SCI USA, V76, P5606, DOI 10.1073/pnas.76.11.5606; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; GROEN AK, 1982, EUR J BIOCHEM, V122, P87, DOI 10.1111/j.1432-1033.1982.tb05851.x; HANIGAN MH, 1995, CARCINOGENESIS, V16, P181, DOI 10.1093/carcin/16.2.181; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hochwald SN, 1996, J NATL CANCER I, V88, P193, DOI 10.1093/jnci/88.3-4.193; Ilkovitch D, 2008, EXP DERMATOL, V17, P977, DOI 10.1111/j.1600-0625.2008.00779.x; Karras JG, 2000, CELL IMMUNOL, V202, P124, DOI 10.1006/cimm.2000.1661; Kovalovich K, 2001, J BIOL CHEM, V276, P26605, DOI 10.1074/jbc.M100740200; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; Leu JI, 2001, MOL CELL BIOL, V21, P414, DOI 10.1128/MCB.21.2.414-424.2001; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; LI L, 1991, CANCER RES, V51, P245; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; MEISTER A, 1983, SCIENCE, V220, P472, DOI 10.1126/science.6836290; MEISTER A, 1991, PHARMACOL THERAPEUT, V51, P155, DOI 10.1016/0163-7258(91)90076-X; Meredith MJ, 1998, BIOCHEM BIOPH RES CO, V248, P458, DOI 10.1006/bbrc.1998.8998; Morgan ET, 2008, DRUG METAB DISPOS, V36, P205, DOI 10.1124/dmd.107.018747; New LS, 2008, J CHROMATOGR SCI, V46, P209, DOI 10.1093/chromsci/46.3.209; Obrador E, 2002, HEPATOLOGY, V35, P74, DOI 10.1053/jhep.2002.30277; OBrien ML, 1996, EUR J CANCER, V32A, P967, DOI 10.1016/0959-8049(96)00051-2; OOKHTENS M, 1994, AM J PHYSIOL, V266, pR979, DOI 10.1152/ajpregu.1994.266.3.R979; Ookhtens M, 1998, SEMIN LIVER DIS, V18, P313, DOI 10.1055/s-2007-1007167; Orr FW, 2000, J PATHOL, V190, P310, DOI 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P; Ortega A, 2003, J BIOL CHEM, V278, P39591, DOI 10.1074/jbc.M303753200; Renton KW, 2004, CURR DRUG METAB, V5, P235, DOI 10.2174/1389200043335559; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Siewert E, 2004, BIOCHEM BIOPH RES CO, V322, P232, DOI 10.1016/j.bbrc.2004.07.102; Singh A, 2006, BIOTECHNOL BIOENG, V95, P850, DOI 10.1002/bit.21026; SINGH B, 1983, ACTA PHYSIOL SCAND, V117, P497, DOI 10.1111/j.1748-1716.1983.tb07218.x; Slaviero KA, 2003, LANCET ONCOL, V4, P224, DOI 10.1016/S1470-2045(03)01034-9; STACKPOLE CW, 1995, CLIN EXP METASTAS, V13, P105, DOI 10.1007/BF00133615; TERRADEZ P, 1993, BIOCHEM J, V292, P477, DOI 10.1042/bj2920477; van der Kolk DM, 1999, ADV EXP MED BIOL, V457, P187; Vee ML, 2009, DRUG METAB DISPOS, V37, P685, DOI DOI 10.1124/DMD.108.023630; Wang Y, 2010, CANCER LETT, V295, P110, DOI 10.1016/j.canlet.2010.02.019; Weiss L, 1990, Adv Cancer Res, V54, P159, DOI 10.1016/S0065-230X(08)60811-8; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang HQ, 2005, METHOD ENZYMOL, V401, P468, DOI 10.1016/S0076-6879(05)01028-1	67	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.196261	http://dx.doi.org/10.1074/jbc.M110.196261			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21393247	hybrid, Green Published			2022-12-25	WOS:000290022800011
J	San Luis, B; Sondgeroth, B; Nassar, N; Carpino, N				San Luis, Boris; Sondgeroth, Ben; Nassar, Nicolas; Carpino, Nick			Sts-2 Is a Phosphatase That Negatively Regulates Zeta-associated Protein (ZAP)-70 and T Cell Receptor Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHATASES; DOMAIN; UBIQUITIN; TULA; IDENTIFICATION; ENDOCYTOSIS; SUBSTRATE; KINASES; ZAP-70; BINDS	T cell activity is controlled in large part by the T cell receptor (TCR). The TCR detects the presence of foreign pathogens and activates the T cell-mediated immune reaction. Numerous intracellular signaling pathways downstream of the TCR are involved in the process of T cell activation. Negative regulation of these pathways helps prevent excessive and deleterious T cell responses. Two homologous proteins, Sts-1 and Sts-2, have been shown to function as critical negative regulators of TCR signaling. The phosphoglycerate mutase-like domain of Sts-1 (Sts-1(PGM)) has a potent phosphatase activity that contributes to the suppression of TCR signaling. The function of Sts-2(PGM) as a phosphatase has been less clear, principally because its intrinsic enzyme activity has been difficult to detect. Here, we demonstrate that Sts-2 regulates the level of tyrosine phosphorylation on targets within T cells, among them the critical T cell tyrosine kinase Zap-70. Utilizing new phosphorylated substrates, we demonstrate that Sts-2(PGM) has clear, albeit weak, phosphatase activity. We further pinpoint Sts-2 residues Glu-481, Ser-552, and Ser-582 as specificity determinants, in that an Sts-2(PGM) triple mutant in which these three amino acids are altered to their counterparts in Sts-1(PGM) has substantially increased activity. Our results suggest that the phosphatase activities of both suppressor of TCR signaling homologues cooperate in a similar but independent fashion to help set the threshold for TCR-induced T cell activation.	[San Luis, Boris; Carpino, Nick] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Sondgeroth, Ben; Nassar, Nicolas] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Carpino, N (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Rm 160 Life Sci Bldg, Stony Brook, NY 11794 USA.	ncarpino@notes.cc.sunysb.edu			National Institutes of Health, NIAID [R21AI075176, R01AI080892, CA-115611]; Stony Brook University [LI07]; Arthritis Foundation; Department of Defense [NF060060]; NATIONAL CANCER INSTITUTE [R01CA115611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080892, R21AI075176] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Stony Brook University; Arthritis Foundation; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AI075176 and R01AI080892 from NIAID and CA-115611 (to N. N.). This work was also supported by Stony Brook University, Grant LI07 from the Arthritis Foundation (to N. C.), and Department of Defense Grant NF060060 (to N. N.).	Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Agrawal R, 2008, J CELL BIOCHEM, V104, P953, DOI 10.1002/jcb.21678; Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Carpino N, 2002, MOL CELL BIOL, V22, P7491, DOI 10.1128/MCB.22.21.7491-7500.2002; Carpino N, 2009, MOL IMMUNOL, V46, P3224, DOI 10.1016/j.molimm.2009.08.015; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chen XW, 2010, J BIOL CHEM, V285, P31268, DOI 10.1074/jbc.M110.114181; Chen YT, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.04C042; Chen YT, 2009, BIOCHEMISTRY-US, V48, P1681, DOI 10.1021/bi802219n; Collingwood TS, 2007, J BIOL CHEM, V282, P30920, DOI 10.1074/jbc.M706870200; Feshchenko EA, 2004, ONCOGENE, V23, P4690, DOI 10.1038/sj.onc.1207627; Gottlin EB, 1996, J BIOL CHEM, V271, P27445, DOI 10.1074/jbc.271.44.27445; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Huang YP, 2004, J BIOL CHEM, V279, P28827, DOI 10.1074/jbc.R400012200; Huang Z, 1999, J BIOMOL SCREEN, V4, P327, DOI 10.1177/108705719900400608; Huston DP, 1997, JAMA-J AM MED ASSOC, V278, P1804, DOI 10.1001/jama.278.22.1804; Jedrzejas MJ, 2000, PROG BIOPHYS MOL BIO, V73, P263, DOI 10.1016/S0079-6107(00)00007-9; Kleinman H, 2006, ACTA CRYSTALLOGR F, V62, P218, DOI 10.1107/S1744309106003320; Kowanetz K, 2004, J BIOL CHEM, V279, P32786, DOI 10.1074/jbc.M403759200; Mikhailik A, 2007, MOL CELL, V27, P486, DOI 10.1016/j.molcel.2007.06.015; Raguz J, 2007, FEBS LETT, V581, P4767, DOI 10.1016/j.febslet.2007.08.077; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Siegel J N, 1991, Semin Immunol, V3, P325; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Tsygankov AY, 2008, IUBMB LIFE, V60, P224, DOI 10.1002/iub.36; Tsygankov AY, 2009, CELL MOL LIFE SCI, V66, P2949, DOI 10.1007/s00018-009-0071-x; Wadham C, 2003, MOL BIOL CELL, V14, P2520, DOI 10.1091/mbc.E02-09-0577; WANG H, 2010, COLD SPRING HARB PER, V2, P1; Wang QP, 1999, BBA-PROTEIN STRUCT M, V1431, P14, DOI 10.1016/S0167-4838(99)00042-4; Wang ZX, 1998, MOL CELL BIOL, V18, P590, DOI 10.1128/MCB.18.1.590	34	44	44	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.177634	http://dx.doi.org/10.1074/jbc.M110.177634			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21393235	Green Published, hybrid			2022-12-25	WOS:000290022800034
J	Xu, B; Zeng, DQ; Wu, YA; Zheng, R; Gu, L; Lin, XA; Hua, XX; Jin, GH				Xu, Bin; Zeng, De-quan; Wu, Yuan; Zheng, Rong; Gu, Le; Lin, Xiao; Hua, Xianxin; Jin, Guang-Hui			Tumor Suppressor Menin Represses Paired Box Gene 2 Expression via Wilms Tumor Suppressor Protein-Polycomb Group Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; KIDNEY DEVELOPMENT; TARGET GENES; ES CELLS; WT1; CANCER; GROWTH; PAX-2; METHYLATION; PROMOTER	Tumor suppressor menin, the product of the MEN1 gene, plays a key role in controlling histone 3 lysine 4 trimethylation (H3K4me3) and gene transcription, which can regulate proliferation, apoptosis, and differentiation. However, little is known as to whether menin controls gene expression and cell proliferation and survival via regulating Polycomb group (PcG) protein complex/H3K27me3. Here we show that menin specifically represses transcription factor Paired box gene 2 (Pax2) through PcG-mediated H3K27me3 and Wilms tumor suppressor protein (WT1), a zinc finger domain-containing DNA-binding protein. Menin does not directly bind to the Pax2 locus, instead, it up-regulates WT1 expression. WT1 recruits PcG complex to the Pax2 promoter and represses expression of Pax2 through PcG-dependent H3K27me3. Moreover, WT1 also interacts with DNA methyltransferase 1 (DNMT1), and recruits DNMT1 to the Pax2 promoter, resulting in hypermethylation of CpG in the Pax2 promoter. Together, these studies have uncovered a novel epigenetic mechanism whereby menin regulates H3K27me3 and promoter DNA methylation via WT1 and suggest that WT1 protein plays an important, yet previously unappreciated role in regulating the function of the menin/PcG axis, H3K27 methylation, and DNA methylation, resulting in repression of gene transcription.	[Xu, Bin; Zeng, De-quan; Wu, Yuan; Zheng, Rong; Gu, Le; Lin, Xiao; Jin, Guang-Hui] Xiamen Univ, Dept Basic Med Sci, Coll Med, Xiamen 361005, Fujian, Peoples R China; [Hua, Xianxin] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA	Xiamen University; University of Pennsylvania	Jin, GH (corresponding author), Daxue Rd 168, Xiamen 361005, Fujian, Peoples R China.	ghjin@xmu.edu.cn			National Natural Science Foundation of China [30701003, 81071926]; Natural Science Foundation of Xiamen [3502Z20104001]; fundamental research funds for the central universities [2010121106]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097555] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Xiamen; fundamental research funds for the central universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Natural Science Foundation of China Grants 30701003 and 81071926 ( to G.-H.J.), Natural Science Foundation of Xiamen Grant 3502Z20104001 ( to G.-H.J.), and fundamental research funds for the central universities grant 2010121106 ( to G.-H.J.).	Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; Feng ZJ, 2010, ONCOGENE, V29, P5416, DOI 10.1038/onc.2010.282; Flock G, 2002, MOL ENDOCRINOL, V16, P2349, DOI 10.1210/me.2002-0149; Gao SB, 2009, ONCOGENE, V28, P4095, DOI 10.1038/onc.2009.273; GERMAN MS, 1992, MOL CELL BIOL, V12, P1777, DOI 10.1128/MCB.12.4.1777; Goode DK, 2009, DEV DYNAM, V238, P2951, DOI 10.1002/dvdy.22146; Hartkamp J, 2010, MOL CELL, V37, P159, DOI 10.1016/j.molcel.2009.12.023; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jin SH, 2010, J CLIN INVEST, V120, P593, DOI 10.1172/JCI38030; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; La P, 2004, ENDOCRINOLOGY, V145, P3443, DOI 10.1210/en.2004-0124; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Metsuyanim S, 2008, STEM CELLS, V26, P1808, DOI 10.1634/stemcells.2007-0322; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; NAKAGAMA H, 1995, MOL CELL BIOL, V15, P1489; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Ritz-Laser B, 2000, J BIOL CHEM, V275, P32708, DOI 10.1074/jbc.M005704200; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; RUPPRECHT HD, 1994, J BIOL CHEM, V269, P6198; RYAN G, 1995, DEVELOPMENT, V121, P867; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Schnepp RW, 2006, CANCER RES, V66, P5707, DOI 10.1158/0008-5472.CAN-05-4518; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Stuart RO, 2001, P NATL ACAD SCI USA, V98, P5649, DOI 10.1073/pnas.091110798; Thakur A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-11; Thiel AT, 2010, CANCER CELL, V17, P148, DOI 10.1016/j.ccr.2009.12.034; Torres M, 1995, DEVELOPMENT, V121, P4057; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wellik DM, 2002, GENE DEV, V16, P1423, DOI 10.1101/gad.993302; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Zaiko M, 2004, EUR J ENDOCRINOL, V150, P389, DOI 10.1530/eje.0.1500389	45	29	29	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13937	13944		10.1074/jbc.M110.197830	http://dx.doi.org/10.1074/jbc.M110.197830			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21378168	Green Published, hybrid			2022-12-25	WOS:000289556200016
J	Erlwein, O; Robinson, MJ; Kaye, S; Wills, G; Izui, S; Wessely, S; Weber, J; Cleare, A; Collier, D; McClure, MO				Erlwein, Otto; Robinson, Mark J.; Kaye, Steve; Wills, Gillian; Izui, Shozo; Wessely, Simon; Weber, Jonathan; Cleare, Anthony; Collier, David; McClure, Myra O.			Investigation into the Presence of and Serological Response to XMRV in CFS Patients	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; MURINE LEUKEMIA-VIRUS; PROSTATE-CANCER; GAMMARETROVIRUS; IDENTIFICATION; PREVALENCE; TUMORS; BLOOD	The novel human gammaretrovirus xenotropic murine leukemia virus-related virus (XMRV), originally described in prostate cancer, has also been implicated in chronic fatigue syndrome (CFS). When later reports failed to confirm the link to CFS, they were often criticised for not using the conditions described in the original study. Here, we revisit our patient cohort to investigate the XMRV status in those patients by means of the original PCR protocol which linked the virus to CFS. In addition, sera from our CFS patients were assayed for the presence of xenotropic virus envelope protein, as well as a serological response to it. The results further strengthen our contention that there is no evidence for an association of XMRV with CFS, at least in the UK.	[Erlwein, Otto; Robinson, Mark J.; Kaye, Steve; Wills, Gillian; Weber, Jonathan; McClure, Myra O.] Univ London Imperial Coll Sci Technol & Med, Jefferiss Res Trust Labs, Infect Dis Sect, Wright Fleming Inst,Fac Med, London, England; [Izui, Shozo] Univ Geneva, Dept Pathol & Immunol, Fac Med, Geneva, Switzerland; [Wessely, Simon; Cleare, Anthony] Kings Coll London, Dept Psychol Med, Inst Psychiat, London WC2R 2LS, England; [Collier, David] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England	Imperial College London; University of Geneva; University of London; King's College London; University of London; King's College London	Erlwein, O (corresponding author), Univ London Imperial Coll Sci Technol & Med, Jefferiss Res Trust Labs, Infect Dis Sect, Wright Fleming Inst,Fac Med, London, England.	m.mcclure@imperial.ac.uk	Cleare, Anthony/AAN-5418-2021; Collier, David A/D-1649-2011; Wessely, Simon C/A-8713-2008	Collier, David A/0000-0003-4087-1559; Wessely, Simon Charles/0000-0002-6743-9929; McClure, Myra/0000-0002-5494-407X	NIHR Biomedical Research Centre; Medical Research Council [G9817803B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10313] Funding Source: researchfish	NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the NIHR Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; D'Arcy F, 2008, EUR UROL SUPPL, V7, P271, DOI 10.1016/S1569-9056(08)60798-8; Danielson BP, 2010, J INFECT DIS, V202, P1470, DOI 10.1086/656146; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; EVANS LH, 1990, J VIROL, V64, P6176, DOI 10.1128/JVI.64.12.6176-6183.1990; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Henrich TJ, 2010, J INFECT DIS, V202, P1478, DOI 10.1086/657168; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; IZUI S, 1983, CLIN EXP IMMUNOL, V71, P45; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Martinez-Fierro ML, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-326; MIKOVITS J, 2010, VIRULENCE, V1, P1; PORTIS JL, 1982, VIROLOGY, V126, P96; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Sharpe M, 1997, GEN HOSP PSYCHIAT, V19, P185, DOI 10.1016/S0163-8343(97)80315-5; STOYE JP, 1987, J VIROL, V61, P2659, DOI 10.1128/JVI.61.9.2659-2669.1987; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJ, BMJ, V340, pc1018; Wilson A, 2001, AUST NZ J PSYCHIAT, V35, P520, DOI 10.1046/j.1440-1614.2001.00888.x	24	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17592	10.1371/journal.pone.0017592	http://dx.doi.org/10.1371/journal.pone.0017592			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408077	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170900029
J	Harrison, JS; Mondor, EB				Harrison, John Scott; Mondor, Edward B.			Evidence for an Invasive Aphid "Superclone": Extremely Low Genetic Diversity in Oleander Aphid (Aphis nerii) Populations in the Southern United States	PLOS ONE			English	Article							GENOTYPIC DIVERSITY; ASEXUAL POPULATIONS; REPRODUCTIVE MODE; SITOBION-AVENAE; GOSSYPII GLOVER; INSECT PEST; F HOMOPTERA; EVOLUTION; LINEAGES; DIFFERENTIATION	Background: The importance of genetic diversity in successful biological invasions is unclear. In animals, but not necessarily plants, increased genetic diversity is generally associated with successful colonization and establishment of novel habitats. The Oleander aphid, Aphis nerii, though native to the Mediterranean region, is an invasive pest species throughout much of the world. Feeding primarily on Oleander (Nerium oleander) and Milkweed (Asclepias spp.) under natural conditions, these plants are unlikely to support aphid populations year round in the southern US. The objective of this study was to describe the genetic variation within and among US populations of A. nerii, during extinction/recolonization events, to better understand the population ecology of this invasive species. Methodology/Principal Findings: We used five microsatellite markers to assess genetic diversity over a two year period within and among three aphid populations separated by small (100 km) and large (3,700 km) geographic distances on two host plant species. Here we provide evidence for A. nerii "superclones". Genotypic variation was absent in all populations (i.e., each population consisted of a single multilocus genotype (MLG) or "clone") and the genetic composition of only one population completely changed across years. There was no evidence of sexual reproduction or host races on different plant species. Conclusions/Significance: Aphis nerii is a well established invasive species despite having extremely low genetic diversity. As this aphid appears to be obligatorily asexual, it may share more similarities with clonally reproducing invasive plants, than with other animals. Patterns of temporal and geographic genetic variation, viewed in the context of its population dynamics, have important implications for the management of invasive pests and the evolutionary biology of asexual species.	[Harrison, John Scott; Mondor, Edward B.] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA	University System of Georgia; Georgia Southern University	Harrison, JS (corresponding author), Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA.	sharrison@georgiasouthern.edu			Georgia Southern University; NSF-STEP [DUE-0622460]	Georgia Southern University; NSF-STEP	This work was supported by Georgia Southern University and Advisement and Scholarship Promoting Inquiry-based Research Experiences in STEM (ASPIRES) funded through NSF-STEP grant (DUE-0622460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlroth P, 2003, OECOLOGIA, V137, P617, DOI 10.1007/s00442-003-1344-y; AKIMOTO S, 1990, OECOLOGIA, V83, P162, DOI 10.1007/BF00317747; Balloux F, 2003, GENETICS, V164, P1635; Blackman R.L., 1984, APHIDS WORLDS CROPS; Brisson JA, 2006, BIOESSAYS, V28, P747, DOI 10.1002/bies.20436; Butlin RK, 2000, TRENDS ECOL EVOL, V15, P389, DOI 10.1016/S0169-5347(00)01937-6; Calabrese PP, 2001, GENETICS, V159, P839; Corrie AM, 2002, HEREDITY, V88, P203, DOI 10.1038/sj.hdy.6800028; De Meeus T, 2006, INFECT GENET EVOL, V6, P163, DOI 10.1016/j.meegid.2005.02.004; Dedryver CA, 2008, B ENTOMOL RES, V98, P159, DOI 10.1017/S0007485307005500; Delmotte F, 2003, EVOLUTION, V57, P1291, DOI 10.1111/j.0014-3820.2003.tb00337.x; Delmotte F, 2002, MOL ECOL, V11, P711, DOI 10.1046/j.1365-294X.2002.01478.x; Fuller SJ, 1999, MOL ECOL, V8, P1867, DOI 10.1046/j.1365-294x.1999.00782.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GROETERS FR, 1989, EVOL ECOL, V3, P327, DOI 10.1007/BF02285263; GROETERS FR, 1989, EVOL ECOL, V3, P313, DOI 10.1007/BF02285262; GROETERS FR, 1993, OECOLOGIA, V93, P406, DOI 10.1007/BF00317885; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Haack L, 2000, MOL ECOL, V9, P2055, DOI 10.1046/j.1365-294X.2000.01108.x; Halkett F, 2008, MOL ECOL, V17, P2998, DOI 10.1111/j.1365-294X.2008.03798.x; HALL RW, 1980, ENVIRON ENTOMOL, V9, P338, DOI 10.1093/ee/9.3.338; Kanbe T, 2009, MOL ECOL, V18, P801, DOI 10.1111/j.1365-294X.2008.04077.x; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Lockwood JL, 2007, INVASION ECOLOGY; LOXDALE HD, 1993, BIOL REV, V68, P291, DOI 10.1111/j.1469-185X.1993.tb00998.x; LOXDALE HD, B ENTOMOLOG IN PRESS, V100, P613; Loxdale H, 2010, ECOL ENTOMOL, V35, DOI 10.1111/j.1365-2311.2009.01151.x; Lushai G, 2003, BIOL J LINN SOC, V79, P193, DOI 10.1046/j.1095-8312.2003.00189.x; Lushai G, 2002, GENET RES, V79, P1, DOI 10.1017/S0016672301009582; LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902; Massonnet B, 2002, MOL ECOL, V11, P2511, DOI 10.1046/j.1365-294X.2002.01633.x; Meselson M, 2007, SCIENCE, V318, P202, DOI 10.1126/science.1150197; Michel AP, 2009, ENVIRON ENTOMOL, V38, P1301, DOI 10.1603/022.038.0442; Miller NJ, 2005, HEREDITY, V94, P556, DOI 10.1038/sj.hdy.6800658; Muller C, 2004, BIOL J LINN SOC, V83, P219, DOI 10.1111/j.1095-8312.2004.00383.x; Peccoud J, 2008, MOL ECOL, V17, P4608, DOI 10.1111/j.1365-294X.2008.03949.x; PORTER SD, 1990, ECOLOGY, V71, P2095, DOI 10.2307/1938623; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; Ruiz-Montoya L, 2003, HEREDITY, V91, P415, DOI 10.1038/sj.hdy.6800338; SHRIVER MD, 1995, MOL BIOL EVOL, V12, P914; Simon JC, 2002, TRENDS ECOL EVOL, V17, P34, DOI 10.1016/S0169-5347(01)02331-X; Simon JC, 1999, MOL ECOL, V8, P531, DOI 10.1046/j.1365-294x.1999.00583.x; Simon JC, 2010, CR BIOL, V333, P488, DOI 10.1016/j.crvi.2010.03.003; STODDART JA, 1988, GENETICS, V118, P705; STOETZEL MB, 1990, FLA ENTOMOL, V73, P580, DOI 10.2307/3495272; Sunnucks P, 1997, MOL ECOL, V6, P1059, DOI 10.1046/j.1365-294X.1997.00280.x; TAKADA H, 1993, APPL ENTOMOL ZOOL, V28, P199, DOI 10.1303/aez.28.199; TAKADA H, 1992, APPL ENTOMOL ZOOL, V27, P117, DOI 10.1303/aez.27.117; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vanlerberghe-Masutti F, 1998, MOL ECOL, V7, P905, DOI 10.1046/j.1365-294x.1998.00421.x; Vanlerberghe-Masutti F, 1999, MOL ECOL, V8, P693, DOI 10.1046/j.1365-294x.1999.00876.x; Via S, 2002, AM NAT, V159, pS76, DOI 10.1086/338374; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; Vialatte A, 2005, P ROY SOC B-BIOL SCI, V272, P1075, DOI 10.1098/rspb.2004.3033; Vorburger C, 2006, J EVOLUTION BIOL, V19, P97, DOI 10.1111/j.1420-9101.2005.00985.x; Vorburger C, 2003, MOL ECOL, V12, P3493, DOI 10.1046/j.1365-294X.2003.01998.x; Ward SM, 2008, INVAS PLANT SCI MANA, V1, P98, DOI 10.1614/IPSM-07-022.1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Wilson ACC, 2003, BIOL J LINN SOC, V79, P115, DOI 10.1046/j.1095-8312.2003.00176.x	60	46	46	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17524	10.1371/journal.pone.0017524	http://dx.doi.org/10.1371/journal.pone.0017524			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408073	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170900025
J	Gopal, U; Bohonowych, JE; Lema-Tome, C; Liu, A; Garrett-Mayer, E; Wang, BC; Isaacs, JS				Gopal, Udhayakumar; Bohonowych, Jessica E.; Lema-Tome, Carla; Liu, Angen; Garrett-Mayer, Elizabeth; Wang, Bingcheng; Isaacs, Jennifer S.			A Novel Extracellular Hsp90 Mediated Co-Receptor Function for LRP1 Regulates EphA2 Dependent Glioblastoma Cell Invasion	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; GENE-EXPRESSION; MIGRATION; ACTIVATION; HYPOXIA; AKT; HSP90-ALPHA; MOTILITY; KINASE; DOMAIN	Background: Extracellular Hsp90 protein (eHsp90) potentiates cancer cell motility and invasion through a poorly understood mechanism involving ligand mediated function with its cognate receptor LRP1. Glioblastoma multiforme (GBM) represents one of the most aggressive and lethal brain cancers. The receptor tyrosine kinase EphA2 is overexpressed in the majority of GBM specimens and is a critical mediator of GBM invasiveness through its AKT dependent activation of EphA2 at S897 (P-EphA2(S897)). We explored whether eHsp90 may confer invasive properties to GBM via regulation of EphA2 mediated signaling. Principal Findings: We find that eHsp90 signaling is essential for sustaining AKT activation, P-EphA2(S897), lamellipodia formation, and concomitant GBM cell motility and invasion. Furthermore, eHsp90 promotes the recruitment of LRP1 to EphA2 in an AKT dependent manner. A finding supported by biochemical methodology and the dual expression of LRP1 and P-EphA2(S897) in primary and recurrent GBM tumor specimens. Moreover, hypoxia mediated facilitation of GBM motility and invasion is dependent upon eHsp90-LRP1 signaling. Hypoxia dramatically elevated surface expression of both eHsp90 and LRP1, concomitant with eHsp90 dependent activation of src, AKT, and EphA2. Significance: We herein demonstrate a novel crosstalk mechanism involving eHsp90-LRP1 dependent regulation of EphA2 function. We highlight a dual role for eHsp90 in transducing signaling via LRP1, and in facilitating LRP1 co-receptor function for EphA2. Taken together, our results demonstrate activation of the eHsp90-LRP1 signaling axis as an obligate step in the initiation and maintenance of AKT signaling and EphA2 activation, thereby implicating this pathway as an integral component contributing to the aggressive nature of GBM.	[Gopal, Udhayakumar; Bohonowych, Jessica E.; Isaacs, Jennifer S.] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA; [Lema-Tome, Carla] Wake Forest Univ, Brain Tumor Ctr Excellence, Winston Salem, NC 27109 USA; [Liu, Angen] Med Univ S Carolina, Hollings Canc Ctr Tissue Biorepository, Charleston, SC 29425 USA; [Garrett-Mayer, Elizabeth] Med Univ S Carolina, Div Biostat & Epidemiol, Charleston, SC 29425 USA; [Wang, Bingcheng] Case Western Reserve Univ, Metrohlth Med Ctr, Rammelkamp Ctr Res, Cleveland, OH USA; [Wang, Bingcheng] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Medical University of South Carolina; Wake Forest University; Medical University of South Carolina; Medical University of South Carolina; Case Western Reserve University; MetroHealth System; Case Western Reserve University	Gopal, U (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA.	isaacsj@musc.edu	Gopal, Udhayakumar/K-9092-2019	gopal, Udhayakumar/0000-0003-2110-0601; Garrett-Mayer, Elizabeth/0000-0003-4709-0333	institutional startup funds; American Cancer Society [IRG-97-219-05]; National Cancer Institute [CA13795-01]; NATIONAL CANCER INSTITUTE [R01CA135297, R01CA152371] Funding Source: NIH RePORTER	institutional startup funds; American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by institutional startup funds, the American Cancer Society (IRG-97-219-05), and the National Cancer Institute (CA13795-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annamalai B, 2009, MOL CANCER RES, V7, P1021, DOI 10.1158/1541-7786.MCR-08-0582; Basso AD, 2002, ONCOGENE, V21, P1159, DOI 10.1038/sj.onc.1205184; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; Bohonowych JE, 2010, J ONCOL, V2010, DOI 10.1155/2010/412985; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; CHEN JS, 2010, J BIOL CHEM; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Drappatz J, 2009, EXPERT REV NEUROTHER, V9, P519, DOI [10.1586/ern.09.10, 10.1586/ERN.09.10]; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Glas M, 2010, ANN NEUROL, V68, P264, DOI 10.1002/ana.22036; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Isaacs JS, 2005, EXPERT OPIN INV DRUG, V14, P569, DOI 10.1517/13543784.14.6.569; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; LOPES MBS, 1994, FEBS LETT, V338, P301, DOI 10.1016/0014-5793(94)80288-2; Luo LY, 2002, BRIT J CANCER, V87, P339, DOI 10.1038/sj.bjc.6600439; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Montel V, 2007, CANCER RES, V67, P9817, DOI 10.1158/0008-5472.CAN-07-0683; Oliver L, 2009, Curr Mol Pharmacol, V2, P263; Parri M, 2007, J BIOL CHEM, V282, P19619, DOI 10.1074/jbc.M701319200; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Qin Z, 2010, VIROLOGY, V403, P92, DOI 10.1016/j.virol.2010.03.052; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Song H, 2009, CANCER RES, V69, P879, DOI 10.1158/0008-5472.CAN-08-3379; Stellas D, 2007, CLIN CANCER RES, V13, P1831, DOI 10.1158/1078-0432.CCR-06-1585; Stellas D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-51; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; ULLRICH SJ, 1986, P NATL ACAD SCI USA, V83, P3121, DOI 10.1073/pnas.83.10.3121; Wang LF, 2008, ONCOL REP, V19, P151; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Weaver AM, 1997, J BIOL CHEM, V272, P14372, DOI 10.1074/jbc.272.22.14372; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Woodley DT, 2009, J CELL SCI, V122, P1495, DOI 10.1242/jcs.047894; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Wykosky J, 2008, CLIN CANCER RES, V14, P199, DOI 10.1158/1078-0432.CCR-07-1990; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Yang NY, 2011, CELL SIGNAL, V23, P201, DOI 10.1016/j.cellsig.2010.09.004; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W	48	97	106	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17649	10.1371/journal.pone.0017649	http://dx.doi.org/10.1371/journal.pone.0017649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408136	gold, Green Submitted, Green Published			2022-12-25	WOS:000288170000050
J	Mollema, NJ; Yuan, Y; Jelcick, AS; Sachs, AJ; von Alpen, D; Schorderet, D; Escher, P; Haider, NB				Mollema, Nissa J.; Yuan, Yang; Jelcick, Austin S.; Sachs, Andrew J.; von Alpen, Desiree; Schorderet, Daniel; Escher, Pascal; Haider, Neena B.			Nuclear Receptor Rev-erb Alpha (Nr1d1) Functions in Concert with Nr2e3 to Regulate Transcriptional Networks in the Retina	PLOS ONE			English	Article							GOLDMANN-FAVRE-SYNDROME; S-CONE SYNDROME; THYROID-HORMONE RECEPTOR; DEVELOPING MOUSE RETINA; PHOTORECEPTOR DEVELOPMENT; REPRESSES TRANSCRIPTION; RESPONSE ELEMENT; CIRCADIAN CLOCK; GENE; DEGENERATION	The majority of diseases in the retina are caused by genetic mutations affecting the development and function of photoreceptor cells. The transcriptional networks directing these processes are regulated by genes such as nuclear hormone receptors. The nuclear hormone receptor gene Rev-erb alpha/Nr1d1 has been widely studied for its role in the circadian cycle and cell metabolism, however its role in the retina is unknown. In order to understand the role of Rev-erb alpha/Nr1d1 in the retina, we evaluated the effects of loss of Nr1d1 to the developing retina and its co-regulation with the photoreceptor-specific nuclear receptor gene Nr2e3 in the developing and mature retina. Knock-down of Nr1d1 expression in the developing retina results in pan-retinal spotting and reduced retinal function by electroretinogram. Our studies show that NR1D1 protein is co-expressed with NR2E3 in the outer neuroblastic layer of the developing mouse retina. In the adult retina, NR1D1 is expressed in the ganglion cell layer and is co-expressed with NR2E3 in the outer nuclear layer, within rods and cones. Several genes co-targeted by NR2E3 and NR1D1 were identified that include: Nr2c1, Recoverin, Rgr, Rarres2, Pde8a, and Nupr1. We examined the cyclic expression of Nr1d1 and Nr2e3 over a twenty-four hour period and observed that both nuclear receptors cycle in a similar manner. Taken together, these studies reveal a novel role for Nr1d1, in conjunction with its cofactor Nr2e3, in regulating transcriptional networks critical for photoreceptor development and function.	[Mollema, Nissa J.; Yuan, Yang; Jelcick, Austin S.; Sachs, Andrew J.; Haider, Neena B.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [von Alpen, Desiree; Schorderet, Daniel; Escher, Pascal] Inst Res Opthalmol, Dept Ophthalmol, Sion, Switzerland; [von Alpen, Desiree; Schorderet, Daniel; Escher, Pascal] Univ Lausanne, Dept Ophthalmol, Lausanne, Switzerland; [Schorderet, Daniel] Ecole Polytech Fed Lausanne, Dept Ophthalmol, Lausanne, Switzerland; [Haider, Neena B.] Univ Nebraska Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Nebraska System; University of Nebraska Medical Center	Mollema, NJ (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.	nhaider@unmc.edu			National Institutes of Health [EY017653, 5P20 RR018788-02]; Hope for Vision; Swiss National Foundation [3100A0-122269/1]; Gottfried-und-Julia-Bangerter-Rhyner-Stiftung; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018788] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Vision; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Gottfried-und-Julia-Bangerter-Rhyner-Stiftung; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants EY017653 and 5P20 RR018788-02 (NBH), Hope for Vision (NBH), The Swiss National Foundation Grant (3100A0-122269/1 PE, DFS), and the Gottfried-und-Julia-Bangerter-Rhyner-Stiftung Grant (PE, DFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; Bandah D, 2009, ARCH OPHTHALMOL-CHIC, V127, P297, DOI 10.1001/archophthalmol.2008.615; Bernal S, 2008, CLIN GENET, V73, P360, DOI 10.1111/j.1399-0004.2008.00963.x; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Chavala SH, 2005, BRIT J OPHTHALMOL, V89, P1065, DOI 10.1136/bjo.2005.068130; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Coppieters F, 2007, AM J HUM GENET, V81, P147, DOI 10.1086/518426; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Donovan SL, 2006, NAT PROTOC, V1, P2710, DOI 10.1038/nprot.2006.454; Egea PF, 2000, FEBS LETT, V476, P62, DOI 10.1016/S0014-5793(00)01672-0; Escher P, 2009, HUM MUTAT, V30, P342, DOI 10.1002/humu.20858; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; FULLER PJ, 1991, FASEB J, V5, P3092, DOI 10.1096/fasebj.5.15.1743440; Gervois P, 1999, MOL ENDOCRINOL, V13, P400, DOI 10.1210/me.13.3.400; Gofflot F, 2007, CELL, V131, P405, DOI 10.1016/j.cell.2007.09.012; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Haider NB, 2008, MAMM GENOME, V19, P145, DOI 10.1007/s00335-008-9092-2; Haider NB, 2006, VISUAL NEUROSCI, V23, P917, DOI 10.1017/S095252380623027X; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Jacobson SG, 2004, HUM MOL GENET, V13, P1893, DOI 10.1093/hmg/ddh198; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Jones G, 1999, J NEUROSCI, V19, P3376; Kachi S, 2005, GENE THER, V12, P843, DOI 10.1038/sj.gt.3302475; Laitinen S, 2005, BIOCHIMIE, V87, P21, DOI 10.1016/j.biochi.2004.12.006; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; Liu H, 2008, J NEUROSCI, V28, P749, DOI 10.1523/JNEUROSCI.4832-07.2008; Marmor MF, 2006, DOC OPHTHALMOL, V113, P213, DOI 10.1007/s10633-006-9031-z; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Onishi A, 2010, P NATL ACAD SCI USA, V107, P11579, DOI 10.1073/pnas.1000102107; Pachydaki SI, 2009, ARCH OPHTHALMOL-CHIC, V127, P71, DOI 10.1001/archophthalmol.2008.534; Peng GH, 2005, VISUAL NEUROSCI, V22, P575, DOI 10.1017/S0952523805225063; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Pircher P, 2005, AM J PHYSIOL-REG I, V288, pR482, DOI 10.1152/ajpregu.00690.2003; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; Sharon D, 2003, ARCH OPHTHALMOL-CHIC, V121, P1316, DOI 10.1001/archopht.121.9.1316; SPANJAARD RA, 1994, MOL ENDOCRINOL, V8, P286, DOI 10.1210/me.8.3.286; Srinivas M, 2006, MOL ENDOCRINOL, V20, P1728, DOI 10.1210/me.2005-0505; Takezawa S, 2007, EMBO J, V26, P764, DOI 10.1038/sj.emboj.7601548; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Wright Alan F, 2004, Hum Mutat, V24, P439, DOI 10.1002/humu.9285; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	50	51	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17494	10.1371/journal.pone.0017494	http://dx.doi.org/10.1371/journal.pone.0017494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408158	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170000034
J	Noel, G; Stevenson, S; Moukhles, H				Noel, Geoffroy; Stevenson, Sarah; Moukhles, Hakima			A High Throughput Screen Identifies Chemical Modulators of the Laminin-Induced Clustering of Dystroglycan and Aquaporin-4 in Primary Astrocytes	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; DYSTROPHIN-ASSOCIATED GLYCOPROTEIN; FOCAL CEREBRAL-ISCHEMIA; WATER TRANSPORT; BETA-DYSTROGLYCAN; MATRIX METALLOPROTEINASES; ALPHA-SYNTROPHIN; TRANSGENIC MICE; GLIAL-CELLS; RAT-BRAIN	Background: Aquaporin-4 (AQP4) constitutes the principal water channel in the brain and is clusteredat the perivascular astrocyte endfeet. This specific distribution of AQP4 plays a major role in maintaining water homeostasis in the brain. A growing body of evidence points to a role ofthe dystroglycan complex and its interaction with perivascular laminin in the clusteringof AQP4 atperivascular astrocyte endfeet. Indeed, mice lacking components of this complex or in which laminin-dystroglycan interaction is disrupted show a delayed onset of brain edema due to a redistribution of AQP4 away from astrocyte endfeet. It is therefore important to identify inhibitory drugs of laminin-dependent AQP4 clustering which may prevent or reduce brain edema. Methodolgy/Principal Findings: In the present study we used primary rat astrocyte cultures toscreen a library of > 3,500 chemicals and identified 6 drugs that inhibit the laminin-induced clustering of dystroglycan and AQP4. Detailed analysis of the inhibitory drug, chloranil, revealed that its inhibition of the clustering is due to the metalloproteinase-2-mediated beta-dystroglycan shedding and subsequent loss of laminin interaction with dystroglycan. Furthermore, chemical variants of chloranil induced a similar effect on beta-dystroglycan and this was prevented by the antioxidant N-acetylcysteine. Conclusion/Significance: These findings reveal the mechanism of action of chloranil in preventing the laminin-induced clustering of dystroglycan and AQP4 and validate the use of high-throughput screening as a tool to identify drugs that modulate AQP4 clustering and that could be tested in models of brain edema.	[Noel, Geoffroy; Stevenson, Sarah; Moukhles, Hakima] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Noel, G (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	moukhles@interchange.ubc.ca		Noel, Geoffroy/0000-0003-2192-7756	Canadian Institutes of Health Research (CIHR); Muscular Dystrophy Canada (MDC); Amyotrophic Lateral Sclerosis (ALS) Society of Canada; University Graduate Fellowship; Edward Squires Memorial Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Canada (MDC); Amyotrophic Lateral Sclerosis (ALS) Society of Canada; University Graduate Fellowship; Edward Squires Memorial Scholarship	This work was supported by grants from the Canadian Institutes of Health Research (CIHR), Muscular Dystrophy Canada (MDC), Amyotrophic Lateral Sclerosis (ALS) Society of Canada to H. M., and a University Graduate Fellowship and Edward Squires Memorial Scholarship to GN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIKO H, 1988, Neurological Research, V10, P145; Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Bloch O, 2006, J CEREBR BLOOD F MET, V26, P1527, DOI 10.1038/sj.jcbfm.9600306; Bragg AD, 2006, GLIA, V53, P879, DOI 10.1002/glia.20347; Dahlhaus M, 1996, ARCH TOXICOL, V70, P457, DOI 10.1007/s002040050299; Detmers FJM, 2006, J BIOL CHEM, V281, P14207, DOI 10.1074/jbc.M513072200; Dibas A, 2008, MOL VIS, V14, P1770; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feng XC, 2009, J NEUROSCI RES, V87, P1150, DOI 10.1002/jnr.21927; Fischer R, 1997, GLIA, V20, P51; Fisher JF, 2006, CANCER METAST REV, V25, P115, DOI 10.1007/s10555-006-7894-9; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; GEE SH, 1993, J BIOL CHEM, V268, P14972; Guadagno E, 2004, GLIA, V47, P138, DOI 10.1002/glia.20039; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; Haorah J, 2007, J NEUROCHEM, V101, P566, DOI 10.1111/j.1471-4159.2006.04393.x; HARTMANN A, 1986, EUR NEUROL, V25, P7, DOI 10.1159/000116058; Huber VJ, 2007, BIOORG MED CHEM LETT, V17, P1270, DOI 10.1016/j.bmcl.2006.12.010; Huber VJ, 2009, BIOORGAN MED CHEM, V17, P418, DOI 10.1016/j.bmc.2007.12.038; Huber VJ, 2009, BIOORGAN MED CHEM, V17, P425, DOI 10.1016/j.bmc.2008.12.013; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Kim SR, 2001, TOXICOL SCI, V62, P176, DOI 10.1093/toxsci/62.1.176; KIMLEE MH, 1992, GLIA, V5, P56, DOI 10.1002/glia.440050109; Lafleur Marc A, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006628; Leonardo CC, 2009, NEUROSCIENCE, V160, P755, DOI 10.1016/j.neuroscience.2009.02.080; Leone L, 2005, J NEUROPATH EXP NEUR, V64, P1007, DOI 10.1097/01.jnen.0000187053.59018.3c; LEYBAERT L, 1994, EXP BRAIN RES, V100, P369, DOI 10.1007/BF02738397; Li Zheng, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010045; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; MAKINEN PL, 1988, BIOCHEM BIOPH RES CO, V153, P74, DOI 10.1016/S0006-291X(88)81191-4; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Mehler MF, 2000, BRAIN RES REV, V32, P277, DOI 10.1016/S0165-0173(99)00090-9; Meli DN, 2003, J INFECT DIS, V187, P1411, DOI 10.1086/374644; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Milner R, 2008, J CEREBR BLOOD F MET, V28, P812, DOI 10.1038/sj.jcbfm.9600585; Mola MG, 2009, ANAL CHEM, V81, P8219, DOI 10.1021/ac901526k; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Nico B, 2003, GLIA, V42, P235, DOI 10.1002/glia.10216; Nielsen S, 1997, J NEUROSCI, V17, P171; Noel G, 2009, J BIOL CHEM, V284, P19694, DOI 10.1074/jbc.M109.010090; Paggi P, 2006, J PHYSIOL-PARIS, V99, P119, DOI 10.1016/j.jphysparis.2005.12.004; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Peng HB, 1998, CELL ADHES COMMUN, V5, P475, DOI 10.3109/15419069809005605; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Rurak J, 2007, J NEUROCHEM, V103, P1940, DOI 10.1111/j.1471-4159.2007.04886.x; Singh J, 2004, CANCER RES, V64, P6152, DOI 10.1158/0008-5472.CAN-04-1638; Siraki AG, 2004, TOXICOL SCI, V81, P148, DOI 10.1093/toxsci/kfh182; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Tait MJ, 2010, NEUROSCIENCE, V167, P60, DOI 10.1016/j.neuroscience.2010.01.053; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; Vajda Z, 2000, BIOCHEM BIOPH RES CO, V270, P495, DOI 10.1006/bbrc.2000.2472; Vajda Z, 2002, P NATL ACAD SCI USA, V99, P13131, DOI 10.1073/pnas.192457099; WORTON R, 1995, SCIENCE, V270, P755, DOI 10.1126/science.270.5237.755; Yamada H, 2001, HUM MOL GENET, V10, P1563, DOI 10.1093/hmg/10.15.1563; Yang BX, 2008, BIOORGAN MED CHEM, V16, P7489, DOI 10.1016/j.bmc.2008.06.005; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200; Zhong D, 2006, BIOCHEM BIOPH RES CO, V345, P867, DOI 10.1016/j.bbrc.2006.05.004; Zumkeller M, 1996, NEUROSURG REV, V19, P253, DOI 10.1007/BF00314841	65	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17559	10.1371/journal.pone.0017559	http://dx.doi.org/10.1371/journal.pone.0017559			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408176	Green Published, Green Submitted, gold			2022-12-25	WOS:000288099800024
J	Peng, HM; Wen, JG; Li, HW; Chang, J; Zhou, XB				Peng, Huiming; Wen, Jianguo; Li, Hongwei; Chang, Jeff; Zhou, Xiaobo			Drug Inhibition Profile Prediction for NF kappa B Pathway in Multiple Myeloma	PLOS ONE			English	Article							PATHOGENESIS; COMBINATIONS	Nuclear factor kappa B (NF kappa B) activation plays a crucial role in anti-apoptotic responses in response to the apoptotic signaling during tumor necrosis factor (TNF alpha) stimulation in Multiple Myeloma (MM). Although several drugs have been found effective for the treatment of MM by mainly inhibiting NF kappa B pathway, there are not any quantitative or qualitative results of comparison assessment on inhibition effect between different drugs either used alone or in combinations. Computational modeling is becoming increasingly indispensable for applied biological research mainly because it can provide strong quantitative predicting power. In this study, a novel computational pathway modeling approach is employed to comparably assess the inhibition effects of specific drugs used alone or in combinations on the NF kappa B pathway in MM and to predict the potential synergistic drug combinations.	[Peng, Huiming; Zhou, Xiaobo] Methodist Hosp, Res Inst, Dept Radiol, Houston, TX 77030 USA; [Peng, Huiming; Wen, Jianguo; Chang, Jeff; Zhou, Xiaobo] Weill Cornell Med Coll, Houston, TX USA; [Peng, Huiming; Li, Hongwei] China Univ Geosci, Sch Math & Phys, Wuhan 430074, Peoples R China; [Wen, Jianguo; Chang, Jeff] Methodist Hosp, Res Inst, Dept Pathol, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; China University of Geosciences; The Methodist Hospital System; The Methodist Hospital - Houston	Peng, HM (corresponding author), Methodist Hosp, Res Inst, Dept Radiol, 6535 Fannin, Houston, TX 77030 USA.	XZhou@tmhs.org	Peng, Huiming/D-1184-2011		NIH [1R01LM010185-01]; Institute for Biomedical Imaging Sciences - IBIS foundation; NATIONAL LIBRARY OF MEDICINE [R01LM010185] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Biomedical Imaging Sciences - IBIS foundation; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work is funded by NIH 1R01LM010185-01 (Zhou & Chang) and The Institute for Biomedical Imaging Sciences - IBIS foundation (Zhou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Calzolari D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000249; Faratian D, 2009, CANCER RES, V69, P6713, DOI 10.1158/0008-5472.CAN-09-0777; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Goryanin I, 2004, METABOLIC ENGINEERING IN THE POST GENOMIC ERA, P321; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hideshima T, 2001, ONCOGENE, V20, P4519, DOI 10.1038/sj.onc.1204623; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; HOOKE R, 1961, J ASSOC COMPUT MACH, V8, P221; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Kumar N, 2008, MOL PHARMACOL, V73, P1668, DOI 10.1124/mol.107.043794; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Li ZW, 2008, CURR OPIN HEMATOL, V15, P391, DOI 10.1097/MOH.0b013e328302c7f4; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; Moehren G, 2002, BIOCHEMISTRY-US, V41, P306, DOI 10.1021/bi011506c; Park SG, 2006, FEBS LETT, V580, P822, DOI 10.1016/j.febslet.2006.01.004; Schilling M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.91; Smith A, 2002, NATURE, V418, P453, DOI 10.1038/418453a; Sung MH, 2004, MOL PHARMACOL, V66, P70, DOI 10.1124/mol.66.1.70; van de Donk NWCJ, 2005, LEUKEMIA, V19, P2177, DOI 10.1038/sj.leu.2403970; Weinberg R, 2007, BIOL CANC GARLAND SC; Wen JG, 2008, BRIT J HAEMATOL, V140, P169, DOI 10.1111/j.1365-2141.2007.06895.x; Wen JG, 2010, LEUKEMIA RES, V34, P85, DOI 10.1016/j.leukres.2009.05.024; Younes H, 2007, CLIN CANCER RES, V13, P3771, DOI 10.1158/1078-0432.CCR-06-2921; YOUNG M, 2008, PREDICTION ATTRACTIO; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008; Zinner RG, 2009, MOL CANCER THER, V8, P521, DOI 10.1158/1535-7163.MCT-08-0937	28	81	82	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e14750	10.1371/journal.pone.0014750	http://dx.doi.org/10.1371/journal.pone.0014750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408099	Green Published, gold, Green Submitted			2022-12-25	WOS:000288099800001
J	Jaszai, J; Fargeas, CA; Graupner, S; Tanaka, EM; Brand, M; Huttner, WB; Corbeil, D				Jaszai, Jozsef; Fargeas, Christine A.; Graupner, Sylvi; Tanaka, Elly M.; Brand, Michael; Huttner, Wieland B.; Corbeil, Denis			Distinct and Conserved Prominin-1/CD133-Positive Retinal Cell Populations Identified across Species	PLOS ONE			English	Article							PLASMA-MEMBRANE PROTRUSIONS; PROMININ-1 CD133; HEMATOPOIETIC STEM; RETINITIS-PIGMENTOSA; SPLICE VARIANTS; NEURAL REGENERATION; FRAMESHIFT MUTATION; DISK MORPHOGENESIS; EPITHELIAL-CELLS; BINDING PROTEIN	Besides being a marker of various somatic stem cells in mammals, prominin-1 (CD133) plays a role in maintaining the photoreceptor integrity since mutations in the PROM1 gene are linked with retinal degeneration. In spite of that, little information is available regarding its distribution in eyes of non-mammalian vertebrates endowed with high regenerative abilities. To address this subject, prominin-1 cognates were isolated from axolotl, zebrafish and chicken, and their retinal compartmentalization was investigated and compared to that of their mammalian orthologue. Interestingly, prominin-1 transcripts-except for the axolotl-were not strictly restricted to the outer nuclear layer (i. e., photoreceptor cells), but they also marked distinct subdivisions of the inner nuclear layer (INL). In zebrafish, where the prominin-1 gene is duplicated (i. e., prominin-1a and prominin-1b), a differential expression was noted for both paralogues within the INL being localized either to its vitreal or scleral subdivision, respectively. Interestingly, expression of prominin-1a within the former domain coincided with Pax-6-positive cells that are known to act as progenitors upon injury-induced retino-neurogenesis. A similar, but minute population of prominin-1-positive cells located at the vitreal side of the INL was also detected in developing and adult mice. In chicken, however, prominin-1-positive cells appeared to be aligned along the scleral side of the INL reminiscent of zebrafish prominin-1b. Taken together our data indicate that in addition to conserved expression of prominin-1 in photoreceptors, significant prominin-1-expressing non-photoreceptor retinal cell populations are present in the vertebrate eye that might represent potential sources of stem/progenitor cells for regenerative therapies.	[Jaszai, Jozsef; Fargeas, Christine A.; Graupner, Sylvi; Corbeil, Denis] Tech Univ Dresden, Tissue Engn Labs BIOTEC, Dresden, Germany; [Tanaka, Elly M.; Brand, Michael; Corbeil, Denis] Tech Univ Dresden, DFG Res Ctr & Cluster Excellence Regenerat Therap, Dresden, Germany; [Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Max Planck Society	Jaszai, J (corresponding author), Tech Univ Dresden, Tissue Engn Labs BIOTEC, Dresden, Germany.	jozsef.jaszai@biotec.tu-dresden.de; corbeil@biotec.tu-dresden.de	Huttner, Wieland B./P-4080-2018; Corbeil, Denis/AFL-1008-2022; Corbeil, Denis/L-2340-2019; Tanaka, Elly M/F-8572-2010; Corbeil, Denis/A-6519-2010; Brand, Michael/A-5509-2010	Corbeil, Denis/0000-0003-1181-3659; Brand, Michael/0000-0001-5711-6512	Medical Faculty of Technische Universitat Dresden; Deutsche Forschungsgemeinschaft (DFG) [2006, 2008, CO298/5-1]	Medical Faculty of Technische Universitat Dresden; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Intramural funds of the Medical Faculty of Technische Universitat Dresden and Deutsche Forschungsgemeinschaft (DFG) supported J.J. (MeDDrive grants 2006 and 2008 and CO298/5-1, respectively). The DFG supported M. B. (SFB655 A3), E. M. T (SFB655 A4), W. B. H. (SFB655 A2; TRR83 #6) and D. C. (SFB655 B3; TRR83 #6 and CO298/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JJ, 2007, NAT MED, V13, P685, DOI 10.1038/nm1596; APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Bartsch U, 2008, EXP EYE RES, V86, P691, DOI 10.1016/j.exer.2008.01.018; Bauer N, 2008, CELLS TISSUES ORGANS, V188, P127, DOI 10.1159/000112847; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Brand Michael, 2002, P7; Carter DA, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-1; Corbeil D, 2001, BIOCHEM BIOPH RES CO, V285, P939, DOI 10.1006/bbrc.2001.5271; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Corbeil D, 2010, FEBS LETT, V584, P1659, DOI 10.1016/j.febslet.2010.01.050; Corbeil D, 2009, GLIA, V57, P860, DOI 10.1002/glia.20812; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Ernsberger U, 1997, MECH DEVELOP, V68, P115, DOI 10.1016/S0925-4773(97)00135-4; Fargeas CA, 2007, TISSUE ANTIGENS, V69, P602, DOI 10.1111/j.1399-0039.2007.00825.x; Fargeas CA, 2004, J CELL SCI, V117, P4301, DOI 10.1242/jcs.01315; Fargeas CA, 2003, STEM CELLS, V21, P506, DOI 10.1634/stemcells.21-4-506; Fargeas CA, 2003, J BIOL CHEM, V278, P8586, DOI 10.1074/jbc.M210640200; Fargeas CA, 2006, FUTURE LIPIDOL, V1, P213, DOI 10.2217/17460875.1.2.213; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Filoni S, 2009, SEMIN CELL DEV BIOL, V20, P528, DOI 10.1016/j.semcdb.2008.11.015; Fischer AJ, 2005, PROG RETIN EYE RES, V24, P161, DOI 10.1016/j.preteyeres.2004.07.003; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; HALDER G, 1995, CURR OPIN GENET DEV, V5, P602, DOI 10.1016/0959-437X(95)80029-8; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; Henderson RH, 2010, MOL VIS, V16, P46; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; Jaszai J, 2007, EXP EYE RES, V85, P585, DOI 10.1016/j.exer.2006.03.022; Jaszai J, 2007, HISTOCHEM CELL BIOL, V128, P409, DOI 10.1007/s00418-007-0334-2; JOHNS PR, 1981, NATURE, V293, P141, DOI 10.1038/293141a0; Jovelin R, 2007, J EXP ZOOL PART B, V308B, P730, DOI 10.1002/jez.b.21193; Kaneko J, 2009, NEUROSCI LETT, V450, P252, DOI 10.1016/j.neulet.2008.11.031; Kania G, 2005, STEM CELLS, V23, P791, DOI 10.1634/stemcells.2004-0232; Karbanova J, 2008, J HISTOCHEM CYTOCHEM, V56, P977, DOI 10.1369/jhc.2008.951897; Kemper K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012325; Leung YF, 2005, ZEBRAFISH, V2, P269, DOI 10.1089/zeb.2005.2.269; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; McGrail M, 2010, DEV DYNAM, V239, P1849, DOI 10.1002/dvdy.22307; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Moshiri A, 2004, INT J DEV BIOL, V48, P1003, DOI 10.1387/ijdb.041870am; Nornes S, 1998, MECH DEVELOP, V77, P185, DOI 10.1016/S0925-4773(98)00156-7; Otteson DC, 2003, VISION RES, V43, P927, DOI 10.1016/S0042-6989(02)00400-5; Permanyer J, 2010, INVEST OPHTH VIS SCI, V51, P2656, DOI 10.1167/iovs.09-4857; Pras E, 2009, MOL VIS, V15, P1709; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Rattner A, 2004, J BIOL CHEM, V279, P42202, DOI 10.1074/jbc.M407928200; RAYMOND PA, 1993, NEURON, V10, P1161, DOI 10.1016/0896-6273(93)90064-X; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Rohlich P, 2000, MICROSC RES TECHNIQ, V50, P327; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Schnapp E, 2005, DEVELOPMENT, V132, P3243, DOI 10.1242/dev.01906; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Stenkamp DL, 1997, J COMP NEUROL, V382, P272, DOI 10.1002/(SICI)1096-9861(19970602)382:2<272::AID-CNE10>3.0.CO;2-U; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Susaki K, 2009, EXP EYE RES, V88, P347, DOI 10.1016/j.exer.2008.06.019; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Westerfield M, 1994, ZEBRAFISH BOOK; WETTS R, 1989, DEV BIOL, V136, P254, DOI 10.1016/0012-1606(89)90146-2; Yang XH, 2004, SEMIN CELL DEV BIOL, V15, P91, DOI 10.1016/j.semcdb.2003.09.004; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yu Y, 2002, J BIOL CHEM, V277, P20711, DOI 10.1074/jbc.M202349200; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128; Zhang J, 2009, VISION RES, V49, P64, DOI 10.1016/j.visres.2008.09.031; Zhang QJ, 2007, HUM GENET, V122, P293, DOI 10.1007/s00439-007-0395-2	78	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17590	10.1371/journal.pone.0017590	http://dx.doi.org/10.1371/journal.pone.0017590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407811	Green Submitted, Green Published, gold			2022-12-25	WOS:000287933300033
J	Marsh, EK; van den Berg, MCW; May, RC				Marsh, Elizabeth K.; van den Berg, Maaike C. W.; May, Robin C.			A Two-Gene Balance Regulates Salmonella Typhimurium Tolerance in the Nematode Caenorhabditis elegans	PLOS ONE			English	Article							MODEL HOST; RESISTANCE; INFECTION; EVOLUTION; CLUSTERS; SYSTEM; WORM	Lysozymes are antimicrobial enzymes that perform a critical role in resisting infection in a wide-range of eukaryotes. However, using the nematode Caenorhabditis elegans as a model host we now demonstrate that deletion of the protist type lysozyme LYS-7 renders animals susceptible to killing by the fatal fungal human pathogen Cryptococcus neoformans, but, remarkably, enhances tolerance to the enteric bacteria Salmonella Typhimurium. This trade-off in immunological susceptibility in C. elegans is further mediated by the reciprocal activity of lys-7 and the tyrosine kinase abl-1. Together this implies a greater complexity in C. elegans innate immune function than previously thought.	[Marsh, Elizabeth K.; May, Robin C.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [van den Berg, Maaike C. W.] Univ Med Ctr Utrecht, Physiol Chem Lab, Utrecht, Netherlands	University of Birmingham; Utrecht University; Utrecht University Medical Center	May, RC (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	R.C.May@bham.ac.uk	May, Robin Charles/ABA-9266-2021	May, Robin Charles/0000-0001-5364-1838; Marsh, Elizabeth/0000-0002-4776-3588	Medical Research Council (MRC); Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F000138/1]; BBSRC [BB/F000138/1] Funding Source: UKRI; MRC [G0601171] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F000138/1] Funding Source: researchfish; Medical Research Council [G0601171] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council (MRC) studentship award to EKM and by a Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/F000138/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Amrit FRG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009978; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Bachali S, 2002, J MOL EVOL, V54, P652, DOI 10.1007/s00239-001-0061-6; BOOKOUT AL, 2003, NUCL RECEPTOR SIGNAL, pE12; Brandt SM, 2004, PLOS BIOL, V2, P2067, DOI 10.1371/journal.pbio.0020418; BRENNER S, 1974, GENETICS, V77, P71; Darby C, 1999, P NATL ACAD SCI USA, V96, P15202, DOI 10.1073/pnas.96.26.15202; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Ewbank JJ, 2002, MICROBES INFECT, V4, P247, DOI 10.1016/S1286-4579(01)01531-3; EWBANK JJ, 2006, WORMBOOK; Gordon MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000111; Hope IA., 1999, C ELEGANS PRACTICAL; Jolles P., 1996, LYSOZYMES MODEL ENZY; Kawli T, 2008, NAT IMMUNOL, V9, P1415, DOI 10.1038/ni.1672; Kim LK, 2007, PLOS BIOL, V5, P2064, DOI 10.1371/journal.pbio.0050238; Koguchi Yoshinobu, 2002, Int Rev Immunol, V21, P423, DOI 10.1080/08830180213274; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Lazzaro BP, 2006, GENETICS, V174, P1539, DOI 10.1534/genetics.105.054593; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; Nicholson LB, 1996, CURR OPIN IMMUNOL, V8, P837, DOI 10.1016/S0952-7915(96)80013-6; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Schneider DS, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030041; Schulenburg H, 2004, IMMUNOL REV, V198, P36, DOI 10.1111/j.0105-2896.2004.0125.x; Schulenburg H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-114; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Thomas JH, 2006, GENETICS, V172, P127, DOI 10.1534/genetics.104.040030; van den Berg MCW, 2006, GENETICS, V173, P677, DOI 10.1534/genetics.106.056093	32	18	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e16839	10.1371/journal.pone.0016839	http://dx.doi.org/10.1371/journal.pone.0016839			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399680	Green Published, gold			2022-12-25	WOS:000287933300002
J	Zeitlin, SG; Chapados, BR; Baker, NM; Tai, C; Slupphaug, G; Wang, JYJ				Zeitlin, Samantha G.; Chapados, Brian R.; Baker, Norman M.; Tai, Caroline; Slupphaug, Geir; Wang, Jean Y. J.			Uracil DNA N-Glycosylase Promotes Assembly of Human Centromere Protein A	PLOS ONE			English	Article							BASE EXCISION-REPAIR; CENP-A; CHROMATIN REQUIRES; CRYSTAL-STRUCTURES; UNG; NUCLEAR; DEFICIENCY; COMPLEX; CELLS; VPR	Uracil is removed from DNA by the conserved enzyme Uracil DNA N-glycosylase (UNG). Previously, we observed that inhibiting UNG in Xenopus egg extracts blocked assembly of CENP-A, a histone H3 variant. CENP-A is an essential protein in all species, since it is required for chromosome segregation during mitosis. Thus, the implication of UNG in CENP-A assembly implies that UNG would also be essential, but UNG mutants lacking catalytic activity are viable in all species. In this paper, we present evidence that UNG2 colocalizes with CENP-A and H2AX phosphorylation at centromeres in normally cycling cells. Reduction of UNG2 in human cells blocks CENP-A assembly, and results in reduced cell proliferation, associated with increased frequencies of mitotic abnormalities and rapid cell death. Overexpression of UNG2 induces high levels of CENP-A assembly in human cells. Using a multiphoton laser approach, we demonstrate that UNG2 is rapidly recruited to sites of DNA damage. Taken together, our data are consistent with a model in which the N-terminus of UNG2 interacts with the active site of the enzyme and with chromatin.	[Zeitlin, Samantha G.; Tai, Caroline; Wang, Jean Y. J.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Zeitlin, Samantha G.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Chapados, Brian R.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Baker, Norman M.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Slupphaug, Geir] Norwegian Univ Sci & Technol NTNU, Fac Med, Trondheim, Norway	University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Scripps Research Institute; University of California System; University of California San Diego; Norwegian University of Science & Technology (NTNU)	Zeitlin, SG (corresponding author), Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA.	szeitlin@sciencegeeks.org	Slupphaug, Geir/AAN-3794-2020	Slupphaug, Geir/0000-0002-7498-3500	NCI [5R01CA058320-15]; NIH [5F32GM069297]; California Institute of Regenerative Medicine (CIRM); Don Cleveland in the Ludwig Institute for Cancer Research; UCSD Neuroscience Microscopy Shared Facility [P30 NS047101]; UCSD Cancer Center Specialized Support [P30 CA23100]; Research Council of Norway; National Programme for Research in Functional Genomics in Norway (FUGE); Norwegian Cancer Association; Cancer Fund at St. Olavs Hospital, Trondheim; Svanhild; Arne Must Fund for Medical Research; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA043054, R37CA043054, R01CA058320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM069297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Don Cleveland in the Ludwig Institute for Cancer Research; UCSD Neuroscience Microscopy Shared Facility; UCSD Cancer Center Specialized Support; Research Council of Norway(Research Council of Norway); National Programme for Research in Functional Genomics in Norway (FUGE)(Research Council of Norway); Norwegian Cancer Association; Cancer Fund at St. Olavs Hospital, Trondheim; Svanhild; Arne Must Fund for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NCI grant 5R01CA058320-15 to JJYW. SGZ was funded by NIH NRSA fellowship 5F32GM069297, and a fellowship from the California Institute of Regenerative Medicine (CIRM), and Don Cleveland in the Ludwig Institute for Cancer Research. The Deltavision microscopes were funded by the UCSD Neuroscience Microscopy Shared Facility Grant P30 NS047101 and the UCSD Cancer Center Specialized Support Grant P30 CA23100. This research was also supported by the Research Council of Norway, the National Programme for Research in Functional Genomics in Norway (FUGE), the Norwegian Cancer Association, the Cancer Fund at St. Olavs Hospital, Trondheim, and the Svanhild and Arne Must Fund for Medical Research, to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; An Q, 2005, EMBO J, V24, P2205, DOI 10.1038/sj.emboj.7600689; Andersen JL, 2008, EXP MOL PATHOL, V85, P2, DOI 10.1016/j.yexmp.2008.03.015; Andersen S, 2005, DNA REPAIR, V4, P1432, DOI 10.1016/j.dnarep.2005.08.004; Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444; Begum NA, 2007, J BIOL CHEM, V282, P731, DOI 10.1074/jbc.M607439200; Begum NA, 2009, P NATL ACAD SCI USA, V106, P2752, DOI 10.1073/pnas.0813252106; Berger SH, 2008, BIOCHEM PHARMACOL, V76, P697, DOI 10.1016/j.bcp.2008.05.019; BRENNER S, 1981, J CELL BIOL, V91, P95, DOI 10.1083/jcb.91.1.95; BURGERS PMJ, 1986, J BACTERIOL, V166, P905, DOI 10.1128/jb.166.3.905-913.1986; Chow JPH, 2010, ADV EXP MED BIOL, V676, P57; D'souza DI, 2003, NUCLEIC ACIDS RES, V31, P4573, DOI 10.1093/nar/gkg493; DIANOV GL, 1991, MOL GEN GENET, V225, P448, DOI 10.1007/BF00261686; DUNCAN BK, 1978, J BACTERIOL, V134, P1039, DOI 10.1128/JB.134.3.1039-1045.1978; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Endres M, 2005, STROKE, V36, P321, DOI 10.1161/01.STR.0000153008.60517.ab; Endres M, 2004, J CLIN INVEST, V113, P1711, DOI 10.1172/JCI200420926; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fischer JA, 2004, DNA REPAIR, V3, P505, DOI 10.1016/j.dnarep.2004.01.012; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Gasparri F, 2006, J BIOMOL SCREEN, V11, P586, DOI 10.1177/1087057106289406; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Handa P, 2002, NUCLEIC ACIDS RES, V30, P3086, DOI 10.1093/nar/gkf425; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Kavli B, 1996, EMBO J, V15, P3442, DOI 10.1002/j.1460-2075.1996.tb00710.x; Kavli B, 2005, J EXP MED, V201, P2011, DOI 10.1084/jem.20050042; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Ko R, 2005, DNA REPAIR, V4, P1421, DOI 10.1016/j.dnarep.2005.08.006; Kracker S, 2010, CLIN IMMUNOL, V135, P193, DOI 10.1016/j.clim.2010.01.012; Kracker S, 2010, ADV EXP MED BIOL, V685, P166; Kronenberg G, 2008, J NEUROSCI, V28, P7219, DOI 10.1523/JNEUROSCI.0940-08.2008; Kruman II, 2004, J BIOL CHEM, V279, P43952, DOI 10.1074/jbc.M408025200; Langevin C, 2009, J VIROL, V83, P10256, DOI 10.1128/JVI.02654-08; Li G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-59; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; Nakamura N, 2008, MUTAGENESIS, V23, P407, DOI 10.1093/mutage/gen030; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Otterlei M, 1998, NUCLEIC ACIDS RES, V26, P4611, DOI 10.1093/nar/26.20.4611; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Pan-Hammarstrom Q, 2007, ADV IMMUNOL, V93, P1, DOI 10.1016/S0065-2776(06)93001-6; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Pulukuri SMK, 2009, MOL CANCER RES, V7, P1285, DOI 10.1158/1541-7786.MCR-08-0508; Putnam CD, 1999, J MOL BIOL, V287, P331, DOI 10.1006/jmbi.1999.2605; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Roederer M, 2001, CYTOMETRY, V45, P37, DOI 10.1002/1097-0320(20010901)45:1<37::AID-CYTO1142>3.0.CO;2-E; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Skjeldam HK, 2010, DNA REPAIR, V9, P861, DOI 10.1016/j.dnarep.2010.04.009; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Studebaker AW, 2005, BIOCHEM BIOPH RES CO, V334, P509, DOI 10.1016/j.bbrc.2005.06.118; VIG BK, 1989, CANCER GENET CYTOGEN, V43, P151, DOI 10.1016/0165-4608(89)90028-9; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Zeitlin SG, 2010, EPIGENETICS-US, V5, P34, DOI 10.4161/epi.5.1.10629; Zeitlin SG, 2009, P NATL ACAD SCI USA, V106, P15762, DOI 10.1073/pnas.0908233106; Zeitlin SG, 2005, DNA REPAIR, V4, P760, DOI 10.1016/j.dnarep.2005.02.007; Zeitlin SG, 2001, J CELL SCI, V114, P653	62	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17151	10.1371/journal.pone.0017151	http://dx.doi.org/10.1371/journal.pone.0017151			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399697	Green Published, gold			2022-12-25	WOS:000287933300012
J	Capsoni, S; Covaceuszach, S; Marinelli, S; Ceci, M; Bernardo, A; Minghetti, L; Ugolini, G; Pavone, F; Cattaneo, A				Capsoni, Simona; Covaceuszach, Sonia; Marinelli, Sara; Ceci, Marcello; Bernardo, Antonietta; Minghetti, Luisa; Ugolini, Gabriele; Pavone, Flaminia; Cattaneo, Antonino			Taking Pain Out of NGF: A "Painless'' NGF Mutant, Linked to Hereditary Sensory Autonomic Neuropathy Type V, with Full Neurotrophic Activity	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; RECEPTOR P75; SIGNALING PATHWAYS; MAST-CELLS; INDUCED HYPERALGESIA; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; TRKA; EXPRESSION	During adulthood, the neurotrophin Nerve Growth Factor (NGF) sensitizes nociceptors, thereby increasing the response to noxious stimuli. The relationship between NGF and pain is supported by genetic evidence: mutations in the NGF TrkA receptor in patients affected by an hereditary rare disease (Hereditary Sensory and Autonomic Neuropathy type IV, HSAN IV) determine a congenital form of severe pain insensitivity, with mental retardation, while a mutation in NGFB gene, leading to the aminoacid substitution R100W in mature NGF, determines a similar loss of pain perception, without overt cognitive neurological defects (HSAN V). The R100W mutation provokes a reduced processing of proNGF to mature NGF in cultured cells and a higher percentage of neurotrophin secreted is in the proNGF form. Moreover, using Surface Plasmon Resonance we showed that the R100W mutation does not affect NGF binding to TrkA, while it abolishes NGF binding to p75NTR receptors. However, it remains to be clarified whether the major impact of the mutation is on the biological function of proNGF or of mature NGF and to what extent the effects of the R100W mutation on the HSAN V clinical phenotype are developmental, or whether they reflect an impaired effectiveness of NGF to regulate and mediate nociceptive transmission in adult sensory neurons. Here we show that the R100 mutation selectively alters some of the signaling pathways activated downstream of TrkA NGF receptors. NGFR100 mutants maintain identical neurotrophic and neuroprotective properties in a variety of cell assays, while displaying a significantly reduced pain-inducing activity in vivo (n = 8-10 mice/group). We also show that proNGF has a significantly reduced nociceptive activity, with respect to NGF. Both sets of results jointly contribute to elucidating the mechanisms underlying the clinical HSAN V manifestations, and to clarifying which receptors and intracellular signaling cascades participate in the pain sensitizing action of NGF.	[Capsoni, Simona; Ceci, Marcello; Cattaneo, Antonino] European Brain Res Inst, Rome, Italy; [Capsoni, Simona; Cattaneo, Antonino] Scuola Normale Super Pisa, Pisa, Italy; [Covaceuszach, Sonia; Ugolini, Gabriele] Rottapharm Biotech Srl, Trieste, Italy; [Marinelli, Sara; Pavone, Flaminia] CNR, Inst Neurosci, Rome, Italy; [Bernardo, Antonietta; Minghetti, Luisa] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	Scuola Normale Superiore di Pisa; Rottapharm; Consiglio Nazionale delle Ricerche (CNR); Istituto Superiore di Sanita (ISS)	Capsoni, S (corresponding author), European Brain Res Inst, Rome, Italy.	antonino.cattaneo@sns.it	Marinelli, Sara/L-7738-2019; Cattaneo, Antonino/K-4471-2016; Minghetti, Luisa/I-9540-2014; Covaceuszach, Sonia/AAA-4116-2021; Antonietta, Bernardo/H-4415-2016; Cattaneo, Antonino/AAA-7252-2019	Marinelli, Sara/0000-0001-5393-4796; Cattaneo, Antonino/0000-0002-6975-8923; Minghetti, Luisa/0000-0002-7065-4689; Antonietta, Bernardo/0000-0002-6590-7530; Pavone, Flaminia/0000-0001-5189-2748; Capsoni, Simona/0000-0003-2670-8237; Ceci, Marcello/0000-0002-5066-1590	Telethon [GGP05234]; EU [037831]	Telethon(Fondazione Telethon); EU(European Commission)	This work was partially supported by, Telethon ( grant n. GGP05234, www.telethon.it) and EU ( Memories project n. 037831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Apfel SC, 2002, INT REV NEUROBIOL, V50, P393; Apfel SC, 2000, CLIN J PAIN, V16, pS7, DOI 10.1097/00002508-200006001-00003; BARDE YA, 1980, P NATL ACAD SCI-BIOL, V77, P1199, DOI 10.1073/pnas.77.2.1199; Bergmann I, 1998, NEUROSCI LETT, V255, P87, DOI 10.1016/S0304-3940(98)00713-7; Bernardo A, 2003, J NEUROPATH EXP NEUR, V62, P509, DOI 10.1093/jnen/62.5.509; Carvalho OP, 2011, J MED GENET, V48, P131, DOI 10.1136/jmg.2010.081455; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Cattaneo A, 1999, J NEUROSCI, V19, P9687; Cattaneo A, 2008, J ALZHEIMERS DIS, V15, P255; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; CHEVALIER S, 1994, BLOOD, V83, P1479; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Covaceuszach S, 2010, BIOCHEM BIOPH RES CO, V391, P824, DOI 10.1016/j.bbrc.2009.11.146; Covaceuszach S, 2009, CURR ALZHEIMER RES, V6, P158, DOI 10.2174/156720509787602870; Culmsee C, 2002, NEUROSCIENCE, V115, P1089, DOI 10.1016/S0306-4522(02)00539-0; de Andrade DC, 2008, EUR J NEUROL, V15, P712, DOI 10.1111/j.1468-1331.2008.02172.x; Doya H, 2005, BIOCHEM BIOPH RES CO, V335, P132, DOI 10.1016/j.bbrc.2005.07.055; Dyck PJ, 1997, NEUROLOGY, V48, P501, DOI 10.1212/WNL.48.2.501; Einarsdottir E, 2004, HUM MOL GENET, V13, P799, DOI 10.1093/hmg/ddh096; ERIKSDOTTER JM, 1998, DEMENT GERIATR COGN, V9, P246, DOI DOI 10.1159/000017069; Feng D, 2010, J MOL BIOL, V396, P967, DOI 10.1016/j.jmb.2009.12.030; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; HEFTI F, 1986, J NEUROSCI, V6, P2155; HORIGOME K, 1993, J BIOL CHEM, V268, P14881; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Kawamoto K, 2002, J IMMUNOL, V168, P6412, DOI 10.4049/jimmunol.168.12.6412; Larsson E, 2009, NEUROBIOL DIS, V33, P221, DOI 10.1016/j.nbd.2008.10.012; Lee X, 2007, J NEUROSCI, V27, P220, DOI 10.1523/JNEUROSCI.4175-06.2007; LEVIMONTALCINI R, 1952, ANN NY ACAD SCI, V55, P330, DOI 10.1111/j.1749-6632.1952.tb26548.x; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; LEWIN GR, 1993, J NEUROSCI, V13, P2136; LEWIN GR, 1994, EUR J NEUROSCI, V6, P1903, DOI 10.1111/j.1460-9568.1994.tb00581.x; Limpert AS, 2007, MOL CELL BIOL, V27, P5686, DOI 10.1128/MCB.01109-06; LOPRESTI P, 1992, CELL GROWTH DIFFER, V3, P627; Luvisetto S, 2007, NEUROSCIENCE, V145, P1, DOI 10.1016/j.neuroscience.2006.12.004; Mahapatra S, 2009, J BIOL CHEM, V284, P33600, DOI 10.1074/jbc.M109.058420; Malik-Hall M, 2005, EUR J NEUROSCI, V21, P3387, DOI 10.1111/j.1460-9568.2005.04173.x; Matrone C, 2008, P NATL ACAD SCI USA, V105, P13139, DOI 10.1073/pnas.0806133105; Minde J, 2004, MUSCLE NERVE, V30, P752, DOI 10.1002/mus.20172; MINDE J, 2008, J NEUROL NEUROSURG P; MOBLEY WC, 1986, MOL BRAIN RES, V1, P53, DOI 10.1016/0169-328X(86)90020-3; Nicol GD, 2007, MOL INTERV, V7, P26, DOI 10.1124/mi.7.1.6; Obata K, 2006, J NEUROSCI, V26, P11974, DOI 10.1523/JNEUROSCI.3188-06.2006; Paoletti F, 2009, PROTEINS, V75, P990, DOI 10.1002/prot.22311; Petersen M, 1998, NEUROSCIENCE, V83, P161, DOI 10.1016/S0306-4522(97)00374-6; PETTY BG, 1994, ANN NEUROL, V36, P244, DOI 10.1002/ana.410360221; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; RITTER AM, 1991, NATURE, V350, P500, DOI 10.1038/350500a0; Rotthier A, 2009, BRAIN, V132, P2699, DOI 10.1093/brain/awp198; Ryden M, 1997, J BIOL CHEM, V272, P16322, DOI 10.1074/jbc.272.26.16322; Sawada J, 2000, BLOOD, V95, P2052, DOI 10.1182/blood.V95.6.2052; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; SONNENFELD KH, 1982, J NEUROSCI RES, V8, P375, DOI 10.1002/jnr.490080226; Svensson P, 2003, PAIN, V104, P241, DOI 10.1016/S0304-3959(03)00012-5; Ugolini G, 2007, P NATL ACAD SCI USA, V104, P2985, DOI 10.1073/pnas.0611253104; Watanabe T, 2008, J NEUROSCI RES, V86, P3566, DOI 10.1002/jnr.21808; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Wood JN, 2010, NEW ENGL J MED, V363, P1572, DOI 10.1056/NEJMe1004416; Zhang YH, 2004, NEUROSCI LETT, V366, P187, DOI 10.1016/j.neulet.2004.05.042; Zhu WG, 2007, MOL CELL NEUROSCI, V34, P689, DOI 10.1016/j.mcn.2007.01.005; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004	68	70	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17321	10.1371/journal.pone.0017321	http://dx.doi.org/10.1371/journal.pone.0017321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387003	Green Submitted, Green Published, gold			2022-12-25	WOS:000287931400056
J	Li, JH; Ma, QY; Liu, H; Guo, K; Li, F; Li, W; Han, LA; Wang, FF; Wu, EX				Li, Junhui; Ma, Qingyong; Liu, Han; Guo, Kun; Li, Feng; Li, Wei; Han, Liang; Wang, Fengfei; Wu, Erxi			Relationship between Neural Alteration and Perineural Invasion in Pancreatic Cancer Patients with Hyperglycemia	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; DIABETES-MELLITUS; NEUROPATHY; PAIN; INNERVATION; RISK	Background: Patients with higher levels of fasting serum glucose have higher death rates from pancreatic cancer compared to patients with lower levels of fasting serum glucose. However, the reasons have not been studied. The goal of the current study was to examine the neural alterations in pancreatic cancer patients with hyperglycemia and to identify the relationship between the neural alterations and perineural invasion. Methodology/Principal Findings: The clinical and pathological features of 61 formalin-fixed pancreatic cancer specimens and 10 normal pancreases as controls were analyzed. Furthermore, the expression of Protein Gene Product 9.5 (PGP9.5), Myelin P0 protein (MPP), NGF, TrkA, and p75 were examined by immunohistochemistry. The median number of nerves, the median area of neural tissue, and the median nerve diameter per 10 mm 2 were larger in the hyperglycemia group than those in the euglycemia group (p = 0.007, p = 0.009, and p = 0.004, respectively). The integrated optical density (IOD) of MPP staining was lower in the hyperglycemia group than those in the euglycemia group (p = 0.019), while the expression levels of NGF and p75 were higher in the hyperglycemia group than those in the euglycemia group (p = 0.002, and p = 0.026, respectively). The nerve bundle invasion of pancreatic cancer was more frequent in the hyperglycemia group than in the euglycemia group (p = 0.000). Conclusions/Significance: Nerve damage and regeneration occur simultaneously in the tumor microenvironment of pancreatic cancer patients with hyperglycemia; the simultaneous occurrence may aggravate the process of perineural invasion. The abnormal expression of NGF and p75 may also be involved in this process and subsequently lead to a lower rate of curative surgery.	[Li, Junhui; Ma, Qingyong; Liu, Han; Guo, Kun; Li, Feng; Li, Wei; Han, Liang] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Coll Med, Xian 710049, Shaanxi, Peoples R China; [Li, Junhui] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Gen Surg, Coll Med, Xian 710049, Shaanxi, Peoples R China; [Wang, Fengfei; Wu, Erxi] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA	Xi'an Jiaotong University; Xi'an Jiaotong University; North Dakota State University Fargo	Li, JH (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Coll Med, Xian 710049, Shaanxi, Peoples R China.	qyma56@mail.xjtu.edu.cn; erxi.wu@ndsu.edu		Wu, Erxi/0000-0002-1680-3639	National Natural Scientific Foundation of China [30900705]; Scientific Grant from Xi'an City [GG06718]; ND EPSCoR	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Grant from Xi'an City; ND EPSCoR	This study was supported by the National Natural Scientific Foundation of China ( 2009 No. 30900705) and a Scientific Grant from Xi'an City ( 2009 No. GG06718) ( Q. Ma), and partially by ND EPSCoR ( E. Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucek Petr, 2006, Review of Diabetic Studies, V3, P143, DOI 10.1900/RDS.2006.3.143; Ceyhan GO, 2010, ANN SURG, V251, P923, DOI 10.1097/SLA.0b013e3181d974d4; Ceyhan GO, 2009, GASTROENTEROLOGY, V136, P177, DOI 10.1053/j.gastro.2008.09.029; Ceyhan GO, 2009, AM J GASTROENTEROL, V104, P2555, DOI 10.1038/ajg.2009.380; Ceyhan GO, 2008, BEST PRACT RES CL GA, V22, P31, DOI 10.1016/j.bpg.2007.10.016; Christianson JA, 2003, EXP NEUROL, V179, P188, DOI 10.1016/S0014-4886(02)00017-1; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Dai H, 2007, HUM PATHOL, V38, P299, DOI 10.1016/j.humpath.2006.08.002; di Mola FF, 2008, LANGENBECK ARCH SURG, V393, P919, DOI 10.1007/s00423-007-0277-z; EVERHART J, 1995, JAMA-J AM MED ASSOC, V273, P1605, DOI 10.1001/jama.273.20.1605; Frade JM, 1996, NATURE, V383, P166; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hirai I, 2002, PANCREAS, V24, P15, DOI 10.1097/00006676-200201000-00003; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Kayahara M, 2007, PANCREAS, V35, P218, DOI 10.1097/mpa.0b013e3180619677; Liebig C, 2009, CANCER-AM CANCER SOC, V115, P3379, DOI 10.1002/cncr.24396; Liu Bin, 2002, Hepatobiliary Pancreat Dis Int, V1, P469; Malik RA, 2005, DIABETOLOGIA, V48, P578, DOI 10.1007/s00125-004-1663-5; Matsuda M, 1983, Nihon Geka Gakkai Zasshi, V84, P719; Mitsunaga S, 2007, AM J SURG PATHOL, V31, P1636, DOI 10.1097/PAS.0b013e318065bfe6; NAKAO A, 1996, PANCREAS, V12, P361; Okusaka T, 2001, PANCREAS, V22, P279, DOI 10.1097/00006676-200104000-00009; Pannala R, 2008, GASTROENTEROLOGY, V134, P981, DOI 10.1053/j.gastro.2008.01.039; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Tomlinson DR, 2008, NAT REV NEUROSCI, V9, P36, DOI 10.1038/nrn2294; Wang Feng, 2003, Mol Cancer, V2, P4, DOI 10.1186/1476-4598-2-4; Wang FR, 2006, CANCER EPIDEM BIOMAR, V15, P1458, DOI 10.1158/1055-9965.EPI-06-0188; Yasuda H, 2003, PROG NEUROBIOL, V69, P229, DOI 10.1016/S0301-0082(03)00034-0; Yi SQ, 2003, PANCREAS, V27, P225, DOI 10.1097/00006676-200310000-00005; Zhan YS, 2010, MED ONCOL, V27, P177, DOI 10.1007/s12032-009-9189-9; Zochodne DW, 2007, MUSCLE NERVE, V36, P144, DOI 10.1002/mus.20785	31	36	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17385	10.1371/journal.pone.0017385	http://dx.doi.org/10.1371/journal.pone.0017385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386984	Green Submitted, gold, Green Published			2022-12-25	WOS:000287931400067
J	Burgess, K; Xu, TS; Brown, R; Han, BJ; Welle, S				Burgess, Kerri; Xu, Tianshun; Brown, Roger; Han, Bajin; Welle, Stephen			Effect of Myostatin Depletion on Weight Gain, Hyperglycemia, and Hepatic Steatosis during Five Months of High-Fat Feeding in Mice	PLOS ONE			English	Article							MUSCLE GROWTH; INSULIN-RESISTANCE; TRANSGENIC MICE; DEFICIENT MICE; MATURE MICE; EXPRESSION; KNOCKOUT; OBESITY; DIET; MASS	The marked hypermuscularity in mice with constitutive myostatin deficiency reduces fat accumulation and hyperglycemia induced by high-fat feeding, but it is unclear whether the smaller increase in muscle mass caused by postdevelopmental loss of myostatin activity has beneficial metabolic effects during high-fat feeding. We therefore examined how postdevelopmental myostatin knockout influenced effects of high-fat feeding. Male mice with ubiquitous expression of tamoxifen-inducible Cre recombinase were fed tamoxifen for 2 weeks at 4 months of age. This depleted myostatin in mice with floxed myostatin genes, but not in control mice with normal myostatin genes. Some mice were fed a high-fat diet (60% of energy) for 22 weeks, starting 2 weeks after cessation of tamoxifen feeding. Myostatin depletion increased skeletal muscle mass similar to 30%. Hypermuscular mice had similar to 50% less weight gain than control mice over the first 8 weeks of high-fat feeding. During the subsequent 3 months of high-fat feeding, additional weight gain was similar in control and myostatin-deficient mice. After 5 months of high-fat feeding, the mass of epididymal and retroperitoneal fat pads was similar in control and myostatin-deficient mice even though myostatin depletion reduced the weight gain attributable to the high-fat diet (mean weight with high-fat diet minus mean weight with low-fat diet: 19.9 g in control mice, 14.1 g in myostatin-deficient mice). Myostatin depletion did not alter fasting blood glucose levels after 3 or 5 months of high-fat feeding, but reduced glucose levels measured 90 min after intraperitoneal glucose injection. Myostatin depletion also attenuated hepatic steatosis and accumulation of fat in muscle tissue. We conclude that blocking myostatin signaling after maturity can attenuate some of the adverse effects of a high-fat diet.	[Burgess, Kerri; Welle, Stephen] Univ Rochester, Dept Med, Div Endocrinol & Metab, Rochester, NY 14627 USA; [Xu, Tianshun; Brown, Roger; Han, Bajin] GlaxoSmithKline Res & Dev Ltd, Muscle Metab DPU & Platform Technol & Sci, Res Triangle Pk, NC USA	University of Rochester; GlaxoSmithKline	Burgess, K (corresponding author), Univ Rochester, Dept Med, Div Endocrinol & Metab, Rochester, NY 14627 USA.	stephen_welle@urmc.rochester.edu			National Institutes of Health [AR054366]; GlaxoSmithKline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054366] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the National Institutes of Health (grant number AR054366) and GlaxoSmithKline. GlaxoSmithKline scientists listed as coauthors contributed to study design, data collection, and manuscript preparation.	Akpan I, 2009, INT J OBESITY, V33, P1265, DOI 10.1038/ijo.2009.162; Bernardo BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011307; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; Hamrick MW, 2006, INT J OBESITY, V30, P868, DOI 10.1038/sj.ijo.0803200; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hittel DS, 2010, MED SCI SPORT EXER, V42, P2023, DOI 10.1249/MSS.0b013e3181e0b9a8; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Koncarevic A, 2010, ENDOCRINOLOGY, V151, P4289, DOI 10.1210/en.2010-0134; LeBrasseur NK, 2009, J GERONTOL A-BIOL, V64, P940, DOI 10.1093/gerona/glp068; Lin J, 2002, BIOCHEM BIOPH RES CO, V291, P701, DOI 10.1006/bbrc.2002.6500; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Morissette MR, 2009, AGING CELL, V8, P573, DOI 10.1111/j.1474-9726.2009.00508.x; O'Fallon JV, 2007, J ANIM SCI, V85, P1511, DOI 10.2527/jas.2006-491; Personius KE, 2010, J APPL PHYSIOL, V109, P886, DOI 10.1152/japplphysiol.00300.2010; Welle S, 2006, AM J PHYSIOL-ENDOC M, V290, pE409, DOI 10.1152/ajpendo.00433.2005; Welle S, 2007, AM J PHYSIOL-ENDOC M, V292, pE985, DOI 10.1152/ajpendo.00531.2006; Welle S, 2009, AM J PHYSIOL-ENDOC M, V297, pE935, DOI 10.1152/ajpendo.00179.2009; Welle S, 2009, PHYSIOL GENOMICS, V38, P342, DOI 10.1152/physiolgenomics.00054.2009; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wilkes JJ, 2009, DIABETES, V58, P1133, DOI 10.2337/db08-0245; Yang JZ, 2006, MOL REPROD DEV, V73, P462, DOI 10.1002/mrd.20452; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097; Zhao BQ, 2005, BIOCHEM BIOPH RES CO, V337, P248, DOI 10.1016/j.bbrc.2005.09.044	23	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17090	10.1371/journal.pone.0017090	http://dx.doi.org/10.1371/journal.pone.0017090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390326	Green Published, gold, Green Submitted			2022-12-25	WOS:000287761700029
J	Lefebvre, V; Fortabat, MN; Ducamp, A; North, HM; Maia-Grondard, A; Trouverie, J; Boursiac, Y; Mouille, G; Durand-Tardif, M				Lefebvre, Valerie; Fortabat, Marie-Noelle; Ducamp, Aloise; North, Helen M.; Maia-Grondard, Alessandra; Trouverie, Jacques; Boursiac, Yann; Mouille, Gregory; Durand-Tardif, Mylene			ESKIMO1 Disruption in Arabidopsis Alters Vascular Tissue and Impairs Water Transport	PLOS ONE			English	Article							ABSCISIC-ACID; CELLULOSE BIOSYNTHESIS; PROTEIN-KINASE; FT-IR; STRESS; MUTANTS; DROUGHT; GENES; COLD; MODEL	Water economy in agricultural practices is an issue that is being addressed through studies aimed at understanding both plant water-use efficiency (WUE), i.e. biomass produced per water consumed, and responses to water shortage. In the model species Arabidopsis thaliana, the ESKIMO1 (ESK1) gene has been described as involved in freezing, cold and salt tolerance as well as in water economy: esk1 mutants have very low evapo-transpiration rates and high water-use efficiency. In order to establish ESK1 function, detailed characterization of esk1 mutants has been carried out. The stress hormone ABA (abscisic acid) was present at high levels in esk1 compared to wild type, nevertheless, the weak water loss of esk1 was independent of stomata closure through ABA biosynthesis, as combining mutant in this pathway with esk1 led to additive phenotypes. Measurement of root hydraulic conductivity suggests that the esk1 vegetative apparatus suffers water deficit due to a defect in water transport. ESK1 promoter-driven reporter gene expression was observed in xylem and fibers, the vascular tissue responsible for the transport of water and mineral nutrients from the soil to the shoots, via the roots. Moreover, in cross sections of hypocotyls, roots and stems, esk1 xylem vessels were collapsed. Finally, using Fourier-Transform Infrared (FTIR) spectroscopy, severe chemical modifications of xylem cell wall composition were highlighted in the esk1 mutants. Taken together our findings show that ESK1 is necessary for the production of functional xylem vessels, through its implication in the laying down of secondary cell wall components.	[Lefebvre, Valerie; Fortabat, Marie-Noelle; Ducamp, Aloise; North, Helen M.; Maia-Grondard, Alessandra; Mouille, Gregory; Durand-Tardif, Mylene] INRA Ctr Versailles Grignon, Inst Jean Pierre Bourgin, INRA AgroParisTech, UMR1318, Versailles, France; [Trouverie, Jacques] Univ Caen Basse Normandie, UMR INRA UCBN, Ecophysiol Vegetale Agron & Nutr NCS, Caen, France; [Boursiac, Yann] Univ Montpellier 2, CNRS, Inst Biol Integrat Plantes, Montpellier SupAgro,INRA,UMR 5004,UMR 0386, Montpellier, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier	Lefebvre, V (corresponding author), INRA Ctr Versailles Grignon, Inst Jean Pierre Bourgin, INRA AgroParisTech, UMR1318, Versailles, France.	Mylene.Durand-Tardif@versailles.inra.fr	North, Helen/AAD-4964-2020; Trouverie, Jacques/AAT-1271-2021; Boursiac, Yann/GQP-1267-2022; Trouverie, Jacques/G-5035-2011	North, Helen/0000-0002-5749-2603; Boursiac, Yann/0000-0002-9545-9003; Trouverie, Jacques/0000-0002-1450-896X; Mouille, Gregory/0000-0002-5493-754X; Mylene, Durand-Tardif/0000-0003-1568-6941	Agence Nationale pour la Recherche - Genoplante [ANR-07-GPLA-003]	Agence Nationale pour la Recherche - Genoplante(French National Research Agency (ANR))	This work was supported by the ANR-07-GPLA-003 grant (Agence Nationale pour la Recherche - Genoplante). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-1; Bischoff V, 2010, PLANT SIGNAL BEHAV, V5, P1057, DOI 10.4161/psb.5.8.12414; Bischoff V, 2010, PLANT PHYSIOL, V153, P590, DOI 10.1104/pp.110.153320; Bosca S, 2006, PLANT PHYSIOL, V142, P1353, DOI 10.1104/pp.106.087700; Bouchabke-Coussa O, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-125; Bray EA, 2004, J EXP BOT, V55, P2331, DOI 10.1093/jxb/erh270; Burton RA, 2000, PLANT CELL, V12, P691, DOI 10.1105/tpc.12.5.691; Chaffey N, 2002, PHYSIOL PLANTARUM, V114, P594, DOI 10.1034/j.1399-3054.2002.1140413.x; Chen ZZ, 2005, PLANT J, V43, P273, DOI 10.1111/j.1365-313X.2005.02452.x; Cholet C, 2002, AUST J GRAPE WINE R, V8, P126, DOI 10.1111/j.1755-0238.2002.tb00221.x; Christmann A, 2007, PLANT J, V52, P167, DOI 10.1111/j.1365-313X.2007.03234.x; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; Elo A, 2009, SEMIN CELL DEV BIOL, V20, P1097, DOI 10.1016/j.semcdb.2009.09.009; Fukuda Y, 2000, PLANT MOL BIOL, V44, P91, DOI 10.1023/A:1006416929665; Hummel I, 2010, PLANT PHYSIOL, V154, P357, DOI 10.1104/pp.110.157008; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Javot H, 2003, PLANT CELL, V15, P509, DOI 10.1105/tpc.008888; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kacurakova M, 2002, CARBOHYD RES, V337, P1145, DOI 10.1016/S0008-6215(02)00102-7; Keppler BD, 2010, MOL PLANT, V3, P834, DOI 10.1093/mp/ssq028; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Lefebvre V, 2006, PLANT J, V45, P309, DOI 10.1111/j.1365-313X.2005.02622.x; Lefebvre V, 2009, INT J MOL SCI, V10, P3547, DOI 10.3390/ijms10083547; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Lugan R, 2009, PLANT CELL ENVIRON, V32, P95, DOI 10.1111/j.1365-3040.2008.01898.x; Maurel C, 2010, J EXP BOT, V61, P3191, DOI 10.1093/jxb/erq150; Merlot S, 2002, PLANT J, V30, P601, DOI 10.1046/j.1365-313X.2002.01322.x; Mouille G, 2003, PLANT J, V35, P393, DOI 10.1046/j.1365-313X.2003.01807.x; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nilson SE, 2007, PLANT PHYSIOL, V143, P19, DOI 10.1104/pp.106.093161; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Persson S, 2007, PLANT CELL, V19, P237, DOI 10.1105/tpc.106.047720; Plomion C, 2001, PLANT PHYSIOL, V127, P1513, DOI 10.1104/pp.010816; Reyes-Diaz M, 2006, J EXP BOT, V57, P3687, DOI 10.1093/jxb/erl125; Sanchez-Rodriguez C, 2010, TRENDS PLANT SCI, V15, P291, DOI 10.1016/j.tplants.2010.03.002; Schwartz SH, 1997, PLANT PHYSIOL, V114, P161, DOI 10.1104/pp.114.1.161; SCOTT TA, 1953, ANAL CHEM, V25, P1656, DOI 10.1021/ac60083a023; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; Sibout R, 2005, PLANT CELL, V17, P2059, DOI 10.1105/tpc.105.030767; Steudle E, 1998, J EXP BOT, V49, P775, DOI 10.1093/jexbot/49.322.775; Taylor NG, 1999, PLANT CELL, V11, P769, DOI 10.1105/tpc.11.5.769; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; THOMASHOW MF, 1994, ARABIDOPSIS, P807, DOI DOI 10.1101/0.807-834; Turner SR, 1997, PLANT CELL, V9, P689, DOI 10.1105/tpc.9.5.689; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Vogel JP, 2004, PLANT J, V40, P968, DOI 10.1111/j.1365-313X.2004.02264.x; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066; Xie XD, 2006, CURR BIOL, V16, P882, DOI 10.1016/j.cub.2006.03.028; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Xin ZG, 2007, PLANT J, V49, P786, DOI 10.1111/j.1365-313X.2006.02994.x; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325	57	54	58	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2011	6	2							e16645	10.1371/journal.pone.0016645	http://dx.doi.org/10.1371/journal.pone.0016645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UR	21408051	Green Published, gold			2022-12-25	WOS:000286835000004
J	Eylenstein, A; Gehring, EM; Heise, N; Shumilina, E; Schmidt, S; Szteyn, K; Munzer, P; Nurbaeva, MK; Eichenmuller, M; Tyan, L; Regel, I; Foller, M; Kuhl, D; Soboloff, J; Penner, R; Lang, F				Eylenstein, Anja; Gehring, Eva-Maria; Heise, Nicole; Shumilina, Ekaterina; Schmidt, Sebastian; Szteyn, Kalina; Muenzer, Patrick; Nurbaeva, Meerim K.; Eichenmueller, Melanie; Tyan, Leonid; Regel, Ivonne; Foeller, Michael; Kuhl, Dietmar; Soboloff, Jonathan; Penner, Reinhold; Lang, Florian			Stimulation of Ca2+-channel Orai1/STIM1 by serum- and glucocorticoid-inducible kinase 1 (SGK1)	FASEB JOURNAL			English	Article						CRAC; store-operated calcium channel; SOCE; degranulation; migration	REGULATING FACTOR NHERF2; CA2+ CHANNEL TRPV5; INTRACELLULAR CALCIUM; CRAC CHANNEL; PROTEIN-KINASE; UP-REGULATION; PORE SUBUNIT; ION CHANNELS; MICE LACKING; STORE	Ca2+ signaling includes store-operated Ca2+ entry (SOCE) following depletion of endoplasmic reticulum (ER) Ca2+ stores. On store depletion, the ER Ca2+ sensor STIM1 activates Orai1, the pore-forming unit of Ca2+-release-activated Ca2+ (CRAC) channels. Here, we show that Orai1 is regulated by serum-and glucocorticoid-inducible kinase 1 (SGK1), a growth factor-regulated kinase. Membrane Orai1 protein abundance, I-CRAC, and SOCE in human embryonic kidney (HEK293) cells stably expressing Orai1 and transfected with STIM1 were each significantly enhanced by coexpression of constitutively active (S422D)SGK1 (by+81, +378, and +136%, respectively) but not by inactive (K127N)SGK1. Coexpression of the ubiquitin ligase Nedd4-2, an established negatively regulated SGK1 target, down-regulated SOCE (by -48%) and I-CRAC (by -60%), an effect reversed by expression of (S422D)SGK1 (by + 175 and +173%, respectively). Orai1 protein abundance and SOCE were significantly lower in mast cells from SGK1-knockout (sgk1(-/-)) mice (by -37% and -52%, respectively) than in mast cells from wild-type (sgk1(+/+)) littermates. Activation of SOCE by sarcoplasmic/endoplasmic reticulum Ca2+-ATPase-inhibitor thapsigargin (2 mu M) stimulated migration, an effect significantly higher (by +306%) in (S422D)SGK1-expressing than in (K127N)SGK1-expressing HEK293 cells, and also significantly higher (by + 108%) in sgk1(+/+) than in sgk1(-/-) mast cells. SGK1 is thus a novel key player in the regulation of SOCE.-Eylenstein, A., Gehring, E.-M., Heise, N., Shumilina, E., Schmidt, S., Szteyn, K., Munzer, P., Nurbaeva, M. K., Eichenmuller, M., Tyan, L., Regel, I., Foller, M., Kuhl, D., Soboloff, J., Penner, R., Lang, R. Stimulation of Ca2+-channel Orai1/STIM1 by serum-and glucocorticoid-inducible kinase 1 (SGK1). FASEB J. 25, 2012-2021 (2011). www.fasebj.org	[Eylenstein, Anja; Gehring, Eva-Maria; Heise, Nicole; Shumilina, Ekaterina; Schmidt, Sebastian; Szteyn, Kalina; Muenzer, Patrick; Nurbaeva, Meerim K.; Eichenmueller, Melanie; Tyan, Leonid; Regel, Ivonne; Foeller, Michael; Lang, Florian] Univ Tubingen, Dept Physiol, D-72076 Tubingen, Germany; [Kuhl, Dietmar] Univ Med Ctr Hamburg Eppendorf UKE, Ctr Mol Neurobiol ZMNH, Inst Mol & Cellular Cognit IMCC, Hamburg, Germany; [Soboloff, Jonathan] Temple Univ, Dept Biochem, Sch Med, Philadelphia, PA 19122 USA; [Penner, Reinhold] Univ Hawaii, Ctr Biomed Res, Queens Med Ctr, Honolulu, HI 96822 USA	Eberhard Karls University of Tubingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; The Queen's Medical Center; University of Hawaii System	Lang, F (corresponding author), Univ Tubingen, Dept Physiol, Gmelinstr 5, D-72076 Tubingen, Germany.	florian.lang@uni-tuebingen.de	Regel, Ivonne/AFS-1831-2022; Soboloff, Jonathan/I-6995-2012; Kuhl, Dietmar/A-4689-2009	Soboloff, Jonathan/0000-0001-5192-1297; Kuhl, Dietmar/0000-0002-4772-6701; Munzer, Patrick/0000-0001-5357-038X; Penner, Reinhold/0000-0002-5366-1537	Deutsche Forschungsgemeinschaft [GK 1302, SFB 773]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097335] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the technical assistance of E. Faber and the preparation of the manuscript by T. Loch and L. Subasic. This study was supported by the Deutsche Forschungsgemeinschaft (GK 1302, SFB 773).	Amato R, 2009, J MOL MED, V87, P1221, DOI 10.1007/s00109-009-0525-5; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Baryshnikov SG, 2009, AM J PHYSIOL-CELL PH, V297, pC1103, DOI 10.1152/ajpcell.00283.2009; Becchetti A, 2010, ADV EXP MED BIOL, V674, P107; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bhalla V, 2006, AM J PHYSIOL-RENAL, V291, pF714, DOI 10.1152/ajprenal.00061.2006; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Boehmer C, 2007, FEBS LETT, V581, P5586, DOI 10.1016/j.febslet.2007.11.006; Boehmer C, 2008, CELL PHYSIOL BIOCHEM, V22, P591, DOI 10.1159/000185543; Bogeski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000672; Bradding P, 2009, BRIT J PHARMACOL, V157, P1330, DOI 10.1111/j.1476-5381.2009.00362.x; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Dehner M, 2008, J BIOL CHEM, V283, P19201, DOI 10.1074/jbc.M710366200; Dietrich A, 2010, THROMB HAEMOSTASIS, V103, P262, DOI 10.1160/TH09-08-0517; Embark HM, 2004, CELL PHYSIOL BIOCHEM, V14, P203, DOI 10.1159/000080329; Faouzi M, 2011, J CELL PHYSIOL, V226, P542, DOI 10.1002/jcp.22363; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Flores SY, 2003, PFLUG ARCH EUR J PHY, V446, P334, DOI 10.1007/s00424-003-1027-x; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Imai S, 2003, LIFE SCI, V72, P2199, DOI 10.1016/S0024-3205(03)00092-4; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Klaus F, 2008, J PHYSIOL-LONDON, V586, P1539, DOI 10.1113/jphysiol.2007.146191; Klingel K, 2000, AM J PHYSIOL-GASTR L, V279, pG998, DOI 10.1152/ajpgi.2000.279.5.G998; Krueger B, 2009, CELL PHYSIOL BIOCHEM, V24, P605, DOI 10.1159/000257516; Lang F, 2000, P NATL ACAD SCI USA, V97, P8157, DOI 10.1073/pnas.97.14.8157; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2010, INT J BIOCHEM CELL B, V42, P1571, DOI 10.1016/j.biocel.2010.05.016; Lang F, 2009, CURR OPIN NEPHROL HY, V18, P439, DOI 10.1097/MNH.0b013e32832f125e; Laufer J, 2009, CELL PHYSIOL BIOCHEM, V23, P25, DOI 10.1159/000204077; Liang XB, 2008, J BIOL CHEM, V283, P27418, DOI 10.1074/jbc.M803687200; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Nagaki K, 2006, BIOCHEMISTRY-US, V45, P6733, DOI 10.1021/bi052640q; Naray-Fejes-Toth A, 1999, J BIOL CHEM, V274, P16973, DOI 10.1074/jbc.274.24.16973; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Palmada M, 2005, CELL PHYSIOL BIOCHEM, V15, P175, DOI 10.1159/000083650; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Peel SE, 2008, AM J RESP CELL MOL, V38, P744, DOI 10.1165/rcmb.2007-0395OC; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; Rajamanickam J, 2007, J NEUROCHEM, V102, P858, DOI 10.1111/j.1471-4159.2007.04585.x; Roberts-Thomson SJ, 2010, PHARMACOL THERAPEUT, V127, P121, DOI 10.1016/j.pharmthera.2010.04.016; Robinson LJ, 2010, ANN NY ACAD SCI, V1192, P351, DOI 10.1111/j.1749-6632.2009.05219.x; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Rotte A, 2009, CELL PHYSIOL BIOCHEM, V23, P133, DOI 10.1159/000204102; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Salter RD, 2009, IMMUNOL REV, V231, P278, DOI 10.1111/j.1600-065X.2009.00806.x; Schaff UY, 2010, BLOOD, V115, P657, DOI 10.1182/blood-2009-05-224659; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Sherk AB, 2008, CANCER RES, V68, P7475, DOI 10.1158/0008-5472.CAN-08-1047; Shin DM, 2008, NAT CELL BIOL, V10, P639, DOI 10.1038/ncb0608-639; Shumilina E, 2008, J IMMUNOL, V180, P8040, DOI 10.4049/jimmunol.180.12.8040; Shumilina E, 2010, CELL PHYSIOL BIOCHEM, V26, P699, DOI 10.1159/000322337; Shuttleworth TJ, 2009, CELL CALCIUM, V45, P602, DOI 10.1016/j.ceca.2009.02.001; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Sobiesiak M, 2009, J IMMUNOL, V183, P4395, DOI 10.4049/jimmunol.0803017; Sopjani M, 2010, J MEMBRANE BIOL, V233, P35, DOI 10.1007/s00232-009-9222-0; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Taruno A, 2008, AM J PHYSIOL-RENAL, V294, pF177, DOI 10.1152/ajprenal.00250.2007; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wang K, 2010, CELL PHYSIOL BIOCHEM, V25, P271, DOI 10.1159/000276561; Woodard GE, 2010, J BIOL CHEM, V285, P8045, DOI 10.1074/jbc.M109.033605; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900	79	76	78	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					2012	2021		10.1096/fj.10-178210	http://dx.doi.org/10.1096/fj.10-178210			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21385992	Green Published			2022-12-25	WOS:000291023800023
J	Tirino, V; Desiderio, V; Paino, F; De Rosa, A; Papaccio, F; Fazioli, F; Pirozzi, G; Papaccio, G				Tirino, Virginia; Desiderio, Vincenzo; Paino, Francesca; De Rosa, Alfredo; Papaccio, Federica; Fazioli, Flavio; Pirozzi, Giuseppe; Papaccio, Gianpaolo			Human primary bone sarcomas contain CD133(+) cancer stem cells displaying high tumorigenicity in vivo	FASEB JOURNAL			English	Article						tumor-initiating cells; sarcospheres; osteosarcoma; chondrosarcoma	SIDE POPULATION CELLS; INITIATING CELLS; OSTEOSARCOMA; IDENTIFICATION; BIOLOGY; TUMORS; DIFFERENTIATION; EXPRESSION; CARCINOMA; EXPANSION	This study aimed to identify, isolate, and characterize cancer stem cells from human primary sarcomas. We performed cytometric analyses for stemness and differentiation antigens, including CD29, CD34, CD44, CD90, CD117, and CD133, on 21 human primary sarcomas on the day of surgery. From sarcoma biopsies, we obtained 2 chondrosarcoma-stabilized cell lines and 2 osteosarcoma stabilized cell lines, on which sphere formation, side population profile, stemness gene expression, and in vivo and in vitro assays were performed. All samples expressed the CD133, CD44, and CD29 markers. Therefore, we selected a CD133(+) subpopulation from stabilized cell lines that displayed the capacity to grow as sarcospheres able to initiate and sustain tumor growth in nonobese diabetic/severe combined (NOD/SCID) mice, to express stemness genes, including OCT3/4, Nanog, Sox2, and Nestin, and to differentiate into mesenchymal lineages, such as osteoblasts and adipocytes. Our findings show the existence of cancer stem cells in human primary bone sarcomas and highlight CD133 as a pivotal marker for identification of these cells. This may be of primary importance in the development of new therapeutic strategies and new prognostic procedures against these highly aggressive and metastatic tumors.-Tirino, V., Desiderio, V., Paino, F., De Rosa, A., Papaccio, F., Fazioli, F., Pirozzi, G., Papaccio, G. Human primary bone sarcomas contain CD133(+) cancer stem cells displaying high tumorigenicity in vivo. FASEB J. 25, 2022-2030 (2011). www.fasebj.org	[Papaccio, Gianpaolo] Univ Naples 2, Dept Expt Med, Sect Histol & Embryol, I-80138 Naples, Italy; [De Rosa, Alfredo] Univ Naples 2, Dept Odontostomatol & Maxillofacial Surg, I-80138 Naples, Italy; [Pirozzi, Giuseppe] Natl Canc Inst, Dept Expt Oncol, Naples, Italy; [Fazioli, Flavio] Natl Canc Inst, Dept Surg Oncol, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale	Papaccio, G (corresponding author), Univ Naples 2, Dept Expt Med, Sect Histol & Embryol, 5 Via L Armanni, I-80138 Naples, Italy.	gianpaolo.papaccio@unina2.it	desiderio, vincenzo/K-4244-2018; paino, francesca/AAC-8150-2019; Papaccio, Gianpaolo/B-7150-2014	paino, francesca/0000-0002-3186-1888; Papaccio, Gianpaolo/0000-0002-4014-5306; Tirino, Virginia/0000-0003-2731-5718; Papaccio, Federica/0000-0002-0302-8696; FAZIOLI, FLAVIO/0000-0002-4308-1192; desiderio, vincenzo/0000-0003-1819-6083	SIRIO-FIRB [06, RBIP06FH7J_006]	SIRIO-FIRB	The authors kindly thank Dr. Maria Vincenza Carriero (National Cancer Institute, Naples, Italy) for supplying the BS15 cell line and thank Biogem Scarl (Ariano Irpino, Italy) for use of the Animal Model facility. The authors kindly thank Dr. Rachel Sammons (University of Birmingham School of Dentistry, Birmingham, UK) for English editing. This study is supported by SIRIO-FIRB 2007/2009 grant 06 n. RBIP06FH7J_006 to G.P. The authors declare no competing financial interests.	ADHIKARI AS, CANC RES, V70, P4602; Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; ARAKI N, 1991, CLIN ORTHOP RELAT R, P271; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deleyrolle Loic P., 2009, V549, P91, DOI 10.1007/978-1-60327-931-4_7; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fukuda K, 2009, INT J ONCOL, V34, P1201, DOI 10.3892/ijo_00000248; Gatta G, 2005, J CLIN ONCOL, V23, P3742, DOI 10.1200/JCO.2005.00.554; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; Hirschmann-Jax C, 2005, CELL CYCLE, V4, P203; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hu C, 2008, CARCINOGENESIS, V29, P2289, DOI 10.1093/carcin/bgn223; JEFFREE GM, 1975, BRIT J CANCER, V32, P87, DOI 10.1038/bjc.1975.136; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; MALKIN D, 1992, NEW ENGL J MED, V326, P1309, DOI 10.1056/NEJM199205143262002; Marina N, 2004, ONCOLOGIST, V9, P422, DOI 10.1634/theoncologist.9-4-422; Meyers PA, 2005, J CLIN ONCOL, V23, P2004, DOI 10.1200/JCO.2005.06.031; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Murase M, 2009, BRIT J CANCER, V101, P1425, DOI 10.1038/sj.bjc.6605330; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olstad OK, 2003, ANTICANCER RES, V23, P2201; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang C, 2007, ANN ACAD MED SINGAP, V36, P352; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Vermeulen L, 2008, CELL DEATH DIFFER, V15, P947, DOI 10.1038/cdd.2008.20; Veselska R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-300; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476	42	154	164	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					2022	2030		10.1096/fj.10-179036	http://dx.doi.org/10.1096/fj.10-179036			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21385990				2022-12-25	WOS:000291023800024
J	Huang, H; Ishida, H; Yamniuk, AP; Vogel, HJ				Huang, Hao; Ishida, Hiroaki; Yamniuk, Aaron P.; Vogel, Hans J.			Solution Structures of Ca2+-CIB1 and Mg2+-CIB1 and Their Interactions with the Platelet Integrin alpha IIb Cytoplasmic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT PROTEINS; LIQUID-CRYSTALLINE PHASE; CALCIUM-BINDING PROTEIN; NMR-SPECTROSCOPY; CHEMICAL-SHIFT; EF-HAND; BIOLOGICAL MACROMOLECULES; CONFORMATIONAL-CHANGES; SECONDARY STRUCTURE; DIPOLAR COUPLINGS	The calcium-and integrin-binding protein 1 (CIB1) is a ubiquitous Ca2+-binding protein and a specific binding partner for the platelet integrin alpha IIb cytoplasmic domain, which confers the key role of CIB1 in hemostasis. CIB1 is also known to be involved in apoptosis, embryogenesis, and the DNA damage response. In this study, the solution structures of both Ca(2+)CIB1 and Mg2+-CIB1 were determined using solution-state NMR spectroscopy. The methyl groups of Ile, Leu, and Val were selectively protonated to compensate for the loss of protons due to deuteration. The solution structure of Ca2+-CIB1 possesses smaller opened EF-hands in its C-domain compared with available crystal structures. Ca2+-CIB1 and Mg2+-CIB1 have similar structures, but the N-lobe of Mg2+-CIB1 is slightly more opened than that of Ca2+-CIB1. Additional NMR experiments, such as chemical shift perturbation and methyl group solvent accessibility as measured by a nitroxide surface probe, were carried out to further characterize the structures of Ca2+-CIB1 and Mg2+-CIB1 as well as their interactions with the integrin alpha IIb cytoplasmic domain. NMR measurements of backbone amide proton slow motion (microsecond to millisecond) dynamics confirmed that the C-terminal helix of Ca2+-CIB1 is displaced upon alpha IIb binding. The EF-hand III of both Ca2+-CIB1 and Mg2+-CIB1 was identified to be directly involved in the interaction of CIB1 with alpha IIb. Together, these data illustrate that CIB1 behaves quite differently from related EF-hand regulatory calcium-binding proteins, such as calmodulin or neuronal calcium sensor proteins.	[Huang, Hao; Ishida, Hiroaki; Yamniuk, Aaron P.; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Biochem Res Grp, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca			Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported in part by the Canadian Institutes of Health Research.; Recipient of an Alberta Heritage Foundation for Medical Research Studentship award.; Recipient of a scientist award from the Alberta Heritage Foundation for Medical Research. To whom correspondence should be addressed: Dept. of Biological Sciences, University of Calgary, 2500 University Dr. NW, Calgary, Alberta T2N 1N4, Canada. Tel.: 403-220-6006; Fax: 403-289-9311; E-mail:vogel@ucalgary.ca.	BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Barry WT, 2002, J BIOL CHEM, V277, P28877, DOI 10.1074/jbc.M202983200; Blamey CJ, 2005, PROTEIN SCI, V14, P1214, DOI 10.1110/ps.041270805; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Chou JJ, 2000, J BIOMOL NMR, V18, P217, DOI 10.1023/A:1026563923774; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Das R, 2006, J AM CHEM SOC, V128, P8406, DOI 10.1021/ja060046d; DeNofrio JC, 2008, THROMB HAEMOSTASIS, V100, P847, DOI 10.1160/TH08-06-0351; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Heineke J, 2010, NAT MED, V16, P872, DOI 10.1038/nm.2181; HOWARTH JW, 1995, PROTEIN SCI, V4, P671; Huang H, 2010, PROTEIN SCI, V19, P475, DOI 10.1002/pro.325; Hwang PM, 2000, J MOL RECOGNIT, V13, P83, DOI 10.1002/(SICI)1099-1352(200003/04)13:2<83::AID-JMR491>3.0.CO;2-A; Ishida H, 2008, J BIOL CHEM, V283, P14619, DOI 10.1074/jbc.M801398200; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kay LE, 2005, J MAGN RESON, V173, P193, DOI 10.1016/j.jmr.2004.11.021; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Leisner TM, 2007, CURR OPIN HEMATOL, V14, P255, DOI 10.1097/MOH.0b013e3280dce543; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; Li CM, 2009, J BIOL CHEM, V284, P2472, DOI 10.1074/jbc.M806513200; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Mulder FAA, 2000, BIOCHEMISTRY-US, V39, P12614, DOI 10.1021/bi001351t; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Ohki SY, 1997, BIOCHEMISTRY-US, V36, P4309, DOI 10.1021/bi962759m; Orban T, 2010, STRUCTURE, V18, P116, DOI 10.1016/j.str.2009.11.008; Ottiger M, 1998, J AM CHEM SOC, V120, P12334, DOI 10.1021/ja9826791; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Park CJ, 2005, NUCLEIC ACIDS RES, V33, P4172, DOI 10.1093/nar/gki736; Pennestri M, 2007, J BIOL CHEM, V282, P667, DOI 10.1074/jbc.M607016200; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; RICHARDS FM, 1988, PROTEINS, V3, P71, DOI 10.1002/prot.340030202; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Stabler SM, 1999, J CELL BIOL, V145, P1277, DOI 10.1083/jcb.145.6.1277; Tsuboi S, 2002, J BIOL CHEM, V277, P1919, DOI 10.1074/jbc.M110643200; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Weljie AM, 2003, PROTEIN SCI, V12, P228, DOI 10.1110/ps.0226203; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yamniuk AP, 2008, BIOCHEMISTRY-US, V47, P1696, DOI 10.1021/bi701494m; Yamniuk AP, 2007, BIOCHEMISTRY-US, V46, P7088, DOI 10.1021/bi700200z; Yamniuk AP, 2006, J BIOL CHEM, V281, P26455, DOI 10.1074/jbc.M603963200; Yamniuk AP, 2009, PROTEIN SCI, V18, P1128, DOI 10.1002/pro.104; Yamniuk AP, 2005, PROTEIN SCI, V14, P1429, DOI 10.1110/ps.041312805; Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b; Yamniuk AP, 2006, CALCIUM BINDING PROT, V1, P150; Yang DW, 1999, J BIOMOL NMR, V14, P333, DOI 10.1023/A:1008314803561; Yang DW, 2004, J AM CHEM SOC, V126, P3710, DOI 10.1021/ja039102q; Yoon KW, 2009, P NATL ACAD SCI USA, V106, P17389, DOI 10.1073/pnas.0812259106; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	57	17	19	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17181	17192		10.1074/jbc.M110.179028	http://dx.doi.org/10.1074/jbc.M110.179028			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21388953	Green Published, hybrid			2022-12-25	WOS:000290301900067
J	Qi, TY; Tang, W; Wang, L; Zhai, L; Guo, LJ; Zeng, XL				Qi, Tianyang; Tang, Wen; Wang, Ling; Zhai, Lei; Guo, Lijing; Zeng, Xianlu			G-actin Participates in RNA Polymerase II-dependent Transcription Elongation by Recruiting Positive Transcription Elongation Factor b (P-TEFb)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROMODOMAIN PROTEIN BRD4; C-TERMINAL DOMAIN; NUCLEAR ACTIN; GENE-EXPRESSION; CDK9/CYCLIN T1; BETA-ACTIN; HIV-1 TAT; 7SK SNRNA; MYOSIN-I; HNRNP-U	Actin is a key regulator of RNA polymerase (Pol) II-dependent transcription. Positive transcription elongation factor b (P-TEFb), a Cdk9/cyclin T1 heterodimer, has been reported to play a critical role in transcription elongation. However, the relationship between actin and P-TEFb is still not clear. In this study, actin was found to interact with Cdk9, a catalytic subunit of P-TEFb, in elongation complexes. Using immunofluorescence and immunoprecipitation assays, Cdk9 was found to bind to G-actin through the conserved Thr-186 in the T-loop. Overexpression and in vitro kinase assays showed that G-actin promotes P-TEFb-dependent phosphorylation of the Pol II C-terminal domain. An in vitro transcription experiment revealed that the interaction between G-actin and Cdk9 stimulated Pol II transcription elongation. ChIP and immobilized template assays indicated that actin recruited Cdk9 to a transcriptional template in vivo and in vitro. Using cytokine IL-6-inducible p21 gene expression system, we revealed that actin recruited Cdk9 to endogenous gene. Moreover, overexpression of actin and Cdk9 increased histone H3 acetylation and acetylized histone H3 binding to a transcriptional template through the interaction with histone acetyltransferase, p300. Taken together, our results suggested that actin participates in transcription elongation by recruiting Cdk9 for phosphorylation of the Pol II C-terminal domain, and the actin-Cdk9 interaction promotes chromatin remodeling.	[Zeng, Xianlu] NE Normal Univ, Key Lab Mol Epigenet MOE, Changchun 130024, Jilin, Peoples R China; NE Normal Univ, Inst Cytol & Genet, Changchun 130024, Jilin, Peoples R China	Northeast Normal University - China; Northeast Normal University - China	Zeng, XL (corresponding author), NE Normal Univ, Key Lab Mol Epigenet MOE, Changchun 130024, Jilin, Peoples R China.	zengx779@nenu.edu.cn	Zhai, Lei/AAJ-1301-2020	Zhai, Lei/0000-0002-3886-2154	National Basic Research Program of China [2005CB522404]; National Natural Science Foundation of China [90608021]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (Grant 2005CB522404) and the National Natural Science Foundation of China (Grant 90608021).	Arndt KM, 2003, TRENDS GENET, V19, P543, DOI 10.1016/j.tig.2003.08.008; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; Choi CH, 2003, NATURE, V424, P965, DOI 10.1038/nature01899; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; Dvir A, 1997, P NATL ACAD SCI USA, V94, P9006, DOI 10.1073/pnas.94.17.9006; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; Fong YW, 2000, MOL CELL BIOL, V20, P5897, DOI 10.1128/MCB.20.16.5897-5907.2000; Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Hu P, 2004, GENE DEV, V18, P3010, DOI 10.1101/gad.1250804; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jockusch BM, 2006, TRENDS CELL BIOL, V16, P391, DOI 10.1016/j.tcb.2006.06.006; Jones KA, 1997, GENE DEV, V11, P2593, DOI 10.1101/gad.11.20.2593; Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Mayeda A, 1999, METH MOL B, V118, P309; McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101; Mellor J, 2005, MOL CELL, V19, P147, DOI 10.1016/j.molcel.2005.06.023; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Obrdlik A, 2008, MOL CELL BIOL, V28, P6342, DOI 10.1128/MCB.00766-08; OBRIEN T, 1994, NATURE, V370, P75, DOI 10.1038/370075a0; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pederson T, 2002, J STRUCT BIOL, V140, P3, DOI 10.1016/S1047-8477(02)00528-2; Percipalle P, 2006, J CELL BIOL, V172, P967, DOI 10.1083/jcb.200512083; Percipalle P, 2003, P NATL ACAD SCI USA, V100, P6475, DOI 10.1073/pnas.1131933100; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Simone C, 2002, ONCOGENE, V21, P4158, DOI 10.1038/sj.onc.1205511; Sjolinder M, 2005, GENE DEV, V19, P1871, DOI 10.1101/gad.339405; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Sunagawa Y, 2010, J BIOL CHEM, V285, P9556, DOI 10.1074/jbc.M109.070458; Vieu E, 2006, NAT CELL BIOL, V8, P650, DOI 10.1038/ncb0706-650; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908; Yik JHN, 2004, MOL CELL BIOL, V24, P5094, DOI 10.1128/MCB.24.12.5094-5105.2004; Yoo YD, 2007, J BIOL CHEM, V282, P7616, DOI 10.1074/jbc.M607596200; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5; ZHOU QA, 1995, EMBO J, V14, P321, DOI 10.1002/j.1460-2075.1995.tb07006.x	53	40	40	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15171	15181		10.1074/jbc.M110.184374	http://dx.doi.org/10.1074/jbc.M110.184374			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21378166	Green Published, hybrid			2022-12-25	WOS:000289788300049
J	Hartlerode, A; Odate, S; Shim, I; Brown, J; Scully, R				Hartlerode, Andrea; Odate, Shobu; Shim, Inbo; Brown, Jenifer; Scully, Ralph			Cell Cycle-Dependent Induction of Homologous Recombination by a Tightly Regulated I-SceI Fusion Protein	PLOS ONE			English	Article							STRAND BREAK REPAIR; SISTER-CHROMATID RECOMBINATION; MAMMALIAN-CELLS; SACCHAROMYCES-CEREVISIAE; ESTROGEN-RECEPTOR; BINDING DOMAINS; GENE CONVERSION; DNA-DAMAGE; BRCA1; MAINTENANCE	Double-strand break repair is executed by two major repair pathways: non-homologous end joining (NHEJ) and homologous recombination (HR). Whereas NHEJ contributes to the repair of ionizing radiation (IR)-induced double strand breaks (DSBs) throughout the cell cycle, HR acts predominantly during the S and G2 phases of the cell cycle. The rare-cutting restriction endonuclease, I-SceI, is in common use to study the repair of site-specific chromosomal DSBs in vertebrate cells. To facilitate analysis of I-SceI-induced DSB repair, we have developed a stably expressed I-SceI fusion protein that enables precise temporal control of I-SceI activation, and correspondingly tight control of the timing of onset of site-specific chromosome breakage. I-SceI-induced HR showed a strong, positive linear correlation with the percentage of cells in S phase, and was negatively correlated with the G1 fraction. Acute depletion of BRCA1, a key regulator of HR, disrupted the relationship between S phase fraction and I-SceI-induced HR, consistent with the hypothesis that BRCA1 regulates HR during S phase.	[Hartlerode, Andrea] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Hartlerode, A (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.	rscully@bidmc.harvard.edu	Scully, Ralph/F-5008-2013		NIH [R01CA095175, R01GM073894, R21CA144022]; NATIONAL CANCER INSTITUTE [R01CA095175, RC1CA145867, R21CA144022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073894] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH R01CA095175; R01GM073894; R21CA144022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; DANIELIAN PS, 1993, MOL ENDOCRINOL, V7, P232, DOI 10.1210/me.7.2.232; Delacote F, 2008, CELL CYCLE, V7, P33, DOI 10.4161/cc.7.1.5149; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gonzalez-Barrera S, 2003, MOL CELL, V11, P1661, DOI 10.1016/S1097-2765(03)00183-7; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Hunter NL, 2005, GENESIS, V41, P99, DOI 10.1002/gene.20101; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jackman J, 2001, Curr Protoc Cell Biol, VChapter 8, DOI 10.1002/0471143030.cb0803s00; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; KADYK LC, 1992, GENETICS, V132, P387; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; MATTIONI T, 1994, METHOD CELL BIOL, V43, P335; McPherson JP, 2006, HUM MOL GENET, V15, P831, DOI 10.1093/hmg/ddl002; Moure CM, 2003, J MOL BIOL, V334, P685, DOI 10.1016/j.jmb.2003.09.068; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Nagaraju G, 2006, MOL CELL BIOL, V26, P8075, DOI 10.1128/MCB.01235-06; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Puget N, 2005, DNA REPAIR, V4, P149, DOI 10.1016/j.dnarep.2004.08.010; Rao S, 1998, ONCOGENE, V17, P2393, DOI 10.1038/sj.onc.1202322; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; SAINTIGNY Y, 2006, ONCOGENE; Savic V, 2009, MOL CELL, V34, P298, DOI 10.1016/j.molcel.2009.04.012; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	38	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e16501	10.1371/journal.pone.0016501	http://dx.doi.org/10.1371/journal.pone.0016501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408059	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170900003
J	Prosser, DJ; Cui, P; Takekawa, JY; Tang, MJ; Hou, YS; Collins, BM; Yan, BP; Hill, NJ; Li, TX; Li, YD; Lei, FM; Guo, S; Xing, Z; He, YB; Zhou, YC; Douglas, DC; Perry, WM; Newman, SH				Prosser, Diann J.; Cui, Peng; Takekawa, John Y.; Tang, Mingjie; Hou, Yuansheng; Collins, Bridget M.; Yan, Baoping; Hill, Nichola J.; Li, Tianxian; Li, Yongdong; Lei, Fumin; Guo, Shan; Xing, Zhi; He, Yubang; Zhou, Yuanchun; Douglas, David C.; Perry, William M.; Newman, Scott H.			Wild Bird Migration across the Qinghai-Tibetan Plateau: A Transmission Route for Highly Pathogenic H5N1	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUSES; CHINA; INFECTION; PERSISTENCE; WATERFOWL; OUTBREAK; GEESE; LAKE; EPIDEMIOLOGY	Background: Qinghai Lake in central China has been at the center of debate on whether wild birds play a role in circulation of highly pathogenic avian influenza virus H5N1. In 2005, an unprecedented epizootic at Qinghai Lake killed more than 6000 migratory birds including over 3000 bar-headed geese (Anser indicus). H5N1 subsequently spread to Europe and Africa, and in following years has re-emerged in wild birds along the Central Asia flyway several times. Methodology/Principal Findings: To better understand the potential involvement of wild birds in the spread of H5N1, we studied the movements of bar-headed geese marked with GPS satellite transmitters at Qinghai Lake in relation to virus outbreaks and disease risk factors. We discovered a previously undocumented migratory pathway between Qinghai Lake and the Lhasa Valley of Tibet where 93% of the 29 marked geese overwintered. From 2003-2009, sixteen outbreaks in poultry or wild birds were confirmed on the Qinghai-Tibet Plateau, and the majority were located within the migratory pathway of the geese. Spatial and temporal concordance between goose movements and three potential H5N1 virus sources (poultry farms, a captive bar-headed goose facility, and H5N1 outbreak locations) indicated ample opportunities existed for virus spillover and infection of migratory geese on the wintering grounds. Their potential as a vector of H5N1 was supported by rapid migration movements of some geese and genetic relatedness of H5N1 virus isolated from geese in Tibet and Qinghai Lake. Conclusions/Significance: This is the first study to compare phylogenetics of the virus with spatial ecology of its host, and the combined results suggest that wild birds play a role in the spread of H5N1 in this region. However, the strength of the evidence would be improved with additional sequences from both poultry and wild birds on the Qinghai-Tibet Plateau where H5N1 has a clear stronghold.	[Prosser, Diann J.; Collins, Bridget M.] US Geol Survey, Patuxent Wildlife Res Ctr, Beltsville, MD USA; [Prosser, Diann J.] Univ Maryland, Marine Estuarine Environm Sci, College Pk, MD 20742 USA; [Cui, Peng; Lei, Fumin] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Cui, Peng; Tang, Mingjie] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Takekawa, John Y.; Hill, Nichola J.; Perry, William M.] US Geol Survey, Western Ecol Res Ctr, Vallejo, CA USA; [Tang, Mingjie; Yan, Baoping; Zhou, Yuanchun] Chinese Acad Sci, Comp Network Informat Ctr, Beijing, Peoples R China; [Hou, Yuansheng; Xing, Zhi; He, Yubang] State Forestry Adm, Qinghai Lake Natl Nat Reserve, Xining, Qinghai, Peoples R China; [Li, Tianxian; Li, Yongdong] Chinese Acad Sci, Wuhan Inst Virol, Wuhan, Hubei, Peoples R China; [Guo, Shan] Chinese Acad Sci, Inst Remote Sensing Applicat, Beijing, Peoples R China; [Douglas, David C.] US Geol Survey, Alaska Sci Ctr, Juneau, AK USA; [Newman, Scott H.] Food & Agr Org United Nations, Anim Prod & Hlth Div, EMPRES Wildlife Unit, Rome, Italy	United States Department of the Interior; United States Geological Survey; University System of Maryland; University of Maryland College Park; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; United States Department of the Interior; United States Geological Survey; Chinese Academy of Sciences; Computer Network Information Center, CAS; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; United States Department of the Interior; United States Geological Survey; Food & Agriculture Organization of the United Nations (FAO)	Prosser, DJ (corresponding author), US Geol Survey, Patuxent Wildlife Res Ctr, Beltsville, MD USA.	dprosser@usgs.gov	Hill, Nichola/G-4003-2011; Douglas, David C./AAU-1087-2021	Douglas, David C./0000-0003-0186-1104; Palm, Eric/0000-0002-5330-4804; /0000-0003-3213-6693; Prosser, Diann/0000-0002-5251-1799	Patuxent Wildlife Research Center; Western Ecological Research Center; Alaska Science Center; Avian Influenza Program; United Nations FAO, Animal Production and Health Division,; EMPRES Wildlife Unit; National Science Foundation [0713027]; Chinese Academy of Sciences [2007FY210700, INFO-115-D02, KSCX2-YW-N-063, 2005CB523007]	Patuxent Wildlife Research Center; Western Ecological Research Center; Alaska Science Center; Avian Influenza Program; United Nations FAO, Animal Production and Health Division,; EMPRES Wildlife Unit; National Science Foundation(National Science Foundation (NSF)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the United States Geological Survey (Patuxent Wildlife Research Center, Western Ecological Research Center, Alaska Science Center, and Avian Influenza Program); the United Nations FAO, Animal Production and Health Division, EMPRES Wildlife Unit; National Science Foundation Small Grants for Exploratory Research (No. 0713027); and the Chinese Academy of Sciences (No. 2007FY210700, INFO-115-D02, KSCX2-YW-N-063 and 2005CB523007). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2006, J WILDLIFE MANAGE, V70, P965, DOI 10.2193/0022-541X(2006)70[965:SUBWGW]2.0.CO;2; AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Alexander DJ, 2008, WORLD POULTRY SCI J, V64, P513, DOI 10.1017/S0043933908000184; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; [Anonymous], 2010, R PROJ STAT COMP; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bin Muzaffar S, 2010, WATERBIRDS, V33, P219, DOI 10.1675/063.033.s116; Bishop MA, 2007, CHINA CRANE NEWS, V11, P24; Bishop Mary A., 1997, Wildfowl, V48, P118; Boere CG, 2006, WATERBIRDS WORLD, P40; BREIMAN L., 1984, CRC PRESS; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Butler D, 2006, NATURE, V441, P263, DOI 10.1038/441263a; Chan S., 2009, DIRECTORY IMPORTANT; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Costa TP, 2010, AVIAN DIS, V54, P1286, DOI 10.1637/9480-072210-Reg.1; Dzubin A. E., 1992, MEASUREMENTS GEESE G; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; FAO, 2007, GRIDD LIV WORLD 2007; FAO, 2007, WILD BIRDS AV INFL I; Feare CJ, 2010, J WILDLIFE DIS, V46, P1340, DOI 10.7589/0090-3558-46.4.1340; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Fisher R. A., 1946, Statistical methods for research workers.; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Fouchier RAM, 2007, J WILDLIFE DIS, V43, pS7; GAIDET N, 2010, J APPL ECOLOGY; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; Guo Y, 1998, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V12, P322; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Horne JS, 2006, ECOLOGY, V87, P1146, DOI 10.1890/0012-9658(2006)87[1146:STBHRM]2.0.CO;2; HORNE JS, 2009, ANIMAL SPACE USE VER; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lang Aaron, 2007, Forktail, V23, P1; Lei FM, 2007, AVIAN DIS, V51, P568, DOI 10.1637/0005-2086(2007)51[568:COHIVI]2.0.CO;2; Li L., 2001, CHINA CRANE NEWS, V5, P36; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Liang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013575; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Liu Jiyuan, 2002, Journal of Geographical Sciences, V12, P275; Liu JY, 2003, INT J REMOTE SENS, V24, P2485, DOI 10.1080/01431160110115582; Manly BFJ, 2002, RESOURCE SELECTION A, DOI 10.1007/978-94-011-1558-2; Miyabayashi Y, 1999, ATLAS KEY SITES ANAT; *MOA, 2009, PREV CONTR AV INFL; MUZAFFAR SB, 2006, WATERBIRDS, V29, P243, DOI DOI 10.1675/1524-4695(2006)29[243:AIAEAE]2.0.CO;2; *NAT BIRD BAND CTR, 1987, CHIN BIRD BAND ALM 1; Newman SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005729; Normile D, 2006, SCIENCE, V311, P1225, DOI 10.1126/science.311.5765.1225; *OIE, 2010, UPD HIGHL PATH AV IN; *OIE, 2004, AV INFL, P465; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; Ramsar Convention Secretariat, 2007, DES RAMS SIT STRAT F; Rhode D, 2010, QUATERN INT, V218, P29, DOI 10.1016/j.quaint.2009.03.004; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sims L. S., 2008, AVIAN INFLUENZA, P251; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Takekawa JY, 2010, AVIAN DIS, V54, P466, DOI 10.1637/8914-043009-Reg.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Therneau T. M., 1997, INTRO RECURSIVE PART; UTTANGI J, 1987, J BOMBAY NAT HIST SO, V10, P22; Weber TP, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-57; Xu H, 2007, PALAEOGEOGR PALAEOCL, V254, P541, DOI 10.1016/j.palaeo.2007.07.007; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yasue M, 2006, BIOSCIENCE, V56, P923, DOI 10.1641/0006-3568(2006)56[923:TEOHAI]2.0.CO;2; Zhang Guo-Gang, 2008, Chinese Journal of Zoology, V43, P51	71	91	99	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17622	10.1371/journal.pone.0017622	http://dx.doi.org/10.1371/journal.pone.0017622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408010	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170900031
J	Teruel, R; Corral, J; Perez-Andreu, V; Martinez-Martinez, I; Vicente, V; Martinez, C				Teruel, Raul; Corral, Javier; Perez-Andreu, Virginia; Martinez-Martinez, Irene; Vicente, Vicente; Martinez, Constantino			Potential Role of miRNAs in Developmental Haemostasis	PLOS ONE			English	Article							BREAST-CANCER CELLS; TARGET RECOGNITION; MICRORNAS	MicroRNAs (miRNAs) are an abundant class of small non-coding RNAs that are negative regulators in a crescent number of physiological and pathological processes. However, their role in haemostasis, a complex physiological process involving multitude of effectors, is just beginning to be characterized. We evaluated the changes of expression of miRNAs in livers of neonates (day one after birth) and adult mice by microarray and qRT-PCR trying to identify miRNAs that potentially may also be involved in the control of the dramatic change of hepatic haemostatic protein levels associated with this transition. Twenty one out of 41 miRNAs overexpressed in neonate mice have hepatic haemostatic mRNA as potential targets. Six of them identified by two in silico algorithms potentially bind the 3'UTR regions of F7, F9, F12, FXIIIB, PLG and SERPINC1 mRNA. Interestingly, miR-18a and miR-19b, overexpressed 5.4 and 8.2-fold respectively in neonates, have antithrombin, a key anticoagulant with strong anti-angiogenic and anti-inflammatory roles, as a potential target. The levels of these two miRNAs inversely correlated with antithrombin mRNA levels during development (miR-19b: R = 0.81; p = 0.03; miR-18a: R = 0.91; p<0.001). These data suggest that miRNAs could be potential modulators of the haemostatic system involved in developmental haemostasis.	[Teruel, Raul; Corral, Javier; Perez-Andreu, Virginia; Martinez-Martinez, Irene; Vicente, Vicente; Martinez, Constantino] Univ Murcia, Ctr Reg Hemodonac, E-30001 Murcia, Spain	University of Murcia	Teruel, R (corresponding author), Univ Murcia, Ctr Reg Hemodonac, E-30001 Murcia, Spain.	constant@um.es	Vicente, Vicente/L-6185-2019; Martinez, Constantino/R-8972-2019; Teruel-Montoya, Raúl/H-9012-2017; Martínez-Martínez, Irene/AAM-8862-2020	Vicente, Vicente/0000-0002-4278-3264; Teruel-Montoya, Raúl/0000-0002-6741-9725; Martínez-Martínez, Irene/0000-0002-1067-6464; Corral, Javier/0000-0003-0288-1107; Martinez, Constantino/0000-0002-2976-2354	Spanish Ministry of Science and Innovation [BES-2007-16973]; ISCIII; FEDER [PI08/1506, EMER07/035, RECAVA RD06/0014/0039, SAF2009-08993]; MCYT; Fundacion Seneca [07703/GERM/07]; Fundacion Mutua Madrilena	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ISCIII(Instituto de Salud Carlos III); FEDER(European Commission); MCYT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Seneca(Fundacion Seneca); Fundacion Mutua Madrilena(Instituto de Salud Carlos III)	RT holds an FPI fellowship from the Spanish Ministry of Science and Innovation (BES-2007-16973). VPA holds a Research Fellowship Rio Hortega from ISCIII. CM and IMM are investigators from Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia (FFIS). This work was supported by research grants from ISCIII (www.isciii.es) and FEDER (PI08/1506, EMER07/035 and RECAVA RD06/0014/0039), MCYT (www.mityc.es) & FEDER (SAF2009-08993), Fundacion Seneca (www.f-seneca.org) 07703/GERM/07 and Fundacion Mutua Madrilena (www.fundacionmutua.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005370.pub2; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; ANDREW M, 1987, BLOOD, V70, P165, DOI 10.1182/blood.V70.1.165.165; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Fort A, 2010, BLOOD, V116, P2608, DOI 10.1182/blood-2010-02-268011; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Lei Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007629; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Monagle P, 2006, THROMB HAEMOSTASIS, V95, P362, DOI 10.1160/TH05-01-0047; Monagle P, 2010, BLOOD REV, V24, P63, DOI 10.1016/j.blre.2009.12.001; Muth M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-33; Schedin-Weiss S, 2008, BIOCHEMISTRY-US, V47, P13610, DOI 10.1021/bi801656u; Spizzo R, 2010, CELL DEATH DIFFER, V17, P246, DOI 10.1038/cdd.2009.117; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tzur G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007511; Wan HY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-16	20	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17648	10.1371/journal.pone.0017648	http://dx.doi.org/10.1371/journal.pone.0017648			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408009	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170900035
J	Becker, SI				Becker, Stefanie I.			Determinants of Dwell Time in Visual Search: Similarity or Perceptual Difficulty?	PLOS ONE			English	Article							EYE-MOVEMENT CONTROL; ATTENTION; SELECTION; CONTRAST; COLOR	The present study examined the factors that determine the dwell times in a visual search task, that is, the duration the gaze remains fixated on an object. It has been suggested that an item's similarity to the search target should be an important determiner of dwell times, because dwell times are taken to reflect the time needed to reject the item as a distractor, and such discriminations are supposed to be harder the more similar an item is to the search target. In line with this similarity view, a previous study shows that, in search for a target ring of thin line-width, dwell times on thin linewidth Landolt C's distractors were longer than dwell times on Landolt C's with thick or medium linewidth. However, dwell times may have been longer on thin Landolt C's because the thin line-width made it harder to detect whether the stimuli had a gap or not. Thus, it is an open question whether dwell times on thin line-width distractors were longer because they were similar to the target or because the perceptual decision was more difficult. The present study de-coupled similarity from perceptual difficulty, by measuring dwell times on thin, medium and thick line-width distractors when the target had thin, medium or thick line-width. The results showed that dwell times were longer on target-similar than target-dissimilar stimuli across all target conditions and regardless of the line-width. It is concluded that prior findings of longer dwell times on thin linewidth-distractors can clearly be attributed to target similarity. As will be discussed towards the end, the finding of similarity effects on dwell times has important implications for current theories of visual search and eye movement control.	Univ Queensland, Sch Psychol, Brisbane, Qld, Australia	University of Queensland	Becker, SI (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	s.becker@psy.uq.edu.au		Becker, Stefanie/0000-0003-4198-5056	University of Queensland	University of Queensland(University of Queensland)	The present research was funded by two University of Queensland grants awarded to Stefanie I. Becker, a post-doctoral UQ fellowship and an early career researcher grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, EYE MOVEMENTS THEIR; Bauer B, 1996, VISION RES, V36, P1439, DOI 10.1016/0042-6989(95)00207-3; Becker SI, 2010, J EXP PSYCHOL GEN, V139, P247, DOI 10.1037/a0018808; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; DZMURA M, 1991, VISION RES, V31, P951, DOI 10.1016/0042-6989(91)90203-H; Findlay JM, 1997, VISION RES, V37, P617, DOI 10.1016/S0042-6989(96)00218-0; Hooge ITC, 1998, VISION RES, V38, P1295, DOI 10.1016/S0042-6989(97)00287-3; Hooge LTC, 1996, PERCEPT PSYCHOPHYS, V58, P969, DOI 10.3758/BF03206825; JACOBS AM, 1986, PERCEPT PSYCHOPHYS, V39, P47, DOI 10.3758/BF03207583; LEGGE GE, 1987, VISION RES, V37, P1165; Nasanen R, 2001, VISION RES, V41, P1817, DOI 10.1016/S0042-6989(01)00056-6; Navalpakkam V, 2006, J VISION, V6, P1180, DOI 10.1167/6.11.4; RAYNER K, 1987, PERCEPT PSYCHOPHYS, V42, P87, DOI 10.3758/BF03211517; RAYNER K, 1987, PSYCHOL BULL, V85, P618; Reichle ED, 1998, PSYCHOL REV, V105, P125, DOI 10.1037/0033-295X.105.1.125; Remington RW, 2001, PSYCHOL SCI, V12, P511, DOI 10.1111/1467-9280.00394; Roufs JAJ, 1997, DISPLAYS, V18, P37, DOI 10.1016/S0141-9382(97)00003-6; Shen JY, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P65, DOI 10.1016/B978-044451020-4/50005-0; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Williams CC, 2007, PERCEPT PSYCHOPHYS, V69, P372, DOI 10.3758/BF03193758; Zelinsky GJ, 1997, J EXP PSYCHOL HUMAN, V23, P244, DOI 10.1037/0096-1523.23.1.244; Zelinsky GJ, 1996, VISION RES, V36, P2177, DOI 10.1016/0042-6989(95)00300-2	22	43	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17740	10.1371/journal.pone.0017740	http://dx.doi.org/10.1371/journal.pone.0017740			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FI	21408139	Green Submitted, Green Published, gold			2022-12-25	WOS:000288170000057
J	Cachat, J; Stewart, A; Utterback, E; Hart, P; Gaikwad, S; Wong, K; Kyzar, E; Wu, N; Kalueff, AV				Cachat, Jonathan; Stewart, Adam; Utterback, Eli; Hart, Peter; Gaikwad, Siddharth; Wong, Keith; Kyzar, Evan; Wu, Nadine; Kalueff, Allan V.			Three-Dimensional Neurophenotyping of Adult Zebrafish Behavior	PLOS ONE			English	Article							MEDAKA ORYZIAS-LATIPES; LARVAL ZEBRAFISH; SUBLETHAL TREATMENTS; SWIMMING BEHAVIOR; VIDEO TRACKING; MODEL SYSTEM; DANIO-RERIO; OPEN-FIELD; FISH; RESPONSES	The use of adult zebrafish (Danio rerio) in neurobehavioral research is rapidly expanding. The present large-scale study applied the newest video-tracking and data-mining technologies to further examine zebrafish anxiety-like phenotypes. Here, we generated temporal and spatial three-dimensional (3D) reconstructions of zebrafish locomotion, globally assessed behavioral profiles evoked by several anxiogenic and anxiolytic manipulations, mapped individual endpoints to 3D reconstructions, and performed cluster analysis to reconfirm behavioral correlates of high- and low-anxiety states. The application of 3D swim path reconstructions consolidates behavioral data (while increasing data density) and provides a novel way to examine and represent zebrafish behavior. It also enables rapid optimization of video tracking settings to improve quantification of automated parameters, and suggests that spatiotemporal organization of zebrafish swimming activity can be affected by various experimental manipulations in a manner predicted by their anxiolytic or anxiogenic nature. Our approach markedly enhances the power of zebrafish behavioral analyses, providing innovative framework for high-throughput 3D phenotyping of adult zebrafish behavior.	[Cachat, Jonathan] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, Neurosci Program, Tulane Neurophenotyping Platform & Zebrafish Neur, New Orleans, LA 70112 USA	Tulane University; Tulane University	Cachat, J (corresponding author), Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA.	avkalueff@gmail.com	Kalueff, Allan V/B-3647-2010; Cachat, Jonathan/AAW-1165-2021; Kalueff, Allan/AAB-8620-2022; Cachat, Jonathan M/B-3719-2010	Kalueff, Allan V/0000-0002-7525-1950; Cachat, Jonathan/0000-0002-6504-0869; Kalueff, Allan/0000-0002-7525-1950; Cachat, Jonathan M/0000-0002-6504-0869; Hart, Peter/0000-0003-1843-9102; Kyzar, Evan/0000-0002-7688-0281; Gaikwad, Siddharth/0000-0001-6437-7016	Tulane University [8k2009b]; Zebrafish Neuroscience Research Consortium (ZNRC) [2010-77]; National Institute on Drug Abuse/National Institutes of Health (NIDA/NIH); LA Board of Regents [LAB548530]	Tulane University; Zebrafish Neuroscience Research Consortium (ZNRC); National Institute on Drug Abuse/National Institutes of Health (NIDA/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); LA Board of Regents	This study was supported by Tulane University Intramural Research program (#8k2009b), Zebrafish Neuroscience Research Consortium (ZNRC) (#2010-77), National Institute on Drug Abuse/National Institutes of Health (NIDA/NIH) Drug Supply Program, and LA Board of Regents P-Fund grant (LAB548530). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; Alsop D, 2009, GEN COMP ENDOCR, V161, P62, DOI 10.1016/j.ygcen.2008.09.011; [Anonymous], ZEBRAFISH NEUROBEHAV; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Best J D, 2008, Neuropsychiatr Dis Treat, V4, P567; Blaser RE, 2010, BEHAV BRAIN RES, V208, P56, DOI 10.1016/j.bbr.2009.11.009; Blaser R, 2006, BEHAV RES METHODS, V38, P456, DOI 10.3758/BF03192800; Bleakley BH, 2006, BEHAV GENET, V36, P783, DOI 10.1007/s10519-005-9044-5; Budick SA, 2000, J EXP BIOL, V203, P2565; BURNE T, 2010, BIG IDEAS SMALL BRAI; Cachat J.M., 2010, ZEBRAFISH MODELS NEU; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Cachat J, 2010, BEHAV BRAIN RES, V208, P371, DOI 10.1016/j.bbr.2009.12.004; Champagne DL, 2010, BEHAV BRAIN RES, V214, P332, DOI 10.1016/j.bbr.2010.06.001; Chatterjee D, 2009, BEHAV BRAIN RES, V200, P208, DOI 10.1016/j.bbr.2009.01.016; Chen YC, 2009, HISTOCHEM CELL BIOL, V132, P375, DOI 10.1007/s00418-009-0619-8; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Chon TS, 2005, ENVIRON MONIT ASSESS, V101, P1; Darrow KO, 2004, ZEBRAFISH, V1, P40, DOI 10.1089/154585404774101662; Delcourt J, 2006, BEHAV RES METHODS, V38, P704, DOI 10.3758/BF03193904; Delcourt J, 2009, BEHAV RES METHODS, V41, P228, DOI 10.3758/BRM.41.1.228; Dlugos CA, 2003, PHARMACOL BIOCHEM BE, V74, P471, DOI 10.1016/S0091-3057(02)01026-2; Dodge S, 2009, COMPUT ENVIRON URBAN, V33, P419, DOI 10.1016/j.compenvurbsys.2009.07.008; Echevarria DJ., 2008, INT J COMP PSYCHOL, V21, P19; Eddins D, 2010, NEUROTOXICOL TERATOL, V32, P99, DOI 10.1016/j.ntt.2009.02.005; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Engeszer RE, 2004, CURR BIOL, V14, P881, DOI 10.1016/j.cub.2004.04.042; Fan CY, 2010, NEUROTOXICOL TERATOL, V32, P91, DOI 10.1016/j.ntt.2009.04.065; FERO K, 2010, ZEBRAFISH MODELS NEU; Fontaine E, 2008, J EXP BIOL, V211, P1305, DOI 10.1242/jeb.010272; FUIMAN LA, 1988, ANIM BEHAV, V36, P250, DOI 10.1016/S0003-3472(88)80268-9; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2003, BEHAV GENET, V33, P461, DOI 10.1023/A:1025762314250; Gerlai R, 2006, PHARMACOL BIOCHEM BE, V85, P752, DOI 10.1016/j.pbb.2006.11.010; Gerlai R, 2010, MOLECULES, V15, P2609, DOI 10.3390/molecules15042609; Gerlai R, 2010, BEHAV BRAIN RES, V207, P223, DOI 10.1016/j.bbr.2009.10.008; Gomez-Laplaza LM, 2010, BEHAV BRAIN RES, V208, P509, DOI 10.1016/j.bbr.2009.12.031; Graham N, 2004, ICES J MAR SCI, V61, P1036, DOI 10.1016/j.icesjms.2004.06.006; Grossman L, 2010, BEHAV BRAIN RES, V214, P277, DOI 10.1016/j.bbr.2010.05.039; Hicks C, 2006, J NEUROBIOL, V66, P977, DOI 10.1002/neu.20290; HUSE I, 1990, AQUACULT ENG, V9, P131, DOI 10.1016/0144-8609(90)90016-S; Jadot C, 2005, J FISH BIOL, V67, P589, DOI 10.1111/j.0022-1112.2005.00761.x; Kane AS, 2004, WATER RES, V38, P3993, DOI 10.1016/j.watres.2004.06.028; Kato S, 2004, J NEUROSCI METH, V134, P1, DOI 10.1016/j.jneumeth.2003.09.028; Kwak IS, 2002, ENVIRON POLLUT, V120, P671, DOI 10.1016/S0269-7491(02)00183-5; Larson ET, 2006, BEHAV BRAIN RES, V167, P94, DOI 10.1016/j.bbr.2005.08.020; Laube P., 2009, BEHAV MONITORING INT; LEE S, 2005, COMPUTER ANAL IMAGES; Levin ED, 2004, NEUROTOXICOL TERATOL, V26, P731, DOI 10.1016/j.ntt.2004.06.010; Levin ED, 2006, NEUROTOXICOL TERATOL, V28, P709, DOI 10.1016/j.ntt.2006.09.016; Levin ED, 2007, PHYSIOL BEHAV, V90, P54, DOI 10.1016/j.physbeh.2006.08.026; Lockwood B, 2004, PHARMACOL BIOCHEM BE, V77, P647, DOI 10.1016/j.pbb.2004.01.003; MacIver MA, 2000, J NEUROSCI METH, V95, P133, DOI 10.1016/S0165-0270(99)00161-2; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Maximino C, 2010, BEHAV BRAIN RES, V210, P1, DOI 10.1016/j.bbr.2010.01.031; Maximino C, 2010, NAT PROTOC, V5, P209, DOI 10.1038/nprot.2009.225; McElligott MB, 2005, BRAIN BEHAV EVOLUT, V66, P177, DOI 10.1159/000087158; McGonnell IM, 2006, J ENDOCRINOL, V189, P425, DOI 10.1677/joe.1.06683; MCHENRY MJ, 1995, J EXP BIOL, V198, P2293; Miller N, 2007, BEHAV BRAIN RES, V184, P157, DOI 10.1016/j.bbr.2007.07.007; Morris JA, 2009, PROG BRAIN RES, V179, P97, DOI 10.1016/S0079-6123(09)17911-6; Nimkerdphol K, 2008, J BIOSCI BIOENG, V105, P486, DOI 10.1263/jbb.105.486; Norton W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-90; Panula P., 2010, NEUROBIOL DIS; Panula P, 2006, ZEBRAFISH, V3, P235, DOI 10.1089/zeb.2006.3.235; Park YS, 2005, AQUAT TOXICOL, V71, P215, DOI 10.1016/j.aquatox.2004.11.002; Patullo BW, 2007, BEHAV RES METHODS, V39, P783, DOI 10.3758/BF03192969; PAULL GC, 2010, DOMINANCE HIERARCHIE; Peitsaro N, 2007, BIOCHEM PHARMACOL, V73, P1205, DOI 10.1016/j.bcp.2007.01.014; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Redolat Rosa, 2009, Curr Drug Abuse Rev, V2, P230; Renier C, 2007, PHARMACOGENET GENOM, V17, P237, DOI 10.1097/FPC.0b013e3280119d62; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; ROSSANCHEZ G, 2010, TURK 20 INT C PATT R; Rubinstein AL, 2006, EXPERT OPIN DRUG MET, V2, P231, DOI 10.1517/17425255.2.2.231; Sackerman James, 2010, Int J Comp Psychol, V23, P43; Salas C, 2006, ZEBRAFISH, V3, P157, DOI 10.1089/zeb.2006.3.157; Sarrazin AF, 2010, J NEUROSCI, V30, P8234, DOI 10.1523/JNEUROSCI.5137-09.2010; Saverino C, 2008, BEHAV BRAIN RES, V191, P77, DOI 10.1016/j.bbr.2008.03.013; Shannon W, 2003, PHARMACOGENOMICS, V4, P41, DOI 10.1517/phgs.4.1.41.22581; Speedie N, 2008, BEHAV BRAIN RES, V188, P168, DOI 10.1016/j.bbr.2007.10.031; Stewart A., 2010, INT J COMP PSYCHOL, V23, P104, DOI [10.1016/j.pnpbp.2010.11.035, DOI 10.1016/J.PNPBP.2013.11.014)]; Suzuki K, 2003, FISH RES, V60, P3, DOI 10.1016/S0165-7836(02)00081-4; Thorsen DH, 2004, J EXP BIOL, V207, P4175, DOI 10.1242/jeb.01285; Webb KJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r81; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wong K, 2010, BRAIN RES, V1348, P209, DOI 10.1016/j.brainres.2010.06.012; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023; Wright D, 2003, NATURWISSENSCHAFTEN, V90, P374, DOI 10.1007/s00114-003-0443-2; Xi YW, 2010, EUR J NEUROSCI, V31, P623, DOI 10.1111/j.1460-9568.2010.07091.x	90	185	190	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e17597	10.1371/journal.pone.0017597	http://dx.doi.org/10.1371/journal.pone.0017597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408171	Green Submitted, Green Published, gold			2022-12-25	WOS:000288099800027
J	Robertson, BA; Doran, PJ; Loomis, ER; Robertson, JR; Schemske, DW				Robertson, Bruce A.; Doran, Patrick J.; Loomis, Elizabeth R.; Robertson, J. Roy; Schemske, Douglas W.			Avian Use of Perennial Biomass Feedstocks as Post-Breeding and Migratory Stopover Habitat	PLOS ONE			English	Article							GRASSLAND BIRDS; FARMLAND BIODIVERSITY; PASSERINE MIGRANTS; LANDSCAPE; ASSOCIATIONS; ABUNDANCE; COMPETITION; DIVERSITY; LANDBIRDS; SELECTION	Increased production of biomass crops in North America will require new agricultural land, intensify the cultivation of land already under production and introduce new types of biomass crops. Assessing the potential biodiversity impacts of novel agricultural systems is fundamental to the maintenance of biodiversity in agricultural landscapes, yet the consequences of expanded biomass production remain unclear. We evaluate the ability of two candidate second generation biomass feedstocks (switchgrass, Panicum virgatum, and mixed-grass prairie) not currently managed as crops to act as post-breeding and fall migratory stopover habitat for birds. In total, we detected 41 bird species, including grassland specialists and species of state and national conservation concern ( e. g. Henslow's Sparrow, Ammodramus henslowii). Avian species richness was generally comparable in switchgrass and prairie and increased with patch size in both patch types. Grassland specialists were less abundant and less likely to occur in patches within highly forested landscapes and were more common and likely to occur in larger patches, indicating that this group is also area-sensitive outside of the breeding season. Variation in the biomass and richness of arthropod food within patches was generally unrelated to richness and abundance metrics. Total bird abundance and that of grassland specialists was higher in patches with greater vegetation structural heterogeneity. Collectively, we find that perennial biomass feedstocks have potential to provide post-breeding and migratory stopover habitat for birds, but that the placement and management of crops will be critical factors in determining their suitability for species of conservation concern. Industrialization of cellulosic bioenergy production that results in reduced crop structural heterogeneity is likely to dramatically reduce the suitability of perennial biomass crops for birds.	[Robertson, Bruce A.; Loomis, Elizabeth R.] Michigan State Univ, Kellogg Biol Stn, US DOE, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Doran, Patrick J.] Nature Conservancy, Lansing, MI USA; [Schemske, Douglas W.] Michigan State Univ, Dept Plant Biol, US DOE, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA	Michigan State University; United States Department of Energy (DOE); Nature Conservancy; Michigan State University; United States Department of Energy (DOE)	Robertson, BA (corresponding author), Michigan State Univ, Kellogg Biol Stn, US DOE, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA.	RobertsonBr@si.edu			DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE))	This work was funded by the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adler PR, 2009, ECOL APPL, V19, P2202, DOI 10.1890/07-2094.1; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; BAIRLEIN F, 1983, ORNIS SCAND, V14, P239, DOI 10.2307/3676157; Bakker KK, 2002, CONSERV BIOL, V16, P1638, DOI 10.1046/j.1523-1739.2002.01328.x; Bakker KK, 2009, WEST N AM NATURALIST, V69, P235, DOI 10.3398/064.069.0212; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Buler JJ, 2007, ECOLOGY, V88, P1789, DOI 10.1890/06-1871.1; Burnham K. P., 1998, MODEL SELECTION INFE; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; Champlin TB, 2009, ECOLOGY, V90, P1586, DOI 10.1890/08-1190.1; Chartier AT, 2004, BIRDERS GUIDE MICHIG; Cimprich DA, 2005, ANIM BEHAV, V69, P1173, DOI 10.1016/j.anbehav.2004.07.021; COLWELL RK, 1997, ESITIMATES STAT ESTI; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Deppe JL, 2008, ECOL MONOGR, V78, P461, DOI 10.1890/07-0163.1; Diehl RH, 2003, AUK, V120, P278, DOI 10.1642/0004-8038(2003)120[0278:ROOBMO]2.0.CO;2; Eggers J, 2009, GCB BIOENERGY, V1, P18, DOI 10.1111/j.1757-1707.2009.01002.x; EMLEN JT, 1977, AUK, V94, P455; ESRI, 2008, ARCGIS; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Fletcher RJ, 2000, J FIELD ORNITHOL, V71, P321, DOI 10.1648/0273-8570-71.2.321; Fletcher RJ, 2011, FRONT ECOL ENVIRON, V9, P161, DOI 10.1890/090091; Forman R.T.T., 1986, LANDSCAPE ECOL; Gardiner MA, 2010, BIOENERG RES, V3, P6, DOI 10.1007/s12155-009-9065-7; Greenberg R., 2005, BIRDS 2 WORLDS ECOLO; GRZYBOWSKI JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P211, DOI 10.1007/BF00299925; Harmoney KR, 1997, AGRON J, V89, P665, DOI 10.2134/agronj1997.00021962008900040020x; Herkert JR, 2007, J WILDLIFE MANAGE, V71, P2749, DOI 10.2193/2007-002; HERKERT JR, 1994, ECOL APPL, V4, P461, DOI 10.2307/1941950; Hodar JA, 1996, ACTA OECOL, V17, P421; HOSMER DW, 1989, APPL LOGISTIC REGRES; HUTTO RL, 1985, AUK, V102, P120, DOI 10.2307/4086827; HUTTO RL, 1981, AUK, V98, P765; Igl LD, 1999, CONDOR, V101, P771, DOI 10.2307/1370064; Keller GS, 2007, WILSON J ORNITHOL, V119, P410, DOI 10.1676/04-034.1; King DI, 2006, J ZOOL, V269, P414, DOI 10.1111/j.1469-7998.2006.00158.x; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Legendre P., 1991, R PACKAGE MULTIDIMEN; Legendre P., 1998, NUMERICAL ECOLOGY, V24; LIMA SL, 1990, OIKOS, V58, P151, DOI 10.2307/3545422; MARTIN TE, 1980, CONDOR, V82, P430, DOI 10.2307/1367570; Matthews SN, 2010, LANDSCAPE ECOL, V25, P955, DOI 10.1007/s10980-010-9475-0; Matthews SN, 2010, CONDOR, V112, P96, DOI 10.1525/cond.2010.090049; Melles S, 2003, CONSERV ECOL, V7; MOORE FR, 1990, WILSON BULL, V102, P487; MOORE FR, 1991, BEHAV ECOL SOCIOBIOL, V28, P85; Moore Frank R., 1995, P121; Murphy MT, 2003, AUK, V120, P20, DOI 10.1642/0004-8038(2003)120[0020:APTWTE]2.0.CO;2; *NAT AUD SOC, 2010, IMP BIRD AR US; NOSS RF, 1995, 0611R01 MF NAT BIOL; Petit DR, 2000, STUD AVIAN BIOL-SER, P15; REMPEL R, 2010, PATCH ANAL 4 2 THUND; Renfrew RB, 2008, LANDSCAPE ECOL, V23, P181, DOI 10.1007/s10980-007-9179-2; Ribic CA, 2001, AM MIDL NAT, V146, P105, DOI 10.1674/0003-0031(2001)146[0105:AOGBWL]2.0.CO;2; Ribic CA, 2009, AUK, V126, P233, DOI 10.1525/auk.2009.1409; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; ROBERTSON BA, GLOBAL CHAN IN PRESS; Rodewald PG, 2007, AUK, V124, P1063, DOI 10.1642/0004-8038(2007)124[1063:SHUBSM]2.0.CO;2; Rodewald PG, 2004, AUK, V121, P1040, DOI 10.1642/0004-8038(2004)121[1040:SHOLDF]2.0.CO;2; ROGERS LE, 1976, ANN ENTOMOL SOC AM, V69, P387, DOI 10.1093/aesa/69.2.387; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROTENBERRY JT, 1980, ECOL MONOGR, V50, P93, DOI 10.2307/2937248; Roth AM, 2005, BIOMASS BIOENERG, V28, P490, DOI 10.1016/j.biombioe.2004.11.001; SAMPLE D, 1989, THESIS U WISCONSIN M; SAMPLE DW, 1997, MANAGEMENT HABITAT G; Sauer J.R., 2008, N AM BREEDING BIRD S; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Skagen SK, 1998, CONSERV BIOL, V12, P896, DOI 10.1046/j.1523-1739.1998.96384.x; SPSS (Statistical package for the Social Sciences), 2006, SPSS VERS 15 WIND; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Twedt DJ, 2008, SOUTHEAST NAT, V7, P11, DOI 10.1656/1528-7092(2008)7[11:WBPSAP]2.0.CO;2; *USDA, 2010, 2009 CROPL DAT LAY; Vickery PD, 1999, STUD AVIAN BIOL, P2; Vickery Peter D., 2000, U S Forest Service Rocky Mountain Research Station Proceedings RMRS-P, V16, P74; WIENS JA, 1974, AM MIDL NAT, V91, P195, DOI 10.2307/2424522	76	29	30	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e16941	10.1371/journal.pone.0016941	http://dx.doi.org/10.1371/journal.pone.0016941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390274	Green Published, gold, Green Submitted			2022-12-25	WOS:000287965200009
J	Hadi-Alijanvand, H; Rouhani, M; Proctor, EA; Dokholyan, NV; Moosavi-Movahedi, AA				Hadi-Alijanvand, Hamid; Rouhani, Maryam; Proctor, Elizabeth A.; Dokholyan, Nikolay V.; Moosavi-Movahedi, Ali A.			A Folding Pathway-Dependent Score to Recognize Membrane Proteins	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; CA2+-ACTIVATED K+ CHANNELS; LONG-TERM POTENTIATION; GATED CA2+ CHANNELS; SMALL-CONDUCTANCE; CALCIUM-CHANNELS; SUBCELLULAR-LOCALIZATION; HIPPOCAMPAL-NEURONS; INTERMEDIATE-CONDUCTANCE; TRANSMEMBRANE SEGMENTS	While various approaches exist to study protein localization, it is still a challenge to predict where proteins localize. Here, we consider a mechanistic viewpoint for membrane localization. Taking into account the steps for the folding pathway of alpha-helical membrane proteins and relating biophysical parameters to each of these steps, we create a score capable of predicting the propensity for membrane localization and call it FP(3)mem. This score is driven from the principal component analysis (PCA) of the biophysical parameters related to membrane localization. FP3mem allows us to rationalize the colocalization of a number of channel proteins with the Cav1.2 channel by their fewer propensities for membrane localization.	[Hadi-Alijanvand, Hamid; Rouhani, Maryam; Moosavi-Movahedi, Ali A.] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran; [Proctor, Elizabeth A.; Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA	University of Tehran; University of North Carolina; University of North Carolina Chapel Hill	Hadi-Alijanvand, H (corresponding author), Univ Tehran, Inst Biochem & Biophys, Tehran, Iran.	moosavi@ibb.ut.ac.ir	Hadi-Alijanvand, Hamid/AAE-3921-2020; Proctor, Elizabeth A./K-2350-2012; Moosavi-Movahedi, Ali A./K-7453-2013; Rouhani, Maryam/AAY-1557-2021; Dokholyan, Nikolay/D-8081-2018	Hadi-Alijanvand, Hamid/0000-0001-8289-2214; Proctor, Elizabeth A./0000-0002-7627-2198; Rouhani, Maryam/0000-0003-2094-6568; Dokholyan, Nikolay/0000-0002-8225-4025; Moosavi-Movahedi, Ali Akbar/0000-0002-1707-8432	Research Council of the University of Tehran; Iran National Science Foundation (INSF)	Research Council of the University of Tehran(University of Tehran); Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF))	The support of the Research Council of the University of Tehran and Iran National Science Foundation (INSF) is gratefully acknowledged.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BLATZ AL, 1986, NATURE, V323, P718, DOI 10.1038/323718a0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Booth PJ, 2010, P NATL ACAD SCI USA, V107, P3947, DOI 10.1073/pnas.0914478107; Bowden SEH, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0006.2001; Catterall WA, 2003, PHARMACOL REV, V55, P579, DOI 10.1124/pr.55.4.8; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CHEN HF, 1995, J BIOL CHEM, V270, P14115, DOI 10.1074/jbc.270.23.14115; Curnow P, 2009, P NATL ACAD SCI USA, V106, P773, DOI 10.1073/pnas.0806953106; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Emanuelsson Olof, 2002, Brief Bioinform, V3, P361, DOI 10.1093/bib/3.4.361; Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2; Faber ES, 2009, CELL BIOCHEM BIOPHYS, V55, P127, DOI 10.1007/s12013-009-9062-7; Freeman TC, 2010, BIOINFORMATICS, V26, P1965, DOI 10.1093/bioinformatics/btq308; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Guda C, 2006, NUCLEIC ACIDS RES, V34, pW210, DOI 10.1093/nar/gkl093; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; HELL JW, 1993, J BIOL CHEM, V268, P19451; Hirschberg B, 1998, J GEN PHYSIOL, V111, P565, DOI 10.1085/jgp.111.4.565; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hristova K, 2005, BIOCHEMISTRY-US, V44, P12614, DOI 10.1021/bi051193b; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jayasinghe S, 2001, PROTEIN SCI, V10, P455, DOI 10.1110/ps.43501; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Koschak A, 2007, J NEUROSCI, V27, P3855, DOI 10.1523/JNEUROSCI.4028-06.2007; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Liang J, 2005, TRENDS BIOCHEM SCI, V30, P355, DOI 10.1016/j.tibs.2005.05.003; LODISH H, 2003, MOL CELL BIOL; Lu L, 2007, CIRC RES, V100, P112, DOI 10.1161/01.RES.0000253095.44186.72; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; MAKHATADZE GI, 1994, BIOPHYS CHEM, V51, P291, DOI 10.1016/0301-4622(94)00050-6; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; McMurry JL, 1999, J BIOL CHEM, V274, P6776, DOI 10.1074/jbc.274.10.6776; Mokrab Y, 2009, PROTEINS, V74, P32, DOI 10.1002/prot.22130; Moller S, 2000, BIOINFORMATICS, V16, P1159, DOI 10.1093/bioinformatics/16.12.1159; Montgomerie S, 2008, NUCLEIC ACIDS RES, V36, pW202, DOI 10.1093/nar/gkn255; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Obermair GJ, 2004, EUR J NEUROSCI, V19, P2109, DOI 10.1111/j.0953-816X.2004.03272.x; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; PARK Y, 1994, J PHYSIOL-LONDON, V481, P555, DOI 10.1113/jphysiol.1994.sp020463; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Pierleoni A, 2007, NUCLEIC ACIDS RES, V35, pD208, DOI 10.1093/nar/gkl775; Pilpel Y, 1999, J MOL BIOL, V294, P921, DOI 10.1006/jmbi.1999.3257; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; Punta M, 2007, METHODS, V41, P460, DOI 10.1016/j.ymeth.2006.07.026; Rimini R, 2000, MOL BRAIN RES, V85, P218, DOI 10.1016/S0169-328X(00)00255-2; Sailer CA, 2004, MOL CELL NEUROSCI, V26, P458, DOI 10.1016/j.mcn.2004.03.002; Sailer CA, 2002, J NEUROSCI, V22, P9698; Schulla V, 2003, EMBO J, V22, P3844, DOI 10.1093/emboj/cdg389; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Sinnegger-Brauns MJ, 2004, J CLIN INVEST, V113, P1430, DOI 10.1172/JCI200420208; Sprenger J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S3; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Striessnig J, 2006, BIOCHEM SOC T, V34, P903, DOI 10.1042/BST0340903; Striessnig J, 2004, BIOCHEM BIOPH RES CO, V322, P1341, DOI 10.1016/j.bbrc.2004.08.039; Szafron D, 2004, NUCLEIC ACIDS RES, V32, pW365, DOI 10.1093/nar/gkh485; Tacconi S, 2001, NEUROSCIENCE, V102, P209, DOI 10.1016/S0306-4522(00)00486-3; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Townend J., 2002, PRACTICAL STAT ENV B; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, pD275, DOI 10.1093/nar/gki002; Van Rijsbergen C, 1980, INFORM RETRIEVAL; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; WHITE SH, 1994, MEMBRANE PROTEIN STR; White SH, 2007, J GEN PHYSIOL, V129, P363, DOI 10.1085/jgp.200709741; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang SN, 1999, P NATL ACAD SCI USA, V96, P10164, DOI 10.1073/pnas.96.18.10164; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhou HY, 2004, PROTEINS, V54, P315, DOI 10.1002/prot.10584	84	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e16778	10.1371/journal.pone.0016778	http://dx.doi.org/10.1371/journal.pone.0016778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390303	Green Submitted, Green Published, gold			2022-12-25	WOS:000287932100003
J	Metz, MC; Vucetich, JA; Smith, DW; Stahler, DR; Peterson, RO				Metz, Matthew C.; Vucetich, John A.; Smith, Douglas W.; Stahler, Daniel R.; Peterson, Rolf O.			Effect of Sociality and Season on Gray Wolf (Canis lupus) Foraging Behavior: Implications for Estimating Summer Kill Rate	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; DOGS LYCAON-PICTUS; PACK SIZE; PREDATION; WOLVES; SYSTEM; PREY; POPULATION; SELECTION; ECOLOGY	Background: Understanding how kill rates vary among seasons is required to understand predation by vertebrate species living in temperate climates. Unfortunately, kill rates are only rarely estimated during summer. Methodology/Principal Findings: For several wolf packs in Yellowstone National Park, we used pairs of collared wolves living in the same pack and the double-count method to estimate the probability of attendance (PA) for an individual wolf at a carcass. PA quantifies an important aspect of social foraging behavior (i.e., the cohesiveness of foraging). We used PA to estimate summer kill rates for packs containing GPS-collared wolves between 2004 and 2009. Estimated rates of daily prey acquisition (edible biomass per wolf) decreased from 8.4 +/- 0.9 kg (mean 6 SE) in May to 4.1 +/- 0.4 kg in July. Failure to account for PA would have resulted in underestimating kill rate by 32%. PA was 0.72 +/- 0.05 for large ungulate prey and 0.46 +/- 0.04 for small ungulate prey. To assess seasonal differences in social foraging behavior, we also evaluated PA during winter for VHF-collared wolves between 1997 and 2009. During winter, PA was 0.95 +/- 0.01. PA was not influenced by prey size but was influenced by wolf age and pack size. Conclusions/Significance: Our results demonstrate that seasonal patterns in the foraging behavior of social carnivores have important implications for understanding their social behavior and estimating kill rates. Synthesizing our findings with previous insights suggests that there is important seasonal variation in how and why social carnivores live in groups. Our findings are also important for applications of GPS collars to estimate kill rates. Specifically, because the factors affecting the PA of social carnivores likely differ between seasons, kill rates estimated through GPS collars should account for seasonal differences in social foraging behavior.	[Metz, Matthew C.; Vucetich, John A.; Peterson, Rolf O.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Metz, Matthew C.; Smith, Douglas W.; Stahler, Daniel R.] Natl Pk Serv, Yellowstone Ctr Resources, Yellowstone Wolf Project, Yellowstone Natl Pk, WY 82190 USA	Michigan Technological University; United States Department of the Interior	Metz, MC (corresponding author), Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA.	mcmetz@mtu.edu			United States National Science Foundation [DEB-06137730]; Yellowstone National Park, Yellowstone Park Foundation; Natural Resources Defense Council	United States National Science Foundation(National Science Foundation (NSF)); Yellowstone National Park, Yellowstone Park Foundation; Natural Resources Defense Council	Funding was provided by the United States National Science Foundation (DEB-06137730), Yellowstone National Park, Yellowstone Park Foundation, an anonymous donor, Annie and Bob Graham, Frank and Kay Yeager, Marc McCurry, Masterfoods, Patagonia, and the Natural Resources Defense Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almberg ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007042; Anderson CR, 2003, J WILDLIFE MANAGE, V67, P307, DOI 10.2307/3802772; Ballard Warren B., 2003, P259; BALLARD WB, 1987, WILDLIFE MONOGR, P1; Feldhamer G., 2003, WILD MAMMALS N AM, V2; FULLER TK, 1990, AFR J ECOL, V28, P330, DOI 10.1111/j.1365-2028.1990.tb01168.x; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; HENSCHEL JR, 1990, AFR J ECOL, V28, P69, DOI 10.1111/j.1365-2028.1990.tb01138.x; Houston D.B., 1982, NO YELLOWSTONE ELK E; Jedrzejewski W, 2002, ECOLOGY, V83, P1341, DOI 10.2307/3071948; Knopff KH, 2010, J WILDLIFE MANAGE, V74, P1435, DOI 10.2193/2009-314; Knopff KH, 2009, J WILDLIFE MANAGE, V73, P586, DOI 10.2193/2008-294; MacNulty DR, 2009, J ANIM ECOL, V78, P532, DOI 10.1111/j.1365-2656.2008.01517.x; MALCOLM JR, 1982, BEHAV ECOL SOCIOBIOL, V10, P1, DOI 10.1007/BF00296390; MEAGHER M, 1986, MAMMALIAN SPECIES, V266, P1; Mech L. David, 2003, P131; MESSIER F, 1994, ECOLOGY, V75, P478, DOI 10.2307/1939551; METZ MC, 2010, THESIS MICHIGAN TECH; Mills L. S., 2007, CONSERVATION WILDLIF; Mosser A, 2009, ANIM BEHAV, V78, P359, DOI 10.1016/j.anbehav.2009.04.024; Murphy KM, 1998, URSUS-SERIES, V10, P55; Nilsen EB, 2009, J ANIM ECOL, V78, P741, DOI 10.1111/j.1365-2656.2009.01547.x; O'Donoghue M, 1998, ECOLOGY, V79, P1193, DOI 10.1890/0012-9658(1998)079[1193:FROCAL]2.0.CO;2; PETERSON RO, 1984, WILDLIFE MONOGR, V88, P1; Peterson Rolf O., 2003, P104; RICKLEFS RE, 2000, ECOLOGY; Sand H, 2005, WILDLIFE SOC B, V33, P914, DOI 10.2193/0091-7648(2005)33[914:UGTAGC]2.0.CO;2; Sand H, 2008, OECOLOGIA, V156, P53, DOI 10.1007/s00442-008-0969-2; Schmidt PA, 1997, AM NAT, V150, P513, DOI 10.1086/286079; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; Smith Douglas W., 2009, P92, DOI 10.1002/9781444312034.ch5; Smith DW, 2004, J WILDLIFE MANAGE, V68, P153, DOI 10.2193/0022-541X(2004)068[0153:WPSAEO]2.0.CO;2; Smith JE, 2008, ANIM BEHAV, V76, P619, DOI 10.1016/j.anbehav.2008.05.001; THURBER JM, 1993, J MAMMAL, V74, P879, DOI 10.2307/1382426; Vucetich JA, 2004, ANIM BEHAV, V67, P1117, DOI 10.1016/j.anbehav.2003.06.018; Vucetich JA, 2002, ECOLOGY, V83, P3003; Webb NF, 2008, J WILDLIFE MANAGE, V72, P798, DOI 10.2193/2006-566; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x	39	50	50	3	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17332	10.1371/journal.pone.0017332	http://dx.doi.org/10.1371/journal.pone.0017332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390256	gold, Green Published, Green Submitted			2022-12-25	WOS:000287932100013
J	Patton, DT; Wilson, MD; Rowan, WC; Soond, DR; Okkenhaug, K				Patton, Daniel T.; Wilson, Marcus D.; Rowan, Wendy C.; Soond, Dalya R.; Okkenhaug, Klaus			The PI3K p110 delta Regulates Expression of CD38 on Regulatory T Cells	PLOS ONE			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; CUTTING EDGE; PHOSPHATIDYLINOSITOL 3-KINASE; FOXP3 EXPRESSION; B-CELL; INDUCTION; ANTIGEN; MICE; DIFFERENTIATION; SIGNAL	The PI3K pathway has emerged as a key regulator of regulatory T cell ( Treg) development and homeostasis and is required for full Treg-mediated suppression. To identify new genes involved in PI3K-dependent suppression, we compared the transcriptome of WT and p110 delta(D910A) Tregs. Among the genes that were differentially expressed was the gene for the transmembrane cyclic ADP ribose hydrolase CD38. Here we show that CD38 is expressed mainly by a subset of Foxp3(+)CD25(+)CD4(+) T cells originating in the thymus and on Tregs in the spleen. CD38(high) WT Tregs showed superior suppressive activity to CD38(low) Tregs, which failed to upregulate CD73, a surface protein which is important for suppression. However, Tregs from heterozygous CD38(+/-) mice were unimpaired despite lower levels of CD38 expression. Therefore, CD38 can be used as a marker for Tregs with high suppressive activity and the impaired Treg function in p110 delta(D910A) mice can in part be explained by the failure of CD38(high) cells to develop.	[Patton, Daniel T.; Wilson, Marcus D.; Soond, Dalya R.; Okkenhaug, Klaus] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England; [Rowan, Wendy C.] GlaxoSmithKline Res & Dev Ltd, Tool Monoclonal Antibody Grp, Stevenage, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; GlaxoSmithKline	Patton, DT (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England.	klaus.okkenhaug@bbsrc.ac.uk	Okkenhaug, Klaus/D-5149-2012; Okkenhaug, Klaus/H-3154-2019	Okkenhaug, Klaus/0000-0002-9432-4051; Okkenhaug, Klaus/0000-0002-9432-4051; Wilson, Marcus/0000-0001-9551-5514	BBSRC; GlaxoSmithKline; BBSRC [BBS/E/B/0000H262, BBS/E/B/0000C236, BB/E009867/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H262, BB/C509890/1, BBS/E/B/0000C236, BB/E009867/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work described in this manuscript was funded by the BBSRC and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; Aswad F, 2006, CELL IMMUNOL, V243, P58, DOI 10.1016/j.cellimm.2006.12.003; Basu S, 2008, J IMMUNOL, V180, P5794, DOI 10.4049/jimmunol.180.9.5794; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Bynoel MS, 2008, TRENDS IMMUNOL, V29, P99, DOI 10.1016/j.it.2007.12.005; Chen J, 2006, J IMMUNOL, V176, P4590, DOI 10.4049/jimmunol.176.8.4590; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864; Daniel C, 2010, P NATL ACAD SCI USA, V107, P16246, DOI 10.1073/pnas.1007422107; Deaglio S, 2010, MOL MED, V16, P87, DOI 10.2119/molmed.2009.00146; DRACH J, 1994, CANCER RES, V54, P1746; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gao Y, 2007, LEUKEMIA RES, V31, P455, DOI 10.1016/j.leukres.2006.07.004; Garcon F, 2008, BLOOD, V111, P1464, DOI 10.1182/blood-2007-08-108050; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Green EA, 2003, P NATL ACAD SCI USA, V100, P10878, DOI 10.1073/pnas.1834400100; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hubert S, 2010, J EXP MED, V207, P2561, DOI 10.1084/jem.20091154; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Krebs C, 2005, J IMMUNOL, V174, P3298, DOI 10.4049/jimmunol.174.6.3298; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; Liu D, 2009, J IMMUNOL, V183, P1921, DOI 10.4049/jimmunol.0901099; Lund FE, 1998, IMMUNOL REV, V161, P79, DOI 10.1111/j.1600-065X.1998.tb01573.x; Lund FE, 2006, MOL MED, V12, P328, DOI 10.2119/2006-00099.Lund; Ma LA, 2010, P NATL ACAD SCI USA, V107, P19461, DOI 10.1073/pnas.1011748107; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Merkenschlager M, 2010, J EXP MED, V207, P1347, DOI 10.1084/jem.20101156; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Munoz P, 2003, J BIOL CHEM, V278, P50791, DOI 10.1074/jbc.M308034200; Oak JS, 2006, P NATL ACAD SCI USA, V103, P16882, DOI 10.1073/pnas.0607984103; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Okkenhaug K, 2002, SCIENCE, V297, P1031; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Park SG, 2010, IMMUNITY, V33, P791, DOI 10.1016/j.immuni.2010.10.014; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; Peola S, 1996, J IMMUNOL, V157, P4354; Read S, 1998, EUR J IMMUNOL, V28, P3435, DOI 10.1002/(SICI)1521-4141(199811)28:11<3435::AID-IMMU3435>3.3.CO;2-G; Salmond RJ, 2009, J IMMUNOL, V183, P7388, DOI 10.4049/jimmunol.0902294; Schmidt EM, 2009, J IMMUNOL, V182, P274, DOI 10.4049/jimmunol.182.1.274; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	52	60	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17359	10.1371/journal.pone.0017359	http://dx.doi.org/10.1371/journal.pone.0017359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390257	Green Published, gold, Green Submitted			2022-12-25	WOS:000287932100014
J	Quan, L; Stassen, APM; Ruivenkamp, CAL; van Wezel, T; Fijneman, RJA; Hutson, A; Kakarlapudi, N; Hart, AAM; Demant, P				Quan, Lei; Stassen, Alphons P. M.; Ruivenkamp, Claudia A. L.; van Wezel, Tom; Fijneman, Remond J. A.; Hutson, Alan; Kakarlapudi, Neelima; Hart, Augustinus A. M.; Demant, Peter			Most Lung and Colon Cancer Susceptibility Genes Are Pair-Wise Linked in Mice, Humans and Rats	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCUS; RECOMBINANT CONGENIC STRAINS; ADENOMA RESISTANCE LOCUS; POSITIVE BREAST-CANCER; MOUSE-CHROMOSOME 3; COLORECTAL-CANCER; TUMOR-SUSCEPTIBILITY; PROSTATE-CANCER; CONFER SUSCEPTIBILITY	Genetic predisposition controlled by susceptibility quantitative trait loci (QTLs) contributes to a large proportion of common cancers. Studies of genetics of cancer susceptibility, however, did not address systematically the relationship between susceptibility to cancers in different organs. We present five sets of data on genetic architecture of colon and lung cancer susceptibility in mice, humans and rats. They collectively show that the majority of genes for colon and lung cancer susceptibility are linked pair-wise and are likely identical or related. Four CcS/Dem recombinant congenic strains, each differing from strain BALB/cHeA by a different small random subset of +/- 12.5% of genes received from strain STS/A, suggestively show either extreme susceptibility or extreme resistance for both colon and lung tumors, which is unlikely if the two tumors were controlled by independent susceptibility genes. Indeed, susceptibility to lung cancer (Sluc) loci underlying the extreme susceptibility or resistance of such CcS/Dem strains, mapped in 226 (CcS-10xCcS-19)F2 mice, co-localize with susceptibility to colon cancer (Scc) loci. Analysis of additional Sluc loci that were mapped in OcB/Dem strains and Scc loci in CcS/Dem strains, respectively, shows their widespread pair-wise co-localization (P = 0.0036). Finally, the majority of published human and rat colon cancer susceptibility genes map to chromosomal regions homologous to mouse Sluc loci. 12/12 mouse Scc loci, 9/11 human and 5/7 rat colon cancer susceptibility loci are close to a Sluc locus or its homologous site, forming 21 clusters of lung and colon cancer susceptibility genes from one, two or three species. Our data shows that cancer susceptibility QTLs can have much broader biological effects than presently appreciated. It also demonstrates the power of mouse genetics to predict human susceptibility genes. Comparison of molecular mechanisms of susceptibility genes that are organ-specific and those with trans-organ effects can provide a new dimension in understanding individual cancer susceptibility.	[Quan, Lei; Kakarlapudi, Neelima; Demant, Peter] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; [Stassen, Alphons P. M.] Maastricht Univ, Dept Genet & Cell Biol Clin Genet, Maastricht, Netherlands; [Ruivenkamp, Claudia A. L.; van Wezel, Tom] Leiden Univ, Dept Human & Clin Genet, Med Ctr, Leiden, Netherlands; [Fijneman, Remond J. A.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Hutson, Alan] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA; [Hart, Augustinus A. M.] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Hart, Augustinus A. M.] Netherlands Canc Inst, Div Radiotherapy, Amsterdam, Netherlands	Roswell Park Cancer Institute; Maastricht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Roswell Park Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Quan, L (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA.	Peter.Demant@roswellpark.org	Fijneman, Remond/X-4199-2019; Quan, Lei/GXN-1280-2022; van Wezel, Tom/AAL-5626-2021; van Wezel, Tom/Z-3092-2019; van Wezel, Tom/A-9599-2008	Fijneman, Remond/0000-0003-2076-5521; van Wezel, Tom/0000-0001-5773-7730; van Wezel, Tom/0000-0001-5773-7730; Quan, Lei/0000-0002-6572-0530	National Institutes of Health-National Cancer Institute [R01CA116158b]; Ralph C. Wilson Sr. and Jr. Medical Foundation; Roswell Park Cancer Institute	National Institutes of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ralph C. Wilson Sr. and Jr. Medical Foundation; Roswell Park Cancer Institute	The work has been funded by the National Institutes of Health-National Cancer Institute grant R01CA116158b, Ralph C. Wilson Sr. and Jr. Medical Foundation, and an institutional grant from the Roswell Park Cancer Institute to Peter Demant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Angel J M, 1999, Prog Exp Tumor Res, V35, P143; Angel JM, 2000, MOL CARCINOGEN, V27, P47, DOI 10.1002/(SICI)1098-2744(200001)27:1<47::AID-MC7>3.0.CO;2-7; Bailey-Wilson JE, 2004, AM J HUM GENET, V75, P460, DOI 10.1086/423857; Bilusic M, 2004, HYPERTENSION, V44, P695, DOI 10.1161/01.HYP.0000144542.57306.5e; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Cordes SP, 2005, MICROBIOL MOL BIOL R, V69, P426, DOI 10.1128/MMBR.69.3.426-439.2005; De Miglio MR, 2007, CARCINOGENESIS, V28, P2367, DOI 10.1093/carcin/bgm119; DEMANT P, 1986, IMMUNOGENETICS, V24, P416, DOI 10.1007/BF00377961; DEMANT P, 1989, ADV CANCER RES, V53, P117; Demant P, 2003, NAT REV GENET, V4, P721, DOI 10.1038/nrg1157; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Festing MFW, 1998, GENOMICS, V53, P129, DOI 10.1006/geno.1998.5450; Fijneman RJA, 2004, CANCER RES, V64, P3458, DOI 10.1158/0008-5472.CAN-03-3767; Fijneman RJA, 1998, CANCER RES, V58, P4794; Fijneman RJA, 1996, NAT GENET, V14, P465, DOI 10.1038/ng1296-465; GARIBOLDI M, 1993, NAT GENET, V3, P132, DOI 10.1038/ng0293-132; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hunter DJ, 2010, J NATL CANCER I, V102, P836, DOI 10.1093/jnci/djq197; Huppi K, 2007, SEMIN CANCER BIOL, V17, P65, DOI 10.1016/j.semcancer.2006.10.004; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Ioannidis JPA, 2010, JNCI-J NATL CANCER I, V102, P846, DOI 10.1093/jnci/djq173; JACOBY RF, 1994, GENOMICS, V22, P381, DOI 10.1006/geno.1994.1399; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang Jun, 2009, V471, P305, DOI 10.1007/978-1-59745-416-2_16; Kakarlapudi N, 2008, CANCER IMMUNOL IMMUN, V57, P217, DOI 10.1007/s00262-007-0367-3; Kemp Z, 2006, HUM MOL GENET, V15, P2903, DOI 10.1093/hmg/ddl231; Kouso H, 2008, J SURG ONCOL, V98, P377, DOI 10.1002/jso.21108; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lesueur F, 2005, HUM MOL GENET, V14, P2349, DOI 10.1093/hmg/ddi237; Lipoldova M, 2005, INT J CANCER, V114, P394, DOI 10.1002/ijc.20731; Liu PY, 2006, NAT GENET, V38, P888, DOI 10.1038/ng1849; Lynch PM, 2009, SURG ONCOL CLIN N AM, V18, P611, DOI 10.1016/j.soc.2009.08.002; Manenti G, 1996, NAT GENET, V12, P455, DOI 10.1038/ng0496-455; Manenti G, 2004, ONCOGENE, V23, P4495, DOI 10.1038/sj.onc.1207584; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Mao JH, 2006, P NATL ACAD SCI USA, V103, P8125, DOI 10.1073/pnas.0602581103; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Meunier C, 2010, ONCOGENE, V29, P647, DOI 10.1038/onc.2009.369; MOEN CJA, 1992, ONCOGENE, V7, P563; MOEN CJA, 1991, MAMM GENOME, V1, P217, DOI 10.1007/BF00352328; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; Nagase H, 1999, P NATL ACAD SCI USA, V96, P15032, DOI 10.1073/pnas.96.26.15032; Obata M, 1996, ONCOGENE, V13, P1599; Pataer A, 1997, CANCER RES, V57, P2904; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Ruivenkamp CAL, 2003, ONCOGENE, V22, P7258, DOI 10.1038/sj.onc.1207096; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Samuelson DJ, 2007, P NATL ACAD SCI USA, V104, P6299, DOI 10.1073/pnas.0701687104; Santos CAF, 2002, MOL GENET GENOMICS, V268, P122, DOI 10.1007/s00438-002-0735-9; Schork NJ, 1996, HYPERTENSION, V28, P1104; Sevignani C, 2007, P NATL ACAD SCI USA, V104, P8017, DOI 10.1073/pnas.0702177104; SHIBUYA T, 1993, MUTAT RES, V297, P3, DOI 10.1016/0165-1110(93)90005-8; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Sun J, 2008, NAT GENET, V40, P1153, DOI 10.1038/ng.214; TENESA A, 2008, NAT GENET; Thomas A, 1999, COMPUT BIOMED RES, V32, P517, DOI 10.1006/cbmr.1999.1525; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; TOMLINSON IP, 2008, NAT GENET; Tripodis N, 2001, J NATL CANCER I, V93, P1484, DOI 10.1093/jnci/93.19.1484; van Wezel T, 1999, CANCER RES, V59, P4216; vanWezel T, 1996, NAT GENET, V14, P468, DOI 10.1038/ng1296-468; Wali RK, 1999, CARCINOGENESIS, V20, P2355, DOI 10.1093/carcin/20.12.2355; Wang YD, 2009, CANCER LETT, V285, P134, DOI 10.1016/j.canlet.2009.05.005; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wiesner GL, 2003, P NATL ACAD SCI USA, V100, P12961, DOI 10.1073/pnas.2132286100; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Xie XB, 2008, THEOR APPL GENET, V116, P613, DOI 10.1007/s00122-007-0695-x; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yi S, 2006, MOL CARCINOGEN, V45, P409, DOI 10.1002/mc.20231; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhang ZQ, 2003, P NATL ACAD SCI USA, V100, P12642, DOI 10.1073/pnas.2133947100	91	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e14727	10.1371/journal.pone.0014727	http://dx.doi.org/10.1371/journal.pone.0014727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390212	gold, Green Published, Green Submitted			2022-12-25	WOS:000287761700005
J	Hennen, E; Czopka, T; Faissner, A				Hennen, Eva; Czopka, Tim; Faissner, Andreas			Structurally Distinct LewisX Glycans Distinguish Subpopulations of Neural Stem/Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; MONOCLONAL-ANTIBODY; RADIAL GLIA; NEURITE OUTGROWTH; ADHESION MOLECULE; NEURONAL LINEAGE; PRECURSOR CELL; ANTIGEN; ASTROCYTES	There is increasing evidence that the stem and progenitor cell population that builds the central nervous system is very heterogeneous. Stem cell markers with the potential to divide this cell pool into subpopulations with distinct characteristics are sparse. We were looking for new cell type-specific antigens to further subdivide the progenitor pool. Here, we introduce the novel monoclonal antibody clone 5750. We show that it specifically labels cell surfaces of neural stem and progenitor cells. When 5750-expressing cells were isolated by fluorescence-activated cell sorting from embryonic mouse brains, the sorted population showed increased neurosphere forming capacity and multipotency. Neurospheres generated from 5750-positive cells could self-renew and remained multipotent even after prolonged passaging. Carbohydrate binding assays revealed that the 5750 antibody specifically binds to LewisX-related carbohydrates. Interestingly, we found that the LewisX epitope recognized by clone 5750 differs from those detected by other anti-LewisX antibody clones like 487(LeX), SSEA-1(LeX), and MMA(LeX). Our data further reveal that individual anti-LewisX clones can be successfully used to label and deplete different subpopulations of neural cells in vivo and in vitro. In conclusion, we present a new tool for the isolation and characterization of neural subpopulations and provide insights into the complexity of cell surface glycosylation.	[Hennen, Eva; Czopka, Tim; Faissner, Andreas] Ruhr Univ Bochum, Dept Cell Morphol & Mol Neurobiol, D-44780 Bochum, Germany; [Hennen, Eva] Ruhr Univ Bochum, Int Grad Sch Neurosci, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Faissner, A (corresponding author), Ruhr Univ Bochum, Dept Cell Morphol & Mol Neurobiol, Univ Str 150,NDEF 05-593, D-44780 Bochum, Germany.	Andreas.Faissner@rub.de	Faissner, Andreas/A-5314-2008	Faissner, Andreas/0000-0002-2211-8259	Consortium for Functional Glycomics [GM62116]; International Graduate School of Neuroscience; Deutsche Forschungsgemeinschaft [GSC 98/1]; Federal Ministry of Education and Research (Federal Ministry of Education and Research); Land Nordrhein Westfalen; stem cell network North Rhine Westphalia; Ruhr-University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Consortium for Functional Glycomics; International Graduate School of Neuroscience; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research (Federal Ministry of Education and Research); Land Nordrhein Westfalen; stem cell network North Rhine Westphalia; Ruhr-University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Consortium for Functional Glycomics Grant GM62116.; Supported by the Ph.D. program of the International Graduate School of Neuroscience and the Research School at the Ruhr-University supported by Deutsche Forschungsgemeinschaft Grant GSC 98/1.; Supported by the Deutsche Forschungsgemeinschaft, the Federal Ministry of Education and Research (Federal Ministry of Education and Research), the Land Nordrhein Westfalen, the stem cell network North Rhine Westphalia, and the Ruhr-University for part of this work.	Allendoerfer KL, 1999, DEV BIOL, V211, P208, DOI 10.1006/dbio.1999.9308; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Brito C, 2007, J NEUROSCI RES, V85, P1260, DOI 10.1002/jnr.21230; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Czopka T, 2009, CELL TISSUE RES, V338, P161, DOI 10.1007/s00441-009-0868-9; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; EGGENS I, 1989, J BIOL CHEM, V264, P9476; EISENBARTH GS, 1979, P NATL ACAD SCI USA, V76, P4913, DOI 10.1073/pnas.76.10.4913; FAISSNER A, 1985, EMBO J, V4, P3105, DOI 10.1002/j.1460-2075.1985.tb04052.x; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; FAISSNER A, 1990, NEURON, V5, P627, DOI 10.1016/0896-6273(90)90217-4; FENDERSON BA, 1984, J EXP MED, V160, P1591, DOI 10.1084/jem.160.5.1591; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Garwood J, 1999, J NEUROSCI, V19, P3888; HANJAN SNS, 1982, CLIN IMMUNOL IMMUNOP, V23, P172, DOI 10.1016/0090-1229(82)90106-4; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Imura T, 2006, GLIA, V53, P277, DOI 10.1002/glia.20281; Jirmanova L, 1999, INT J DEV BIOL, V43, P555; KRUSE J, 1985, NATURE, V316, P146, DOI 10.1038/316146a0; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; Lieberoth A, 2009, J NEUROSCI, V29, P6677, DOI 10.1523/JNEUROSCI.4361-08.2009; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MILNER R, 1994, DEVELOPMENT, V120, P3497; Nishihara S, 2003, GLYCOBIOLOGY, V13, P445, DOI 10.1093/glycob/cwg048; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Pellegrini W, 2007, HAEMATOL-HEMATOL J, V92, P708, DOI 10.3324/haematol.11002; RAFF MC, 1983, J NEUROSCI, V3, P1289; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Strathmann FG, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-33; STREIT A, 1990, J NEUROCHEM, V55, P1494, DOI 10.1111/j.1471-4159.1990.tb04931.x; Streit A, 1996, J NEUROCHEM, V66, P834; STREIT A, 1993, J CELL BIOL, V120, P799, DOI 10.1083/jcb.120.3.799; SUDOU A, 1995, J BIOCHEM-TOKYO, V117, P271, DOI 10.1093/jb/117.2.271; von Holst A, 2006, J NEUROSCI, V26, P4082, DOI 10.1523/JNEUROSCI.0422-06.2006; Yagi H, 2010, GLYCOBIOLOGY, V20, P976, DOI 10.1093/glycob/cwq054; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x	43	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.201095	http://dx.doi.org/10.1074/jbc.M110.201095			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21385876	hybrid, Green Published			2022-12-25	WOS:000290022800070
J	Tafel, AA; Wu, L; McHugh, PJ				Tafel, Agnieszka A.; Wu, Leonard; McHugh, Peter J.			Human HEL308 Localizes to Damaged Replication Forks and Unwinds Lagging Strand Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINK REPAIR; SENSITIVITY PROTEIN MUS308; FANCONI-ANEMIA PROTEIN; DNA HELICASE; HOMOLOGOUS RECOMBINATION; IN-VITRO; SULFOLOBUS-TOKODAII; POLYMERASE; FANCD2; REGRESSION	HEL308 is a superfamily II DNA helicase, conserved from archaea through to humans. HEL308 family members were originally isolated by their similarity to the Drosophila melanogaster Mus308 protein, which contributes to the repair of replication-blocking lesions such as DNA interstrand cross-links. Biochemical studies have established that human HEL308 is an ATP-dependent enzyme that unwinds DNA with a 3' to 5' polarity, but little else is know about its mechanism. Here, we show that GFP-tagged HEL308 localizes to replication forks following camptothecin treatment. Moreover, HEL308 colocalizes with two factors involved in the repair of damaged forks by homologous recombination, Rad51 and FANCD2. Purified HEL308 requires a 3' single-stranded DNA region to load and unwind duplex DNA structures. When incubated with substrates that model stalled replication forks, HEL308 preferentially unwinds the parental strands of a structure that models a fork with a nascent lagging strand, and the unwinding action of HEL308 is specifically stimulated by human replication protein A. Finally, we show that HEL308 appears to target and unwind from the junction between single-stranded to double-stranded DNA on model fork structures. Together, our results suggest that one role for HEL308 at sites of blocked replication might be to open up the parental strands to facilitate the loading of subsequent factors required for replication restart.	[Tafel, Agnieszka A.; Wu, Leonard; McHugh, Peter J.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	McHugh, PJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	peter.mchugh@imm.ox.ac.uk		McHugh, Peter/0000-0002-8679-4627	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK grants (to P. J. M. and L. W.).	Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Bernstein KA, 2010, ANNU REV GENET, V44, P393, DOI 10.1146/annurev-genet-102209-163602; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Blastyak A, 2010, MOL CELL BIOL, V30, P684, DOI 10.1128/MCB.00863-09; BOYD JB, 1990, GENETICS, V125, P813; Cadman CJ, 2006, J MOL BIOL, V362, P18, DOI 10.1016/j.jmb.2006.06.032; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Fujikane R, 2006, GENES CELLS, V11, P99, DOI 10.1111/j.1365-2443.2006.00925.x; Fujikane R, 2005, J BIOL CHEM, V280, P12351, DOI 10.1074/jbc.M413417200; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Guy CP, 2005, NUCLEIC ACIDS RES, V33, P3678, DOI 10.1093/nar/gki685; Harris PV, 1996, MOL CELL BIOL, V16, P5764; Hussain S, 2004, HUM MOL GENET, V13, P1241, DOI 10.1093/hmg/ddh135; Li Z, 2008, J BACTERIOL, V190, P3006, DOI 10.1128/JB.01662-07; Liu YL, 2010, DNA REPAIR, V9, P325, DOI 10.1016/j.dnarep.2010.01.006; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Lu SH, 2008, BIOCHEM BIOPH RES CO, V376, P369, DOI 10.1016/j.bbrc.2008.08.150; Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200; MacKay C, 2009, BIOCHEM BIOPH RES CO, V390, P187, DOI 10.1016/j.bbrc.2009.08.151; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Marini F, 2003, J BIOL CHEM, V278, P32014, DOI 10.1074/jbc.M305646200; Marini F, 2002, J BIOL CHEM, V277, P8716, DOI 10.1074/jbc.M110271200; Moldovan GL, 2010, MOL CELL BIOL, V30, P1088, DOI 10.1128/MCB.01124-09; Muzzini DM, 2008, DNA REPAIR, V7, P941, DOI 10.1016/j.dnarep.2008.03.021; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rossi ML, 2010, DNA REPAIR, V9, P331, DOI 10.1016/j.dnarep.2009.12.011; Seki M, 2003, NUCLEIC ACIDS RES, V31, P6117, DOI 10.1093/nar/gkg814; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Woodman IL, 2011, DNA REPAIR, V10, P306, DOI 10.1016/j.dnarep.2010.12.001; Woodman IL, 2009, BIOCHEM SOC T, V37, P74, DOI 10.1042/BST0370074; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Yoshimura M, 2006, MOL CELL, V24, P115, DOI 10.1016/j.molcel.2006.07.032	36	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.228189	http://dx.doi.org/10.1074/jbc.M111.228189			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21398521	Green Published, hybrid			2022-12-25	WOS:000290022800024
J	Hartfield, EM; Rinaldi, F; Glover, CP; Wong, LF; Caldwell, MA; Uney, JB				Hartfield, Elizabeth M.; Rinaldi, Federica; Glover, Colin P.; Wong, Liang-Fong; Caldwell, Maeve A.; Uney, James B.			Connexin 36 Expression Regulates Neuronal Differentiation from Neural Progenitor Cells	PLOS ONE			English	Article							GAP-JUNCTIONS; CX36; PROLIFERATION; COMMUNICATION; SPECIFICATION; HEMICHANNELS; MIGRATION; MEMBRANE; SURVIVAL; MOBILITY	Background: Gap junction communication has been shown in glial and neuronal cells and it is thought they mediate inter- and intra-cellular communication. Connexin 36 (Cx36) is expressed extensively in the developing brain, with levels peaking at P14 after which its levels fall and its expression becomes entirely neuronal. These and other data have led to the hypothesis that Cx36 may direct neuronal coupling and neurogenesis during development. Methodology/Principal Findings: To investigate Cx36 function we used a neurosphere model of neuronal cell development and developed lentiviral Cx36 knockdown and overexpression strategies. Cx36 knockdown was confirmed by western blotting, immunocytochemistry and functionally by fluorescence recovery after photobleaching (FRAP). We found that knockdown of Cx36 in neurosphere neuronal precursors significantly reduced neuronal coupling and the number of differentiated neurons. Correspondingly, the lentiviral mediated overexpression of Cx36 significantly increased the number of neurons derived from the transduced neurospheres. The number of oligodendrocytes was also significantly increased following transduction with Cx36 indicating they may support neuronal differentiation. Conclusions/Significance: Our data suggests that astrocytic and neuronal differentiation during development are governed by mechanisms that include the differential expression of Cx36.	[Hartfield, Elizabeth M.; Rinaldi, Federica; Wong, Liang-Fong; Caldwell, Maeve A.; Uney, James B.] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Labs Integrated Neurosci & Endocrinol, Bristol, Avon, England; [Glover, Colin P.] GlaxoSmithKline, Neurosci CEDD, Harlow, Essex, England	University of Bristol; GlaxoSmithKline	Hartfield, EM (corresponding author), Univ Oxford, Oxford Parkinsons Dis Ctr, Dept Physiol Anat & Genet, Oxford, England.	maeve.caldwell@bristol.ac.uk; james.uney@bristol.ac.uk	Caldwell, Maeve/HHN-1986-2022	Caldwell, Maeve/0000-0001-7442-711X	MRC; GSK; Wellcome Trust; BBSRC; Neurosciences CEDD GlaxoSmithKline; GlaxoSmithKline; Engineering and Physical Sciences Research Council [EP/E500110/1] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GSK(GlaxoSmithKline); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Neurosciences CEDD GlaxoSmithKline(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The MRC and GSK provided the studentship that funded EH. Grants from the Wellcome Trust and BBSRC to JBU also helped support this work. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding for the research was also provided by Neurosciences CEDD GlaxoSmithKline to Colin Glover who is an employee of Neurosciences CEDD GlaxoSmithKline. This funder therefore had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.; GlaxoSmithKline provided some funding toward the studentship. However, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Belluardo N, 2000, BRAIN RES, V865, P121, DOI 10.1016/S0006-8993(00)02300-3; Cai JL, 2004, J NEUROCHEM, V88, P212, DOI 10.1046/j.1471-4159.2003.02184.x; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Cheng AW, 2004, DEV BIOL, V272, P203, DOI 10.1016/j.ydbio.2004.04.031; Condorelli DF, 1998, EUR J NEUROSCI, V10, P1202, DOI 10.1046/j.1460-9568.1998.00163.x; Condorelli DF, 2000, BRAIN RES REV, V32, P72, DOI 10.1016/S0165-0173(99)00068-5; De Vuyst E, 2006, EMBO J, V25, P34, DOI 10.1038/sj.emboj.7600908; Elias LAB, 2008, TRENDS NEUROSCI, V31, P243, DOI 10.1016/j.tins.2008.02.007; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; Fraga C, 2002, HISTOCHEM CELL BIOL, V117, P547, DOI 10.1007/s00418-002-0413-3; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gulisano M, 2000, NEUROREPORT, V11, P3823, DOI 10.1097/00001756-200011270-00045; Harper SQ, 2005, METH MOL B, V309, P219; Howarth JL, 2007, MOL THER, V15, P1100, DOI 10.1038/sj.mt.6300163; Huettner JE, 2006, STEM CELLS, V24, P1654, DOI 10.1634/stemcells.2005-0003; Laux-Fenton WT, 2003, CORNEA, V22, P457, DOI 10.1097/00003226-200307000-00012; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Parekkadan B, 2008, NEUROSCI LETT, V438, P190, DOI 10.1016/j.neulet.2008.03.094; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Prime G, 2000, DEV BRAIN RES, V119, P111, DOI 10.1016/S0165-3806(99)00132-7; Rozental R, 1998, J NEUROSCI, V18, P1753; Santiago MF, 2010, J BIOL CHEM, V285, P11836, DOI 10.1074/jbc.M109.058750; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; TODOROVA MG, 2004, J CELL PHYSL, V214, P354; Verselis VK, 2008, J GEN PHYSIOL, V132, P315, DOI 10.1085/jgp.200810029; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Windoffer R, 2000, CELL TISSUE RES, V299, P347, DOI 10.1007/s004419900162; Wong RCB, 2004, STEM CELLS, V22, P883, DOI 10.1634/stemcells.22-6-883; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	37	37	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e14746	10.1371/journal.pone.0014746	http://dx.doi.org/10.1371/journal.pone.0014746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408068	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170900002
J	Sankhala, RS; Damai, RS; Swamy, MJ				Sankhala, Rajeshwer S.; Damai, Rajani S.; Swamy, Musti J.			Correlation of Membrane Binding and Hydrophobicity to the Chaperone-Like Activity of PDC-109, the Major Protein of Bovine Seminal Plasma	PLOS ONE			English	Article							ALPHA-CRYSTALLIN; MODEL MEMBRANES; PHOSPHORYLCHOLINE; FLUORESCENCE; SPECIFICITY; BSP-A1/-A2; MECHANISM; LIGANDS; EFFLUX; DOMAIN	The major protein of bovine seminal plasma, PDC-109 binds to choline phospholipids present on the sperm plasma membrane upon ejaculation and plays a crucial role in the subsequent events leading to fertilization. PDC-109 also shares significant similarities with small heat shock proteins and exhibits chaperone-like activity (CLA). Although the polydisperse nature of this protein has been shown to be important for its CLA, knowledge of other factors responsible for such an activity is scarce. Since surface exposure of hydrophobic residues is known to be an important factor which modulates the CLA of chaperone proteins, in the present study we have probed the surface hydrophobicity of PDC-109 using bisANS and ANS. Further, effect of phospholipids on the structure and chaperone-like activity of PDC-109 was studied. Presence of DMPC was found to increase the CLA of PDC-109 significantly, which could be due to the considerable exposure of hydrophobic regions on the lipid-protein recombinants, which can interact productively with the nonnative structures of target proteins, resulting in their protection. However, inclusion of DMPG instead of DMPC did not significantly alter the CLA of PDC-109, which could be due to the lower specificity of PDC-109 for DMPG as compared to DMPC. Cholesterol incorporation into DMPC membranes led to a decrease in the CLA of PDC-109-lipid recombinants, which could be attributed to reduced accessibility of hydrophobic surfaces to the substrate protein(s). These results underscore the relevance of phospholipid binding and hydrophobicity to the chaperone-like activity of PDC-109.	[Sankhala, Rajeshwer S.; Damai, Rajani S.; Swamy, Musti J.] Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Sankhala, RS (corresponding author), Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India.	mjssc@uohyd.ernet.in	Swamy, Musti/B-9418-2009	Swamy, Musti/0000-0002-3108-3633	Department of Science and Technology (India) [SR/SO/BB/0067/2007]	Department of Science and Technology (India)(Department of Science & Technology (India))	This work was supported by research grant No. SR/SO/BB/0067/2007 from the Department of Science and Technology (India) to MJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbazhagan V, 2008, BBA-PROTEINS PROTEOM, V1784, P891, DOI 10.1016/j.bbapap.2008.03.002; Anbazhagan V, 2005, FEBS LETT, V579, P2933, DOI 10.1016/j.febslet.2005.04.046; ANBAZHAGAN V, 2010, THERMODYNAMICS UNPUB; BAKER ME, 1985, BIOCHEM BIOPH RES CO, V130, P1010, DOI 10.1016/0006-291X(85)91715-2; Bhattacharyya M, 2004, J BIOL CHEM, V279, P55080, DOI 10.1074/jbc.M406418200; Calvete JJ, 1996, PROTEIN EXPRES PURIF, V8, P48, DOI 10.1006/prep.1996.0073; CHANDONNET L, 1990, MOL REPROD DEV, V26, P313, DOI 10.1002/mrd.1080260404; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Damai RS, 2010, IUBMB LIFE, V62, P841, DOI 10.1002/iub.394; Damai RS, 2009, BBA-PROTEINS PROTEOM, V1794, P1725, DOI 10.1016/j.bbapap.2009.08.010; DAS KP, 1995, BIOCHEM J, V311, P367, DOI 10.1042/bj3110367; Datta SA, 1999, J BIOL CHEM, V274, P34773, DOI 10.1074/jbc.274.49.34773; DESNOYERS L, 1992, J BIOL CHEM, V267, P10149; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; ESCH FS, 1983, BIOCHEM BIOPH RES CO, V113, P861, DOI 10.1016/0006-291X(83)91078-1; Gasset M, 1997, EUR J BIOCHEM, V250, P735, DOI 10.1111/j.1432-1033.1997.00735.x; Gasset M, 2000, ARCH BIOCHEM BIOPHYS, V374, P241, DOI 10.1006/abbi.1999.1593; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Greube A, 2001, BIOCHEMISTRY-US, V40, P8326, DOI 10.1021/bi010552+; Guha S, 1998, J BIOL CHEM, V273, P30077, DOI 10.1074/jbc.273.46.30077; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hawe A, 2011, J PHARM SCI-US, V100, P1294, DOI 10.1002/jps.22368; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2004, EXP EYE RES, V79, P817, DOI 10.1016/j.exer.2004.05.007; Kavitha M, 2009, J PHOTOCH PHOTOBIO B, V94, P59, DOI 10.1016/j.jphotobiol.2008.10.002; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; Kumarasamy A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003175; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; Lassiseraye D, 2008, BBA-BIOMEMBRANES, V1778, P502, DOI 10.1016/j.bbamem.2007.10.025; LIANG JN, 1991, EXP EYE RES, V53, P61, DOI 10.1016/0014-4835(91)90145-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mancek-Keber M, 2006, FASEB J, V20, P1836, DOI 10.1096/fj.06-5862com; MANJUNATH P, 1987, BIOSCIENCE REP, V7, P231, DOI 10.1007/BF01124794; MANJUNATH P, 1987, BIOCHEM J, V241, P685, DOI 10.1042/bj2410685; Manjunath P, 2002, BIOL REPROD, V67, P1250, DOI 10.1095/biolreprod67.4.1250; Moreau R, 1998, BIOCHEM BIOPH RES CO, V246, P148, DOI 10.1006/bbrc.1998.8513; Qu J, 2009, BIOCHEMISTRY-US, V48, P4926, DOI 10.1021/bi9004039; Rajaraman K, 1996, J BIOL CHEM, V271, P27595, DOI 10.1074/jbc.271.44.27595; Ramakrishnan M, 2001, BIOPHYS J, V81, P2215, DOI 10.1016/S0006-3495(01)75869-9; Reddy GB, 2000, J BIOL CHEM, V275, P4565, DOI 10.1074/jbc.275.7.4565; ROBERTS DD, 1982, J BIOL CHEM, V257, P1274; Sankhala RS, 2010, BIOCHEMISTRY-US, V49, P3908, DOI 10.1021/bi100051d; Scolari S, 2010, BIOCHEMISTRY-US, V49, P9027, DOI 10.1021/bi101257c; SEIDAH NG, 1987, BIOCHEM J, V243, P195, DOI 10.1042/bj2430195; Sharma KK, 1998, J BIOL CHEM, V273, P8965, DOI 10.1074/jbc.273.15.8965; Shivaji S., 1990, PROTEINS SEMINAL PLA, P1; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Swamy MJ, 2004, CURR SCI INDIA, V87, P203; Tannert A, 2007, EUR BIOPHYS J BIOPHY, V36, P461, DOI 10.1007/s00249-006-0105-3; Therien I, 1998, BIOL REPROD, V59, P768, DOI 10.1095/biolreprod59.4.768; Thomas CJ, 2003, BIOPHYS J, V84, P3037, DOI 10.1016/S0006-3495(03)70029-0; Wah DA, 2002, STRUCTURE, V10, P505, DOI 10.1016/S0969-2126(02)00751-7; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; Yanagimachi R., 1994, P189	55	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17330	10.1371/journal.pone.0017330	http://dx.doi.org/10.1371/journal.pone.0017330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408153	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170000021
J	van Eijk, R; Licht, J; Schrumpf, M; Yazdi, MT; Ruano, D; Forte, GI; Nederlof, PM; Veselic, M; Rabe, KF; Annema, JT; Smit, V; Morreau, H; van Wezel, T				van Eijk, Ronald; Licht, Jappe; Schrumpf, Melanie; Yazdi, Mehrdad Talebian; Ruano, Dina; Forte, Giusi I.; Nederlof, Petra M.; Veselic, Maud; Rabe, Klaus F.; Annema, Jouke T.; Smit, Vincent; Morreau, Hans; van Wezel, Tom			Rapid KRAS, EGFR, BRAF and PIK3CA Mutation Analysis of Fine Needle Aspirates from Non-Small-Cell Lung Cancer Using Allele-Specific qPCR	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATION; ENDOSCOPIC ULTRASOUND; PCR; ADENOCARCINOMA; AMPLIFICATION; GUIDELINES; DIAGNOSIS; THERAPY; NSCLC	Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA) and Trans-esophageal Ultrasound Scanning with Fine Needle Aspiration (EUS-FNA) are important, novel techniques for the diagnosis and staging of non-small cell lung cancer (NSCLC) that have been incorporated into lung cancer staging guidelines. To guide and optimize treatment decisions, especially for NSCLC patients in stage III and IV, EGFR and KRAS mutation status is often required. The concordance rate of the mutation analysis between these cytological aspirates and histological samples obtained by surgical staging is unknown. Therefore, we studied the extent to which allele-specific quantitative real-time PCR with hydrolysis probes could be reliably performed on EBUS and EUS fine needle aspirates by comparing the results with histological material from the same patient. We analyzed a series of 43 NSCLC patients for whom cytological and histological material was available. We demonstrated that these standard molecular techniques can be accurately applied on fine needle cytological aspirates from NSCLC patients. Importantly, we show that all mutations detected in the histological material of primary tumor were also identified in the cytological samples. We conclude that molecular profiling can be reliably performed on fine needle cytology aspirates from NSCLC patients.	[van Eijk, Ronald; Licht, Jappe; Schrumpf, Melanie; Ruano, Dina; Forte, Giusi I.; Veselic, Maud; Smit, Vincent; Morreau, Hans; van Wezel, Tom] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Yazdi, Mehrdad Talebian; Rabe, Klaus F.; Annema, Jouke T.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Nederlof, Petra M.] Netherlands Canc Inst NKI AVL, Dept Pathol, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute	van Eijk, R (corresponding author), Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands.	t.van_wezel@lumc.nl	Smit, Vincent/AAD-1811-2022; van Wezel, Tom/Z-3092-2019; van Wezel, Tom/AAL-5626-2021; Rabe, Klaus F./AAW-6296-2021; van Wezel, Tom/A-9599-2008	Smit, Vincent/0000-0003-3730-5652; van Wezel, Tom/0000-0001-5773-7730; Rabe, Klaus F./0000-0002-7020-1401; van Wezel, Tom/0000-0001-5773-7730; Forte, Giusi Irma/0000-0003-0161-9828; van Eijk, Ronald/0000-0001-7955-6295	Leiden University Medical Center	Leiden University Medical Center	This work was funded by the Leiden University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annema JT, 2005, JAMA-J AM MED ASSOC, V294, P931, DOI 10.1001/jama.294.8.931; Annema JT, 2005, J CLIN ONCOL, V23, P8357, DOI 10.1200/JCO.2005.01.1965; Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; BOLDRINI L, 2007, J THORACIC ONCOLOGY, V2; Brose MS, 2002, CANCER RES, V62, P6997; De Leyn P, 2007, EUR J CARDIO-THORAC, V32, P1, DOI 10.1016/j.ejcts.2007.01.075; Detterbeck FC, 2007, CHEST, V132, p202S, DOI 10.1378/chest.07-1362; Endo K, 2005, LUNG CANCER, V50, P375, DOI 10.1016/j.lungcan.2005.08.009; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Gu P, 2009, EUR J CANCER, V45, P1389, DOI 10.1016/j.ejca.2008.11.043; Hirsch FR, 2006, J CLIN ONCOL, V24, P5034, DOI 10.1200/JCO.2006.06.3958; Horiike A, 2007, CHEST, V131, P1628, DOI 10.1378/chest.06-1673; Jancik S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/150960; Jang Tae Won, 2009, Korean Journal of Internal Medicine, V24, P48, DOI [10.3904/kjim.2009.24.1.48, 10.3904/kjim.2009.24.1.43]; Kalikaki A, 2008, BRIT J CANCER, V99, P923, DOI 10.1038/sj.bjc.6604629; Kotoula V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007746; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Ladanyi M, 2008, MODERN PATHOL, V21, pS16, DOI 10.1038/modpathol.3801018; Lim EH, 2009, J THORAC ONCOL, V4, P12, DOI 10.1097/JTO.0b013e3181913e28; Micames CG, 2007, CHEST, V131, P539, DOI 10.1378/chest.06-1437; Molina JR, 2006, CHEST, V130, P1211, DOI 10.1378/chest.130.4.1211; MOLINAVILA MA, 2008, J THORACIC ONCOLOGY, V3; Monaco SE, 2010, HUM PATHOL, V41, P94, DOI 10.1016/j.humpath.2009.06.019; MOTOI N, 2008, AM J SURG PATHOLOGY, V32; Nakajima T, 2007, CHEST, V132, P597, DOI 10.1378/chest.07-0095; Okudela K, 2007, PATHOL INT, V57, P664, DOI 10.1111/j.1440-1827.2007.02155.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rossi G, 2009, INT J SURG PATHOL, V17, P206, DOI 10.1177/1066896909336178; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Sasaki H, 2007, ONCOL REP, V18, P623; Tournoy KG, 2009, LUNG CANCER, V63, P45, DOI 10.1016/j.lungcan.2008.04.004; van Eijk R, 2010, J MOL DIAGN, V12, P27, DOI 10.2353/jmoldx.2010.090028; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622; Zou ZQ, 2009, INT J MOL MED, V24, P97, DOI 10.3892/ijmm_00000212	36	137	138	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17791	10.1371/journal.pone.0017791	http://dx.doi.org/10.1371/journal.pone.0017791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408138	gold, Green Submitted, Green Published			2022-12-25	WOS:000288170000060
J	Komarova, TV; Kosorukov, VS; Frolova, OY; Petrunia, IV; Skrypnik, KA; Gleba, YY; Dorokhov, YL				Komarova, Tatiana V.; Kosorukov, Vyacheslav S.; Frolova, Olga Y.; Petrunia, Igor V.; Skrypnik, Ksenia A.; Gleba, Yuri Y.; Dorokhov, Yuri L.			Plant-Made Trastuzumab (Herceptin) Inhibits HER2/Neu+ Cell Proliferation and Retards Tumor Growth	PLOS ONE			English	Article							HER2-POSITIVE BREAST-CANCER; MONOCLONAL-ANTIBODY; ADJUVANT CHEMOTHERAPY; TRANSIENT EXPRESSION; VIRAL VECTORS; IN-VIVO; PROTEINS; PHARMACEUTICALS; VACCINES; SYSTEMS	Background: Plant biotechnology provides a valuable contribution to global health, in part because it can decrease the cost of pharmaceutical products. Breast cancer can now be successfully treated by a humanized monoclonal antibody (mAb), trastuzumab (Herceptin). A course of treatment, however, is expensive and requires repeated administrations of the mAb. Here we used an Agrobacterium-mediated transient expression system to produce trastuzumab in plant cells. Methodology/Principal Findings: We describe the cloning and expression of gene constructs in Nicotiana benthamiana plants using intron-optimized Tobacco mosaic virus-and Potato virus X-based vectors encoding, respectively, the heavy and light chains of trastuzumab. Full-size antibodies extracted and purified from plant tissues were tested for functionality and specificity by (i) binding to HER2/neu on the surface of a human mammary gland adenocarcinoma cell line, SK-BR-3, in fluorescence-activated cell sorting assay and (ii) testing the in vitro and in vivo inhibition of HER-2-expressing cancer cell proliferation. We show that plant-made trastuzumab (PMT) bound to the Her2/neu oncoprotein of SK-BR-3 cells and efficiently inhibited SK-BR-3 cell proliferation. Furthermore, mouse intraperitoneal PMT administration retarded the growth of xenografted tumors derived from human ovarian cancer SKOV3 Her2+ cells. Conclusions/Significance: We conclude that PMT is active in suppression of cell proliferation and tumor growth.	[Komarova, Tatiana V.; Dorokhov, Yuri L.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Kosorukov, Vyacheslav S.; Skrypnik, Ksenia A.] Russian Acad Med Sci, NN Blokhin Natl Canc Res Ctr, Moscow, Russia; [Frolova, Olga Y.; Petrunia, Igor V.; Dorokhov, Yuri L.] Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow, Russia; [Gleba, Yuri Y.] Nomad Biosci GmbH, Biozentrum Halle, Halle, Saale, Germany	Lomonosov Moscow State University; N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences; Russian Academy of Sciences; Vavilov Institute of General Genetics	Komarova, TV (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.	dorokhov@genebee.msu.su	Dorokhov, Yuri L/D-3565-2012; Komarova, Tatiana V./D-5824-2012; Kosorukov, Viacheslav S/A-3901-2014	Dorokhov, Yuri L/0000-0002-4066-8940; Komarova, Tatiana V./0000-0001-6558-8755; Kosorukov, Viacheslav S/0000-0002-8462-2178; Gleba, Yuri/0000-0003-4675-7474	Moscow Government [41-10-GeneM]; Nomad Bioscience GmbH	Moscow Government; Nomad Bioscience GmbH	This work was partly supported by grants from Moscow Government(#41-10-GeneM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by Nomad Bioscience GmbH, who did have a role in data collection and analysis. No additional external funding was received for this study.	Arntzen CJ, 2008, SCIENCE, V321, P1052, DOI 10.1126/science.1163420; Boothe J, 2010, PLANT BIOTECHNOL J, V8, P588, DOI 10.1111/j.1467-7652.2010.00511.x; Cervera M, 2010, TRANSGENIC RES, V19, P1001, DOI 10.1007/s11248-010-9378-5; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; Daniell H, 2001, TRENDS PLANT SCI, V6, P219, DOI 10.1016/S1360-1385(01)01922-7; De Muynck B, 2010, PLANT BIOTECHNOL J, V8, P529, DOI 10.1111/j.1467-7652.2009.00494.x; Dorokhov YL, 2006, J GEN VIROL, V87, P2693, DOI 10.1099/vir.0.82095-0; Frolova OY, 2010, VIROLOGY, V407, P7, DOI 10.1016/j.virol.2010.08.005; Galeffi P, 2005, VACCINE, V23, P1823, DOI 10.1016/j.vaccine.2004.11.025; Garrett JT, 2007, J IMMUNOL, V178, P7120, DOI 10.4049/jimmunol.178.11.7120; Gijsen M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000563; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Gleba Y, 2005, VACCINE, V23, P2042, DOI 10.1016/j.vaccine.2005.01.006; Gleba Y, 2004, CURR OPIN PLANT BIOL, V7, P182, DOI 10.1016/j.pbi.2004.01.003; Gleba Y, 2007, CURR OPIN BIOTECH, V18, P134, DOI 10.1016/j.copbio.2007.03.002; Gleba Yuri, 2004, Biotechnol Genet Eng Rev, V21, P325; Gomord W, 2004, PLANT BIOTECHNOL J, V2, P83, DOI 10.1111/j.1467-7652.2004.00062.x; Gomord W, 2005, TRENDS BIOTECHNOL, V23, P559, DOI 10.1016/j.tibtech.2005.09.003; Grohs BM, 2010, J AGR FOOD CHEM, V58, P10056, DOI 10.1021/jf102284f; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; Jobling SA, 2003, NAT BIOTECHNOL, V21, P77, DOI 10.1038/nbt772; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; KNABLEIN J, 2003, TRENDS DRUG DISCOVER, V6, P33; Ko K, 2005, P NATL ACAD SCI USA, V102, P7026, DOI 10.1073/pnas.0502533102; Komarova TV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P846, DOI 10.1134/S0006297906080049; Komarova TV, 2010, EXPERT REV VACCINES, V9, P859, DOI [10.1586/erv.10.85, 10.1586/ERV.10.85]; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai HF, 2010, P NATL ACAD SCI USA, V107, P2419, DOI 10.1073/pnas.0914503107; Lienard D, 2007, BIOTECHNOL ANN REV, V13, P115, DOI 10.1016/S1387-2656(07)13006-4; Longva KE, 2005, INT J CANCER, V116, P359, DOI 10.1002/ijc.21015; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Marillonnet S, 2004, P NATL ACAD SCI USA, V101, P6852, DOI 10.1073/pnas.0400149101; Martin VS, 2006, APPL SPECTROSC, V60, P994, DOI 10.1366/000370206778397498; McCormick AA, 2008, P NATL ACAD SCI USA, V105, P10131, DOI 10.1073/pnas.0803636105; Mison D, 2000, BIOPHARM-APPL T BIO, V13, P48; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Orzaez Diego, 2009, Biotechnology Journal, V4, P1712, DOI 10.1002/biot.200900223; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pujol M, 2007, TRENDS BIOTECHNOL, V25, P455, DOI 10.1016/j.tibtech.2007.09.001; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Schahs M, 2007, PLANT BIOTECHNOL J, V5, P657, DOI 10.1111/j.1467-7652.2007.00273.x; Schwartz AM, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1377, DOI 10.1134/S0006297906120145; Semenyuk EG, 2007, BIOCHIMIE, V89, P31, DOI 10.1016/j.biochi.2006.07.012; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Sourrouille Christophe, 2009, V483, P1, DOI 10.1007/978-1-59745-407-0_1; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Vancanneyt Guy, 2009, V483, P209, DOI 10.1007/978-1-59745-407-0_12; Villani ME, 2009, PLANT BIOTECHNOL J, V7, P59, DOI 10.1111/j.1467-7652.2008.00371.x; Vitale A, 2005, MOL INTERV, V5, P216, DOI 10.1124/mi.5.4.5; Yajima W, 2010, NEW BIOTECHNOL, V27, P816, DOI 10.1016/j.nbt.2010.09.010	54	31	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17541	10.1371/journal.pone.0017541	http://dx.doi.org/10.1371/journal.pone.0017541			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390232	Green Submitted, gold, Green Published			2022-12-25	WOS:000287965200021
J	dos Santos, HF; Cury, JC; do Carmo, FL; dos Santos, AL; Tiedje, J; van Elsas, JD; Rosado, AS; Peixoto, RS				dos Santos, Henrique Fragoso; Cury, Juliano Carvalho; do Carmo, Flavia Lima; dos Santos, Adriana Lopes; Tiedje, James; van Elsas, Jan Dirk; Rosado, Alexandre Soares; Peixoto, Raquel Silva			Mangrove Bacterial Diversity and the Impact of Oil Contamination Revealed by Pyrosequencing: Bacterial Proxies for Oil Pollution	PLOS ONE			English	Article							SP-NOV.; MICROBIAL DIVERSITY; SOIL; GAMMAPROTEOBACTERIA; DEGRADATION; ECOSYSTEMS; SEDIMENTS; MEMBER; BAY	Background: Mangroves are transitional coastal ecosystems in tropical and sub-tropical regions and represent biologically important and productive ecosystems. Despite their great ecological and economic importance, mangroves are often situated in areas of high anthropogenic influence, being exposed to pollutants, such as those released by oil spills. Methodology/Principal Findings: A microcosm experiment was conducted, which simulated an oil spill in previously pristine mangrove sediment. The effect of the oil spill on the extant microbial community was studied using direct pyrosequencing. Extensive bacterial diversity was observed in the pristine mangrove sediment, even after oil contamination. The number of different OTUs only detected in contaminated samples was significantly higher than the number of OTUs only detected in non-contaminated samples. The phylum Proteobacteria, in particular the classes Gammaproteobacteria and Deltaproteobacteria, were prevalent before and after the simulated oil spill. On the other hand, the order Chromatiales and the genus Haliea decreased upon exposure to 2 and 5% oil, these are proposed as sensitive indicators of oil contamination. Three other genera, Marinobacterium, Marinobacter and Cycloclasticus increased their prevalence when confronted with oil. These groups are possible targets for the biomonitoring of the impact of oil in mangrove settings. Conclusions/Significance: We suggest the use of sequences of the selected genera as proxies for oil pollution, using qPCR assessments. The quantification of these genera in distinct mangrove systems in relation to the local oil levels would permit the evaluation of the level of perturbance of mangroves, being useful in field monitoring. Considering the importance of mangroves to many other environments and the susceptibility of such areas to oil spills this manuscript will be of broad interest.	[dos Santos, Henrique Fragoso; Cury, Juliano Carvalho; do Carmo, Flavia Lima; dos Santos, Adriana Lopes; Rosado, Alexandre Soares; Peixoto, Raquel Silva] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Gen Microbiol, Lab Mol Microbial Ecol, Rio De Janeiro, Brazil; [Tiedje, James] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [van Elsas, Jan Dirk] Univ Groningen, Dept Microbial Ecol, Groningen, Netherlands	Universidade Federal do Rio de Janeiro; Michigan State University; University of Groningen	dos Santos, HF (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Gen Microbiol, Lab Mol Microbial Ecol, Rio De Janeiro, Brazil.	raquelpeixoto@micro.ufrj.br	Rosado, Alexandre Soares/G-1955-2012; dos Santos, Adriana Lopes/B-7252-2018; surname, name s/A-2183-2010; Santos, Henrique/AAI-9410-2020; Santos, Henrique Fragoso dos/G-3697-2014; bardakov, Dima/E-6747-2011; dos Santos, Adriana Lopes/J-6960-2019; Peixoto, Raquel/V-2554-2019	Rosado, Alexandre Soares/0000-0001-5135-1394; dos Santos, Adriana Lopes/0000-0002-0736-4937; Santos, Henrique/0000-0001-8850-7399; Santos, Henrique Fragoso dos/0000-0001-8850-7399; dos Santos, Adriana Lopes/0000-0002-0736-4937; Cury, Juliano/0000-0002-1450-5726; Peixoto, Raquel/0000-0002-9536-3132	Petrobras fellowship; Brazilian National Research Council (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Brazilian Army; Colonel Cardoso	Petrobras fellowship; Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian Army; Colonel Cardoso	H.F.S. was awarded with a Petrobras fellowship. A.S.R. and R.S.P. also greatly appreciate the support of Brazilian National Research Council (CNPq) and the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; To the Brazilian Army and to the Colonel Cardoso, who have supported and allowed us to sampling in Restinga da Marambaia mangrove.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Bordoloi NK, 2009, J HAZARD MATER, V170, P495, DOI 10.1016/j.jhazmat.2009.04.136; BURNS KA, 1993, MAR POLLUT BULL, V26, P239, DOI 10.1016/0025-326X(93)90062-O; Castine SA, 2009, AQUACULTURE, V297, P91, DOI 10.1016/j.aquaculture.2009.09.013; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Gu J, 2007, INT J SYST EVOL MICR, V57, P250, DOI 10.1099/ijs.0.64522-0; Hara A, 2003, ENVIRON MICROBIOL, V5, P746, DOI 10.1046/j.1468-2920.2003.00468.x; Holguin G, 2001, BIOL FERT SOILS, V33, P265, DOI 10.1007/s003740000319; Jukes T. H., 1969, MAMMALIAN PROTEIN ME; Kasai Y, 2002, APPL ENVIRON MICROB, V68, P5625, DOI 10.1128/AEM.68.11.5625-5633.2002; Kathiresan K, 2005, BIODIVERSITY MANGROV; Kumar S, 2007, REV BIOL TROP, V55, P777; Li CH, 2009, SCI TOTAL ENVIRON, V407, P5772, DOI 10.1016/j.scitotenv.2009.07.034; Li HL, 2007, MAR POLLUT BULL, V54, P1146, DOI 10.1016/j.marpolbul.2007.04.015; Liang JB, 2007, MAR BIOL, V150, P739, DOI 10.1007/s00227-006-0377-2; Lucena T, 2010, INT J SYST EVOL MICR, V60, P1844, DOI 10.1099/ijs.0.017061-0; Peixoto RS, 2010, ANTON LEEUW INT J G, V98, P403, DOI 10.1007/s10482-010-9454-0; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Brito EM, 2006, RES MICROBIOL, V157, P752, DOI 10.1016/j.resmic.2006.03.005; Santos HF, 2011, WATER AIR SOIL POLL, V216, P329, DOI 10.1007/s11270-010-0536-4; Santos HF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012437; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STALEY JT, 2010, HDB HYDROCARBON LIPI, V19, P1781; Teixeira LCRS, 2010, ISME J, V4, P989, DOI 10.1038/ismej.2010.35; Tian Y, 2008, MAR POLLUT BULL, V56, P1184, DOI 10.1016/j.marpolbul.2008.02.014; Urios L, 2008, INT J SYST EVOL MICR, V58, P1233, DOI 10.1099/ijs.0.65470-0; Urios L, 2009, INT J SYST EVOL MICR, V59, P1188, DOI 10.1099/ijs.0.002220-0; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yakimov MM, 2005, ENVIRON MICROBIOL, V7, P1426, DOI 10.1111/j.1462-5822.2005.00829.x	35	173	180	2	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e16943	10.1371/journal.pone.0016943	http://dx.doi.org/10.1371/journal.pone.0016943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399677	gold, Green Published, Green Submitted			2022-12-25	WOS:000287933300003
J	Evans, HC; Elliot, SL; Hughes, DP				Evans, Harry C.; Elliot, Simon L.; Hughes, David P.			Hidden Diversity Behind the Zombie-Ant Fungus Ophiocordyceps unilateralis: Four New Species Described from Carpenter Ants in Minas Gerais, Brazil	PLOS ONE			English	Article							TROPICAL FOREST ECOSYSTEMS; CORDYCEPS; COMPLEX; FORMICIDAE	Background: Ophiocordyceps unilateralis (Clavicipitaceae: Hypocreales) is a fungal pathogen specific to ants of the tribe Camponotini (Formicinae: Formicidae) with a pantropical distribution. This so-called zombie or brain-manipulating fungus alters the behaviour of the ant host, causing it to die in an exposed position, typically clinging onto and biting into the adaxial surface of shrub leaves. We (HCE and DPH) are currently undertaking a worldwide survey to assess the taxonomy and ecology of this highly variable species. Methods: We formally describe and name four new species belonging to the O. unilateralis species complex collected from remnant Atlantic rainforest in the south-eastern region (Zona da Mata) of the State of Minas Gerais, Brazil. Fully illustrated descriptions of both the asexual (anamorph) and sexual (teleomorph) stages are provided for each species. The new names are registered in Index Fungorum (registration. indexfungorum.org) and have received IF numbers. This paper is also a test case for the electronic publication of new names in mycology. Conclusions: We are only just beginning to understand the taxonomy and ecology of the Ophiocordyceps unilateralis species complex associated with carpenter ants; macroscopically characterised by a single stalk arising from the dorsal neck region of the ant host on which the anamorph occupies the terminal region and the teleomorph occurs as lateral cushions or plates. Each of the four ant species collected - Camponotus rufipes, C. balzani, C. melanoticus and C. novogranadensis - is attacked by a distinct species of Ophiocordyceps readily separated using traditional micromorphology. The new taxa are named according to their ant host.	[Evans, Harry C.; Elliot, Simon L.] Univ Fed Vicosa, Dept Anim Biol, Minas Gerais, Brazil; [Evans, Harry C.] CAB Int, E UK, Surrey, England; [Hughes, David P.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Hughes, David P.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Hughes, David P.] Univ Exeter, Sch Biosci, Exeter, Devon, England	Universidade Federal de Vicosa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Exeter	Evans, HC (corresponding author), Univ Fed Vicosa, Dept Anim Biol, Minas Gerais, Brazil.	h.evans@cabi.org; dhughes@psu.edu	Elliot, Simon Luke/A-5557-2013	Elliot, Simon Luke/0000-0002-7469-2949	Brazilian National Council for Research (CNPq) [401610/2009-8]; Individual International Marie Curie Fellowship [PIOF-GA-2008-221041]	Brazilian National Council for Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Individual International Marie Curie Fellowship	When this study was undertaken, HCE was a visiting scientist at the Postgraduate Programme in Entomology (UFV), whilst in receipt of a scholarship from the Brazilian National Council for Research (CNPq, grant no. 401610/2009-8). DPH was supported by an Individual International Marie Curie Fellowship (PIOF-GA-2008-221041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Evans HC, 2010, FUNGAL BIOL-UK, V114, P451, DOI 10.1016/j.funbio.2010.03.007; EVANS HC, 1982, T BRIT MYCOL SOC, V79, P431, DOI 10.1016/S0007-1536(82)80037-5; EVANS HC, 1984, T BRIT MYCOL SOC, V82, P127, DOI 10.1016/S0007-1536(84)80219-3; Evans HC, 2002, TRICHOMYCETES OTHER, P119; Hughes DP, 2009, ECOL ENTOMOL, V34, P214, DOI 10.1111/j.1365-2311.2008.01066.x; KOBAYASI Y., 1941, Science Reports of the Tokyo Bunrika Daigaku, V5, P53; MAINS EB, 1958, MYCOLOGIA, V50, P169, DOI 10.2307/3756193; PETCH T., 1931, Transactions of the British Mycological Society, V16, P55; SILVA GL, 2007, AN 8 C EC BRAS SOC E; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Tulasne LR, 1865, SELECTA FUNGORUM CAR, V3, P1; TZEAN SS, 1997, ATLAS ENTOMOPATHOGEN, P1	12	79	83	2	180	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17024	10.1371/journal.pone.0017024	http://dx.doi.org/10.1371/journal.pone.0017024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399679	gold, Green Published			2022-12-25	WOS:000287933300006
J	Jayaraman, A; Pappas, C; Raman, R; Belser, JA; Viswanathan, K; Shriver, Z; Tumpey, TM; Sasisekharan, R				Jayaraman, Akila; Pappas, Claudia; Raman, Rahul; Belser, Jessica A.; Viswanathan, Karthik; Shriver, Zachary; Tumpey, Terrence M.; Sasisekharan, Ram			A Single Base-Pair Change in 2009 H1N1 Hemagglutinin Increases Human Receptor Affinity and Leads to Efficient Airborne Viral Transmission in Ferrets	PLOS ONE			English	Article							A(H1N1) INFLUENZA-VIRUSES; A VIRUSES	The 2009 H1N1 influenza A virus continues to circulate among the human population as the predominant H1N1 subtype. Epidemiological studies and airborne transmission studies using the ferret model have shown that the transmission efficiency of 2009 H1N1 viruses is lower than that of previous seasonal strains and the 1918 pandemic H1N1 strain. We recently correlated this reduced transmission efficiency to the lower binding affinity of the 2009 H1N1 hemagglutinin (HA) to alpha 2 -> 6 sialylated glycan receptors (human receptors). Here we report that a single point mutation (Ile219 -> Lys; a base pair change) in the glycan receptor-binding site (RBS) of a representative 2009 H1N1 influenza A virus, A/California/04/09 or CA04/09, quantitatively increases its human receptor-binding affinity. The increased human receptor-affinity is in the same range as that of the HA from highly transmissible seasonal and 1918 pandemic H1N1 viruses. Moreover, a 2009 H1N1 virus carrying this mutation in the RBS (generated using reverse genetics) transmits efficiently in ferrets by respiratory droplets thereby reestablishing our previously observed correlation between human receptor-binding affinity and transmission efficiency. These findings are significant in the context of monitoring the evolution of the currently circulating 2009 H1N1 viruses.	[Jayaraman, Akila; Raman, Rahul; Viswanathan, Karthik; Shriver, Zachary; Sasisekharan, Ram] MIT, Harvard Mit Div Hlth Sci & Technol, Singapore MIT Alliance Res & Technol, Dept Biol Engn,Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Pappas, Claudia; Belser, Jessica A.; Tumpey, Terrence M.] Centers Dis Control & Prevent CDC, Influenza Div, Atlanta, GA USA	Harvard University; Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART); Centers for Disease Control & Prevention - USA	Jayaraman, A (corresponding author), MIT, Harvard Mit Div Hlth Sci & Technol, Singapore MIT Alliance Res & Technol, Dept Biol Engn,Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.	rams@mit.edu			National Institutes of Health and the Singapore-MIT Alliance for Research and Technology [R37 GM057073-13]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073] Funding Source: NIH RePORTER	National Institutes of Health and the Singapore-MIT Alliance for Research and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by a merit award to RS (R37 GM057073-13) from the National Institutes of Health and the Singapore-MIT Alliance for Research and Technology. The authors acknowledge the Consortium for Functional Glycomics for providing the glycan standards. The confocal microscopy analysis of the human tissue sections was performed at the W. M. Keck Imaging Facility in the Whitehead Institute at MIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barr IG, 2010, EURO SURVEILL, V15; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Doyle TJ, 2011, EPIDEMIOL INFECT, V139, P45, DOI 10.1017/S095026881000141X; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hai R, 2008, J VIROL, V82, P10580, DOI 10.1128/JVI.01213-08; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Morens DM, 2010, MBIO, V1, DOI 10.1128/mBio.00211-10; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Soundararajan V, 2009, NAT BIOTECHNOL, V27, P510, DOI 10.1038/nbt0609-510; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Viswanathan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013768; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; World Health Organization, 2010, PAND H1N1 2009 UPD 1; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905	34	44	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17616	10.1371/journal.pone.0017616	http://dx.doi.org/10.1371/journal.pone.0017616			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407805	gold, Green Published, Green Submitted			2022-12-25	WOS:000287933300036
J	Yu, JY; Chau, KF; Vodyanik, MA; Jiang, JL; Jiang, Y				Yu, Junying; Chau, Kevin Fongching; Vodyanik, Maxim A.; Jiang, Jinlan; Jiang, Yong			Efficient Feeder-Free Episomal Reprogramming with Small Molecules	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; GENERATION; INDUCTION; VIRUS; ADULT; VECTOR; DNA; FIBROBLASTS; GROWTH	Genetic reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) could offer replenishable cell sources for transplantation therapies. To fulfill their promises, human iPSCs will ideally be free of exogenous DNA (footprint-free), and be derived and cultured in chemically defined media free of feeder cells. Currently, methods are available to enable efficient derivation of footprint-free human iPSCs. However, each of these methods has its limitations. We have previously derived footprint-free human iPSCs by employing episomal vectors for transgene delivery, but the process was inefficient and required feeder cells. Here, we have greatly improved the episomal reprogramming efficiency using a cocktail containing MEK inhibitor PD0325901, GSK3 beta inhibitor CHIR99021, TGF-beta/Activin/Nodal receptor inhibitor A-83-01, ROCK inhibitor HA-100 and human leukemia inhibitory factor. Moreover, we have successfully established a feeder-free reprogramming condition using chemically defined medium with bFGF and N2B27 supplements and chemically defined human ESC medium mTeSR1 for the derivation of footprint-free human iPSCs. These improvements enabled the routine derivation of footprint-free human iPSCs from skin fibroblasts, adipose tissue-derived cells and cord blood cells. This technology will likely be valuable for the production of clinical-grade human iPSCs.	[Yu, Junying; Chau, Kevin Fongching; Vodyanik, Maxim A.; Jiang, Jinlan; Jiang, Yong] Cellular Dynam Int Inc, Adv Dev Programs, Madison, WI 53711 USA		Yu, JY (corresponding author), Cellular Dynam Int Inc, Adv Dev Programs, Madison, WI 53711 USA.	jyu@cellulardynamics.com		Chau, Kevin Fongching/0000-0002-7899-3247	Cellular Dynamics International, Inc.	Cellular Dynamics International, Inc.	This study was supported by Cellular Dynamics International, Inc. (http://www.cellulardynamics.com/). The funder had a role in the decision to publish the manuscript.	Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Chen ZY, 2004, GENE THER, V11, P856, DOI 10.1038/sj.gt.3302231; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kameda T, 2006, BIOCHEM BIOPH RES CO, V349, P1269, DOI 10.1016/j.bbrc.2006.08.175; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Liu YX, 2006, BIOCHEM BIOPH RES CO, V346, P131, DOI 10.1016/j.bbrc.2006.05.086; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; MIDDLETON T, 1994, J VIROL, V68, P4067, DOI 10.1128/JVI.68.6.4067-4071.1994; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Shimada H, 2010, MOL REPROD DEV, V77, P2, DOI 10.1002/mrd.21117; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Ziegler K, 2004, J VIROL METHODS, V122, P123, DOI 10.1016/j.jviromet.2004.08.012	37	163	172	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17557	10.1371/journal.pone.0017557	http://dx.doi.org/10.1371/journal.pone.0017557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390254	gold, Green Published, Green Submitted			2022-12-25	WOS:000287932100023
J	Ghirardo, A; Gutknecht, J; Zimmer, I; Bruggemann, N; Schnitzler, JP				Ghirardo, Andrea; Gutknecht, Jessica; Zimmer, Ina; Brueggemann, Nicolas; Schnitzler, Joerg-Peter			Biogenic Volatile Organic Compound and Respiratory CO2 Emissions after C-13-Labeling: Online Tracing of C Translocation Dynamics in Poplar Plants	PLOS ONE			English	Article							CARBON-ISOTOPE COMPOSITION; ISOPRENE BIOSYNTHESIS; NATURAL-ABUNDANCE; LEAF DEVELOPMENT; PHOTOSYNTHESIS; LEAVES; HYDROCARBONS; (CO2)-C-13; DELTA-C-13; METHANOL	Background: Globally plants are the primary sink of atmospheric CO2, but are also the major contributor of a large spectrum of atmospheric reactive hydrocarbons such as terpenes (e. g. isoprene) and other biogenic volatile organic compounds (BVOC). The prediction of plant carbon (C) uptake and atmospheric oxidation capacity are crucial to define the trajectory and consequences of global environmental changes. To achieve this, the biosynthesis of BVOC and the dynamics of C allocation and translocation in both plants and ecosystems are important. Methodology: We combined tunable diode laser absorption spectrometry (TDLAS) and proton transfer reaction mass spectrometry (PTR-MS) for studying isoprene biosynthesis and following C fluxes within grey poplar (Populus x canescens) saplings. This was achieved by feeding either (CO2)-C-13 to leaves or C-13-glucose to shoots via xylem uptake. The translocation of (CO2)-C-13 from the source to other plant parts could be traced by C-13-labeled isoprene and respiratory (CO2)-C-13 emission. Principal Finding: In intact plants, assimilated (CO2)-C-13 was rapidly translocated via the phloem to the roots within 1 hour, with an average phloem transport velocity of 20.3 +/- 2.5 cm h(-1).C-13 label was stored in the roots and partially reallocated to the plants' apical part one day after labeling, particularly in the absence of photosynthesis. The daily C loss as BVOC ranged between 1.6% in mature leaves and 7.0% in young leaves. Non-isoprene BVOC accounted under light conditions for half of the BVOC C loss in young leaves and one-third in mature leaves. The C loss as isoprene originated mainly (76-78%) from recently fixed CO2, to a minor extent from xylem-transported sugars (7-11%) and from photosynthetic intermediates with slower turnover rates (8-11%). Conclusion: We quantified the plants' C loss as respiratory CO2 and BVOC emissions, allowing in tandem with metabolic analysis to deepen our understanding of ecosystem C flux.	[Ghirardo, Andrea; Gutknecht, Jessica; Zimmer, Ina; Brueggemann, Nicolas; Schnitzler, Joerg-Peter] Inst Meteorol & Climate Res, Karlsruhe Inst Technol, Garmisch Partenkirchen, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Ghirardo, A (corresponding author), Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, Dept Environm Engn, Neuherberg, Germany.	jp.schnitzler@helmholtz-muenchen.de	Zimmer, Ina/M-1295-2015; Brueggemann, Nicolas/C-4263-2014; Schnitzler, Joerg-Peter/C-5268-2011; Ghirardo, Andrea/P-1764-2019	Zimmer, Ina/0000-0002-6441-8495; Brueggemann, Nicolas/0000-0003-3851-2418; Schnitzler, Joerg-Peter/0000-0002-9825-867X; Ghirardo, Andrea/0000-0003-1973-4007	Human Frontier Science Program; German Research Foundation [DFG SCHN653/4]	Human Frontier Science Program(Human Frontier Science Program); German Research Foundation(German Research Foundation (DFG))	Financial support was given by the Human Frontier Science Program ( to J. P. S. and A. G.) and the German Research Foundation ( to J. P. S., DFG SCHN653/4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affek HP, 2003, PLANT PHYSIOL, V131, P1727, DOI 10.1104/pp.102.012294; Bahn M, 2009, NEW PHYTOL, V182, P451, DOI 10.1111/j.1469-8137.2008.02755.x; Behnke K, 2007, PLANT J, V51, P485, DOI 10.1111/j.1365-313X.2007.03157.x; Brandes E, 2006, GLOBAL CHANGE BIOL, V12, P1922, DOI 10.1111/j.1365-2486.2006.01205.x; Brilli F, 2007, NEW PHYTOL, V175, P244, DOI 10.1111/j.1469-8137.2007.02094.x; Brilli F, 2009, PLANT CELL ENVIRON, V32, P542, DOI 10.1111/j.1365-3040.2009.01948.x; Bruggemann N, 2002, PHYSIOL PLANTARUM, V115, P190, DOI 10.1034/j.1399-3054.2002.1150203.x; BUYSSE J, 1993, J EXP BOT, V44, P1627, DOI 10.1093/jxb/44.10.1627; CHAMEIDES WL, 1988, SCIENCE, V241, P1473, DOI 10.1126/science.3420404; Cinege G, 2009, PLANT MOL BIOL, V69, P593, DOI 10.1007/s11103-008-9441-2; Coplen TB, 2006, ANAL CHEM, V78, P2439, DOI 10.1021/ac052027c; DELWICHE CF, 1993, PLANT CELL ENVIRON, V16, P587, DOI 10.1111/j.1365-3040.1993.tb00907.x; DICKSON RE, 1981, PLANTA, V152, P461, DOI 10.1007/BF00385364; Ehlting B, 2007, PLANT CELL ENVIRON, V30, P796, DOI 10.1111/j.1365-3040.2007.01668.x; Ekblad A, 2001, OECOLOGIA, V127, P305, DOI 10.1007/s004420100667; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; FROMMER WB, 1995, J EXP BOT, V46, P587, DOI 10.1093/jxb/46.6.587; Ghirardo A, 2010, PLANT CELL ENVIRON, V33, P781, DOI 10.1111/j.1365-3040.2009.02104.x; Graus M, 2004, PLANT PHYSIOL, V135, P1967, DOI 10.1104/pp.104.043240; Hakola H, 1998, ATMOS ENVIRON, V32, P1825, DOI 10.1016/S1352-2310(97)00482-2; HANSEL A, 1995, INT J MASS SPECTROM, V149, P609, DOI 10.1016/0168-1176(95)04294-U; Heizmann U, 2001, PLANT BIOLOGY, V3, P132, DOI 10.1055/s-2001-12898; Hogberg P, 2008, NEW PHYTOL, V177, P220, DOI 10.1111/j.1469-8137.2007.02238.x; Hogberg P, 2006, TRENDS ECOL EVOL, V21, P548, DOI 10.1016/j.tree.2006.06.004; Huve K, 2007, J EXP BOT, V58, P1783, DOI 10.1093/jxb/erm038; JACOB DJ, 1988, J GEOPHYS RES-ATMOS, V93, P1477, DOI 10.1029/JD093iD02p01477; Knohl A, 2005, OECOLOGIA, V142, P70, DOI 10.1007/s00442-004-1702-4; Kreuzwieser J, 1999, J EXP BOT, V50, P757, DOI 10.1093/jexbot/50.335.757; Kreuzwieser J, 2002, NEW PHYTOL, V156, P171, DOI 10.1046/j.1469-8137.2002.00516.x; LARSON PR, 1969, AM J BOT, V56, P1058, DOI 10.2307/2440930; Lehning A, 1999, PLANT CELL ENVIRON, V22, P495, DOI 10.1046/j.1365-3040.1999.00425.x; LOESCHER WH, 1990, HORTSCIENCE, V25, P274, DOI 10.21273/HORTSCI.25.3.274; Loreto F, 2010, TRENDS PLANT SCI, V15, P154, DOI 10.1016/j.tplants.2009.12.006; Magel E, 2006, ATMOS ENVIRON, V40, pS138, DOI 10.1016/j.atmosenv.2005.09.091; Mayrhofer S, 2004, PLANT BIOLOGY, V6, P730, DOI 10.1055/s-2004-821268; NEMECEKMARSHALL M, 1995, PLANT PHYSIOL, V108, P1359, DOI 10.1104/pp.108.4.1359; NOVAKOV T, 1993, NATURE, V365, P823, DOI 10.1038/365823a0; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Rasulov B, 2009, PLANT PHYSIOL, V149, P1609, DOI 10.1104/pp.108.133512; Schnitzler JP, 2010, PLANT BIOLOGY, V12, P302, DOI 10.1111/j.1438-8677.2009.00284.x; Schnitzler JP, 2004, PLANT PHYSIOL, V135, P152, DOI 10.1104/pp.103.037374; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Subke JA, 2009, NEW PHYTOL, V183, P349, DOI 10.1111/j.1469-8137.2009.02883.x; TRAINER M, 1987, J GEOPHYS RES-ATMOS, V92, P11879, DOI 10.1029/JD092iD10p11879; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Werner RA, 2001, RAPID COMMUN MASS SP, V15, P501, DOI 10.1002/rcm.258	47	53	53	5	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17393	10.1371/journal.pone.0017393	http://dx.doi.org/10.1371/journal.pone.0017393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387007	Green Published, gold, Green Submitted			2022-12-25	WOS:000287931400068
J	Zhang, YY; Post, WS; Dalal, D; Blasco-Colmenares, E; Tomaselli, GF; Guallar, E				Zhang, Yiyi; Post, Wendy S.; Dalal, Darshan; Blasco-Colmenares, Elena; Tomaselli, Gordon F.; Guallar, Eliseo			Coffee, Alcohol, Smoking, Physical Activity and QT Interval Duration: Results from the Third National Health and Nutrition Examination Survey	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SUDDEN CARDIAC DEATH; CIGARETTE-SMOKING; PROLONGED QTC; VENTRICULAR REPOLARIZATION; CARDIOVASCULAR MORTALITY; GENERAL-POPULATION; RISK-FACTORS; DISPERSION; ASSOCIATION	Background: Abnormalities in the electrocardiographic QT interval duration have been associated with an increased risk of ventricular arrhythmias and sudden cardiac death. However, there is substantial uncertainty about the effect of modifiable factors such as coffee intake, cigarette smoking, alcohol consumption, and physical activity on QT interval duration. Methods: We studied 7795 men and women from the Third National Health and Nutrition Survey (NHANES III, 1988-1994). Baseline QT interval was measured from the standard 12-lead electrocardiogram. Coffee and tea intake, alcohol consumption, leisure-time physical activities over the past month, and lifetime smoking habits were determined using validated questionnaires during the home interview. Results: In the fully adjusted model, the average differences in QT interval comparing participants drinking >= 6 cups/day to those who did not drink any were -1.2 ms (95% CI -4.4 to 2.0) for coffee, and -2.0 ms (-11.2 to 7.3) for tea, respectively. The average differences in QT interval duration comparing current to never smokers was 1.2 ms (-0.6 to 2.9) while the average difference in QT interval duration comparing participants drinking >= 7 drinks/week to non-drinkers was 1.8 ms (-0.5 to 4.0). The age, race/ethnicity, and RR-interval adjusted differences in average QT interval duration comparing men with binge drinking episodes to non-drinkers or drinkers without binge drinking were 2.8 ms (0.4 to 5.3) and 4.0 ms (1.6 to 6.4), respectively. The corresponding differences in women were 1.1 (-2.9 to 5.2) and 1.7 ms (-2.3 to 5.7). Finally, the average differences in QT interval comparing the highest vs. the lowest categories of total physical activity was 20.8 ms (-3.0 to 1.4). Conclusion: Binge drinking was associated with longer QT interval in men but not in women. QT interval duration was not associated with other modifiable factors including coffee and tea intake, smoking, and physical activity.	[Zhang, Yiyi; Post, Wendy S.; Blasco-Colmenares, Elena; Guallar, Eliseo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Zhang, Yiyi; Post, Wendy S.; Blasco-Colmenares, Elena; Guallar, Eliseo] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Post, Wendy S.; Dalal, Darshan; Tomaselli, Gordon F.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Guallar, Eliseo] Natl Ctr Cardiovasc Res CNIC, Dept Cardiovasc Epidemiol & Populat Genet, Madrid, Spain	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Zhang, YY (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	eguallar@jhsph.edu	zhang, yiyi/J-2592-2012; Guallar, Eliseo/D-3807-2014	Guallar, Eliseo/0000-0002-4471-9565	National Center for Cardiovascular Research (CNIC Translational Cardiology) [2008-03]; National Institutes of Health [ES015597, HL091062]; Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University; Fondation Leducq.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015597] Funding Source: NIH RePORTER	National Center for Cardiovascular Research (CNIC Translational Cardiology); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University(Johns Hopkins University); Fondation Leducq.(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The present study was funded in part by grants from the National Center for Cardiovascular Research (CNIC Translational Cardiology grant 2008-03), the National Institutes of Health (grants ES015597 and HL091062), the Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University and the Fondation Leducq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agarwal S, 2009, ANGIOLOGY, V60, P335, DOI 10.1177/0003319708330526; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Akylbekova EL, 2009, CIRC-ARRHYTHMIA ELEC, V2, P427, DOI 10.1161/CIRCEP.109.858894; ALGRA A, 1993, BRIT HEART J, V70, P43; Ammar R, 2001, PHARMACOTHERAPY, V21, P437, DOI 10.1592/phco.21.5.437.34502; Andrassy G, 2003, AM J CARDIOL, V92, P489, DOI 10.1016/S0002-9149(03)00678-7; [Anonymous], 1994, VITAL HLTH STAT, P1; [Anonymous], DRUGS PROLONG QT INT; Benoit SR, 2005, EUR J CARDIOV PREV R, V12, P363, DOI 10.1097/01.hjr.0000173110.21851.a9; Bernert JT, 1997, CLIN CHEM, V43, P2281; *CDC, 2010, 4 CDC HUM EXP ENV CH; Choi HK, 2007, ARTHRIT RHEUM-ARTHR, V57, P816, DOI 10.1002/art.22762; DAY CP, 1993, LANCET, V341, P1423; DEKKER JM, 1994, CIRCULATION, V90, P779, DOI 10.1161/01.CIR.90.2.779; Dekker JM, 2004, J AM COLL CARDIOL, V43, P565, DOI 10.1016/j.jacc.2003.09.040; Dilaveris P, 2001, AM HEART J, V142, P833, DOI 10.1067/mhj.2001.118737; ETTINGER PO, 1978, AM HEART J, V95, P555, DOI 10.1016/0002-8703(78)90296-X; FANKUSHEN D, 1964, AM J MED, V37, P802, DOI 10.1016/0002-9343(64)90028-2; Fauchier L, 2000, AM J CARDIOL, V86, P557, DOI 10.1016/S0002-9149(00)01015-8; Gaita F, 2003, CIRCULATION, V108, P965, DOI 10.1161/01.CIR.0000085071.28695.C4; GIACOBINI E, 1960, EXPERIENTIA, V16, P467, DOI 10.1007/BF02171159; Gussak I, 2000, CARDIOLOGY, V94, P99, DOI 10.1159/000047299; HOGNESTAD J, 1973, ACTA PATH MICRO IM A, VA 81, P315; Ileri M, 2001, AM J CARDIOL, V88, P322, DOI 10.1016/S0002-9149(01)01653-8; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; Karjalainen J, 1997, HEART, V77, P543, DOI 10.1136/hrt.77.6.543; KINO M, 1981, BRIT HEART J, V46, P545; Kobza R, 2009, HEART RHYTHM, V6, P652, DOI 10.1016/j.hrthm.2009.01.009; KOIDE T, 1980, JPN HEART J, V21, P451; Lewis MJ, CLIN PHYSL FUNCT IMA, V30, P43; LIM P, 1972, METABOLISM, V21, P1045, DOI 10.1016/0026-0495(72)90035-2; LINUMA H, 1978, EUR J CARDIOL, V7, P465; Montanez A, 2004, ARCH INTERN MED, V164, P943, DOI 10.1001/archinte.164.9.943; Nilsson G, 2006, EUROPACE, V8, P233, DOI 10.1093/europace/euj040; Okin PM, 2000, CIRCULATION, V101, P61, DOI 10.1161/01.CIR.101.1.61; Perkiomaki JS, 2001, ANN NONINVAS ELECTRO, V6, P183, DOI 10.1111/j.1542-474X.2001.tb00106.x; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Pytlak A, 2000, ANE, V5, P322; Rautaharju PM, 2006, CIRCULATION, V113, P473, DOI 10.1161/CIRCULATIONAHA.104.496091; RAUTAHARJU PM, 1990, METHOD INFORM MED, V29, P362; Robbins J, 2003, AM J MED, V115, P689, DOI 10.1016/j.amjmed.2003.07.014; Romero Mestre J C, 1996, Rev Esp Cardiol, V49, P259; Rossinen J, 1999, CLIN CARDIOL, V22, P591, DOI 10.1002/clc.4960220910; Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005; Sauer AJ, 2007, J AM COLL CARDIOL, V49, P329, DOI 10.1016/j.jacc.2006.08.057; SCHENK EA, 1970, PATHOL MICROBIOL, V35, P96, DOI 10.1159/000162206; Schimpf R, 2008, CURR OPIN CARDIOL, V23, P192, DOI 10.1097/HCO.0b013e3282fbf756; Sheehan J, 2004, EUR J CARDIOV PREV R, V11, P63, DOI 10.1097/01.hjr.0000114970.39211.9e; Shiels MS, 2009, CANCER CAUSE CONTROL, V20, P877, DOI 10.1007/s10552-009-9318-y; Singh K, 2004, Indian Heart J, V56, P140; Straus SMJM, 2006, J AM COLL CARDIOL, V47, P362, DOI 10.1016/j.jacc.2005.08.067; SUTHERLAND DJ, 1985, CHEST, V87, P319, DOI 10.1378/chest.87.3.319; Tsai CS, 2005, ALCOHOL CLIN EXP RES, V29, P1787, DOI 10.1097/01.alc.0000183512.31705.74; VETTER WR, 1967, ARCH INTERN MED, V120, P536, DOI 10.1001/archinte.120.5.536	54	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17584	10.1371/journal.pone.0017584	http://dx.doi.org/10.1371/journal.pone.0017584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386989	Green Submitted, Green Published, gold			2022-12-25	WOS:000287931400086
J	Kormos, B; Belso, N; Bebes, A; Szabad, G; Bacsa, S; Szell, M; Kemeny, L; Bata-Csorgo, Z				Kormos, Bernadett; Belso, Nora; Bebes, Attila; Szabad, Gabor; Bacsa, Sarolta; Szell, Marta; Kemeny, Lajos; Bata-Csoergo, Zsuzsanna			In Vitro Dedifferentiation of Melanocytes from Adult Epidermis	PLOS ONE			English	Article							C-KIT EXPRESSION; FIBROBLAST-GROWTH-FACTOR; NEURAL CREST; MELANOMA-CELLS; TRANSCRIPTION FACTOR; ALPHA-MELANOTROPIN; PRECURSOR CELLS; CHOLERA-TOXIN; CYCLIC-AMP; PROLIFERATION	In previous work we described a novel culture technique using a cholera toxin and PMA-free medium (Mel-mix) for obtaining pure melanocyte cultures from human adult epidermis. In Mel-mix medium the cultured melanocytes are bipolar, unpigmented and highly proliferative. Further characterization of the cultured melanocytes revealed the disappearance of c-Kit and TRP-1 and induction of nestin expression, indicating that melanocytes dedifferentiated in this in vitro culture. Cholera toxin and PMA were able to induce c-Kit and TRP-1 protein expressions in the cells, reversing dedifferentiation. TRP-1 mRNA expression was induced in dedifferentiated melanocytes by UV-B irradiated keratinocyte supernatants, however direct UV-B irradiation of the cells resulted in further decrease of TRP-1 mRNA expression. These dedifferentiated, easily accessible cultured melanocytes provide a good model for studying melanocyte differentiation and possibly transdifferentiation. Because melanocytes in Mel-mix medium can be cultured with human serum as the only supplement, this culture system is also suitable for autologous cell transplantation.	[Kormos, Bernadett; Szell, Marta; Kemeny, Lajos; Bata-Csoergo, Zsuzsanna] Hungarian Acad Sci, Dermatol Res Grp, Szeged, Hungary; [Belso, Nora; Bebes, Attila; Szabad, Gabor; Bacsa, Sarolta; Kemeny, Lajos; Bata-Csoergo, Zsuzsanna] Univ Szeged, Fac Med, Dept Dermatol & Allergol, Szeged, Hungary	Hungarian Academy of Sciences; Szeged University	Kormos, B (corresponding author), Hungarian Acad Sci, Dermatol Res Grp, Szeged, Hungary.	kormosbetti@mail.derma.szote.u-szeged.hu	Kemeny, Lajos/ABF-1339-2021	Kemeny, Lajos/0000-0002-2119-9501; Bata-Csorgo, Zsuzsanna/0000-0002-3732-1743	Egeszsegugyi Tudomanyos Tanacs, Medical Scientific Board [ETT 429-07];  [TAMOP-4.2.2-08/1-2008-0001];  [OTKA NK77434];  [OTKA K77436]	Egeszsegugyi Tudomanyos Tanacs, Medical Scientific Board; ; ; 	This work was supported by grants ETT 429-07 (Egeszsegugyi Tudomanyos Tanacs, Medical Scientific Board), TAMOP-4.2.2-08/1-2008-0001, OTKA NK77434, and OTKA K77436. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Brychtova S, 2007, J CUTAN PATHOL, V34, P370, DOI 10.1111/j.1600-0560.2006.00627.x; Cook AL, 2003, J INVEST DERMATOL, V121, P1150, DOI 10.1046/j.1523-1747.2003.12562.x; DONATIEN P, 1993, ARCH DERMATOL RES, V285, P385, DOI 10.1007/BF00372130; Dupin E, 2000, P NATL ACAD SCI USA, V97, P7882, DOI 10.1073/pnas.97.14.7882; Dupin E, 2003, ONCOGENE, V22, P3016, DOI 10.1038/sj.onc.1206460; Ehrmann J, 2005, J CLIN PATHOL, V58, P222, DOI 10.1136/jcp.2004.021238; EISINGER M, 1982, P NATL ACAD SCI-BIOL, V79, P2018, DOI 10.1073/pnas.79.6.2018; FALABELLA R, 1989, J AM ACAD DERMATOL, V21, P257, DOI 10.1016/S0190-9622(89)70170-5; Flammiger A, 2009, J INVEST DERMATOL, V129, P945, DOI 10.1038/jid.2008.316; Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z; Grichnik JM, 2006, J INVEST DERMATOL, V126, P945, DOI 10.1038/sj.jid.5700164; Grichnik JM, 1996, J INVEST DERMATOL, V106, P967, DOI 10.1111/1523-1747.ep12338471; HALABAN R, 1987, IN VITRO CELL DEV B, V23, P47; HALABAN R, 1983, J CELL BIOL, V97, P480, DOI 10.1083/jcb.97.2.480; HARA H, 1994, J INVEST DERMATOL, V102, P495, DOI 10.1111/1523-1747.ep12373136; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x; HIROBE T, 1992, DEVELOPMENT, V114, P435; Im SB, 1998, CANCER RES, V58, P47; Kawaguchi Y, 2001, J INVEST DERMATOL, V116, P920, DOI 10.1046/j.0022-202x.2001.01370.x; Kim NS, 2000, ARCH DERMATOL RES, V292, P233, DOI 10.1007/s004030050480; LASSAM N, 1992, ONCOGENE, V7, P51; LERNER AB, 1987, J INVEST DERMATOL, V89, P219, DOI 10.1111/1523-1747.ep12470973; Liu B, 2007, J NEUROSCI RES, V85, P3523, DOI 10.1002/jnr.21364; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; LUO D, 1995, MELANOMA RES, V5, P303, DOI 10.1097/00008390-199510000-00002; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; MENGEAUD V, 1994, PIGM CELL RES, V7, P245, DOI 10.1111/j.1600-0749.1994.tb00059.x; Montone KT, 1997, MODERN PATHOL, V10, P939; Nakazawa K, 1998, J INVEST DERMATOL, V110, P972, DOI 10.1046/j.1523-1747.1998.00204.x; Nishioka E, 1999, MELANOMA RES, V9, P433, DOI 10.1097/00008390-199910000-00002; Papageorgiou N, 2008, NEUROREPORT, V19, P1787, DOI 10.1097/WNR.0b013e3283193e82; Park HY, 2009, INT J CELL BIOL, V2009; Peters EMJ, 2002, J HISTOCHEM CYTOCHEM, V50, P751, DOI 10.1177/002215540205000602; Prince S, 2003, PIGM CELL RES, V16, P26, DOI 10.1034/j.1600-0749.2003.00008.x; Real C, 2006, DEV BIOL, V300, P656, DOI 10.1016/j.ydbio.2006.09.032; Sarangarajan R, 2001, PIGM CELL RES, V14, P437, DOI 10.1034/j.1600-0749.2001.140603.x; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Suh Y, 2009, MOL CELL NEUROSCI, V42, P308, DOI 10.1016/j.mcn.2009.08.003; SWOPE VB, 1995, EXP CELL RES, V217, P453, DOI 10.1006/excr.1995.1109; Szabad G, 2007, ARCH DERMATOL RES, V299, P191, DOI 10.1007/s00403-007-0742-0; Szell M, 2004, J INVEST DERMATOL, V123, P537, DOI 10.1111/j.0022-202X.2004.23224.x; Thomas AJ, 2008, PIGM CELL MELANOMA R, V21, P598, DOI 10.1111/j.1755-148X.2008.00506.x; Varga B, 2009, NEUROSCI LETT, V462, P257, DOI 10.1016/j.neulet.2009.06.051; WEHRLEHALLER B, 1995, DEVELOPMENT, V121, P731; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Yaar M, 1997, J CLIN INVEST, V100, P2333, DOI 10.1172/JCI119772; Yaar M, 1997, ARCH DERMATOL, V133, P1287, DOI 10.1001/archderm.133.10.1287	49	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17197	10.1371/journal.pone.0017197	http://dx.doi.org/10.1371/journal.pone.0017197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383848	gold, Green Published, Green Submitted			2022-12-25	WOS:000287657500041
J	Panouilleres, M; Urquizar, C; Salemme, R; Pelisson, D				Panouilleres, Muriel; Urquizar, Christian; Salemme, Romeo; Pelisson, Denis			Sensory Processing of Motor Inaccuracy Depends on Previously Performed Movement and on Subsequent Motor Corrections: A Study of the Saccadic System	PLOS ONE			English	Article							SHORT-TERM ADAPTATION; EYE-MOVEMENTS; VOLUNTARY SACCADES; GAIN ADAPTATION; VOLITIONAL SACCADES; ANTISACCADE TASK; CORTICAL CONTROL; VISUAL ERROR; REFLEXIVE; SEPARATE	When goal-directed movements are inaccurate, two responses are generated by the brain: a fast motor correction toward the target and an adaptive motor recalibration developing progressively across subsequent trials. For the saccadic system, there is a clear dissociation between the fast motor correction (corrective saccade production) and the adaptive motor recalibration (primary saccade modification). Error signals used to trigger corrective saccades and to induce adaptation are based on post-saccadic visual feedback. The goal of this study was to determine if similar or different error signals are involved in saccadic adaptation and in corrective saccade generation. Saccadic accuracy was experimentally altered by systematically displacing the visual target during motor execution. Post-saccadic error signals were studied by manipulating visual information in two ways. First, the duration of the displaced target after primary saccade termination was set at 15, 50, 100 or 800 ms in different adaptation sessions. Second, in some sessions, the displaced target was followed by a visual mask that interfered with visual processing. Because they rely on different mechanisms, the adaptation of reactive saccades and the adaptation of voluntary saccades were both evaluated. We found that saccadic adaptation and corrective saccade production were both affected by the manipulations of post-saccadic visual information, but in different ways. This first finding suggests that different types of error signal processing are involved in the induction of these two motor corrections. Interestingly, voluntary saccades required a longer duration of post-saccadic target presentation to reach the same amount of adaptation as reactive saccades. Finally, the visual mask interfered with the production of corrective saccades only during the voluntary saccades adaptation task. These last observations suggest that post-saccadic perception depends on the previously performed action and that the differences between saccade categories of motor correction and adaptation occur at an early level of visual processing.	[Panouilleres, Muriel] Lyon Neurosci Res Ctr, CNRS UMR5292, INSERM U1028, IMPACT Integrat Multisensory Percept Act & Cognit, Lyon, France; Univ Lyon 1, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Panouilleres, M (corresponding author), Lyon Neurosci Res Ctr, CNRS UMR5292, INSERM U1028, IMPACT Integrat Multisensory Percept Act & Cognit, Lyon, France.	muriel.panouilleres@inserm.fr	Pelisson, Denis/H-2916-2017	Pelisson, Denis/0000-0002-9114-7758; Panouilleres, Muriel/0000-0003-0264-2093	Agence Nationale pour la Recherche; Institut National de la Sante et de la Recherche Medicale [U864]; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by an Agence Nationale pour la Recherche grant (ANR Adapt-Eye) and Institut National de la Sante et de la Recherche Medicale U864. MP was supported by Universite Claude Bernard Lyon 1, and DP was supported by Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitsebaomo AP, 2000, OPTOMETRY VISION SCI, V77, P321, DOI 10.1097/00006324-200006000-00012; Alahyane N, 2008, CEREBELLUM, V7, P595, DOI 10.1007/s12311-008-0065-5; Alahyane N, 2007, BRAIN RES, V1135, P107, DOI 10.1016/j.brainres.2006.11.077; Albano JE, 1996, VISION RES, V36, P2087, DOI 10.1016/0042-6989(96)89627-1; Bahcall DO, 2000, VISION RES, V40, P2779, DOI 10.1016/S0042-6989(00)00117-6; Cameron BD, 2009, EXP BRAIN RES, V195, P445, DOI 10.1007/s00221-009-1812-7; Collins T, 2008, J NEUROPHYSIOL, V99, P2708, DOI 10.1152/jn.01082.2007; Collins T, 2006, VISION RES, V46, P3659, DOI 10.1016/j.visres.2006.04.004; Cotti J, 2007, J NEUROPHYSIOL, V98, P602, DOI 10.1152/jn.00293.2007; Cotti J, 2009, J PHYSIOL-LONDON, V587, P127, DOI 10.1113/jphysiol.2008.159459; DEGRAAF JB, 1995, NEUROREPORT, V6, P1733, DOI 10.1097/00001756-199509000-00007; DEUBEL H, 1995, VISION RES, V35, P3529, DOI 10.1016/0042-6989(95)00058-M; DEUBEL H, 1986, HUM NEUROBIOL, V5, P245; DEUBEL H, 1987, BIOL CYBERN, V57, P37, DOI 10.1007/BF00318714; ERKELENS CJ, 1993, EXP BRAIN RES, V93, P157; FRENS MA, 1994, EXP BRAIN RES, V100, P293, DOI 10.1007/BF00227199; Fuchs AF, 1996, J NEUROPHYSIOL, V76, P2522, DOI 10.1152/jn.1996.76.4.2522; Fujita M, 2002, COGNITIVE BRAIN RES, V13, P41, DOI 10.1016/S0926-6410(01)00088-X; Gaveau V, 2003, NEUROREPORT, V14, P875, DOI 10.1097/00001756-200305060-00020; Hernandez TD, 2008, J VISION, V8, DOI 10.1167/8.8.3; Hopp J, 2004, PROG NEUROBIOL, V72, P27, DOI 10.1016/j.pneurobio.2003.12.002; Iwamoto Y, 2010, EXP BRAIN RES, V204, P145, DOI 10.1007/s00221-010-2314-3; Kroller J, 1996, EXP BRAIN RES, V111, P477; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; Montagnini A, 2005, VISION RES, V45, P3391, DOI 10.1016/j.visres.2005.07.013; Muri RM, 2008, BRAIN COGNITION, V68, P284, DOI 10.1016/j.bandc.2008.08.018; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Noto CT, 2001, COGNITIVE BRAIN RES, V12, P301, DOI 10.1016/S0926-6410(01)00062-3; Panouilleres M, 2009, J NEUROPHYSIOL, V101, P1550, DOI 10.1152/jn.90988.2008; Pelisson D, 2010, NEUROSCI BIOBEHAV R, V34, P1103, DOI 10.1016/j.neubiorev.2009.12.010; Pierrot-Deseilligny C, 2003, PROG BRAIN RES, V142, P3; PIERROTDESEILLIGNY C, 1995, ANN NEUROL, V37, P557, DOI 10.1002/ana.410370504; Reingold EM, 2004, J EXP PSYCHOL HUMAN, V30, P194, DOI 10.1037/0096-1523.30.1.194; Reingold EM, 2002, J COGNITIVE NEUROSCI, V14, P371, DOI 10.1162/089892902317361903; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Shafer JL, 2000, J NEUROPHYSIOL, V84, P88, DOI 10.1152/jn.2000.84.1.88; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; Wallman J, 1998, J NEUROPHYSIOL, V80, P2405, DOI 10.1152/jn.1998.80.5.2405; Watanabe S, 2003, AURIS NASUS LARYNX, V30, pS41; Zimmermann E, 2009, J NEUROSCI, V29, P11055, DOI 10.1523/JNEUROSCI.1604-09.2009	43	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17329	10.1371/journal.pone.0017329	http://dx.doi.org/10.1371/journal.pone.0017329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383849	Green Published, Green Submitted, gold			2022-12-25	WOS:000287657500051
J	Kutz, WE; Wang, LW; Bader, HL; Majors, AK; Iwata, K; Traboulsi, EI; Sakai, LY; Keene, DR; Apte, SS				Kutz, Wendy E.; Wang, Lauren W.; Bader, Hannah L.; Majors, Alana K.; Iwata, Kazushi; Traboulsi, Elias I.; Sakai, Lynn Y.; Keene, Douglas R.; Apte, Suneel S.			ADAMTS10 Protein Interacts with Fibrillin-1 and Promotes Its Deposition in Extracellular Matrix of Cultured Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEILL-MARCHESANI-SYNDROME; MARFAN-SYNDROME; ECTOPIA LENTIS; MOUSE MODEL; MICROFIBRILS; MUTATIONS; METALLOPROTEASES; FAMILY; GLYCOPROTEIN; PATHOGENESIS	Autosomal recessive and autosomal dominant forms of Weill-Marchesani syndrome, an inherited connective tissue disorder, are caused by mutations in ADAMTS10 (encoding a secreted metalloprotease) and FBN1 (encoding fibrillin-1, which forms tissue microfibrils), respectively, yet they are clinically indistinguishable. This genetic connection prompted investigation of a potential functional relationship between ADAMTS10 and fibrillin-1. Specifically, fibrillin-1 was investigated as a potential ADAMTS10 binding partner and substrate, and the role of ADAMTS10 in influencing microfibril biogenesis was addressed. Using ligand affinity blotting and surface plasmon resonance, recombinant ADAMTS10 was found to bind to fibrillin-1 with a high degree of specificity and with high affinity. Two sites of ADAMTS10 binding to fibrillin-1 were identified, one toward the N terminus and another in the C-terminal half of fibrillin-1. Confocal microscopy and immunoelectron microscopy localized ADAMTS10 to fibrillin-1-containing microfibrils in human tissues. Furin-activated ADAMTS10 could cleave fibrillin-1, but innate resistance of ADAMTS10 zymogen to propeptide excision by furin was observed, suggesting that, unless activated, ADAMTS10 is an inefficient fibrillinase. To investigate the role of ADAMTS10 in microfibril biogenesis, fetal bovine nuchal ligament cells were cultured in the presence or absence of ADAMTS10. Exogenously added ADAMTS10 led to accelerated fibrillin-1 microfibril biogenesis. Conversely, fibroblasts obtained from a Weill-Marchesani syndrome patient with ADAMTS10 mutations deposited fibrillin-1 microfibrils sparsely compared with unaffected control cells. Taken together, these findings suggest that ADAMTS10 participates in microfibril biogenesis rather than in fibrillin-1 turnover.	[Kutz, Wendy E.; Wang, Lauren W.; Bader, Hannah L.; Iwata, Kazushi; Apte, Suneel S.] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA; [Majors, Alana K.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Traboulsi, Elias I.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44195 USA; [Sakai, Lynn Y.; Keene, Douglas R.] Shriners Hosp Children, Portland, OR 97201 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Apte, SS (corresponding author), Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, ND20,9500 Euclid Ave, Cleveland, OH 44195 USA.	aptes@ccf.org	Traboulsi, Elias/AAY-7443-2020	Apte, Suneel/0000-0001-8441-1226	NIAMS [AR53890, EY21151, T32 AR050959, T32 HL007914-08]; National Marfan Foundation; NATIONAL EYE INSTITUTE [R01EY021151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050959, R01AR053890] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Marfan Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR53890 from the NIAMS and Grant EY21151 (to S. S. A.) and Postdoctoral Training Grants T32 AR050959 (to W. E. K.; training program in orthopedics; principal investigator, Joseph P. Iannotti) and T32 HL007914-08 (to H. L. B.; training program in vascular biology and pathology; principal investigator, Edward Plow). This work was also supported by a grant from the National Marfan Foundation.	Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; Apte SS, 2004, INT J BIOCHEM CELL B, V36, P981, DOI 10.1016/j.biocel.2004.01.014; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Cain SA, 2006, PROTEOMICS, V6, P111, DOI 10.1002/pmic.200401340; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; Faivre L, 2003, AM J MED GENET A, V123A, P204, DOI 10.1002/ajmg.a.20289; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Farias FHG, 2010, INVEST OPHTH VIS SCI, V51, P4716, DOI 10.1167/iovs.09-5142; Greene VB, 2010, OPHTHALMIC GENET, V31, P47, DOI 10.3109/13816810903567604; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hall NG, 2003, MATRIX BIOL, V22, P501, DOI 10.1016/S0945-053X(03)00075-1; Hanssen E, 2001, MATRIX BIOL, V20, P77, DOI 10.1016/S0945-053X(01)00122-6; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Koo BH, 2007, J BIOL CHEM, V282, P16146, DOI 10.1074/jbc.M610161200; Koo BH, 2010, J BIOL CHEM, V285, P197, DOI 10.1074/jbc.M109.039677; Kutz WE, 2008, HUM MUTAT, V29, P1425, DOI 10.1002/humu.20797; Le Goff C, 2006, DEVELOPMENT, V133, P1587, DOI 10.1242/dev.02308; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Pyeritz RE, 2000, ANNU REV MED, V51, P481, DOI 10.1146/annurev.med.51.1.481; Ramirez F, 2004, PHYSIOL GENOMICS, V19, P151, DOI 10.1152/physiolgenomics.00092.2004; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Somerville RPT, 2004, J BIOL CHEM, V279, P51208, DOI 10.1074/jbc.M409036200; SPENCE MJ, 1995, SOMAT CELL MOLEC GEN, V21, P1, DOI 10.1007/BF02255818; Tsutsui K, 2010, J BIOL CHEM, V285, P4870, DOI 10.1074/jbc.M109.076919	36	100	103	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17156	17167		10.1074/jbc.M111.231571	http://dx.doi.org/10.1074/jbc.M111.231571			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21402694	Green Published, hybrid			2022-12-25	WOS:000290301900065
J	Dahlback, M; Jorgensen, LM; Nielsen, MA; Clausen, TM; Ditlev, SB; Resende, M; Pinto, VV; Arnot, DE; Theander, TG; Salanti, A				Dahlback, Madeleine; Jorgensen, Lars M.; Nielsen, Morten A.; Clausen, Thomas M.; Ditlev, Sisse B.; Resende, Mafalda; Pinto, Vera V.; Arnot, David E.; Theander, Thor G.; Salanti, Ali			The Chondroitin Sulfate A-binding Site of the VAR2CSA Protein Involves Multiple N-terminal Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; PREGNANCY-ASSOCIATED MALARIA; VARIANT SURFACE-ANTIGENS; PLASMODIUM-FALCIPARUM; PARASITE ADHESION; ANTIBODIES; ADHERENCE; GENE; IDENTIFICATION; PROTEOGLYCANS	Malaria during pregnancy is a major health problem for African women. The disease is caused by Plasmodium falciparum malaria parasites, which accumulate in the placenta by adhering to chondroitin sulfate A (CSA). The interaction between infected erythrocytes and the placental receptor is mediated by a parasite expressed protein named VAR2CSA. Avaccine protecting pregnant women against placental malaria should induce antibodies inhibiting the interaction between VAR2CSA and CSA. Much effort has been put into defining the part of the 350 kDa VAR2CSA protein that is responsible for binding. It has been shown that full-length recombinant VAR2CSA binds specifically to CSA with high affinity, however to date no sub-fragment of VAR2CSA has been shown to interact with CSA with similar affinity or specificity. In this study, we used a biosensor technology to examine the binding properties of a panel of truncated VAR2CSA proteins. The experiments indicate that the core of the CSA-binding site is situated in three domains, DBL2X-CIDRPAM and a flanking domain, located in the N-terminal part of VAR2CSA. Furthermore, recombinant VAR2CSA subfragments containing this region elicit antibodies with high parasite adhesion blocking activity in animal immunization experiments.	[Dahlback, Madeleine] Univ Copenhagen, Ctr Med Parasitol, Fac Hlth Sci,CSS, Inst Int Hlth Immunol & Microbiol,Dept Int Hlth I, DK-1014 Copenhagen K, Denmark; [Dahlback, Madeleine; Jorgensen, Lars M.; Nielsen, Morten A.; Clausen, Thomas M.; Ditlev, Sisse B.; Resende, Mafalda; Pinto, Vera V.; Arnot, David E.; Theander, Thor G.; Salanti, Ali] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, CSS, DK-1014 Copenhagen K, Denmark; [Arnot, David E.] Univ Edinburgh, Inst Immunol & Infect Res, Ashworth Lab, Edinburgh EH9 3JT, Midlothian, Scotland	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Edinburgh	Dahlback, M (corresponding author), Univ Copenhagen, Ctr Med Parasitol, Fac Hlth Sci,CSS, Inst Int Hlth Immunol & Microbiol,Dept Int Hlth I, Oster Farimagsgade 5 A, DK-1014 Copenhagen K, Denmark.	dahlback@sund.ku.dk; salanti@sund.ku.dk	Theander, Thor/F-6714-2015; Arnot, David/S-1984-2019	Theander, Thor/0000-0002-3509-7514; Arnot, David/0000-0002-3027-1130; Nielsen, Morten Agertoug/0000-0003-2668-4992; Salanti, Ali/0000-0003-2207-5575; Ditlev, Sisse Bolm/0000-0003-4417-9711	Danish Council for Independent Research/Medical Sciences [271-07-0696]; Seventh Framework Programme [201222, 200889]; Bill and Melinda Gates Foundation [47029 (PMI2)]; VTU [07-017766]; University of Copenhagen; Danish National Research Foundation	Danish Council for Independent Research/Medical Sciences(Det Frie Forskningsrad (DFF)); Seventh Framework Programme(European Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); VTU; University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was funded in part by the Danish Council for Independent Research/Medical Sciences (FSS) Grant 271-07-0696, the Seventh Framework Programme ([FP7/2007-2013]) under Grant Agreements 201222 (PreMalStruct) and 200889 (STOPPAM), and the Bill and Melinda Gates Foundation, Grant 47029 (PMI2). This study also received Proof-of-Concept Funding from VTU, Grant 07-017766, support from University of Copenhagen Program of Excellence (Membrane Topology and Quaternary Structure of Key Parasite Proteins Involved in P. falciparum Malaria Pathogenesis and Immunity), and a Grant for a Visiting Professorship from the Danish National Research Foundation (to D. E. A.).	Achur RN, 2000, J BIOL CHEM, V275, P40344, DOI 10.1074/jbc.M006398200; Alkhalil A, 2000, J BIOL CHEM, V275, P40357, DOI 10.1074/jbc.M006399200; Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Brown A, 2010, CURR OPIN STRUC BIOL, V20, P560, DOI 10.1016/j.sbi.2010.06.008; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Dahlback M, 2010, TRENDS PARASITOL, V26, P230, DOI 10.1016/j.pt.2010.02.002; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Howell DPG, 2008, MOL MICROBIOL, V67, P78, DOI 10.1111/j.1365-2958.2007.06019.x; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Magistrado PA, 2011, VACCINE, V29, P437, DOI 10.1016/j.vaccine.2010.10.080; Nielsen MA, 2007, EXP PARASITOL, V117, P1, DOI 10.1016/j.exppara.2007.03.002; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Oleinikov AV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000386; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Resende M, 2009, INT J PARASITOL, V39, P1195, DOI 10.1016/j.ijpara.2009.02.022; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; Singh K, 2010, J BIOL CHEM, V285, P24855, DOI 10.1074/jbc.M110.118612; Smith JD, 1998, MOL BIOCHEM PARASIT, V97, P133, DOI 10.1016/S0166-6851(98)00145-5; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; Staalsoe T, 2001, J INFECT DIS, V184, P618, DOI 10.1086/322809; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vogt AM, 2003, BLOOD, V101, P2405, DOI 10.1182/blood-2002-07-2016	37	62	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.191510	http://dx.doi.org/10.1074/jbc.M110.191510			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21398524	Green Published, hybrid			2022-12-25	WOS:000290022800031
J	Chen, CG; Wang, YL; Huang, P; Liu-Chen, LY				Chen, Chongguang; Wang, Yulin; Huang, Peng; Liu-Chen, Lee-Yuan			Effects of C-terminal Modifications of GEC1 Protein and gamma-Aminobutyric Acid Type A (GABA(A)) Receptor-associated Protein (GABARAP), Two Microtubule-associated Proteins, on kappa Opioid Receptor Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-TRANSPORT MODULATOR; GABA(A)-RECEPTOR-ASSOCIATED PROTEIN; AUTOPHAGIC VESICLES; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; DOWN-REGULATION; BINDING; GATE-16; LOCALIZATION; TRAFFICKING	We demonstrated previously that GEC1, a member of the microtubule-associated protein (MAP) family, bound to the human kappa opioid receptor (hKOPR) and promoted hKOPR cell surface expression by facilitating its trafficking along the secretory pathway. GABA(A) receptor-associated protein (GABARAP), a GEC1 analog, also enhanced KOPR expression, but to a lesser extent. The MAP family proteins undergo cleavage of their C-terminal residue(s), and the exposed conserved glycine forms conjugates with phosphatidylethanolamine, which associate with membranes. Here, we examined whether such modifications were required for GEC1 and GABARAP to enhance hKOPR expression. When transiently transfected into CHO or Neuro2A cells, GEC1 and GABARAP were cleaved at the C termini. G116A mutation alone or combined with deletion of Lys(117) in GEC1 (GEC1-A) or Leu(117) in GABARAP (GABARAP-A) blocked their C-terminal cleavage, indicating that the conserved Gly(116) is necessary for C-terminal modification. The two GEC1 mutants enhanced hKOPR expression to similar extents as the wildtype GEC1; however, the two GABARAP mutants did not. Immunofluorescence studies showed that HA-GEC1, HA-GEC1-A, and HA-GABARAP were distributed in a punctate manner and co-localized with KOPR-EGFP in the Golgi apparatus, whereas HA-GABARAP-A did not. Pulldown assay of GST-KOPR-C-tail with HA-GEC1 or HA-GABARAP revealed that GEC1 had stronger association with KOPR-C-tail than GABARAP. These results suggest that because of its stronger binding for hKOPR, GEC1 is able to be recruited by hKOPR sufficiently without membrane association via its C-terminal modification; however, due to its weaker affinity for the hKOPR, GABARAP appears to require C-terminal modifications to enhance KOPR expression.	[Chen, Chongguang; Wang, Yulin; Huang, Peng; Liu-Chen, Lee-Yuan] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Liu-Chen, LY (corresponding author), Temple Univ, Sch Med, Dept Pharmacol, 3420 N Broad St, Philadelphia, PA 19140 USA.	lliuche@temple.edu			National Institutes of Health [R01 DA17302, P30 DA13429]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA013429, R01DA017302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DA17302 and P30 DA13429.	Alam J, 2010, REGUL PEPTIDES, V159, P78, DOI 10.1016/j.regpep.2009.09.002; Bavro VN, 2002, EMBO REP, V3, P183, DOI 10.1093/embo-reports/kvf026; Beardsley PM, 2005, PSYCHOPHARMACOLOGY, V183, P118, DOI 10.1007/s00213-005-0167-4; Carlezon WA, 2006, J PHARMACOL EXP THER, V316, P440, DOI 10.1124/jpet.105.092304; Chakrama FZ, 2010, AUTOPHAGY, V6, P495, DOI 10.4161/auto.6.4.11819; Chen CG, 2006, J BIOL CHEM, V281, P7983, DOI 10.1074/jbc.M509805200; Chen Y, 2009, J BIOL CHEM, V284, P1673, DOI 10.1074/jbc.M808303200; Chen ZW, 2007, J NEUROSCI, V27, P6655, DOI 10.1523/JNEUROSCI.0919-07.2007; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Cook JL, 2008, CIRC RES, V102, P1539, DOI 10.1161/CIRCRESAHA.108.176594; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; Green F, 2002, FEBS LETT, V518, P101, DOI 10.1016/S0014-5793(02)02655-8; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kittler JT, 2001, MOL CELL NEUROSCI, V18, P13, DOI 10.1006/mcne.2001.1005; Knight D, 2002, J BIOL CHEM, V277, P5556, DOI 10.1074/jbc.M109753200; Knoll AT, 2007, J PHARMACOL EXP THER, V323, P838, DOI 10.1124/jpet.107.127415; LAFNEZ S, 2010, FASEB J, V24, P1958; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Leil TA, 2004, J NEUROSCI, V24, P11429, DOI 10.1523/JNEUROSCI.3355-04.2004; Li J, 2002, MOL PHARMACOL, V61, P73, DOI 10.1124/mol.61.1.73; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Liu-Chen LY, 2004, LIFE SCI, V75, P511, DOI 10.1016/j.lfs.2003.10.041; Mansuy V, 2004, BIOCHEM BIOPH RES CO, V325, P639, DOI 10.1016/j.bbrc.2004.10.072; Nemos C, 2003, MOL BRAIN RES, V119, P216, DOI 10.1016/j.molbrainres.2003.09.011; O'Sullivan GA, 2005, EUR J NEUROSCI, V22, P2644, DOI 10.1111/j.1460-9568.2005.04448.x; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; PELLERIN I, 1993, MOL CELL ENDOCRINOL, V90, pR17, DOI 10.1016/0303-7207(93)90161-C; Reining SC, 2009, AM J PHYSIOL-RENAL, V296, pF1118, DOI 10.1152/ajprenal.90492.2008; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2003, BIOCHEM BIOPH RES CO, V300, P637, DOI 10.1016/S0006-291X(02)02907-8; Tanida I, 2006, FEBS J, V273, P2553, DOI 10.1111/j.1742-4658.2006.05260.x; Wang HB, 2000, J NEUROCHEM, V75, P644, DOI 10.1046/j.1471-4159.2000.0750644.x; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Wang Y, 2006, NEUROSCIENCE, V140, P1265, DOI 10.1016/j.neuroscience.2006.03.013; Wikstrom B, 2005, J AM SOC NEPHROL, V16, P3742, DOI 10.1681/ASN.2005020152; Xin YR, 2001, GENOMICS, V74, P408, DOI 10.1006/geno.2001.6555; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Zhang FQ, 2002, J PHARMACOL EXP THER, V302, P1184, DOI 10.1124/jpet.302.3.1184	44	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15106	15115		10.1074/jbc.M111.230896	http://dx.doi.org/10.1074/jbc.M111.230896			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388957	hybrid, Green Published			2022-12-25	WOS:000289788300041
J	Flynn, GE; Zagotta, WN				Flynn, Galen E.; Zagotta, William N.			Molecular Mechanism Underlying Phosphatidylinositol 4,5-Bisphosphate-induced Inhibition of SpIH Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNELS; HCN PACEMAKER CHANNELS; PHYSIOLOGICAL-FUNCTION; CATION CHANNELS; TERMINAL REGION; ION CHANNELS; K+ CHANNEL; VOLTAGE; MODULATION; FAMILY	Many ion channels have been shown to be regulated by the membrane signaling phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2). Here, we demonstrate that the binding of PIP2 to SpIH, a sea urchin hyperpolarization-activated cyclic nucleotide-gated ion channel (HCN), has a dual effect: potentiation and inhibition. The potentiation is observed as a shift in the voltage dependence of activation to more depolarized voltages. The inhibition is observed as a reduction in the currents elicited by the partial agonist cGMP. These two effects were separable and arose from PIP2 binding to two different regions. Deletion of the C-terminal region of SpIH removed PIP2-induced inhibition but not the PIP2-induced shift in voltage dependence. Mutating key positively charged amino acids in the C-terminal region adjacent to the membrane selectively disrupted PIP2-induced inhibition, suggesting a direct interaction between PIP2 in the membrane and amino acids in the C-terminal region that stabilizes the closed state relative to the open state in HCN channels.	[Flynn, Galen E.; Zagotta, William N.] Univ Washington, Dept Physiol & Biophys, Howard Hughes Med Inst, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Dept Physiol & Biophys, Howard Hughes Med Inst, POB 357290, Seattle, WA 98195 USA.	zagotta@u.washington.edu			National Institutes of Health from NEI [EY10329]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER	National Institutes of Health from NEI; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY10329 from NEI (to W. N. Z.). This work was also supported by the Howard Hughes Medical Institute.	Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Bian JS, 2007, PFLUG ARCH EUR J PHY, V455, P105, DOI 10.1007/s00424-007-0292-5; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; DiFrancesco D, 2006, PROG BIOPHYS MOL BIO, V90, P13, DOI 10.1016/j.pbiomolbio.2005.05.001; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Kornev AP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000056; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 1999, CELL PHYSIOL BIOCHEM, V9, P179, DOI 10.1159/000016315; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Pian P, 2007, PFLUG ARCH EUR J PHY, V455, P125, DOI 10.1007/s00424-007-0295-2; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Shin KS, 2004, NEURON, V41, P737, DOI 10.1016/S0896-6273(04)00083-2; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Vemana S, 2004, J GEN PHYSIOL, V123, P21, DOI 10.1085/jgp.200308916; Viscomi C, 2001, J BIOL CHEM, V276, P29930, DOI 10.1074/jbc.M103971200; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Womack KB, 2000, J NEUROSCI, V20, P2792; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	32	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15535	15542		10.1074/jbc.M110.214650	http://dx.doi.org/10.1074/jbc.M110.214650			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21383006	hybrid, Green Published			2022-12-25	WOS:000289788300081
J	Heimbach, L; Li, ZW; Berkowitz, P; Zhao, ML; Li, N; Rubenstein, DS; Diaz, LA; Liu, Z				Heimbach, Lisa; Li, Zhuowei; Berkowitz, Paula; Zhao, Minglang; Li, Ning; Rubenstein, David S.; Diaz, Luis A.; Liu, Zhi			The C5a Receptor on Mast Cells Is Critical for the Autoimmune Skin-blistering Disease Bullous Pemphigoid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT ACTIVATION; HERPES-GESTATIONIS; ALTERNATE-PATHWAY; ANTIGEN BPAG2; PROTEIN; INHIBITION; MOUSE; CLONING; CDNA; ANTIBODIES	Bullous pemphigoid (BP) is an autoimmune skin-blistering disease characterized by the presence of autoantibodies against the hemidesmosomal proteins BP230 and BP180. In the IgG passive transfer mouse model of BP, subepidermal blistering is triggered by anti-BP180 antibodies and depends on the complement system, mast cell (MC) degranulation, and neutrophil infiltration. In this study, we have identified the signaling events that connect the activation of the complement system and MC degranulation. We found that mice deficient in MCs or the C5a receptor (C5aR) injected with pathogenic anti-BP180 IgG failed to develop subepidermal blisters and exhibited a drastic reduction in p38 MAPK phosphorylation compared with WT mice. Local reconstitution with MCs from WT but not C5aR-deficient mice restored high levels of p38 MAPK phosphorylation and subepidermal blistering in MC-deficient mice. Local injection of recombinant C5a induced phosphorylation of p38 MAPK in WT but not MC-deficient mice. Cultured mouse MCs treated with recombinant C5a exhibited a significant increase in p38 MAPK phosphorylation and MC degranulation. Taken together, these data demonstrate that C5a interacts with C5aR on MCs and that this C5a-C5aR interaction triggers activation of the p38 MAPK pathway, subsequent MC degranulation, and ultimately BP blistering.	[Heimbach, Lisa; Li, Zhuowei; Berkowitz, Paula; Zhao, Minglang; Li, Ning; Rubenstein, David S.; Diaz, Luis A.; Liu, Zhi] Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27599 USA; [Heimbach, Lisa; Liu, Zhi] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Liu, Z (corresponding author), Univ N Carolina, Dept Dermatol, Rm 422,116 Manning Dr, Chapel Hill, NC 27599 USA.	zhiliu@med.unc.edu		Diaz, Luis/0000-0002-7079-8914	National Institutes of Health [AI40768, AI61430, AR052109, AR053313, AI49427]; United States Public Health Service [AR32599, AR32081]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040768, R01AI040768, R01AI049427, R56AI049427, R01AI061430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR032081, R01AR032599, R03AR053313, K01AR052109, R01AR032081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI40768 and AI61430 (to Z.L.), AR052109 and AR053313 (to N.L.), AI49427 (to D.S.R.), and AR32599 and AR32081 (to L.A.D.) from the United States Public Health Service.	Adcock IM, 2006, EUR J PHARMACOL, V533, P118, DOI 10.1016/j.ejphar.2005.12.054; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Chen RY, 2002, J IMMUNOL, V169, P3987, DOI 10.4049/jimmunol.169.7.3987; Chen RY, 2001, J CLIN INVEST, V108, P1151, DOI 10.1172/jci11494; Church MK, 1999, ANN ALLERG ASTHMA IM, V83, P471, DOI 10.1016/S1081-1206(10)62853-0; Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; FUREDER W, 1995, J IMMUNOL, V155, P3152; GALLI SJ, 1987, AM J PATHOL, V127, P191; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; HOPKINSON SB, 1992, J INVEST DERMATOL, V99, P264, DOI 10.1111/1523-1747.ep12616615; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; JORDON RE, 1975, J INVEST DERMATOL, V65, P162, DOI 10.1111/1523-1747.ep12598113; JORDON RE, 1967, J AMER MED ASSOC, V200, P751, DOI 10.1001/jama.200.9.751; JORDON RE, 1975, CLIN IMMUNOL IMMUNOP, V3, P307, DOI 10.1016/0090-1229(75)90017-3; Kalesnikoff J, 2002, J IMMUNOL, V168, P4737, DOI 10.4049/jimmunol.168.9.4737; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; la Sala A, 2005, J IMMUNOL, V175, P2994, DOI 10.4049/jimmunol.175.5.2994; LAWRENCE ID, 1987, J IMMUNOL, V139, P3062; LEVER WF, 1953, MEDICINE, V32, P1; LI KH, 1993, J BIOL CHEM, V268, P8825; LI KH, 1992, J INVEST DERMATOL, V99, P258, DOI 10.1111/1523-1747.ep12616611; Liu Z, 1997, J CLIN INVEST, V100, P1256, DOI 10.1172/JCI119639; LIU Z, 1995, J CLIN INVEST, V95, P1539, DOI 10.1172/JCI117826; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; LIU Z, 1992, J BIOL CHEM, V267, P15829; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; MULLIGAN MS, 1993, J IMMUNOL, V150, P5585; Nelson KC, 2006, J CLIN INVEST, V116, P2892, DOI 10.1172/JCI17891; NISHIZAWA Y, 1993, J BIOCHEM-TOKYO, V113, P493, DOI 10.1093/oxfordjournals.jbchem.a124072; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Perez OA, 2009, DRUG AGING, V26, P833, DOI 10.2165/11316810-000000000-00000; PROVOST TT, 1973, J CLIN INVEST, V52, P1779, DOI 10.1172/JCI107359; Rousseau S, 2006, CELL SIGNAL, V18, P1897, DOI 10.1016/j.cellsig.2006.02.006; Ryan JJ, 1998, J IMMUNOL, V161, P6915; Schett G, 2008, ANN RHEUM DIS, V67, P909, DOI 10.1136/ard.2007.074278; STANLEY JR, 1984, J INVEST DERMATOL, V82, P108, DOI 10.1111/1523-1747.ep12259224; STANLEY JR, 1981, CELL, V24, P897, DOI 10.1016/0092-8674(81)90115-X; STANLEY JR, 1999, DERMATOLOGY GEN MED, P666; TANAKA T, 1990, J INVEST DERMATOL, V94, P617, DOI 10.1111/1523-1747.ep12876200; WERSHIL BK, 1987, J IMMUNOL, V139, P2605; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	50	55	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15003	15009		10.1074/jbc.M111.221036	http://dx.doi.org/10.1074/jbc.M111.221036			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21393236	Green Published, hybrid			2022-12-25	WOS:000289788300030
J	McDonagh, B; Padilla, CA; Pedrajas, JR; Barcena, JA				McDonagh, Brian; Alicia Padilla, C.; Rafael Pedrajas, Jose; Antonio Barcena, Jose			Biosynthetic and Iron Metabolism Is Regulated by Thiol Proteome Changes Dependent on Glutaredoxin-2 and Mitochondrial Peroxiredoxin-1 in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST UROPORPHYRINOGEN DECARBOXYLASE; OXIDATIVE STRESS; MASS-SPECTROMETRY; FERRIC REDUCTASE; REDOX REGULATION; ENZYMES; EXPRESSION; PROTEINS; BIOLOGY; GENES	Redoxins are involved in maintenance of thiol redox homeostasis, but their exact sites of action are only partly known. We have applied a combined redox proteomics and transcriptomics experimental strategy to discover specific functions of two interacting redoxins: dually localized glutaredoxin 2 (Grx2p) and mitochondrial peroxiredoxin 1 (Prx1p). We have identified 139 proteins showing differential postranslational thiol redox modifications when the cells do not express Grx2p, Prx1p, or both and have mapped the precise cysteines involved in each case. Some of these modifications constitute functional switches that affect metabolic and signaling pathways as the primary effect, leading to gene transcription remodeling as the secondary adaptive effect as demonstrated by a parallel high throughput gene expression analysis. The results suggest that in the absence of Grx2p, the metabolic flow toward nucleotide and aromatic amino acid biosynthesis is slowed down by redox modification of the key enzymes Rpe1p (D-ribulose-5-phosphate 3-epimerase), Tkl1p (transketolase) and Aro4p (3-deoxy-D-arabino-heptulosonate-7-phosphate synthase). The glycolytic mainstream is then diverted toward carbohydrate storage by induction of trehalose and glycogen biosynthesis genes. Porphyrin biosynthesis may also be compromised by inactivation of the redox-sensitive cytosolic enzymes Hem12p (uroporphyrinogen decarboxylase) and Sam1p (S-adenosyl methionine synthetase) and a battery of respiratory genes sensitive to low heme levels are induced. Genes of the Aft1p-dependent iron regulon were induced specifically in the absence of Prx1p despite optimal mitochondrial Fe-S biogenesis, suggesting dysfunction of the mitochondria to the cytosol signaling pathway. Strikingly, requirement of Grx2p for these events places dithiolic Grx2 in the framework of iron metabolism.	[McDonagh, Brian; Alicia Padilla, C.; Antonio Barcena, Jose] Univ Cordoba, Dept Biochem & Mol Biol, E-14071 Cordoba, Spain; [McDonagh, Brian; Alicia Padilla, C.; Antonio Barcena, Jose] Univ Cordoba, Cordoba Maimonides Inst Biomed Res IMIBIC, E-14071 Cordoba, Spain; [Rafael Pedrajas, Jose] Univ Jaen, Unit Mol Signaling & Antioxidant Syst Plants, Dept Expt Biol, Jaen 23071, Spain	Universidad de Cordoba; Universidad de Cordoba; Universidad de Jaen	Barcena, JA (corresponding author), Campus Rabanales,Ed Severo Ochoa,Pl 1, Cordoba 14071, Spain.	ja.barcena@uco.es	Pedrajas, José Rafael/M-9758-2015; Bárcena, José Antonio/I-2622-2015; Padilla, C. Alicia/H-4736-2015; McDonagh, Brian/I-1903-2015	Pedrajas, José Rafael/0000-0003-1998-0638; Bárcena, José Antonio/0000-0002-5626-5943; Padilla, C. Alicia/0000-0002-9503-8284; McDonagh, Brian/0000-0003-2534-4427	Andalusian Government [P06-CVI-01611]; Spanish Government [BFU2006-02990, BFU2009-08004]	Andalusian Government; Spanish Government(Spanish GovernmentEuropean Commission)	This work was supported by Andalusian Government Grant P06-CVI-01611 and Spanish Government Grants BFU2006-02990 and BFU2009-08004.	Abid MR, 1997, BIOL SIGNAL, V6, P157; Alberola TM, 2004, INT MICROBIOL, V7, P199; Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; Binley KM, 1999, YEAST, V15, P1459, DOI 10.1002/(SICI)1097-0061(199910)15:14<1459::AID-YEA472>3.0.CO;2-A; Boisnard S, 2009, EUKARYOT CELL, V8, P1429, DOI 10.1128/EC.00106-09; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Coles SJ, 2009, BIOCHEMISTRY-US, V48, P645, DOI 10.1021/bi801805h; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; DiFlumeri C, 1997, CAN J MICROBIOL, V43, P792; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; FELIX F, 1990, EUR J BIOCHEM, V188, P393, DOI 10.1111/j.1432-1033.1990.tb15416.x; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gstaiger M, 2009, NAT REV GENET, V10, P617, DOI 10.1038/nrg2633; Hazelwood LA, 2009, APPL ENVIRON MICROB, V75, P6876, DOI 10.1128/AEM.01464-09; He YX, 2009, PROTEINS, V76, P249, DOI 10.1002/prot.22403; Helmstaedt K, 2005, P NATL ACAD SCI USA, V102, P9784, DOI 10.1073/pnas.0504238102; Jin C, 2003, J BIOL CHEM, V278, P14698, DOI 10.1074/jbc.M300593200; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Klomsiri C, 2011, ANTIOXID REDOX SIGN, V14, P1065, DOI 10.1089/ars.2010.3376; Le Moan N, 2006, J BIOL CHEM, V281, P10420, DOI 10.1074/jbc.M513346200; Lewinska A, 2006, REDOX REP, V11, P231, DOI 10.1179/135100006X154987; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; LOWRY CV, 1988, MOL CELL BIOL, V8, P4651, DOI 10.1128/MCB.8.11.4651; Lushchak V, 2005, ARCH BIOCHEM BIOPHYS, V441, P35, DOI 10.1016/j.abb.2005.06.010; Malmstrom J, 2007, CURR OPIN BIOTECH, V18, P378, DOI 10.1016/j.copbio.2007.07.005; MartinezChantar ML, 1996, FEBS LETT, V397, P293, DOI 10.1016/S0014-5793(96)01201-X; McDonagh B, 2005, AQUAT TOXICOL, V73, P315, DOI 10.1016/j.aquatox.2005.03.020; McDonagh B, 2009, J PROTEOMICS, V72, P677, DOI 10.1016/j.jprot.2009.01.023; Molina MM, 2004, J BIOL CHEM, V279, P51923, DOI 10.1074/jbc.M410219200; Moore RE, 2002, J AM SOC MASS SPECTR, V13, P378, DOI 10.1016/S1044-0305(02)00352-5; Nilsson T, 2010, NAT METHODS, V7, P681, DOI 10.1038/nmeth0910-681; PARKS LW, 1995, LIPIDS, V30, P227, DOI 10.1007/BF02537825; Pedrajas JR, 2000, J BIOL CHEM, V275, P16296, DOI 10.1074/jbc.275.21.16296; Porras P, 2006, J BIOL CHEM, V281, P16551, DOI 10.1074/jbc.M600790200; Porras P, 2010, BBA-PROTEINS PROTEOM, V1804, P839, DOI 10.1016/j.bbapap.2009.12.012; Pedrajas JR, 2010, ANTIOXID REDOX SIGN, V13, P249, DOI 10.1089/ars.2009.2950; Rahier A, 2008, BIOCHEM J, V414, P247, DOI 10.1042/BJ20080292; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rintala E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-461; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Stenbaek A, 2010, PHYTOCHEMISTRY, V71, P853, DOI 10.1016/j.phytochem.2010.03.022; Unnikrishnan I, 2003, J BIOL CHEM, V278, P26450, DOI 10.1074/jbc.M211808200; Vernis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004376; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; Wallace MA, 2004, J BIOL CHEM, V279, P32055, DOI 10.1074/jbc.M403590200; Wang QY, 2010, J BIOL CHEM, V285, P10408, DOI 10.1074/jbc.M109.085787; Wilson WA, 2002, MOL CELL PROTEOMICS, V1, P232, DOI 10.1074/mcp.M100024-MCP200; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	56	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15565	15576		10.1074/jbc.M110.193102	http://dx.doi.org/10.1074/jbc.M110.193102			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21385868	Green Published, hybrid			2022-12-25	WOS:000289788300084
J	Franz, R; Soliva, CR; Kreuzer, M; Hatt, JM; Furrer, S; Hummel, J; Clauss, M				Franz, Ragna; Soliva, Carla R.; Kreuzer, Michael; Hatt, Jean-Michel; Furrer, Samuel; Hummel, Juergen; Clauss, Marcus			Methane Output of Tortoises: Its Contribution to Energy Loss Related to Herbivore Body Mass	PLOS ONE			English	Article							MAMMALIAN HERBIVORES; TRANSIT-TIME; FOOD-INTAKE; XEROBATES-AGASSIZII; CELLULOSE DIGESTION; SAUROPOD DINOSAURS; GEOCHELONE-NIGRA; HEALTHY-SUBJECTS; CHELONIA-MYDAS; IGUANA-IGUANA	An increase in body mass (M) is traditionally considered advantageous for herbivores in terms of digestive efficiency. However, recently increasing methane losses with increasing M were described in mammals. To test this pattern in non-mammal herbivores, we conducted feeding trails with 24 tortoises of various species (M range 0.52-180 kg) fed a diet of grass hay ad libitum and salad. Mean daily dry matter and gross energy intake measured over 30 consecutive days scaled to M0.75 (95% CI 0.64-0.87) and M0.77 (95% CI 0.66-0.88), respectively. Methane production was measured over two consecutive days in respiration chambers and scaled to M1.03 (95% CI 0.84-1.22). When expressed as energy loss per gross energy intake, methane losses scaled to 0.70 (95% CI 0.47-1.05) M0.29(95% CI 0.14-0.45). This scaling overlaps in its confidence intervals to that calculated for nonruminant mammals 0.79 (95% CI 0.63-0.99) M0.15(95% CI 0.09-0.20), but is lower than that for ruminants. The similarity between nonruminant mammals and tortoises suggest a common evolution of the gut fauna in ectotherms and endotherms, and that the increase in energetic losses due to methane production with increasing body mass is a general allometric principle in herbivores. These findings add evidence to the view that large body size itself does not necessarily convey a digestive advantage.	[Franz, Ragna; Hatt, Jean-Michel; Clauss, Marcus] Univ Zurich, Clin Zoo Anim Exot Pets & Wildlife, Vetsuisse Fac, Zurich, Switzerland; [Soliva, Carla R.; Kreuzer, Michael] Swiss Fed Inst Technol, Inst Plant Anim & Agroecosyst Sci, Zurich, Switzerland; [Furrer, Samuel] Zurich Zoo, Zurich, Switzerland; [Hummel, Juergen] Rhein Freidrich Wilhelms Univ Bonn, Inst Anim Sci, D-53113 Bonn, Germany	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bonn	Franz, R (corresponding author), Univ Zurich, Clin Zoo Anim Exot Pets & Wildlife, Vetsuisse Fac, Zurich, Switzerland.	mclauss@vetclinics.uzh.ch	Clauss, Marcus/A-4710-2008; Clauss, Marcus/M-8702-2019; Clauss, Marcus/GRR-7996-2022; Hatt, Jean-Michel/C-3850-2015; Kreuzer, Michael/E-7697-2015	Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Kreuzer, Michael/0000-0002-9978-1171; Hatt, Jean-Michel/0000-0002-7043-7430; Hummel, Jurgen/0000-0002-8876-7745	DFG (German Research Foundation) [CL 182/5-1]	DFG (German Research Foundation)(German Research Foundation (DFG))	This study was funded by DFG (German Research Foundation) grant CL 182/5-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 1997, OFF METH AN; BARBOZA PS, 1995, J COMP PHYSIOL B, V165, P193; Barboza PS, 2000, J MAMMAL, V81, P473, DOI 10.1644/1545-1542(2000)081&lt;0473:SSIDDA&gt;2.0.CO;2; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; Bennett A.F., 1976, P127; BJORNDAL KA, 1979, COMP BIOCHEM PHYS A, V63, P127, DOI 10.1016/0300-9629(79)90638-8; Chatterjee S, 2007, AM J GASTROENTEROL, V102, P837, DOI 10.1111/j.1572-0241.2007.01072.x; Clauss M, 2005, MAMMAL REV, V35, P174, DOI 10.1111/j.1365-2907.2005.00062.x; Clauss M, 2007, COMP BIOCHEM PHYS A, V148, P249, DOI 10.1016/j.cbpa.2007.05.024; Clauss M, 2009, COMP BIOCHEM PHYS A, V154, P376, DOI 10.1016/j.cbpa.2009.07.016; CLOAREC D, 1990, GUT, V31, P300, DOI 10.1136/gut.31.3.300; Codron D, 2007, J ANIM ECOL, V76, P526, DOI 10.1111/j.1365-2656.2007.01222.x; CRUTZEN P J, 1986, Tellus Series B Chemical and Physical Meteorology, V38, P271; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; ElOufir L, 1996, GUT, V38, P870, DOI 10.1136/gut.38.6.870; FENCHEL TM, 1979, APPL ENVIRON MICROB, V37, P348, DOI 10.1128/AEM.37.2.348-350.1979; FLEMING TH, 1991, J MAMMAL, V72, P493, DOI 10.2307/1382132; FOLEY WJ, 1992, J ZOOL, V226, P387, DOI 10.1111/j.1469-7998.1992.tb07486.x; Franz R, 2010, EVOL ECOL RES, V12, P727; Franz R, 2011, COMP BIOCHEM PHYS A, V158, P94, DOI 10.1016/j.cbpa.2010.09.007; Franz R, 2011, COMP BIOCHEM PHYS A, V158, P177, DOI 10.1016/j.cbpa.2010.10.019; Franz R, 2009, P ROY SOC B-BIOL SCI, V276, P1731, DOI 10.1098/rspb.2008.1735; Fritz J, 2010, J EXP ZOOL PART A, V313A, P579, DOI 10.1002/jez.629; Fritz J, 2009, OIKOS, V118, P1623, DOI 10.1111/j.1600-0706.2009.17807.x; GAULIN SJC, 1979, HUM ECOL, V7, P1, DOI 10.1007/BF00889349; GEIST V, 1974, AM ZOOL, V14, P205, DOI 10.1093/icb/14.1.205; Goel G, 2009, BRIT J NUTR, V101, P1484, DOI 10.1017/S0007114508076198; Hackstein JHP, 1996, EVOLUTION, V50, P559, DOI [10.2307/2410831, 10.1111/j.1558-5646.1996.tb03868.x]; Hailey A, 1997, CAN J ZOOL, V75, P787, DOI 10.1139/z97-100; Hatt JM, 2005, ZOO BIOL, V24, P185, DOI 10.1002/zoo.20039; Hatt JM, 2002, HERPETOL J, V12, P45; Hwang L, 2010, DIGEST DIS SCI, V55, P398, DOI 10.1007/s10620-009-0778-4; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; KARASOV WH, 1986, J COMP PHYSIOL B, V156, P599, DOI 10.1007/BF00691047; KIRKWOOD JK, 1996, BSAVA MANUAL COMPANI, P235; Low K, 2010, J CLIN GASTROENTEROL, V44, P547, DOI 10.1097/MCG.0b013e3181c64c90; Mackie RI, 2004, PHYSIOL BIOCHEM ZOOL, V77, P127, DOI 10.1086/383498; Martin C, 2010, ANIMAL, V4, P351, DOI 10.1017/S1751731109990620; McBee R.H., 1982, P77; McCrabb GJ, 1997, AUST J AGR RES, V48, P323, DOI 10.1071/A96119; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; MEIENBERGER C, 1993, PHYSIOL ZOOL, V66, P847, DOI 10.1086/physzool.66.5.30163827; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; NAGY KA, 1977, COPEIA, P355; OKINE EK, 1989, J ANIM SCI, V67, P3388; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; Parra R., 1978, P205; Perez-Barberia FJ, 2004, P ROY SOC B-BIOL SCI, V271, P1081, DOI 10.1098/rspb.2004.2714; Pimentel M, 2006, DIGEST DIS SCI, V51, P1297, DOI 10.1007/s10620-006-9104-6; Pimentel M, 2006, AM J PHYSIOL-GASTR L, V290, pG1089, DOI 10.1152/ajpgi.00574.2004; Pinares-Patino CS, 2003, J AGR SCI-CAMBRIDGE, V140, P205, DOI 10.1017/S0021859603003046; PRINS RA, 1991, RUMEN ECOSYSTEM MICR, P109; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; SAWYER MS, 1974, J ANIM SCI, V38, P908, DOI 10.2527/jas1974.384908x; Smith FA, 2010, NAT GEOSCI, V3, P374, DOI 10.1038/ngeo877; Soares ACF, 2005, J CLIN GASTROENTEROL, V39, P512, DOI 10.1097/01.mcg.0000165665.94777.bd; Soliva C. R., 2007, P15, DOI 10.1007/978-1-4020-6133-2_2; STEPHEN AM, 1986, BRIT J NUTR, V56, P349, DOI 10.1079/BJN19860116; Tomkins NW, 2009, ANIM PROD SCI, V49, P1053, DOI 10.1071/EA08223; TROYER K, 1984, PHYSIOL ZOOL, V57, P1; TROYER K, 1984, BEHAV ECOL SOCIOBIOL, V14, P189, DOI 10.1007/BF00299618; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN	64	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17628	10.1371/journal.pone.0017628	http://dx.doi.org/10.1371/journal.pone.0017628			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408074	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170900032
J	Hayasaka, N; Aoki, K; Kinoshita, S; Yamaguchi, S; Wakefield, JK; Tsuji-Kawahara, S; Horikawa, K; Ikegami, H; Wakana, S; Murakami, T; Ramabhadran, R; Miyazawa, M; Shibata, S				Hayasaka, Naoto; Aoki, Kazuyuki; Kinoshita, Saori; Yamaguchi, Shoutaroh; Wakefield, John K.; Tsuji-Kawahara, Sachiyo; Horikawa, Kazumasa; Ikegami, Hiroshi; Wakana, Shigeharu; Murakami, Takamichi; Ramabhadran, Ram; Miyazawa, Masaaki; Shibata, Shigenobu			Attenuated Food Anticipatory Activity and Abnormal Circadian Locomotor Rhythms in Rgs16 Knockdown Mice	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; LENTIVIRAL VECTORS; ANIMAL TRANSGENESIS; FEEDING SCHEDULES; OSCILLATORS; LESIONS; RATS; REGULATORS; MELATONIN	Regulators of G protein signaling (RGS) are a multi-functional protein family, which functions in part as GTPase-activating proteins (GAPs) of G protein alpha-subunits to terminate G protein signaling. Previous studies have demonstrated that the Rgs16 transcripts exhibit robust circadian rhythms both in the suprachiasmatic nucleus (SCN), the master circadian light-entrainable oscillator (LEO) of the hypothalamus, and in the liver. To investigate the role of RGS16 in the circadian clock in vivo, we generated two independent transgenic mouse lines using lentiviral vectors expressing short hairpin RNA (shRNA) targeting the Rgs16 mRNA. The knockdown mice demonstrated significantly shorter free-running period of locomotor activity rhythms and reduced total activity as compared to the wild-type siblings. In addition, when feeding was restricted during the daytime, food-entrainable oscillator (FEO)-driven elevated food-anticipatory activity (FAA) observed prior to the scheduled feeding time was significantly attenuated in the knockdown mice. Whereas the restricted feeding phase-advanced the rhythmic expression of the Per2 clock gene in liver and thalamus in the wild-type animals, the above phase shift was not observed in the knockdown mice. This is the first in vivo demonstration that a common regulator of G protein signaling is involved in the two separate, but interactive circadian timing systems, LEO and FEO. The present study also suggests that liver and/or thalamus regulate the food-entrained circadian behavior through G protein-mediated signal transduction pathway(s).	[Hayasaka, Naoto] Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osaka 589, Japan; [Aoki, Kazuyuki; Yamaguchi, Shoutaroh; Horikawa, Kazumasa; Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Dept Physiol & Pharmacol, Shinjuku Ku, Tokyo, Japan; [Kinoshita, Saori; Tsuji-Kawahara, Sachiyo; Miyazawa, Masaaki] Kinki Univ, Sch Med, Dept Immunol, Osaka 589, Japan; [Wakefield, John K.; Ramabhadran, Ram] Tranzyme Pharma, Durham, NC USA; [Ikegami, Hiroshi] Kinki Univ, Sch Med, Dept Endocrinol Metab & Dis, Osaka 589, Japan; [Wakana, Shigeharu] RIKEN, Bioresource Ctr, Technol & Dev Team Mouse Phenotype Anal, Japan Mouse Clin, Tsukuba, Ibaraki, Japan; [Murakami, Takamichi] Kinki Univ, Sch Med, Dept Radiol, Osaka 589, Japan	Kindai University (Kinki University); Waseda University; Kindai University (Kinki University); Kindai University (Kinki University); RIKEN; Kindai University (Kinki University)	Hayasaka, N (corresponding author), Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osaka 589, Japan.	hayasaka@med.kindai.ac.jp	Hayasaka, Naoto/C-9370-2011; Miyazawa, Masaaki/AAA-3916-2020; Ikegami, Hiroshi/AGP-9878-2022	Miyazawa, Masaaki/0000-0002-7300-119X; 	Japan Society for the Promotion of Science [19590235, 21590264]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan for Research on HIV/AIDS; Japan Health Sciences Foundation; Grants-in-Aid for Scientific Research [21390143] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan for Research on HIV/AIDS; Japan Health Sciences Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research: No. 19590235 and 21590264 from the Japan Society for the Promotion of Science, Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan including the High-Tech Research Center and Anti-aging Center grants, those from the Ministry of Health, Labor and Welfare of Japan for Research on HIV/AIDS, and those from the Japan Health Sciences Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2004, EUR J NEUROSCI, V20, P3054, DOI 10.1111/j.1460-9568.2004.03749.x; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Blum ID, 2009, NEUROSCIENCE, V164, P351, DOI 10.1016/j.neuroscience.2009.08.009; Challet E, 2009, EUR J NEUROSCI, V30, P1676, DOI 10.1111/j.1460-9568.2009.06962.x; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dubocovich ML, 2007, SLEEP MED, V8, pS34, DOI 10.1016/j.sleep.2007.10.007; Escobar C, 2009, EUR J NEUROSCI, V30, P1665, DOI 10.1111/j.1460-9568.2009.06972.x; Gillette MU, 2002, CELL TISSUE RES, V309, P99, DOI 10.1007/s00441-002-0576-1; Grafstein-Dunn E, 2001, MOL BRAIN RES, V88, P113, DOI 10.1016/S0169-328X(01)00038-9; Hannibal J, 2002, CELL TISSUE RES, V309, P73, DOI 10.1007/s00441-002-0574-3; Hirao A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006909; Huang Jie, 2006, Comp Hepatol, V5, P8, DOI 10.1186/1476-5926-5-8; KRIEGER DT, 1977, SCIENCE, V197, P398, DOI 10.1126/science.877566; Lamont EW, 2007, SLEEP MED, V8, P547, DOI 10.1016/j.sleep.2006.11.002; Landry GJ, 2007, BRAIN RES, V1141, P108, DOI 10.1016/j.brainres.2007.01.032; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maywood ES, 2007, ENDOCRINOLOGY, V148, P5624, DOI 10.1210/en.2007-0660; Mendoza J, 2007, J NEUROENDOCRINOL, V19, P127, DOI 10.1111/j.1365-2826.2006.01510.x; Mieda M, 2004, J NEUROSCI, V24, P10493, DOI 10.1523/JNEUROSCI.3171-04.2004; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Oishi K, 2004, BIOCHEM BIOPH RES CO, V317, P330, DOI 10.1016/j.bbrc.2004.03.055; Park F, 2007, PHYSIOL GENOMICS, V31, P159, DOI 10.1152/physiolgenomics.00069.2007; Pevet P, 2006, CHRONOBIOL INT, V23, P39, DOI 10.1080/07420520500482074; Rashotte ME, 1996, PHYSIOL BEHAV, V59, P1005, DOI 10.1016/0031-9384(95)02125-6; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Shaughnessy L, 2004, J MOL NEUROSCI, V24, P23, DOI 10.1385/JMN:24:1:023; Singer O, 2008, CURR GENE THER, V8, P483, DOI 10.2174/156652308786848067; Sosa MAG, 2010, BRAIN STRUCT FUNCT, V214, P91, DOI 10.1007/s00429-009-0230-8; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; Stephan FK, 1997, PHYSIOL BEHAV, V62, P995, DOI 10.1016/S0031-9384(97)00204-7; STEPHAN FK, 2001, CIRCADIAN CLOCKS, V12, P223; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; Wu XY, 2000, MOL THER, V2, P47, DOI 10.1006/mthe.2000.0095	38	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17655	10.1371/journal.pone.0017655	http://dx.doi.org/10.1371/journal.pone.0017655			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408016	gold, Green Submitted, Green Published			2022-12-25	WOS:000288170900036
J	Meng, JH; Adkin, CF; Xu, SW; Muntoni, F; Morgan, JE				Meng, Jinhong; Adkin, Carl F.; Xu, Shi-wen; Muntoni, Francesco; Morgan, Jennifer E.			Contribution of Human Muscle-Derived Cells to Skeletal Muscle Regeneration in Dystrophic Host Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN MYOBLAST TRANSPLANTATION; ENDOTHELIAL PROGENITOR CELLS; DUCHENNE MUSCULAR-DYSTROPHY; SIDE POPULATION CELLS; SATELLITE CELLS; MYOGENIC DIFFERENTIATION; SELF-RENEWAL; MDX MOUSE; IN-VITRO	Background: Stem cell transplantation is a promising potential therapy for muscular dystrophies, but for this purpose, the cells need to be systemically-deliverable, give rise to many muscle fibres and functionally reconstitute the satellite cell niche in the majority of the patient's skeletal muscles. Human skeletal muscle-derived pericytes have been shown to form muscle fibres after intra-arterial transplantation in dystrophin-deficient host mice. Our aim was to replicate and extend these promising findings. Methodology/Principal Findings: Isolation and maintenance of human muscle derived cells (mdcs) was performed as published for human pericytes. Mdscs were characterized by immunostaining, flow cytometry and RT-PCR; also, their ability to differentiate into myotubes in vitro and into muscle fibres in vivo was assayed. Despite minor differences between human mdcs and pericytes, mdscs contributed to muscle regeneration after intra-muscular injection in mdx nu/nu mice, the CD56+ sub-population being especially myogenic. However, in contrast to human pericytes delivered intra-arterially in mdx SCID hosts, mdscs did not contribute to muscle regeneration after systemic delivery in mdx nu/nu hosts. Conclusions/Significance: Our data complement and extend previous findings on human skeletal muscle-derived stem cells, and clearly indicate that further work is necessary to prepare pure cell populations from skeletal muscle that maintain their phenotype in culture and make a robust contribution to skeletal muscle regeneration after systemic delivery in dystrophic mouse models. Small differences in protocols, animal models or outcome measurements may be the reason for differences between our findings and previous data, but nonetheless underline the need for more detailed studies on muscle-derived stem cells and independent replication of results before use of such cells in clinical trials.	[Meng, Jinhong; Adkin, Carl F.; Muntoni, Francesco; Morgan, Jennifer E.] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Xu, Shi-wen] UCL, Ctr Rheumatol, Dept Med, London, England	University of London; University College London; University of London; University College London	Meng, JH (corresponding author), UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.	j.morgan@ich.ucl.ac.uk			International Collaborative Effort for DMD (ICE); Wellcome Trust [084241/Z/07/Z]; Medical Research Council [G0900872]; Duchenne Parent Project, Netherlands; MRC Centre for Neuromuscular Diseases Biobank; Medical Research Council [G0601943] Funding Source: researchfish; MRC [G0900872, G0601943] Funding Source: UKRI	International Collaborative Effort for DMD (ICE); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Duchenne Parent Project, Netherlands(Netherlands Government); MRC Centre for Neuromuscular Diseases Biobank(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the International Collaborative Effort for DMD (ICE), the Wellcome Trust (http://www.wellcome.ac.uk/) grant number 084241/Z/07/Z, and the Medical Research Council (http://www.mrc.ac.uk/index.htm) grant number G0900872. J.M. was funded by the International Collaborative Effort for DMD (ICE) and the Medical Research Council, and J.E.M. holds a Wellcome Trust University award. J.E.M. and F. M. are PIs of the MRC Centre for Neuromuscular Diseases. C. A. was funded by the Duchenne Parent Project, Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The support of the MRC Centre for Neuromuscular Diseases Biobank is gratefully acknowledged. We thank Dr. Francesco Conti for his critical reading of the manuscript, and Dr. Ayad Eddaoudi and Mr. Prabhjoat Chana for their help with FACS sorting and analysis. We also thank Dr. Geraldine Edge and Mr. Paolo De Coppi for their help in obtaining the muscle biopsies.	Abuzakouk M, 1996, J IMMUNOL METHODS, V194, P211, DOI 10.1016/0022-1759(96)00038-5; Allegra A, 2009, J NEPHROL, V22, P463; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; BELLESISLES M, 1993, EUR J HISTOCHEM, V37, P375; Benchaouir R, 2007, CELL STEM CELL, V1, P646, DOI 10.1016/j.stem.2007.09.016; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; Brimah K, 2004, HUM GENE THER, V15, P1109, DOI 10.1089/hum.2004.15.1109; Cao BH, 2004, CELL CYCLE, V3, P104; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; Chan J, 2007, STEM CELLS, V25, P875, DOI 10.1634/stemcells.2006-0694; Chan J, 2006, STEM CELLS, V24, P1879, DOI 10.1634/stemcells.2005-0564; Chen CW, 2009, CYTOKINE GROWTH F R, V20, P429, DOI 10.1016/j.cytogfr.2009.10.014; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Collins CA, 2006, CURR OPIN PHARMACOL, V6, P301, DOI 10.1016/j.coph.2006.01.006; Conboy IM, 2005, CELL CYCLE, V4, P407, DOI 10.4161/cc.4.3.1518; Cooper RN, 2001, HUM GENE THER, V12, P823, DOI 10.1089/104303401750148784; Cossu G, 2003, CURR OPIN GENET DEV, V13, P537, DOI 10.1016/j.gde.2003.08.001; De B. C, 2003, J CELL BIOL, V160, P909; Deasy BM, 2007, J CELL BIOL, V177, P73, DOI 10.1083/jcb.200612094; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Eberli D, 2009, METHODS, V47, P98, DOI 10.1016/j.ymeth.2008.10.016; Ehrhardt J, 2007, NEUROMUSCULAR DISORD, V17, P631, DOI 10.1016/j.nmd.2007.04.009; FIDZIANSKA A, 1995, FOLIA NEUROPATHOL, V33, P125; Fukada S, 2010, AM J PATHOL, V176, P2414, DOI 10.2353/ajpath.2010.090887; Gang EJ, 2004, STEM CELLS, V22, P617, DOI 10.1634/stemcells.22-4-617; Grounds MD, 2007, NEUROMUSCULAR DISORD, V17, P206, DOI 10.1016/j.nmd.2007.01.007; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; Huard Johnny, 2003, Birth Defects Research, V69, P230, DOI 10.1002/bdrc.10020; Ieronimakis N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010920; Jankowski RJ, 2001, HUM GENE THER, V12, P619, DOI 10.1089/104303401300057306; Kemp KC, 2005, LEUKEMIA LYMPHOMA, V46, P1531, DOI 10.1080/10428190500215076; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Law P K, 1992, Cell Transplant, V1, P235; Lecourt S, 2010, EXP CELL RES, V316, P2513, DOI 10.1016/j.yexcr.2010.04.020; Mastrandrea F, 2008, EUR ANN ALLERGY CLIN, V40, P90; MENDELL JR, 1990, ADV EXP MED BIOL, V280, P287; MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303; Meng JH, 2010, NEUROMUSCULAR DISORD, V20, P6, DOI 10.1016/j.nmd.2009.11.007; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; MORETTA A, 1989, INT J CANCER, P48; Morosetti R, 2007, STEM CELLS, V25, P3173, DOI 10.1634/stemcells.2007-0465; Morosetti R, 2006, P NATL ACAD SCI USA, V103, P16995, DOI 10.1073/pnas.0603386103; Nielsen JS, 2009, MICROCIRCULATION, V16, P487, DOI 10.1080/10739680902941737; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Pisani DF, 2010, STEM CELLS, V28, P753, DOI 10.1002/stem.317; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Quinlan JG, 1997, MUSCLE NERVE, V20, P1016, DOI 10.1002/(SICI)1097-4598(199708)20:8<1016::AID-MUS12>3.0.CO;2-T; Ramalho-Santos Miguel, 2007, Cell Stem Cell, V1, P35, DOI 10.1016/j.stem.2007.05.013; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Silva-Barbosa SD, 2005, CELL TRANSPLANT, V14, P457, DOI 10.3727/000000005783982837; Tamaki T, 2005, CIRCULATION, V112, P2857, DOI 10.1161/CIRCULATIONAHA.105.554832; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Tonlorenzi Rossana, 2007, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02b01s3; TREMBLAY JP, 1993, CELL TRANSPLANT, V2, P99, DOI 10.1177/096368979300200203; Uezumi A, 2006, BIOCHEM BIOPH RES CO, V341, P864, DOI 10.1016/j.bbrc.2006.01.037; Vauchez K, 2009, MOL THER, V17, P1948, DOI 10.1038/mt.2009.204; WAKEFORD S, 1991, MUSCLE NERVE, V14, P42, DOI 10.1002/mus.880140108; Zheng B, 2007, NAT BIOTECHNOL, V25, P1025, DOI 10.1038/nbt1334	64	47	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17454	10.1371/journal.pone.0017454	http://dx.doi.org/10.1371/journal.pone.0017454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408080	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170900018
J	Liu, XQ; Zhang, N; Li, X; Moran, MS; Yuan, CZ; Yan, S; Jiang, LY; Ma, TT; Haffty, BG; Yang, QF				Liu, Xianqiang; Zhang, Ning; Li, Xiao; Moran, Meena S.; Yuan, Cunzhong; Yan, Shi; Jiang, Liyu; Ma, Tingting; Haffty, Bruce G.; Yang, Qifeng			Identification of Novel Variants of Metadherin in Breast Cancer	PLOS ONE			English	Article							ASTROCYTE ELEVATED GENE-1; TUMOR PROGRESSION; EXPRESSION; PROTEIN; METASTASIS; ACTIVATION; SURVIVAL; ENVELOPE	Metadherin (MTDH, also known as AEG-1, and Lyric) has been demonstrated to play a potential role in several significant aspects of tumor progression. It has been reported that overexpression of MTDH is associated with progression of disease and poorer prognosis in breast cancer. However, there are no studies to date assessing variants of the MTDH gene and their potential relationship with breast cancer susceptibility. Thus, we investigated all variants of the MTDH gene and explored the association of the variants with breast cancer development. Our cohort consisted of full-length gene sequencing of 108 breast cancer cases and 100 healthy controls; variants were detected in 11 breast cancer cases and 13 controls. Among the variants detected, 9 novel variants were discovered and 2 were found to be associated with the susceptibility of breast cancer. However, additional studies need to be conducted in larger sample sizes to validate these findings and to further investigate whether these variants are prognostic in breast cancer patients.	[Liu, Xianqiang; Zhang, Ning; Jiang, Liyu; Ma, Tingting; Yang, Qifeng] Shandong Univ, Sch Med, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China; [Liu, Xianqiang] Shandong Univ, Affiliated Jinan Cent Hosp, Dept Surg, Jinan 250100, Shandong, Peoples R China; [Moran, Meena S.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Haffty, Bruce G.] UMDNJ Robert Wood Johnson Sch Med, Dept Radiat Oncol, New Brunswick, NJ USA; [Haffty, Bruce G.] Canc Inst New Jersey, New Brunswick, NJ USA	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Yale University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Liu, XQ (corresponding author), Shandong Univ, Sch Med, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China.	qifengy@gmail.com	Zhang, Ning/GNP-1966-2022; yang, qiang/GYJ-0971-2022; Zhang, Ning/GOJ-8058-2022	Zhang, Ning/0000-0002-6430-4236; Li, Xiao/0000-0001-9504-605X; Yuan, Cunzhong/0000-0002-8785-2139; Yang, Qifeng/0000-0003-0576-8513	Program for New Century Excellent Talents in University; Chinese Ministry of Education [108080]; National Natural Science Foundation of China [30772133, 81072150]; Independent Innovation Foundation of Shandong University (IIFSDU) [2009JQ007]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Chinese Ministry of Education(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University (IIFSDU)	This project is supported by the Program for New Century Excellent Talents in University, the Key Project of Chinese Ministry of Education (No. 108080), the National Natural Science Foundation of China (No. 30772133; No. 81072150) and the Independent Innovation Foundation of Shandong University (IIFSDU, No. 2009JQ007) to Prof. Q. Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Britt DE, 2004, EXP CELL RES, V300, P134, DOI 10.1016/j.yexcr.2004.06.026; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; KIM DH, 1995, INT J CANCER, V60, P812, DOI 10.1002/ijc.2910600615; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103; Li J, 2009, ONCOGENE, V28, P3188, DOI 10.1038/onc.2009.171; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Poon TCW, 2006, GASTROENTEROLOGY, V131, P1262, DOI 10.1053/j.gastro.2006.08.014; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Su P, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-38; Su ZZ, 2002, ONCOGENE, V21, P3592, DOI 10.1038/sj.onc.1205445; Sutherland HGE, 2004, EXP CELL RES, V294, P94, DOI 10.1016/j.yexcr.2003.11.020; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460	21	32	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17582	10.1371/journal.pone.0017582	http://dx.doi.org/10.1371/journal.pone.0017582			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408129	Green Submitted, Green Published, gold			2022-12-25	WOS:000288170000041
J	El Baroudi, M; Cora, D; Bosia, C; Osella, M; Caselle, M				El Baroudi, Mariama; Cora, Davide; Bosia, Carla; Osella, Matteo; Caselle, Michele			A Curated Database of miRNA Mediated Feed-Forward Loops Involving MYC as Master Regulator	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE NETWORKS; MICRORNAS; CANCER; IDENTIFICATION; INTEGRATION; CIRCUITS; FEEDBACK; TARGETS	Background: The MYC transcription factors are known to be involved in the biology of many human cancer types. But little is known about the Myc/microRNAs cooperation in the regulation of genes at the transcriptional and post- transcriptional level. Methodology/Principal Findings: Employing independent databases with experimentally validated data, we identified several mixed microRNA/Transcription Factor Feed-Forward Loops regulated by Myc and characterized completely by experimentally supported regulatory interactions, in human. We then studied the statistical and functional properties of these circuits and discussed in more detail a few interesting examples involving E2F1, PTEN, RB1 and VEGF. Conclusions/Significance: We have assembled and characterized a catalogue of human mixed Transcription Factor/microRNA Feed- Forward Loops, having Myc as master regulator and completely defined by experimentally verified regulatory interactions.	[El Baroudi, Mariama; Bosia, Carla; Osella, Matteo; Caselle, Michele] Univ Turin, Dept Theoret Phys, Turin, Italy; [El Baroudi, Mariama; Bosia, Carla; Osella, Matteo; Caselle, Michele] Natl Inst Nucl Phys, Turin, Italy; [El Baroudi, Mariama; Cora, Davide; Bosia, Carla; Osella, Matteo; Caselle, Michele] Univ Turin, Ctr Complex Syst Mol Biol & Med, Turin, Italy; [Cora, Davide] Univ Turin, Sch Med, Inst Canc Res & Treatment IRCC, Syst Biol Lab, Turin, Italy	University of Turin; Istituto Nazionale di Fisica Nucleare (INFN); University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin	El Baroudi, M (corresponding author), Univ Turin, Dept Theoret Phys, Turin, Italy.	caselle@to.infn.it	El Baroudi, Mariama/B-3865-2013; Caselle, Michele/E-3724-2013; Osella, Matteo/AAB-3888-2019	Caselle, Michele/0000-0001-5488-142X; Osella, Matteo/0000-0002-4916-5434; Cora', Davide/0000-0003-4123-1705; Bosia, Carla/0000-0002-8960-3443				Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Coller HA, 2007, PLOS GENET, V3, P1319, DOI 10.1371/journal.pgen.0030146; Drakaki A, 2009, CURR GENOMICS, V10, P35, DOI 10.2174/138920209787581299; Friard O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-435; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim JW, 2010, CANCER RES, V70, P4820, DOI 10.1158/0008-5472.CAN-10-0659; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lotterman CD, 2008, CELL CYCLE, V7, P2493, DOI 10.4161/cc.7.16.6452; Martinez NJ, 2009, BIOESSAYS, V31, P435, DOI 10.1002/bies.200800212; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; MUKHERJEE B, 1992, GENE DEV, V6, P1480, DOI 10.1101/gad.6.8.1480; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; OSELLA M, PLOS COMPUT IN PRESS; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Re A, 2009, MOL BIOSYST, V5, P854, DOI 10.1039/b900177h; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; SINHA AU, 2008, BMC GENOMICS, V23, P9; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; WANG J, 2009, NUCLEIC ACIDS RES, V1, P4; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yu XP, 2008, NUCLEIC ACIDS RES, V36, P6494, DOI 10.1093/nar/gkn712; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	33	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e14742	10.1371/journal.pone.0014742	http://dx.doi.org/10.1371/journal.pone.0014742			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390222	Green Submitted, Green Published, gold			2022-12-25	WOS:000287965200002
J	Michel, J; DeLeon-Rangel, J; Zhu, ST; Van Ree, K; Vik, SB				Michel, Jose; DeLeon-Rangel, Jessica; Zhu, Shaotong; Van Ree, Kalie; Vik, Steven B.			Mutagenesis of the L, M, and N Subunits of Complex I from Escherichia coli Indicates a Common Role in Function	PLOS ONE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; IRON-SULFUR CLUSTERS; AEROBIC RESPIRATORY-CHAIN; QUINONE OXIDOREDUCTASE; MEMBRANE DOMAIN; NADHUBIQUINONE OXIDOREDUCTASE; TRANSMEMBRANE TOPOLOGY; PHOTOAFFINITY ANALOG; EPR CHARACTERIZATION; ELECTRON-TRANSFER	Background: The membrane arm of Complex I (NADH: ubiquinone oxidoreductase) contains three large, and closely related subunits, which are called L, M, and N in E. coli. These subunits are homologous to components of multi-subunit Na+/H+ antiporters, and so are implicated in proton translocation. Methodology/Principal Findings: Nineteen site-specific mutations were constructed at two corresponding positions in each of the three subunits. Two positions were selected in each subunit: L_K169, M_K173, N_K158 and L_Q236, M_H241, N_H224. Membrane vesicles were prepared from all of the resulting mutant strains, and were assayed for deamino-NADH oxidase activity, proton translocation, ferricyanide reductase activity, and sensitivity to capsaicin. Corresponding mutations in the three subunits were found to have very similar effects on all activities measured. In addition, the effect of adding exogenous decylubiquinone on these activities was tested. 50 mM decylubiquinone stimulated both deamino-NADH oxidase activity and proton translocation by wild type membrane vesicles, but was inhibitory towards the same activities by membrane vesicles bearing the lysine substitution at the L236/M241/N224 positions. Conclusions/Significance: The results show a close correlation with reduced activity among the corresponding mutations, and provide evidence that the L, M, and N subunits have a common role in Complex I.	[Michel, Jose; DeLeon-Rangel, Jessica; Zhu, Shaotong; Van Ree, Kalie; Vik, Steven B.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA	Southern Methodist University	Michel, J (corresponding author), So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA.	svik@smu.edu	zhu, shaotong/ABE-6352-2020	Vik, Steven/0000-0002-5285-015X; ZHU, SHAOTONG/0000-0002-5066-3166	Welch Foundation [N-1378]; American Heart Association, Texas [0455139Y]	Welch Foundation(The Welch Foundation); American Heart Association, Texas(American Heart Association)	This work was funded in part from grants from the Welch Foundation (N-1378; http://www.welch1.org/) and from the American Heart Association, Texas Affiliate (# 0455139Y; http://www.heart.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Amarneh B, 2006, BBA-BIOENERGETICS, V1757, P1557, DOI 10.1016/j.bbabio.2006.08.003; Amarneh B, 2010, J BIOENERG BIOMEMBR, V42, P511, DOI 10.1007/s10863-010-9318-3; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Birrell JA, 2010, FEBS LETT, V584, P4247, DOI 10.1016/j.febslet.2010.09.017; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Dutton PL, 1998, BBA-BIOENERGETICS, V1364, P245, DOI 10.1016/S0005-2728(98)00031-0; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; Euro L, 2008, BIOCHEMISTRY-US, V47, P3185, DOI 10.1021/bi702063t; Flemming D, 2003, J BIOL CHEM, V278, P47602, DOI 10.1074/jbc.M308967200; Gong X, 2003, J BIOL CHEM, V278, P25731, DOI 10.1074/jbc.M302361200; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; HAMAMOTO T, 1994, MOL MICROBIOL, V14, P939, DOI 10.1111/j.1365-2958.1994.tb01329.x; Holt PJ, 2003, J BIOL CHEM, V278, P43114, DOI 10.1074/jbc.M308247200; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; Magnitsky S, 2002, J BIOENERG BIOMEMBR, V34, P193, DOI 10.1023/A:1016083419979; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; MEINHARDT SW, 1989, BIOCHEMISTRY-US, V28, P2153, DOI 10.1021/bi00431a029; Morino M, 2010, J BIOL CHEM, V285, P30942, DOI 10.1074/jbc.M110.118661; Nakamaru-Ogiso E, 2003, BIOCHEMISTRY-US, V42, P746, DOI 10.1021/bi0269660; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Nakamaru-Ogiso E, 2010, FEBS LETT, V584, P883, DOI 10.1016/j.febslet.2010.01.004; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1891, DOI 10.1016/j.bbabio.2010.06.010; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Ohnishi T, 1998, BBA-BIOENERGETICS, V1365, P301, DOI 10.1016/S0005-2728(98)00082-6; Ohnishi T, 2010, FEBS LETT, V584, P4131, DOI 10.1016/j.febslet.2010.08.039; Pohl T, 2007, BIOCHEMISTRY-US, V46, P6588, DOI 10.1021/bi700371c; PRUSS BM, 1994, J BACTERIOL, V176, P2143; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sherwood S, 2006, BIOCHEM J, V400, P541, DOI 10.1042/BJ20060766; Swartz TH, 2005, EXTREMOPHILES, V9, P345, DOI 10.1007/s00792-005-0451-6; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; WEIDNER U, 1993, J MOL BIOL, V233, P109, DOI 10.1006/jmbi.1993.1488; Yakovlev G, 2007, P NATL ACAD SCI USA, V104, P12720, DOI 10.1073/pnas.0705593104; Yano T, 2005, BIOCHEMISTRY-US, V44, P1744, DOI 10.1021/bi048132i; Zwicker K, 2006, J BIOL CHEM, V281, P23013, DOI 10.1074/jbc.M603442200	46	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17420	10.1371/journal.pone.0017420	http://dx.doi.org/10.1371/journal.pone.0017420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387012	Green Submitted, gold, Green Published			2022-12-25	WOS:000287931400073
J	Van Ziffle, J; Yang, WD; Chehab, FF				Van Ziffle, Jessica; Yang, Wendy; Chehab, Farid F.			Homozygous Deletion of Six Olfactory Receptor Genes in a Subset of Individuals with Beta-Thalassemia	PLOS ONE			English	Article							GLOBIN GENE; FETAL-HEMOGLOBIN; MOLECULAR-BASIS; FAMILY; IDENTIFICATION; CLUSTER; ASSOCIATION; EXPRESSION; DIAGNOSIS; MALAYSIA	Progress in the functional studies of human olfactory receptors has been largely hampered by the lack of a reliable experimental model system. Although transgenic approaches in mice could characterize the function of individual olfactory receptors, the presence of over 300 functional genes in the human genome becomes a daunting task. Thus, the characterization of individuals with a genetic susceptibility to altered olfaction coupled with the absence of particular olfactory receptor genes will allow phenotype/genotype correlations and vindicate the function of specific olfactory receptors with their cognate ligands. We characterized a 118 kb beta-globin deletion and found that its 3' end breakpoint extends to the neighboring olfactory receptor region downstream of the beta-globin gene cluster. This deletion encompasses six contiguous olfactory receptor genes (OR51V1, OR52Z1, OR51A1P, OR52A1, OR52A5, and OR52A4) all of which are expressed in the brain. Topology analysis of the encoded proteins from these olfactory receptor genes revealed that OR52Z1, OR52A1, OR52A5, and OR52A4 are predicted to be functional receptors as they display integral characteristics of G-proteins coupled receptors. Individuals homozygous for the 118 kb beta-globin deletion are afflicted with beta-thalassemia due to a homozygous deletion of the beta-globin gene and have no alleles for the above mentioned olfactory receptors genes. This is the first example of a homozygous deletion of olfactory receptor genes in human. Although altered olfaction remains to be ascertained in these individuals, such a study can be carried out in beta-thalassemia patients from Malaysia, Indonesia and the Philippines where this mutation is common. Furthermore, OR52A1 contains a gamma-globin enhancer, which was previously shown to confer continuous expression of the fetal gamma-globin genes. Thus, the hypothesis that beta-thalassemia individuals, who are homozygous for the 118 kb deletion, may also have an exacerbation of their anemia due to the deletion of two copies of the gamma-globin enhancer element is worthy of consideration.	[Van Ziffle, Jessica; Yang, Wendy; Chehab, Farid F.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Van Ziffle, J (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	chehabf@labmed2.ucsf.edu			Department of Laboratory Medicine at the University of California, San Francisco	Department of Laboratory Medicine at the University of California, San Francisco	This work was supported by funds from the Department of Laboratory Medicine at the University of California, San Francisco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers MW, 2006, CURR NEUROL NEUROSCI, V6, P379, DOI 10.1007/s11910-996-0018-7; ANSARI KA, 1975, J CHRON DIS, V28, P493, DOI 10.1016/0021-9681(75)90058-2; Brantberg A, 2009, HAEMATOL-HEMATOL J, V94, P1157, DOI 10.3324/haematol.2009.007534; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bulger M, 2000, P NATL ACAD SCI USA, V97, P14560, DOI 10.1073/pnas.97.26.14560; ENG B, 1993, HUM MUTAT, V2, P375, DOI 10.1002/humu.1380020509; FEINGOLD EA, 1989, BLOOD, V74, P2178; Feingold EA, 1999, GENOMICS, V61, P15, DOI 10.1006/geno.1999.5935; Game L, 2003, BRIT J HAEMATOL, V123, P154, DOI 10.1046/j.1365-2141.2003.04564.x; GEORGE E, 1992, HEMOGLOBIN, V16, P51, DOI 10.3109/03630269209005676; Hasin Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000249; Hatt H, 1999, CELL MOL BIOL, V45, P285; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; KALLMANN F, 1944, AM J MENT DEFIC, V158, P203; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Ko TM, 1998, ANN HEMATOL, V77, P257, DOI 10.1007/s002770050454; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Menashe I, 2007, PLOS BIOL, V5, P2462, DOI 10.1371/journal.pbio.0050284; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; MORTON CC, 1984, AM J HUM GENET, V36, P576; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013; Setianingsih I, 1998, MOL DIAGN, V3, P11, DOI 10.1016/S1084-8592(98)80022-2; Sherva R, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-51; Sofro A S, 1995, Southeast Asian J Trop Med Public Health, V26 Suppl 1, P221; Solovieff N, 2010, BLOOD, V115, P1815, DOI 10.1182/blood-2009-08-239517; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Tahmaz F E, 2001, J Med Genet, V38, pE9, DOI 10.1136/jmg.38.3.e9; Thong M K, 1999, Hum Mutat, V13, P413, DOI 10.1002/(SICI)1098-1004(1999)13:5<413::AID-HUMU14>3.0.CO;2-H; WAYE JS, 1994, HUM GENET, V94, P530; Wee YC, 2008, COMMUNITY GENET, V11, P129, DOI 10.1159/000113874; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86	36	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17327	10.1371/journal.pone.0017327	http://dx.doi.org/10.1371/journal.pone.0017327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390308	Green Submitted, Green Published, gold			2022-12-25	WOS:000287761700046
J	Testoni, B; Schinzari, V; Guerrieri, F; Gerbal-Chaloin, S; Blandino, G; Levrero, M				Testoni, B.; Schinzari, V.; Guerrieri, F.; Gerbal-Chaloin, S.; Blandino, G.; Levrero, M.			p53-paralog DNp73 oncogene is repressed by IFN alpha/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor	ONCOGENE			English	Article						transcription; p53 family; epigenetics; chromatin dynamics; apoptosis	HEPATOCELLULAR-CARCINOMA DEVELOPMENT; INTERFERON-ALPHA; HEPATITIS-C; COMBINATION THERAPY; CURATIVE TREATMENT; GENE-EXPRESSION; PROTEIN EED; APOPTOSIS; P53; METAANALYSIS	The DNp73 proteins act as trans-repressors of p53 and p73-dependent transcription and exert both anti-apoptotic activity and pro-proliferative activity. DNp73s are frequently up-regulated in a variety of human cancers, including human hepatocellular carcinomas (HCCs). Increased levels of DNp73 proteins confer to HCC cells resistance to apoptosis and, irrespective to p53 status, a chemoresistant phenotype. Here, we show that interferon (IFN)alpha down-regulates DNp73 expression in primary human hepatocytes (PHHs) and HCC cell lines. IFN alpha has been used as pro-apoptotic agent in the treatment of malignancies and there is increasing evidence of IFN alpha effectiveness in HCC treatment and prevention of recurrence. The precise mechanisms by which class I IFNs exert their anti-proliferative and anti-tumor activity remain unclear. IFN alpha binding to its receptor activates multiple intracellular signaling cascades regulating the transcription of numerous direct target genes through the recruitment of a complex comprising of STAT1, STAT2 and IFN regulatory factor (IRF) 9 to their promoters. We found that, in response to IFN alpha, the P2p73 promoter undergoes substantial chromatin remodeling. Histone deacetylases (HDACs) replace histone acetyl transferases. STAT2 is recruited onto the endogenous P2p73 promoter together with the polycomb group protein Ezh2, leading to increased H3K27 methylation and transcriptional repression. The reduction of DNp73 levels by IFN alpha is paralleled by an increased susceptibility to IFN alpha-triggered apoptosis of Huh7 hepatoma cells. Our results show, for the first time, that IFN-stimulated gene factor 3 recruitment may serve both in activating and repressing gene expression and identify the down-regulation of DNp73 as an additional mechanism to counteract the chemoresistance of liver cancer cells. Oncogene (2011) 30, 2670-2678; doi:10.1038/onc.2010.635; published online 14 March 2011	[Testoni, B.; Schinzari, V.; Guerrieri, F.; Levrero, M.] Fdn A Cesalpino, Gene Express Lab, Rome, Italy; [Testoni, B.; Levrero, M.] Univ Roma La Sapienza, Dept Internal Med, Rome, Italy; [Testoni, B.; Blandino, G.; Levrero, M.] IRE, Rome Oncogen Ctr, Rome, Italy; [Schinzari, V.; Guerrieri, F.; Levrero, M.] LEA INSERM U785, Villejuif, France; [Gerbal-Chaloin, S.] INSERM U632, Inst Rech Biotherapie, Montpellier, France	Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Testoni, B (corresponding author), Univ Roma La Sapienza, Gene Express Lab, Dipartimento Med Interna, Policlin Umberto I, Viale Policlin 155, I-00161 Rome, Italy.	barbara.testoni@uniroma1.it; massimo.levrero@uniroma1.it	GERBAL-CHALOIN, sabine/M-8783-2017; Guerrieri, Francesca/K-5504-2016; guerrieri, francesca/G-3908-2013; Levrero, Massimo/G-5680-2016; TESTONI, Barbara/F-3767-2017	GERBAL-CHALOIN, sabine/0000-0002-2549-7899; Guerrieri, Francesca/0000-0003-2751-6050; Levrero, Massimo/0000-0002-4978-0875; Guerrieri, Francesca/0000-0002-2021-4394; TESTONI, Barbara/0000-0001-5588-5465	AIRC; European Community [LSHC-CT-2004-503576]; MIUR-Cofin and Progetti di Ateneo; Sapienza University of Rome; Schering-Plough; AICF (American Italian Cancer Foundation); Fondazione Adriano Buzzati-Traverso; Fondazione A Cesalpino; Rome Oncogenomic Center at the Regina Elena Cancer Institute	AIRC(Fondazione AIRC per la ricerca sul cancro); European Community(European Commission); MIUR-Cofin and Progetti di Ateneo; Sapienza University of Rome; Schering-Plough(Merck & CompanySchering Plough Corporation); AICF (American Italian Cancer Foundation); Fondazione Adriano Buzzati-Traverso; Fondazione A Cesalpino; Rome Oncogenomic Center at the Regina Elena Cancer Institute	ML was supported by grants from AIRC, European Community (LSHC-CT-2004-503576), MIUR-Cofin and Progetti di Ateneo, Sapienza University of Rome and Schering-Plough. BT has been supported by fellowships from the AICF (American Italian Cancer Foundation) and from the Fondazione Adriano Buzzati-Traverso. FG has been supported by fellowships from the Fondazione A Cesalpino and Rome Oncogenomic Center at the Regina Elena Cancer Institute.	Belloni L, 2006, ONCOGENE, V25, P3606, DOI 10.1038/sj.onc.1209321; Breitenstein S, 2009, BRIT J SURG, V96, P975, DOI 10.1002/bjs.6731; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chattopadhyay D, 2007, CURR PHARM DESIGN, V13, P3292, DOI 10.2174/138161207782360717; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Craxi Antonio, 2005, Clin Liver Dis, V9, P329, DOI 10.1016/j.cld.2004.12.008; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; Fujioka N, 2006, BIOMED RES-TOKYO, V27, P219, DOI 10.2220/biomedres.27.219; Herzer K, 2009, CANCER RES, V69, P855, DOI 10.1158/0008-5472.CAN-08-2831; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Levrero M, 2000, J CELL SCI, V113, P1661; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lim R, 2006, HEPATOLOGY, V43, P1074, DOI 10.1002/hep.21170; Lok AS, 2009, GASTROENTEROLOGY, V136, P138, DOI 10.1053/j.gastro.2008.09.014; Lunghi P, 2009, CLIN CANCER RES, V15, P6495, DOI 10.1158/1078-0432.CCR-09-1229; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Melen K, 2000, J HEPATOL, V33, P764, DOI 10.1016/S0168-8278(00)80308-6; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Miyake Y, 2010, J VIRAL HEPATITIS, V17, P287, DOI 10.1111/j.1365-2893.2009.01181.x; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Moradpour D, 2005, EUR J GASTROEN HEPAT, V17, P477, DOI 10.1097/00042737-200505000-00002; Muller M, 2005, CELL DEATH DIFFER, V12, P1564, DOI 10.1038/sj.cdd.4401774; Nakaji M, 2004, CARCINOGENESIS, V25, P389, DOI 10.1093/carcin/bgh028; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Noguchi R, 2008, INT J ONCOL, V32, P193; Obi S, 2006, CANCER-AM CANCER SOC, V106, P1990, DOI 10.1002/cncr.21832; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pichard-Garcia L, 2002, METHOD ENZYMOL, V357, P311; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; Shiratori Y, 2005, ANN INTERN MED, V142, P105, DOI 10.7326/0003-4819-142-2-200501180-00009; Steele JC, 2006, BRIT J CANCER, V95, P1202, DOI 10.1038/sj.bjc.6603369; Stiewe T, 2004, CLIN CANCER RES, V10, P626, DOI 10.1158/1078-0432.CCR-0153-03; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Sudo T, 2005, BRIT J CANCER, V92, P1754, DOI 10.1038/sj.bjc.6602531; TESTONI B, CHROMATIN DYNA UNPUB; Testoni B, 2006, CELL CYCLE, V5, P2805, DOI 10.4161/cc.5.23.3525; Uddin S, 2004, J BIOCHEM MOL BIOL, V37, P635; Uka K, 2008, ONCOLOGY-BASEL, V75, P8, DOI 10.1159/000151614; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Vossio S, 2002, ONCOGENE, V21, P3796, DOI 10.1038/sj.onc.1205465; Xu DW, 2000, BLOOD, V96, P4313, DOI 10.1182/blood.V96.13.4313.h8004313_4313_4318; Yonemitsu Y, 2009, HUM PATHOL, V40, P1304, DOI 10.1016/j.humpath.2009.01.017	48	20	22	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	23					2670	2678		10.1038/onc.2010.635	http://dx.doi.org/10.1038/onc.2010.635			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	778CV	21399658	Green Published, hybrid			2022-12-25	WOS:000291677800007
J	Jung, SR; Kuok, ITD; Couron, D; Rizzo, N; Margineantu, DH; Hockenbery, DM; Kim, F; Sweet, IR				Jung, Seung-Ryoung; Kuok, Iok Teng Denise; Couron, Drew; Rizzo, Norma; Margineantu, Daciana H.; Hockenbery, David M.; Kim, Francis; Sweet, Ian R.			Reduced Cytochrome c Is an Essential Regulator of Sustained Insulin Secretion by Pancreatic Islets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELLS; CALCIUM-CHANNELS; MITOCHONDRIAL SIGNAL; OXYGEN-CONSUMPTION; B-CELLS; PYRUVATE-CARBOXYLASE; MOUSE ISLETS; GLUCOSE; APOPTOSOME; RELEASE	Influx of calcium is an essential but insufficient signal in sustained nutrient-stimulated insulin secretion, and increased metabolic rate of the beta cell is also required. The aim of the study was to test the hypothesis that the reduced state of cytochrome c is a metabolic co-factor necessary for insulin secretion, over and above its participation in the ATP-generating function of electron transport/oxidative phosphorylation. We found that nutrient stimulation of insulin secretion by isolated rat islets was strongly correlated with reduced cytochrome c, and agents that acutely and specifically reduced cytochrome c led to increased insulin secretion, even in the face of decreased oxygen consumption and calcium influx. In contrast, neither sites 1 nor 4 of the electron transport chain were both necessary and essential for the stimulation of insulin secretion to occur. Importantly, stimulation of islets with glucose, alpha-ketoisocaproate, or glyceraldehyde resulted in the appearance of cytochrome c in the cytosol, suggesting a pathway for the regulation of exocytotic machinery by reduction of cytochrome c. The data suggest that the metabolic factor essential for sustained calcium-stimulated insulin secretion to occur is linked to reduction and translocation of cytochrome c.	[Jung, Seung-Ryoung; Kuok, Iok Teng Denise; Couron, Drew; Rizzo, Norma; Kim, Francis; Sweet, Ian R.] Univ Washington, Diabet & Obes Ctr, Dept Med, Seattle, WA 98195 USA; [Margineantu, Daciana H.; Hockenbery, David M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Sweet, IR (corresponding author), Univ Washington, Diabet & Obes Ctr, Dept Med, Box 358055,815 Mercer St, Seattle, WA 98195 USA.	isweet@u.washington.edu			National Institutes of Health [DK17047]; National Science Foundation [IIP-0750508]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK17047 (a DERC Islet Core and an R24 seed grant supplement) and National Science Foundation Grant IIP-0750508.	Aizawa T, 1992, Endocr Regul, V26, P159; Bao Q, 2007, MOL CELL, V25, P181, DOI 10.1016/j.molcel.2006.12.013; BOKVIST K, 1995, EMBO J, V14, P50, DOI 10.1002/j.1460-2075.1995.tb06974.x; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; Brown GC, 2008, BBA-BIOENERGETICS, V1777, P877, DOI 10.1016/j.bbabio.2008.03.024; Cain K, 2001, J BIOL CHEM, V276, P41985, DOI 10.1074/jbc.M107419200; CAVINATO AG, 1990, ANAL CHEM, V62, P1977, DOI 10.1021/ac00217a015; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; Deeney JT, 2000, SEMIN CELL DEV BIOL, V11, P267, DOI 10.1006/scdb.2000.0175; DENTON RM, 1985, AM J PHYSIOL, V249, pE543, DOI 10.1152/ajpendo.1985.249.6.E543; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; Gao Z, 2003, ENDOCRINOLOGY, V144, P1949, DOI 10.1210/en.2002-0072; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; GEMBAL M, 1993, J CLIN INVEST, V91, P871, DOI 10.1172/JCI116308; Gilbert M, 2008, J BIOL CHEM, V283, P24334, DOI 10.1074/jbc.M802097200; GRODSKY GM, 1966, DIABETES, V15, P910, DOI 10.2337/diab.15.12.910; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; HENQUIN JC, 1994, DIABETES METAB, V20, P132; Ishihara H, 2000, IUBMB LIFE, V49, P391; Ishiyama N, 2006, AM J PHYSIOL-ENDOC M, V290, pE540, DOI 10.1152/ajpendo.00032.2005; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jung SR, 2009, AM J PHYSIOL-ENDOC M, V297, pE717, DOI 10.1152/ajpendo.00282.2009; KASHIWAGURA T, 1984, J CELL PHYSIOL, V120, P13, DOI 10.1002/jcp.1041200103; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Malaisse WJ, 1999, BBA-MOL CELL RES, V1451, P255, DOI 10.1016/S0167-4889(99)00099-3; MALAISSELAGAE F, 1984, BIOCHEM BIOPH RES CO, V123, P1062, DOI 10.1016/S0006-291X(84)80241-7; MATSCHINSKY FM, 1986, J BIOL CHEM, V261, P14057; Matsumoto S, 1999, TRANSPLANTATION, V67, pS220, DOI 10.1097/00007890-199904150-00880; Pan ZH, 1999, CELL DEATH DIFFER, V6, P683, DOI 10.1038/sj.cdd.4400544; Pi JB, 2010, TOXICOL APPL PHARM, V244, P77, DOI 10.1016/j.taap.2009.05.025; Prentki M, 1996, EUR J ENDOCRINOL, V134, P272, DOI 10.1530/eje.0.1340272; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Ravier MA, 1999, DIABETES, V48, P2374, DOI 10.2337/diabetes.48.12.2374; SATIN LS, 1995, ENDOCRINOLOGY, V136, P4589, DOI 10.1210/en.136.10.4589; Satin LS, 2000, ENDOCRINE, V13, P251, DOI 10.1385/ENDO:13:3:251; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P661, DOI 10.1089/152091502320798303; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P67, DOI 10.1089/15209150252924111; Sweet IR, 2005, TRANSPLANTATION, V80, P1003, DOI 10.1097/01.tp.0000178381.35014.37; Sweet IR, 2004, BIOCHEM BIOPH RES CO, V314, P976, DOI 10.1016/j.bbrc.2003.12.182; Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401; Sweet IR, 1996, AM J PHYSIOL-ENDOC M, V271, pE606, DOI 10.1152/ajpendo.1996.271.3.E606; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302; Zhou YP, 2000, AM J PHYSIOL-ENDOC M, V278, pE340, DOI 10.1152/ajpendo.2000.278.2.E340	55	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17422	17434		10.1074/jbc.M110.202820	http://dx.doi.org/10.1074/jbc.M110.202820			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21393241	Green Published, hybrid			2022-12-25	WOS:000290585200004
J	Feltham, R; Bettjeman, B; Budhidarmo, R; Mace, PD; Shirley, S; Condon, SM; Chunduru, SK; McKinlay, MA; Vaux, DL; Silke, J; Day, CL				Feltham, Rebecca; Bettjeman, Bodhi; Budhidarmo, Rhesa; Mace, Peter D.; Shirley, Sarah; Condon, Stephen M.; Chunduru, Srinivas K.; McKinlay, Mark A.; Vaux, David L.; Silke, John; Day, Catherine L.			Smac Mimetics Activate the E3 Ligase Activity of cIAP1 Protein by Promoting RING Domain Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; UBIQUITIN-CONJUGATING ENZYME; ALPHA-DEPENDENT APOPTOSIS; IAP ANTAGONISTS; CELL-SURVIVAL; TNF-ALPHA; ALLOSTERIC ACTIVATION; CRYSTAL-STRUCTURES; SIGNALING COMPLEX; INHIBITOR	The inhibitor of apoptosis (IAP) proteins are important ubiquitin E3 ligases that regulate cell survival and oncogenesis. The cIAP1 and cIAP2 paralogs bear three N-terminal baculoviral IAP repeat (BIR) domains and a C-terminal E3 ligase RING domain. IAP antagonist compounds, also known as Smac mimetics, bind the BIR domains of IAPs and trigger rapid RING-dependent autoubiquitylation, but the mechanism is unknown. We show that RING dimerization is essential for the E3 ligase activity of cIAP1 and cIAP2 because monomeric RING mutants could not interact with the ubiquitin-charged E2 enzyme and were resistant to Smac mimetic-induced autoubiquitylation. Unexpectedly, the BIR domains inhibited cIAP1 RING dimerization, and cIAP1 existed predominantly as an inactive monomer. However, addition of either mono-or bivalent Smac mimetics relieved this inhibition, thereby allowing dimer formation and promoting E3 ligase activation. In contrast, the cIAP2 dimer was more stable, had higher intrinsic E3 ligase activity, and was not highly activated by Smac mimetics. These results explain how Smac mimetics promote rapid destruction of cIAP1 and suggest mechanisms for activating cIAP1 in other pathways.	[Bettjeman, Bodhi; Budhidarmo, Rhesa; Mace, Peter D.; Shirley, Sarah; Day, Catherine L.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand; [Feltham, Rebecca; Vaux, David L.; Silke, John] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Condon, Stephen M.; Chunduru, Srinivas K.; McKinlay, Mark A.] TetraLog Pharmaceut, Malvern, PA 19355 USA	University of Otago; La Trobe University	Day, CL (corresponding author), Univ Otago, Dept Biochem, Dunedin 9054, New Zealand.	catherine.day@otago.ac.nz	Silke, John/B-7622-2008; Vaux, David L/C-7249-2013	Silke, John/0000-0002-7611-5774; Vaux, David L/0000-0003-2703-1651; Mace, Peter/0000-0003-2175-9537; Day, Catherine/0000-0003-1571-4367; Feltham, Rebecca/0000-0001-8376-6869	National Health and Medical Research Council (NHMRC) [461221, 356256, 433013, 541901, 541902]; Marsden Fund (New Zealand); Genesis Oncology Trust; Health Research Council of New Zealand	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Marsden Fund (New Zealand)(Royal Society of New ZealandMarsden Fund (NZ)); Genesis Oncology Trust; Health Research Council of New Zealand(Health Research Council of New Zealand)	Supported by National Health and Medical Research Council (NHMRC) Program Grant 461221.; Supported by NHMRC Grants 356256, 433013, 461221, 541901, and 541902.; Supported by the Marsden Fund (New Zealand), Genesis Oncology Trust, and Health Research Council of New Zealand. To whom correspondence should be addressed. Tel.: 64-3-479-7871; Fax: 64-3-479-7866; E-mail: catherine.day@otago.ac.nz.	Barbash O, 2008, CANCER CELL, V14, P68, DOI 10.1016/j.ccr.2008.05.017; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Blankenship JW, 2009, BIOCHEM J, V417, P149, DOI 10.1042/BJ20081885; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cheng Q, 2009, EMBO J, V28, P3857, DOI 10.1038/emboj.2009.294; Cheung HH, 2008, MOL BIOL CELL, V19, P2729, DOI 10.1091/mbc.E08-01-0107; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Feltham R, 2010, J BIOL CHEM, V285, P17525, DOI 10.1074/jbc.M109.087635; Flygare JA, 2010, EXPERT OPIN THER PAT, V20, P251, DOI 10.1517/13543770903567077; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Huang A, 2009, J MOL BIOL, V385, P507, DOI 10.1016/j.jmb.2008.10.044; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Knipscheer P, 2007, CURR OPIN STRUC BIOL, V17, P665, DOI 10.1016/j.sbi.2007.09.001; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Mace PD, 2010, CELL DEATH DIFFER, V17, P46, DOI 10.1038/cdd.2009.45; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Serniwka SA, 2009, BIOCHEMISTRY-US, V48, P12169, DOI 10.1021/bi901686j; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Vucic D, 2007, CLIN CANCER RES, V13, P5995, DOI 10.1158/1078-0432.CCR-07-0729; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang CJ, 2007, J MOL BIOL, V366, P1115, DOI 10.1016/j.jmb.2006.11.096; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	52	118	121	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17015	17028		10.1074/jbc.M111.222919	http://dx.doi.org/10.1074/jbc.M111.222919			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21393245	Green Published, hybrid			2022-12-25	WOS:000290301900052
J	Lei, X; Shi, FJ; Basu, D; Huq, A; Routhier, S; Day, R; Jin, WJ				Lei, Xia; Shi, Fujun; Basu, Debapriya; Huq, Afroza; Routhier, Sophie; Day, Robert; Jin, Weijun			Proteolytic Processing of Angiopoietin-like Protein 4 by Proprotein Convertases Modulates Its Inhibitory Effects on Lipoprotein Lipase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL LIPASE; INTERACTS; ANGPTL4; OLIGOMERIZATION; METABOLISM; MIGRATION; INSIGHTS; PLASMA; TISSUE; DOMAIN	Angiopoietin-like protein 4 (ANGPTL4) has been associated with a variety of diseases. It is known as an endogenous inhibitor of lipoprotein lipase (LPL), and it modulates lipid deposition and energy homeostasis. ANGPTL4 is cleaved by unidentified protease(s), and the biological importance of this cleavage event is not fully understood with respect to its inhibitory effect on LPL activity. Here, we show that ANGPTL4 appears on the cell surface as the full-length form, where it can be released by heparin treatment in culture and in vivo. ANGPTL4 protein is then proteolytically cleaved into several forms by proprotein convertases (PCs). Several PCs, including furin, PC5/6, paired basic amino acid-cleaving enzyme 4, and PC7, are able to cleave human ANGPTL4 at a consensus site. PC-specific inhibitors block the processing of ANGPTL4. Blockage of ANGPTL4 cleavage reduces its inhibitory effects on LPL activity and decreases its ability to raise plasma triglyceride levels. In summary, the cleavage of ANGPTL4 by these PCs modulates its inhibitory effect on LPL activity.	[Jin, Weijun] SUNY Hlth Sci Ctr, Dept Cell Biol, BSB, Brooklyn, NY 11203 USA; [Routhier, Sophie; Day, Robert] Univ Sherbrooke, Fac Med Sci Sante, Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Sherbrooke	Jin, WJ (corresponding author), SUNY Hlth Sci Ctr, Dept Cell Biol, BSB, 2-106,450 Clarkson Ave, Brooklyn, NY 11203 USA.	weijun.jin@downstate.edu	Basu, Debapriya/AAS-3752-2020	Basu, Debapriya/0000-0002-5312-8169; SHI, FUJUN/0000-0003-1863-7686	National Institutes of Health, NHLBI [HL081861, HL55323, HL08186104S1]; Canadian Institutes of Health Research; Fonds de la Recherche en Sante du Quebec; Ministere du Developpement Economique, de l'Innovation et de l'Exportation du Quebec; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL055323, R01HL081861, R01HL055323] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Ministere du Developpement Economique, de l'Innovation et de l'Exportation du Quebec; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL081861, HL55323, and HL08186104S1 from the NHLBI. This work was also supported by research grants from the Canadian Institutes of Health Research, Fonds de la Recherche en Sante du Quebec, and the Ministere du Developpement Economique, de l'Innovation et de l'Exportation du Quebec (to R. D.).	Adachi H, 2009, BIOCHEM BIOPH RES CO, V379, P806, DOI 10.1016/j.bbrc.2008.12.018; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; Folsom AR, 2008, METABOLISM, V57, P1591, DOI 10.1016/j.metabol.2008.06.016; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Goh YY, 2010, AM J PATHOL, V177, P2791, DOI 10.2353/ajpath.2010.100129; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; Hermann LM, 2005, CLIN IMMUNOL, V115, P93, DOI 10.1016/j.clim.2004.12.002; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Jin WJ, 2005, J BIOL CHEM, V280, P36551, DOI 10.1074/jbc.M502264200; Jin WJ, 2003, CIRC RES, V92, P644, DOI 10.1161/01.RES.0000064502.47539.6D; Li C, 2009, CURR OPIN LIPIDOL, V20, P357, DOI 10.1097/MOL.0b013e32832dd55a; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Liu J, 2010, J BIOL CHEM, V285, P27561, DOI 10.1074/jbc.M110.144279; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; McCoy MG, 2002, J LIPID RES, V43, P921; Miida T, 2010, CURR OPIN LIPIDOL, V21, P70, DOI 10.1097/MOL.0b013e328333269e; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Welm AL, 2008, CELL, V133, P27, DOI 10.1016/j.cell.2008.03.012; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776; Yin W, 2009, J BIOL CHEM, V284, P13213, DOI 10.1074/jbc.M900553200	31	94	102	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.217638	http://dx.doi.org/10.1074/jbc.M110.217638			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21398697	hybrid, Green Published			2022-12-25	WOS:000290022800014
J	Wiseman, DA; Kalwat, MA; Thurmond, DC				Wiseman, Dean A.; Kalwat, Michael A.; Thurmond, Debbie C.			Stimulus-induced S-Nitrosylation of Syntaxin 4 Impacts Insulin Granule Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE PRODUCTION; BETA-CELL DYSFUNCTION; PROTEIN-KINASE-C; TYROSINE PHOSPHORYLATION; PANCREATIC-ISLETS; GLUT4 TRANSLOCATION; OXIDATIVE STRESS; 3T3L1 ADIPOCYTES; MEMBRANE-FUSION; SECRETION	Glucose-stimulated insulin release from pancreatic islet beta-cells involves increased levels of reactive oxygen and nitrogen species. Although this is normal, under pathophysiological conditions such as chronic hyperglycemia and inflammation, insulin exocytosis fails, and yet the mechanistic reason for failure is unclear. Hypothesizing that exocytotic proteins might be targets of S-nitrosylation, with their dysfunction under conditions of nitrosative stress serving as a mechanistic basis for insulin secretory dysfunction, we identified the t-SNARE protein Syntaxin 4 as a target of modification by S-nitrosylation. The cellular content of S-nitrosylated Syntaxin 4 peaked acutely, within 5 min of glucose stimulation in both human islets and MIN6 beta-cells, corresponding to the time at which Syntaxin 4 activation was detectable. S-Nitrosylation was mapped to Syntaxin 4 residue Cys(141), located within the Hc domain predicted to increase accessibility for v-SNARE interaction. A C141S-Syntaxin 4 mutant resisted S-nitrosylation induced in vitro by the nitric oxide donor compound S-nitroso-L-glutathione, failed to exhibit glucose-induced activation and VAMP2 binding, and failed to potentiate insulin release akin to that of wild-type Syntaxin 4. Strikingly, S-nitrosylation of Syntaxin 4 could be induced by acute treatment with inflammatory cytokines (TNF alpha, IL-1 beta, and IFN gamma), coordinate with inappropriate Syntaxin 4 activation and insulin release in the absence of the glucose stimulus, consistent with nitrosative stress and dysfunctional exocytosis, preceding the cell dysfunction and death associated with more chronic stimulation (24 h). Taken together, these data indicate a significant role for reactive nitrogen species in the insulin exocytosis mechanism in beta-cells and expose a potential pathophysiological exploitation of this mechanism to underlie dysfunctional exocytosis.	[Wiseman, Dean A.; Thurmond, Debbie C.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Basic Diabet Res Grp, Indianapolis, IN 46202 USA; [Kalwat, Michael A.; Thurmond, Debbie C.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Thurmond, DC (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Basic Diabet Res Grp, 635 Barnhill Dr,MS2031, Indianapolis, IN 46202 USA.	dthurmon@iupui.edu	Kalwat, Michael A/H-3184-2013; Kalwat, Michael/GRJ-4422-2022	Kalwat, Michael A/0000-0002-8349-9470; Wiseman, Dean/0000-0002-5831-2862	National Institutes of Health [K01 DK087811, F32 HL090198, R01 DK067912, DK76614]; American Heart Association [T32 DK64466]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL090198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067912, T32DK064466, K01DK087811, R01DK076614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01 DK087811 and F32 HL090198 (to D. A. W.) and R01 DK067912 and DK76614 (to D. C. T.) and National Institutes of Health and American Heart Association Predoctoral Fellowship T32 DK64466 (to M. A. K.).	Arnush M, 1998, J IMMUNOL, V160, P2684; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; CETKOVICCVRLJE M, 1994, CYTOKINE, V6, P399, DOI 10.1016/1043-4666(94)90064-7; Chen GL, 2003, FEBS LETT, V534, P54, DOI 10.1016/S0014-5793(02)03774-2; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P8992, DOI 10.1073/pnas.90.19.8992; CORBETT JA, 1992, DIABETES, V41, P897, DOI 10.2337/diabetes.41.8.897; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Goh CS, 2002, J MOL BIOL, V324, P177, DOI 10.1016/S0022-2836(02)01038-0; Gray JP, 2010, TOXICOL MECH METHOD, V20, P167, DOI 10.3109/15376511003695181; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jewell JL, 2008, J BIOL CHEM, V283, P21734, DOI 10.1074/jbc.M710445200; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Ke B, 2007, J BIOL CHEM, V282, P21786, DOI 10.1074/jbc.M701661200; Koeck T, 2009, ARCH BIOCHEM BIOPHYS, V484, P221, DOI 10.1016/j.abb.2009.01.021; Laffranchi R, 1995, BIOCHEM BIOPH RES CO, V217, P584, DOI 10.1006/bbrc.1995.2815; LEAHY JL, 1990, DIABETES CARE, V13, P992, DOI 10.2337/diacare.13.9.992; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Meffert MK, 1996, NEURON, V16, P1229, DOI 10.1016/S0896-6273(00)80149-X; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Nakada S, 2003, PFLUG ARCH EUR J PHY, V447, P305, DOI 10.1007/s00424-003-1176-y; Nakata M, 2003, PANCREAS, V27, P209, DOI 10.1097/00006676-200310000-00001; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; Nili U, 2006, NEUROSCIENCE, V143, P487, DOI 10.1016/j.neuroscience.2006.08.014; Oh E, 2006, J BIOL CHEM, V281, P17624, DOI 10.1074/jbc.M601581200; Palmer ZJ, 2008, BIOCHEM J, V413, P479, DOI 10.1042/BJ20080069; Prior IA, 2000, BBA-GEN SUBJECTS, V1475, P281, DOI 10.1016/S0304-4165(00)00078-7; Rizzo MA, 2003, J CELL BIOL, V161, P243, DOI 10.1083/jcb.200301063; Sadoul K, 1997, J BIOL CHEM, V272, P33023, DOI 10.1074/jbc.272.52.33023; Schmelzle K, 2006, DIABETES, V55, P2171, DOI 10.2337/db06-0148; Scott JA, 2004, ANN NY ACAD SCI, V1031, P204, DOI 10.1196/annals.1331.020; Smukler SR, 2002, DIABETES, V51, P3450, DOI 10.2337/diabetes.51.12.3450; SPINAS GA, 1988, ACTA ENDOCRINOL-COP, V119, P307, DOI 10.1530/acta.0.1190307; Spinas GA, 1998, DIABETOLOGIA, V41, P292, DOI 10.1007/s001250050906; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Spurlin BA, 2004, DIABETES, V53, P2223, DOI 10.2337/diabetes.53.9.2223; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Thomas HE, 2002, DIABETES, V51, P311, DOI 10.2337/diabetes.51.2.311; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Umahara M, 2008, ENDOCRINOLOGY, V149, P40, DOI 10.1210/en.2006-1549; VINCENT SR, 1992, SCIENCE, V258, P1376; Watanabe M, 2005, MOL BIOL CELL, V16, P4519, DOI 10.1091/mbc.E05-03-0252; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; Wu JJ, 2001, J SURG RES, V101, P190, DOI 10.1006/jsre.2001.6285	56	43	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.214031	http://dx.doi.org/10.1074/jbc.M110.214031			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21393240	Green Published, hybrid			2022-12-25	WOS:000290022800072
J	He, C; Murthy, S; McCormick, ML; Spitz, DR; Ryan, AJ; Carter, AB				He, Chao; Murthy, Shubha; McCormick, Michael L.; Spitz, Douglas R.; Ryan, Alan J.; Carter, A. Brent			Mitochondrial Cu,Zn-Superoxide Dismutase Mediates Pulmonary Fibrosis by Augmenting H2O2 Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER CHAPERONE CCS; SUPEROXIDE-DISMUTASE; INTERMEMBRANE SPACE; GENE-EXPRESSION; LUNG-DISEASE; ANTIOXIDANT ENZYMES; HEART-MITOCHONDRIA; S-NITROSYLATION; ASBESTOS; INHALATION	The release of H2O2 from alveolar macrophages has been linked to the development of pulmonary fibrosis, but little is known about its source or mechanism of production. We found that alveolar macrophages from asbestosis patients spontaneously produce high levels of H2O2 and have high expression of Cu,Zn-superoxide dismutase (SOD). Because Cu,Zn-SOD is found in the mitochondrial intermembrane space (IMS), we hypothesized that mitochondrial Cu,Zn-SOD-mediated H2O2 generation contributed to pulmonary fibrosis. Asbestos-induced translocation of Cu,Zn-SOD to the IMS was unique to macrophages and dependent on functional mitochondrial respiration and the presence of at least one of the conserved cysteines required for disulfide bond formation. These conserved cysteine residues were also necessary for enzyme activation and H2O2 generation. Cu,Zn-SOD-mediated H2O2 generation was inhibited by knockdown of the iron-sulfur protein, Rieske, in complex III. The role of Cu,Zn-SOD was biologically relevant in that Cu,Zn-SOD-/- mice generated significantly less H2O2 and had less oxidant stress in bronchoalveolar lavage fluid and lung parenchyma. Furthermore, Cu,Zn-SOD-/- mice did not develop pulmonary fibrosis, and knockdown of Cu,Zn-SOD in monocytes attenuated collagen I deposition by lung fibroblasts. Our findings demonstrate a novel mechanism for the pathogenesis of pulmonary fibrosis where the antioxidant enzyme Cu,Zn-SOD translocates to the mitochondrial IMS to increase H2O2 generation in alveolar macrophages.	[He, Chao; McCormick, Michael L.; Spitz, Douglas R.; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Murthy, Shubha; Ryan, Alan J.; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [He, Chao; McCormick, Michael L.; Spitz, Douglas R.; Carter, A. Brent] Univ Iowa, Carver Coll Med, Grad Program Free Rad & Radiat Biol, Iowa City, IA 52242 USA; [Carter, A. Brent] Univ Iowa, Coll Publ Hlth, Dept Human Toxicol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Carter, AB (corresponding author), Univ Iowa, Carver Coll Med, Dept Radiat Oncol, C33 GH, Iowa City, IA 52242 USA.	brent-carter@uiowa.edu		Spitz, Douglas/0000-0002-1254-8765	National Institutes of Health [ES015981, ES014871, P30 CA086862]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014871, R01ES015981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES015981, ES014871 (to A. B. C.), and P30 CA086862 (to University of Iowa Cancer Center).	ANDERSON ME, 1985, TISSUE GLUTATHIONE; Attfield M. D., 2004, Morbidity and Mortality Weekly Report, V53, P627; AUWERX JH, 1989, BLOOD, V74, P1807; BITTERMAN PB, 1986, J CLIN INVEST, V77, P700, DOI 10.1172/JCI112364; BROOKSBANK BWL, 1984, DEV BRAIN RES, V16, P37, DOI 10.1016/0165-3806(84)90060-9; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; Carter AB, 2004, AM J RESP CELL MOL, V31, P43, DOI 10.1165/rcmb.2003-0377OC; Carter KB, 2000, J BIOL CHEM, V275, P27858; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; FRIDOVICH I, 1986, ANNU REV PHYSIOL, V48, P693; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; GILLIARD N, 1994, J CLIN INVEST, V93, P2608, DOI 10.1172/JCI117273; Goldsteins G, 2008, J BIOL CHEM, V283, P8446, DOI 10.1074/jbc.M706111200; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Guo CJ, 2008, PLOS BIOL, V6, P2414, DOI 10.1371/journal.pbio.0060266; HANCE AJ, 1985, J IMMUNOL, V134, P284; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Inarrea P, 2005, BIOCHEM J, V387, P203, DOI 10.1042/BJ20041683; Ischiropoulos H, 2005, TOXICOLOGY, V208, P299, DOI 10.1016/j.tox.2004.11.018; JANSSEN YMW, 1990, FREE RADICAL RES COM, V11, P53, DOI 10.3109/10715769009109667; JANSSEN YMW, 1992, J BIOL CHEM, V267, P10625; Kamp DW, 1999, THORAX, V54, P638, DOI 10.1136/thx.54.7.638; Krombach F, 1996, EUR RESPIR J, V9, P984, DOI 10.1183/09031936.96.09050984; Marden JJ, 2007, J CLIN INVEST, V117, P2913, DOI 10.1172/JCI31265; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; MOSSMAN BT, 1989, ENVIRON HEALTH PERSP, V81, P91, DOI 10.2307/3430811; MOSSMAN BT, 1990, AM REV RESPIR DIS, V141, P1266, DOI 10.1164/ajrccm/141.5_Pt_1.1266; Murthy S, 2010, J BIOL CHEM, V285, P25062, DOI 10.1074/jbc.M109.099655; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; OBERLEY LW, 1984, METHOD ENZYMOL, V105, P457; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Panduri V, 2004, AM J PHYSIOL-LUNG C, V286, pL1220, DOI 10.1152/ajplung.00371.2003; PANUS PC, 1993, FREE RADICAL BIO MED, V14, P217, DOI 10.1016/0891-5849(93)90013-K; ROM WN, 1987, AM REV RESPIR DIS, V136, P1429, DOI 10.1164/ajrccm/136.6.1429; Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Tephly LA, 2007, AM J PHYSIOL-LUNG C, V293, pL1143, DOI 10.1152/ajplung.00114.2007; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Venkatachalam P, 2008, ONCOGENE, V27, P20, DOI 10.1038/sj.onc.1210634	42	51	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15597	15607		10.1074/jbc.M110.187377	http://dx.doi.org/10.1074/jbc.M110.187377			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21393238	Green Published, hybrid			2022-12-25	WOS:000289788300087
J	Mouquet, N; Matthiessen, B; Miller, T; Gonzalez, A				Mouquet, Nicolas; Matthiessen, Birte; Miller, Tom; Gonzalez, Andrew			Extinction Debt in Source-Sink Metacommunities	PLOS ONE			English	Article							HABITAT DESTRUCTION; SPATIAL HETEROGENEITY; FRAGMENTED LANDSCAPES; SPECIES RICHNESS; DYNAMICS; COEXISTENCE; BIODIVERSITY; FOREST; COMPETITION; RELAXATION	In an increasingly modified world, understanding and predicting the consequences of landscape alteration on biodiversity is a challenge for ecologists. To this end, metacommunity theory has developed to better understand the complexity of local and regional interactions that occur across larger landscapes. While metacommunity ecology has now provided several alternative models of species coexistence at different spatial scales, predictions regarding the consequences of landscape alteration have been done exclusively for the competition-colonization trade off model (CC). In this paper we investigate the effects of landscape perturbation on source-sink metacommunities. We show that habitat destruction perturbs the equilibria among species competitive effects within the metacommunity, driving both direct extinctions and an indirect extinction debt. As in CC models, we found a time lag for extinction following habitat destruction that varied in length depending upon the relative importance of direct and indirect effects. However, in contrast to CC models, we found that the less competitive species are more affected by habitat destruction. The best competitors can sometimes even be positively affected by habitat destruction, which corresponds well with the results of field studies. Our results are complementary to those results found in CC models of metacommunity dynamics. From a conservation perspective, our results illustrate that landscape alteration jeopardizes species coexistence in patchy landscapes through complex indirect effects and delayed extinctions patterns.	[Mouquet, Nicolas] Univ Montpellier 2, CNRS, Inst Sci Evolut, Montpellier, France; [Matthiessen, Birte] Leibniz Inst Marine Sci, D-24105 Kiel, Germany; [Miller, Tom] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Gonzalez, Andrew] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; State University System of Florida; Florida State University; McGill University	Mouquet, N (corresponding author), Univ Montpellier 2, CNRS, Inst Sci Evolut, Pl Eugene Bataillon, Montpellier, France.	nmouquet@univ-montp2.fr	Gonzalez, Andrew/F-2247-2010; MOUQUET, Nicolas/AAL-1440-2021; Matthiessen, Birte/U-5459-2017	Gonzalez, Andrew/0000-0001-6075-8081; Matthiessen, Birte/0000-0001-9673-1876; Mouquet, Nicolas/0000-0003-1840-6984	CNRS; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair Program; Fonds Quebecois de la Recherche sur la Nature et les Technologies; National Science Foundation [DEB 0716891];  [ANR-BACH-09-JCJC-0110-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair Program(Canada Research Chairs); Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT); National Science Foundation(National Science Foundation (NSF)); 	NM was supported by the CNRS and a research grant ANR-BACH-09-JCJC-0110-01. AG was supported by grants from the Natural Sciences and Engineering Research Council of Canada, and the Canada Research Chair Program, and a team grant from Fonds Quebecois de la Recherche sur la Nature et les Technologies. TM has support from the National Science Foundation (DEB 0716891). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2001, AM NAT, V158, P572, DOI 10.1086/323586; Amarasekare P, 2008, ANNU REV ECOL EVOL S, V39, P479, DOI 10.1146/annurev.ecolsys.39.110707.173434; Boughton DA, 1999, ECOLOGY, V80, P2727; Brown J. H., 1998, BIOGEOGRAPHY; Crowder LB, 2000, B MAR SCI, V66, P799; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Eklof A, 2006, J ANIM ECOL, V75, P239, DOI 10.1111/j.1365-2656.2006.01041.x; Eriksson O, 1996, OIKOS, V77, P248, DOI 10.2307/3546063; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Gonzalez A, 2000, ECOL LETT, V3, P441, DOI 10.1046/j.1461-0248.2000.00171.x; Gonzalez A., 2009, BIODIVERSITY ECOSYST; Gouhier TC, 2010, AM NAT, V175, pE16, DOI 10.1086/649579; Gravel D, 2010, ECOLOGY, V91, P2172, DOI 10.1890/09-0843.1; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Hanski I., 1999, METAPOPULATION ECOLO; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; HASTINGS A, 1980, THEOR POPUL BIOL, V18, P363, DOI 10.1016/0040-5809(80)90059-3; Helm A, 2006, ECOL LETT, V9, P72, DOI 10.1111/j.1461-0248.2005.00841.x; Hill MF, 1999, ECOL LETT, V2, P121, DOI 10.1046/j.1461-0248.1999.22061.x; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; Holt Robert D., 1996, P313; Hoopes MF, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P35; Klausmeier CA, 2001, ECOL LETT, V4, P57, DOI 10.1046/j.1461-0248.2001.00195.x; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lindborg R, 2004, ECOLOGY, V85, P1840, DOI 10.1890/04-0367; Loreau M, 2003, ECOL LETT, V6, P673, DOI 10.1046/j.1461-0248.2003.00483.x; MAC ARTHUR ROBERT H., 1967; MASSOL F, ECOLOGY LET IN PRESS; McCarthy MA, 1997, CONSERV BIOL, V11, P221, DOI 10.1046/j.1523-1739.1997.95381.x; Melbourne BA, 2004, BIODIVERS CONSERV, V13, P275, DOI 10.1023/B:BIOC.0000004321.58196.d8; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Mouquet N, 2006, OIKOS, V113, P481, DOI 10.1111/j.2006.0030-1299.14582.x; Mouquet N, 2002, AM NAT, V159, P420, DOI 10.1086/338996; Muko S, 2000, THEOR POPUL BIOL, V57, P273, DOI 10.1006/tpbi.2000.1456; NEE S, 1992, J ANIM ECOL, V61, P37, DOI 10.2307/5506; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Rozdilsky ID, 2001, ECOL RES, V16, P983, DOI 10.1046/j.1440-1703.2001.00446.x; Schwartz MW, 1999, ANNU REV ECOL SYST, V30, P83, DOI 10.1146/annurev.ecolsys.30.1.83; STONE L, 1995, P ROY SOC B-BIOL SCI, V261, P381, DOI 10.1098/rspb.1995.0163; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 1997, AM NAT, V149, P407, DOI 10.1086/285998; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Vellend M, 2006, ECOLOGY, V87, P542, DOI 10.1890/05-1182	49	16	16	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17567	10.1371/journal.pone.0017567	http://dx.doi.org/10.1371/journal.pone.0017567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408133	gold, Green Published, Green Accepted			2022-12-25	WOS:000288170000039
J	Foresta, C; Patassini, C; Bertoldo, A; Menegazzo, M; Francavilla, F; Barzon, L; Ferlin, A				Foresta, Carlo; Patassini, Cristina; Bertoldo, Alessandro; Menegazzo, Massimo; Francavilla, Felice; Barzon, Luisa; Ferlin, Alberto			Mechanism of Human Papillomavirus Binding to Human Spermatozoa and Fertilizing Ability of Infected Spermatozoa	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HEPARAN-SULFATE; DNA	Human papillomaviruses (HPVs) are agents of the most common sexually transmitted diseases in females and males. Precise data about the presence, mechanism of infection and clinical significance of HPV in the male reproductive tract and especially in sperm are not available. Here we show that HPV can infect human sperm, it localizes at the equatorial region of sperm head through interaction between the HPV capsid protein L1 and syndecan-1. Sperm transfected with HPV E6/E7 genes and sperm exposed to HPV L1 capsid protein are capable to penetrate the oocyte and transfer the virus into oocytes, in which viral genes are then activated and transcribed. These data show that sperm might function as vectors for HPV transfer into the oocytes, and open new perspectives on the role of HPV infection in males and are particularly intriguing in relation to assisted reproduction techniques.	[Foresta, Carlo; Patassini, Cristina; Bertoldo, Alessandro; Menegazzo, Massimo; Ferlin, Alberto] Univ Padua, Sect Clin Pathol, Padua, Italy; [Foresta, Carlo; Patassini, Cristina; Bertoldo, Alessandro; Menegazzo, Massimo; Ferlin, Alberto] Univ Padua, Ctr Male Gamete Cryopreservat, Dept Histol Microbiol & Med Biotechnol, Padua, Italy; [Francavilla, Felice] Univ Aquila, Androl Unit, Dept Internal Med, I-67100 Laquila, Italy; [Barzon, Luisa] Univ Padua, Dept Histol Microbiol & Med Biotechnol, Sect Microbiol & Virol, Padua, Italy	University of Padua; University of Padua; University of L'Aquila; University of Padua	Foresta, C (corresponding author), Univ Padua, Sect Clin Pathol, Padua, Italy.	carlo.foresta@unipd.it	Ferlin, Alberto/AAO-3541-2020; Barzon, Luisa/K-7961-2016	Ferlin, Alberto/0000-0001-5817-8141; Barzon, Luisa/0000-0003-0720-8456; FRANCAVILLA, Felice/0000-0003-1255-4062	University of Padova; Hospital of Padova	University of Padova; Hospital of Padova	This work was funded by the University of Padova and the Hospital of Padova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aynaud O, 2002, INT J STD AIDS, V13, P547, DOI 10.1258/095646202760159666; Bocharova E N, 2007, Dokl Biol Sci, V412, P82, DOI 10.1134/S0012496607010279; Bocharova E N, 2003, Dokl Biol Sci, V391, P379, DOI 10.1023/A:1025179307236; Boulet G, 2007, INT J BIOCHEM CELL B, V39, P2006, DOI 10.1016/j.biocel.2007.07.004; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P1118; Combita AL, 2001, FEMS MICROBIOL LETT, V204, P183, DOI 10.1111/j.1574-6968.2001.tb10883.x; Drobni P, 2003, VIROLOGY, V310, P163, DOI 10.1016/S0042-6822(03)00114-4; Flores R, 2008, CANCER EPIDEM BIOMAR, V17, P3573, DOI 10.1158/1055-9965.EPI-08-0467; Foresta C, 2010, INT J ANDROL, V33, P28; FORESTA C, 2010, FERTIL STERIL   0105; Foresta C, 2010, FERTIL STERIL, V93, P802, DOI 10.1016/j.fertnstert.2008.10.050; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Horvath CAJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-11; JDOORBAR J, 2005, J CLIN VIROL S, V32, pS7; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; Kadze R, 2002, ASIAN J ANDROL, V4, P169; Kotronias D, 1998, IN VIVO, V12, P391; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; Lai YM, 1997, FERTIL STERIL, V67, P1152, DOI 10.1016/S0015-0282(97)81454-9; Lee CA, 2002, GYNECOL ONCOL, V85, P511, DOI 10.1006/gyno.2002.6662; Letian Tan, 2010, Virol J, V7, P2, DOI 10.1186/1743-422X-7-2; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; LOWY DR, 1994, P NATL ACAD SCI USA, V91, P2436, DOI 10.1073/pnas.91.7.2436; Martorell M, 2005, ARCH PATHOL LAB MED, V129, P1132; Nielson CM, 2007, CANCER EPIDEM BIOMAR, V16, P1107, DOI 10.1158/1055-9965.EPI-06-0997; Perez-Andino J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005847; Piomboni P, 2000, MOL REPROD DEV, V56, P238, DOI 10.1002/(SICI)1098-2795(200006)56:2+&lt;238::AID-MRD5&gt;3.0.CO;2-1; Rintala MAM, 2004, INT J STD AIDS, V15, P740, DOI 10.1258/0956462042395122; RODEN RBS, 1994, J VIROL, V68, P7260, DOI 10.1128/JVI.68.11.7260-7266.1994; Sapp M, 2009, FEBS J, V276, P7206, DOI 10.1111/j.1742-4658.2009.07400.x; Shafti-Keramat S, 2003, J VIROL, V77, P13125, DOI 10.1128/JVI.77.24.13125-13135.2003; Svec A, 2003, ARCH PATHOL LAB MED, V127, P1471; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th	35	86	107	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2011	6	3							e15036	10.1371/journal.pone.0015036	http://dx.doi.org/10.1371/journal.pone.0015036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	731IP	21408100	Green Published, Green Submitted, gold			2022-12-25	WOS:000288099800002
J	van Passel, MWJ; Kant, R; Zoetendal, EG; Plugge, CM; Derrien, M; Malfatti, SA; Chain, PSG; Woyke, T; Palva, A; de Vos, WM; Smidt, H				van Passel, Mark W. J.; Kant, Ravi; Zoetendal, Erwin G.; Plugge, Caroline M.; Derrien, Muriel; Malfatti, Stephanie A.; Chain, Patrick S. G.; Woyke, Tanja; Palva, Airi; de Vos, Willem M.; Smidt, Hauke			The Genome of Akkermansia muciniphila, a Dedicated Intestinal Mucin Degrader, and Its Use in Exploring Intestinal Metagenomes	PLOS ONE			English	Article							GUT MICROBIOTA; DIVERSITY; BACTERIA; TOOL; PROKARYOTES; RESISTANCE; SELECTION; SEQUENCE; INFANTS; TRACT	Background: The human gastrointestinal tract contains a complex community of microbes, fulfilling important health-promoting functions. However, this vast complexity of species hampers the assignment of responsible organisms to these functions. Recently, Akkermansia muciniphila, a new species from the deeply branched phylum Verrucomicrobia, was isolated from the human intestinal tract based on its capacity to efficiently use mucus as a carbon and nitrogen source. This anaerobic resident is associated with the protective mucus lining of the intestines. Methodology/Principal Findings: In order to uncover the functional potential of A. muciniphila, its genome was sequenced and annotated. It was found to contain numerous candidate mucinase-encoding genes, but lacking genes encoding canonical mucus-binding domains. Numerous phage-associated sequences found throughout the genome indicate that viruses have played an important part in the evolution of this species. Furthermore, we mined 37 GI tract metagenomes for the presence, and genetic diversity of Akkermansia sequences. Out of 37, eleven contained 16S ribosomal RNA gene sequences that are > 95% identical to that of A. muciniphila. In addition, these libraries were found to contain large amounts of Akkermansia DNA based on average nucleotide identity scores, which indicated in one subject co-colonization by different Akkermansia phylotypes. An additional 12 libraries also contained Akkermansia sequences, making a total of similar to 16 Mbp of new Akkermansia pangenomic DNA. The relative abundance of Akkermansia DNA varied between,0.01% to nearly 4% of the assembled metagenomic reads. Finally, by testing a large collection of full length 16S sequences, we find at least eight different representative species in the genus Akkermansia. Conclusions/Significance: These large repositories allow us to further mine for genetic heterogeneity and species diversity in the genus Akkermansia, providing novel insight towards the functionality of this abundant inhabitant of the human intestinal tract.	[van Passel, Mark W. J.; Zoetendal, Erwin G.; Plugge, Caroline M.; Derrien, Muriel; de Vos, Willem M.; Smidt, Hauke] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Kant, Ravi; Palva, Airi; de Vos, Willem M.] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland; [Malfatti, Stephanie A.; Chain, Patrick S. G.; Woyke, Tanja] DOE Joint Genome Inst, Walnut Creek, CA USA; [Malfatti, Stephanie A.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Chain, Patrick S. G.] Los Alamos Natl Lab, Los Alamos, NM USA	Wageningen University & Research; University of Helsinki; United States Department of Energy (DOE); United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	van Passel, MWJ (corresponding author), Wageningen Univ, Microbiol Lab, Wageningen, Netherlands.	mark.vanpassel@wur.nl	Derrien, Muriel/AAS-6845-2021; van Passel, Mark WJ/K-5698-2012; Chain, Patrick/O-4140-2019; chain, patrick/B-9777-2013; Kant, Ravi/F-7025-2013; Kant, Ravi/AAF-8495-2021; Smidt, Hauke/D-7054-2014	Derrien, Muriel/0000-0001-8841-9153; Chain, Patrick/0000-0003-3949-3634; Kant, Ravi/0000-0003-3878-9775; Kant, Ravi/0000-0003-3878-9775; Smidt, Hauke/0000-0002-6138-5026; Malfatti, Stephanie/0000-0003-4225-9857	Netherlands Organization for Scientific Research (NWO); Center of Excellence in Microbial Food Safety Research (MiFoSa), Academy of Finland; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Center of Excellence in Microbial Food Safety Research (MiFoSa), Academy of Finland(Academy of Finland); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	MWJvP and WMdV are funded by the Netherlands Organization for Scientific Research (NWO) via a VENI and SPINOZA grant. RK was supported by the Center of Excellence in Microbial Food Safety Research (MiFoSa), Academy of Finland. The work conducted by the U. S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2006, PLOS GENET, V2, P224, DOI 10.1371/journal.pgen.0020022; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arumugam M, 2010, BIOINFORMATICS, V26, P2977, DOI 10.1093/bioinformatics/btq536; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Haft DH, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-29; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Klaassens ES, 2009, APPL ENVIRON MICROB, V75, P2668, DOI 10.1128/AEM.02492-08; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; MELLO LV, 2010, FEBS LETT; Moal VLL, 2006, CLIN MICROBIOL REV, V19, P315, DOI 10.1128/CMR.19.2.315-337.2006; OPHIR T, 1994, APPL ENVIRON MICROB, V60, P740, DOI 10.1128/AEM.60.2.740-745.1994; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; PNG CW, 2010, AM J GASTROENTEROL; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Saunders NJ, 2000, MOL MICROBIOL, V37, P207, DOI 10.1046/j.1365-2958.2000.02000.x; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; van Passel MWJ, 2007, TRENDS GENET, V23, P601, DOI 10.1016/j.tig.2007.08.017; van Passel MWJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-596; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	45	237	380	10	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e16876	10.1371/journal.pone.0016876	http://dx.doi.org/10.1371/journal.pone.0016876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390229	Green Published, Green Submitted, gold			2022-12-25	WOS:000287965200007
J	Williams, RJ				Williams, Richard J.			Biology, Methodology or Chance? The Degree Distributions of Bipartite Ecological Networks	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; FOOD-WEB STRUCTURE; ASYMMETRIC SPECIALIZATION; COEVOLUTIONARY NETWORKS; NULL MODEL; POLLINATION; PATTERNS; CONNECTANCE; ENTROPY	The distribution of the number of links per species, or degree distribution, is widely used as a summary of the topology of complex networks. Degree distributions have been studied in a range of ecological networks, including both mutualistic bipartite networks of plants and pollinators or seed dispersers and antagonistic bipartite networks of plants and their consumers. The shape of a degree distribution, for example whether it follows an exponential or power-law form, is typically taken to be indicative of the processes structuring the network. The skewed degree distributions of bipartite mutualistic and antagonistic networks are usually assumed to show that ecological or co-evolutionary processes constrain the relative numbers of specialists and generalists in the network. I show that a simple null model based on the principle of maximum entropy cannot be rejected as a model for the degree distributions in most of the 115 bipartite ecological networks tested here. The model requires knowledge of the number of nodes and links in the network, but needs no other ecological information. The model cannot be rejected for 159 (69%) of the 230 degree distributions of the 115 networks tested. It performed equally well on the plant and animal degree distributions, and cannot be rejected for 81 (70%) of the 115 plant distributions and 78 (68%) of the animal distributions. There are consistent differences between the degree distributions of mutualistic and antagonistic networks, suggesting that different processes are constraining these two classes of networks. Fit to the MaxEnt null model is consistently poor among the largest mutualistic networks. Potential ecological and methodological explanations for deviations from the model suggest that spatial and temporal heterogeneity are important drivers of the structure of these large networks.	Microsoft Res, Cambridge, England	Microsoft	Williams, RJ (corresponding author), Microsoft Res, Cambridge, England.	ricw@microsoft.com	Williams, Richard J/B-8344-2011	Williams, Richard J/0000-0001-8847-3213				Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Camacho J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.228102; Clements F. E., 1916, PLANT SUCCESSION ANA; COHEN JE, 1993, ECOLOGY, V74, P252, DOI 10.2307/1939520; COHEN JE, 1978, FOOD WEBS NICHE SPAC; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; Cover T. M, 2006, ELEMENTS INFORM THEO, V2nd, DOI 10.1002/0471200611; DEWAR R, 2008, J THEORETICAL BIOL; Diamond J.M., 1975, P342; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Dunne JA, 2006, SFI S SCI C, P27; Elton C. S., 1927, ANIMAL ECOLOGY; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Haegeman B, 2010, AM NAT, V175, pE74, DOI 10.1086/650718; Harte J, 2008, ECOLOGY, V89, P2700, DOI 10.1890/07-1369.1; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Laird S, 2006, EUROPHYS LETT, V76, P710, DOI 10.1209/epl/i2006-10319-x; Martinez ND, 1998, COM ECO SYS, P207; May RM, 2006, TRENDS ECOL EVOL, V21, P394, DOI 10.1016/j.tree.2006.03.013; MCMULLEN CK, 1993, PAN-PAC ENTOMOL, V69, P95; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; Montoya JM, 2002, J THEOR BIOL, V214, P405, DOI 10.1006/jtbi.2001.2460; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Morales JM, 2008, OIKOS, V117, P1362, DOI 10.1111/j.0030-1299.2008.16737.x; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Okuyama T, 2008, ECOL COMPLEX, V5, P59, DOI 10.1016/j.ecocom.2007.06.006; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Petanidou T., 1993, Biodiversity Letters, V1, P9, DOI 10.2307/2999643; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Philipp M, 2006, ECOGRAPHY, V29, P531, DOI 10.1111/j.0906-7590.2006.04546.x; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Rossberg AG, 2006, J THEOR BIOL, V238, P401, DOI 10.1016/j.jtbi.2005.05.025; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; Stang M, 2007, OECOLOGIA, V151, P442, DOI 10.1007/s00442-006-0585-y; Storch D, 2008, ECOL LETT, V11, P771, DOI 10.1111/j.1461-0248.2008.01206.x; Stouffer DB, 2007, P ROY SOC B-BIOL SCI, V274, P1931, DOI 10.1098/rspb.2007.0571; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Vazquez DP, 2005, OIKOS, V108, P421, DOI 10.1111/j.0030-1299.2005.13619.x; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Vazquez DP, 2003, ECOLOGY, V84, P2493, DOI 10.1890/02-0587; Vermaat JE, 2009, ECOLOGY, V90, P278, DOI 10.1890/07-0978.1; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Williams RJ, 2010, THEOR ECOL-NETH, V3, P45, DOI 10.1007/s12080-009-0052-6	51	32	33	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17645	10.1371/journal.pone.0017645	http://dx.doi.org/10.1371/journal.pone.0017645			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390231	Green Submitted, Green Published, gold			2022-12-25	WOS:000287965200034
J	Barone-Adesi, F; Gasparrini, A; Vizzini, L; Merletti, F; Richiardi, L				Barone-Adesi, Francesco; Gasparrini, Antonio; Vizzini, Loredana; Merletti, Franco; Richiardi, Lorenzo			Effects of Italian Smoking Regulation on Rates of Hospital Admission for Acute Coronary Events: A Country-Wide Study	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; FREE LEGISLATION; HEART-DISEASE; BAN; TIME; ACT	Background: Several studies have reported a reduction in acute coronary events (ACEs) in the general population after the enforcement of smoking regulations, although there is uncertainty concerning the magnitude of the effect of such interventions. We conducted a country-wide evaluation of the health effects of the introduction of a smoking ban in public places, using data on hospital admissions for ACEs from the Italian population after the implementation of a national smoking regulation in January 2005. Methods and Findings: Rates of admission for ACEs in the 20 Italian regions from January 2002 to November 2006 were analysed using mixed-effect regression models that allowed for long-term trends and seasonality. Standard methods for interrupted time-series were adopted to assess the immediate and gradual effects of the smoking ban. Effect modification by age was investigated, with the assumption that exposure to passive smoking in public places would be greater among young people. In total, 936,519 hospital admissions for ACEs occurred in the Italian population during the study period. A 4% reduction in hospital admissions for ACEs among persons aged less than 70 years was evident after the introduction of the ban (Rate Ratio [RR], 0.96; 95% Confidence Interval [CI], 0.95-0.98). No effect was found among persons aged at least 70 years (RR 1.00; 95% CI 0.99-1.02). Effect modification by age was further suggested by analyses using narrower age categories. Conclusions: Smoke-free policies can constitute a simple and inexpensive intervention for the prevention of cardiovascular diseases and thus should be included in prevention programmes.	[Barone-Adesi, Francesco; Vizzini, Loredana; Merletti, Franco; Richiardi, Lorenzo] Univ Turin, Canc Epidemiol Unit, CeRMS, Turin, Italy; [Barone-Adesi, Francesco; Vizzini, Loredana; Merletti, Franco; Richiardi, Lorenzo] Univ Turin, CPO Piemonte, Turin, Italy; [Gasparrini, Antonio] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England	University of Turin; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of Turin; University of London; London School of Hygiene & Tropical Medicine	Barone-Adesi, F (corresponding author), Univ Turin, Canc Epidemiol Unit, CeRMS, Turin, Italy.	fbaroneadesi@yahoo.it	Gasparrini, Antonio/F-7627-2012; Barone-Adesi, Francesco/ABG-1580-2020; richiardi, lorenzo/J-3480-2018	Gasparrini, Antonio/0000-0002-2271-3568; Barone-Adesi, Francesco/0000-0003-1550-436X; richiardi, lorenzo/0000-0003-0316-9402	Compagnia San Paolo/Fondazione Internazionale in Medicina Sperimentale (FIRMS); Regione Piemonte	Compagnia San Paolo/Fondazione Internazionale in Medicina Sperimentale (FIRMS)(Compagnia di San Paolo); Regione Piemonte(Regione Piemonte)	This work was partially supported by the Compagnia San Paolo/Fondazione Internazionale in Medicina Sperimentale (FIRMS) and the Regione Piemonte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett R, 2009, AUST NZ J PUBL HEAL, V33, P515, DOI 10.1111/j.1753-6405.2009.00446.x; Barnoya J, 2005, CIRCULATION, V112, P456, DOI 10.1161/CIRCULATIONAHA.105.554741; Barone-Adesi F, 2006, EUR HEART J, V27, P2468, DOI 10.1093/eurheartj/ehl201; Brocco S, 2006, J CARDIOVASC MED, V7, P45, DOI 10.2459/01.JCM.0000199787.45940.68; Cesaroni G, 2008, CIRCULATION, V117, P1183, DOI 10.1161/CIRCULATIONAHA.107.729889; CHENG TO, 2010, INT J CARDI IN PRESS; DOLL R, 1967, INT J CANCER, V2, P269, DOI 10.1002/ijc.2910020310; *EPA CAL OFF ENV H, HLTH EFF ASS ENV TOB; Gallus S, 2006, ANN ONCOL, V17, P346, DOI 10.1093/annonc/mdj070; Gasparrini A, 2009, EUR J EPIDEMIOL, V24, P597, DOI 10.1007/s10654-009-9377-0; Gorini G, 2007, ANN ONCOL, V18, P1620, DOI 10.1093/annonc/mdm279; Gorini G, 2007, PREV MED, V45, P123, DOI 10.1016/j.ypmed.2007.06.019; Hunsberger S, 2002, BIOSTATISTICS, V3, P289, DOI 10.1093/biostatistics/3.2.289; Institute of Medicine, 2009, SEC SMOK EXP CARD EF; Juster HR, 2007, AM J PUBLIC HEALTH, V97, P2035, DOI 10.2105/AJPH.2006.099994; Lightwood JM, 2009, CIRCULATION, V120, P1373, DOI 10.1161/CIRCULATIONAHA.109.870691; Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Palmieri L, 2010, AM J PUBLIC HEALTH, V100, P684, DOI 10.2105/AJPH.2008.147173; Panagiotakos DB, 2004, INT J CARDIOL, V94, P229, DOI 10.1016/j.ijcard.2003.04.050; Pell JP, 2008, NEW ENGL J MED, V359, P482, DOI 10.1056/NEJMsa0706740; *PRACT MAN INF COR, 1993, INT CLASS DIS CLIN M; Richiardi L, 2009, PREV MED, V48, P167, DOI 10.1016/j.ypmed.2008.11.013; Salomaa V, 2005, EUR HEART J, V26, P1719, DOI 10.1093/eurheartj/ehi185; SCHULZE A, 2006, SOZIALE UNTERSCHIEDE; Seo DC, 2007, J DRUG EDUC, V37, P217, DOI 10.2190/DE.37.3.a; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; Twose J, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-194; Vasselli S, 2008, Minerva Cardioangiol, V56, P197; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	31	50	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17419	10.1371/journal.pone.0017419	http://dx.doi.org/10.1371/journal.pone.0017419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	729FF	21399685	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000287933300022
J	Tajino, K; Hosokawa, H; Maegawa, S; Matsumura, K; Dhaka, A; Kobayashi, S				Tajino, Koji; Hosokawa, Hiroshi; Maegawa, Shingo; Matsumura, Kiyoshi; Dhaka, Ajay; Kobayashi, Shigeo			Cooling-Sensitive TRPM8 Is Thermostat of Skin Temperature against Cooling	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; COLD SENSITIVITY; TRPA1 CHANNELS; MENTHOL; NEURONS; MICE; THERMOREGULATION; IDENTIFICATION; HYPOTHALAMUS; SENSATION	We have shown that cutaneous cooling-sensitive receptors can work as thermostats of skin temperature against cooling. However, molecule of the thermostat is not known. Here, we studied whether cooling-sensitive TRPM8 channels act as thermostats. TRPM8 in HEK293 cells generated output (y) when temperature (T) was below threshold of 28.4 degrees C. Output (y) is given by two equations: At T > 28.4 degrees C, y=0; At T < 28.4 degrees C, y = -k(T -28.4 degrees C). These equations show that TRPM8 is directional comparator to elicits output (y) depending on negative value of thermal difference (Delta T = T -28.4 degrees C). If negative Delta T-dependent output of TRPM8 in the skin induces responses to warm the skin for minimizing Delta T recursively, TRPM8 acts as thermostats against cooling. With TRPM8-deficient mice, we explored whether TRPM8 induces responses to warm the skin against cooling. In behavioral regulation, when room temperature was 10 degrees C, TRPM8 induced behavior to move to heated floor (35 degrees C) for warming the sole skin. In autonomic regulation, TRPM8 induced activities of thermogenic brown adipose tissue (BAT) against cooling. When menthol was applied to the whole trunk skin at neutral room temperature (27 degrees C), TRPM8 induced a rise in core temperature, which warmed the trunk skin slightly. In contrast, when room was cooled from 27 to 10 degrees C, TRPM8 induced a small rise in core temperature, but skin temperature was severely reduced in both TRPM8-deficient and wild-type mice by a large heat leak to the surroundings. This shows that TRPM8-driven endothermic system is less effective for maintenance of skin temperature against cooling. In conclusion, we found that TRPM8 is molecule of thermostat of skin temperature against cooling.	[Tajino, Koji; Hosokawa, Hiroshi; Maegawa, Shingo; Kobayashi, Shigeo] Kyoto Univ, Dept Intelligence Sci & Technol, Grad Sch Informat, Kyoto, Japan; [Matsumura, Kiyoshi] Osaka Inst Technol, Fac Informat Sci & Technol, Osaka 535, Japan; [Dhaka, Ajay] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	Kyoto University; Osaka Institute of Technology; University of Washington; University of Washington Seattle	Tajino, K (corresponding author), Kyoto Univ, Dept Intelligence Sci & Technol, Grad Sch Informat, Kyoto, Japan.	skoba@i.kyoto-u.ac.jp	Maegawa, Shingo/AAB-3924-2021		Ministry of Education, Science, Sports and Culture and Technology; Grants-in-Aid for Scientific Research [22687016] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Ministry of Education, Science, Sports and Culture and Technology Grant-in-Aid for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2006, NEUROSCI LETT, V397, P140, DOI 10.1016/j.neulet.2005.12.005; Abe J, 2005, MOL BRAIN RES, V136, P91, DOI 10.1016/j.molbrainres.2005.01.013; Adrian E.D., 1928, BASIS SENSATION; Alberts B, 2008, MOL BIOL CELL; Almeida MC, 2006, EUR J NEUROSCI, V23, P3359, DOI 10.1111/j.1460-9568.2006.04854.x; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; BENZINGER TH, 1969, PHYSIOL REV, V49, P671, DOI 10.1152/physrev.1969.49.4.671; Bligh J, 1973, TEMPERATURE REGULATI; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; GONZALEZ RR, 1971, J APPL PHYSIOL, V31, P728, DOI 10.1152/jappl.1971.31.5.728; Green BG, 2007, BEHAV BRAIN RES, V176, P284, DOI 10.1016/j.bbr.2006.10.013; GREEN BG, 1992, SOMATOSENS MOT RES, V9, P235, DOI 10.3109/08990229209144774; HARDY JD, 1961, PHYSIOL REV, V41, P521, DOI 10.1152/physrev.1961.41.3.521; HENSEL H, 1973, PHYSIOL REV, V53, P948, DOI 10.1152/physrev.1973.53.4.948; Hensel H, 1981, THERMORECEPTION TEMP; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; KOBAYASHI S, 1989, PROG NEUROBIOL, V32, P103, DOI 10.1016/0301-0082(89)90012-9; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Mazzarello P, 1999, NAT CELL BIOL, V1, pE13, DOI 10.1038/8964; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; MITCHELL D, 1970, PFLUG ARCH EUR J PHY, V321, P293, DOI 10.1007/BF00588644; Nakamura K, 2008, NAT NEUROSCI, V11, P62, DOI 10.1038/nn2027; Nakamura K, 2007, AM J PHYSIOL-REG I, V292, pR127, DOI 10.1152/ajpregu.00427.2006; NAKAYAMA T, 1961, SCIENCE, V134, P560, DOI 10.1126/science.134.3478.560; Okazawa M, 2002, J NEUROSCI, V22, P3994, DOI 10.1523/JNEUROSCI.22-10-03994.2002; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Penfield W, 1950, CEREBRAL CORTEX MAN; Rim JS, 2004, J BIOL CHEM, V279, P25916, DOI 10.1074/jbc.M402102200; SATINOFF E, 1978, SCIENCE, V201, P16, DOI 10.1126/science.351802; Sawada Y, 2007, BRAIN RES, V1160, P39, DOI 10.1016/j.brainres.2007.05.047; Sherkheli MA, 2010, J PHARM PHARM SCI, V13, P242, DOI 10.18433/J3N88N; Tajino K, 2007, AM J PHYSIOL-REG I, V293, pR2128, DOI 10.1152/ajpregu.00377.2007; Takashima Y, 2007, J NEUROSCI, V27, P14147, DOI 10.1523/JNEUROSCI.4578-07.2007; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368; ZOTTERMAN Y, 1936, SCANDINAVICA ARCHIV, V75, P105	41	58	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17504	10.1371/journal.pone.0017504	http://dx.doi.org/10.1371/journal.pone.0017504			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407809	Green Published, Green Submitted, gold			2022-12-25	WOS:000287933300030
J	Tanton, C; Weiss, HA; Le Goff, J; Changalucha, J; Rusizoka, M; Baisley, K; Everett, D; Ross, DA; Belec, L; Hayes, RJ; Watson-Jones, D				Tanton, Clare; Weiss, Helen A.; Le Goff, Jerome; Changalucha, John; Rusizoka, Mary; Baisley, Kathy; Everett, Dean; Ross, David A.; Belec, Laurent; Hayes, Richard J.; Watson-Jones, Deborah			Correlates of HIV-1 Genital Shedding in Tanzanian Women	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; SEXUALLY-TRANSMITTED-DISEASES; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; BACTERIAL VAGINOSIS; INFECTED WOMEN; RISK-FACTORS; CERVICOVAGINAL SECRETIONS; HORMONAL CONTRACEPTION; INTERVENTION TRIALS	Background: Understanding the correlates of HIV shedding is important to inform strategies to reduce HIV infectiousness. We examined correlates of genital HIV-1 RNA in women who were seropositive for both herpes simplex virus (HSV)-2 and HIV-1 and who were enrolled in a randomised controlled trial of HSV suppressive therapy (aciclovir 400 mg b.i.d vs. placebo) in Tanzania. Methodology: Samples, including a cervico-vaginal lavage, were collected and tested for genital HIV-1 and HSV and reproductive tract infections (RTIs) at randomisation and 6, 12 and 24 months follow-up. Data from all women at randomisation and women in the placebo arm during follow-up were analysed using generalised estimating equations to determine the correlates of cervico-vaginal HIV-1 RNA detection and load. Principal Findings: Cervico-vaginal HIV-1 RNA was detected at 52.0% of 971 visits among 482 women, and was independently associated with plasma viral load, presence of genital ulcers, pregnancy, bloody cervical or vaginal discharge, abnormal vaginal discharge, cervical ectopy, Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, an intermediate bacterial vaginosis score and HSV DNA detection. Similar factors were associated with genital HIV-1 RNA load. Conclusions: RTIs were associated with increased presence and quantity of genital HIV-1 RNA in this population. These results highlight the importance of integrating effective RTI treatment into HIV care services.	[Tanton, Clare; Weiss, Helen A.; Baisley, Kathy; Everett, Dean; Ross, David A.; Hayes, Richard J.; Watson-Jones, Deborah] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Tanton, Clare; Changalucha, John; Baisley, Kathy] NIMR, Natl Inst Med Res NIMR Mwanza Ctr, Mwanza, Tanzania; [Le Goff, Jerome] Hop St Louis, Microbiol Lab, Paris, France; [Rusizoka, Mary] AMREF, African Med & Res Fdn AMREF Lake Zone Off, Mwanza, Tanzania; [Everett, Dean; Watson-Jones, Deborah] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England; [Belec, Laurent] Hop Europeen Georges Pompidou, Virol Lab, Paris, France; [Belec, Laurent] Univ Paris 05, Paris, France	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; African Medical & Research Foundation (AMREF); University of London; London School of Hygiene & Tropical Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Tanton, C (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.	c.tanton@ucl.ac.uk	le goff, jerome/B-3447-2016; weiss, helen/ABC-7823-2021; LeGoff, jerome/AAP-7880-2021	le goff, jerome/0000-0001-7111-1865; weiss, helen/0000-0003-3547-7936; Everett, Dean/0000-0002-8458-6779; Tanton, Clare/0000-0002-4612-1858; Hayes, Richard/0000-0002-1729-9892	Wellcome Trust [066688]; UK Medical Research Council [G0400456]; UK Department for International Development; Medical Research Council [G0700837, G0400456, G0901756] Funding Source: researchfish; MRC [G0700837, G0400456, G0901756] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for the study was provided by the Wellcome Trust (066688, www.wellcome.ac.uk), the UK Medical Research Council (G0400456, www.mrc.ac.uk) and the UK Department for International Development (www.dfid.gov.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harthi L, 1999, J ACQ IMMUN DEF SYND, V21, P194, DOI 10.1097/00126334-199907010-00003; Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Baisley K, 2009, SEX TRANSM INFECT, V85, P370, DOI 10.1136/sti.2008.035543; BELEC L, 1995, CLIN DIAGN LAB IMMUN, V2, P57; Benki S, 2004, J INFECT DIS, V189, P2192, DOI 10.1086/421298; CELUM C, 2002, NEW ENGL J MED, V362, P427; CLARK RA, 2007, SEX TRANSM DIS; CLEMETSON DBA, 1993, JAMA-J AM MED ASSOC, V269, P2860, DOI 10.1001/jama.269.22.2860; Coombs RW, 2003, AIDS, V17, P455, DOI 10.1097/00002030-200303070-00001; Cu-Uvin S, 2001, CLIN INFECT DIS, V33, P894, DOI 10.1086/322613; Delany S, 2009, AIDS, V23, P461, DOI 10.1097/QAD.0b013e32831db217; Dunne EF, 2008, JAIDS-J ACQ IMM DEF, V49, P77, DOI 10.1097/QAI.0b013e3181831832; Ghys PD, 1997, AIDS, V11, pF85, DOI 10.1097/00002030-199712000-00001; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gregson S, 2007, PLOS MED, V4, P545, DOI 10.1371/journal.pmed.0040102; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Hashemi FB, 1999, J INFECT DIS, V179, P924, DOI 10.1086/314674; HAYES R, AIDS S4, V24, pS15; HENIN Y, 1993, J ACQ IMMUN DEF SYND, V6, P72; Ison CA, 2002, SEX TRANSM INFECT, V78, P413, DOI 10.1136/sti.78.6.413; JOHNSON LF, 2008, SEX TRANSM DIS; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Kessler HH, 2000, J CLIN MICROBIOL, V38, P2638, DOI 10.1128/JCM.38.7.2638-2642.2000; Korenromp EL, 2005, J INFECT DIS, V191, pS168, DOI 10.1086/425274; MAYAUD P, 2008, SEX TRANSM INFECT; Mayaud P, 2009, J INFECT DIS, V200, P216, DOI 10.1086/599991; McClelland RS, 2001, AIDS, V15, P105, DOI 10.1097/00002030-200101050-00015; Mostad SB, 1997, LANCET, V350, P922, DOI 10.1016/S0140-6736(97)04240-2; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Ouedraogo A, 2006, AIDS, V20, P2305, DOI 10.1097/QAD.0b013e328010238d; PAZBAILEY G, 2007, IMPACT EPISODIC ACYC; PHIRI S, SEX TRANSM INFECT; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Seck K, 2001, SEX TRANSM INFECT, V77, P190, DOI 10.1136/sti.77.3.190; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; TANTON C, J INFECT DIS, V201, P1285; Wang CC, 2004, AIDS, V18, P205, DOI 10.1097/00002030-200401230-00009; Wang CC, 2001, J INFECT DIS, V183, P1017, DOI 10.1086/319287; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Watson-Jones D, 2007, JAIDS-J ACQ IMM DEF, V46, P631, DOI 10.1097/QAI.0b013e31815b2d9c; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; White RG, 2004, JAIDS-J ACQ IMM DEF, V37, P1500, DOI 10.1097/01.qai.0000127062.94627.31; Wolday D, 2004, AIDS, V18, P781, DOI 10.1097/00002030-200403260-00009; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523; Zuckerman RA, 2009, AIDS, V23, P479, DOI 10.1097/QAD.0b013e328326ca62	46	46	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17480	10.1371/journal.pone.0017480	http://dx.doi.org/10.1371/journal.pone.0017480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390251	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000287932100018
J	Jin, JS; Kwon, SO; Moon, DC; Gurung, M; Lee, JH; Kim, SI; Lee, JC				Jin, Jong Sook; Kwon, Sang-Oh; Moon, Dong Chan; Gurung, Mamata; Lee, Jung Hwa; Kim, Seung Il; Lee, Je Chul			Acinetobacter baumannii Secretes Cytotoxic Outer Membrane Protein A via Outer Membrane Vesicles	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; PROTEOMICS; PATHOGEN; ACTIVATION; VIRULENCE; BIOFILM; EXPORT; TOXIN; CELLS	Acinetobacter baumannii is an important nosocomial pathogen that causes a high morbidity and mortality rate in infected patients, but pathogenic mechanisms of this microorganism regarding the secretion and delivery of virulence factors to host cells have not been characterized. Gram-negative bacteria naturally secrete outer membrane vesicles (OMVs) that play a role in the delivery of virulence factors to host cells. A. baumannii has been shown to secrete OMVs when cultured in vitro, but the role of OMVs in A. baumannii pathogenesis is not well elucidated. In the present study, we evaluated the secretion and delivery of virulence factors of A. baumannii to host cells via the OMVs and assessed the cytotoxic activity of outer membrane protein A (AbOmpA) packaged in the OMVs. A. baumannii ATCC 19606(T) secreted OMVs during in vivo infection as well as in vitro cultures. Potential virulence factors, including AbOmpA and tissue-degrading enzymes, were associated with A. baumannii OMVs. A. baumannii OMVs interacted with lipid rafts in the plasma membranes and then delivered virulence factors to host cells. The OMVs from A. baumannii ATCC 19606(T) induced apoptosis of host cells, whereas this effect was not detected in the OMVs from the DompA mutant, thereby reflecting AbOmpA-dependent host cell death. The N-terminal region of AbOmpA(22-170) was responsible for host cell death. In conclusion, the OMV-mediated delivery of virulence factors to host cells may well contribute to pathogenesis during A. baumannii infection.	[Jin, Jong Sook; Moon, Dong Chan; Gurung, Mamata; Lee, Jung Hwa; Lee, Je Chul] Kyungpook Natl Univ, Sch Med, Dept Microbiol, Taegu, South Korea; [Kwon, Sang-Oh; Kim, Seung Il] Korea Basic Sci Inst, Proteome Res Team, Taejon, South Korea	Kyungpook National University; Korea Basic Science Institute (KBSI)	Jin, JS (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Microbiol, Taegu, South Korea.	ksi@kbsi.re.kr; leejc@knu.ac.kr			Korea government (MEST) [R01-2008-000-11083-0]; Korea Basic Science Institute [K-MeP T30100]	Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Basic Science Institute	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (Project No. R01-2008-000-11083-0). SI Kim & SO Kwon were supported by a grant (K-MeP T30100) from the Korea Basic Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Bauman SJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-26; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, CELL MICROBIOL, V10, P309, DOI 10.1111/j.1462-5822.2007.01041.x; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Ellis TN, 2010, INFECT IMMUN, V78, P3822, DOI 10.1128/IAI.00433-10; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Falagas ME, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-24; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Galka F, 2008, INFECT IMMUN, V76, P1825, DOI 10.1128/IAI.01396-07; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ismail S, 2003, INFECT IMMUN, V71, P5670, DOI 10.1128/IAI.71.10.5670-5675.2003; Kato S, 2002, MICROB PATHOGENESIS, V32, P1, DOI 10.1006/mpat.2001.0474; Keenan JI, 2008, INNATE IMMUN, V14, P279, DOI 10.1177/1753425908096857; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Kolling GL, 1999, APPL ENVIRON MICROB, V65, P1843; KONDO K, 1993, MICROBIOL IMMUNOL, V37, P149, DOI 10.1111/j.1348-0421.1993.tb03192.x; Kouokam JC, 2006, INFECT IMMUN, V74, P2022, DOI 10.1128/IAI.74.4.2022-2030.2006; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Kwon SO, 2009, FEMS MICROBIOL LETT, V297, P150, DOI 10.1111/j.1574-6968.2009.01669.x; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Lee JC, 2001, APMIS, V109, P679, DOI 10.1034/j.1600-0463.2001.d01-132.x; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Lee JS, 2007, BIOCHEM PHARMACOL, V74, P86, DOI 10.1016/j.bcp.2007.02.012; Lim JS, 2010, AGING CELL, V9, P243, DOI 10.1111/j.1474-9726.2010.00554.x; Lindmark B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-220; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; OCALLAGHAN CH, 1972, ANTIMICROB AGENTS CH, V1, P283, DOI 10.1128/AAC.1.4.283; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Scorza FB, 2008, MOL CELL PROTEOMICS, V7, P473, DOI 10.1074/mcp.M700295-MCP200; Sidhu VK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-87; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Van Faassen H, 2007, INFECT IMMUN, V75, P5597, DOI 10.1128/IAI.00762-07; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Yun SH, 2008, J MICROBIOL, V46, P720, DOI 10.1007/s12275-008-0202-3; Zimbler D, 2009, BIOMETALS, V22, P23, DOI 10.1007/s10534-008-9202-3	44	171	184	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17027	10.1371/journal.pone.0017027	http://dx.doi.org/10.1371/journal.pone.0017027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386968	Green Submitted, Green Published, gold			2022-12-25	WOS:000287931400024
J	Wang, D; Li, YJ; Wu, CY; Liu, YH				Wang, Dan; Li, Yingjian; Wu, Chuanyue; Liu, Youhua			PINCH1 Is Transcriptional Regulator in Podocytes That Interacts with WT1 and Represses Podocalyxin Expression	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; TO-MESENCHYMAL TRANSITION; CELL-SHAPE MODULATION; ONLY PROTEIN PINCH; MOLECULAR DISSECTION; GLOMERULAR PODOCYTE; ACTIN CYTOSKELETON; INJURY; NEPHRIN; ILK	Background: PINCH1, an adaptor protein containing five LIM domains, plays an important role in regulating the integrin-mediated cell adhesion, migration and epithelial-mesenchymal transition. PINCH1 is induced in the fibrotic kidney after injury, and it primarily localizes at the sites of focal adhesion. Whether it can translocate to the nucleus and directly participate in gene regulation is completely unknown. Methodology/Principal Findings: Using cultured glomerular podocytes as a model system, we show that PINCH1 expression was induced by TGF-beta 1, a fibrogenic cytokine that promotes podocyte dysfunction. Interestingly, increased PINCH1 not only localized at the sites of focal adhesions, but also underwent nuclear translocation after TGF-beta 1 stimulation. This nuclear translocation of PINCH1 was apparently dependent on the putative nuclear export/localization signals (NES/NLS) at its C-terminus, as deletion or site-directed mutations abolished its nuclear shuttling. Co-immunoprecipitation and pull-down experiments revealed that PINCH1 interacted with Wilms tumor 1 protein (WT1), a nuclear transcription factor that is essential for regulating podocyte-specific gene expression in adult kidney. Interaction of PINCH1 and WT1 was mediated by the LIM1 domain of PINCH1 and C-terminal zinc-finger domain of WT1, which led to the suppression of the WT1-mediated podocalyxin expression in podocytes. PINCH1 also repressed podocalyxin gene transcription in a promoter-luciferase reporter assay. Conclusion/Significance: These results indicate that PINCH1 can shuttle into the nucleus from cytoplasm in podocytes, wherein it interacts with WT1 and suppresses podocyte-specific gene expression. Our studies reveal a previously unrecognized, novel function of PINCH1, in which it acts as a transcriptional regulator through controlling specific gene expression.	[Wang, Dan; Li, Yingjian; Wu, Chuanyue; Liu, Youhua] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, D (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	liuy@upmc.edu		Liu, Youhua/0000-0002-4740-805X	National Institutes of Health [DK061408, DK064005, DK054639]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064005, R01DK061408, R01DK054639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health Grants DK061408 and DK064005 (Y.L.), and DK054639 (C.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Campana WM, 2003, GLIA, V41, P213, DOI 10.1002/glia.10138; Chiswell BP, 2008, P NATL ACAD SCI USA, V105, P20677, DOI 10.1073/pnas.0811415106; Dai CS, 2006, J AM SOC NEPHROL, V17, P2164, DOI 10.1681/ASN.2006010033; Dai CS, 2010, KIDNEY INT, V77, P962, DOI 10.1038/ki.2010.40; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Guo G, 2004, J AM SOC NEPHROL, V15, P2851, DOI 10.1097/01.ASN.0000143474.91362.C4; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Jung KY, 2007, J AM SOC NEPHROL, V18, P66, DOI 10.1681/ASN.2006050421; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kim JH, 2010, J BIOL CHEM, V285, P9995, DOI 10.1074/jbc.M109.061671; Lahiri D, 2007, MOL REPROD DEV, V74, P300, DOI 10.1002/mrd.20491; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Li YJ, 2007, J AM SOC NEPHROL, V18, P2534, DOI 10.1681/ASN.2007030315; Li YJ, 2009, J AM SOC NEPHROL, V20, P1907, DOI 10.1681/ASN.2008090930; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Macconi D, 2006, AM J PATHOL, V168, P42, DOI 10.2353/ajpath.2006.050398; Menke AL, 2003, J PATHOL, V200, P667, DOI 10.1002/path.1390; Morrison AA, 2008, AM J PHYSIOL-RENAL, V295, pF12, DOI 10.1152/ajprenal.00597.2007; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Palmer RE, 2001, CURR BIOL, V11, P1805, DOI 10.1016/S0960-9822(01)00560-7; Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Rico M, 2005, AM J PHYSIOL-RENAL, V289, pF431, DOI 10.1152/ajprenal.00389.2004; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Srichai MB, 2004, J BIOL CHEM, V279, P14398, DOI 10.1074/jbc.M314155200; Stanchi F, 2009, J CELL SCI, V122, P1800, DOI 10.1242/jcs.044602; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Wagner KD, 2003, J CELL SCI, V116, P1653, DOI 10.1242/jcs.00405; Wagner N, 2004, J AM SOC NEPHROL, V15, P3044, DOI 10.1097/01.ASN.0000146687.99058.25; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Wu CY, 2005, TRENDS CELL BIOL, V15, P460, DOI 10.1016/j.tcb.2005.07.002; Xu Z, 2005, J BIOL CHEM, V280, P27631, DOI 10.1074/jbc.M504189200; Yang YW, 2009, J BIOL CHEM, V284, P5836, DOI 10.1074/jbc.M805319200	42	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17048	10.1371/journal.pone.0017048	http://dx.doi.org/10.1371/journal.pone.0017048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390327	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000287761700027
J	Charoenfuprasert, S; Yang, YY; Lee, YC; Chao, KC; Chu, PY; Lai, CR; Hsu, KF; Chang, KC; Chen, YC; Chen, LT; Chang, JY; Leu, SJ; Shih, NY				Charoenfuprasert, S.; Yang, Y-Y; Lee, Y-C; Chao, K-C; Chu, P-Y; Lai, C-R; Hsu, K-F; Chang, K-C; Chen, Y-C; Chen, L-T; Chang, J-Y; Leu, S-J; Shih, N-Y			Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancer	ONCOGENE			English	Article						tumor-associated antigen; ovarian cancer; CA125; malignant ascitic fluid; phage display	RECEPTOR; GROWTH; CELLS; SIK1; LKB1; STEROIDOGENESIS; STANNIOCALCIN; ADIPOGENESIS; EXPRESSION; CREB	Existence of humoral immunity has been previously demonstrated in malignant ascitic fluids. However, only a limited number of immunogenic tumor-associated antigens (TAAs) were identified, and few of which are associated with ovarian cancer. Here, we identified salt-inducible kinase 3 (SIK3) as a TAA through screening of a random peptide library in the phage display system. Overexpression of SIK3 markedly promoted cell proliferation, attenuated p21(Waf/Cip1) and p27(Kip) expressions in low-grade OVCAR3 cells, and permitted the cells to grow in mice. Decrease in SIK3 expression in high-grade SK-OV3 cells consistently demonstrated its tumorigenic potency by modulating the protein levels of cell cycle regulators. When the expressions of SIK3 and CA125 were compared in cancer tissues, immunohistochemical (IHC) studies indicated that cytoplasm-localized SIK3 was highly expressed in 55% of the ovarian cancer samples. In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer. Moreover, experiments using pharmacological inhibitors to block SIK3-induced p21(Waf/Cip1) expression revealed that activation of c-Src and phosphoinositide-3-kinase were critically required for its biological activity, suggesting that they are the downstream signaling mediators of SIK3. These data were further supported by IHC studies, showing coexpression of c-Src with SIK3 in 85% of the ovarian tumor samples stained positive for SIK3. Collectively, our findings indicate that SIK3 is a novel ovarian TAA. Overexpression of SIK3 promotes G1/S cell cycle progression, bestows survival advantages to cancer cells for growth and correlates the clinicopathological conditions of patients with ovarian cancer. Oncogene (2011) 30, 3570-3584; doi:10.1038/onc.2011.77; published online 14 March 2011	[Charoenfuprasert, S.; Leu, S-J] Taipei Med Univ, Coll Med, Sch Med, Dept Microbiol & Immunol, Taipei 110, Taiwan; [Charoenfuprasert, S.; Leu, S-J] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan; [Yang, Y-Y; Lee, Y-C] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei 110, Taiwan; [Chao, K-C] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chu, P-Y] Changhua Christian Hosp, Dept Surg Pathol, Changhua, Taiwan; [Lai, C-R] Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan; [Hsu, K-F] Natl Cheng Kung Univ, Dept Obstet & Gynecol, Tainan 70101, Taiwan; [Chang, K-C] Natl Cheng Kung Univ, Dept Pathol, Tainan 70101, Taiwan; [Charoenfuprasert, S.; Chen, Y-C; Chen, L-T; Chang, J-Y; Shih, N-Y] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Veterans General Hospital; Changhua Christian Hospital; Taipei Veterans General Hospital; National Cheng Kung University; National Cheng Kung University; National Health Research Institutes - Taiwan	Leu, SJ (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Microbiol & Immunol, Taipei 110, Taiwan.	cmbsycl@tmu.edu.tw; jshih@nhri.org.tw	Shih, Neng-Yao/D-2086-2010; Chen, Li-Tzong/D-2071-2010; Chang, Jang-Yang/D-2099-2010	Chu, Pei-Yi/0000-0001-7336-2465	National Health Research Institutes; Department of Health, Executive Yuan, Taiwan [DOH97-TD-G-111-022 (NYS)]; National Science Council of Taiwan [NSC 99-2320-B-400-011-MY3, NSC 96-2314-B-038-022, NSC 97-2314-B-038-004-MY3, NSC 96-2320-B-038-005/NSC 97-2320-B-038-012-MY2]	National Health Research Institutes(National Health Research Institutes, Japan); Department of Health, Executive Yuan, Taiwan; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was partially supported by the Intramural Research Grant of the National Health Research Institutes, the National Research Program for Genomic Medicine Grant from the Department of Health, Executive Yuan, Taiwan, DOH97-TD-G-111-022 (NYS), and by the National Science Council Grants of Taiwan, NSC 99-2320-B-400-011-MY3 (NYS), NSC 96-2314-B-038-022 (SJL), NSC 97-2314-B-038-004-MY3 (SJL), as well as NSC 96-2320-B-038-005/NSC 97-2320-B-038-012-MY2 (YYY). We are also grateful to Dr Nagase from the Kazusa DNA Research Institute for kindly providing the FJ10213 plasmid to facilitate the SIK3 study, and thank National Research Program for Genomic Medicine, Taiwan (National Clinical Core, NSC-95-3112-B-001-010 and National Genotyping Core, NSC-95-3112-B-001-011) for supply of interfering small hairpin RNA plasmids.	Ahmed AA, 2010, CANCER CELL, V18, P109, DOI 10.1016/j.ccr.2010.06.018; Amin N, 2009, P NATL ACAD SCI USA, V106, P8941, DOI 10.1073/pnas.0812469106; Baron AT, 2005, CANCER EPIDEM BIOMAR, V14, P306, DOI 10.1158/1055-9965.EPI-04-0423; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Brewer BG, 2009, EXP MOL PATHOL, V86, P192, DOI 10.1016/j.yexmp.2008.12.002; Bright NJ, 2009, ACTA PHYSIOL, V196, P15, DOI 10.1111/j.1748-1716.2009.01971.x; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chang GC, 2006, CLIN CANCER RES, V12, P5746, DOI 10.1158/1078-0432.CCR-06-0324; Cheng HL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000369; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Gagnon A, 2008, CLIN CANCER RES, V14, P764, DOI 10.1158/1078-0432.CCR-07-0856; GIANCOTTI FR, 1990, GYNECOL ONCOL, V37, P24, DOI 10.1016/0090-8258(90)90301-Z; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Katoh Y, 2004, MOL CELL ENDOCRINOL, V217, P109, DOI 10.1016/j.mce.2003.10.016; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Liu GZ, 2010, JNCI-J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Mizrachy-Schwartz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000628; O'Brien TJ, 2002, TUMOR BIOL, V23, P154, DOI 10.1159/000064032; Okamoto M, 2004, TRENDS ENDOCRIN MET, V15, P21, DOI 10.1016/j.tem.2003.11.002; Old Lloyd J, 2008, Cancer Immun, V8 Suppl 1, P1; Paciga M, 2003, J BIOL CHEM, V278, P49549, DOI 10.1074/jbc.M307302200; Reuschenbach M, 2009, CANCER IMMUNOL IMMUN, V58, P1535, DOI 10.1007/s00262-009-0733-4; Rosenthal AN, 2006, CLIN OBSTET GYNECOL, V49, P433, DOI 10.1097/00003081-200609000-00004; Ruda JM, 2006, INVEST NEW DRUG, V24, P377, DOI 10.1007/s10637-006-6271-4; Runnebaum IB, 2001, J CANCER RES CLIN, V127, P73, DOI 10.1007/s004320000153; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Serlachius M, 2002, BRIT J HAEMATOL, V119, P359, DOI 10.1046/j.1365-2141.2002.03916.x; Sjostrom M, 2007, P NATL ACAD SCI USA, V104, P16922, DOI 10.1073/pnas.0706838104; Taylor DD, 2009, GYNECOL ONCOL, V115, P112, DOI 10.1016/j.ygyno.2009.06.031	33	30	44	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2011	30	33					3570	3584		10.1038/onc.2011.77	http://dx.doi.org/10.1038/onc.2011.77			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	808UL	21399663	Bronze			2022-12-25	WOS:000294005100002
J	Dhawan, P; Ahmad, R; Chaturvedi, R; Smith, JJ; Midha, R; Mittal, MK; Krishnan, M; Chen, X; Eschrich, S; Yeatman, TJ; Harris, RC; Washington, MK; Wilson, KT; Beauchamp, RD; Singh, AB				Dhawan, P.; Ahmad, R.; Chaturvedi, R.; Smith, J. J.; Midha, R.; Mittal, M. K.; Krishnan, M.; Chen, X.; Eschrich, S.; Yeatman, T. J.; Harris, R. C.; Washington, M. K.; Wilson, K. T.; Beauchamp, R. D.; Singh, A. B.			Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation	ONCOGENE			English	Article						tight junction; claudin; EGFR; colon cancer; proliferation	INFLAMMATORY-BOWEL-DISEASE; EPITHELIAL TIGHT JUNCTIONS; EGF-RECEPTOR; TRANSEPITHELIAL RESISTANCE; DIFFERENTIAL EXPRESSION; JUXTACRINE ACTIVATION; ULCERATIVE-COLITIS; COLORECTAL-CANCER; TYROSINE KINASE; CROHNS-DISEASE	Claudin-2 is a unique member of the claudin family of transmembrane proteins, as its expression is restricted to the leaky epithelium in vivo and correlates with epithelial leakiness in vitro. However, recent evidence suggests potential functions of claudin-2 that are relevant to neoplastic transformation and growth. In accordance, here we report, on the basis of analysis of mRNA and protein expression using a total of 309 patient samples that claudin-2 expression is significantly increased in colorectal cancer and correlates with cancer progression. We also report similar increases in claudin-2 expression in inflammatory bowel disease-associated colorectal cancer. Most importantly, we demonstrate that the increased claudin-2 expression in colorectal cancer is causally associated with tumor growth as forced claudin-2 expression in colon cancer cells that do not express claudin-2 resulted in significant increases in cell proliferation, anchorage-independent growth and tumor growth in vivo. We further show that the colonic microenvironment regulates claudin-2 expression in a manner dependent on signaling through the EGF receptor (EGFR), a key regulator of colon tumorigenesis. In addition, claudin-2 expression is specifically decreased in the colon of waved-2 mice, naturally deficient in EGFR activation. Furthermore, genetic silencing of claudin-2 expression in Caco-2, a colon cancer cell line, prevents the EGF-induced increase in cell proliferation. Taken together, these results uncover a novel role for claudin-2 in promoting colon cancer, potentially via EGFR transactivation. Oncogene (2011) 30, 3234-3247; doi:10.1038/onc.2011.43; published online 7 March 2011	[Dhawan, P.; Ahmad, R.; Smith, J. J.; Midha, R.; Mittal, M. K.; Krishnan, M.; Beauchamp, R. D.; Singh, A. B.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA; [Dhawan, P.; Wilson, K. T.; Beauchamp, R. D.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA; [Chaturvedi, R.; Harris, R. C.; Wilson, K. T.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Chen, X.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA; [Eschrich, S.; Yeatman, T. J.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Washington, M. K.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Vanderbilt University	Singh, AB (corresponding author), Vanderbilt Univ, Med Ctr, Dept Surg, CCC-4513,1161 21st Ave S, Nashville, TN 37232 USA.	amar.singh@vanderbilt.edu	Eschrich, Steven/K-6848-2013; Smith, Jesse Joshua/AAN-5440-2020	Eschrich, Steven/0000-0002-9833-2788; Smith, Jesse Joshua/0000-0003-2538-5456; Beauchamp, Robert Daniel/0000-0002-8446-4114; Wilson, Keith/0000-0003-4421-1830; Mittal, Mukul/0000-0002-9795-7372	Pilot projects [5P50DK044757, P30DK058404]; NIH [CA119005, CA124977]; NATIONAL CANCER INSTITUTE [R01CA124977, R21CA119005] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, R01DK088902, P50DK044757] Funding Source: NIH RePORTER	Pilot projects; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by 5P50DK044757 and P30DK058404 Pilot projects (ABS) and by NIH grants CA119005, CA124977 (PD). We thank Dr Ambra Pozzi and Mingjian Shi for providing waved-2 mice and Dr Wael El-Rifai for providing 5-FU.	Amasheh M, 2009, SCAND J GASTROENTERO, V44, P1226, DOI 10.1080/00365520903131973; Angelow S, 2007, J MEMBRANE BIOL, V215, P147, DOI 10.1007/s00232-007-9014-3; ANSFIELD F, 1977, CANCER-AM CANCER SOC, V39, P34, DOI 10.1002/1097-0142(197701)39:1<34::AID-CNCR2820390107>3.0.CO;2-2; Bos M, 1997, CLIN CANCER RES, V3, P2099; Buchert M, 2010, P NATL ACAD SCI USA, V107, P2628, DOI 10.1073/pnas.0903747107; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Cereijido M, 2004, PHYSIOL REV, V84, P1229, DOI 10.1152/physrev.00001.2004; Cutler NS, 2003, CANCER RES, V63, P1748; D'Inca R, 1999, AM J GASTROENTEROL, V94, P2956, DOI 10.1111/j.1572-0241.1999.01444.x; Dahlhoff M, 2008, FEBS LETT, V582, P2911, DOI 10.1016/j.febslet.2008.07.026; DAVIES RJ, 1989, ARCH SURG-CHICAGO, V124, P480; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Escaffit F, 2005, J CELL PHYSIOL, V203, P15, DOI 10.1002/jcp.20189; Flores-Benitez D, 2007, AM J PHYSIOL-RENAL, V292, pF828, DOI 10.1152/ajprenal.00369.2006; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Guillemot L, 2006, MOL BIOL CELL, V17, P3569, DOI 10.1091/mbc.E06-02-0122; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Helmrath MA, 1998, J SURG RES, V77, P17, DOI 10.1006/jsre.1998.5362; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Kim EC, 1998, AM J PHYSIOL-CELL PH, V275, pC988, DOI 10.1152/ajpcell.1998.275.4.C988; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Kinugasa T, 2007, ANTICANCER RES, V27, P3729; Krishnan M, 2010, ONCOGENE, V29, P305, DOI 10.1038/onc.2009.324; Lal-Nag M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-235; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Mankertz J, 2004, BIOCHEM BIOPH RES CO, V314, P1001, DOI 10.1016/j.bbrc.2003.12.185; Mankertz J, 2009, CELL TISSUE RES, V336, P67, DOI 10.1007/s00441-009-0751-8; Mima S, 2008, CARCINOGENESIS, V29, P1994, DOI 10.1093/carcin/bgn134; MULLIN JM, 1992, J CELL PHYSIOL, V152, P35, DOI 10.1002/jcp.1041520106; MULLIN JM, 1986, AM J PHYSIOL, V251, pC597, DOI 10.1152/ajpcell.1986.251.4.C597; MULLIN JM, 1987, FEBS LETT, V221, P359, DOI 10.1016/0014-5793(87)80956-0; MULLIN JM, 2004, SCI STKE, pPE2, DOI DOI 10.1126/STKE.2162004PE2; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Peter Y, 2009, MOL CARCINOGEN, V48, P488, DOI 10.1002/mc.20485; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Rego RL, 2009, BRIT J CANCER, V102, P165; Reyes JL, 2002, KIDNEY INT, V62, P476, DOI 10.1046/j.1523-1755.2002.00479.x; Ridyard AE, 2007, J HISTOCHEM CYTOCHEM, V55, P1049, DOI 10.1369/jhc.7A7211.2007; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Sakaguchi T, 2002, J BIOL CHEM, V277, P21361, DOI 10.1074/jbc.M110261200; Shiou SR, 2007, CANCER RES, V67, P1571, DOI 10.1158/0008-5472.CAN-06-1680; Singh AB, 2004, J BIOL CHEM, V279, P3543, DOI 10.1074/jbc.M308682200; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; Singh AB, 2007, AM J PHYSIOL-CELL PH, V293, pC1660, DOI 10.1152/ajpcell.00274.2007; Singh AB, 2007, J BIOL CHEM, V282, P32890, DOI 10.1074/jbc.M702677200; Soler AP, 1999, CARCINOGENESIS, V20, P1425, DOI 10.1093/carcin/20.8.1425; Takehara M, 2009, BIOL PHARM BULL, V32, P825, DOI 10.1248/bpb.32.825; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; Yabana T, 2009, J PATHOL, V218, P350, DOI 10.1002/path.2535; Yamaoka T, 2008, P NATL ACAD SCI USA, V105, P11772, DOI 10.1073/pnas.0801463105; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zhu YT, 2003, CANCER RES, V63, P522	54	108	109	3	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2011	30	29					3234	3247		10.1038/onc.2011.43	http://dx.doi.org/10.1038/onc.2011.43			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	795VW	21383692	Green Accepted			2022-12-25	WOS:000293006800003
J	Law, A; Boulanger, MJ				Law, Adrienne; Boulanger, Martin J.			Defining a Structural and Kinetic Rationale for Paralogous Copies of Phenylacetate-CoA Ligases from the Cystic Fibrosis Pathogen Burkholderia cenocepacia J2315	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; AEROBIC METABOLISM; CATABOLIC PATHWAY; COENZYME; ENZYME; ACID; DLTA; PHENYLALANINE; ACTIVATION; BINDING	The phenylacetic acid (PAA) degradation pathway is the sole aerobic route for phenylacetic acid metabolism in bacteria and facilitates degradation of environmental pollutants such as styrene and ethylbenzene. The PAA pathway also is implicated in promoting Burkholderia cenocepacia infections in cystic fibrosis patients. Intriguingly, the first enzyme in the PAA pathway is present in two copies (paaK1 and paaK2), yet each subsequent enzyme is present in only a single copy. Furthermore, sequence divergence indicates that PaaK1 and PaaK2 form a unique subgroup within the adenylate-forming enzyme (AFE) superfamily. To establish a biochemical rationale for the existence of the PaaK paralogs in B. cenocepacia, we present high resolution x-ray crystal structures of a selenomethionine derivative of PaaK1 in complex with ATP and adenylated phenylacetate intermediate complexes of PaaK1 and PaaK2 in distinct conformations. Structural analysis reveals a novel N-terminal microdomain that may serve to recruit subsequent PAA enzymes, whereas a bifunctional role is proposed for the P-loop in stabilizing the C-terminal domain in conformation 2. The potential for different kinetic profiles was suggested by a structurally divergent extension of the aryl substrate pocket in PaaK1 relative to PaaK2. Functional characterization confirmed this prediction, with PaaK1 possessing a lower K-m for phenylacetic acid and better able to accommodate 3' and 4' substitutions on the phenyl ring. Collectively, these results offer detailed insight into the reaction mechanism of a novel subgroup of the AFE superfamily and provide a clear biochemical rationale for the presence of paralogous copies of PaaK of B. cenocepacia.	[Law, Adrienne; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	University of Victoria	Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	mboulang@uvic.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC Alexander Graham Bell Canada	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Alexander Graham Bell Canada	This work was supported by a research grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada (to M. J. B.).; Supported by an NSERC Alexander Graham Bell Canada Graduate Scholarship.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bains J, 2007, J MOL BIOL, V373, P965, DOI 10.1016/j.jmb.2007.08.008; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; CORKERY DM, 1994, FEMS MICROBIOL LETT, V124, P23, DOI 10.1111/j.1574-6968.1994.tb07256.x; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Du LQ, 2008, BIOCHEMISTRY-US, V47, P11473, DOI 10.1021/bi801363b; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erb TJ, 2008, CURR MICROBIOL, V57, P27, DOI 10.1007/s00284-008-9147-3; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gulick AM, 2004, BIOCHEMISTRY-US, V43, P8670, DOI 10.1021/bi049384m; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Hunt TA, 2004, INFECT IMMUN, V72, P4010, DOI 10.1128/IAI.72.7.4010-4022.2004; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Law RJ, 2008, J BACTERIOL, V190, P7209, DOI 10.1128/JB.00481-08; LESLIE AGW, 1991, RECENT CHANGES MOSFL; MARTINEZBLANCO H, 1990, J BIOL CHEM, V265, P7084; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Mohamed ME, 2000, J BACTERIOL, V182, P286, DOI 10.1128/JB.182.2.286-294.2000; Mohamed MES, 2002, ARCH MICROBIOL, V178, P180, DOI 10.1007/s00203-002-0438-y; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Osman KT, 2009, J MOL BIOL, V388, P345, DOI 10.1016/j.jmb.2009.03.040; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Velasco A, 1998, J BACTERIOL, V180, P1063, DOI 10.1128/JB.180.5.1063-1071.1998; Wu R, 2007, BIOCHEMISTRY-US, V46, P14487, DOI 10.1021/bi701609w; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Yoder-Himes DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008724; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200; ZIEGLER K, 1989, ARCH MICROBIOL, V151, P171, DOI 10.1007/BF00414434	36	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15577	15585		10.1074/jbc.M111.219683	http://dx.doi.org/10.1074/jbc.M111.219683			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388965	hybrid, Green Published			2022-12-25	WOS:000289788300085
J	Liu, JX; Hunter, CS; Du, AP; Ediger, B; Walp, E; Murray, J; Stein, R; May, CL				Liu, Jingxuan; Hunter, Chad S.; Du, Aiping; Ediger, Benjamin; Walp, Erik; Murray, Johanna; Stein, Roland; May, Catherine Lee			Islet-1 Regulates Arx Transcription during Pancreatic Islet alpha-Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPROVES GLUCOSE-TOLERANCE; BETA-CELL; ENDOCRINE PANCREAS; HOMEODOMAIN PROTEINS; GENE; GLUCAGON; LIM; DOMAIN; DIFFERENTIATION; INSULIN	Aristaless related homeodomain protein (Arx) specifies the formation of the pancreatic islet alpha-cell during development. This cell type produces glucagon, a major counteracting hormone to insulin in regulating glucose homeostasis in adults. However, little is known about the factors that regulate Arx transcription in the pancreas. In this study, we showed that the number of Arx(+) cells was significantly reduced in the pancreata of embryos deficient for the Islet-1 (Isl-1) transcription factor, which was also supported by the reduction in Arx mRNA levels. Chromatin immunoprecipitation analysis localized Isl-1 activator binding sites within two highly conserved noncoding regulatory regions (Re) in the Arx locus, termed Re1 (+5.6 to +6.1 kb) and Re2 (+23.6 to +24 kb). Using cell line-based transfection assays, we demonstrated that a Re1- and Re2-driven reporter was selectively activated in islet alpha-cells,a process mediated by Isl-1 in overexpression, knockdown, and site-directed mutation experiments. Moreover, Arx mRNA levels were upregulated in islet alpha-cells upon Isl-1 overexpression in vivo. Isl-1 represents the first known activator of Arx transcription in alpha-cells, here established to be acting through the conserved Re1 and Re2 control domains.	[Liu, Jingxuan; Du, Aiping; Ediger, Benjamin; Walp, Erik; Murray, Johanna; May, Catherine Lee] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [May, Catherine Lee] Univ Penn, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA; [May, Catherine Lee] Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Hunter, Chad S.; Stein, Roland] Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, Nashville, TN 37232 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Vanderbilt University	May, CL (corresponding author), 3615 Civ Ctr Blvd,Room 516E, Philadelphia, PA 19104 USA.	catheril@mail.med.upenn.edu		Hunter, Chad/0000-0002-1644-447X	National Institutes of Health [DK078606, F32DK083160, T32GM07229]; JDRF [2-2007-703]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK078606, P30DK019525, R56DK078606, F32DK083160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK078606 (to C. L. M. and R. S.), F32DK083160 (to C. S. H.), T32GM07229 (to B. E.), and JDRF 2-2007-703 (to C. L. M.).	Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Burcelin R, 1996, DIABETES METAB, V22, P373; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cobos I, 2005, J COMP NEUROL, V483, P292, DOI 10.1002/cne.20405; Colasante G, 2008, J NEUROSCI, V28, P10674, DOI 10.1523/JNEUROSCI.1283-08.2008; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; DOBBS R, 1975, SCIENCE, V187, P544, DOI 10.1126/science.1089999; Du AP, 2009, DIABETES, V58, P2059, DOI 10.2337/db08-0987; Gannon M, 2000, DEVELOPMENT, V127, P2883; GERICH JE, 1975, NEW ENGL J MED, V292, P985, DOI 10.1056/NEJM197505082921901; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; Hancock AS, 2010, MOL ENDOCRINOL, V24, P1605, DOI 10.1210/me.2010-0120; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Itoh M, 2010, DIFFERENTIATION, V80, P118, DOI 10.1016/j.diff.2010.05.003; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; LILJENQUIST JE, 1979, DIABETOLOGIA, V17, P139, DOI 10.1007/BF01219739; Matthews JM, 2003, EMBO REP, V4, P1132, DOI 10.1038/sj.embor.7400030; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; PICTET RL, 1972, DEV BIOL, V29, P436, DOI 10.1016/0012-1606(72)90083-8; RASKIN P, 1978, NEW ENGL J MED, V299, P433, DOI 10.1056/NEJM197808312990901; Sander M, 2000, DEVELOPMENT, V127, P5533; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Toft I, 2002, METABOLISM, V51, P1128, DOI 10.1053/meta.2002.34702; Tuteja G, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp536; UNGER RJ, 1971, DIABETES, V20, P834, DOI 10.2337/diab.20.12.834; WANG M, 1995, J BIOL CHEM, V270, P12646, DOI 10.1074/jbc.270.21.12584; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Yu X, 2008, P NATL ACAD SCI USA, V105, P14070, DOI 10.1073/pnas.0806993105	43	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15352	15360		10.1074/jbc.M111.231670	http://dx.doi.org/10.1074/jbc.M111.231670			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388963	Green Published, hybrid			2022-12-25	WOS:000289788300066
J	Matsumoto, K; Shima, F; Muraoka, S; Araki, M; Hu, LZ; Ijiri, Y; Hirai, R; Liao, JL; Yoshioka, T; Kumasaka, T; Yamamoto, M; Tamura, A; Kataoka, T				Matsumoto, Kousuke; Shima, Fumi; Muraoka, Shin; Araki, Mitsugu; Hu, Lizhi; Ijiri, Yuichi; Hirai, Rina; Liao, Jingling; Yoshioka, Takashi; Kumasaka, Takashi; Yamamoto, Masaki; Tamura, Atsuo; Kataoka, Tohru			Critical Roles of Interactions among Switch I-preceding Residues and between Switch II and Its Neighboring alpha-Helix in Conformational Dynamics of the GTP-bound Ras Family Small GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACTIVATING PROTEIN; STRUCTURAL BASIS; BINDING; P21(RAS); STATE	GTP-bound forms of Ras family small GTPases exhibit dynamic equilibrium between two interconverting conformations, "inactive" state 1 and "active" state 2. A great variation exists in their state distribution; H-Ras mainly adopts state 2, whereas M-Ras predominantly adopts state 1. Our previous studies based on comparison of crystal structures representing state 1 and state 2 revealed the importance of the hydrogen-bonding interactions of two flexible effector-interacting regions, switch I and switch II, with the gamma-phosphate of GTP in establishing state 2 conformation. However, failure to obtain both state structures from a single protein hampered further analysis of state transition mechanisms. Here, we succeed in solving two crystal structures corresponding to state 1 and state 2 from a single Ras polypeptide, M-RasD41E, carrying an H-Ras-type substitution in residue 41, immediately preceding switch I, in complex with guanosine 5'-(beta,gamma-imido)triphosphate. Comparison among the two structures and other state 1 and state 2 structures of H-Ras/M-Ras reveal two new structural features playing critical roles in state dynamics; interaction of residues 31/41 (H-Ras/M-Ras) with residues 29/39 and 30/40, which induces a conformational change of switch I favoring its interaction with the gamma-phosphate, and the hydrogen-bonding interaction of switch II with its neighboring alpha-helix, alpha 3-helix, which induces a conformational change of switch II favoring its interaction with the gamma-phosphate. The importance of the latter interaction is proved by mutational analyses of the residues involved in hydrogen bonding. These results define the two novel functional regions playing critical roles during state transition.	[Matsumoto, Kousuke; Shima, Fumi; Muraoka, Shin; Hu, Lizhi; Ijiri, Yuichi; Hirai, Rina; Liao, Jingling; Kataoka, Tohru] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Araki, Mitsugu; Yoshioka, Takashi; Tamura, Atsuo] Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan; [Kumasaka, Takashi] Japan Synchrotron Radiat Res Inst JASRI, Sayo, Hyogo 6795198, Japan; [Muraoka, Shin; Yamamoto, Masaki] RIKEN SPring 8 Ctr, Mikazuki, Hyogo 6795148, Japan	Kobe University; Kobe University; Japan Synchrotron Radiation Research Institute; RIKEN	Kataoka, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kataoka@people.kobe-u.ac.jp	Kumasaka, Takashi/D-7428-2018; Yamamoto, Masaki/B-7844-2015; Araki, Mitsugu/C-7470-2016	Kumasaka, Takashi/0000-0001-9289-1557; Yamamoto, Masaki/0000-0002-1311-1768; Tamura, Atsuo/0000-0001-8238-8851	Ministry of Education, Science, Sports and Culture of Japan [17014061, 18057014, A08]; National Institute of Biomedical Innovation; Grants-in-Aid for Scientific Research [23390071] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research in Priority Areas 17014061 and 18057014, and Global COE Program A08 from the Ministry of Education, Science, Sports and Culture of Japan, and by a grant from the Program for Promotion of Fundamental Studies of Health Sciences 06-3 from the National Institute of Biomedical Innovation.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Corbett KD, 2001, TRENDS BIOCHEM SCI, V26, P710, DOI 10.1016/S0968-0004(01)01974-0; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fenwick RB, 2009, BIOCHEMISTRY-US, V48, P2192, DOI 10.1021/bi802129d; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; Ford B, 2009, BIOCHEMISTRY-US, V48, P11449, DOI 10.1021/bi901479b; Geyer M, 1997, NAT STRUCT BIOL, V4, P694, DOI 10.1038/nsb0997-694; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EACBM, V26; Liao JL, 2008, BIOCHEM BIOPH RES CO, V369, P327, DOI 10.1016/j.bbrc.2008.01.169; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nicely NI, 2004, STRUCTURE, V12, P2025, DOI 10.1016/j.str.2004.08.011; O'Connor C, 2008, BIOCHEMISTRY-US, V47, P10244, DOI 10.1021/bi801076c; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Quilliam LA, 1999, J BIOL CHEM, V274, P23850, DOI 10.1074/jbc.274.34.23850; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Scheidig AJ, 1999, STRUCTURE, V7, P1311, DOI 10.1016/S0969-2126(00)80021-0; Shima F, 2010, J BIOL CHEM, V285, P22696, DOI 10.1074/jbc.M110.125161; Spoerner M, 2004, FEBS LETT, V578, P305, DOI 10.1016/j.febslet.2004.11.020; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2007, FEBS J, V274, P1419, DOI 10.1111/j.1742-4658.2007.05681.x; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Ye M, 2005, J BIOL CHEM, V280, P31267, DOI 10.1074/jbc.M505503200	32	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15403	15412		10.1074/jbc.M110.204933	http://dx.doi.org/10.1074/jbc.M110.204933			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388959	Green Published, hybrid			2022-12-25	WOS:000289788300070
J	Hidaka, S; Teramoto, W; Sugita, Y; Manaka, Y; Sakamoto, S; Suzuki, Y				Hidaka, Souta; Teramoto, Wataru; Sugita, Yoichi; Manaka, Yuko; Sakamoto, Shuichi; Suzuki, Yoiti			Auditory Motion Information Drives Visual Motion Perception	PLOS ONE			English	Article							SENSORY MODALITIES; SOUND; VENTRILOQUIST; INTEGRATION; DIRECTION; CAPTURE; VISION	Background: Vision provides the most salient information with regard to the stimulus motion. However, it has recently been demonstrated that static visual stimuli are perceived as moving laterally by alternating left-right sound sources. The underlying mechanism of this phenomenon remains unclear; it has not yet been determined whether auditory motion signals, rather than auditory positional signals, can directly contribute to visual motion perception. Methodology/Principal Findings: Static visual flashes were presented at retinal locations outside the fovea together with a lateral auditory motion provided by a virtual stereo noise source smoothly shifting in the horizontal plane. The flash appeared to move by means of the auditory motion when the spatiotemporal position of the flashes was in the middle of the auditory motion trajectory. Furthermore, the lateral auditory motion altered visual motion perception in a global motion display where different localized motion signals of multiple visual stimuli were combined to produce a coherent visual motion perception. Conclusions/Significance: These findings suggest there exist direct interactions between auditory and visual motion signals, and that there might be common neural substrates for auditory and visual motion processing.	[Hidaka, Souta] Rikkyo Univ, Dept Psychol, Niiza, Saitama, Japan; [Hidaka, Souta; Teramoto, Wataru] Tohoku Univ, Dept Psychol, Grad Sch Arts & Letters, Sendai, Miyagi 980, Japan; [Teramoto, Wataru; Sakamoto, Shuichi; Suzuki, Yoiti] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 980, Japan; [Sugita, Yoichi] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki, Japan; [Manaka, Yuko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Tokyo, Japan	Rikkyo University; Tohoku University; Tohoku University; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Hidaka, S (corresponding author), Rikkyo Univ, Dept Psychol, Niiza, Saitama, Japan.	hidaka@rikkyo.ac.jp	Suzuki, Yoiti/AAC-3765-2019; Hidaka, Souta/L-6393-2019	Hidaka, Souta/0000-0001-6727-5322	Ministry of Education, Science, and Culture, Japan [19001004]	Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Specially Promoted Research (19001004) of the Ministry of Education, Science, and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alais D, 2004, COGNITIVE BRAIN RES, V19, P185, DOI 10.1016/j.cogbrainres.2003.11.011; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRIGGS RM, 1972, J EXP PSYCHOL, V92, P83, DOI 10.1037/h0032148; Calvert G., 2004, HDB MULTISENSORY PRO; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Freeman E, 2008, CURR BIOL, V18, P1262, DOI 10.1016/j.cub.2008.07.066; Hidaka S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008188; Kitagawa N, 2002, NATURE, V416, P172, DOI 10.1038/416172a; Macmillan N. A., 2004, DETECTION THEORY USE; Meyer GF, 2001, NEUROREPORT, V12, P2557, DOI 10.1097/00001756-200108080-00053; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RADEAU M, 1987, PSYCHOL RES-PSYCH FO, V49, P17, DOI 10.1007/BF00309198; RAMACHANDRAN VS, 1987, NATURE, V328, P645, DOI 10.1038/328645a0; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; Sanabria D, 2007, EXP BRAIN RES, V178, P415, DOI 10.1007/s00221-007-0919-y; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Soto-Faraco S, 2004, J EXP PSYCHOL HUMAN, V30, P330, DOI 10.1037/0096-1523.30.2.330; Soto-Faraco S, 2004, CURR DIR PSYCHOL SCI, V13, P29, DOI 10.1111/j.0963-7214.2004.01301008.x; Soto-Faraco S, 2003, NEUROPSYCHOLOGIA, V41, P1847, DOI 10.1016/S0028-3932(03)00185-4; Soto-Faraco S, 2002, COGNITIVE BRAIN RES, V14, P139, DOI 10.1016/S0926-6410(02)00068-X; Teramoto W, 2010, NEUROSCI LETT, V479, P221, DOI 10.1016/j.neulet.2010.05.065; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319; Welch R.B, 1986, HDB PERCEPTION HUMAN, V1; WILLIAMS DW, 1984, VISION RES, V24, P55, DOI 10.1016/0042-6989(84)90144-5	26	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17499	10.1371/journal.pone.0017499	http://dx.doi.org/10.1371/journal.pone.0017499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FR	21408078	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170900022
J	Silveira, CB; Vieira, RP; Cardoso, AM; Paranhos, R; Albano, RM; Martins, OB				Silveira, Cynthia B.; Vieira, Ricardo P.; Cardoso, Alexander M.; Paranhos, Rodolfo; Albano, Rodolpho M.; Martins, Orlando B.			Influence of Salinity on Bacterioplankton Communities from the Brazilian Rain Forest to the Coastal Atlantic Ocean	PLOS ONE			English	Article							BACTERIAL DIVERSITY; MICROBIAL ECOLOGY; GUANABARA BAY; MARINE; FRESH; BIOGEOCHEMISTRY; ENVIRONMENT; LINEAGES; ARCHAEAL; REVEAL	Background: Planktonic bacteria are recognized as important drivers of biogeochemical processes in all aquatic ecosystems, however, the taxa that make up these communities are poorly known. The aim of this study was to investigate bacterial communities in aquatic ecosystems at IIha Grande, Rio de Janeiro, Brazil, a preserved insular environment of the Atlantic rain forest and how they correlate with a salinity gradient going from terrestrial aquatic habitats to the coastal Atlantic Ocean. Methodology/Principal Findings: We analyzed chemical and microbiological parameters of water samples and constructed 16S rRNA gene libraries of free living bacteria obtained at three marine (two coastal and one offshore) and three freshwater (water spring, river, and mangrove) environments. A total of 836 sequences were analyzed by MOTHUR, yielding 269 freshwater and 219 marine operational taxonomic units (OTUs) grouped at 97% stringency. Richness and diversity indexes indicated that freshwater environments were the most diverse, especially the water spring. The main bacterial group in freshwater environments was Betaproteobacteria (43.5%), whereas Cyanobacteria (30.5%), Alphaproteobacteria (25.5%), and Gammaproteobacteria (26.3%) dominated the marine ones. Venn diagram showed no overlap between marine and freshwater OTUs at 97% stringency. LIBSHUFF statistics and PCA analysis revealed marked differences between the freshwater and marine libraries suggesting the importance of salinity as a driver of community composition in this habitat. The phylogenetic analysis of marine and freshwater libraries showed that the differences in community composition are consistent. Conclusions/Significance: Our data supports the notion that a divergent evolutionary scenario is driving community composition in the studied habitats. This work also improves the comprehension of microbial community dynamics in tropical waters and how they are structured in relation to physicochemical parameters. Furthermore, this paper reveals for the first time the pristine bacterioplankton communities in a tropical island at the South Atlantic Ocean.	[Silveira, Cynthia B.; Vieira, Ricardo P.; Martins, Orlando B.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Paranhos, Rodolfo] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Cardoso, Alexander M.] Inst Nacl Metrol Normalizacao & Qualidade Ind, Rio De Janeiro, Brazil; [Albano, Rodolpho M.] Univ Estado Rio de Janeiro, Dept Bioquim, BR-20550011 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade do Estado do Rio de Janeiro	Silveira, CB (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.	amcardoso@bioqmed.ufrj.br	Paranhos, Rodolfo/F-1927-2011; Cardoso, Alexander/S-6687-2017; Cardoso, Alexander/AAX-2505-2021; Silveira, Cynthia/D-6829-2013	Cardoso, Alexander/0000-0003-2974-0232; Albano, Rodolpho/0000-0002-0643-901X; Silveira, Cynthia/0000-0002-9533-5588	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida WI, 2009, EXTREMOPHILES, V13, P263, DOI 10.1007/s00792-008-0214-2; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrade L, 2003, J MICROBIOL METH, V55, P841, DOI 10.1016/j.mimet.2003.08.002; Baltazar LD, 2008, REV SOC BRAS MED TRO, V41, P449; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Carlson CA, 2004, LIMNOL OCEANOGR, V49, P1073, DOI 10.4319/lo.2004.49.4.1073; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carvalho FRS, 2007, CURR MICROBIOL, V55, P288, DOI 10.1007/s00284-006-0589-1; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Cottrell MT, 2005, ENVIRON MICROBIOL, V7, P1883, DOI 10.1111/j.1462-2920.2005.00762.x; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; Crump BC, 2004, APPL ENVIRON MICROB, V70, P1494, DOI 10.1128/AEM.70.3.1494-1505.2004; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fuhrman JA, 2002, ANTON LEEUW INT J G, V81, P521, DOI 10.1023/A:1020513506777; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Giovannoni SJ, 1995, NATO ADV SCI INST SE, V38, P217; GIOVANNONI SJ, 2000, MICROBIAL ECOLOGY OC, P47; Gonzalez AM, 2000, BRAZ ARCH BIOL TECHN, V43, P493, DOI 10.1590/S1516-89132000000500008; GONZALEZ JM, 1990, APPL ENVIRON MICROB, V56, P583, DOI 10.1128/AEM.56.3.583-589.1990; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd, P600, DOI DOI 10.1002/9783527613984; Hahn MW, 2006, CURR OPIN BIOTECH, V17, P256, DOI 10.1016/j.copbio.2006.05.006; HOBBIE JE, 1988, LIMNOL OCEANOGR, V33, P750, DOI 10.4319/lo.1988.33.4_part_2.0750; Hooper SD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002607; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Jickells TD, 1998, SCIENCE, V281, P217, DOI 10.1126/science.281.5374.217; Kan JJ, 2006, LIMNOL OCEANOGR, V51, P2157, DOI 10.4319/lo.2006.51.5.2157; Karl DM, 2002, NATURE, V415, P590, DOI 10.1038/415590b; KIRCHMAN D, 1985, APPL ENVIRON MICROB, V49, P599, DOI 10.1128/AEM.49.3.599-607.1985; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lambais MR, 2006, SCIENCE, V312, P1917, DOI 10.1126/science.1124696; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Lima-Bittencourt CI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-58; Logares R, 2010, MOL BIOL EVOL, V27, P347, DOI 10.1093/molbev/msp239; Logares R, 2009, TRENDS MICROBIOL, V17, P414, DOI 10.1016/j.tim.2009.05.010; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; MARENGO JA, 2001, ACAO AMBIENTAL, V4, P10; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Methe BA, 1998, LIMNOL OCEANOGR, V43, P368, DOI 10.4319/lo.1998.43.2.0368; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x; MULLINS TD, 1995, LIMNOL OCEANOGR, V40, P148, DOI 10.4319/lo.1995.40.1.0148; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; PACE NR, 1986, ADV MICROB ECOL, V9, P1; Parsons T. R., 1984, MANUAL CHEM BIOL MET, DOI [10.1016/B978-0-08-030287-4.50004-9, DOI 10.1016/C2009-0-07774-5]; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; RIEMANN L, 2006, APPL ENVIRON MICROB, V74, P503; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2004, APPL ENVIRON MICROB, V70, P5485, DOI 10.1128/AEM.70.9.5485-5492.2004; Sigee DC, 2005, FRESHWATER MICROBIOL, P287; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Smith MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013312; Souchie EL, 2006, AN ACAD BRAS CIENC, V78, P183, DOI 10.1590/S0001-37652006000100016; Strom SL, 2008, SCIENCE, V320, P1043, DOI 10.1126/science.1153527; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Urbach E, 2001, LIMNOL OCEANOGR, V46, P557, DOI 10.4319/lo.2001.46.3.0557; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vieira RP, 2008, ENVIRON MICROBIOL, V10, P189, DOI 10.1111/j.1462-2920.2007.01443.x; Vieira RP, 2007, MICROB ECOL, V54, P460, DOI 10.1007/s00248-007-9261-y; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; YILMAZ P, 2010, NATURE P, DOI DOI 10.1038/NPRE.2010.5252.1	64	28	28	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17789	10.1371/journal.pone.0017789	http://dx.doi.org/10.1371/journal.pone.0017789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408023	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170900048
J	Dupont, E; Stevens, L; Cochon, L; Falempin, M; Bastide, B; Canu, MH				Dupont, Erwan; Stevens, Laurence; Cochon, Laetitia; Falempin, Maurice; Bastide, Bruno; Canu, Marie-Helene			ERK Is Involved in the Reorganization of Somatosensory Cortical Maps in Adult Rats Submitted to Hindlimb Unloading	PLOS ONE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; HYPODYNAMIA-HYPOKINESIA; SYNAPTIC PLASTICITY; BARREL CORTEX; PROTEIN; KINASE; ACTIVATION; SUSPENSION; CASCADE; SYSTEM	Sensorimotor restriction by a 14-day period of hindlimb unloading (HU) in the adult rat induces a reorganization of topographic maps and receptive fields. However, the underlying mechanisms are still unclear. Interest was turned towards a possible implication of intracellular MAPK signaling pathway since Extracellular-signal-Regulated Kinase 1/2 (ERK1/2) is known to play a significant role in the control of synaptic plasticity. In order to better understand the mechanisms underlying cortical plasticity in adult rats submitted to a sensorimotor restriction, we analyzed the time-course of ERK1/2 activation by immunoblot and of cortical reorganization by electrophysiological recordings, on rats submitted to hindlimb unloading over four weeks. Immunohistochemistry analysis provided evidence that ERK1/2 phosphorylation was increased in layer III neurons of the somatosensory cortex. This increase was transient, and parallel to the changes in hindpaw cortical map area (layer IV). By contrast, receptive fields were progressively enlarged from 7 to 28 days of hindlimb unloading. To determine whether ERK1/2 was involved in cortical remapping, we administered a specific ERK1/2 inhibitor (PD-98059) through osmotic mini-pump in rats hindlimb unloaded for 14 days. Results demonstrate that focal inhibition of ERK1/2 pathway prevents cortical reorganization, but had no effect on receptive fields. These results suggest that ERK1/2 plays a role in the induction of cortical plasticity during hindlimb unloading.	[Dupont, Erwan; Stevens, Laurence; Cochon, Laetitia; Falempin, Maurice; Bastide, Bruno; Canu, Marie-Helene] Univ Lille Nord France, Lille, France; [Dupont, Erwan; Stevens, Laurence; Cochon, Laetitia; Falempin, Maurice; Bastide, Bruno; Canu, Marie-Helene] Univ Lille 1, IFR 114, EA 4488, F-59655 Villeneuve Dascq, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Dupont, E (corresponding author), Univ Lille Nord France, Lille, France.	erwan.dupont@univ-lille1.fr	CANU, Marie-Hélène/AAW-7356-2020	Bastide, bruno/0000-0002-7544-463X; CANU, Marie-Helene/0000-0003-4035-9619; Dupont, Erwan/0000-0003-0777-9734	Centre National d'Etudes Spatiales [8941]; Fonds Europeen de Developpement Regional [0066019F]; Nord-Pas de Calais regional council [06-1912]	Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales); Fonds Europeen de Developpement Regional; Nord-Pas de Calais regional council(Region Hauts-de-France)	This study was supported by the Centre National d'Etudes Spatiales (Grant 8941), by the Fonds Europeen de Developpement Regional (Grant 0066019F), and by the Nord-Pas de Calais regional council (Grant 06-1912). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ALFORD EK, 1987, EXP NEUROL, V96, P635, DOI 10.1016/0014-4886(87)90225-1; Boggio EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000604; Canu MH, 2007, EXP NEUROL, V203, P521, DOI 10.1016/j.expneurol.2006.09.005; Canu MH, 2006, EXP BRAIN RES, V173, P623, DOI 10.1007/s00221-006-0401-2; Canu MH, 2003, BRAIN RES, V978, P162, DOI 10.1016/S0006-8993(03)02804-X; DAmelio F, 1996, J NEUROSCI RES, V44, P532; De-Doncker L, 2005, J EXP BIOL, V208, P4585, DOI 10.1242/jeb.01931; Derkinderen P, 1999, NEUROREPORT, V10, pR24; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Diamond ME, 1999, J NEUROBIOL, V41, P64, DOI 10.1002/(SICI)1097-4695(199910)41:1<64::AID-NEU9>3.0.CO;2-N; Dupont E, 2005, MOL BRAIN RES, V133, P78, DOI 10.1016/j.molbrainres.2004.09.019; Dupont E, 2002, BRAIN RES, V926, P51, DOI 10.1016/S0006-8993(01)03293-0; Dupont E, 2001, NEUROSCI LETT, V309, P121, DOI 10.1016/S0304-3940(01)02050-X; DUPONT E, 2011, AM J PHYSL IN PRESS; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Huang W, 1998, J NEUROPHYSIOL, V80, P3261, DOI 10.1152/jn.1998.80.6.3261; Kawano F, 2004, AM J PHYSIOL-REG I, V287, pR76, DOI 10.1152/ajpregu.00694.2003; Kennedy PM, 2002, J PHYSIOL-LONDON, V538, P995, DOI 10.1113/jphysiol.2001.013087; Kondoh K, 2005, CHROMOSOMA, V114, P86, DOI 10.1007/s00412-005-0341-9; Langlet C, 1999, NEUROSCI LETT, V266, P145, DOI 10.1016/S0304-3940(99)00296-7; Langlet C, 2001, BRAIN RES, V905, P72, DOI 10.1016/S0006-8993(01)02507-0; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; Molina-Luna K, 2008, NEUROIMAGE, V40, P1748, DOI 10.1016/j.neuroimage.2007.11.018; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Rasmusson DD, 2000, BEHAV BRAIN RES, V115, P205, DOI 10.1016/S0166-4328(00)00259-X; Ratto GM, 2006, ADV EXP MED BIOL, V557, P122; Rosenblum K, 2000, J NEUROSCI, V20, P977, DOI 10.1523/JNEUROSCI.20-03-00977.2000; Rosselet C, 2006, J NEUROSCI, V26, P10667, DOI 10.1523/JNEUROSCI.3253-06.2006; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; STRATTON KR, 1989, P NATL ACAD SCI USA, V86, P2498, DOI 10.1073/pnas.86.7.2498; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Van der Zee EA, 1999, PROG NEUROBIOL, V58, P409, DOI 10.1016/S0301-0082(98)00092-6; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Xerri C, 2008, BEHAV BRAIN RES, V192, P26, DOI 10.1016/j.bbr.2008.02.038	41	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17564	10.1371/journal.pone.0017564	http://dx.doi.org/10.1371/journal.pone.0017564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408155	Green Submitted, Green Published, gold			2022-12-25	WOS:000288170000038
J	Malaviya, P; Picado, A; Singh, P; Hasker, E; Singh, RP; Boelaert, M; Sundar, S				Malaviya, Paritosh; Picado, Albert; Singh, Shri Prakash; Hasker, Epco; Singh, Rudra Pratap; Boelaert, Marleen; Sundar, Shyam			Visceral Leishmaniasis in Muzaffarpur District, Bihar, India from 1990 to 2008	PLOS ONE			English	Article							PHLEBOTOMUS-ARGENTIPES DIPTERA; KALA-AZAR; PSYCHODIDAE; ELIMINATION	Background: Visceral Leishmaniasis (VL) is a vector-borne disease transmitted by Phlebotomus argentipes. To understand the VL seasonality, annual and monthly variations of VL incidence and its relationship to meteorological variables, the numbers of VL cases reported in Muzaffarpur district, Bihar, India from 1990 to 2008 were studied. Methods: Annual VL incidence per 10,000 and the total number of annual VL cases reported at block Community Health Centres (CHC), Public Hospitals or Non-Governmental Organisations (NGO) and the number of VL cases per month from 2000 to 2008 as well as the monthly average of cases for 2000-08, 2000-04 and 2005-08 periods along with the monthly averages of temperature, rainfall and relative humidity were plotted. VL Standardised Incidence Ratios per block were computed for the periods of 1990-1993, 1994-1998, 1999-2004 and 2005-2008 and month wise from 2002 to 2008. A negative binomial regression model was used to evaluate the association between meteorological variables and the number of VL cases per month from 2000 to 2008. Results: A total of 68,358 VL cases were reported in Muzaffarpur district from 1990 to 2008, ranging from 1,2481 in 1992 to 1,161 in 2001. The blocks with the highest number of cases shifted from East (1990-98) to West (1999-2008). Monthly averages of cases ranged from 149 to 309, highest peak in March-April and another one in July. Monthly VL incidence was associated positively to rainfall and negatively to relative humidity and the numbers of VL cases in the previous month. Interpretation: The number of cases reported to the public health sector allowed the describing of the spatial distribution and temporal variations in the Muzaffarpur from 1990 to 2008. However, to assess the actual VL burden, as well as the efficacy of the control measures applied in the district, reporting from private practices and NGOs should be encouraged.	[Malaviya, Paritosh; Singh, Shri Prakash; Singh, Rudra Pratap; Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Picado, Albert; Hasker, Epco; Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium	Banaras Hindu University (BHU); Institute of Tropical Medicine (ITM)	Malaviya, P (corresponding author), Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India.	drshyamsundar@hotmail.com	Singh, Priyanka/N-1372-2018; Singh, Priyanka/GRF-6098-2022; Malaviya, Paritosh/B-1819-2012; Boelaert, Marleen/E-2698-2012	Singh, Priyanka/0000-0003-0841-1544; Malaviya, Paritosh/0000-0002-7558-152X; Boelaert, Marleen/0000-0001-8051-6776; Picado, Albert/0000-0001-7344-628X	National Institute of Allergic and Infectious Diseases, National Institutes of Health, TMRC [1P50AI074321]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI074321] Funding Source: NIH RePORTER	National Institute of Allergic and Infectious Diseases, National Institutes of Health, TMRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergic and Infectious Diseases, National Institutes of Health, TMRC Grant No. 1P50AI074321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya SK, 2006, INDIAN J MED RES, V123, P195; Bhunia GS, 2010, ANN TROP MED PARASIT, V104, P35, DOI 10.1179/136485910X12607012373678; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dinesh DS, 2001, ANN TROP MED PARASIT, V95, P197, DOI 10.1080/00034980120041071; Dohoo I.R., 2003, VET EPIDEMIOLOGIC RE; Ghosh K, 1999, J MED ENTOMOL, V36, P588, DOI 10.1093/jmedent/36.5.588; Haghdoost AA, 2008, TROP MED INT HEALTH, V13, P1501, DOI 10.1111/j.1365-3156.2008.02166.x; Hasker E, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02562.x; Joshi A., 2008, Journal of Vector Borne Diseases, V45, P105; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; OSTYN B, 2008, TROP MED INT HLTH; Picado A, 2010, J MED ENTOMOL, V47, P283, DOI 10.1603/ME09175; *PROGR NVBDG, KAL CONTR EFF IND; Singh A, 2008, J ECOPHYSIOLOGY OCCU, V8; Singh NS, 2009, SE ASIAN J TROP MED, V40, P458; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh VP, 2010, AM J TROP MED HYG, V82, P9, DOI 10.4269/ajtmh.2010.09-0235; Thakur CP, 2007, INDIAN J MED RES, V126, P447; 2010, KALAAZAR FREQUENTLY; PERCENTAGE DECADAL V	20	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e14751	10.1371/journal.pone.0014751	http://dx.doi.org/10.1371/journal.pone.0014751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394195	Green Submitted, gold, Green Published			2022-12-25	WOS:000288025500003
J	Pavli, OI; Kelaidi, GI; Tampakaki, AP; Skaracis, GN				Pavli, Ourania I.; Kelaidi, Georgia I.; Tampakaki, Anastasia P.; Skaracis, George N.			The hrpZ Gene of Pseudomonas syringae pv. phaseolicola Enhances Resistance to Rhizomania Disease in Transgenic Nicotiana benthamiana and Sugar Beet	PLOS ONE			English	Article							YELLOW-VEIN-VIRUS; SYSTEMIC ACQUIRED-RESISTANCE; HYPERSENSITIVE CELL-DEATH; BNYVV COAT PROTEIN; ERWINIA-AMYLOVORA; BIOCONTROL BACTERIUM; MEDIATED RESISTANCE; SALICYLIC-ACID; III EFFECTOR; HARPIN	To explore possible sources of transgenic resistance to the rhizomania-causing Beet necrotic yellow vein virus ( BNYVV), Nicotiana benthamiana plants were constructed to express the harpin of Pseudomonas syringae pv. phaseolicola (HrpZ(Psph)). The HrpZ protein was expressed as an N-terminal fusion to the PR1 signal peptide (SP/HrpZ) to direct harpin accumulation to the plant apoplast. Transgene integration was verified by mPCR in all primary transformants (T0), while immunoblot analysis confirmed that the protein HrpZPsph was produced and the signal peptide was properly processed. Neither T0 plants nor selfed progeny (T1) showed macroscopically visible necrosis or any other macroscopic phenotypes. However, plants expressing the SP/HrpZPsph showed increased vigor and grew faster in comparison with non-transgenic control plants. Transgenic resistance was assessed after challenge inoculation with BNYVV on T1 progeny by scoring of disease symptoms and by DAS-ELISA at 20 and 30 dpi. Transgenic and control lines showed significant differences in terms of the number of plants that became infected, the timing of infection and the disease symptoms displayed. Plants expressing the SP/HrpZPsph developed localized leaf necrosis in the infection area and had enhanced resistance upon challenge with BNYVV. In order to evaluate the SP/HrpZ-based resistance in the sugar beet host, A. rhizogenes-mediated root transformation was exploited as a transgene expression platform. Upon BNYVV inoculation, transgenic sugar beet hairy roots showed high level of BNYVV resistance. In contrast, the aerial non-transgenic parts of the same seedlings had virus titers that were comparable to those of the seedlings that were untransformed or transformed with wild type R1000 cells. These findings indicate that the transgenically expressed SP/HrpZ protein results in enhanced rhizomania resistance both in a model plant and sugar beet, the natural host of BNYVV. Possible molecular mechanisms underlying the enhanced resistance and plant growth phenotypes observed in SP/HrpZ transgenic plants are discussed.	[Pavli, Ourania I.; Kelaidi, Georgia I.; Skaracis, George N.] Univ Agr, Dept Crop Sci, Athens, Greece; [Tampakaki, Anastasia P.] Univ Agr, Dept Agr Biotechnol, Athens, Greece	Agricultural University of Athens; Agricultural University of Athens	Pavli, OI (corresponding author), Univ Agr, Dept Crop Sci, Athens, Greece.	tampakaki@aua.gr	Tampakaki, Anastasia/ABF-8966-2021	Tampakaki, Anastasia/0000-0003-4439-0920; Pavli, Ourania/0000-0002-5276-2184	Laboratory of Plant Breeding and Biometry of the Agricultural University of Athens	Laboratory of Plant Breeding and Biometry of the Agricultural University of Athens	The work was supported by the Laboratory of Plant Breeding and Biometry of the Agricultural University of Athens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Leal R, 2008, VIROLOGY, V376, P60, DOI 10.1016/j.virol.2008.03.008; Ahmad M, 2001, MOL PLANT MICROBE IN, V14, P1223, DOI 10.1094/MPMI.2001.14.10.1223; Andika IB, 2005, MOL PLANT MICROBE IN, V18, P194, DOI 10.1094/MPMI-18-0194; ARLAT M, 1994, EMBO J, V13, P543, DOI 10.1002/j.1460-2075.1994.tb06292.x; Biancardi E, 2002, EUPHYTICA, V127, P383, DOI 10.1023/A:1020310718166; BleykastenGrosshans C, 1997, MOL PLANT MICROBE IN, V10, P240, DOI 10.1094/MPMI.1997.10.2.240; Bocsanczy AM, 2008, MOL PLANT PATHOL, V9, P425, DOI 10.1111/J.1364-3703.2008.00471.X; Charkowski AO, 1998, J BACTERIOL, V180, P5211, DOI 10.1128/JB.180.19.5211-5217.1998; Chen L, 2008, PHYTOPATHOLOGY, V98, P792, DOI 10.1094/PHYTO-98-7-0792; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Dong HP, 2004, PLANT PHYSIOL, V136, P3628, DOI 10.1104/pp.104.048900; Dong HP, 2005, PLANTA, V221, P313, DOI 10.1007/s00425-004-1444-x; Dong HS, 1999, PLANT J, V20, P207, DOI 10.1046/j.1365-313x.1999.00595.x; *EFSA, 2008, SCI OP PAN GUID RISK; Engelhardt S, 2009, PLANT J, V57, P706, DOI 10.1111/j.1365-313X.2008.03723.x; Fecker LF, 1997, ARCH VIROL, V142, P1857, DOI 10.1007/s007050050203; Gaudriault S, 1998, FEBS LETT, V428, P224, DOI 10.1016/S0014-5793(98)00534-1; Gopalan S, 1996, PLANT J, V10, P591, DOI 10.1046/j.1365-313X.1996.10040591.x; HE SY, 1993, CELL, V73, P1255, DOI 10.1016/0092-8674(93)90354-S; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hoyos ME, 1996, MOL PLANT MICROBE IN, V9, P608, DOI 10.1094/MPMI-9-0608; Huo R, 2010, TRANSGENIC RES, V19, P841, DOI 10.1007/s11248-010-9365-x; Jang YS, 2006, PLANTA, V223, P449, DOI 10.1007/s00425-005-0100-4; Johansson E., 1985, Sveriges Utsadesforenings Tidskrift, V95, P115; *JRC, 2006, JRC TECHN REP SER; Kim JF, 2000, FIRE BLIGHT, P141, DOI 10.1079/9780851992945.0141; Kim JF, 1998, J BACTERIOL, V180, P5203, DOI 10.1128/JB.180.19.5203-5210.1998; Kim JG, 2004, J BACTERIOL, V186, P6239, DOI 10.1128/JB.186.18.6239-6247.2004; Kim JG, 2003, J BACTERIOL, V185, P3155, DOI 10.1128/JB.185.10.3155-3166.2003; Kvitko BH, 2007, J BACTERIOL, V189, P8059, DOI 10.1128/JB.01146-07; Lee J, 2001, P NATL ACAD SCI USA, V98, P289, DOI 10.1073/pnas.011265298; Lennefors BL, 2006, MOL BREEDING, V18, P313, DOI 10.1007/s11032-006-9030-5; LEWELLEN RT, 1988, P 5 INT C PLANT PATH; Lewer R. P., 1987, Proceedings of the the Sixth Conference, Australian Association of Animal Breeding and Genetics, University of Western Australia, Perth, WA, Australia, 9-11 February 1987., P139; Li JG, 2010, MOL PLANT PATHOL, V11, P371, DOI [10.1111/j.1364-3703.2010.00610.x, 10.1111/J.1364-3703.2010.00610.X]; Mannerlof M, 1996, EUPHYTICA, V90, P293, DOI 10.1007/BF00027479; Miao WG, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-67; Oh CS, 2007, PLANT PHYSIOL, V145, P426, DOI 10.1104/pp.107.103432; PAVLI OI, 2010, PROTOCOLS NETWORK NA, DOI DOI 10.1038/NPROT.2010.98; PAVLI OI, 2010, EUR J PLANT PATHOL; Pavli OI, 2010, TRANSGENIC RES, V19, P915, DOI 10.1007/s11248-010-9364-y; Peng JL, 2004, PHYTOPATHOLOGY, V94, P1048, DOI 10.1094/PHYTO.2004.94.10.1048; Peng JL, 2003, PHYSIOL MOL PLANT P, V62, P317, DOI 10.1016/S0885-5765(03)00078-X; Racape J, 2005, MOL MICROBIOL, V58, P1406, DOI 10.1111/j.1365-2958.2004.04910.x; Rairdan GJ, 2001, MOL PLANT MICROBE IN, V14, P1235, DOI 10.1094/MPMI.2001.14.10.1235; Reboutier D, 2008, PLANT SIGNAL BEHAV, V3, P314, DOI 10.4161/psb.3.5.5304; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; Ren HY, 2006, ANN MICROBIOL, V56, P281, DOI 10.1007/BF03175019; Ren HY, 2006, J BIOSCIENCES, V31, P617, DOI 10.1007/BF02708414; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Schirmer A, 2005, J GEN VIROL, V86, P2897, DOI 10.1099/vir.0.81167-0; SEO S, 1995, SCIENCE, V270, P1988, DOI 10.1126/science.270.5244.1988; Shao M, 2008, PLANT BIOTECHNOL J, V6, P73, DOI 10.1111/j.1467-7652.2007.00304.x; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Strobel NE, 1996, PLANT J, V9, P431, DOI 10.1046/j.1365-313X.1996.09040431.x; Takakura Y, 2004, PHYSIOL MOL PLANT P, V64, P83, DOI 10.1016/j.pmpp.2004.06.002; Tamada T., 1999, ENCY VIROLOGY, P154; Tampakaki AP, 2000, MOL PLANT MICROBE IN, V13, P1366, DOI 10.1094/MPMI.2000.13.12.1366; TAMPAKAKI AP, 2010, ANNU REV PHYTOPATHOL, V48; Ward L, 2007, ARCH VIROL, V152, P59, DOI 10.1007/s00705-006-0832-x; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; [闻伟刚 Wen Weigang], 2003, [农业生物技术学报, Journol of Agricultural Biotechnology], V11, P192; Wu XJ, 2007, J BIOSCIENCES, V32, P1119, DOI 10.1007/s12038-007-0113-1	63	23	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17306	10.1371/journal.pone.0017306	http://dx.doi.org/10.1371/journal.pone.0017306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394206	Green Submitted, Green Published, gold			2022-12-25	WOS:000288025500009
J	Zampighi, GA; Schietroma, C; Zampighi, LM; Woodruff, M; Wright, EM; Brecha, NC				Zampighi, Guido A.; Schietroma, Cataldo; Zampighi, Lorenzo M.; Woodruff, Michael; Wright, Ernest M.; Brecha, Nicholas C.			Conical Tomography of a Ribbon Synapse: Structural Evidence for Vesicle Fusion	PLOS ONE			English	Article							RETINAL BIPOLAR CELLS; FROG NEUROMUSCULAR-JUNCTION; SENSITIVE CALCIUM-CHANNEL; SALAMANDER ROD SYNAPSE; OUTER PLEXIFORM LAYER; ACTIVE ZONE PROTEINS; SACCULAR HAIR-CELLS; TRANSMITTER RELEASE; ELECTRON TOMOGRAPHY; PHOTORECEPTOR TERMINALS	To characterize the sites of synaptic vesicle fusion in photoreceptors, we evaluated the three-dimensional structure of rod spherules from mice exposed to steady bright light or dark-adapted for periods ranging from 3 to 180 minutes using conical electron tomography. Conical tilt series from mice retinas were reconstructed using the weighted back projection algorithm, refined by projection matching and analyzed using semiautomatic density segmentation. In the light, rod spherules contained similar to 470 vesicles that were hemi-fused and similar to 187 vesicles that were fully fused (omega figures) with the plasma membrane. Active zones, defined by the presence of fully fused vesicles, extended along the entire area of contact between the rod spherule and the horizontal cell ending, and included the base of the ribbon, the slope of the synaptic ridge and ribbon-free regions apposed to horizontal cell axonal endings. There were transient changes of the rod spherules during dark adaptation. At early periods in the dark (3-15 minutes), there was a) an increase in the number of fully fused synaptic vesicles, b) a decrease in rod spherule volume, and c) an increase in the surface area of the contact between the rod spherule and horizontal cell endings. These changes partially compensate for the increase in the rod spherule plasma membrane following vesicle fusion. After 30 minutes of dark-adaptation, the rod spherules returned to dimensions similar to those measured in the light. These findings show that vesicle fusion occurs at both ribbon-associated and ribbon-free regions, and that transient changes in rod spherules and horizontal cell endings occur shortly after dark onset.	[Zampighi, Guido A.; Schietroma, Cataldo; Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Zampighi, Guido A.; Zampighi, Lorenzo M.; Wright, Ernest M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Woodruff, Michael] Univ Calif Los Angeles, Coll Letters & Sci, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Zampighi, GA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	nbrecha@ucla.edu		Schietroma, Cataldo/0000-0002-0865-9956	National Institutes of Health [EY04410, DK44602, EY15573]; Jules Stein Eye Institute; NATIONAL EYE INSTITUTE [R01EY015573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jules Stein Eye Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health EY04410 (GZ), DK44602 (EMW), EY15573 (NCB) and the Jules Stein Eye Institute. NCB is a VA Career Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Babai N, 2010, NEUROSCIENCE, V165, P1447, DOI 10.1016/j.neuroscience.2009.11.032; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Bayley PR, 2007, J COMP NEUROL, V500, P286, DOI 10.1002/cne.21188; Beaumont V, 2005, P NATL ACAD SCI USA, V102, P10700, DOI 10.1073/pnas.0501961102; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BRANDON C, 1983, J COMP NEUROL, V217, P167, DOI 10.1002/cne.902170205; Brandstatter JH, 1999, EUR J NEUROSCI, V11, P3683, DOI 10.1046/j.1460-9568.1999.00793.x; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; BUNT AH, 1971, BRAIN RES, V25, P571, DOI 10.1016/0006-8993(71)90461-6; Buran BN, 2010, J NEUROSCI, V30, P7587, DOI 10.1523/JNEUROSCI.0389-10.2010; Cadetti L, 2006, EUR J NEUROSCI, V23, P2983, DOI 10.1111/j.1460-9568.2006.04845.x; Cantele F, 2007, J STRUCT BIOL, V158, P59, DOI 10.1016/j.jsb.2006.10.015; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; Chol SY, 2008, VISUAL NEUROSCI, V25, P693, DOI 10.1017/S0952523808080814; COOPER NGF, 1982, J ULTRA MOL STRUCT R, V79, P58, DOI 10.1016/S0022-5320(82)90052-1; COPENHAGEN DR, 1989, NATURE, V341, P536, DOI 10.1038/341536a0; COUTEAUX R, 1970, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences Serie D Sciences Naturelles, V271, P2346; Deguchi-Tawarada M, 2006, J COMP NEUROL, V495, P480, DOI 10.1002/cne.20893; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; Dresbach T, 2001, CELL MOL LIFE SCI, V58, P94, DOI 10.1007/PL00000781; Edmonds BW, 2004, J PHYSIOL-LONDON, V560, P439, DOI 10.1113/jphysiol.2004.066035; EVANS EM, 1966, Z ZELLFORSCH MIK ANA, V71, P499, DOI 10.1007/BF00349610; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; GRAY EG, 1971, BRAIN RES, V35, P1, DOI 10.1016/0006-8993(71)90591-9; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haverkamp S, 2000, NEURON, V27, P85, DOI 10.1016/S0896-6273(00)00011-8; Heidelberger R, 2005, PROG RETIN EYE RES, V24, P682, DOI 10.1016/j.preteyeres.2005.04.002; HEUSER JE, 1989, Q J EXP PHYSIOL CMS, V74, P1051, DOI 10.1113/expphysiol.1989.sp003333; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; Hoopmann P, 2010, P NATL ACAD SCI USA, V107, P19055, DOI 10.1073/pnas.1007037107; Hosoya O, 2004, EUR J NEUROSCI, V19, P2179, DOI 10.1111/j.0953-816X.2004.03340.x; Jackman SL, 2009, NAT NEUROSCI, V12, P303, DOI 10.1038/nn.2267; Jarsky T, 2010, J NEUROSCI, V30, P11885, DOI 10.1523/JNEUROSCI.1415-10.2010; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Krizaj D, 2003, J PHYSIOL-LONDON, V547, P761, DOI 10.1113/jphysiol.2002.035683; Kroger RHH, 1996, VISION RES, V36, P3879, DOI 10.1016/S0042-6989(96)00132-0; Lanzavecchia S, 2005, J STRUCT BIOL, V149, P87, DOI 10.1016/j.jsb.2004.09.004; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; Li GL, 2009, J NEUROSCI, V29, P7558, DOI 10.1523/JNEUROSCI.0514-09.2009; LIBERMAN MC, 1980, HEARING RES, V3, P45, DOI 10.1016/0378-5955(80)90007-6; Llobet A, 2003, J NEUROSCI, V23, P2706; LoGiudice L, 2009, NEUROSCIENCE, V164, P1546, DOI 10.1016/j.neuroscience.2009.09.023; LoGiudice L, 2008, J NEUROSCI, V28, P3150, DOI 10.1523/JNEUROSCI.5753-07.2008; LoGiudice L, 2009, NEUROSCIENTIST, V15, P380, DOI 10.1177/1073858408331373; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Matthews G, 2008, J NEUROSCI, V28, P5403, DOI 10.1523/JNEUROSCI.0935-08.2008; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; MERCER AJ, 2010, PHYSIOLOGY IN PRESS; Midorikawa M, 2007, NAT NEUROSCI, V10, P1268, DOI 10.1038/nn1963; MISSOTTEN L, 1966, THESIS KATHOLIEKE U; Morgans CW, 2005, VISUAL NEUROSCI, V22, P561, DOI 10.1017/S0952523805225038; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; Neef A, 2007, J NEUROSCI, V27, P12933, DOI 10.1523/JNEUROSCI.1996-07.2007; Nouvian R, 2006, J MEMBRANE BIOL, V209, P153, DOI 10.1007/s00232-005-0854-4; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Peters A., 1991, FINE STRUCTURE NERVO; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Prescott ED, 2005, CURR OPIN NEUROBIOL, V15, P431, DOI 10.1016/j.conb.2005.07.005; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; Rabl K, 2005, J NEUROSCI, V25, P4633, DOI 10.1523/JNEUROSCI.4298-04.2005; RAOMIROTZNIK R, 1995, NEURON, V14, P561, DOI 10.1016/0896-6273(95)90312-7; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; RAYNAULD JP, 1979, SCIENCE, V204, P1436, DOI 10.1126/science.451577; Rea R, 2004, NEURON, V41, P755, DOI 10.1016/S0896-6273(04)00088-1; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; RIPPS H, 1976, J CELL BIOL, V70, P86, DOI 10.1083/jcb.70.1.86; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Salvi E, 2008, J STRUCT BIOL, V161, P287, DOI 10.1016/j.jsb.2007.06.011; SCHACHER S, 1976, J CELL BIOL, V70, P178, DOI 10.1083/jcb.70.1.178; SCHAEFFER SF, 1978, J CELL BIOL, V79, P802, DOI 10.1083/jcb.79.3.802; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schmitz F, 2009, NEUROSCIENTIST, V15, P611, DOI 10.1177/1073858409340253; Schmitz Y, 1997, NEUROSCIENCE, V78, P1209, DOI 10.1016/S0306-4522(96)00678-1; SEJNOWSKI TJ, 1982, J NEUROCYTOL, V11, P897, DOI 10.1007/BF01148307; Sherry DM, 2005, J COMP NEUROL, V484, P440, DOI 10.1002/cne.20504; Siksou L, 2007, J NEUROSCI, V27, P6868, DOI 10.1523/JNEUROSCI.1773-07.2007; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; SJOSTRAND FS, 1958, J ULTRA MOL STRUCT R, V2, P122, DOI 10.1016/S0022-5320(58)90050-9; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; Steele EC, 2005, J NEUROPHYSIOL, V94, P4544, DOI 10.1152/jn.01193.2004; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Suryanarayanan A, 2006, J NEUROSCI, V26, P1759, DOI 10.1523/JNEUROSCI.3895-05.2006; Szikra T, 2006, NEUROSCIENCE, V141, P143, DOI 10.1016/j.neuroscience.2006.03.054; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; TOWNESANDERSON E, 1985, J CELL BIOL, V100, P175, DOI 10.1083/jcb.100.1.175; Trifonov I U, 1968, Biofizika, V13, P809; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; WAGNER HJ, 1993, TRENDS NEUROSCI, V16, P201, DOI 10.1016/0166-2236(93)90155-F; WAGNER HJ, 1980, J NEUROCYTOL, V9, P573, DOI 10.1007/BF01205026; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; Wilkinson MF, 1996, J GEN PHYSIOL, V107, P621, DOI 10.1085/jgp.107.5.621; Xu JW, 2005, J NEUROSCI, V25, P7660, DOI 10.1523/JNEUROSCI.1572-05.2005; Zampighi GA, 2006, BIOPHYS J, V91, P2910, DOI 10.1529/biophysj.106.084814; Zampighi GA, 2005, J STRUCT BIOL, V151, P263, DOI 10.1016/j.jsb.2005.05.008; Zampighi GA, 2003, CELL COMMUN ADHES, V10, P265, DOI 10.1080/15419060390263001; Zampighi GA, 2008, J NEUROSCI, V28, P4151, DOI 10.1523/JNEUROSCI.4639-07.2008; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6; Zenisek D, 2003, J NEUROSCI, V23, P2538; Zenisek D, 2008, P NATL ACAD SCI USA, V105, P4922, DOI 10.1073/pnas.0709067105; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	119	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e16944	10.1371/journal.pone.0016944	http://dx.doi.org/10.1371/journal.pone.0016944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390245	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000287932100008
J	Ambatipudi, S; Gerstung, M; Gowda, R; Pai, P; Borges, AM; Schaffer, AA; Beerenwinkel, N; Mahimkar, MB				Ambatipudi, Srikant; Gerstung, Moritz; Gowda, Ravindra; Pai, Prathamesh; Borges, Anita M.; Schaeffer, Alejandro A.; Beerenwinkel, Niko; Mahimkar, Manoj B.			Genomic Profiling of Advanced-Stage Oral Cancers Reveals Chromosome 11q Alterations as Markers of Poor Clinical Outcome	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR GENE; COPY NUMBER; NECK-CANCER; HEAD; AMPLICON; ARRAY; AMPLIFICATION; EXPRESSION; DISTAL	Identifying oral cancer lesions associated with high risk of relapse and predicting clinical outcome remain challenging questions in clinical practice. Genomic alterations may add prognostic information and indicate biological aggressiveness thereby emphasizing the need for genome-wide profiling of oral cancers. High-resolution array comparative genomic hybridization was performed to delineate the genomic alterations in clinically annotated primary gingivo-buccal complex and tongue cancers (n = 60). The specific genomic alterations so identified were evaluated for their potential clinical relevance. Copy-number changes were observed on chromosomal arms with most frequent gains on 3q (60%), 5p (50%), 7p (50%), 8q (73%), 11q13 (47%), 14q11.2 (47%), and 19p13.3 (58%) and losses on 3p14.2 (55%) and 8p (83%). Univariate statistical analysis with correction for multiple testing revealed chromosomal gain of region 11q22.1-q22.2 and losses of 17p13.3 and 11q23-q25 to be associated with loco-regional recurrence (P = 0.004, P = 0.003, and P = 0.0003) and shorter survival (P = 0.009, P = 0.003, and P 0.0001) respectively. The gain of 11q22 and loss of 11q23-q25 were validated by interphase fluorescent in situ hybridization (I-FISH). This study identifies a tractable number of genomic alterations with few underlying genes that may potentially be utilized as biological markers for prognosis and treatment decisions in oral cancers.	[Ambatipudi, Srikant; Gowda, Ravindra; Mahimkar, Manoj B.] Adv Ctr Treatment Res & Educ Canc, Tata Mem Ctr, Canc Res Inst, Navi Mumbai, India; [Gerstung, Moritz; Beerenwinkel, Niko] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Gerstung, Moritz; Beerenwinkel, Niko] Swiss Inst Bioinformat, Lausanne, Switzerland; [Pai, Prathamesh] Tata Mem Hosp, Tata Mem Ctr, Head & Neck Unit, Mumbai 400012, Maharashtra, India; [Borges, Anita M.] SL Raheja Hosp, Dept Pathol & Lab Med, Mumbai, Maharashtra, India; [Schaeffer, Alejandro A.] NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, DHHS, Bethesda, MD 20892 USA	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; Tata Memorial Centre (TMC); Tata Memorial Hospital; National Institutes of Health (NIH) - USA	Ambatipudi, S (corresponding author), Adv Ctr Treatment Res & Educ Canc, Tata Mem Ctr, Canc Res Inst, Navi Mumbai, India.	mmahimkar@actrec.gov.in	Ambatipudi, Srikant/GLV-6259-2022; Ambatipudi, Srikant/J-4648-2012; Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019	Pai, Prathamesh/0000-0001-9989-5534; Ambatipudi, Srikant/0000-0003-3102-3603; Gerstung, Moritz/0000-0001-6709-963X	Council of Scientific and Industrial Research [CSIR] [27(0207)/09/EMR-II]; Tata Memorial Center; SystemsX.ch, Swiss initiative in systems biology [2009/024]; National Institutes of Health, NLM; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	Council of Scientific and Industrial Research [CSIR](Council of Scientific & Industrial Research (CSIR) - India); Tata Memorial Center; SystemsX.ch, Swiss initiative in systems biology; National Institutes of Health, NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors are thankful to the Council of Scientific and Industrial Research [CSIR Grant No: 27(0207)/09/EMR-II]; Tata Memorial Center - Intramural Research Grant for funding the project. MG and NB have been funded by SystemsX.ch, the Swiss initiative in systems biology, under grant No. 2009/024, evaluated by the Swiss National Science Foundation. This research was supported in part by the Intramural research Program of the National Institutes of Health, NLM. The authors thank CSIR for providing a fellowship to SA during his tenure as a PhD student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akervall J, 2004, ACTA OTO-LARYNGOL, V124, P851, DOI 10.1080/00016480410017323; Akervall J, 2006, EUR ARCH OTO-RHINO-L, V263, P297, DOI 10.1007/s00405-006-1039-1; Baldwin C, 2005, CANCER RES, V65, P7561, DOI 10.1158/0008-5472.CAN-05-1513; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chigurupati S, 2010, CANCER RES, V70, P418, DOI 10.1158/0008-5472.CAN-09-2654; Ding X, 2010, JNCI-J NATL CANCER I, V102, P1052, DOI 10.1093/jnci/djq217; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Freier K, 2010, GENE CHROMOSOME CANC, V49, P9, DOI 10.1002/gcc.20714; Frohling S, 2008, NEW ENGL J MED, V359, P722, DOI 10.1056/NEJMra0803109; Garnis C, 2004, ONCOGENE, V23, P2582, DOI 10.1038/sj.onc.1207367; Gillison ML, 2004, SEMIN ONCOL, V31, P744, DOI 10.1053/j.seminoncol.2004.09.011; Goi T, 2002, ONCOL REP, V9, P1189; Gollin SM, 2001, HEAD NECK-J SCI SPEC, V23, P238, DOI 10.1002/1097-0347(200103)23:3<238::AID-HED1025>3.0.CO;2-H; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Huang X, 2002, P NATL ACAD SCI USA, V99, P11369, DOI 10.1073/pnas.172285799; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jarvinen AK, 2008, GENE CHROMOSOME CANC, V47, P500, DOI 10.1002/gcc.20551; Jin C, 2006, CYTOGENET GENOME RES, V115, P99, DOI 10.1159/000095228; Jin YS, 1998, GENE CHROMOSOME CANC, V22, P312, DOI 10.1002/(SICI)1098-2264(199808)22:4<312::AID-GCC7>3.0.CO;2-Y; Kallioniemi A, 2008, CURR OPIN BIOTECH, V19, P36, DOI 10.1016/j.copbio.2007.11.004; Klussmann JP, 2009, CLIN CANCER RES, V15, P1779, DOI 10.1158/1078-0432.CCR-08-1463; Kohno T, 2010, GENE CHROMOSOME CANC, V49, P342, DOI 10.1002/gcc.20746; Konishi H, 1998, ONCOGENE, V17, P2095, DOI 10.1038/sj.onc.1202128; la Cour JM, 2008, MOL ONCOL, V1, P431, DOI 10.1016/j.molonc.2007.08.002; Lippman SM, 2001, NEW ENGL J MED, V344, P1323, DOI 10.1056/NEJM200104263441710; Liu AM, 2010, EXPERT OPIN THER TAR, V14, P855, DOI 10.1517/14728222.2010.499361; Liu CJ, 2006, MOL CARCINOGEN, V45, P721, DOI 10.1002/mc.20213; Liu T, 2010, DNA REPAIR, V9, P1241, DOI 10.1016/j.dnarep.2010.09.016; Nakamura E, 2008, CANCER SCI, V99, P1390, DOI 10.1111/j.1349-7006.2008.00838.x; Nakaya K, 2007, ONCOGENE, V26, P5300, DOI 10.1038/sj.onc.1210330; Parikh RA, 2007, GENE CHROMOSOME CANC, V46, P761, DOI 10.1002/gcc.20462; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Paterson IC, 1996, ORAL ONCOL, V32B, P150, DOI 10.1016/0964-1955(95)00065-8; Reshmi SC, 2007, CYTOGENET GENOME RES, V116, P46, DOI 10.1159/000097425; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Scully C, 2000, ORAL ONCOL, V36, P311, DOI 10.1016/S1368-8375(00)00021-X; Shah JP, 2006, LANCET ONCOL, V7, P356, DOI 10.1016/S1470-2045(06)70667-2; Shu ST, 2010, ANTICANCER RES, V30, P1937; Smith JS, 1999, GENOMICS, V59, P97, DOI 10.1006/geno.1999.5864; Smith M, 2006, SNAPCGH SEGMENTATION; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Suzuki E, 2007, ONCOGENE, V26, P7921, DOI 10.1038/sj.onc.1210589; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646	49	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17250	10.1371/journal.pone.0017250	http://dx.doi.org/10.1371/journal.pone.0017250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386901	Green Published, gold, Green Submitted			2022-12-25	WOS:000287931400043
J	Latasa, MJ; Cosgaya, JM				Latasa, Maria-Jesus; Miguel Cosgaya, Jose			Regulation of Retinoid Receptors by Retinoic Acid and Axonal Contact in Schwann Cells	PLOS ONE			English	Article							PERIPHERAL NERVOUS-SYSTEM; X-RECEPTOR; IN-VITRO; GENE-EXPRESSION; GROWTH-FACTOR; STEM-CELLS; RAR-BETA-2 PROMOTER; HUMAN NEUROBLASTOMA; STROMAL CELLS; NEURAL CREST	Background: Schwann cells (SCs) are the cell type responsible for the formation of the myelin sheath in the peripheral nervous system (PNS). As retinoic acid (RA) and other retinoids have a profound effect as regulators of the myelination program, we sought to investigate how their nuclear receptors levels were regulated in this cell type. Methodology/Principal Findings: In the present study, by using Schwann cells primary cultures from neonatal Wistar rat pups, as well as myelinating cocultures of Schwann cells with embryonic rat dorsal root ganglion sensory neurons, we have found that sustained expression of RXR-gamma depends on the continuous presence of a labile activator, while axonal contact mimickers produced an increase in RXR-gamma mRNA and protein levels, increment that could be prevented by RA. The upregulation by axonal contact mimickers and the transcriptional downregulation by RA were dependent on de novo protein synthesis and did not involve changes in mRNA stability. On the other hand, RAR-beta mRNA levels were only slightly modulated by axonal contact mimickers, while RA produced a strong transcriptional upregulation that was independent of de novo protein synthesis without changes in mRNA stability. Conclusions/Significance: All together, our results show that retinoid receptors are regulated in a complex manner in Schwann cells, suggesting that they could have a prominent role as regulators of Schwann cell physiology.	[Latasa, Maria-Jesus; Miguel Cosgaya, Jose] Univ Autonoma Madrid, Dept Endocrine & Nervous Syst Physiopathol, Inst Invest Biomed, Consejo Super Invest Cient, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Latasa, MJ (corresponding author), Univ Autonoma Madrid, Dept Endocrine & Nervous Syst Physiopathol, Inst Invest Biomed, Consejo Super Invest Cient, Madrid, Spain.	jmcosgaya@iib.uam.es	Latasa, Maria-Jesus/M-8704-2014; Cosgaya, Jose M/B-4936-2008	Latasa, Maria-Jesus/0000-0003-2840-8692; Cosgaya, Jose Miguel/0000-0002-6005-2916	Spanish Ministerio de Educacion y Ciencia [SAF2003-02528, SAF2004-05343, SAF2007-61693]; Comunidad de Madrid-CSIC; Fundacion Mutua Madrilena; Spanish Ministerio de Eduacion y Ciencia	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Comunidad de Madrid-CSIC(Comunidad de Madrid); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Spanish Ministerio de Eduacion y Ciencia(Spanish Government)	This work was supported by grants to JMC from the Spanish Ministerio de Educacion y Ciencia (SAF2003-02528; SAF2004-05343; SAF2007-61693), Comunidad de Madrid-CSIC, and Fundacion Mutua Madrilena. MJL was supported by the Ramon y Cajal program from the Spanish Ministerio de Eduacion y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; ASTROM A, 1990, BIOCHEM BIOPH RES CO, V173, P339, DOI 10.1016/S0006-291X(05)81062-9; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Ballow M, 2003, J CLIN IMMUNOL, V23, P46, DOI 10.1023/A:1021900331580; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Corcoran J, 1999, NAT NEUROSCI, V2, P307, DOI 10.1038/7214; Cosgaya JM, 1997, ONCOGENE, V14, P579, DOI 10.1038/sj.onc.1200865; Cosgaya JM, 1996, J NEUROCHEM, V66, P89; Cosgaya JM, 2001, J NEUROCHEM, V76, P661, DOI 10.1046/j.1471-4159.2001.00078.x; DAVIS JB, 1990, J CELL BIOL, V110, P1353, DOI 10.1083/jcb.110.4.1353; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x; DIMITROULAKOS J, 1994, CELL GROWTH DIFFER, V5, P373; Elferink CJ, 1996, BIOTECHNIQUES, V20, P470; Escriva H, 2002, DEVELOPMENT, V129, P2905; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; Georgiades P, 1998, ANAT EMBRYOL, V197, P477, DOI 10.1007/s004290050158; Han QX, 1997, DIAGN MOL PATHOL, V6, P42, DOI 10.1097/00019606-199702000-00007; HAUSSLER M, 1983, P NATL ACAD SCI-BIOL, V80, P5525, DOI 10.1073/pnas.80.18.5525; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Jang SW, 2006, J NEUROCHEM, V98, P1678, DOI 10.1111/j.1471-4159.2006.04069.x; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JESSEN KR, 1994, NEURON, V12, P509, DOI 10.1016/0896-6273(94)90209-7; Jessen KR, 2002, J ANAT, V200, P367, DOI 10.1046/j.1469-7580.2002.00046.x; Jiang L, 2008, NEUROREPORT, V19, P1015, DOI 10.1097/WNR.0b013e3283040efc; Johann V, 2003, NEUROSCI LETT, V339, P13, DOI 10.1016/S0304-3940(02)01427-1; Kazakova N, 2006, DEV BIOL, V297, P1, DOI 10.1016/j.ydbio.2006.03.020; Kinameri E, 2003, MOL BRAIN RES, V117, P221, DOI 10.1016/S0169-328X(03)00326-7; Krezel W, 1996, P NATL ACAD SCI USA, V93, P9010, DOI 10.1073/pnas.93.17.9010; KRUYT FAE, 1992, NUCLEIC ACIDS RES, V20, P6393, DOI 10.1093/nar/20.23.6393; Latasa MJ, 2010, GLIA, V58, P1451, DOI 10.1002/glia.21020; LEMKE G, 1988, DEVELOPMENT, V102, P499; LOVAT PE, 1993, NEUROSCI LETT, V162, P109, DOI 10.1016/0304-3940(93)90572-3; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Matsuse D, 2010, J NEUROPATH EXP NEUR, V69, P973, DOI 10.1097/NEN.0b013e3181eff6dc; McCaffery P, 2000, CYTOKINE GROWTH F R, V11, P233, DOI 10.1016/S1359-6101(00)00002-2; Mey J, 2007, GLIA, V55, P152, DOI 10.1002/glia.20444; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Murphy P, 1996, DEVELOPMENT, V122, P2847; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Nikawa T, 2001, AM J PHYSIOL-GASTR L, V280, pG510, DOI 10.1152/ajpgi.2001.280.3.G510; PERRIMON N, 1995, CELL, V80, P517, DOI 10.1016/0092-8674(95)90503-0; Ponnamperuma RM, 2000, NUTR CANCER, V37, P82, DOI 10.1207/S15327914NC3701_11; Robson LG, 2010, NEUROBIOL AGING, V31, P678, DOI 10.1016/j.neurobiolaging.2008.05.027; ROWE A, 1995, ANAT EMBRYOL, V192, P1; ROWE A, 1991, DEVELOPMENT, V111, P1007; SCHEIBE RJ, 1991, J CELL BIOL, V113, P1173, DOI 10.1083/jcb.113.5.1173; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Tesmer JJG, 1998, CURR OPIN STRUC BIOL, V8, P713, DOI 10.1016/S0959-440X(98)80090-0; Tong L, 2010, BIOCHEM BIOPH RES CO, V401, P592, DOI 10.1016/j.bbrc.2010.09.107; Topilko P, 1997, J NEUROSCI RES, V50, P702, DOI 10.1002/(SICI)1097-4547(19971201)50:5<702::AID-JNR7>3.0.CO;2-L; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; WAN YJY, 1994, EXP CELL RES, V210, P56, DOI 10.1006/excr.1994.1009; Zhelyaznik N, 2006, NEUROSCIENCE, V141, P1761, DOI 10.1016/j.neuroscience.2006.05.021; Zhelyaznik N, 2003, EUR J NEUROSCI, V18, P1033, DOI 10.1046/j.1460-9568.2003.02834.x	58	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17023	10.1371/journal.pone.0017023	http://dx.doi.org/10.1371/journal.pone.0017023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386894	Green Published, Green Submitted, gold			2022-12-25	WOS:000287931400023
J	McMullan, R; Nurrish, SJ				McMullan, Rachel; Nurrish, Stephen J.			The RHO-1 RhoGTPase Modulates Fertility and Multiple Behaviors in Adult C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; NEUROTRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; MENTAL-RETARDATION; SIGNALING PATHWAY; CELLULAR BASIS; GTPASES; KINASE; MUTANTS; RAC2	The Rho family of small GTPases are essential during early embryonic development making it difficult to study their functions in adult animals. Using inducible transgenes expressing either a constitutively active version of the single C. elegans Rho ortholog, RHO-1, or an inhibitor of endogenous Rho (C3 transferase), we demonstrate multiple defects caused by altering Rho signaling in adult C. elegans. Changes in RHO-1 signaling in cholinergic neurons affected locomotion, pharyngeal pumping and fecundity. Changes in RHO-1 signaling outside the cholinergic neurons resulted in defective defecation, ovulation, and changes in C. elegans body morphology. Finally both increased and decreased RHO-1 signaling in adults resulted in death within hours. The multiple post-developmental roles for Rho in C. elegans demonstrate that RhoA signaling pathways continue to be used post-developmentally and the resulting phenotypes provide an opportunity to further study post-developmental Rho signaling pathways using genetic screens.	UCL, MRC Lab Mol Cell Biol, MRC Cell Biol Unit, London, England; UCL, Dept Neurosci Physiol & Pharmacol, London, England	MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London	McMullan, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Div Cell & Mol Biol, London, England.	s.nurrish@ucl.ac.uk	McMullan, Rachel/ABJ-3519-2022	McMullan, Rachel/0000-0003-2677-8016; Nurrish, Stephen/0000-0002-2653-9384	UK Medical Research Council; MRC [MC_U122665004] Funding Source: UKRI; Medical Research Council [MC_U122665004] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a core grant to the MRC Cell Biology Unit from the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Bany IA, 2003, J NEUROSCI, V23, P8060; Branicky R, 2006, TRENDS GENET, V22, P571, DOI 10.1016/j.tig.2006.08.006; BRENNER S, 1974, GENETICS, V77, P71; Bustelo XR, 2002, BIOESSAYS, V24, P602, DOI 10.1002/bies.10107; Canevascini S, 2005, EMBO REP, V6, P1169, DOI 10.1038/sj.embor.7400574; Chechlacz M, 2003, PEDIATR NEUROL, V29, P11, DOI 10.1016/S0887-8994(03)00152-8; Chen JC, 2003, J BIOL CHEM, V278, P2807, DOI 10.1074/jbc.M207943200; Corbetta S, 2005, MOL CELL BIOL, V25, P5763, DOI 10.1128/MCB.25.13.5763-5776.2005; Davis MW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000028; Diogon M, 2007, DEVELOPMENT, V134, P2469, DOI 10.1242/dev.005074; Eisenmann DM, 2000, GENETICS, V156, P1097; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Fujishiro SH, 2008, BIOCHEM BIOPH RES CO, V368, P162, DOI 10.1016/j.bbrc.2008.01.066; Fukushige T, 2006, GENE DEV, V20, P3395, DOI 10.1101/gad.1481706; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Gu Y, 2001, J BIOL CHEM, V276, P15929, DOI 10.1074/jbc.M010445200; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hiley E, 2006, EMBO J, V25, P5884, DOI 10.1038/sj.emboj.7601458; Hodgkin J, 2000, CURR BIOL, V10, P1615, DOI 10.1016/S0960-9822(00)00867-8; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; KAYNE PS, 1995, CURR OPIN GENET DEV, V5, P38, DOI 10.1016/S0959-437X(95)90051-9; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Li SJ, 2002, J IMMUNOL, V169, P5043, DOI 10.4049/jimmunol.169.9.5043; Li WQ, 2001, J BIOL CHEM, V276, P34728, DOI 10.1074/jbc.M103496200; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; LIU DWC, 1994, J NEUROSCI, V14, P1953; Lundquist Erik A, 2006, WormBook, P1; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mahoney TR, 2008, P NATL ACAD SCI USA, V105, P16350, DOI 10.1073/pnas.0803617105; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; McMullan R, 2006, GENE DEV, V20, P65, DOI 10.1101/gad.359706; McMullan R, 2007, GENE DEV, V21, P2077, DOI 10.1101/gad.1615807; Meng YH, 2004, NEUROPHARMACOLOGY, V47, P746, DOI 10.1016/j.neuropharm.2004.06.030; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; NGUYEN M, 1995, GENETICS, V140, P527; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; Norman KR, 2005, CELL, V123, P119, DOI 10.1016/j.cell.2005.08.001; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; RAIZEN DM, 1995, GENETICS, V141, P1365; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; RAND JB, 1984, GENETICS, V106, P227; Rand JB., 2007, ACETYLCHOLINE, V1, DOI [10.1895/wormbook.1.131.1, DOI 10.1895/WORMBOOK.1.131.1]; Rogers CM, 2001, J NEUROBIOL, V49, P235, DOI 10.1002/neu.1078; Rolfe BE, 2005, ATHEROSCLEROSIS, V183, P1, DOI 10.1016/j.atherosclerosis.2005.04.023; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Schafer William R, 2005, WormBook, P1; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Sharpe CC, 2003, J AM SOC NEPHROL, V14, P261, DOI 10.1097/01.ASN.0000048223.05219.E4; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Soto MC, 2002, GENE DEV, V16, P620, DOI 10.1101/gad.955702; Steven R, 2005, GENE DEV, V19, P2016, DOI 10.1101/gad.1319905; STIERNAGLE T, COMMUNITY TCER; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; SUNDARAM MV, 2006, RTK RAS MAPK SIGNALI, P1, DOI DOI 10.1895/WORMBOOK.1.80.1; Sward K, 2003, CURR HYPERTENS REP, V5, P66, DOI 10.1007/s11906-003-0013-1; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; van der Linden AM, 2003, CURR BIOL, V13, P516, DOI 10.1016/S0960-9822(03)00164-7; Wang L, 2007, TRENDS CELL BIOL, V17, P58, DOI 10.1016/j.tcb.2006.11.009; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; Williams DA, 2000, BLOOD, V96, P1646; Williams SL, 2007, GENE DEV, V21, P2731, DOI 10.1101/gad.1592007; Wissmann A, 1997, GENE DEV, V11, P409, DOI 10.1101/gad.11.4.409; Withee J, 2004, GENETICS, V167, P1165, DOI 10.1534/genetics.103.025676; Zallen JA, 2000, MOL BIOL CELL, V11, P3177, DOI 10.1091/mbc.11.9.3177	74	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17265	10.1371/journal.pone.0017265	http://dx.doi.org/10.1371/journal.pone.0017265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387015	Green Published, gold, Green Submitted			2022-12-25	WOS:000287931400045
J	Petnicki-Ocwieja, T; DeFrancesco, AS; Chung, E; Darcy, CT; Bronson, RT; Kobayashi, KS; Hu, LT				Petnicki-Ocwieja, Tanja; DeFrancesco, Alicia S.; Chung, Erin; Darcy, Courtney T.; Bronson, Roderick T.; Kobayashi, Koichi S.; Hu, Linden T.			Nod2 Suppresses Borrelia burgdorferi Mediated Murine Lyme Arthritis and Carditis through the Induction of Tolerance	PLOS ONE			English	Article							INNATE IMMUNE ACTIVATION; TOLL-LIKE RECEPTOR-2; CROHNS-DISEASE; HOST-DEFENSE; INFLAMMATORY RESPONSES; I IFN; BINDING; RECOGNITION; PLAYS; MICE	The internalization of Borrelia burgdorferi, the causative agent of Lyme disease, by phagocytes is essential for an effective activation of the immune response to this pathogen. The intracellular, cytosolic receptor Nod2 has been shown to play varying roles in either enhancing or attenuating inflammation in response to different infectious agents. We examined the role of Nod2 in responses to B. burgdorferi. In vitro stimulation of Nod2 deficient bone marrow derived macrophages (BMDM) resulted in decreased induction of multiple cytokines, interferons and interferon regulated genes compared with wild-type cells. However, B. burgdorferi infection of Nod2 deficient mice resulted in increased rather than decreased arthritis and carditis compared to control mice. We explored multiple potential mechanisms for the paradoxical response in in vivo versus in vitro systems and found that prolonged stimulation with a Nod2 ligand, muramyl dipeptide (MDP), resulted in tolerance to stimulation by B. burgdorferi. This tolerance was lost with stimulation of Nod2 deficient cells that cannot respond to MDP. Cytokine patterns in the tolerance model closely paralleled cytokine profiles in infected Nod2 deficient mice. We propose a model where Nod2 has an enhancing role in activating inflammation in early infection, but moderates inflammation after prolonged exposure to the organism through induction of tolerance.	[Petnicki-Ocwieja, Tanja; DeFrancesco, Alicia S.; Chung, Erin; Darcy, Courtney T.; Hu, Linden T.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA; [Bronson, Roderick T.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Kobayashi, Koichi S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Tufts Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Petnicki-Ocwieja, T (corresponding author), Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA.	lhu@tuftsmedicalcenter.org	Hu, Linden/L-6314-2016; Chung, Erin/AAZ-8699-2021	Hu, Linden/0000-0003-1659-5558; Chung, Erin/0000-0002-9324-8544; Kobayashi, Koichi/0000-0003-2930-0114	 [R01AI071107];  [R56AI80646];  [T32AI007329]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071107, R56AI080646, T32AI007329, R01AI050043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074738] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01AI071107 ( L. T. H.), R56AI80646 ( L. T. H.), and T32AI007329 (T.P.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Behera AK, 2006, INFECT IMMUN, V74, P1462, DOI 10.1128/IAI.74.3.1462-1470.2006; Behera AK, 2006, ARTHRITIS RHEUM-US, V54, P3319, DOI 10.1002/art.22128; Behera AK, 2006, J IMMUNOL, V177, P657, DOI 10.4049/jimmunol.177.1.657; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Bolz DD, 2004, J IMMUNOL, V173, P2003, DOI 10.4049/jimmunol.173.3.2003; Boughan PK, 2006, J BIOL CHEM, V281, P11637, DOI 10.1074/jbc.M510275200; Chauhan VS, 2009, GLIA, V57, P414, DOI 10.1002/glia.20770; Cruz AR, 2008, INFECT IMMUN, V76, P56, DOI 10.1128/IAI.01039-07; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Frutuoso MS, 2010, MICROBES INFECT, V12, P819, DOI 10.1016/j.micinf.2010.05.006; Geddes K, 2010, INFECT IMMUN, V78, P5107, DOI 10.1128/IAI.00759-10; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; GIRARDIN SE, 2003, J BIOL CHEM; HEDL M, 2010, GASTROENTEROLOGY; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Heilpern AJ, 2009, INFECT IMMUN, V77, P2643, DOI 10.1128/IAI.00214-09; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kapetanovic R, 2010, MICROBES INFECT, V12, P759, DOI 10.1016/j.micinf.2010.05.003; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; KRAMER M, 2006, J LEUKOC BIOL; Lazarus JJ, 2006, J IMMUNOL, V177, P7076, DOI 10.4049/jimmunol.177.10.7076; Lee PY, 2008, J IMMUNOL, V180, P5101, DOI 10.4049/jimmunol.180.7.5101; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Liu N, 2009, INFECT IMMUN, V77, P3320, DOI 10.1128/IAI.00100-09; Liu NY, 2004, INFECT IMMUN, V72, P3195, DOI 10.1128/IAI.72.6.3195-3203.2004; Liu XJ, 2010, NEUROSCI LETT, V474, P93, DOI 10.1016/j.neulet.2010.03.013; Liu XJ, 2010, GLIA, V58, P839, DOI 10.1002/glia.20968; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Marques A, 2008, INFECT DIS CLIN N AM, V22, P341, DOI 10.1016/j.idc.2007.12.011; Marques AR, 2010, CURR ALLERGY ASTHM R, V10, P13, DOI 10.1007/s11882-009-0077-3; Marre ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012871; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miller JC, 2010, INFECT IMMUN, V78, P3144, DOI 10.1128/IAI.01070-09; Miller JC, 2008, J IMMUNOL, V181, P8492, DOI 10.4049/jimmunol.181.12.8492; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Moore MW, 2007, INFECT IMMUN, V75, P2046, DOI 10.1128/IAI.01666-06; Netea MG, 2004, EUR J IMMUNOL, V34, P2052, DOI 10.1002/eji.200425229; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Oosting M, 2010, J INFECT DIS, V201, P1849, DOI 10.1086/652871; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Petzke MM, 2009, J IMMUNOL, V183, P5279, DOI 10.4049/jimmunol.0901390; Puius YA, 2008, INFECT DIS CLIN N AM, V22, P289, DOI 10.1016/j.idc.2007.12.014; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Roehrl J, 2008, J BIOL CHEM, V283, P5414, DOI 10.1074/jbc.M709103200; Saha S, 2009, CELL HOST MICROBE, V5, P137, DOI 10.1016/j.chom.2008.12.010; Sahay B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000687; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Shin OS, 2008, INFECT IMMUN, V76, P2341, DOI 10.1128/IAI.01600-07; Varoga D, 2005, ANN ANAT, V187, P499, DOI 10.1016/j.aanat.2005.03.004; Vignal C, 2007, MICROBES INFECT, V9, P658, DOI 10.1016/j.micinf.2007.01.016; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JC133145, 10.1172/JCI33145]; Watanabe T, 2006, IMMUNITY, V25, P473, DOI 10.1016/j.immuni.2006.06.018; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402; Wooten RM, 2002, VECTOR-BORNE ZOONOT, V2, P275, DOI 10.1089/153036602321653860; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Yamamoto S, 2009, MICROBES INFECT, V11, P912, DOI 10.1016/j.micinf.2009.06.005; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	69	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17414	10.1371/journal.pone.0017414	http://dx.doi.org/10.1371/journal.pone.0017414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387014	Green Published, Green Submitted, gold			2022-12-25	WOS:000287931400071
J	Wilson, JA; D'Emic, MD; Ikejiri, T; Moacdieh, EM; Whitlock, JA				Wilson, Jeffrey A.; D'Emic, Michael D.; Ikejiri, Takehito; Moacdieh, Emile M.; Whitlock, John A.			A Nomenclature for Vertebral Fossae in Sauropods and Other Saurischian Dinosaurs	PLOS ONE			English	Article							RAPETOSAURUS-KRAUSEI SAUROPODA; POSTCRANIAL PNEUMATICITY; EVOLUTION; ANATOMY; LAMINAE; TITANOSAURIA; PHYLOGENY; OSTEOLOGY; PATAGONIA; SKELETON	Background: The axial skeleton of extinct saurischian dinosaurs (i.e., theropods, sauropodomorphs), like living birds, was pneumatized by epithelial outpocketings of the respiratory system. Pneumatic signatures in the vertebral column of fossil saurischians include complex branching chambers within the bone (internal pneumaticity) and large chambers visible externally that are bounded by neural arch laminae (external pneumaticity). Although general aspects of internal pneumaticity are synapomorphic for saurischian subgroups, the individual internal pneumatic spaces cannot be homologized across species or even along the vertebral column, due to their variability and absence of topographical landmarks. External pneumatic structures, in contrast, are defined by ready topological landmarks (vertebral laminae), but no consistent nomenclatural system exists. This deficiency has fostered confusion and limited their use as character data in phylogenetic analysis. Methodology/Principal Findings: We present a simple system for naming external neural arch fossae that parallels the one developed for the vertebral laminae that bound them. The nomenclatural system identifies fossae by pointing to reference landmarks (e. g., neural spine, centrum, costal articulations, zygapophyses). We standardize the naming process by creating tripartite names from "primary landmarks," which form the zygodiapophyseal table, "secondary landmarks," which orient with respect to that table, and "tertiary landmarks," which further delineate a given fossa. Conclusions/Significance: The proposed nomenclatural system for lamina-bounded fossae adds clarity to descriptions of complex vertebrae and allows these structures to be sourced as character data for phylogenetic analyses. These anatomical terms denote potentially homologous pneumatic structures within Saurischia, but they could be applied to any vertebrate with vertebral laminae that enclose spaces, regardless of their developmental origin or phylogenetic distribution.	[Wilson, Jeffrey A.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wilson, JA (corresponding author), Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA.	wilsonja@umich.edu	Wilson, Jeffrey/C-2737-2008; Ikejiri, Takehito/AAW-8933-2020; Whitlock, John/G-5814-2018; Whitlock, John/A-3079-2009	Whitlock, John/0000-0002-1118-2925; Whitlock, John/0000-0002-1118-2925	National Science Foundation [DEB-0640434]	National Science Foundation(National Science Foundation (NSF))	Research was supported by National Science Foundation grant DEB-0640434 (to JAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2004, CR PALEVOL, V3, P199, DOI 10.1016/j.crpv.2004.03.001; Allain R, 2008, GEODIVERSITAS, V30, P345; [Anonymous], 1993, PNEUMATIC POSTCRANIA; Benson RBJ, 2008, J VERTEBR PALEONTOL, V28, P732, DOI 10.1671/0272-4634(2008)28[732:NIOSAT]2.0.CO;2; Bonaparte JF, 1999, AMEGHINIANA, V36, P115; Calvo JO, 2003, REV GEOL CHILE, V30, P333; Calvo Jorge O., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P485; CAMP CHARLES L., 1930, MEM UNIV CALIFORNIA, V10, P1; Campos D.D.A., 2005, ARQ MUS NAC, V63, P565; CHATTERJEE S, 1985, PHILOS T ROY SOC B, V309, P395, DOI 10.1098/rstb.1985.0092; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Cope ED, 1877, PALEONTOLOGICAL B, V25, P5; Coria R., 2000, GAIA, V102, P89; Farke AA, 2010, ZOOL J LINN SOC-LOND, V159, P988, DOI 10.1111/j.1096-3642.2009.00586.x; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Gilmore C. W., 1936, Memoirs of the Carnegie Museum, V11, P175; Gomani EM, 2005, PALAEONTOL ELECTRON, V8; Gower DJ, 2001, NATURWISSENSCHAFTEN, V88, P119, DOI 10.1007/s001140100206; Harris JD, 2006, PALAEONTOLOGY, V49, P1091, DOI 10.1111/j.1475-4983.2006.00577.x; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P21; Ikejiri T, 2005, LIFE O PAST, P154; Janensch W., 1950, PALAEONTOGRAPHICA, V3, P27; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Madsen JH., 2000, UTAH GEOLOGICAL SURV, V2, P1; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; McIntosh J.S., 1990, P345; McIntosh John S., 1996, Bulletin of Gunma Museum of Natural History, V1, P1; O'Connor PM, 2007, J VERTEBR PALEONTOL, V27, P127; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; Osborn H. F., 1921, MEMOIRS AM MUSEUM NA, V3, P249; OUYANG H, 2001, 1 MAMENCHISAURIAN SK, P111; Paul G.S., 1988, HUNTERIA, V2, P1; Riga BJG, 2003, AMEGHINIANA, V40, P155; Rogers KC, 2001, NATURE, V412, P530, DOI 10.1038/35087566; Rogers KC, 2004, J VERTEBR PALEONTOL, V24, P121, DOI 10.1671/A1109-10; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Rogers KC, 2009, J VERTEBR PALEONTOL, V29, P1046, DOI 10.1671/039.029.0432; Salgado Leonardo, 2006, Revista del Museo Argentino de Ciencias Naturales, V8, P69; Salgado L, 2010, J VERTEBR PALEONTOL, V30, P1760, DOI 10.1080/02724634.2010.520783; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; Suteethorn S, 2010, NEUES JAHRB GEOL P-A, V256, P109, DOI 10.1127/0077-7749/2010/0036; Taylor MP, 2009, J VERTEBR PALEONTOL, V29, P787, DOI 10.1671/039.029.0309; Upchurch P., 2004, NATL SCI MUS MONOGR, V26, P1; Wedel MJ, 2009, J EXP ZOOL PART A, V311A, P611, DOI 10.1002/jez.513; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Wedel MJ, 2000, ACTA PALAEONTOL POL, V45, P343; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; WHITLOCK JA, ZOOLOGICAL IN PRESS; WHITLOCK JA, PALAEONTOLO IN PRESS; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; WILSON JA, 1998, SOC VERTEBRATE PALEO, V5, P1, DOI DOI 10.2307/3889325; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P511, DOI 10.1671/0272-4634(2006)26[511:ANOFVS]2.0.CO;2; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Yates AM, 2007, SPEC PAP PALAEONTOL, P9; Young C.C., 1972, I VERTEBRATE PALEO A, V8, P1; Young C. C., 1954, ACTA SCI SINICA, V3, P491	61	171	177	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17114	10.1371/journal.pone.0017114	http://dx.doi.org/10.1371/journal.pone.0017114			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386963	Green Submitted, gold, Green Published			2022-12-25	WOS:000287931400030
J	Yin, XH; Zhu, J; Feng, YN; Chambers, JR; Gong, J; Gyles, CL				Yin, Xianhua; Zhu, Jing; Feng, Yanni; Chambers, James R.; Gong, Joshua; Gyles, Carlton L.			Differential Gene Expression and Adherence of Escherichia coli O157:H7 In Vitro and in Ligated Pig Intestines	PLOS ONE			English	Article							LEE PATHOGENICITY ISLAND; ENTEROCYTE EFFACEMENT; III SECRETION; CATABOLITE REPRESSION; ACID RESISTANCE; VIRULENCE; LOCUS; IDENTIFICATION; O157-H7; SYSTEM	Background: Escherichia coli O157:H7 strain 86-24 grown in MacConkey broth (MB) shows almost no adherence to cultured epithelial cells but adheres well in pig ligated intestines. This study investigated the mechanisms associated with the difference between in-vitro and in-vivo adherence of the MB culture. Methodology/Principal Findings: It was found that decreased adherence in vitro by bacteria grown in MB was mainly due to lactose, possibly implicating the involvement of carbon catabolite repression (CCR). Expression of selected virulence-related genes associated with adherence and CCR was then examined by quantitative PCR. When bacteria were grown in MB and Brain Heart Infusion with NaHCO3 (BHIN) plus lactose, pH was reduced to 5.5-5.9 and there was a significant decrease in expression of the locus of enterocyte effacement (LEE) genes eae, tir, espD, grlA/R and ler, and an increase in cya (cAMP), and two negative regulators of the LEE, gadE and hfq. Putative virulence genes stcE, hlyA, ent and nleA were also decreased in vitro. Reversal of these changes was noted for bacteria recovered from the intestine, where transcripts for qseF and fis and putative virulence factors AidA15, TerC and Ent/EspL2 were significantly increased, and transcripts for AIDA48, Iha, UreC, Efa1A, Efa1B, ToxB, EhxA, StcE, NleA and NleB were expressed at high levels. Conclusions/Significance: Presence of lactose resulted in decreased expression of LEE genes and the failure of EHEC O157: H7 to adhere to epithelial cells in vitro but this repression was overcome in vivo. CCR and/or acidic pH may have played a role in repression of the LEE genes. Bacterial pathogens need to integrate their nutritional metabolism with expression of virulence genes but little is known of how this is done in E. coli O157: H7. This study indicates one aspect of the subject that should be investigated further.	[Yin, Xianhua; Chambers, James R.; Gong, Joshua] Agr & Agri Food Canada, Guelph Food Res Ctr, Guelph, ON, Canada; [Zhu, Jing] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Feng, Yanni] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao, Peoples R China; [Yin, Xianhua; Gyles, Carlton L.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada	Agriculture & Agri Food Canada; Shanghai Jiao Tong University; Qingdao Agricultural University; University of Guelph	Yin, XH (corresponding author), Agr & Agri Food Canada, Guelph Food Res Ctr, Guelph, ON, Canada.	cgyles@ovc.uoguelph.ca		Feng, Yanni/0000-0002-3590-788X	Guelph Food Research Centre, Agriculture and Agri-Food Canada	Guelph Food Research Centre, Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	The research was supported financially by Guelph Food Research Centre, Agriculture and Agri-Food Canada. There is no grant number. The URL is http://www4.agr.gc.ca/AAFC-AAC/display-afficher. do?id=1180620168432. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea L, 2003, MICROB PATHOGENESIS, V34, P205, DOI 10.1016/S0882-4010(03)00026-3; Balsalobre C, 2006, J BACTERIOL, V188, P5935, DOI 10.1128/JB.00235-06; Barba J, 2005, J BACTERIOL, V187, P7918, DOI 10.1128/JB.187.23.7918-7930.2005; Brinkman AB, 2003, MOL MICROBIOL, V48, P287, DOI 10.1046/j.1365-2958.2003.03442.x; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; Coldewey SM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-21; Coombes BK, 2008, APPL ENVIRON MICROB, V74, P2153, DOI 10.1128/AEM.02566-07; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349; Dong T, 2009, MOL GENET GENOMICS, V281, P19, DOI 10.1007/s00438-008-0389-3; Dziva F, 2007, FEMS MICROBIOL LETT, V271, P258, DOI 10.1111/j.1574-6968.2007.00724.x; Elliott SJ, 1999, MOL MICROBIOL, V33, P1176, DOI 10.1046/j.1365-2958.1999.01559.x; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Freestone PPE, 2008, TRENDS MICROBIOL, V16, P55, DOI 10.1016/j.tim.2007.11.005; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; Gruenheid S, 2004, MOL MICROBIOL, V51, P1233, DOI 10.1046/j.1365-2958.2003.03911.x; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Hansen AM, 2009, MOL MICROBIOL, V73, P446, DOI 10.1111/j.1365-2958.2009.06781.x; Hogema BM, 1997, MOL MICROBIOL, V24, P857, DOI 10.1046/j.1365-2958.1997.3991761.x; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; KAILASAN V, 2009, J BACTERIOLOGY, V0191; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; Lim JY, 2010, J MICROBIOL BIOTECHN, V20, P5, DOI 10.4014/jmb.0908.08007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Z, 2003, MOL MICROBIOL, V49, P1309, DOI 10.1046/j.1365-2958.2003.03633.x; Maurer JJ, 1999, APPL ENVIRON MICROB, V65, P2954; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Mellies JL, 1999, MOL MICROBIOL, V33, P296, DOI 10.1046/j.1365-2958.1999.01473.x; Metzner M, 2004, MOL MICROBIOL, V51, P799, DOI 10.1046/j.1365-2958.2003.03867.x; Mika F, 2005, GENE DEV, V19, P2770, DOI 10.1101/gad.353705; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Muffler A, 1996, GENE DEV, V10, P1143, DOI 10.1101/gad.10.9.1143; Muller CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000303; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; PEASE AJ, 1994, J BACTERIOL, V176, P115, DOI 10.1128/JB.176.1.115-122.1994; Perna NT, 2002, ESCHERICHIA COLI VIR, P3; Poncet S, 2009, CONTRIB MICROBIOL, V16, P88, DOI 10.1159/000219374; Pullinger GD, 2010, INFECT IMMUN, V78, P372, DOI 10.1128/IAI.01203-09; Rashid RA, 2006, INFECT IMMUN, V74, P4142, DOI 10.1128/IAI.00299-06; Reading NC, 2007, J BACTERIOL, V189, P2468, DOI 10.1128/JB.01848-06; Reading NC, 2009, P NATL ACAD SCI USA, V106, P5889, DOI 10.1073/pnas.0811409106; Shakhnovich EA, 2009, MOL MICROBIOL, V74, P347, DOI 10.1111/j.1365-2958.2009.06856.x; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Sperandio V, 2001, J BACTERIOL, V183, P5187, DOI 10.1128/JB.183.17.5187-5197.2001; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Stevens MP, 2004, INFECT IMMUN, V72, P5402, DOI 10.1128/IAI.72.9.5402-5411.2004; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Tatsuno I, 2003, INFECT IMMUN, V71, P2598, DOI 10.1128/IAI.71.5.2598-2606.2003; Taylor DE, 2002, J BACTERIOL, V184, P4690, DOI 10.1128/JB.184.17.4690-4698.2002; Toma C, 2004, J CLIN MICROBIOL, V42, P4937, DOI 10.1128/JCM.42.11.4937-4946.2004; Torres AG, 2007, INT J MED MICROBIOL, V297, P177, DOI 10.1016/j.ijmm.2007.01.005; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Walters M, 2006, INFECT IMMUN, V74, P5445, DOI 10.1128/IAI.00099-06; Wickham ME, 2006, J INFECT DIS, V194, P819, DOI 10.1086/506620; YIN X, 2010, J VET RES IN PRESS; Yin XH, 2009, APPL ENVIRON MICROB, V75, P5779, DOI 10.1128/AEM.00507-09; Yin XH, 2009, APPL ENVIRON MICROB, V75, P4975, DOI 10.1128/AEM.00297-09; Zhang LH, 2004, INFECT IMMUN, V72, P7282, DOI 10.1128/IAI.72.12.7282-7293.2004; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	68	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17424	10.1371/journal.pone.0017424	http://dx.doi.org/10.1371/journal.pone.0017424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387009	Green Published, gold, Green Submitted			2022-12-25	WOS:000287931400074
J	Zhu, T; Tian, JA; Zhang, SY; Wu, NF; Fan, YL				Zhu, Tao; Tian, Jian; Zhang, Shuangyu; Wu, Ningfeng; Fan, Yunliu			Identification of the Transcriptional Regulator NcrB in the Nickel Resistance Determinant of Leptospirillum ferriphilum UBK03	PLOS ONE			English	Article							ONE-HYBRID SYSTEM; ESCHERICHIA-COLI; STREPTOMYCES-COELICOLOR; ALCALIGENES-EUTROPHUS; HELICOBACTER-PYLORI; XYLOSOXIDANS 31A; COBALT; GENE; BIOOXIDATION; CADMIUM	The nickel resistance determinant ncrABCY was identified in Leptospirillum ferriphilum UBK03. Within this operon, ncrA and ncrC encode two membrane proteins that form an efflux system, and ncrB encodes NcrB, which belongs to an uncharacterized family (DUF156) of proteins. How this determinant is regulated remains unknown. Our data indicate that expression of the nickel resistance determinant is induced by nickel. The promoter of ncrA, designated pncrA, was cloned into the promoter probe vector pPR9TT, and co-transformed with either a wild-type or mutant nickel resistance determinant. The results revealed that ncrB encoded a transcriptional regulator that could regulate the expression of ncrA, ncrB, and ncrC. A GC-rich inverted repeat sequence was identified in the promoter pncrA. Electrophoretic mobility shift assays (EMSAs) and footprinting assays showed that purified NcrB could specifically bind to the inverted repeat sequence of pncrA in vitro; this was confirmed by bacterial one-hybrid analysis. Moreover, this binding was inhibited in the presence of nickel ions. Thus, we classified NcrB as a transcriptional regulator that recognizes the inverted repeat sequence binding motif to regulate the expression of the key nickel resistance gene, ncrA.	[Zhu, Tao; Tian, Jian; Zhang, Shuangyu; Wu, Ningfeng; Fan, Yunliu] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Zhu, T (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China.	wunf@caas.net.cn	Zhu, Tao/I-5069-2019; , 田健/AAX-7731-2020; Tian, Jian/D-1052-2011	Zhu, Tao/0000-0003-0228-3916; , 田健/0000-0002-9997-6518; Tian, Jian/0000-0002-9997-6518	National Natural Science Foundation of China [30770038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant no. 30770038) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YJ, 2008, ACTA CRYSTALLOGR F, V64, P130, DOI 10.1107/S1744309108001760; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Coram NJ, 2002, APPL ENVIRON MICROB, V68, P838, DOI 10.1128/AEM.68.2.838-845.2002; EITINGER T, 1994, MOL MICROBIOL, V12, P1025, DOI 10.1111/j.1365-2958.1994.tb01090.x; Ernst FD, 2005, INFECT IMMUN, V73, P7252, DOI 10.1128/IAI.73.11.7252-7258.2005; Grass G, 2000, J BACTERIOL, V182, P1390, DOI 10.1128/JB.182.5.1390-1398.2000; Grass G, 2001, J BACTERIOL, V183, P2803, DOI 10.1128/JB.183.9.2803-2807.2001; Grosse C, 1999, J BACTERIOL, V181, P2385; Haritha A, 2009, J BACTERIOL, V191, P5976, DOI 10.1128/JB.00465-09; Hebbeln P, 2004, FEMS MICROBIOL LETT, V230, P129, DOI 10.1016/S0378-1097(03)00885-1; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Iwig JS, 2006, MOL MICROBIOL, V62, P252, DOI 10.1111/j.1365-2958.2006.05369.x; Kunito T, 1996, BIOSCI BIOTECH BIOCH, V60, P699, DOI 10.1271/bbb.60.699; LATCHMAN D, 1999, TRANSCRIPTION FACTOR; Li R, 2010, MOL MICROBIOL, V75, P349, DOI 10.1111/j.1365-2958.2009.06968.x; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng XD, 2005, NAT BIOTECHNOL, V23, P988, DOI 10.1038/nbt1120; Meng X, 2006, NAT PROTOC, V1, P30, DOI 10.1038/nprot.2006.6; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mulrooney SB, 2003, FEMS MICROBIOL REV, V27, P239, DOI 10.1016/S0168-6445(03)00042-1; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; NIES DH, 1995, J IND MICROBIOL, V14, P186, DOI 10.1007/BF01569902; NIES DH, 1992, PLASMID, V27, P17, DOI 10.1016/0147-619X(92)90003-S; NIES DH, 2007, MOL MICROBIOLOGY HEA; Quatrini R, 2007, NUCLEIC ACIDS RES, V35, P2153, DOI 10.1093/nar/gkm068; Rawlings DE, 1999, MICROBIOL-UK, V145, P5, DOI 10.1099/13500872-145-1-5; Rodrigue A, 2005, J BACTERIOL, V187, P2912, DOI 10.1128/JB.187.8.2912-2916.2005; Santos PM, 2001, FEMS MICROBIOL LETT, V195, P91, DOI 10.1111/j.1574-6968.2001.tb10503.x; SCHMIDT T, 1994, J BACTERIOL, V176, P7045, DOI 10.1128/JB.176.22.7045-7054.1994; Siunova T V, 2009, Genetika, V45, P336; Stahler FN, 2006, INFECT IMMUN, V74, P3845, DOI 10.1128/IAI.02025-05; Stoof J, 2010, BIOMETALS, V23, P145, DOI 10.1007/s10534-009-9275-7; Tian J, 2007, APPL ENVIRON MICROB, V73, P2364, DOI 10.1128/AEM.00207-07; Tuffin IM, 2006, APPL ENVIRON MICROB, V72, P2247, DOI 10.1128/AEM.72.3.2247-2253.2006; Yang H, 2007, MOL MICROBIOL, V65, P1064, DOI 10.1111/j.1365-2958.2007.05848.x	37	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17367	10.1371/journal.pone.0017367	http://dx.doi.org/10.1371/journal.pone.0017367			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387010	Green Published, Green Submitted, gold			2022-12-25	WOS:000287931400064
J	Cavel, E; Pillot, M; Pontier, D; Lahmy, S; Bies-Etheve, N; Vega, D; Grimanelli, D; Lagrange, T				Cavel, Emilie; Pillot, Marion; Pontier, Dominique; Lahmy, Sylvie; Bies-Etheve, Natacha; Vega, Danielle; Grimanelli, Daniel; Lagrange, Thierry			A Plant-Specific Transcription Factor IIB-Related Protein, pBRP2, Is Involved in Endosperm Growth Control	PLOS ONE			English	Article							RNA-POLYMERASE-II; TFIIB-RELATED PROTEIN; SEED DEVELOPMENT; CORE PROMOTER; ARABIDOPSIS; DNA; EXPRESSION; IV; COMPLEX; ELEMENT	General transcription factor IIB (TFIIB) and TFIIB-related factor (BRF), are conserved RNA polymerase II/III (RNAPII/III) selectivity factors that are involved in polymerase recruitment and transcription initiation in eukaryotes. Recent findings have shown that plants have evolved a third type of B-factor, plant-specific TFIIB-related protein 1 (pBRP1), which seems to be involved in RNAPI transcription. Here, we extend the repertoire of B-factors in plants by reporting the characterization of a novel TFIIB-related protein, plant-specific TFIIB-related protein 2 (pBRP2), which is found to date only in the Brassicacea family. Unlike other B-factors that are ubiquitously expressed, PBRP2 expression is restricted to reproductive organs and seeds as shown by RT-PCR, immunofluorescence labelling and GUS staining experiments. Interestingly, pbrp2 loss-of-function specifically affects the development of the syncytial endosperm, with both parental contributions required for wild-type development. pBRP2, is the first B-factor to exhibit cell-specific expression and regulation in eukaryotes, and might play a role in enforcing bi-parental reproduction in angiosperms.	[Cavel, Emilie; Pontier, Dominique; Lahmy, Sylvie; Bies-Etheve, Natacha; Vega, Danielle; Lagrange, Thierry] Univ Perpignan, Lab Genome & Dev Plantes, CNRS, Inst Rech Dev, F-66025 Perpignan, France; [Pillot, Marion; Grimanelli, Daniel] Inst Rech Dev, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Perpignan Via Domitia; Institut de Recherche pour le Developpement (IRD)	Cavel, E (corresponding author), Umea Univ, Dept Plant Physiol, S-90187 Umea, Sweden.	daniel.grimanelli@ird.fr; lagrange@univ-perp.fr	Grimanelli, Daniel/ABE-4777-2020	Pontier, Dominique/0000-0001-9032-4620; Grimanelli, Daniel/0000-0001-5424-114X; Lagrange, Thierry/0000-0003-3090-0918	Centre National de la Recherche Scientifique (CNRS); Ministere de la Recherche et de l'Enseignement Superieur (MRES); Institut de Recherche et Developpement (IRD); Agence Nationale de la Recherche (ANR) [ANR-BLANC-07]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de la Recherche et de l'Enseignement Superieur (MRES); Institut de Recherche et Developpement (IRD); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by Centre National de la Recherche Scientifique (CNRS) and Ministere de la Recherche et de l'Enseignement Superieur (MRES) funding to TL and EC, and by Institut de Recherche et Developpement (IRD) and Agence Nationale de la Recherche (ANR) (ANR-BLANC-07) funding to DG and MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baroux C, 2007, CURR OPIN GENET DEV, V17, P473, DOI 10.1016/j.gde.2007.09.004; Bass HW, 1997, J CELL BIOL, V137, P5, DOI 10.1083/jcb.137.1.5; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Boisnard-Lorig C, 2001, PLANT CELL, V13, P495, DOI 10.1105/tpc.13.3.495; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Gazdag E, 2009, GENE DEV, V23, P2210, DOI 10.1101/gad.535209; Haig D, 2006, NAT GENET, V38, P271, DOI 10.1038/ng0306-271; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Imamura S, 2008, EMBO J, V27, P2317, DOI 10.1038/emboj.2008.151; KANNO T, 2005, NAT GENET, V37, P61; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lagrange T, 2003, MOL CELL BIOL, V23, P3274, DOI 10.1128/MCB.23.9.3274-3286.2003; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; MULLER F, 2010, J BIOL, V8, P97; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Nowack MK, 2007, NATURE, V447, P312, DOI 10.1038/nature05770; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Reina JH, 2007, GENE DEV, V21, P2855, DOI 10.1101/gad.1623207; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Schramm L, 2000, GENE DEV, V14, P2650, DOI 10.1101/gad.836400; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; SURANI MAH, 1987, NATURE, V326, P395, DOI 10.1038/326395a0; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188	33	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17216	10.1371/journal.pone.0017216	http://dx.doi.org/10.1371/journal.pone.0017216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390310	Green Submitted, Green Published, gold			2022-12-25	WOS:000287761700036
J	FitzGerald, J; Moureau, S; Drogaris, P; O'Connell, E; Abshiru, N; Verreault, A; Thibault, P; Grenon, M; Lowndes, NF				FitzGerald, Jennifer; Moureau, Sylvie; Drogaris, Paul; O'Connell, Enda; Abshiru, Nebiyu; Verreault, Alain; Thibault, Pierre; Grenon, Muriel; Lowndes, Noel F.			Regulation of the DNA Damage Response and Gene Expression by the Dot1L Histone Methyltransferase and the 53Bp1 Tumour Suppressor	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; SILENCING PROTEIN; MAMMALIAN-CELLS; ENAC-ALPHA; METHYLATION; CHROMATIN; H3; NUCLEOSOME; LYSINE-79; DIMETHYLATION	Background: Dot1L, a histone methyltransferase that targets histone H3 lysine 79 (H3K79), has been implicated in gene regulation and the DNA damage response although its functions in these processes remain poorly defined. Methodology/Principal Findings: Using the chicken DT40 model system, we generated cells in which the Dot1L gene is disrupted to examine the function and focal recruitment of the 53Bp1 DNA damage response protein. Detailed kinetic and dose response assays demonstrate that, despite the absence of H3K79 methylation demonstrated by mass spectrometry, 53Bp1 focal recruitment is not compromised in these cells. We also describe, for the first time, the phenotypes of a cell line lacking both Dot1L and 53Bp1. Dot1L(-/-) and wild type cells are equally resistant to ionising radiation, whereas 53Bp1(-/-)/Dot1L(-/-) cells display a striking DNA damage resistance phenotype. Dot1L and 53Bp1 also affect the expression of many genes. Loss of Dot1L activity dramatically alters the mRNA levels of over 1200 genes involved in diverse biological functions. These results, combined with the previously reported list of differentially expressed genes in mouse ES cells knocked down for Dot1L, demonstrates surprising cell type and species conservation of Dot1L-dependent gene expression. In 53Bp1(-/-) cells, over 300 genes, many with functions in immune responses and apoptosis, were differentially expressed. To date, this is the first global analysis of gene expression in a 53Bp1-deficient cell line. Conclusions/Significance: Taken together, our results uncover a negative role for Dot1L and H3K79 methylation in the DNA damage response in the absence of 53Bp1. They also enlighten the roles of Dot1L and 53Bp1 in gene expression and the control of DNA double-strand repair pathways in the context of chromatin.	[FitzGerald, Jennifer; Moureau, Sylvie; Grenon, Muriel; Lowndes, Noel F.] Natl Univ Ireland Galway, Ctr Chromosome Biol, Genome Stabil Lab, Sch Nat Sci, Galway, Ireland; [O'Connell, Enda] Natl Univ Ireland Galway, Natl Ctr Biomed Engn Sci, Galway, Ireland; [Drogaris, Paul; Abshiru, Nebiyu; Verreault, Alain; Thibault, Pierre] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Verreault, Alain] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada; [Thibault, Pierre] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Universite de Montreal; Universite de Montreal; Universite de Montreal	FitzGerald, J (corresponding author), Natl Univ Ireland Galway, Ctr Chromosome Biol, Genome Stabil Lab, Sch Nat Sci, Galway, Ireland.	muriel.grenon@nuigalway.ie; noel.lowndes@nuigalway.ie	Grenon, Muriel/D-5228-2011; Lowndes, Noel F/B-9084-2008	Lowndes, Noel F/0000-0002-3216-4427; O'Connell, Enda/0000-0001-7441-0262; Thibault, Pierre/0000-0001-5993-0331; Grenon, Muriel/0000-0002-9910-5974	Irish Research Council for Science, Engineering and Technology; European Union [F16R-CT-2003-508842]; Science Foundation Ireland [07/IN1/B958]; Canadian Institutes for Health Research [FRN 89928]; Natural Sciences and Engineering Research Council of Canada; Canadian Centre of Excellence in Commercialisation and Research; Canadian Foundation for Innovation; Fonds de Recherche en Sante du Quebec; Cancer Research Ireland [CR105GRE]	Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); European Union(European Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Centre of Excellence in Commercialisation and Research; Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Cancer Research Ireland	This work was supported by an Irish Research Council for Science, Engineering and Technology (http://www.ircset.ie/) grant to JF, a Cancer Research Ireland project grant (http://www.cancer.ie/) to MG (CR105GRE), the European Union FP6 Integrated Project "Radiosensitivity of Individuals and Susceptibility to Cancer induced by Ionising RADiations" (http://www.riscrad.org/) contract number F16R-CT-2003-508842 and Science Foundation Ireland (http://www.sfi.ie/) Principal Investigator award 07/IN1/B958 to NL. AV's laboratory is funded by the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/) grant FRN 89928. PT's research is funded by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/). IRIC's infrastructure is supported by funds from the Canadian Centre of Excellence in Commercialisation and Research, the Canadian Foundation for Innovation, and the Fonds de Recherche en Sante du Quebec. The funding agencies played no role in experimental design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; ARAKAWA H, 2001, BMC BIOTECHNOLOGY, V1; Barry ER, 2009, STEM CELLS, V27, P1538, DOI 10.1002/stem.86; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; BREE RT, 2007, CELL CYCLE, V10, P6; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; BUNTING SF, 2010, CELL; Costelloe T, 2006, EXP CELL RES, V312, P2677, DOI 10.1016/j.yexcr.2006.06.031; Dlakic M, 2001, TRENDS BIOCHEM SCI, V26, P405, DOI 10.1016/S0968-0004(01)01856-4; Downs JA, 2003, MOL CELL, V11, P1685, DOI 10.1016/S1097-2765(03)00197-7; Drogaris P, 2009, ANAL CHEM, V81, P6300, DOI 10.1021/ac9004259; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Grenon M, 2007, YEAST, V24, P105, DOI 10.1002/yea.1441; Habermann FA, 2001, CHROMOSOME RES, V9, P569, DOI 10.1023/A:1012447318535; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; *INT CHICK GEN SEQ, 2004, SEQ COMP AN CHICK GE, P695; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Iwabuchi K, 1998, J BIOL CHEM, V273, P26061, DOI 10.1074/jbc.273.40.26061; Janzen CJ, 2006, MOL CELL, V23, P497, DOI 10.1016/j.molcel.2006.06.027; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Lin YH, 2009, BLOOD, V114, P651, DOI 10.1182/blood-2009-03-209395; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Martino F, 2009, MOL CELL, V33, P323, DOI 10.1016/j.molcel.2009.01.009; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Nakamura K, 2006, DNA REPAIR, V5, P741, DOI 10.1016/j.dnarep.2006.03.008; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Osborne EA, 2009, NAT GENET, V41, P800, DOI 10.1038/ng.402; PAIK WK, 1975, FEBS LETT, V58, P39, DOI 10.1016/0014-5793(75)80220-1; Rauch T, 2005, CELL CYCLE, V4, P1078; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Saba J, 2009, J PROTEOME RES, V8, P3355, DOI 10.1021/pr801106a; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; SCHULZE JM, 2009, MOL CELL; Shanower GA, 2005, GENETICS, V169, P173, DOI 10.1534/genetics.104.033191; Singer MS, 1998, GENETICS, V150, P613; Smith J, 2000, ANIM GENET, V31, P96, DOI 10.1046/j.1365-2052.2000.00565.x; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Verzijlbergen KF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-76; Winding P, 2001, J IMMUNOL METHODS, V249, P1, DOI 10.1016/S0022-1759(00)00333-1; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200; Zhang KL, 2004, PROTEOMICS, V4, P3765, DOI 10.1002/pmic.200400819; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200; Zhang WZ, 2006, AM J PHYSIOL-CELL PH, V290, pC936, DOI 10.1152/ajpcell.00431.2005; Zhang WZ, 2004, BIOCHEM J, V377, P641, DOI 10.1042/BJ20030839; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	69	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e14714	10.1371/journal.pone.0014714	http://dx.doi.org/10.1371/journal.pone.0014714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383990	Green Published, Green Submitted, gold			2022-12-25	WOS:000287761700003
J	Lubell, Y; Staedke, SG; Greenwood, BM; Kamya, MR; Molyneux, M; Newton, PN; Reyburn, H; Snow, RW; D'Alessandro, U; English, M; Day, N; Kremsner, P; Dondorp, A; Mbacham, W; Dorsey, G; Owusu-Agyei, S; Maitland, K; Krishna, S; Newton, C; Pasvol, G; Taylor, T; von Seidlein, L; White, NJ; Binka, F; Mills, A; Whitty, CJM				Lubell, Yoel; Staedke, Sarah G.; Greenwood, Brian M.; Kamya, Moses R.; Molyneux, Malcolm; Newton, Paul N.; Reyburn, Hugh; Snow, Robert W.; D'Alessandro, Umberto; English, Mike; Day, Nick; Kremsner, Peter; Dondorp, Arjen; Mbacham, Wilfred; Dorsey, Grant; Owusu-Agyei, Seth; Maitland, Kathryn; Krishna, Sanjeev; Newton, Charles; Pasvol, Geoffrey; Taylor, Terrie; von Seidlein, Lorenz; White, Nicholas J.; Binka, Fred; Mills, Anne; Whitty, Christopher J. M.			Likely Health Outcomes for Untreated Acute Febrile Illness in the Tropics in Decision and Economic Models; A Delphi Survey	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; COST-EFFECTIVENESS; COMBINATION THERAPY; SOUTH-AFRICA; MALARIA; CHILDREN	Background: Modelling is widely used to inform decisions about management of malaria and acute febrile illnesses. Most models depend on estimates of the probability that untreated patients with malaria or bacterial illnesses will progress to severe disease or death. However, data on these key parameters are lacking and assumptions are frequently made based on expert opinion. Widely diverse opinions can lead to conflicting outcomes in models they inform. Methods and Findings: A Delphi survey was conducted with malaria experts aiming to reach consensus on key parameters for public health and economic models, relating to the outcome of untreated febrile illnesses. Survey questions were stratified by malaria transmission intensity, patient age, and HIV prevalence. The impact of the variability in opinion on decision models is illustrated with a model previously used to assess the cost-effectiveness of malaria rapid diagnostic tests. Some consensus was reached around the probability that patients from higher transmission settings with untreated malaria would progress to severe disease (median 3%, inter-quartile range (IQR) 1-5%), and the probability that a non-malaria illness required antibiotics in areas of low HIV prevalence (median 20%). Children living in low transmission areas were considered to be at higher risk of progressing to severe malaria (median 30%, IQR 10-58%) than those from higher transmission areas (median 13%, IQR 7-30%). Estimates of the probability of dying from severe malaria were high in all settings (medians 60-73%). However, opinions varied widely for most parameters, and did not converge on resurveying. Conclusions: This study highlights the uncertainty around potential consequences of untreated malaria and bacterial illnesses. The lack of consensus on most parameters, the wide range of estimates, and the impact of variability in estimates on model outputs, demonstrate the importance of sensitivity analysis for decision models employing expert opinion. Results of such models should be interpreted cautiously. The diversity of expert opinion should be recognised when policy options are debated.	[Lubell, Yoel; Staedke, Sarah G.; Greenwood, Brian M.; Reyburn, Hugh; Mills, Anne; Whitty, Christopher J. M.] London Sch Hyg & Trop Med, London WC1, England; [Lubell, Yoel; Day, Nick; Dondorp, Arjen; White, Nicholas J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Kamya, Moses R.] Makerere Univ, Sch Med, Dept Med, Kampala, Uganda; [Staedke, Sarah G.] Univ Calif San Francisco, Res Collaborat, Mulago Hosp, Kampala, Uganda; [Molyneux, Malcolm] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi; [Newton, Paul N.] Mahosot Hosp, Wellcome Trust Mahosot Hosp, Oxford Trop Med Res Collaborat, Viangchan, Lao Pdr, Laos; [Newton, Paul N.; Snow, Robert W.; White, Nicholas J.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [Reyburn, Hugh] Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania; [Snow, Robert W.; English, Mike] Kenya Govt Med Res Ctr, Ctr Geog Med, Malaria Publ Hlth & Epidemiol Grp, Nairobi, Kenya; [D'Alessandro, Umberto] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Kremsner, Peter] Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; [Kremsner, Peter] Univ Tubingen, Inst Tropenmed, Tubingen, Germany; [Mbacham, Wilfred] Univ Yaounde, Ctr Biotechnol, Yaounde, Cameroon; [Dorsey, Grant] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA; [Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Ghana Hlth Serv, Kintampo, Ghana; [Maitland, Kathryn; Newton, Charles] Ctr Geog Med Res Coast, Kenya Med Res Inst, Wellcome Trust Res Programme, Kilifi, Kenya; [Krishna, Sanjeev] St George Hosp, Sch Med, Fac Med & Biomed Sci, London, England; [Pasvol, Geoffrey] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Taylor, Terrie] Coll Med, Blantyre Malaria Project, Blantyre, Malawi; [Taylor, Terrie] Michigan State Univ, Coll Osteopath Med, Dept Internal Med, E Lansing, MI 48824 USA; [von Seidlein, Lorenz] Hosp Teule, Joint Malaria Programme, Muheza, Tanzania; [Binka, Fred] Demog Evaluat Populat & Their Hlth Developing Cou, Int Network, Accra, Ghana	University of London; London School of Hygiene & Tropical Medicine; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Makerere University; Mulago National Referral Hospital; University of Malawi; University of Oxford; Kilimanjaro Christian Medical Centre; Kenya Medical Research Institute; Institute of Tropical Medicine (ITM); Eberhard Karls University of Tubingen; University of Yaounde I; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Ghana Health Service; Kintampo Health Research Centre; Kenya Medical Research Institute; St Georges University London; Imperial College London; University of Malawi; Michigan State University; Michigan State University College of Osteopathic Medicine	Lubell, Y (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	yoel@tropmedres.ac	White, Nick/AAC-6527-2019; White, Nicholas J/I-4629-2012; Newton, Charles RJC/B-7578-2014; Snow, Robert William/AFR-1436-2022; Newton, Charles/V-7872-2019; Whitty, Christopher/C-7740-2012; D'Alessandro, Umberto/D-3457-2015	White, Nick/0000-0002-1897-1978; Newton, Charles RJC/0000-0002-6999-5507; Snow, Robert William/0000-0003-3725-6088; Newton, Charles/0000-0002-6999-5507; D'Alessandro, Umberto/0000-0001-6341-5009; Lubell, Yoel/0000-0002-0237-1070; Whitty, Christopher/0000-0002-6076-5027; Maitland, Kathryn/0000-0002-0007-0645; Newton, Paul/0000-0002-4608-6431; Mbacham, Wilfred/0000-0002-3934-3233; English, Michael/0000-0002-7427-0826; Mills, Anne/0000-0001-9863-9950; Krishna, Sanjeev/0000-0003-0066-0634; Owusu-Agyei, Seth/0000-0002-0807-1781	Bill & Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine	Bill & Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine	This research was supported by the ACT Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WORLD MAL REP 2009; Bachmann MO, 2006, AIDS CARE, V18, P109, DOI 10.1080/09540120500159334; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BRUCE-CHWATT L J, 1954, Br Med J, V1, P169; BUTTERWORTH T, 1995, J ADV NURS, V22, P24, DOI 10.1046/j.1365-2648.1995.22010024.x; Coleman PG, 2004, AM J TROP MED HYG, V71, P196, DOI 10.4269/ajtmh.2004.71.196; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Evans D, 2003, J CLIN NURS, V12, P77, DOI 10.1046/j.1365-2702.2003.00662.x; Goodman CA, 1999, LANCET, V354, P378, DOI 10.1016/S0140-6736(99)02141-8; Goodman CA, 2001, TROP MED INT HEALTH, V6, P280, DOI 10.1046/j.1365-3156.2001.00700.x; Graham B, 2003, J CLIN EPIDEMIOL, V56, P1150, DOI 10.1016/S0895-4356(03)00211-7; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Haynes RB, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-3; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Lubell Y, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-21; Morel C. M, 2005, BMJ-BRIT MED J; Muheki C, 2004, TROP MED INT HEALTH, V9, P959, DOI 10.1111/j.1365-3156.2004.01292.x; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; SUDRE P, 1992, INT J EPIDEMIOL, V21, P146, DOI 10.1093/ije/21.1.146; Suputtamongkol Y, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000610; White NJ, 2003, AM J RESP CRIT CARE, V167, P673, DOI 10.1164/rccm.2212001; *WHO, 2000, MAN SEV MAL	29	42	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17439	10.1371/journal.pone.0017439	http://dx.doi.org/10.1371/journal.pone.0017439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	726XY	21390277	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000287761700057
J	Nagata-Kuroiwa, R; Furutani, N; Hara, J; Hondo, M; Ishii, M; Abe, T; Mieda, M; Tsujino, N; Motoike, T; Yanagawa, Y; Kuwaki, T; Yamamoto, M; Yanagisawa, M; Sakurai, T				Nagata-Kuroiwa, Ruby; Furutani, Naoki; Hara, Junko; Hondo, Mari; Ishii, Makoto; Abe, Tomomi; Mieda, Michihiro; Tsujino, Natsuko; Motoike, Toshiyuki; Yanagawa, Yuchio; Kuwaki, Tomoyuki; Yamamoto, Miyuki; Yanagisawa, Masashi; Sakurai, Takeshi			Critical Role of Neuropeptides B/W Receptor 1 Signaling in Social Behavior and Fear Memory	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; AMYGDALA; GPR7; IDENTIFICATION; ANXIETY; SOMATOSTATIN; LIGANDS; NUCLEUS; MODEL	Neuropeptide B/W receptor 1 (NPBWR1) is a G-protein coupled receptor, which was initially reported as an orphan receptor, and whose ligands were identified by this and other groups in 2002 and 2003. To examine the physiological roles of NPBWR1, we examined phenotype of Npbwr1(-/-) mice. When presented with an intruder mouse, Npbwr1(-/-) mice showed impulsive contact with the strange mice, produced more intense approaches toward them, and had longer contact and chasing time along with greater and sustained elevation of heart rate and blood pressure compared to wild type mice. Npbwr1(-/-) mice also showed increased autonomic and neuroendocrine responses to physical stress, suggesting that impairment of NPBWR1 leads to stress vulnerability. We also observed that these mice show abnormality in the contextual fear conditioning test. These data suggest that NPBWR1 plays a critical role in limbic system function and stress responses. Histological and electrophysiological studies showed that NPBWR1 acts as an inhibitory regulator on a subpopulation of GABAergic neurons in the lateral division of the CeA and terminates stress responses. These findings suggest important roles of NPBWR1 in regulating amygdala function during physical and social stress.	[Nagata-Kuroiwa, Ruby; Furutani, Naoki; Hara, Junko; Hondo, Mari; Abe, Tomomi; Mieda, Michihiro; Tsujino, Natsuko; Sakurai, Takeshi] Kanazawa Univ, Dept Mol Neurosci & Integrat Physiol, Fac Med, Kanazawa, Ishikawa, Japan; [Nagata-Kuroiwa, Ruby; Ishii, Makoto; Motoike, Toshiyuki; Yanagisawa, Masashi; Sakurai, Takeshi] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO Yanagisawa Orph, Tokyo, Japan; [Ishii, Makoto] Cornell Univ, New York Presbyterian Hosp, Dept Neurol, Weill Med Coll, New York, NY 10021 USA; [Motoike, Toshiyuki; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Motoike, Toshiyuki; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma 371, Japan; [Yanagawa, Yuchio] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Kuwaki, Tomoyuki] Kagoshima Univ, Dept Physiol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Yamamoto, Miyuki] Univ Tsukuba, Tsukuba, Ibaraki, Japan	Kanazawa University; Japan Science & Technology Agency (JST); Cornell University; NewYork-Presbyterian Hospital; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Gunma University; Japan Science & Technology Agency (JST); Kagoshima University; University of Tsukuba	Nagata-Kuroiwa, R (corresponding author), Kanazawa Univ, Dept Mol Neurosci & Integrat Physiol, Fac Med, Kanazawa, Ishikawa, Japan.	tsakurai@med.kanazawa-u.ac.jp	Kuwaki, Tomoyuki/B-3247-2019	Kuwaki, Tomoyuki/0000-0003-4226-3610; Mieda, Michihiro/0000-0002-2451-7034; Ishii, Makoto/0000-0003-3397-9908	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; ERATO from the Japan Science and Technology Agency; Takeda Science Foundation; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ERATO from the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas "System study on higher-order brain functions", the 21st Century COE Program for University of Tsukuba and Kanazawa University from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, ERATO from the Japan Science and Technology Agency, Takeda Science Foundation and Uehara Memorial Foundation. M.Y. is an investigator at the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouwknecht JA, 2007, NEUROSCI BIOBEHAV R, V31, P41, DOI 10.1016/j.neubiorev.2006.02.002; Brezillon S, 2003, J BIOL CHEM, V278, P776, DOI 10.1074/jbc.M206396200; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Ferry B, 1999, BIOL PSYCHIAT, V46, P1140, DOI 10.1016/S0006-3223(99)00157-2; Fujii R, 2002, J BIOL CHEM, V277, P34010, DOI 10.1074/jbc.M205883200; Hondo Mari, 2008, V46, P239, DOI 10.1007/400_2007_056; Ishii M, 2003, P NATL ACAD SCI USA, V100, P10540, DOI 10.1073/pnas.1334189100; Kalueff AV, 2007, BEHAV BRAIN RES, V179, P1, DOI 10.1016/j.bbr.2007.01.023; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Kitamura Y, 2006, BRAIN RES, V1093, P123, DOI 10.1016/j.brainres.2006.03.041; Lee DK, 1999, MOL BRAIN RES, V71, P96, DOI 10.1016/S0169-328X(99)00171-0; Machado CJ, 2006, BEHAV NEUROSCI, V120, P761, DOI 10.1037/0735-7044.120.4.761; Mason WA, 2006, EMOTION, V6, P73, DOI 10.1037/1528-3542.6.1.73; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; ODOWD BF, 1995, GENOMICS, V28, P84, DOI 10.1006/geno.1995.1109; Ramos A, 1997, BEHAV BRAIN RES, V85, P57, DOI 10.1016/S0166-4328(96)00164-7; Rogan MT, 2005, NEURON, V46, P309, DOI 10.1016/j.neuron.2005.02.017; RUSSELL JA, 1977, J RES PERS, V11, P273, DOI 10.1016/0092-6566(77)90037-X; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tanaka H, 2003, P NATL ACAD SCI USA, V100, P6251, DOI 10.1073/pnas.0837789100; Zhang W, 2010, J PHYSIOL-LONDON, V588, P4117, DOI 10.1113/jphysiol.2010.195099	24	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16972	10.1371/journal.pone.0016972	http://dx.doi.org/10.1371/journal.pone.0016972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390312	gold, Green Published			2022-12-25	WOS:000287761700024
J	Martin, C; Uribe, KB; Gomez-Bilbao, G; Ostolaza, H				Martin, Cesar; Uribe, Kepa B.; Gomez-Bilbao, Geraxane; Ostolaza, Helena			Adenylate Cyclase Toxin Promotes Internalisation of Integrins and Raft Components and Decreases Macrophage Adhesion Capacity	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; LIPID RAFTS; ESCHERICHIA-COLI; BACTERIAL INVASION; EPITHELIAL-CELLS; ALPHA-HEMOLYSIN; MEMBRANE RAFTS; INFECTION; CLATHRIN; PHOSPHORYLATION	Bordetella pertussis, the bacterium that causes whooping cough, secretes an adenylate cyclase toxin (ACT) that must be post-translationally palmitoylated in the bacterium cytosol to be active. The toxin targets phagocytes expressing the CD11b/CD18 integrin receptor. It delivers a catalytic adenylate cyclase domain into the target cell cytosol producing a rapid increase of intracellular cAMP concentration that suppresses bactericidal functions of the phagocyte. ACT also induces calcium fluxes into target cells. Biochemical, biophysical and cell biology approaches have been applied here to show evidence that ACT and integrin molecules, along with other raft components, are rapidly internalized by the macrophages in a toxin-induced calcium rise-dependent process. The toxin-triggered internalisation events occur through two different routes of entry, chlorpromazine-sensitive receptor-mediated endocytosis and clathrin-independent internalisation, maybe acting in parallel. ACT locates into raft-like domains, and is internalised, also in cells devoid of receptor. Altogether our results suggest that adenylate cyclase toxin, and maybe other homologous pathogenic toxins from the RTX (Repeats in Toxin) family to which ACT belongs, may be endowed with an intrinsic capacity to, directly and efficiently, insert into raft-like domains, promoting there its multiple activities. One direct consequence of the integrin removal from the cell surface of the macrophages is the hampering of their adhesion ability, a fundamental property in the immune response of the leukocytes that could be instrumental in the pathogenesis of Bordetella pertussis.	[Martin, Cesar] Univ Basque Country, Unidad Biofis, E-48080 Bilbao, Spain; Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Martin, C (corresponding author), Univ Basque Country, Unidad Biofis, E-48080 Bilbao, Spain.	gbzoseth@ehu.es	martin, cesar/L-1303-2014; Uribe, Kepa B./AGZ-5717-2022; Uribe, Kepa B./AAC-2163-2019	martin, cesar/0000-0002-4087-8729; Uribe, Kepa B./0000-0002-4502-4853; Uribe, Kepa B./0000-0002-4502-4853; OSTOLAZA ECHABE, ELENA AMAYA/0000-0003-2933-9975	Spanish Ministerio de Ciencia y Tecnologia [BFU 2007-62062]; Basque Government; University of Basque Country (UPV/EHU) [UE06/10]; University of Basque Country; Bizkaia Biophysics Foundation	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basque Government(Basque Government); University of Basque Country (UPV/EHU); University of Basque Country; Bizkaia Biophysics Foundation	This study was supported by grants from the Spanish Ministerio de Ciencia y Tecnologia (Project BFU 2007-62062), the Basque Government (ETORTEK Program), and the University of Basque Country (UPV/EHU, Project UE06/10). G. G. B. was the recipient of a pre-doctoral fellowship from the University of Basque Country and K. B. U. was the recipient of a fellowship from the Bizkaia Biophysics Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNAOUT MA, 1990, BLOOD, V75, P1037; Atapattu DN, 2007, INFECT IMMUN, V75, P4719, DOI 10.1128/IAI.00534-07; BENZ R, 1994, J BIOL CHEM, V269, P27231; Berkowitz S.A., 1980, ANN NY ACAD SCI, V1, P356, DOI DOI 10.1111/J.1749-6632.1980.TB29626.X6263154; BRETSCHER MS, 1992, EMBO J, V11, P383, DOI 10.1002/j.1460-2075.1992.tb05066.x; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; Bumba L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000901; BUYON JP, 1990, J IMMUNOL, V144, P191; Carbonetti NH, 2005, INFECT IMMUN, V73, P2698, DOI 10.1128/IAI.73.5.2698-2703.2005; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Eby JC, 2010, J BIOL CHEM, V285, P10662, DOI 10.1074/jbc.M109.089219; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; Fivaz M, 1999, TRENDS CELL BIOL, V9, P212, DOI 10.1016/S0962-8924(99)01567-6; Fong KP, 2006, CELL MICROBIOL, V8, P1753, DOI 10.1111/j.1462-5822.2006.00746.x; Gargalovic P, 2001, J BIOL CHEM, V276, P26164, DOI 10.1074/jbc.M011291200; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; Harder T, 2007, CURR OPIN IMMUNOL, V19, P470, DOI 10.1016/j.coi.2007.05.002; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; HEWLETT EL, 1989, J BIOL CHEM, V264, P19379; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Khelef N, 2001, CELL MICROBIOL, V3, P721, DOI 10.1046/j.1462-5822.2001.00151.x; Koschinski A, 2006, FASEB J, V20, P973, DOI 10.1096/fj.05-4561fje; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LADANT D, 1986, J BIOL CHEM, V261, P6264; Lafont F, 2005, CELL MICROBIOL, V7, P613, DOI 10.1111/j.1462-5822.2005.00515.x; Leitinger B, 2002, J CELL SCI, V115, P963; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; Martin C, 2004, J BACTERIOL, V186, P3760, DOI 10.1128/JB.186.12.3760-3765.2004; Martin C, 2010, J BIOL CHEM, V285, P357, DOI 10.1074/jbc.M109.003491; Mattoo S, 2001, FRONT BIOSCI-LANDMRK, V6, pE168, DOI 10.2741/Mattoo; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; MOUALLEM M, 1990, INFECT IMMUN, V58, P3759, DOI 10.1128/IAI.58.11.3759-3764.1990; Olsson S, 2006, MOL IMMUNOL, V43, P607, DOI 10.1016/j.molimm.2005.04.011; Paccani SR, 2008, INFECT IMMUN, V76, P2822, DOI 10.1128/IAI.00200-08; Pizarro-Cerda J, 2010, BIOESSAYS, V32, P496, DOI 10.1002/bies.200900172; ROGEL A, 1991, J BIOL CHEM, V266, P3154; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Uhlen P, 2000, NATURE, V405, P694, DOI 10.1038/35015091; van der Goot FG, 2004, J BIOL CHEM, V279, P47792, DOI 10.1074/jbc.M406824200; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; Vojtova J, 2006, MICROSC RES TECHNIQ, V69, P119, DOI 10.1002/jemt.20277; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85	49	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17383	10.1371/journal.pone.0017383	http://dx.doi.org/10.1371/journal.pone.0017383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383852	gold, Green Submitted, Green Published			2022-12-25	WOS:000287657500053
J	Ackerman, SH; Gatti, DL				Ackerman, Sharon H.; Gatti, Domenico L.			The Contribution of Coevolving Residues to the Stability of KDO8P Synthase	PLOS ONE			English	Article							3-DEOXY-D-MANNO-OCTULOSONATE 8-PHOSPHATE SYNTHASE; MULTIPLE SEQUENCE ALIGNMENTS; LOCALLY WEIGHTED REGRESSION; PROTEIN STABILITY; MUTUAL INFORMATION; ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; METAL; MUTATION; BINDING	Background: The evolutionary tree of 3-deoxy-D-manno-octulosonate 8-phosphate (KDO8P) synthase (KDO8PS), a bacterial enzyme that catalyzes a key step in the biosynthesis of bacterial endotoxin, is evenly divided between metal and non-metal forms, both having similar structures, but diverging in various degrees in amino acid sequence. Mutagenesis, crystallographic and computational studies have established that only a few residues determine whether or not KDO8PS requires a metal for function. The remaining divergence in the amino acid sequence of KDO8PSs is apparently unrelated to the underlying catalytic mechanism. Methodology/Principal Findings: The multiple alignment of all known KDO8PS sequences reveals that several residue pairs coevolved, an indication of their possible linkage to a structural constraint. In this study we investigated by computational means the contribution of coevolving residues to the stability of KDO8PS. We found that about 1/4 of all strongly coevolving pairs probably originated from cycles of mutation (decreasing stability) and suppression (restoring it), while the remaining pairs are best explained by a succession of neutral or nearly neutral covarions. Conclusions/Significance: Both sequence conservation and coevolution are involved in the preservation of the core structure of KDO8PS, but the contribution of coevolving residues is, in proportion, smaller. This is because small stability gains or losses associated with selection of certain residues in some regions of the stability landscape of KDO8PS are easily offset by a large number of possible changes in other regions. While this effect increases the tolerance of KDO8PS to deleterious mutations, it also decreases the probability that specific pairs of residues could have a strong contribution to the thermodynamic stability of the protein.	[Ackerman, Sharon H.; Gatti, Domenico L.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA; [Gatti, Domenico L.] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI USA	Wayne State University; Wayne State University	Ackerman, SH (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA.	dgatti@med.wayne.edu			U.S. Public Health Service [GM41857, GM69840]; Wayne State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069840] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Wayne State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by U.S. Public Health Service Grants GM41857 to SHA, GM69840 to DLG, and by a Wayne State University Research Enhancement Program in Computational Biology Grant to DLG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison TM, 2010, BBA-PROTEINS PROTEOM, V1804, P1526, DOI 10.1016/j.bbapap.2010.04.005; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Bowers K.J., 2006, P 2006 ACM IEEE C SU, DOI [10.1109/SC.2006.54, DOI 10.1109/SC.2006.54]; Brown CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010779; BYRD RH, 1994, MATH PROGRAM, V63, P129, DOI 10.1007/BF01582063; Caporaso JG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-327; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Chaparro-Riggers Javier F., 2007, Biotechnology Journal, V2, P180, DOI 10.1002/biot.200600170; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cochrane FC, 2009, J MOL BIOL, V390, P646, DOI 10.1016/j.jmb.2009.05.014; Codoner FM, 2008, EVOL BIOINFORM, V4, P29; Codoner FM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-106; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; Deutsch C, 2007, BIOINFORMATICS, V23, P3009, DOI 10.1093/bioinformatics/btm481; Duewel HS, 2001, J BIOL CHEM, V276, P8393, DOI 10.1074/jbc.M007884200; Duewel HS, 2000, J BIOL CHEM, V275, P22824, DOI 10.1074/jbc.M000133200; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Eddy S., 2001, HMMER USERS GUIDE BI; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Fernandes AD, 2010, BIOINFORMATICS, V26, P1135, DOI 10.1093/bioinformatics/btq111; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Gloor GB, 2010, MOL BIOL EVOL, V27, P1181, DOI 10.1093/molbev/msq004; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Horner DS, 2008, BRIEF BIOINFORM, V9, P46, DOI 10.1093/bib/bbm052; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Kiel C, 2006, J MOL BIOL, V355, P821, DOI 10.1016/j.jmb.2005.10.010; KLIG LS, 1988, GENETICS, V120, P651; Kona F, 2007, BIOCHEMISTRY-US, V46, P4532, DOI 10.1021/bi6024879; Kona F, 2009, BIOCHEMISTRY-US, V48, P3610, DOI 10.1021/bi801955h; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kowarsch A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000923; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; KULLBACK S, 1987, AM STAT, V41, P340; Kullback S., 1978, INFORM THEORY STAT; Lehmann M, 2001, CURR OPIN BIOTECH, V12, P371, DOI 10.1016/S0958-1669(00)00229-9; Lehmann M, 2000, BBA-PROTEIN STRUCT M, V1543, P408, DOI 10.1016/S0167-4838(00)00238-7; Li JJ, 2004, J AM CHEM SOC, V126, P7448, DOI 10.1021/ja0480872; Little DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004762; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Ludlam A, 2009, J BIOL CHEM, V284, P17138, DOI 10.1074/jbc.M109.002568; Buslje CM, 2009, BIOINFORMATICS, V25, P1125, DOI 10.1093/bioinformatics/btp135; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035; Mendes J, 2002, CURR OPIN STRUC BIOL, V12, P441, DOI 10.1016/S0959-440X(02)00345-7; Merlo LMF, 2007, P NATL ACAD SCI USA, V104, P10938, DOI 10.1073/pnas.0701900104; Nagatani RA, 2007, BIOCHEMISTRY-US, V46, P6688, DOI 10.1021/bi700507d; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohage EC, 1997, PROTEIN SCI, V6, P233; Oliynyk Z, 2004, PROTEIN ENG DES SEL, V17, P383, DOI 10.1093/protein/gzh046; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Pokala N, 2005, J MOL BIOL, V347, P203, DOI 10.1016/j.jmb.2004.12.019; Polizzi KM, 2007, CURR OPIN CHEM BIOL, V11, P220, DOI 10.1016/j.cbpa.2007.01.685; Poon A, 2005, GENETICS, V170, P1323, DOI 10.1534/genetics.104.037259; Poon A, 2005, GENETICS, V170, P989, DOI 10.1534/genetics.104.039438; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Press WH, 1992, NUMERICAL RECIPES C, P626; Radaev S, 2000, J BIOL CHEM, V275, P9476, DOI 10.1074/jbc.275.13.9476; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reza F. M., 1994, INTRO INFORM THEORY; Roca M, 2007, BIOCHEMISTRY-US, V46, P15076, DOI 10.1021/bi701732a; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shulami S, 2004, J BIOL CHEM, V279, P45110, DOI 10.1074/jbc.M404561200; Sigala PA, 2008, J AM CHEM SOC, V130, P13696, DOI 10.1021/ja803928m; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Tao P, 2010, J INORG BIOCHEM, V104, P1267, DOI 10.1016/j.jinorgbio.2010.08.008; Tao P, 2009, BIOCHEMISTRY-US, V48, P11706, DOI 10.1021/bi901341h; Tillier ERM, 2003, BIOINFORMATICS, V19, P750, DOI 10.1093/bioinformatics/btg072; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Wagner T, 2000, J MOL BIOL, V301, P233, DOI 10.1006/jmbi.2000.3956; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Warshel A, 2001, Q REV BIOPHYS, V34, P563, DOI 10.1017/S0033583501003730; Weil P, 2009, COMPUT BIOL CHEM, V33, P440, DOI 10.1016/j.compbiolchem.2009.10.003; Witten I. H., 2005, DATA MINING PRACTICA; YANOFSKY C, 1964, SCIENCE, V146, P1593, DOI 10.1126/science.146.3651.1593; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420, DOI 10.1063/1.1740409	106	14	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17459	10.1371/journal.pone.0017459	http://dx.doi.org/10.1371/journal.pone.0017459			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408011	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170900019
J	Amrouni, D; Meiller, A; Gautier-Sauvigne, S; Piraud, M; Bouteille, B; Vincendeau, P; Buguet, A; Cespuglio, R				Amrouni, Donia; Meiller, Anne; Gautier-Sauvigne, Sabine; Piraud, Monique; Bouteille, Bernard; Vincendeau, Philippe; Buguet, Alain; Cespuglio, Raymond			Cerebral Changes Occurring in Arginase and Dimethylarginine Dimethylaminohydrolase (DDAH) in a Rat Model of Sleeping Sickness	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ASYMMETRIC DIMETHYLARGININE; L-ARGININE; CORTICAL INTERNEURONS; AMINO-ACIDS; EXPRESSION; INFECTION; GAMBIENSE; TISSUE; BRAIN	Background: Involvement of nitric oxide (NO) in the pathophysiology of human African trypanosomiasis (HAT) was analyzed in a HAT animal model (rat infected with Trypanosoma brucei brucei). With this model, it was previously reported that trypanosomes were capable of limiting trypanocidal properties carried by NO by decreasing its blood concentration. It was also observed that brain NO concentration, contrary to blood, increases throughout the infection process. The present approach analyses the brain impairments occurring in the regulations exerted by arginase and N-G, N-G-dimethylarginine dimethylaminohydrolase (DDAH) on NO Synthases (NOS). In this respect: (i) cerebral enzymatic activities, mRNA and protein expression of arginase and DDAH were determined; (ii) immunohistochemical distribution and morphometric parameters of cells expressing DDAH-1 and DDAH-2 isoforms were examined within the diencephalon; (iii) amino acid profiles relating to NOS/arginase/DDAH pathways were established. Methodology/Principal Findings: Arginase and DDAH activities together with mRNA (RT-PCR) and protein (western-blot) expressions were determined in diencephalic brain structures of healthy or infected rats at various days post-infection (D5, D10, D16, D22). While arginase activity remained constant, that of DDAH increased at D10 (+65%) and D16 (+51%) in agreement with western-blot and amino acids data (liquid chromatography tandem-mass spectrometry). Only DDAH-2 isoform appeared to be up-regulated at the transcriptional level throughout the infection process. Immunohistochemical staining further revealed that DDAH-1 and DDAH-2 are contained within interneurons and neurons, respectively. Conclusion/Significance: In the brain of infected animals, the lack of change observed in arginase activity indicates that polyamine production is not enhanced. Increases in DDAH-2 isoform may contribute to the overproduction of NO. These changes are at variance with those reported in the periphery. As a whole, the above processes may ensure additive protection against trypanosome entry into the brain, i. e., maintenance of NO trypanocidal pressure and limitation of polyamine production, necessary for trypanosome growth.	[Amrouni, Donia; Meiller, Anne; Gautier-Sauvigne, Sabine; Buguet, Alain; Cespuglio, Raymond] Univ Lyon 1, Fac Med, EA 4170, F-69365 Lyon, France; [Piraud, Monique] Hosp Civils Lyon, Lab Malad Hereditaires Metab, Ctr Biol Est, Lyon, France; [Bouteille, Bernard] Univ Limoges, Fac Med, EA 3174, Limoges, France; [Bouteille, Bernard] IFR 145 GEIST, Limoges, France; [Vincendeau, Philippe] Univ Bordeaux 2, UMR IRD CIRAD 177, F-33076 Bordeaux, France; [Amrouni, Donia; Meiller, Anne; Gautier-Sauvigne, Sabine; Buguet, Alain; Cespuglio, Raymond] Plateau NeuroChem, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Universite de Limoges; CIRAD; UDICE-French Research Universities; Universite de Bordeaux	Amrouni, D (corresponding author), Univ Lyon 1, Fac Med, EA 4170, F-69365 Lyon, France.	cespuglio@univ-lyon1.fr	Bouteille, Bernard/M-4547-2018; Buguet, Alain/W-1610-2019; Bouteille, Bernard/T-6519-2019	Bouteille, Bernard/0000-0001-9661-0302; MEILLER, Anne/0000-0001-5546-3035; CESPUGLIO, Raymond/0000-0003-2246-8643	University of Lyon	University of Lyon	University of Lyon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2001, NEUROSCI LETT, V312, P177, DOI 10.1016/S0304-3940(01)02214-5; ABOLARIN MO, 1982, BRIT MED J, V285, P1380, DOI 10.1136/bmj.285.6352.1380; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Amrouni D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009211; Antoine-Moussiaux N, 2008, TRENDS PARASITOL, V24, P411, DOI 10.1016/j.pt.2008.05.010; Bertini G, 1996, BRAIN RES BULL, V39, P261, DOI 10.1016/0361-9230(95)02133-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buguet A, 2001, SLEEP MED REV, V5, P139, DOI 10.1053/smrv.2000.0130; Cespuglio R, 2005, PHYSIOLOGIC NATURE OF SLEEP, P3, DOI 10.1142/9781860947186_0001; Cua DJ, 2001, J IMMUNOL, V166, P602, DOI 10.4049/jimmunol.166.1.602; Dayoub H, 2003, CIRCULATION, V108, P3042, DOI 10.1161/01.CIR.0000101924.04515.2E; De Baetselier P, 2001, INT J PARASITOL, V31, P575, DOI 10.1016/S0020-7519(01)00170-9; Duleu S, 2004, J IMMUNOL, V172, P6298, DOI 10.4049/jimmunol.172.10.6298; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Fliser D, 2005, EUR J CLIN INVEST, V35, P71, DOI 10.1111/j.1365-2362.2005.01457.x; Gobert AP, 2000, INFECT IMMUN, V68, P4653, DOI 10.1128/IAI.68.8.4653-4657.2000; Gow AJ, 2002, J BIOL CHEM, V277, P9637, DOI 10.1074/jbc.C100746200; HECKER M, 1995, FEBS LETT, V359, P251, DOI 10.1016/0014-5793(95)00039-C; Koliatsos VE, 2006, ACTA NEUROPATHOL, V112, P147, DOI 10.1007/s00401-006-0068-6; Kurz K, 2009, PHARMACOL RES, V60, P508, DOI 10.1016/j.phrs.2009.07.009; Leiper J, 2002, P NATL ACAD SCI USA, V99, P13527, DOI 10.1073/pnas.212269799; Liu P, 2003, HIPPOCAMPUS, V13, P859, DOI 10.1002/hipo.10138; Masocha W, 2007, PHYSIOL BEHAV, V92, P110, DOI 10.1016/j.physbeh.2007.05.045; MATTERN P, 1972, CR ACAD SCI D NAT, V274, P1513; Meiller A, 2007, NUCLEIC ACIDS RES, V35, P6924, DOI 10.1093/nar/gkm824; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; NEWPORT GR, 1977, J PARASITOL, V63, P15, DOI 10.2307/3280098; ORMEROD WE, 1971, T ROY SOC TROP MED H, V65, P736, DOI 10.1016/0035-9203(71)90088-5; Piraud M, 2005, RAPID COMMUN MASS SP, V19, P3287, DOI 10.1002/rcm.2197; PRESCOTT LM, 1969, ANAL BIOCHEM, V32, P408, DOI 10.1016/S0003-2697(69)80008-4; Quan N, 1999, J COMP NEUROL, V414, P114, DOI 10.1002/(SICI)1096-9861(19991108)414:1&lt;114::AID-CNE9&gt;3.0.CO;2-G; Schroecksnadel K, 2007, SCAND J IMMUNOL, V65, P525, DOI 10.1111/j.1365-3083.2007.01935.x; Schwedhelm E, 2005, CLIN CHEM, V51, P1268, DOI 10.1373/clinchem.2004.046037; Stoppini L, 2000, INT J MED MICROBIOL, V290, P105; Swamy M, 2009, DRUG CHEM TOXICOL, V32, P326, DOI 10.1080/01480540903130641; Tran CTL, 2000, GENOMICS, V68, P101, DOI 10.1006/geno.2000.6262; Tran CTL, 2003, ATHEROSCLEROSIS SUPP, V4, P33, DOI 10.1016/S1567-5688(03)00032-1; Tsikas D, 2000, FEBS LETT, V478, P1, DOI 10.1016/S0014-5793(00)01686-0; Ueda S, 2003, CIRC RES, V92, P226, DOI 10.1161/01.RES.0000052990.68216.EF; Uzonna JE, 1999, PARASITE IMMUNOL, V21, P57, DOI 10.1046/j.1365-3024.1999.00202.x; VANMARCK EAE, 1981, ANN SOC BELG MED TR, V61, P57; Yu H, 2001, J NEUROSCI RES, V66, P406, DOI 10.1002/jnr.1233	42	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e16891	10.1371/journal.pone.0016891	http://dx.doi.org/10.1371/journal.pone.0016891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408057	Green Submitted, Green Published, gold			2022-12-25	WOS:000288170900005
J	Bird, AD; Flecknoe, SJ; Tan, KH; Olsson, PF; Antony, N; Mantamadiotis, T; Hooper, SB; Cole, TJ				Bird, A. Daniel; Flecknoe, Sharon J.; Tan, Kheng H.; Olsson, P. Fredrik; Antony, Nisha; Mantamadiotis, Theo; Hooper, Stuart B.; Cole, Timothy J.			cAMP Response Element Binding Protein Is Required for Differentiation of Respiratory Epithelium during Murine Development	PLOS ONE			English	Article							FETAL LUNG DEVELOPMENT; TRANSCRIPTION FACTOR-I; DEVELOPING MOUSE LUNG; PROBE LEVEL DATA; GENE-EXPRESSION; CELL PHENOTYPES; MICE LACKING; CREB; SHEEP; LOCALIZATION	The cAMP response element binding protein 1 (Creb1) transcription factor regulates cellular gene expression in response to elevated levels of intracellular cAMP. Creb1(-/-) fetal mice are phenotypically smaller than wildtype littermates, predominantly die in utero and do not survive after birth due to respiratory failure. We have further investigated the respiratory defect of Creb1(-/-) fetal mice during development. Lungs of Creb1(-/-) fetal mice were pale in colour and smaller than wildtype controls in proportion to their reduced body size. Creb1(-/-) lungs also did not mature morphologically beyond E16.5 with little or no expansion of airway luminal spaces, a phenotype also observed with the Creb1(-/-) lung on a Crem(-/-) genetic background. Creb1 was highly expressed throughout the lung at all stages examined, however activation of Creb1 was detected primarily in distal lung epithelium. Cell differentiation of E17.5 Creb1(-/-) lung distal epithelium was analysed by electron microscopy and showed markedly reduced numbers of type-I and type-II alveolar epithelial cells. Furthermore, immunomarkers for specific lineages of proximal epithelium including ciliated, non-ciliated (Clara), and neuroendocrine cells showed delayed onset of expression in the Creb1(-/-) lung. Finally, gene expression analyses of the E17.5 Creb1(-/-) lung using whole genome microarray and qPCR collectively identified respiratory marker gene profiles and provide potential novel Creb1-regulated genes. Together, these results demonstrate a crucial role for Creb1 activity for the development and differentiation of the conducting and distal lung epithelium.	[Bird, A. Daniel; Tan, Kheng H.; Olsson, P. Fredrik; Antony, Nisha; Cole, Timothy J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Flecknoe, Sharon J.; Hooper, Stuart B.] Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Mantamadiotis, Theo] Univ Patras, Dept Med, Patras, Greece	Monash University; Monash University; University of Patras	Bird, AD (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	daniel.bird@monash.edu	Bird, Anthony/AAM-6018-2021; Mantamadiotis, Theo/AAM-1346-2020; Mantamadiotis, Theo/W-9010-2019	Bird, Anthony/0000-0003-3012-7160; Mantamadiotis, Theo/0000-0003-3971-5380; Hooper, Stuart/0000-0003-1676-4825	National Health and Medical Research Council of Australia [384100]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a program grant of the National Health and Medical Research Council of Australia (ID no. 384100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama J, 2002, J HISTOCHEM CYTOCHEM, V50, P993, DOI 10.1177/002215540205000713; ALCORN DG, 1981, ANAT REC, V201, P655, DOI 10.1002/ar.1092010410; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; DAMOREBRUNO MA, 1992, AM J PHYSIOL, V262, pL40, DOI 10.1152/ajplung.1992.262.1.L40; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; Dave V, 2004, J BIOL CHEM, V279, P34578, DOI 10.1074/jbc.M404296200; Dave V, 2006, J CLIN INVEST, V116, P2597, DOI 10.1172/JCI27331; deFelice M, 2003, J BIOL CHEM, V278, P35574, DOI 10.1074/jbc.M304885200; EVANS MJ, 1975, EXP MOL PATHOL, V22, P142, DOI 10.1016/0014-4800(75)90059-3; FITZGERALD ML, 2006, J LIPID RES; Flecknoe S, 2000, AM J PHYSIOL-LUNG C, V278, pL1180, DOI 10.1152/ajplung.2000.278.6.L1180; Flecknoe SJ, 2004, AM J PHYSIOL-LUNG C, V287, pL1207, DOI 10.1152/ajplung.00375.2003; Flecknoe SJ, 2003, AM J PHYSIOL-LUNG C, V285, pL664, DOI 10.1152/ajplung.00306.2002; Flecknoe SJ, 2002, J PHYSIOL-LONDON, V542, P245, DOI 10.1113/jphysiol.2001.014274; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FORBES LR, CLIN EXP ALLERGY, V40, P547; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; He YC, 2002, J BIOL CHEM, V277, P19530, DOI 10.1074/jbc.M201126200; He YC, 2000, J BIOL CHEM, V275, P31051, DOI 10.1074/jbc.M003499200; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kramer BW, 2009, SEMIN FETAL NEONAT M, V14, P2, DOI 10.1016/j.siny.2008.08.011; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Liu Yuru, 2002, Gene Expression Patterns, V2, P229, DOI 10.1016/S1567-133X(02)00057-1; Long FX, 2001, DEVELOPMENT, V128, P541; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Markart P, 2004, AM J RESP CRIT CARE, V169, P454, DOI 10.1164/rccm.200305-669OC; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Matus M, 2007, FASEB J, V21, P1884, DOI 10.1096/fj.06-7915com; Mendelson CR, 2000, ANNU REV PHYSIOL, V62, P875, DOI 10.1146/annurev.physiol.62.1.875; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Sozo F, 2006, PEDIATR RES, V59, P151, DOI 10.1203/01.pdr.0000190574.94285.a2; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tichelaar JW, 1999, J HISTOCHEM CYTOCHEM, V47, P823, DOI 10.1177/002215549904700612; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Wong CJ, 1996, PEDIATR RES, V39, P930, DOI 10.1203/00006450-199606000-00002; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	51	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17843	10.1371/journal.pone.0017843	http://dx.doi.org/10.1371/journal.pone.0017843			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408140	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170000062
J	Hauri, AM; Westbrock, HJ; Claus, H; Geis, S; Giernat, S; Forssbohm, M; Uphoff, H				Hauri, Anja M.; Westbrock, Hans-Juergen; Claus, Herman; Geis, Steffen; Giernat, Siegfried; Forssbohm, Michael; Uphoff, Helmut			Electronic Outbreak Surveillance in Germany: A First Evaluation for Nosocomial Norovirus Outbreaks	PLOS ONE			English	Article							GASTROENTERITIS; COMPLETENESS; DISEASES; EUROPE; SYSTEM	Background: In Germany, surveillance for infectious disease outbreaks is integrated into an electronic surveillance system. For 2007, the national surveillance database contains case-based information on 201,224 norovirus cases, three-quarters of which are linked to outbreaks. We evaluated the data quality of the national database in reflecting nosocomial norovirus outbreak (NNO) data available in 19 Hessian local public health authorities (LPHAs) and the influence of differences between LPHA's follow-up procedures for laboratory notifications of Norovirus positive stool samples on outbreak under-ascertainment. Methods: Data on NNO beginning in 2007 and notified to the 19 LPHAs were extracted from the national database, investigated regarding internal validity and compared to data collected from LPHAs for a study on NNO control. LPHAs were questioned whether they routinely contacted all persons for whom a laboratory diagnosis of norovirus infection was notified. The number of outbreaks per 1,000 hospital beds and the number of cases within NNOs for acute care and rehabilitation hospitals were compared between counties with and without complete follow-up. Results: The national database contained information on 155 NNOs, including 3,115 cases. Cases were missed in the national database in 58 (37%) of the outbreaks. Information on hospitalisation was incorrect for an estimated 47% of NNO cases. Information on county of infection was incorrect for 24% (199/820) of cases being forwarded between LPHAs for data entry. Reported NNO incidence and number of NNO cases in acute care hospitals was higher in counties with complete follow-up (incidence-rate ratio (IRR) 2.7, 95% CI 1.4-5.7, p-value 0.002 and IRR 2.1, 95% CI 1.9-2.4, p-value 0.001, respectively). Conclusions: Many NNOs are not notified by hospitals and differences in LPHA procedures have an impact on the number of outbreaks captured in the surveillance system. Forwarding of case-by-case data on Norovirus outbreak cases from the local to the state and national level should not be required.	[Hauri, Anja M.; Westbrock, Hans-Juergen; Geis, Steffen; Uphoff, Helmut] Hesse State Hlth Off, Dillenburg, Germany; [Claus, Herman; Geis, Steffen] Robert Koch Inst, D-1000 Berlin, Germany; [Geis, Steffen] Robert Koch Inst, Postgrad Training Appl Epidemiol PAE, D-1000 Berlin, Germany; [Giernat, Siegfried] Publ Hlth Author, Main Kinzig Kreis, Gelnhausen, Germany; [Forssbohm, Michael] Publ Hlth Author, Wiesbaden, Germany	Robert Koch Institute; Robert Koch Institute	Hauri, AM (corresponding author), Hesse State Hlth Off, Dillenburg, Germany.	anja.hauri@hlpug.hessen.de		Claus, Hermann/0000-0002-0120-1846				Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Doherty J A, 2006, Can Commun Dis Rep, V32, P211; Doyle TJ, 2009, EPIDEMIOL INFECT, V137, P617, DOI 10.1017/S0950268808000630; Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866; Faensen D, 2006, Euro Surveill, V11, P7, DOI 10.2807/esm.11.04.00614-en; Gray JJ, 2007, CLIN VACCINE IMMUNOL, V14, P1349, DOI 10.1128/CVI.00214-07; Hauri AM, 2004, GESUNDHEITSWESEN, V66, P779, DOI 10.1055/s-2004-813822; HAURI AM, 2008, 2 EUR SCI C APPL INF; Jajosky RA, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-29; Jansson A, 2005, EPIDEMIOL INFECT, V133, P401, DOI 10.1017/S0950268804003632; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P161; Krause G, 2007, EMERG INFECT DIS, V13, P1548, DOI 10.3201/eid1310.070253; Kroneman A, 2008, J CLIN MICROBIOL, V46, P2959, DOI 10.1128/JCM.00499-08; LESCANO AG, 2008, BMC P S3, V14; Lopmam BA, 2003, EMERG INFECT DIS, V9, P90; Lopman BA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-108; Mattner F, 2006, CLIN MICROBIOL INFEC, V12, P69, DOI 10.1111/j.1469-0691.2005.01299.x; *NAT DIS SURV CTR, COMP INF DIS REP CID; National Electronic Disease Surveillance System Working Group, 2001, J Public Health Manag Pract, V7, P43; Pillaye J, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-31; *R KOCH I, 2008, INF JB 2007; *R KOCH I, 2004, FALLD R KOCH I UB ER; *R KOCH I, R KOCH I SURVSTAT; *R KOCH I, 2010, EPIDEMIOLOGISCHES B, V49, P497; *R KOCH I, 2010, INF JB MELD KRANKH 2; Rockx B, 2002, CLIN INFECT DIS, V35, P246, DOI 10.1086/341408; Verhoef LPB, 2009, EMERG INFECT DIS, V15, P31, DOI 10.3201/eid1501.080673; 2006, BUNDESGESETZBLATT 1	28	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17341	10.1371/journal.pone.0017341	http://dx.doi.org/10.1371/journal.pone.0017341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408157	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170000022
J	Davies, SJA; Shih, CH; Noble, M; Mayer-Proschel, M; Davies, JE; Proschel, C				Davies, Stephen J. A.; Shih, Chung-Hsuan; Noble, Mark; Mayer-Proschel, Margot; Davies, Jeannette E.; Proschel, Christoph			Transplantation of Specific Human Astrocytes Promotes Functional Recovery after Spinal Cord Injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GLIAL-RESTRICTED PRECURSORS; EMBRYONIC STEM-CELLS; ADULT-RAT-BRAIN; GAP-JUNCTIONS; OLIGODENDROCYTE PROGENITORS; GLUTAMATE TRANSPORTERS; AXONAL REGENERATION; REACTIVE ASTROCYTES; LOCOMOTOR RECOVERY	Repairing trauma to the central nervous system by replacement of glial support cells is an increasingly attractive therapeutic strategy. We have focused on the less-studied replacement of astrocytes, the major support cell in the central nervous system, by generating astrocytes from embryonic human glial precursor cells using two different astrocyte differentiation inducing factors. The resulting astrocytes differed in expression of multiple proteins thought to either promote or inhibit central nervous system homeostasis and regeneration. When transplanted into acute transection injuries of the adult rat spinal cord, astrocytes generated by exposing human glial precursor cells to bone morphogenetic protein promoted significant recovery of volitional foot placement, axonal growth and notably robust increases in neuronal survival in multiple spinal cord laminae. In marked contrast, human glial precursor cells and astrocytes generated from these cells by exposure to ciliary neurotrophic factor both failed to promote significant behavioral recovery or similarly robust neuronal survival and support of axon growth at sites of injury. Our studies thus demonstrate functional differences between human astrocyte populations and suggest that pre-differentiation of precursor cells into a specific astrocyte subtype is required to optimize astrocyte replacement therapies. To our knowledge, this study is the first to show functional differences in ability to promote repair of the injured adult central nervous system between two distinct subtypes of human astrocytes derived from a common fetal glial precursor population. These findings are consistent with our previous studies of transplanting specific subtypes of rodent glial precursor derived astrocytes into sites of spinal cord injury, and indicate a remarkable conservation from rat to human of functional differences between astrocyte subtypes. In addition, our studies provide a specific population of human astrocytes that appears to be particularly suitable for further development towards clinical application in treating the traumatically injured or diseased human central nervous system.	[Davies, Stephen J. A.; Davies, Jeannette E.] Univ Colorado Denver, Dept Neurosurg, Aurora, CO USA; [Shih, Chung-Hsuan; Noble, Mark; Mayer-Proschel, Margot; Proschel, Christoph] Univ Rochester, Med Ctr, Dept Biomed Genet, Inst Stem Cell & Regenerat Med, Rochester, NY 14642 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Rochester	Davies, SJA (corresponding author), Univ Colorado Denver, Dept Neurosurg, Anschutz Med Campus, Aurora, CO USA.	Jeannette.Davies@ucdenver.edu			National Institutes of Health [RO1-NS046442, RO1-NS42820]; CareCure SCI community; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046442, R01NS042820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CareCure SCI community; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the National Institutes of Health [grant numbers RO1-NS046442, RO1-NS42820]; and the CareCure SCI community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTAL M, 1992, J COMP NEUROL, V325, P22, DOI 10.1002/cne.903250103; Archer DR, 1997, NAT MED, V3, P54, DOI 10.1038/nm0197-54; Barami K, 2001, NEUROL RES, V23, P321, DOI 10.1179/016164101101198686; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Bradford J, 2009, P NATL ACAD SCI USA, V106, P22480, DOI 10.1073/pnas.0911503106; Brunet JF, 2004, GLIA, V46, P8, DOI 10.1002/glia.10348; CASALE EJ, 1988, J COMP NEUROL, V278, P275, DOI 10.1002/cne.902780210; Cassiani-Ingoni R, 2006, EXP NEUROL, V201, P349, DOI 10.1016/j.expneurol.2006.04.030; Chen Y, 2008, J NEUROSCI, V28, P10983, DOI 10.1523/JNEUROSCI.3545-08.2008; Cloutier F, 2006, REGEN MED, V1, P469, DOI 10.2217/17460751.1.4.469; Davies J. E., 2006, J BIOL, V5; Davies Jeannette E, 2008, J Biol, V7, P24, DOI 10.1186/jbiol85; Davies SJA, 1996, EXP NEUROL, V142, P203, DOI 10.1006/exnr.1996.0192; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Dietrich J, 2005, NAT MED, V11, P277, DOI 10.1038/nm1195; Dietrich J, 2002, GLIA, V40, P65, DOI 10.1002/glia.10116; Gomori E, 2006, INT J DEV NEUROSCI, V24, P295, DOI 10.1016/j.ijdevneu.2006.05.003; GRANT G, 2004, SPINAL CORD CYTOARCH; GUMPEL M, 1987, ANN NY ACAD SCI, V495, P71, DOI 10.1111/j.1749-6632.1987.tb23666.x; HAGLID KG, 1976, J NEUROSCI RES, V2, P175, DOI 10.1002/jnr.490020302; HOLSTEGE JC, 1987, NEUROSCIENCE, V23, P809, DOI 10.1016/0306-4522(87)90160-6; Huang WL, 2007, EUR J NEUROSCI, V25, P362, DOI 10.1111/j.1460-9568.2006.05284.x; Izrael M, 2007, MOL CELL NEUROSCI, V34, P310, DOI 10.1016/j.mcn.2006.11.008; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; JONES SL, 1990, J COMP NEUROL, V297, P267, DOI 10.1002/cne.902970209; Joosten EAJ, 2004, J NEUROSCI RES, V77, P127, DOI 10.1002/jnr.20088; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kerr CL, 2010, INT J NEUROSCI, V120, P305, DOI 10.3109/00207450903585290; KLIOT M, 1990, EXP NEUROL, V109, P57, DOI 10.1016/S0014-4886(05)80008-1; Lee SY, 2003, J IND ENG CHEM, V9, P9; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Li ZB, 2007, PLOS BIOL, V5, P212, DOI 10.1371/journal.pbio.0050035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUDWIN SK, 1976, J COMP NEUROL, V165, P197, DOI 10.1002/cne.901650206; Maeda S, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-65; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Massey JM, 2008, EXP NEUROL, V209, P426, DOI 10.1016/j.expneurol.2007.03.029; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Muir GD, 2000, EUR J NEUROSCI, V12, P1113, DOI 10.1046/j.1460-9568.2000.00987.x; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nakase T, 2003, CELL COMMUN ADHES, V10, P413, DOI 10.1080/714040461; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; O'Carroll SJ, 2008, CELL COMMUN ADHES, V15, P27, DOI 10.1080/15419060802014164; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Ochalski PAY, 1997, NEUROSCIENCE, V76, P931; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; SEIFERT G, 2009, BRAIN RES REV; Sharp J, 2010, STEM CELLS, V28, P152, DOI 10.1002/stem.245; SMITH GM, 1988, PROG BRAIN RES, V78, P353; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; WANG JJ, 1995, NEUROSCIENCE, V65, P973, DOI 10.1016/0306-4522(94)00519-B; WARRINGTON AE, 1993, J NEUROSCI RES, V34, P1, DOI 10.1002/jnr.490340102; Weible MW, 2007, GLIA, V55, P1156, DOI 10.1002/glia.20539; WINDLE WF, 1952, J COMP NEUROL, V96, P359, DOI 10.1002/cne.900960207; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; WUNDERLICH G, 1994, GLIA, V10, P49, DOI 10.1002/glia.440100107; Xu L, 2009, NEUROBIOL DIS, V34, P291, DOI 10.1016/j.nbd.2009.01.010; Zhao JW, 2009, EUR J NEUROSCI, V29, P1853, DOI 10.1111/j.1460-9568.2009.06736.x; Zuo J, 1998, EXP NEUROL, V154, P654, DOI 10.1006/exnr.1998.6951	66	107	111	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17328	10.1371/journal.pone.0017328	http://dx.doi.org/10.1371/journal.pone.0017328			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407803	Green Published, Green Submitted, gold			2022-12-25	WOS:000287933300017
J	Wang, GZ; Liu, JA; Wang, W; Zhang, HY; Lercher, MJ				Wang, Guang-Zhong; Liu, Jian; Wang, Wei; Zhang, Hong-Yu; Lercher, Martin J.			A Gene's Ability to Buffer Variation Is Predicted by Its Fitness Contribution and Genetic Interactions	PLOS ONE			English	Article							EVOLUTIONARY CAPACITANCE; HSP90	Background: Many single-gene knockouts result in increased phenotypic (e.g., morphological) variability among the mutant's offspring. This has been interpreted as an intrinsic ability of genes to buffer genetic and environmental variation. A phenotypic capacitor is a gene that appears to mask phenotypic variation: when knocked out, the offspring shows more variability than the wild type. Theory predicts that this phenotypic potential should be correlated with a gene's knockout fitness and its number of negative genetic interactions. Based on experimentally measured phenotypic capacity, it was suggested that knockout fitness was unimportant, but that phenotypic capacitors tend to be hubs in genetic and physical interaction networks. Methodology/Principal Findings: We re-analyse the available experimental data in a combined model, which includes knockout fitness and network parameters as well as expression level and protein length as predictors of phenotypic potential. Contrary to previous conclusions, we find that the strongest predictor is in fact haploid knockout fitness (responsible for 9% of the variation in phenotypic potential), with an additional contribution from the genetic interaction network (5%); once these two factors are taken into account, protein-protein interactions do not make any additional contribution to the variation in phenotypic potential. Conclusions/Significance: We conclude that phenotypic potential is not a mysterious "emergent" property of cellular networks. Instead, it is very simply determined by the overall fitness reduction of the organism (which in its compromised state can no longer compensate for multiple factors that contribute to phenotypic variation), and by the number (and presumably nature) of genetic interactions of the knocked-out gene. In this light, Hsp90, the prototypical phenotypic capacitor, may not be representative: typical phenotypic capacitors are not direct "buffers" of variation, but are simply genes encoding central cellular functions.	[Wang, Guang-Zhong; Lercher, Martin J.] Univ Dusseldorf, Inst Comp Sci, Dusseldorf, Germany; [Liu, Jian; Wang, Wei] Shandong Univ Technol, Shandong Prov Res Ctr Bioinformat Engn & Tech, Ctr Adv Study, Zibo, Peoples R China; [Zhang, Hong-Yu] Huazhong Agr Univ, Inst Bioinformat, Wuhan, Peoples R China; [Zhang, Hong-Yu] Huazhong Agr Univ, State Key Lab Crop Genet Improvement, Coll Life Sci & Technol, Wuhan, Peoples R China	Heinrich Heine University Dusseldorf; Shandong University of Technology; Huazhong Agricultural University; Huazhong Agricultural University	Wang, GZ (corresponding author), Univ Dusseldorf, Inst Comp Sci, Dusseldorf, Germany.	lercher@cs.uni-duesseldorf.de	Lercher, Martin/K-7939-2013	Lercher, Martin/0000-0003-3940-1621; Wang, Wei/0000-0001-5060-4185				Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Bogumil D, 2010, GENOME BIOL EVOL, V2, P602, DOI 10.1093/gbe/evq044; Cooper TF, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-237; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hermisson J, 2004, GENETICS, V168, P2271, DOI 10.1534/genetics.104.029173; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; KIMURA M, 1969, GENETICS, V61, P763; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Lehar J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.51; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Masel J, 2005, GENETICS, V170, P1359, DOI 10.1534/genetics.105.040493; Milton CC, 2003, P NATL ACAD SCI USA, V100, P13396, DOI 10.1073/pnas.1835613100; Mitchell-Olds T, 2002, SCIENCE, V296, P2348, DOI 10.1126/science.1073846; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; Wagner GP, 2003, CURR BIOL, V13, pR958, DOI 10.1016/j.cub.2003.11.042; Warnecke T, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.94; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; [No title captured]	22	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17650	10.1371/journal.pone.0017650	http://dx.doi.org/10.1371/journal.pone.0017650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407817	Green Submitted, Green Published, gold			2022-12-25	WOS:000287933300040
J	Kveiborg, M; Instrell, R; Rowlands, C; Howell, M; Parker, PJ				Kveiborg, Marie; Instrell, Rachael; Rowlands, Christina; Howell, Michael; Parker, Peter J.			PKC alpha and PKC delta Regulate ADAM17-Mediated Ectodomain Shedding of Heparin Binding-EGF through Separate Pathways	PLOS ONE			English	Article							PROTEIN-KINASE-C; CONVERTING-ENZYME; GROWTH-FACTOR; HB-EGF; CELL-MIGRATION; BREAST-CANCER; TUMOR PROGRESSION; CALCIUM INFLUX; POTENTIAL ROLE; TGF-ALPHA	Epidermal growth factor receptor (EGFR) signalling is initiated by the release of EGFR-ligands from membrane-anchored precursors, a process termed ectodomain shedding. This proteolytic event, mainly executed by A Disintegrin And Metalloproteases (ADAMs), is regulated by a number of signal transduction pathways, most notably those involving protein kinase C (PKC). However, the molecular mechanisms of PKC-dependent ectodomain shedding of EGFR-ligands, including the involvement of specific PKC isoforms and possible functional redundancy, are poorly understood. To address this issue, we employed a cell-based system of PMA-induced PKC activation coupled with shedding of heparin binding (HB)-EGF. In agreement with previous studies, we demonstrated that PMA triggers a rapid ADAM17-mediated release of HB-EGF. However, PMA-treatment also results in a protease-independent loss of cell surface HB-EGF. We identified PKC alpha as the key participant in the activation of ADAM17 and suggest that it acts in parallel with a pathway linking PKC delta and ERK activity. While PKC alpha specifically regulated PMA-induced shedding, PKC delta and ERK influenced both constitutive and inducible shedding by apparently affecting the level of HB-EGF on the cell surface. Together, these findings indicate the existence of multiple modes of regulation controlling EGFR-ligand availability and subsequent EGFR signal transduction.	[Kveiborg, Marie; Rowlands, Christina; Parker, Peter J.] Canc Res UK, London Res Inst, Prot Phosphorylat Lab, London, England; [Kveiborg, Marie] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Kveiborg, Marie] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Instrell, Rachael; Howell, Michael] Canc Res UK, London Res Inst, High Throughput Screening Lab, London, England; [Parker, Peter J.] Kings Coll London, Div Canc Studies, London WC2R 2LS, England	Cancer Research UK; University of Copenhagen; University of Copenhagen; Cancer Research UK; University of London; King's College London	Kveiborg, M (corresponding author), Canc Res UK, London Res Inst, Prot Phosphorylat Lab, London, England.	marie.kveiborg@bric.ku.dk	Parker, Peter j/D-5192-2013; Kveiborg, Marie/AAM-3019-2020	Kveiborg, Marie/0000-0002-1293-1019; parker, peter/0000-0002-6218-2933; Howell, Michael/0000-0003-0912-0079	Cancer Research UK through the London Research Institute	Cancer Research UK through the London Research Institute	This work was supported by Cancer Research UK through the London Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas J, 2006, CANCER METAST REV, V25, P57, DOI 10.1007/s10555-006-7889-6; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Borrell-Pages M, 2003, EMBO J, V22, P1114, DOI 10.1093/emboj/cdg111; Dean-Colomb W, 2008, EUR J CANCER, V44, P2806, DOI 10.1016/j.ejca.2008.09.013; Dethlefsen SM, 1998, J CELL BIOCHEM, V69, P143, DOI 10.1002/(SICI)1097-4644(19980501)69:2<143::AID-JCB5>3.0.CO;2-S; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Gechtman Z, 1999, J BIOL CHEM, V274, P28828, DOI 10.1074/jbc.274.40.28828; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Herrlich A, 2008, FASEB J, V22, P4281, DOI 10.1096/fj.08-113852; Higashiyama S, 2005, BBA-PROTEINS PROTEOM, V1751, P110, DOI 10.1016/j.bbapap.2004.11.009; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Li XJ, 2004, J BIOL CHEM, V279, P27365, DOI 10.1074/jbc.M401690200; Lonne GK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-76; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; Peduto L, 2005, CANCER RES, V65, P9312, DOI 10.1158/0008-5472.CAN-05-1063; Pories SE, 2008, CANCER EPIDEM BIOMAR, V17, P1034, DOI 10.1158/1055-9965.EPI-07-0365; Reddy ABM, 2009, ENDOCRINOLOGY, V150, P63, DOI 10.1210/en.2008-0677; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Thabard W, 2001, BIOCHEM J, V358, P193, DOI 10.1042/0264-6021:3580193; Uchiyama K, 2009, EUR J PHARM SCI, V38, P504, DOI 10.1016/j.ejps.2009.09.016; von Tresckow B, 2004, J IMMUNOL, V172, P4324, DOI 10.4049/jimmunol.172.7.4324; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; YAMAMOTO T, 2010, OBESITY SILVER SPRIN; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	43	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17168	10.1371/journal.pone.0017168	http://dx.doi.org/10.1371/journal.pone.0017168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386996	gold, Green Submitted, Green Published			2022-12-25	WOS:000287931400035
J	Wang, BB; Zhang, YB; Zhang, F; Lin, HB; Wang, XM; Wan, N; Ye, ZQ; Weng, HY; Zhang, LL; Li, X; Yan, JW; Wang, PP; Wu, TT; Cheng, LF; Wang, J; Wang, DM; Ma, X; Yu, J				Wang, Binbin; Zhang, Yong-Biao; Zhang, Feng; Lin, Hongbin; Wang, Xumin; Wan, Ning; Ye, Zhenqing; Weng, Haiyu; Zhang, Lili; Li, Xin; Yan, Jiangwei; Wang, Panpan; Wu, Tingting; Cheng, Longfei; Wang, Jing; Wang, Duen-Mei; Ma, Xu; Yu, Jun			On the Origin of Tibetans and Their Genetic Basis in Adapting High-Altitude Environments	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; NATURAL-SELECTION; OXYGEN-TRANSPORT; ADAPTATION; POPULATION; HYPOXIA; GENOME; HIF-2-ALPHA; HIF-1-ALPHA; PATTERNS	Since their arrival in the Tibetan Plateau during the Neolithic Age, Tibetans have been well-adapted to extreme environmental conditions and possess genetic variation that reflect their living environment and migratory history. To investigate the origin of Tibetans and the genetic basis of adaptation in a rigorous environment, we genotyped 30 Tibetan individuals with more than one million SNP markers. Our findings suggested that Tibetans, together with the Yi people, were descendants of Tibeto-Burmans who diverged from ancient settlers of East Asia. The valleys of the Hengduan Mountain range may be a major migration route. We also identified a set of positively-selected genes that belong to functional classes of the embryonic, female gonad, and blood vessel developments, as well as response to hypoxia. Most of these genes were highly correlated with population-specific and beneficial phenotypes, such as high infant survival rate and the absence of chronic mountain sickness.	[Wang, Binbin; Cheng, Longfei; Wang, Jing; Ma, Xu] Natl Res Inst Family Planning, Beijing, Peoples R China; [Wang, Binbin; Cheng, Longfei; Wang, Jing; Ma, Xu] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Zhang, Yong-Biao; Zhang, Feng; Lin, Hongbin; Wang, Xumin; Wan, Ning; Ye, Zhenqing; Zhang, Lili; Li, Xin; Yan, Jiangwei; Wang, Panpan; Wu, Tingting; Wang, Duen-Mei; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Weng, Haiyu] Publ Secur Dept, Technol Div CID Regiment, Lhasa, Peoples R China; [Ma, Xu] World Hlth Org Collaborating Ctr Res Human Reprod, Beijing, Peoples R China	National Research Institute for Family Planning - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; World Health Organization	Wang, BB (corresponding author), Natl Res Inst Family Planning, Beijing, Peoples R China.	wangdm@big.ac.cn; NICGR@263.net; junyu@big.ac.cn	郑, 征/C-8514-2011; wang, xumin/HII-8627-2022; Ye, Zhenqing/L-7954-2019; Ye, Zhenqing/ABF-1433-2020	Wang, Binbin/0000-0002-1597-5930	National Infrastructure Program of Chinese Genetic Resources [2006DKA21300]; Ministry of Science and Technology [2009AA01A130]	National Infrastructure Program of Chinese Genetic Resources; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by grants from the National Infrastructure Program of Chinese Genetic Resources (2006DKA21300) and 863 Program of the Ministry of Science and Technology (2009AA01A130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Beall CA, 2007, RESP PHYSIOL NEUROBI, V158, P161, DOI 10.1016/j.resp.2007.05.013; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; GARNIERGERE P, 1992, J HERED, V83, P239, DOI 10.1093/oxfordjournals.jhered.a111204; Gayden T, 2007, AM J HUM GENET, V80, P884, DOI 10.1086/516757; Geva E, 2002, J CLIN ENDOCR METAB, V87, P4213, DOI 10.1210/jc.2002-020195; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; HARRELL S, 2001, PERSPECTIVES YI SW C, P28; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kang LL, 2010, J HUM GENET, V55, P270, DOI 10.1038/jhg.2010.21; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; MONGE C, 1991, PHYSIOL REV, V71, P1135, DOI 10.1152/physrev.1991.71.4.1135; Moore LG, 2004, PLACENTA, V25, pS60, DOI 10.1016/j.placenta.2004.01.008; Moore LG, 2001, AM J PHYS ANTHROPOL, V114, P42, DOI 10.1002/1096-8644(200101)114:1<42::AID-AJPA1004>3.0.CO;2-B; Novembre J, 2009, NAT REV GENET, V10, P745, DOI 10.1038/nrg2632; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Rodriguez-Trelles F, 2003, P NATL ACAD SCI USA, V100, P13413, DOI 10.1073/pnas.1835646100; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; SHIS, 2008, J SW U NATL, V29, P1; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wen B, 2004, AM J HUM GENET, V74, P856, DOI 10.1086/386292; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhang DD, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013749; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106	48	107	122	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17002	10.1371/journal.pone.0017002	http://dx.doi.org/10.1371/journal.pone.0017002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386899	Green Submitted, Green Published, gold			2022-12-25	WOS:000287931400019
J	Jia, PL; Ewers, JM; Zhao, ZM				Jia, Peilin; Ewers, Jeffrey M.; Zhao, Zhongming			Prioritization of Epilepsy Associated Candidate Genes by Convergent Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TEMPORAL-LOBE EPILEPSY; COPY NUMBER VARIATION; HIPPOCAMPAL-NEURONS; SCHIZOPHRENIA; EXPRESSION; DISEASE; DISORDERS; NETWORKS; SUBUNITS	Background: Epilepsy is a severe neurological disorder affecting a large number of individuals, yet the underlying genetic risk factors for epilepsy remain unclear. Recent studies have revealed several recurrent copy number variations (CNVs) that are more likely to be associated with epilepsy. The responsible gene(s) within these regions have yet to be definitively linked to the disorder, and the implications of their interactions are not fully understood. Identification of these genes may contribute to a better pathological understanding of epilepsy, and serve to implicate novel therapeutic targets for further research. Methodology/Principal Findings: In this study, we examined genes within heterozygous deletion regions identified in a recent large-scale study, encompassing a diverse spectrum of epileptic syndromes. By integrating additional protein-protein interaction data, we constructed subnetworks for these CNV-region genes and also those previously studied for epilepsy. We observed 20 genes common to both networks, primarily concentrated within a small molecular network populated by GABA receptor, BDNF/MAPK signaling, and estrogen receptor genes. From among the hundreds of genes in the initial networks, these were designated by convergent evidence for their likely association with epilepsy. Importantly, the identified molecular network was found to contain complex interrelationships, providing further insight into epilepsy's underlying pathology. We further performed pathway enrichment and crosstalk analysis and revealed a functional map which indicates the significant enrichment of closely related neurological, immune, and kinase regulatory pathways. Conclusions/Significance: The convergent framework we proposed here provides a unique and powerful approach to screening and identifying promising disease genes out of typically hundreds to thousands of genes in disease-related CNV-regions. Our network and pathway analysis provides important implications for the underlying molecular mechanisms for epilepsy. The strategy can be applied for the study of other complex diseases.	[Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Bioinformat Resource Ctr, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Jia, PL (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	zhongming.zhao@vanderbilt.edu	Jia, Peilin/B-4519-2013		National Institutes of Health [AA017437]; NARSAD; Department of Psychiatry at the Vanderbilt University; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA017437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); Department of Psychiatry at the Vanderbilt University; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grant No. AA017437, a 2009 NARSAD Maltz Investigator Award to Z.Z., and the Department of Psychiatry at the Vanderbilt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; ATHANASIU L, 2010, J PSYCHIAT RES; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Bouilleret V, 2000, HIPPOCAMPUS, V10, P305; Cascella NG, 2009, NEUROSCI RES, V63, P227, DOI 10.1016/j.neures.2009.01.002; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Colmers William F., 2003, Epilepsy Curr, V3, P53, DOI 10.1046/j.1535-7597.2003.03208.x; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; DING L, 2010, J BIOL CHEM; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Fucic A, 2009, MED HYPOTHESES, V73, P703, DOI 10.1016/j.mehy.2009.03.051; Heinzen EL, 2010, AM J HUM GENET, V86, P707, DOI 10.1016/j.ajhg.2010.03.018; Heinzen EL, 2010, J ALZHEIMERS DIS, V19, P69, DOI 10.3233/JAD-2010-1212; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Ikeda T, 2006, J NEUROSCI RES, V84, P1771, DOI 10.1002/jnr.21083; Isojarvi J, 2008, SEIZURE-EUR J EPILEP, V17, P111, DOI 10.1016/j.seizure.2007.11.007; Jacobsen NW, 2008, TOXICOL IN VITRO, V22, P146, DOI 10.1016/j.tiv.2007.09.004; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Kimura N, 2008, J MOL ENDOCRINOL, V40, P75, DOI 10.1677/JME-07-0108; KLEIN P, 1995, J ALGORITHM, V19, P104, DOI 10.1006/jagm.1995.1029; KURIAN SM, 2009, MOL PSYCHIAT; Lerner JT, 2008, CELL MOL LIFE SCI, V65, P1864, DOI 10.1007/s00018-008-8161-8; Mefford HC, 2009, CURR OPIN GENET DEV, V19, P196, DOI 10.1016/j.gde.2009.04.003; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; ORTEGA JA, 2009, CEREB CORTEX; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pirker S, 2003, J NEUROPATH EXP NEUR, V62, P820, DOI 10.1093/jnen/62.8.820; Roberts DS, 2006, J BIOL CHEM, V281, P29431, DOI 10.1074/jbc.C600167200; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Smialowska M, 2009, NEUROPEPTIDES, V43, P235, DOI 10.1016/j.npep.2009.02.002; Stephens SH, 2009, SCHIZOPHR RES, V109, P102, DOI 10.1016/j.schres.2008.12.017; Sun J, 2008, AM J MED GENET B, V147B, P1173, DOI 10.1002/ajmg.b.30743; Sun JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011351; Sun JC, 2009, BIOINFORMATICS, V25, P2595, DOI 10.1093/bioinformatics/btp428; Winum JY, 2004, EXPERT OPIN THER PAT, V14, P1273, DOI 10.1517/13543776.14.9.1273; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124	40	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17162	10.1371/journal.pone.0017162	http://dx.doi.org/10.1371/journal.pone.0017162			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390307	Green Submitted, Green Published, gold			2022-12-25	WOS:000287761700034
J	Morales, E; Bustamante, M; Gonzalez, JR; Guxens, M; Torrent, M; Mendez, M; Garcia-Esteban, R; Julvez, J; Forns, J; Vrijheid, M; Molto-Puigmarti, C; Lopez-Sabater, C; Estivill, X; Sunyer, J				Morales, Eva; Bustamante, Mariona; Ramon Gonzalez, Juan; Guxens, Monica; Torrent, Maties; Mendez, Michelle; Garcia-Esteban, Raquel; Julvez, Jordi; Forns, Joan; Vrijheid, Martine; Molto-Puigmarti, Carolina; Lopez-Sabater, Carmen; Estivill, Xavier; Sunyer, Jordi			Genetic Variants of the FADS Gene Cluster and ELOVL Gene Family, Colostrums LC-PUFA Levels, Breastfeeding, and Child Cognition	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; LINOLEIC-ACID; HUMAN-MILK; ASSOCIATION; EXPOSURE; BRAIN; N-6; NEURODEVELOPMENT; PHOSPHOLIPIDS; ENVIRONMENT	Introduction: Breastfeeding effects on cognition are attributed to long-chain polyunsaturated fatty acids (LC-PUFAs), but controversy persists. Genetic variation in fatty acid desaturase (FADS) and elongase (ELOVL) enzymes has been overlooked when studying the effects of LC-PUFAs supply on cognition. We aimed to: 1) to determine whether maternal genetic variants in the FADS cluster and ELOVL genes contribute to differences in LC-PUFA levels in colostrum; 2) to analyze whether these maternal variants are related to child cognition; and 3) to assess whether children's variants modify breastfeeding effects on cognition. Methods: Data come from two population-based birth cohorts (n = 400 mother-child pairs from INMA-Sabadell; and n = 340 children from INMA-Menorca). LC-PUFAs were measured in 270 colostrum samples from INMA-Sabadell. Tag SNPs were genotyped both in mothers and children (13 in the FADS cluster, 6 in ELOVL2, and 7 in ELOVL5). Child cognition was assessed at 14 mo and 4 y using the Bayley Scales of Infant Development and the McCarthy Scales of Children's Abilities, respectively. Results: Children of mothers carrying genetic variants associated with lower FADS1 activity (regulating AA and EPA synthesis), higher FADS2 activity (regulating DHA synthesis), and with higher EPA/AA and DHA/AA ratios in colostrum showed a significant advantage in cognition at 14 mo (3.5 to 5.3 points). Not being breastfed conferred an 8- to 9-point disadvantage in cognition among children GG homozygote for rs174468 (low FADS1 activity) but not among those with the A allele. Moreover, not being breastfed resulted in a disadvantage in cognition (5 to 8 points) among children CC homozygote for rs2397142 (low ELOVL5 activity), but not among those carrying the G allele. Conclusion: Genetically determined maternal supplies of LC-PUFAs during pregnancy and lactation appear to be crucial for child cognition. Breastfeeding effects on cognition are modified by child genetic variation in fatty acid desaturase and elongase enzymes.	[Morales, Eva; Bustamante, Mariona; Ramon Gonzalez, Juan; Guxens, Monica; Mendez, Michelle; Garcia-Esteban, Raquel; Julvez, Jordi; Forns, Joan; Vrijheid, Martine; Sunyer, Jordi] Ctr Res Environm Epidemiol CREAL, Barcelona, Catalonia, Spain; [Morales, Eva; Bustamante, Mariona; Ramon Gonzalez, Juan; Guxens, Monica; Mendez, Michelle; Garcia-Esteban, Raquel; Julvez, Jordi; Forns, Joan; Vrijheid, Martine; Sunyer, Jordi] Hosp Mar Res Inst IMIM, Barcelona, Catalonia, Spain; [Morales, Eva; Bustamante, Mariona; Ramon Gonzalez, Juan; Guxens, Monica; Mendez, Michelle; Garcia-Esteban, Raquel; Julvez, Jordi; Forns, Joan; Vrijheid, Martine; Molto-Puigmarti, Carolina; Lopez-Sabater, Carmen; Estivill, Xavier; Sunyer, Jordi] CIBER Epidemiol & Salud Publ, Barcelona, Catalonia, Spain; [Bustamante, Mariona; Estivill, Xavier] CRG, Genes & Dis Program, Genet Causes Dis Grp, Barcelona, Catalonia, Spain; [Torrent, Maties] IB SALUT, Area Salud Menorca, Menorca, Spain; [Molto-Puigmarti, Carolina; Lopez-Sabater, Carmen] Univ Barcelona, Fac Pharm, Dept Nutr & Food Sci, Barcelona, Catalonia, Spain; [Estivill, Xavier] Pompeu Fabra Univ, Dept Hlth & Expt Life Sci, Genet Unit, Barcelona, Catalonia, Spain; [Sunyer, Jordi] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Barcelona, Catalonia, Spain	Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Atencio Primaria de Menorca; University of Barcelona; Pompeu Fabra University; Pompeu Fabra University	Morales, E (corresponding author), Ctr Res Environm Epidemiol CREAL, Barcelona, Catalonia, Spain.	emorales1@creal.cat	Estivill, Xavier/A-3125-2013; Gonzalez, Juan R/B-7860-2018; Sunyer, Jordi/G-6909-2014; Guxens, Monica/T-2285-2018; Bustamante, Mariona/M-7277-2015; Bustamante, Mariona/ABB-9142-2021; Estivill, Xavier/E-2957-2012; Julvez, Jordi/R-4531-2017; Vrijheid, Martine/H-2702-2014; Morales, Eva/HHS-0651-2022	Estivill, Xavier/0000-0002-0723-2256; Gonzalez, Juan R/0000-0003-3267-2146; Sunyer, Jordi/0000-0002-2602-4110; Guxens, Monica/0000-0002-8624-0333; Bustamante, Mariona/0000-0003-0127-2860; Bustamante, Mariona/0000-0003-0127-2860; Julvez, Jordi/0000-0003-0818-4003; Vrijheid, Martine/0000-0002-7090-1758; Morales, Eva/0000-0003-3145-7022; Lopez-Sabater, Maria Carmen/0000-0002-8670-7044; Forns, Joan/0000-0002-1066-0358; Molto-Puigmarti, Carolina/0000-0001-6831-6210; Garcia, Raquel/0000-0002-5663-6388	Instituto de Salud Carlos III [Red INMA G03/176, CB06/02/0041]; Spanish Ministry of Health [FIS-PI041436, FIS-PI081151, 97/0588, 00/0021-2, PI061756, PS0901958]; Generalitat de Catalunya-CIRIT [1999SGR 00241]; Beca de la IV convocatoria de Ayudas a la Investigacion en Enfermedades Neurodegenerativas de La Caixa, EC [QLK4-CT-2000-00263]; Fundacion Roger Torne, and Fundacio La Marato de TV3 [090430]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya-CIRIT(Generalitat de Catalunya); Beca de la IV convocatoria de Ayudas a la Investigacion en Enfermedades Neurodegenerativas de La Caixa, EC(European CommissionEuropean Commission Joint Research Centre); Fundacion Roger Torne, and Fundacio La Marato de TV3; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by grants from Instituto de Salud Carlos III (Red INMA G03/176, CB06/02/0041), Spanish Ministry of Health (FIS-PI041436, FIS-PI081151, 97/0588, 00/0021-2, PI061756 and PS0901958), Generalitat de Catalunya-CIRIT 1999SGR 00241, Beca de la IV convocatoria de Ayudas a la Investigacion en Enfermedades Neurodegenerativas de La Caixa, EC Contract No. QLK4-CT-2000-00263, Fundacion Roger Torne, and Fundacio La Marato de TV3 (Project No. 090430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 1999, AM J CLIN NUTR, V70, P525; Bayley N., 1977, ESCALAS BAYLEY DESAR; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Brookes KJ, 2006, BIOL PSYCHIAT, V60, P1053, DOI 10.1016/j.biopsych.2006.04.025; Caspi A, 2007, P NATL ACAD SCI USA, V104, P18860, DOI 10.1073/pnas.0704292104; Der G, 2006, BMJ-BRIT MED J, V333, P945, DOI 10.1136/bmj.38978.699583.55; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Haag M, 2003, CAN J PSYCHIAT, V48, P195, DOI 10.1177/070674370304800308; He CW, 2009, P NATL ACAD SCI USA, V106, P11370, DOI 10.1073/pnas.0904835106; Heird WC, 2005, ANNU REV NUTR, V25, P549, DOI 10.1146/annurev.nutr.24.012003.132254; Innis SM, 2000, DEV NEUROSCI-BASEL, V22, P474, DOI 10.1159/000017478; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Julvez J, 2007, INT J EPIDEMIOL, V36, P825, DOI 10.1093/ije/dym107; Koletzko B, 2008, J PERINAT MED, V36, P5, DOI 10.1515/JPM.2008.001; Kothapalli KSD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000370; Lattka E, 2010, J LIPID RES, V51, P182, DOI 10.1194/jlr.M900289-JLR200; Leonard AE, 2002, LIPIDS, V37, P733, DOI 10.1007/s11745-002-0955-6; MAKRIDES M, 1994, AM J CLIN NUTR, V60, P189, DOI 10.1093/ajcn/60.2.189; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Martinelli N, 2008, AM J CLIN NUTR, V88, P941, DOI 10.1093/ajcn/88.4.941; Marza E, 2006, BIOCHEM SOC T, V34, P77, DOI 10.1042/BST0340077; McCarthy D., 1972, MANUAL MCCARTHY SCAL; Molto-Puigmarti C, 2007, ANAL CHIM ACTA, V602, P122, DOI 10.1016/j.aca.2007.09.011; Molto-Puigmarti C, 2010, AM J CLIN NUTR, V91, P1368, DOI 10.3945/ajcn.2009.28789; Morales E, 2009, AM J EPIDEMIOL, V169, P1327, DOI 10.1093/aje/kwp067; Mortensen EL, 2002, JAMA-J AM MED ASSOC, V287, P2365, DOI 10.1001/jama.287.18.2365; Polk S, 2004, AM J RESP CRIT CARE, V170, P273, DOI 10.1164/rccm.200310-1348OC; Posthuma D, 2005, AM J HUM GENET, V77, P318, DOI 10.1086/432647; Ribas-Fito N, 2003, PEDIATRICS, V111, pE580, DOI 10.1542/peds.111.5.e580; Ribas-Fito N, 2007, AM J EPIDEMIOL, V166, P1198, DOI 10.1093/aje/kwm207; Ribas-Fito N, 2006, PAEDIATR PERINAT EP, V20, P403, DOI 10.1111/j.1365-3016.2006.00745.x; Robson LG, 2010, NEUROBIOL AGING, V31, P678, DOI 10.1016/j.neurobiolaging.2008.05.027; Rodriguez-Cruz M, 2006, J LIPID RES, V47, P553, DOI 10.1194/jlr.M500407-JLR200; Salvati S, 2008, J NEUROSCI RES, V86, P776, DOI 10.1002/jnr.21537; Sauerwald TU, 2001, LIPIDS, V36, P991, DOI 10.1007/s11745-001-0810-9; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Schuchardt JP, 2010, EUR J PEDIATR, V169, P149, DOI 10.1007/s00431-009-1035-8; Simmer K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000375.pub3; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Sorgi PJ, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-16; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Uauy R, 2001, LIPIDS, V36, P885, DOI 10.1007/s11745-001-0798-1; Vrijheid M, 2010, EPIDEMIOLOGY, V21, P259, DOI 10.1097/EDE.0b013e3181cb41e0; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37; World Health Organization (Department of Child and Adolescent Health and Development), 2008, CONCL CONS M HELD 6; Xiang M, 2000, ACTA PAEDIATR, V89, P142, DOI 10.1080/080352500750028735; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156	50	88	91	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17181	10.1371/journal.pone.0017181	http://dx.doi.org/10.1371/journal.pone.0017181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383846	Green Published, gold			2022-12-25	WOS:000287657500039
J	Chong, BM; Russell, TD; Schaack, J; Orlicky, DJ; Reigan, P; Ladinsky, M; McManaman, JL				Chong, Brandi M.; Russell, Tanya D.; Schaack, Jerome; Orlicky, David J.; Reigan, Philip; Ladinsky, Mark; McManaman, James L.			The Adipophilin C Terminus Is a Self-folding Membrane-binding Domain That Is Important for Milk Lipid Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; MAMMARY EPITHELIAL-CELLS; XANTHINE-OXIDOREDUCTASE; DROPLET FORMATION; GLOBULE-MEMBRANE; APOLIPOPROTEIN-E; SOLVENT MODELS; TIP47; GLAND; BIOGENESIS	Cytoplasmic lipid droplets (CLD) in mammary epithelial cells undergo secretion by a unique membrane envelopment process to produce milk lipids. Adipophilin (ADPH/Plin2), a member of the perilipin/PAT family of lipid droplet-associated proteins, is hypothesized to mediate CLD secretion through interactions with apical plasma membrane elements. We found that the secretion of CLD coated by truncated ADPH lacking the C-terminal region encoding a putative four-helix bundle structure was impaired relative to that of CLD coated by full-length ADPH. We used homology modeling and analyses of the solution and membrane binding properties of purified recombinant ADPHC terminus to understand how this region possibly mediates CLD secretion. Homology modeling supports the concept that the ADPH C terminus forms a four-helix bundle motif and suggests that this structure can form stable membrane bilayer interactions. Circular dichroism and protease mapping studies confirmed that the ADPH C terminus is an independently folding alpha-helical structure that is relatively resistant to urea denaturation. Liposome binding studies showed that the purified C terminus binds to phospholipid membranes through electrostatic dependent interactions, and cell culture studies documented that it localizes to the plasma membrane. Collectively, these data provide direct evidence that the ADPH C terminus forms a stable membrane binding helical structure that is important for CLD secretion. We speculate that interactions between the four-helix bundle of ADPH and membrane phospholipids may be an initial step in milk lipid secretion.	[Chong, Brandi M.; Russell, Tanya D.; Schaack, Jerome; McManaman, James L.] Univ Colorado, Grad Program Mol Biol, Div Basic Reprod Sci, Aurora, CO 80045 USA; [Chong, Brandi M.; Russell, Tanya D.; McManaman, James L.] Univ Colorado, Dept Obstet & Gynecol, Aurora, CO 80045 USA; [Schaack, Jerome] Univ Colorado, Dept Microbiol, Aurora, CO 80045 USA; [Orlicky, David J.] Univ Colorado, Dept Pathol, Aurora, CO 80045 USA; [Reigan, Philip] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Ladinsky, Mark] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	McManaman, JL (corresponding author), 12800 E 19th Ave,Mailstop 8309, Aurora, CO 80045 USA.	jim.mcmanaman@ucdenver.edu			National Institutes of Health [2RO1-HD045962, PO1-HD38129]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD038129, R01HD045965] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD045962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants 2RO1-HD045962 and PO1-HD38129 (to J. L. M.).	Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Chroni A, 2008, BIOCHEMISTRY-US, V47, P9071, DOI 10.1021/bi800469r; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Evans RK, 2004, J PHARM SCI-US, V93, P2458, DOI 10.1002/jps.20157; Feig M, 2004, CURR OPIN STRUC BIOL, V14, P217, DOI 10.1016/j.sbi.2004.03.009; Gao J, 1999, J BIOL CHEM, V274, P16825, DOI 10.1074/jbc.274.24.16825; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heid HW, 1996, BIOCHEM J, V320, P1025, DOI 10.1042/bj3201025; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Kirwan JP, 2010, J STRUCT BIOL, V170, P294, DOI 10.1016/j.jsb.2010.01.020; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; McManaman JL, 2007, J MAMMARY GLAND BIOL, V12, P259, DOI 10.1007/s10911-007-9053-5; McManaman JL, 2009, CLIN LIPIDOL, V4, P391, DOI 10.2217/CLP.09.15; McManaman JL, 2003, J LIPID RES, V44, P668, DOI 10.1194/jlr.C200021-JLR200; McManaman JL, 2002, J PHYSIOL-LONDON, V545, P567, DOI 10.1113/jphysiol.2002.027185; McManaman JL, 2004, ADV EXP MED BIOL, V554, P263; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Narayanaswami V, 2004, J BIOL CHEM, V279, P14273, DOI 10.1074/jbc.M313318200; Narayanaswami V, 2010, COMP BIOCHEM PHYS A, V155, P123, DOI 10.1016/j.cbpa.2009.09.009; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Orlicky DJ, 2008, J CELL SCI, V121, P2921, DOI 10.1242/jcs.026153; Orlicky DJ, 2001, J LIPID RES, V42, P460; Reinhardt TA, 2008, J DAIRY SCI, V91, P2307, DOI 10.3168/jds.2007-0952; Robenek H, 2005, J LIPID RES, V46, P1331, DOI 10.1194/jlr.M400323-JLR200; Robenek H, 2006, J CELL SCI, V119, P4215, DOI 10.1242/jcs.03191; Robenek H, 2006, P NATL ACAD SCI USA, V103, P10385, DOI 10.1073/pnas.0600795103; Russell TD, 2008, J LIPID RES, V49, P206, DOI 10.1194/jlr.M700396-JLR200; Russell TD, 2007, J LIPID RES, V48, P1463, DOI 10.1194/jlr.M600474-JLR200; Russell TD, 2003, J VIROL, V77, P5801, DOI 10.1128/JVI.77.10.5801-5809.2003; Schaack J, 2001, VIROLOGY, V291, P101, DOI 10.1006/viro.2001.1211; Spassov VZ, 2002, J PHYS CHEM B, V106, P8726, DOI 10.1021/jp020674r; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7	46	29	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23254	23265		10.1074/jbc.M110.217091	http://dx.doi.org/10.1074/jbc.M110.217091			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21383012	hybrid, Green Published			2022-12-25	WOS:000292025000059
J	Nelson, DE; Laman, H				Nelson, David E.; Laman, Heike			A Competitive Binding Mechanism between Skp1 and Exportin 1 (CRM1) Controls the Localization of a Subset of F-box Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCF UBIQUITIN-LIGASE; PARKINSONIAN-PYRAMIDAL SYNDROME; CELL-CYCLE; SUBCELLULAR-LOCALIZATION; PROTEOLYSIS MACHINERY; FBXO7; PHOSPHORYLATION; COMPLEX; INHIBITOR; P27(KIP1)	SCF-type E3 ubiquitin ligases are crucial regulators of cell cycle progression. As the F-box protein is the substrate-specifying subunit of this family of ligases, their availability dictates the timing and the location of the ubiquitination of substrates. We report here our investigation into the regulation of the localization of F-box proteins, in particular Fbxo7, whose mislocalization is associated with human disease. We identified a motif in Fbxo7 that we have characterized as a functional leucine-rich nuclear export sequence (NES), and which allowed binding to the nuclear export protein, exportin 1 (CRM1). Unusually, the NES was embedded within the F-box domain, which is bound by Skp1 and enables the F-box protein to form part of an E3 ubiquitin ligase. The NES of Fbxo7 controlled its localization and was conserved in Fbxo7 homologues in other species. Skp1 binding prevented Fbxo7 from contacting CRM1. We propose that this competitive binding allowed Fbxo7 to accumulate within the nucleus starting at the G1/S transition. More than ten other F-box proteins also contain an NES at the same location in their F-box domains, indicating that this competitive binding mechanism may contribute to the regulation of a sixth of the known F-box proteins.	[Nelson, David E.; Laman, Heike] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Cambridge	Laman, H (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	hl316@cam.ac.uk	Nelson, David/AAX-5648-2021	Nelson, David/0000-0002-5034-0885; Laman, Heike/0000-0002-6089-171X	BBSRC [BB/F012764/1]; Biotechnology and Biological Sciences Research Council [BB/F012764/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the BBSRC (BB/F012764/1).	Bagui TK, 2003, MOL CELL BIOL, V23, P7285, DOI 10.1128/MCB.23.20.7285-7290.2003; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bashir T, 2010, CELL CYCLE, V9, P971, DOI 10.4161/cc.9.5.10914; Boutonnet C, 2010, CELL CYCLE, V9, P975, DOI 10.4161/cc.9.5.10915; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chang YF, 2006, BIOCHEM BIOPH RES CO, V342, P1022, DOI 10.1016/j.bbrc.2006.02.061; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Di Fonzo A, 2009, NEUROLOGY, V72, P240, DOI 10.1212/01.wnl.0000338144.10967.2b; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kirk R, 2008, J BIOL CHEM, V283, P22325, DOI 10.1074/jbc.M709900200; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Laman H, 2006, CELL CYCLE, V5, P279, DOI 10.4161/cc.5.3.2403; Laman H, 2005, EMBO J, V24, P3104, DOI 10.1038/sj.emboj.7600775; Li FN, 1997, EMBO J, V16, P5629, DOI 10.1093/emboj/16.18.5629; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Nelson G, 2002, J CELL SCI, V115, P1137; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Shojaee S, 2008, AM J HUM GENET, V82, P1375, DOI 10.1016/j.ajhg.2008.05.005; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083	25	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19804	19815		10.1074/jbc.M111.220079	http://dx.doi.org/10.1074/jbc.M111.220079			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21378169	Green Published, hybrid			2022-12-25	WOS:000291027700062
J	Nagy, P; Karton, A; Betz, A; Peskin, AV; Pace, P; O'Reilly, RJ; Hampton, MB; Radom, L; Winterbourn, CC				Nagy, Peter; Karton, Amir; Betz, Andrea; Peskin, Alexander V.; Pace, Paul; O'Reilly, Robert J.; Hampton, Mark B.; Radom, Leo; Winterbourn, Christine C.			Model for the Exceptional Reactivity of Peroxiredoxins 2 and 3 with Hydrogen Peroxide A KINETIC AND COMPUTATIONAL STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE SULFENIC ACID; BACTERIAL PEROXIREDOXIN; PEROXYNITRITE; MECHANISMS; SUBSTRATE; OXIDATION; AHPC	Peroxiredoxins (Prx) are thiol peroxidases that exhibit exceptionally high reactivity toward peroxides, but the chemical basis for this is not well understood. We present strong experimental evidence that two highly conserved arginine residues play a vital role in this activity of human Prx2 and Prx3. Point mutation of either ArgI or ArgII (in Prx3 Arg-123 and Arg-146, which are similar to 3-4 angstrom or similar to 6-7 angstrom away from the active site peroxidative cysteine (C-p), respectively) in each case resulted in a 5 orders of magnitude loss in reactivity. A further 2 orders of magnitude decrease in the second-order rate constant was observed for the double arginine mutants of both isoforms, suggesting a cooperative function for these residues. Detailed ab initio theoretical calculations carried out with the high level G4 procedure suggest strong catalytic effects of H-bond-donating functional groups to the C-p sulfur and the reactive and leaving oxygens of the peroxide in a cooperative manner. Using a guanidinium cation in the calculations to mimic the functional group of arginine, we were able to locate two transition structures that indicate rate enhancements consistent with our experimentally observed rate constants. Our results provide strong evidence for a vital role of ArgI in activating the peroxide that also involves H-bonding to ArgII. This mechanism could explain the exceptional reactivity of peroxiredoxins toward H2O2 and may have wider implications for protein thiol reactivity toward peroxides.	[Winterbourn, Christine C.] Univ Otago Christchurch, Dept Pathol, Christchurch, New Zealand; [Winterbourn, Christine C.] Univ Otago Christchurch, Natl Res Ctr Growth & Dev, Christchurch, New Zealand; [Karton, Amir; O'Reilly, Robert J.; Radom, Leo] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Karton, Amir; O'Reilly, Robert J.; Radom, Leo] Univ Sydney, ARC Ctr Excellence Free Radical Chem & Biotechnol, Sydney, NSW 2006, Australia	University of Otago; University of Otago; University of Sydney; University of Sydney	Nagy, P (corresponding author), Natl Inst Oncol, Dept Mol Immunol & Toxicol, Rath Gyorgy 7-9, H-1122 Budapest, Hungary.	peter.nagy@oncol.hu	O'Reilly, Robert/E-9421-2010; Hampton, Mark B/A-8490-2008; Nagy, Peter/C-6768-2008; O'Reilly, Robert John/AFR-4026-2022; Karton, Amir/P-1942-2019; Peskin, alexander/R-6457-2019; O'Reilly, Robert/M-2456-2015; Pace, Paul E/A-3104-2012; Karton, Amir/B-7628-2008	O'Reilly, Robert/0000-0001-6938-9999; Hampton, Mark B/0000-0002-7349-3729; Nagy, Peter/0000-0003-3393-235X; O'Reilly, Robert John/0000-0002-5000-1920; Karton, Amir/0000-0002-7981-508X; O'Reilly, Robert/0000-0002-5000-1920; Pace, Paul E/0000-0003-1855-5760; Karton, Amir/0000-0002-7981-508X; Radom, Leo/0000-0001-8249-1314	Marsden Fund; Health Research Council of New Zealand; Australian Research Council	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand); Australian Research Council(Australian Research Council)	This work was supported by the Marsden Fund, the Health Research Council of New Zealand, and the Australian Research Council.	Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Cox AG, 2009, BIOCHEMISTRY-US, V48, P6495, DOI 10.1021/bi900558g; DOLMAN D, 1975, CAN J BIOCHEM CELL B, V53, P495, DOI 10.1139/o75-069; Fourquet S, 2008, ANTIOXID REDOX SIGN, V10, P1565, DOI 10.1089/ars.2008.2049; HALL A, 2010, ANTIOXID RE IN PRESS; Hall A, 2010, J MOL BIOL, V402, P194, DOI 10.1016/j.jmb.2010.07.022; Konig J, 2003, J BIOL CHEM, V278, P24409, DOI 10.1074/jbc.M301145200; Nagy P., 2010, ADV MOL TOXICOLOGY, P183, DOI DOI 10.1016/S0012-821X(03)00488-6; Nagy P, 2007, J AM CHEM SOC, V129, P14082, DOI 10.1021/ja0737218; Nagy P, 2007, J ORG CHEM, V72, P8838, DOI 10.1021/jo701813f; Nakamura T, 2008, P NATL ACAD SCI USA, V105, P6238, DOI 10.1073/pnas.0709822105; Nakamura T, 2010, J BIOCHEM, V147, P109, DOI 10.1093/jb/mvp154; Nelson KJ, 2008, BIOCHEMISTRY-US, V47, P12860, DOI 10.1021/bi801718d; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Parsonage D, 2008, P NATL ACAD SCI USA, V105, P8209, DOI 10.1073/pnas.0708308105; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Peskin AV, 2010, BIOCHEM J, V432, P313, DOI 10.1042/BJ20101156; Sandala GM, 2010, ACCOUNTS CHEM RES, V43, P642, DOI 10.1021/ar900260c; Stacey MM, 2009, FREE RADICAL BIO MED, V47, P1468, DOI 10.1016/j.freeradbiomed.2009.08.022; Trujillo Madia, 2007, V44, P83; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9	21	86	88	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18048	18055		10.1074/jbc.M111.232355	http://dx.doi.org/10.1074/jbc.M111.232355			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21385867	Green Published, hybrid			2022-12-25	WOS:000290585200066
J	Morizane, Y; Thanos, A; Takeuchi, K; Murakami, Y; Kayama, M; Trichonas, G; Miller, J; Foretz, M; Viollet, B; Vavvas, DG				Morizane, Yuki; Thanos, Aristomenis; Takeuchi, Kimio; Murakami, Yusuke; Kayama, Maki; Trichonas, George; Miller, Joan; Foretz, Marc; Viollet, Benoit; Vavvas, Demetrios G.			AMP-activated Protein Kinase Suppresses Matrix Metalloproteinase-9 Expression in Mouse Embryonic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IV COLLAGENASE EXPRESSION; CENTRAL-NERVOUS-SYSTEM; MURINE MAMMARY CELLS; GLUCOKINASE TRANSLOCATION; MATRIX METALLOPROTEINASES; METASTATIC PHENOTYPE; PROTEOLYTIC-ENZYMES; ENDOTHELIAL-CELLS; DEPENDENT KINASE	Matrix metalloproteinase-9 (MMP-9) plays a critical role in tissue remodeling under both physiological and pathological conditions. Although MMP-9expression is low in most cells and is tightly controlled, the mechanism of its regulation is poorly understood. We utilized mouse embryonic fibroblasts (MEFs) that were nullizygous for the catalytic alpha subunit of AMP-activated protein kinase (AMPK), which is a key regulator of energy homeostasis, to identify AMPK as a suppressor of MMP-9 expression. Total AMPK alpha deletion significantly elevated MMP-9 expression compared with wild-type (WT) MEFs, whereas single knock-out of the isoforms AMPK alpha 1 and AMPK alpha 2 caused minimal change in the level of MMP-9 expression. The suppressive role of AMPK on MMP-9 expression was mediated through both its activity and presence. The AMPK activators 5-amino-4-imidazole carboxamide riboside and A769662 suppressed MMP-9 expression in WT MEFs, and AMPK inhibition by the overexpression of dominant negative (DN) AMPK alpha elevated MMP-9 expression. However, in AMPK alpha(-/-) MEFs transduced with DN AMPK alpha, MMP-9 expression was suppressed. AMPK alpha(-/-) MEFs showed increased phosphorylation of I kappa B alpha, expression of I kappa B alpha mRNA, nuclear localization of nuclear factor-kappa B (NF-kappa B), and DNA-binding activity of NF-kappa B compared with WT. Consistently, selective NF-kappa B inhibitors BMS345541 and SM7368 decreased MMP-9 expression in AMPK alpha(-/-) MEFs. Overall, our results suggest that both AMPK alpha isoforms suppress MMP-9 expression and that both the activity and presence of AMPK alpha contribute to its function as a regulator of MMP-9 expression by inhibiting the NF-kappa B pathway.	[Morizane, Yuki; Thanos, Aristomenis; Takeuchi, Kimio; Murakami, Yusuke; Kayama, Maki; Trichonas, George; Miller, Joan; Vavvas, Demetrios G.] Harvard Univ, Sch Med, Retina Serv, Angiogenesis Lab,Massachusetts Eye & Ear Infirm,D, Boston, MA 02114 USA; [Foretz, Marc; Viollet, Benoit] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] CNRS, UMR 8104, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, F-75014 Paris, France	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Vavvas, DG (corresponding author), 243 Charles St, Boston, MA 02114 USA.	vavvas@meei.harvard.edu	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017; FORETZ, Marc/O-7334-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; Miller, Joan/0000-0003-2046-3996; Vavvas, Demetrios/0000-0002-8622-6478	National Institutes of Health through the NEI [EY014104]; Bacardi Fund; Research to Prevent Blindness Foundation; Lions Eye Research Fund; Onassis Foundation; Fight for Sight Grant in Aid; Harvard Ophthalmology Department; Bausch and Lomb Japan Vitreoretinal; NATIONAL EYE INSTITUTE [P30EY014104] Funding Source: NIH RePORTER	National Institutes of Health through the NEI; Bacardi Fund; Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Lions Eye Research Fund; Onassis Foundation; Fight for Sight Grant in Aid; Harvard Ophthalmology Department; Bausch and Lomb Japan Vitreoretinal; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY014104 through the NEI. This work was also supported by the Bacardi Fund (to D. G. V.), the Research to Prevent Blindness Foundation (to D. G. V.), the Lions Eye Research Fund (to D. G. V.), the Onassis Foundation (to D. G. V.), a Fight for Sight Grant in Aid (to D. G. V.), the Harvard Ophthalmology Department (to D. G. V.), and a Bausch and Lomb Japan Vitreoretinal fellowship (to Y. M. and M. K.).	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Bronner M, 2004, BIOCHEM J, V384, P295, DOI 10.1042/BJ20040955; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Foretz M, 2011, FASEB J, V25, P337, DOI 10.1096/fj.10-169383; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; GARBISA S, 1987, CANCER RES, V47, P1523; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Grossoni VC, 2007, CLIN EXP METASTAS, V24, P513, DOI 10.1007/s10585-007-9088-4; Gueron G, 2009, MOL CANCER RES, V7, P1745, DOI 10.1158/1541-7786.MCR-08-0325; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Guigas B, 2009, IUBMB LIFE, V61, P18, DOI 10.1002/iub.135; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; Gum R, 1997, ONCOGENE, V14, P1481, DOI 10.1038/sj.onc.1200973; Han F, 2010, J SURG RES, V159, P443, DOI 10.1016/j.jss.2009.03.079; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Himelstein BP, 1997, ONCOGENE, V14, P1995, DOI 10.1038/sj.onc.1201012; Hwang YP, 2010, BRIT J PHARMACOL, V160, P1195, DOI 10.1111/j.1476-5381.2010.00762.x; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Katerelos M, 2010, IMMUNOL CELL BIOL, V88, P754, DOI 10.1038/icb.2010.44; Kim S, 2011, CELL METAB, V13, P215, DOI 10.1016/j.cmet.2011.01.007; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Moens U, 1997, VIRUS GENES, V15, P135, DOI 10.1023/A:1007962908248; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Mukhtar MH, 2008, AM J PHYSIOL-REG I, V294, pR766, DOI 10.1152/ajpregu.00593.2007; Nair RR, 2006, J BIOL CHEM, V281, P26424, DOI 10.1074/jbc.M602703200; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Robert I, 2009, ONCOGENE, V28, P1626, DOI 10.1038/onc.2009.6; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Singh S, 1998, ANAL BIOCHEM, V265, P185, DOI 10.1006/abio.1998.2882; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; STAHL H, 1987, BIOCHIM BIOPHYS ACTA, V910, P1, DOI 10.1016/0167-4781(87)90088-1; Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takagi S, 2009, CANCER RES, V69, P1502, DOI 10.1158/0008-5472.CAN-08-2635; Theodoropoulou S, 2010, FASEB J, V24, P2620, DOI 10.1096/fj.09-152546; THORGEIRSSON UP, 1985, MOL CELL BIOL, V5, P259, DOI 10.1128/MCB.5.1.259; Turnley AM, 1999, J NEUROCHEM, V72, P1707, DOI 10.1046/j.1471-4159.1999.721707.x; Urtreger AJ, 2005, MOL CARCINOGEN, V42, P29, DOI 10.1002/mc.20066; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Wang W, 2009, ACTA PHYSIOL, V196, P55, DOI 10.1111/j.1748-1716.2009.01980.x; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948	62	44	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.199398	http://dx.doi.org/10.1074/jbc.M110.199398			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21402702	Green Published, hybrid			2022-12-25	WOS:000290022800043
J	Park, JS; Wang, CZ; Han, Y; Huang, Z; Niu, L				Park, Jae-Seon; Wang, Congzhou; Han, Yan; Huang, Zhen; Niu, Li			Potent and Selective Inhibition of a Single alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Subunit by an RNA Aptamer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL-OPENING KINETICS; GLUTAMATE-OPERATED CHANNELS; LASER-PULSE PHOTOLYSIS; MOLECULAR DETERMINANT; BINDING DOMAIN; GLUR2; MECHANISM; ANTAGONISTS; NEURONS; FLIP	Inhibitors of AMPA-type glutamate ion channels are useful as biochemical probes for structure-function studies and as drug candidates for a number of neurological disorders and diseases. Here, we describe the identification of an RNA inhibitor or aptamer by an in vitro evolution approach and a characterization of its mechanism of inhibition on the sites of interaction by equilibrium binding and on the receptor channel opening rate by a laser-pulse photolysis technique. Our results show that the aptamer is a noncompetitive inhibitor that selectively inhibits the GluA2Q(flip) AMPA receptor subunit without any effect on other AMPA receptor subunits or kainate or NMDA receptors. On the GluA2 subunit, this aptamer preferentially inhibits the flip variant. Furthermore, the aptamer preferentially inhibits the closed-channel state of GluA2Q(flip) with a K-I = 1.5 mu M or by similar to 15-fold over the open-channel state. The potency and selectivity of this aptamer rival those of small molecule inhibitors. Together, these properties make this aptamer a promising candidate for the development of water-soluble, highly potent, and GluA2 subunit-selective drugs.	[Niu, Li] SUNY Albany, Dept Chem, Albany, NY 12222 USA; SUNY Albany, Neurosci Res Ctr, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Niu, L (corresponding author), SUNY Albany, Dept Chem, Albany, NY 12222 USA.	lniu@albany.edu	Han, Yan/G-6027-2014		National Institutes of Health [R01 NS060812]; Department of Defense [W81XWH-04-1-0106, GW080163]; Muscular Dystrophy Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant R01 NS060812. This work was also supported by the Department of Defense (Grants W81XWH-04-1-0106 and GW080163) and the Muscular Dystrophy Association.	Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Ahmed AH, 2009, BIOCHEMISTRY-US, V48, P3894, DOI 10.1021/bi900107m; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dixon SJ, 2009, CURR OPIN CHEM BIOL, V13, P549, DOI 10.1016/j.cbpa.2009.08.003; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; Hruby VJ, 2009, J ORG CHEM, V74, P9245, DOI 10.1021/jo901767e; Huang Z, 2007, BIOCHEMISTRY-US, V46, P12648, DOI 10.1021/bi701036p; Huang Z, 2010, BIOCHEMISTRY-US, V49, P5790, DOI 10.1021/bi100690k; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Koike M, 2000, J NEUROSCI, V20, P2166; Kuner T, 2001, J NEUROSCI, V21, P4162, DOI 10.1523/JNEUROSCI.21-12-04162.2001; Kwak S, 2005, J MOL MED, V83, P110, DOI 10.1007/s00109-004-0599-z; Li G, 2005, BIOCHEMISTRY-US, V44, P5835, DOI 10.1021/bi047413n; Li G, 2004, J BIOL CHEM, V279, P3990, DOI 10.1074/jbc.M310410200; Li G, 2003, BIOCHEMISTRY-US, V42, P12367, DOI 10.1021/bi034797t; Li G, 2003, BIOCHEMISTRY-US, V42, P12358, DOI 10.1021/bi0347961; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Lunn ML, 2003, J MED CHEM, V46, P872, DOI 10.1021/jm021020+; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marcaurelle Lisa A., 2008, V66; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Niu L, 1995, P NATL ACAD SCI USA, V92, P12008, DOI 10.1073/pnas.92.26.12008; Niu Li, 1993, Biochemistry, V32, P3831, DOI 10.1021/bi00066a001; Oguro K, 1999, J NEUROSCI, V19, P9218; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Pei WM, 2007, J BIOL CHEM, V282, P22731, DOI 10.1074/jbc.M611821200; Pei WM, 2007, BIOCHEMISTRY-US, V46, P2027, DOI 10.1021/bi062213s; Pei WM, 2009, BIOCHEMISTRY-US, V48, P3767, DOI 10.1021/bi8015907; Ritz M, 2008, BIOCHEMISTRY-US, V47, P1061, DOI 10.1021/bi700782x; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Solyom S, 2002, CURR PHARM DESIGN, V8, P913, DOI 10.2174/1381612024607081; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Tanaka Y, 1999, NUCLEIC ACIDS RES, V27, P949, DOI 10.1093/nar/27.4.949; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Voss NR, 2005, J MOL BIOL, V346, P477, DOI 10.1016/j.jmb.2004.11.072; Weiser T, 2005, CNS NEUROL DISORD-DR, V4, P153, DOI 10.2174/1568007053544129; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WIEBOLDT R, 1994, P NATL ACAD SCI USA, V91, P8752, DOI 10.1073/pnas.91.19.8752; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Zappala M, 2001, MINI-REV MED CHEM, V1, P243, DOI 10.2174/1389557013406783; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	14	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15608	15617		10.1074/jbc.M111.229559	http://dx.doi.org/10.1074/jbc.M111.229559			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21402710	hybrid, Green Published			2022-12-25	WOS:000289788300088
J	Moshiri, H; Acoca, S; Kala, S; Najafabadi, HS; Hogues, H; Purisima, E; Salavati, R				Moshiri, Houtan; Acoca, Stephane; Kala, Smriti; Najafabadi, Hamed Shateri; Hogues, Herve; Purisima, Enrico; Salavati, Reza			Naphthalene-based RNA Editing Inhibitor Blocks RNA Editing Activities and Editosome Assembly in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL RIBONUCLEOPROTEIN COMPLEXES; URIDYLYL TRANSFERASE TUTASE; SOLVATED INTERACTION ENERGY; BOUNDARY-ELEMENT METHOD; BINDING PROTEIN; GUIDE RNA; MESSENGER-RNA; DELETION; INSERTION; LIGASE	RNA editing, catalyzed by the multiprotein editosome complex, is an essential step for the expression of most mitochondrial genes in trypanosomatid pathogens. It has been shown previously that Trypanosoma brucei RNA editing ligase 1 (TbREL1), a core catalytic component of the editosome, is essential in the mammalian life stage of these parasitic pathogens. Because of the availability of its crystal structure and absence from human, the adenylylation domain of TbREL1 has recently become the focus of several studies for designing inhibitors that target its adenylylation pocket. Here, we have studied new and existing inhibitors of TbREL1 to better understand their mechanism of action. We found that these compounds are moderate to weak inhibitors of adenylylation of TbREL1 and in fact enhance adenylylation at higher concentrations of protein. Nevertheless, they can efficiently block deadenylylation of TbREL1 in the editosome and, consequently, result in inhibition of the ligation step of RNA editing. Further experiments directly showed that the studied compounds inhibit the interaction of the editosome with substrate RNA. This was supported by the observation that not only the ligation activity of TbREL1 but also the activities of other editosome proteins such as endoribonuclease, terminal RNA uridylyltransferase, and uridylate-specific exoribonuclease, all of which require the interaction of the editosome with the substrate RNA, are efficiently inhibited by these compounds. In addition, we found that these compounds can interfere with the integrity and/or assembly of the editosome complex, opening the exciting possibility of using them to study the mechanism of assembly of the editosome components.	[Moshiri, Houtan; Acoca, Stephane; Purisima, Enrico; Salavati, Reza] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Moshiri, Houtan; Kala, Smriti; Najafabadi, Hamed Shateri; Salavati, Reza] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Najafabadi, Hamed Shateri; Salavati, Reza] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ H3G 0B1, Canada; [Hogues, Herve; Purisima, Enrico] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	McGill University; McGill University; McGill University; National Research Council Canada	Salavati, R (corresponding author), McGill Univ, Dept Biochem, McIntyre Med Bldg,3655 Promenade Sir William Osle, Montreal, PQ H3G 1Y6, Canada.	reza.salavati@mcgill.ca		Najafabadi, Hamed/0000-0003-2735-4231	Natural Sciences and Engineering Research Council of Canada [328186]; Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) Fellowship [134818, 134790]; McGill University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) Fellowship(FQRNT); McGill University	This work was supported in part by Natural Sciences and Engineering Research Council of Canada Grant 328186 (to R. S.).; Recipient of Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) Fellowship 134818.; Recipient of FQRNT Fellowship 134790.; Recipient of a Lloyd Carr-Harris fellowship (McGill University).	ALLISON J, 1984, NUCLEIC ACIDS RES, V12, P9051, DOI 10.1093/nar/12.23.9051; Amaro RE, 2008, P NATL ACAD SCI USA, V105, P17278, DOI 10.1073/pnas.0805820105; Aphasizhev R, 2003, EMBO J, V22, P913, DOI 10.1093/emboj/cdg083; Aphasizhev R, 2002, CELL, V108, P637, DOI 10.1016/S0092-8674(02)00647-5; Bhat S, 2006, PROTEINS, V62, P244, DOI 10.1002/prot.20682; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Cruz-Reyes J, 2002, MOL CELL BIOL, V22, P4652, DOI 10.1128/MCB.22.13.4652-4660.2002; Cui QZ, 2008, J MOL BIOL, V379, P787, DOI 10.1016/j.jmb.2008.04.035; Delespaux V, 2007, DRUG RESIST UPDATE, V10, P30, DOI 10.1016/j.drup.2007.02.004; Denise H, 2001, BIOCHEM PHARMACOL, V61, P1, DOI 10.1016/S0006-2952(00)00477-9; Doherty AJ, 2000, NUCLEIC ACIDS RES, V28, P4051, DOI 10.1093/nar/28.21.4051; Domingo GJ, 2003, EUKARYOT CELL, V2, P569, DOI 10.1128/EC.2.3.569-577.2003; Durrant JD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000803; Ernst NL, 2003, MOL CELL, V11, P1525, DOI 10.1016/S1097-2765(03)00185-0; Gao GH, 2010, PROTIST, V161, P489, DOI 10.1016/j.protis.2010.01.001; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; GORINGER HU, 1994, P NATL ACAD SCI USA, V91, P1776, DOI 10.1073/pnas.91.5.1776; Guo XM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008913; Igo RP, 2000, MOL CELL BIOL, V20, P8447, DOI 10.1128/MCB.20.22.8447-8457.2000; Igo RP, 2002, EUKARYOT CELL, V1, P112, DOI 10.1128/EC.1.1.112-118.2002; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kable ML, 1997, TRENDS BIOCHEM SCI, V22, P162, DOI 10.1016/S0968-0004(97)01041-4; Kala S, 2010, RNA, V16, P1951, DOI 10.1261/rna.2124610; Kang XD, 2005, P NATL ACAD SCI USA, V102, P1017, DOI 10.1073/pnas.0409275102; Law JA, 2008, RNA, V14, P1187, DOI 10.1261/rna.899508; McManus MT, 2001, RNA, V7, P167, DOI 10.1017/S1355838201002072; Moshiri H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq333; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Niemann M, 2008, NUCLEIC ACIDS RES, V36, P4465, DOI 10.1093/nar/gkn410; Panigrahi AK, 2003, RNA, V9, P484, DOI 10.1261/rna.2194603; Panigrahi AK, 2001, MOL CELL BIOL, V21, P380, DOI 10.1128/MCB.21.2.380-389.2001; PURISIMA EO, 1995, J COMPUT CHEM, V16, P681, DOI 10.1002/jcc.540160604; Purisima EO, 1998, J COMPUT CHEM, V19, P1494, DOI 10.1002/(SICI)1096-987X(199810)19:13<1494::AID-JCC6>3.0.CO;2-L; READ LK, 1994, MOL CELL BIOL, V14, P2629, DOI 10.1128/MCB.14.4.2629; SABATINI R, 1995, J BIOL CHEM, V270, P7233, DOI 10.1074/jbc.270.13.7233; Salavati R, 2006, RNA, V12, P819, DOI 10.1261/rna.2244106; Salavati R, 2002, MOL BIOCHEM PARASIT, V120, P23, DOI 10.1016/S0166-6851(01)00431-5; Sbicego S, 2003, EUKARYOT CELL, V2, P560, DOI 10.1128/EC.2.3.560-568.2003; Schnaufer A, 2003, MOL CELL, V12, P307, DOI 10.1016/S1097-2765(03)00286-7; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Schneider Andre, 2007, Methods Mol Biol, V372, P67, DOI 10.1007/978-1-59745-365-3_5; Seiwert SD, 1996, CELL, V84, P831, DOI 10.1016/S0092-8674(00)81062-4; Shaneh A, 2010, J MOL MODEL, V16, P61, DOI 10.1007/s00894-009-0506-1; Simpson L, 2003, RNA, V9, P265, DOI 10.1261/rna.2178403; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Swift RV, 2009, BIOCHEMISTRY-US, V48, P709, DOI 10.1021/bi8018114; Tarun SZ, 2008, RNA, V14, P347, DOI 10.1261/rna.763308; Trotter JR, 2005, MOL CELL, V20, P403, DOI 10.1016/j.molcel.2005.09.016; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P6392, DOI 10.1093/nar/gkg870	51	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14178	14189		10.1074/jbc.M110.199646	http://dx.doi.org/10.1074/jbc.M110.199646			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21378165	Green Published, hybrid			2022-12-25	WOS:000289556200041
J	Comley, LH; Wishart, TM; Baxter, B; Murray, LM; Nimmo, A; Thomson, D; Parson, SH; Gillingwater, TH				Comley, Laura H.; Wishart, Thomas M.; Baxter, Becki; Murray, Lyndsay M.; Nimmo, Ailish; Thomson, Derek; Parson, Simon H.; Gillingwater, Thomas H.			Induction of Cell Stress in Neurons from Transgenic Mice Expressing Yellow Fluorescent Protein: Implications for Neurodegeneration Research	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; WALLERIAN DEGENERATION; IN-VIVO; MOUSE MODEL; PATHOLOGY; WLD(S); GENE; CORTEX; GFP	Background: Mice expressing fluorescent proteins in neurons are one of the most powerful tools in modern neuroscience research and are increasingly being used for in vivo studies of neurodegeneration. However, these mice are often used under the assumption that the fluorescent proteins present are biologically inert. Methodology/Principal Findings: Here, we show that thy1-driven expression of yellow fluorescent protein (YFP) in neurons triggers multiple cell stress responses at both the mRNA and protein levels in vivo. The presence of YFP in neurons also subtly altered neuronal morphology and modified the time-course of dying-back neurodegeneration in experimental axonopathy, but not in Wallerian degeneration triggered by nerve injury. Conclusions/Significance: We conclude that fluorescent protein expressed in thy1-YFP mice is not biologically inert, modifies molecular and cellular characteristics of neurons in vivo, and has diverse and unpredictable effects on neurodegeneration pathways.	[Comley, Laura H.; Wishart, Thomas M.; Baxter, Becki; Murray, Lyndsay M.; Nimmo, Ailish; Thomson, Derek; Parson, Simon H.; Gillingwater, Thomas H.] Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Lothian, Scotland; [Comley, Laura H.; Wishart, Thomas M.; Baxter, Becki; Murray, Lyndsay M.; Nimmo, Ailish; Thomson, Derek; Parson, Simon H.; Gillingwater, Thomas H.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Lothian, Scotland	University of Edinburgh; University of Edinburgh	Comley, LH (corresponding author), Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Lothian, Scotland.	T.Gillingwater@ed.ac.uk	Gillingwater, Thomas/G-2880-2011	Gillingwater, Thomas/0000-0002-0306-5577; wishart, thomas/0000-0002-1973-6654; Nimmo, Ailish/0000-0001-6044-5827; Parson, Simon/0000-0002-8848-8738	BBSRC; Anatomical Society of Great Britain Ireland; SMA Trust; Wellcome Trust	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Anatomical Society of Great Britain Ireland; SMA Trust; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by funding from the BBSRC (LHC/THG), the Anatomical Society of Great Britain & Ireland (LMM/BB/SHP/THG), the SMA Trust (THG) and the Wellcome Trust (THG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6; Detrait ER, 2002, MOL THER, V5, P723, DOI 10.1006/mthe.2002.0609; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Huang WY, 2000, NAT MED, V6, P482, DOI 10.1038/74914; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Mi WQ, 2005, BRAIN, V128, P405, DOI 10.1093/brain/awh368; Murray LM, 2010, NEUROMUSCULAR DISORD, V20, P740, DOI 10.1016/j.nmd.2010.06.013; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Murray LM, 2010, HUM MOL GENET, V19, P420, DOI 10.1093/hmg/ddp506; Murray LM, 2008, J ANAT, V213, P633, DOI 10.1111/j.1469-7580.2008.01007.x; Stevens JC, 2010, PLOS ONE, V5, pA8, DOI 10.1371/journal.pone.0009541; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wishart TM, 2007, MOL CELL PROTEOMICS, V6, P1318, DOI 10.1074/mcp.M600457-MCP200; Wishart TM, 2010, HUM MOL GENET, V19, P4216, DOI 10.1093/hmg/ddq340; Wishart TM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r101; Wright AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015108; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373	22	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17639	10.1371/journal.pone.0017639	http://dx.doi.org/10.1371/journal.pone.0017639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408118	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170000049
J	Miller, SJ; Joshi, BP; Feng, Y; Gaustad, A; Fearon, ER; Wang, TD				Miller, Sharon J.; Joshi, Bishnu P.; Feng, Ying; Gaustad, Adam; Fearon, Eric R.; Wang, Thomas D.			In Vivo Fluorescence-Based Endoscopic Detection of Colon Dysplasia in the Mouse Using a Novel Peptide Probe	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; COLORECTAL-CANCER; PHAGE DISPLAY; BINDING PEPTIDE; UNITED-KINGDOM; FLAT ADENOMAS; MICE; SELECTION; LIBRARY; MODEL	Colorectal cancer (CRC) is a major cause of cancer-related deaths in much of the world. Most CRCs arise from pre-malignant (dysplastic) lesions, such as adenomatous polyps, and current endoscopic screening approaches with white light do not detect all dysplastic lesions. Thus, new strategies to identify such lesions, including non-polypoid lesions, are needed. We aim to identify and validate novel peptides that specifically target dysplastic colonic epithelium in vivo. We used phage display to identify a novel peptide that binds to dysplastic colonic mucosa in vivo in a genetically engineered mouse model of colo-rectal tumorigenesis, based on somatic Apc (adenomatous polyposis coli) gene inactivation. Binding was confirmed using confocal microscopy on biopsied adenomas and excised adenomas incubated with peptide ex vivo. Studies of mice where a mutant Kras allele was somatically activated in the colon to generate hyperplastic epithelium were also performed for comparison. Several rounds of in vivo T7 library biopanning isolated a peptide, QPIHPNNM. The fluorescent-labeled peptide bound to dysplastic lesions on endoscopic analysis. Quantitative assessment revealed the fluorescent-labeled peptide (target/background: 2.17 +/- 0.61) binds similar to 2-fold greater to the colonic adenomas when compared to the control peptide (target/background: 1.14 +/- 0.15), p < 0.01. The peptide did not bind to the non-dysplastic (hyperplastic) epithelium of the Kras mice. This work is first to image fluorescence-labeled peptide binding in vivo that is specific towards colonic dysplasia on wide-area surveillance. This finding highlights an innovative strategy for targeted detection to localize premalignant lesions that can be generalized to the epithelium of hollow organs.	[Miller, Sharon J.; Joshi, Bishnu P.; Feng, Ying; Fearon, Eric R.; Wang, Thomas D.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Gaustad, Adam; Wang, Thomas D.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Fearon, Eric R.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Fearon, Eric R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Fearon, Eric R.; Wang, Thomas D.] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Miller, SJ (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	thomaswa@umich.edu		Miller, Sharon/0000-0002-1768-5945	National Institutes of Health (NIH) [U54 CA13642, P50 CA93990, R01 CA142750, P30 DK34933, R01 CA082223]; Department of Defense (DOD) [W81XWH-09-2-0014]; NATIONAL CANCER INSTITUTE [P50CA093990, U54CA136429, R01CA142750, R01CA082223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DOD)(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge funding support from National Institutes of Health (NIH) U54 CA13642, P50 CA93990, R01 CA142750, P30 DK34933 (pilot award), R01 CA082223, and the Department of Defense (DOD) Award W81XWH-09-2-0014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol A, 2008, NAT METHODS, V5, P231, DOI 10.1038/NMETH.1182; Alencar H, 2007, RADIOLOGY, V244, P232, DOI 10.1148/radiol.2441052114; American Cancer Society (ACS), CANC FACTS FIG; Arap W, 2002, P NATL ACAD SCI USA, V99, P1527, DOI 10.1073/pnas.241655998; Arnold CN, 2005, CANCER-AM CANCER SOC, V104, P2035, DOI 10.1002/cncr.21462; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Brammer LA, 2008, ANAL BIOCHEM, V373, P88, DOI 10.1016/j.ab.2007.10.015; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; Deo S, 2000, J AM CHEM SOC, V122, P174, DOI 10.1021/ja992238x; Essler M, 2002, P NATL ACAD SCI USA, V99, P2252, DOI 10.1073/pnas.251687998; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fujii T, 1998, ENDOSCOPY, V30, P437, DOI 10.1055/s-2007-1001304; Gualco Gabriela, 2006, Ann Diagn Pathol, V10, P333, DOI 10.1016/j.anndiagpath.2006.03.003; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hart AR, 1998, GUT, V43, P229, DOI 10.1136/gut.43.2.229; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Hurlstone DP, 2003, AM J GASTROENTEROL, V98, P2543, DOI 10.1016/S0002-9270(03)00664-6; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Joshi BP, 2007, BIOORG MED CHEM LETT, V17, P6425, DOI 10.1016/j.bmcl.2007.10.008; Joyce JA, 2003, CANCER CELL, V4, P393, DOI 10.1016/S1535-6108(03)00271-X; Judge Thomas A, 2002, Gastrointest Endosc Clin N Am, V12, P495, DOI 10.1016/S1052-5157(02)00014-4; Kay BK, 2000, FEBS LETT, V480, P55, DOI 10.1016/S0014-5793(00)01778-6; Kelly KA, 2003, NEOPLASIA, V5, P437, DOI 10.1016/S1476-5586(03)80046-5; Kelly KA, 2006, NEOPLASIA, V8, P1011, DOI 10.1593/neo.06610; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Krumpe LRH, 2006, PROTEOMICS, V6, P4210, DOI 10.1002/pmic.200500606; Kubo N, 2008, J DRUG TARGET, V16, P396, DOI [10.1080/10611860802088796, 10.1080/10611860802088796 ]; Lee SM, 2007, MOL CANCER RES, V5, P11, DOI 10.1158/1541-7786.MCR-06-0069; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Li M, 2010, GASTROENTEROLOGY, V139, P1472, DOI 10.1053/j.gastro.2010.07.007; Lin HY, 2006, FASEB J, V20, P1742, DOI 10.1096/fj.06-5743fje; Ludtke JJ, 2007, DRUG DELIV, V14, P357, DOI 10.1080/10717540601098765; Mandava S, 2004, PROTEOMICS, V4, P1439, DOI 10.1002/pmic.200300680; McGuire MJ, 2004, J MOL BIOL, V342, P171, DOI 10.1016/j.jmb.2004.06.029; Newton JR, 2006, NEOPLASIA, V8, P772, DOI 10.1593/neo.06331; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Rasmussen UB, 2002, CANCER GENE THER, V9, P606, DOI 10.1038/sj.cgt.7700476; Ruoslahti E, 2005, CURR PHARM DESIGN, V11, P3655, DOI 10.2174/138161205774580787; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Trobridge P, 2009, GASTROENTEROLOGY, V136, P1680, DOI 10.1053/j.gastro.2009.01.066; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Walkup GK, 1997, J AM CHEM SOC, V119, P3443, DOI 10.1021/ja9642121; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zhang YD, 2007, J BIOMOL SCREEN, V12, P429, DOI 10.1177/1087057106299164; Zou J, 2004, MOL BIOL REP, V31, P121, DOI 10.1023/B:MOLE.0000031459.14448.af; Zurita AJ, 2004, CANCER RES, V64, P435, DOI 10.1158/0008-5472.CAN-03-2675	52	63	66	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17384	10.1371/journal.pone.0017384	http://dx.doi.org/10.1371/journal.pone.0017384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408169	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170000027
J	Wu, WW; de Folter, S; Shen, X; Zhang, WQ; Tao, SH				Wu, Wenwu; de Folter, Stefan; Shen, Xia; Zhang, Wenqian; Tao, Shiheng			Vertebrate Paralogous MEF2 Genes: Origin, Conservation, and Evolution	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MEF2C; DETECTING POSITIVE SELECTION; SERUM RESPONSE FACTOR; MADS-BOX GENES; ADAPTIVE EVOLUTION; HIGHER RATES; DNA-BINDING; MUSCLE; EXPRESSION; ACTIVATION	Background: The myocyte enhancer factor 2 (MEF2) gene family is broadly expressed during the development and maintenance of muscle cells. Although a great deal has been elucidated concerning MEF2 transcription factors' regulation of specific gene expression in diverse programs and adaptive responses, little is known about the origin and evolution of the four members of the MEF2 gene family in vertebrates. Methodology/Principal Findings: By phylogenetic analyses, we investigated the origin, conservation, and evolution of the four MEF2 genes. First, among the four MEF2 paralogous branches, MEF2B is clearly distant from the other three branches in vertebrates, mainly because it lacks the HJURP_C (Holliday junction recognition protein C-terminal) region. Second, three duplication events might have occurred to produce the four MEF2 paralogous genes and the latest duplication event occurred near the origin of vertebrates producing MEF2A and MEF2C. Third, the ratio (K-a/K-s) of non-synonymous to synonymous nucleotide substitution rates showed that MEF2B evolves faster than the other three MEF2 proteins despite purifying selection on all of the four MEF2 branches. Moreover, a pair model of M0 versus M3 showed that variable selection exists among MEF2 proteins, and branch-site analysis presented that sites 53 and 64 along the MEF2B branch are under positive selection. Finally, and interestingly, substitution rates showed that type II MADS genes (i.e., MEF2-like genes) evolve as slowly as type I MADS genes (i.e., SRF-like genes) in animals, which is inconsistent with the fact that type II MADS genes evolve much slower than type I MADS genes in plants. Conclusion: Our findings shed light on the relationship of MEF2A, B, C, and D with functional conservation and evolution in vertebrates. This study provides a rationale for future experimental design to investigate distinct but overlapping regulatory roles of the four MEF2 genes in various tissues.	[Wu, Wenwu; Zhang, Wenqian; Tao, Shiheng] Northwest A& F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Wu, Wenwu; Tao, Shiheng] Northwest A& F Univ, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China; [de Folter, Stefan] Inst Politecn Nacl, Ctr Invest Estudios Avanzados, Lab Nacl Genom Biodiversidad Langebio, Guanajuato, Mexico; [Shen, Xia] Shaanxi Univ Chinese Med, Coll Drug Res, Xian, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Shaanxi University of Chinese Medicine	Tao, SH (corresponding author), Northwest A& F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	shihengt@nwsuaf.edu.cn	Wu, Wenwu/HDO-7873-2022; /E-9373-2013; de Folter, Stefan/S-6428-2019; Wu, Wenwu/AAP-1966-2021	Wu, Wenwu/0000-0003-2996-8675; /0000-0003-4363-7274; de Folter, Stefan/0000-0003-4363-7274; Wu, Wenwu/0000-0003-2996-8675	PhD Programs Foundation of Ministry of Education of China [20100204110026]; Ministry of Education; Mexican Science Council [CONACyT 82826]	PhD Programs Foundation of Ministry of Education of China(Ministry of Education, China); Ministry of Education; Mexican Science Council	The authors gratefully acknowledge The PhD Programs Foundation of Ministry of Education of China (20100204110026) in SHT Lab, The Scholarship Award for Excellent Doctoral Student granted by Ministry of Education to WWW, and the Mexican Science Council (CONACyT 82826) in SDF Lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla ER, 2010, SEMIN CELL DEV BIOL, V21, P108, DOI 10.1016/j.semcdb.2009.11.010; Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; ANDRES V, 1995, MOL CELL BIOL, V15, P4272; ANDRES V, 1995, J BIOL CHEM, V270, P23246, DOI 10.1074/jbc.270.40.23246; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Bielawski JP, 2005, STAT BIOL HEALTH, P103, DOI 10.1007/0-387-27733-1_5; Black B., 2010, HEART DEV REGENERATI, V2, P673; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Brand NJ, 1997, INT J BIOCHEM CELL B, V29, P1467, DOI 10.1016/S1357-2725(97)00084-8; Bromham L, 2009, BIOL LETTERS, V5, P401, DOI 10.1098/rsbl.2009.0136; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; CHOI DW, 1994, ANN NY ACAD SCI, V747, P162; Cooper SJ, 2007, GENOME RES, V17, P136, DOI 10.1101/gr.5875007; Cripps RM, 1999, DEV BIOL, V215, P420, DOI 10.1006/dbio.1999.9446; De Bodt S, 2003, TRENDS PLANT SCI, V8, P475, DOI 10.1016/j.tplants.2003.09.006; De Bodt S, 2003, J MOL EVOL, V56, P573, DOI 10.1007/s00239-002-2426-x; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Gu X, 1992, MOL PHYLOGENET EVOL, V1, P211, DOI 10.1016/1055-7903(92)90017-B; Hernandez-Hernandez T, 2007, MOL BIOL EVOL, V24, P465, DOI 10.1093/molbev/msl182; HOBSON GM, 1995, GENOMICS, V29, P704, DOI 10.1006/geno.1995.9007; Hosking BM, 2001, BIOCHEM BIOPH RES CO, V287, P493, DOI 10.1006/bbrc.2001.5589; Huang K, 2000, EMBO J, V19, P2615, DOI 10.1093/emboj/19.11.2615; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Jimenez S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-81; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kimura M, 1985, NEUTRAL THEORY MOL E; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Litt A, 2010, SEMIN CELL DEV BIOL, V21, P129, DOI 10.1016/j.semcdb.2009.11.019; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; MARTIN JF, 1994, MOL CELL BIOL, V14, P1647, DOI 10.1128/MCB.14.3.1647; MARTIN JF, 1993, P NATL ACAD SCI USA, V90, P5282, DOI 10.1073/pnas.90.11.5282; Martinez-Castilla LP, 2003, P NATL ACAD SCI USA, V100, P13407, DOI 10.1073/pnas.1835864100; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Molkentin JD, 1996, MOL CELL BIOL, V16, P2627; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Nadruz W, 2003, CIRC RES, V92, P243, DOI 10.1161/01.RES.0000053184.94618.97; Nam J, 2004, P NATL ACAD SCI USA, V101, P1910, DOI 10.1073/pnas.0308430100; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Nowakowska BA, 2010, AM J MED GENET B, V153B, P1042, DOI 10.1002/ajmg.b.31071; Ornatsky OI, 1997, J BIOL CHEM, V272, P33271, DOI 10.1074/jbc.272.52.33271; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rao S, 1998, J BIOL CHEM, V273, P26123, DOI 10.1074/jbc.273.40.26123; Sablowski R, 2010, SEMIN CELL DEV BIOL, V21, P94, DOI 10.1016/j.semcdb.2009.08.008; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santelli E, 2000, J MOL BIOL, V297, P437, DOI 10.1006/jmbi.2000.3568; Shalizi AK, 2005, CURR TOP DEV BIOL, V69, P239, DOI 10.1016/S0070-2153(05)69009-6; Shan HY, 2009, MOL BIOL EVOL, V26, P2229, DOI 10.1093/molbev/msp129; Sharma G, 2005, MOL CELL ENDOCRINOL, V245, P93, DOI 10.1016/j.mce.2005.10.027; Sonnhammer ELL, 2002, TRENDS GENET, V18, P619, DOI 10.1016/S0168-9525(02)02793-2; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vanpoucke G, 2004, NUCLEIC ACIDS RES, V32, P4155, DOI 10.1093/nar/gkh727; Verzi MP, 2007, DEV CELL, V12, P645, DOI 10.1016/j.devcel.2007.03.007; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Vong L, 2006, DEV DYNAM, V235, P1809, DOI 10.1002/dvdy.20828; Wallin JJ, 1999, J BIOL CHEM, V274, P15959, DOI 10.1074/jbc.274.22.15959; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wilker PR, 2008, NAT IMMUNOL, V9, P603, DOI 10.1038/ni.1609; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Wu WW, 2011, MOL BIOL EVOL, V28, P501, DOI 10.1093/molbev/msq214; Wu WW, 2010, MAMM GENOME, V21, P104, DOI 10.1007/s00335-009-9238-x; Yan C, 1999, J BIOL CHEM, V274, P143, DOI 10.1074/jbc.274.1.143; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Zhu BM, 2005, J BIOL CHEM, V280, P28749, DOI 10.1074/jbc.M502491200; Zhu BM, 2004, MOL CELL BIOL, V24, P8264, DOI 10.1128/MCB.24.18.8264-8275.2004	80	26	27	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17334	10.1371/journal.pone.0017334	http://dx.doi.org/10.1371/journal.pone.0017334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394201	Green Submitted, Green Published, gold			2022-12-25	WOS:000288025500010
J	Zhong, P; Yan, Z				Zhong, Ping; Yan, Zhen			Differential Regulation of the Excitability of Prefrontal Cortical Fast-Spiking Interneurons and Pyramidal Neurons by Serotonin and Fluoxetine	PLOS ONE			English	Article							PROTEIN-KINASE-C; WORKING-MEMORY; IN-VIVO; MEMBRANE EXCITABILITY; MAJOR DEPRESSION; 5-HT2A RECEPTORS; FRONTAL-CORTEX; RAT; TRANSMISSION; OSCILLATIONS	Serotonin exerts a powerful influence on neuronal excitability. In this study, we investigated the effects of serotonin on different neuronal populations in prefrontal cortex (PFC), a major area controlling emotion and cognition. Using whole-cell recordings in PFC slices, we found that bath application of 5-HT dose-dependently increased the firing of FS (fast spiking) interneurons, and decreased the firing of pyramidal neurons. The enhancing effect of 5-HT in FS interneurons was mediated by 5-HT2 receptors, while the reducing effect of 5-HT in pyramidal neurons was mediated by 5-HT1 receptors. Fluoxetine, the selective serotonin reuptake inhibitor, also induced a concentration-dependent increase in the excitability of FS interneurons, but had little effect on pyramidal neurons. In rats with chronic fluoxetine treatment, the excitability of FS interneurons was significantly increased, while pyramidal neurons remained unchanged. Fluoxetine injection largely occluded the enhancing effect of 5-HT in FS interneurons, but did not alter the reducing effect of 5-HT in pyramidal neurons. These data suggest that the excitability of PFC interneurons and pyramidal neurons is regulated by exogenous 5-HT in an opposing manner, and FS interneurons are the major target of Fluoxetine. It provides a framework for understanding the action of 5-HT and antidepressants in altering PFC network activity.	[Zhong, Ping; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zhong, P (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14260 USA.	zhenyan@buffalo.edu			National Institutes of Health [MH84233]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grant MH84233 to ZY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian GK, 1997, NEUROPHARMACOLOGY, V36, P589, DOI 10.1016/S0028-3908(97)00051-8; Amargos-Bosch M, 2004, CEREB CORTEX, V14, P281, DOI 10.1093/cercor/bhg128; Andrade R, 1998, ANN NY ACAD SCI, V861, P190, DOI 10.1111/j.1749-6632.1998.tb10191.x; ARANEDA R, 1991, NEUROSCIENCE, V40, P399, DOI 10.1016/0306-4522(91)90128-B; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Beique JC, 2004, J NEUROSCI, V24, P4807, DOI 10.1523/JNEUROSCI.5113-03.2004; Beique JC, 2007, P NATL ACAD SCI USA, V104, P9870, DOI 10.1073/pnas.0700436104; CACCIA S, 1992, NEUROPHARMACOLOGY, V31, P343, DOI 10.1016/0028-3908(92)90066-X; Cauli B, 1997, J NEUROSCI, V17, P3894; Contreras CM, 2001, J PSYCHOPHARMACOL, V15, P231, DOI 10.1177/026988110101500401; Cornelisse LN, 2007, J NEUROPHYSIOL, V98, P196, DOI 10.1152/jn.00109.2007; Deng PY, 2007, MOL PHARMACOL, V72, P208, DOI 10.1124/mol.107.034389; DOLAN RJ, 1994, PSYCHOL MED, V24, P849, DOI 10.1017/S0033291700028944; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Feng J, 2001, J NEUROSCI, V21, P6502, DOI 10.1523/JNEUROSCI.21-17-06502.2001; Foehring RC, 1996, J NEUROPHYSIOL, V75, P648, DOI 10.1152/jn.1996.75.2.648; Gao WJ, 2003, J NEUROSCI, V23, P1622; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; Gronier BS, 2003, NEUROSCI LETT, V349, P196, DOI 10.1016/S0304-3940(03)00851-6; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Lambe EK, 2000, CEREB CORTEX, V10, P974, DOI 10.1093/cercor/10.10.974; Lei WB, 2001, J BIOL CHEM, V276, P16720, DOI 10.1074/jbc.M100207200; Lemonde S, 2003, J NEUROSCI, V23, P8788; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Liu ZP, 2003, J NEUROPHYSIOL, V90, P3201, DOI 10.1152/jn.00281.2003; Meltzer HY, 2008, PROG BRAIN RES, V172, P177, DOI 10.1016/S0079-6123(08)00909-6; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mizoguchi K, 2004, J NEUROSCI, V24, P5492, DOI 10.1523/JNEUROSCI.0086-04.2004; Mukherjee J, 1999, SYNAPSE, V31, P285, DOI 10.1002/(SICI)1098-2396(19990315)31:4<285::AID-SYN6>3.0.CO;2-5; Nierenberg AA, 2000, AM J PSYCHIAT, V157, P1423, DOI 10.1176/appi.ajp.157.9.1423; Nitsche MA, 2009, EXP NEUROL, V219, P14, DOI 10.1016/j.expneurol.2009.03.038; Puig MV, 2010, J NEUROSCI, V30, P2211, DOI 10.1523/JNEUROSCI.3335-09.2010; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; Santana N, 2004, CEREB CORTEX, V14, P1100, DOI 10.1093/cercor/bhh070; Schenberg LC, 2001, NEUROSCI BIOBEHAV R, V25, P647, DOI 10.1016/S0149-7634(01)00060-4; Shakesby AC, 2002, J NEUROSCI, V22, P3638; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; STARK P, 1985, J CLIN PSYCHIAT, V46, P7; Stockmeier CA, 1997, ANN NY ACAD SCI, V836, P220, DOI 10.1111/j.1749-6632.1997.tb52362.x; Traboulsie A, 2006, MOL PHARMACOL, V69, P1963, DOI 10.1124/mol.105.020842; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Williams GV, 2002, J NEUROSCI, V22, P2843, DOI 10.1523/JNEUROSCI.22-07-02843.2002; WONG DT, 1995, LIFE SCI, V57, P411, DOI 10.1016/0024-3205(95)00209-O; Zhang ZW, 2003, J NEUROSCI, V23, P3373; Zhong P, 2004, NEUROSCIENCE, V129, P65, DOI 10.1016/j.neuroscience.2004.06.072; Zhong P, 2003, J BIOL CHEM, V278, P26888, DOI 10.1074/jbc.M302789200; Zhong P, 2008, MOL CELL NEUROSCI, V38, P290, DOI 10.1016/j.mcn.2008.03.003; Zhou FM, 1999, J NEUROPHYSIOL, V82, P2989, DOI 10.1152/jn.1999.82.6.2989	56	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16970	10.1371/journal.pone.0016970	http://dx.doi.org/10.1371/journal.pone.0016970			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383986	Green Published, Green Submitted, gold			2022-12-25	WOS:000287761700023
J	Zimmerman, SW; Manandhar, G; Yi, YJ; Gupta, SK; Sutovsky, M; Odhiambo, JF; Powell, MD; Miller, DJ; Sutovsky, P				Zimmerman, Shawn W.; Manandhar, Gaurishankar; Yi, Young-Joo; Gupta, Satish K.; Sutovsky, Miriam; Odhiambo, John F.; Powell, Michael D.; Miller, David J.; Sutovsky, Peter			Sperm Proteasomes Degrade Sperm Receptor on the Egg Zona Pellucida during Mammalian Fertilization	PLOS ONE			English	Article							ACROSOMAL EXOCYTOSIS; MONOCLONAL-ANTIBODIES; CATALYTIC-PROPERTIES; BOAR SPERMATOZOA; PROTEIN; PENETRATION; MOUSE; UBIQUITIN; MEMBRANE; GLYCOPROTEINS	Despite decades of research, the mechanism by which the fertilizing spermatozoon penetrates the mammalian vitelline membrane, the zona pellucida (ZP) remains one of the unexplained fundamental events of human/mammalian development. Evidence has been accumulating in support of the 26S proteasome as a candidate for echinoderm, ascidian and mammalian egg coat lysin. Monitoring ZP protein degradation by sperm during fertilization is nearly impossible because those few spermatozoa that penetrate the ZP leave behind a virtually untraceable residue of degraded proteins. We have overcome this hurdle by designing an experimentally consistent in vitro system in which live boar spermatozoa are co-incubated with ZP-proteins (ZPP) solubilized from porcine oocytes. Using this assay, mimicking sperm-egg interactions, we demonstrate that the sperm-borne proteasomes can degrade the sperm receptor protein ZPC. Upon coincubation with motile spermatozoa, the solubilized ZPP, which appear to be ubiquitinated, adhered to sperm acrosomal caps and induced acrosomal exocytosis/formation of the acrosomal shroud. The degradation of the sperm receptor protein ZPC was assessed by Western blotting band-densitometry and proteomics. A nearly identical pattern of sperm receptor degradation, evident already within the first 5 min of coincubation, was observed when the spermatozoa were replaced with the isolated, enzymatically active, sperm-derived proteasomes. ZPC degradation was blocked by proteasomal inhibitors and accelerated by ubiquitin-aldehyde(UBAL), a modified ubiquitin protein that stimulates proteasomal proteolysis. Such a degradation pattern of ZPC is consistent with in vitro fertilization studies, in which proteasomal inhibitors completely blocked fertilization, and UBAL increased fertilization and polyspermy rates. Preincubation of intact zona-enclosed ova with isolated active sperm proteasomes caused digestion, abrasions and loosening of the exposed zonae, and significantly reduced the fertilization/polyspermy rates after IVF, accompanied by en-mass detachment of zona bound sperm. Thus, the sperm borne 26S proteasome is a candidate zona lysin in mammals. This new paradigm has implications for contraception and assisted reproductive technologies in humans, as well as animals.	[Zimmerman, Shawn W.; Manandhar, Gaurishankar; Sutovsky, Miriam; Odhiambo, John F.; Sutovsky, Peter] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Zimmerman, Shawn W.; Manandhar, Gaurishankar; Sutovsky, Miriam; Odhiambo, John F.; Sutovsky, Peter] Univ Missouri, Dept Obstet, Columbia, MO USA; [Zimmerman, Shawn W.; Manandhar, Gaurishankar; Sutovsky, Miriam; Odhiambo, John F.; Sutovsky, Peter] Univ Missouri, Dept Gynecol, Columbia, MO USA; [Zimmerman, Shawn W.; Manandhar, Gaurishankar; Sutovsky, Miriam; Odhiambo, John F.; Sutovsky, Peter] Univ Missouri, Dept Womens Hlth, Columbia, MO USA; [Yi, Young-Joo] Chungnam Natl Univ, Res Ctr Transgen Cloned Pigs, Taejon, South Korea; [Gupta, Satish K.] Natl Inst Immunol, Reprod Cell Biol Lab, New Delhi 110067, India; [Powell, Michael D.] Morehouse Univ, Morehouse Sch Med, Atlanta, GA USA; [Miller, David J.] Univ Illinois, Dept Anim Sci, Urbana, IL USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Chungnam National University; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Morehouse College; Morehouse School of Medicine; University of Illinois System; University of Illinois Urbana-Champaign	Zimmerman, SW (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	SutovskyP@missouri.edu	Miller, David J/ABC-2156-2020; Gupta, Satish/B-9934-2009; odhiambo, john/AAC-2444-2020	Miller, David J/0000-0001-7147-5546; Gupta, Satish/0000-0003-3717-0436; odhiambo, john/0000-0002-1005-3486; Sutovsky, Peter/0000-0002-9231-2823	National Research Initiative Competitive [2007-01319]; Missouri Life Sciences Trust Fund [13324]; University of Missouri	National Research Initiative Competitive(United States Department of Agriculture (USDA)); Missouri Life Sciences Trust Fund; University of Missouri	National Research Initiative Competitive Grant no. 2007-01319 Missouri Life Sciences Trust Fund award number 13324 Seed funding was provided by the Food for the 21st Century Program of The University of Missouri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian TN, 1997, J BIOL CHEM, V272, P1791, DOI 10.1074/jbc.272.3.1791; AUSTIN CR, 1958, PROC R SOC SER B-BIO, V149, P241, DOI 10.1098/rspb.1958.0066; AUSTIN CR, 1975, J REPROD FERTIL, V44, P155, DOI 10.1530/jrf.0.0440155; BABA T, 1989, J BIOL CHEM, V264, P11920; BABA T, 1994, J BIOL CHEM, V269, P31845; BABA T, 1994, J BIOL CHEM, V269, P10133; BAGOLA K, BIOCH BIOPHYS ACTA; Bedford JM, 2008, INT J DEV BIOL, V52, P415, DOI 10.1387/ijdb.072551jb; Bedford JM, 1998, BIOL REPROD, V59, P1275, DOI 10.1095/biolreprod59.6.1275; Blackmore DG, 2004, BIOL REPROD, V71, P661, DOI 10.1095/biolreprod.104.028779; BLEIL JD, 1980, CELL, V20, P873, DOI 10.1016/0092-8674(80)90334-7; Bohring C, 2003, AM J REPROD IMMUNOL, V50, P411, DOI 10.1034/j.1600-0897.2003.00103.x; Buffone MG, 2008, INT J DEV BIOL, V52, P511, DOI 10.1387/ijdb.072532mb; Burkin Heather R, 2004, Methods Mol Biol, V253, P79; Chakravarty S, 2008, REPROD BIOMED ONLINE, V16, P391, DOI 10.1016/S1472-6483(10)60601-3; Diaz ES, 2007, HUM REPROD, V22, P1420, DOI 10.1093/humrep/dem023; EINSPANIER R, 1993, THERIOGENOLOGY, V40, P181, DOI 10.1016/0093-691X(93)90351-5; Flechon Jacques E, 2003, Reprod Biol Endocrinol, V1, P124, DOI 10.1186/1477-7827-1-124; GOECKELER JL, DIABETES OBES MET S2, V12, P32; GREEN DPL, 1984, BIOPHYS J, V45, P659, DOI 10.1016/S0006-3495(84)84207-1; GREEN DPL, 1987, EXP CELL RES, V169, P31, DOI 10.1016/0014-4827(87)90221-7; Gupta Manju, 1994, Indian Journal of Experimental Biology, V32, P376; GUPTA SK, 1995, MOL REPROD DEV, V42, P220, DOI 10.1002/mrd.1080420211; GUPTA SK, 1993, AM J REPROD IMMUNOL, V30, P95, DOI 10.1111/j.1600-0897.1993.tb00608.x; Guterman A, 2004, CURR PROTEIN PEPT SC, V5, P201, DOI 10.2174/1389203043379756; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Honda A, 2002, J BIOL CHEM, V277, P16976, DOI 10.1074/jbc.M112470200; Kawano N, 2010, BIOL REPROD; Kolle S, 1996, HISTOCHEM J, V28, P441, DOI 10.1007/BF02331435; Lambert CC, 2002, J EXP ZOOL, V292, P88, DOI 10.1002/jez.1145; Lee VH, 2000, BIOL REPROD, V63, P401, DOI 10.1095/biolreprod63.2.401; Luria A, 2002, BIOL REPROD, V66, P429, DOI 10.1095/biolreprod66.2.429; Morales P, 2003, HUM REPROD, V18, P1010, DOI 10.1093/humrep/deg111; Morales Patricio, 2007, Soc Reprod Fertil Suppl, V65, P269; Moreno RD, 2006, MOL REPROD DEV, V73, P1430, DOI 10.1002/mrd.20581; NAZ RK, J REPROD IMMUNOL, V84, P24; Olds-Clarke P, 2003, INT REV CYTOL, V232, P129, DOI 10.1016/S0074-7696(03)32004-2; Pasten C, 2005, MOL REPROD DEV, V71, P209, DOI 10.1002/mrd.20280; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Qi HY, 2002, MOL BIOL CELL, V13, P530, DOI 10.1091/mbc.01-09-0440; Reidlinger J, 1997, J BIOL CHEM, V272, P24899, DOI 10.1074/jbc.272.40.24899; Rivkin E, 2009, DEV DYNAM, V238, P1851, DOI 10.1002/dvdy.22004; Rodriguez-Miranda E, 2008, BIOL REPROD, V79, P164, DOI 10.1095/biolreprod.107.065565; Rossato M, 1999, HUM REPROD, V14, P694, DOI 10.1093/humrep/14.3.694; Sakai N, 2004, INT J BIOCHEM CELL B, V36, P776, DOI 10.1016/S1357-2725(03)00263-2; Sawada H, 2002, P NATL ACAD SCI USA, V99, P1223, DOI 10.1073/pnas.032389499; Sixt SU, 2008, BBA-MOL BASIS DIS, V1782, P817, DOI 10.1016/j.bbadis.2008.06.005; Sutovsky P, 2004, BIOL REPROD, V71, P1625, DOI 10.1095/biolreprod.104.032532; Sutovsky Peter, 2004, Methods Mol Biol, V253, P59; Tengowski MW, 2007, BIOL REPROD, V76, P149, DOI 10.1095/biolreprod.106.053173; Vazquez JM, 1996, ACTA HISTOCHEM, V98, P93, DOI 10.1016/S0065-1281(96)80056-0; Yanagimachi R, 1994, MAMMALIAN FERTILIZAT; Yi Young-Joo, 2007, Soc Reprod Fertil Suppl, V63, P385; Yi YJ, 2007, BIOL REPROD, V77, P780, DOI 10.1095/biolreprod.107.061275; Yi YJ, 2009, SYST BIOL REPROD MED, V55, P85, DOI 10.1080/19396360802699074; Yokota N, 2007, DEV BIOL, V308, P222, DOI 10.1016/j.ydbio.2007.05.025; Yu Y, 2006, DEV BIOL, V290, P32, DOI 10.1016/j.ydbio.2005.11.003; Yurewicz EC, 1998, J BIOL CHEM, V273, P7488, DOI 10.1074/jbc.273.13.7488; Zimmerman S, 2009, J REPROD IMMUNOL, V83, P19, DOI 10.1016/j.jri.2009.07.006	59	58	59	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17256	10.1371/journal.pone.0017256	http://dx.doi.org/10.1371/journal.pone.0017256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383844	gold, Green Submitted, Green Published			2022-12-25	WOS:000287657500046
J	Feng, YX; Wang, YM; Li, L; Wu, LA; Hoffmann, S; Gretz, N; Hammes, HP				Feng, Yuxi; Wang, Yumei; Li, Li; Wu, Liang; Hoffmann, Sigrid; Gretz, Norbert; Hammes, Hans-Peter			Gene Expression Profiling of Vasoregression in the Retina-Involvement of Microglial Cells	PLOS ONE			English	Article							DEGENERATION; ACTIVATION; PATHOGENESIS; MIGRATION; PERICYTES	Vasoregression is a hallmark of vascular eye diseases but the mechanisms involved are still largely unknown. We have recently characterized a rat ciliopathy model which develops primary photoreceptor degeneration and secondary vasoregression. To improve the understanding of secondary vasoregression in retinal neurodegeneration, we used microarray techniques to compare gene expression profiles in this new model before and after retinal vasoregression. Differential gene expression was validated by quantitative RT-PCR, Western blot and immunofluorescence. Of the 157 genes regulated more than twofold, the MHC class II invariant chain CD74 yielded the strongest upregulation, and was allocated to activated microglial cells close to the vessels undergoing vasoregression. Pathway clustering identified genes of the immune system including inflammatory signaling, and components of the complement cascade upregulated during vasoregression. Together, our data suggest that microglial cells involved in retinal immune response participate in the initiation of vasoregression in the retina.	[Feng, Yuxi; Wang, Yumei; Wu, Liang; Hammes, Hans-Peter] Heidelberg Univ, Med Fac Mannheim, Med Dept 5, D-6800 Mannheim, Germany; [Li, Li; Hoffmann, Sigrid; Gretz, Norbert] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr, D-6800 Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Feng, YX (corresponding author), Heidelberg Univ, Med Fac Mannheim, Med Dept 5, D-6800 Mannheim, Germany.	hans-peter.hammes@med5.ma.uni-heidelberg.de	Hammes, Hans-Peter/S-3719-2019		Deutsche Forschungsgemeinschaft [Ha 1755/8-1, GRK 880]; Deutsche Diabetes-Gesellschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Diabetes-Gesellschaft	This study was supported by the Deutsche Forschungsgemeinschaft (Ha 1755/8-1 to YF and HPH; GRK 880 to YW, YF, and HPH) and the Deutsche Diabetes-Gesellschaft (to YF, YW, and HPH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beswick EJ, 2005, J IMMUNOL, V175, P171, DOI 10.4049/jimmunol.175.1.171; Bryan KJ, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-13; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Feng YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007328; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Gallagher AR, 2006, J AM SOC NEPHROL, V17, P2719, DOI 10.1681/ASN.2005090979; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Martin-Ventura JL, 2009, CARDIOVASC RES, V83, P586, DOI 10.1093/cvr/cvp141; Matsuda S, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-41; Matza D, 2003, TRENDS IMMUNOL, V24, P264, DOI 10.1016/S1471-4906(03)00073-5; Pennesi ME, 2008, EXP EYE RES, V87, P561, DOI 10.1016/j.exer.2008.09.004; Roque RS, 1996, INVEST OPHTH VIS SCI, V37, P196; SEATON AD, 1994, INVEST OPHTH VIS SCI, V35, P162; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; von Leithner PL, 2009, AM J PATHOL, V175, P412, DOI 10.2353/ajpath.2009.080927; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Zeng HY, 2008, ARCH OPHTHALMOL-CHIC, V126, P227, DOI 10.1001/archophthalmol.2007.65; Zeng HY, 2005, INVEST OPHTH VIS SCI, V46, P2992, DOI 10.1167/iovs.05-0118; Zhang C, 2005, EXP EYE RES, V81, P700, DOI 10.1016/j.exer.2005.04.008; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	27	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16865	10.1371/journal.pone.0016865	http://dx.doi.org/10.1371/journal.pone.0016865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379381	gold, Green Submitted, Green Published			2022-12-25	WOS:000287482300022
J	Weger, BD; Sahinbas, M; Otto, GW; Mracek, P; Armant, O; Dolle, D; Lahiri, K; Vallone, D; Ettwiller, L; Geisler, R; Foulkes, NS; Dickmeis, T				Weger, Benjamin D.; Sahinbas, Meltem; Otto, Georg W.; Mracek, Philipp; Armant, Olivier; Dolle, Dirk; Lahiri, Kajori; Vallone, Daniela; Ettwiller, Laurence; Geisler, Robert; Foulkes, Nicholas S.; Dickmeis, Thomas			The Light Responsive Transcriptome of the Zebrafish: Function and Regulation	PLOS ONE			English	Article							HEAT-SHOCK FACTOR-1; CIRCADIAN CLOCK; GENE ONTOLOGY; DNA-REPAIR; CELL-CYCLE; EXPRESSION; CYTOSCAPE; ACTIVATION; MECHANISMS; MELANOPSIN	Most organisms possess circadian clocks that are able to anticipate the day/night cycle and are reset or "entrained'' by the ambient light. In the zebrafish, many organs and even cultured cell lines are directly light responsive, allowing for direct entrainment of the clock by light. Here, we have characterized light induced gene transcription in the zebrafish at several organizational levels. Larvae, heart organ cultures and cell cultures were exposed to 1- or 3-hour light pulses, and changes in gene expression were compared with controls kept in the dark. We identified 117 light regulated genes, with the majority being induced and some repressed by light. Cluster analysis groups the genes into five major classes that show regulation at all levels of organization or in different subset combinations. The regulated genes cover a variety of functions, and the analysis of gene ontology categories reveals an enrichment of genes involved in circadian rhythms, stress response and DNA repair, consistent with the exposure to visible wavelengths of light priming cells for UV-induced damage repair. Promoter analysis of the induced genes shows an enrichment of various short sequence motifs, including E-and D-box enhancers that have previously been implicated in light regulation of the zebrafish period2 gene. Heterologous reporter constructs with sequences matching these motifs reveal light regulation of D-box elements in both cells and larvae. Morpholino-mediated knock-down studies of two homologues of the D-box binding factor Tef indicate that these are differentially involved in the cell autonomous light induction in a gene-specific manner. These findings suggest that the mechanisms involved in period2 regulation might represent a more general pathway leading to light induced gene expression.	[Weger, Benjamin D.; Sahinbas, Meltem; Mracek, Philipp; Armant, Olivier; Lahiri, Kajori; Vallone, Daniela; Foulkes, Nicholas S.; Dickmeis, Thomas] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany; [Otto, Georg W.; Geisler, Robert] Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany; [Dolle, Dirk; Ettwiller, Laurence] Heidelberg Univ, Heidelberg Inst Zool, Heidelberg, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Max Planck Society; Ruprecht Karls University Heidelberg	Weger, BD (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany.	nicholas.foulkes@kit.edu; thomas.dickmeis@kit.edu	Sahinbas, Meltem/H-6482-2013; Geisler, Robert/K-6201-2013; Weger, Meltem/AAG-6735-2019; Vallone, Daniela/S-2244-2019; Foulkes, Nicholas S/K-7003-2013; Weger, Benjamin D/AAG-7551-2019; Dickmeis, Thomas/H-1355-2013	Geisler, Robert/0000-0002-3909-8311; Weger, Meltem/0000-0002-9452-2373; Foulkes, Nicholas S/0000-0002-1794-9891; Weger, Benjamin D/0000-0002-1831-3561; Dolle, Dirk-Dominik/0000-0003-1786-6452; Ettwiller, Laurence/0000-0002-3957-6539; Otto, Georg W/0000-0002-3929-948X; armant, olivier/0000-0001-7101-9209	Max-Planck-Society; Karlsruhe Institute of Technology; EMBO; DFG; Studienstiftung des Deutschen Volkes; European Commission [LSHG-CT-2003-503496]; EU	Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Karlsruhe Institute of Technology(Helmholtz Association); EMBO(European Molecular Biology Organization (EMBO)); DFG(German Research Foundation (DFG)); Studienstiftung des Deutschen Volkes; European Commission(European CommissionEuropean Commission Joint Research Centre); EU(European Commission)	This work was supported by the Max-Planck-Society (GWO, PM, KL, DV, RG, NSF and TD) and the Karlsruhe Institute of Technology (MS, PM, KL, DV, NSF and TD) as well as by grants from EMBO (TD), DFG (TD and BDW), the Studienstiftung des Deutschen Volkes (MS), the European Commission's 6th Framework Programme (Contract No LSHG-CT-2003-503496, ZF-MODELS) (GWO and RG) and the EU 6th Framework STREP Project ZF-TOOLS (KL, DV and NSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; BAILES IIJ, 2009, CELL MOL LIFE SCI; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Ben-Moshe Z, 2010, CHRONOBIOL INT, V27, P1509, DOI 10.3109/07420528.2010.510229; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; Carr AJF, 2005, NAT CELL BIOL, V7, P319, DOI 10.1038/ncb1232; Cermakian N, 2002, CURR BIOL, V12, P844, DOI 10.1016/S0960-9822(02)00835-7; CIRCU ML, FREE RADIC BIOL MED, V48, P749; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Dunlap J., 2004, CHRONOBIOLOGY; Ettwiller L, 2007, NAT METHODS, V4, P563, DOI 10.1038/NMETH1061; Frisch M, 2009, NUCLEIC ACIDS RES, V37, pW135, DOI 10.1093/nar/gkp303; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gavriouchkina D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012542; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Girotti AW, 2004, ANTIOXID REDOX SIGN, V6, P301, DOI 10.1089/152308604322899369; Guler AD, 2007, COLD SPRING HARB SYM, V72, P509, DOI 10.1101/sqb.2007.72.074; GUO C, CELL, V140, pE751; GUO C, CELL, V140, P754; Haudry Y, 2010, NAT PROTOC, V5, P323, DOI 10.1038/nprot.2009.158; Herrlich P, 2008, MOL CELL, V29, P279, DOI 10.1016/j.molcel.2008.01.001; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hirayama J, 2005, P NATL ACAD SCI USA, V102, P10194, DOI 10.1073/pnas.0502610102; Hirayama J, 2009, CELL CYCLE, V8, P2794, DOI 10.4161/cc.8.17.9447; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Kalsbeek A, 2006, J BIOL RHYTHM, V21, P458, DOI 10.1177/0748730406293854; Kaneko M, 2005, PLOS BIOL, V3, P313, DOI 10.1371/journal.pbio.0030034; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kuhlman SJ, 2006, J BIOL RHYTHM, V21, P470, DOI 10.1177/0748730406294316; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; Lee I, 2008, BBA-PROTEINS PROTEOM, V1784, P727, DOI 10.1016/j.bbapap.2008.02.010; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Moutsaki P, 2003, MOL BRAIN RES, V112, P135, DOI 10.1016/S0169-328X(03)00059-7; Nusslein-Volhard C, 2002, ZEBRAFISH; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Pando MP, 2001, P NATL ACAD SCI USA, V98, P10178, DOI 10.1073/pnas.181228598; PAUL KN, 2009, REV ENDOCR METAB DIS; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; Pinzar E, 2000, P NATL ACAD SCI USA, V97, P4903, DOI 10.1073/pnas.090093997; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Pulivarthy SR, 2007, P NATL ACAD SCI USA, V104, P20356, DOI 10.1073/pnas.0708877104; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schibler U, 2009, J BIOL RHYTHM, V24, P3, DOI 10.1177/0748730408329383; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siu TL, 2008, CLIN EXP OPHTHALMOL, V36, P176, DOI 10.1111/j.1442-9071.2008.01699.x; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tamai TK, 2007, P NATL ACAD SCI USA, V104, P14712, DOI 10.1073/pnas.0704588104; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; Team. RDC, 2007, R LANG ENV STAT COMP; UCHIDA Y, BIOL PHARM B, V33, P535; Ukai H, 2007, NAT CELL BIOL, V9, P1327, DOI 10.1038/ncb1653; Vallone D, 2004, P NATL ACAD SCI USA, V101, P4106, DOI 10.1073/pnas.0305436101; Vallone D, 2007, DEV DYNAM, V236, P142, DOI 10.1002/dvdy.20998; Vatine G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000223; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; WU Z, 2004, MODEL BASED BACKGROU, P1; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	74	70	73	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17080	10.1371/journal.pone.0017080	http://dx.doi.org/10.1371/journal.pone.0017080			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21390203	Green Submitted, gold, Green Published			2022-12-25	WOS:000287369200019
J	Kim, HD; Kim, TS; Kim, J				Kim, H. D.; Kim, T-S; Kim, J.			Aberrant ribosome biogenesis activates c-Myc and ASK1 pathways resulting in p53-dependent G1 arrest	ONCOGENE			English	Article						ASK1; c-Myc; p53; rpL11; rpS3; ribosomal stress	DIAMOND-BLACKFAN ANEMIA; RIBOTOXIC STRESS-RESPONSE; CELL-CYCLE; MESSENGER-RNA; PROTEIN L26; P53; TRANSLATION; CANCER; CHECKPOINT; L11	The largest energy consumer in the cell is the ribosome biogenesis whose aberrancy elicits various diseases in humans. It has been recently revealed that p53 induction, along with cell cycle arrest, is related with abnormal ribosome biogenesis, but the exact mechanism still remains unknown. In this study, we have found that aberrant ribosome biogenesis activates two parallel cellular pathways, c-Myc and ASK1/p38, which result in p53 induction and G1 arrest. The c-Myc stabilizes p53 by rpL11-mediated HDM2 inhibition, and ASK1/p38 activates p53 by phosphorylation on serine 15 and 33. Our studies demonstrate the relationship between these two pathways and p53 induction. The changes caused by impaired ribosomal stress, such as p53 induction and G1 arrest, were completely disappeared by inhibition of either pathway. These findings suggest a monitoring mechanism of c-Myc and ASK1/p38 against abnormal ribosome biogenesis through controlling the stability and activity of p53 protein. Oncogene (2011) 30, 3317-3327; doi:10.1038/onc.2011.47; published online 7 March 2011	[Kim, J.] Korea Univ, Biochem Lab, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Kim, J.] Korea Univ, BioInst, Seoul 136701, South Korea	Korea University; Korea University	Kim, J (corresponding author), Korea Univ, Biochem Lab, Sch Life Sci & Biotechnol, Seoul 136701, South Korea.	joonkim@korea.ac.kr			Ministry of Education and Science of Korea [FPR08B1-230, 2008-0059301, 2009-0086319]	Ministry of Education and Science of Korea(Ministry of Education (MOE), Republic of Korea)	We thank Professor E-J Choi (Korea University, Seoul, Korea) for the kind gifts of ASK1 antibody and GST-MKK6 protein. This work was supported in part by FPR08B1-230, 2008-0059301 and 2009-0086319 NRF Grants from Ministry of Education and Science of Korea.	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Belin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007147; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Cazzaniga G, 2005, BLOOD, V106, P1419, DOI 10.1182/blood-2005-03-0899; Cleveland JL, 2004, CANCER CELL, V6, P309, DOI 10.1016/j.ccr.2004.09.020; Dai MS, 2007, CELL CYCLE, V6, P2735, DOI 10.4161/cc.6.22.4895; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; Ellis SR, 2008, CURR TOP DEV BIOL, V82, P217, DOI 10.1016/S0070-2153(07)00008-7; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Idol RA, 2007, BLOOD CELL MOL DIS, V39, P35, DOI 10.1016/j.bcmd.2007.02.001; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Kim HD, 2010, J CELL BIOCHEM, V110, P294, DOI 10.1002/jcb.22537; Kim TS, 2009, BBA-MOL CELL RES, V1793, P395, DOI 10.1016/j.bbamcr.2008.10.017; Kim TS, 2006, MOL BIOL CELL, V17, P824, DOI 10.1091/mbc.E05-08-0713; Kishi H, 2001, J BIOL CHEM, V276, P39115, DOI 10.1074/jbc.M105134200; Laskin JD, 2002, TOXICOL SCI, V69, P289, DOI 10.1093/toxsci/69.2.289; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Liu JM, 2006, BLOOD, V107, P4583, DOI 10.1182/blood-2005-12-4831; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Maggi LB, 2005, CANCER INVEST, V23, P599, DOI 10.1080/07357900500283085; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Opferman JT, 2006, CELL DEATH DIFFER, V13, P898, DOI 10.1038/sj.cdd.4401923; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Robledo S, 2008, RNA, V14, P1918, DOI 10.1261/rna.1132008; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; Sumbayev VV, 2005, ARCH BIOCHEM BIOPHYS, V436, P406, DOI 10.1016/j.abb.2005.02.021; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; ULLRICH SJ, 1992, J BIOL CHEM, V267, P15259; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zimmermann RA, 2003, CELL, V115, P130, DOI 10.1016/S0092-8674(03)00804-3	45	18	18	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2011	30	30					3317	3327		10.1038/onc.2011.47	http://dx.doi.org/10.1038/onc.2011.47			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	798NO	21383696				2022-12-25	WOS:000293215700002
J	Matthews, EE; Thevenin, D; Rogers, JM; Gotow, L; Lira, PD; Reiter, LA; Brissette, WH; Engelman, DM				Matthews, Erin E.; Thevenin, Damien; Rogers, Julia M.; Gotow, Lisa; Lira, Paul D.; Reiter, Lawrence A.; Brissette, William H.; Engelman, Donald M.			Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation	FASEB JOURNAL			English	Article						transmembrane domain; small-molecule agonist; disulfide bond cross-linking; TOXCAT	GROWTH-HORMONE RECEPTOR; ERYTHROPOIETIN RECEPTOR; EXTRACELLULAR JUXTAMEMBRANE; LEUCINE-ZIPPER; DOMAIN; AGONISTS; IDENTIFICATION; MEMBRANE; MIMICS; MEGAKARYOCYTOPOIESIS	We report how rotational variations in transmembrane (TM) helix interactions participate in the activity states of the thrombopoietin receptor (TpoR), a type 1 cytokine receptor that controls the production of blood platelets. We also explore the mechanism of small-molecule agonists that do not mimic the natural ligand. We show, by a combination of cysteine cross-linking, alanine-scanning mutagenesis, and computational simulations, that the TpoR TM dimerizes strongly and can adopt 3 different stable, rotationally related conformations, which may correspond to specific states of the full-length receptor (active, inactive, and partially active). Thus, our data suggest that signaling and inactive states of the receptor are related by receptor subunit rotations, rather than a simple monomer-dimer transition. Moreover, results from experiments with and without agonists in vitro and in cells allow us to propose a novel allosteric mechanism of action for a class of small molecules, in which they activate TpoR by binding to the TM region and by exploiting the rotational states of the dimeric receptor. Overall, our results support the emerging view of the participation of mutual rotations of the TM domains in cytokine receptor activation.-Matthews, E. E., Thevenin, D., Rogers, J. M., Gotow, L., Lira, P. D., Reiter, L. A., Brissette, W. H., Engelman, D. M. Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation. FASEB J. 25, 2234-2244 (2011). www.fasebj.org	[Matthews, Erin E.; Thevenin, Damien; Rogers, Julia M.; Engelman, Donald M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gotow, Lisa; Lira, Paul D.; Reiter, Lawrence A.; Brissette, William H.] Pfizer Global Res & Dev, Groton Labs, Groton, CT USA	Yale University; Pfizer	Engelman, DM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 208114, New Haven, CT 06520 USA.	donald.engelman@yale.edu		Rogers, Julia M/0000-0001-6518-5470; Thevenin, Damien/0000-0002-1866-0694	U.S. National Institutes of Health [GM073857, CA133890]; Pfizer [N-926702]; NATIONAL CANCER INSTITUTE [R01CA133890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073857] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the U.S. National Institutes of Health (grants GM073857 and CA133890) and by Pfizer (grant N-926702).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B; ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154; Antonchuk J, 2001, EXP HEMATOL, V29, P1125, DOI 10.1016/S0301-472X(01)00681-6; Brooks AJ, 2008, INT J BIOCHEM CELL B, V40, P1984, DOI 10.1016/j.biocel.2007.07.008; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; de Sauvage FJ, 1998, J LAB CLIN MED, V131, P496, DOI 10.1016/S0022-2143(98)90057-9; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Ding F, 2004, BLOOD, V103, P4198, DOI 10.1182/blood-2003-10-3471; Ding JM, 2009, BLOOD, V114, P3325, DOI 10.1182/blood-2008-04-149047; Drachman JG, 1997, P NATL ACAD SCI USA, V94, P2350, DOI 10.1073/pnas.94.6.2350; Duffy KJ, 2002, J MED CHEM, V45, P3573, DOI 10.1021/jm025535c; Duffy KJ, 2002, J MED CHEM, V45, P3576, DOI 10.1021/jm0255365; Duffy KJ, 2001, J MED CHEM, V44, P3730, DOI 10.1021/jm010283l; Fox NE, 2010, EXP HEMATOL, V38, P384, DOI 10.1016/j.exphem.2010.02.007; Gadd SL, 2006, MOL ENDOCRINOL, V20, P2734, DOI 10.1210/me.2006-0114; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; Kim MJ, 2007, J BIOL CHEM, V282, P14253, DOI 10.1074/jbc.M611616200; Kubatzky KF, 2005, J BIOL CHEM, V280, P14844, DOI 10.1074/jbc.M411251200; Kubatzky KF, 2001, CURR BIOL, V11, P110, DOI 10.1016/S0960-9822(01)00018-5; Kuter DJ, 2007, BLOOD, V109, P4607, DOI 10.1182/blood-2006-10-019315; Kuter DJ, 2009, ANNU REV MED, V60, P193, DOI 10.1146/annurev.med.60.042307.181154; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Lu XH, 2006, J BIOL CHEM, V281, P7002, DOI 10.1074/jbc.M512638200; MIYAKAWA Y, 1995, BLOOD, V86, P23, DOI 10.1182/blood.V86.1.23.bloodjournal86123; Munchhof MJ, 2009, BIOORG MED CHEM LETT, V19, P1428, DOI 10.1016/j.bmcl.2009.01.032; Nakamura T, 2006, BLOOD, V107, P4300, DOI 10.1182/blood-2005-11-4433; Nogami W, 2008, HAEMATOL-HEMATOL J, V93, P1495, DOI 10.3324/haematol.12752; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; Onishi M, 1996, BLOOD, V88, P1399, DOI 10.1182/blood.V88.4.1399.bloodjournal8841399; Qazi AM, 2006, MOL ENDOCRINOL, V20, P1912, DOI 10.1210/me.2005-0291; Reiter LA, 2008, BIOORG MED CHEM LETT, V18, P3000, DOI 10.1016/j.bmcl.2008.03.052; Reiter LA, 2007, BIOORG MED CHEM LETT, V17, P5447, DOI 10.1016/j.bmcl.2007.07.038; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Ruan WM, 2004, J BIOL CHEM, V279, P3273, DOI 10.1074/jbc.M309311200; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Safonov IG, 2006, BIOORG MED CHEM LETT, V16, P1212, DOI 10.1016/j.bmcl.2005.11.096; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Staerk J, 2006, BLOOD, V107, P1864, DOI 10.1182/blood-2005-06-2600; Stasi R, 2008, DRUGS, V68, P901, DOI 10.2165/00003495-200868070-00002; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Tarasova A, 2009, CHEMMEDCHEM, V4, P2002, DOI 10.1002/cmdc.200900340; Yamane N, 2008, EUR J PHARMACOL, V586, P44, DOI 10.1016/j.ejphar.2008.02.060; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	48	50	51	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2234	2244		10.1096/fj.10-178673	http://dx.doi.org/10.1096/fj.10-178673			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21402716	Green Published			2022-12-25	WOS:000292242200015
J	Roberts, CG; Millar, EKA; O'Toole, SA; McNeil, CM; Lehrbach, GM; Pinese, M; Tobelmann, P; McCloy, RA; Musgrove, EA; Sutherland, RL; Butt, AJ				Roberts, C. G.; Millar, E. K. A.; O'Toole, S. A.; McNeil, C. M.; Lehrbach, G. M.; Pinese, M.; Tobelmann, P.; McCloy, R. A.; Musgrove, E. A.; Sutherland, R. L.; Butt, A. J.			Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer	ONCOGENE			English	Article						PUMA; breast cancer; tamoxifen	ENDOCRINE RESISTANCE; BH3-ONLY PROTEIN; C-MYC; EXPRESSION; P53; SURVIVAL; THERAPY; DETERMINANTS; NETWORKS	Recognition of the pivotal role of estrogen in the aetiology of breast cancer has led to the development of antiestrogens (AE), such as tamoxifen (TAM) as effective therapies for the treatment and prevention of this disease. However, despite their widespread clinical efficacy, response to AEs is often short-lived, and acquired or innate therapeutic resistance remains a major obstacle in the successful treatment of breast cancer. Thus, delineating the intracellular pathways that mediate the cellular response to estrogen could potentially lead to new, more effective approaches to the treatment of breast cancer, particularly endocrine-resistant disease. Here, we have identified the BCL-2 homology 3 (BH3)-only, proapoptotic regulator, PUMA (p53 upregulated modulator of apoptosis) as an estrogen target gene that is acutely downregulated in response to estrogen in breast cancer cell lines, independently of their p53 status. PUMA is transcriptionally upregulated following treatment with TAM, and knock down of PUMA expression in these cells attenuates the apoptotic response to TAM. Furthermore, low PUMA expression in breast carcinomas is significantly associated with breast cancer-specific death (P=0.0014 and P=0.0115, for mRNA and protein, respectively), and worse outcome in TAM-treated patients (mRNA, P=1.49e-05). These findings suggest that the dysregulation of apoptotic signaling pathways such as those executed through PUMA, can significantly impact on both the progression and therapeutic responsiveness of breast cancer. Moreover, they provide a convincing rationale for exploring new therapeutic approaches involving endocrine and non-endocrine therapies that target apoptotic pathways as an effective strategy for tackling endocrine refractory disease. Oncogene (2011) 30, 3186-3197; doi:10.1038/onc.2011.36; published online 7 March 2011	[Butt, A. J.] St Vincents Hosp, Garvan Inst Med Res, Apoptosis Res Grp, Canc Res Program, Darlinghurst, NSW 2010, Australia; [Millar, E. K. A.] St George Hosp, S Eastern Area Lab Serv, Dept Anat Pathol, Kogarah, NSW, Australia; [Millar, E. K. A.; Musgrove, E. A.; Sutherland, R. L.; Butt, A. J.] Univ Western Sydney, Sch Med, Campbelltown, NSW, Australia; [O'Toole, S. A.] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia; [O'Toole, S. A.] Royal Prince Alfred Hosp, Dept Tissue Pathol & Diagnost Oncol, Camperdown, NSW 2050, Australia; [O'Toole, S. A.] Univ Sydney, Sydney Med Sch, Cent Clin Sch, Sydney, NSW 2006, Australia; [McNeil, C. M.] Westmead Hosp, Dept Med Oncol, Westmead, NSW 2145, Australia; [McNeil, C. M.] Univ Sydney, Western Clin Sch, Sydney, NSW 2006, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; St George Hospital; Western Sydney University; University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney	Butt, AJ (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Apoptosis Res Grp, Canc Res Program, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	abutt@garvan.org.au	Millar, Ewan/ABE-9127-2020; Sutherland, Robert L/A-8378-2008	Millar, Ewan/0000-0002-9778-3253; Pinese, Mark/0000-0001-5078-6687; Butt, Alison/0000-0002-6216-5105; McCloy, Rachael/0000-0001-7791-4044	National Health and Medical Research Council (NHMRC) of Australia [535903]; Australian Cancer Research Fund; RT Hall Trust; Petre Foundation	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Fund; RT Hall Trust; Petre Foundation	This research was supported by a National Health and Medical Research Council (NHMRC) of Australia Program Grant 535903, the Australian Cancer Research Fund, the RT Hall Trust, the Petre Foundation, a Cancer Institute NSW Career Development and Support Fellowship (AJB), Cancer Institute NSW Clinical Research Fellowships (EKAM and SAO'T) and an NHMRC health professional training fellowship (SAO'T).	Anderson LR, 2010, ONCOGENE, V29, P527, DOI 10.1038/onc.2009.362; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Butt AJ, 2008, ADV EXP MED BIOL, V630, P189; Butt AJ, 2006, MOL CANCER THER, V5, P2300, DOI 10.1158/1535-7163.MCT-06-0170; Butt AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1779; Cannings E, 2007, BREAST CANCER RES TR, V102, P173, DOI 10.1007/s10549-006-9323-8; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Ellis MJ, 2003, J STEROID BIOCHEM, V86, P301, DOI 10.1016/S0960-0760(03)00371-6; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Garrison SP, 2008, MOL CELL BIOL, V28, P5391, DOI 10.1128/MCB.00907-07; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hammerich-Hille S, 2010, J BIOL CHEM, V285, P3608, DOI 10.1074/jbc.M109.066431; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hur JY, 2004, P NATL ACAD SCI USA, V101, P2351, DOI 10.1073/pnas.0307337101; Hurvitz SA, 2008, CANCER-AM CANCER SOC, V113, P2385, DOI 10.1002/cncr.23875; JEFFERS JR, 2003, CANCER RES, V52, P5204; Jordan VC, 2009, CANCER RES, V69, P1243, DOI 10.1158/0008-5472.CAN-09-0029; Karst AM, 2005, ONCOGENE, V24, P1111, DOI 10.1038/sj.onc.1208374; MILLAR EKA, 2008, BRIT J CANCER, V100, P123; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Musgrove EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002987; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Naresh A, 2008, CANCER RES, V68, P6387, DOI 10.1158/0008-5472.CAN-08-0538; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Reimer T, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr456; RUNNEBAUM IB, 1991, P NATL ACAD SCI USA, V88, P10657, DOI 10.1073/pnas.88.23.10657; Swaby RF, 2007, REV ENDOCR METAB DIS, V8, P229, DOI 10.1007/s11154-007-9034-4; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vousden KH, 2005, SCIENCE, V309, P1685, DOI 10.1126/science.1118232; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100	36	18	21	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2011	30	28					3186	3197		10.1038/onc.2011.36	http://dx.doi.org/10.1038/onc.2011.36			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	792FQ	21383694				2022-12-25	WOS:000292726300007
J	Boutz, DR; Collins, PJ; Suresh, U; Lu, MZ; Ramirez, CM; Fernandez-Hernando, C; Huang, YF; Abreu, RD; Le, SY; Shapiro, BA; Liu, AM; Luk, JM; Aldred, SF; Trinklein, ND; Marcotte, EM; Penalva, LOF				Boutz, Daniel R.; Collins, Patrick J.; Suresh, Uthra; Lu, Mingzhu; Ramirez, Cristina M.; Fernandez-Hernando, Carlos; Huang, Yufei; Abreu, Raquel de Sousa; Le, Shu-Yun; Shapiro, Bruce A.; Liu, Angela M.; Luk, John M.; Aldred, Shelley Force; Trinklein, Nathan D.; Marcotte, Edward M.; Penalva, Luiz O. F.			Two-tiered Approach Identifies a Network of Cancer and Liver Disease-related Genes Regulated by miR-122	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; HUMAN BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; STIMULATED PHOSPHORYLATION; INSULIN SENSITIVITY; PYRUVATE-KINASE; MESSENGER-RNAS; IN-VIVO; MICRORNA	MicroRNAs function as important regulators of gene expression and are commonly linked to development, differentiation, and diseases such as cancer. To better understand their roles in various biological processes, identification of genes targeted by microRNAs is necessary. Although prediction tools have significantly helped with this task, experimental approaches are ultimately required for extensive target search and validation. We employed two independent yet complementary high throughput approaches to map a large set of mRNAs regulated by miR-122, a liver-specific microRNA implicated in regulation of fatty acid and cholesterol metabolism, hepatitis C infection, and hepatocellular carcinoma. The combination of luciferase reporter-based screening and shotgun proteomics resulted in the identification of 260 proteins significantly down-regulated in response to miR-122 in at least one method, 113 of which contain predicted miR-122 target sites. These proteins are enriched for functions associated with the cell cycle, differentiation, proliferation, and apoptosis. Among these miR-122-sensitive proteins, we identified a large group with strong connections to liver metabolism, diseases, and hepatocellular carcinoma. Additional analyses, including examination of consensus binding motifs for both miR-122 and target sequences, provide further insight into miR-122 function.	[Boutz, Daniel R.; Marcotte, Edward M.] Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Collins, Patrick J.; Aldred, Shelley Force; Trinklein, Nathan D.] SwitchGear Genom, Menlo Pk, CA 94025 USA; [Suresh, Uthra; Huang, Yufei; Abreu, Raquel de Sousa; Penalva, Luiz O. F.] Univ Texas Hlth Sci Ctr San Antonio, Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Lu, Mingzhu; Huang, Yufei] Univ Texas San Antonio, Dept Elect & Comp Engn, San Antonio, TX 78249 USA; [Ramirez, Cristina M.; Fernandez-Hernando, Carlos] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY 10016 USA; [Le, Shu-Yun; Shapiro, Bruce A.; Penalva, Luiz O. F.] NCI, Ctr Canc Res, Nanobiol Program, NIH, Frederick, MD 21702 USA; [Liu, Angela M.; Luk, John M.] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Liu, Angela M.; Luk, John M.] Natl Univ Singapore, Dept Pharmacol, Singapore 117597, Singapore; [Luk, John M.] Natl Univ Singapore, Dept Surg, Singapore 117597, Singapore; [Luk, John M.] Natl Univ Singapore, Canc Sci Inst, Singapore 117597, Singapore; [Marcotte, Edward M.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Penalva, Luiz O. F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Hong Kong; National University of Singapore; National University of Singapore; National University of Singapore; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio	Boutz, DR (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, 2500 Speedway,MBB 3-210, Austin, TX 78712 USA.	dboutz@mail.utexas.edu; penalva@uthscsa.edu	Huang, Yufei/AAU-2891-2021; Ramírez, Cristina/ABI-1568-2020; Ramírez, Cristina/A-6975-2016; Luk, John/A-4085-2008; Boutz, Daniel/M-4872-2013	Ramírez, Cristina/0000-0003-2589-0786; Ramírez, Cristina/0000-0003-2589-0786; Luk, John/0000-0002-6323-7940; Boutz, Daniel/0000-0001-7462-4105; Penalva, Luiz/0000-0003-4491-6769; de Sousa Abreu, Raquel/0000-0002-8211-6052; Collins, Patrick/0000-0002-7141-7503; Marcotte, Edward/0000-0001-8808-180X	National Institutes of Health [GM076536, GM067779, GM088624]; Welch Foundation [F-1515]; Packard Foundation; NCI Center for Cancer Research; Children's Cancer Research Institute; University of Texas Health Science Center at San Antonio; SwitchGear Genomics; NATIONAL CANCER INSTITUTE [ZIABC008382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088624, R01GM067779, R01GM076536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Packard Foundation(The David & Lucile Packard Foundation); NCI Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Children's Cancer Research Institute; University of Texas Health Science Center at San Antonio; SwitchGear Genomics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM076536, GM067779, and GM088624, and Grant F-1515 from the Welch Foundation and by the Packard Foundation. (to E. M. M.) and the NCI Center for Cancer Research Intramural Research Program (to the B. A. S. laboratory). This work was also supported by the Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio (to the L. O. F. P. laboratory), and by SwitchGear Genomics. N. D. T., S. F. A., and P. J. C. are employees of and hold stock in SwitchGear Genomics. SwitchGear Genomics sells 3'UTR reporter vectors commercially. SwitchGear Genomics is the owner by assignment of patents or patent applications related to the 3'UTR reporter platform.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Burchard J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.58; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Cahova M, 2007, PHYSIOL RES, V56, P1, DOI 10.33549/physiolres.930882; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Colombat M, 2003, J PATHOL, V201, P260, DOI 10.1002/path.1451; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Czech MP, 2006, NEW ENGL J MED, V354, P1194, DOI 10.1056/NEJMcibr060065; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fang YJ, 2009, INT J COLORECTAL DIS, V24, P875, DOI 10.1007/s00384-009-0725-z; Farnebo M, 2010, BIOCHEM BIOPH RES CO, V396, P85, DOI 10.1016/j.bbrc.2010.02.152; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Frayn KN, 2003, BIOCHEM SOC T, V31, P1115, DOI 10.1042/BST0311115; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hao K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-389; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; HENDRIX MJC, 1992, JNCI-J NATL CANCER I, V84, P165, DOI 10.1093/jnci/84.3.165; Hirashima M, 2009, ANAT SCI INT, V84, P95, DOI 10.1007/s12565-009-0026-1; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; ISHIBASHI H, 1978, J BIOL CHEM, V253, P8767; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Koren S, 2007, BEST PRACT RES CL EN, V21, P621, DOI 10.1016/j.beem.2007.08.004; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Langhans W, 2003, CURR OPIN CLIN NUTR, V6, P449, DOI 10.1097/01.mco.0000078993.96795.16; Le S. Y., 1990, P 6 CONV BIOM STER S; LE SY, 1989, J THEOR BIOL, V138, P495, DOI 10.1016/S0022-5193(89)80047-5; Le SY, 2002, KNOWL-BASED SYST, V15, P243, DOI 10.1016/S0950-7051(01)00146-0; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li HG, 2005, WORLD J GASTROENTERO, V11, P1445; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu M, 2010, MOL BIOL REP, V37, P3601, DOI 10.1007/s11033-010-0009-2; Liu SJ, 2008, J AM CHEM SOC, V130, P8251, DOI 10.1021/ja711125p; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; NAGANO M, 1980, ARCH BIOCHEM BIOPHYS, V203, P271, DOI 10.1016/0003-9861(80)90177-0; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Ou L, 2006, PROTEIN EXPRES PURIF, V47, P367, DOI 10.1016/j.pep.2006.01.016; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Sanchez-Diaz Patricia, 2006, RNA Biol, V3, P101; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Shi WD, 2009, CANCER LETT, V283, P84, DOI 10.1016/j.canlet.2009.03.030; Silverman-Gavrila R, 2008, THESCIENTIFICWORLDJO, V8, P611, DOI 10.1100/tsw.2008.87; Siu YT, 2007, FEBS J, V274, P3224, DOI 10.1111/j.1742-4658.2007.05884.x; Soucek L, 2010, CURR OPIN GENET DEV, V20, P91, DOI 10.1016/j.gde.2009.11.001; Sun S, 2010, J PROTEOME RES, V9, P1923, DOI 10.1021/pr901085z; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Tsubota A, 2010, CARCINOGENESIS, V31, P504, DOI 10.1093/carcin/bgp313; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Turner CE, 2000, J CELL SCI, V113, P4139; Vadlamudi R, 1999, CANCER RES, V59, P2843; Vella MC, 2004, CHEM BIOL, V11, P1619, DOI 10.1016/j.chembiol.2004.09.010; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wu X, 2009, SCAND J GASTROENTERO, V44, P1332, DOI 10.3109/00365520903215305; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Zhai Y F, 1996, Cancer Treat Res, V83, P107; ZHAI YF, 1993, CANCER RES, V53, P2272; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	87	44	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					18066	18078		10.1074/jbc.M110.196451	http://dx.doi.org/10.1074/jbc.M110.196451			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21402708	Green Published, hybrid			2022-12-25	WOS:000290585200068
J	Mysliwiec, MR; Bresnick, EH; Lee, Y				Mysliwiec, Matthew R.; Bresnick, Emery H.; Lee, Youngsook			Endothelial Jarid2/Jumonji Is Required for Normal Cardiac Development and Proper Notch1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; CARDIOMYOCYTE PROLIFERATION; JUMONJI FAMILY; MOUSE EMBRYOS; TARGET GENES; MICE LACKING; TRANSCRIPTION; NEUREGULIN	Jarid2/Jumonji critically regulates developmental processes including cardiovascular development. Jarid2 knock-out mice exhibit cardiac defects including hypertrabeculation with noncompaction of the ventricular wall. However, molecular mechanisms underlying Jarid2-mediated cardiac development remain unknown. To determine the cardiac lineage-specific roles of Jarid2, we generated myocardial, epicardial, cardiac neural crest, or endothelial conditional Jarid2 knockout mice using Cre-loxP technology. Only mice with an endothelial deletion of Jarid2 recapitulate phenotypic defects observed in whole body mutants including hypertrabeculation and noncompaction of the ventricle. To identify potential targets of Jarid2, combinatorial approaches using microarray and candidate gene analyses were employed on Jarid2 knock-out embryonic hearts. Whole body or endothelial deletion of Jarid2 leads to increased endocardial Notch1 expression in the developing ventricle, resulting in increased Notch1-dependent signaling to the adjacent myocardium. Using quantitative chromatin immunoprecipitation analysis, Jarid2 was found to occupy a specific region on the endogenous Notch1 locus. We propose that failure to properly regulate Notch signaling in Jarid2 mutants likely leads to the defects in the developing ventricular chamber. The identification of Jarid2 as a potential regulator of Notch1 signaling has broad implications for many cellular processes including development, stem cell maintenance, and tumor formation.	[Mysliwiec, Matthew R.; Lee, Youngsook] Univ Wisconsin, Dept Anat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Bresnick, Emery H.] Univ Wisconsin, Wisconsin Inst Med Res, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Lee, Y (corresponding author), Univ Wisconsin, Dept Anat, Sch Med & Publ Hlth, 1300 Univ Ave,SMI 322, Madison, WI 53706 USA.	youngsooklee@wisc.edu			National Institutes of Health [HL67050, DK068634]; American Heart Association [0815663G, 0615633Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068634, R56DK068634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL67050 (to Y. L.) and DK068634 (to E. H. B.). This work was also supported by American Heart Association Grants 0815663G and 0615633Z (to M. R. M.).	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Balciunas D, 2000, TRENDS BIOCHEM SCI, V25, P274, DOI 10.1016/S0968-0004(00)01593-0; Barth JL, 2010, DEV DYNAM, V239, P2024, DOI 10.1002/dvdy.22341; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Campa VM, 2008, J CELL BIOL, V183, P129, DOI 10.1083/jcb.200806104; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Chu JL, 2002, J BIOL CHEM, V277, P7587, DOI 10.1074/jbc.M111044200; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; Collesi C, 2008, J CELL BIOL, V183, P117, DOI 10.1083/jcb.200806091; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fiddes RJ, 1998, ONCOGENE, V16, P2803, DOI 10.1038/sj.onc.1201815; Finsterer J., 2009, INT J CARDIOL; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Gitler AD, 2003, NAT GENET, V33, P75, DOI 10.1038/ng1059; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iso T, 2006, BIOCHEM BIOPH RES CO, V341, P708, DOI 10.1016/j.bbrc.2006.01.020; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iwamoto R, 2006, CELL STRUCT FUNCT, V31, P1, DOI 10.1247/csf.31.1; Johnson KD, 2006, P NATL ACAD SCI USA, V103, P15939, DOI 10.1073/pnas.0604041103; Jung J, 2005, J BIOL CHEM, V280, P30916, DOI 10.1074/jbc.M414482200; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; Kim T, 2005, BIOCHEM BIOPH RES CO, V329, P544, DOI 10.1016/j.bbrc.2005.01.154; Kim T, 2004, MOL CELL BIOL, V24, P10151, DOI 10.1128/MCB.24.23.10151-10160.2004; Kim TG, 2003, J BIOL CHEM, V278, P42247, DOI 10.1074/jbc.M307386200; Koibuchi N, 2007, CIRC RES, V100, P850, DOI 10.1161/01.RES.0000261693.13269.bf; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lee Y, 2000, CIRC RES, V86, P932, DOI 10.1161/01.RES.86.9.932; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Liu XF, 1998, P NATL ACAD SCI USA, V95, P13024, DOI 10.1073/pnas.95.22.13024; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Moore AW, 1998, MECH DEVELOP, V79, P169, DOI 10.1016/S0925-4773(98)00188-9; Mysliwiec MR, 2006, GENESIS, V44, P407, DOI 10.1002/dvg.20221; Mysliwiec MR, 2007, FEBS LETT, V581, P2633, DOI 10.1016/j.febslet.2007.05.006; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Neve RM, 2002, ONCOGENE, V21, P4567, DOI 10.1038/sj.onc.1205555; Nielsen AL, 2004, MOL CELL BIOL, V24, P5184, DOI 10.1128/MCB.24.12.5184-5196.2004; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; OKA C, 1995, DEVELOPMENT, V121, P3291; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355; SCHNURCH H, 1993, DEVELOPMENT, V119, P957; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shirato H, 2009, J BIOL CHEM, V284, P733, DOI 10.1074/jbc.M804994200; Shou WN, 1998, NATURE, V391, P489, DOI 10.1038/35146; Stahl M, 2006, CANCER RES, V66, P7562, DOI 10.1158/0008-5472.CAN-06-0974; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; Sun Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003406; Takeuchi T, 1999, MECH DEVELOP, V86, P29, DOI 10.1016/S0925-4773(99)00100-8; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Talora C, 2008, BBA-MOL BASIS DIS, V1782, P489, DOI 10.1016/j.bbadis.2008.06.008; Timms JF, 2002, ONCOGENE, V21, P6573, DOI 10.1038/sj.onc.1205847; Toyoda M, 2003, DEV CELL, V5, P85, DOI 10.1016/S1534-5807(03)00189-8; Vijapurkar U, 2003, EXP CELL RES, V284, P291, DOI 10.1016/S0014-4827(02)00040-X; Vollrath AL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-280; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261	77	57	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					17193	17204		10.1074/jbc.M110.205146	http://dx.doi.org/10.1074/jbc.M110.205146			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21402699	Green Published, hybrid			2022-12-25	WOS:000290301900068
J	Dogar, AM; Towbin, H; Hall, J				Dogar, Afzal M.; Towbin, Harry; Hall, Jonathan			Suppression of Latent Transforming Growth Factor (TGF)-beta 1 Restores Growth Inhibitory TGF-beta Signaling through microRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIR-200 FAMILY; MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR; PROTEOLYTIC ACTIVATION; REPRESSORS ZEB1; PATHWAYS; SMAD; TGF-BETA-1; CELLS; P53	Cancer cells secreting excess latent TGF-beta are often resistant to TGF-beta induced growth inhibition. We observed that RNAi against TGF-beta 1 led to apoptotic death in such cell lines with features that were, paradoxically, reminiscent of TGF-beta signaling activity and that included transiently enhanced SMAD2 and AKT phosphorylation. A comprehensive search in Hela cells for potential microRNA drivers of this mechanism revealed that RNAi against TGF-beta 1 led to induction of pro-apoptotic miR-34a and to a globally decreased oncomir expression. The reduced levels of the oncomirs miR-18a and miR-24 accounted for the observed derepression of two TGF-beta 1 processing factors, thrombospondin-1, and furin, respectively. Our data suggest a novel mechanism in which latent TGF-beta 1, thrombospondin 1, and furin form a microRNA-mediated regulatory feedback loop. For cells with high levels of latent TGF-beta, this provides a potentially widespread mechanism of escape from TGF-beta-mediated growth arrest at the earliest point in the signaling pathway, TGF-beta processing.	[Dogar, Afzal M.; Towbin, Harry; Hall, Jonathan] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Hall, J (corresponding author), Swiss Fed Inst Technol, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, HCI H437,Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	jonathan.hall@pharma.ethz.ch		Hall, Jonathan/0000-0003-4160-7135				ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Blakytny R, 2004, J CELL PHYSIOL, V199, P67, DOI 10.1002/jcp.10454; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DERYNCK R, 1987, CANCER RES, V47, P707; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; DISERENS AC, 1981, ACTA NEUROPATHOL, V53, P21, DOI 10.1007/BF00697180; Dumon N, 2003, J BIOL CHEM, V278, P3275, DOI 10.1074/jbc.M204623200; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P12513, DOI 10.1073/pnas.97.23.12513; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Jenkins G, 2008, INT J BIOCHEM CELL B, V40, P1068, DOI 10.1016/j.biocel.2007.11.026; JENNINGS MT, 1991, INT J CANCER, V49, P129, DOI 10.1002/ijc.2910490124; Kloth JN, 2005, CARCINOGENESIS, V26, P1493, DOI 10.1093/carcin/bgi110; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Luna C, 2011, J CELL PHYSIOL, V226, P1407, DOI 10.1002/jcp.22476; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Oren M, 2002, BIOCHEM PHARMACOL, V64, P865, DOI 10.1016/S0006-2952(02)01149-8; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26775; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; Solovyan VT, 2006, J CELL PHYSIOL, V207, P445, DOI 10.1002/jcp.20607; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Teicher BA, 2007, CLIN CANCER RES, V13, P6247, DOI 10.1158/1078-0432.CCR-07-1654; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tritschler I, 2009, INT J CANCER, V125, P530, DOI 10.1002/ijc.24443; VAN MEIR EG, 1994, CANCER RES, V54, P649; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang J, 2004, J BIOL CHEM, V279, P40237, DOI 10.1074/jbc.M401665200; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wischhusen J, 2003, ONCOGENE, V22, P8233, DOI 10.1038/sj.onc.1207198; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Yao GD, 2010, MOL ENDOCRINOL, V24, P540, DOI 10.1210/me.2009-0432; Ye SC, 1999, CANCER RES, V59, P4725; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	57	25	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.208652	http://dx.doi.org/10.1074/jbc.M110.208652			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21402698	Green Published, hybrid			2022-12-25	WOS:000290022800082
J	Mullen, TD; Jenkins, RW; Clarke, CJ; Bielawski, J; Hannun, YA; Obeid, LM				Mullen, Thomas D.; Jenkins, Russell W.; Clarke, Christopher J.; Bielawski, Jacek; Hannun, Yusuf A.; Obeid, Lina M.			Ceramide Synthase-dependent Ceramide Generation and Programmed Cell Death INVOLVEMENT OF SALVAGE PATHWAY IN REGULATING POSTMITOCHONDRIAL EVENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADIATION-INDUCED APOPTOSIS; LONGEVITY ASSURANCE GENE-1; LONG-CHAIN CERAMIDE; ACID SPHINGOMYELINASE; SPHINGOLIPID METABOLISM; BCL-2 FAMILY; RESPIRATORY-CHAIN; FUMONISIN B1; PROTEIN BAK; DNA-DAMAGE	The sphingolipid ceramide has been widely implicated in the regulation of programmed cell death or apoptosis. The accumulation of ceramide has been demonstrated in a wide variety of experimental models of apoptosis and in response to a myriad of stimuli and cellular stresses. However, the detailed mechanisms of its generation and regulatory role during apoptosis are poorly understood. We sought to determine the regulation and roles of ceramide production in a model of ultraviolet light-C (UV-C)-induced programmed cell death. We found that UV-C irradiation induces the accumulation of multiple sphingolipid species including ceramide, dihydroceramide, sphingomyelin, and hexosylceramide. Late ceramide generation was also found to be regulated by Bcl-xL, Bak, and caspases. Surprisingly, inhibition of de novo synthesis using myriocin or fumonisin B1 resulted in decreased overall cellular ceramide levels basally and in response to UV-C, but only fumonisin B1 inhibited cell death, suggesting the presence of a ceramide synthase (CerS)-dependent, sphingosine-derived pool of ceramide in regulating programmed cell death. We found that this pool did not regulate the mitochondrial pathway, but it did partially regulate activation of caspase-7 and, more importantly, was necessary for late plasma membrane permeabilization. Attempting to identify the CerS responsible for this effect, we found that combined knockdown of CerS5 and CerS6 was able to decrease long-chain ceramide accumulation and plasma membrane permeabilization. These data identify a novel role for CerS and the sphingosine salvage pathway in regulating membrane permeability in the execution phase of programmed cell death.	[Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Jenkins, Russell W.; Clarke, Christopher J.; Bielawski, Jacek; Hannun, Yusuf A.; Obeid, Lina M.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Obeid, LM (corresponding author), Med Univ S Carolina, Dept Med, 114 Doughty St,Rm 603 STRB,MSC 779, Charleston, SC 29425 USA.	obeidl@musc.edu		obeid, lina/0000-0002-0734-0847	National Institutes of Health, NIEHS [5T32ES012878]; NIEHS [1 F30 ES016975-01]; NCI [R01 AG016583, P01 CA097132]; National Center for Research Resources [GM08716, C06 RR018823]; American Heart Association [081509E]; Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES016975, T32ES012878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 5T32ES012878 from the NIEHS (through the Medical University of South Carolina (MUSC) Department of Pharmaceutical Sciences training program in environmental stress signaling) and Ruth L. Kirschstein National Research Service Award 1 F30 ES016975-01 from the NIEHS (to T. D. M.), Grant R01 AG016583 (to L. M. O.), Grant P01 CA097132 from the NCI (to Y. A. H.), Medical Scientist Training Program Grant GM08716 (to R. W. J.), and Grant C06 RR018823 from the Extramural Research Facilities Program of the National Center for Research Resources (for the HPLC/MS analysis at the MUSC Lipidomics Core Facility). This work was also supported by American Heart Association Predoctoral Fellowship 081509E (to R. W. J.) and in part by a Method to Extend Research in Time award (to L. M. O.) from the Office of Research and Development, Department of Veterans Affairs, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Andrieu-Abadie N, 2002, BBA-MOL CELL BIOL L, V1585, P126, DOI 10.1016/S1388-1981(02)00332-3; Baran Y, 2007, J BIOL CHEM, V282, P10922, DOI 10.1074/jbc.M610157200; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Ch'ang HJ, 2005, NAT MED, V11, P484, DOI 10.1038/nm1237; Charruyer A, 2005, J BIOL CHEM, V280, P19196, DOI 10.1074/jbc.M412867200; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; Clarke CJ, 2006, BBA-BIOMEMBRANES, V1758, P1893, DOI 10.1016/j.bbamem.2006.06.025; Cuzzocrea S, 2008, J PHARMACOL EXP THER, V327, P45, DOI 10.1124/jpet.108.139808; Cuzzocrea S, 2009, SHOCK, V31, P634, DOI 10.1097/SHK.0b013e3181891396; Cuzzocrea S, 2009, SHOCK, V31, P170, DOI 10.1097/SHK.0b013e31817fbd4a; Dbaibo GS, 1998, J CLIN INVEST, V102, P329, DOI 10.1172/JCI1180; Dbaibo GS, 2001, FEBS LETT, V503, P7, DOI 10.1016/S0014-5793(01)02625-4; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; El-Assaad W, 1998, BIOCHEM J, V336, P735, DOI 10.1042/bj3360735; Enongene EN, 2002, TOXICOL SCI, V67, P173, DOI 10.1093/toxsci/67.2.173; Galluzzi L, 2009, BBA-BIOENERGETICS, V1787, P402, DOI 10.1016/j.bbabio.2008.09.006; Gamard CJ, 1997, J BIOL CHEM, V272, P16474, DOI 10.1074/jbc.272.26.16474; Gamen S, 1998, CELL DEATH DIFFER, V5, P241, DOI 10.1038/sj.cdd.4400344; Gouaze-Andersson V, 2006, BBA-BIOMEMBRANES, V1758, P2096, DOI 10.1016/j.bbamem.2006.08.012; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jenkins RW, 2010, J BIOL CHEM, V285, P35706, DOI 10.1074/jbc.M110.125609; Jin JF, 2008, J BIOL CHEM, V283, P26509, DOI 10.1074/jbc.M801597200; Jin JF, 2009, J LIPID RES, V50, P2389, DOI 10.1194/jlr.M900119-JLR200; Kashkar H, 2005, J BIOL CHEM, V280, P20804, DOI 10.1074/jbc.M410869200; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroesen BJ, 2001, J BIOL CHEM, V276, P13606, DOI 10.1074/jbc.M009517200; Lemasters JJ, 2005, GASTROENTEROLOGY, V129, P351, DOI 10.1053/j.gastro.2005.06.006; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Novgorodov SA, 2005, J BIOL CHEM, V280, P16096, DOI 10.1074/jbc.M411707200; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Okamoto Y, 2002, FEBS LETT, V530, P104, DOI 10.1016/S0014-5793(02)03435-X; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Sawada N, 2000, CELL DEATH DIFFER, V7, P761, DOI 10.1038/sj.cdd.4400711; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2010, J BIOL CHEM, V285, P11818, DOI 10.1074/jbc.M109.078121; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P143, DOI 10.1007/s10863-005-6567-7; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Taha TA, 2004, J BIOL CHEM, V279, P20546, DOI 10.1074/jbc.M401259200; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tepper AD, 1999, J CLIN INVEST, V103, P971, DOI 10.1172/JCI5457; Uchida Y, 2003, J INVEST DERMATOL, V120, P662, DOI 10.1046/j.1523-1747.2003.12098.x; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Wiesner DA, 1997, J BIOL CHEM, V272, P9868; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zhang JD, 1996, P NATL ACAD SCI USA, V93, P5325, DOI 10.1073/pnas.93.11.5325	75	72	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.230870	http://dx.doi.org/10.1074/jbc.M111.230870			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21388949	Green Published, hybrid			2022-12-25	WOS:000290022800033
J	Tao, RY; Wei, D; Gao, HL; Liu, YL; DePinho, RA; Dong, XC				Tao, Rongya; Wei, Dan; Gao, Hanlin; Liu, Yunlong; DePinho, Ronald A.; Dong, X. Charlie			Hepatic FoxOs Regulate Lipid Metabolism via Modulation of Expression of the Nicotinamide Phosphoribosyltransferase Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; TRANSCRIPTION FACTOR FOXO1; FORKHEAD BOX O1; INSULIN ACTION; MITOCHONDRIAL-FUNCTION; DEPENDENT REGULATION; NAD BIOSYNTHESIS; CIRCADIAN-CLOCK; SIRT3; LIVER	FoxO transcription factors have been implicated in lipid metabolism; however, the underlying mechanisms are not well understood. Here, in an effort to elucidate such mechanisms, we examined the phenotypic consequences of liver-specific deletion of three members of the FoxO family: FoxO1, FoxO3, and FoxO4. These liver-specific triply null mice, designated LTKO, exhibited elevated triglycerides in the liver on regular chow diet. More remarkably, LTKO mice developed severe hepatic steatosis following placement on a high fat diet. Further analyses revealed that hepatic NAD(+) levels and Sirt1 activity were decreased in the liver of the LTKO mice relative to controls. At the mechanistic level, expression profile analyses showed that LTKO livers had significantly down-regulated expression of the nicotinamide phosphoribosyltransferase (Nampt) gene encoding the rate-limiting enzyme in the salvage pathway of NAD(+) biosynthesis. Luciferase reporter assays and chromatin immunoprecipitation analyses demonstrated that Nampt is a transcriptional target gene of FoxOs. Significantly, overexpression of Nampt gene reduced, whereas knockdown increased, hepatic triglyceride levels in vitro and in vivo. Thus, FoxOs control the Nampt gene expression and the NAD(+) signaling in the regulation of hepatic triglyceride homeostasis.	[Tao, Rongya; Wei, Dan; Dong, X. Charlie] Indiana Univ Sch Med, Ctr Med Genom, Dept Biochem & Mol Biol, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Liu, Yunlong] Indiana Univ Sch Med, Ctr Med Genom, Dept Med & Mol Genet, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Gao, Hanlin] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; City of Hope; Beckman Research Institute of City of Hope; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Dong, XC (corresponding author), Indiana Univ Sch Med, Ctr Med Genom, Dept Biochem & Mol Biol, Ctr Computat Biol & Bioinformat, 635 Barnhill Dr,MS1021D, Indianapolis, IN 46202 USA.	xcdong@iupui.edu	tao, rongya/B-8042-2014	tao, rongya/0000-0002-3316-5587; DePinho, Ronald/0000-0002-5625-577X	NIDDK [R00DK077505]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK077505] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R00DK077505 from the NIDDK.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Altomonte J, 2004, J CLIN INVEST, V114, P1493, DOI 10.1172/JCI200419992; Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Bao JJ, 2010, FREE RADICAL BIO MED, V49, P1230, DOI 10.1016/j.freeradbiomed.2010.07.009; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bruce KD, 2010, J NUTR, V140, P648, DOI 10.3945/jn.109.111179; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Dahl TB, 2010, J CLIN ENDOCR METAB, V95, P3039, DOI 10.1210/jc.2009-2148; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; FRIEBE D, 2011, DIABETOLOGI IN PRESS; Garten A, 2010, BIOCHEM BIOPH RES CO, V391, P376, DOI 10.1016/j.bbrc.2009.11.066; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Ghoshal K, 2002, MOL CELL BIOL, V22, P8302, DOI 10.1128/MCB.22.23.8302-8319.2002; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Haeusler RA, 2010, J BIOL CHEM, V285, P26861, DOI 10.1074/jbc.M110.134023; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Hsieh MC, 2010, INT J OBESITY, V34, P227, DOI 10.1038/ijo.2009.228; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2009, FRONT BIOSCI-LANDMRK, V14, P2983, DOI 10.2741/3428; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kamagate A, 2010, ENDOCRINOLOGY, V151, P3521, DOI 10.1210/en.2009-1306; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kim JJ, 2009, DIABETES, V58, P1275, DOI 10.2337/db08-1001; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Kralisch S, 2005, J ENDOCRINOL, V185, pR1, DOI 10.1677/joe.1.06211; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; MacLaren R, 2007, DIABETES OBES METAB, V9, P490, DOI 10.1111/j.1463-1326.2006.00625.x; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Moschen AR, 2010, CURR PHARM DESIGN, V16, P1913, DOI 10.2174/138161210791208947; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nasrin N, 2010, J BIOL CHEM, V285, P31995, DOI 10.1074/jbc.M110.124164; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Shi T, 2010, J DIGEST DIS, V11, P55, DOI 10.1111/j.1751-2980.2009.00416.x; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Tanaka M, 2007, BIOCHEM BIOPH RES CO, V359, P194, DOI 10.1016/j.bbrc.2007.05.096; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Wang RH, 2010, INT J BIOL SCI, V6, P682; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; Wu ZD, 2010, J CLIN INVEST, V120, P3901, DOI 10.1172/JCI43250; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	90	101	107	1	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14681	14690		10.1074/jbc.M110.201061	http://dx.doi.org/10.1074/jbc.M110.201061			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21388966	hybrid, Green Published			2022-12-25	WOS:000289556200087
J	George, M; Rainey, MA; Naramura, M; Foster, KW; Holzapfel, MS; Willoughby, LL; Ying, GG; Goswami, RM; Gurumurthy, CB; Band, V; Satchell, SC; Band, H				George, Manju; Rainey, Mark A.; Naramura, Mayumi; Foster, Kirk W.; Holzapfel, Melissa S.; Willoughby, Laura L.; Ying, GuoGuang; Goswami, Rasna M.; Gurumurthy, Channabasavaiah B.; Band, Vimla; Satchell, Simon C.; Band, Hamid			Renal Thrombotic Microangiopathy in Mice with Combined Deletion of Endocytic Recycling Regulators EHD3 and EHD4	PLOS ONE			English	Article							GLOMERULAR-FILTRATION BARRIER; NEPHROTIC SYNDROME; ENDOTHELIAL-CELLS; PROTEINS; NEPHRIN; KIDNEY; CYTOSKELETON; COMPARTMENT; EXPRESSION; PARACRINE	Eps15 Homology Domain-containing 3 (EHD3), a member of the EHD protein family that regulates endocytic recycling, is the first protein reported to be specifically expressed in the glomerular endothelium in the kidney; therefore we generated Ehd3(-/-) mice and assessed renal development and pathology. Ehd3(-/-) animals showed no overt defects, and exhibited no proteinuria or glomerular pathology. However, as the expression of EHD4, a related family member, was elevated in the glomerular endothelium of Ehd3(-/-) mice and suggested functional compensation, we generated and analyzed Ehd3(-/-); Ehd4(-/-) mice. These mice were smaller, possessed smaller and paler kidneys, were proteinuric and died between 3-24 weeks of age. Detailed analyses of Ehd3(-/-) ; Ehd4(-/-) kidneys demonstrated thrombotic microangiopathy (TMA)-like glomerular lesions including thickening and duplication of glomerular basement membrane, endothelial swelling and loss of fenestrations. Other changes included segmental podocyte foot process effacement, mesangial interposition, and abnormal podocytic and mesangial marker expression. The glomerular lesions observed were strikingly similar to those seen in human pre-eclampsia and mouse models of reduced VEGF expression. As altered glomerular endothelial VEGFR2 expression and localization and increased apoptosis was observed in the absence of EHD3 and EHD4, we propose that EHD-mediated endocytic traffic of key surface receptors such as VEGFR2 is essential for physiological control of glomerular function. Furthermore, Ehd3(-/-); Ehd4(-/-) mice provide a unique model to elucidate mechanisms of glomerular endothelial injury which is observed in a wide variety of human renal and extra-renal diseases.	[George, Manju; Naramura, Mayumi; Willoughby, Laura L.; Band, Vimla; Band, Hamid] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Rainey, Mark A.] Creighton Univ, Dept Pharmacol, Omaha, NE 68178 USA; [Foster, Kirk W.; Holzapfel, Melissa S.; Band, Hamid] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Coll Med, Omaha, NE USA; [Ying, GuoGuang] Tianjin Med Univ, Oncol Cent Lab, Canc Inst & Hosp, Tianjin, Peoples R China; [Goswami, Rasna M.] Abbott Labs, Abbott Pk, IL 60064 USA; [Gurumurthy, Channabasavaiah B.; Band, Vimla; Band, Hamid] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Coll Med, Omaha, NE USA; [Satchell, Simon C.] Univ Bristol, Acad Renal Unit, Bristol, Avon, England; [Band, Hamid] Univ Nebraska Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE USA; [Band, Hamid] Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol, Omaha, NE USA; [Band, Hamid] Univ Nebraska Med Ctr, Coll Med, Dept Expt Neurosci, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; Creighton University; University of Nebraska System; University of Nebraska Medical Center; Tianjin Medical University; Abbott Laboratories; University of Nebraska System; University of Nebraska Medical Center; University of Bristol; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	George, M (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	manjuggm@gmail.com; mnaramura@unmc.edu; hband@unmc.edu	Gurumurthy, Channabasavaiah B/H-8268-2016; Band, Hamid/AAF-4701-2020; Gurumurthy, Channabasavaiah B/E-7205-2011	Gurumurthy, Channabasavaiah B/0000-0002-8022-4033; Naramura, Mayumi/0000-0003-3658-0767	NIH [CA105489, CA099163, CA879862, CA116552, CA096844, P20RR018788]; Department of Defense Breast Cancer Research [DAMD W81XWH-07-1-0351, W81XWH-11-1-0171, W81XWH-11-1-0166, W81 XWH-10-1-0740, W81XWH-08-1-0621]; National Center for Research Resources (NCRR); UNMC-Eppley Cancer Center Pilot Grant; NCI; NATIONAL CANCER INSTITUTE [R01CA105489, R01CA116552, R01CA099163, R01CA087986, R01CA096844] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018788] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research(United States Department of Defense); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UNMC-Eppley Cancer Center Pilot Grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	NIH Grants CA105489, CA099163, CA87986, CA116552 (HB), CA096844 (VB); Department of Defense Breast Cancer Research Grant DAMD W81XWH-07-1-0351, W81XWH-11-1-0171 (VB), W81XWH-11-1-0166 (HB), W81 XWH-10-1-0740 (MN), W81XWH-08-1-0621 (MG); CoBRE Pilot funding (MG) from NIH grant 2P20RR018788 from the CoBRE Program of the National Center for Research Resources (NCRR); UNMC-Eppley Cancer Center Pilot Grant (MN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the UNMC Comparative Medicine Core Facility for animal husbandry and veterinary care; Maureen Harmon of Tissue sciences core facility and Janice Taylor and James Talaska of the Confocal Core Facility at the University of Nebraska Medical Center (supported by the Nebraska Research Initiative and the Eppley Cancer Center Core Grant from the NCI) for technical assistance; and Dr. Babu Padanilam, Dr. Dale Abrahamson and the Band Lab members for helpful discussions.	Abrahamson DR, 2009, ORGANOGENESIS, V5, P275; Ballermann BJ, 2007, NEPHRON PHYSIOL, V106, P19, DOI 10.1159/000101796; Blume JJ, 2007, EXP CELL RES, V313, P219, DOI 10.1016/j.yexcr.2006.10.006; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Brunskill EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012034; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Eremina V, 2007, NEPHRON PHYSIOL, V106, P32, DOI 10.1159/000101798; Eremina V, 2006, J AM SOC NEPHROL, V17, P724, DOI 10.1681/ASN.2005080810; Foster RR, 2009, NEPHRON EXP NEPHROL, V113, pE8, DOI 10.1159/000228078; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; George M, 2010, GENESIS, V48, P328, DOI 10.1002/dvg.20620; GRANT BD, 2008, MECH EHD REM 1 PROTE; GUDMUNDSSON H, 2010, CIRC RES; Guilherme A, 2004, J BIOL CHEM, V279, P40062, DOI 10.1074/jbc.M401918200; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Huber TB, 2009, J AM SOC NEPHROL, V20, P798, DOI 10.1681/ASN.2008080871; Jarad G, 2009, CURR OPIN NEPHROL HY, V18, P226, DOI 10.1097/MNH.0b013e3283296044; Jia JH, 2010, PROTEOMICS, V10, P224, DOI 10.1002/pmic.200900607; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Lindahl P, 1998, DEVELOPMENT, V125, P3313; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2007, J BIOL CHEM, V282, P16612, DOI 10.1074/jbc.M609493200; Patrakka J, 2007, J AM SOC NEPHROL, V18, P689, DOI 10.1681/ASN.2006060675; Patrakka J, 2010, BIOCHEM BIOPH RES CO, V396, P164, DOI 10.1016/j.bbrc.2010.04.069; Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108; PORTER GA, 1990, EUR J CELL BIOL, V51, P85; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Rainey MA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-37; Sano H, 2002, AM J PATHOL, V161, P135, DOI 10.1016/S0002-9440(10)64165-X; Scott A, 2009, BIOCHEM SOC T, V37, P1184, DOI 10.1042/BST0371184; Sengupta S, 2009, J BIOL CHEM, V284, P20121, DOI 10.1074/jbc.M109.025668; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Stillman IE, 2007, J AM SOC NEPHROL, V18, P2281, DOI 10.1681/ASN.2007020255; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Yap CCC, 2010, J NEUROSCI, V30, P6646, DOI 10.1523/JNEUROSCI.5428-09.2010	43	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17838	10.1371/journal.pone.0017838	http://dx.doi.org/10.1371/journal.pone.0017838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408024	Green Submitted, Green Published, gold			2022-12-25	WOS:000288170900050
J	O'Brien, KB; Morrison, TE; Dundore, DY; Heise, MT; Schultz-Cherry, S				O'Brien, Kevin B.; Morrison, Thomas E.; Dundore, David Y.; Heise, Mark T.; Schultz-Cherry, Stacey			A Protective Role for Complement C3 Protein during Pandemic 2009 H1N1 and H5N1 Influenza A Virus Infection	PLOS ONE			English	Article							NATURAL ANTIBODY; VIRAL-INFECTIONS; INNATE; PATHOGENESIS; REPLICATION; INHIBITION; RESPONSES; SYSTEM; MODEL	Highly pathogenic H5N1 influenza infections are associated with enhanced inflammatory and cytokine responses, severe lung damage, and an overall dysregulation of innate immunity. C3, a member of the complement system of serum proteins, is a major component of the innate immune and inflammatory responses. However, the role of this protein in the pathogenesis of H5N1 infection is unknown. Here we demonstrate that H5N1 influenza virus infected mice had increased levels of C5a and C3 activation byproducts as compared to mice infected with either seasonal or pandemic 2009 H1N1 influenza viruses. We hypothesized that the increased complement was associated with the enhanced disease associated with the H5N1 infection. However, studies in knockout mice demonstrated that C3 was required for protection from influenza infection, proper viral clearance, and associated with changes in cellular infiltration. These studies suggest that although the levels of complement activation may differ depending on the influenza virus subtype, complement is an important host defense mechanism.	[O'Brien, Kevin B.; Dundore, David Y.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [O'Brien, Kevin B.; Schultz-Cherry, Stacey] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Morrison, Thomas E.] Univ Colorado Denver, Dept Microbiol, Aurora, CO USA; [Heise, Mark T.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Heise, Mark T.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Heise, Mark T.] Univ N Carolina, Carolina Vaccine Inst, Chapel Hill, NC USA	University of Wisconsin System; University of Wisconsin Madison; St Jude Children's Research Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	O'Brien, KB (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	stacey.schultz-cherry@stjude.org	Schultz-Cherry, Stacey/N-2506-2018		University of Wisconsin-Madison; NIH [AR047190, AI059049]; NIH NIAID [HHSN266200700005C]; American Lebanese Syrian Associated Charities (ALSAC); Howard Hughes Medical Institute; Sigma Xi; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047190] Funding Source: NIH RePORTER	University of Wisconsin-Madison; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sigma Xi; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a Howard Hughes Medical Institute Gilliam Fellowship, an Advanced Opportunity Fellowship (AOF) from the University of Wisconsin-Madison, and a Sigma Xi Grants-in-Aid-of-Research grant to K. O'Brien, NIH grant AR047190 to M. T. Heise, and NIH AI059049, and in part by the NIH NIAID contract number HHSN266200700005C and the American Lebanese Syrian Associated Charities (ALSAC) to S. Schultz-Cherry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Coffey LL, 2009, MICROBES INFECT, V11, P143, DOI 10.1016/j.micinf.2008.12.006; Daha MR, 2010, CRIT REV IMMUNOL, V30, P47, DOI 10.1615/CritRevImmunol.v30.i1.30; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gonzalez SF, 2008, VACCINE, V26, pI86, DOI 10.1016/j.vaccine.2008.11.057; Hartshorn KL, 2006, J IMMUNOL, V176, P6962, DOI 10.4049/jimmunol.176.11.6962; Hartshorn KL, 2006, BIOCHEM J, V393, P545, DOI 10.1042/BJ20050695; HIRSCH RL, 1980, J IMMUNOL, V124, P2507; HIRSCH RL, 1980, J INFECT DIS, V141, P212, DOI 10.1093/infdis/141.2.212; JANEWAY CAJ, COMPLEMENT SYSTEM IN; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Jones JC, 2006, J VIROL, V80, P11960, DOI 10.1128/JVI.01678-06; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Mollnes TE, 2007, MOL IMMUNOL, V44, P3838, DOI 10.1016/j.molimm.2007.06.150; Morrison TE, 2008, CURR DRUG TARGETS, V9, P165; Morrison TE, 2008, J VIROL, V82, P11263, DOI 10.1128/JVI.01352-08; Morrison TE, 2007, J VIROL, V81, P5132, DOI 10.1128/JVI.02799-06; Morton D B, 2000, ILAR J, V41, P80; Nakayama Y, 2009, J IMMUNOL, V183, P2921, DOI 10.4049/jimmunol.0801191; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; REED L. J., 1938, AMER JOUR HYG, V27, P493; Richmond JY, 1993, BIOSAFETY MICROBIOLO, P26; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Salvatore M, 2007, J INFECT DIS, V196, P835, DOI 10.1086/521027; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Thio CL, 2008, CLIN LIVER DIS, V12, P713, DOI 10.1016/j.cld.2008.03.002; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Van Hoeven N, 2009, J VIROL, V83, P2851, DOI 10.1128/JVI.02174-08; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	39	75	76	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17377	10.1371/journal.pone.0017377	http://dx.doi.org/10.1371/journal.pone.0017377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408070	Green Submitted, Green Published, gold			2022-12-25	WOS:000288170900013
J	Gleason, C; Foley, RC; Singh, KB				Gleason, Cynthia; Foley, Rhonda C.; Singh, Karam B.			Mutant Analysis in Arabidopsis Provides Insight into the Molecular Mode of Action of the Auxinic Herbicide Dicamba	PLOS ONE			English	Article							CLEAVERS GALIUM-APARINE; BOX PROTEIN TIR1; RESISTANT MUTANTS; ROOT GRAVITROPISM; PLANT DEVELOPMENT; RESPONSIVE GENES; INDUCED ETHYLENE; ACID; FAMILY; EXPRESSION	Herbicides that mimic the natural auxin indole-3-acetic acid are widely used in weed control. One common auxin-like herbicide is dicamba, but despite its wide use, plant gene responses to dicamba have never been extensively studied. To further understand dicamba's mode of action, we utilized Arabidopsis auxin-insensitive mutants and compared their sensitivity to dicamba and the widely-studied auxinic herbicide 2,4-dichlorophenoxyacetic acid (2,4-D). The mutant axr4-2, which has disrupted auxin transport into cells, was resistant to 2,4-D but susceptible to dicamba. By comparing dicamba resistance in auxin signalling F-box receptor mutants (tir1-1, afb1, afb2, afb3, and afb5), only tir1-1 and afb5 were resistant to dicamba, and this resistance was additive in the double tir1-1/afb5 mutant. Interestingly, tir1-1 but not afb5 was resistant to 2,4-D. Whole genome analysis of dicamba-induced gene expression showed that 10 hours after application, dicamba stimulated many stress-responsive and signalling genes, including those involved in biosynthesis or signalling of auxin, ethylene, and abscisic acid (ABA), with TIR1 and AFB5 required for the dicamba-responsiveness of some genes. Research into dicamba-regulated gene expression and the selectivity of auxin receptors has provided molecular insight into dicamba-regulated signalling and could help in the development of novel herbicide resistance in crop plants.	[Gleason, Cynthia; Foley, Rhonda C.; Singh, Karam B.] CSIRO Plant Ind, Ctr Environm & Life Sci, Wembley, WA, Australia; [Singh, Karam B.] Univ Western Australia, Inst Agr, Crawley, WA, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia	Gleason, C (corresponding author), CSIRO Plant Ind, Ctr Environm & Life Sci, Wembley, WA, Australia.	karam.singh@csiro.au	Foley, Rhonda C/G-6716-2012; Singh, Karam B/C-3235-2012; Singh, Karam B/A-7790-2008	Singh, Karam B/0000-0002-2777-7448; 	Commonwealth Scientific and Industrial Research Organisation (CSIRO); Grains Research and Development Corporation [CSP00061]	Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Grains Research and Development Corporation(Grains R&D Corp)	This work was supported by Commonwealth Scientific and Industrial Research Organisation (CSIRO). Grains Research and Development Corporation (http://www.grdc.com.au/, Grant number CSP00061) provided funding for the microarray related aspects of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Behrens MR, 2007, SCIENCE, V316, P1185, DOI 10.1126/science.1141596; Benjamins R, 2008, ANNU REV PLANT BIOL, V59, P443, DOI 10.1146/annurev.arplant.58.032806.103805; Calderon-Villalobos LI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005546; Chen WQ, 1996, PLANT J, V10, P955, DOI 10.1046/j.1365-313X.1996.10060955.x; Chen WQ, 1999, PLANT J, V19, P667, DOI 10.1046/j.1365-313x.1999.00560.x; Cosio C, 2009, J EXP BOT, V60, P391, DOI 10.1093/jxb/ern318; Cranston HJ, 2001, WEED SCI, V49, P164, DOI 10.1614/0043-1745(2001)049[0164:DRIK]2.0.CO;2; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Delker C, 2008, PLANTA, V227, P929, DOI 10.1007/s00425-008-0710-8; Delker C, 2010, PLANT CELL, V22, P2184, DOI 10.1105/tpc.110.073957; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dharmasiri S, 2006, SCIENCE, V312, P1218, DOI 10.1126/science.1122847; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Foley RC, 2006, PLANT PHYSIOL, V142, P245, DOI 10.1104/pp.106.079509; Gao LL, 2007, MOL PLANT MICROBE IN, V20, P82, DOI 10.1094/MPMI-20-0082; Grossmann K, 2003, J PLANT GROWTH REGUL, V22, P109, DOI 10.1007/s00344-003-0020-0; Grossmann K, 2000, TRENDS PLANT SCI, V5, P506, DOI 10.1016/S1360-1385(00)01791-X; Grossmann K, 2001, J EXP BOT, V52, P1811, DOI 10.1093/jexbot/52.362.1811; Grossmann K, 2010, PEST MANAG SCI, V66, P113, DOI 10.1002/ps.1860; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hansen H, 2000, PLANT PHYSIOL, V124, P1437, DOI 10.1104/pp.124.3.1437; HEAP I, 2010, INT SURVEY HERBICIDE; Hiraga S, 2001, PLANT CELL PHYSIOL, V42, P462, DOI 10.1093/pcp/pce061; HOBBIE L, 1995, PLANT J, V7, P211, DOI 10.1046/j.1365-313X.1995.7020211.x; JASIENIUK M, 1995, WEED SCI, V43, P192, DOI 10.1017/S0043174500081054; Kelley KB, 2007, PESTIC BIOCHEM PHYS, V89, P1, DOI 10.1016/j.pestbp.2007.04.002; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kern AJ, 2005, WEED SCI, V53, P139, DOI 10.1614/WS-04-090R; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Kraft M, 2007, J EXP BOT, V58, P1497, DOI 10.1093/jxb/erm011; Lee DJ, 2009, J EXP BOT, V60, P3935, DOI 10.1093/jxb/erp230; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Nandula VK, 2002, WEED TECHNOL, V16, P50, DOI 10.1614/0890-037X(2002)016[0050:ROKKSI]2.0.CO;2; Okushima Y, 2005, PLANT J, V43, P29, DOI 10.1111/j.1365-313X.2005.02426.x; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Perl-Treves R, 2004, MOL PLANT MICROBE IN, V17, P70, DOI 10.1094/MPMI.2004.17.1.70; Powles SB, 2008, PEST MANAG SCI, V64, P360, DOI 10.1002/ps.1525; Powles SB, 2006, WEED TECHNOL, V20, P282, DOI 10.1614/WT-04-142R.1; Preston C, 2009, WEED SCI, V57, P43, DOI 10.1614/WS-08-098.1; Provart NJ., 2003, CURRENT COMPUTER MOL, V2003, P271; Pufky John, 2003, Functional & Integrative Genomics, V3, P135, DOI 10.1007/s10142-003-0093-7; Raghavan Chitra, 2006, Functional & Integrative Genomics, V6, P60, DOI 10.1007/s10142-005-0012-1; Raghavan Chitra, 2005, Functional & Integrative Genomics, V5, P4, DOI 10.1007/s10142-004-0119-9; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; SAPPL PG, 2009, PLANT J; Smyth G, 2005, LIMMA LINEAR MODELS; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Taylor IB, 2000, J EXP BOT, V51, P1563, DOI 10.1093/jexbot/51.350.1563; Thatcher LF, 2007, J BIOL CHEM, V282, P28915, DOI 10.1074/jbc.M702207200; Uquillas C, 2004, MOL PLANT MICROBE IN, V17, P34, DOI 10.1094/MPMI.2004.17.1.34; Walsh TA, 2006, PLANT PHYSIOL, V142, P542, DOI 10.1104/pp.106.085969; Wei YD, 2000, PEST MANAG SCI, V56, P377, DOI 10.1002/(SICI)1526-4998(200005)56:5<377::AID-PS154>3.3.CO;2-D; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yamamoto M, 1999, J PLANT RES, V112, P391, DOI 10.1007/PL00013892; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798	62	48	48	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17245	10.1371/journal.pone.0017245	http://dx.doi.org/10.1371/journal.pone.0017245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408147	gold, Green Submitted, Green Published			2022-12-25	WOS:000288170000017
J	Rakovic, A; Grunewald, A; Kottwitz, J; Bruggemann, N; Pramstaller, PP; Lohmann, K; Klein, C				Rakovic, Aleksandar; Gruenewald, Anne; Kottwitz, Jan; Brueggemann, Norbert; Pramstaller, Peter P.; Lohmann, Katja; Klein, Christine			Mutations in PINK1 and Parkin Impair Ubiquitination of Mitofusins in Human Fibroblasts	PLOS ONE			English	Article							COMPLEX I DEFICIENCY; MITOCHONDRIAL-FUNCTION; DISEASE; DROSOPHILA; MITOPHAGY; DEGRADATION; MORPHOLOGY; FUSION; PROTEASOME; MUTANTS	PINK1 and Parkin mutations cause recessive Parkinson's disease (PD). In Drosophila and SH-SY5Y cells, Parkin is recruited by PINK1 to damaged mitochondria, where it ubiquitinates Mitofusins and consequently promotes mitochondrial fission and mitophagy. Here, we investigated the impact of mutations in endogenous PINK1 and Parkin on the ubiquitination of mitochondrial fusion and fission factors and the mitochondrial network structure. Treating control fibroblasts with mitochondrial membrane potential (Delta psi) inhibitors or H(2)O(2) resulted in ubiquitination of Mfn1/2 but not of OPA1 or Fis1. Ubiquitination of Mitofusins through the PINK1/Parkin pathway was observed within 1 h of treatment. Upon combined inhibition of Delta psi and the ubiquitin proteasome system (UPS), no ubiquitination of Mitofusins was detected. Regarding morphological changes, we observed a trend towards increased mitochondrial branching in PD patient cells upon mitochondrial stress. For the first time in PD patient-derived cells, we demonstrate that mutations in PINK1 and Parkin impair ubiquitination of Mitofusins. In the presence of UPS inhibitors, ubiquitinated Mitofusin is deubiquitinated by the UPS but not degraded, suggesting that the UPS is involved in Mitofusin degradation.	[Rakovic, Aleksandar; Gruenewald, Anne; Kottwitz, Jan; Brueggemann, Norbert; Lohmann, Katja; Klein, Christine] Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, Lubeck, Germany; [Pramstaller, Peter P.] European Acad, Inst Med Genet, Bolzano, Italy	University of Lubeck; European Academy of Bozen-Bolzano	Rakovic, A (corresponding author), Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, Lubeck, Germany.	christine.klein@neuro.uni-luebeck.de	Klein, Christine/AGK-8003-2022; Grünewald, Anne/ABD-1255-2021; Pramstaller, Peter P/C-2357-2008	Grünewald, Anne/0000-0002-4179-2994; Pramstaller, Peter P/0000-0002-9831-8302; Kottwitz, Jan/0000-0002-2993-4312; Klein, Christine/0000-0003-2102-3431	Medical Faculty of the University of Lubeck; Volkswagen Foundation; Hermann and Lilly Schilling Foundation; German Research Foundation (DFG) [GR 3731/1-1]; Hilde Ulrichs Foundation for Parkinson's Disease Research; EU [EU-LSHB-CT-2006-037544]; German 'Bundesministerium fur Bildung und Forschung' (NGFN plus) [PNP-01GS08135-3]	Medical Faculty of the University of Lubeck; Volkswagen Foundation(Volkswagen); Hermann and Lilly Schilling Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); Hilde Ulrichs Foundation for Parkinson's Disease Research; EU(European Commission); German 'Bundesministerium fur Bildung und Forschung' (NGFN plus)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Medical Faculty of the University of Lubeck [to A. G.], the Volkswagen Foundation [to C. K.], the Hermann and Lilly Schilling Foundation [to C. K.], the German Research Foundation (DFG) [GR 3731/1-1 to A. G.], the Hilde Ulrichs Foundation for Parkinson's Disease Research [to C. K.], the EU Grant GENEPARK [EU-LSHB-CT-2006-037544 to C. K.], and the German 'Bundesministerium fur Bildung und Forschung' (NGFN plus) [PNP-01GS08135-3 to C. K.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 1997, BRAIN RES, V764, P167, DOI 10.1016/S0006-8993(97)00453-8; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cohen MMJ, 2008, MOL BIOL CELL, V19, P2457, DOI 10.1091/mbc.E08-02-0227; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; GEGG ME, 2010, HUM MOL GENET; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Grunewald A, 2007, NEUROGENETICS, V8, P103, DOI 10.1007/s10048-006-0072-y; Hedrich K, 2006, ARCH NEUROL-CHICAGO, V63, P833, DOI 10.1001/archneur.63.6.833; Jeyaraju DV, 2006, P NATL ACAD SCI USA, V103, P18562, DOI 10.1073/pnas.0604983103; Kaiser P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-233; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; Klein C, 2007, NEUROLOGY, V69, P2093, DOI 10.1212/01.wnl.0000271880.27321.a7; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; LUTZ AK, 2009, J BIOL CHEM; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Moro E, 2008, NEUROLOGY, V70, P1186, DOI 10.1212/01.wnl.0000307748.11216.03; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Piccoli C, 2008, J MED GENET, V45, P596, DOI 10.1136/jmg.2008.058628; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Pramstaller PP, 2005, ANN NEUROL, V58, P411, DOI 10.1002/ana.20587; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Verma R, 2005, METHOD ENZYMOL, V398, P391, DOI 10.1016/S0076-6879(05)98032-4; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	44	159	166	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e16746	10.1371/journal.pone.0016746	http://dx.doi.org/10.1371/journal.pone.0016746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408142	gold, Green Published, Green Submitted			2022-12-25	WOS:000288170000007
J	Huang, T; Xu, ZP; Chen, L; Cai, YD; Kong, XY				Huang, Tao; Xu, Zhongping; Chen, Lei; Cai, Yu-Dong; Kong, Xiangyin			Computational Analysis of HIV-1 Resistance Based on Gene Expression Profiles and the Virus-Host Interaction Network	PLOS ONE			English	Article							INFECTION; LYMPHOCYTES; PROSTITUTES; NAIROBI; ANTIGEN	A very small proportion of people remain negative for HIV infection after repeated HIV-1 viral exposure, which is called HIV-1 resistance. Understanding the mechanism of HIV-1 resistance is important for the development of HIV-1 vaccines and Acquired Immune Deficiency Syndrome (AIDS) therapies. In this study, we analyzed the gene expression profiles of CD4+ T cells from HIV-1-resistant individuals and HIV-susceptible individuals. One hundred eighty-five discriminative HIV-1 resistance genes were identified using the Minimum Redundancy-Maximum Relevance (mRMR) and Incremental Feature Selection (IFS) methods. The virus protein target enrichment analysis of the 185 HIV-1 resistance genes suggested that the HIV-1 protein nef might play an important role in HIV-1 infection. Moreover, we identified 29 infection information exchanger genes from the 185 HIV-1 resistance genes based on a virus-host interaction network analysis. The infection information exchanger genes are located on the shortest paths between virus-targeted proteins and are important for the coordination of virus infection. These proteins may be useful targets for AIDS prevention or therapy, as intervention in these pathways could disrupt communication with virus-targeted proteins and HIV-1 infection.	[Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Xu, Zhongping; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, RuiJin Hosp, State Key Lab Med Genom,Shanghai Inst Hematol, Shanghai 200030, Peoples R China; [Chen, Lei; Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Jiao Tong University; Fudan University; Shanghai Maritime University; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn; xykong@sibs.ac.cn	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979	National High-Tech R&D Program of China (863 Program) [2006AA02Z334, 2007DFA31040]; China National Key Projects for Infectious Disease [2008ZX10002-021]; National Basic Research Program of China [2006CB910700]; National Natural Science Foundation of China [31070752]; CAS [KSCX2-YW-R-112]	National High-Tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); China National Key Projects for Infectious Disease; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences)	This work was supported by grants from National High-Tech R&D Program of China (863 Program) (2006AA02Z334, 2007DFA31040), China National Key Projects for Infectious Disease (2008ZX10002-021), National Basic Research Program of China (2006CB910700), National Natural Science Foundation of China (Grant No. 31070752) and Key Research Program (CAS) (KSCX2-YW-R-112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernasconi P, 2005, CANCER GENET CYTOGEN, V162, P146, DOI 10.1016/j.cancergencyto.2005.04.002; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chakrabarti LA, 2010, CURR OPIN IMMUNOL, V22, P488, DOI 10.1016/j.coi.2010.06.006; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Das SR, 2005, INDIAN J MED RES, V121, P315; De Keersmaecker K, 2008, Verh K Acad Geneeskd Belg, V70, P245; Dijkstra E. W., 1959, NUMER MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Fowke KR, 2000, IMMUNOL CELL BIOL, V78, P586, DOI 10.1046/j.1440-1711.2000.00944.x; FREDRICKSON TN, 1984, J NATL CANCER I, V72, P447; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FRIEDMAN JH, 1975, IEEE T COMPUT, V24, P1000, DOI 10.1109/T-C.1975.224110; Hakansson P, 2004, EXP HEMATOL, V32, P476, DOI 10.1016/j.exphem.2004.02.012; HUANG T, 2010, INT J COMPU IN PRESS; HUANG T, 2010, WORKSH GEN NETW PATH; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011900; Huang Tao, 2010, BMC Res Notes, V3, P142, DOI 10.1186/1756-0500-3-142; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2009, BIOCHEM BIOPH RES CO, V390, P1111, DOI 10.1016/j.bbrc.2009.08.131; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kaul R, 2001, J CLIN INVEST, V107, P341, DOI 10.1172/JCI10714; Kharas NG, 2005, CANCER RES, V65, P2047, DOI 10.1158/0008-5472.CAN-04-3888; Kulkarni Prasad S., 2003, AIDS Reviews, V5, P87; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; LECRON JC, 1987, CR ACAD SCI III-VIE, V305, P639; PAUL JM, 2010, J INFECT DIS, V202, pS339; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pinney JW, 2009, AIDS, V23, P549, DOI 10.1097/QAD.0b013e328325a495; Simmons A, 2005, IMMUNITY, V23, P621, DOI 10.1016/j.immuni.2005.11.003; Temesgen Z, 1999, ANN ALLERG ASTHMA IM, V83, P1, DOI 10.1016/S1081-1206(10)63503-X; Tezuka T, 1996, J EXP MED, V183, P675, DOI 10.1084/jem.183.2.675; WEISS RA, 1993, SCIENCE, V260, P1273, DOI 10.1126/science.8493571; Yang PL, 2005, VIROLOGY, V336, P219, DOI 10.1016/j.virol.2005.03.021; Yi XF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012495; ZOLA H, 1991, CLIN IMMUNOL IMMUNOP, V59, P16, DOI 10.1016/0090-1229(91)90078-O	38	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17291	10.1371/journal.pone.0017291	http://dx.doi.org/10.1371/journal.pone.0017291			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394196	Green Published, gold, Green Submitted			2022-12-25	WOS:000288025500008
J	Fiuza-Luces, C; Ruiz, JR; Rodriguez-Romo, G; Santiago, C; Gomez-Gallego, F; Yvert, T; Cano-Nieto, A; Garatachea, N; Moran, M; Lucia, A				Fiuza-Luces, Carmen; Ruiz, Jonatan R.; Rodriguez-Romo, Gabriel; Santiago, Catalina; Gomez-Gallego, Felix; Yvert, Thomas; Cano-Nieto, Amalia; Garatachea, Nuria; Moran, Maria; Lucia, Alejandro			Are 'Endurance' Alleles 'Survival' Alleles? Insights from the ACTN3 R577X Polymorphism	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; MUSCLE POWER PHENOTYPES; NON-ATHLETIC ADULTS; ALPHA-ACTININ-3 DEFICIENCY; PHYSICAL-ACTIVITY; HUMAN LONGEVITY; PERFORMANCE; GENOTYPE; ASSOCIATION; POPULATION	Exercise phenotypes have played a key role for ensuring survival over human evolution. We speculated that some genetic variants that influence exercise phenotypes could be associated with exceptional survival (i.e. reaching >= 100years of age). Owing to its effects on muscle structure/function, a potential candidate is the Arg(R) 577Ter(X) polymorphism (rs1815739) in ACTN3, the structural gene encoding the skeletal muscle protein alpha-actinin-3. We compared the ACTN3 R577X genotype/allele frequencies between the following groups of ethnically-matched (Spanish) individuals: centenarians (cases, n = 64; 57 female; age range: 100-108 years), young healthy controls (n = 283, 67 females, 216 males; 21 +/- 2 years), and humans who are at the two end-points of exercise capacity phenotypes, i.e. muscle endurance (50 male professional road cyclists) and muscle power (63 male jumpers/sprinters). Although there were no differences in genotype/allele frequencies between centenarians (RR: 28.8%; RX: 47.5%; XX:23.7%), and controls (RR: 31.8%; RX: 49.8%; XX:18.4%) or endurance athletes (RR:28.0%; RX:46%; XX:26.0%), we observed a significantly higher frequency of the X allele (P = 0.019) and XX genotype (P = 0.011) in centenarians compared with power athletes (RR:47.6%; RX:36.5%; XX:15.9%). Notably, the frequency of the null XX (alpha-actinin-3 deficient) genotype in centenarians was the highest ever reported in non-athletic Caucasian populations. In conclusion, despite there were no significant differences with the younger, control population, overall the ACTN3 genotype of centenarians resembles that of world-class elite endurance athletes and differs from that of elite power athletes. Our preliminary data would suggest a certain 'survival' advantage brought about by alpha-actinin-3 deficiency and the 'endurance'/oxidative muscle phenotype that is commonly associated with this condition.	[Fiuza-Luces, Carmen; Santiago, Catalina; Gomez-Gallego, Felix; Yvert, Thomas; Lucia, Alejandro] Univ Europea Madrid, Madrid, Spain; [Ruiz, Jonatan R.] Univ Granada, Dept Phys Educ, Sch Phys Activ & Sport Sci, Granada, Spain; [Ruiz, Jonatan R.] Karolinska Inst, Dept Biosci & Nutr, Novum, Unit Prevent Nutr, Stockholm, Sweden; [Rodriguez-Romo, Gabriel] Univ Politecn Madrid, INEF, Madrid, Spain; [Cano-Nieto, Amalia] Hosp Morales Meseguer, SUAP Archena, Murcia, Spain; [Garatachea, Nuria] Univ Zaragoza, Fac Hlth & Sport Sci, Dept Physiotherapy & Nursing, Zaragoza, Spain; [Moran, Maria] Hosp 12 Octubre, Ctr Invest, E-28041 Madrid, Spain; [Moran, Maria] CIBERER, Madrid, Spain	European University of Madrid; University of Granada; Karolinska Institutet; Universidad Politecnica de Madrid; Facultad de Ciencias de la Actividad Fisica del Deporte (INEF); University of Zaragoza; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Lucia, A (corresponding author), Univ Europea Madrid, Madrid, Spain.	alejandro.lucia@uem.es	Rodriguez-Romo, Gabriel/AAD-1603-2022; RUIZ, JONATAN R/M-1338-2015; Gomez-Gallego, Felix/AAD-9617-2020; Santiago, Catalina/P-8177-2019; Moran, Maria/HHS-1798-2022; Gomez-Gallego, Felix/H-6925-2013; Santiago, Catalina/K-6803-2014; Lucia, Alejandro/M-2759-2014; Garatachea, Nuria/ABF-8732-2020	Rodriguez-Romo, Gabriel/0000-0003-3111-6340; RUIZ, JONATAN R/0000-0002-7548-7138; Santiago, Catalina/0000-0003-3852-8217; Gomez-Gallego, Felix/0000-0002-1968-1761; Santiago, Catalina/0000-0003-3852-8217; Lucia, Alejandro/0000-0002-3025-2060; Garatachea Vallejo, Nuria/0000-0001-8374-9081; Yvert, Thomas/0000-0002-9451-9799; Fiuza-Luces, Carmen/0000-0001-8131-7007; Lucia, Alejandro/0000-0002-5565-0997	Fondo de Investigaciones Sanitarias (FIS) [PS09/00194]; Swedish Council for Working Life and Social Research (FAS)	Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was funded by the Fondo de Investigaciones Sanitarias (FIS, ref. # PS09/00194), and Swedish Council for Working Life and Social Research (FAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bustamante-Ara N, 2010, INT J SPORTS MED, V31, P221, DOI 10.1055/s-0030-1247529; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cordain L, 1998, INT J SPORTS MED, V19, P328, DOI 10.1055/s-2007-971926; Delmonico MJ, 2007, J GERONTOL A-BIOL, V62, P206, DOI 10.1093/gerona/62.2.206; Galinsky D, 1997, ATHEROSCLEROSIS, V129, P177, DOI 10.1016/S0021-9150(96)06027-3; GARLAND T, 1990, EXPERIENTIA, V46, P530, DOI 10.1007/BF01954257; Giaccaglia V, 2008, INT J SPORTS MED, V29, P40, DOI 10.1055/s-2007-964842; Koch LG, 2008, J PHYSIOL-LONDON, V586, P83, DOI 10.1113/jphysiol.2007.144709; Liebenberg L, 2008, J HUM EVOL, V55, P1156, DOI 10.1016/j.jhevol.2008.07.004; Lucia A, 2006, INT J SPORTS MED, V27, P880, DOI 10.1055/s-2006-923862; Lucia A, 2002, MED SCI SPORT EXER, V34, P2079, DOI 10.1249/01.MSS.0000039306.92778.DF; Lucia A, 2008, NAT CLIN PRACT CARD, V5, P372, DOI 10.1038/ncpcardio1241; Lucia A, 2007, NEUROMUSCULAR DISORD, V17, P603, DOI 10.1016/j.nmd.2007.04.006; MacArthur DG, 2008, HUM MOL GENET, V17, P1076, DOI 10.1093/hmg/ddm380; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; MacArthur DG, 2007, EXERC SPORT SCI REV, V35, P30, DOI 10.1097/JES.0b013e31802d8874; Manini TM, 2009, BRIT J SPORT MED, V43, P28, DOI 10.1136/bjsm.2008.053736; Martin GM, 2007, PLOS GENET, V3, P1121, DOI 10.1371/journal.pgen.0030125; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; O'Keefe JH, 2004, MAYO CLIN PROC, V79, P101, DOI 10.4065/79.1.101; Rodriguez-Romo G, 2010, EUR J APPL PHYSIOL, V110, P1099, DOI 10.1007/s00421-010-1608-2; San Juan AF, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019539; Santiago C, 2010, SCAND J MED SCI SPOR, V20, P771, DOI 10.1111/j.1600-0838.2009.01017.x; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Seripa D, 2006, J GERONTOL A-BIOL, V61, P918, DOI 10.1093/gerona/61.9.918; SETO JT, 2010, EXP GERONTOL; Solvioli Stefano, 2008, Biotechnology Journal, V3, P740, DOI 10.1002/biot.200800046; Tejedor D, 2005, CLIN CHEM, V51, P1137, DOI 10.1373/clinchem.2004.045203; Van Damme R, 2002, NATURE, V415, P755, DOI 10.1038/415755b; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Walsh S, 2008, J APPL PHYSIOL, V105, P1486, DOI 10.1152/japplphysiol.90856.2008; Williams SB, 2009, BIOL LETTERS, V5, P610, DOI 10.1098/rsbl.2009.0360; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Yang JK, 2009, J RENIN-ANGIO-ALDO S, V10, P115, DOI 10.1177/1470320309104873; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Yang N, 2007, MED SCI SPORT EXER, V39, P1985, DOI 10.1249/mss.0b013e31814844c9	37	26	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17558	10.1371/journal.pone.0017558	http://dx.doi.org/10.1371/journal.pone.0017558			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21407828	Green Submitted, Green Published, gold			2022-12-25	WOS:000287965200026
J	Schmidt, JP; Drake, JM				Schmidt, John Paul; Drake, John M.			Time since Introduction, Seed Mass, and Genome Size Predict Successful Invaders among the Cultivated Vascular Plants of Hawaii	PLOS ONE			English	Article							INVASION SUCCESS; RISK-ASSESSMENT; ECOLOGICAL STRATEGIES; ALIEN PLANTS; INVASIVENESS; EVOLUTION; HISTORY; HYBRIDIZATION; PATTERNS; TRAITS	Extensive economic and environmental damage has been caused by invasive exotic plant species in many ecosystems worldwide. Many comparative studies have therefore attempted to predict, from biological traits, which species among the pool of naturalized non-natives become invasive. However, few studies have investigated which species establish and/or become pests from the larger pool of introduced species and controlled for time since introduction. Here we present results from a study aimed at quantifying predicting three classes of invasive species cultivated in Hawaii. Of 7,866 ornamental species cultivated in Hawaii between 1840 and 1999, 420 (5.3%) species naturalized, 141 (1.8%) have been classified as weeds, and 39 (0.5%) were listed by the state of Hawaii as noxious. Of the 815 species introduced > 80 years ago, 253 (31%) have naturalized, 90 (11%) are classed as weeds, and 22 (3%) as noxious by the state of Hawaii. Using boosted regression trees we classified each group with nearly 90% accuracy, despite incompleteness of data and the low proportion of naturalized or pest species. Key biological predictors were seed mass and highest chromosome number standardized by genus which, when data on residence time was removed, were able to predict all three groups with 76-82% accuracy. We conclude that, when focused on a single region, screening for potential weeds or noxious plants based on a small set of biological traits can be achieved with sufficient accuracy for policy and management purposes.	[Schmidt, John Paul; Drake, John M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Schmidt, JP (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	jps@uga.edu	Schmidt, John Paul/A-3583-2013; Drake, John/D-6622-2012	Schmidt, John Paul/0000-0001-8549-0587; Drake, John/0000-0003-4646-1235	United States Department of Agriculture [10-21-RR551]	United States Department of Agriculture(United States Department of Agriculture (USDA))	Research was funded by United States Department of Agriculture agreement no. 10-21-RR551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2004, BIOL J LINN SOC, V82, P467, DOI 10.1111/j.1095-8312.2004.00333.x; Ainouche ML, 2009, BIOL INVASIONS, V11, P1159, DOI 10.1007/s10530-008-9383-2; Beaulieu JM, 2007, NEW PHYTOL, V173, P422, DOI 10.1111/j.1469-8137.2006.01919.x; Bennett MD, 1998, ANN BOT-LONDON, V82, P121, DOI 10.1006/anbo.1998.0785; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Bucharova A, 2009, J ECOL, V97, P230, DOI 10.1111/j.1365-2745.2008.01469.x; Cadotte MW, 2006, BIOL INVASIONS, V8, P809, DOI 10.1007/s10530-005-3839-4; Caley P, 2008, DIVERS DISTRIB, V14, P196, DOI 10.1111/j.1472-4642.2007.00440.x; Daehler CC, 2004, CONSERV BIOL, V18, P360, DOI 10.1111/j.1523-1739.2004.00066.x; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Gordon DR, 2008, DIVERS DISTRIB, V14, P234, DOI 10.1111/j.1472-4642.2007.00460.x; Grotkopp E, 2004, EVOLUTION, V58, P1705, DOI 10.1111/j.0014-3820.2004.tb00456.x; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; Herron PM, 2007, DIVERS DISTRIB, V13, P633, DOI 10.1111/j.1472-4642.2007.00381.x; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Hurka Herbert, 2003, Biological Invasions, V5, P281; Keller RP, 2007, P NATL ACAD SCI USA, V104, P203, DOI 10.1073/pnas.0605787104; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; KOWARIK I, 1995, PLANT INVASIONS, P15; Kuster EC, 2008, J ECOL, V96, P860, DOI 10.1111/j.1365-2745.2008.01406.x; Moles AT, 2004, J ECOL, V92, P384, DOI 10.1111/j.0022-0477.2004.00880.x; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; PYSEK P, 1995, PLANT INVASIONS, P39; Pysek Petr, 2007, V193, P97; Pysek P, 2009, DIVERS DISTRIB, V15, P891, DOI 10.1111/j.1472-4642.2009.00602.x; Reichard SH, 1997, CONSERV BIOL, V11, P193, DOI 10.1046/j.1523-1739.1997.95473.x; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; Ridgeway G., 1999, COMPUT SCI STAT, P172; Ridgeway G., GEN BOOSTED REGRESSI; Schlaepfer DR, 2010, OECOLOGIA, V163, P661, DOI 10.1007/s00442-010-1595-3; SCHMIDT JP, 2010, COST SENSITIVE RISK; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; THOMPSON K, 1993, FUNCT ECOL, V7, P236, DOI 10.2307/2389893; Thuiller W, 2006, ECOLOGY, V87, P1755, DOI 10.1890/0012-9658(2006)87[1755:IBESTA]2.0.CO;2; van Kleunen M, 2003, ECOLOGY, V84, P2816, DOI 10.1890/02-0494; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Williamson M, 1999, ECOGRAPHY, V22, P5, DOI 10.1111/j.1600-0587.1999.tb00449.x; Williamson M., 1996, BIOL INVASIONS; Wilson JRU, 2007, DIVERS DISTRIB, V13, P11, DOI 10.1111/j.1366-9516.2006.00302.x	47	19	19	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17391	10.1371/journal.pone.0017391	http://dx.doi.org/10.1371/journal.pone.0017391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407804	Green Published, Green Submitted, gold			2022-12-25	WOS:000287933300020
J	Teixeira, TF; Dezen, D; Cibulski, SP; Varela, APM; Holz, CL; Franco, AC; Roehe, PM				Teixeira, Thais Fumaco; Dezen, Diogenes; Cibulski, Samuel Paulo; Muterle Varela, Ana Paula; Holz, Carine Lidiane; Franco, Ana Claudia; Roehe, Paulo Michel			Torque Teno Sus Virus (TTSuV) in Cell Cultures and Trypsin	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; SPECIES-SPECIFIC TTVS; NONHUMAN-PRIMATES; HIGHLY PREVALENT; GNOTOBIOTIC PIGS; DNA VIRUS; SWINE; GENOMES; HUMANS; IDENTIFICATION	Torque teno sus virus (TTSuV), a member of the family Anelloviridae, is a single-stranded, circular DNA virus, widely distributed in swine populations. Presently, two TTSuV genogroups are recognized: Torque teno sus virus 1 (TTSuV1) and Torque teno sus virus 2 (TTSuV2). TTSuV genomes have been found in commercial vaccines for swine, enzyme preparations and other drugs containing components of porcine origin. However, no studies have been made looking for TTSuV in cell cultures. In the present study, a search for TTSuV genomes was carried out in cell culture lineages, in sera used as supplement for cell culture media as well as in trypsin used for cell disaggregation. DNA obtained from twenty-five cell lineages (ten from cultures in routine multiplication and fifteen from frozen ampoules), nine samples of sera used in cell culture media and five batches of trypsin were examined for the presence of TTSuV DNA. Fifteen cell lineages, originated from thirteen different species contained amplifiable TTSuV genomes, including an ampoule with a cell lineage frozen in 1985. Three cell lineages of swine origin were co-infected with both TTSuV1 and TTSuV2. One batch of trypsin contained two distinct TTSuV1 plus one TTSuV2 genome, suggesting that this might have been the source of contamination, as supported by phylogenetic analyses of sequenced amplicons. Samples of fetal bovine and calf sera used in cell culture media did not contain amplifiable TTSuV DNA. This is the first report on the presence of TTSuV as contaminants in cell lineages. In addition, detection of the viral genome in an ampoule frozen in 1985 provides evidence that TTSuV contamination is not a recent event. These findings highlight the risks of TTSuV contamination in cell cultures, what may be source for contamination of biological products or compromise results of studies involving in vitro multiplied cells.	[Teixeira, Thais Fumaco; Dezen, Diogenes; Cibulski, Samuel Paulo; Muterle Varela, Ana Paula; Roehe, Paulo Michel] FEPAGRO Anim Hlth Inst Pesquisas Vet Desiderio Fi, Equipe Virol, Eldorado Do Sul, RS, Brazil; [Teixeira, Thais Fumaco; Franco, Ana Claudia; Roehe, Paulo Michel] Univ Fed Rio Grande do Sul, Virol Lab, Dept Microbiol Immunol & Parasitol, Inst Ciencias Basicas Saude, Porto Alegre, RS, Brazil; [Holz, Carine Lidiane] CIRAD, Dept Syst Biol, UR 15, Montpellier, France	Universidade Federal do Rio Grande do Sul; CIRAD	Teixeira, TF (corresponding author), FEPAGRO Anim Hlth Inst Pesquisas Vet Desiderio Fi, Equipe Virol, Eldorado Do Sul, RS, Brazil.	proehe@gmail.com	Cibulski, Samuel P/G-5190-2017; ROEHE, PAULO MICHEL/K-1208-2012; Dezen, Diogenes/Q-3581-2019; Franco, Ana Cláudia AC/N-4373-2015	ROEHE, PAULO MICHEL/0000-0002-2370-7661; Dezen, Diogenes/0000-0002-0941-9954; Cibulski, Samuel/0000-0003-0503-8692; Franco, Ana/0000-0001-7747-5125	Brazilian National Research Council (CNPq); Financiadora de Estudos e Projetos (FINEP); Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS)	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	This work was supported by the Brazilian National Research Council (CNPq), Financiadora de Estudos e Projetos (FINEP) and by Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biagini P, 2005, VIRUS TAXONOMY, P335; Biagini P, 2007, J GEN VIROL, V88, P2696, DOI 10.1099/vir.0.83071-0; Bigarre L, 2005, J GEN VIROL, V86, P631, DOI 10.1099/vir.0.80573-0; Brassard J, 2008, VET MICROBIOL, V126, P271, DOI 10.1016/j.vetmic.2007.07.014; Ellis JA, 2008, AM J VET RES, V69, P1608, DOI 10.2460/ajvr.69.12.1608; Freshney R, 1992, ANIMAL CELL CULTURE; Griffiths P, 1999, REV MED VIROL, V9, P73, DOI 10.1002/(SICI)1099-1654(199904/06)9:2&lt;73::AID-RMV254&gt;3.0.CO;2-5; Kekarainen T, 2007, THERIOGENOLOGY, V68, P966, DOI 10.1016/j.theriogenology.2007.07.010; Kekarainen T, 2006, J GEN VIROL, V87, P833, DOI 10.1099/vir.0.81586-0; Kekarainen T, 2009, J GEN VIROL, V90, P648, DOI 10.1099/vir.0.006841-0; Krakowka S, 2008, AM J VET RES, V69, P1615, DOI 10.2460/ajvr.69.12.1615; Leary TP, 1999, J GEN VIROL, V80, P2115, DOI 10.1099/0022-1317-80-8-2115; Martelli F, 2006, J VET MED B, V53, P234, DOI 10.1111/j.1439-0450.2006.00949.x; Martinez L, 2006, VET MICROBIOL, V118, P223, DOI 10.1016/j.vetmic.2006.07.022; Martinez-Guino L, 2009, THERIOGENOLOGY, V71, P1390, DOI 10.1016/j.theriogenology.2009.01.010; McKeown NE, 2004, VET MICROBIOL, V104, P113, DOI 10.1016/j.vetmic.2004.08.013; Niel C, 2005, J GEN VIROL, V86, P1343, DOI 10.1099/vir.0.80794-0; Ninomiya M, 2007, ARCH VIROL, V152, P1961, DOI 10.1007/s00705-007-1046-6; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Okamoto H, 2000, VIROLOGY, V277, P368, DOI 10.1006/viro.2000.0588; Okamoto H, 2002, J GEN VIROL, V83, P1291, DOI 10.1099/0022-1317-83-6-1291; Okamoto H, 2009, CURR TOP MICROBIOL, V331, P1, DOI 10.1007/978-3-540-70972-5_1; Okamoto H, 2001, J GEN VIROL, V82, P2041, DOI 10.1099/0022-1317-82-9-2041; Sambrook J, 2001, MOL CLONING LAB MANU; Scobie L, 2009, CURR OPIN ORGAN TRAN, V14, P175, DOI 10.1097/MOT.0b013e328327984d; Segales J, 2009, VET MICROBIOL, V134, P199, DOI 10.1016/j.vetmic.2008.08.002; Takahashi K, 2000, ARCH VIROL, V145, P979, DOI 10.1007/s007050050689; TEIXEIRA T, 2008, THESIS U FEDERAL RIO	28	17	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17501	10.1371/journal.pone.0017501	http://dx.doi.org/10.1371/journal.pone.0017501			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407810	Green Submitted, Green Published, gold			2022-12-25	WOS:000287933300029
J	Chen, Q; Hooper, DU; Lin, S				Chen, Qing; Hooper, David U.; Lin, Shan			Shifts in Species Composition Constrain Restoration of Overgrazed Grassland Using Nitrogen Fertilization in Inner Mongolian Steppe, China	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; TERRESTRIAL ECOSYSTEMS; SEMIARID STEPPE; USE EFFICIENCY; SOIL-WATER; LAND-USE; PRECIPITATION; MANAGEMENT; DEPOSITION; DIVERSITY	Long-term livestock over-grazing causes nitrogen outputs to exceed inputs in Inner Mongolia, suggesting that low levels of nitrogen fertilization could help restore grasslands degraded by overgrazing. However, the effectiveness of such an approach depends on the response of production and species composition to the interactive drivers of nitrogen and water availability. We conducted a five-year experiment manipulating precipitation (NP: natural precipitation and SWP: simulated wet year precipitation) and nitrogen (0, 25 and 50 kg N ha(-1) yr(-1)) addition in Inner Mongolia. We hypothesized that nitrogen fertilization would increase forage production when water availability was relatively high. However, the extent to which nitrogen would co-limit production under average or below average rainfall in these grasslands was unknown. Aboveground net primary production (ANPP) increased in response to nitrogen when precipitation was similar to or higher than the long-term average, but not when precipitation was below average. This shift in limitation was also reflected by water and nitrogen use efficiency. Belowground live biomass significantly increased with increasing water availability, but was not affected by nitrogen addition. Under natural precipitation (NP treatment), the inter-annual variation of ANPP was 3-fold greater than with stable water availability (CVANPP = 61 +/- 6% and 17 +/- 3% for NP and SWP treatment, respectively) and nitrogen addition increased CVANPP even more (89 +/- 14%). This occurred in part because fertilizer nitrogen left in the soil in dry years remained available for uptake during wet years and because of high production by unpalatable annual species in wet years in the NP treatment. In summary, plant growth by residual fertilizer nitrogen could lead to sufficient yields to offset lack of additional production in dry years. However, the utility of fertilization for restoration may be constrained by shifts in species composition and the lack of response by belowground biomass, which reduces replacement of soil carbon and nitrogen.	[Chen, Qing; Lin, Shan] China Agr Univ, Dept Plant Nutr, Beijing 100094, Peoples R China; [Hooper, David U.] Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA	China Agricultural University; Western Washington University	Chen, Q (corresponding author), China Agr Univ, Dept Plant Nutr, Beijing 100094, Peoples R China.	linshan@cau.edu.cn		Chen, Qing/0000-0002-4589-0161	National Nature Science Foundation of China [NSFC 41071207/30821003]; Deutsche Forschungsgemeinschaft (DFG) [546/3-2]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the National Nature Science Foundation of China (NSFC 41071207/30821003, www.nfsc.gov.cn) and partly by the Deutsche Forschungsgemeinschaft (DFG, project DI 546/3-2, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Tsuyoshi, 2007, Grassland Science, V53, P1, DOI 10.1111/j.1744-697X.2007.00073.x; Austin AT, 2002, ECOLOGY, V83, P328, DOI 10.1890/0012-9658(2002)083[0328:DEOPOP]2.0.CO;2; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Bai YF, 2007, J APPL ECOL, V44, P1023, DOI 10.1111/j.1365-2664.2007.01351.x; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bationo A, 2001, NUTR CYCL AGROECOSYS, V61, P131, DOI 10.1023/A:1013355822946; Bobbink R, 1998, J ECOL, V86, P717, DOI 10.1046/j.1365-2745.1998.8650717.x; BROUWER R, 1983, NETH J AGR SCI, V31, P335; Camill P, 2004, ECOL APPL, V14, P1680, DOI 10.1890/03-5273; Christensen L, 2004, CLIMATIC CHANGE, V63, P351, DOI 10.1023/B:CLIM.0000018513.60904.fe; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Dutt HR, 1997, J FUTURES MARKETS, V17, P341, DOI 10.1002/(SICI)1096-9934(199705)17:3<341::AID-FUT5>3.0.CO;2-I; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fay PA, 2000, ECOSYSTEMS, V3, P308, DOI 10.1007/s100210000028; Fay PA, 2003, OECOLOGIA, V137, P245, DOI 10.1007/s00442-003-1331-3; Fenn ME, 1998, ECOL APPL, V8, P706, DOI 10.1890/1051-0761(1998)008[0706:NEINAE]2.0.CO;2; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; GIBBENS RP, 1988, J RANGE MANAGE, V41, P186, DOI 10.2307/3899165; Grman E, 2010, ECOL LETT, V13, P1400, DOI 10.1111/j.1461-0248.2010.01533.x; Han JG, 2008, RANGELAND J, V30, P233, DOI 10.1071/RJ08009; Harpole WS, 2007, GLOBAL CHANGE BIOL, V13, P2341, DOI 10.1111/j.1365-2486.2007.01447.x; Heisler-White JL, 2008, OECOLOGIA, V158, P129, DOI 10.1007/s00442-008-1116-9; Hooper DU, 1999, BIOGEOCHEMISTRY, V46, P247, DOI 10.1007/BF01007582; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Jobbagy EG, 2002, ECOLOGY, V83, P307, DOI 10.1890/0012-9658(2002)083[0307:PACOPP]2.0.CO;2; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Knapp AK, 2001, ECOSYSTEMS, V4, P19, DOI 10.1007/s100210000057; LAUENROTH WK, 1994, ECOL APPL, V4, P741, DOI 10.2307/1942004; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Li SG, 2000, AGR FOREST METEOROL, V102, P125, DOI 10.1016/S0168-1923(00)00101-5; Ludwig F, 2004, PLANT ECOL, V170, P93, DOI 10.1023/B:VEGE.0000019023.29636.92; Marcelis LFM, 1998, SCI HORTIC-AMSTERDAM, V74, P83, DOI 10.1016/S0304-4238(98)00083-1; Matson P, 2002, AMBIO, V31, P113, DOI 10.1639/0044-7447(2002)031[0113:TGONDC]2.0.CO;2; Ngugi MR, 2003, NEW FOREST, V26, P187, DOI 10.1023/A:1024493917483; Ni J, 2000, J ARID ENVIRON, V46, P313, DOI 10.1006/jare.2000.0667; O'Connor TG, 2001, J ECOL, V89, P850, DOI 10.1046/j.0022-0477.2001.00605.x; Paruelo JM, 1999, ECOSYSTEMS, V2, P64, DOI 10.1007/s100219900058; Schonbach P, 2009, CROP PASTURE SCI, V60, P963, DOI 10.1071/CP09048; Schonbach P, 2011, PLANT SOIL, V340, P103, DOI 10.1007/s11104-010-0366-6; SEAGLE SW, 1993, BIOGEOCHEMISTRY, V22, P157, DOI 10.1007/BF00000645; Sneath D, 1998, SCIENCE, V281, P1147, DOI 10.1126/science.281.5380.1147; Steffens M, 2008, GEODERMA, V143, P63, DOI 10.1016/j.geoderma.2007.09.004; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Su YZ, 2005, CATENA, V59, P267, DOI 10.1016/j.catena.2004.09.001; Swemmer AM, 2007, J ECOL, V95, P780, DOI 10.1111/j.1365-2745.2007.01237.x; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; van der Waal C, 2009, J ECOL, V97, P430, DOI 10.1111/j.1365-2745.2009.01498.x; Verburg PH, 1999, AGR SYST, V62, P51, DOI 10.1016/S0308-521X(99)00055-4; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; Wang J. W., 1988, Research on Grassland Ecosystem, P23; Wang WY, 2006, ECOL RES, V21, P181, DOI 10.1007/s11284-005-0108-z; Weltzin JF, 2003, BIOSCIENCE, V53, P941, DOI 10.1641/0006-3568(2003)053[0941:ATROTE]2.0.CO;2; Xie YZ, 2004, ACTA OECOL, V25, P197, DOI 10.1016/j.actao.2004.01.004; Xu ZZ, 2005, PHYSIOL PLANTARUM, V123, P272, DOI 10.1111/j.1399-3054.2005.00455.x; Zhou Z, 2006, FUNCT ECOL, V20, P753, DOI 10.1111/j.1365-2435.2006.01175.x	57	40	46	8	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e16909	10.1371/journal.pone.0016909	http://dx.doi.org/10.1371/journal.pone.0016909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390304	gold, Green Published, Green Submitted			2022-12-25	WOS:000287932100007
J	Komiya, T; Fujita, S; Watanabe, K				Komiya, Takefumi; Fujita, Sari; Watanabe, Katsutoshi			A Novel Resource Polymorphism in Fish, Driven by Differential Bottom Environments: An Example from an Ancient Lake in Japan	PLOS ONE			English	Article							GASTEROSTEUS-ACULEATUS L; FRESH-WATER FISHES; ECOLOGICAL SPECIATION; COTTID FISHES; MORPHOLOGY; POPULATION; BLUEGILL; HABITAT; SARCOCHEILICHTHYS; DIVERSIFICATION	Divergent natural selection rooted in differential resource use can generate and maintain intraspecific eco-morphological divergence (i. e., resource polymorphism), ultimately leading to population splitting and speciation. Differing bottom environments create lake habitats with different benthos communities, which may cause selection in benthivorous fishes. Here, we document the nature of eco-morphological and genetic divergence among local populations of the Japanese gudgeon Sarcocheilichthys (Cyprinidae), which inhabits contrasting habitats in the littoral zones (rocky vs. pebbly habitats) in Lake Biwa, a representative ancient lake in East Asia. Eco-morphological analyses revealed that Sarcocheilichthys variegatus microoculus from rocky and pebbly zones differed in morphology and diet, and that populations from rocky environments had longer heads and deeper bodies, which are expected to be advantageous for capturing cryptic and/or attached prey in structurally complex, rocky habitats. Sarcocheilichthys biwaensis, a rock-dwelling specialist, exhibited similar morphologies to the sympatric congener, S. v. microoculus, except for body/fin coloration. Genetic analyses based on mitochondrial and nuclear microsatellite DNA data revealed no clear genetic differentiation among local populations within/between the gudgeon species. Although the morphogenetic factors that contribute to morphological divergence remain unclear, our results suggest that the gudgeon populations in Lake Biwa show a state of resource polymorphism associated with differences in the bottom environment. This is a novel example of resource polymorphism in fish within an Asian ancient lake, emphasizing the importance and generality of feeding adaptation as an evolutionary mechanism that generates morphological diversification.	[Komiya, Takefumi; Fujita, Sari; Watanabe, Katsutoshi] Kyoto Univ, Grad Sch Sci, Kyoto, Japan	Kyoto University	Komiya, T (corresponding author), Kyoto Univ, Grad Sch Sci, Kyoto, Japan.	komiya@terra.zool.kyoto-u.ac.jp	Watanabe, Katsutoshi/H-3414-2011		Ministry of Education, Culture, Sports, Science, and Technology, Japan [18570086, 21370035]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (nos. 18570086, 21370035, Biodiversity Research of the 21st Century COE: A14 http://ethol.zool.kyoto-u.ac.jp/coe/eng/coe.htm, and "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem" of the GCOE http://gcoe.biol.sci.kyoto-u.ac.jp/gcoe/) and by the Foundation of Ito Grant for Ichthyology, Fujiwara Natural History Foundation http://fujiwara-nh.or.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aoyama J, 2000, ICHTHYOL RES, V47, P157, DOI 10.1007/BF02684236; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; EHLINGER TJ, 1990, ECOLOGY, V71, P886, DOI 10.2307/1937360; EHLINGER TJ, 1988, P NATL ACAD SCI USA, V85, P1878, DOI 10.1073/pnas.85.6.1878; EHLINGER TJ, 1989, ANIM BEHAV, V38, P643, DOI 10.1016/S0003-3472(89)80010-7; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fujita S, 2008, MOL ECOL RESOUR, V8, P1335, DOI 10.1111/j.1755-0998.2008.02303.x; Horne A.J., 1994, LIMNOLOGY; HOSOYA K, 1982, JPN J ICHTHYOL, V29, P127; HOSOYA K, 1994, GLOSSY ATLAS FISH AN, P78; Hosoya K, 2001, FRESHWATER FISHES JA, P310; HYNES HBN, 1950, J ANIM ECOL, V19, P36, DOI 10.2307/1570; Kawabe T., 1989, J GEOSCI-OSAKA CITY, V32, P39; Kawanabe H, 1996, ENVIRON BIOL FISH, V47, P219, DOI 10.1007/BF00000495; Klemetsen Anders, 1997, Nordic Journal of Freshwater Research, V73, P13; KORNFIELD I, 1982, EVOLUTION, V36, P658, DOI 10.1111/j.1558-5646.1982.tb05433.x; Kristjansson BK, 2002, EVOL ECOL RES, V4, P659; Kristjansson BK, 2002, BIOL J LINN SOC, V76, P247, DOI 10.1046/j.1095-8312.2002.00063.x; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Langerhans RB, 2004, EVOLUTION, V58, P2305, DOI 10.1111/j.0014-3820.2004.tb01605.x; MARCUS LF, 1996, ADV MORPHOMETRICS; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; MEYERS PA, 1993, QUATERNARY RES, V39, P154, DOI 10.1006/qres.1993.1019; Nakamura M., 1969, CYPRINID FISHES JAPA; Nemeth DH, 1997, J EXP BIOL, V200, P2155; NISHINO M, 1991, LANDSCAPE ECOLOGICAL, P47; NORTON SF, 1995, ENVIRON BIOL FISH, V44, P61, DOI 10.1007/BF00005907; NORTON SF, 1991, ECOLOGY, V72, P1807, DOI 10.2307/1940980; Nosil P, 2006, P NATL ACAD SCI USA, V103, P9090, DOI 10.1073/pnas.0601575103; OKSANEN J, 2008, VEGAN COMMUNITY ECOL, V1, P17; Palumbi S., 2002, SIMPLE FOOLS GUIDE P; Pritchard JK, 2000, GENETICS, V155, P945; ROBINSON BW, 1994, AM NAT, V144, P596, DOI 10.1086/285696; Rohlf F. J., 2008, TPSDIG2 PROGRAM LAND; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; ROHLF FJ, 2006, TPSPLS PROGRAM LANDM; ROHLF FJ, 2009, TPSREGR PROGRAM LAND; Ruzzante DE, 2003, BIOL J LINN SOC, V78, P497, DOI 10.1046/j.0024-4066.2002.00159.x; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Skulason S, 1999, EVOLUTION OF BIOLOGICAL DIVERSITY, P70; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; Svanback R, 2003, OIKOS, V102, P273, DOI 10.1034/j.1600-0706.2003.12657.x; Svanback R, 2002, OECOLOGIA, V131, P61, DOI 10.1007/s00442-001-0861-9; TAKAHASHI S, 1988, Journal of Paleolimnology, V1, P279; Tomoda Y, 1991, NATURAL HIST SHIGA P, P1399; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Via S, 2008, MOL ECOL, V17, P4334, DOI 10.1111/j.1365-294X.2008.03921.x; Walker JA, 1997, BIOL J LINN SOC, V61, P3, DOI 10.1111/j.1095-8312.1997.tb01777.x; Watanabe K, 2010, ICHTHYOL RES, V57, P107, DOI 10.1007/s10228-009-0129-7; WEBB PW, 1984, AM ZOOL, V24, P107; WEBB PW, 1986, T AM FISH SOC, V115, P115, DOI 10.1577/1548-8659(1986)115<115:FLMOEL>2.0.CO;2; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x; YOKOYAMA T, 1992, MOVING HIST LAKE BIW; YOKOYAMA T, 1984, MONOGRAPHIAE BIOL, V54, P43; Yuma M, 1998, ENVIRON BIOL FISH, V52, P97, DOI 10.1023/A:1007451417556	63	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17430	10.1371/journal.pone.0017430	http://dx.doi.org/10.1371/journal.pone.0017430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387005	gold, Green Submitted, Green Published			2022-12-25	WOS:000287931400075
J	Sahar, T; Reddy, KS; Bharadwaj, M; Pandey, AK; Singh, S; Chitnis, CE; Gaur, D				Sahar, Tajali; Reddy, K. Sony; Bharadwaj, Mitasha; Pandey, Alok K.; Singh, Shailja; Chitnis, Chetan E.; Gaur, Deepak			Plasmodium falciparum Reticulocyte Binding-Like Homologue Protein 2 (PfRH2) Is a Key Adhesive Molecule Involved in Erythrocyte Invasion	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; RECEPTOR SPECIFICITY; MEROZOITE PROTEINS; MALARIA PARASITES; CELL INVASION; VIVAX; EXPRESSION; IDENTIFICATION; POLYMORPHISM; ANTIBODIES	Erythrocyte invasion by Plasmodium merozoites is a complex, multistep process that is mediated by a number of parasite ligand-erythrocyte receptor interactions. One such family of parasite ligands includes the P. falciparum reticulocyte binding homologue (PfRH) proteins that are homologous with the P. vivax reticulocyte binding proteins and have been shown to play a role in erythrocyte invasion. There are five functional PfRH proteins of which only PfRH2a/2b have not yet been demonstrated to bind erythrocytes. In this study, we demonstrated that native PfRH2a/2b is processed near the N-terminus yielding fragments of 220 kDa and 80 kDa that exhibit differential erythrocyte binding specificities. The erythrocyte binding specificity of the 220 kDa processed fragment of native PfRH2a/2b was sialic acid-independent, trypsin resistant and chymotrypsin sensitive. This specific binding phenotype is consistent with previous studies that disrupted the PfRH2a/2b genes and demonstrated that PfRH2b is involved in a sialic acid independent, trypsin resistant, chymotrypsin sensitive invasion pathway. Interestingly, we found that the smaller 80 kDa PfRH2a/2b fragment is processed from the larger 220 kDa fragment and binds erythrocytes in a sialic acid dependent, trypsin resistant and chymotrypsin sensitive manner. Thus, the two processed fragments of PfRH2a/2b differed with respect to their dependence on sialic acids for erythrocyte binding. Further, we mapped the erythrocyte binding domain of PfRH2a/2b to a conserved 40 kDa N-terminal region (rPfRH2(40)) in the ectodomain that is common to both PfRH2a and PfRH2b. We demonstrated that recombinant rPfRH2(40) bound human erythrocytes with the same specificity as the native 220 kDa processed protein. Moreover, antibodies generated against rPfRH2(40) blocked erythrocyte invasion by P. falciparum through a sialic acid independent pathway. PfRH2a/2b thus plays a key role in erythrocyte invasion and its conserved receptor-binding domain deserves attention as a promising candidate for inclusion in a blood-stage malaria vaccine.	[Sahar, Tajali; Reddy, K. Sony; Bharadwaj, Mitasha; Pandey, Alok K.; Singh, Shailja; Chitnis, Chetan E.; Gaur, Deepak] Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Sahar, T (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi, India.	dgaur@icgeb.res.in	Pandey, Alok Kumar/ABD-9897-2021; Sahar, Tajali/AAI-5707-2020; Reddy, K Sony/AAR-6285-2020; Gaur, Deepak/AAF-4379-2019	Reddy, K. Sony/0000-0002-8437-5250; Chitnis, Chetan/0000-0002-8773-9865	Department of Biotechnology, Government of India; Bill and Melinda Gates Foundation; European Commission	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre)	Deepak Gaur, Chetan Chitnis, and Shailja Singh are recipients of the Ramalingaswami Fellowship, TATA Innovation Fellowship, and Innovative Young Biotechnologist Award, respectively, from the Department of Biotechnology, Government of India. The work has been funded by grants from the Department of Biotechnology, Government of India through the Rapid Grant Scheme for Young Investigators (Deepak Gaur) and Indo-Australia Biotechnology Fund (Chetan Chitnis). Deepak Gaur is also the recipient of the Grand Challenges Exploration grant from the Bill and Melinda Gates Foundation. Work in the laboratory of Chetan Chitnis was supported by MalSig and EVIMalaR grants from the European Commission (FP7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1990, CELL, V63, P141, DOI 10.1016/0092-8674(90)90295-P; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; Blackman MJ, 2004, CELL MICROBIOL, V6, P893, DOI 10.1111/j.1462-5822.2004.00437.x; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; Chandra BR, 2005, MOL BIOCHEM PARASIT, V142, P237, DOI 10.1016/j.molbiopara.2005.04.006; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DeSimone TM, 2009, MOL MICROBIOL, V72, P578, DOI 10.1111/j.1365-2958.2009.06667.x; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Dvorin JD, 2010, MOL MICROBIOL, V75, P990, DOI 10.1111/j.1365-2958.2009.07040.x; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Gao XH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000104; Gaur D, 2006, MOL BIOCHEM PARASIT, V145, P205, DOI 10.1016/j.molbiopara.2005.10.004; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gaur D, 2007, P NATL ACAD SCI USA, V104, P17789, DOI 10.1073/pnas.0708772104; Hayton K, 2008, CELL HOST MICROBE, V4, P40, DOI 10.1016/j.chom.2008.06.001; Howell SA, 2001, J BIOL CHEM, V276, P31311, DOI 10.1074/jbc.M103076200; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; KAIN KC, 1993, J EXP MED, V178, P1497, DOI 10.1084/jem.178.5.1497; Kaneko O, 2002, MOL BIOCHEM PARASIT, V121, P275, DOI 10.1016/S0166-6851(02)00042-7; Liang H, 2000, INFECT IMMUN, V68, P3564, DOI 10.1128/IAI.68.6.3564-3568.2000; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Mayer DCG, 2004, P NATL ACAD SCI USA, V101, P2518, DOI 10.1073/pnas.0307318101; Mayer DCG, 2002, J EXP MED, V196, P1523, DOI 10.1084/jem.20020750; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; Reiling L, 2010, J IMMUNOL, V185, P6157, DOI 10.4049/jimmunol.1001555; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Taylor HM, 2002, INFECT IMMUN, V70, P5779, DOI 10.1128/IAI.70.10.5779-5789.2002; Taylor HM, 2001, INFECT IMMUN, V69, P3635, DOI 10.1128/IAI.69.6.3635-3645.2001; Tham WH, 2009, INFECT IMMUN, V77, P2427, DOI 10.1128/IAI.00048-09; Triglia T, 2005, MOL MICROBIOL, V55, P162, DOI 10.1111/j.1365-2958.2004.04388.x; Triglia T, 2001, MOL BIOCHEM PARASIT, V116, P55, DOI 10.1016/S0166-6851(01)00303-6; Triglia T, 2001, INFECT IMMUN, V69, P1084, DOI 10.1128/IAI.69.2.1084-1092.2001; Triglia T, 2009, CELL MICROBIOL, V11, P1671, DOI 10.1111/j.1462-5822.2009.01358.x	40	52	52	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17102	10.1371/journal.pone.0017102	http://dx.doi.org/10.1371/journal.pone.0017102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386888	Green Published, gold, Green Submitted			2022-12-25	WOS:000287931400028
J	Sartori, SB; Hauschild, M; Bunck, M; Gaburro, S; Landgraf, R; Singewald, N				Sartori, Simone B.; Hauschild, Markus; Bunck, Mirjam; Gaburro, Stefano; Landgraf, Rainer; Singewald, Nicolas			Enhanced Fear Expression in a Psychopathological Mouse Model of Trait Anxiety: Pharmacological Interventions	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; GLUCOCORTICOID-INDUCED IMPAIRMENT; NATIONAL COMORBIDITY SURVEY; C-FOS EXPRESSION; CONDITIONED FEAR; MEMORY RETRIEVAL; POTENTIATED STARTLE; CONTEXTUAL FEAR; INDIVIDUAL-DIFFERENCES; CIRCADIAN MODULATION	The propensity to develop an anxiety disorder is thought to be determined by genetic and environmental factors. Here we investigated the relationship between a genetic predisposition to trait anxiety and experience-based learned fear in a psychopathological mouse model. Male CD-1 mice selectively bred for either high (HAB), or normal (NAB) anxiety-related behaviour on the elevated plus maze were subjected to classical fear conditioning. During conditioning both mouse lines showed increased fear responses as assessed by freezing behaviour. However, 24 h later, HAB mice displayed more pronounced conditioned responses to both a contextual or cued stimulus when compared with NAB mice. Interestingly, 6 h and already 1 h after fear conditioning, freezing levels were high in HAB mice but not in NAB mice. These results suggest that trait anxiety determines stronger fear memory and/or a weaker ability to inhibit fear responses in the HAB line. The enhanced fear response of HAB mice was attenuated by treatment with either the alpha(2,3,5)-subunit selective benzodiazepine partial agonist L-838,417, corticosterone or the selective neurokinin-1 receptor antagonist L-822,429. Overall, the HAB mouse line may represent an interesting model (i) for identifying biological factors underlying misguided conditioned fear responses and (ii) for studying novel anxiolytic pharmacotherapies for patients with fear-associated disorders, including post-traumatic stress disorder and phobias.	[Sartori, Simone B.; Hauschild, Markus; Gaburro, Stefano; Singewald, Nicolas] Univ Innsbruck, Dept Pharmacol & Toxicol, CMBI, A-6020 Innsbruck, Austria; [Sartori, Simone B.; Hauschild, Markus; Gaburro, Stefano; Singewald, Nicolas] Univ Innsbruck, Inst Pharm, A-6020 Innsbruck, Austria; [Bunck, Mirjam; Landgraf, Rainer] Max Planck Inst Psychiat, Dept Behav Neuroendocrinol, D-80804 Munich, Germany	University of Innsbruck; University of Innsbruck; Max Planck Society	Sartori, SB (corresponding author), Univ Innsbruck, Dept Pharmacol & Toxicol, CMBI, A-6020 Innsbruck, Austria.	simone.sartori@uibk.ac.at	Gaburro, Stefano/AAN-3752-2020	Singewald, Nicolas/0000-0002-0166-3370; , Markus/0000-0003-3539-7661; Sartori, Simone B./0000-0002-2396-1838; Gaburro, Stefano/0000-0001-9297-3472	Austrian Science Fund (FWF) [NFN-S102]; University of Innsbruck	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); University of Innsbruck	This work was supported by the Austrian Science Fund (FWF): NFN-S102 to NS and a Young Investigator Funding by the University of Innsbruck to SBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2002, BEHAV BRAIN RES, V133, P351, DOI 10.1016/S0166-4328(02)00020-7; Aerni A, 2004, AM J PSYCHIAT, V161, P1488, DOI 10.1176/appi.ajp.161.8.1488; ASMUNDSON GJG, 1995, BEHAV RES THER, V33, P771, DOI 10.1016/0005-7967(95)00012-M; Atack JR, 2003, CNS NEUROL DISORD-DR, V2, P213, DOI 10.2174/1568007033482841; BARNES CA, 1977, SCIENCE, V197, P91, DOI 10.1126/science.194313; Barrett J, 2009, PSYCHOL MED, V39, P255, DOI 10.1017/S0033291708003516; Bentz D, 2010, J ANXIETY DISORD, V24, P223, DOI 10.1016/j.janxdis.2009.10.011; BLANCHAR.RJ, 1969, J COMP PHYSIOL PSYCH, V68, P129, DOI 10.1037/h0027676; Borta A, 2006, BEHAV BRAIN RES, V166, P271, DOI 10.1016/j.bbr.2005.08.009; Brigman JL, 2009, BEHAV PHARMACOL, V20, P204, DOI 10.1097/FBP.0b013e32830c368c; Bunck M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005129; Burns JW, 2006, EMOTION, V6, P180, DOI 10.1037/1528-3542.6.2.180; Bush DEA, 2007, J TRAUMA STRESS, V20, P413, DOI 10.1002/jts.20261; Busquet P, 2008, LEARN MEMORY, V15, P378, DOI 10.1101/lm.886208; Chambers JA, 2004, J ANXIETY DISORD, V18, P587, DOI 10.1016/j.janxdis.2003.09.001; Chaudhury D, 2005, J BIOL RHYTHM, V20, P225, DOI 10.1177/0748730405276352; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Czeh B, 2006, EXPERT OPIN INV DRUG, V15, P479, DOI 10.1517/13543784.15.5.479; DAVIS A, 2000, AMYGDALA FUNCTIONAL, P213; DAVIS M, 1979, PSYCHOPHARMACOLOGY, V62, P1, DOI 10.1007/BF00426027; de Quervain DJF, 2003, EUR J NEUROSCI, V17, P1296, DOI 10.1046/j.1460-9568.2003.02542.x; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; Defrin R, 2008, PAIN, V138, P450, DOI 10.1016/j.pain.2008.05.006; Diana G, 2007, P NATL ACAD SCI USA, V104, P636, DOI 10.1073/pnas.0610059104; Ebner K, 2006, AMINO ACIDS, V31, P251, DOI 10.1007/s00726-006-0335-9; Ebner K, 2009, CURR PHARM DESIGN, V15, P1647, DOI 10.2174/138161209788168074; EVANS WO, 1961, PSYCHOPHARMACOLOGIA, V2, P318, DOI 10.1007/BF00404119; Falconer D. S, 1996, INTRO QUANTITATIVE G; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Fernandez RI, 2003, P NATL ACAD SCI USA, V100, P14415, DOI 10.1073/pnas.2336172100; Fernandez-Teruel A, 2002, GENOME RES, V12, P618, DOI [10.1101/gr.203402, 10.1101/gr.203402. Article published online before print in March ]; Heim C, 2009, CNS SPECTRUMS, V14, P13; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Kart-Teke E, 2007, NEUROBIOL LEARN MEM, V87, P324, DOI 10.1016/j.nlm.2006.09.007; Keogh E, 2001, EUR J PAIN, V5, P11, DOI 10.1053/eujp.2000.0210; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kraus A, 2009, PAIN, V143, P179, DOI 10.1016/j.pain.2008.12.018; Kromer SA, 2005, J NEUROSCI, V25, P4375, DOI 10.1523/JNEUROSCI.0115-05.2005; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lehner M, 2010, ACTA NEUROBIOL EXP, V70, P56; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Lopez-Aumatell R, 2009, BEHAV BRAIN RES, V202, P92, DOI 10.1016/j.bbr.2009.03.024; Lopez-Aumatell R, 2009, PSICOTHEMA, V21, P27; Maren S, 2008, EUR J NEUROSCI, V28, P1661, DOI 10.1111/j.1460-9568.2008.06485.x; Marschner A, 2008, J NEUROSCI, V28, P9030, DOI 10.1523/JNEUROSCI.1651-08.2008; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Mikics E, 2006, BEHAV PHARMACOL, V17, P223; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Muigg P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005346; Muigg P, 2008, EUR J NEUROSCI, V28, P2299, DOI 10.1111/j.1460-9568.2008.06511.x; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pape HC, 2003, ANN NY ACAD SCI, V985, P92; Pavlov I.P., 1927, CONDITIONED REFLEXES; PITMAN RK, 1990, ARCH GEN PSYCHIAT, V47, P541; Ponder CA, 2007, GENES BRAIN BEHAV, V6, P736, DOI 10.1111/j.1601-183X.2007.00306.x; Risbrough VB, 2003, NEUROPSYCHOPHARMACOL, V28, P654, DOI 10.1038/sj.npp.1300079; Roeska K, 2009, NEUROSCI LETT, V464, P160, DOI 10.1016/j.neulet.2009.08.031; Roozendaal B, 2004, NEUROBIOL LEARN MEM, V81, P150, DOI 10.1016/j.nlm.2003.10.001; Roozendaal B, 2004, J NEUROSCI, V24, P8161, DOI 10.1523/JNEUROSCI.2574-04.2004; Roozendaal B, 2003, P NATL ACAD SCI USA, V100, P1328, DOI 10.1073/pnas.0337480100; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sandi C, 2009, TRENDS NEUROSCI, V32, P312, DOI 10.1016/j.tins.2009.02.004; Santos JM, 2005, EUR NEUROPSYCHOPHARM, V15, P239, DOI 10.1016/j.euroneuro.2004.10.004; Singewald N, 2008, J NEUROCHEM, V106, P2476, DOI 10.1111/j.1471-4159.2008.05596.x; Skorzewska A, 2007, HORM BEHAV, V52, P317, DOI 10.1016/j.yhbeh.2007.05.007; Skorzewska A, 2006, PHARMACOL BIOCHEM BE, V85, P522, DOI 10.1016/j.pbb.2006.10.001; Soravia LM, 2006, P NATL ACAD SCI USA, V103, P5585, DOI 10.1073/pnas.0509184103; Talbot CJ, 2003, MAMM GENOME, V14, P223, DOI 10.1007/s00335-002-3059-5; Thompson BL, 2004, BEHAV BRAIN RES, V149, P209, DOI 10.1016/S0166-4328(03)00216-X; Valentinuzzi VS, 1998, LEARN MEMORY, V5, P391; Watson JB, 1920, J EXP PSYCHOL, V3, P1, DOI 10.1037/h0069608; Wittmann W, 2009, NEUROPSYCHOPHARMACOL, V34, P775, DOI 10.1038/npp.2008.142; Wolf OT, 2004, ANN NY ACAD SCI, V1032, P195, DOI 10.1196/annals.1314.019; Xu K, 2006, NEUROINFORMATICS, V4, P51, DOI 10.1385/NI:4:1:51; Yehuda R, 2004, PSYCHIATRY, V67, P391, DOI 10.1521/psyc.67.4.391.56572	82	39	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16849	10.1371/journal.pone.0016849	http://dx.doi.org/10.1371/journal.pone.0016849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386891	Green Published, gold			2022-12-25	WOS:000287931400013
J	Liljander, A; Bejon, P; Mwacharo, J; Kai, O; Ogada, E; Peshu, N; Marsh, K; Farnert, A				Liljander, Anne; Bejon, Philip; Mwacharo, Jedidah; Kai, Oscar; Ogada, Edna; Peshu, Norbert; Marsh, Kevin; Faernert, Anna			Clearance of Asymptomatic P. falciparum Infections Interacts with the Number of Clones to Predict the Risk of Subsequent Malaria in Kenyan Children	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CLINICAL MALARIA; REDUCED RISK; TRANSMISSION; COMPLEXITY; IMMUNITY; AGE; RESPONSES; EPIDEMIOLOGY; POPULATION	Background: Protective immunity to malaria is acquired after repeated infections in endemic areas. Asymptomatic multiclonal P. falciparum infections are common and may predict host protection. Here, we have investigated the effect of clearing asymptomatic infections on the risk of clinical malaria. Methods: Malaria episodes were continuously monitored in 405 children (1-6 years) in an area of moderate transmission, coastal Kenya. Blood samples collected on four occasions were assessed by genotyping the polymorphic P. falciparum merozoite surface protein 2 using fluorescent PCR and capillary electrophoresis. Following the second survey, asymptomatic infections were cleared with a full course of dihydroartemisinin. Results: Children who were parasite negative by PCR had a lower risk of subsequent malaria regardless of whether treatment had been given. Children with >= 2 clones had a reduced risk of febrile malaria compared with 1 clone after clearance of asymptomatic infections, but not if asymptomatic infections were not cleared. Multiclonal infection was associated with an increased risk of re-infection after drug treatment. However, among the children who were re-infected, multiclonal infections were associated with a shift from clinical malaria to asymptomatic parasitaemia. Conclusion: The number of clones was associated with exposure as well as blood stage immunity. These effects were distinguished by clearing asymptomatic infection with anti-malarials. Exposure to multiple P. falciparum infections is associated with protective immunity, but there appears to be an additional effect in untreated multiclonal infections that offsets this protective effect.	[Liljander, Anne; Faernert, Anna] Karolinska Inst, Infect Dis Unit, Dept Med Solna, Stockholm, Sweden; [Bejon, Philip; Mwacharo, Jedidah; Kai, Oscar; Ogada, Edna; Peshu, Norbert; Marsh, Kevin] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Bejon, Philip; Marsh, Kevin] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	Karolinska Institutet; Kenya Medical Research Institute; University of Oxford	Liljander, A (corresponding author), Karolinska Inst, Infect Dis Unit, Dept Med Solna, Stockholm, Sweden.	Anna.Farnert@ki.se		Farnert, Anna/0000-0001-7583-282X; Ogada, Edna/0000-0003-0181-2505	Swedish International Development Agency; Anna Whitlocks Foundation; Erik and Edith Fernstroms Foundation; Sigurd and Elsa Goljes Foundation; Swedish Society for Tropical Medicine and International Health; NIHR Biomedical Research Centre Oxford	Swedish International Development Agency; Anna Whitlocks Foundation; Erik and Edith Fernstroms Foundation; Sigurd and Elsa Goljes Foundation; Swedish Society for Tropical Medicine and International Health; NIHR Biomedical Research Centre Oxford(National Institute for Health Research (NIHR))	The project was supported by the Swedish International Development Agency, Anna Whitlocks Foundation, Erik and Edith Fernstroms Foundation, Sigurd and Elsa Goljes Foundation and the Swedish Society for Tropical Medicine and International Health. Philip Bejon is supported by the NIHR Biomedical Research Centre Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; AlYaman F, 1997, T ROY SOC TROP MED H, V91, P602, DOI 10.1016/S0035-9203(97)90046-8; Bejon P, 2007, J IMMUNOL, V179, P4193, DOI 10.4049/jimmunol.179.6.4193; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; Bejon P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000707; Bejon P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008321; Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; Bendixen M, 2001, T ROY SOC TROP MED H, V95, P143, DOI 10.1016/S0035-9203(01)90140-3; Bereczky S, 2007, MICROBES INFECT, V9, P103, DOI 10.1016/j.micinf.2006.10.014; Branch OH, 2001, INFECT IMMUN, V69, P7783, DOI 10.1128/IAI.69.12.7783-7792.2001; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Farnert A, 1999, J INFECT DIS, V179, P989, DOI 10.1086/314652; Farnert A, 2001, T ROY SOC TROP MED H, V95, P225, DOI 10.1016/S0035-9203(01)90175-0; Farnert A, 2008, TRENDS PARASITOL, V24, P340, DOI 10.1016/j.pt.2008.04.008; Farnert A, 2009, J INFECT DIS, V200, P1166, DOI 10.1086/605652; FRUH K, 1991, INFECT IMMUN, V59, P1319; Greenwood BM, 1995, T ROY SOC TROP MED H, V89, P629, DOI 10.1016/0035-9203(95)90419-0; Henning L, 2004, T ROY SOC TROP MED H, V98, P687, DOI 10.1016/j.trstmh.2004.03.010; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Konate L, 1999, T ROY SOC TROP MED H, V93, pS21, DOI 10.1016/S0035-9203(99)90323-1; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Liljander A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013649; Liljander A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-78; Mayor A, 2003, TROP MED INT HEALTH, V8, P3, DOI 10.1046/j.1365-3156.2003.00968.x; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; NTOUMI F, 1995, AM J TROP MED HYG, V52, P81, DOI 10.4269/ajtmh.1995.52.81; Osier FHA, 2007, PARASITE IMMUNOL, V29, P387, DOI 10.1111/j.1365-3024.2007.00951.x; OTOO LN, 1988, T ROY SOC TROP MED H, V82, P59, DOI 10.1016/0035-9203(88)90263-5; OTOO LN, 1989, T ROY SOC TROP MED H, V83, P778, DOI 10.1016/0035-9203(89)90324-6; Owusu-Agyei S, 2002, TROP MED INT HEALTH, V7, P421, DOI 10.1046/j.1365-3156.2002.00881.x; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Roper C, 1998, PARASITOLOGY, V116, P501, DOI 10.1017/S0031182098002650; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Zwetyenga J, 1998, AM J TROP MED HYG, V59, P726, DOI 10.4269/ajtmh.1998.59.726	36	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16940	10.1371/journal.pone.0016940	http://dx.doi.org/10.1371/journal.pone.0016940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383984	Green Published, gold, Green Submitted			2022-12-25	WOS:000287761700021
J	Tumurbaatar, I; Cizmecioglu, O; Hoffmann, I; Grummt, I; Voit, R				Tumurbaatar, Indra; Cizmecioglu, Onur; Hoffmann, Ingrid; Grummt, Ingrid; Voit, Renate			Human Cdc14B Promotes Progression through Mitosis by Dephosphorylating Cdc25 and Regulating Cdk1/Cyclin B Activity	PLOS ONE			English	Article							RIBOSOMAL-RNA SYNTHESIS; MITOTIC EXIT; INHIBITORY PHOSPHORYLATION; CHROMOSOME SEGREGATION; PHOSPHATASE CDC14B; CDK1; DEGRADATION; TRANSITION	Entry into and progression through mitosis depends on phosphorylation and dephosphorylation of key substrates. In yeast, the nucleolar phosphatase Cdc14 is pivotal for exit from mitosis counteracting Cdk1-dependent phosphorylations. Whether hCdc14B, the human homolog of yeast Cdc14, plays a similar function in mitosis is not yet known. Here we show that hCdc14B serves a critical role in regulating progression through mitosis, which is distinct from hCdc14A. Unscheduled overexpression of hCdc14B delays activation of two master regulators of mitosis, Cdc25 and Cdk1, and slows down entry into mitosis. Depletion of hCdc14B by RNAi prevents timely inactivation of Cdk1/cyclin B and dephosphorylation of Cdc25, leading to severe mitotic defects, such as delay of metaphase/anaphase transition, lagging chromosomes, multipolar spindles and binucleation. The results demonstrate that hCdc14B-dependent modulation of Cdc25 phosphatase and Cdk1/cyclin B activity is tightly linked to correct chromosome segregation and bipolar spindle formation, processes that are required for proper progression through mitosis and maintenance of genomic stability.	[Tumurbaatar, Indra; Grummt, Ingrid; Voit, Renate] German Canc Res Ctr, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Tumurbaatar, I (corresponding author), German Canc Res Ctr, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany.	r.voit@dkfz.de	Cizmecioglu, Onur/AAA-6289-2020; Cizmecioglu, Onur/AAF-5874-2020	Cizmecioglu, Onur/0000-0002-7608-6950	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie; DKFZ	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); DKFZ(Helmholtz Association)	This work was supported by the Deutsche Forschungsgemeinschaft, the Fonds der Chemischen Industrie, and the Intramural Program (DKFZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Berdougo E, 2008, CELL CYCLE, V7, P1184, DOI 10.4161/cc.7.9.5792; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Cho HP, 2005, MOL CELL BIOL, V25, P4541, DOI 10.1128/MCB.25.11.4541-4551.2005; D'Amours D, 2004, GENE DEV, V18, P2581, DOI 10.1101/gad.1247304; D'Angiolella V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000247; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Esteban V, 2006, CELL CYCLE, V5, P2894, DOI 10.4161/cc.5.24.3566; Gray CH, 2003, EMBO J, V22, P3524, DOI 10.1093/emboj/cdg348; Hassepass I, 2003, J BIOL CHEM, V278, P29824, DOI 10.1074/jbc.M302704200; Hassepass Ingo, 2004, Methods Mol Biol, V281, P153; Heix J, 1998, EMBO J, V17, P7373, DOI 10.1093/emboj/17.24.7373; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Hoppe S, 2009, P NATL ACAD SCI USA, V106, P17781, DOI 10.1073/pnas.0909873106; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Lammer C, 1998, J CELL SCI, V111, P2445; Lanzetti L, 2007, J BIOL CHEM, V282, P15258, DOI 10.1074/jbc.M700914200; Li LW, 2000, J BIOL CHEM, V275, P2410, DOI 10.1074/jbc.275.4.2410; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Mocciaro A, 2010, J CELL BIOL, V189, P631, DOI 10.1083/jcb.200910057; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Potapova TA, 2009, MOL BIOL CELL, V20, P1737, DOI 10.1091/mbc.E08-07-0771; Rodier G, 2008, EMBO J, V27, P679, DOI 10.1038/emboj.2008.6; Rosso L, 2008, PLOS BIOL, V6, P1281, DOI 10.1371/journal.pbio.0060140; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Schokraie E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009502; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Tanguay PL, 2010, BIOCHEM J, V428, P103, DOI 10.1042/BJ20091604; Timofeev O, 2010, J BIOL CHEM, V285, P16978, DOI 10.1074/jbc.M109.096552; Trinkle-Mulcahy L, 2006, CURR OPIN CELL BIOL, V18, P623, DOI 10.1016/j.ceb.2006.09.001; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Wolfe BA, 2004, EMBO J, V23, P919, DOI 10.1038/sj.emboj.7600103; Wu J, 2008, J CELL BIOL, V181, P475, DOI 10.1083/jcb.200710127	50	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e14711	10.1371/journal.pone.0014711	http://dx.doi.org/10.1371/journal.pone.0014711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379580	Green Submitted, gold, Green Published			2022-12-25	WOS:000287482300011
J	Dery, KJ; Gaur, S; Gencheva, M; Yen, Y; Shively, JE; Gaur, RK				Dery, Kenneth J.; Gaur, Shikha; Gencheva, Marieta; Yen, Yun; Shively, John E.; Gaur, Rajesh K.			Mechanistic Control of Carcinoembryonic Antigen-related Cell Adhesion Molecule-1 (CEACAM1) Splice Isoforms by the Heterogeneous Nuclear Ribonuclear Proteins hnRNP L, hnRNP A1, and hnRNP M	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT CYTOPLASMIC DOMAIN; RNA-BINDING PROTEINS; MESSENGER-RNA; CANCER-CELLS; SR PROTEINS; THERAPEUTIC TARGET; C-CAM; FAMILY; EXPRESSION; APOPTOSIS	Carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) is expressed in a variety of cell types and is implicated in carcinogenesis. Alternative splicing of CEACAM1 pre-mRNA generates two cytoplasmic domain splice variants characterized by the inclusion (L-isoform) or exclusion (S-isoform) of exon 7. Here we show that the alternative splicing of CEACAM1 pre-mRNA is regulated by novel cis elements residing in exon 7. We report the presence of three exon regulatory elements that lead to the inclusion or exclusion of exon 7 CEACAM1 mRNA in ZR75 breast cancer cells. Heterologous splicing reporter assays demonstrated that the maintenance of authentic alternative splicing mechanisms were independent of the CEACAM1 intron sequence context. We show that forced expression of these exon regulatory elements could alter CEACAM1 splicing in HEK-293 cells. Using RNA affinity chromatography, three members of the heterogeneous nuclear ribonucleoprotein family (hnRNP L, hnRNP A1, and hnRNP M) were identified. RNA immunoprecipitation of hnRNP L and hnRNP A1 revealed a binding motif located central and 3' to exon 7, respectively. Depletion of hnRNP A1 or L by RNAi in HEK-293 cells promoted exon 7 inclusion, whereas overexpression led to exclusion of the variable exon. By contrast, overexpression of hnRNP M showed exon 7 inclusion and production of CEACAM1-L mRNA. Finally, stress-induced cytoplasmic accumulation of hnRNP A1 in MDA-MB-468 cells dynamically alters the CEACAM1-S: CEACAM1: L ratio in favor of the L-isoform. Thus, we have elucidated the molecular factors that control the mechanism of splice-site recognition in the alternative splicing regulation of CEACAM1.	[Dery, Kenneth J.; Gencheva, Marieta; Shively, John E.] Beckman Res Inst City Hope, Dept Immunol, Duarte, CA 91010 USA; [Gaur, Rajesh K.] Beckman Res Inst City Hope, Dept Mol & Cellular Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Shively, JE (corresponding author), Beckman Res Inst City Hope, Dept Immunol, 1450 E Duarte Rd, Duarte, CA 91010 USA.	JShively@coh.org; rkg@caltech.edu			National Institutes of Health [CA84202]; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA84202.	Aarons CB, 2007, CLIN EXP METASTAS, V24, P201, DOI 10.1007/s10585-007-9069-7; Akerman M, 2006, NUCLEIC ACIDS RES, V34, P23, DOI 10.1093/nar/gkj408; BARNETT TR, 1993, MOL CELL BIOL, V13, P1273, DOI 10.1128/MCB.13.2.1273; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BRUMMER J, 1995, ONCOGENE, V11, P1649; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; Chen T, 2001, J LEUKOCYTE BIOL, V70, P335; Cloutier P, 2008, J BIOL CHEM, V283, P21315, DOI 10.1074/jbc.M800353200; COBIANCHI F, 1988, J BIOL CHEM, V263, P1063; Dery KJ, 2009, METHODS MOL BIOL, V555, P127, DOI 10.1007/978-1-60327-295-7_10; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Edlund M, 1998, FEBS LETT, V425, P166, DOI 10.1016/S0014-5793(98)00222-1; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Gangopadhyay A, 1996, ARCH BIOCHEM BIOPHYS, V334, P151, DOI 10.1006/abbi.1996.0440; Garcia-Blanco MA, 2006, PROG MOLEC, V44, P47; Gaur S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-46; Graveley BR, 1998, EMBO J, V17, P6747, DOI 10.1093/emboj/17.22.6747; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Griffith BN, 2006, BBA-GENE STRUCT EXPR, V1759, P552, DOI 10.1016/j.bbaexp.2006.10.001; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Hamilton BJ, 1999, BIOCHEM BIOPH RES CO, V261, P646, DOI 10.1006/bbrc.1999.1040; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hovhannisyan RH, 2007, J BIOL CHEM, V282, P36265, DOI 10.1074/jbc.M704188200; HSIEH JT, 1995, CANCER RES, V55, P190; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Kamma H, 1999, EXP CELL RES, V246, P399, DOI 10.1006/excr.1998.4323; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; Kim DS, 2005, RNA, V11, P1667, DOI 10.1261/rna.2162205; Kim JH, 2000, J MOL BIOL, V298, P395, DOI 10.1006/jmbi.2000.3687; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; KONARSKA MM, 1986, CELL, V46, P845, DOI 10.1016/0092-8674(86)90066-8; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Laguinge L, 2005, ANTICANCER RES, V25, P23; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Ma YL, 2009, J PROTEOME RES, V8, P4525, DOI 10.1021/pr900365e; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Matter N, 2000, J BIOL CHEM, V275, P35353, DOI 10.1074/jbc.M004692200; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; MCCUAIG K, 1992, CELL GROWTH DIFFER, V3, P165; Miriami E, 2003, NUCLEIC ACIDS RES, V31, P1974, DOI 10.1093/nar/gkg279; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Nayler O, 2000, J CELL BIOL, V150, P949, DOI 10.1083/jcb.150.5.949; Nittka S, 2004, ONCOGENE, V23, P9306, DOI 10.1038/sj.onc.1208259; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; Okunola HL, 2009, MOL CELL BIOL, V29, P5620, DOI 10.1128/MCB.01678-08; Orengo JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl967; Patry C, 2003, CANCER RES, V63, P7679; Pozzoli U, 2005, CELL MOL LIFE SCI, V62, P1579, DOI 10.1007/s00018-005-5030-6; Riethdorf L, 1997, J HISTOCHEM CYTOCHEM, V45, P957, DOI 10.1177/002215549704500705; Schumann D, 2001, J BIOL CHEM, V276, P47421, DOI 10.1074/jbc.M109110200; SHIVELY JE, 1985, CRC CR REV ONCOL-HEM, V2, P355, DOI 10.1016/S1040-8428(85)80008-1; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; Suyama M, 2010, NUCLEIC ACIDS RES, V38, P7916, DOI 10.1093/nar/gkq705; Szeszel-Fedorowicz W, 2006, J BIOL CHEM, V281, P34146, DOI 10.1074/jbc.M603825200; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	68	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.204057	http://dx.doi.org/10.1074/jbc.M110.204057			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21398516	Green Published, hybrid			2022-12-25	WOS:000290022800044
J	Giral, H; Lanzano, L; Caldas, Y; Blaine, J; Verlander, JW; Lei, T; Gratton, E; Levi, M				Giral, Hector; Lanzano, Luca; Caldas, Yupanqui; Blaine, Judith; Verlander, Jill W.; Lei, Tim; Gratton, Enrico; Levi, Moshe			Role of PDZK1 Protein in Apical Membrane Expression of Renal Sodium-coupled Phosphate Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULE CELLS; P-I COTRANSPORTER; NAPI-IIA; TARGETED DISRUPTION; PARATHYROID-HORMONE; IMAGING MICROSCOPY; ADAPTER PROTEINS; OK CELLS; MOUSE; NHERF	The sodium-dependent phosphate (Na/P-i) transporters NaPi-2a and NaPi-2c play a major role in the renal reabsorption of P-i. The functional need for several transporters accomplishing the same role is still not clear. However, the fact that these transporters show differential regulation under dietary and hormonal stimuli suggests different roles in P-i reabsorption. The pathways controlling this differential regulation are still unknown, but one of the candidates involved is the NHERF family of scaffolding PDZ proteins. We propose that differences in the molecular interaction with PDZ proteins are related with the differential adaptation of Na/P-i transporters. Pdzk1(-/-) mice adapted to chronic low P-i diets showed an increased expression of NaPi-2a protein in the apical membrane of proximal tubules but impaired up-regulation of NaPi-2c. These results suggest an important role for PDZK1 in the stabilization of NaPi-2c in the apical membrane. We studied the specific protein-protein interactions of Na/P-i transporters with NHERF-1 and PDZK1 by FRET. FRET measurements showed a much stronger interaction of NHERF-1 with NaPi-2a than with NaPi-2c. However, both Na/P-i transporters showed similar FRET efficiencies with PDZK1. Interestingly, in cells adapted to low P-i concentrations, there were increases in NaPi-2c/PDZK1 and NaPi-2a/NHERF-1 interactions. The differential affinity of the Na/P-i transporters for NHERF-1 and PDZK1 proteins could partially explain their differential regulation and/or stability in the apical membrane. In this regard, direct interaction between NaPi-2c and PDZK1 seems to play an important role in the physiological regulation of NaPi-2c.	[Giral, Hector; Caldas, Yupanqui; Blaine, Judith; Levi, Moshe] Univ Colorado, Dept Med, Aurora, CO 80045 USA; [Lanzano, Luca; Gratton, Enrico] Univ Calif Irvine, Fluorescence Dynam Lab, Irvine, CA 92697 USA; [Verlander, Jill W.] Univ Florida, Dept Med, Div Nephrol Hypertens & Transplantat, Gainesville, FL 32610 USA; [Lei, Tim] Univ Colorado, Dept Elect Engn, Denver, CO 80202 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Irvine; State University System of Florida; University of Florida; University of Colorado System; University of Colorado Denver	Levi, M (corresponding author), Univ Colorado Denver, 12700 E 19th Ave,Res 2,Rm 7002, Aurora, CO 80045 USA.	Moshe.Levi@ucdenver.edu	Verlander, Jill/I-5991-2015	Levi, Moshe/0000-0002-6225-946X; Lanzano', Luca/0000-0001-6539-394X	National Institutes of Health [R01 DK066029, P41-RRO3155, P50-GM076516, K08 DK080989]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066029, K08DK080989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK066029 (M.L., Y.C., L.L., H.G., and E.G.), P41-RRO3155 (to E.G. and L.L.), P50-GM076516 (to E.G. and L.L.), and K08 DK080989 (to J.B.).	Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Blaine J, 2009, AM J PHYSIOL-CELL PH, V297, pC1339, DOI 10.1152/ajpcell.00260.2009; Breusegem SY, 2009, AM J PHYSIOL-RENAL, V297, pF350, DOI 10.1152/ajprenal.90765.2008; Breusegem SY, 2005, AM J PHYSIOL-RENAL, V289, pF154, DOI 10.1152/ajprenal.00331.2004; Caiolfa VR, 2007, J CELL BIOL, V179, P1067, DOI 10.1083/jcb.200702151; Capuano P, 2005, PFLUG ARCH EUR J PHY, V449, P392, DOI 10.1007/s00424-004-1351-9; Clayton AHA, 2004, J MICROSC-OXFORD, V213, P1, DOI 10.1111/j.1365-2818.2004.01265.x; COLE JA, 1989, AM J PHYSIOL, V256, pF672, DOI 10.1152/ajprenal.1989.256.4.F672; Colyer RA, 2008, MICROSC RES TECHNIQ, V71, P201, DOI 10.1002/jemt.20540; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Cunningham R, 2006, AM J PHYSIOL-RENAL, V291, pF896, DOI 10.1152/ajprenal.00036.2006; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Dobrinskikh E, 2010, AM J PHYSIOL-CELL PH, V299, pC1324, DOI 10.1152/ajpcell.00183.2010; Forster IC, 2002, PROG BIOPHYS MOL BIO, V80, P69, DOI 10.1016/S0079-6107(02)00015-9; Gisler SM, 2003, KIDNEY INT, V64, P1733, DOI 10.1046/j.1523-1755.2003.00266.x; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; GRATTON E, 1984, ANNU REV BIOPHYS BIO, V13, P105; Hernando N, 2005, J PHYSIOL-LONDON, V567, P21, DOI 10.1113/jphysiol.2005.087049; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Hoag HM, 1999, J CLIN INVEST, V104, P679, DOI 10.1172/JCI7103; Kato Y, 2006, EUR J PHARM SCI, V27, P487, DOI 10.1016/j.ejps.2005.11.006; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Lan DB, 2005, J BIOL CHEM, V280, P23390, DOI 10.1074/jbc.M502777200; Lanaspa MA, 2007, AM J PHYSIOL-RENAL, V292, pF230, DOI 10.1152/ajprenal.00075.2006; Levi M, 1996, J MEMBRANE BIOL, V154, P1, DOI 10.1007/s002329900127; LEVI M, 1994, AM J PHYSIOL-RENAL, V267, pF900, DOI 10.1152/ajprenal.1994.267.5.F900; Lotscher M, 1997, J CLIN INVEST, V99, P1302, DOI 10.1172/JCI119289; McWilliams RR, 2005, AM J PHYSIOL-CELL PH, V289, pC1042, DOI 10.1152/ajpcell.00568.2004; Miyamoto KI, 2007, AM J NEPHROL, V27, P503, DOI 10.1159/000107069; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Redford GI, 2005, J FLUORESC, V15, P805, DOI 10.1007/s10895-005-2990-8; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Segawa H, 2005, AM J PHYSIOL-RENAL, V288, pF587, DOI 10.1152/ajprenal.00097.2004; Segawa H, 2002, J BIOL CHEM, V277, P19665, DOI 10.1074/jbc.M200943200; Segawa H, 2007, AM J PHYSIOL-RENAL, V292, pF395, DOI 10.1152/ajprenal.00100.2006; Seidler U, 2009, EXP PHYSIOL, V94, P175, DOI 10.1113/expphysiol.2008.043018; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Suhling K, 2005, PHOTOCH PHOTOBIO SCI, V4, P13, DOI 10.1039/b412924p; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Villa-Bellosta R, 2008, KIDNEY INT, V73, P456, DOI 10.1038/sj.ki.5002703; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Weinman EJ, 2005, PFLUG ARCH EUR J PHY, V450, P137, DOI 10.1007/s00424-005-1384-8; Weinman EJ, 2003, AM J PHYSIOL-RENAL, V285, pF1225, DOI 10.1152/ajprenal.00215.2003; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5	47	38	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15032	15042		10.1074/jbc.M110.199752	http://dx.doi.org/10.1074/jbc.M110.199752			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21388960	hybrid, Green Published			2022-12-25	WOS:000289788300033
J	Chang, HY; Jennings, PC; Stewart, J; Verrills, NM; Jones, KT				Chang, Heng-Yu; Jennings, Phoebe C.; Stewart, Jessica; Verrills, Nicole M.; Jones, Keith T.			Essential Role of Protein Phosphatase 2A in Metaphase II Arrest and Activation of Mouse Eggs Shown by Okadaic Acid, Dominant Negative Protein Phosphatase 2A, and FTY720	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERMINAL VESICLE BREAKDOWN; CELL-CYCLE PROGRESSION; XENOPUS-LAEVIS EGGS; MEIOTIC ARREST; MICROTUBULE DYNAMICS; CYTOSTATIC FACTOR; MAPK PATHWAY; MEIOSIS-II; CHROMOSOME CONDENSATION; LYMPHOCYTIC-LEUKEMIA	Vertebrate eggs arrest at second meiotic metaphase. The fertilizing sperm causes meiotic exit through Ca2+-mediated activation of the anaphase-promoting complex/cyclosome (APC/C). Although the loss in activity of the M-phase kinase CDK1 is known to be an essential downstream event of this process, the contribution of phosphatases to arrest and meiotic resumption is less apparent, especially in mammals. Therefore, we explored the role of protein phosphatase 2A (PP2A) in mouse eggs using pharmacological inhibition and activation as well as a functionally dominant-negative catalytic PP2A subunit (dn-PP2Ac-L199P) coupled with live cell imaging. We observed that PP2A inhibition using okadaic acid induced events normally observed at fertilization: degradation of the APC/C substrates cyclin B1 and securin resulting from loss of the APC/C inhibitor Emi2. Although sister chromatids separated, chromatin remained condensed, and polar body extrusion was blocked as a result of a rapid spindle disruption, which could be ameliorated by non-degradable cyclin B1, suggesting that spindle integrity was affected by CDK1 loss. Similar cell cycle effects to okadaic acid were also observed using dominant-negative PP2Ac. Preincubation of eggs with the PP2A activator FTY720 could block many of the actions of okadaic acid, including Emi2, cyclin B1, and securin degradation and sister chromatid separation. Therefore, in conclusion, we used okadaic acid, dn-PP2Ac-L199P, and FTY720 on mouse eggs to demonstrate that PP2A is needed to for both continued metaphase arrest and successful exit from meiosis.	[Chang, Heng-Yu; Jennings, Phoebe C.; Stewart, Jessica; Verrills, Nicole M.; Jones, Keith T.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia	University of Newcastle	Jones, KT (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia.	keith.jones@newcastle.edu.au	Jones, Keith/C-9821-2013; Jones, Keith/AAA-3479-2021	Jones, Keith/0000-0002-0294-0851; Jones, Keith/0000-0002-0294-0851; Barnes, Jessica/0000-0002-5386-4123; Verrills, Nicole/0000-0002-7894-0137	Australian Research Council [DP0986217]	Australian Research Council(Australian Research Council)	This work was funded by Australian Research Council Discovery Project Grant DP0986217 (to K. T. J.).	Andersen SSL, 1997, NATURE, V389, P640, DOI 10.1038/39382; Arrighi CD, 2000, BIOL REPROD, V63, P658, DOI 10.1095/biolreprod63.2.658; BosMikich A, 1997, DEV BIOL, V182, P172, DOI 10.1006/dbio.1996.8468; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; Chang HY, 2009, DEVELOPMENT, V136, P4077, DOI 10.1242/dev.042143; Chang HY, 2004, J CELL SCI, V117, P6289, DOI 10.1242/jcs.01567; COLLEDGE WH, 1994, NATURE, V370, P65, DOI 10.1038/370065a0; DEPENNART H, 1993, DEV BIOL, V157, P170, DOI 10.1006/dbio.1993.1121; Di Agostino S, 2002, DEVELOPMENT, V129, P1715; Ducibella T, 2006, SEMIN CELL DEV BIOL, V17, P324, DOI 10.1016/j.semcdb.2006.02.010; DYBAN AP, 1993, MOL REPROD DEV, V34, P402, DOI 10.1002/mrd.1080340409; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Evans DRH, 2000, GENETICS, V156, P21; Evans DRH, 1999, J BIOL CHEM, V274, P24038, DOI 10.1074/jbc.274.34.24038; GAVIN AC, 1994, J CELL SCI, V107, P275; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; HASHIMOTO N, 1994, NATURE, V370, P68, DOI 10.1038/370068a0; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; Holland AJ, 2006, J CELL SCI, V119, P3325, DOI 10.1242/jcs.03083; Holt JE, 2010, DEVELOPMENT, V137, P1297, DOI 10.1242/dev.047555; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; Jones KT, 2005, REPRODUCTION, V130, P813, DOI 10.1530/rep.1.00710; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; KUBIAK JZ, 1993, EMBO J, V12, P3773, DOI 10.1002/j.1460-2075.1993.tb06055.x; Lane SIR, 2010, REPRODUCTION, V140, P521, DOI 10.1530/REP-10-0223; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; Liu Q, 2008, BLOOD, V111, P275, DOI 10.1182/blood-2006-10-053884; Madgwick S, 2005, J CELL SCI, V118, P3849, DOI 10.1242/jcs.02506; Madgwick S, 2004, DEV BIOL, V275, P68, DOI 10.1016/j.ydbio.2004.07.024; Madgwick S, 2006, J CELL BIOL, V174, P791, DOI 10.1083/jcb.200604140; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Matsuoka Y, 2003, BRIT J PHARMACOL, V138, P1303, DOI 10.1038/sj.bjp.0705182; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; MOOS J, 1995, BIOL REPROD, V53, P692, DOI 10.1095/biolreprod53.3.692; Nabti I, 2008, DEV BIOL, V321, P379, DOI 10.1016/j.ydbio.2008.06.036; Neviani P, 2007, J CLIN INVEST, V117, P2408, DOI 10.1172/JCI31095; Nishiyama T, 2007, NATURE, V449, P341, DOI 10.1038/nature06136; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; Nixon VL, 2000, BIOL CELL, V92, P187, DOI 10.1016/S0248-4900(00)01068-6; Ookata K, 1997, BIOCHEMISTRY-US, V36, P15873, DOI 10.1021/bi971251w; Perry ACF, 2008, EMBO REP, V9, P246, DOI 10.1038/embor.2008.22; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Phillips KP, 2002, MOL BIOL CELL, V13, P3800, DOI 10.1091/mbc.E02-04-0242; Reis A, 2006, NAT CELL BIOL, V8, P539, DOI 10.1038/ncb1406; Reis A, 2007, NAT CELL BIOL, V9, P1192, DOI 10.1038/ncb1640; Reis A, 2006, EMBO REP, V7, P1040, DOI 10.1038/sj.embor.7400772; RIME H, 1990, DEV BIOL, V141, P115, DOI 10.1016/0012-1606(90)90106-S; Roberts KG, 2010, CANCER RES, V70, P5438, DOI 10.1158/0008-5472.CAN-09-2544; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Sanhaji M, 2010, MOL CELL BIOL, V30, P2594, DOI 10.1128/MCB.00098-10; Schmidt A, 2006, J CELL SCI, V119, P1213, DOI 10.1242/jcs.02919; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shiina N, 1999, MOL BIOL CELL, V10, P597, DOI 10.1091/mbc.10.3.597; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Suzuki T, 2010, DEVELOPMENT, V137, P3281, DOI 10.1242/dev.052480; Swain JE, 2007, BIOL REPROD, V76, P628, DOI 10.1095/biolreprod.106.055798; Swain JE, 2003, MOL REPROD DEV, V65, P96, DOI 10.1002/mrd.10258; Tang WL, 2008, MOL BIOL CELL, V19, P3536, DOI 10.1091/mbc.E08-04-0417; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; Vasquez RJ, 1999, CELL MOTIL CYTOSKEL, V43, P310, DOI 10.1002/(SICI)1097-0169(1999)43:4<310::AID-CM4>3.3.CO;2-A; Vigneron S, 2009, EMBO J, V28, P2786, DOI 10.1038/emboj.2009.228; Wang L, 2008, DEV BIOL, V313, P155, DOI 10.1016/j.ydbio.2007.10.009; Wang X, 2004, REPRODUCTION, V128, P493, DOI 10.1530/rep.1.00173; Wu JQ, 2008, J CELL SCI, V121, P3509, DOI 10.1242/jcs.036855; Wu JQ, 2007, P NATL ACAD SCI USA, V104, P16564, DOI 10.1073/pnas.0707537104; Wu QJ, 2007, CURR BIOL, V17, P213, DOI 10.1016/j.cub.2006.12.045; Yang KT, 2010, MOL BIOL CELL, V21, P2371, DOI 10.1091/mbc.E10-02-0170; ZERNICKAGOETZ M, 1993, EXP CELL RES, V207, P189, DOI 10.1006/excr.1993.1179	72	28	28	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14705	14712		10.1074/jbc.M110.193227	http://dx.doi.org/10.1074/jbc.M110.193227			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21383018	hybrid, Green Published			2022-12-25	WOS:000289556200089
J	Song, Z; Yue, W; Wei, B; Wang, N; Li, T; Guan, LD; Shi, SS; Zeng, QA; Pei, XT; Chen, L				Song, Zhou; Yue, Wen; Wei, Bo; Wang, Ning; Li, Tao; Guan, Lidong; Shi, Shuangshuang; Zeng, Quan; Pei, Xuetao; Chen, Lin			Sonic Hedgehog Pathway Is Essential for Maintenance of Cancer Stem-Like Cells in Human Gastric Cancer	PLOS ONE			English	Article							SIDE POPULATION; MYELOID-LEUKEMIA; SELF-RENEWAL; IDENTIFICATION; GLIOBLASTOMA; TUMORS; LINE; GROWTH	Abnormal activation of the Sonic hedgehog (SHH) pathway has been described in a wide variety of human cancers and in cancer stem cells (CSCs), however, the role of SHH pathway in gastric CSCs has not been reported. In this study, we investigated the possibility that abnormal activation of the SHH pathway maintained the characteristics of gastric CSCs. First, we identified cancer stem-like cells (CSLCs) from human gastric cancer cell lines (HGC-27, MGC-803 and MKN-45) using tumorsphere culture. Compared with adherent cells, the floating tumorsphere cells had more self-renewing capacity and chemoresistance. The cells expressing CSCs markers (CD44, CD24 and CD133) were also significantly more in tumorsphere cells than in adherent cells. More importantly, in vivo xenograft studies showed that tumors could be generated with 2610 4 tumorsphere cells, which was 100-fold less than those required for tumors seeding by adherent cells. Next, RT-PCR and Western blot showed that the expression levels of Ptch and Gli1 (SHH pathway target genes) were significantly higher in tumorsphere cells than in adherent cells. The results of quantitative real-time PCR were similar to those of RT-PCR and Western blot. Further analysis revealed that SHH pathway blocked by cyclopamine or 5E1 caused a higher reduction in self-renewing capacity of HGC-27 tumorsphere cells than that of adherent cells. We also found that SHH pathway blocking strongly enhanced the efficacy of chemotherapeutic drugs in HGC-27 tumorsphere cells in vitro and in vivo but had no significant effect in adherent cells. Finally, we isolated the tumorspheres from gastric cancer specimen, these cells also had chemoresistance and tumorigenic capacity, and SHH pathway maintained the gastric CSLCs characteristics of tumorsphere cells from primary tumor samples. In conclusion, our data suggested that SHH pathway was essential for maintenance of CSLCs in human gastric cancer.	[Song, Zhou; Wei, Bo; Wang, Ning; Li, Tao; Chen, Lin] Gen Hosp Chinese PLA, Dept Gen Surg, Beijing, Peoples R China; [Yue, Wen; Guan, Lidong; Shi, Shuangshuang; Zeng, Quan; Pei, Xuetao] Beijing Inst Transfus Med, Stem Cell & Regenerat Med Lab, Beijing, Peoples R China		Song, Z (corresponding author), Gen Hosp Chinese PLA, Dept Gen Surg, Beijing, Peoples R China.	peixt@nic.bmi.ac.cn; chenlinbj@vip.sina.com		Yue, Wen/0000-0002-3935-360X	National High Technology Research and Development Program of China [2006AA402A04, 2006AA02A107]; Major State Basic Research Program of China [2009CB521704]; National Nature Science Foundation of China [30872468, 30873031]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major State Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program of China (# 2006AA402A04, # 2006AA02A107), the Major State Basic Research Program of China (# 2009CB521704), and the National Nature Science Foundation of China (# 30872468, # 30873031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Christgen M, 2007, MOL CELL BIOCHEM, V306, P201, DOI 10.1007/s11010-007-9570-y; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kang SK, 2006, STEM CELLS DEV, V15, P423, DOI 10.1089/scd.2006.15.423; Kobune M, 2009, CANCER SCI, V100, P948, DOI 10.1111/j.1349-7006.2009.01111.x; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Lee J, 1997, DEVELOPMENT, V124, P2537; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Ma XL, 2005, CARCINOGENESIS, V26, P1698, DOI 10.1093/carcin/bgi130; Ohta M, 2005, CANCER RES, V65, P10822, DOI 10.1158/0008-5472.CAN-05-0777; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Setoguchi T, 2004, CELL CYCLE, V3, P414; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Suzuki H, 2005, J PATHOL, V206, P186, DOI 10.1002/path.1763; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Vermeulen L, 2008, CELL DEATH DIFFER, V15, P947, DOI 10.1038/cdd.2008.20; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Yi L, 2007, MODERN PATHOL, V20, P1061, DOI 10.1038/modpathol.3800942; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zhong XF, 2007, INT J CANCER, V121, P2125, DOI 10.1002/ijc.22880	30	133	144	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17687	10.1371/journal.pone.0017687	http://dx.doi.org/10.1371/journal.pone.0017687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394208	Green Published, Green Submitted, gold			2022-12-25	WOS:000288025500020
J	Valkov, A; Sorbye, SW; Kilvaer, TK; Donnem, T; Smeland, E; Bremnes, RM; Busund, LT				Valkov, Andrej; Sorbye, Sveinung W.; Kilvaer, Thomas K.; Donnem, Tom; Smeland, Eivind; Bremnes, Roy M.; Busund, Lill-Tove			The Prognostic Impact of TGF-beta 1, Fascin, NF-kappa B and PKC-zeta Expression in Soft Tissue Sarcomas	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; KINASE-C-ZETA; CELL LUNG-CANCER; TGF-BETA; E-CADHERIN; GROWTH; PROGRESSION; CARCINOMA; RHABDOMYOSARCOMA; METASTASIS	Aims: Transforming growth factor-beta (TGF-beta), fascin, nuclear factor-kappa B (NF-kappa B) p105, protein-kinase C-zeta (PKC-zeta), partioning-defective protein-6 (Par-6), E-cadherin and vimentin are tumor promoting molecules through mechanisms involved in cell dedifferentiation. In soft tissue sarcomas, their expression profile is poorly defined and their significance is uncertain. We aimed to investigate the prognostic impact of TGF-beta 1, NF-kappa B p105, PKC-zeta, Par-6 alpha, E-cadherin and vimentin in non-gastrointestinal stromal tumor soft tissue sarcomas (non-GIST STSs). Patients and Methods: Tumor samples and clinical data from 249 patients with non-GIST STS were obtained, and tissue microarrays (TMAs) were constructed for each specimen. Immunohistochemistry (IHC) was used to evaluate marker expression in tumor cells. Results: In univariate analysis, the expression levels of TGF-b1 (P = 0.016), fascin (P = 0.006), NF-kappa B p105 (P = 0.022) and PKCf, (P = 0.042) were significant indicators for disease specific survival (DSS). In the multivariate analysis, high TGF-beta 1 expression was an independent negative prognostic factor for DSS (HR = 1.6, 95% CI = 1.1-2.4, P = 0.019) in addition to tumor depth, malignancy grade, metastasis at diagnosis, surgery and positive resection margins. Conclusion: Expression of TGF- b1 was significantly associated with aggressive behavior and shorter DSS in non- GIST STSs.	[Valkov, Andrej; Sorbye, Sveinung W.; Busund, Lill-Tove] Univ Hosp No Norway, Dept Clin Pathol, Tromso, Norway; [Valkov, Andrej; Sorbye, Sveinung W.; Kilvaer, Thomas K.; Busund, Lill-Tove] Univ Tromso, Inst Med Biol, Tromso, Norway; [Donnem, Tom; Smeland, Eivind; Bremnes, Roy M.] Univ Hosp No Norway, Dept Oncol, Tromso, Norway; [Donnem, Tom; Bremnes, Roy M.] Univ Tromso, Inst Clin Med, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Valkov, A (corresponding author), Univ Hosp No Norway, Dept Clin Pathol, Tromso, Norway.	Andrej.Yurjevic.Valkov@unn.no	Kilvaer, Thomas/AAI-7418-2020; Sorbye, Sveinung Wergeland/AAE-7208-2020	Kilvaer, Thomas/0000-0003-1669-0117; Sorbye, Sveinung Wergeland/0000-0002-8250-3992	Norwegian Childhood Cancer Network; Norwegian Sarcoma Group; Norwegian Cancer Society	Norwegian Childhood Cancer Network; Norwegian Sarcoma Group; Norwegian Cancer Society(Norwegian Cancer Society)	This study was funded by the Helse Nord, the Norwegian Childhood Cancer Network, the Norwegian Sarcoma Group and the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saad S, 2008, BRIT J CANCER, V99, P1476, DOI 10.1038/sj.bjc.6604713; Beck AH, 2010, VIRCHOWS ARCH, V456, P141, DOI 10.1007/s00428-009-0774-2; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blaukovitsch M, 2006, VIRCHOWS ARCH, V449, P455, DOI 10.1007/s00428-006-0256-8; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Campbell KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-101; Chen MF, 2009, J MOL MED-JMM, V87, P307, DOI 10.1007/s00109-008-0430-3; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Dickinson IC, 2006, ANZ J SURG, V76, P104, DOI 10.1111/j.1445-2197.2006.03615.x; Engellau J, 2004, CANCER-AM CANCER SOC, V100, P2233, DOI 10.1002/cncr.20254; Guillou L, 2009, VIRCHOWS ARCH; Guizzetti M, 2000, BIOCHEM PHARMACOL, V60, P1457, DOI 10.1016/S0006-2952(00)00468-8; Guo H, 2007, CHINESE MED J-PEKING, V120, P515, DOI 10.1097/00029330-200703020-00016; Guo H, 2009, J NEUROCHEM, V109, P203, DOI 10.1111/j.1471-4159.2009.05946.x; GUSTAFSON P, 1994, ACTA ORTHOP SCAND, V65, P1; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Javelaud D, 2002, INT J CANCER, V98, P193, DOI 10.1002/ijc.10192; Kefeli M, 2009, INT J GYNECOL PATHOL, V28, P328, DOI 10.1097/PGP.0b013e318195da9f; Kiatisevi Piya, 2006, Journal of the Medical Association of Thailand, V89, P334; Kilvaer TK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015368; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Kloen P, 1997, CANCER, V80, P2230; Koea JB, 2003, ANN SURG ONCOL, V10, P432, DOI 10.1245/ASO.2003.05.014; Liu J, 2006, MOL CANCER RES, V4, P803, DOI 10.1158/1541-7786.MCR-06-0201; Liu LK, 2009, MOD PATHOL; Liu XF, 2004, MOL CELL BIOL, V24, P6665, DOI 10.1128/mcb.24.15.6665-6675.2004; Masi L, 2002, VIRCHOWS ARCH, V440, P491, DOI 10.1007/s00428-001-0544-2; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mendenhall WM, 2005, CANCER-AM CANCER SOC, V104, P669, DOI 10.1002/cncr.21264; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; RANEY RB, 1983, CANCER-AM CANCER SOC, V52, P44, DOI 10.1002/1097-0142(19830701)52:1<44::AID-CNCR2820520110>3.0.CO;2-V; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Sorbye SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014611; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Thiery JP, 2005, DEV CELL, V8, P456, DOI 10.1016/j.devcel.2005.03.002; Verweij J, 2010, EUR J CANCER, V46, P863, DOI 10.1016/j.ejca.2010.01.016; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Vora HH, 2009, INT J BIOL MARKER, V24, P38, DOI 10.1177/172460080902400106; Wibmer C, 2010, ANN ONCOL, V21, P1106, DOI 10.1093/annonc/mdp415; Yamamoto T, 2004, CLIN CANCER RES, V10, P5804, DOI 10.1158/1078-0432.CCR-0770-03; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; YANG RS, 1995, CANCER-AM CANCER SOC, V76, P1398, DOI 10.1002/1097-0142(19951015)76:8<1398::AID-CNCR2820760815>3.0.CO;2-B; Zagars GK, 2003, INT J RADIAT ONCOL, V57, P739, DOI 10.1016/S0360-3016(03)00714-4; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zou J, 2010, EUR J CANCER PREV, V19, P11, DOI 10.1097/CEJ.0b013e32832f9aa6	48	29	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17507	10.1371/journal.pone.0017507	http://dx.doi.org/10.1371/journal.pone.0017507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390241	Green Published, gold			2022-12-25	WOS:000287965200017
J	Gao, P; Tang, Q; An, XM; Yan, XX; Liang, DC				Gao, Pu; Tang, Qun; An, XiaoMin; Yan, XiaoXue; Liang, DongCai			Structure of HsdS Subunit from Thermoanaerobacter tengcongensis Sheds Lights on Mechanism of Dynamic Opening and Closing of Type I Methyltransferase	PLOS ONE			English	Article							RESTRICTION-ENDONUCLEASE; DNA METHYLTRANSFERASES; CRYSTAL-STRUCTURE; MODEL; RECOGNITION; M.ECOR124I; SEQUENCE; COMPLEX; SYSTEM; ENZYME	Type I DNA methyltransferases contain one specificity subunit (HsdS) and two modification subunits (HsdM). The electron microscopy model of M.EcoKI-M2S1 methyltransferase shows a reasonable closed state of this clamp-like enzyme, but the structure of the open state is still unclear. The 1.95 angstrom crystal structure of the specificity subunit from Thermoanaerobacter tengcongensis (TTE-HsdS) shows an unreported open form inter-domain orientation of this subunit. Based on the crystal structure of TTE-HsdS and the closed state model of M.EcoKI-M2S1, we constructed a potential open state model of type I methyltransferase. Mutational studies indicated that two alpha-helices (aa30-59 and aa466-495) of the TTE-HsdM subunit are important inter-subunit interaction sites in the TTE-M2S1 complex. DNA binding assays also highlighted the importance of the C-terminal region of TTE-HsdM for DNA binding by the TTE-M2S1 complex. On the basis of structural analysis, biochemical experiments and previous studies, we propose a dynamic opening and closing mechanism for type I methyltransferase.	[Gao, Pu; Tang, Qun; An, XiaoMin; Yan, XiaoXue; Liang, DongCai] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Gao, Pu] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, P (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	snow@moon.ibp.ac.cn; dcliang@sun5.ibp.ac.cn	Tang, Qun/AHC-5915-2022	Tang, Qun/0000-0001-8943-0012	National Program on Key Basic Research [2007CB914302, 2011CB966303, 2011CB910302, 2011CB911101]; National Natural Science Foundation of China [30600102, 31070684]; Institute of Biophysics, Chinese Academy of Sciences	National Program on Key Basic Research(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Institute of Biophysics, Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by grants from the National Program on Key Basic Research Project "973 Program" No. 2007CB914302, No. 2011CB966303, No. 2011CB910302 and No. 2011CB911101. Additional support was provided by the National Natural Science Foundation of China, No. 30600102 and No. 31070684. Funding for open access charge: Institute of Biophysics, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABADJIEVA A, 1994, J MOL BIOL, V241, P35, DOI 10.1006/jmbi.1994.1471; Bao QY, 2002, GENOME RES, V12, P689, DOI 10.1101/gr.219302; BICKLE TA, 1993, MICROBIOL REV, V57, P434, DOI 10.1128/MMBR.57.2.434-450.1993; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calisto RM, 2005, J MOL BIOL, V351, P749, DOI 10.1016/j.jmb.2005.06.050; Chang Q, 2008, PROTEINS, V73, P254, DOI 10.1002/prot.22151; COOPER LP, 1994, J MOL BIOL, V236, P1011, DOI 10.1016/0022-2836(94)90008-6; DRYDEN DTF, 1993, J BIOL CHEM, V268, P13228; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENDLICH B, 1985, J BIOL CHEM, V260, P5729; Goedecke K, 2001, NAT STRUCT BIOL, V8, P121, DOI 10.1038/84104; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; KELLEHER JE, 1991, J MOL BIOL, V221, P431, DOI 10.1016/0022-2836(91)80064-2; Kennaway CK, 2009, NUCLEIC ACIDS RES, V37, P762, DOI 10.1093/nar/gkn988; Kim JS, 2005, P NATL ACAD SCI USA, V102, P3248, DOI 10.1073/pnas.0409851102; KNEALE GG, 1994, J MOL BIOL, V243, P1, DOI 10.1006/jmbi.1994.1624; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; O'Neill M, 2001, J MOL BIOL, V307, P951, DOI 10.1006/jmbi.2001.4543; O'Neill M, 1998, EMBO J, V17, P7118, DOI 10.1093/emboj/17.23.7118; Obarska A, 2006, NUCLEIC ACIDS RES, V34, P1992, DOI 10.1093/nar/gkl132; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PITTARD J, 1964, J BACTERIOL, V87, P1256, DOI 10.1128/JB.87.5.1256-1257.1964; Redaschi N, 1996, J MOL BIOL, V257, P790, DOI 10.1006/jmbi.1996.0202; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Szczelkun MD, 1996, EMBO J, V15, P6335, DOI 10.1002/j.1460-2075.1996.tb01023.x; TAYLOR IA, 1994, EMBO J, V13, P5772, DOI 10.1002/j.1460-2075.1994.tb06915.x; Taylor JE, 2010, J MOL BIOL, V398, P391, DOI 10.1016/j.jmb.2010.03.008; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	32	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17346	10.1371/journal.pone.0017346	http://dx.doi.org/10.1371/journal.pone.0017346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399684	Green Submitted, Green Published, gold			2022-12-25	WOS:000287933300018
J	Lazzarino, AI; Palmer, W; Bottle, A; Aylin, P				Lazzarino, Antonio Ivan; Palmer, William; Bottle, Alex; Aylin, Paul			Inequalities in Stroke Patients' Management in English Public Hospitals: A Survey on 200,000 Patients	PLOS ONE			English	Article								Background: According to clinical guidelines, every patient affected by stroke should be given a brain-imaging scan (BIS) Computerized Tomography or Magnetic Resonance Imaging - immediately after being admitted to hospital. Aim of the study: To describe the variation in use of BIS among English public hospitals and identify any patient groups being excluded from appropriate care. Methods: We collected hospital administrative data for all patients admitted to any English public hospital with a principal diagnosis of stroke from 2006 to 2009. We calculated the proportion of patients treated with BIS in the whole sample and after stratification by hospital. We compared hospitals' performance using funnel plots. We performed a multiple logistic regression analysis using BIS as outcome and age, gender, socio-economic deprivation, and comorbidity as covariates. Results: In English public hospitals there are about 70,000 emergency admissions for stroke per year. Nationally, only 35% receive a BIS immediately, and only 84% receive it within the admission. There is large variation in the use of BIS for stroke patients among English public hospitals, with some of them approaching the recommended 100% and some having very low rates. Young (P < 0.001), male (P=0.012), and least socio-economically deprived patients (P=0.001), as well as patients with fewer comorbidities (P < 0.001) appear to have more chance of being selected for a brain scan. Conclusion: Some English public hospitals appear to be falling well below the clinical guideline standards for scanning stroke patients and inappropriate patient selection criteria may be being applied, leading to health inequalities.	[Lazzarino, Antonio Ivan; Palmer, William; Bottle, Alex; Aylin, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England	Imperial College London	Lazzarino, AI (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England.	a.lazzarino@imperial.ac.uk	Lazzarino, Antonio Ivan/F-9011-2010; Aylin, Paul/A-1073-2014	Lazzarino, Antonio Ivan/0000-0001-8045-2346; Bottle, Alex/0000-0001-9978-2011; Aylin, Paul/0000-0003-4589-1743	Dr Foster intelligence; National Institute of Health Research; National Institute for Health Research Biomedical Research Centre	Dr Foster intelligence; National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR))	WP, AB, and PA have support from the Dr Foster Unit at Imperial College London for the submitted work. The Dr Foster Unit at Imperial College is funded by the Dr Foster intelligence, an independent health care information company. The Dr Foster Unit at Imperial is affiliated with the Imperial Centre for Patient Safety and Service Quality at Imperial College Healthcare NHS Trust, which is funded by the National Institute of Health Research. The Department of Primary Care and Public Health is grateful for support from the National Institute for Health Research Biomedical Research Centre Funding Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; [Anonymous], 2008, 68 NICE, V68; Beech R, 1996, STROKE, V27, P1958, DOI 10.1161/01.STR.27.11.1958; CARSTAIRS V, 1989, BRIT MED J, V299, P886, DOI 10.1136/bmj.299.6704.886; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; *DEP HLTH LOND, 2007, NAT STROK STRAT; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Feigin VL, 2005, LANCET, V365, P2160, DOI 10.1016/S0140-6736(05)66755-4; National Audit Office, 2010, PROGR IMPR STROK CAR; *ROYAL COLL PHYS C, 2008, NAT SENT STROK AUD P; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970	12	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17219	10.1371/journal.pone.0017219	http://dx.doi.org/10.1371/journal.pone.0017219			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399683	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000287933300014
J	Dharia, S; Rabbitt, RD				Dharia, Sameera; Rabbitt, Richard D.			Monitoring Voltage-Dependent Charge Displacement of Shaker B-IR K+ Ion Channels Using Radio Frequency Interrogation	PLOS ONE			English	Article							OUTER HAIR-CELLS; IMPEDANCE SPECTROSCOPY; POTASSIUM CHANNELS; INACTIVATION; ELECTRODES; MOVEMENT; PRESTIN; SENSOR; MOTOR	Here we introduce a new technique that probes voltage-dependent charge displacements of excitable membrane-bound proteins using extracellularly applied radio frequency (RF, 500 kHz) electric fields. Xenopus oocytes were used as a model cell for these experiments, and were injected with cRNA encoding Shaker B-IR (ShB-IR) K+ ion channels to express large densities of this protein in the oocyte membranes. Two-electrode voltage clamp (TEVC) was applied to command whole-cell membrane potential and to measure channel-dependent membrane currents. Simultaneously, RF electric fields were applied to perturb the membrane potential about the TEVC level and to measure voltage-dependent RF displacement currents. ShB-IR expressing oocytes showed significantly larger changes in RF displacement currents upon membrane depolarization than control oocytes. Voltage-dependent changes in RF displacement currents further increased in ShB-IR expressing oocytes after,120 mM Cu2+ addition to the external bath. Cu2+ is known to bind to the ShB-IR ion channel and inhibit Shaker K+ conductance, indicating that changes in the RF displacement current reported here were associated with RF vibration of the Cu2+-linked mobile domain of the ShB-IR protein. Results demonstrate the use of extracellular RF electrodes to interrogate voltage-dependent movement of charged mobile protein domains-capabilities that might enable detection of small changes in charge distribution associated with integral membrane protein conformation and/ or drug-protein interactions.	[Dharia, Sameera; Rabbitt, Richard D.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Dharia, S (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.	sameera_dharia@yahoo.com		Rabbitt, Richard/0000-0002-2959-7248	National Institutes of Health [R01 DC004928, R01 DC006685]; National Science Foundation [IGERT DGE-9987616]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC006685, R01DC004928, R01DC006685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grant numbers R01 DC004928 and R01 DC006685, and National Science Foundation grant number IGERT DGE-9987616. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Ayliffe HE, 1999, J MICROELECTROMECH S, V8, P50, DOI 10.1109/84.749402; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Cheung K, 2005, CYTOM PART A, V65A, P124, DOI 10.1002/cyto.a.20141; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; DHARIA S, 2010, P ANN INT C IEEE EMB, P889; Dharia S, 2009, LAB CHIP, V9, P3370, DOI 10.1039/b912881f; Elinder F, 2003, Q REV BIOPHYS, V36, P373, DOI 10.1017/S0033583504003932; Gawad S, 2001, LAB CHIP, V1, P76, DOI 10.1039/b103933b; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gritsch S, 1998, LANGMUIR, V14, P3118, DOI 10.1021/la9710381; Han A, 2006, LAB CHIP, V6, P1412, DOI 10.1039/b608930e; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; IVERSON LE, 1990, J NEUROSCI, V10, P2903; Ma ZM, 2008, J GEN PHYSIOL, V131, P483, DOI 10.1085/jgp.200809980; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Rabbitt RD, 2005, BIOPHYS J, V88, P2257, DOI 10.1529/biophysj.104.050872; Santos-Sacchi J, 2002, PFLUG ARCH EUR J PHY, V444, P99, DOI 10.1007/s00424-002-0804-2; Sigg D, 1997, J GEN PHYSIOL, V109, P27, DOI 10.1085/jgp.109.1.27; SIGG D, 1994, SCIENCE, V264, P578, DOI 10.1126/science.8160016; STUHMER W, 1992, METHOD ENZYMOL, V207, P319; Werdich AA, 2004, LAB CHIP, V4, P357, DOI 10.1039/B315648F; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	25	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17363	10.1371/journal.pone.0017363	http://dx.doi.org/10.1371/journal.pone.0017363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387000	Green Published, gold, Green Submitted			2022-12-25	WOS:000287931400062
J	Knutsen, JHJ; Rein, ID; Rothe, C; Stokke, T; Grallert, B; Boye, E				Knutsen, Jon Halvor Jonsrud; Rein, Idun Dale; Rothe, Christiane; Stokke, Trond; Grallert, Beata; Boye, Erik			Cell-Cycle Analysis of Fission Yeast Cells by Flow Cytometry	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; DNA-REPLICATION; START; GENE	The cell cycle of the fission yeast, Schizosaccharomyces pombe, does not easily lend itself to analysis by flow cytometry, mainly because cells in G(1) and G(2) phase contain the same amount of DNA. This occurs because fission yeast cells under standard growth conditions do not complete cytokinesis until after G(1) phase. We have devised a flow cytometric method exploiting the fact that cells in G(1) phase contain two nuclei, whereas cells in G(2) are mononuclear. Measurements of the width as well as the total area of the DNA-associated fluorescence signal allows the discrimination between cells in G(1) and in G(2) phase and the cell-cycle progression of fission yeast can be followed in detail by flow cytometry. Furthermore, we show how this method can be used to monitor the timing of cell entry into anaphase. Fission yeast cells tend to form multimers, which represents another problem of flow cytometry-based cell-cycle analysis. Here we present a method employing light-scatter measurements to enable the exclusion of cell doublets, thereby further improving the analysis of fission yeast cells by flow cytometry.	[Knutsen, Jon Halvor Jonsrud; Rothe, Christiane; Grallert, Beata; Boye, Erik] Oslo Univ Hosp, Inst Canc Res, Dept Cell Biol, Oslo, Norway; [Rein, Idun Dale; Stokke, Trond] Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol, Oslo, Norway; [Rothe, Christiane; Boye, Erik] Univ Oslo, Inst Mol Biosci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Knutsen, JHJ (corresponding author), Oslo Univ Hosp, Inst Canc Res, Dept Cell Biol, Oslo, Norway.	eboye@rr-research.no		Rein, Idun Dale/0000-0002-2002-8946	Norwegian Research Council; Norwegian Cancer Society; Simon Fougner Hartmann Family Legacy	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Simon Fougner Hartmann Family Legacy	This work was funded by several grants from the Norwegian Research Council (www.forskningradet.no), from the Norwegian Cancer Society (www.kreftforeningen.no) and one from the Simon Fougner Hartmann Family Legacy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlson CR, 1999, J CELL SCI, V112, P939; FANTES P, 1979, NATURE, V279, P428, DOI 10.1038/279428a0; Forsburg Susan L, 2005, Gravit Space Biol Bull, V18, P3; Hulst H.C., 1957, LIGHT SCATTERING SMA; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; KIPPERT F, 1995, FEMS MICROBIOL LETT, V132, P215; LATT SA, 1977, J HISTOCHEM CYTOCHEM, V25, P927, DOI 10.1177/25.7.70460; LEUPOLD U., 1950, Comptes rendus des Travaux du Laboratoire Carlsberg, V24, P381; MORENO S, 1991, METHOD ENZYMOL, V194, P795; REYMOND A, 1992, MOL GEN GENET, V234, P449, DOI 10.1007/BF00538705; SABATINOS SA, 2008, METHODS MOL BIOL; SAZER S, 1990, J CELL SCI, V97, P509; Tvegard T, 2007, GENE DEV, V21, P649, DOI 10.1101/gad.421807	13	30	31	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17175	10.1371/journal.pone.0017175	http://dx.doi.org/10.1371/journal.pone.0017175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386895	Green Published, gold, Green Submitted			2022-12-25	WOS:000287931400036
J	Pons, M; Marin-Castano, ME				Pons, Marianne; Marin-Castano, Maria E.			Cigarette Smoke-Related Hydroquinone Dysregulates MCP-1, VEGF and PEDF Expression in Retinal Pigment Epithelium in Vitro and in Vivo	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AGE-RELATED MACULOPATHY; NONLETHAL OXIDANT INJURY; SUB-RPE DEPOSITS; MACULAR DEGENERATION; BRUCHS MEMBRANE; CHOROIDAL NEOVASCULARIZATION; OXIDATIVE STRESS; PROTEIN-1 MCP-1; GENE-EXPRESSION	Background: Age-related macular degeneration (AMD) is the leading cause of legal blindness in the elderly population. Debris (termed drusen) below the retinal pigment epithelium (RPE) have been recognized as a risk factor for dry AMD and its progression to wet AMD, which is characterized by choroidal neovascularization (CNV). The underlying mechanism of how drusen might elicit CNV remains undefined. Cigarette smoking, oxidative damage to the RPE and inflammation are postulated to be involved in the pathophysiology of the disease. To better understand the cellular mechanism(s) linking oxidative stress and inflammation to AMD, we examined the expression of pro-inflammatory monocyte chemoattractant protein-1 (MCP-1), pro-angiogenic vascular endothelial growth factor (VEGF) and anti-angiogenic pigment epithelial derived factor (PEDF) in RPE from smoker patients with AMD. We also evaluated the effects of hydroquinone (HQ), a major pro-oxidant in cigarette smoke on MCP-1, VEGF and PEDF expression in cultured ARPE-19 cells and RPE/choroids from C57BL/6 mice. Principal Findings: MCP-1, VEGF and PEDF expression was examined by real-time PCR, Western blot, and ELISA. Low levels of MCP-1 protein were detected in RPE from AMD smoker patients relative to controls. Both MCP-1 mRNA and protein were downregulated in ARPE-19 cells and RPE/choroids from C57BL/6 mice after 5 days and 3 weeks of exposure to HQ-induced oxidative injury. VEGF protein expression was increased and PEDF protein expression was decreased in RPE from smoker patients with AMD versus controls resulting in increased VEGF/PEDF ratio. Treatment with HQ for 5 days and 3 weeks increased the VEGF/PEDF ratio in vitro and in vivo. Conclusion: We propose that impaired RPE-derived MCP-1-mediated scavenging macrophages recruitment and phagocytosis might lead to incomplete clearance of proinflammatory debris and infiltration of proangiogenic macrophages which along with increased VEGF/PEDF ratio favoring angiogenesis might promote drusen accumulation and progression to CNV in smoker patients with dry AMD.	[Pons, Marianne; Marin-Castano, Maria E.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA	Bascom Palmer Eye Institute; University of Miami	Pons, M (corresponding author), Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	Mcastano@med.miami.edu			Flight Attendant Medical Research Institute [072100_CIA]; Research to Prevent Blindness [P30-EY14801]; NATIONAL EYE INSTITUTE [P30EY014801] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by a Flight Attendant Medical Research Institute 072100_CIA grant and an unrestricted grant from Research to Prevent Blindness to the University of Miami P30-EY14801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript file.	ADAMIS AP, 1993, BIOCHEM BIOPH RES CO, V193, P631, DOI 10.1006/bbrc.1993.1671; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Apte RS, 2004, INVEST OPHTH VIS SCI, V45, P4491, DOI 10.1167/iovs.04-0172; Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bertram KM, 2009, AM J PHYSIOL-CELL PH, V297, pC1200, DOI 10.1152/ajpcell.00126.2009; Bhutto IA, 2006, EXP EYE RES, V82, P99, DOI 10.1016/j.exer.2005.05.007; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; BRESSLER SB, 1990, ARCH OPHTHALMOL-CHIC, V108, P1442, DOI 10.1001/archopht.1990.01070120090035; Christen WG, 1996, JAMA-J AM MED ASSOC, V276, P1147, DOI 10.1001/jama.276.14.1147; DASTGHEIB K, 1994, ARCH OPHTHALMOL-CHIC, V112, P813, DOI 10.1001/archopht.1994.01090180111045; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Delcourt C, 1998, ARCH OPHTHALMOL-CHIC, V116, P1031, DOI 10.1001/archopht.116.8.1031; Dhubhghaill SSN, 2010, ADV EXP MED BIOL, V664, P437, DOI 10.1007/978-1-4419-1399-9_50; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Espinosa-Heidmann DG, 2006, INVEST OPHTH VIS SCI, V47, P729, DOI 10.1167/iovs.05-0719; Evans JR, 2001, PROG RETIN EYE RES, V20, P227, DOI 10.1016/S1350-9462(00)00023-9; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Grossniklaus HE, 2002, MOL VIS, V8, P119; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Higgins GT, 2003, INVEST OPHTH VIS SCI, V44, P1775, DOI 10.1167/iovs.02-0742; Holekamp NM, 2002, AM J OPHTHALMOL, V134, P220, DOI 10.1016/S0002-9394(02)01549-0; Holtkamp GM, 1999, CLIN EXP IMMUNOL, V118, P35; Husain Deeba, 2002, Ophthalmol Clin North Am, V15, P87, DOI 10.1016/S0896-1549(01)00009-8; Javitt JC, 2003, OPHTHALMOLOGY, V110, P1534, DOI 10.1016/S0161-6420(03)00495-0; Joly S, 2009, INVEST OPHTH VIS SCI, V50, P1423, DOI 10.1167/iovs.08-2432; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; KILLINGSWORTH MC, 1990, EYE, V4, P613, DOI 10.1038/eye.1990.86; KLEIN R, 1993, AM J EPIDEMIOL, V137, P190, DOI 10.1093/oxfordjournals.aje.a116659; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P115, DOI 10.1001/archopht.126.1.115; Kliffen M, 1997, BRIT J OPHTHALMOL, V81, P154, DOI 10.1136/bjo.81.2.154; Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929; Kwak N, 2000, INVEST OPHTH VIS SCI, V41, P3158; Lommatzsch A, 2008, GRAEF ARCH CLIN EXP, V246, P803, DOI 10.1007/s00417-007-0749-4; LOPEZ PF, 1991, AM J OPHTHALMOL, V112, P647, DOI 10.1016/S0002-9394(14)77270-8; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Marin-Castano ME, 2006, INVEST OPHTH VIS SCI, V47, P4098, DOI 10.1167/iovs.05-1230; Marin-Castano ME, 2005, INVEST OPHTH VIS SCI, V46, P3331, DOI 10.1167/iovs.04-1224; Ogata N, 2002, INVEST OPHTH VIS SCI, V43, P1168; Oh H, 1999, INVEST OPHTH VIS SCI, V40, P1891; Ohno-Matsui K, 2003, BIOCHEM BIOPH RES CO, V303, P962, DOI 10.1016/S0006-291X(03)00446-7; Ohno-Matsui K, 2001, J CELL PHYSIOL, V189, P323, DOI 10.1002/jcp.10026; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Patel M, 2008, SEMIN IMMUNOPATHOL, V30, P97, DOI 10.1007/s00281-008-0112-9; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Pons M, 2010, AM J PATHOL, V177, P1198, DOI 10.2353/ajpath.2010.091108; Praddaude F, 2009, EXP EYE RES, V89, P109, DOI 10.1016/j.exer.2009.02.020; Reich S, 2003, MOL VIS, V9, P210; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; SARKS SH, 1980, T OPHTHAL SOC UK, V100, P414; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; Smith W, 1996, ARCH OPHTHALMOL-CHIC, V114, P1518, DOI 10.1001/archopht.1996.01100140716016; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Strunnikova N, 2004, INVEST OPHTH VIS SCI, V45, P3767, DOI 10.1167/iovs.04-0311; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; Tamakoshi A, 1997, BRIT J OPHTHALMOL, V81, P901, DOI 10.1136/bjo.81.10.901; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Tong HP, 2006, CLIN BIOCHEM, V39, P267, DOI 10.1016/j.clinbiochem.2005.11.013; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Uetama T, 2003, J CELL PHYSIOL, V197, P77, DOI 10.1002/jcp.10342; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VINDING T, 1990, ACTA OPHTHALMOL, V68, P410; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Yang H, 2006, MOL VIS, V12, P511; Yi XJ, 1996, JPN J OPHTHALMOL, V40, P192; Yi XJ, 1997, GRAEF ARCH CLIN EXP, V235, P313, DOI 10.1007/BF01739641; YOUNG RW, 1987, SURV OPHTHALMOL, V31, P291, DOI 10.1145/1165387.275645	73	57	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16722	10.1371/journal.pone.0016722	http://dx.doi.org/10.1371/journal.pone.0016722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386905	Green Submitted, Green Published, gold			2022-12-25	WOS:000287931400011
J	Mello, MAR; Marquitti, FMD; Guimaraes, PR; Kalko, EKV; Jordano, P; de Aguiar, MAM				Ribeiro Mello, Marco Aurelio; Darcie Marquitti, Flavia Maria; Guimaraes, Paulo Roberto, Jr.; Viktoria Kalko, Elisabeth Klara; Jordano, Pedro; Martinez de Aguiar, Marcus Aloizio			The Missing Part of Seed Dispersal Networks: Structure and Robustness of Bat-Fruit Interactions	PLOS ONE			English	Article							CAROLLIA-PERSPICILLATA; MUTUALISTIC NETWORKS; FRUGIVOROUS BATS; NESTEDNESS; SPECIALIZATION; ARCHITECTURE; CONSTRAINTS; CHIROPTERA; TOLERANCE; PHENOLOGY	Mutualistic networks are crucial to the maintenance of ecosystem services. Unfortunately, what we know about seed dispersal networks is based only on bird-fruit interactions. Therefore, we aimed at filling part of this gap by investigating bat-fruit networks. It is known from population studies that: (i) some bat species depend more on fruits than others, and (ii) that some specialized frugivorous bats prefer particular plant genera. We tested whether those preferences affected the structure and robustness of the whole network and the functional roles of species. Nine bat-fruit datasets from the literature were analyzed and all networks showed lower complementary specialization (H-2' = 0.3760.10, mean 6 SD) and similar nestedness (NODF = 0.5660.12) than pollination networks. All networks were modular (M=0.32 +/- 0.07), and had on average four cohesive subgroups (modules) of tightly connected bats and plants. The composition of those modules followed the genus-genus associations observed at population level (Artibeus-Ficus, Carollia-Piper, and Sturnira-Solanum), although a few of those plant genera were dispersed also by other bats. Bat-fruit networks showed high robustness to simulated cumulative removals of both bats (R = 0.55 +/- 0.10) and plants (R = 0.68 +/- 0.09). Primary frugivores interacted with a larger proportion of the plants available and also occupied more central positions; furthermore, their extinction caused larger changes in network structure. We conclude that bat-fruit networks are highly cohesive and robust mutualistic systems, in which redundancy is high within modules, although modules are complementary to each other. Dietary specialization seems to be an important structuring factor that affects the topology, the guild structure and functional roles in bat-fruit networks.	[Ribeiro Mello, Marco Aurelio; Viktoria Kalko, Elisabeth Klara] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Darcie Marquitti, Flavia Maria] Univ Estadual Campinas, Programa Posgrad Ecol, Campinas, SP, Brazil; [Guimaraes, Paulo Roberto, Jr.] Univ Sao Paulo, Dept Ecol, Sao Paulo, Brazil; [Viktoria Kalko, Elisabeth Klara] Smithsonian Trop Res Inst, Balboa, Panama; [Jordano, Pedro] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Martinez de Aguiar, Marcus Aloizio] Univ Estadual Campinas, Inst Fis Gleb Wataghin, Campinas, SP, Brazil	Ulm University; Universidade Estadual de Campinas; Universidade de Sao Paulo; Smithsonian Institution; Smithsonian Tropical Research Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidade Estadual de Campinas	Mello, MAR (corresponding author), Univ Ulm, Inst Expt Ecol, Ulm, Germany.	marmello@gmail.com	Jordano, Pedro/A-5162-2008; Guimarães-Junior, Paulo R/M-1298-2016; Marquitti, Flavia Maria/B-2697-2013; Guimaraes, Paulo/B-1099-2008; de Aguiar, Marcus A. M./N-1377-2019; Guimaraes, Paulo R./E-1915-2016; Habe, Neusa K/D-6316-2011; Mello, Marco A. R./B-1095-2008; de Aguiar, Marcus A M/C-9137-2012	Jordano, Pedro/0000-0003-2142-9116; Marquitti, Flavia Maria/0000-0003-0510-3992; Guimaraes, Paulo R./0000-0001-9161-8305; Mello, Marco A. R./0000-0002-9098-9427; de Aguiar, Marcus A M/0000-0003-1379-7568	Humboldt Foundation [1134644]; DFG; MEC;  [2006/00265-0]	Humboldt Foundation(Alexander von Humboldt Foundation); DFG(German Research Foundation (DFG)); MEC(European Commission); 	Fapesp (http://www.fapesp.br) sponsored M. A. R. Mello (2006/00265-0), F. M. D. Marquitti, M. A. M. Aguiar, and P. R. Guimaraes. M. A. R. Mello was also supported (1134644) by the Humboldt Foundation (http://www.humboldt-foundation.de), E. K. V. Kalko by DFG (http://www.dfg.de), and P. Jordano by MEC (http://www.educacion.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; BATAGELJ V, 2008, PAJEK PROGRAM LARGE; Bianconi GV, 2007, BIOTROPICA, V39, P136, DOI 10.1111/j.1744-7429.2006.00236.x; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; Bravo A, 2010, J TROP ECOL, V26, P173, DOI 10.1017/S0266467409990472; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Campbell P, 2006, ANIM BEHAV, V72, P687, DOI 10.1016/j.anbehav.2006.03.002; Cipollini ML, 1997, ECOLOGY, V78, P782; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Datzmann T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-165; Dennis A.J., 2007, SEED DISPERSAL THEOR; Dormann C.F., 2008, R NEWS, V8, P8, DOI DOI 10.1159/000265935; Elton, 2001, ANIMAL ECOLOGY; Fleming, 1986, FRUGIVORES SEED DISP, P105, DOI DOI 10.1007/978-94-009-4812-9_11; Fleming T.H., 1982, P287; Galindo-Gonzalez J, 2000, CONSERV BIOL, V14, P1693, DOI [10.1046/j.1523-1739.2000.99072.x, 10.1111/j.1523-1739.2000.99072.x]; Geiselman C.K., 2002, DATABASE NEOTROPICAL; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; da Silva AG, 2008, J MAMMAL, V89, P43, DOI 10.1644/06-MAMM-A-300.1; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Heithaus E.R., 1982, P327; HOWE HF, 1984, AM NAT, V123, P764, DOI 10.1086/284238; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; JOHNSON S, 2002, EMERGENCE CONNECTED, P288; Kalko Elisabeth K.V., 1996, P503, DOI 10.1016/B978-012178075-3/50017-9; Kissling WD, 2009, GLOBAL ECOL BIOGEOGR, V18, P150, DOI 10.1111/j.1466-8238.2008.00431.x; Lobova TA, 2009, SEED DISPERSAL BATS; MARINHOFILHO JS, 1991, J TROP ECOL, V7, P59, DOI 10.1017/S0266467400005083; Mello MAR, 2004, MAMMALIA, V68, P49, DOI 10.1515/mamm.2004.006; MELLO MAR, 2008, BIOTROPICA, V40, P777; Mello MAR, 2008, J MAMMAL, V89, P485, DOI 10.1644/06-MAMM-A-411R.1; MELO FPL, 2009, BIOTROPICA IN PRESS; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Muscarella R, 2007, BIOL REV, V82, P573, DOI 10.1111/j.1469-185X.2007.00026.x; Nogueira MR, 2003, J MAMMAL, V84, P225, DOI 10.1644/1545-1542(2003)084<0225:FSPBSO>2.0.CO;2; NOOY WD, 2005, EXPLORATORY SOCIAL N; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Ollerton J, 2007, P ROY SOC B-BIOL SCI, V274, P591, DOI 10.1098/rspb.2006.3758; ROOT RB, 1967, ECOL MONOGR, V37, P317, DOI 10.2307/1942327; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Terborgh J., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P1, DOI 10.1079/9780851995250.0001; Thies W, 2004, OIKOS, V104, P362, DOI 10.1111/j.0030-1299.2004.12747.x; Thompson J. N., 2005, INTERSPEC INTERACT; Tschapka M, 2005, BIOTROPICA, V37, P409, DOI 10.1111/j.1744-7429.2005.00054.x; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Zortéa M., 2003, Braz. J. Biol., V63, P159, DOI 10.1590/S1519-69842003000100020	56	66	73	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17395	10.1371/journal.pone.0017395	http://dx.doi.org/10.1371/journal.pone.0017395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386981	Green Published, gold, Green Submitted			2022-12-25	WOS:000287931400069
J	Wachtler, B; Wilson, D; Haedicke, K; Dalle, F; Hube, B				Waechtler, Betty; Wilson, Duncan; Haedicke, Katja; Dalle, Frederic; Hube, Bernhard			From Attachment to Damage: Defined Genes of Candida albicans Mediate Adhesion, Invasion and Damage during Interaction with Oral Epithelial Cells	PLOS ONE			English	Article							PROTEIN-KINASE; TRANSCRIPTIONAL RESPONSE; EXPRESSION; VIRULENCE; PATHOGEN; DISRUPTION; MORPHOGENESIS; MECHANISMS; EFFICIENT; ISOFORMS	Candida albicans frequently causes superficial infections by invading and damaging epithelial cells, but may also cause systemic infections by penetrating through epithelial barriers. C. albicans is an unusual pathogen because it can invade epithelial cells via two distinct mechanisms: induced endocytosis, analogous to facultative intracellular enteropathogenic bacteria, and active penetration, similar to plant pathogenic fungi. Here we investigated the molecular basis of C. albicans epithelial interactions. By systematically assessing the contributions of defined fungal pathways and factors to different stages of epithelial interactions, we provide an expansive portrait of the processes and activities involved in epithelial infection. We strengthen the concept that hyphal formation is critical for epithelial invasion. Importantly, our data support a model whereby initial epithelial invasion per se does not elicit host damage, but that C. albicans relies on a combination of contact-sensing, directed hyphal extension, active penetration and the expression of novel pathogenicity factors for further inter-epithelial invasion, dissemination and ultimate damage of host cells. Finally, we explore the transcriptional landscape of C. albicans during the early stages of epithelial interaction, and, via genetic analysis, identify ICL1 and PGA34 as novel oral epithelial pathogenicity factors.	[Waechtler, Betty; Wilson, Duncan; Haedicke, Katja; Hube, Bernhard] Hans Knoell Inst Jena, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany; [Dalle, Frederic] Univ Bourgogne, Fac Med, Lab Interact Muqueuses Agents Transmissibles, IFR Sante STIC,EA 562, Dijon, France; [Dalle, Frederic] Univ Hosp, Dijon, France; [Hube, Bernhard] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Universite de Bourgogne; CHU Dijon Bourgogne; Friedrich Schiller University of Jena	Wachtler, B (corresponding author), Hans Knoell Inst Jena, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany.	bernhard.hube@hki-jena.de		Hube, Bernhard/0000-0002-6028-0425; Wilson, Duncan/0000-0001-6617-0123	Deutsche Forschungsgemeinschaft [Hu528/10, Sch897/3]; Hans Knoell Institute Jena	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hans Knoell Institute Jena	This work was supported by the Deutsche Forschungsgemeinschaft Hu528/10 and Sch897/3 with the URL www.dfg.de and the Hans Knoell Institute Jena with the URL www.hki-jena.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonazzi M, 2006, FEBS LETT, V580, P2962, DOI 10.1016/j.febslet.2006.04.010; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Brand A, 2008, EUKARYOT CELL, V7, P712, DOI 10.1128/EC.00453-07; Brand A, 2009, CURR OPIN MICROBIOL, V12, P350, DOI 10.1016/j.mib.2009.05.007; Bruno VM, 2005, MOL MICROBIOL, V56, P559, DOI 10.1111/j.1365-2958.2005.04562.x; Calderone RA., 2002, CANDIDA CANDIDIASIS; Cantero PD, 2007, MOL MICROBIOL, V64, P1115, DOI 10.1111/j.1365-2958.2007.05723.x; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; Chiang LY, 2007, CELL MICROBIOL, V9, P233, DOI 10.1111/j.1462-5822.2006.00784.x; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; DENFERT C, 2007, COMP FUNCTIONAL GENE; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Filler SG, 2006, PLOS PATHOG, V2, P1099, DOI 10.1371/journal.ppat.0020129; FONZI WA, 1993, GENETICS, V134, P717; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Hromatka BS, 2005, MOL BIOL CELL, V16, P4814, DOI 10.1091/mbc.E05-05-0435; Hube B, 2004, CURR OPIN MICROBIOL, V7, P336, DOI 10.1016/j.mib.2004.06.003; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Kumamoto CA, 2005, P NATL ACAD SCI USA, V102, P5576, DOI 10.1073/pnas.0407097102; Kumamoto CA, 2008, NAT REV MICROBIOL, V6, P667, DOI 10.1038/nrmicro1960; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Lane S, 2001, MOL CELL BIOL, V21, P6418, DOI 10.1128/MCB.21.19.6418-6428.2001; Liu HP, 2001, CURR OPIN MICROBIOL, V4, P728, DOI 10.1016/S1369-5274(01)00275-2; Liu TT, 2005, ANTIMICROB AGENTS CH, V49, P2226, DOI 10.1128/AAC.49.6.2226-2236.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Mavor AL, 2005, CURR DRUG TARGETS, V6, P863, DOI 10.2174/138945005774912735; Monteoliva L, 1996, YEAST, V12, P1097, DOI 10.1002/(SICI)1097-0061(19960915)12:11<1097::AID-YEA990>3.0.CO;2-E; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Negredo A, 1997, MICROBIOL-UK, V143, P297, DOI 10.1099/00221287-143-2-297; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Odds F, 1988, ECOLOGY EPIDEMIOLOGY; Park H, 2005, CELL MICROBIOL, V7, P499, DOI 10.1111/j.1462-5822.2004.00476.x; Park H, 2009, EUKARYOT CELL, V8, P1498, DOI 10.1128/EC.00165-09; Phan QT, 2005, J BIOL CHEM, V280, P10455, DOI 10.1074/jbc.M412592200; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Prill SKH, 2005, MOL MICROBIOL, V55, P546, DOI 10.1111/j.1365-2958.2004.04401.x; Rouabhia M, 2005, INFECT IMMUN, V73, P4571, DOI 10.1128/IAI.73.8.4571-4580.2005; ROUSSET M, 1986, BIOCHIMIE, V68, P1035, DOI 10.1016/S0300-9084(86)80177-8; RUHNKE M, 2002, SKIN MUCOUS MEMBRANE, P307; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Schaller M, 1999, MOL MICROBIOL, V34, P169, DOI 10.1046/j.1365-2958.1999.01590.x; Schaller M, 2006, NAT PROTOC, V1, P2767, DOI 10.1038/nprot.2006.474; Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Thissen D, 2002, J EDUC BEHAV STAT, V27, P77, DOI 10.3102/10769986027001077; Tronchin G, 2008, MED MYCOL, V46, P749, DOI 10.1080/13693780802206435; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Wang A, 2009, MOL CELL BIOL, V29, P4406, DOI 10.1128/MCB.01502-08; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x	58	174	207	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17046	10.1371/journal.pone.0017046	http://dx.doi.org/10.1371/journal.pone.0017046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21407800	Green Submitted, gold, Green Published			2022-12-25	WOS:000287657500028
J	Guo, Y; He, B; Xu, XB; Wang, JD				Guo, Yong; He, Bin; Xu, Xiangbo; Wang, Jiedong			Comprehensive Analysis of Leukocytes, Vascularization and Matrix Metalloproteinases in Human Menstrual Xenograft Model	PLOS ONE			English	Article							HUMAN ENDOMETRIUM; NUDE-MICE; IMMUNODEFICIENT MICE; SILASTIC IMPLANTS; MOUSE; PROGESTERONE; BREAKDOWN; UTERUS; TISSUE	In our previous study, menstrual-like changes in mouse were provoked through the pharmacologic withdrawal of progesterone with mifepristone following induction of decidualization. However, mouse is not a natural menstruation animal, and the menstruation model using external stimuli may not truly reflect the occurrence and development of the human menstrual process. Therefore, we established a model of menstruation based on human endometrial xenotransplantation. In this model, human endometrial tissues were transplanted subcutaneously into SCID mice that were ovarectomized and supplemented with estrogen and progestogen by silastic implants with a scheme imitating the endocrinological milieu of human menstrual cycle. Morphology, hormone levels, and expression of vimentin and cytokeratin markers were evaluated to confirm the menstrual-like changes in this model. With 28 days of hormone treatment, transplanted human endometrium survived and underwent proliferation, differentiation and disintegration, similar to human endometrium in vivo. Human CD45(+) cells showed a peak of increase 28 days post-transplantation. Three days after progesterone withdrawal, mouse CD45(+) cells increased rapidly in number and were significantly greater than human CD45(+) cell counts. Mouse CD31(+) blood vascular-like structures were detected in both transplanted and host tissues. After progesterone withdrawal, the expression levels of matrix metalloproteinases (MMP) 1, 2, and 9 were increased. In summary, we successfully established a human endometrial xenotransplantation model in SCID mice, based on the results of menstrual-like changes in which MMP-1, 2 and 9 are involved. We showed that leukocytes are originated from in situ proliferation in human xenografts and involved in the occurrence of menstruation. This model will help to further understand the occurrence, growth, and differentiation of the endometrium and the underlying mechanisms of menstruation.	[Guo, Yong] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Guo, Yong; He, Bin; Xu, Xiangbo; Wang, Jiedong] Natl Res Inst Family Planning, Dept Cell Biol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Research Institute for Family Planning - China	Guo, Y (corresponding author), Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China.	hebox@263.net; jdwangmail-hr@yahoo.com.cn		Guo, Yong/0000-0002-3148-4525	Fundamental Research Funds for the Central Institutes [2007GJSSJKA07]; National Nature Science Foundation of China [30872766]	Fundamental Research Funds for the Central Institutes; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Fundamental Research Funds for the Central Institutes (No. 2007GJSSJKA07) and the National Nature Science Foundation of China (No. 30872766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beliard A, 2002, FERTIL STERIL, V78, P973, DOI 10.1016/S0015-0282(02)03370-8; BERGQVIST A, 1985, AM J PATHOL, V121, P337; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Brasted M, 2003, BIOL REPROD, V69, P1273, DOI 10.1095/biolreprod.103.016550; Brenner RM, 1996, HUM REPROD, V11, P150, DOI 10.1093/humrep/11.suppl_2.150; COHEN PE, 1993, J REPROD FERTIL, V99, P219, DOI 10.1530/jrf.0.0990219; DALLENBACHHELLW.G, 1987, HISTOPATHOLOGY ENDOM, P158; FINN CA, 1984, J ENDOCRINOL, V100, P295, DOI 10.1677/joe.0.1000295; Gonzalez MLA, 2009, HUM REPROD, V24, P697, DOI 10.1093/humrep/den437; Gordon H, 1936, AM J PATHOL, V12, P545; Grummer R, 2001, HUM REPROD, V16, P1736, DOI 10.1093/humrep/16.8.1736; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; Kaitu'u TJ, 2005, BIOL REPROD, V73, P672, DOI 10.1095/biolreprod.105.042473; King AE, 2010, J STEROID BIOCHEM, V120, P116, DOI 10.1016/j.jsbmb.2010.01.003; Marbaix E, 1996, P NATL ACAD SCI USA, V93, P9120, DOI 10.1073/pnas.93.17.9120; Masuda H, 2007, P NATL ACAD SCI USA, V104, P1925, DOI 10.1073/pnas.0604310104; Matsuura-Sawada R, 2005, HUM REPROD, V20, P1477, DOI 10.1093/humrep/deh783; MILLIGAN SR, 1994, REPROD FERT DEVELOP, V6, P235, DOI 10.1071/RD9940235; Nisolle M, 2000, HUM REPROD, V15, P572, DOI 10.1093/humrep/15.3.572; Ozawa Y, 2006, FERTIL STERIL, V86, P1146, DOI 10.1016/j.fertnstert.2006.01.057; Popovici RM, 2006, ENDOCRINOLOGY, V147, P5662, DOI 10.1210/en.2006-0916; Salamonsen LA, 2002, J REPROD IMMUNOL, V57, P95, DOI 10.1016/S0165-0378(02)00011-6; Tibbetts TA, 1999, BIOL REPROD, V60, P1158, DOI 10.1095/biolreprod60.5.1158; Xu XB, 2007, HUM REPROD, V22, P3184, DOI 10.1093/humrep/dem312	24	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16840	10.1371/journal.pone.0016840	http://dx.doi.org/10.1371/journal.pone.0016840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379384	gold, Green Submitted, Green Published			2022-12-25	WOS:000287482300021
J	Schultz, KM; Banisadr, G; Lastra, RO; McGuire, T; Kessler, JA; Miller, RJ; McGarry, TJ				Schultz, Kathryn M.; Banisadr, Ghazal; Lastra, Ruben O.; McGuire, Tammy; Kessler, John A.; Miller, Richard J.; McGarry, Thomas J.			Geminin-Deficient Neural Stem Cells Exhibit Normal Cell Division and Normal Neurogenesis	PLOS ONE			English	Article							DNA-REPLICATION; DEVELOPMENTAL-CHANGES; CYCLE; XENOPUS; EXPRESSION; CNS; DIFFERENTIATION; RESPONSIVENESS; PROLIFERATION; REREPLICATION	Neural stem cells (NSCs) are the progenitors of neurons and glial cells during both embryonic development and adult life. The unstable regulatory protein Geminin (Gmnn) is thought to maintain neural stem cells in an undifferentiated state while they proliferate. Geminin inhibits neuronal differentiation in cultured cells by antagonizing interactions between the chromatin remodeling protein Brg1 and the neural-specific transcription factors Neurogenin and NeuroD. Geminin is widely expressed in the CNS during throughout embryonic development, and Geminin expression is down-regulated when neuronal precursor cells undergo terminal differentiation. Over-expression of Geminin in gastrula-stage Xenopus embryos can expand the size of the neural plate. The role of Geminin in regulating vertebrate neurogenesis in vivo has not been rigorously examined. To address this question, we created a strain of Nestin-Cre/Gmnn(fl/fl) mice in which the Geminin gene was specifically deleted from NSCs. Interestingly, we found no major defects in the development or function of the central nervous system. Neural-specific Gmnn(Delta/Delta) mice are viable and fertile and display no obvious neurological or neuroanatomical abnormalities. They have normal numbers of BrdU(+) NSCs in the subgranular zone of the dentate gyrus, and Gmnn(Delta/Delta) NSCs give rise to normal numbers of mature neurons in pulse-chase experiments. Gmnn(Delta/Delta) neurosphere cells differentiate normally into both neurons and glial cells when grown in growth factor-deficient medium. Both the growth rate and the cell cycle distribution of cultured Gmnn(Delta/Delta) neurosphere cells are indistinguishable from controls. We conclude that Geminin is largely dispensable for most of embryonic and adult mammalian neurogenesis.	[Schultz, Kathryn M.; Lastra, Ruben O.; McGarry, Thomas J.] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA; [Schultz, Kathryn M.; Lastra, Ruben O.; McGarry, Thomas J.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [McGarry, Thomas J.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Canc Ctr, Chicago, IL 60611 USA; [Banisadr, Ghazal; Miller, Richard J.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [McGuire, Tammy; Kessler, John A.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Schultz, KM (corresponding author), Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA.	t-mcgarry@northwestern.edu			American Heart Association [0630290N]; Illinois Division of the American Cancer Society; National Heart Lung and Blood Institute [R21HL093500]; Schweppe Foundation; NATIONAL CANCER INSTITUTE [P30CA060553, U54CA151880] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020013, R01NS020778] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Illinois Division of the American Cancer Society(American Cancer Society); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Schweppe Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to TJM from the American Heart Association (#0630290N, www.aha.org), the Illinois Division of the American Cancer Society (www.cancer.org), the National Heart Lung and Blood Institute (R21HL093500), and the Schweppe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner S, 2005, DEV CELL, V9, P171, DOI 10.1016/j.devcel.2005.07.005; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Balestrini A, 2010, NAT CELL BIOL, V12, P484, DOI 10.1038/ncb2050; Benjamin JM, 2004, J BIOL CHEM, V279, P45957, DOI 10.1074/jbc.M407726200; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Darzynkiewicz Z, 2001, CURRENT PROTOCOLS CY; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gonzalez MA, 2006, GENE DEV, V20, P1880, DOI 10.1101/gad.379706; Hara K, 2006, GENES CELLS, V11, P1281, DOI 10.1111/j.1365-2443.2006.01019.x; Harlow E., 1988, ANTIBODIES LAB MANUA, VVolume 1, P726; Karamitros D, 2010, J IMMUNOL, V184, P2432, DOI 10.4049/jimmunol.0901983; Kerns SL, 2007, J BIOL CHEM, V282, P5514, DOI 10.1074/jbc.M609289200; Kim MY, 2006, P NATL ACAD SCI USA, V103, P13074, DOI 10.1073/pnas.0601915103; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Luo LF, 2004, CELL CYCLE, V3, P711; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; McGarry TJ, 2002, MOL BIOL CELL, V13, P3662, DOI 10.1091/mbc.E02-04-0199; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Prophet E, 1992, AFIP LAB METHODS HIS; Quinn LM, 2001, GENE DEV, V15, P2741, DOI 10.1101/gad.916201; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Seo S, 2006, CELL CYCLE, V5, P374, DOI 10.4161/cc.5.4.2438; SHINNICK KM, 2010, J CLIN INVE IN PRESS; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spella M, 2007, NEUROSCIENCE, V147, P373, DOI 10.1016/j.neuroscience.2007.03.050; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; Yanagi K, 2005, J BIOL CHEM, V280, P19689, DOI 10.1074/jbc.C500070200; Yu TS, 2005, GENESIS, V41, P147, DOI 10.1002/gene.20110; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhu G, 1999, J NEUROSCI RES, V56, P131, DOI 10.1002/(SICI)1097-4547(19990415)56:2<131::AID-JNR3>3.0.CO;2-I	40	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17736	10.1371/journal.pone.0017736	http://dx.doi.org/10.1371/journal.pone.0017736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408022	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170900044
J	Kurikawa, T; Kaneko, K				Kurikawa, Tomoki; Kaneko, Kunihiko			Learning Shapes Spontaneous Activity Itinerating over Memorized States	PLOS ONE			English	Article							TRANSIENT DYNAMICS; NETWORKS; REPRESENTATIONS; REINFORCEMENT; SYSTEMS; NEURONS; TIME	Learning is a process that helps create neural dynamical systems so that an appropriate output pattern is generated for a given input. Often, such a memory is considered to be included in one of the attractors in neural dynamical systems, depending on the initial neural state specified by an input. Neither neural activities observed in the absence of inputs nor changes caused in the neural activity when an input is provided were studied extensively in the past. However, recent experimental studies have reported existence of structured spontaneous neural activity and its changes when an input is provided. With this background, we propose that memory recall occurs when the spontaneous neural activity changes to an appropriate output activity upon the application of an input, and this phenomenon is known as bifurcation in the dynamical systems theory. We introduce a reinforcement-learning-based layered neural network model with two synaptic time scales; in this network, I/O relations are successively memorized when the difference between the time scales is appropriate. After the learning process is complete, the neural dynamics are shaped so that it changes appropriately with each input. As the number of memorized patterns is increased, the generated spontaneous neural activity after learning shows itineration over the previously learned output patterns. This theoretical finding also shows remarkable agreement with recent experimental reports, where spontaneous neural activity in the visual cortex without stimuli itinerate over evoked patterns by previously applied signals. Our results suggest that itinerant spontaneous activity can be a natural outcome of successive learning of several patterns, and it facilitates bifurcation of the network when an input is provided.	[Kurikawa, Tomoki; Kaneko, Kunihiko] Univ Tokyo, Dept Basic Sci, Tokyo, Japan	University of Tokyo	Kurikawa, T (corresponding author), Univ Tokyo, Dept Basic Sci, Tokyo, Japan.	kurikawa@complex.c.u-tokyo.ac.jp			MEXT Japan [21120004]	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding was provided by Grants-in-Aid for scientific research (No. 21120004) from MEXT Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTO AG, 1981, BIOL CYBERN, V40, P201, DOI 10.1007/BF00453370; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Gros C, 2009, COGN COMPUT, V1, P77, DOI 10.1007/s12559-008-9000-9; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Jordan M.I., 1990, ARTIFICIAL NEURAL NE, P112; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kurikawa T, 2010, LECT NOTES COMPUT SC, V6443, P155, DOI 10.1007/978-3-642-17537-4_20; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Rabinovich MI, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000072; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; Tsuda I, 2001, BEHAV BRAIN SCI, V24, P793, DOI 10.1017/S0140525X01000097; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; Xie XH, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041909	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17432	10.1371/journal.pone.0017432	http://dx.doi.org/10.1371/journal.pone.0017432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408170	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170000029
J	Yi, ZZ; Song, WB				Yi, Zhenzhen; Song, Weibo			Evolution of the Order Urostylida (Protozoa, Ciliophora): New Hypotheses Based on Multi-Gene Information and Identification of Localized Incongruence	PLOS ONE			English	Article							SUBUNIT RIBOSOMAL-RNA; NOV SPEC. CILIOPHORA; N-COMB. CILIOPHORA; ACTIN-I GENE; MOLECULAR PHYLOGENY; DIVISIONAL MORPHOGENESIS; MARINE CILIATE; YELLOW SEA; STICHOTRICHIA; SPIROTRICHEA	Previous systematic arrangement on the ciliate order Urostylida was mainly based on morphological data and only about 20% taxa were analyzed using molecular phylogenetic analyses. In the present investigation, 22 newly sequenced species for which alpha-tubulin, SSU rRNA genes or ITS1-5.8S-ITS2 region were sampled, refer to all families within the order. Following conclusions could be drawn: (1) the order Urostylida is not monophyletic, but a core group is always present; (2) among the family Urostylidae, six of 10 sequenced genera are rejected belonging to this family; (3) the genus Epiclintes is confirmed belonging to its own taxon; (4) the family Pseudokeronopsidae undoubtedly belongs to the core portion of urostylids; however, some or most of its members should be transferred to the family Urostylidae; (5) Bergeriellidae is confirmed to be a valid family; (6) the distinction of the taxon Acaudalia is not supported; (7) the morphology-based genus Anteholosticha is extremely polyphyletic; (8) ITS2 secondary structures of Pseudoamphisiella and Psammomitra are rather different from other urostylids; (9) partition addition bootstrap alteration (PABA) result shows that bootstrap values usually tend to increase as more gene partitions are included.	[Yi, Zhenzhen; Song, Weibo] Ocean Univ China, Inst Evolut & Marine Biodivers, Lab Protozool, Qingdao, Peoples R China; [Yi, Zhenzhen] S China Normal Univ, Coll Life Sci, Key Lab Ecol & Environm Sci Guangdong Higher Educ, Lab Protozool, Guangzhou, Guangdong, Peoples R China	Ocean University of China; South China Normal University	Yi, ZZ (corresponding author), Ocean Univ China, Inst Evolut & Marine Biodivers, Lab Protozool, Qingdao, Peoples R China.	wsong@ouc.edu.cn			Natural Science Foundation of China [31030059, 41006098]; Foundation for Distinguished Yong Talents in Higher Education of Guangdong, China [LYM10060]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Distinguished Yong Talents in Higher Education of Guangdong, China	This work was supported by the Natural Science Foundation of China (Project No. 31030059, 41006098). Its website is http://www.nsfc.gov.cn/Portal0/default124.htm. It was also supported by Foundation for Distinguished Yong Talents in Higher Education of Guangdong, China (Project No. LYM10060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2008, V88, P1; BAMFORTH SS, 1962, OFFICIAL PUBLICATION, V9, P34; Barker FK, 2002, SYST BIOL, V51, P625, DOI 10.1080/10635150290102302; Berger H, 2003, EUR J PROTISTOL, V39, P373, DOI 10.1078/0932-4739-00006; BERGER H, 2006, MONOGR BIOL, V85, pR11; Berger H., 1999, MONOGRAPHIAE BIOL, V78, P1, DOI DOI 10.1007/978-94-011-4637-1; Bernhard D, 2001, MOL PHYLOGENET EVOL, V21, P86, DOI 10.1006/mpev.2001.0997; BORROR A, 1972, Acta Protozoologica, V10, P29; BORROR AC, 1983, ACTA PROTOZOOL, V22, P97; BORROR AC, 1979, J PROTOZOOL, V26, P544, DOI 10.1111/j.1550-7408.1979.tb04192.x; BORROR AC, 1972, J PROTOZOOL, V19, P1, DOI 10.1111/j.1550-7408.1972.tb03407.x; Brochier C, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-36; CALKINS GN, 1926, BIOL PROTOZOA; Cameron SL, 2001, MOL PHYLOGENET EVOL, V20, P302, DOI 10.1006/mpev.2001.0986; Carey P.G, 1992, MARINE INTERSTITIAL; Chen XR, 2010, INT J SYST EVOL MICR, V60, P234, DOI 10.1099/ijs.0.008037-0; Chen XM, 2010, EUR J PROTISTOL, V46, P43, DOI 10.1016/j.ejop.2009.08.002; CHIPPINDALE PT, 1994, SYST BIOL, V43, P278, DOI 10.2307/2413469; Coleman AW, 2005, J EUKARYOT MICROBIOL, V52, P68, DOI 10.1111/j.1550-7408.2005.3327r.x; CORLISS J O, 1979, P455; CORLISS JO, 1977, T AM MICROSC SOC, V96, P104, DOI 10.2307/3225971; CORLISS JO, 1961, INT SERIES MONOGRAPH; Croft KE, 2003, J MOL EVOL, V56, P341, DOI 10.1007/s00239-002-2405-2; Dalby AB, 2004, CHROMOSOMA, V112, P247, DOI 10.1007/s00412-003-0270-4; de Puytorac Pierre, 1994, P1; DeRijk P, 1997, NUCLEIC ACIDS RES, V25, P4679, DOI 10.1093/nar/25.22.4679; DINI F, 1995, CHECKLIST SPECIE FAU; EIGNER P, 1992, EUR J PROTISTOL, V28, P460, DOI 10.1016/S0932-4739(11)80011-8; Eigner P, 2001, J EUKARYOT MICROBIOL, V48, P70, DOI 10.1111/j.1550-7408.2001.tb00417.x; ELWOOD HJ, 1985, MOL BIOL EVOL, V2, P399; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FAUREFREMIET E, 1961, CR HEBD ACAD SCI, V252, P3515; Foissner W, 2004, EUR J PROTISTOL, V40, P265, DOI 10.1016/j.ejop.2004.05.004; Foissner W, 2008, ACTA PROTOZOOL, V47, P1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HEMBERGER H, 1982, REVISION ORDNUMG HYP; Hewitt EA, 2003, MOL PHYLOGENET EVOL, V29, P258, DOI 10.1016/S1055-7903(03)00097-6; Hogan DJ, 2001, P NATL ACAD SCI USA, V98, P15101, DOI 10.1073/pnas.011578598; Hu XY, 2009, ACTA PROTOZOOL, V48, P203; Hu XZ, 2002, EUR J PROTISTOL, V38, P351, DOI 10.1078/0932-4739-00880; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jankowski A., 1979, T ZOOL I LENINGR, V86, P48; JERKA-DZIADOSZ M, 1972, Acta Protozoologica, V10, P249; Kahl A., 1932, Tierwelt Deutschlands Jena, V25, P399; KALTENBACH A, 1960, WASS ABWASS WIEN, P151; Leigh JW, 2008, SYST BIOL, V57, P104, DOI 10.1080/10635150801910436; Levasseur C, 2001, SYST BIOL, V50, P881, DOI 10.1080/106351501753462858; Li LF, 2009, PROG NAT SCI-MATER, V19, P769, DOI 10.1016/j.pnsc.2008.06.027; Li LQ, 2008, EUR J PROTISTOL, V44, P208, DOI 10.1016/j.ejop.2008.01.001; Li LQ, 2007, J EUKARYOT MICROBIOL, V54, P527, DOI 10.1111/j.1550-7408.2007.00294.x; Li LQ, 2009, EUR J PROTISTOL, V45, P237, DOI 10.1016/j.ejop.2009.01.004; Liu WW, 2010, ZOOL J LINN SOC-LOND, V158, P697, DOI 10.1111/j.1096-3642.2009.00565.x; Lynn D.H., 2008, CILIATED PROTOZOA; LYNN DH, 2002, ILLUSTRATED GUIDE PR, V1; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; MIAO M, 2011, SCI CHINA C IN PRESS, V54; Nygren A, 2003, MOL PHYLOGENET EVOL, V29, P235, DOI 10.1016/S1055-7903(03)00095-2; NYLANDER JA, MRMODELTEST V2 EVOLU; OBERSCHMIDLEITN.R, 1996, BEITR NATURK OBEROST, V3, P3; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paiva TS, 2009, GENET MOL RES, V8, P223, DOI 10.4238/vol8-1gmr529; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Schmidt SL, 2007, J EUKARYOT MICROBIOL, V54, P201, DOI 10.1111/j.1550-7408.2007.00250.x; SHANG H, 2004, MOL PHYLOGENY SCUTIC; Shao C, 2007, J EUKARYOT MICROBIOL, V54, P392, DOI 10.1111/j.1550-7408.2007.00278.x; Shao C, 2007, ACTA PROTOZOOL, V46, P25; Shao C, 2008, ACTA PROTOZOOL, V47, P363; Shi X, 1999, PROGR PROTOZOOLOGY, P189; SHI X, 1999, PROGR PROTOZOOLOGY, P77; Shi Xin-Lu, 1999, Acta Zootaxonomica Sinica, V24, P241; Shi Xin-Lu, 1999, Acta Zootaxonomica Sinica, V24, P361; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Siebert S, 2005, BIOINFORMATICS, V21, P3352, DOI 10.1093/bioinformatics/bti550; Snoeyenbos-West OLO, 2002, INT J SYST EVOL MICR, V52, P1901, DOI 10.1099/00207713-52-5-1901; Song WB, 1997, ARCH PROTISTENKD, V147, P265, DOI 10.1016/S0003-9365(97)80053-X; Stoeck T, 2007, J EUKARYOT MICROBIOL, V54, P436, DOI 10.1111/j.1550-7408.2007.00283.x; Struck TH, 2006, SYST BIOL, V55, P1, DOI 10.1080/10635150500354910; Struder-Kypke MC, 2006, PROTIST, V157, P261, DOI 10.1016/j.protis.2006.03.003; Sung GH, 2007, MOL PHYLOGENET EVOL, V44, P1204, DOI 10.1016/j.ympev.2007.03.011; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TUFFRAU M, 1979, T AM MICROSC SOC, V98, P521, DOI 10.2307/3225902; TUFFRAU M, 1987, ANN SCI NAT ZOOL, V8, P111; Tuffrau M., 1994, TRAIT ZOOLOGIE INFUS, P83; Wicklow B.J., 1983, Dissertation Abstracts International B Sciences and Engineering, V43, P2135; WICKLOW BJ, 1990, EUR J PROTISTOL, V26, P182, DOI 10.1016/S0932-4739(11)80113-6; Yi Z, 2008, J ZOOL, V275, P268, DOI 10.1111/j.1469-7998.2008.00438.x; Yi ZZ, 2008, EUR J PROTISTOL, V44, P45, DOI 10.1016/j.ejop.2007.08.002; Yi ZZ, 2010, SYST BIODIVERS, V8, P149, DOI 10.1080/14772000903523493; Yi ZZ, 2009, ZOOL J LINN SOC-LOND, V157, P227, DOI 10.1111/j.1096-3642.2008.00524.x; Yi ZZ, 2009, PROG NAT SCI-MATER, V19, P581, DOI 10.1016/j.pnsc.2008.05.033; Yi ZZ, 2009, MOL PHYLOGENET EVOL, V50, P599, DOI 10.1016/j.ympev.2008.12.006; Yi ZZ, 2008, EUR J PROTISTOL, V44, P254, DOI 10.1016/j.ejop.2007.12.002; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	97	64	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17471	10.1371/journal.pone.0017471	http://dx.doi.org/10.1371/journal.pone.0017471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408166	gold, Green Submitted, Green Published			2022-12-25	WOS:000288170000033
J	English, P; Blount, B; Wong, M; Copan, L; Olmedo, L; Patton, S; Haas, R; Atencio, R; Xu, JH; Valentin-Blasini, L				English, Paul; Blount, Ben; Wong, Michelle; Copan, Lori; Olmedo, Luis; Patton, Sharyle; Haas, Robert; Atencio, Ryan; Xu, Juhua; Valentin-Blasini, Liza			Direct Measurement of Perchlorate Exposure Biomarkers in a Highly Exposed Population: A Pilot Study	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; SODIUM-IODIDE SYMPORTER; UNITED-STATES; INHIBITORS; CREATININE; PREGNANCY; NITRATE; HEALTH; WOMEN	Exposure to perchlorate is ubiquitous in the United States and has been found to be widespread in food and drinking water. People living in the lower Colorado River region may have perchlorate exposure because of perchlorate in ground water and locally-grown produce. Relatively high doses of perchlorate can inhibit iodine uptake and impair thyroid function, and thus could impair neurological development in utero. We examined human exposures to perchlorate in the Imperial Valley among individuals consuming locally grown produce and compared perchlorate exposure doses to state and federal reference doses. We collected 24-hour urine specimen from a convenience sample of 31 individuals and measured urinary excretion rates of perchlorate, thiocyanate, nitrate, and iodide. In addition, drinking water and local produce were also sampled for perchlorate. All but two of the water samples tested negative for perchlorate. Perchlorate levels in 79 produce samples ranged from non-detect to 1816 ppb. Estimated perchlorate doses ranged from 0.02 to 0.51 mu g/kg of body weight/day. Perchlorate dose increased with the number of servings of dairy products consumed and with estimated perchlorate levels in produce consumed. The geometric mean perchlorate dose was 70% higher than for the NHANES reference population. Our sample of 31 Imperial Valley residents had higher perchlorate dose levels compared with national reference ranges. Although none of our exposure estimates exceeded the U. S. EPA reference dose, three participants exceeded the acceptable daily dose as defined by bench mark dose methods used by the California Office of Environmental Health Hazard Assessment.	[English, Paul; Wong, Michelle] Calif Dept Publ Hlth, Calif Environm Hlth Tracking Program, Richmond, CA 94804 USA; [Blount, Ben; Valentin-Blasini, Liza] Ctr Dis Control & Prevent, Div Sci Lab, Atlanta, GA USA; [Copan, Lori] Calif Dept Publ Hlth, Environm Hlth Invest Branch, Richmond, CA USA; [Olmedo, Luis] Comite Civ Valle, Brawley, CA USA; [Patton, Sharyle] Commonweal, Bolinas, CA USA; [Haas, Robert; Xu, Juhua] Calif Dept Publ Hlth, Food & Drug Lab Branch, Richmond, CA USA; [Atencio, Ryan] Calif Dept Tox Subst & Control, El Centro, CA USA	California Department of Public Health; Centers for Disease Control & Prevention - USA; California Department of Public Health; California Department of Public Health	English, P (corresponding author), Calif Dept Publ Hlth, Calif Environm Hlth Tracking Program, Richmond, CA 94804 USA.	penglish@dhs.ca.gov	English, Paul/GQB-1018-2022		Centers for Disease Control and Prevention (CDC) [1U38EH000186-01]; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [U38EH000186] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This project was funded in part by Grant/Cooperative Agreement Number 1U38EH000186-01 from the Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Berbel P, 2009, THYROID, V19, P511, DOI 10.1089/thy.2008.0341; Blount BC, 2007, J EXPO SCI ENV EPID, V17, P400, DOI 10.1038/sj.jes.7500535; Blount BC, 2006, ENVIRON HEALTH PERSP, V114, P1865, DOI 10.1289/ehp.9466; Blount BC, 2010, ENVIRON SCI TECHNOL, V44, P9564, DOI 10.1021/es1025195; Blount BC, 2009, ENVIRON SCI TECHNOL, V43, P7543, DOI 10.1021/es9008486; California Environmental Protection Agency (CalEPA), 2004, PUBL HLTH GOALS CHEM; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Corder G. W., 2009, NONPARAMETRIC STAT N, DOI DOI 10.1002/; De Groef B, 2006, EUR J ENDOCRINOL, V155, P17, DOI 10.1530/eje.1.02190; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; HARVEY GJ, 2005, GEOL SOC AM 2005 SAL; Kirk AB, 2006, ANAL CHIM ACTA, V567, P4, DOI 10.1016/j.aca.2006.03.047; Klein RZ, 2001, J MED SCREEN, V8, P18, DOI 10.1136/jms.8.1.18; Krynitsky AJ, 2004, ANAL CHEM, V76, P5518, DOI 10.1021/ac049281+; Mage DT, 2004, J EXPO ANAL ENV EPID, V14, P457, DOI 10.1038/sj.jea.7500343; Murray CW, 2008, J EXPO SCI ENV EPID, V18, P571, DOI 10.1038/sj.jes.7500648; NAS, 2005, HLTH IMPL PERCHL ING; Poppe K, 2008, NAT CLIN PRACT ENDOC, V4, P394, DOI 10.1038/ncpendmet0846; Sanchez CA, 2008, J AGR FOOD CHEM, V56, P5443, DOI 10.1021/jf0733923; Sanchez CA, 2009, J EXPO SCI ENV EPID, V19, P359, DOI 10.1038/jes.2008.26; Tonacchera M, 2004, THYROID, V14, P1012, DOI 10.1089/thy.2004.14.1012; U.S. Environ. Prot. Agency, 2007, METH 6850 PERCHL WAT; *US EPA, 2005, OCC DAT ACC UNR CONT; US EPA (U.S. Environmental Protection Agency), 2005, PERCHL PERCHL SALTS; Valentin-Blasini L, 2007, J CHROMATOGR A, V1155, P40, DOI 10.1016/j.chroma.2007.04.014; Yu L, 2004, ECOTOX ENVIRON SAFE, V58, P44, DOI 10.1016/S0147-6513(03)00108-8	26	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17015	10.1371/journal.pone.0017015	http://dx.doi.org/10.1371/journal.pone.0017015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394205	Green Published, gold, Green Submitted			2022-12-25	WOS:000288025500005
J	Persson, C; Jia, YB; Pettersson, H; Dillner, J; Nyren, O; Ye, WM				Persson, Christina; Jia, Yanbin; Pettersson, Helena; Dillner, Joakim; Nyren, Olof; Ye, Weimin			H. pylori Seropositivity before Age 40 and Subsequent Risk of Stomach Cancer: A Glimpse of the True Relationship?	PLOS ONE			English	Article							HELICOBACTER-PYLORI; GASTRIC-CANCER; ATROPHIC GASTRITIS; INFECTION; EPIDEMIOLOGY; ADENOCARCINOMAS; COMPLETENESS; METAANALYSIS; IMMUNOBLOT; CARCINOMA	Stomach carcinogenesis involves mucosal and luminal changes that favor spontaneous disappearance of Helicobacter pylori. Therefore, the association between the infection and cancer risk might typically be underestimated. As acquisition of the infection almost invariably occurs before adulthood, the serostatus at age 16-40 should best reflect the lifetime occurrence of the infection. We therefore conducted a case-control study nested within a historic cohort of about 400,000 individuals who donated sera before age 40 to either of two large Swedish Biobanks between 1968 and 2006, and whose records were linked to complete nationwide registers. For each stomach adenocarcinoma case occurring at least 5 years after serum donation 2 controls were selected matched on age, sex and year of donation and biobank. Serum immunoglobulin G antibodies against H. pylori cell-surface antigens (Hp-CSAs) were measured with an enzyme-linked immunosorbent assay and antibodies against CagA with an immunoblot assay. Conditional logistic regression models were used to estimate odds ratios (ORs) for stomach adenocarcinoma among H. pylori infected relative to uninfected. We confirmed 59 incident cases of stomach adenocarcinoma (41 non-cardia tumors) during follow-up. ORs for non-cardia stomach adenocarcinoma among subjects with Hp-CSA antibodies (regardless of CagA serostatus), antibodies against CagA (regardless of Hp-CSA serostatus), and antibodies to both, relative to those who were seronegative to both, were 17.1 (95% confidence interval [CI] 4.0-72.9), 10.9 (95% CI 3.2-36.9), and 48.5 (95% CI 5.8-407.4), respectively. H. pylori infection is a much stronger risk factor for non-cardia stomach adenocarcinoma than initially realized. However, further studies are needed to answer whether it is a necessary cause, as the possibility of misclassification of H. pylori status could not be ruled out in our study.	[Persson, Christina; Jia, Yanbin; Dillner, Joakim; Nyren, Olof; Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Pettersson, Helena] Swedish Inst Infect Dis Control, Solna, Sweden; [Dillner, Joakim] Karolinska Inst, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Karolinska Institutet	Persson, C (corresponding author), NCI, Div Canc Epidemiol & Genet, Hormonal & Reprod Epidemiol Branch, Bethesda, MD 20892 USA.	Weimin.Ye@ki.se			Martin Rind Stiftelse; Swedish Research Council [K2009-69X-15372-05-2]	Martin Rind Stiftelse; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by a grant from Martin Rind Stiftelse and partly by a grant from the Swedish Research Council (K2009-69X-15372-05-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamu MA, 2010, EUR J EPIDEMIOL, V25, P439, DOI 10.1007/s10654-010-9482-0; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Brenner H, 2004, AM J EPIDEMIOL, V159, P252, DOI 10.1093/aje/kwh039; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; CAVALEIROPINTO M, 2010, CANC CAUSES CONTROL; CRABTREE JE, 1995, J CLIN PATHOL, V48, P41, DOI 10.1136/jcp.48.1.41; de Vries AC, 2007, HELICOBACTER, V12, P22, DOI 10.1111/j.1523-5378.2007.00562.x; Ekstrom AM, 2001, GASTROENTEROLOGY, V121, P784, DOI 10.1053/gast.2001.27999; Eslick GD, 1999, AM J GASTROENTEROL, V94, P2373, DOI 10.1111/j.1572-0241.1999.01360.x; FORMAN D, 1994, LANCET, V343, P243, DOI 10.1016/S0140-6736(94)91034-0; Forman D, 2006, BEST PRACT RES CL GA, V20, P633, DOI 10.1016/j.bpg.2006.04.008; Hsu PI, 2007, AM J GASTROENTEROL, V102, P725, DOI 10.1111/j.1572-0241.2006.01109.x; IARC, 1994, IARC MONOGRAPHS EVAL, VVolume 61, P1; Kamangar F, 2006, JNCI-J NATL CANCER I, V98, P1445, DOI 10.1093/jnci/djj393; Klaamas K, 1996, INT J CANCER, V67, P1, DOI 10.1002/(SICI)1097-0215(19960703)67:1<1::AID-IJC1>3.0.CO;2-0; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Malaty HM, 2003, HELICOBACTER, V8, P8, DOI 10.1046/j.1523-5378.2003.00163.x; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Storskrubb T, 2008, SCAND J GASTROENTERO, V43, P1448, DOI 10.1080/00365520802273025; Takashima M, 2001, GUT, V48, P765, DOI 10.1136/gut.48.6.765; TALLEY NJ, 1991, J CLIN MICROBIOL, V29, P1635, DOI 10.1128/JCM.29.8.1635-1639.1991; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Veijola L, 2008, CLIN VACCINE IMMUNOL, V15, P1705, DOI 10.1128/CVI.00165-08; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; WEILAND O, 1980, SCAND J INFECT DIS, V12, P171, DOI 10.3109/inf.1980.12.issue-3.03; Yanaoka K, 2008, INT J CANCER, V123, P917, DOI 10.1002/ijc.23571	27	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17404	10.1371/journal.pone.0017404	http://dx.doi.org/10.1371/journal.pone.0017404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399687	Green Submitted, gold, Green Published			2022-12-25	WOS:000287933300021
J	Morales-Garcia, JA; Redondo, M; Alonso-Gil, S; Gil, C; Perez, C; Martinez, A; Santos, A; Perez-Castillo, A				Morales-Garcia, Jose A.; Redondo, Miriam; Alonso-Gil, Sandra; Gil, Carmen; Perez, Concepcion; Martinez, Ana; Santos, Angel; Perez-Castillo, Ana			Phosphodiesterase 7 Inhibition Preserves Dopaminergic Neurons in Cellular and Rodent Models of Parkinson Disease	PLOS ONE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; BINDING-PROTEIN-BETA; ANTIINFLAMMATORY DRUGS; SUBSTANTIA-NIGRA; PDE7 INHIBITORS; MESSENGER-RNA; RAT-BRAIN; CAMP; CREB; CELLS	Background: Phosphodiesterase 7 plays a major role in down-regulation of protein kinase A activity by hydrolyzing cAMP in many cell types. This cyclic nucleotide plays a key role in signal transduction in a wide variety of cellular responses. In the brain, cAMP has been implicated in learning, memory processes and other brain functions. Methodology/Principal Findings: Here we show a novel function of phosphodiesterase 7 inhibition on nigrostriatal dopaminergic neuronal death. We found that S14, a heterocyclic small molecule inhibitor of phosphodiesterase 7, conferred significant neuronal protection against different insults both in the human dopaminergic cell line SH-SY5Y and in primary rat mesencephalic cultures. S14 treatment also reduced microglial activation, protected dopaminergic neurons and improved motor function in the lipopolysaccharide rat model of Parkinson disease. Finally, S14 neuroprotective effects were reversed by blocking the cAMP signaling pathways that operate through cAMP-dependent protein kinase A. Conclusions/Significance: Our findings demonstrate that phosphodiesterase 7 inhibition can protect dopaminergic neurons against different insults, and they provide support for the therapeutic potential of phosphodiesterase 7 inhibitors in the treatment of neurodegenerative disorders, particularly Parkinson disease.	[Morales-Garcia, Jose A.; Alonso-Gil, Sandra; Perez-Castillo, Ana] CSIC UAM, Inst Invest Biomed, Madrid, Spain; [Morales-Garcia, Jose A.; Alonso-Gil, Sandra; Perez-Castillo, Ana] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Redondo, Miriam; Gil, Carmen; Perez, Concepcion; Martinez, Ana] CSIC, Inst Quim Med, E-28006 Madrid, Spain; [Santos, Angel] Univ Complutense Madrid, Fac Med, Dept Bioquim & Biol Mol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Medica (IQM); CSIC - Instituto de Quimica Organica General (IQOG); Complutense University of Madrid	Morales-Garcia, JA (corresponding author), CSIC UAM, Inst Invest Biomed, Arturo Duperier 4, Madrid, Spain.	aperez@iib.uam.es	Perez-Castillo, Ana/A-9505-2015; Perez, Concepcion/K-3684-2014; Morales-Garcia, Jose A/L-4552-2014; Martinez, Ana/L-6414-2014; Gil, Carmen/J-8932-2014; Martin, Perez/B-4158-2015; Santos, Angel/K-3744-2014	Perez, Concepcion/0000-0001-7183-4035; Morales-Garcia, Jose A/0000-0001-9008-0056; Martinez, Ana/0000-0002-2707-8110; Gil, Carmen/0000-0002-3882-6081; Martin, Perez/0000-0001-7183-4035; Santos, Angel/0000-0002-7551-8483; Perez-Castillo, Ana/0000-0002-2632-5853	Ministerio de Ciencia y Tecnologia [SAF2007-62811, SAF 2010-16365, SAF2009-13015-C02-01]; ARACLON [PET2008-0245]; Instituto de Salud Carlos III (Red Tematica de Investigacion en Esclerosis Multiple); Araclon Biotech	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ARACLON; Instituto de Salud Carlos III (Red Tematica de Investigacion en Esclerosis Multiple)(Instituto de Salud Carlos III); Araclon Biotech	This work was supported by the Ministerio de Ciencia y Tecnologia (www.micinn.es) (SAF2007-62811 and SAF 2010-16365 to A.P.-C.), and SAF2009-13015-C02-01 to A.M., and by the Ministerio de Ciencia y Tecnologia (www.micinn.es) and ARACLON (www.araclon.com) in the joint project PET2008-0245 and by Instituto de Salud Carlos III (Red Tematica de Investigacion en Esclerosis Multiple (to A.M.)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors state that Araclon Biotech has been a commercial funder, together with the MICINN, for this work, but they have not participated in the experimental design on the manuscript and none of the authors is an employee of the company. This funding does not alter the authors' adherence to the PloS ONE policies on sharing data and materials. Some of the results here presented are protected by patent application P200930189 (owner CSIC). A license transfer agreement has been recently reached with ARACLON.	ANDEN NE, 1966, ACTA PHARMACOL TOX, V24, P263; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Castano T, 2009, CHEMMEDCHEM, V4, P866, DOI 10.1002/cmdc.200900043; Castro A, 2005, MED RES REV, V25, P229, DOI 10.1002/med.20020; Castro A, 2008, EUR J MED CHEM, V43, P1349, DOI 10.1016/j.ejmech.2007.10.027; Charles MP, 2003, BIOCHEM BIOPH RES CO, V304, P795, DOI 10.1016/S0006-291X(03)00666-1; Chen HQ, 2008, NEUROSCI LETT, V448, P175, DOI 10.1016/j.neulet.2008.10.046; Chen HL, 2003, ARCH NEUROL-CHICAGO, V60, P1059, DOI 10.1001/archneur.60.8.1059; Cicchetti F, 2002, EUR J NEUROSCI, V15, P991, DOI 10.1046/j.1460-9568.2002.01938.x; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Cortes-Canteli M, 2004, J BIOL CHEM, V279, P14409, DOI 10.1074/jbc.M313253200; Cortes-Canteli M, 2008, J CELL SCI, V121, P1224, DOI 10.1242/jcs.025031; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Dutta G, 2008, FUND CLIN PHARMACOL, V22, P453, DOI 10.1111/j.1472-8206.2008.00616.x; Gagne JJ, 2010, NEUROLOGY, V74, P995, DOI 10.1212/WNL.0b013e3181d5a4a3; Giembycz MA, 2006, CURR PHARM DESIGN, V12, P3207, DOI 10.2174/138161206778194123; Gil C, 2008, EXPERT OPIN THER PAT, V18, P1127, DOI 10.1517/13543776.18.10.1127; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; Heneka MT, 2000, J NEUROSCI, V20, P6862, DOI 10.1523/JNEUROSCI.20-18-06862.2000; Houslay MD, 2000, MOL PHARMACOL, V58, P659, DOI 10.1124/mol.58.4.659; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Kleppisch Thomas, 2009, V191, P71, DOI 10.1007/978-3-540-68964-5_5; Lastres-Becker I, 2008, MOL CELL NEUROSCI, V39, P291, DOI 10.1016/j.mcn.2008.07.009; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Liu B, 2000, J PHARMACOL EXP THER, V293, P607; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; Luna-Medina R, 2007, J NEUROSCI, V27, P5766, DOI 10.1523/JNEUROSCI.1004-07.2007; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Martinez A, 2000, J MED CHEM, V43, P683, DOI 10.1021/jm990382n; Mccoy MK, 2006, J NEUROSCI, V26, P9365, DOI 10.1523/JNEUROSCI.1504-06.2006; McGeer EG, 2007, CNS DRUGS, V21, P789, DOI 10.2165/00023210-200721100-00001; McGeer PL, 2003, ANN NEUROL, V54, P599, DOI 10.1002/ana.10728; Mehats C, 2002, TRENDS ENDOCRIN MET, V13, P29, DOI 10.1016/S1043-2760(01)00523-9; Miro X, 2001, SYNAPSE, V40, P201, DOI 10.1002/syn.1043; Morales-Garcia JA, 2009, J NEUROSCI RES, V87, P3687, DOI 10.1002/jnr.22165; Nakata A, 2002, CLIN EXP IMMUNOL, V128, P460, DOI 10.1046/j.1365-2249.2002.01856.x; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Orr CF, 2005, BRAIN, V128, P2665, DOI 10.1093/brain/awh625; Ouyang MX, 2006, J NEUROCHEM, V97, P234, DOI 10.1111/j.1471-4159.2006.03730.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pham N, 2000, CURR BIOL, V10, P555, DOI 10.1016/S0960-9822(00)00473-5; Reyes-Irisarri E, 2005, NEUROSCIENCE, V132, P1173, DOI 10.1016/j.neuroscience.2005.01.050; Sasaki T, 2002, BIOCHEM J, V361, P211, DOI 10.1042/0264-6021:3610211; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Stetler RA, 2010, P NATL ACAD SCI USA, V107, P3204, DOI 10.1073/pnas.1000030107; TAKAHASHI T, 1994, J NEURAL TRANSM-GEN, V98, P107, DOI 10.1007/BF01277014; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Toledo-Aral JJ, 2002, BRAIN RES BULL, V57, P847, DOI 10.1016/S0361-9230(01)00771-7; Townsend KP, 2005, FASEB J, V19, P1592, DOI 10.1096/fj.04-3620rev; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Volakakis N, 2010, P NATL ACAD SCI USA, V107, P12317, DOI 10.1073/pnas.1007088107	56	74	75	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17240	10.1371/journal.pone.0017240	http://dx.doi.org/10.1371/journal.pone.0017240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390306	Green Published, Green Submitted, gold			2022-12-25	WOS:000287761700039
J	Gupta, DK; Shah, P; Misra, A; Bharadwaj, S; Gulati, S; Gupta, N; Sharma, R; Pandey, RM; Goel, K				Gupta, Deepak Kumar; Shah, Priyali; Misra, Anoop; Bharadwaj, Swati; Gulati, Seema; Gupta, Nidhi; Sharma, Rekha; Pandey, Ravindra M.; Goel, Kashish			Secular Trends in Prevalence of Overweight and Obesity from 2006 to 2009 in Urban Asian Indian Adolescents Aged 14-17 Years	PLOS ONE			English	Article							BODY-MASS INDEX; ABDOMINAL ADIPOSE-TISSUE; METABOLIC SYNDROME; INSULIN-RESISTANCE; SCHOOL-CHILDREN; UNITED-STATES; US CHILDREN; ADULTS; SCHOOLCHILDREN; EPIDEMIOLOGY	The present study examines the secular trends in prevalence of overweight and obesity among urban Asian Indian adolescents in New Delhi (North India). The data were derived from cross-sectional sampling of children, 3493 in year 2006 and 4908 in year 2009, aged 14-17 years studying in privately-funded and government-funded schools. Age, gender and Asian Indian-specific cut offs of body mass index (BMI) were used to define overweight and obesity. The prevalence of obesity increased significantly from 9.8% in 2006 to 11.7% in 2009 (p<0.01), whereas underweight decreased from 11.3% to 3.9% (p<0.001). There was a significantly higher risk of being overweight (OR 1.28; 95% CI, 1.15-1.42) and obese (OR 1.44; 95% CI, 1.24-1.66) in year 2009 than 2006, after adjusting for age, gender and type of school. Males and privately-funded school children had significantly higher increase in prevalence and risk of being overweight and obese over the three years. In conclusion, this study showed an increasing trend in prevalence of overweight and obesity in urban Asian Indian adolescents. More specifically, the study showed the association of this increasing trend of overweight and obesity prevalence with male gender and high socio-economic status, calling for an urgent need for immediate and targeted preventive measures.	[Gupta, Deepak Kumar; Shah, Priyali; Misra, Anoop; Bharadwaj, Swati; Gulati, Seema; Gupta, Nidhi; Sharma, Rekha; Goel, Kashish] Natl Diabet Obes & Cholesterol Dis Fdn, SDA, New Delhi, India; [Gupta, Deepak Kumar; Shah, Priyali; Misra, Anoop; Bharadwaj, Swati; Gulati, Seema; Gupta, Nidhi; Sharma, Rekha; Goel, Kashish] Diabet Fdn India, SDA, New Delhi, India; [Misra, Anoop] Fortis Flt Lt Rajan Dhall Hosp, Dept Diabet & Metab Dis, New Delhi, India; [Pandey, Ravindra M.] All India Inst Med Sci, Dept Biostat, New Delhi, India; [Gupta, Nidhi] Children Hosp Michigan, Dept Pediat, Detroit, MI USA; [Goel, Kashish] Wayne State Univ, Dept Internal Med, Detroit, MI 48202 USA	All India Institute of Medical Sciences (AIIMS) New Delhi; Children's Hospital of Michigan; Wayne State University	Gupta, DK (corresponding author), Natl Diabet Obes & Cholesterol Dis Fdn, SDA, New Delhi, India.	anoopmisra@metabolicresearchindia.com	Gupta, Deepak/U-4569-2019; GARG, RAKESH/H-4591-2011; Goel, Kashish/E-4916-2011	Gupta, Deepak/0000-0002-0722-9030; GARG, RAKESH/0000-0001-5842-8024; Gupta, Nidhi/0000-0001-6485-3318; Shah (Pathak), Priyali/0000-0003-2806-6100	World Diabetes Foundation; Rotary Club Delhi, South East	World Diabetes Foundation; Rotary Club Delhi, South East	World Diabetes Foundation (http://www.worlddiabetesfoundation.org/) and Rotary Club Delhi, South East. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; ADLAKHA A, 1996, POPULATION TRENDS IN; Bhardwaj S, 2008, ASIA PAC J CLIN NUTR, V17, P172; Blum WF, 1997, J CLIN ENDOCR METAB, V82, P2904, DOI 10.1210/jc.82.9.2904; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dietz WH, 1999, AM J CLIN NUTR, V70, p123S; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Ford ES, 2008, J CLIN ENDOCR METAB, V93, pS1, DOI 10.1210/jc.2008-1356; Goel K, 2010, HEART, V96, P579, DOI 10.1136/hrt.2009.183236; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; GUPTA A K, 1990, Indian Pediatrics, V27, P333; Gupta N, 2010, J AM COLL NUTR, V29, P81, DOI 10.1080/07315724.2010.10719820; Gupta R, 1998, Indian Heart J, V50, P511; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Kapil Umesh, 2002, Indian Pediatr, V39, P449; Kaur S, 2008, ASIA PAC J CLIN NUTR, V17, P592; Kelishadi R, 2007, EPIDEMIOL REV, V29, P62, DOI 10.1093/epirev/mxm003; Lissner L, 2010, OBES REV, V11, P553, DOI 10.1111/j.1467-789X.2009.00696.x; Misra A, 2003, INT J OBESITY, V27, P1294, DOI 10.1038/sj.ijo.0802412; Misra A, 2004, NUTRITION, V20, P482, DOI 10.1016/j.nut.2004.01.020; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Misra A, 2007, NUTRITION, V23, P895, DOI 10.1016/j.nut.2007.08.018; Misra A, 2010, METAB SYNDR RELAT D, V8, P243, DOI 10.1089/met.2009.0046; Mohan Bishav, 2004, Indian Heart J, V56, P310; Mukherjee D., 1999, SOCIOECONOMIC STATUS; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Neovius M, 2005, INT J OBESITY, V29, P163, DOI 10.1038/sj.ijo.0802867; *NFHS, 2005, KEY FIND REP NAT FAM; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Pandey RM, 2009, METAB SYNDR RELAT D, V7, P133, DOI 10.1089/met.2008.0053; Pohlmann VC, 1956, J EDUC SOCIOL, V29, P392, DOI 10.2307/2264801; Popkin BM, 1998, NUTR REV, V56, P106; Premanath M, 2010, INDIAN PEDIATR, V47, P171, DOI 10.1007/s13312-010-0027-0; Raj M, 2007, NATL MED J INDIA, V20, P288; Ramachandran A, 2002, DIABETES RES CLIN PR, V57, P185, DOI 10.1016/S0168-8227(02)00056-6; Rasheed P, 1998, PUBLIC HEALTH, V112, P409, DOI 10.1016/S0033-3506(98)00288-1; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Shah P, 2010, BRIT J NUTR, V104, P427, DOI 10.1017/S0007114510000681; Sharma A, 2007, PUBLIC HEALTH NUTR, V10, P485, DOI 10.1017/S1368980007223894; Singhal N, 2010, ANN NUTR METAB, V56, P176, DOI 10.1159/000282281; Subramanyam MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011392; Troiano RP, 1998, PEDIATRICS, V101, P497; Wang Y, 2009, OBES REV, V10, P456, DOI 10.1111/j.1467-789X.2009.00568.x; Wasir JS, 2004, METAB SYNDR RELAT D, V2, P14, DOI 10.1089/met.2004.2.14	53	68	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17221	10.1371/journal.pone.0017221	http://dx.doi.org/10.1371/journal.pone.0017221			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383840	Green Published, Green Submitted, gold			2022-12-25	WOS:000287657500044
J	Akita, H; Nagano, H; Takeda, Y; Eguchi, H; Wada, H; Kobayashi, S; Marubashi, S; Tanemura, M; Takahashi, H; Ohigashi, H; Tomita, Y; Ishikawa, O; Mori, M; Doki, Y				Akita, H.; Nagano, H.; Takeda, Y.; Eguchi, H.; Wada, H.; Kobayashi, S.; Marubashi, S.; Tanemura, M.; Takahashi, H.; Ohigashi, H.; Tomita, Y.; Ishikawa, O.; Mori, M.; Doki, Y.			Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity	ONCOGENE			English	Article						pancreatic cancer; Ep-CAM; prognosis; invasion; surgery	CARCINOMA-ASSOCIATED ANTIGEN; ADHESION MOLECULE; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; THERAPEUTIC TARGET; POOR SURVIVAL; EXPRESSION; ADENOCARCINOMA; EPCAM; GEMCITABINE	The identification of molecular markers useful for predicting prognosis in pancreatic cancer patients is crucial for advances in disease management. The epithelial cell adhesion molecule (Ep-CAM) is known to express in most epithelial malignancies and was reported as a tumor marker or a candidate of molecular targeting therapy. However, the clinical significance of Ep-CAM expression in pancreatic cancer is not well-known. We determined the difference of malignant potential between parental and Ep-CAM-transfected pancreatic cancer cell lines by using proliferation, invasion and migration assay. Furthermore, we determined the relationship between tumoral Ep-CAM expression of resected specimens and clinical prognosis in 95 pancreatic cancer patients receiving radical surgery at two different cancer centers. One of the three Ep-CAM-transfected cell lines showed significantly low proliferation rate compared with the parental cell, while there was no difference in the other two cell lines. In invasion and migration assays, Ep-CAM-transfected cells showed significantly lower malignant potential than parental in all of the three cell lines. In 95 pancreatic cancer patients, 47 patients showed high-Ep-CAM expression, while 48 patients showed low, and there was no difference of clinicopathological features between Ep-CAM high and low-expression group. High-Ep-CAM expression group showed significantly good prognosis in overall survival (3-year survival; 56.2 versus 19.2%, P = 0.0018) as well as in disease-free survival (3-year survival; 40.3 versus 14.4%, P = 0.038) compared with low-expression group. In addition, the impact of Ep-CAM was observed strongly in LN-negative group when the influence of Ep-CAM was examined with dividing patients into LN-positive and negative group. In multivariate analysis, Ep-CAM expression was one of the independent prognostic factors as well as histology and lymph node metastasis. Ep-CAM expression was found to be related to the suppression of pancreatic cancer cell activity and the good prognosis in pancreatic cancer patients receiving the curative resection. Oncogene (2011) 30, 3468-3476; doi:10.1038/onc.2011.59; published online 14 March 2011	[Akita, H.; Nagano, H.; Takeda, Y.; Eguchi, H.; Wada, H.; Kobayashi, S.; Marubashi, S.; Tanemura, M.; Mori, M.; Doki, Y.] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka 5650871, Japan; [Takahashi, H.; Ohigashi, H.; Ishikawa, O.] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan; [Tomita, Y.] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol & Cytol, Osaka, Japan	Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases	Nagano, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Surg, 2-2,Yamadaoka E-2, Suita, Osaka 5650871, Japan.	hnagano@gesurg.med.osaka-u.ac.jp	Takahashi, Hidenori/I-1231-2019	Takahashi, Hidenori/0000-0003-4801-3540	Grants-in-Aid for Scientific Research [21590412] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Armstrong A, 2003, CANCER BIOL THER, V2, P320, DOI 10.4161/cbt.2.4.451; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Balzar M, 1999, EXP CELL RES, V246, P108, DOI 10.1006/excr.1998.4263; Basak S, 1998, JNCI-J NATL CANCER I, V90, P691, DOI 10.1093/jnci/90.9.691; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Calabrese G, 2001, CYTOGENET CELL GENET, V92, P164, DOI 10.1159/000056891; Cirulli V, 1998, J CELL BIOL, V140, P1519, DOI 10.1083/jcb.140.6.1519; EDWARDS DP, 1986, CANCER RES, V46, P1306; Evans DB, 2008, J CLIN ONCOL, V26, P3496, DOI 10.1200/JCO.2007.15.8634; Fong D, 2008, J CLIN PATHOL, V61, P31, DOI 10.1136/jcp.2006.037333; Gastl G, 2000, LANCET, V356, P1981, DOI 10.1016/S0140-6736(00)03312-2; GEER RJ, 1993, AM J SURG, V165, P68, DOI 10.1016/S0002-9610(05)80406-4; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Gosens MJEM, 2007, MODERN PATHOL, V20, P221, DOI 10.1038/modpathol.3800733; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Infante JR, 2007, J CLIN ONCOL, V25, P319, DOI 10.1200/JCO.2006.07.8824; Jojovic M, 1998, HISTOCHEM J, V30, P723, DOI 10.1023/A:1003486630314; Kahlert C, 2009, BRIT J CANCER, V101, P457, DOI 10.1038/sj.bjc.6605136; KAYAHARA M, 1993, CANCER, V72, P2118, DOI 10.1002/1097-0142(19931001)72:7<2118::AID-CNCR2820720710>3.0.CO;2-4; Kimura H, 2007, INT J ONCOL, V30, P171; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; Litvinov SV, 1996, AM J PATHOL, V148, P865; Manuyakorn A, 2010, J CLIN ONCOL, V28, P1358, DOI 10.1200/JCO.2009.24.5639; MOMBURG F, 1987, CANCER RES, V47, P2883; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; NITECKI SS, 1995, ANN SURG, V221, P59, DOI 10.1097/00000658-199501000-00007; Noda T, 2009, BRIT J CANCER, V100, P1647, DOI 10.1038/sj.bjc.6605064; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Ogawa M, 2004, HEPATOLOGY, V39, P528, DOI 10.1002/hep.20048; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Rao CG, 2005, INT J ONCOL, V27, P49; ROSS AH, 1986, BIOCHEM BIOPH RES CO, V135, P297, DOI 10.1016/0006-291X(86)90976-9; Rothenberg ML, 1996, ANN ONCOL, V7, P347; Sankpal NV, 2009, CANCER RES, V69, P753, DOI 10.1158/0008-5472.CAN-08-2708; Schmidt M, 2008, CLIN CANCER RES, V14, P5849, DOI 10.1158/1078-0432.CCR-08-0669; Seligson DB, 2004, CLIN CANCER RES, V10, P2659, DOI 10.1158/1078-0432.CCR-1132-03; Sener SF, 1999, J AM COLL SURGEONS, V189, P1, DOI 10.1016/S1072-7515(99)00075-7; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; Songun I, 2005, BRIT J CANCER, V92, P1767, DOI 10.1038/sj.bjc.6602519; Staley CA, 1996, AM J SURG, V171, P118, DOI 10.1016/S0002-9610(99)80085-3; Stoecklein NH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-165; Tai KY, 2007, ONCOGENE, V26, P3989, DOI 10.1038/sj.onc.1210176; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Tsujie M, 2003, EXP CELL RES, V289, P143, DOI 10.1016/S0014-4827(03)00263-5; Varga M, 2004, CLIN CANCER RES, V10, P3131, DOI 10.1158/1078-0432.CCR-03-0528; Winter MJ, 2003, AM J PATHOL, V163, P2139, DOI 10.1016/S0002-9440(10)63570-5; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Zhang SL, 1998, CLIN CANCER RES, V4, P2669	50	28	29	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2011	30	31					3468	3476		10.1038/onc.2011.59	http://dx.doi.org/10.1038/onc.2011.59			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	802KA	21399662				2022-12-25	WOS:000293508100007
J	Wang, H; Bell, M; Sreenevasan, U; Hu, H; Liu, J; Dalen, K; Londos, C; Yamaguchi, T; Rizzo, MA; Coleman, R; Gong, DW; Brasaemle, D; Sztalryd, C				Wang, Hong; Bell, Ming; Sreenevasan, Urmilla; Hu, Hong; Liu, Jun; Dalen, Knut; Londos, Constantine; Yamaguchi, Tomohiro; Rizzo, Mark A.; Coleman, Rosalind; Gong, Dawei; Brasaemle, Dawn; Sztalryd, Carole			Unique Regulation of Adipose Triglyceride Lipase (ATGL) by Perilipin 5, a Lipid Droplet-associated Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; DIFFERENTIATION-RELATED PROTEIN; CHANARIN-DORFMAN-SYNDROME; MEDIATED LIPOLYSIS; INSULIN-RESISTANCE; ADIPOCYTES; CGI-58; MICE; OBESITY; TISSUE	Lipolysis is a critical metabolic pathway contributing to energy homeostasis through degradation of triacylglycerides stored in lipid droplets (LDs), releasing fatty acids. Neutral lipid lipases act at the oil/water interface. In mammalian cells, LD surfaces are coated with one or more members of the perilipin protein family, which serve important functions in regulating lipolysis. We investigated mechanisms by which three perilipin proteins control lipolysis by adipocyte triglyceride lipase (ATGL), a key lipase in adipocytes and non-adipose cells. Using a cell culture model, we examined interactions of ATGL and its co-lipase CGI-58 with perilipin 1 (perilipin A), perilipin 2 (adipose differentiation-related protein), and perilipin 5 (LSDP5) using multiple techniques as follows: anisotropy Forster resonance energy transfer, co-immunoprecipitation, [P-32] orthophosphate radiolabeling, and measurement of lipolysis. The results show that ATGL interacts with CGI-58 and perilipin 5; the latter is selectively expressed in oxidative tissues. Both proteins independently recruited ATGL to the LD surface, but with opposite effects; interaction of ATGL with CGI-58 increased lipolysis, whereas interaction of ATGL with perilipin 5 decreased lipolysis. In contrast, neither perilipin 1 nor 2 interacted directly with ATGL. Activation of protein kinase A (PKA) increased [P-32] orthophosphate incorporation into perilipin 5 by 2-fold, whereas neither ATGL nor CGI-58 was labeled under the incubation conditions. Cells expressing both ectopic perilipin 5 and ATGL showed a 3-fold increase in lipolysis following activation of PKA. Our studies establish perilipin 5 as a novel ATGL partner and provide evidence that the protein composition of perilipins at the LD surface regulates lipolytic activity of ATGL.	[Wang, Hong; Bell, Ming; Sreenevasan, Urmilla; Gong, Dawei; Sztalryd, Carole] Univ Maryland, Sch Med, Dept Med,Div Endocrinol, Geriatr Res Educ & Clin Ctr,Baltimore Vet Affairs, Baltimore, MD 21201 USA; [Liu, Jun] Univ Kentucky, Dept Pediat, Lexington, KY 40506 USA; [Dalen, Knut; Londos, Constantine] NIDDK, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA; [Yamaguchi, Tomohiro] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Rizzo, Mark A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Coleman, Rosalind] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Brasaemle, Dawn] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA	Geriatric Research Education & Clinical Center; University System of Maryland; University of Maryland Baltimore; University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Hyogo; University System of Maryland; University of Maryland Baltimore; University of North Carolina; University of North Carolina Chapel Hill; Rutgers State University New Brunswick	Sztalryd, C (corresponding author), Univ Maryland, Sch Med, Dept Med,Div Endocrinol, Geriatr Res Educ & Clin Ctr,Baltimore Vet Affairs, Rm 445,Howard Hall,660 W Redwood St, Baltimore, MD 21201 USA.	csztalry@grecc.umaryland.edu	Gong, Dawei/AAB-4283-2020; Dalen, Knut Tomas/C-4719-2016	Dalen, Knut Tomas/0000-0002-0270-5982	National Institutes of Health [1RO1 DK 075017, R01 DK54797]; NIDDK; American Diabetes Association [1-05-CD-17]; Geriatric Research, Education and Clinical Center; Baltimore Veterans Affairs Health Care Center; Clinical Nutrition Research Unit of Maryland [DK072488]; Grants-in-Aid for Scientific Research [23790098] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488, R01DK054797, P30DK079637, R01DK075017, R21DK067415, R01DK089178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); Geriatric Research, Education and Clinical Center; Baltimore Veterans Affairs Health Care Center; Clinical Nutrition Research Unit of Maryland; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RO1 DK 075017 (to C. S.) and R01 DK54797 (to D. B.) and by Intramural Research Programs of NIDDK. This work was also supported by Career Development Award 1-05-CD-17 from the American Diabetes Association (to C. S.), the Geriatric Research, Education and Clinical Center, Baltimore Veterans Affairs Health Care Center, and Clinical Nutrition Research Unit of Maryland Grant DK072488.	Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; DeFronzo RA, 2010, DIABETOLOGIA, V53, P1270, DOI 10.1007/s00125-010-1684-1; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Magra AL, 2006, J LIPID RES, V47, P2367, DOI 10.1194/jlr.M600157-JLR200; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726; Wang SP, 2001, OBES RES, V9, P119, DOI 10.1038/oby.2001.15; WILLIAMS ML, 1991, BIOCHIM BIOPHYS ACTA, V1096, P162, DOI 10.1016/0925-4439(91)90055-E; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2006, MOL CELL BIOCHEM, V284, P167, DOI 10.1007/s11010-005-9045-y; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	38	123	132	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.207779	http://dx.doi.org/10.1074/jbc.M110.207779			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21393244	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000290022800010
J	Ferrari, S; Sanguinetti, M; Torelli, R; Posteraro, B; Sanglard, D				Ferrari, Selene; Sanguinetti, Maurizio; Torelli, Riccardo; Posteraro, Brunella; Sanglard, Dominique			Contribution of CgPDR1-Regulated Genes in Enhanced Virulence of Azole-Resistant Candida glabrata	PLOS ONE			English	Article							TRANSPORTER-ENCODING GENE; GENOME-WIDE EXPRESSION; SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; CRYPTOCOCCUS-NEOFORMANS; TRANSCRIPTION FACTOR; ANTIFUNGAL AGENTS; IN-VIVO; YEAST	In Candida glabrata, the transcription factor CgPdr1 is involved in resistance to azole antifungals via upregulation of ATP binding cassette (ABC)-transporter genes including at least CgCDR1, CgCDR2 and CgSNQ2. A high diversity of GOF (gain-of-function) mutations in CgPDR1 exists for the upregulation of ABC-transporters. These mutations enhance C. glabrata virulence in animal models, thus indicating that CgPDR1 might regulate the expression of yet unidentified virulence factors. We hypothesized that CgPdr1-dependent virulence factor(s) should be commonly regulated by all GOF mutations in CgPDR1. As deduced from transcript profiling with microarrays, a high number of genes (up to 385) were differentially regulated by a selected number (7) of GOF mutations expressed in the same genetic background. Surprisingly, the transcriptional profiles resulting from expression of GOF mutations showed minimal overlap in co-regulated genes. Only two genes, CgCDR1 and PUP1 (for PDR1 upregulated and encoding a mitochondrial protein), were commonly upregulated by all tested GOFs. While both genes mediated azole-resistance, although to different extents, their deletions in an azoleresistant isolate led to a reduction of virulence and decreased tissue burden as compared to clinical parents. As expected from their role in C. glabrata virulence, the two genes were expressed as well in vitro and in vivo. The individual overexpression of these two genes in a CgPDR1-independent manner could partially restore phenotypes obtained in clinical isolates. These data therefore demonstrate that at least these two CgPDR1-dependent and -upregulated genes contribute to the enhanced virulence of C. glabrata that acquired azole resistance.	[Sanguinetti, Maurizio; Torelli, Riccardo; Posteraro, Brunella] Univ Cattolica Sacro Cuore, Inst Microbiol, Rome, Italy; [Ferrari, Selene; Sanglard, Dominique] Univ Lausanne, Inst Microbiol, Lausanne, Switzerland; [Ferrari, Selene; Sanglard, Dominique] Univ Hosp Ctr, Lausanne, Switzerland	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Lausanne	Ferrari, S (corresponding author), Univ Lausanne, Inst Microbiol, Lausanne, Switzerland.	dominique.sanglard@chuv.ch	Sanglard, Dominique/K-6032-2017; Sanguinetti, Maurizio/A-1453-2019; Torelli, Riccardo/N-8813-2019; Posteraro, Brunella/K-8499-2018; Torelli, Riccardo/K-8822-2018	Sanglard, Dominique/0000-0002-5244-4178; Sanguinetti, Maurizio/0000-0002-9780-7059; Posteraro, Brunella/0000-0002-1663-7546; Torelli, Riccardo/0000-0001-7927-4343	Swiss Research National Foundation [31003A_127378]; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) "Lazzaro Spallanzani" (Italy); Universita Cattolica del S. Cuore	Swiss Research National Foundation; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) "Lazzaro Spallanzani" (Italy); Universita Cattolica del S. Cuore	This work was supported by a grant of the Swiss Research National Foundation 31003A_127378 to DS. M. S. was supported by a grant from the Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) "Lazzaro Spallanzani" (Strategic Research Program 2006, Italy) and from Universita Cattolica del S. Cuore (Linea D1, 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2004, J BIOL CHEM, V279, P27855, DOI 10.1074/jbc.M403487200; Akache B, 2002, J BIOL CHEM, V277, P21254, DOI 10.1074/jbc.M202566200; Anderson JB, 2005, NAT REV MICROBIOL, V3, P547, DOI 10.1038/nrmicro1179; Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002; Bennett JE, 2004, ANTIMICROB AGENTS CH, V48, P1773, DOI 10.1128/AAC.48.5.1773-1777.2004; Berila N, 2010, MYCOPATHOLOGIA, V170, P99, DOI 10.1007/s11046-010-9298-1; Borst A, 2005, ANTIMICROB AGENTS CH, V49, P783, DOI 10.1128/AAC.49.2.783-787.2005; Coste AT, 2004, EUKARYOT CELL, V3, P1639, DOI 10.1128/EC.3.6.1639-1652.2004; Devauz F, 2001, EMBO REP, V2, P493, DOI 10.1093/embo-reports/kve114; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Dryden MW, 2005, VET THER, V6, P260; FERRARI S, 2011, ANTIMICROB IN PRESS; Ferrari S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000268; Gulshan K, 2007, EUKARYOT CELL, V6, P1933, DOI 10.1128/EC.00254-07; Hellauer K, 2002, J BIOL CHEM, V277, P17671, DOI 10.1074/jbc.M201637200; Izumikawa K, 2003, YEAST, V20, P249, DOI 10.1002/yea.962; Jacobsen ID, 2010, INFECT IMMUN, V78, P1066, DOI 10.1128/IAI.01244-09; Kaur R, 2005, CURR OPIN MICROBIOL, V8, P378, DOI 10.1016/j.mib.2005.06.012; Kaur R, 2007, P NATL ACAD SCI USA, V104, P7628, DOI 10.1073/pnas.0611195104; Keppler-Ross S, 2008, GENETICS, V179, P705, DOI 10.1534/genetics.108.087080; Kretschmer M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000696; Lass-Florl C, 2009, MYCOSES, V52, P197, DOI 10.1111/j.1439-0507.2009.01691.x; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Liu TT, 2007, EUKARYOT CELL, V6, P2122, DOI 10.1128/EC.00327-07; Mamnun YM, 2002, MOL MICROBIOL, V46, P1429, DOI 10.1046/j.1365-2958.2002.03262.x; Martens JA, 1996, J BIOL CHEM, V271, P15884, DOI 10.1074/jbc.271.27.15884; Morschhauser J, 2007, PLOS PATHOG, V3, P1603, DOI 10.1371/journal.ppat.0030164; Orsi CF, 2009, FEMS YEAST RES, V9, P301, DOI 10.1111/j.1567-1364.2008.00470.x; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, DIAGN MICR INFEC DIS, V67, P162, DOI 10.1016/j.diagmicrobio.2010.01.002; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Ruhnke M, 2006, CURR DRUG TARGETS, V7, P495, DOI 10.2174/138945006776359421; Saleh A, 1997, J BIOL CHEM, V272, P5571, DOI 10.1074/jbc.272.9.5571; Sanglard D, 1999, ANTIMICROB AGENTS CH, V43, P2753, DOI 10.1128/AAC.43.11.2753; Sanglard D, 2002, LANCET INFECT DIS, V2, P73, DOI 10.1016/S1473-3099(02)00181-0; Sanglard D, 2001, ANTIMICROB AGENTS CH, V45, P1174, DOI 10.1128/AAC.45.4.1174-1183.2001; Sanguinetti M, 2006, INFECT IMMUN, V74, P1352, DOI 10.1128/IAI.74.2.1352-1359.2006; Sanguinetti M, 2005, ANTIMICROB AGENTS CH, V49, P668, DOI 10.1128/AAC.49.2.668-679.2005; Shahi P, 2010, MOL BIOL CELL, V21, P2469, DOI 10.1091/mbc.E09-10-0899; Sionov E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000848; Sionov E, 2009, ANTIMICROB AGENTS CH, V53, P2804, DOI 10.1128/AAC.00295-09; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; Torelli R, 2008, MOL MICROBIOL, V68, P186, DOI 10.1111/j.1365-2958.2008.06143.x; Tsai HF, 2006, ANTIMICROB AGENTS CH, V50, P1384, DOI 10.1128/AAC.50.4.1384-1392.2006; Tsai HF, 2010, ANTIMICROB AGENTS CH, V54, P3308, DOI 10.1128/AAC.00535-10; Tudela JLR, 2008, CLIN MICROBIOL INFEC, V14, P193, DOI 10.1111/j.1469-0691.2007.01899.x; Vermitsky JP, 2006, MOL MICROBIOL, V61, P704, DOI 10.1111/j.1365-2958.2006.05235.x; Zhang XT, 2001, J BIOL CHEM, V276, P8812, DOI 10.1074/jbc.M010686200	48	86	103	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17589	10.1371/journal.pone.0017589	http://dx.doi.org/10.1371/journal.pone.0017589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408004	Green Submitted, gold, Green Published			2022-12-25	WOS:000288170900028
J	Neiman, M; Lundin, S; Savolainen, P; Ahmadian, A				Neiman, Marten; Lundin, Sverker; Savolainen, Peter; Ahmadian, Afshin			Decoding a Substantial Set of Samples in Parallel by Massive Sequencing	PLOS ONE			English	Article							HIGH-THROUGHPUT; HIGH-RESOLUTION; DNA; PROBES	There has been a dramatic increase of throughput of sequenced bases in the last years but sequencing a multitude of samples in parallel has not yet developed equally. Here we present a novel strategy where the combination of two tags is used to link sequencing reads back to their origins from a pool of samples. By incorporating the tags in two steps sample-handling complexity is lowered by nearly 100 times compared to conventional indexing protocols. In addition, the method described here enables accurate identification and typing of thousands of samples in parallel. In this study the system was designed to test 4992 samples using only 122 tags. To prove the concept of the two-tagging method, the highly polymorphic 2(nd) exon of DLA-DRB1 in dogs and wolves was sequenced using the 454 GS FLX Titanium Chemistry. By requiring a minimum sequence depth of 20 reads per sample, 94% of the successfully amplified samples were genotyped. In addition, the method allowed digital detection of chimeric fragments. These results demonstrate that it is possible to sequence thousands of samples in parallel without complex pooling patterns or primer combinations. Furthermore, the method is highly scalable as only a limited number of additional tags leads to substantial increase of the sample size.	[Neiman, Marten; Lundin, Sverker; Savolainen, Peter; Ahmadian, Afshin] Royal Inst Technol KTH, Sch Biotechnol, Dept Gene Technol, Sci Life Lab, Solna, Sweden	Royal Institute of Technology	Neiman, M (corresponding author), Royal Inst Technol KTH, Sch Biotechnol, Dept Gene Technol, Sci Life Lab, Solna, Sweden.	afshin.ahmadian@scilifelab.se			Swedish Board of Agriculture (Jordbruksverket); Knut and Alice Wallenberg Foundation	Swedish Board of Agriculture (Jordbruksverket); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by a grant from The Swedish Board of Agriculture (Jordbruksverket). Peter Savolainen is a Royal Swedish Academy of Sciences Research Fellow supported by a grant from the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babik W, 2009, MOL ECOL RESOUR, V9, P713, DOI 10.1111/j.1755-0998.2009.02622.x; Bentley G, 2009, TISSUE ANTIGENS, V74, P393, DOI 10.1111/j.1399-0039.2009.01345.x; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; Galan M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-296; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Kennedy LJ, 2005, J HERED, V96, P836, DOI 10.1093/jhered/esi112; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Pettersson E, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl103; Pettersson E, 2008, HUM MUTAT, V29, P323, DOI 10.1002/humu.20655; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Wegner KM, 2009, MOL ECOL, V18, P1818, DOI 10.1111/j.1365-294X.2009.04173.x; Zajac P, 2008, GENOMICS, V91, P209, DOI 10.1016/j.ygeno.2007.10.012	23	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17785	10.1371/journal.pone.0017785	http://dx.doi.org/10.1371/journal.pone.0017785			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408018	Green Submitted, gold, Green Published			2022-12-25	WOS:000288170900047
J	Nguyen, C; Berezne, A; Baubet, T; Mestre-Stanislas, C; Rannou, F; Papelard, A; Morell-Dubois, S; Revel, M; Guillevin, L; Poiraudeau, S; Mouthon, L				Nguyen, Christelle; Berezne, Alice; Baubet, Thierry; Mestre-Stanislas, Caroline; Rannou, Francois; Papelard, Agathe; Morell-Dubois, Sandrine; Revel, Michel; Guillevin, Loic; Poiraudeau, Serge; Mouthon, Luc		Grp Francais Rech Sclerodermie	Association of Gender with Clinical Expression, Quality of Life, Disability, and Depression and Anxiety in Patients with Systemic Sclerosis	PLOS ONE			English	Article							CROSS-SECTIONAL SURVEY; FORM HEALTH SURVEY; HOSPITAL ANXIETY; ORGAN INVOLVEMENT; SCLERODERMA; SCALE; QUESTIONNAIRE; SYMPTOMS; VALIDATION; SURVIVAL	Objectives: To assess the association of gender with clinical expression, health-related quality of life (HRQoL), disability, and self-reported symptoms of depression and anxiety in patients with systemic sclerosis (SSc). Methods: SSc patients fulfilling the American College of Rheumatology and/or the Leroy and Medsger criteria were assessed for clinical symptoms, disability, HRQoL, self-reported symptoms of depression and anxiety by specific measurement scales. Results: Overall, 381 SSc patients (62 males) were included. Mean age and disease duration at the time of evaluation were 55.9 (13.3) and 9.5 (7.8) years, respectively. One-hundred-and-forty-nine (40.4%) patients had diffuse cutaneous SSc (dcSSc). On bivariate analysis, differences were observed between males and females for clinical symptoms and self-reported symptoms of depression and anxiety, however without reaching statistical significance. Indeed, a trend was found for higher body mass index (BMI) (25.0 [4.1] vs 23.0 [4.5], p = 0.013), more frequent dcSSc, echocardiography systolic pulmonary artery pressure >35 mmHg and interstitial lung disease in males than females (54.8% vs 37.2%, p = 0.010; 24.2% vs 10.5%, p = 0.003; and 54.8% vs 41.2%, p = 0.048, respectively), whereas calcinosis and self-reported anxiety symptoms tended to be more frequent in females than males (36.0% vs 21.4%, p = 0.036, and 62.3% vs 43.5%, p = 0.006, respectively). On multivariate analysis, BMI, echocardiography PAP>35 mmHg, and anxiety were the variables most closely associated with gender. Conclusions: In SSc patients, male gender tends to be associated with diffuse disease and female gender with calcinosis and self-reported symptoms of anxiety. Disease-associated disability and HRQoL were similar in both groups.	[Nguyen, Christelle; Berezne, Alice; Mestre-Stanislas, Caroline; Guillevin, Loic; Mouthon, Luc] Univ Paris 05, Fac Med Paris Descartes, Ctr Reference Vascularites Necrosantes & Sclerode, Hop Cochin,AP HP, Paris, France; [Nguyen, Christelle; Rannou, Francois; Papelard, Agathe; Revel, Michel; Poiraudeau, Serge] Univ Paris 05, Fac Med Paris Descartes, Inst Federatif Rech Handicap, Hop Cochin,AP HP,Serv Med Phys & Readaptat, Paris, France; [Baubet, Thierry] Univ Paris 13, EA 3413, Serv Psychopathol, Hop Avicenne,AP HP, Bobigny, France; [Morell-Dubois, Sandrine] Univ Lille 2, Serv Med Interne, Ctr Reference Sclerodermie Syst, Hop Claude Huriez, Lille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Nguyen, C (corresponding author), Univ Paris 05, Fac Med Paris Descartes, Ctr Reference Vascularites Necrosantes & Sclerode, Hop Cochin,AP HP, Paris, France.	luc.mouthon@cch.aphp.fr	POIRAUDEAU, SERGE/P-5301-2016	Nguyen, MD, PhD, Christelle/0000-0001-7141-3230; Baubet, Thierry/0000-0002-4112-1592; Poiraudeau, Serge/0000-0002-1988-9124				Al-Dhaher FF, 2010, SEMIN ARTHRITIS RHEU, V39, P269, DOI 10.1016/j.semarthrit.2008.06.002; Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Angelopoulos NV, 2001, PSYCHOTHER PSYCHOSOM, V70, P145, DOI 10.1159/000056240; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Assassi S, 2009, ARTHRIT CARE RES, V61, P1403, DOI 10.1002/art.24734; Azad N, 2008, JCPSP-J COLL PHYSICI, V18, P569, DOI 09.2008/JCPSP.569573; Benrud-Larson LM, 2002, PAIN, V95, P267, DOI 10.1016/S0304-3959(01)00409-2; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BLACK CM, 1993, J INTERN MED, V234, P3, DOI 10.1111/j.1365-2796.1993.tb00697.x; Boulman N, 2005, SEMIN ARTHRITIS RHEU, V34, P805, DOI 10.1016/j.semarthrit.2005.01.016; Carreira PE, 2009, ANN RHEUM DIS, V68, P96; Chifflot H, 2008, SEMIN ARTHRITIS RHEU, V37, P223, DOI 10.1016/j.semarthrit.2007.05.003; Duruoz MT, 1996, J RHEUMATOL, V23, P1167; EVANS C, 1985, LANCET, V1, P1204; Ferri C, 2002, MEDICINE, V81, P139, DOI 10.1097/00005792-200203000-00004; Gaultier JB, 2008, REV MED INTERNE, V29, P181, DOI 10.1016/j.revmed.2007.07.010; Georges C, 2005, CLIN RHEUMATOL, V24, P3, DOI 10.1007/s10067-004-0942-3; Haythornthwaite JA, 2003, RHEUM DIS CLIN N AM, V29, P427, DOI 10.1016/S0889-857X(03)00020-6; Hesselstrand R, 1998, ANN RHEUM DIS, V57, P682, DOI 10.1136/ard.57.11.682; Honarmand K, 2009, MULT SCLER J, V15, P1518, DOI 10.1177/1352458509347150; Hudson M, 2008, ARTHRIT RHEUM-ARTHR, V59, P279, DOI 10.1002/art.23344; Hudson M, 2009, ARTHRIT RHEUM-ARTHR, V61, P274, DOI 10.1002/art.24284; Hunzelmann N, 2008, RHEUMATOLOGY, V47, P1185, DOI 10.1093/rheumatology/ken179; Hyphantis TN, 2007, J PSYCHOSOM RES, V62, P47, DOI 10.1016/j.jpsychores.2006.07.028; Joven B, 2006, ANN RHEUM DIS, V65, P395; Legendre U, 2005, JOINT BONE SPINE, V72, P408, DOI 10.1016/j.jbspin.2003.11.008; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; Matsuura E, 2003, J RHEUMATOL, V30, P1782; Mayes MD, 2003, ARTHRITIS RHEUM, V48, P2246, DOI 10.1002/art.11073; McLean CP, 2009, CLIN PSYCHOL REV, V29, P496, DOI 10.1016/j.cpr.2009.05.003; Merkel PA, 2002, ARTHRITIS RHEUM-US, V46, P2410, DOI 10.1002/art.10486; MESTRESTANISLAS C, 2010, PRESSE MED; Mouthon L, 2007, ANN RHEUM DIS, V66, P1651, DOI 10.1136/ard.2007.070532; Mouthon L, 2010, ANN RHEUM DIS, V69, P214, DOI 10.1136/ard.2008.094193; Mouthon L, 2008, ARTHRIT RHEUM-ARTHR, V59, P968, DOI 10.1002/art.23819; Nguyen C, 2010, RHEUMATOLOGY, V49, P982, DOI 10.1093/rheumatology/kep400; Nguyen C, 2010, J RHEUMATOL, V37, P359, DOI 10.3899/jrheum.090632; Oliver JE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2585; PETERSGOLDEN M, 1984, MEDICINE, V63, P221, DOI 10.1097/00005792-198407000-00004; Poole J L, 1991, Arthritis Care Res, V4, P27, DOI 10.1002/art.1790040106; Ramjeet J, 2005, RHEUMATOLOGY, V44, P1166, DOI 10.1093/rheumatology/keh699; Rannou F, 2007, ARTHRIT RHEUM-ARTHR, V57, P94, DOI 10.1002/art.22468; Robertson LP, 2003, ANN RHEUM DIS, V62, P267, DOI 10.1136/ard.62.3.267; Roca RP, 1996, ARTHRITIS RHEUM, V39, P1035, DOI 10.1002/art.1780390623; Simeon CP, 1996, BRIT J RHEUMATOL, V35, P910; Steen VD, 2000, ARTHRITIS RHEUM-US, V43, P2437, DOI 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; Straszecka J, 1996, CLIN RHEUMATOL, V15, P621, DOI 10.1007/BF02238557; Tamby MC, 2003, AUTOIMMUN REV, V2, P152, DOI 10.1016/S1568-9972(03)00004-1; Thombs BD, 2008, ARTHRIT RHEUM-ARTHR, V59, P504, DOI 10.1002/art.23524; TUGWELL P, 1987, J RHEUMATOL, V14, P446; Waheed Abdul, 2006, JPMA Journal of the Pakistan Medical Association, V56, P243; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WYNN J, 1985, AM HEART J, V110, P123, DOI 10.1016/0002-8703(85)90525-3; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	55	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17551	10.1371/journal.pone.0017551	http://dx.doi.org/10.1371/journal.pone.0017551			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FR	21408076	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170900027
J	Chatre, L; Ricchetti, M				Chatre, Laurent; Ricchetti, Miria			Nuclear Mitochondrial DNA Activates Replication in Saccharomyces cerevisiae	PLOS ONE			English	Article							CHROMOSOMAL REPLICATOR; CONSENSUS SEQUENCE; YEAST; ORIGINS; GENOME; ELEMENTS; TRANSFORMATION; PREDICTION; MUTATIONS; REGIONS	The nuclear genome of eukaryotes is colonized by DNA fragments of mitochondrial origin, called NUMTs. These insertions have been associated with a variety of germ-line diseases in humans. The significance of this uptake of potentially dangerous sequences into the nuclear genome is unclear. Here we provide functional evidence that sequences of mitochondrial origin promote nuclear DNA replication in Saccharomyces cerevisiae. We show that NUMTs are rich in key autonomously replicating sequence (ARS) consensus motifs, whose mutation results in the reduction or loss of DNA replication activity. Furthermore, 2D-gel analysis of the mrc1 mutant exposed to hydroxyurea shows that several NUMTs function as late chromosomal origins. We also show that NUMTs located close to or within ARS provide key sequence elements for replication. Thus NUMTs can act as independent origins, when inserted in an appropriate genomic context or affect the efficiency of pre-existing origins. These findings show that migratory mitochondrial DNAs can impact on the replication of the nuclear region they are inserted in.	[Chatre, Laurent; Ricchetti, Miria] Inst Pasteur, Dept Immunol, F-75724 Paris, France; [Chatre, Laurent; Ricchetti, Miria] Inst Pasteur, Unite Genet Mol Levures, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Chatre, L (corresponding author), Inst Pasteur, Dept Immunol, F-75724 Paris, France.	mricch@pasteur.fr	Chatre, Laurent/S-5704-2019	Chatre, Laurent/0000-0001-9066-4342	PTR Institut Pasteur [217]; Association pour la Recherche sur le Cancer [4022]	PTR Institut Pasteur; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by PTR Institut Pasteur [217]; and the Association pour la Recherche sur le Cancer [4022]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATI B, 1990, MOL CELL BIOL, V10, P5442, DOI 10.1128/MCB.10.10.5442; Angeletti PC, 2002, J VIROL, V76, P3350, DOI 10.1128/JVI.76.7.3350-3358.2002; BECKER DM, 1991, METHOD ENZYMOL, V194, P182; BLANC H, 1980, P NATL ACAD SCI-BIOL, V77, P3942, DOI 10.1073/pnas.77.7.3942; Blanc H., 1982, MITOCHONDRIAL GENES, P279; Borensztajn K, 2002, BRIT J HAEMATOL, V117, P168, DOI 10.1046/j.1365-2141.2002.03397.x; Breier AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r22; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BROACH JR, 1982, COLD SPRING HARB SYM, V47, P1165, DOI 10.1101/SQB.1983.047.01.132; Crabbe L, 2010, NAT STRUCT MOL BIOL, V17, P1391, DOI 10.1038/nsmb.1932; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Donato JJ, 2006, PLOS GENET, V2, P1328, DOI 10.1371/journal.pgen.0020141; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; Fukuhara H, 2006, FEMS YEAST RES, V6, P1281, DOI 10.1111/j.1567-1364.2006.00125.x; Goldin E, 2004, HUM MUTAT, V24, P460, DOI 10.1002/humu.20094; Hadler HI, 1998, J CELL BIOCHEM, V68, P100, DOI 10.1002/(SICI)1097-4644(19980101)68:1<100::AID-JCB10>3.0.CO;2-L; HINDLEY J, 1987, MOL CELL BIOL, V7, P504, DOI 10.1128/MCB.7.1.504; Huberman JA, 1999, METHODS, V18, P356, DOI 10.1006/meth.1999.0792; HYMAN BC, 1982, P NATL ACAD SCI-BIOL, V79, P1578, DOI 10.1073/pnas.79.5.1578; HYMAN BC, 1983, GENE, V26, P223, DOI 10.1016/0378-1119(83)90192-0; LENGLEZ S, GENOME RES; Lin S, 1997, MOL CELL BIOL, V17, P5473, DOI 10.1128/MCB.17.9.5473; MacAlpine D, 2005, CHROMOSOME RES, V13, P309, DOI 10.1007/s10577-005-1508-1; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; MARGULYS L, 1970, ORIGIN EUKARYOTIC CE; McCune HJ, 2008, GENETICS, V180, P1833, DOI 10.1534/genetics.108.094359; Nieduszynski CA, 2007, NUCLEIC ACIDS RES, V35, pD40, DOI 10.1093/nar/gkl758; Nieduszynski CA, 2006, GENE DEV, V20, P1874, DOI 10.1101/gad.385306; Noutsos C, 2005, GENOME RES, V15, P616, DOI 10.1101/gr.3788705; Podnar M, 2007, J MOL EVOL, V64, P308, DOI 10.1007/s00239-005-0259-0; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; REID RA, 1983, TRENDS BIOCHEM SCI, V8, P190, DOI 10.1016/0968-0004(83)90205-0; Ricchetti M, 1999, NATURE, V402, P96, DOI 10.1038/47076; Ricchetti M, 2004, PLOS BIOL, V2, P1313, DOI 10.1371/journal.pbio.0020273; Ricchetti M, 2003, J MOL BIOL, V328, P847, DOI 10.1016/S0022-2836(03)00315-2; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; SACERDOT C, 2008, FEMS YEAST RES; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SHAY JW, 1991, ONCOGENE, V6, P1869; SIKORSKI RS, 1989, GENETICS, V122, P19; SRIENC F, 1985, MOL CELL BIOL, V5, P1676, DOI 10.1128/MCB.5.7.1676; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; Theis JF, 1997, P NATL ACAD SCI USA, V94, P10786, DOI 10.1073/pnas.94.20.10786; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Turner C, 2003, HUM GENET, V112, P303, DOI 10.1007/s00439-002-0892-2; Van Brabant AJ, 1999, MOL CELL BIOL, V19, P4231; VANHOUTEN JV, 1990, MOL CELL BIOL, V10, P3917, DOI 10.1128/MCB.10.8.3917; Vartanian JP, 2002, P NATL ACAD SCI USA, V99, P7566, DOI 10.1073/pnas.112205999; WALKER SS, 1991, NUCLEIC ACIDS RES, V19, P6255, DOI 10.1093/nar/19.22.6255; Willett-Brozick JE, 2001, HUM GENET, V109, P216, DOI 10.1007/s004390100564; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Xu WH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-276; Yu X, 1999, MOL CELL, V4, P873, DOI 10.1016/S1097-2765(00)80397-4; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17235	10.1371/journal.pone.0017235	http://dx.doi.org/10.1371/journal.pone.0017235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408151	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170000016
J	Garcia, MC; Lee, JT; Ramsook, CB; Alsteens, D; Dufrene, YF; Lipke, PN				Garcia, Melissa C.; Lee, Janis T.; Ramsook, Caleen B.; Alsteens, David; Dufrene, Yves F.; Lipke, Peter N.			A Role for Amyloid in Cell Aggregation and Biofilm Formation	PLOS ONE			English	Article							CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; ALZHEIMERS-DISEASE; CONGO RED; ADHERENCE PROPERTIES; GENE; PROTEIN; YEAST; ADHESINS; BINDING	Cell adhesion molecules in Saccharomyces cerevisiae and Candida albicans contain amyloid-forming sequences that are highly conserved. We have now used site-specific mutagenesis and specific peptide perturbants to explore amyloid-dependent activity in the Candida albicans adhesin Als5p. A V326N substitution in the amyloid-forming region conserved secondary structure and ligand binding, but abrogated formation of amyloid fibrils in soluble Als5p and reduced cell surface thioflavin T fluorescence. When displayed on the cell surface, Als5p with this substitution prevented formation of adhesion nanodomains and formation of large cellular aggregates and model biofilms. In addition, amyloid nanodomains were regulated by exogenous peptides. An amyloid-forming homologous peptide rescued aggregation and biofilm activity of Als5p V326N cells, and V326N substitution peptide inhibited aggregation and biofilm activity in Als5p(WT) cells. Therefore, specific site mutation, inhibition by anti-amyloid peturbants, and sequence-specificity of pro-amyloid and anti-amyloid peptides showed that amyloid formation is essential for nanodomain formation and activation.	[Garcia, Melissa C.; Lee, Janis T.; Ramsook, Caleen B.; Lipke, Peter N.] CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA; [Alsteens, David; Dufrene, Yves F.] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium	City University of New York (CUNY) System; Brooklyn College (CUNY); Universite Catholique Louvain	Garcia, MC (corresponding author), CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA.	plipke@brooklyn.cuny.edu	Alsteens, David/AAU-5475-2020; Lipke, Peter N./AAW-4914-2020; Alsteens, David A/F-2669-2014	Alsteens, David/0000-0001-9229-113X; Lipke, Peter N./0000-0003-1733-0690; Alsteens, David A/0000-0001-9229-113X; Garcia-Sherman, Melissa/0000-0003-1409-4397; Dufrene, Yves/0000-0002-7289-4248	National Institutes of Health (NIH) [SC1 GM 083756]; National Foundation for Scientific Research (FNRS); Universite catholique de Louvain (Fonds Speciaux de Recherche); Region Wallonne; Federal Office for Scientific, Technical and Cultural Affairs; Research Department of the Communaute francaise de Belgique; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM083756] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite catholique de Louvain (Fonds Speciaux de Recherche); Region Wallonne; Federal Office for Scientific, Technical and Cultural Affairs; Research Department of the Communaute francaise de Belgique; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work at Brooklyn College was supported by National Institutes of Health (NIH) grant SC1 GM 083756. Work at the Universite catholique de Louvain was supported by the National Foundation for Scientific Research (FNRS), the Universite catholique de Louvain (Fonds Speciaux de Recherche), the Region Wallonne, the Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme), and the Research Department of the Communaute francaise de Belgique (Concerted Research Action). Y.F.D. and D.A. are Senior Research Associate and Research Fellow of the FRS-FNRS. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; ALSTEENS D, 2010, P NATL ACAD SCI US; Alsteens D, 2009, ACS NANO, V3, P3063, DOI 10.1021/nn900778t; CANTOR CR, 1980, BIOPHYSICAL CHEM 3, P878; Cegelski L, 2009, NAT CHEM BIOL, V5, P913, DOI 10.1038/nchembio.242; Chandra J, 2001, J DENT RES, V80, P903, DOI 10.1177/00220345010800031101; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; de Jong W, 2009, MOL MICROBIOL, V73, P1128, DOI 10.1111/j.1365-2958.2009.06838.x; Dranginis AM, 2007, MICROBIOL MOL BIOL R, V71, P282, DOI 10.1128/MMBR.00037-06; Eisert R, 2006, ANAL BIOCHEM, V353, P144, DOI 10.1016/j.ab.2006.03.015; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fowler Douglas M, 2006, PLoS Biol, V4, pe6; Frank AT, 2010, EUKARYOT CELL, V9, P405, DOI 10.1128/EC.00235-09; Gaur NK, 2004, MICROBIOL-SGM, V150, P277, DOI 10.1099/mic.0.26738-0; Gaur NK, 2002, CELL COMMUN ADHES, V9, P45, DOI 10.1080/15419060212187; Gaur NK, 1997, INFECT IMMUN, V65, P5289, DOI 10.1128/IAI.65.12.5289-5294.1997; Gaur NK, 1999, INFECT IMMUN, V67, P6040, DOI 10.1128/IAI.67.11.6040-6047.1999; Gonzalez M, 2010, YEAST, V27, P583, DOI 10.1002/yea.1797; Granic I, 2010, J ALZHEIMERS DIS, V19, P991, DOI 10.3233/JAD-2010-1297; Harriott MM, 2009, ANTIMICROB AGENTS CH, V53, P3914, DOI 10.1128/AAC.00657-09; HAWSER SP, 1995, ANTIMICROB AGENTS CH, V39, P2128, DOI 10.1128/AAC.39.9.2128; Hoyer LL, 2001, YEAST, V18, P49, DOI 10.1002/1097-0061(200101)18:1&lt;49::AID-YEA646&gt;3.0.CO;2-M; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Inbar P, 2006, BIOORG MED CHEM LETT, V16, P1076, DOI 10.1016/j.bmcl.2005.10.067; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Kapteyn JC, 2000, MOL MICROBIOL, V35, P601, DOI 10.1046/j.1365-2958.2000.01729.x; Kim YS, 2003, J BIOL CHEM, V278, P10842, DOI 10.1074/jbc.M212540200; Klotz SA, 2007, MED MYCOL, V45, P363, DOI 10.1080/13693780701299333; Lockhart A, 2005, J BIOL CHEM, V280, P7677, DOI 10.1074/jbc.M412056200; Lorenzo A, 1996, ANN NY ACAD SCI, V777, P89, DOI 10.1111/j.1749-6632.1996.tb34406.x; Loza L, 2004, YEAST, V21, P473, DOI 10.1002/yea.1111; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Muller DJ, 2009, NAT CHEM BIOL, V5, P383, DOI 10.1038/nchembio.181; Nobbs AH, 2010, EUKARYOT CELL, V9, P1622, DOI 10.1128/EC.00103-10; Nobile CJ, 2008, CURR BIOL, V18, P1017, DOI 10.1016/j.cub.2008.06.034; Otoo HN, 2008, EUKARYOT CELL, V7, P776, DOI 10.1128/EC.00309-07; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Ramsook CB, 2010, EUKARYOT CELL, V9, P393, DOI 10.1128/EC.00068-09; Rauceo JM, 2006, EUKARYOT CELL, V5, P1664, DOI 10.1128/EC.00120-06; Rauceo JM, 2004, INFECT IMMUN, V72, P4948, DOI 10.1128/IAI.72.9.4948-4955.2004; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sheppard DC, 2004, J BIOL CHEM, V279, P30480, DOI 10.1074/jbc.M401929200; SILVERMAN RJ, 2010, INFECT IMMUN; Simkovsky R, 2006, P NATL ACAD SCI USA, V103, P3575, DOI 10.1073/pnas.0509087103; ten Cate JM, 2009, J DENT RES, V88, P105, DOI 10.1177/0022034508329273; Uppuluri P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000828; Wang X, 2008, J BIOL CHEM, V283, P21530, DOI 10.1074/jbc.M800466200	54	89	97	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17632	10.1371/journal.pone.0017632	http://dx.doi.org/10.1371/journal.pone.0017632			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408122	Green Published, gold			2022-12-25	WOS:000288170000048
J	Lima-Camara, TN; Bruno, RV; Luz, PM; Castro, MG; Lourenco-de-Oliveira, R; Sorgine, MHF; Peixoto, AA				Lima-Camara, Tamara N.; Bruno, Rafaela V.; Luz, Paula M.; Castro, Marcia G.; Lourenco-de-Oliveira, Ricardo; Sorgine, Marcos H. F.; Peixoto, Alexandre A.			Dengue Infection Increases the Locomotor Activity of Aedes aegypti Females	PLOS ONE			English	Article							FEEDING-BEHAVIOR; VIRUS-INFECTION; CULICIDAE; DIPTERA; EXPRESSION; DROSOPHILA; MOSQUITOS; PARASITES; VECTORS; BRAZIL	Background: Aedes aegypti is the main vector of the virus causing Dengue fever, a disease that has increased dramatically in importance in recent decades, affecting many tropical and sub-tropical areas of the globe. It is known that viruses and other parasites can potentially alter vector behavior. We investigated whether infection with Dengue virus modifies the behavior of Aedes aegypti females with respect to their activity level. Methods/Principal Findings: We carried out intrathoracic Dengue 2 virus (DENV-2) infections in Aedes aegypti females and recorded their locomotor activity behavior. We observed an increase of up to,50% in the activity of infected mosquitoes compared to the uninfected controls. Conclusions: Dengue infection alters mosquito locomotor activity behavior. We speculate that the higher levels of activity observed in infected Aedes aegypti females might involve the circadian clock. Further studies are needed to assess whether this behavioral change could have implications for the dynamics of Dengue virus transmission.	[Lima-Camara, Tamara N.; Bruno, Rafaela V.; Peixoto, Alexandre A.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, BR-21045900 Rio De Janeiro, Brazil; [Luz, Paula M.] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, Lab Pesquisa Clin DST & AIDS, BR-21045900 Rio De Janeiro, Brazil; [Castro, Marcia G.; Lourenco-de-Oliveira, Ricardo] Fiocruz MS, Inst Oswaldo Cruz, Lab Transmissores Hematozoarios, BR-21045900 Rio De Janeiro, Brazil; [Sorgine, Marcos H. F.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil; [Sorgine, Marcos H. F.; Peixoto, Alexandre A.] INCT EM, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Lima-Camara, TN (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, BR-21045900 Rio De Janeiro, Brazil.	apeixoto@ioc.fiocruz.br	Bruno, Rafaela/AAQ-7611-2020; Camara, Tamara N Lima/G-3476-2016	Luz, Paula/0000-0001-9746-719X; Bruno, Rafaela/0000-0002-7082-9768	Howard Hughes Medical Institute; CNPq; Faperj; FIOCRUZ	Howard Hughes Medical Institute(Howard Hughes Medical Institute); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FIOCRUZ	This work was supported by grants from the Howard Hughes Medical Institute, CNPq, Faperj, and FIOCRUZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; Clements AN., 1999, SENSORY RECEPTION BE; Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS; David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019; Lima-Camara Tamara Nunes de, 2006, Cad. Saúde Pública, V22, P2079, DOI 10.1590/S0102-311X2006001000013; Evans O, 2009, J EXP BIOL, V212, P1436, DOI 10.1242/jeb.028951; Gentile C, 2006, INSECT BIOCHEM MOLEC, V36, P878, DOI 10.1016/j.ibmb.2006.08.008; Gentile C, 2009, J BIOL RHYTHM, V24, P444, DOI 10.1177/0748730409349169; GRIMSTAD PR, 1980, J MED ENTOMOL, V17, P1, DOI 10.1093/jmedent/17.1.1; Hall JC, 2003, ADV GENET, V48, P1, DOI 10.1016/S0065-2660(03)48000-0; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Kuo TH, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-17; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lee JE, 2008, CURR BIOL, V18, P195, DOI 10.1016/j.cub.2007.12.054; Linthicum KJ, 1996, MED VET ENTOMOL, V10, P87, DOI 10.1111/j.1365-2915.1996.tb00086.x; Miagostovich Marize P., 2003, Rev. Inst. Med. trop. S. Paulo, V45, P17, DOI 10.1590/S0036-46652003000100004; MOORE J, 1993, J PARASITOL, V79, P1, DOI 10.2307/3283270; Moreira LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000568; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119; PUTNAM JL, 1995, AM J TROP MED HYG, V52, P225, DOI 10.4269/ajtmh.1995.52.225; Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009; ROSSIGNOL PA, 1984, AM J TROP MED HYG, V33, P17, DOI 10.4269/ajtmh.1984.33.17; ROWLAND MW, 1986, PHYSIOL ENTOMOL, V11, P325, DOI 10.1111/j.1365-3032.1986.tb00420.x; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Saunders DS, 2002, INSECT CLOCKS; Schaub GA, 2006, INT J MED MICROBIOL, V296, P37, DOI 10.1016/j.ijmm.2005.12.004; Shirasu-Hiza MM, 2007, CURR BIOL, V17, pR353, DOI 10.1016/j.cub.2007.03.049; Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678; Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098	34	78	80	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17690	10.1371/journal.pone.0017690	http://dx.doi.org/10.1371/journal.pone.0017690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408119	gold, Green Published, Green Submitted			2022-12-25	WOS:000288170000055
J	Ludin, P; Nilsson, D; Maser, P				Ludin, Philipp; Nilsson, Daniel; Maeser, Pascal			Genome-Wide Identification of Molecular Mimicry Candidates in Parasites	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; COMPLEMENT C2 RECEPTOR; PLASMODIUM-FALCIPARUM; TRYPANOSOMA-CRUZI; HUMAN MALARIA; DRAFT GENOME; SPOROZOITE INVASION; SCHISTOSOMA-MANSONI; SEQUENCE; THROMBOSPONDIN	Among the many strategies employed by parasites for immune evasion and host manipulation, one of the most fascinating is molecular mimicry. With genome sequences available for host and parasite, mimicry of linear amino acid epitopes can be investigated by comparative genomics. Here we developed an in silico pipeline for genome-wide identification of molecular mimicry candidate proteins or epitopes. The predicted proteome of a given parasite was broken down into overlapping fragments, each of which was screened for close hits in the human proteome. Control searches were carried out against unrelated, free-living eukaryotes to eliminate the generally conserved proteins, and with randomized versions of the parasite proteins to get an estimate of statistical significance. This simple but computation-intensive approach yielded interesting candidates from human-pathogenic parasites. From Plasmodium falciparum, it returned a 14 amino acid motif in several of the PfEMP1 variants identical to part of the heparin-binding domain in the immunosuppressive serum protein vitronectin. And in Brugia malayi, fragments were detected that matched to periphilin-1, a protein of cell-cell junctions involved in barrier formation. All the results are publicly available by means of mimicDB, a searchable online database for molecular mimicry candidates from pathogens. To our knowledge, this is the first genome-wide survey for molecular mimicry proteins in parasites. The strategy can be adopted to any pair of host and pathogen, once appropriate negative control organisms are chosen. MimicDB provides a host of new starting points to gain insights into the molecular nature of host-pathogen interactions.	[Ludin, Philipp; Nilsson, Daniel; Maeser, Pascal] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Ludin, Philipp; Maeser, Pascal] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Ludin, Philipp; Maeser, Pascal] Univ Basel, Basel, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Ludin, P (corresponding author), Univ Bern, Inst Cell Biol, Bern, Switzerland.	pascal.maeser@unibas.ch	Nilsson, Daniel/B-8365-2009	Nilsson, Daniel/0000-0001-5831-385X; Maser, Pascal/0000-0003-3122-1941	Swedish National Science Foundation; Swiss National Science Foundation	Swedish National Science Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Daniel Nilsson was supported by a fellowship of the Swedish National Science Foundation, and Pacal Maser was supported by a research professorship grant of the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; BENISMAIL R, 1982, J PARASITOL, V68, P402, DOI 10.2307/3280949; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Biron DG, 2005, P ROY SOC B-BIOL SCI, V272, P2117, DOI 10.1098/rspb.2005.3213; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P29, DOI 10.1016/0166-6851(91)90127-R; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; DAMIAN RAYMOND T., 1962, JOUR PARASITOL, V48, P16; DAMIAN RT, 1964, AM NAT, V98, P129, DOI 10.1086/282313; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; DELEON PP, 2005, REV INST MED TROP SP, V47, P159; Diaz A, 1997, J IMMUNOL, V158, P3779; DUVAUXMIRET O, 1992, P NATL ACAD SCI USA, V89, P778, DOI 10.1073/pnas.89.2.778; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gamulin V, 2000, BIOL J LINN SOC, V71, P821, DOI [10.1111/j.1095-8312.2000.tb01293.x, 10.1006/bijl.2000.0476]; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghansah TJ, 2002, J EUKARYOT MICROBIOL, V49, P383, DOI 10.1111/j.1550-7408.2002.tb00216.x; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Goodridge HS, 2005, IMMUNOLOGY, V115, P296, DOI 10.1111/j.1365-2567.2005.02167.x; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; HALL R, 1994, ADV PARASIT, V34, P81, DOI 10.1016/S0065-308X(08)60137-2; Han HJ, 2004, BIOCHEM BIOPH RES CO, V320, P563, DOI 10.1016/j.bbrc.2004.06.008; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; HIDE G, 1989, MOL BIOCHEM PARASIT, V36, P51, DOI 10.1016/0166-6851(89)90199-0; HOLMQUIST G, 1988, INFECT IMMUN, V56, P1545, DOI 10.1128/IAI.56.6.1545-1550.1988; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Howell DPG, 2008, MOL MICROBIOL, V67, P78, DOI 10.1111/j.1365-2958.2007.06019.x; Inal JM, 2005, SPRINGER SEMIN IMMUN, V27, P320, DOI 10.1007/s00281-005-0009-9; Inal JM, 2005, J IMMUNOL, V174, P356, DOI 10.4049/jimmunol.174.1.356; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; KASLOW DC, 1988, NATURE, V333, P74, DOI 10.1038/333074a0; Kazerounian S, 2003, J BIOL CHEM, V278, P36707, DOI 10.1074/jbc.M303896200; Kraiczy P, 2006, MOL IMMUNOL, V43, P31, DOI 10.1016/j.molimm.2005.06.016; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lehr T, 2007, GLYCOBIOLOGY, V17, P82, DOI 10.1093/glycob/cwl048; Lu B, 2008, INFECT IMMUN, V76, P3530, DOI 10.1128/IAI.00411-08; Matuschewski K, 2002, EMBO J, V21, P1597, DOI 10.1093/emboj/21.7.1597; Mauss ER, 1941, J IMMUNOL, V42, P71; Menard R, 2000, MICROBES INFECT, V2, P633, DOI 10.1016/S1286-4579(00)00362-2; Meri T, 2002, J INFECT DIS, V185, P1786, DOI 10.1086/340649; Michelson S, 2004, HUM IMMUNOL, V65, P465, DOI 10.1016/j.humimm.2004.02.002; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MULLER HM, 1993, EMBO J, V12, P2881, DOI 10.1002/j.1460-2075.1993.tb05950.x; Nagamune K, 2004, J EXP MED, V199, P1445, DOI 10.1084/jem.20030635; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Nyame AK, 1998, GLYCOBIOLOGY, V8, P615, DOI 10.1093/glycob/8.6.615; Oliver-Gonalez J, 1944, J INFECT DIS, V74, P173, DOI 10.1093/infdis/74.3.173; OLIVERGONZALEZ J, 1946, J INFECT DIS, V78, P232, DOI 10.1093/infdis/78.3.232; OUAISSI MA, 1986, SCIENCE, V234, P603, DOI 10.1126/science.3094145; OUAISSI MA, 1984, NATURE, V308, P380, DOI 10.1038/308380a0; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Ponce de León Patricia, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P107, DOI 10.1590/S0036-46652003000200011; Ramos M, 2002, J BIOL CHEM, V277, P37573, DOI 10.1074/jbc.M205470200; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; ROBSON KJH, 1995, EMBO J, V14, P3883, DOI 10.1002/j.1460-2075.1995.tb00060.x; ROBSON KJH, 1988, NATURE, V335, P79, DOI 10.1038/335079a0; Rubin-de-Celis SSC, 2006, CELL MICROBIOL, V8, P1888, DOI 10.1111/j.1462-5822.2006.00755.x; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; Seki Y, 2002, P NATL ACAD SCI USA, V99, P13003, DOI 10.1073/pnas.202477099; SHEAR HL, 1979, J EXP MED, V149, P1288, DOI 10.1084/jem.149.6.1288; SHERWOOD JA, 1987, AM J TROP MED HYG, V36, P228, DOI 10.4269/ajtmh.1987.36.228; SINGH B, 2010, MOL MICROBI IN PRESS; Spiliotis M, 2003, GENE, V323, P57, DOI 10.1016/j.gene.2003.09.007; SRINIVASAPPA J, 1986, J VIROL, V57, P397, DOI 10.1128/JVI.57.1.397-401.1986; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vicogne J, 2004, J BIOL CHEM, V279, P37407, DOI 10.1074/jbc.M313738200; Wang SP, 1997, EMBO J, V16, P4107, DOI 10.1093/emboj/16.13.4107; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	83	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17546	10.1371/journal.pone.0017546	http://dx.doi.org/10.1371/journal.pone.0017546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408160	Green Submitted, Green Published, gold			2022-12-25	WOS:000288170000037
J	Colomer-Lluch, M; Jofre, J; Muniesa, M				Colomer-Lluch, Marta; Jofre, Juan; Muniesa, Maite			Antibiotic Resistance Genes in the Bacteriophage DNA Fraction of Environmental Samples	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; ESCHERICHIA-COLI STRAINS; WASTE-WATER; STAPHYLOCOCCUS-AUREUS; PHAGE; TRANSDUCTION; EVOLUTION; TRANSFORMATION; DISSEMINATION; INACTIVATION	Antibiotic resistance is an increasing global problem resulting from the pressure of antibiotic usage, greater mobility of the population, and industrialization. Many antibiotic resistance genes are believed to have originated in microorganisms in the environment, and to have been transferred to other bacteria through mobile genetic elements. Among others, beta-lactam antibiotics show clinical efficacy and low toxicity, and they are thus widely used as antimicrobials. Resistance to beta-lactam antibiotics is conferred by beta-lactamase genes and penicillin-binding proteins, which are chromosomal-or plasmid-encoded, although there is little information available on the contribution of other mobile genetic elements, such as phages. This study is focused on three genes that confer resistance to beta-lactam antibiotics, namely two b-lactamase genes (blaTEM and blaCTX-M9) and one encoding a penicillin-binding protein (mecA) in bacteriophage DNA isolated from environmental water samples. The three genes were quantified in the DNA isolated from bacteriophages collected from 30 urban sewage and river water samples, using quantitative PCR amplification. All three genes were detected in the DNA of phages from all the samples tested, in some cases reaching 104 gene copies (GC) of blaTEM or 102 GC of blaCTX-M and mecA. These values are consistent with the amount of fecal pollution in the sample, except for mecA, which showed a higher number of copies in river water samples than in urban sewage. The bla genes from phage DNA were transferred by electroporation to sensitive host bacteria, which became resistant to ampicillin. blaTEM and blaCTX were detected in the DNA of the resistant clones after transfection. This study indicates that phages are reservoirs of resistance genes in the environment.	[Colomer-Lluch, Marta; Jofre, Juan; Muniesa, Maite] Univ Barcelona, Dept Microbiol, Barcelona, Spain	University of Barcelona	Colomer-Lluch, M (corresponding author), Univ Barcelona, Dept Microbiol, Barcelona, Spain.	mmuniesa@ub.edu	Muniesa, Maite/K-4577-2014	Muniesa, Maite/0000-0001-5549-1394	Generalitat de Catalunya [2009SGR1043]; Spanish Ministry of Education and Science [AGL2009-07576, SOSTAQUA-CENIT]; Xarxa de Referencia en Biotecnologia (XRB)	Generalitat de Catalunya(Generalitat de Catalunya); Spanish Ministry of Education and Science(Spanish Government); Xarxa de Referencia en Biotecnologia (XRB)	This study was supported by the Generalitat de Catalunya (2009SGR1043), the Spanish Ministry of Education and Science (AGL2009-07576 and SOSTAQUA-CENIT) and the Xarxa de Referencia en Biotecnologia (XRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Microbiology, 2009, ANT RES EC PERSP OLD; Tormo-Mas MA, 2010, NATURE, V465, P779, DOI 10.1038/nature09065; [Anonymous], 2000, 107052 ISO; [Anonymous], 1996, WORLD HLTH REP; [Anonymous], 1998, STANDARD METHODS EXA; Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; Barlow M, 2008, EMERG INFECT DIS, V14, P423, DOI 10.3201/eid1403.070405; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Berger-Bachi B, 2002, ARCH MICROBIOL, V178, P165, DOI 10.1007/s00203-002-0436-0; BLAHOVA J, 1993, ACTA VIROL, V37, P429; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Borjesson S, 2009, WATER RES, V43, P925, DOI 10.1016/j.watres.2008.11.036; Brabban AD, 2005, FOODBORNE PATHOG DIS, V2, P287, DOI 10.1089/fpd.2005.2.287; CANGELOSI GA, 2004, ENV MICROORGANISMS H; Canton R, 2009, CLIN MICROBIOL INFEC, V15, P20, DOI 10.1111/j.1469-0691.2008.02679.x; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; COOKE MD, 1976, ANTIMICROB AGENTS CH, V9, P885, DOI 10.1128/AAC.9.6.885; Coque TM, 2008, EURO SURVEILL, V13; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Diaz MA, 2010, J CLIN MICROBIOL, V48, P2840, DOI 10.1128/JCM.02147-09; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dupray E, 1997, J APPL MICROBIOL, V82, P507, DOI 10.1046/j.1365-2672.1997.00143.x; Duran AE, 2002, J APPL MICROBIOL, V92, P338, DOI 10.1046/j.1365-2672.2002.01536.x; Edge TA, 2005, CAN J MICROBIOL, V51, P501, DOI 10.1139/W05-028; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; HYDER SL, 1978, J INFECT DIS, V138, P281, DOI 10.1093/infdis/138.3.281; Imamovic L, 2009, APPL ENVIRON MICROB, V75, P1764, DOI 10.1128/AEM.02273-08; Ito T, 2003, DRUG RESIST UPDATE, V6, P41, DOI 10.1016/S1368-7646(03)00003-7; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Jansen WTM, 2006, DRUG RESIST UPDATE, V9, P123, DOI 10.1016/j.drup.2006.06.002; Lachmayr KL, 2009, APPL ENVIRON MICROB, V75, P203, DOI 10.1128/AEM.01254-08; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Lingohr EJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-122; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Lucena F, 2004, J APPL MICROBIOL, V97, P1069, DOI 10.1111/j.1365-2672.2004.02397.x; McShan WM, 2000, GRAM-POSITIVE PATHOGENS, P105; Muniesa M, 2005, APPL ENVIRON MICROB, V71, P4269, DOI 10.1128/AEM.71.8.4269-4275.2005; Muniesa M, 2004, EMERG INFECT DIS, V10, P1134, DOI 10.3201/eid1006.030472; Muniesa M, 2003, ANTON LEEUW INT J G, V83, P305, DOI 10.1023/A:1023384714481; Muniesa M, 1999, APPL ENVIRON MICROB, V65, P5615; MURRAY BE, 1992, PHARMACOTHERAPY, V12, pS86; Novais A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000735; Oliver A, 2005, ANTIMICROB AGENTS CH, V49, P1567, DOI 10.1128/AAC.49.4.1567-1571.2005; Parsley LC, 2010, APPL ENVIRON MICROB, V76, P3753, DOI 10.1128/AEM.03080-09; Patterson JE, 2003, SEMIN RESP CRIT CARE, V24, P79, DOI 10.1055/s-2003-37919; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Rodriguez-Bano J, 2008, ARCH INTERN MED, V168, P1897, DOI 10.1001/archinte.168.17.1897; Sambrook J, 2001, MOL CLONING LAB MANU; Sander M, 2001, APPL ENVIRON MICROB, V67, P1490, DOI 10.1128/AEM.67.4.1490-1493.2001; Schmieger H, 1999, FEMS MICROBIOL LETT, V170, P251, DOI 10.1016/S0378-1097(98)00553-9; Schuch R, 2006, J BACTERIOL, V188, P3037, DOI 10.1128/JB.188.8.3037-3051.2006; Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x; SMITH HW, 1972, NATURE-NEW BIOL, V238, P205, DOI 10.1038/newbio238205a0; Volkmann H, 2004, J MICROBIOL METH, V56, P277, DOI 10.1016/j.mimet.2003.10.014; Walther-Rasmussen J, 2004, CAN J MICROBIOL, V50, P137, DOI 10.1139/W03-111; Willi K, 1997, CELL MOL LIFE SCI, V53, P904, DOI 10.1007/s000180050109; Witte W, 2004, INFECT GENET EVOL, V4, P187, DOI 10.1016/j.meegid.2003.12.005; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005; Zhu B, 2006, WATER RES, V40, P3231, DOI 10.1016/j.watres.2006.06.040	61	213	227	5	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17549	10.1371/journal.pone.0017549	http://dx.doi.org/10.1371/journal.pone.0017549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390233	Green Published, Green Submitted, gold			2022-12-25	WOS:000287965200023
J	Lee, VJ; Yap, J; Cook, AR; Tan, CH; Loh, JP; Koh, WH; Lim, EAS; Liaw, JCW; Chew, JSW; Hossain, I; Chan, KW; Ting, PJ; Ng, SH; Gao, QH; Kelly, PM; Chen, MI; Tambyah, PA; Tan, BH				Lee, Vernon J.; Yap, Jonathan; Cook, Alex R.; Tan, Chi Hsien; Loh, Jin-Phang; Koh, Wee-Hong; Lim, Elizabeth A. S.; Liaw, Jasper C. W.; Chew, Janet S. W.; Hossain, Iqbal; Chan, Ka Wei; Ting, Pei-Jun; Ng, Sock-Hoon; Gao, Qiuhan; Kelly, Paul M.; Chen, Mark I.; Tambyah, Paul A.; Tan, Boon Huan			A Clinical Diagnostic Model for Predicting Influenza among Young Adult Military Personnel with Febrile Respiratory Illness in Singapore	PLOS ONE			English	Article							SYMPTOMS	Introduction: Influenza infections present with wide-ranging clinical features. We aim to compare the differences in presentation between influenza and non-influenza cases among those with febrile respiratory illness (FRI) to determine predictors of influenza infection. Methods: Personnel with FRI (defined as fever >= 37.5 degrees C, with cough or sore throat) were recruited from the sentinel surveillance system in the Singapore military. Nasal washes were collected, and tested using the Resplex II and additional PCR assays for etiological determination. Interviewer-administered questionnaires collected information on patient demographics and clinical features. Univariate comparison of the various parameters was conducted, with statistically significant parameters entered into a multivariate logistic regression model. The final multivariate model for influenza versus non-influenza cases was used to build a predictive probability clinical diagnostic model. Results: 821 out of 2858 subjects recruited from 11 May 2009 to 25 Jun 2010 had influenza, of which 434 (52.9%) had 2009 influenza A (H1N1), 58 (7.1%) seasonal influenza A (H3N2) and 269 (32.8%) influenza B. Influenza-positive cases were significantly more likely to present with running nose, chills and rigors, ocular symptoms and higher temperature, and less likely with sore throat, photophobia, injected pharynx, and nausea/vomiting. Our clinical diagnostic model had a sensitivity of 65% (95% CI: 58%, 72%), specificity of 69% (95% CI: 62%, 75%), and overall accuracy of 68% (95% CI: 64%, 71%), performing significantly better than conventional influenza-like illness (ILI) criteria. Conclusions: Use of a clinical diagnostic model may help predict influenza better than the conventional ILI definition among young adults with FRI.	[Lee, Vernon J.; Yap, Jonathan; Tan, Chi Hsien; Gao, Qiuhan] Minist Def, Biodef Ctr, Singapore, Singapore; [Lee, Vernon J.] Natl Univ Singapore, Ctr Hlth Serv Res, Singapore 117548, Singapore; [Lee, Vernon J.; Chen, Mark I.] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Lee, Vernon J.; Kelly, Paul M.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Cook, Alex R.] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Chen, Mark I.] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore; [Loh, Jin-Phang; Koh, Wee-Hong; Lim, Elizabeth A. S.; Liaw, Jasper C. W.; Chew, Janet S. W.; Hossain, Iqbal; Chan, Ka Wei; Ting, Pei-Jun; Ng, Sock-Hoon; Tan, Boon Huan] Def Med & Environm Res Inst, DSO Natl Labs, Singapore, Singapore; [Tambyah, Paul A.] Natl Univ Singapore, Div Infect Dis, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Australian National University; National University of Singapore; Tan Tock Seng Hospital; National University of Singapore	Lee, VJ (corresponding author), Minist Def, Biodef Ctr, Singapore, Singapore.	vernonljm@hotmail.com	Chen, Mark/CAG-2949-2022; Yap, Jonathan/AAJ-7266-2020; Tan, Boon Huan/ABB-8381-2021; Cook, Alex/S-3576-2019; Cook, Alex/B-5941-2011; Chen, Mark/AGC-5338-2022	Chen, Mark/0000-0001-9369-5830; Yap, Jonathan/0000-0002-5227-8536; Tan, Boon Huan/0000-0002-4976-7988; Cook, Alex/0000-0002-6271-5832; Chen, Mark/0000-0001-9369-5830	Singapore Ministry of Defence; GSK; Baxter; Adamas; Merlion Pharma; Novartis	Singapore Ministry of Defence(Ministry of Defence, Singapore); GSK(GlaxoSmithKline); Baxter; Adamas; Merlion Pharma; Novartis(Novartis)	The work was supported by a Singapore Ministry of Defence funded operational research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; VJL has received unrelated research support from GSK. PAT has received research support and honoraria from Baxter, Adamas, Merlion Pharma, and Novartis, as well as travel support from Pfizer and Wyeth, and sits on the boards of the Asia Pacific Advisory Committee on Influenza and the Asian Hygiene Council. The rest of the authors declare no conflict of interests, financial or otherwise, in this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Angoulvant F, 2011, EMERG MED J, V28, P924, DOI 10.1136/emj.2010.098533; Brunstein JD, 2008, J CLIN MICROBIOL, V46, P97, DOI 10.1128/JCM.01117-07; *CDCP, 2010, COLD VERS FLU QUEST; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Ciblak MA, 2010, SCAND J INFECT DIS, V42, P902, DOI 10.3109/00365548.2010.502903; Cutter JL, 2010, ANN ACAD MED SINGAP, V39, P273; Gavin P.J., 2004, CLIN APPL IMMUNOL RE, V4, P151, DOI DOI 10.1016/S1529-1049(03)00064-3; Hong CY, 2004, FAM PRACT, V21, P317, DOI 10.1093/fampra/cmh319; Lee VJ, 2007, EMERG INFECT DIS, V13, P449, DOI 10.3201/eid1303.060309; Lee VJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008096; Li H, 2007, J CLIN MICROBIOL, V45, P2105, DOI 10.1128/JCM.00210-07; *MIN HLTH SING, 2009, 11 CONF NEW CAS INFL; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Ong AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008453; Spyridaki IS, 2009, J VIROL METHODS, V156, P102, DOI 10.1016/j.jviromet.2008.10.027; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; Tang JWT, 2010, ARCH INTERN MED, V170, P861, DOI 10.1001/archinternmed.2010.108; Wang W, 2009, J VIROL METHODS, V162, P40, DOI 10.1016/j.jviromet.2009.07.004; WHO, 2009, CDC PROT REALT RT PC	20	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17468	10.1371/journal.pone.0017468	http://dx.doi.org/10.1371/journal.pone.0017468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399686	gold, Green Published, Green Submitted			2022-12-25	WOS:000287933300026
J	Chen, GD; Cheng, YB; Zhang, ZZ; Martinka, M; Li, G				Chen, Guangdi; Cheng, Yabin; Zhang, Zhizhong; Martinka, Magdalena; Li, Gang			Cytoplasmic Skp2 Expression Is Increased in Human Melanoma and Correlated with Patient Survival	PLOS ONE			English	Article							KINASE-ASSOCIATED PROTEIN-2; UBIQUITIN LIGASE; CUL1 EXPRESSION; CELL-GROWTH; CYCLIN D1; OVEREXPRESSION; METASTASIS; P27(KIP1); P27; AMPLIFICATION	Background: S-phase kinase protein 2 (Skp2), an F-box protein, targets cell cycle regulators via ubiquitin-mediated degradation. Skp2 is frequently overexpressed in a variety of cancers and associated with patient survival. In melanoma, however, the prognostic significance of subcellular Skp2 expression remains controversial. Methods: To investigate the role of Skp2 in melanoma development, we constructed tissue microarrays and examined Skp2 expression in melanocytic lesions at different stages, including 30 normal nevi, 61 dysplastic nevi, 290 primary melanomas and 146 metastatic melanomas. The TMA was assessed for cytoplasmic and nuclear Skp2 expression by immunohistochemistry. The Kaplan-Meier method was used to evaluate the patient survival. The univariate and multivariate Cox regression models were performed to estimate the harzard ratios (HR) at five-year follow-up. Results: Cytoplasmic but not nuclear Skp2 expression was gradually increased from normal nevi, dysplastic nevi, primary melanomas to metastatic melanomas. Cytoplasmic Skp2 expression correlated with AJCC stages (I vs II-IV, P < 0.001), tumor thickness (<= 2.00 vs > 2.00 mm, P < 0.001) and ulceration (P = 0.005). Increased cytoplasmic Skp2 expression was associated with a poor five-year disease-specific survival of patients with primary melanoma (P = 0.018) but not metastatic melanoma (P > 0.05). Conclusion: This study demonstrates that cytoplasmic Skp2 plays an important role in melanoma pathogenesis and its expression correlates with patient survival. Our data indicate that cytoplasmic Skp2 may serve as a potential biomarker for melanoma progression and a therapeutic target for this disease.	[Chen, Guangdi; Cheng, Yabin; Zhang, Zhizhong; Li, Gang] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Jack Bell Res Ctr, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada; [Martinka, Magdalena] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Jack Bell Res Ctr, Dept Pathol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health Research Institute	Chen, GD (corresponding author), Univ British Columbia, Vancouver Coastal Hlth Res Inst, Jack Bell Res Ctr, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada.	gangli@interchange.ubc.ca	Li, Gang/A-8257-2011; Cheng, Yabin/P-7071-2015; Cheng, Yabin/AAY-2178-2020	Cheng, Yabin/0000-0002-6205-3648; Cheng, Yabin/0000-0002-6205-3648	Canadian Institutes of Health Research [MOP-84559, MOP-93810]; Canadian Dermatology Foundation; Michael Smith Foundation; VGH & UBC Hospital Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Dermatology Foundation; Michael Smith Foundation(Michael Smith Foundation for Health Research); VGH & UBC Hospital Foundation	This work is supported by Canadian Institutes of Health Research (MOP-84559 and MOP-93810) and Canadian Dermatology Foundation (G.L.). G.C. is a recipient of Postdoctoral Trainee Award from Michael Smith Foundation for Health Research jointly funded with VGH & UBC Hospital Foundation. Y.C. is a recipient of Canadian Institutes of Health Research Skin Research Training Centre PhD Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Barnhill RL, 2010, ADV ANAT PATHOL, V17, P73, DOI 10.1097/PAP.0b013e3181cfe758; Bhatt KV, 2007, ONCOGENE, V26, P1056, DOI 10.1038/sj.onc.1209861; Bhatt KV, 2005, ONCOGENE, V24, P3459, DOI 10.1038/sj.onc.1208544; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen G, 2010, ONCOGENE, V29, P1498, DOI 10.1038/onc.2009.424; Chen GD, 2010, INT J ONCOL, V37, P1339, DOI 10.3892/ijo_00000786; Chen GD, 2010, PIGM CELL MELANOMA R, V23, P572, DOI 10.1111/j.1755-148X.2010.00725.x; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Crowson AN, 2007, SEMIN ONCOL, V34, P476, DOI 10.1053/j.seminoncol.2007.09.007; Dai DL, 2005, J CLIN ONCOL, V23, P1473, DOI 10.1200/JCO.2005.07.168; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Einama T, 2006, PANCREAS, V32, P376, DOI 10.1097/01.mpa.0000220862.78248.c4; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Friedman RJ, 2009, CLIN DERMATOL, V27, P103, DOI 10.1016/j.clindermatol.2008.09.008; Geller AC, 2007, J AM ACAD DERMATOL, V57, P555, DOI 10.1016/j.jaad.2007.06.032; Govindarajan B, 2003, J BIOL CHEM, V278, P9790, DOI 10.1074/jbc.M212929200; Govindarajan B, 2007, J CLIN INVEST, V117, P719, DOI 10.1172/JCI30102; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada K, 2005, ANTICANCER RES, V25, P2471; HERLYN M, 1987, LAB INVEST, V56, P461; Hershko DD, 2008, CANCER-AM CANCER SOC, V112, P1415, DOI 10.1002/cncr.23317; Hofmann UB, 2005, BIOCHIMIE, V87, P307, DOI 10.1016/j.biochi.2005.01.013; Houghton AN, 2002, CANCER CELL, V2, P275, DOI 10.1016/S1535-6108(02)00161-7; HOUGHTON AN, 1987, J EXP MED, V165, P812, DOI 10.1084/jem.165.3.812; Hu R, 2008, MOL BIOL CELL, V19, P4602, DOI 10.1091/mbc.E07-11-1137; Hung WC, 2010, CANCER LETT, V288, P156, DOI 10.1016/j.canlet.2009.06.032; Ibrahim N, 2009, ANNU REV PATHOL-MECH, V4, P551, DOI 10.1146/annurev.pathol.3.121806.151541; Katagiri Y, 2006, J DERMATOL SCI, V42, P215, DOI 10.1016/j.jdermsci.2005.12.016; Li JQ, 2004, INT J ONCOL, V25, P87; Li Q, 2004, J CUTAN PATHOL, V31, P633, DOI 10.1111/j.0303-6987.2004.00243.x; Li Y, 2002, SEMIN ONCOL, V29, P413, DOI 10.1053/sonc.2002.35237; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Liu SC, 2009, CANCER LETT, V286, P240, DOI 10.1016/j.canlet.2009.05.038; Ma XM, 2005, WORLD J GASTROENTERO, V11, P6716, DOI 10.3748/wjg.v11.i42.6716; Motti ML, 2007, CELL CYCLE, V6, P2817, DOI 10.4161/cc.6.22.4883; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; REMMELE W, 1987, PATHOLOGE, V8, P138; ROSE AE, PIGMENT CEL IN PRESS; Salon C, 2007, ONCOGENE, V26, P6927, DOI 10.1038/sj.onc.1210499; Skaar JR, 2009, CELL, V137, DOI 10.1016/j.cell.2009.05.039; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Sumimoto H, 2006, INT J CANCER, V118, P472, DOI 10.1002/ijc.21286; TOSCO P, ORAL DIS IN PRESS; Trinh VA, 2008, AM J HEALTH-SYST PH, V65, pS3, DOI 10.2146/ajhp080460; Wang XC, 2009, MOL CANCER RES, V7, P12, DOI 10.1158/1541-7786.MCR-08-0092; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Woenckhaus C, 2005, HISTOL HISTOPATHOL, V20, P501, DOI 10.14670/HH-20.501; Yokoi S, 2004, AM J PATHOL, V165, P175, DOI 10.1016/S0002-9440(10)63286-5	51	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17578	10.1371/journal.pone.0017578	http://dx.doi.org/10.1371/journal.pone.0017578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386910	Green Published, gold, Green Submitted			2022-12-25	WOS:000287931400085
J	Paul, D; Kumar, R; Nanduri, B; French, T; Pendarvis, K; Brown, A; Lawrence, ML; Burgess, SC				Paul, Debarati; Kumar, Ranjit; Nanduri, Bindu; French, Todd; Pendarvis, Ken; Brown, Ashli; Lawrence, Mark L.; Burgess, Shane C.			Proteome and Membrane Fatty Acid Analyses on Oligotropha carboxidovorans OM5 Grown under Chemolithoautotrophic and Heterotrophic Conditions	PLOS ONE			English	Article							GAS-CHROMATOGRAPHIC QUANTIFICATION; CARBON-MONOXIDE DEHYDROGENASE; CYCLE ENZYME-ACTIVITIES; ESCHERICHIA-COLI; BRADYRHIZOBIUM-JAPONICUM; GLYOXYLATE CYCLE; MEGAPLASMID PHCG3; METHYL-ESTERS; GENE-CLUSTER; PURIFICATION	Oligotropha carboxidovorans OM5 T. (DSM 1227, ATCC 49405) is a chemolithoautotrophic bacterium able to utilize CO and H(2) to derive energy for fixation of CO(2). Thus, it is capable of growth using syngas, which is a mixture of varying amounts of CO and H(2) generated by organic waste gasification. O. carboxidovorans is capable also of heterotrophic growth in standard bacteriologic media. Here we characterize how the O. carboxidovorans proteome adapts to different lifestyles of chemolithoautotrophy and heterotrophy. Fatty acid methyl ester (FAME) analysis of O. carboxidovorans grown with acetate or with syngas showed that the bacterium changes membrane fatty acid composition. Quantitative shotgun proteomic analysis of O. carboxidovorans grown in the presence of acetate and syngas showed production of proteins encoded on the megaplasmid for assimilating CO and H(2) as well as proteins encoded on the chromosome that might have contributed to fatty acid and acetate metabolism. We found that adaptation to chemolithoautotrophic growth involved adaptations in cell envelope, oxidative homeostasis, and metabolic pathways such as glyoxylate shunt and amino acid/cofactor biosynthetic enzymes.	[Paul, Debarati; Kumar, Ranjit; Nanduri, Bindu; Lawrence, Mark L.; Burgess, Shane C.] Mississippi State Univ, Coll Vet Med, Mississippi State, MS 39762 USA; [French, Todd; Burgess, Shane C.] Mississippi State Univ, Dept Chem Engn, Mississippi State, MS 39762 USA; [Pendarvis, Ken] Mississippi State Univ, Life Sci & Biotechnol Inst, Mississippi State, MS 39762 USA; [Brown, Ashli] Mississippi State Univ, Dept Biochem & Mol Biol, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University; Mississippi State University; Mississippi State University	Paul, D (corresponding author), Mississippi State Univ, Coll Vet Med, Mississippi State, MS 39762 USA.	lawrence@cvm.msstate.edu	Paul, Debarati/ABE-8692-2020	Paul, Debarati/0000-0002-3893-658X	United States Department of Energy [DE-FG3606GO86025]	United States Department of Energy(United States Department of Energy (DOE))	This research was supported by the United States Department of Energy under award number DE-FG3606GO86025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbaro SE, 2002, CAN J MICROBIOL, V48, P239, DOI 10.1139/W02-012; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bridges SM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S24; CLAASSEN PAM, 1986, ARCH MICROBIOL, V145, P148, DOI 10.1007/BF00446772; CRONAN JE, 1972, BIOCHIM BIOPHYS ACTA, V265, P25, DOI 10.1016/0304-4157(72)90018-4; Denich TJ, 2003, J MICROBIOL METH, V52, P149, DOI 10.1016/S0167-7012(02)00155-0; Dodds ED, 2005, LIPIDS, V40, P419, DOI 10.1007/s11745-006-1399-8; ESCHENBRENNER M, 1995, J BIOL CHEM, V270, P20550, DOI 10.1074/jbc.270.35.20550; Fuhrmann S, 2003, GENE, V322, P67, DOI 10.1016/j.gene.2003.08.027; Green LS, 1998, ARCH MICROBIOL, V169, P445, DOI 10.1007/s002030050595; GUTNIKOV G, 1995, J CHROMATOGR B, V671, P71, DOI 10.1016/0378-4347(95)00116-Z; Han L, 1997, J BACTERIOL, V179, P5157, DOI 10.1128/jb.179.16.5157-5164.1997; HAYASHI M, 1990, BIOCHIM BIOPHYS ACTA, V1035, P230, DOI 10.1016/0304-4165(90)90122-D; Henstra AM, 2007, CURR OPIN BIOTECH, V18, P200, DOI 10.1016/j.copbio.2007.03.008; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Jones P, 2006, NUCLEIC ACIDS RES, V34, pD659, DOI 10.1093/nar/gkj138; KEEFE RG, 1993, BIOCHIM BIOPHYS ACTA, V1183, P91, DOI 10.1016/0005-2728(93)90008-4; Kieft TL, 1997, APPL ENVIRON MICROB, V63, P1531, DOI 10.1128/AEM.63.4.1531-1542.1997; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; Kutchma AJ, 1999, J BACTERIOL, V181, P5498, DOI 10.1128/JB.181.17.5498-5504.1999; Lorite MJ, 2000, APPL ENVIRON MICROB, V66, P1871, DOI 10.1128/AEM.66.5.1871-1876.2000; Martens L, 2005, PROTEOMICS, V5, P3537, DOI 10.1002/pmic.200401303; MARUYAMA Y, 1958, INFLUENCE GROWTH PHA, P169; MEYER O, 1978, ARCH MICROBIOL, V118, P35, DOI 10.1007/BF00406071; Meyer O, 2000, BIOL CHEM, V381, P865, DOI 10.1515/BC.2000.108; MEYER O, 1983, ANNU REV MICROBIOL, V37, P277, DOI 10.1146/annurev.mi.37.100183.001425; Nanduri B, 2005, PROTEOMICS, V5, P4852, DOI 10.1002/pmic.200500112; Neilan BA, 2008, ADV EXP MED BIOL, V619, P417; Ohshima N, 2008, J BACTERIOL, V190, P1219, DOI 10.1128/JB.01223-07; Orchard Sandra, 2007, Proteomics, V7 Suppl 1, P28, DOI 10.1002/pmic.200700286; Oshiro G, 2002, GENOME RES, V12, P1210, DOI 10.1101/gr.226802; Paul D, 2008, J BACTERIOL, V190, P5531, DOI 10.1128/JB.00614-08; Santiago B, 1999, GENE, V236, P115, DOI 10.1016/S0378-1119(99)00245-0; Santiago B, 1997, J BACTERIOL, V179, P6053, DOI 10.1128/jb.179.19.6053-6060.1997; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; Thurnhofer S, 2006, J AGR FOOD CHEM, V54, P3209, DOI 10.1021/jf053022j; Unnikrishnan M, 1999, INFECT IMMUN, V67, P5495, DOI 10.1128/IAI.67.10.5495-5499.1999	38	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17111	10.1371/journal.pone.0017111	http://dx.doi.org/10.1371/journal.pone.0017111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386900	Green Published, gold, Green Submitted			2022-12-25	WOS:000287931400029
J	Zhou, JW; Tsui, SKW; Ng, MCY; Geng, H; Li, SK; So, WY; Ma, RC; Wang, Y; Tao, QA; Chen, ZY; Chan, JCN; Ho, YY				Zhou, Jun-Wei; Tsui, Stephen K. W.; Ng, Maggie C. Y.; Geng, Hua; Li, Sai-Kam; So, Wing-Yee; Ma, Ronald C.; Wang, Ying; Tao, Qian; Chen, Zhen-Yu; Chan, Juliana C. N.; Ho, Yuan-Yuan			Apolipoprotein M Gene (APOM) Polymorphism Modifies Metabolic and Disease Traits in Type 2 Diabetes	PLOS ONE			English	Article							CHINESE; LINKAGE; ATHEROSCLEROSIS; SUSCEPTIBILITY; CHOLESTEROL; POPULATION; EXPRESSION; MULTIPLE; DATABASE; BROWSER	This study aimed at substantiating the associations of the apolipoproein M gene (APOM) with type 2 diabetes (T2D) as well as with metabolic traits in Hong Kong Chinese. In addition, APOM gene function was further characterized to elucidate its activity in cholesterol metabolism. Seventeen APOM SNPs documented in the NCBI database were genotyped. Five SNPs were confirmed in our study cohort of 1234 T2D and 606 control participants. Three of the five SNPs rs707921(C+1871A), rs707922(G+1837T) and rs805264(G+203A) were in linkage disequilibrium (LD). We chose rs707922 to tag this LD region for down stream association analyses and characterized the function of this SNP at molecular level. No association between APOM and T2D susceptibility was detected in our Hong Kong Chinese cohort. Interestingly, the C allele of rs805297 was significantly associated with T2D duration of longer than 10 years (OR = 1.245, p = 0.015). The rs707922 TT genotype was significantly associated with elevated plasma total-and LDL- cholesterol levels (p = 0.006 and p = 0.009, respectively) in T2D patients. Molecular analyses of rs707922 lead to the discoveries of a novel transcript APOM5 as well as the cryptic nature of exon 5 of the gene. Ectopic expression of APOM5 transcript confirmed rs707922 allele-dependent activity of the transcript in modifying cholesterol homeostasis in vitro. In conclusion, the results here did not support APOM as a T2D susceptibility gene in Hong Kong Chinese. However, in T2D patients, a subset of APOM SNPs was associated with disease duration and metabolic traits. Further molecular analysis proved the functional activity of rs707922 in APOM expression and in regulation of cellular cholesterol content.	[Zhou, Jun-Wei] Chinese Univ Hong Kong, Sch Biomed Sci, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Ng, Maggie C. Y.] Wake Forest Univ Hlth Sci, Dept Pediat, Ctr Diabet Res, Winston Salem, NC USA; [Geng, Hua; Tao, Qian] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, State Key Lab Oncol S China, Canc Epigenet Lab,Dept Clin Oncol,Sir YK Pao Ctr, Hong Kong, Hong Kong, Peoples R China; [So, Wing-Yee; Ma, Ronald C.; Wang, Ying; Chan, Juliana C. N.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Chan, Juliana C. N.] Hong Kong Inst Diabet & Obes, Hong Kong, Hong Kong, Peoples R China; [Ho, Yuan-Yuan] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA; [Ho, Yuan-Yuan] Columbia Univ, Dept Biostat, New York, NY USA; [Ho, Yuan-Yuan] Columbia Univ, Dept Psychiat, New York, NY USA	Chinese University of Hong Kong; Wake Forest University; Wake Forest University School of Medicine; Chinese University of Hong Kong; Chinese University of Hong Kong; Columbia University; Columbia University; Columbia University	Zhou, JW (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	yyh2@columbia.edu	Tao, Qian/T-4743-2018; Tsui, Stephen Kwok-Wing/E-4385-2015; Chan, Juliana/B-7918-2016; Ma, Ronald/C-2788-2009	Tao, Qian/0000-0001-5383-4808; Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Chan, Juliana/0000-0003-1325-1194; Ma, Ronald/0000-0002-1227-803X	National Institute of Mental Health, USA [T32-MH-65213]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065213] Funding Source: NIH RePORTER	National Institute of Mental Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	T32-MH-65213, National Institute of Mental Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Dahlback B, 2006, CURR OPIN LIPIDOL, V17, P291, DOI 10.1097/01.mol.0000226122.10005.88; Geng H, 2005, FEBS LETT, V579, P6763, DOI 10.1016/j.febslet.2005.11.007; Han Xiu-jie, 2007, Zhonghua Yixue Yichuanxue Zazhi, V24, P350; Hao GQ, 2007, CLIN BIOCHEM, V40, P1108, DOI 10.1016/j.clinbiochem.2007.04.023; Kruit JK, 2010, DIABETOLOGIA, V53, P1110, DOI 10.1007/s00125-010-1691-2; Lee KY, 2008, ONCOGENE, V27, P5267, DOI 10.1038/onc.2008.147; Niu NF, 2007, DIABETES-METAB RES, V23, P21, DOI 10.1002/dmrr.641; OOI EM, ATHEROSCLEROSIS, V210, P326; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Richter S, 2003, DIABETES, V52, P2989, DOI 10.2337/diabetes.52.12.2989; Sambrook J., 2001, MOL CLONING; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Skupien Jan, 2007, Rev Diabet Stud, V4, P231, DOI 10.1900/RDS.2007.4.231; Stenger JE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-95; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Su WQ, 2009, CLIN BIOCHEM, V42, P365, DOI 10.1016/j.clinbiochem.2008.11.010; Tao Q, 1998, BLOOD, V91, P1373, DOI 10.1182/blood.V91.4.1373; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Xiang KS, 2004, DIABETES, V53, P228, DOI 10.2337/diabetes.53.1.228; Xu N, 2004, J NUTR BIOCHEM, V15, P579, DOI 10.1016/j.jnutbio.2004.03.001; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Yang X, 2007, DIABETES CARE, V30, P65, DOI 10.2337/dc06-1273; ZHAO D, J MOL NEURO IN PRESS; ZHAO T, 1989, HUM GENET, V83, P101, DOI 10.1007/BF00286699	28	24	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17324	10.1371/journal.pone.0017324	http://dx.doi.org/10.1371/journal.pone.0017324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390319	gold, Green Published, Green Submitted			2022-12-25	WOS:000287761700045
J	Gao, XN; Lin, J; Li, YH; Gao, L; Wang, XR; Wang, W; Kang, HY; Yan, GT; Wang, LL; Yu, L				Gao, X-N; Lin, J.; Li, Y-H; Gao, L.; Wang, X-R; Wang, W.; Kang, H-Y; Yan, G-T; Wang, L-L; Yu, L.			MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia	ONCOGENE			English	Article						c-kit; microRNAs; DNA methylation; acute myeloid leukemia; proto-oncogenes; tumor suppressor genes	ACUTE LYMPHOBLASTIC-LEUKEMIA; HUMAN CANCER; PROGNOSTIC IMPACT; DNA METHYLATION; GENE-EXPRESSION; CELL-LINES; MUTATIONS; AML; HYPERMETHYLATION; T(8/21)	Aberrant activation of c-kit proto-oncogene contributes to abnormal cell proliferation by altering the tyrosine kinase signaling and constitutes a crucial impetus for leukemo-genesis. Epigenetic silencing of tumor-suppressive microRNAs (miRNAs) is a key oncogenic mechanism for the activation of oncogenes in tumors. In this study, several miRNAs potentially binding to the 3'-untranslated region of human c-kit mRNA were screened by luciferase reporter assays. Among these miRNAs, miR-193a was embedded in a CpG island and epigenetically repressed by promoter hypermethylation in acute myeloid leukemia (AML) cell lines and primary AML blasts, but not in normal bone marrow cells. Importantly, miR-193a levels were inversely correlated with c-kit levels measured in 9 leukemia cell lines and 27 primary AML samples. Restoring miR-193a expression in AML cells harboring c-kit mutation and/or overexpression, either by synthetic miR-193a transfection or by DNA hypomethylating agent 5-azacytidine (5-aza) treatment, resulted in a significant reduction in c-kit expression at both RNA and protein levels and inhibition of cell growth. The growth-inhibitory activity of miR-193a was associated with apoptosis and granulocytic differentiation. Moreover, 5-aza-induced c-kit reduction could be partially blocked by miR-193a inhibitor, leading to a reversal of antiproliferative and proapoptotic effects of 5-aza. These data reveal a critical role for methylation-repressed miR-193a in myeloid leukemogenesis and the therapeutic promise of upregulating miR-193a expression for c-kit-positive AML. Oncogene (2011) 30, 3416-3428; doi:10.1038/onc.2011.62; published online 14 March 2011	[Gao, X-N; Li, Y-H; Gao, L.; Wang, X-R; Wang, W.; Kang, H-Y; Wang, L-L; Yu, L.] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing 100853, Peoples R China; [Lin, J.; Yan, G-T] Chinese Peoples Liberat Army Gen Hosp, Basic Med Inst, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Yu, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, 28 Fuxing Rd, Beijing 100853, Peoples R China.	chunhuiliyu@yahoo.com	yang, xiao-jun/B-1927-2009	Yu, Li/0000-0001-6872-2665	National Natural Science Foundation of China [81000221, 90919044, 30971297]; National 973 Project of China [2005CB522400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Project of China(National Basic Research Program of China)	We thank Y Ding, Y-Y Xu, N Wang, C-W Xu, M Li, M-X Chen and W-D Han for excellent technical assistance. We also thank Professor X-F Zheng and H-J Fu from Beijing Institute of Radiation Medicine, China, for presenting the modified pGL3-control plasmid and miRNA expression plasmids. This work was supported by the National Natural Science Foundation of China (nos 81000221, 90919044 and 30971297) and the National 973 Project of China (no. 2005CB522400).	Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; Agrawal S, 2007, CANCER RES, V67, P1370, DOI 10.1158/0008-5472.CAN-06-1681; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beghini A, 2004, HAEMATOLOGICA, V89, P920; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Berg T, 2007, LEUKEMIA RES, V31, P497, DOI 10.1016/j.leukres.2006.08.008; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boissel N, 2006, LEUKEMIA, V20, P965, DOI 10.1038/sj.leu.2404188; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Cairoli R, 2006, BLOOD, V107, P3463, DOI 10.1182/blood-2005-09-3640; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2008, LEUKEMIA, V22, P1095, DOI 10.1038/leu.2008.30; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Heidel F, 2007, CANCER, V109, P907, DOI 10.1002/cncr.22471; Jacquel A, 2007, ONCOGENE, V26, P2445, DOI 10.1038/sj.onc.1210034; Jiao B, 2009, LEUKEMIA, V23, P1598, DOI 10.1038/leu.2009.104; Jun C, 2007, PROG BIOCHEM BIOPHYS, V34, P389; Kindler T, 2004, BLOOD, V103, P3644, DOI 10.1182/blood-2003-06-2071; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Larizza L, 2005, LEUKEMIA LYMPHOMA, V46, P247, DOI 10.1080/10428190400007565; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; Osada H, 2007, CARCINOGENESIS, V28, P2, DOI 10.1093/carcin/bgl185; Paschka P, 2006, J CLIN ONCOL, V24, P3904, DOI 10.1200/JCO.2006.06.9500; Reilly JT, 2003, BLOOD REV, V17, P241, DOI 10.1016/S0268-960X(03)00024-9; Renneville A, 2008, LEUKEMIA, V22, P915, DOI 10.1038/leu.2008.19; Roman-Gomez J, 2009, J CLIN ONCOL, V27, P1316, DOI 10.1200/JCO.2008.19.3441; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schnittger S, 2006, BLOOD, V107, P1791, DOI 10.1182/blood-2005-04-1466; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Wang YY, 2005, P NATL ACAD SCI USA, V102, P1104, DOI 10.1073/pnas.0408831102; Youssef EM, 2004, CANCER RES, V64, P2411, DOI 10.1158/0008-5472.CAN-03-0164	45	128	139	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2011	30	31					3416	3428		10.1038/onc.2011.62	http://dx.doi.org/10.1038/onc.2011.62			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	802KA	21399664				2022-12-25	WOS:000293508100003
J	Dongre, M; Singh, NS; Dureja, C; Peddada, N; Solanki, AK; Ashish; Raychaudhuri, S				Dongre, Mitesh; Singh, Naorem Santa; Dureja, Chetna; Peddada, Nagesh; Solanki, Ashish K.; Ashish; Raychaudhuri, Saumya			Evidence on How a Conserved Glycine in the Hinge Region of HapR Regulates Its DNA Binding Ability LESSONS FROM A NATURAL VARIANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; VIBRIO-CHOLERAE; PROTEIN; RESOLUTION; RECEPTOR; HARVEYI	HapR has been recognized as a quorum-sensing master regulator in Vibrio cholerae. Because it controls a plethora of disparate cellular events, the absence of a functional HapR affects the physiology of V. cholerae to a great extent. In the current study, we pursued an understanding of an observation of a natural protease-deficient non-O1, non-O139 variant V. cholerae strain V2. Intriguingly, a nonfunctional HapR (henceforth designated as HapR(V2)) harboring a substitution of glycine to aspartate at position 39 of the N-terminal hinge region has been identified. An in vitro gel shift assay clearly suggested the inability of HapR(V2) to interact with various cognate promoters. Reinstatement of glycine at position 39 restores DNA binding ability of HapR(V2) (HapR(V2G)), thereby rescuing the protease-negative phenotype of this strain. The elution profile of HapR(V2) and HapR(V2G) proteins in size-exclusion chromatography and their circular dichroism spectra did not reflect any significant differences to explain the functional discrepancies between the two proteins. To gain insight into the structure-function relationship of these two proteins, we acquired small/wide angle x-ray scattering data from samples of the native and G39D mutant. Although Guinier analysis and indirect Fourier transformation of scattering indicated only a slight difference in the shape parameters, structure reconstruction using dummy amino acids concluded that although HapR adopts a "Y" shape similar to its crystal structure, the G39D mutation in hinge drastically altered the DNA binding domains by bringing them in close proximity. This altered spatial orientation of the helix-turn-helix domains in this natural variant provides the first structural evidence on the functional role of the hinge region in quorum sensing-related DNA-binding regulatory proteins of Vibrio spp.	[Dongre, Mitesh; Singh, Naorem Santa; Dureja, Chetna; Peddada, Nagesh; Solanki, Ashish K.; Ashish; Raychaudhuri, Saumya] CSIR, Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Ashish (corresponding author), CSIR, Inst Microbial Technol, Sector 39A, Chandigarh 160036, India.	ashgang@imtech.res.in; saumya@rocketmail.com	Peddada, Nagesh/L-6760-2019; Raychaudhuri, Saumya/AFL-0368-2022; Solanki, Ashish K/F-5210-2017	Solanki, Ashish K/0000-0002-5043-1699; dongre, mitesh/0000-0002-7151-1137; Peddada, Nagesh/0000-0003-4033-7305	Council of Scientific and Industrial Research India; Department of Biotechnology [BT/PR6918/BRB/10/454/2005]; Supra Institutional Project [SIP-10/IMTECH/CSIR]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; Council of Scientific and Industrial Research and Department of Biotechnology, India	Council of Scientific and Industrial Research India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; Supra Institutional Project; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Council of Scientific and Industrial Research and Department of Biotechnology, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the grants from the Council of Scientific and Industrial Research India, Department of Biotechnology Grant BT/PR6918/BRB/10/454/2005 and Supra Institutional Project SIP-10/IMTECH/CSIR. Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.; Supported by Council of Scientific and Industrial Research and Department of Biotechnology, India, research fellowships.	De Silva RS, 2007, J BACTERIOL, V189, P5683, DOI 10.1128/JB.01807-06; Glatter O., 1982, SMALL ANGLE X RAY SC; Griese JJ, 2010, NUCLEIC ACIDS RES, V38, P3454, DOI 10.1093/nar/gkq038; Haelens A, 2007, CANCER RES, V67, P4514, DOI 10.1158/0008-5472.CAN-06-1701; Ishikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006734; Joelsson A, 2006, INFECT IMMUN, V74, P1141, DOI 10.1128/IAI.74.2.1141-1147.2006; Joelsson A, 2007, APPL ENVIRON MICROB, V73, P3742, DOI 10.1128/AEM.02804-06; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; LITTLE JW, 1985, P NATL ACAD SCI USA, V82, P2301, DOI 10.1073/pnas.82.8.2301; Matz C, 2005, P NATL ACAD SCI USA, V102, P16819, DOI 10.1073/pnas.0505350102; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Raychaudhuri S, 2006, GENE, V369, P126, DOI 10.1016/j.gene.2005.10.031; Silva AJ, 2004, J BACTERIOL, V186, P6374, DOI 10.1128/JB.186.19.6374-6382.2004; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tsou AM, 2009, NUCLEIC ACIDS RES, V37, P2747, DOI 10.1093/nar/gkp121; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	21	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15043	15049		10.1074/jbc.M110.209346	http://dx.doi.org/10.1074/jbc.M110.209346			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21383015	hybrid, Green Published			2022-12-25	WOS:000289788300034
J	Alborghetti, MR; Furlan, AS; Kobarg, J				Alborghetti, Marcos R.; Furlan, Ariane S.; Kobarg, Joerg			FEZ2 Has Acquired Additional Protein Interaction Partners Relative to FEZ1: Functional and Evolutionary Implications	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; AXONAL OUTGROWTH; NEURAL DIFFERENTIATION; INTERACTION NETWORK; NEURITE OUTGROWTH; 2-HYBRID SYSTEM; COILED COILS; ZETA-1 FEZ1; CELLS; FASCICULATION	Background: The FEZ (fasciculation and elongation protein zeta) family designation was purposed by Bloom and Horvitz by genetic analysis of C. elegans unc-76. Similar human sequences were identified in the expressed sequence tag database as FEZ1 and FEZ2. The unc-76 function is necessary for normal axon fasciculation and is required for axon-axon interactions. Indeed, the loss of UNC-76 function results in defects in axonal transport. The human FEZ1 protein has been shown to rescue defects caused by unc-76 mutations in nematodes, indicating that both UNC-76 and FEZ1 are evolutionarily conserved in their function. Until today, little is known about FEZ2 protein function. Methodology/ Principal Findings: Using the yeast two-hybrid system we demonstrate here conserved evolutionary features among orthologs and non-conserved features between paralogs of the FEZ family of proteins, by comparing the interactome profiles of the C-terminals of human FEZ1, FEZ2 and UNC-76 from C. elegans. Furthermore, we correlate our data with an analysis of the molecular evolution of the FEZ protein family in the animal kingdom. Conclusions/ Significance: We found that FEZ2 interacted with 59 proteins and that of these only 40 interacted with FEZ1. Of the 40 FEZ1 interacting proteins, 36 (90%), also interacted with UNC-76 and none of the 19 FEZ2 specific proteins interacted with FEZ1 or UNC-76. This together with the duplication of unc-76 gene in the ancestral line of chordates suggests that FEZ2 is in the process of acquiring new additional functions. The results provide also an explanation for the dramatic difference between C. elegans and D. melanogaster unc-76 mutants on one hand, which cause serious defects in the nervous system, and the mouse FEZ1 -/- knockout mice on the other, which show no morphological and no strong behavioural phenotype. Likely, the ubiquitously expressed FEZ2 can completely compensate the lack of neuronal FEZ1, since it can interact with all FEZ1 interacting proteins and additional 19 proteins.	[Alborghetti, Marcos R.; Furlan, Ariane S.; Kobarg, Joerg] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Sao Paulo, Brazil; [Alborghetti, Marcos R.; Furlan, Ariane S.; Kobarg, Joerg] Univ Estadual Campinas, Inst Biol, Dept Bioquim, Programa Posgrad Biol Func & Mol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	Alborghetti, MR (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Sao Paulo, Brazil.	jorg.kobarg@lnbio.org.br	Alborghetti, Marcos/K-7547-2012; Kobarg, Jörg/T-4736-2019	Alborghetti, Marcos/0000-0003-4517-5579; Kobarg, Jörg/0000-0002-9419-0145	Fundacao de Amparo a Pesquisa do Estado Sao Paulo; Conselho Nacional de Pesquisa e Desenvolvimento; LNBio-CNPEM	Fundacao de Amparo a Pesquisa do Estado Sao Paulo; Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); LNBio-CNPEM	This work was financially supported by Fundacao de Amparo a Pesquisa do Estado Sao Paulo, the Conselho Nacional de Pesquisa e Desenvolvimento and the LNBio-CNPEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Brunet-De Carvalho N, 2003, GROWTH FACTORS, V21, P139, DOI 10.1080/08977190310001621014; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fox A, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P391; Fujita T, 2007, BIOCHEM BIOPH RES CO, V361, P605, DOI 10.1016/j.bbrc.2007.07.050; Fujita T, 2004, BIOCHEM BIOPH RES CO, V313, P738, DOI 10.1016/j.bbrc.2003.12.006; Furuta M, 2004, DEV BRAIN RES, V152, P189, DOI 10.1016/j.devbrainres.2004.06.014; Gindhart JG, 2003, MOL BIOL CELL, V14, P3356, DOI 10.1091/mbc.E02-12-0800; Greene LA, 2005, NEUROCHEM RES, V30, P1347, DOI 10.1007/s11064-005-8807-y; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Hennah W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004906; Ikuta J, 2007, BIOCHEM BIOPH RES CO, V353, P127, DOI 10.1016/j.bbrc.2006.11.142; Kuroda S, 1999, J CELL BIOL, V144, P403, DOI 10.1083/jcb.144.3.403; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Lanza DCF, 2008, EXP CELL RES, V314, P2028, DOI 10.1016/j.yexcr.2008.02.012; Lanza DCF, 2010, MOL CELL BIOCHEM, V338, P35, DOI 10.1007/s11010-009-0317-9; Lanza DCF, 2009, PROTEINS, V74, P104, DOI 10.1002/prot.22135; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Makino T., 2007, V3, P13, DOI 10.1159/000107601; MATURANA AD, SCIENTIFICWORLDJOURN, V10, P1646; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Naghavi MH, 2005, GENE DEV, V19, P1105, DOI 10.1101/gad.1290005; Okumura F, 2004, J BIOL CHEM, V279, P53533, DOI 10.1074/jbc.M402916200; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Sakae N, 2008, HUM MOL GENET, V17, P3191, DOI 10.1093/hmg/ddn215; SilosSantiago I, 1996, J NEUROBIOL, V31, P283, DOI 10.1002/(SICI)1097-4695(199611)31:3<283::AID-NEU2>3.0.CO;2-6; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Strauss H. M., 2008, V186, P461, DOI 10.1007/978-3-540-72843-6_19; SU CW, 2006, J BIOL-LONDON, V5, pNIL5; Suzuki T, 2005, J BIOL CHEM, V280, P24948, DOI 10.1074/jbc.M411499200; WALHOUT AJM, 2000, SCIENCE, V287, P116; Whitehouse C, 2002, EUR J BIOCHEM, V269, P538, DOI 10.1046/j.0014-2956.2001.02681.x; Zechel C, 2005, MOL ENDOCRINOL, V19, P1629, DOI 10.1210/me.2004-0540	43	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17426	10.1371/journal.pone.0017426	http://dx.doi.org/10.1371/journal.pone.0017426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408165	Green Submitted, gold, Green Published			2022-12-25	WOS:000288170000028
J	Antenos, M; Lei, L; Xu, M; Malipatil, A; Kiesewetter, S; Woodruff, TK				Antenos, Monica; Lei, Lei; Xu, Min; Malipatil, Anjali; Kiesewetter, Sarah; Woodruff, Teresa K.			Role of PCSK5 Expression in Mouse Ovarian Follicle Development: Identification of the Inhibin alpha- and beta-Subunits as Candidate Substrates	PLOS ONE			English	Article							KEX2-LIKE PROCESSING ENDOPROTEASE; IN-VITRO CULTURE; GENE-EXPRESSION; PROPROTEIN CONVERTASES; ACTIVIN-A; RAT; SECRETION; FAMILY; CELLS; CYCLE	Inhibin and activin are essential dimeric glycoproteins belonging to the transforming growth factor-beta (TGF beta) superfamily. Inhibin is a heterodimer of alpha-and beta-subunits, whereas activin is a homodimer of beta-subunits. Production of inhibin is regulated during the reproductive cycle and requires the processing of pro-ligands to produce mature hormone. Furin is a subtilisin-like proprotein convertase (proconvertase) that activates precursor proteins by cleavage at basic sites during their transit through the secretory pathway and/or at the cell surface. We hypothesized that furin-like proconvertases are central regulators of inhibin alpha-and beta-subunit processing within the ovary. We analyzed the expression of the proconvertases furin, PCSK5, PCSK6, and PCSK7 in the developing mouse ovary by real-time quantitative RT-PCR. The data showed that proconvertase enzymes are temporally expressed in ovarian cells. With the transition from two-layer secondary to pre-antral follicle, only PCSK5 mRNA was significantly elevated. Activin A selectively enhanced expression of PCSK5 mRNA and decreased expression of furin and PCSK6 in cultured two-layer secondary follicles. Inhibition of proconvertase enzyme activity by dec-RVKR-chloromethylketone (CMK), a highly specific and potent competitive inhibitor of subtilisin-like proconvertases, significantly impeded both inhibin alpha-and beta-subunit maturation in murine granulosa cells. Overexpression of PC5/6 in furin-deficient cells led to increased inhibin alpha-and beta(B)-subunit maturation. Our data support the role of proconvertase PCSK5 in the processing of ovarian inhibin subunits during folliculogenesis and suggest that this enzyme may be an important regulator of inhibin and activin bioavailability.	[Antenos, Monica; Lei, Lei; Xu, Min; Malipatil, Anjali; Kiesewetter, Sarah; Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Antenos, Monica; Lei, Lei; Xu, Min; Malipatil, Anjali; Kiesewetter, Sarah; Woodruff, Teresa K.] Northwestern Univ, Ctr Reprod Sci, Evanston, IL USA; [Woodruff, Teresa K.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Antenos, M (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	tkw@northwestern.edu	Antenos, Monica/J-8985-2017	Antenos, Monica/0000-0001-6350-2911; Woodruff, Teresa/0000-0002-1197-3399	National Institutes of Health [R01 HD37096]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health grant R01 HD37096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antenos M, 2007, MOL ENDOCRINOL, V21, P1670, DOI 10.1210/me.2007-0050; Antenos M, 2008, J BIOL CHEM, V283, P33059, DOI 10.1074/jbc.M804190200; Bae JA, 2008, MOL CELL ENDOCRINOL, V289, P29, DOI 10.1016/j.mce.2008.04.006; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Burkart AD, 2005, ENDOCRINOLOGY, V146, P1909, DOI 10.1210/en.2004-0842; de Kretser DM, 2000, MOL CELL ENDOCRINOL, V161, P43, DOI 10.1016/S0303-7207(99)00222-1; Diaz FJ, 2008, BIOL REPROD, V78, P176, DOI 10.1095/biolreprod.107.063537; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Kenny HA, 2006, ENDOCRINOLOGY, V147, P51, DOI 10.1210/en.2005-0242; Kipp JL, 2007, ENDOCRINOLOGY, V148, P1968, DOI 10.1210/en.2006-1083; Knight PG, 2003, ANIM REPROD SCI, V78, P165, DOI 10.1016/S0378-4320(03)00089-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUSSON J, 1993, P NATL ACAD SCI USA, V90, P6691, DOI 10.1073/pnas.90.14.6691; Mason AJ, 1996, MOL ENDOCRINOL, V10, P1055, DOI 10.1210/me.10.9.1055; Mather JP, 1997, P SOC EXP BIOL MED, V215, P209; MCLACHLAN RI, 1987, J CLIN ENDOCR METAB, V65, P954, DOI 10.1210/jcem-65-5-954; NAKAGAWA T, 1993, J BIOCHEM-TOKYO, V113, P132, DOI 10.1093/oxfordjournals.jbchem.a124015; NAKAGAWA T, 1993, FEBS LETT, V327, P165, DOI 10.1016/0014-5793(93)80163-O; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Ogiwara K, 2004, J EXP ZOOL PART A, V301A, P449, DOI 10.1002/jez.a.20071; Pangas SA, 2002, J ENDOCRINOL, V172, P199, DOI 10.1677/joe.0.1720199; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; SEIDAH NG, 1994, METHOD ENZYMOL, V244, P175; Smitz J, 1998, HUM REPROD, V13, P927, DOI 10.1093/humrep/13.4.927; Smitz J, 1998, MOL REPROD DEV, V50, P294, DOI 10.1002/(SICI)1098-2795(199807)50:3&lt;294::AID-MRD5&gt;3.0.CO;2-E; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Takumi I, 1998, MODERN PATHOL, V11, P232; Telfer EE, 2008, HUM REPROD, V23, P1151, DOI 10.1093/humrep/den070; Thomas Fiona H, 2003, Reprod Biol Endocrinol, V1, P76, DOI 10.1186/1477-7827-1-76; West-Farrell ER, 2009, BIOL REPROD, V80, P432, DOI 10.1095/biolreprod.108.071142; WOODRUFF TK, 1990, ANNU REV PHYSIOL, V52, P807, DOI 10.1146/annurev.ph.52.030190.004111; WOODRUFF TK, 1990, ENDOCRINOLOGY, V127, P3196, DOI 10.1210/endo-127-6-3196; WOODRUFF TK, 1988, SCIENCE, V239, P1296, DOI 10.1126/science.3125611; WOODRUFF TK, 1989, ENDOCRINOLOGY, V124, P2193, DOI 10.1210/endo-124-5-2193; Xu M, 2006, TISSUE ENG, V12, P2739, DOI 10.1089/ten.2006.12.2739; Xu M, 2006, BIOL REPROD, V75, P916, DOI 10.1095/biolreprod.106.054833; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	38	17	17	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17348	10.1371/journal.pone.0017348	http://dx.doi.org/10.1371/journal.pone.0017348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408162	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170000024
J	Benlahrech, A; Gotch, F; Kelleher, P; Patterson, S				Benlahrech, Adel; Gotch, Frances; Kelleher, Peter; Patterson, Steven			Loss of NK Stimulatory Capacity by Plasmacytoid and Monocyte-Derived DC but Not Myeloid DC in HIV-1 Infected Patients	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HIV-INFECTED PATIENTS; IMMUNODEFICIENCY-VIRUS-INFECTION; NECROSIS-FACTOR-ALPHA; DENDRITIC CELLS; ANTIRETROVIRAL THERAPY; INTERFERON-ALPHA; MEDIATED LYSIS; 1-INFECTED INDIVIDUALS; TNF-ALPHA	Dendritic cells (DC) are potent inducers of natural killer (NK) cells. There are two distinct populations in blood, myeloid (mDC) and plasmacytoid (pDC) but they can also be generated In vitro from monocytes (mdDC). Although it is established that blood DC are lost in HIV-1 infection, the full impact of HIV-1 infection on DC-NK cell interactions remains elusive. We thus investigated the ability of pDC, mDC, and mdDC from viremic and anti-retroviral therapy-treated aviremic HIV-1+ patients to stimulate various NK cell functions. Stimulated pDC and mdDC from HIV-1+ patients showed reduced secretion of IFN-alpha and IL-12p70 respectively and their capacity to stimulate expression of CD25 and CD69, and IFN-gamma secretion in NK cells was also reduced. pDC activation of NK cell degranulation in response to a tumour cell line was severely reduced in HIV-1+ patients but the ability of mDC to activate NK cells was not affected by HIV-1 infection, with the exception of HLA-DR induction. No differences were observed between viremic and aviremic patients indicating that anti-retroviral therapy had minimal effect on restoration on pDC and mdDC-mediated activation of NK cells. Results from this study provide further insight into HIV-1 mediated suppression of innate immune functions.	[Benlahrech, Adel; Gotch, Frances; Kelleher, Peter; Patterson, Steven] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Immunol, London, England	Imperial College London	Benlahrech, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Immunol, London, England.	s.patterson@imperial.ac.uk		Patterson, Steven/0000-0003-0652-7797	Medical Research Council, UK; Algerian Embassy; MRC [G0501957, G0100482] Funding Source: UKRI; Medical Research Council [G0501957, G0100482] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Algerian Embassy; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by the Medical Research Council, UK, and the Algerian Embassy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Amakata Y, 2001, CLIN EXP IMMUNOL, V124, P214, DOI 10.1046/j.1365-2249.2001.01550.x; Azzoni L, 2007, AIDS, V21, P293, DOI 10.1097/QAD.0b013e328012b85f; BANDYOPADHYAY S, 1990, CLIN EXP IMMUNOL, V79, P430, DOI 10.1111/j.1365-2249.1990.tb08107.x; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Benlahrech A, 2009, SENSORS-BASEL, V9, P386, DOI 10.3390/s90100386; Buisson S, 2009, J INFECT DIS, V199, P1862, DOI 10.1086/599122; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Chung AW, 2009, J IMMUNOL, V182, P1202, DOI 10.4049/jimmunol.182.2.1202; Clausen J, 2003, IMMUNOBIOLOGY, V207, P85, DOI 10.1078/0171-2985-00219; Conry SJ, 2009, J VIROL, V83, P11175, DOI 10.1128/JVI.00753-09; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Douglas SD, 2001, AIDS RES HUM RETROV, V17, P543, DOI 10.1089/08892220151126643; Feldman S, 2001, CLIN IMMUNOL, V101, P201, DOI 10.1006/clim.2001.5111; Ferlazzo G, 2005, IMMUNOL LETT, V101, P12, DOI 10.1016/j.imlet.2005.04.015; Ferlazzo G, 2003, EUR J IMMUNOL, V33, P306, DOI 10.1002/immu.200310004; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Finke JS, 2004, J CLIN IMMUNOL, V24, P647, DOI 10.1007/s10875-004-6250-5; Fortis C, 1999, EUR J IMMUNOL, V29, P3654, DOI 10.1002/(SICI)1521-4141(199911)29:11<3654::AID-IMMU3654>3.0.CO;2-B; Gerosa F, 2005, J IMMUNOL, V174, P727, DOI 10.4049/jimmunol.174.2.727; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Grassi F, 1999, AIDS, V13, P759, DOI 10.1097/00002030-199905070-00004; Hanna J, 2004, J CLIN INVEST, V114, P1612, DOI 10.1172/JCI200422787; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kamga I, 2005, J INFECT DIS, V192, P303, DOI 10.1086/430931; Killian MS, 2006, AIDS, V20, P1247, DOI 10.1097/01.aids.0000232231.34253.bd; Kottilil S, 2004, J INFECT DIS, V189, P1193, DOI 10.1086/382090; Kottilil Shyam, 2003, Indian Journal of Experimental Biology, V41, P1219; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; LOPEZCABRERA M, 1993, J EXP MED, V178, P537, DOI 10.1084/jem.178.2.537; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Marshall JD, 2006, IMMUNOLOGY, V117, P38, DOI 10.1111/j.1365-2567.2005.02261.x; Mavilio D, 2006, J EXP MED, V203, P2339, DOI 10.1084/jem.20060894; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Pacanowski M, 2004, J INFECT DIS, V190, P1889, DOI 10.1086/425020; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Reitano KN, 2009, AIDS RES HUM RETROV, V25, P1029, DOI 10.1089/aid.2008.0311; ROOK AH, 1983, J CLIN INVEST, V72, P398, DOI 10.1172/JCI110981; Ruggeri L, 1999, BLOOD, V94, P333, DOI 10.1182/blood.V94.1.333.413a31_333_339; Sabado RL, 2010, BLOOD, V116, P3839, DOI 10.1182/blood-2010-03-273763; Sacchi A, 2007, JAIDS-J ACQ IMM DEF, V46, P519, DOI 10.1097/QAI.0b013e31815b1278; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Scott-Algara D, 2003, J IMMUNOL, V171, P5663, DOI 10.4049/jimmunol.171.11.5663; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Siegal FP, 2001, AIDS, V15, P1603, DOI 10.1097/00002030-200109070-00002; Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x; Tasca S, 2003, AIDS, V17, P2291, DOI 10.1097/00002030-200311070-00003; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; ULLUM H, 1995, J EXP MED, V182, P789, DOI 10.1084/jem.182.3.789; van der Meer A, 2001, TRANSPLANTATION, V72, P923, DOI 10.1097/00007890-200109150-00030; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; Yonkers NL, 2009, CLIN IMMUNOL, V131, P288, DOI 10.1016/j.clim.2008.12.012	58	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17525	10.1371/journal.pone.0017525	http://dx.doi.org/10.1371/journal.pone.0017525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408163	Green Submitted, Green Published, gold			2022-12-25	WOS:000288170000035
J	Li, SQ; Moffett, HF; Lu, J; Werner, L; Zhang, H; Ritz, J; Neuberg, D; Wucherpfennig, KW; Brown, JR; Novina, CD				Li, Shuqiang; Moffett, Howell F.; Lu, Jun; Werner, Lillian; Zhang, Hao; Ritz, Jerome; Neuberg, Donna; Wucherpfennig, Kai W.; Brown, Jennifer R.; Novina, Carl D.			MicroRNA Expression Profiling Identifies Activated B Cell Status in Chronic Lymphocytic Leukemia Cells	PLOS ONE			English	Article							CLL PATIENTS; DISEASE PROGRESSION; MIRNA EXPRESSION; DOWN-REGULATION; PHENOTYPE; APOPTOSIS; LYMPHOMA; REVEALS; DIFFERENTIATION; PROLIFERATION	Chronic lymphocytic leukemia (CLL) is thought to be a disease of resting lymphocytes. However, recent data suggest that CLL cells may more closely resemble activated B cells. Using microRNA (miRNA) expression profiling of highly-enriched CLL cells from 38 patients and 9 untransformed B cells from normal donors before acute CpG activation and 5 matched B cells after acute CpG activation, we demonstrate an activated B cell status for CLL. Gene set enrichment analysis (GSEA) identified statistically-significant similarities in miRNA expression between activated B cells and CLL cells including upregulation of miR-34a, miR-155, and miR-342-3p and downregulation of miR-103, miR-181a and miR-181b. Additionally, decreased levels of two CLL signature miRNAs miR-29c and miR-223 are associated with ZAP70(+) and IgVH unmutated status and with shorter time to first therapy. These data indicate an activated B cell status for CLL cells and suggest that the direction of change of individual miRNAs may predict clinical course in CLL.	[Li, Shuqiang; Moffett, Howell F.; Wucherpfennig, Kai W.; Novina, Carl D.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Moffett, Howell F.] Harvard Univ, Sch Med, Div Med Sci, Boston, MA USA; [Lu, Jun; Zhang, Hao; Novina, Carl D.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Werner, Lillian; Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Ritz, Jerome; Brown, Jennifer R.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ritz, Jerome; Brown, Jennifer R.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Novina, Carl D.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Li, SQ (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	carl_novina@dfci.harvard.edu	Pillay, Nischalan/F-9536-2012; Ritz, Jerome/C-7929-2009	Ritz, Jerome/0000-0001-5526-4669; Moffett, Howell/0000-0002-7799-1688	NIH [PO1-CA081534, K23 CA115682]; NRSA [DFCI/NCI T32 CA70083]; Carreras International Leukemia; Doris Duke Clinical Scientist Development Awards; NATIONAL CANCER INSTITUTE [K23CA115682, P01CA081534, T32CA070083] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carreras International Leukemia; Doris Duke Clinical Scientist Development Awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders of the study include NIH grant (PO1-CA081534), NIH grant (K23 CA115682), NRSA Fellowship (DFCI/NCI T32 CA70083), Carreras International Leukemia and Doris Duke Clinical Scientist Development Awards.	Aalto Y, 2001, LEUKEMIA, V15, P1721, DOI 10.1038/sj.leu.2402282; Basso K, 2009, IMMUNITY, V30, P744, DOI 10.1016/j.immuni.2009.03.017; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen LG, 2008, BLOOD, V111, P2685, DOI 10.1182/blood-2006-12-062265; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Damle RN, 2007, BLOOD, V110, P3352, DOI 10.1182/blood-2007-04-083832; Damle RN, 2002, BLOOD, V99, P4087, DOI 10.1182/blood.V99.11.4087; de Yebenes VG, 2008, J EXP MED, V205, P2199, DOI 10.1084/jem.20080579; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Ghia P, 2003, BLOOD, V101, P1262, DOI 10.1182/blood-2002-06-1801; Gobessi S, 2007, BLOOD, V109, P2032, DOI 10.1182/blood-2006-03-011759; Hewamana S, 2008, BLOOD, V111, P4681, DOI 10.1182/blood-2007-11-125278; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kusenda J, 2004, NEOPLASMA, V51, P97; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marton S, 2008, LEUKEMIA, V22, P330, DOI 10.1038/sj.leu.2405022; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Mraz M, 2009, LEUKEMIA, V23, P1159, DOI 10.1038/leu.2008.377; Mraz M, 2009, LEUKEMIA LYMPHOMA, V50, P506, DOI 10.1080/10428190902763517; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Ringshausen I, 2002, BLOOD, V100, P3741, DOI 10.1182/blood-2002-02-0539; Roccaro AM, 2009, BLOOD, V113, P6669, DOI 10.1182/blood-2009-01-198408; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Schuh K, 1996, LEUKEMIA LYMPHOMA, V23, P583, DOI 10.3109/10428199609054868; Stamatopoulos B, 2009, BLOOD, V113, P5237, DOI 10.1182/blood-2008-11-189407; Stratowa C, 2001, INT J CANCER, V91, P474, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1078>3.0.CO;2-C; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Volinia S., 2006, P NATL ACAD SCI US; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Zanette DL, 2007, BRAZ J MED BIOL RES, V40, P1435, DOI 10.1590/S0100-879X2007001100003; Zhang J, 2009, BLOOD, V113, P4586, DOI 10.1182/blood-2008-09-178186	43	52	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e16956	10.1371/journal.pone.0016956	http://dx.doi.org/10.1371/journal.pone.0016956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408091	Green Submitted, Green Published, gold			2022-12-25	WOS:000288170000012
J	Park, SB; Bin Jang, H; Nho, SW; Cha, IS; Hikima, J; Ohtani, M; Aoki, T; Jung, TS				Park, Seong Bin; Bin Jang, Ho; Nho, Seong Won; Cha, In Seok; Hikima, Jun-ichi; Ohtani, Maki; Aoki, Takashi; Jung, Tae Sung			Outer Membrane Vesicles as a Candidate Vaccine against Edwardsiellosis	PLOS ONE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; NEISSERIA-MENINGITIDIS; JAPANESE FLOUNDER; VIBRIO-CHOLERAE; PROTEIN-A; TARDA; RELEASE; CELL; SECRETION	Infection with Edwardsiella tarda, a Gram-negative bacterium, causes high morbidity and mortality in both marine and freshwater fish. Outer membrane vesicles (OMVs) released from Gram-negative bacteria are known to play important roles in bacterial pathogenesis and host immune responses, but no such roles for E. tarda OMVs have yet been described. In the present study, we investigated the proteomic composition of OMVs and the immunostimulatory effect of OMVs in a natural host, as well as the efficacy of OMVs when used as a vaccine against E. tarda infection. A total of 74 proteins, from diverse subcellular fractions, were identified in OMVs. These included a variety of important virulence factors, such as hemolysin, OmpA, porin, GAPDH, EseB, EseC, EseD, EvpC, EvpP, lipoprotein, flagellin, and fimbrial protein. When OMVs were administrated to olive flounder, significant induction of mRNAs encoding IL-1 beta, IL-6, TNF alpha, and IFN gamma was observed, compared with the levels seen in fish injected with formalin-killed E. tarda. In a vaccine trial, olive flounder given OMVs were more effectively protected ( p,< 0.0001) than were control fish. Investigation of OMVs may be useful not only for understanding the pathogenesis of E. tarda but also in development of an effective vaccine against edwardsiellosis.	[Park, Seong Bin; Bin Jang, Ho; Nho, Seong Won; Cha, In Seok; Hikima, Jun-ichi; Ohtani, Maki; Aoki, Takashi; Jung, Tae Sung] Gyeongsang Natl Univ, Coll Vet Med, Aquatic Biotechnol Ctr, Jinju, South Korea	Gyeongsang National University	Park, SB (corresponding author), Gyeongsang Natl Univ, Coll Vet Med, Aquatic Biotechnol Ctr, Jinju, South Korea.	aoki@kaiyodai.ac.jp; jungts@gnu.ac.kr	Hikima, Jun-ichi/AAI-6983-2020; Jung, Tae Sung/G-8245-2017	Hikima, Jun-ichi/0000-0002-4184-7422; Jung, Tae Sung/0000-0001-6028-0946; Jang, Ho Bin/0000-0003-1316-316X	Ministry of Education, Science and Technology, of South Korea [R32-10253]	Ministry of Education, Science and Technology, of South Korea	This work was supported by a grant (no. R32-10253) from the World Class University Program funded by the Ministry of Education, Science and Technology, of South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alaniz RC, 2007, J IMMUNOL, V179, P7692, DOI 10.4049/jimmunol.179.11.7692; Amend D.F., 1981, FISH BIOL SERODIAGNO, V49, P447; Aoki M, 2007, VACCINE, V25, P561, DOI 10.1016/j.vaccine.2006.07.047; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bolton A, 2004, CAN J MICROBIOL, V50, P423, DOI [10.1139/w04-016, 10.1139/W04-016]; Castro N, 2008, FISH SHELLFISH IMMUN, V25, P208, DOI 10.1016/j.fsi.2008.05.008; DEVOE IW, 1973, J EXP MED, V138, P1156, DOI 10.1084/jem.138.5.1156; Egusa S., 1976, Fish Pathology, V10, P103; Fiocca R, 1999, J PATHOL, V188, P220, DOI 10.1002/(SICI)1096-9896(199906)188:2<220::AID-PATH307>3.0.CO;2-C; Galka F, 2008, INFECT IMMUN, V76, P1825, DOI 10.1128/IAI.01396-07; Gonzalez S, 2006, VACCINE, V24, P1633, DOI 10.1016/j.vaccine.2005.09.050; HERMAN RL, 1986, T AM FISH SOC, V115, P232, DOI 10.1577/1548-8659(1986)115&lt;232:PCBTBE&gt;2.0.CO;2; Hirono I, 2004, IMMUNOGENETICS, V56, P38, DOI 10.1007/s00251-004-0657-2; HOEKSTRA D, 1976, BIOCHIM BIOPHYS ACTA, V455, P889, DOI 10.1016/0005-2736(76)90058-4; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; JANDA JM, 1993, FEMS MICROBIOL LETT, V111, P275; JENDHOLM J, PLOS PATHOG, V6; Kadurugamuwa JL, 1999, MICROBIOL-SGM, V145, P2051, DOI 10.1099/13500872-145-8-2051; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Kawai K, 2004, VACCINE, V22, P3411, DOI 10.1016/j.vaccine.2004.02.026; Kesty NC, 2004, J BIOL CHEM, V279, P2069, DOI 10.1074/jbc.M307628200; KONDO K, 1993, MICROBIOL IMMUNOL, V37, P149, DOI 10.1111/j.1348-0421.1993.tb03192.x; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kumar G, 2010, J APPL MICROBIOL, V108, P2214, DOI 10.1111/j.1365-2672.2009.04627.x; KUSUDA R, 1976, B JPN SOC SCI FISH, V42, P271; Kwon SR, 2006, FISH SHELLFISH IMMUN, V20, P621, DOI 10.1016/j.fsi.2005.08.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Mekuchi T, 1995, FISH PATHOL, V30, P251, DOI 10.3147/jsfp.30.251; MEYER FP, 1973, APPL MICROBIOL, V25, P155, DOI 10.1128/AEM.25.1.155-156.1973; Mohanty BR, 2007, J BIOSCIENCES, V32, P1331, DOI 10.1007/s12038-007-0143-8; Nakatsugawa T., 1983, Fish Pathology, V18, P99; Nevot M, 2006, ENVIRON MICROBIOL, V8, P1523, DOI 10.1111/j.1462-2920.2006.01043.x; NOUGAYREDE PH, 1994, EAFP B, V14, P128; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Prasadarao NV, 1996, INFECT IMMUN, V64, P154, DOI 10.1128/IAI.64.1.154-160.1996; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Rao PSS, 2003, MICROBIOL-SGM, V149, P2635, DOI 10.1099/mic.0.26478-0; Roberts R, 2008, VACCINE, V26, P4639, DOI 10.1016/j.vaccine.2008.07.004; Schild S, 2009, INFECT IMMUN, V77, P472, DOI 10.1128/IAI.01139-08; Shin GW, 2006, DIS AQUAT ORGAN, V70, P71, DOI 10.3354/dao070071; Strauss EJ, 1997, INFECT IMMUN, V65, P3924, DOI 10.1128/IAI.65.9.3924-3932.1997; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Ullah M. A., 1983, Fish Pathology, V18, P65; van den Dobbelsteen GPJM, 2007, VACCINE, V25, P2491, DOI 10.1016/j.vaccine.2006.09.025; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Wang B, 2010, MAR BIOTECHNOL, V12, P678, DOI 10.1007/s10126-009-9255-5; Whyte SK, 2007, FISH SHELLFISH IMMUN, V23, P1127, DOI 10.1016/j.fsi.2007.06.005; Wu CC, 2003, NAT BIOTECHNOL, V21, P262, DOI 10.1038/nbt0303-262; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	55	65	70	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17629	10.1371/journal.pone.0017629	http://dx.doi.org/10.1371/journal.pone.0017629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408115	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170000047
J	Rehman, MT; Dey, P; Hassan, MI; Ahmad, F; Batra, JK				Rehman, Md Tabish; Dey, Punyatirtha; Hassan, Md Imtaiyaz; Ahmad, Faizan; Batra, Janendra K.			Functional Role of Glutamine 28 and Arginine 39 in Double Stranded RNA Cleavage by Human Pancreatic Ribonuclease	PLOS ONE			English	Article							CATALYTIC-PROPERTIES; BINDING; PROTEINS; DEGRADATION; STABILITY; VARIANTS; RESIDUES; FEATURES; MODEL; CHAIN	Human pancreatic ribonuclease (HPR), a member of RNase A superfamily, has a high activity on double stranded (ds) RNA. By virtue of this activity HPR appears to be involved in the host-defense against pathogenic viruses. To delineate the mechanism of dsRNA cleavage by HPR, we have investigated the role of glutamine 28 and arginine 39 of HPR in its activity on dsRNA. A non-basic residue glycine 38, earlier shown to be important for dsRNA cleavage by HPR was also included in the study in the context of glutamine 28 and arginine 39. Nine variants of HPR respectively containing Q28A, Q28L, R39A, G38D, Q28A/R39A, Q28L/R39A, Q28A/G38D, R39A/G38D and Q28A/G38D/R39A mutations were generated and functionally characterized. The far-UV CD-spectral analysis revealed all variants, except R39A, to have structures similar to that of HPR. The catalytic activity of all HPR variants on single stranded RNA substrate was similar to that of HPR, whereas on dsRNA, the catalytic efficiency of all single residue variants, except for the Q28L, was significantly reduced. The dsRNA cleavage activity of R39A/G38D and Q28A/G38D/R39A variants was most drastically reduced to 4% of that of HPR. The variants having reduced dsRNA cleavage activity also had reduction in their dsDNA melting activity and thermal stability. Our results indicate that in HPR both glutamine 28 and arginine 39 are important for the cleavage of dsRNA. Although these residues are not directly involved in catalysis, both arginine 39 and glutamine 28 appear to be facilitating a productive substrate-enzyme interaction during the dsRNA cleavage by HPR.	[Rehman, Md Tabish; Hassan, Md Imtaiyaz; Ahmad, Faizan] Ctr Interdisciplinary Res Basic Sci, New Delhi, India; [Dey, Punyatirtha; Batra, Janendra K.] Natl Inst Immunol, Immunochem Lab, New Delhi 110067, India	Jamia Millia Islamia; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Rehman, MT (corresponding author), Ctr Interdisciplinary Res Basic Sci, New Delhi, India.	janendra@nii.res.in	Batra, Janendra/GWQ-8031-2022; Hassan, Md Imtaiyaz/G-7072-2017; REHMAN, TABISH/H-8471-2012; Hassan, Mohammad/GZA-7507-2022; Ahmad, Faizan/AGH-4493-2022; Hassan, Imtaiyaz/ABF-6485-2020; Rehman, Md Tabish/AAC-8512-2019	Hassan, Md Imtaiyaz/0000-0002-3663-4940; REHMAN, TABISH/0000-0003-2341-900X; Hassan, Mohammad/0000-0002-1712-0004; Ahmad, Faizan/0000-0001-7021-7502; Hassan, Imtaiyaz/0000-0002-3663-4940; Rehman, Md Tabish/0000-0003-2341-900X; Batra, Janendra/0000-0003-2206-3398	Department of Biotechnology, Government of India; Department of Science and Technology, Government of India [SP/SO/BB-01/2003]; Council of Scientific and Industrial Research, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants to the National Institute of Immunology from the Department of Biotechnology, Government of India, and a grant number SP/SO/BB-01/2003 from the Department of Science and Technology, Government of India to JKB. MTR and PD were supported by senior research fellowships from Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; ARUS A, 1981, BIOCHIM BIOPHYS ACTA, V680, P117; Bal HP, 1997, EUR J BIOCHEM, V245, P465, DOI 10.1111/j.1432-1033.1997.t01-1-00465.x; BIENTEMA JJ, 1997, RIBONUCLEASES STRUCT, P245; BOIX E, 1994, J BIOL CHEM, V269, P2529; BUCHNER J, 1992, ANAL BIOCHEM, V205, P263, DOI 10.1016/0003-2697(92)90433-8; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Dey P, 2007, BIOCHEM BIOPH RES CO, V360, P809, DOI 10.1016/j.bbrc.2007.06.141; Fisher BM, 1998, BIOCHEMISTRY-US, V37, P12121, DOI 10.1021/bi980743l; Fisher BM, 1998, J BIOL CHEM, V273, P34134, DOI 10.1074/jbc.273.51.34134; FONTECILLACAMPS JC, 1994, J BIOL CHEM, V269, P21526; Gaur D, 2002, BIOCHEM BIOPH RES CO, V297, P390, DOI 10.1016/S0006-291X(02)02216-7; Gaur D, 2001, J BIOL CHEM, V276, P24978, DOI 10.1074/jbc.M102440200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; IRIE M, 1984, J BIOCHEM-TOKYO, V96, P89, DOI 10.1093/oxfordjournals.jbchem.a134833; IWAHASHI K, 1981, J BIOCHEM-TOKYO, V90, P1685, DOI 10.1093/oxfordjournals.jbchem.a133644; JENSEN DE, 1976, J BIOL CHEM, V251, P7198; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Larson SB, 2010, ACTA CRYSTALLOGR F, V66, P113, DOI 10.1107/S174430910905194X; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee-Huang S, 1999, P NATL ACAD SCI USA, V96, P2678, DOI 10.1073/pnas.96.6.2678; Libonati M, 2004, BIOCHEM J, V380, P311, DOI 10.1042/BJ20031922; LIBONATI M, 1992, MOL CELL BIOCHEM, V117, P139; Libonati M, 2001, METHOD ENZYMOL, V341, P234, DOI 10.1016/S0076-6879(01)41155-4; MCPHERSON A, 1986, SCIENCE, V232, P765, DOI 10.1126/science.3961503; MITSUI Y, 1978, BIOCHIM BIOPHYS ACTA, V536, P299; Nicholson AW, 1996, PROG NUCLEIC ACID RE, V52, P1, DOI 10.1016/S0079-6603(08)60963-0; Opitz JG, 1998, BIOCHEMISTRY-US, V37, P4023, DOI 10.1021/bi9722047; Patel S, 2004, J COMPUT CHEM, V25, P1504, DOI 10.1002/jcc.20077; Pous J, 2000, J MOL BIOL, V303, P49, DOI 10.1006/jmbi.2000.4506; RICHARDS FM, 1971, ENZYMES, V4, P647; Sorrentino S, 1997, FEBS LETT, V404, P1, DOI 10.1016/S0014-5793(97)00086-0; Sorrentino S, 2003, BIOCHEMISTRY-US, V42, P10182, DOI 10.1021/bi030040q; SORRENTINO S, 1994, ARCH BIOCHEM BIOPHYS, V312, P340, DOI 10.1006/abbi.1994.1318; Zhang JZ, 2003, MOL BIOL EVOL, V20, P1310, DOI 10.1093/molbev/msg143; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852	36	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17159	10.1371/journal.pone.0017159	http://dx.doi.org/10.1371/journal.pone.0017159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21408145	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170000013
J	Okamoto, H; Teismann, H; Kakigi, R; Pantev, C				Okamoto, Hidehiko; Teismann, Henning; Kakigi, Ryusuke; Pantev, Christo			Broadened Population-Level Frequency Tuning in Human Auditory Cortex of Portable Music Player Users	PLOS ONE			English	Article							RECREATIONAL NOISE EXPOSURE; INDUCED HEARING-LOSS; INFERIOR COLLICULUS; COCHLEAR LESIONS; ADULT CATS; BALANCED INHIBITION; PLASTICITY; DAMAGE; RISK; ORGANIZATION	Nowadays, many people use portable players to enrich their daily life with enjoyable music. However, in noisy environments, the player volume is often set to extremely high levels in order to drown out the intense ambient noise and satisfy the appetite for music. Extensive and inappropriate usage of portable music players might cause subtle damages in the auditory system, which are not behaviorally detectable in an early stage of the hearing impairment progress. Here, by means of magnetoencephalography, we objectively examined detrimental effects of portable music player misusage on the population-level frequency tuning in the human auditory cortex. We compared two groups of young people: one group had listened to music with portable music players intensively for a long period of time, while the other group had not. Both groups performed equally and normally in standard audiological examinations (pure tone audiogram, speech test, and hearing-in-noise test). However, the objective magnetoencephalographic data demonstrated that the population-level frequency tuning in the auditory cortex of the portable music player users was significantly broadened compared to the non-users, when attention was distracted from the auditory modality; this group difference vanished when attention was directed to the auditory modality. Our conclusion is that extensive and inadequate usage of portable music players could cause subtle damages, which standard behavioral audiometric measures fail to detect in an early stage. However, these damages could lead to future irreversible hearing disorders, which would have a huge negative impact on the quality of life of those affected, and the society as a whole.	[Okamoto, Hidehiko; Teismann, Henning; Pantev, Christo] Univ Munster, Inst Biomagnetism & Biosignalanal, D-4400 Munster, Germany; [Okamoto, Hidehiko; Kakigi, Ryusuke] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 444, Japan	University of Munster; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Okamoto, H (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, D-4400 Munster, Germany.	okamotoh@uni-muenster.de	Okamoto, Hidehiko/A-7934-2008	Okamoto, Hidehiko/0000-0003-2799-3340	Deutsche Forschungsgemeinschaft [Pa 392/13-1, Pa 392/10-3]; Tinnitus Research Initiative [BD169968]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tinnitus Research Initiative	This work was supported by the Deutsche Forschungsgemeinschaft, Pa 392/13-1 and Pa 392/10-3, and the Tinnitus Research Initiative, BD169968. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELSSON A, 1994, SCAND AUDIOL, V23, P129, DOI 10.3109/01050399409047497; Biassoni EC, 2005, INT J AUDIOL, V44, P74, DOI 10.1080/14992020500031728; CALFORD MB, 1993, NEUROSCIENCE, V55, P953, DOI 10.1016/0306-4522(93)90310-C; Caspary DM, 2008, J EXP BIOL, V211, P1781, DOI 10.1242/jeb.013581; Clark WW, 1999, JAMA-J AM MED ASSOC, V281, P1658, DOI 10.1001/jama.281.17.1658; Danhauer JL, 2009, J AM ACAD AUDIOL, V20, P5, DOI 10.3766/jaaa.20.1.2; Diesch E, 2010, NEUROSCIENCE, V167, P540, DOI 10.1016/j.neuroscience.2010.02.003; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Fligor BJ, 2004, EAR HEARING, V25, P513, DOI 10.1097/00003446-200412000-00001; Irvine DRF, 2003, J COMP NEUROL, V467, P354, DOI 10.1002/cne.10921; Izquierdo MA, 2008, NEUROSCIENCE, V154, P355, DOI 10.1016/j.neuroscience.2008.01.057; Kamke MR, 2003, J COMP NEUROL, V459, P355, DOI 10.1002/cne.10586; Kauramaki J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000909; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; LeBeau FEN, 2001, J NEUROSCI, V21, P7303, DOI 10.1523/JNEUROSCI.21-18-07303.2001; LeBeau FEN, 1996, J NEUROPHYSIOL, V75, P902, DOI 10.1152/jn.1996.75.2.902; MeyerBisch C, 1996, AUDIOLOGY, V35, P121; Milbrandt JC, 2000, HEARING RES, V147, P251, DOI 10.1016/S0378-5955(00)00135-0; MORATA TC, 1993, SCAND J WORK ENV HEA, V19, P245, DOI 10.5271/sjweh.1477; Morata TC, 2007, INT J AUDIOL, V46, P111, DOI 10.1080/14992020601103079; Mossop JE, 2000, HEARING RES, V147, P183, DOI 10.1016/S0378-5955(00)00054-X; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Norena AJ, 2003, J NEUROPHYSIOL, V90, P2387, DOI 10.1152/jn.00139.2003; Okamoto H, 2007, J NEUROSCI, V27, P10383, DOI 10.1523/JNEUROSCI.2963-07.2007; Okamoto H, 2010, J NEUROPHYSIOL, V103, P244, DOI 10.1152/jn.00530.2009; Okamoto H, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-1; Oswald AMM, 2006, CURR OPIN NEUROBIOL, V16, P371, DOI 10.1016/j.conb.2006.06.015; Pantev C, 2004, EUR J NEUROSCI, V19, P2337, DOI 10.1111/j.0953-816X.2004.03296.x; Peng JH, 2007, J OTOLARYNGOL, V36, P181, DOI 10.2310/7070.2007.0032; Rabinowitz PM, 2000, AM FAM PHYSICIAN, V61, P2749; Rajan R, 1998, NAT NEUROSCI, V1, P138, DOI 10.1038/388; RAJAN R, 1993, J COMP NEUROL, V338, P17, DOI 10.1002/cne.903380104; ROSLER G, 1994, SCAND AUDIOL, V23, P13, DOI 10.3109/01050399409047483; SAMS M, 1994, HEARING RES, V75, P67, DOI 10.1016/0378-5955(94)90057-4; Serra MR, 2005, INT J AUDIOL, V44, P65, DOI 10.1080/14992020400030010; Suga N, 1997, J NEUROPHYSIOL, V77, P2098, DOI 10.1152/jn.1997.77.4.2098; TESCHE CD, 1995, ELECTROEN CLIN NEURO, V95, P189, DOI 10.1016/0013-4694(95)00064-6; Tucci DL, 2010, OTOL NEUROTOL, V31, P31, DOI 10.1097/MAO.0b013e3181c0eaec; von Bekesy G, 1967, SENSORY INHIBITION; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Zhao F, 2010, INT J AUDIOL, V49, P54, DOI 10.3109/14992020903202520; Zwicker E., 1999, PSYCHOACOUSTICS FACT	44	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17022	10.1371/journal.pone.0017022	http://dx.doi.org/10.1371/journal.pone.0017022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399676	Green Published, Green Submitted, gold			2022-12-25	WOS:000287933300005
J	Herculano-Houzel, S				Herculano-Houzel, Suzana			Scaling of Brain Metabolism with a Fixed Energy Budget per Neuron: Implications for Neuronal Activity, Plasticity and Evolution	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; OXIDATIVE-METABOLISM; PRIMATE BRAINS; VISUAL-CORTEX; IN-VIVO; MAMMALS; MATTER; RULES; NEUROSCIENCE; STIMULATION	It is usually considered that larger brains have larger neurons, which consume more energy individually, and are therefore accompanied by a larger number of glial cells per neuron. These notions, however, have never been tested. Based on glucose and oxygen metabolic rates in awake animals and their recently determined numbers of neurons, here I show that, contrary to the expected, the estimated glucose use per neuron is remarkably constant, varying only by 40% across the six species of rodents and primates (including humans). The estimated average glucose use per neuron does not correlate with neuronal density in any structure. This suggests that the energy budget of the whole brain per neuron is fixed across species and brain sizes, such that total glucose use by the brain as a whole, by the cerebral cortex and also by the cerebellum alone are linear functions of the number of neurons in the structures across the species (although the average glucose consumption per neuron is at least 10 x higher in the cerebral cortex than in the cerebellum). These results indicate that the apparently remarkable use in humans of 20% of the whole body energy budget by a brain that represents only 2% of body mass is explained simply by its large number of neurons. Because synaptic activity is considered the major determinant of metabolic cost, a conserved energy budget per neuron has several profound implications for synaptic homeostasis and the regulation of firing rates, synaptic plasticity, brain imaging, pathologies, and for brain scaling in evolution.	[Herculano-Houzel, Suzana] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Herculano-Houzel, Suzana] Ministerio Ciencia & Tecnol, Inst Nacl Neurociencia Translac, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro	Herculano-Houzel, S (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.	suzanahh@gmail.com	Neurociencia, Inct/I-1011-2013		Faperj; CNPq; National Institute for Translational Neuroscience (INNT - MCT); James S. McDonnell Foundation	Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute for Translational Neuroscience (INNT - MCT); James S. McDonnell Foundation	This work was supported by Faperj, CNPq, the National Institute for Translational Neuroscience (INNT - MCT), and the James S. McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Aschoff J, 1971, ENERGIEHAUSHALT TEMP; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Baddeley R, 1997, P ROY SOC B-BIOL SCI, V264, P1775, DOI 10.1098/rspb.1997.0246; Balasubramanian V, 2001, NEURAL COMPUT, V13, P799, DOI 10.1162/089976601300014358; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; CAMPOS LR, 2008, SOC NEUROSCI; Carmody RN, 2009, J HUM EVOL, V57, P379, DOI 10.1016/j.jhevol.2009.02.011; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Clarke Donald D., 1999, P637; CRAGG BG, 1967, J ANAT, V101, P639; d'Avila JC, 2008, CRIT CARE MED, V36, P1925, DOI 10.1097/CCM.0b013e3181760c4b; Finsterer J, 2008, J NEUROL SCI, V272, P20, DOI 10.1016/j.jns.2008.05.011; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Gabi M, 2010, BRAIN BEHAV EVOLUT, V76, P32, DOI 10.1159/000319872; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Grossman LI, 2001, MOL PHYLOGENET EVOL, V18, P26, DOI 10.1006/mpev.2000.0890; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Herculano-Houzel S, 2011, BRAIN BEHAV IN PRESS; Herculano-Houzel S, 2007, P NATL ACAD SCI USA, V104, P3562, DOI 10.1073/pnas.0611396104; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; Herculano-Houzel S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00012; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; HOFMAN MA, 1983, Q REV BIOL, V58, P495, DOI 10.1086/413544; HYDER F, 2006, J CEREB BLOOD FLOW M, V26, P856; Karbowski J, 2009, J COMPUT NEUROSCI, V27, P415, DOI 10.1007/s10827-009-0153-7; Karbowski J, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-18; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kety S.S., 1957, METABOLISM NERVOUS S, P221; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Koulakov AA, 2001, NEURON, V29, P519, DOI 10.1016/S0896-6273(01)00223-9; la Fougere C, 2009, EPILEPSY BEHAV, V15, P50, DOI 10.1016/j.yebeh.2009.02.025; Lebon V, 2002, J NEUROSCI, V22, P1523, DOI 10.1523/JNEUROSCI.22-05-01523.2002; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; Lin AL, 2010, P NATL ACAD SCI USA, V107, P8446, DOI 10.1073/pnas.0909711107; Loaiza A, 2003, J NEUROSCI, V23, P7337; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; MARTIN RD, 1996, NATURE L, V293, P57; MINK JW, 1981, AM J PHYSIOL, V241, pR203, DOI 10.1152/ajpregu.1981.241.3.R203; MITCHISON G, 1992, TRENDS NEUROSCI, V15, P122, DOI 10.1016/0166-2236(92)90352-9; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Owen-Smith NR, 1988, MEGAHERBIVORES; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PHELPS ME, 1975, J NUCL MED, V16, P210; PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR1213, DOI 10.1152/ajpregu.1995.269.5.R1213; PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR226, DOI 10.1152/ajpregu.1995.269.1.R226; REICHENBACH A, 1989, GLIA, V2, P71, DOI 10.1002/glia.440020202; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Sarko DK, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.008.2009; Shen J, 1999, P NATL ACAD SCI USA, V96, P8235, DOI 10.1073/pnas.96.14.8235; Shoham S, 2006, J COMP PHYSIOL A, V192, P777, DOI 10.1007/s00359-006-0117-6; Shulman RG, 2009, P NATL ACAD SCI USA, V106, P11096, DOI 10.1073/pnas.0903941106; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; SOKOLOFF L, 1977, J NEUROCHEM, V29, P13, DOI 10.1111/j.1471-4159.1977.tb03919.x; Sokoloff L., 1960, HANDBOOK PHYSIOLOG 1, P1843; TOWER DB, 1954, J COMP NEUROL, V101, P19, DOI 10.1002/cne.901010103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Uddin M, 2004, P NATL ACAD SCI USA, V101, P2957, DOI 10.1073/pnas.0308725100; Wen Q, 2008, J NEUROPHYSIOL, V99, P2320, DOI 10.1152/jn.00280.2007; Wen Q, 2005, PLOS COMPUT BIOL, V1, P617, DOI 10.1371/journal.pcbi.0010078; Wilson NR, 2007, J NEUROSCI, V27, P13581, DOI 10.1523/JNEUROSCI.3863-07.2007; Wrangham RW, 2009, CATCHING FIRE COOKIN; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com	69	175	175	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17514	10.1371/journal.pone.0017514	http://dx.doi.org/10.1371/journal.pone.0017514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390261	Green Published, gold, Green Submitted			2022-12-25	WOS:000287932100021
J	O'Rourke, SM; Carter, C; Carter, L; Christensen, SN; Jones, MP; Nash, B; Price, MH; Turnbull, DW; Garner, AR; Hamill, DR; Osterberg, VR; Lyczak, R; Madison, EE; Nguyen, MH; Sandberg, NA; Sedghi, N; Willis, JH; Yochem, J; Johnson, EA; Bowerman, B				O'Rourke, Sean M.; Carter, Clayton; Carter, Luke; Christensen, Sara N.; Jones, Minh P.; Nash, Bruce; Price, Meredith H.; Turnbull, Douglas W.; Garner, Aleena R.; Hamill, Danielle R.; Osterberg, Valerie R.; Lyczak, Rebecca; Madison, Erin E.; Nguyen, Michael H.; Sandberg, Nathan A.; Sedghi, Noushin; Willis, John H.; Yochem, John; Johnson, Eric A.; Bowerman, Bruce			A Survey of New Temperature-Sensitive, Embryonic-Lethal Mutations in C. elegans: 24 Alleles of Thirteen Genes	PLOS ONE			English	Article							CELL-DIVISION CYCLE; POLO-LIKE KINASE; CAENORHABDITIS-ELEGANS; DNA-REPLICATION; SCHIZOSACCHAROMYCES-POMBE; CENTRIOLE DUPLICATION; FUNCTIONAL-ANALYSIS; MITOTIC SPINDLE; PHOSPHATASE 2A; SPT-1 MUTATION	To study essential maternal gene requirements in the early C. elegans embryo, we have screened for temperature-sensitive, embryonic lethal mutations in an effort to bypass essential zygotic requirements for such genes during larval and adult germline development. With conditional alleles, multiple essential requirements can be examined by shifting at different times from the permissive temperature of 15 degrees C to the restrictive temperature of 26 degrees C. Here we describe 24 conditional mutations that affect 13 different loci and report the identity of the gene mutations responsible for the conditional lethality in 22 of the mutants. All but four are mis-sense mutations, with two mutations affecting splice sites, another creating an in-frame deletion, and one creating a premature stop codon. Almost all of the mis-sense mutations affect residues conserved in orthologs, and thus may be useful for engineering conditional mutations in other organisms. We find that 62% of the mutants display additional phenotypes when shifted to the restrictive temperature as L1 larvae, in addition to causing embryonic lethality after L4 upshifts. Remarkably, we also found that 13 out of the 24 mutations appear to be fast-acting, making them particularly useful for careful dissection of multiple essential requirements. Our findings highlight the value of C. elegans for identifying useful temperature-sensitive mutations in essential genes, and provide new insights into the requirements for some of the affected loci.	[O'Rourke, Sean M.; Carter, Clayton; Carter, Luke; Christensen, Sara N.; Jones, Minh P.; Nash, Bruce; Price, Meredith H.; Turnbull, Douglas W.; Garner, Aleena R.; Hamill, Danielle R.; Osterberg, Valerie R.; Lyczak, Rebecca; Madison, Erin E.; Nguyen, Michael H.; Sandberg, Nathan A.; Sedghi, Noushin; Willis, John H.; Yochem, John; Johnson, Eric A.; Bowerman, Bruce] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon	O'Rourke, SM (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	bbowerman@molbio.uoregon.edu		Garner, Aleena/0000-0002-3488-2959	Leukemia and Lymphoma Society; NIH [GM050817, GM049869]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050817, R01GM049869, R21GM050817] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Leukemia and Lymphoma Society of America fellowship to SOR, and NIH grants GM050817 and GM049869 to BB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBER T, 1987, BIOCHEMISTRY-US, V26, P3754, DOI 10.1021/bi00387a002; Banaszynski LA, 2006, CHEM BIOL, V13, P11, DOI 10.1016/j.chembiol.2005.10.010; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; BONATTI S, 1972, J BACTERIOL, V109, P484, DOI 10.1128/JB.109.2.484-491.1972; Boyd L, 1996, DEVELOPMENT, V122, P3075; BRENNER S, 1974, GENETICS, V77, P71; Budirahardja Y, 2008, DEVELOPMENT, V135, P1303, DOI 10.1242/dev.019075; CASSADA R, 1981, DEV BIOL, V84, P193, DOI 10.1016/0012-1606(81)90383-3; Chase D, 2000, GENESIS, V26, P26, DOI 10.1002/(SICI)1526-968X(200001)26:1<26::AID-GENE6>3.0.CO;2-O; Dorfman M, 2009, GENETICS, V182, P1035, DOI 10.1534/genetics.109.104885; EISEN JS, 1991, NEURON, V6, P767, DOI 10.1016/0896-6273(91)90173-W; EKI T, 1990, J BIOL CHEM, V265, P26; Ellis GC, 2004, J CELL SCI, V117, P457, DOI 10.1242/jcs.00869; Encalada SE, 2005, MOL BIOL CELL, V16, P1056, DOI 10.1091/mbc.E04-08-0712; Encalada SE, 2000, DEV BIOL, V228, P225, DOI 10.1006/dbio.2000.9965; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Golden A, 2000, J CELL BIOL, V151, P1469, DOI 10.1083/jcb.151.7.1469; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Guedes S, 1997, DEVELOPMENT, V124, P731; HARTWELL LH, 1970, P NATL ACAD SCI USA, V66, P352, DOI 10.1073/pnas.66.2.352; HARTWELL LH, 1967, J BACTERIOL, V93, P1662, DOI 10.1128/JB.93.5.1662-1670.1967; HARTWELL LH, 1973, GENETICS, V74, P267; HERMAN RK, 1984, GENETICS, V108, P165; HILLMAN R, 1962, GENETICS, V47, P11; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; ISNENGHI E, 1983, DEV BIOL, V98, P465, DOI 10.1016/0012-1606(83)90376-7; Kaletta T, 1997, NATURE, V390, P294, DOI 10.1038/36869; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kao GT, 2004, DEVELOPMENT, V131, P755, DOI 10.1242/dev.00987; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Koushika SP, 2004, J NEUROSCI, V24, P3907, DOI 10.1523/JNEUROSCI.5039-03.2004; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; LEVITAN DJ, 1994, P NATL ACAD SCI USA, V91, P6108, DOI 10.1073/pnas.91.13.6108; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; MAINS PE, 1990, GENETICS, V125, P351; MAINS PE, 1990, GENETICS, V126, P593; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; MELLO CC, 1992, CELL, V70, P163, DOI 10.1016/0092-8674(92)90542-K; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; Nishi Y, 2008, DEVELOPMENT, V135, P687, DOI 10.1242/dev.013425; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; O'Rourke SM, 2007, PLOS GENET, V3, P1339, DOI 10.1371/journal.pgen.0030128; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Phillips JB, 2004, CELL MOTIL CYTOSKEL, V58, P112, DOI 10.1002/cm.20003; Quintin S, 2003, EMBO REP, V4, P1175, DOI 10.1038/sj.embor.7400029; Rivers DM, 2008, J CELL BIOL, V180, P877, DOI 10.1083/jcb.200710018; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Sarin S, 2008, NAT METHODS, V5, P865, DOI 10.1038/NMETH.1249; Schlaitz AL, 2007, CELL, V128, P115, DOI 10.1016/j.cell.2006.10.050; Schmidt DJ, 2005, MOL BIOL CELL, V16, P1200, DOI 10.1091/mbc.E04-06-0523; Schnabel R, 1996, MECH DEVELOP, V54, P133, DOI 10.1016/0925-4773(95)00466-1; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Shirayama M, 2006, CURR BIOL, V16, P47, DOI 10.1016/j.cub.2005.11.070; Sieburth DS, 1999, GENE DEV, V13, P2562, DOI 10.1101/gad.13.19.2562; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Srayko M, 2000, GENE DEV, V14, P1072; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579	66	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e16644	10.1371/journal.pone.0016644	http://dx.doi.org/10.1371/journal.pone.0016644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390299	Green Published, gold, Green Submitted			2022-12-25	WOS:000287932100002
J	Zhu, WL; Yang, L; Shan, HL; Zhang, Y; Zhou, R; Su, Z; Du, ZM				Zhu, Wenliang; Yang, Lei; Shan, Hongli; Zhang, Yong; Zhou, Rui; Su, Zhe; Du, Zhimin			MicroRNA Expression Analysis: Clinical Advantage of Propranolol Reveals Key MicroRNAs in Myocardial Infarction	PLOS ONE			English	Article							HEART-DISEASE; MORTALITY; PROTEIN; METOPROLOL	Background: As playing important roles in gene regulation, microRNAs (miRNAs) are believed as indispensable involvers in the pathogenesis of myocardial infarction (MI) that causes significant morbidity and mortality. Working on a hypothesis that modulation of only some key members in the miRNA superfamily could benefit ischemic heart, we proposed a microarray based network biology approach to identify them with the recognized clinical effect of propranolol as a prompt. Methods: A long-term MI model of rat was established in this study. The microarray technology was applied to determine the global miRNA expression change intervened by propranolol. Multiple network analyses were sequentially applied to evaluate the regulatory capacity, efficiency and emphasis of the miRNAs which dysexpression in MI were significantly reversed by propranolol. Results: Microarray data analysis indicated that long-term propranolol administration caused 18 of the 31 dysregulated miRNAs in MI undergoing reversed expression, implying that intentional modulation of miRNA expression might show favorable effects for ischemic heart. Our network analysis identified that, among these miRNAs, the prime players in MI were miR-1, miR-29b and miR-98. Further finding revealed that miR-1 focused on regulation of myocyte growth, yet miR-29b and miR-98 stressed on fibrosis and inflammation, respectively. Conclusion: Our study illustrates how a combination of microarray technology and functional protein network analysis can be used to identify disease-related key miRNAs.	[Zhu, Wenliang; Zhou, Rui; Su, Zhe; Du, Zhimin] Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China; [Yang, Lei] Harbin Med Univ, Affiliated Hosp 1, Harbin, Peoples R China; [Shan, Hongli; Zhang, Yong] Harbin Med Univ, Dept Pharmacol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Du, ZM (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China.	dzm1956@126.com			National Natural Science Foundation of China [30873065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30873065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Asli NS, 2008, CURR MOL MED, V8, P698, DOI 10.2174/156652408786733739; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; da Silva R, 2004, PHYSIOL GENOMICS, V20, P117, DOI 10.1152/physiolgenomics.00166.2004; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; HJALMARSON A, 1983, CIRCULATION, V67, P26; Hu GK, 2009, J IMMUNOL, V183, P1617, DOI 10.4049/jimmunol.0804362; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Larsen JA, 2000, DRUG AGING, V16, P341, DOI 10.2165/00002512-200016050-00004; Li F, 2010, BIOINFORMATICS, V26, P275, DOI 10.1093/bioinformatics/btp634; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lu YJ, 2009, CARDIOVASC RES, V84, P434, DOI 10.1093/cvr/cvp232; Maraziotis IA, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-93; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MICHAEL VGL, 2009, NAT REV CARDIOL, V6, P419; Naeem Haroon, 2010, BMC Bioinformatics, V11, P135, DOI 10.1186/1471-2105-11-135; OLSSON G, 1985, J AM COLL CARDIOL, V5, P1428, DOI 10.1016/S0735-1097(85)80360-0; Pan ZW, 2010, ACTA PHARMACOL SIN, V31, P1, DOI 10.1038/aps.2009.175; PARAS KM, 2009, J CELL MOL MED, V13, P778; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sam GJ, 2008, NUCLEIC ACIDS RES, V36, P154; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Waldo AL, 1996, LANCET, V348, P7, DOI 10.1016/S0140-6736(96)02149-6; Yang BF, 2008, CARDIOVASC RES, V79, P571, DOI 10.1093/cvr/cvn181; Yu W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-528	33	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e14736	10.1371/journal.pone.0014736	http://dx.doi.org/10.1371/journal.pone.0014736			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386882	Green Submitted, Green Published, gold			2022-12-25	WOS:000287931400001
J	Simoes, RD; Emmert-Streib, F				Simoes, Ricardo de Matos; Emmert-Streib, Frank			Influence of Statistical Estimators of Mutual Information and Data Heterogeneity on the Inference of Gene Regulatory Networks	PLOS ONE			English	Article							EXPRESSION DATA; ENTROPY ESTIMATION; NORMALIZATION	The inference of gene regulatory networks from gene expression data is a difficult problem because the performance of the inference algorithms depends on a multitude of different factors. In this paper we study two of these. First, we investigate the influence of discrete mutual information (MI) estimators on the global and local network inference performance of the C3NET algorithm. More precisely, we study 4 different MI estimators (Empirical, Miller-Madow, Shrink and Schurmann-Grassberger) in combination with 3 discretization methods (equal frequency, equal width and global equal width discretization). We observe the best global and local inference performance of C3NET for the Miller-Madow estimator with an equal width discretization. Second, our numerical analysis can be considered as a systems approach because we simulate gene expression data from an underlying gene regulatory network, instead of making a distributional assumption to sample thereof. We demonstrate that despite the popularity of the latter approach, which is the traditional way of studying MI estimators, this is in fact not supported by simulated and biological expression data because of their heterogeneity. Hence, our study provides guidance for an efficient design of a simulation study in the context of network inference, supporting a systems approach.	[Simoes, Ricardo de Matos; Emmert-Streib, Frank] Queens Univ Belfast, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland	Queens University Belfast	Simoes, RD (corresponding author), Queens Univ Belfast, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland.	v@bio-complexity.com	Conceição, Teresa/M-3449-2014; Emmert-Streib, Frank/AAF-2878-2020; da Costa, Paulo Martins/C-3080-2014; Emmert-Streib, Frank/G-8099-2011	Conceição, Teresa/0000-0002-9818-2767; Emmert-Streib, Frank/0000-0003-0745-5641; da Costa, Paulo Martins/0000-0001-6115-8811; Emmert-Streib, Frank/0000-0003-0745-5641; /0000-0001-6816-8932; de Matos Simoes, Ricardo/0000-0002-1700-5276; Antunes, Filipa/0000-0002-8472-078X; Aires-de-Sousa, Marta/0000-0001-5036-2446	Engineering and Physical Sciences Research Council (EPSRC); EPSRC [EP/H048871/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H048871/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Part of this work has been supported by the Engineering and Physical Sciences Research Council (EPSRC). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 1955, AM DOCUMENTATION PRE, V6, P93, DOI [10.1002/, DOI 10.1002/ASI.5090060209]; Almudevar Anthony, 2006, NeuroRx, V3, P384, DOI 10.1016/j.nurx.2006.05.037; Alon U, 2007, INTRO SYSTEMS BIOL D; Altay G, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-31; Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bulashevska S, 2005, BIOINFORMATICS, V21, P2706, DOI 10.1093/bioinformatics/bti388; Butte A J, 2000, Pac Symp Biocomput, P418; Cover T. M, 2006, ELEMENTS INFORM THEO, V2nd, DOI 10.1002/0471200611; Csardi N., 2006, INT J COMP SYST, V1695, P1; Dehmer M, APPL STAT NETWORK BI; Dudoit S, 2008, SPRINGER SER STAT, P1; Emmert-Streib F, 2010, IET SYST BIOL, V4, P277, DOI 10.1049/iet-syb.2010.0028; Emmert-Streib F, 2011, WIRES SYST BIOL MED, V3, P379, DOI 10.1002/wsbm.134; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; Harrell, 2010, HMISC HARRELL MISCEL; Hausser J, 2009, J MACH LEARN RES, V10, P1469; Husmeier D, 2003, BIOINFORMATICS, V19, P2271, DOI 10.1093/bioinformatics/btg313; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Khan S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026209; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; LI WT, 1990, J STAT PHYS, V60, P823, DOI 10.1007/BF01025996; Liang KC, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/253894; Liang S, 1998, Pac Symp Biocomput, P18; Luo WJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-467; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Miller GA., 1955, INF THEORY PSYCHOL P, V2, P95; Nemenman I, 2002, ADV NEURAL INFORM PR, V14, P569; Olsen C, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/308959; Palsson B O, 2006, SYSTEMS BIOL; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; R Core Team, 2021, R LANG ENV STAT COMP; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Scheines R., 2000, CAUSATION PREDICTION; Schurmann T, 1996, CHAOS, V6, P414, DOI 10.1063/1.166191; Shannon CE., 1949, MATH THEORY COMMUNIC; Sheskin D., 2011, HDB PARAMETRIC NONPA, V5th; Steinhoff C, 2006, BRIEF BIOINFORM, V7, P166, DOI 10.1093/bib/bbl002; Stolovitzky G, REVERSE ENG BIOL NET; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Stouffer S. A., 1949, AM SOLDIER, V1; Van den Bulcke T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-43; Verma T, 1990, P 4 WORKSH UNC ART I, P352; Vidal M, 2009, FEBS LETT, V583, P3891, DOI 10.1016/j.febslet.2009.11.024; von Bertalanffy Ludwig, 1950, BRIT J PHILOS SCI, V1, P134, DOI [DOI 10.1093/BJPS/I.2.134, 10.1093/bjps/I.2.134]; VONBERTALANFFY L, 1950, SCIENCE, V111, P23, DOI 10.1126/science.111.2872.23; Watkinson J, 2009, ANN NY ACAD SCI, V1158, P302, DOI 10.1111/j.1749-6632.2008.03757.x; Xing B, 2005, BIOINFORMATICS, V21, P4007, DOI 10.1093/bioinformatics/bti648; Yang Y, 2001, P EMCL 01 P 12 EUR C	56	74	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29279	10.1371/journal.pone.0029279	http://dx.doi.org/10.1371/journal.pone.0029279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242113	Green Published, gold, Green Submitted			2022-12-25	WOS:000300677000024
J	Simoes, RR; Aires-de-Sousa, M; Conceicao, T; Antunes, F; da Costa, PM; de Lencastre, H				Simoes, Romeo Rocha; Aires-de-Sousa, Marta; Conceicao, Teresa; Antunes, Filipa; da Costa, Paulo Martins; de Lencastre, Herminia			High Prevalence of EMRSA-15 in Portuguese Public Buses: A Worrisome Finding	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; PCR STRATEGY; COMMUNITY; STRAINS; CLONE; MRSA; TRANSPORT; INFECTIONS; EMERGENCE	Background: The nosocomial prevalence of methicillin resistant Staphylococcus aureus (MRSA) in Portugal remains one of highest in Europe and is currently around 50%. Transmission of S. aureus, including MRSA, occurs principally by direct human-to-human skin contact. However, S. aureus can survive for long periods on inanimate objects, which may represent an important reservoir for dissemination as well. Methodology/Principal Findings: Between May 2009 and February 2010, handrails of 85 public urban buses circulating in Oporto, Portugal, were screened for the occurrence of MRSA. Twenty-two (26%) buses showed MRSA contamination. The molecular characterization of a total of 55 MRSA, by pulsed-field gel electrophoresis (PFGE), staphylococcal cassette chromosome (SCC) mec typing, spa typing, and multilocus sequence typing (MLST), clustered the isolates into three clonal types. However, the overwhelming majority (n = 50; 91%) of the isolates belonged to a single clone (PFGE A, spa types t747, t032, t025 or t020, ST22, SCCmec type IVh) that exhibits the characteristics of the pandemic EMRSA-15, currently the major lineage circulating in Portuguese hospitals, namely in the Oporto region. Two additional clones were found but in much lower numbers: (i) PFGE B, ST5, spa type t002, SCCmec IVa (n = 3), and (ii) PFGE C, spa type t008, ST8, SCCmec IVa (n = 2). None of the 55 isolates was PVL positive. Conclusions/Significance: Public buses in Oporto seem to be an important reservoir of MRSA of nosocomial origin, providing evidence that the major hospital-associated MRSA clone in Portugal is escaping from the primary ecological niche of hospitals to the community environment. Infection control measures are urgently warranted to limit the spread of EMRSA-15 to the general population and future studies are required to assess the eventual increase of MRSA in the Portuguese community, which so far remains low.	[Simoes, Romeo Rocha; Conceicao, Teresa; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Simoes, Romeo Rocha; Antunes, Filipa; da Costa, Paulo Martins] Univ Porto, Inst Ciencias Biomed Abel Salazar, Oporto, Portugal; [Aires-de-Sousa, Marta] Escola Super Saude Cruz Vermelha Portuguesa, Lisbon, Portugal; [da Costa, Paulo Martins] CIIMAR Ctr Interdisciplinar Invest Marinha & Ambi, Oporto, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Universidade Nova de Lisboa; Universidade do Porto; Universidade do Porto; Rockefeller University	Simoes, RR (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal.	lencash@mail.rockefeller.edu	Conceição, Teresa/M-3449-2014; Emmert-Streib, Frank/AAF-2878-2020; da Costa, Paulo Martins/C-3080-2014; Emmert-Streib, Frank/G-8099-2011	Conceição, Teresa/0000-0002-9818-2767; Emmert-Streib, Frank/0000-0003-0745-5641; da Costa, Paulo Martins/0000-0001-6115-8811; Emmert-Streib, Frank/0000-0003-0745-5641; /0000-0001-6816-8932; de Matos Simoes, Ricardo/0000-0002-1700-5276; Antunes, Filipa/0000-0002-8472-078X; Aires-de-Sousa, Marta/0000-0001-5036-2446	European Community [TROCAR-HEALTH-F3-2008-223031, 095/BI-BI/2010]; EPSRC [EP/H048871/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H048871/1] Funding Source: researchfish	European Community(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was partially supported by Project TROCAR (TROCAR-HEALTH-F3-2008-223031) from the European Community to HL and by grant 095/BI-BI/2010 from the same Project to T. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Aires-De-Sousa M, 2007, APPL ENVIRON MICROB, V73, P3845, DOI 10.1128/AEM.00019-07; Allen KD, 1997, J HOSP INFECT, V35, P307, DOI 10.1016/S0195-6701(97)90225-5; Amorim ML, 2007, J CLIN MICROBIOL, V45, P2881, DOI 10.1128/JCM.00603-07; Bocher S, 2010, J ANTIMICROB CHEMOTH, V65, P717, DOI 10.1093/jac/dkq001; Cars O, 2001, LANCET, V357, P1851, DOI 10.1016/S0140-6736(00)04972-2; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; Clinical and Laboratory Standards Institute, 2018, METHODS DILUTION ANT, VEleventh; Conceicao T, 2011, EUR J CLIN MICROBIOL, V30, P293, DOI 10.1007/s10096-010-1087-8; Conceicao T, 2010, EUR J CLIN MICROBIOL, V29, P543, DOI 10.1007/s10096-010-0892-4; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; Faria NA, 2008, J CLIN MICROBIOL, V46, P136, DOI 10.1128/JCM.01684-07; Gonzalez BE, 2006, INFECT CONT HOSP EP, V27, P1051, DOI 10.1086/507923; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Kassem II, 2009, LETT APPL MICROBIOL, V48, P268, DOI 10.1111/j.1472-765X.2008.02518.x; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Manning N, 2004, J HOSP INFECT, V56, P250, DOI 10.1016/j.jhin.2003.12.021; McAdams RM, 2008, PEDIATR INT, V50, P810, DOI 10.1111/j.1442-200X.2008.02646.x; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Mollaghan AM, 2010, EPIDEMIOL INFECT, V138, P673, DOI 10.1017/S0950268810000191; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Neely AN, 2000, J CLIN MICROBIOL, V38, P724, DOI 10.1128/JCM.38.2.724-726.2000; O'Brien FG, 2004, J CLIN MICROBIOL, V42, P3185, DOI 10.1128/JCM.42.7.3185-3190.2004; Otter JA, 2009, LETT APPL MICROBIOL, V49, P803, DOI 10.1111/j.1472-765X.2009.02728.x; RAMALHINHO I, EVOLUCAO CONSUMO ANT; Roline CE, 2007, PREHOSP EMERG CARE, V11, P241, DOI 10.1080/10903120701205125; Sa-Leao R, 1999, J CLIN MICROBIOL, V37, P1913; Sa-Leao R, 2001, MICROB DRUG RESIST, V7, P237, DOI 10.1089/10766290152652783; Sexton JD, 2010, AM J INFECT CONTROL, V38, P368, DOI 10.1016/j.ajic.2010.01.004; Stepanovic S, 2008, LETT APPL MICROBIOL, V47, P339, DOI 10.1111/j.1472-765X.2008.02436.x; Tavares DA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-110; Tolba O, 2007, AM J INFECT CONTROL, V35, P342, DOI 10.1016/j.ajic.2006.10.015; Udo EE, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-31	36	74	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17630	10.1371/journal.pone.0017630	http://dx.doi.org/10.1371/journal.pone.0017630			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	22242113	Green Published, Green Submitted, gold			2022-12-25	WOS:000287933300037
J	Parnell, G; McLean, A; Booth, D; Huang, S; Nalos, M; Tang, B				Parnell, Grant; McLean, Anthony; Booth, David; Huang, Stephen; Nalos, Marek; Tang, Benjamin			Aberrant Cell Cycle and Apoptotic Changes Characterise Severe Influenza A Infection - A Meta-Analysis of Genomic Signatures in Circulating Leukocytes	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; VIRAL LOAD; IMMUNE; DEATH	Influenza A infection is a global disease that has been responsible for four pandemics over the last one hundred years. However, it remains poorly understood as to why some infected individuals succumb to life threatening complications whilst others recover and are relatively unaffected. Using gene-expression analysis of circulating leukocytes, here we show that the progression towards severe influenza A infection is characterised by an abnormal transcriptional reprogramming of cell cycle and apoptosis pathways. In severely infected humans, leukocyte gene-expression profiles display opposing cell cycle activities; an increased aberrant DNA replication in the G(1)/S phase yet delayed progression in the G(2)/M phase. In mild infection, cell cycle perturbations are fewer and are integrated with an efficient apoptotic program. Importantly, the loss of integration between cell cycle perturbations and apoptosis marks the transition from a mild viral illness to a severe, life threatening infection. Our findings suggest that circulating immune cells may play a significant role in the evolution of the host response. Further study may reveal alternative host response factors previously unrecognized in the current disease model of influenza.	[Parnell, Grant; McLean, Anthony; Huang, Stephen; Nalos, Marek; Tang, Benjamin] Univ Sydney, Nepean Hosp, Western Clin Sch, Dept Intens Care Med, Sydney, NSW 2006, Australia; [Booth, David] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia	Nepean Hospital; University of Sydney; University of Sydney; Westmead Institute for Medical Research	Parnell, G (corresponding author), Univ Sydney, Nepean Hosp, Western Clin Sch, Dept Intens Care Med, Sydney, NSW 2006, Australia.	gpar3109@uni.sydney.edu.au	Parnell, Grant/AAB-8155-2021; Huang, Stephen/O-6195-2019; Booth, David/A-7184-2012	Huang, Stephen/0000-0003-2518-0506; Booth, David/0000-0002-3801-0488; Parnell, Grant/0000-0002-2898-0253; Nalos, Marek/0000-0002-7977-9410	Nepean Institute of Critical Care Education and Research; Nepean Medical Research Foundation	Nepean Institute of Critical Care Education and Research; Nepean Medical Research Foundation	This work was supported by the Nepean Institute of Critical Care Education and Research and Nepean Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Gandhi KS, 2010, HUM MOL GENET, V19, P2134, DOI 10.1093/hmg/ddq090; Heilman DW, 2005, CELL CYCLE, V4, P560; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; MEUNIER I, 2009, CRIT CARE MED S, V38; Nagata K, 2008, REV MED VIROL, V18, P247, DOI 10.1002/rmv.575; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; *WHO, 2010, WHO INFL FACT SHEETS; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	21	70	74	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e17186	10.1371/journal.pone.0017186	http://dx.doi.org/10.1371/journal.pone.0017186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21826236	Green Published, Green Submitted, gold			2022-12-25	WOS:000288170000015
J	Anderson, SC; Flemming, JM; Watson, R; Lotze, HK				Anderson, Sean C.; Flemming, Joanna Mills; Watson, Reg; Lotze, Heike K.			Rapid Global Expansion of Invertebrate Fisheries: Trends, Drivers, and Ecosystem Effects	PLOS ONE			English	Article							SEA-URCHIN FISHERIES; TROPHIC-LEVEL; FOOD WEBS; MANAGEMENT; COMMUNITIES; DEPLETION; COLLAPSE; RECOVERY; DECLINE; SCALE	Background: Worldwide, finfish fisheries are receiving increasing assessment and regulation, slowly leading to more sustainable exploitation and rebuilding. In their wake, invertebrate fisheries are rapidly expanding with little scientific scrutiny despite increasing socio-economic importance. Methods and Findings: We provide the first global evaluation of the trends, drivers, and population and ecosystem consequences of invertebrate fisheries based on a global catch database in combination with taxa-specific reviews. We also develop new methodologies to quantify temporal and spatial trends in resource status and fishery development. Since 1950, global invertebrate catches have increased 6-fold with 1.5 times more countries fishing and double the taxa reported. By 2004, 34% of invertebrate fisheries were over-exploited, collapsed, or closed. New fisheries have developed increasingly rapidly, with a decrease of 6 years (+/-3 years) in time to peak from the 1950s to 1990s. Moreover, some fisheries have expanded further and further away from their driving market, encompassing a global fishery by the 1990s. 71% of taxa (53% of catches) are harvested with habitat-destructive gear, and many provide important ecosystem functions including habitat, filtration, and grazing. Conclusions: Our findings suggest that invertebrate species, which form an important component of the basis of marine food webs, are increasingly exploited with limited stock and ecosystem-impact assessments, and enhanced management attention is needed to avoid negative consequences for ocean ecosystems and human well-being.	[Anderson, Sean C.; Lotze, Heike K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Flemming, Joanna Mills] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada; [Watson, Reg] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada	Dalhousie University; Dalhousie University; University of British Columbia	Anderson, SC (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	sean.anderson@dal.ca	Watson, Reg A/F-4850-2012; Anderson, Sean C./AFN-3267-2022	Watson, Reg A/0000-0001-7201-8865; Anderson, Sean C./0000-0001-9563-1937; Mills Flemming, Joanna/0000-0002-3517-3089; Watson, Jolanta/0000-0002-5027-9025; Lotze, Heike/0000-0001-6258-1304; Watson, Gregory/0000-0001-9843-9211	Natural Sciences and Engineering Research Council of Canada; Sloan Foundation (Census of Marine Life, Future of Marine Animal Populations); University of British Columbia; Pew Environment Group; National Science Foundation; Gordon and Betty Moore Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Sloan Foundation (Census of Marine Life, Future of Marine Animal Populations)(Alfred P. Sloan Foundation); University of British Columbia; Pew Environment Group; National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	Financial support is acknowledged from the Natural Sciences and Engineering Research Council of Canada with grants to HKL and JMF; the Sloan Foundation (Census of Marine Life, Future of Marine Animal Populations) with grants to HKL; and the Sea Around Us Project, a scientific collaboration between the University of British Columbia and the Pew Environment Group. This project was part of a National Center for Ecological Analysis and Synthesis working group funded by the National Science Foundation and the Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON SC, 2010, FISH FISH IN PRESS; Anderson SC, 2008, CAN J FISH AQUAT SCI, V65, P2553, DOI 10.1139/F08-156; Andrew NL, 2002, OCEANOGR MAR BIOL, V40, P343; [Anonymous], 2005, DISCARDS WORLDS MARI; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Botsford LW, 2004, CAN J FISH AQUAT SCI, V61, P1325, DOI 10.1139/F04-131; Breen PA, 1997, MAR FRESHWATER RES, V48, P1103, DOI 10.1071/MF97141; Castilla JC, 1998, ECOL APPL, V8, pS124, DOI 10.1890/1051-0761(1998)8[S124:SBFICO]2.0.CO;2; Essington TE, 2006, P NATL ACAD SCI USA, V103, P3171, DOI 10.1073/pnas.0510964103; *FAO, 2008, 516 UN FAO; FAO, 2009, STAT WORLD FISH AQ 2; Ferdouse F., 2004, ADV SEA CUCUMBER AQU, V463, P425; FROESE R, 2000, FISHBASE 2000 CONCEP; Hiddink JG, 2006, CAN J FISH AQUAT SCI, V63, P721, DOI 10.1139/F05-266; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jamieson G. S., 1998, CANADIAN SPECIAL PUB; JAMIESON GS, 1993, AM ZOOL, V33, P551; Kaiser MJ, 2006, MAR ECOL PROG SER, V311, P1, DOI 10.3354/meps311001; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; Leiva GE, 2002, REV FISH BIOL FISHER, V11, P283; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; NEWELL RIE, 1988, ADV CHESAPEAKE BAY R, P29; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pauly D, 2008, J BIOL RES-THESSALON, V9, P3; Perry RI, 1999, REV FISH BIOL FISHER, V9, P125, DOI 10.1023/A:1008946522213; Peterson CH, 2003, MAR ECOL PROG SER, V264, P249, DOI 10.3354/meps264249; PHILLIPS BF, 2007, FISHERIES MANAGEMENT, P231; Salomon AK, 2007, ECOL APPL, V17, P1752, DOI 10.1890/06-1369.1; Sethi SA, 2010, P NATL ACAD SCI USA, V107, P12163, DOI 10.1073/pnas.1003236107; Shepherd SA, 1998, J SHELLFISH RES, V17, P839; Tegner MJ, 2000, ICES J MAR SCI, V57, P579, DOI 10.1006/jmsc.2000.0715; Tillin HM, 2006, MAR ECOL PROG SER, V318, P31, DOI 10.3354/meps318031; Uthicke S, 2001, J EXP MAR BIOL ECOL, V265, P153, DOI 10.1016/S0022-0981(01)00329-X; Watson R, 2005, MAR POLICY, V29, P281, DOI 10.1016/j.marpol.2004.06.006; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; ZELLER D, 2007, RECONSTRUCTION MARIN, V15; [No title captured]	39	174	179	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2011	6	3							e14735	10.1371/journal.pone.0014735	http://dx.doi.org/10.1371/journal.pone.0014735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FI	21935401	Green Published, gold, Green Submitted			2022-12-25	WOS:000288170000001
J	Li, J; Chen, CS; Chen, CH; He, QH; Li, H; Li, J; Moyzis, RK; Xue, G; Dong, Q				Li, Jin; Chen, Chuansheng; Chen, Chunhui; He, Qinghua; Li, He; Li, Jun; Moyzis, Robert K.; Xue, Gui; Dong, Qi			Neurotensin Receptor 1 Gene (NTSR1) Polymorphism Is Associated with Working Memory	PLOS ONE			English	Article							PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; CORTICAL DOPAMINE; SCHIZOPHRENIA; LOCALIZATION; EXPRESSION; NEURONS; BRAIN; ENDOPHENOTYPE; STIMULATION	Background: Recent molecular genetics studies showed significant associations between dopamine-related genes (including genes for dopamine receptors, transporters, and degradation) and working memory, but little is known about the role of genes for dopamine modulation, such as those related to neurotensin (NT), in working memory. A recent animal study has suggested that NT antagonist administration impaired working memory in a learning task. The current study examined associations between NT genes and working memory among humans. Methods: Four hundred and sixty healthy undergraduate students were assessed with a 2-back working memory paradigm. 5 SNPs in the NTSR1 gene were genotyped. 5 ANOVA tests were conducted to examine whether and how working memory differed by NTSR1 genotype, with each SNP variant as the independent variable and the average accuracy on the working memory task as the dependent variable. Results: ANOVA results suggested that two SNPs in the NTSR1 gene (rs4334545 and rs6090453) were significantly associated with working memory. These results survived corrections for multiple comparisons. Conclusions: Our results demonstrated that NTSR1 SNP polymorphisms were significantly associated with variance in working memory performance among healthy adults. This result extended previous rodent studies showing that the NT deficiency impairs the working memory function. Future research should replicate our findings and extend to an examination of other dopamine modulators.	[Li, Jin; Chen, Chunhui; He, Qinghua; Li, He; Li, Jun; Xue, Gui; Dong, Qi] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Li, Jin; Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA; [He, Qinghua; Xue, Gui] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Moyzis, Robert K.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA	Beijing Normal University; University of California System; University of California Irvine; University of Southern California; University of California System; University of California Irvine	Li, J (corresponding author), Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	cschen@uci.edu; dongqi@bnu.edu.cn	Xue, Gui/A-1762-2009; He, Qinghua/B-2573-2008	Xue, Gui/0000-0001-7891-8151; He, Qinghua/0000-0001-6396-6273; li, jin/0000-0002-4413-5746; Chen, Chuansheng/0000-0002-8224-1005	Ministry of Education of China [B07008]	Ministry of Education of China(Ministry of Education, China)	This research was supported by the 111 Project from the Ministry of Education of China (B07008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MJ, 1998, J COMP NEUROL, V402, P475; Ando J, 2001, BEHAV GENET, V31, P615, DOI 10.1023/A:1013353613591; Austin J, 2000, MOL PSYCHIATR, V5, P552, DOI 10.1038/sj.mp.4000761; Azmi N, 2006, BEHAV PHARMACOL, V17, P357, DOI 10.1097/01.fbp.0000224382.63744.20; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Binder EB, 2001, PHARMACOL REV, V53, P453; Binder EB, 2001, J NEUROSCI, V21, P601, DOI 10.1523/JNEUROSCI.21-02-00601.2001; Boudin H, 1996, J COMP NEUROL, V373, P76; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Castner SA, 2000, SCIENCE, V287, P2020, DOI 10.1126/science.287.5460.2020; Fatigati MD, 2000, BRAIN RES, V876, P196, DOI 10.1016/S0006-8993(00)02654-8; Froehlich TE, 2007, BIOL PSYCHIAT, V62, P243, DOI 10.1016/j.biopsych.2006.09.039; Glahn DC, 2003, BIOL PSYCHIAT, V53, P624, DOI 10.1016/S0006-3223(02)01641-4; Hamid EH, 2002, BIOL PSYCHIAT, V51, P795, DOI 10.1016/S0006-3223(01)01325-7; HETIER E, 1988, N-S ARCH PHARMACOL, V337, P13; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huezo-Diaz P, 2004, SCHIZOPHR RES, V66, P193, DOI 10.1016/S0920-9964(03)00128-2; Jomphe C, 2006, EUR J NEUROSCI, V24, P2789, DOI 10.1111/j.1460-9568.2006.05151.x; Kimberg DY, 2003, NEUROPSYCHOLOGIA, V41, P1020, DOI 10.1016/S0028-3932(02)00317-2; Kondo H, 2004, NEUROIMAGE, V23, P670, DOI 10.1016/j.neuroimage.2004.06.014; Kremen WS, 2007, NEUROPSYCHOLOGY, V21, P569, DOI 10.1037/0894-4105.21.5.569; LAMBERT PD, 1995, ANN NY ACAD SCI, V757, P377, DOI 10.1111/j.1749-6632.1995.tb17496.x; LAURENT P, 1994, MAMM GENOME, V5, P303, DOI 10.1007/BF00389545; Le F, 1997, J BIOL CHEM, V272, P1315, DOI 10.1074/jbc.272.2.1315; Lee YS, 1999, SCHIZOPHR RES, V36, P92; Liang YQ, 2010, NEUROPHARMACOLOGY, V58, P1199, DOI 10.1016/j.neuropharm.2010.02.015; MAI JK, 1987, NEUROSCIENCE, V22, P499, DOI 10.1016/0306-4522(87)90349-6; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Mizumoto Y, 1997, MOL CELL ENDOCRINOL, V135, P129, DOI 10.1016/S0303-7207(97)00195-0; Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Ohinata K, 2007, PEPTIDES, V28, P1470, DOI 10.1016/j.peptides.2007.06.002; Petkova-Kirova P, 2008, NEUROCHEM INT, V53, P355, DOI 10.1016/j.neuint.2008.08.010; Prus AJ, 2007, BRAIN RES, V1184, P354, DOI 10.1016/j.brainres.2007.09.092; QUIRION R, 1983, PEPTIDES, V4, P609, DOI 10.1016/0196-9781(83)90005-0; QUIRION R, 1985, BRAIN RES, V327, P385, DOI 10.1016/0006-8993(85)91542-2; ROMPRE PP, 1992, EUR J PHARMACOL, V211, P295, DOI 10.1016/0014-2999(92)90384-G; Saperstein AM, 2006, SCHIZOPHRENIA BULL, V32, P498, DOI 10.1093/schbul/sbj072; SEROOGY KB, 1987, EXP BRAIN RES, V68, P277; SEUTIN V, 1989, NEUROPHARMACOLOGY, V28, P949, DOI 10.1016/0028-3908(89)90194-9; Sharma RP, 1997, AM J PSYCHIAT, V154, P1019; STUDLER JM, 1988, NEUROPEPTIDES, V11, P95, DOI 10.1016/0143-4179(88)90076-5; Tirado-Santiago G, 2006, BEHAV NEUROSCI, V120, P1093, DOI 10.1037/0735-7044.120.5.1093; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wright M, 2001, Twin Res, V4, P48, DOI 10.1375/1369052012146; Xue G, 2004, NEUROIMAGE, V22, P1, DOI 10.1016/j.neuroimage.2004.01.013; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104; Zhu B, 2010, MEMORY, V18, P543, DOI 10.1080/09658211.2010.487051	54	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17365	10.1371/journal.pone.0017365	http://dx.doi.org/10.1371/journal.pone.0017365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21738684	Green Published, gold			2022-12-25	WOS:000288025500012
J	Kim, SH; Lu, HF; Alano, CC				Kim, Sun Hee; Lu, Hua Fei; Alano, Conrad C.			Neuronal Sirt3 Protects against Excitotoxic Injury in Mouse Cortical Neuron Culture	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; POLY(ADP-RIBOSE) PAR POLYMER; APOPTOSIS-INDUCING FACTOR; NMDA RECEPTOR ACTIVATION; CEREVISIAE LIFE-SPAN; INDUCED CELL-DEATH; NAD(+) DEPLETION; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; CEREBRAL-ISCHEMIA	Background: Sirtuins (Sirt), a family of nicotinamide adenine nucleotide (NAD) dependent deacetylases, are implicated in energy metabolism and life span. Among the known Sirt isoforms (Sirt1-7), Sirt3 was identified as a stress responsive deacetylase recently shown to play a role in protecting cells under stress conditions. Here, we demonstrated the presence of Sirt3 in neurons, and characterized the role of Sirt3 in neuron survival under NMDA-induced excitotoxicity. Methodology/Principal Findings: To induce excitotoxic injury, we exposed primary cultured mouse cortical neurons to NMDA (30 mu M). NMDA induced a rapid decrease of cytoplasmic NAD (but not mitochondrial NAD) in neurons through poly (ADP-ribose) polymerase-1 (PARP-1) activation. Mitochondrial Sirt3 was increased following PARP-1 mediated NAD depletion, which was reversed by either inhibition of PARP-1 or exogenous NAD. We found that massive reactive oxygen species (ROS) produced under this NAD depleted condition mediated the increase in mitochondrial Sirt3. By transfecting primary neurons with a Sirt3 overexpressing plasmid or Sirt3 siRNA, we showed that Sirt3 is required for neuroprotection against excitotoxicity. Conclusions: This study demonstrated for the first time that mitochondrial Sirt3 acts as a prosurvival factor playing an essential role to protect neurons under excitotoxic injury.	[Kim, Sun Hee; Lu, Hua Fei; Alano, Conrad C.] Vet Affairs Med Ctr, Dept Neurol, San Francisco, CA 94121 USA; [Alano, Conrad C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Kim, SH (corresponding author), Vet Affairs Med Ctr, Dept Neurol, San Francisco, CA 94121 USA.	conrad.alano@ucsf.edu	Kim, Sun/GSN-4867-2022; Gaquerel, Emmanuel/I-2503-2014	Gaquerel, Emmanuel/0000-0003-0796-6417; Baldwin, Ian/0000-0001-5371-2974; Yon, Felipe/0000-0002-5667-873X; Gulati, Jyotasana/0000-0003-0163-1296	Department of Veterans Affairs; American Heart Association	Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association)	This work was supported by the Department of Veterans Affairs (CCA) and the American Heart Association (CCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alano CC, 2002, J NEUROCHEM, V80, P531, DOI 10.1046/j.0022-3042.2001.00738.x; Alano CC, 2007, J NEUROSCI RES, V85, P3378, DOI 10.1002/jnr.21479; Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Castilho RF, 1999, J NEUROCHEM, V72, P1394, DOI 10.1046/j.1471-4159.1999.721394.x; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Ciani E, 1996, BRAIN RES, V728, P1; Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624; Cooper HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004986; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Goebel DJ, 2006, J NEUROCHEM, V98, P1732, DOI 10.1111/j.1471-4159.2006.04065.x; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; Gwag BJ, 1997, NEUROSCIENCE, V77, P393, DOI 10.1016/S0306-4522(96)00473-3; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Halmosi R, 2001, MOL PHARMACOL, V59, P1497, DOI 10.1124/mol.59.6.1497; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kaundal RK, 2006, LIFE SCI, V79, P2293, DOI 10.1016/j.lfs.2006.07.034; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; KOH JY, 1995, SCIENCE, V268, P573, DOI 10.1126/science.7725105; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Liu D, 2008, ANN NY ACAD SCI, V1147, P275, DOI 10.1196/annals.1427.028; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; Mattson MP, 2002, NEUROMOL MED, V2, P215, DOI 10.1385/NMM:2:2:215; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; SOKOLOFF L, 1981, FED PROC, V40, P2311; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; TAO R, 2010, J CARDIOVASC PHARM; Tao R, 2007, BIOCHEM BIOPH RES CO, V363, P257, DOI 10.1016/j.bbrc.2007.08.041; Vergun O, 2001, J PHYSIOL-LONDON, V531, P147, DOI 10.1111/j.1469-7793.2001.0147j.x; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; YAN T, 2009, NEUROCHEM INT; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang YJ, 2010, J CELL BIOCHEM, V111, P1051, DOI 10.1002/jcb.22795; Ying WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P2728, DOI 10.2741/2267; Ying WH, 2001, P NATL ACAD SCI USA, V98, P12227, DOI 10.1073/pnas.211202598; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zelphati O, 2001, J BIOL CHEM, V276, P35103, DOI 10.1074/jbc.M104920200; Zeng JY, 2007, J CEREBR BLOOD F MET, V27, P304, DOI 10.1038/sj.jcbfm.9600335	71	166	176	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e14731	10.1371/journal.pone.0014731	http://dx.doi.org/10.1371/journal.pone.0014731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390294	Green Published, gold, Green Submitted			2022-12-25	WOS:000287932100001
